PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ng, J; Guo, ZJ; Mueller-Cajar, O				Ng, Jediael; Guo, Zhijun; Mueller-Cajar, Oliver			Rubisco activase requires residues in the large subunit N terminus to remodel inhibited plant Rubisco	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; POSTTRANSLATIONAL MODIFICATIONS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; OXYGENASE; PROTEIN; PHOSPHORYLATION; PHOTOSYNTHESIS; SUBSTITUTION; SPECIFICITY; EFFICIENCY	The photosynthetic CO2 fixing enzyme ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) forms dead-end inhibited complexes while binding multiple sugar phosphates, including its substrate ribulose 1,5-bisphosphate. Rubisco can be rescued from this inhibited form by molecular chaperones belonging to the ATPases associated with diverse cellular activities (AAA+ proteins) termed Rubisco activases (Rcas). The mechanism of green-type Rca found in higher plants has proved elusive, in part because until recently higher-plant Rubiscos could not be expressed recombinantly. Identifying the interaction sites between Rubisco and Rca is critical to formulate mechanistic hypotheses. Toward that end here we purify and characterize a suite of 33 Arabidopsis Rubisco mutants for their ability to be activated by Rca. Mutation of 17 surface-exposed large subunit residues did not yield variants that were perturbed in their interaction with Rca. In contrast, we find that Rca activity is highly sensitive to truncations and mutations in the conserved N terminus of the Rubisco large subunit. Large subunits lacking residues 1-4 are functional Rubiscos but cannot be activated. Both T5A and T7A substitutions result in functional carboxylases that are poorly activated by Rca, indicating the side chains of these residues form a critical interaction with the chaperone. Many other AAA+ proteins function by threading macromolecules through a central pore of a disc-shaped hexamer. Our results are consistent with a model in which Rca transiently threads the Rubisco large subunit N terminus through the axial pore of the AAA+ hexamer.	[Ng, Jediael; Guo, Zhijun; Mueller-Cajar, Oliver] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mueller-Cajar, O (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	cajar@ntu.edu.sg	Mueller-Cajar, Oliver/A-7237-2018	Mueller-Cajar, Oliver/0000-0003-2866-5963	Ministry of Education of Singapore [MOE2016-T2-2-088]; National Research Foundation of Singapore [NRF2017-NRF-ISF002-2667]	Ministry of Education of Singapore(Ministry of Education, Singapore); National Research Foundation of Singapore(National Research Foundation, Singapore)	This work was funded by Grant MOE2016-T2-2-088 from the Ministry of Education of Singapore and Grant NRF2017-NRF-ISF002-2667 from the National Research Foundation of Singapore (to O. M.-C.).	AGGARWAL KK, 1993, PHYTOCHEMISTRY, V34, P329, DOI 10.1016/0031-9422(93)80004-C; Aigner H, 2017, SCIENCE, V358, P1272, DOI 10.1126/science.aap9221; Bar-On YM, 2019, P NATL ACAD SCI USA, V116, P4738, DOI 10.1073/pnas.1816654116; Bhat JY, 2017, MOL CELL, V67, P744, DOI 10.1016/j.molcel.2017.07.004; Bi XZ, 2018, APPL MICROBIOL BIOT, V102, P4159, DOI 10.1007/s00253-018-8886-8; Bracher A, 2017, ANNU REV PLANT BIOL, V68, P29, DOI 10.1146/annurev-arplant-043015-111633; Carmo-Silva E, 2015, PLANT CELL ENVIRON, V38, P1817, DOI 10.1111/pce.12425; Chen XH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-37; Flecken M., 2020, BIORXIV, DOI [10.1101/000000, DOI 10.1101/000000]; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; GUTTERIDGE S, 1986, FEBS LETT, V196, P263, DOI 10.1016/0014-5793(86)80260-5; Han H, 2017, ELIFE, V6, DOI 10.7554/eLife.31324; Hayer-Hartl M, 2020, TRENDS BIOCHEM SCI, V45, P748, DOI 10.1016/j.tibs.2020.05.001; Horecker B. L., 1958, BIOCHEM PREP, V6, P83; HOUTZ RL, 1992, PLANT PHYSIOL, V98, P1170, DOI 10.1104/pp.98.3.1170; HOUTZ RL, 1989, P NATL ACAD SCI USA, V86, P1855, DOI 10.1073/pnas.86.6.1855; Houtz RL, 2008, J EXP BOT, V59, P1635, DOI 10.1093/jxb/erm360; Kane HJ, 1998, PLANT PHYSIOL, V117, P1059, DOI 10.1104/pp.117.3.1059; Kubien DS, 2011, METHODS MOL BIOL, V684, P349, DOI 10.1007/978-1-60761-925-3_27; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; Lin M.T., 2019, BIORXIV, DOI [10.1101/562223, DOI 10.1101/562223]; Loganathan N, 2016, P NATL ACAD SCI USA, V113, P14019, DOI 10.1073/pnas.1610758113; Lohrig K, 2009, PLANTA, V229, P1123, DOI 10.1007/s00425-009-0901-y; Long SP, 2015, CELL, V161, P56, DOI 10.1016/j.cell.2015.03.019; Martin-Avila E, 2020, PLANT CELL, V32, P2898, DOI 10.1105/tpc.20.00288; Mininno M, 2012, J BIOL CHEM, V287, P21034, DOI 10.1074/jbc.M112.359976; Mueller-Cajar O, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00031; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; MULLIGAN RM, 1988, P NATL ACAD SCI USA, V85, P1513, DOI 10.1073/pnas.85.5.1513; Oltrogge LM, 2020, NAT STRUCT MOL BIOL, V27, P281, DOI 10.1038/s41594-020-0387-7; Ott CM, 2000, J BIOL CHEM, V275, P26241, DOI 10.1074/jbc.M004580200; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Puchades C, 2017, SCIENCE, V358, P609, DOI 10.1126/science.aao0464; Raven JA, 2013, NEW PHYTOL, V198, P1, DOI 10.1111/nph.12197; SALVUCCI ME, 1985, PHOTOSYNTH RES, V7, P193, DOI 10.1007/BF00037012; Satagopan S, 2004, J BIOL CHEM, V279, P14240, DOI 10.1074/jbc.M313215200; SCHREUDER HA, 1993, P NATL ACAD SCI USA, V90, P9968, DOI 10.1073/pnas.90.21.9968; Shivhare D, 2019, P NATL ACAD SCI USA, V116, P24041, DOI 10.1073/pnas.1914245116; Shivhare D, 2017, PLANT PHYSIOL, V174, P1505, DOI 10.1104/pp.17.00554; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Taylor TC, 2001, J BIOL CHEM, V276, P48159, DOI 10.1074/jbc.M107765200; Tsai YCC, 2020, P NATL ACAD SCI USA, V117, P381, DOI 10.1073/pnas.1911123117; Tsai YCC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9883; vandeLoo FJ, 1996, BIOCHEMISTRY-US, V35, P8143, DOI 10.1021/bi9604901; Wang H, 2019, NATURE, V566, P131, DOI 10.1038/s41586-019-0880-5; WANG ZY, 1992, PLANT PHYSIOL, V100, P1858, DOI 10.1104/pp.100.4.1858; Wilson RH, 2019, FEBS LETT, V593, P611, DOI 10.1002/1873-3468.13352; Wilson RH, 2018, J BIOL CHEM, V293, P18, DOI 10.1074/jbc.M117.810861; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE9560, DOI 10.1073/pnas.1810648115; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	58	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16427	16435		10.1074/jbc.RA120.015759	http://dx.doi.org/10.1074/jbc.RA120.015759			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32948656	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000598519500020
J	Gut, U				Gut, Urs			Assessing site signal preservation in reference chronologies for dendro-provenancing	PLOS ONE			English	Article							NORWAY SPRUCE; GROWTH-RESPONSE; TREE GROWTH; CLIMATE; TIMBER; SHIP; DENDROCHRONOLOGY; GRADIENT; OAK; NETHERLANDS	Regional differences in tree growth can be used to approximate the geographical provenance of ring-width series ('dendro-provenancing'). This method relies on cross-dated ring-width series (reference chronologies) that are thought to represent the radial growth signal of trees in a given region. Reference chronologies are often established from ring-width series of living tree populations. Frequently, they are too short to allow for investigating the provenance of historical wood. Thus, references are extended by ring-width series from buildings and art-historical objects that exhibit best matching growth patterns with the living tree references. Yet, series from other provenances may erroneously be included. Thereby the local or regional growth signal of the references is progressively contaminated, but this has received little attention to date. I investigate this contamination risk using a simulation approach that allows for generating pseudo site chronologies that preserve the relevant statistical properties of the real site chronologies. While the exact provenance of historical wood is unknown, for simulated ring-width series the provenance is unambiguous. Hence, pseudo reference chronologies may be established while monitoring the signal mixture. Specifically, 15 site chronologies of Norway spruce (Picea abies(L.) H. Karst.) from northeastern Switzerland were used to generate 15 pseudo site growth signals that span 1000 years. The simulation demonstrates that quasi uncontaminated references can be established in ideal circumstances for the study area. However, the thresholds for the similarity in between-series correlation must be very high. Even then, contaminated pseudo references occurred in rare cases during the simulation. Yet, elevation-specific pseudo references were established with lower thresholds. Simulation currently offers the only approach for assessing the contamination risk of reference chronologies, and it allows for elucidating the conditions under which acceptable levels of contamination can be guaranteed. Therefore, the present approach paves the way towards a practical simulation tool for dendro-provenancing.	[Gut, Urs] Univ Zurich, Inst Archaol, Fachbereich Prahist Archaol, Zurich, Switzerland; [Gut, Urs] Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Terr Ecosyst, Forest Ecol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gut, U (corresponding author), Univ Zurich, Inst Archaol, Fachbereich Prahist Archaol, Zurich, Switzerland.; Gut, U (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Terr Ecosyst, Forest Ecol, Zurich, Switzerland.	u.gut@posteo.de			Swiss National Science Foundation [P0ZHP1_162299]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was financially supported by the Swiss National Science Foundation, grant no. P0ZHP1_162299. There was no additional external or internal funding received for this study.	Abanda A, 2019, DATA MIN KNOWL DISC, V33, P378, DOI 10.1007/s10618-018-0596-4; Afifi TO, 2010, CLIN PSYCHOL REV, V30, P101, DOI 10.1016/j.cpr.2009.10.002; [Anonymous], 1996, TREE RINGS ENV DENDR; [Anonymous], 1985, TIME SERIES ANAL APP; Arbeitskreis fur Hausforschung, 2007, ARBEITSKREIS HAUSFOR, P23; Babst F, 2018, QUATERNARY SCI REV, V197, P1, DOI 10.1016/j.quascirev.2018.07.009; BAILLIE M G L, 1973, Tree-Ring Bulletin, V33, P7; Bernabei M, 2011, J CULT HERIT, V12, P196, DOI 10.1016/j.culher.2010.12.001; Billamboz A, 2014, HOLOCENE, V24, P1278, DOI 10.1177/0959683614540956; Bleicher N, 2014, AGR PASTROL LANDSCAP, P239; Bleicher N, 2018, ANTIQUITY, V92, P1210, DOI 10.15184/aqy.2018.109; Bridge M, 2012, J ARCHAEOL SCI, V39, P2828, DOI 10.1016/j.jas.2012.04.028; Bridges M. C., 2000, VERNAC ARCHIT, V31, P67; Bunn AG, 2008, DENDROCHRONOLOGIA, V26, P115, DOI 10.1016/j.dendro.2008.01.002; Cook E.R., 2013, METHODS DENDROCHRONO; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Creasman PP, 2015, DENDROCHRONOLOGIA, V33, P8, DOI 10.1016/j.dendro.2014.10.001; Daly A, 2008, INT J NAUT ARCHAEOL, V37, P153, DOI 10.1111/j.1095-9270.2007.00157.x; Daly A, 2007, INT J NAUT ARCHAEOL, V36, P155, DOI 10.1111/j.1095-9270.2006.00103.x; Dittmar C, 2012, DENDROCHRONOLOGIA, V30, P73, DOI 10.1016/j.dendro.2011.01.013; Dominguez-Delmas M, 2018, J ARCHAEOL SCI, V95, P64, DOI 10.1016/j.jas.2018.05.002; Dominguez-Delmas M, 2014, J ARCHAEOL SCI, V41, P642, DOI 10.1016/j.jas.2013.09.009; Drake BL, 2018, DENDROCHRONOLOGIA, V47, P38, DOI 10.1016/j.dendro.2017.12.004; Eckstein D., 2007, P S TREE RINGS ARCH, V5, P8; Ei&beta;ing T., 2011, TREE RINGS ART ARCHA, P137; Eissing T., 2010, KONSUM KULTURLANDSCH, P87; Fowler AM, 2017, DENDROCHRONOLOGIA, V44, P84, DOI 10.1016/j.dendro.2017.04.003; Fowler AM, 2017, DENDROCHRONOLOGIA, V42, P51, DOI 10.1016/j.dendro.2016.12.006; Fowler AM, 2015, DENDROCHRONOLOGIA, V35, P24, DOI 10.1016/j.dendro.2015.05.008; Fraiture P, 2009, DENDROCHRONOLOGIA, V27, P95, DOI 10.1016/j.dendro.2009.06.002; Frank David, 2005, Dendrochronologia, V22, P107, DOI 10.1016/j.dendro.2005.02.004; FRITTS HC, 1972, SCI AM, V226, P92, DOI 10.1038/scientificamerican0572-92; Garcia-Gonzalez I, 2008, TREE-RING RES, V64, P27, DOI 10.3959/2007-2.1; Gennaretti F, 2017, CLIM DYNAM, V49, P4107, DOI 10.1007/s00382-017-3565-5; Grabner M, 2018, INT J ARCHIT HERIT, V12, P178, DOI 10.1080/15583058.2017.1372824; Gut U, 2018, DENDROCHRONOLOGIA, V52, P131, DOI 10.1016/j.dendro.2018.09.008; Haneca K, 2005, J ARCHAEOL SCI, V32, P261, DOI 10.1016/j.jas.2004.09.005; Hellmann L, 2017, QUATERNARY SCI REV, V162, P1, DOI 10.1016/j.quascirev.2017.02.025; Hollstein E, 1980, MITTELEUROPAISCHE EI; Jansma E, 2014, J ARCHAEOL SCI, V50, P484, DOI 10.1016/j.jas.2014.07.019; Kagawa A, 2010, J WOOD SCI, V56, P175, DOI 10.1007/s10086-009-1085-6; Karanitsch-Ackerl S, 2017, DENDROCHRONOLOGIA, V45, P39, DOI 10.1016/j.dendro.2017.06.004; Kaya H, 2015, INFORM SYST, V51, P27, DOI 10.1016/j.is.2015.02.005; King GM, 2013, OECOLOGIA, V173, P1587, DOI 10.1007/s00442-013-2696-6; Kolar T, 2017, AGR FOREST METEOROL, V239, P24, DOI 10.1016/j.agrformet.2017.02.028; Konig J, 2007, TREE RINGS ARCHEOLOG; Lyu LX, 2017, BIOGEOSCIENCES, V14, P3083, DOI 10.5194/bg-14-3083-2017; Martin-Benito D, 2014, TREE-RING RES, V70, P65, DOI 10.3959/1536-1098-70.2.65; Parker, 1979, INTRO STAT BIOL; Pearson K., 1895, Proceedings of the Royal Society London, Vlviii, P240; R Core Team, 2021, R LANGUAGE ENV STAT; Rich SA, 2013, THESIS; Ripley B.D., 1987, STOCHASTIC SIMULATIO; Rodriguez-Trobajo E, 2015, J ARCHAEOL SCI, V54, P148, DOI 10.1016/j.jas.2014.11.039; Savva Y, 2006, TREES-STRUCT FUNCT, V20, P735, DOI 10.1007/s00468-006-0088-9; Speer JH, 2010, FUNDAMENTALS TREE RI; Stock J. H., 2015, INTRO ECONOMETRICS, V3rd; Taormina R, 2016, TREE-RING RES, V72, P78, DOI 10.3959/1536-1098-72.02.78; Timber Daly A., 2007, THESIS; Venables WN., 2007, MODERN APPL STAT S; Wazny Tomasz, 2002, Dendrochronologia, V20, P313, DOI 10.1078/1125-7865-00024; Wilson R. J. S., 2001, Dendrochronologia, V19, P67; Wilson R, 2017, J ARCHAEOL SCI, V78, P99, DOI 10.1016/j.jas.2016.11.011; Xing Z., 2010, ACM SIGKDD EXPLOR NE, V12, P40, DOI DOI 10.1145/1882471.1882478	64	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239425	10.1371/journal.pone.0239425	http://dx.doi.org/10.1371/journal.pone.0239425			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970744	Green Published, Green Accepted, gold			2022-12-26	WOS:000576265600024
J	Toghyani, M; McQuade, LR; Mclnerney, BV; Moss, AF; Selle, PH; Liu, SY				Toghyani, M.; McQuade, L. R.; Mclnerney, B., V; Moss, A. F.; Selle, P. H.; Liu, S. Y.			Initial assessment of protein and amino acid digestive dynamics in protein-rich feedstuffs for broiler chickens	PLOS ONE			English	Article							APPARENT ILEAL DIGESTIBILITY; METABOLIZABLE ENERGY; SMALL-INTESTINE; STARCH; PERFORMANCE; INGREDIENTS; MEAT	A study evaluating apparent digestibilities of protein and amino acids and their corresponding digestion rates in four small intestinal sites in broiler chickens was completed to further investigate dietary optimisation via synchronised nutrient digestion and absorption. A total of 288 male Ross 308 broiler chickens were offered semi-purified diets with eight protein-rich feedstuffs, including; blood meal (BM), plasma protein meal (PPM), cold pressed (CCM) and expeller-pressed (ECM) canola meal, high (SBM HCP) and low (SBM LCP) crude protein soybean meals, lupins and peas. Diets were iso-caloric, iso-nitrogenous and the test ingredient was the sole source of dietary nitrogen. Each diet was offered to 6 bioassay cages with 6 birds per cage from day 21 to 28 post hatch. On day 28, all birds were euthanized and digesta samples were collected from the proximal jejunum, distal jejunum, proximal ileum and distal ileum to determine apparent protein and amino acids digestibility coefficients, digestion rates and potential digestible protein and amino acids. Dietary protein source significantly influenced energy utilisation, nitrogen retention, apparent protein (N) digestibilities, digestion rates and potential digestible protein along the small intestine. Diets containing BM and SBM LCP exhibited the highest protein digestion rate and potential digestible protein, respectively. Digestibility coefficients and disappearance rates of the majority of amino acids in four sections of the small intestine were influenced by dietary protein source (P < 0.01) and blood meal had the fastest protein digestion rate. In general, jejunal amino acid and protein digestibilities were more variable in comparison to ileal digestibilities, and the differences in protein and amino acid disappearance rates were more pronounced between types of feedstuffs than sources of similar feedstuffs.	[Toghyani, M.; Liu, S. Y.] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [Toghyani, M.; Selle, P. H.; Liu, S. Y.] Univ Sydney, Poultry Res Fdn, Camden, NSW, Australia; [McQuade, L. R.; Mclnerney, B., V] Macquarie Univ, Australian Proteome Anal Facil, Sydney, NSW, Australia; [Moss, A. F.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of Sydney; University of Sydney; Macquarie University; University of New England	Liu, SY (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.; Liu, SY (corresponding author), Univ Sydney, Poultry Res Fdn, Camden, NSW, Australia.	sonia.liu@sydney.edu.au		McInerney, Bernie/0000-0002-2097-4393; Moss, Amy/0000-0002-8647-8448; Toghyani, Mehdi/0000-0002-5065-1739	AgriFutures Chicken-meat [PRJ-010216]	AgriFutures Chicken-meat	The present study was funded by AgriFutures Chicken-meat (https://www.agrifutures.com.au/) PRJ-010216 "Formulating broiler diets based on protein and starch digestive dynamics" to author S.Y.L.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Black J. L., 2005, Proceedings of the 17th Australian Poultry Science Symposium, Sydney, New South Wales, Australia, 7-9 February 2005, P21; Cant JP, 1996, J ANIM SCI, V74, P2541; Classen H. L., 2004, Proceedings of the 16th Australian Poultry Science Symposium, Sydney, New South Wales, Australia, 9-11 February 2004, P1; Cohen SA, 2000, METH MOL B, V159, P39; Enting H., 2005, Proceedings of the 17th Australian Poultry Science Symposium, Sydney, New South Wales, Australia, 7-9 February 2005, P17; HILL FW, 1958, J NUTR, V64, P587, DOI 10.1093/jn/64.4.587; Huang KH, 2007, J SCI FOOD AGR, V87, P47, DOI 10.1002/jsfa.2667; JACKSON S, 1982, POULTRY SCI, V61, P2224, DOI 10.3382/ps.0612224; Jeroch H, 2016, EUR POULTRY SCI, V80, DOI 10.1399/eps.2016.125; Liu S, 2013, EUR S POULTR NUTR PO; Liu SY, 2017, ANIM PROD SCI, V57, P2250, DOI 10.1071/AN17296; Liu SY, 2015, WORLD POULTRY SCI J, V71, P297, DOI 10.1017/S0043933915000306; Liu SY, 2014, ANIM FEED SCI TECH, V197, P164, DOI 10.1016/j.anifeedsci.2014.08.005; Liu SY, 2013, ANIM PROD SCI, V53, P1033, DOI 10.1071/AN12364; Liu SY, 2019, P AUSTR POULTRY SCI, V30, P15; Liu SY, 2020, P AUST POULTRY SCI S, V31, P90; Macelline SP, 2020, ANIM NUTR; MARTINEZ V, 1995, AM J PHYSIOL-REG I, V269, pR445, DOI 10.1152/ajpregu.1995.269.2.R445; Moss AF, 2019, ANIM FEED SCI TECHNO, DOI [10.1016/j.anifeedsci.2019.05.011, DOI 10.1016/J.ANIFEEDSCI.2019.05.011]; ORSKOV ER, 1979, J AGR SCI, V92, P499, DOI 10.1017/S0021859600063048; Palander S, 2006, ANIM FEED SCI TECH, V127, P89, DOI 10.1016/j.anifeedsci.2005.07.003; Ravindran V, 2005, ANIM SCI, V81, P85, DOI 10.1079/ASC42240085; Ravindran V, 2002, AUST J AGR RES, V53, P1257, DOI 10.1071/AR02055; Rostagno H.S., 2017, BRAZILIAN TABLES POU, V3rd ed.; Selle PH, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10040729; SIRIWAN P, 1993, BRIT POULTRY SCI, V34, P939, DOI 10.1080/00071669308417654; Smith A, 2000, BRIT POULTRY SCI, V41, P598, DOI 10.1080/713654976; Toghyani M, 2015, POULTRY SCI, V94, P992, DOI 10.3382/ps/pev047; Truong HH, 2017, BRIT J NUTR, V118, P1031, DOI 10.1017/S0007114517003257; Truong HH, 2015, ANIM NUTR, V1, P220, DOI 10.1016/j.aninu.2015.08.002; WATFORD M, 1979, BIOCHEM J, V178, P589, DOI 10.1042/bj1780589; Weurding RE, 2001, J NUTR, V131, P2329, DOI 10.1093/jn/131.9.2329	33	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239156	10.1371/journal.pone.0239156	http://dx.doi.org/10.1371/journal.pone.0239156			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970742	gold, Green Published			2022-12-26	WOS:000576265600040
J	Eberle, JJ; von Koenigswald, W; Eberth, DA				Eberle, Jaelyn J.; von Koenigswald, Wighart; Eberth, David A.			Using tooth enamel microstructure to identify mammalian fossils at an Eocene Arctic forest	PLOS ONE			English	Article							EUREKA-SOUND-GROUP; ELLESMERE-ISLAND; CANADA; PERISSODACTYLA	Lower Eocene (Wasatchian-aged) sediments of the Margaret Formation on Ellesmere Island in Canada's High Arctic preserve evidence of a rainforest inhabited by alligators, turtles, and a diverse mammalian fauna. The mammalian fossils are fragmentary and often poorly preserved. Here, we offer an alternative method for their identification. Among the best preserved and extensive of the Eocene Arctic forests is the Strathcona Fiord Fossil Forest, which contains permineralizedin situtree stumps protruding from a prominent coal seam, but a paucity of vertebrate fossils. In 2010 and 2018, we recovered mammalian tooth fragments at the fossil forest, but they are so incomplete as to be undiagnostic by using their external morphology. We used a combination of light microscopy and SEM analysis to study the enamel microstructure of two tooth fragments from the fossil forest-NUFV2092B and 2092E. The results of our analysis indicate that NUFV2092B and 2092E haveCoryphodon-enamel, which is characterized by vertical bodies that manifest as bands of nested chevrons or treelike structures visible in the tangential section under light microscopy. This enamel type is not found in other mammals known from the Arctic. Additionally, when studied under SEM, the enamel of NUFV2092B and 2092E has rounded prisms that open to one side and are surrounded by interprismatic matrix that is nearly parallel to the prisms, which also occurs inCoryphodonenamel, based on prior studies. The tooth fragments reported here, along with some poorly preserved bone fragments, thus far are the only documented vertebrate fossils from the Strathcona Fiord Fossil Forest. However, fossils ofCoryphodonoccur elsewhere in the Margaret Formation, so its presence at the fossil forest is not surprising. What is novel in our study is the way in which we identified the fossils using their enamel microstructure.	[Eberle, Jaelyn J.] Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA; [Eberle, Jaelyn J.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [von Koenigswald, Wighart] Rheinische Friedrich Wilhelms Univ, Inst Geosci, Sect Palaeontol, Bonn, Germany; [Eberth, David A.] Royal Tyrrell Museum, Drumheller, AB, Canada	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Bonn	Eberle, JJ (corresponding author), Univ Colorado, Museum Nat Hist, Boulder, CO 80309 USA.; Eberle, JJ (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	Jaelyn.Eberle@Colorado.edu		EBERLE, JAELYN/0000-0001-6890-9112	National Science Foundation [ARC-0804627, DRL-1713552]; Deutscher Akademischer Austauschdienst German Academic Exchange Service (DAAD); University of Colorado Boulder Libraries Open Access Fund	National Science Foundation(National Science Foundation (NSF)); Deutscher Akademischer Austauschdienst German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Colorado Boulder Libraries Open Access Fund	The 2010 fieldwork that resulted in the discovery of the tooth fragments at the Strathcona Fiord Fossil Forest was supported by National Science Foundation grant ARC-0804627 to JJE (https://www.nsf.gov/).The 2018 fieldwork by JJE that recovered additional tooth fragments was made possible by support from the National Science Foundation Grant No. DRL-1713552 awarded to WGBH Educational Foundation (July 18, 2017) for the project entitled "Polar Extremes: Enhancing Experiential Digital Learning." Enamel microstructure analysis of the fossils by JJE and WvK at the University of Bonn, Germany was supported by an award to JJE from the Deutscher Akademischer Austauschdienst German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank colleagues at the Nunavut Government (A. Stubbing, S. LeBlanc) and the Canadian Museum of Nature (K. Shepherd, M. Currie) for loan of the fossils. Enamel microstructure analysis of the tooth fragments was carried out by J. Eberle and W. v. Koenigswald in the Paleontology Section of the Institute of Geosciences at the University of Bonn in Germany. We thank T. Martin, Chair of Palaeontology at the Institute of Geosciences at the University of Bonn, for allowing use of his enamel and imaging labs for preparation and imaging of the fossils. We also thank G. Oleschinski (Palaeontology, University of Bonn) and H.-J. Ensikat (Institut fur Biodiversitat der Pflanzen, University of Bonn) who worked with us to produce the SEM images. Careful reviews by K. Rose, K.C. Beard, an anonymous reviewer, and Academic Editor A. Csank improved the manuscript. Publication of this article was funded by the University of Colorado Boulder Libraries Open Access Fund.	Clemens WA, 1997, TOOTH ENAMEL MICROSTRUCTURE, P85; DACULSI G, 1984, CALCIFIED TISSUE INT, V36, P550, DOI 10.1007/BF02405364; Dawson Mary R., 2012, Swiss Journal of Palaeontology, V131, P11, DOI 10.1007/s13358-011-0028-1; DAWSON MR, 1976, SCIENCE, V192, P781, DOI 10.1126/science.192.4241.781; Eberle J, 2009, GEOLOGY, V37, P499, DOI 10.1130/G25633A.1; Eberle JJ, 2006, J VERTEBR PALEONTOL, V26, P381, DOI 10.1671/0272-4634(2006)26[381:EEBPFT]2.0.CO;2; Eberle JJ, 2015, CAN J EARTH SCI, V52, P123, DOI 10.1139/cjes-2014-0195; Eberle JJ, 2012, GEOL SOC AM BULL, V124, P3, DOI 10.1130/B30571.1; Eberle JJ, 2010, EARTH PLANET SC LETT, V296, P481, DOI 10.1016/j.epsl.2010.06.005; Eberle JJ, 2005, PALAEOGEOGR PALAEOCL, V227, P311, DOI 10.1016/j.palaeo.2005.06.008; Eberle JJ, 2002, CAN J EARTH SCI, V39, P899, DOI 10.1139/E02-001; Eberle JJ, 1999, J PALEONTOL, V73, P979, DOI 10.1017/S0022336000040828; Eberle JJ, 2019, AM MUS NOVIT, V3943, P1, DOI [10.1206/3943.1, DOI 10.1206/3943.1]; EFFINGER JA, 1998, EVOLUTION TERTIARY M, V1, P375; Fortelius M., 1985, ACTA ZOOL FENN, V180, P1; FRANCIS JE, 1988, ARCTIC, V41, P314, DOI 10.14430/arctic1738; Greely A. W., 1886, 3 YEARS ARCTIC SERVI, V2, P419; Harrison JC, 1999, B CAN PETROL GEOL, V47, P223; JOECKEL RM, 1990, PALEOBIOLOGY, V16, P459, DOI 10.1017/S0094837300010198; Koenigswald W.v., 1993, P303; Koenigswald W.v., 2011, ACTA PALAEONTOLONICA, V56, P1; Koenigswald Wighart V., 2005, Journal of Mammalian Evolution, V12, P419, DOI 10.1007/s10914-005-6970-1; Koenigswald Wighart v., 1994, Annals of the Carnegie Museum, V63, P49; KUMAGAI H, 1995, PALAEOGEOGR PALAEOCL, V116, P247, DOI 10.1016/0031-0182(94)00100-M; Martin T, 1997, TOOTH ENAMEL MICROSTRUCTURE, P163; Martin T., 1992, PALAEOVERTEBRATA MEM, V1992, P1; MIALL A D, 1986, Bulletin of Canadian Petroleum Geology, V34, P240; Pfretzschner H.-U., 1988, Memoires du Museum National d'Histoire Naturelle Serie C Sciences de la Terre, V53, P133; Pfretzschner Hans Ulrich, 1994, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V234, P1; Rensberger J.M., 1992, P163; RENSBERGER JM, 1980, PALEOBIOLOGY, V6, P477, DOI 10.1017/S009483730000364X; Rensberger John M., 2004, Bulletin of Carnegie Museum of Natural History, V36, P199, DOI 10.2992/0145-9058(2004)36[199:EFTEMF]2.0.CO;2; Ricketts, 1986, CURR RES GEOL SURV B, P363; RIEDIGER CL, 1987, B CAN PETROL GEOL, V35, P123; Secord R, 2008, PALEOBIOLOGY, V34, P282, DOI 10.1666/0094-8373(2008)034[0282:SIIEEM]2.0.CO;2; Stefen C, 1997, TOOTH ENAMEL MICROSTRUCTURE, P123; Stefen C, 1995, THESIS; Tabuce R, 2007, ZOOL J LINN SOC-LOND, V149, P611, DOI 10.1111/j.1096-3642.2007.00272.x; Tabuce Rodolphe, 2016, J MAMM EVOL, V24, P91; v. Koenigswald Wighart, 1997, P267; Von Koenigswald W, 2014, J VERTEBR PALEONTOL, V34, P166, DOI 10.1080/02724634.2014.957293; VONKOENIGSWALD W, 1992, SCANNING MICROSCOPY, V6, P195; VONKOENIGSWALD W, 1987, ZOOMORPHOLOGY, V106, P329; vonKoenigswald W, 1997, TOOTH ENAMEL MICROSTRUCTURE, P203; Weijers JWH, 2007, EARTH PLANET SC LETT, V261, P230, DOI 10.1016/j.epsl.2007.06.033; West CK, 2015, EARTH PLANET SC LETT, V427, P18, DOI 10.1016/j.epsl.2015.06.036; West R. M., 1981, GEOLOGY N ATLANTIC B, V7, P279	47	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239073	10.1371/journal.pone.0239073	http://dx.doi.org/10.1371/journal.pone.0239073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966343	gold, Green Published			2022-12-26	WOS:000575688700052
J	Tackenberg, C; Kulic, L; Nitsch, RM				Tackenberg, Christian; Kulic, Luka; Nitsch, Roger M.			Familial Alzheimer's disease mutations at position 22 of the amyloid beta-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in anex vivosystem	PLOS ONE			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; INTRACELLULAR A-BETA; PATHOLOGY; DEFICITS	Familial forms of Alzheimer's disease (AD) are caused by mutations in the presenilin genes or in the gene encoding for the amyloid precursor protein (APP). Proteolytic cleavage of APP generates the beta-amyloid peptide (A beta), which aggregates into amyloid plaques, one of the major hallmarks of AD. APP mutations within the A beta sequence, so-called intra-A beta mutations, cluster around position E693 of APP, which corresponds to position E22 in the A beta sequence. One of these mutations is the Osaka mutation, E693 Delta, which has unique aggregation properties with patients showing unusually low brain amyloid levels on amyloid PET scans. Despite intense research on the pathomechanisms of different intra-A beta mutants, our knowledge is limited due to controversial findings in various studies. Here, we investigated in anex vivoexperimental system the neuro- and synaptotoxic properties of two intra-A beta mutants with different intrinsic aggregation propensities, the Osaka mutation E22 Delta and the Arctic mutation E22G, and compared them to wild-type (wt) A beta. Experiments in hippocampal slice cultures from transgenic mice were complemented by treating wild-type slices with recombinantly produced A beta 40 or A beta 42 containing the respective intra-A beta mutations. Our analyses revealed that wt A beta and E22G A beta, both recombinant and transgenic, caused a loss of dendritic spines along with an increase in tau phosphorylation and tau-dependent neurodegeneration. In all experiments, the 42-residue variants of wt and E22G A beta showed stronger effects than the respective A beta 40 isoforms. In contrast, E22 Delta A beta neither reduced dendritic spine density nor resulted in increased tau phosphorylation or neuronal cell death in ourex vivosystem. Our findings suggest that the previously reported major differences in the aggregation kinetics between E22G and E22 Delta A beta are likely reflected in different disease pathomechanisms.	[Tackenberg, Christian; Kulic, Luka; Nitsch, Roger M.] Univ Zurich, Inst Regenerat Med, Schlieren, Switzerland; [Tackenberg, Christian; Kulic, Luka; Nitsch, Roger M.] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Tackenberg, Christian; Kulic, Luka; Nitsch, Roger M.] Swiss Fed Inst Technol, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Tackenberg, C (corresponding author), Univ Zurich, Inst Regenerat Med, Schlieren, Switzerland.; Tackenberg, C (corresponding author), Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland.; Tackenberg, C (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	christian.tackenberg@irem.uzh.ch	Tackenberg, Christian/AGZ-3801-2022; Tackenberg, Christian/AHE-1886-2022	Tackenberg, Christian/0000-0002-0019-3055; Tackenberg, Christian/0000-0002-0019-3055	Deutsche Forschungsgemeinschaft (DFG) [Ta762/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	CT was supported by the Deutsche Forschungsgemeinschaft (DFG, Ta762/1-1).	American Institute of Ultrasound in Medicine, 2020, J ULTRASOUND MED, V21, pE1; Bakota L, 2016, DRUGS, V76, P301, DOI 10.1007/s40265-015-0529-0; Birnbaum JH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.160; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Bugiani O, 2010, ARCH NEUROL-CHICAGO, V67, P987, DOI 10.1001/archneurol.2010.178; Cloe AL, 2011, BIOCHEMISTRY-US, V50, P2026, DOI 10.1021/bi1016217; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Inayathullah M, 2011, AMYLOID, V18, P98, DOI 10.3109/13506129.2011.580399; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Kulic L, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.109; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Ortiz-Sanz C, 2020, FRONT SYNAPTIC NEURO, V12, DOI 10.3389/fnsyn.2020.00002; Ovchinnikova OY, 2011, J MOL BIOL, V408, P780, DOI 10.1016/j.jmb.2011.02.049; Penazzi L, 2016, NEUROPHARMACOLOGY, V105, P84, DOI 10.1016/j.neuropharm.2016.01.002; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Scholl M, 2012, NEUROLOGY, V79, P229, DOI 10.1212/WNL.0b013e31825fdf18; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sundermann Frederik, 2012, Methods Mol Biol, V846, P277, DOI 10.1007/978-1-61779-536-7_24; Suzuki Takayuki, 2010, Int J Alzheimers Dis, V2011, P431320, DOI 10.4061/2011/431320; Tackenberg C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.129; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Tackenberg C, 2009, J NEUROSCI, V29, P14439, DOI 10.1523/JNEUROSCI.3590-09.2009; Takuma H, 2008, NEUROREPORT, V19, P615, DOI 10.1097/WNR.0b013e3282fb78c4; Tanzi Rudolph E, 2012, Cold Spring Harb Perspect Med, V2, DOI 10.1101/cshperspect.a006296; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Umeda T, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0230-2; Umeda T, 2014, ACTA NEUROPATHOL, V127, P685, DOI 10.1007/s00401-014-1259-1	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239584	10.1371/journal.pone.0239584	http://dx.doi.org/10.1371/journal.pone.0239584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966331	Green Published, gold, Green Accepted			2022-12-26	WOS:000575688700039
J	Loosen, SH; Wirtz, TH; Roy, S; Vucur, M; Castoldi, M; Schneider, AT; Koppe, C; Ulmer, TF; Roeth, AA; Bednarsch, J; Alizai, PH; Paffenholz, P; Demir, M; Trautwein, C; Tacke, F; Neumann, UP; Roderburg, C; Luedde, T				Loosen, Sven H.; Wirtz, Theresa H.; Roy, Sanchari; Vucur, Mihael; Castoldi, Mirco; Schneider, Anne T.; Koppe, Christiane; Ulmer, Tom F.; Roeth, Anjali A.; Bednarsch, Jan; Alizai, Patrick H.; Paffenholz, Pia; Demir, Muenevver; Trautwein, Christian; Tacke, Frank; Neumann, Ulf P.; Roderburg, Christoph; Luedde, Tom			Circulating levels of microRNA193a-5p predict outcome in early stage hepatocellular carcinoma	PLOS ONE			English	Article							CANCER; GENES	While tumor resection and liver transplantation (LT) represent potentially curative therapeutic options for patients with early-stage hepatocellular carcinoma (HCC), the identification of the ideal surgical candidates has remained challenging. Just recently, miRNA-193a-5p was described as a tumor suppressor in murine and human HCC but only little is known about circulating miRNA-193a-5p in HCC patients. Here, we evaluated serum levels of miR-193a-5p by qPCR in 41 HCC patients undergoing tumor resection (n = 33) or LT (n = 8) and 20 controls. Circulating relative miR-193a-5p levels were significantly elevated in HCC patients compared to healthy controls. While relative miR-193a-5p levels were comparable between patients of different underlying disease etiology and tumor size, high relative miR-193a-5p levels were predictive for the patients' postoperative outcome, which was confirmed in uni- and multivariate Cox-regression analysis. As such, HCC patients with a preoperative relative miR-193a-5p level above the ideal cut-off value (3.57) had a median overall survival (OS) of only 451 days compared to 1158 days in patients with a relative miR-193a-5p level below this cut-off value. Our data support a novel function of miR-193a-5p as a biomarker in early-stage HCC patients that might help to identify the best surgical candidates in terms of postoperative outcome.	[Loosen, Sven H.; Luedde, Tom] Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Med Fac, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Loosen, Sven H.; Wirtz, Theresa H.; Trautwein, Christian] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany; [Roy, Sanchari; Vucur, Mihael; Castoldi, Mirco; Schneider, Anne T.; Koppe, Christiane] Univ Hosp RWTH Aachen, Div Gastroenterol Hepatol & Hepatobiliary Oncol, Aachen, Germany; [Ulmer, Tom F.; Roeth, Anjali A.; Bednarsch, Jan; Alizai, Patrick H.; Neumann, Ulf P.] Univ Hosp RWTH Aachen, Dept Visceral & Transplantat Surg, Aachen, Germany; [Paffenholz, Pia] Univ Hosp Cologne, Dept Urol, Cologne, Germany; [Demir, Muenevver; Tacke, Frank; Roderburg, Christoph] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Luedde, T (corresponding author), Heinrich Heine Univ Dusseldorf, Univ Hosp Dusseldorf, Med Fac, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany.; Roderburg, C (corresponding author), Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, Berlin, Germany.	christoph.roderburg@charite.de; tluedde@ukaachen.de	Roderburg, Christoph/AAR-3051-2021; Roderburg, Christoph/AHC-8101-2022; Loosen, Sven/AHC-5236-2022; Tacke, Frank/ABF-2212-2020; Luedde, Tom/AAE-9135-2022	Roderburg, Christoph/0000-0002-1409-7697; Loosen, Sven/0000-0002-2799-2287; Luedde, Tom/0000-0002-6288-8821; Demir, Munevver/0000-0002-7050-797X	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program through the ERC Consolidator Grant PhaseControl [771083]; German Cancer Aid (Deutsche Krebshilfe) [110043]; German Cancer Aid (Mildred-Scheel-Professorship); German-Research-Foundation [SFB-TRR57/P06, LU 1360/3-1]; Ernst-Jung-Foundation Hamburg; IZKF (interdisciplinary centre of clinical research) Aachen; medical faculty of the RWTH Aachen	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program through the ERC Consolidator Grant PhaseControl(European Research Council (ERC)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); German Cancer Aid (Mildred-Scheel-Professorship); German-Research-Foundation(German Research Foundation (DFG)); Ernst-Jung-Foundation Hamburg; IZKF (interdisciplinary centre of clinical research) Aachen; medical faculty of the RWTH Aachen	Work in the lab of T.L. was funded from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program through the ERC Consolidator Grant PhaseControl (Grant Agreement no 771083). The lab of T.L. was further supported by the German Cancer Aid (Deutsche Krebshilfe 110043 and a Mildred-Scheel-Professorship), the German-Research-Foundation (SFB-TRR57/P06 and LU 1360/3-1), the Ernst-Jung-Foundation Hamburg, the IZKF (interdisciplinary centre of clinical research) Aachen and a grant from the medical faculty of the RWTH Aachen.	Bhan I, 2019, LIQUID BIOPSY HEPATO; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Bruix J, 2015, LANCET ONCOL, V16, P1344, DOI 10.1016/S1470-2045(15)00198-9; Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI 10.2147/HMER.S16316; Dilsiz N, 2020, FUTUR SCI OA, V6, DOI 10.2144/fsoa-2019-0116; Dragomir MP, 2020, GUT, V69, P748, DOI 10.1136/gutjnl-2019-318279; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Fayyad-Kazan M, 2019, INFECT GENET EVOL, V74, DOI 10.1016/j.meegid.2019.103938; Fiorino S, 2016, WORLD J GASTROENTERO, V22, P3907, DOI 10.3748/wjg.v22.i15.3907; Ge W, 2014, CLIN LAB, V60, P427, DOI 10.7754/Clin.Lab.2013.130133; Ghouri Yezaz Ahmed, 2017, J Carcinog, V16, P1, DOI 10.4103/jcar.JCar_9_16; Hester CA, 2019, SURG THERAPIES HEPAT; Hydbring P, 2017, CANCER CELL, V31, P576, DOI 10.1016/j.ccell.2017.03.004; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Li P, 2019, J CELL MOL MED, V23, P2475, DOI 10.1111/jcmm.14121; Liao QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130677; Loosen SH, 2019, CARCINOGENESIS, V40, P947, DOI 10.1093/carcin/bgz033; Lorenzen S, 2020, Z GASTROENTEROL, V58, P542, DOI 10.1055/a-1071-8322; Mao BJ, 2015, ONCOL REP, V34, P2811, DOI 10.3892/or.2015.4275; Parizadeh SM, 2019, CURR DRUG TARGETS, V20, P1129, DOI 10.2174/1389450120666190307095720; Roderburg C, 2017, J HEPATOL, V66, P655, DOI 10.1016/j.jhep.2016.09.015; Roderburg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032999; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Roy S, 2018, GASTROENTEROLOGY, V155, P1951, DOI 10.1053/j.gastro.2018.08.032; Roy S, 2015, J DIGEST DIS, V16, P513, DOI 10.1111/1751-2980.12266; Tellapuri S, 2018, INDIAN J GASTROENTER, V37, P481, DOI 10.1007/s12664-018-0915-0; Wang LS, 2015, MOL MED REP, V12, P615, DOI 10.3892/mmr.2015.3428; Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45846	29	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239386	10.1371/journal.pone.0239386	http://dx.doi.org/10.1371/journal.pone.0239386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960907	Green Published, gold			2022-12-26	WOS:000575109500003
J	Makori, DM; Abdel-Rahman, EM; Landmann, T; Mutanga, O; Odindi, J; Nguku, E; Tonnang, HE; Raina, S				Makori, David Masereti; Abdel-Rahman, Elfatih M.; Landmann, Tobias; Mutanga, Onisimo; Odindi, John; Nguku, Evelyn; Tonnang, Henry E.; Raina, Suresh			Suitability of resampled multispectral datasets for mapping flowering plants in the Kenyan savannah	PLOS ONE			English	Article							TREE SPECIES CLASSIFICATION; COLOR PREFERENCES; CROP POLLINATION; LAND-COVER; FORESTS; QUALITY; COASTAL; IMAGERY; BEES; DISCRIMINATION	Pollination services and honeybee health in general are important in the African savannahs particularly to farmers who often rely on honeybee products as a supplementary source of income. Therefore, it is imperative to understand the floral cycle, abundance and spatial distribution of melliferous plants in the African savannah landscapes. Furthermore, placement of apiaries in the landscapes could benefit from information on spatiotemporal patterns of flowering plants, by optimising honeybees' foraging behaviours, which could improve apiary productivity. This study sought to assess the suitability of simulated multispectral data for mapping melliferous (flowering) plants in the African savannahs. Bi-temporal AISA Eagle hyperspectral images, resampled to four sensors (i.e. WorldView-2, RapidEye, Spot-6 and Sentinel-2) spatial and spectral resolutions, and a 10-cm ultra-high spatial resolution aerial imagery coinciding with onset and peak flowering periods were used in this study. Ground reference data was collected at the time of imagery capture. The advanced machine learning random forest (RF) classifier was used to map the flowering plants at a landscape scale and a classification accuracy validated using 30% independent test samples. The results showed that 93.33%, 69.43%, 67.52% and 82.18% accuracies could be achieved using WorldView-2, RapidEye, Spot-6 and Sentinel-2 data sets respectively, at the peak flowering period. Our study provides a basis for the development of operational and cost-effective approaches for mapping flowering plants in an African semiarid agroecological landscape. Specifically, such mapping approaches are valuable in providing timely and reliable advisory tools for guiding the implementation of beekeeping systems at a landscape scale.	[Makori, David Masereti; Abdel-Rahman, Elfatih M.; Landmann, Tobias; Nguku, Evelyn; Tonnang, Henry E.; Raina, Suresh] Int Ctr Insect Physiol & Ecol ICIPE, Nairobi, Kenya; [Makori, David Masereti; Mutanga, Onisimo; Odindi, John] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Pietermaritzburg, South Africa; [Abdel-Rahman, Elfatih M.] Univ Khartoum, Dept Agron, Fac Agr, Khartoum, Sudan	International Centre of Insect Physiology & Ecology (ICIPE); University of Kwazulu Natal; University of Khartoum	Makori, DM (corresponding author), Int Ctr Insect Physiol & Ecol ICIPE, Nairobi, Kenya.; Makori, DM (corresponding author), Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Pietermaritzburg, South Africa.	davidmakori@gmail.com	Landmann, Tobias/AAE-5467-2022; TONNANG, Henri/AAQ-2206-2021; Mutanga, Onisimo/D-8094-2013	TONNANG, Henri/0000-0002-9424-9186; Makori, David/0000-0003-0849-778X; Mutanga, Onisimo/0000-0002-7358-8111; Odindi, John/0000-0002-4934-1346	European Union [DCI-FOOD-2011/023-520]; University of Helsinki; UK Aid from the Government of the United Kingdom; Department for International Development Cooperation Agency (Sida); Swiss Agency for Development for Economic Cooperation and Development (BMZ); Germany Federal Democratic Republic of Ethiopia; Kenyan Government	European Union(European Commission); University of Helsinki; UK Aid from the Government of the United Kingdom; Department for International Development Cooperation Agency (Sida); Swiss Agency for Development for Economic Cooperation and Development (BMZ); Germany Federal Democratic Republic of Ethiopia; Kenyan Government	The European Union funded the project "African reference laboratory (with satellite stations) for the management of pollinator bee diseases and pests for food security" under grant number DCI-FOOD-2011/023-520. The European Union also facilitated the acquisition of the April 2014 WorldView-2 data that was used in this study. The University of Helsinki funded the research community GIMMEC-Geoinformatics for monitoring and modelling of environmental change for facilitating the acquisition and processing of the AISA Eagle hyperspectral data. DMM, EN, SR, and TL's salaries were made possible by the financial support given by the European Union through project DCI-FOOD-2011/023-520. EMAR, EN, HEZT, and TL received salaries from icipe. icipe core funding was provided by UK Aid from the Government of the United Kingdom; Department for International Development Cooperation Agency (Sida); the Swiss Agency for Development for Economic Cooperation and Development (BMZ), Germany Federal Democratic Republic of Ethiopia; and the Kenyan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman EM, 2015, REMOTE SENS-BASEL, V7, P13298, DOI 10.3390/rs71013298; Adolkar V. V., 2007, International Journal of Tropical Insect Science, V27, P6, DOI 10.1017/S174275840774537X; Allsopp MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003128; Anderson C, 2014, C CHAR RAD CAL REM S; Anderson NT, 2012, PROC SPIE, V8390, DOI 10.1117/12.919756; [Anonymous], 2018, Intensive Care Med Exp, V6, P40, DOI 10.1186/s40635-018-0201-6; [Anonymous], 2003, D39502 ASTM, V98, P1; [Anonymous], 2007, ZH RETS NOVYI EPOS, V44, P41; [Anonymous], 2008, J ENDOD S, V34, pe151; [Anonymous], 2009, EJSO S, V35, pS1; Asner GP, 2012, ECOL LETT, V15, P1001, DOI 10.1111/j.1461-0248.2012.01821.x; Becker BL, 2007, REMOTE SENS ENVIRON, V108, P111, DOI 10.1016/j.rse.2006.11.005; Blay Dominic, 2008, Environment Development and Sustainability, V10, P503, DOI 10.1007/s10668-006-9077-9; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buchmann S.L., 2012, FORGOTTEN POLLINATOR; Cho MA, 2012, REMOTE SENS ENVIRON, V125, P214, DOI 10.1016/j.rse.2012.07.010; Clark ML, 2010, REMOTE SENS ENVIRON, V114, P2816, DOI 10.1016/j.rse.2010.07.001; Clasen A, 2015, REMOTE SENS-BASEL, V7, P15361, DOI 10.3390/rs71115361; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Colgan MS, 2012, REMOTE SENS-BASEL, V4, P3462, DOI 10.3390/rs4113462; Congalton R.G., 2008, ASSESSING ACCURACY R, V2nd ed., DOI 10.1201/9781420055139; Cooley AM, 2008, ANN BOT-LONDON, V101, P641, DOI 10.1093/aob/mcn014; Dalponte M, 2013, IEEE T GEOSCI REMOTE, V51, P2632, DOI 10.1109/TGRS.2012.2216272; de Ibarra NH, 2014, J COMP PHYSIOL A, V200, P411, DOI 10.1007/s00359-014-0915-1; Delaplane K.S., 2010, HONEY BEES BEEKEEPIN; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Exelis VIS, 2015, EXELIS VIS ENVI 5 3; Fauvel M, 2008, IEEE IMAGE PROC, P1884, DOI 10.1109/ICIP.2008.4712147; Hammouch A, 2012, ARXIV12100052; Hedley J, 2012, REMOTE SENS ENVIRON, V120, P145, DOI 10.1016/j.rse.2011.06.028; Hines HM, 2005, ENVIRON ENTOMOL, V34, P1477, DOI 10.1603/0046-225X-34.6.1477; Immitzer M, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8030166; Immitzer M, 2012, REMOTE SENS-BASEL, V4, P2661, DOI 10.3390/rs4092661; Jung-Rothenhausler F, 2007, RAPIDEYE NOVEL APPRO, P4; Kasina JM, 2009, J ECON ENTOMOL, V102, P467, DOI 10.1603/029.102.0201; Kenya GIS Data, 2007, KEN GIS DAT; Kiatoko N, 2014, ENTOMOL SCI, V17, P106, DOI 10.1111/ens.12030; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Landmann T, 2015, REMOTE SENS ENVIRON, V166, P50, DOI 10.1016/j.rse.2015.06.006; Latif Z. A., 2012, 2012 IEEE 8th International Colloquium on Signal Processing & its Applications, P383, DOI 10.1109/CSPA.2012.6194754; Lawrence RL, 2006, REMOTE SENS ENVIRON, V100, P356, DOI 10.1016/j.rse.2005.10.014; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Makori DM, 2017, ISPRS INT GEO-INF, V6, DOI 10.3390/ijgi6030066; Marshall V, 2012, INT ARCH PHOTOGRAMM, V39-B8, P277; Mitchell JJ, 2012, REMOTE SENS ENVIRON, V124, P217, DOI 10.1016/j.rse.2012.05.002; Morawetz L, 2013, J COMP PHYSIOL A, V199, P817, DOI 10.1007/s00359-013-0843-5; Muok B. O., 2000, Agroforestry Today, V12, P13; Naughton D, 2011, J APPL REMOTE SENS, V5, DOI 10.1117/1.3613950; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Peters J, 2007, ECOL MODEL, V207, P304, DOI 10.1016/j.ecolmodel.2007.05.011; Pickering CM, 2003, NORD J BOT, V23, P217, DOI 10.1111/j.1756-1051.2003.tb00384.x; Pirk CWW, 2016, APIDOLOGIE, V47, P276, DOI 10.1007/s13592-015-0406-6; Pohl NB, 2011, ECOL ENTOMOL, V36, P290, DOI 10.1111/j.1365-2311.2011.01271.x; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Raina S. K., 2005, International Journal of Tropical Insect Science, V25, P281; Raina SK, 2011, ANNU REV ENTOMOL, V56, P465, DOI 10.1146/annurev-ento-120709-144805; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Rodriguez-Galiano VF, 2012, REMOTE SENS ENVIRON, V121, P93, DOI 10.1016/j.rse.2011.12.003; Sande SO, 2009, BIOL CONSERV, V142, P2703, DOI 10.1016/j.biocon.2009.06.023; Schmidt KS, 2003, REMOTE SENS ENVIRON, V85, P92, DOI 10.1016/S0034-4257(02)00196-7; Shen MG, 2010, INT J REMOTE SENS, V31, P2139, DOI 10.1080/01431160903578812; Stratoulias D, 2015, SENSORS-BASEL, V15, P22956, DOI 10.3390/s150922956; Thulin S, 2012, INT J APPL EARTH OBS, V19, P322, DOI 10.1016/j.jag.2012.06.006; Ushimaru A, 2007, AM J BOT, V94, P249, DOI 10.3732/ajb.94.2.249; Vanbrabant Y, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10030407; Wang AQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135538; Warrens MJ, 2015, INT J REMOTE SENS, V36, P5959, DOI 10.1080/01431161.2015.1110265; Warrens MJ, 2015, INT J REMOTE SENS, V36, P1439, DOI 10.1080/01431161.2015.1011794; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Winfree R, 2008, J APPL ECOL, V45, P793, DOI 10.1111/j.1365-2664.2007.01418.x; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Yin JH, 2012, IEEE T IND INFORM, V8, P935, DOI 10.1109/TII.2012.2205397; Zayed A, 2009, APIDOLOGIE, V40, P237, DOI 10.1051/apido/2009026; Zhang J, 2009, ABSORPTION SPECTRUM; Zheng Q, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18030868	80	0	0	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0232313	10.1371/journal.pone.0232313	http://dx.doi.org/10.1371/journal.pone.0232313			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960879	Green Submitted, Green Published, gold			2022-12-26	WOS:000575109500008
J	Cubillos-Angulo, JM; Vinhaes, CL; Fukutani, ER; Albuquerque, VVS; Queiroz, ATL; Andrade, BB; Fukutani, KF				Cubillos-Angulo, Juan M.; Vinhaes, Caian L.; Fukutani, Eduardo R.; Albuquerque, Victor V. S.; Queiroz, Artur T. L.; Andrade, Bruno B.; Fukutani, Kiyoshi F.			In silicotranscriptional analysis of mRNA and miRNA reveals unique biosignatures that characterizes different types of diabetes	PLOS ONE			English	Article							EXPRESSION PROFILES; PANCREATIC-ISLETS; MICRORNAS; MELLITUS; BIOMARKERS; TUBERCULOSIS; INFLAMMATION; APOPTOSIS; DISEASE; CELLS	Diabetes (DM) has a significant impact on public health. We performed anin silicostudy of paired datasets of messenger RNA (mRNA) micro-RNA (miRNA) transcripts to delineate potential biosignatures that could distinguish prediabetes (pre-DM), type-1DM (T1DM) and type-2DM (T2DM). Two publicly available datasets containing expression values of mRNA and miRNA obtained from individuals diagnosed with pre-DM, T1DM or T2DM, and normoglycemic controls (NC), were analyzed using systems biology approaches to define combined signatures to distinguish different clinical groups. The mRNA profile of both pre-DM and T2DM was hallmarked by several differentially expressed genes (DEGs) compared to NC. Nevertheless, T1DM was characterized by an overall low number of DEGs. The miRNA signature profiles were composed of a substantially lower number of differentially expressed targets. Gene enrichment analysis revealed several inflammatory pathways in T2DM and fewer in pre-DM, but with shared findings such as Tuberculosis. The integration of mRNA and miRNA datasets improved the identification and discriminated the group composed by pre-DM and T2DM patients from that constituted by normoglycemic and T1DM individuals. The integrated transcriptomic analysis of mRNA and miRNA expression revealed a unique biosignature able to characterize different types of DM.	[Cubillos-Angulo, Juan M.; Vinhaes, Caian L.; Fukutani, Eduardo R.; Queiroz, Artur T. L.; Andrade, Bruno B.; Fukutani, Kiyoshi F.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Cubillos-Angulo, Juan M.; Andrade, Bruno B.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Cubillos-Angulo, Juan M.; Vinhaes, Caian L.; Andrade, Bruno B.; Fukutani, Kiyoshi F.] Fac Tecnol & Ciencias FTC, Curso Med, Salvador, BA, Brazil; [Vinhaes, Caian L.; Queiroz, Artur T. L.; Andrade, Bruno B.; Fukutani, Kiyoshi F.] Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil; [Albuquerque, Victor V. S.; Andrade, Bruno B.] Escola Bahiana Med & Saude Publ EBMSP, Salvador, BA, Brazil; [Andrade, Bruno B.] Univ Salvador UNIFACS, Laureate Univ, Salvador, BA, Brazil	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Escola Bahiana de Medicina e Saude Publica; Universidade Salvador (UNIFACS)	Queiroz, ATL; Andrade, BB; Fukutani, KF (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Fed Bahia, Fac Med, Salvador, BA, Brazil.; Andrade, BB; Fukutani, KF (corresponding author), Fac Tecnol & Ciencias FTC, Curso Med, Salvador, BA, Brazil.; Queiroz, ATL; Andrade, BB; Fukutani, KF (corresponding author), Multinatl Org Network Sponsoring Translat & Epide, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Escola Bahiana Med & Saude Publ EBMSP, Salvador, BA, Brazil.; Andrade, BB (corresponding author), Univ Salvador UNIFACS, Laureate Univ, Salvador, BA, Brazil.	arturlopo@gmail.com; bruno.andrade@fiocruz.br; ferreirak@gmail.com	Queiroz, Artur/AAT-9330-2021	Cubillos Angulo, Juan Manuel/0000-0002-3877-5077	Intramural Program of Fundacao Oswaldo Cruz (FIOCRUZ); Brazilian National Council for Scientific and Technological Development (CNPq); Programa Nacional de Pos-Doutorado, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; NIH [U01AI115940, R01AI069923-08, R01AI2079002]; Organization of American States -Partnerships Program for Education and Training (OAS-PAEC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	Intramural Program of Fundacao Oswaldo Cruz (FIOCRUZ); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Nacional de Pos-Doutorado, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Organization of American States -Partnerships Program for Education and Training (OAS-PAEC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Intramural Program of Fundacao Oswaldo Cruz (FIOCRUZ) and by the Brazilian National Council for Scientific and Technological Development (CNPq). K.F.F. received a fellowship from the Programa Nacional de Pos-Doutorado, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Finance Code 001). The work of B.B.A. was supported by grants from the NIH (U01AI115940, R01AI069923-08, R01AI2079002). BBA and A.T.L.Q are senior investigators from CNPq. J. M. C-A. was supported by the Organization of American States -Partnerships Program for Education and Training (OAS-PAEC) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (Finance Code 001). C. L.V. is a research fellow from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2017, INT J MYCOBACT, V6, P97, DOI 10.4103/ijmy.ijmy_13_17; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Argelaguet R, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178124; Banerjee J, 2017, BIOCHIMIE, V139, P9, DOI 10.1016/j.biochi.2017.05.007; Belgardt BF, 2015, NAT MED, V21, P619, DOI 10.1038/nm.3862; Bixler GV, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-40; Bolstad B, 2019, PREPROCESSCORE COLLE; Cai WJ, 2006, P NATL ACAD SCI USA, V103, P13801, DOI 10.1073/pnas.0600362103; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Chu DT, 2014, J BIOL CHEM, V289, P23330, DOI 10.1074/jbc.A114.555821; Coccurello R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208596; Danza K, 2017, ONCOTARGET, V8, P50715, DOI 10.18632/oncotarget.14899; Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020; Eseberri I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184875; Fan BQ, 2018, ANTIOXID REDOX SIGN, V29, P1041, DOI 10.1089/ars.2017.7318; Fan HX, 2018, CANCER LETT, V429, P89, DOI 10.1016/j.canlet.2018.05.010; Gao L, 2019, EPIGENOMICS-UK, V11, P685, DOI 10.2217/epi-2018-0055; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; He YF, 2017, EXCLI J, V16, P1297, DOI 10.17179/excli2017-491; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Kato M, 2011, KIDNEY INT, V80, P358, DOI 10.1038/ki.2011.43; Kim JH, 2018, FEBS OPEN BIO, V8, P1866, DOI 10.1002/2211-5463.12528; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kumar S, 2017, PROG MOL BIOL TRANSL, V146, P47, DOI 10.1016/bs.pmbts.2016.12.013; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Narvekar P, 2009, DIABETES, V58, P1040, DOI 10.2337/db08-1184; Nathella PK, 2017, IMMUNOLOGY, V152, P13, DOI 10.1111/imm.12762; Noble JA, 2011, CURR DIABETES REP, V11, P533, DOI 10.1007/s11892-011-0223-x; Petersmann A, 2019, EXP CLIN ENDOCR DIAB, V127, pS1, DOI 10.1055/a-1018-9078; Regazzi R, 2018, EXPERT OPIN THER TAR, V22, P153, DOI 10.1080/14728222.2018.1420168; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shao K, 2018, J CELL PHYSIOL, V233, P4068, DOI 10.1002/jcp.26174; Shen J, 2019, CELL TISSUE RES, V378, P67, DOI 10.1007/s00441-019-03026-6; Shivakumar SVBY, 2018, INT J TUBERC LUNG D, V22, P686, DOI 10.5588/ijtld.17.0598; Shodja Mary Michelle, 2017, Jacobs J Diabetes Endocrinol, V8, P9, DOI 10.5897/JDE2017.0110; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; Sim CK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174761; Singh GB, 2017, MOL CELL BIOCHEM, V424, P1, DOI 10.1007/s11010-016-2838-3; Turkmen K, 2017, INT UROL NEPHROL, V49, P837, DOI 10.1007/s11255-016-1488-4; Wang GF, 2018, BIOCHEM BIOPH RES CO, V498, P382, DOI 10.1016/j.bbrc.2017.06.196; Wu B, 2017, METHODS MOL BIOL, V1617, P225, DOI 10.1007/978-1-4939-7046-9_17; Wu XH, 2019, DIABETES METAB SYNDR, V12, P1645, DOI 10.2147/DMSO.S211700; Yang ML, 2015, J DIABETES, V7, P158, DOI 10.1111/1753-0407.12163; Yang YS, 2016, ENDOCR REV, V37, P190, DOI 10.1210/er.2015-1116; Youn BS, 2009, DIABETES, V58, P627, DOI 10.2337/db08-1147; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zaki MB, 2019, DIABETES METAB SYNDR, V12, P601, DOI 10.2147/DMSO.S187422; Zand Ashkan, 2018, Methodist Debakey Cardiovasc J, V14, P289, DOI 10.14797/mdcj-14-4-289; Zeng LQ, 2015, MOL MED REP, V11, P67, DOI 10.3892/mmr.2014.2723; Zhang HN, 2016, DIABETES, V65, P1196, DOI 10.2337/db15-1067; Zhu HM, 2015, DIABETOLOGIA, V58, P900, DOI 10.1007/s00125-015-3510-2	57	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239061	10.1371/journal.pone.0239061	http://dx.doi.org/10.1371/journal.pone.0239061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956382	gold, Green Published			2022-12-26	WOS:000574571500029
J	Jakubec, M; Maple-Grodem, J; Akbari, S; Nesse, S; Halskau, O; Mork-Jansson, AE				Jakubec, Martin; Maple-Grodem, Jodi; Akbari, Saleha; Nesse, Susanne; Halskau, Oyvind; Mork-Jansson, Astrid Elisabeth			Plasma-derived exosome-like vesicles are enriched in lyso-phospholipids and pass the blood-brain barrier	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; DRUG-DELIVERY; MEMBRANE; STRATEGIES; MECHANISM	Exosomes are vesicles involved in intercellular communication. Their membrane structure and core content is largely dependent on the cell of origin. Exosomes have been investigated both for their biological roles and their possible use as disease biomarkers and drug carriers. These potential technological applications require the rigorous characterization of exosomal blood brain barrier permeability and a description of their lipid bilayer composition. To achieve these goals, we have established a 3D static blood brain barrier system based on existing systems for liposomes and a complementary LC-MS/MS and(31)P nuclear magnetic resonance methodology for the analysis of purified human plasma-derived exosome-like vesicles. Results show that the isolated vesicles pass the blood brain barrier and are taken up in endothelial cells. The compositional analysis revealed that the isolated vesicles are enriched in lyso phospholipids and do not contain phosphatidylserine. These findings deviate significantly from the composition of exosomes originating from cell culture, and may reflect active removal by macrophages that respond to exposed phosphahtidylserine.	[Jakubec, Martin; Halskau, Oyvind] Univ Bergen, Fac Math & Nat Sci, Dept Biol Sci, Bergen, Norway; [Maple-Grodem, Jodi; Akbari, Saleha; Nesse, Susanne; Mork-Jansson, Astrid Elisabeth] Univ Stavanger, Dept Chem Biochem & Environm Technol, Fac Sci & Technol, Stavanger, Norway; [Maple-Grodem, Jodi] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, Stavanger, Norway	University of Bergen; Universitetet i Stavanger; Stavanger University Hospital	Mork-Jansson, AE (corresponding author), Univ Stavanger, Dept Chem Biochem & Environm Technol, Fac Sci & Technol, Stavanger, Norway.	astrid.mork-jansson@uis.no		Mork-Jansson, Astrid Elisabeth/0000-0003-1525-2270; Jakubec, Martin/0000-0002-6180-6900; Maple-Grodem, Jodi/0000-0001-7142-0078	University of Stavanger Norway; Norwegian Epilepsy Union Norway; Valide TTO Stavanger Norway; Norwegian research counsil grant [240063, 226244/F50]; Bergen Research Foundation [BFS-NMR-1]; Sparebankstiftinga Sogn og Fjordane [509-42/16]	University of Stavanger Norway; Norwegian Epilepsy Union Norway; Valide TTO Stavanger Norway; Norwegian research counsil grant; Bergen Research Foundation; Sparebankstiftinga Sogn og Fjordane	AM: The University of Stavanger Norway, https://www.uis.no/frontpage/#Research, The Norwegian Epilepsy Union Norway, https://www.epilepsi.no/Valide TTO Stavanger Norway https://valide.no/en/home OH: The Norwegian research counsil grant #240063 and #226244/F50 https://www.forskningsradet.no/en/Bergen Research Foundation (BFS-NMR-1) https://mohnfoundation.no/?lang=en Sparebankstiftinga Sogn og Fjordane (509-42/16). https://www.sparebankstiftinga.no/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2015, CHRON HIGHER EDUC, V31, P3; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Antonny B, 2015, TRENDS CELL BIOL, V25, P427, DOI 10.1016/j.tcb.2015.03.004; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Boing AN, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23430; Bosco M, 1997, ANAL BIOCHEM, V245, P38, DOI 10.1006/abio.1996.9907; Brouwers JF, 2013, PROTEOMICS, V13, P1660, DOI 10.1002/pmic.201200348; Chapuy-Regaud S, 2017, BIOCHIMIE, V141, P70, DOI 10.1016/j.biochi.2017.05.003; Chen CC, 2016, CELL MOL BIOENG, V9, P509, DOI 10.1007/s12195-016-0458-3; Chen HL, 2010, EUR J PHARM SCI, V40, P94, DOI 10.1016/j.ejps.2010.03.007; DELI MA, 1995, J NEUROSCI RES, V41, P717, DOI 10.1002/jnr.490410602; Fuller N, 2001, BIOPHYS J, V81, P243, DOI 10.1016/S0006-3495(01)75695-0; Furse S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06855-z; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Hubbard Jacqueline A., 2016, P1, DOI 10.1016/B978-0-12-802401-0.00001-6; Jakubec M, 2019, FAST QUANTITATIVE PH; Jethwa SA, 2016, J CELL SCI, V129, P3948, DOI 10.1242/jcs.184424; JOHNSTONE RM, 1992, BIOCHEM CELL BIOL, V70, P179, DOI 10.1139/o92-028; Kalra H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001450; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Kochen MA, 2016, ANAL CHEM, V88, P5733, DOI 10.1021/acs.analchem.6b00021; Koelmel JP, 2017, J AM SOC MASS SPECTR, V28, P908, DOI 10.1007/s13361-017-1608-0; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; Llorente A, 2013, BBA-MOL CELL BIOL L, V1831, P1302, DOI 10.1016/j.bbalip.2013.04.011; Martins TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198820; Masyuk AI, 2013, J HEPATOL, V59, P621, DOI 10.1016/j.jhep.2013.03.028; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mommaerts Maurice Yves, 2016, Ann Maxillofac Surg, V6, P287, DOI 10.4103/2231-0746.200325; Pardridge WM, 2007, PHARM RES, V24, P1733, DOI 10.1007/s11095-007-9324-2; Parrish KE, 2015, CLIN PHARMACOL THER, V97, P336, DOI 10.1002/cpt.71; Azevedo LCP, 2007, CRIT CARE, V11, DOI 10.1186/cc6176; Rak J, 2012, BIOESSAYS, V34, P489, DOI 10.1002/bies.201100169; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Saeedi S, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0459-9; Sagini K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041227; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Skotland T, 2017, PROG LIPID RES, V66, P30, DOI 10.1016/j.plipres.2017.03.001; Skotland T, 2017, EUR J CANCER, V70, P122, DOI 10.1016/j.ejca.2016.10.011; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Vella LJ, 2008, EUR BIOPHYS J BIOPHY, V37, P323, DOI 10.1007/s00249-007-0246-z; Vieira DB, 2016, INT J NANOMED, V11, P5381, DOI 10.2147/IJN.S117210; Wubbolts R, 2003, J BIOL CHEM, V278, P10963, DOI 10.1074/jbc.M207550200; Zhang Y, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0282-2	51	12	12	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0232442	10.1371/journal.pone.0232442	http://dx.doi.org/10.1371/journal.pone.0232442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956358	gold, Green Published, Green Submitted			2022-12-26	WOS:000574571500050
J	Nyumba, TO; Emenye, OE; Leader-Williams, N				Nyumba, Tobias Ochieng; Emenye, Olobeli Engini; Leader-Williams, Nigel			Assessing impacts of human-elephant conflict on human wellbeing: An empirical analysis of communities living with elephants around Maasai Mara National Reserve in Kenya	PLOS ONE			English	Article							QUALITY-OF-LIFE; HUMAN-WILDLIFE CONFLICT; PROPENSITY SCORE; BIODIVERSITY CONSERVATION; PATTERNS; AREA; UTTARAKHAND; PERCEPTIONS; ATTITUDES; POVERTY	Human-elephant conflict is an often intractable problem that threatens the contribution of conservation interventions to human wellbeing and securing livelihoods in Africa and Asia. Local human populations living in key elephant ranges are among the world's most poor and vulnerable people. In efforts to address this problem, previous studies have mainly focused on the direct impacts of conflict and applied standard regression models based on the assumption of individual-level homogeneity. More recently, human-elephant conflict has been seen to extend well beyond the physical, to the psychological and social sides of wellbeing. However, the impacts on human wellbeing have not been robustly explored, especially for local communities co-existing with elephants. We evaluated the impacts of conflicts on the wellbeing of local communities around the world-famous Masai Mara National Reserve in Kenya. We conducted 18 focus group discussions with 120 community members in different locations and administered a questionnaire survey to 367 sampled households from 26 sub-locations in Trans Mara. We used descriptive statistics with appropriate statistical tests, including propensity score matching, to evaluate the impacts of conflict on human wellbeing. Before matching, the results of the descriptive statistics showed differences between households experiencing conflicts and those without in terms of gender, age, education level, household size, benefiting from elephant conservation, main occupation and number of income sources. Our matching results indicate the existence of a significant negative and positive impacts on four and one of our eight wellbeing indicators for households that experienced conflicts, respectively. Better conflict mitigation approaches and conservation policies need to be adopted to realize the harmonious and concurrent development of ecological and wellbeing objectives.	[Nyumba, Tobias Ochieng] African Conservat Ctr, Nairobi, Kenya; [Nyumba, Tobias Ochieng] Univ Nairobi, Inst Climate Change & Adaptat, Nairobi, Kenya; [Nyumba, Tobias Ochieng; Leader-Williams, Nigel] Univ Cambridge, Dept Geog, Cambridge, England; [Emenye, Olobeli Engini] Kenya Agr & Livestock Res Org, Nairobi, Kenya	University of Nairobi; University of Cambridge	Nyumba, TO (corresponding author), African Conservat Ctr, Nairobi, Kenya.; Nyumba, TO (corresponding author), Univ Nairobi, Inst Climate Change & Adaptat, Nairobi, Kenya.; Nyumba, TO (corresponding author), Univ Cambridge, Dept Geog, Cambridge, England.	tnyumba@uonbi.ac.ke	Nyumba, Tobias Ochieng/AAD-3583-2021	Nyumba, Tobias Ochieng/0000-0002-7821-5197	Cambridge Commonwealth Trust through the Churchill/Sidney Sussex Southern African Cambridge Scholarship; WildiZe Foundation; Wildlife Conservation Society (Tellus Leadership Scholarship); Wildlife Conservation Network (Schink Scholarship for Wildlife Conservation); Churchill College (Pennett Fund Grant); Churchill College (Lundgren Research Award)	Cambridge Commonwealth Trust through the Churchill/Sidney Sussex Southern African Cambridge Scholarship; WildiZe Foundation; Wildlife Conservation Society (Tellus Leadership Scholarship); Wildlife Conservation Network (Schink Scholarship for Wildlife Conservation); Churchill College (Pennett Fund Grant); Churchill College (Lundgren Research Award)	NT received financially supported by the Cambridge Commonwealth Trust through the Churchill/Sidney Sussex Southern African Cambridge Scholarship (https://www.cambridgetrust.org/about/cambridgecommonwealth-trust/). Additional funding came from the WildiZe Foundation (https://wildize.org/), the Wildlife Conservation Society (Tellus Leadership Scholarship) (https://www.wcs.org/about-us/grants/graduate-scholarship-program), the Wildlife Conservation Network (Schink Scholarship for Wildlife Conservation) (https://wildnet.org/tag/wcn-scholarship-program/), and Churchill College (Pennett Fund Grant and Lundgren Research Award) (https://www.chu.cam.ac.uk/student-hub/resources/financial-support/small-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; [Anonymous], 1998, SUSTAINABLE RURAL LI; Balmford A, 2001, SCIENCE, V291, P2616, DOI 10.1126/science.291.5513.2616; Baral N, 2007, BIODIVERS CONSERV, V16, P2903, DOI 10.1007/s10531-006-9143-5; Barnes RFW, 1996, MAMMAL REV, V26, P67, DOI 10.1111/j.1365-2907.1996.tb00147.x; Barua M, 2013, BIOL CONSERV, V157, P309, DOI 10.1016/j.biocon.2012.07.014; Barua M, 2010, SCI COMMUN, V32, P55, DOI 10.1177/1075547009353177; Bell RHV, 1984, CONSERVATION WILDLIF, P389; Brockington D, 2006, CONSERV BIOL, V20, P250, DOI 10.1111/j.1523-1739.2006.00335.x; Brookhart MA, 2006, AM J EPIDEMIOL, V163, P1149, DOI 10.1093/aje/kwj149; Brundtland G. H., 1987, REPORT WORLD COMMISI; Bryson A, 2003, EVALUATION ACTIVE LA, P1; Cahyat A., 2007, ASSESSING HOUSEHOLD; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Clutton-Brock J, 1999, ORIG DEV AFRICAN LIV; Coulthard S, 2011, GLOBAL ENVIRON CHANG, V21, P453, DOI 10.1016/j.gloenvcha.2011.01.003; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Davies TE, 2014, ANIM CONSERV, V17, P303, DOI 10.1111/acv.12094; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Douglas LR, 2013, ENVIRON SOC, V4, P98, DOI 10.3167/ares.2013.040107; Dunn RR, 2010, BIOTROPICA, V42, P555, DOI 10.1111/j.1744-7429.2010.00698.x; Ellis Frank, 2000, RURAL LIVELIHOODS DI; George D, 2003, SPSS WINDOWS STEP ST; GoK, 2009, KEN POP HOUS CENS EN; GoK WHO, 2011, MOT REL ROAD TRAFF C; Graham K, 2005, BIOL CONSERV, V122, P159, DOI 10.1016/j.biocon.2004.06.006; Graham MD, 2010, SYST BIODIVERS, V8, P435, DOI 10.1080/14772000.2010.533716; Heckman JJ., 2004, PAC ECON REV, V9, P155, DOI DOI 10.1111/PER.2004.9.ISSUE-3; Hill CM, 1998, ENVIRON CONSERV, V25, P244, DOI 10.1017/S0376892998000307; Hill CM, 2000, INT J PRIMATOL, V21, P299, DOI 10.1023/A:1005481605637; Hill CM., 2004, HUMAN DIMENSIONS WIL, V9, P279, DOI [10.1080/10871200490505710, DOI 10.1080/10871200490505710]; Hinks T, 2007, SOC INDIC RES, V82, P311, DOI 10.1007/s11205-006-9036-8; Hoare RE, 1999, CONSERV BIOL, V13, P633, DOI 10.1046/j.1523-1739.1999.98035.x; HOFT R, 1995, BIOL CONSERV, V73, P67, DOI 10.1016/0006-3207(94)00105-Y; Homewood K, 1999, GLOBAL ECOL BIOGEOGR, V8, P301, DOI 10.1046/j.1365-2699.1999.00144.x; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; IUCN, 2002, EV HUM EL CONF WORK; Jadhav S, 2012, HEALTH PLACE, V18, P1356, DOI 10.1016/j.healthplace.2012.06.019; Jean-Gael JEC, 2009, THESIS; Kangwana k, 1995, PACHYDERM, V19, P11; Kenya National Bureau of Statistics, 2020, SEL CHAR HOUS SOC CL; KIIRU W., 1995, PACHYDERM, V19, P15; Kimega GM, 2003, UNRESOLVED HUMAN WIL; Kiyiapi J, 1996, FOREST RESOURCES TRA; LEADERWILLIAMS N, 2000, PRIORITIES CONSERVAT, P53; Leisher C, 2013, SUSTAINABILITY-BASEL, V5, P997, DOI 10.3390/su5030997; Mackenzie CA, 2012, ECOL ECON, V75, P72, DOI 10.1016/j.ecolecon.2011.12.018; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Milner-Gulland EJ, 2014, CONSERV BIOL, V28, P1160, DOI 10.1111/cobi.12277; Moser C., 1972, SURVEY METHODS SOCIA; NCC & TCC, 2009, MAAS MAR NAT RES MAN; Nyamwaro SO, 2006, POL RES C PAST POV R, P1; Nyhus PJ, 2005, CONSERV BIOL SER, V9, P107; Nyumba TO, 2018, THESIS; Ogra M, 2008, HUM ECOL, V36, P717, DOI 10.1007/s10745-008-9189-y; Ogra MV, 2008, GEOFORUM, V39, P1408, DOI 10.1016/j.geoforum.2007.12.004; Parker G. E., 2007, HUMAN ELEPHANT CONFL; Parker I. S. C., 1989, S ZOOLOGICAL SOC LON, V61, P241; POATE CD, 1993, DATA AGRARIAN DEV; Poole J., 2016, MARA ECOSYSTEM CONNE; Rahman T, 2005, MEASURING QUALITY LI, V5; Richards R, 2007, SOC INDIC RES, V81, P375, DOI 10.1007/s11205-006-9014-1; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rossouw S, 2008, SOC INDIC RES, V86, P433, DOI 10.1007/s11205-007-9178-3; Rubin DB, 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Schweitzer A, 1922, EDGE PRIMEVAL FOREST; Sirgy MJ, 2006, SOC INDIC RES, V76, P343, DOI 10.1007/s11205-005-2877-8; Sitati N., 2007, WET DRY SEASON ELEPH; Sitati N. W., 2012, International Journal of Biodiversity and Conservation, V4, P614; Sitati N. W., 2003, THESIS; Sitati NW, 2006, ORYX, V40, P279, DOI 10.1017/S0030605306000834; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Sitati NW, 2007, TOUR NAT AFR THEM P, V1, P71; Sitati NW., 2012, ADV ANTHR, V2, P107, DOI [10.4236/aa.2012.23012, DOI 10.4236/AA.2012.23012]; Smith RJ, 2000, SPATIAL ANAL HUMAN E, DOI [10.1093/jhered/est112, DOI 10.1093/JHERED/EST112]; Tchamba MN, 1996, BIOL CONSERV, V75, P35, DOI 10.1016/0006-3207(95)00040-2; Thoemmes F, 2012, J STAT SCI; Thouless Chris R., 1994, Oryx, V28, P119; Turner WR, 2012, BIOSCIENCE, V62, P85, DOI 10.1525/bio.2012.62.1.13; WALPOLE MJ, 2003, WILDLIFE DEV SERIES, V14; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308; White S.C., 2008, WHAT IS WELLBEING FR; White SC, 2004, 200457 UNUWIDER; Woodroffe R., 2005, CONSERV BIOL; Yaro JA, 2006, J MOD AFR STUD, V44, P125, DOI 10.1017/S0022278X05001448	88	9	9	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239545	10.1371/journal.pone.0239545	http://dx.doi.org/10.1371/journal.pone.0239545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946538	Green Published, gold			2022-12-26	WOS:000573851100063
J	Bolus, S; Malapi-Wight, M; Grinstead, SC; Fuentes-Bueno, I; Hendrickson, L; Hammond, RW; Mollov, D				Bolus, Stephen; Malapi-Wight, Martha; Grinstead, Samuel C.; Fuentes-Bueno, Irazema; Hendrickson, Leticia; Hammond, Rosemarie W.; Mollov, Dimitre			Identification and characterization of Miscanthus yellow fleck virus, a new polerovirus infectingMiscanthus sinensis	PLOS ONE			English	Article							LEAF-VIRUS; MOSAIC-VIRUS; 1ST REPORT; BARLEY	Miscanthus sinensisis a grass used for sugarcane breeding and bioenergy production. Using high throughput sequencing technologies, we identified a new viral genome in infectedM.sinensisleaf tissue displaying yellow fleck symptoms. This virus is most related to members of the genusPolerovirusin the familyLuteoviridae. The canonical ORFs were computationally identified, the P3 coat protein was expressed, and virus-like particles were purified and found to conform to icosahedral shapes, characteristic of the familyLuteoviridae. We propose the name Miscanthus yellow fleck virus for this new virus.	[Bolus, Stephen; Grinstead, Samuel C.; Fuentes-Bueno, Irazema; Mollov, Dimitre] USDA ARS, Natl Germplasm Resources Lab, Beltsville, MD 20705 USA; [Malapi-Wight, Martha; Hendrickson, Leticia] USDA, APHIS, PPQ, Plant Germplasm Quarantine Program, Beltsville, MD 20705 USA; [Malapi-Wight, Martha] USDA, APHIS, BRS, Biotechnol Risk Anal Programs, Riverdale, MD USA; [Hammond, Rosemarie W.] USDA ARS, Mol Plant Pathol Lab, Beltsville, MD USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Mollov, D (corresponding author), USDA ARS, Natl Germplasm Resources Lab, Beltsville, MD 20705 USA.	Dimitre.mollov@usda.gov		Grinstead, Samuel/0000-0002-1708-8235; Fuentes-Bueno, Irazema/0000-0002-4692-8109; Mollov, Dimitre/0000-0002-4750-6194; Bolus, Stephen/0000-0001-5472-095X	United States Department of Agriculture, Agricultural Research Service and Animal and Plant Health Inspection Service	United States Department of Agriculture, Agricultural Research Service and Animal and Plant Health Inspection Service	This work was supported by the United States Department of Agriculture, Agricultural Research Service and Animal and Plant Health Inspection Service.	Agindotan B, 2013, CAN J PLANT PATHOL, V35, P81, DOI 10.1080/07060661.2012.752763; Boukari W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230066; CHEN S, 2016, VIRUSES-BASEL, V8, DOI DOI 10.3390/V8050120; Comstock J. C., 1998, Sugar Cane, P21; Domier L.L., 2012, VIRUS TAXONOMY, P1045; ElSayed AI, 2015, ARCH VIROL, V160, P2921, DOI 10.1007/s00705-015-2618-5; Fu SH, 2011, PLOS NEGL TROP DIS, V5, pe1231; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Grisham MP, 2012, PLANT DIS, V96, P150, DOI 10.1094/PDIS-07-11-0617; Huggett D.A.J., 1999, Agricultural and Forest Entomology, V1, P143, DOI 10.1046/j.1461-9563.1999.00019.x; Kar S, 2019, GCB BIOENERGY, V11, P1318, DOI 10.1111/gcbb.12632; Komor E, 2011, EUR J PLANT PATHOL, V129, P379, DOI 10.1007/s10658-010-9701-2; Kumar LM, 2018, PLANT DIS, V102, P466, DOI 10.1094/PDIS-09-17-1390-PDN; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lamptey JNL, 2003, J PHYTOPATHOL, V151, P463, DOI 10.1046/j.1439-0434.2003.00752.x; Lim HS, 2010, VIROLOGY, V402, P149, DOI 10.1016/j.virol.2010.03.022; Miller W.A., 1999, ENCY VIROLOGY, P901; MILLER WA, 1995, CRIT REV PLANT SCI, V14, P179, DOI 10.1080/713608119; Mo XH, 2010, VIRUS GENES, V41, P425, DOI 10.1007/s11262-010-0524-1; Moonan F, 2000, VIROLOGY, V269, P156, DOI 10.1006/viro.1999.0162; Pazhouhandeh M, 2006, P NATL ACAD SCI USA, V103, P1994, DOI 10.1073/pnas.0510784103; Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269; Scagliusi SM, 2000, PHYTOPATHOLOGY, V90, P120, DOI 10.1094/PHYTO.2000.90.2.120; Smirnova E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004868; Smith GR, 2000, J GEN VIROL, V81, P1865, DOI 10.1099/0022-1317-81-7-1865; Steckelberg AL, 2018, MBIO, V9, DOI 10.1128/mBio.02461-18; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Van der Weijde T, 2017, GCB BIOENERGY, V9, P176, DOI 10.1111/gcbb.12355; Yang XP, 2019, PHYTOPATHOLOGY, V109, P623, DOI 10.1094/PHYTO-08-18-0282-R; Zhang PP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01689; Zhao YL, 2017, GCB BIOENERGY, V9, P965, DOI 10.1111/gcbb.12404	31	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239199	10.1371/journal.pone.0239199	http://dx.doi.org/10.1371/journal.pone.0239199			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941541	gold, Green Published			2022-12-26	WOS:000573848800102
J	Cheung, J; Leary, EB; Lu, HY; Zeitzer, JM; Mignot, E				Cheung, Joseph; Leary, Eileen B.; Lu, Haoyang; Zeitzer, Jamie M.; Mignot, Emmanuel			PSG Validation of minute-to-minute scoring for sleep and wake periods in a consumer wearable device	PLOS ONE			English	Article							AMERICAN ACADEMY; ACTIGRAPHY; POLYSOMNOGRAPHY; TECHNOLOGY; MEDICINE; FRACTURE; DESIGN	Background Actigraphs are wrist-worn devices that record tri-axial accelerometry data used clinically and in research studies. The expense of research-grade actigraphs, however, limit their widespread adoption, especially in clinical settings. Tri-axial accelerometer-based consumer wearable devices have gained worldwide popularity and hold potential for a cost-effective alternative. The lack of independent validation of minute-to-minute accelerometer data with polysomnographic data or even research-grade actigraphs, as well as access to raw data has hindered the utility and acceptance of consumer-grade actigraphs. Methods Sleep clinic patients wore a consumer-grade wearable (Huami Arc) on their non-dominant wrist while undergoing an overnight polysomnography (PSG) study. The sample was split into two, 20 in a training group and 21 in a testing group. In addition to the Arc, the testing group also wore a research-grade actigraph (Philips Actiwatch Spectrum). Sleep was scored for each 60-s epoch on both devices using the Cole-Kripke algorithm. Results Based on analysis of our training group, Arc and PSG data were aligned best when a threshold of 10 units was used to examine the Arc data. Using this threshold value in our testing group, the Arc has an accuracy of 90.3%+/- 4.3%, sleep sensitivity (or wake specificity) of 95.5%+/- 3.5%, and sleep specificity (wake sensitivity) of 55.6%+/- 22.7%. Compared to PSG, Actiwatch has an accuracy of 88.7%+/- 4.5%, sleep sensitivity of 92.6%+/- 5.2%, and sleep specificity of 60.5%+/- 20.2%, comparable to that observed in the Arc. Conclusions An optimized sleep/wake threshold value was identified for a consumer-grade wearable Arc trained by PSG data. By applying this sleep/wake threshold value for Arc generated accelerometer data, when compared to PSG, sleep and wake estimates were adequate and comparable to those generated by a clinical-grade actigraph. As with other actigraphs, sleep specificity plateaus due to limitations in distinguishing wake without movement from sleep. Further studies are needed to evaluate the Arc's ability to differentiate between sleep and wake using other sources of data available from the Arc, such as high resolution accelerometry and photoplethysmography.	[Cheung, Joseph; Leary, Eileen B.; Zeitzer, Jamie M.; Mignot, Emmanuel] Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA; [Cheung, Joseph; Lu, Haoyang; Zeitzer, Jamie M.; Mignot, Emmanuel] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Zeitzer, Jamie M.] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Cheung, Joseph] Mayo Clin, Div Pulm & Sleep Med, Jacksonville, FL 32224 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Mayo Clinic	Cheung, J (corresponding author), Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA.; Cheung, J (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.; Cheung, J (corresponding author), Mayo Clin, Div Pulm & Sleep Med, Jacksonville, FL 32224 USA.	Cheung.joseph@mayo.edu	Leary, Eileen B/AAX-2519-2021; Zeitzer, Jamie M/A-1168-2007	Zeitzer, Jamie M/0000-0001-6174-5282; Cheung, Joseph/0000-0002-1222-7603; Leary, Eileen/0000-0002-7389-6384	Stanford Clinical and Translational Science Award to Spectrum [UL1 TR001085]; National Institute of Neurological Disorders and Stroke [K23 NS101094]; Klarman Family Foundation; Stanford University Department of Psychiatry and Behavioral Sciences Small Grant Program	Stanford Clinical and Translational Science Award to Spectrum; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Klarman Family Foundation; Stanford University Department of Psychiatry and Behavioral Sciences Small Grant Program	This work was supported by the Stanford Clinical and Translational Science Award to Spectrum (Grant No. UL1 TR001085) to JC, the National Institute of Neurological Disorders and Stroke (Grant No. K23 NS101094) to JC, the Klarman Family Foundation to EM, and the Stanford University Department of Psychiatry and Behavioral Sciences Small Grant Program. The device maker Huami, Inc. was not involved in the design, conduct, funding, or analysis of the research, nor were they involved in the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], 2018, J CANC RES THER, V14, pS622; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Cheung J., 2018, SLEEP SCI PRACTICE, V2, P11, DOI [10.1186/s41606-018-0029-8, DOI 10.1186/S41606-018-0029-8]; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; de Zambotti M, 2019, BEHAV SLEEP MED, V17, P124, DOI 10.1080/15402002.2017.1300587; de Zambotti M, 2016, SLEEP, V39, P1761, DOI 10.5665/sleep.6108; de Zambotti M, 2015, SLEEP, V38, P1461, DOI 10.5665/sleep.4990; Fonseca P, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx097; Gallo LC, 2014, ETHNIC DIS, V24, P77; Khosla S, 2018, J CLIN SLEEP MED, V14, P877, DOI 10.5664/jcsm.7128; Kripke DF, 2010, J SLEEP RES, V19, P612, DOI 10.1111/j.1365-2869.2010.00835.x; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; Mccall C, 2012, J SLEEP RES, V21, P122, DOI 10.1111/j.1365-2869.2011.00917.x; Meltzer LJ, 2015, SLEEP, V38, P1323, DOI 10.5665/sleep.4918; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; Roomkham Sirinthip, 2018, IEEE Rev Biomed Eng, V11, P53, DOI 10.1109/RBME.2018.2811735; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Smith MT, 2018, USE ACTIGRAPHY EVALU; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364	23	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238464	10.1371/journal.pone.0238464	http://dx.doi.org/10.1371/journal.pone.0238464			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941498	gold, Green Published			2022-12-26	WOS:000573848800057
J	Xu, F; Chen, XL; Sun, XH; Dong, F; Li, CY; Li, PY; Ding, HT; Chen, Y; Zhang, YZ; Wang, P				Xu, Fei; Chen, Xiu-Lan; Sun, Xiao-Hui; Dong, Fang; Li, Chun-Yang; Li, Ping-Yi; Ding, Haitao; Chen, Yin; Zhang, Yu-Zhong; Wang, Peng			Structural and molecular basis for the substrate positioning mechanism of a new PL7 subfamily alginate lyase from the arctic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alginate lyase; PL7 family; subfamily; substrate positioning; Arctic; algae; metabolism; enzyme degradation; enzyme mechanism	KEY FEATURES; MARINE; POLYSACCHARIDES; CLONING; GENES; RECOGNITION; AGARIVORANS; VIBRIO; ACID; PL-7	Alginate lyases play important roles in alginate degradation in the ocean. Although a large number of alginate lyases have been characterized, little is yet known about those in extremely cold polar environments, which may have unique mechanisms for environmental adaptation and for alginate degradation. Here, we report the characterization of a novel PL7 alginate lyase AlyC3 from Psychromonas sp. C-3 isolated from the Arctic brown alga Laminaria, including its phylogenetic classification, catalytic properties, and structure. We propose the establishment of a new PM-specific subfamily of PL7 (subfamily 6) represented by AlyC3 based on phylogenetic analysis and enzymatic properties. Structural and biochemical analyses showed that AlyC3 is a dimer, representing the first dimeric endo-alginate lyase structure. AlyC3 is activated by NaCl and adopts a novel salt-activated mechanism; that is, salinity adjusts the enzymatic activity by affecting its aggregation states. We further solved the structure of an inactive mutant H127A/Y244A in complex with a dimannuronate molecule and proposed the catalytic process of AlyC3 based on structural and biochemical analyses. We show that Arg(82) and Tyr(190) at the two ends of the catalytic canyon help the positioning of the repeated units of the substrate and that His(127), Tyr(244), Arg(78), and Gln(125) mediate the catalytic reaction. Our study uncovers, for the first time, the amino acid residues for alginate positioning in an alginate lyase and demonstrates that such residues involved in alginate positioning are conserved in other alginate lyases. This study provides a better understanding of the mechanisms of alginate degradation by alginate lyases.	[Xu, Fei; Chen, Xiu-Lan; Sun, Xiao-Hui; Dong, Fang; Li, Ping-Yi; Zhang, Yu-Zhong] Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China; [Xu, Fei; Chen, Xiu-Lan; Sun, Xiao-Hui; Dong, Fang; Li, Ping-Yi; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, Qingdao, Peoples R China; [Chen, Xiu-Lan; Li, Chun-Yang; Zhang, Yu-Zhong; Wang, Peng] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Li, Chun-Yang; Chen, Yin; Zhang, Yu-Zhong; Wang, Peng] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Li, Chun-Yang; Chen, Yin; Zhang, Yu-Zhong; Wang, Peng] Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Qingdao, Peoples R China; [Ding, Haitao] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai, Peoples R China; [Chen, Yin] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	Shandong University; Shandong University; Qingdao National Laboratory for Marine Science & Technology; Ocean University of China; Ocean University of China; Polar Research Institute of China; University of Warwick	Wang, P (corresponding author), Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Wang, P (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.; Wang, P (corresponding author), Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Qingdao, Peoples R China.	wangpeng3331@ouc.edu.cn		Zhang, Yu-Zhong/0000-0002-2017-1005; Chen, Yin/0000-0002-0367-4276; Li, Chun-Yang/0000-0002-1151-4897; Wang, Peng/0000-0002-4983-9953	National Key Research and Development Program of China [2018YFC1406700]; National Science Foundation of China [91851205, 31870052, 31800107, U1706207, 91751101, 41706152, 41676180]; Major Scientific and Technological Innovation Project of Shandong Province [2019JZZY010817]; Program of Shandong for Taishan Scholars [tspd20181203]; AoShan Talents Cultivation Program - Qingdao National Laboratory for Marine Science and Technology [2017ASTCP-OS14, QNLM2016ORP0310]; Young Scholars Program of Shandong University [2017WLJH57]	National Key Research and Development Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Innovation Project of Shandong Province; Program of Shandong for Taishan Scholars; AoShan Talents Cultivation Program - Qingdao National Laboratory for Marine Science and Technology; Young Scholars Program of Shandong University	This work was supported by Grant 2018YFC1406700 from the National Key Research and Development Program of China; Grants 91851205, 31870052, 31800107, U1706207, 91751101, 41706152, and 41676180 from the National Science Foundation of China; Grant 2019JZZY010817 from the Major Scientific and Technological Innovation Project of Shandong Province; Grant tspd20181203 from the Program of Shandong for Taishan Scholars; Grants 2017ASTCP-OS14 and QNLM2016ORP0310 from the AoShan Talents Cultivation Program Supported by Qingdao National Laboratory for Marine Science and Technology; and Grant 2017WLJH57 from the Young Scholars Program of Shandong University.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Chen XL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01120; Dong F, 2019, J MOL BIOL, V431, P4897, DOI 10.1016/j.jmb.2019.10.023; Dong S, 2014, J BIOL CHEM, V289, P29558, DOI 10.1074/jbc.M114.584573; Dong S, 2012, MAR DRUGS, V10, P2481, DOI 10.3390/md10112481; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; Gao S, 2018, INT J BIOL MACROMOL, V120, P729, DOI 10.1016/j.ijbiomac.2018.08.164; GORIN PAJ, 1966, CAN J CHEMISTRY, V44, P993, DOI 10.1139/v66-147; Hehemann JH, 2014, CURR OPIN STRUC BIOL, V28, P77, DOI 10.1016/j.sbi.2014.07.009; Helbert W, 2019, P NATL ACAD SCI USA, V116, P6063, DOI 10.1073/pnas.1815791116; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hough DW, 1999, CURR OPIN CHEM BIOL, V3, P39, DOI 10.1016/S1367-5931(99)80008-8; Hu XK, 2004, J APPL PHYCOL, V16, P73, DOI 10.1023/B:JAPH.0000019139.35046.0c; Huang GY, 2018, MAR DRUGS, V16, DOI 10.3390/md16040120; Inoue Akira, 2015, Curr Biotechnol, V4, P240, DOI 10.2174/2211550104666150915210434; Islan GA, 2013, MACROMOL BIOSCI, V13, P1238, DOI 10.1002/mabi.201300134; Iwamoto M, 2005, FEBS LETT, V579, P4423, DOI 10.1016/j.febslet.2005.07.007; Kawamoto H, 2006, MAR BIOTECHNOL, V8, P481, DOI 10.1007/s10126-005-6157-z; Li SY, 2015, J MICROBIOL BIOTECHN, V25, P681, DOI 10.4014/jmb.1409.09031; LINKER A, 1966, J BIOL CHEM, V241, P3845; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; MALISSARD M, 1993, FEMS MICROBIOL LETT, V110, P101, DOI 10.1016/0378-1097(93)90249-2; Meillisa A, 2015, FOOD CHEM, V171, P70, DOI 10.1016/j.foodchem.2014.08.097; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Osawa T, 2005, J MOL BIOL, V345, P1111, DOI 10.1016/j.jmb.2004.10.081; Qin HM, 2018, CHEM COMMUN, V54, P555, DOI 10.1039/c7cc06523j; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sakatoku A, 2013, J MICROBIOL BIOTECHN, V23, P872, DOI 10.4014/jmb.1301.01075; Sim PF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13288-1; SMITH SV, 1981, SCIENCE, V211, P838, DOI 10.1126/science.211.4484.838; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Uchimura K, 2010, MAR BIOTECHNOL, V12, P526, DOI 10.1007/s10126-009-9237-7; Ulaganathan T, 2018, J BIOL CHEM, V293, P4026, DOI 10.1074/jbc.RA117.001642; USOV AI, 1995, BOT MAR, V38, P43, DOI 10.1515/botm.1995.38.1-6.43; Vuoristo KS, 2019, J AGR FOOD CHEM, V67, P2936, DOI 10.1021/acs.jafc.8b07190; Wang YJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02457; Wang ZP, 2020, MAR DRUGS, V18, DOI 10.3390/md18040189; Wang ZJ, 2016, J SYNCHROTRON RADIAT, V23, P1323, DOI 10.1107/S160057751601451X; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Xu F, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02040-17; Xu F, 2017, J BIOL CHEM, V292, P4457, DOI 10.1074/jbc.M116.766030; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075; Yamasaki M, 2004, J BIOL CHEM, V279, P31863, DOI 10.1074/jbc.M402466200; Zeng YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep33031	47	18	18	5	40	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16380	16392		10.1074/jbc.RA120.015106	http://dx.doi.org/10.1074/jbc.RA120.015106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32967968	Green Published, hybrid			2022-12-26	WOS:000598519500017
J	Kawasaki, Y; Park, S; Miyamoto, K; Ueki, R; Kariya, N; Tatara, T; Hirose, M				Kawasaki, Yui; Park, Soonhee; Miyamoto, Kazunori; Ueki, Ryusuke; Kariya, Nobutaka; Tatara, Tsuneo; Hirose, Munetaka			Modified model for predicting early C-reactive protein levels after gastrointestinal surgery: A prospective cohort study	PLOS ONE			English	Article							POSTOPERATIVE PANCREATIC FISTULA; LAPAROSCOPIC GASTRECTOMY; INFLAMMATORY RESPONSE; ELDERLY-PATIENTS; STRESS-RESPONSE; COMPLICATIONS; BIOMARKERS; MORBIDITY; ESMOLOL; MARKERS	Background Postoperative serum concentration of C-reactive protein (CRP) is one of the objective quantitative indices integrating the effects of preoperative and intraoperative variables. Higher levels of CRP after gastrointestinal surgery are associated with major postoperative complications. To develop a model for predicting CRP levels on postoperative day (POD) 1 in surgical patients both with and without serious conditions and comorbidities, we modified the previous formula for prediction of CRP levels on POD1, and assessed the accuracy of our modified predictive formula for CRP levels. Material and methods Consecutive patients of all ages undergoing gastrointestinal surgery under general anesthesia were enrolled in this single-institution prospective cohort study. We developed a modified predictive formula in a calculation cohort. Next, associations between measured CRP levels on POD1, predicted CRP levels on POD1 using the previous and modified models, and major complications after surgery were examined in a validation cohort. Results We obtained the following model in the calculation cohort (n = 222): Modified model for predicting CRP levels on POD1 (mg center dot dL(-1)) = -10.13 + 0.0025 Duration of surgery (min) + 15.9 Mean Nociceptive Response (NR) + 0.66 Preoperative CRP level (mg center dot dL(-1)). In the validation cohort (n = 440), there was a significant association between measured and predicted CRP levels on POD1 (P< 0.001) No significant difference between the measured and predicted CRP levels using the modified model was observed (P= 0.847). There were also significant associations between the predicted CRP levels and major complications after surgery. Conclusion CRP levels predicted using duration of surgery, mean NR, and preoperative CRP levels are likely identical to measured CRP levels on POD1, being associated with major complications after gastrointestinal surgery.	[Kawasaki, Yui; Park, Soonhee; Miyamoto, Kazunori; Ueki, Ryusuke; Kariya, Nobutaka; Tatara, Tsuneo; Hirose, Munetaka] Hyogo Coll Med, Dept Anesthesiol & Pain Med, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine	Hirose, M (corresponding author), Hyogo Coll Med, Dept Anesthesiol & Pain Med, Nishinomiya, Hyogo, Japan.	mhirose@hyo-med.ac.jp			 [18K08875]		This study was supported by a Grant-in-Aid for Scientific Research KAKENHI (18K08875). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abet E, 2020, INT J COLORECTAL DIS, V35, P1125, DOI 10.1007/s00384-020-03594-y; Aktimur R, 2016, J MINIM ACCESS SURG, V12, P143, DOI 10.4103/0972-9941.156203; Benoit O, 2019, DIS COLON RECTUM, V62, P88, DOI 10.1097/DCR.0000000000001216; Olivares MC, 2018, J SURG ONCOL, V117, P717, DOI 10.1002/jso.24909; Cheng WM, 2014, J CHIN MED ASSOC, V77, P234, DOI 10.1016/j.jcma.2014.02.008; Dobson GP, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00043; Esme H, 2011, INT J MED SCI, V8, P216, DOI 10.7150/ijms.8.216; Fant F, 2013, BRIT J ANAESTH, V110, P747, DOI 10.1093/bja/aes491; Glance LG, 2012, ANN SURG, V255, P696, DOI 10.1097/SLA.0b013e31824b45af; Hirose M, 2018, MED SCI MONITOR, V24, P3324, DOI 10.12659/MSM.907484; Karayiannakis AJ, 1997, BRIT J SURG, V84, P467; Katayama H, 2016, SURG TODAY, V46, P668, DOI 10.1007/s00595-015-1236-x; Kim SY, 2016, BJOG-INT J OBSTET GY, V123, P580, DOI 10.1111/1471-0528.13785; Kim YS, 2013, ANAESTHESIA, V68, P924, DOI 10.1111/anae.12229; Kim Y, 2015, SURG INNOV, V22, P177, DOI 10.1177/1553350614532534; Kroll D, 2018, OBES SURG, V28, P2760, DOI 10.1007/s11695-018-3240-x; Kurata K, 2017, INT J SURG, V48, P215, DOI 10.1016/j.ijsu.2017.11.002; Kurokawa Y, 2020, GASTRIC CANCER, V23, P937, DOI 10.1007/s10120-020-01073-5; Lindholm EE, 2015, ACTA ANAESTH SCAND, V59, P773, DOI 10.1111/aas.12466; Mari G, 2016, CHIRURGIA-BUCHAREST, V111, P476, DOI 10.21614/chirurgia.111.6.476; Maruta Kazuto, 2016, Ann Vasc Dis, V9, P168; Matsubara D, 2020, INT J CLIN ONCOL, V25, P602, DOI 10.1007/s10147-019-01580-1; Matsunaga T, 2017, ASIAN J ENDOSC SURG, V10, P382, DOI 10.1111/ases.12374; Nakamoto S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226032; Ogata H, 2020, J CLIN MONIT COMPUT, V34, P575, DOI 10.1007/s10877-019-00347-3; Panhofer P, 2014, INT J SURG, V12, P334, DOI 10.1016/j.ijsu.2014.01.012; Paradis T, 2020, J GASTROINTEST SURG, V24, P1392, DOI 10.1007/s11605-020-04599-2; Purdy M, 2016, ANTICANCER RES, V36, P3005; Ray S, 2019, J SURG RES, V244, P417, DOI 10.1016/j.jss.2019.06.093; Straatman J, 2018, SURG ENDOSC, V32, P2877, DOI 10.1007/s00464-017-5996-9; Velickovic J, 2020, J SURG RES, V247, P397, DOI 10.1016/j.jss.2019.10.003; Volk T, 2004, ANESTH ANALG, V98, P1086, DOI 10.1213/01.ANE.0000104586.12700.3A; Watt DG, 2015, SURGERY, V157, P362, DOI 10.1016/j.surg.2014.09.009; Yamada S, 2019, J MED INVESTIG, V66, P285, DOI 10.2152/jmi.66.285; Zhang KC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003798; Zhao GB, 2014, SUPPORT CARE CANCER, V22, P351, DOI 10.1007/s00520-013-1979-0	36	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239709	10.1371/journal.pone.0239709	http://dx.doi.org/10.1371/journal.pone.0239709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970767	gold, Green Published			2022-12-26	WOS:000576265600023
J	Kondratieva, T; Shleeva, M; Kapina, M; Rubakova, E; Linge, I; Dyatlov, A; Kondratieva, E; Kaprelyants, A; Apt, A				Kondratieva, Tatiana; Shleeva, Margarita; Kapina, Marina; Rubakova, Elvira; Linge, Irina; Dyatlov, Alexander; Kondratieva, Elena; Kaprelyants, Arseny; Apt, Alexander			Prolonged infection triggered by dormant Mycobacterium tuberculosis: Immune and inflammatory responses in lungs of genetically susceptible and resistant mice	PLOS ONE			English	Article							IN-VITRO; MODELS; TB; REACTIVATION; GENES	We developed an approach for substantial attenuation ofMycobacterium tuberculosisby prolonged culturing under gradually acidifying conditions. Bacteria subjected to acidification lost the capacity to form colonies on solid media, but readily resuscitated their growth in the murine host, providing a useful model to studyin vivodevelopment of infection mimicking latent and reactivation tuberculosis (TB) in humans. Here we characterize biomarkers of lung pathology and immune responses triggered by such attenuated bacteria in genetically TB-susceptible and resistant mice. In susceptible I/St mice, CFU counts in lungs and spleens were similar to 1.5-log higher than in resistant B6 mice, accompanied by diffuse pneumonia and excessive lung infiltration with highly activated CD44(+)CD62L(-)T-lymphocytes resulting in death between months 7-9 post challenge. B6 mice were characterized by development of local inflammatory foci, higher production of pro-inflammatory IL-6 and IL-11 cytokines and a more balanced T-cell activation in their lungs. CFU counts remained stable in B6 mice during the whole 18-mo observation period, and all mice survived. Thus, we established a mouse model of fatal reactivation TBvs. indefinite mycobacterial possession after identical challenge and characterized the features of immune responses in the lung tissue underlining these polar phenotypes.	[Kondratieva, Tatiana; Kapina, Marina; Rubakova, Elvira; Linge, Irina; Dyatlov, Alexander; Kondratieva, Elena; Apt, Alexander] Cent Inst TB, Lab Immunogenet, Moscow, Russia; [Shleeva, Margarita; Kaprelyants, Arseny] Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, AN Bach Inst Biochem, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences	Apt, A (corresponding author), Cent Inst TB, Lab Immunogenet, Moscow, Russia.	alexapt0151@gmail.com	Shleeva, Margarita/ADL-9159-2022; Linge, Irina/HHM-3272-2022; Dyatlov, Alexander/AAA-8060-2022	Linge, Irina/0000-0003-1535-5800; Apt, Alexander/0000-0002-3683-3085	Russian Science Foundation [18-45-04015, 19-15-00324]; Russian Ministry of Science and Higher Education	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Ministry of Science and Higher Education	This work was supported by the Russian Science Foundation (http://rscf.ru/en/) grants 18-45-04015 (to AA, in vivo experiments) and 19-15-00324 (to MS, mycobacteria establishment). AS acknowledges the support from the Russian Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt A, 2009, TUBERCULOSIS, V89, P195, DOI 10.1016/j.tube.2009.02.002; Apt AS, 2011, IMMUNOLOGY, V134, P109, DOI 10.1111/j.1365-2567.2011.03472.x; APT AS, 1993, CLIN EXP IMMUNOL, V94, P322, DOI 10.1111/j.1365-2249.1993.tb03451.x; BALASUBRAMANIAN V, 1994, TUBERCLE LUNG DIS, V75, P168, DOI 10.1016/0962-8479(94)90002-7; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bhavanam S, 2016, FUTURE MICROBIOL, V11, P1073, DOI 10.2217/fmb-2016-0005; Brites D, 2017, ADV EXP MED BIOL, V1019, P1, DOI 10.1007/978-3-319-64371-7_1; Brites D, 2015, IMMUNOL REV, V264, P6, DOI 10.1111/imr.12264; Cadena AM, 2017, NAT REV IMMUNOL, V17, P691, DOI 10.1038/nri.2017.69; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; Correa-Macedo W, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00865; Crouser ED, 2017, AM J RESP CELL MOL, V57, P487, DOI 10.1165/rcmb.2016-0321OC; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; Dutta NK, 2014, MICROBIOL MOL BIOL R, V78, P343, DOI 10.1128/MMBR.00010-14; Eruslanov EB, 2004, CLIN EXP IMMUNOL, V135, P19, DOI 10.1111/j.1365-2249.2004.02328.x; Gibson SER, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7040088; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Kaufmann SHE, 2010, IMMUNITY, V33, P567, DOI 10.1016/j.immuni.2010.09.015; Kondratieva T, 2011, TUBERCULOSIS, V91, P219, DOI 10.1016/j.tube.2011.01.005; Kondratieva TK, 2018, TUBERCULOSIS, V113, P130, DOI 10.1016/j.tube.2018.10.003; Lillebaek T, 2002, EMERG INFECT DIS, V8, P679, DOI 10.3201/eid0807.010482; Logunova N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005672; MCCUNE RM, 1966, J EXP MED, V123, P445, DOI 10.1084/jem.123.3.445; MCCUNE RM, 1966, J EXP MED, V123, P469, DOI 10.1084/jem.123.3.469; Mischenko VV, 2004, J INFECT DIS, V190, P2137, DOI 10.1086/425909; Orme IM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0002-2015; Orme IM, 2011, FUTURE MICROBIOL, V6, P161, DOI 10.2217/FMB.10.168; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Radaeva TV, 2008, TUBERCULOSIS, V88, P576, DOI 10.1016/j.tube.2008.05.003; Radaeva TV, 2005, TUBERCULOSIS, V85, P65, DOI 10.1016/j.tube.2004.09.014; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Saini D, 2012, TUBERCULOSIS, V92, P160, DOI 10.1016/j.tube.2011.11.007; Shi CH, 2011, SCAND J INFECT DIS, V43, P848, DOI 10.3109/00365548.2011.603745; Shleeva M, 2015, MICROB PATHOGENESIS, V78, P63, DOI 10.1016/j.micpath.2014.11.016; Shleeva MO, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00370; Shleeva MO, 2011, TUBERCULOSIS, V91, P146, DOI 10.1016/j.tube.2010.12.006; Trutneva KA, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00026; Williams A, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TBTB2-0004-2015	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239668	10.1371/journal.pone.0239668	http://dx.doi.org/10.1371/journal.pone.0239668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970762	Green Published, gold			2022-12-26	WOS:000576265600025
J	Waselkov, KE; Regenold, ND; Lum, RC; Olsen, KM				Waselkov, Katherine E.; Regenold, Nathaniel D.; Lum, Romy C.; Olsen, Kenneth M.			Agricultural adaptation in the native North American weed waterhemp,Amaranthus tuberculatus(Amaranthaceae)	PLOS ONE			English	Article							WATERHEMP AMARANTHUS-RUDIS; COMMON MORNING GLORY; HERBICIDE-RESISTANCE; SEED DORMANCY; ADAPTIVE EVOLUTION; TILLAGE SYSTEMS; FITNESS COSTS; TUBERCULATUS; POPULATIONS; EMERGENCE	There is increasing interest in documenting adaptation of weedy plant species to agricultural ecosystems, beyond the evolution of herbicide resistance. Waterhemp (Amaranthus tuberculatus) is a native plant of the Midwestern U.S. that began infesting agricultural fields in the 20(th)century within the central portion of its range. We hypothesized that the vegetative growth and reproductive traits of waterhemp from this heavily infested central region provide differential fitness benefits in agricultural environments. We collected seeds from across the species' native range, representing regions with varying degrees of waterhemp infestation, and planted them together in common garden soybean plots. A 2010 common garden experiment was conducted within the range of agriculturally weedy waterhemp (in Missouri), and a 2011 common garden experiment was conducted outside of this range (in Ohio). Days to flowering and flowering plant height, mature plant size data (height, number of branches, and length of the longest branch), and above-ground biomass were measured to estimate relative fitness. In both common garden locations, plants from regions where waterhemp occurs as an agricultural weed - including those from the heavily infested Mississippi Valley region (Iowa, Illinois, and Missouri) and the less severely infested Plains region (Nebraska, Kansas, and Oklahoma) - had higher relative performance in almost all fitness-related measures than plants from the Northeast region (Ohio, Michigan, and Ontario), which had little to no agriculturally weedy waterhemp at the time of our study. Further analysis revealed that fewer days to flowering in the Northeast populations can be largely accounted for by latitude of origin, suggesting a strong genetic influence on this reproductive trait. These findings suggest intraspecific variation in agricultural adaptation in a native U.S. weed, and support the use of agricultural weeds to study adaptation.	[Waselkov, Katherine E.; Regenold, Nathaniel D.; Olsen, Kenneth M.] Washington Univ, Dept Biol, Coll Arts & Sci, Campus Box 1137, St Louis, MO 63130 USA; [Waselkov, Katherine E.; Lum, Romy C.] Calif State Univ Fresno, Dept Biol, Coll Sci & Math, Fresno, CA 93740 USA; [Regenold, Nathaniel D.] Simpson Thacher & Bartlett LLP, New York, NY USA	Washington University (WUSTL); California State University System; California State University Fresno	Waselkov, KE (corresponding author), Washington Univ, Dept Biol, Coll Arts & Sci, Campus Box 1137, St Louis, MO 63130 USA.; Waselkov, KE (corresponding author), Calif State Univ Fresno, Dept Biol, Coll Sci & Math, Fresno, CA 93740 USA.	kwaselkov@csufresno.edu		Waselkov, Katherine/0000-0001-8521-3694	Washington University College of Arts and Sciences; National Science Foundation; Howard Hughes Medical Institute; Washington University	Washington University College of Arts and Sciences; National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Washington University	KMO, no grant number (start-up funding), Washington University College of Arts and Sciences, https://artsci.wustl.edu/; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KEW, no grant number (Graduate Research Fellowship awarded 2007), National Science Foundation, www.nsf.gov; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NDR, no grant number (Summer Undergraduate Research Fellowship 2010), Howard Hughes Medical Institute and Washington University, https://undergradresearch.wustl.edu/wu_biosurf; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare an affiliation of one author (Nathaniel D. Regenold) with a commercial law firm, Simpson Thacher & Bartlett LLP, New York, New York, U.S.A. The funder provided support in the form of salaries for authors NDR, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen JA, 1876, B US GEOL GEOGR SURV, V2, P309, DOI [DOI 10.3133/70157321, 10.3133/70157321]; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Baucom RS, 2019, NEW PHYTOL, V223, P68, DOI 10.1111/nph.15723; Begg GS, 2012, ECOGRAPHY, V35, P446, DOI 10.1111/j.1600-0587.2011.07030.x; Benech-Arnold RL, 2000, FIELD CROP RES, V67, P105, DOI 10.1016/S0378-4290(00)00087-3; Bernards ML, 2012, WEED SCI, V60, P379, DOI 10.1614/WS-D-11-00170.1; BUHLER DD, 1995, CROP SCI, V35, P1247, DOI 10.2135/cropsci1995.0011183X003500050001x; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Campbell LG, 2009, NEW PHYTOL, V184, P806, DOI 10.1111/j.1469-8137.2009.03036.x; Cano L, 2008, J ECOL, V96, P468, DOI 10.1111/j.1365-2745.2008.01363.x; Capellini I, 2015, ECOL LETT, V18, P1099, DOI 10.1111/ele.12493; Chaney L, 2012, AM J BOT, V99, P1524, DOI 10.3732/ajb.1200096; Clements DR, 2004, AGR ECOSYST ENVIRON, V104, P379, DOI 10.1016/j.agee.2004.03.003; Corbi J, 2018, MOL ECOL, V27, P233, DOI 10.1111/mec.14202; Costea M, 2005, CAN J PLANT SCI, V85, P507, DOI 10.4141/P04-101; Costea M, 2004, CAN J PLANT SCI, V84, P631, DOI 10.4141/P02-183; Costea M, 2003, RHODORA, V105, P260; Cristescu ME, 2015, MOL ECOL, V24, P2212, DOI 10.1111/mec.13117; Delye C, 2010, NEW PHYTOL, V186, P1005, DOI 10.1111/j.1469-8137.2010.03233.x; DEWET JMJ, 1975, ECON BOT, V29, P99, DOI 10.1007/BF02863309; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duff MG, 2009, WEED SCI, V57, P169, DOI 10.1614/WS-08-104.1; Erfmeier A, 2005, ECOGRAPHY, V28, P417, DOI 10.1111/j.0906-7590.2005.03967.x; Foes MJ, 1998, WEED SCI, V46, P514, DOI 10.1017/S0043174500091013; Gassmann AJ, 2005, OECOLOGIA, V145, P575, DOI 10.1007/s00442-005-0112-6; Ghersa CM, 1995, WEED RES, V35, P461, DOI 10.1111/j.1365-3180.1995.tb01643.x; Hager A, 2000, 2000 ILLINOIS AGR PE, P91; Hager AG, 2002, CROP PROT, V21, P277, DOI 10.1016/S0261-2194(01)00098-9; Hartzler RG, 2004, WEED SCI, V52, P242, DOI 10.1614/WS-03-004R; Hausman NE, 2011, PEST MANAG SCI, V67, P258, DOI 10.1002/ps.2100; Hawes C, 2003, PHILOS T ROY SOC B, V358, P1899, DOI 10.1098/rstb.2003.1406; Heap I., INT HERBICIDE RESIST; Heneghan JM, 2017, WEED SCI, V65, P247, DOI 10.1017/wsc.2016.20; Hierro JL, 2005, J ECOL, V93, P5, DOI 10.1111/j.0022-0477.2004.00953.x; Hilgenfeld KL, 2004, WEED TECHNOL, V18, P284, DOI 10.1614/WT-03-045R1; HORAK MJ, 1995, WEED TECHNOL, V9, P192, DOI 10.1017/S0890037X00023174; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; Jasieniuk M, 1996, WEED SCI, V44, P176, DOI 10.1017/S0043174500093747; Jha P., 2008, THESIS; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kreiner JM, 2019, P NATL ACAD SCI USA, V116, P21076, DOI 10.1073/pnas.1900870116; Kuester A, 2016, MOL ECOL, V25, P4508, DOI 10.1111/mec.13737; Lai Z, 2008, GENETICS, V179, P1881, DOI 10.1534/genetics.108.091041; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Legleiter TR, 2008, WEED SCI, V56, P582, DOI 10.1614/WS-07-204.1; Leon RG, 2007, WEED RES, V47, P335, DOI 10.1111/j.1365-3180.2007.00571.x; Leon RG, 2006, WEED SCI, V54, P1037, DOI 10.1614/WS-06-009.1; Leon RG, 2006, WEED SCI, V54, P305; Liebman M., 2001, WEEDS SOIL ENV; Meiri S, 2009, P ROY SOC B-BIOL SCI, V276, P1469, DOI 10.1098/rspb.2008.1318; Moloney KA, 2009, PERSPECT PLANT ECOL, V11, P311, DOI 10.1016/j.ppees.2009.05.002; Montgomery JS, 2019, WEED SCI, V67, P412, DOI 10.1017/wsc.2019.27; Mosyakin SL, 2003, AMARANTHUS, V4, P410; Muller MH, 2009, GENET RESOUR CROP EV, V56, P869, DOI 10.1007/s10722-009-9409-3; Neve P, 2009, NEW PHYTOL, V184, P783, DOI 10.1111/j.1469-8137.2009.03034.x; Norsworthy JK, 2010, WEED SCI, V58, P402, DOI 10.1614/WS-D-10-00034.1; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; Owen MDK, 2005, PEST MANAG SCI, V61, P301, DOI 10.1002/ps.1015; Owen MDK, 2008, PEST MANAG SCI, V64, P377, DOI 10.1002/ps.1539; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pironon S, 2017, BIOL REV, V92, P1877, DOI 10.1111/brv.12313; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Pratt DB, 2001, J TORREY BOT SOC, V128, P282, DOI 10.2307/3088718; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Refsell DE, 2009, WEED TECHNOL, V23, P129, DOI 10.1614/WT-08-045.1; SAUER J, 1957, EVOLUTION, V11, P11, DOI 10.2307/2405808; Sauer JD, 1972, MADRONO, V21, P427; SAUER JONATHAN, 1955, MADRONO, V13, P5; Schryver MG, 2017, CAN J PLANT SCI, V97, P1057, DOI 10.1139/cjps-2016-0371; Schutte BJ, 2012, WEED SCI, V60, P19, DOI 10.1614/WS-D-11-00049.1; Shivrain VK, 2009, WEED SCI, V57, P94, DOI 10.1614/WS-08-112.1; Shoup DE, 2003, WEED SCI, V51, P145, DOI 10.1614/0043-1745(2003)051[0145:CWARRT]2.0.CO;2; Sibony M, 2003, WEED RES, V43, P40, DOI 10.1046/j.1365-3180.2003.00315.x; Steckel LE, 2007, WEED TECHNOL, V21, P567, DOI 10.1614/WT-06-045.1; Steckel LE, 2002, WEED TECHNOL, V16, P755, DOI 10.1614/0890-037X(2002)016[0755:CWARCI]2.0.CO;2; Strom SA, 2019, WEED SCI, V67, P369, DOI 10.1017/wsc.2019.13; SWANTON CJ, 1993, WEED TECHNOL, V7, P286, DOI 10.1017/S0890037X00027615; Tardif FJ, 2006, NEW PHYTOL, V169, P251, DOI 10.1111/j.1469-8137.2005.01596.x; Tranel P.J., 2009, WEEDY INVASIVE PLANT, V53, P81, DOI DOI 10.1002/9780813806198.CH5; USDA (United States Department of Agriculture), 2019, ACR; van Boheemen LA, 2019, NEW PHYTOL, V222, P614, DOI 10.1111/nph.15564; Van Etten ML, 2016, EVOLUTION, V70, P2199, DOI 10.1111/evo.13016; Vigueira CC, 2013, HEREDITY, V110, P303, DOI 10.1038/hdy.2012.104; Waselkov KE, 2014, AM J BOT, V101, P1726, DOI 10.3732/ajb.1400064; Wedger MJ, 2019, J HERED, V110, P601, DOI 10.1093/jhered/esz030; Wu CX, 2018, PEST MANAG SCI, V74, P293, DOI 10.1002/ps.4706; Wu CX, 2014, WEED SCI, V62, P107, DOI 10.1614/WS-D-13-00079.1; Zhang WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00286-0	89	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238861	10.1371/journal.pone.0238861	http://dx.doi.org/10.1371/journal.pone.0238861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970699	gold, Green Published			2022-12-26	WOS:000576265600042
J	Bassin, EJ; Buckley, AR; Piganelli, JD; Little, SR				Bassin, Ethan J.; Buckley, Abigail R.; Piganelli, Jon D.; Little, Steven R.			TRI microparticles prevent inflammatory arthritis in a collagen-induced arthritis model	PLOS ONE			English	Article							REGULATORY T-CELLS; TGF-BETA; RHEUMATOID-ARTHRITIS; AUTOIMMUNE ARTHRITIS; INDUCTION; RAPAMYCIN; TOLERANCE; PEPTIDE; COMPLEX; IL-2	Despite recent progress in the treatment of rheumatoid arthritis (RA), many patients still fail to achieve remission or low disease activity. An imbalance between auto-reactive effector T cells (Teff) and regulatory T cells (Treg) may contribute to joint inflammation and damage in RA. Therefore, restoring this balance is a promising approach for the treatment of inflammatory arthritis. Accordingly, our group has previously shown that the combination of TGF-beta-releasing microparticles (MP), rapamycin-releasing MP, and IL-2-releasing MP (TRI MP) can effectively increase the ratio of Tregs to Teffin vivoand provide disease protection in several preclinical models. In this study TRI MP was evaluated in the collagen-induced arthritis (CIA) model. Although this formulation has been tested previously in models of destructive inflammation and transplantation, this is the first model of autoimmunity for which this therapy has been applied. In this context, TRI MP effectively reduced arthritis incidence, the severity of arthritis scores, and bone erosion. The proposed mechanism of action includes not only reducing CD4(+)T cell proliferation, but also expanding a regulatory population in the periphery soon after TRI MP administration. These changes were reflected in the CD4(+)T cell population that infiltrated the paws at the onset of arthritis and were associated with a reduction of immune infiltrate and inflammatory myeloid cells in the paws. TRI MP administration also reduced the titer of collagen antibodies, however the contribution of this reduced titer to disease protection remains uncertain since there was no correlation between collagen antibody titer and arthritis score.	[Bassin, Ethan J.; Buckley, Abigail R.; Piganelli, Jon D.; Little, Steven R.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Buckley, Abigail R.; Piganelli, Jon D.] Univ Pittsburgh, Dept Surg, Div Pediat Surg, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; [Little, Steven R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Little, Steven R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Little, Steven R.] Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Little, Steven R.] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Piganelli, JD; Little, SR (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.; Piganelli, JD (corresponding author), Univ Pittsburgh, Dept Surg, Div Pediat Surg, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA.; Little, SR (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.; Little, SR (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Little, SR (corresponding author), Univ Pittsburgh, Dept Ophthalmol, Pittsburgh, PA 15260 USA.; Little, SR (corresponding author), Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15260 USA.	jdp51@pitt.edu; srlittle@pitt.edu		Piganelli, Jon/0000-0003-2699-9011; Bassin, Ethan/0000-0002-4883-4413	NIH National Institute of Allergy and Infectious Diseases [T32-AI074490]; ARCS Foundation Scholar Award	NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ARCS Foundation Scholar Award	The authors received no specific funding for this work. E.J.B. was supported in part by a fellowship (T32-AI074490) from the NIH National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov) and the ARCS Foundation Scholar Award (https://arcsfoundation.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2018, ACS BIOMATER SCI ENG, V4, P900, DOI 10.1021/acsbiomaterials.7b00831; [Anonymous], 2016, CANC DISCOV; [Anonymous], 2018, DIAB PRAKT, V4, P1, DOI DOI 10.1186/s40798-017-0116-x; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; [Anonymous], 2004, OBESITY RES S2, p51S; [Anonymous], 2016, J NATL COMPR CANC NE, V14, pr34; Balmert SC, 2017, J CONTROL RELEASE, V261, P223, DOI 10.1016/j.jconrel.2017.07.006; Barck KH, 2004, ARTHRITIS RHEUM-US, V50, P3377, DOI 10.1002/art.20557; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brunstein CG, 2013, BIOL BLOOD MARROW TR, V19, P1271, DOI 10.1016/j.bbmt.2013.06.004; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Capini C, 2009, J IMMUNOL, V182, P3556, DOI 10.4049/jimmunol.0802972; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clemente-Casares X, 2016, NATURE, V530, P434, DOI 10.1038/nature16962; COFFEY RJ, 1987, J CLIN INVEST, V80, P750, DOI 10.1172/JCI113130; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Comas M, 2012, AGING-US, V4, P715, DOI 10.18632/aging.100496; Cordova KN, 2013, J IMMUNOL, V190, P1457, DOI 10.4049/jimmunol.1201517; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Davidson TS, 2007, J IMMUNOL, V178, P4022, DOI 10.4049/jimmunol.178.7.4022; Deenick EK, 2005, EUR J IMMUNOL, V35, P2949, DOI 10.1002/eji.200425719; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Ehinger M, 2001, IMMUNOLOGY, V103, P291, DOI 10.1046/j.1365-2567.2001.01257.x; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Fisher JD, 2019, P NATL ACAD SCI USA, V116, P25784, DOI 10.1073/pnas.1910701116; Ganesan K, 2008, RHEUMATOL INT, V28, P345, DOI 10.1007/s00296-007-0446-y; Gertel S, 2015, J IMMUNOL, V194, P5674, DOI 10.4049/jimmunol.1402457; Jhunjhunwala S, 2012, J CONTROL RELEASE, V159, P78, DOI 10.1016/j.jconrel.2012.01.013; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Klatzmann D, 2015, NAT REV IMMUNOL, V15, P283, DOI 10.1038/nri3823; Kohane DS, 2007, BIOTECHNOL BIOENG, V96, P203, DOI 10.1002/bit.21301; Kopf H, 2007, INT IMMUNOPHARMACOL, V7, P1819, DOI 10.1016/j.intimp.2007.08.027; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Lundkvist J, 2008, EUR J HEALTH ECON, V8, pS49, DOI 10.1007/s10198-007-0088-8; Luross JA, 2001, IMMUNOLOGY, V103, P407, DOI 10.1046/j.1365-2567.2001.01267.x; MarinovaMutafchieva L, 1997, CLIN EXP IMMUNOL, V107, P507, DOI 10.1046/j.1365-2249.1997.2901181.x; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Myasoedova E, 2010, ARTHRITIS RHEUM-US, V62, P1576, DOI 10.1002/art.27425; Nestle, 2010, HALAL J, P10; Paik J, 2019, DRUGS, V79, P455, DOI 10.1007/s40265-019-01083-3; RANGES GE, 1985, J EXP MED, V162, P1105, DOI 10.1084/jem.162.3.1105; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Romano M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00043; Roncarolo MG, 2018, IMMUNITY, V49, P1004, DOI 10.1016/j.immuni.2018.12.001; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Saez V, 2013, PHARM RES-DORDR, V30, P606, DOI 10.1007/s11095-012-0916-0; Saito E, 2019, J CONTROL RELEASE, V300, P185, DOI 10.1016/j.jconrel.2019.02.025; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Sarantopoulos S, 2004, J CLIN INVEST, V114, P1218, DOI 10.1172/JCI200423152; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Shan J, 2014, IMMUNOL LETT, V162, P74, DOI 10.1016/j.imlet.2014.07.006; Singh AK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01969; Smolen JS, 2015, NAT REV RHEUMATOL, V11, P276, DOI 10.1038/nrrheum.2015.8; Sun GZ, 2018, INFLAMMATION, V41, P485, DOI 10.1007/s10753-017-0704-4; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Taylor PC, 2019, RHEUMATOLOGY, V58, P17, DOI 10.1093/rheumatology/key225; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Turner MS, 2009, J IMMUNOL, V183, P4895, DOI 10.4049/jimmunol.0901459; van Amelsfort JMR, 2007, ARTHRITIS RHEUM, V56, P732, DOI 10.1002/art.22414; van der Net JB, 2016, TRANSPL INT, V29, P3, DOI 10.1111/tri.12608; WATSON WC, 1985, J EXP MED, V162, P1878, DOI 10.1084/jem.162.6.1878; Williams Richard O, 2007, Methods Mol Biol, V361, P265; WILLIAMS RO, 1992, P NATL ACAD SCI USA, V89, P9784, DOI 10.1073/pnas.89.20.9784; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; YOSHINO S, 1991, ARTHRITIS RHEUM, V34, P1039, DOI 10.1002/art.1780340814; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	71	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239396	10.1371/journal.pone.0239396	http://dx.doi.org/10.1371/journal.pone.0239396			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966314	Green Published, gold			2022-12-26	WOS:000575688700050
J	Hosseinpanah, F; Tasdighi, E; Barzin, M; Mahdavi, M; Ghanbarian, A; Valizadeh, M; Azizi, F				Hosseinpanah, Farhad; Tasdighi, Erfan; Barzin, Maryam; Mahdavi, Maryam; Ghanbarian, Arash; Valizadeh, Majid; Azizi, Fereidoun			The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study	PLOS ONE			English	Article							NATURAL COURSE; RISK-FACTORS; PREVALENCE; EVENTS; DIFFERENCE; OUTCOMES; ADULTS	Considering that the data available on the cardiovascular (CV) risk of metabolically healthy obesity phenotype, and the effect of transition to an unhealthy status are inconsistent, the aim of this study was to investigate the possible role of transition to unhealthy status among metabolically healthy overweight/obese (MHO) subjects on CVD incidence over a median follow-up of 15.9 years. In this large population-based cohort, 6758 participants (41.6% men) aged >= 20 years, were enrolled. Participants were divided into 4 groups based on their obesity phenotypes and follow-up results, including persistent metabolically healthy normal weight (MHNW), persistent MHO, transitional MHO and metabolically unhealthy overweight/obese (MUO). Metabolic health was defined as not having metabolic syndrome based on the Joint Interim Statement (JIS) criteria. Multivariable adjusted hazard ratios (HRs) were calculated for cardiovascular events. During follow-up, rate of CVD Incidence per 1000 person-years were 12 and 7 in males and females, respectively. Multivariable adjusted HRs (CI 95%) of CVD incidence among males and females were 1.37 (.78-2.41) and .85 (.34-2.15) in persistent MHO group, 1.55 (1.02-2.37) and .93 (.41-2.12) in transitional MHO group and 2.64 (1.89-3.70) and 2.65 (1.24-5.68) in MUO group. Our findings showed that CVD risk did not increase in the persistent MHO phenotype over a 15.9-year follow-up in both sexes. However, transition from MHO to MUO status during follow-up increased the CVD risk just in male individuals. Further studies are needed to provide conclusive evidence in favor of benign nature of transitional MHO phenotype in females.	[Hosseinpanah, Farhad; Tasdighi, Erfan; Barzin, Maryam; Mahdavi, Maryam; Valizadeh, Majid] Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Ghanbarian, Arash] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Hosseinpanah, F (corresponding author), Shahid Beheshti Univ Med Sci, Obes Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	fhospanah@endocrine.ac.ir	tasdighi, erfan/AAU-9342-2021; Azizi, Fereidoun/ABD-4136-2021; Valizadeh, Majid/AAD-9338-2022; GHANBARIAN, ARASH/K-2738-2017	tasdighi, erfan/0000-0003-2146-7083; Azizi, Fereidoun/0000-0002-6470-2517; Valizadeh, Majid/0000-0002-3155-1951; GHANBARIAN, ARASH/0000-0001-9662-2944; mahdavi, maryam/0000-0002-8371-0694				AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bell JA, 2015, J AM COLL CARDIOL, V65, P101, DOI 10.1016/j.jacc.2014.09.077; Bobbioni-Harsch E, 2012, OBESITY, V20, P2063, DOI 10.1038/oby.2012.69; Caleyachetty R, 2017, J AM COLL CARDIOL, V70, P1429, DOI 10.1016/j.jacc.2017.07.763; Committee IPAQR, 2005, GUID DAT PROC AN INT, V15; Delavari A, 2009, DIABETES CARE, V32, P1092, DOI 10.2337/dc08-1800; Eckel N, 2018, LANCET DIABETES ENDO, V6, P714, DOI 10.1016/S2213-8587(18)30137-2; Eckel N, 2016, EUR J PREV CARDIOL, V23, P956, DOI 10.1177/2047487315623884; Eshtiaghi R, 2015, INT J OBESITY, V39, P514, DOI 10.1038/ijo.2014.176; Fan JY, 2013, INT J CARDIOL, V168, P4761, DOI 10.1016/j.ijcard.2013.07.230; Hadaegh F, 2006, EUR J CARDIOV PREV R, V13, P571, DOI 10.1097/01.hjr.0000216552.81882.ca; Hosseinpanah F, 2011, AM J CARDIOL, V107, P412, DOI 10.1016/j.amjcard.2010.09.034; Huang LO, 2018, PHYSIOL GENOMICS, V50, P169, DOI 10.1152/physiolgenomics.00044.2017; Kouvari M, 2019, METABOLISM, V93, P18, DOI 10.1016/j.metabol.2019.01.003; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Krishnan KC, 2018, CURR OPIN LIPIDOL, V29, P404, DOI 10.1097/MOL.0000000000000536; KRISKA AM, 1990, DIABETES CARE, V13, P401, DOI 10.2337/diacare.13.4.401; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mongraw-Chaffin M, 2018, J AM COLL CARDIOL, V71, P1857, DOI 10.1016/j.jacc.2018.02.055; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Navarro E, 2015, MOL NUTR FOOD RES, V59, P75, DOI 10.1002/mnfr.201400521; Onat A, 2016, EXPERT REV CARDIOVAS, V14, P513, DOI 10.1586/14779072.2016.1150782; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Palmer BF, 2015, MOL CELL ENDOCRINOL, V402, P113, DOI 10.1016/j.mce.2014.11.029; Pucci G, 2017, PHARMACOL RES, V120, P34, DOI 10.1016/j.phrs.2017.03.008; Rahmani Asghar, 2015, Acta Med Iran, V53, P596; Rey-Lopez JP, 2014, OBES REV, V15, P781, DOI 10.1111/obr.12198; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Tohidi M, 2014, CLIN BIOCHEM, V47, P432, DOI 10.1016/j.clinbiochem.2014.02.007; Zheng RZ, 2016, J EPIDEMIOL COMMUN H, V70, P1024, DOI 10.1136/jech-2015-206948	33	10	10	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239164	10.1371/journal.pone.0239164	http://dx.doi.org/10.1371/journal.pone.0239164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32947607	gold, Green Published			2022-12-26	WOS:000573851100002
J	Teixeira, LPR; Lopes, FED; Antunes, ASLM; Alves, MS; Miranda, AM; Neto, SG; Martins, LT; Moreira, ACDM; Tavares, KCS				Rodrigues Teixeira, Louhanna Pinheiro; de Moura Lopes, Francisco Eder; Leao Marcelo Antunes, Andre Saraiva; Alves, Matheus Soares; Miranda, Andre Marrocos; Gaudencio Neto, Saul; Martins, Leonardo Tondello; de Oliveira Monteiro Moreira, Ana Cristina; Simiano Tavares, Kaio Cesar			Application of a cost-effective DNA extraction protocol for screening transgenic and CRISPR-edited primary goat cells	PLOS ONE			English	Article							AMPLIFICATION; PCR; MECHANISMS; MILK	The genotyping of genetically-modified cells is a crucial step in studies of transgenics and genomic editing with systems such as CRISPR/Cas. The detection of genome editing events can be directly related to the genotyping methodology used, which is influenced by its costs, since many experiments require the analysis of a large number of samples. The aim of this study was to compare the performance of direct lysis methods of genomic DNA (gDNA) extraction for the detection of knockins and knockouts in primary goat cells. Initially, three gDNA extraction protocols (protocol A, heat denaturation/freeze-thaw in water; protocol B, heat denaturation/proteinase K; and protocol C, CellsDirect Kit) were tested using different quantities (1,000, 5,000 and 10,000 cells) and types of goat primary cells (fibroblasts and goat mammary epithelial cells-GMECs) for subsequent validation by PCR amplification of small (GAPDH) and large amplicons (hLF transgene). All protocols were successful in the detection of the small amplicon; however, in GMECs, only protocol B resulted efficient amplification (protocol A-0%, protocol B-93%, protocol C-13.33%, P <0.05). In a proof-of-principle experiment, theTP53gene was knocked out in GMECs by CRISPR/Cas9-mediated deletion while constructs containing the anti-VEGF monoclonal antibody (pBC-anti-VEGF) and bacterial L-Asparaginase (pBC-ASNase) transgenes were knocked-in separately in fibroblasts. Detection of successful editing was performed using protocol B and PCR. The integration rates of the pBC-ASNase and pBC-anti-VEGF transgenes were 93.6% and 72%, respectively, as per PCR. The efficiency of biallelic editing in GMECs using CRISPR/Cas9 for theTP53deletion was 5.4%. Our results suggest that protocol B (heat denaturation/proteinase K) can be used as an inexpensive and quick methodology for detecting genetic modifications in different types of primary goat cells, with efficiency rates consistent with values previously described in the literature when using extraction kits or more complex proteinase K formulations.	[Rodrigues Teixeira, Louhanna Pinheiro; de Moura Lopes, Francisco Eder; Leao Marcelo Antunes, Andre Saraiva; Alves, Matheus Soares; Miranda, Andre Marrocos; Gaudencio Neto, Saul; Martins, Leonardo Tondello; de Oliveira Monteiro Moreira, Ana Cristina; Simiano Tavares, Kaio Cesar] Univ Fortaleza UNIFOR, Expt Biol Ctr NUBEX, Fortaleza, Ceara, Brazil	Universidade Fortaleza	Tavares, KCS (corresponding author), Univ Fortaleza UNIFOR, Expt Biol Ctr NUBEX, Fortaleza, Ceara, Brazil.	kaio@unifor.br	Antunes, André/AAB-4519-2019; Tavares, Kaio/S-3875-2016	Antunes, André/0000-0002-0692-8948; Tavares, Kaio/0000-0003-3919-161X; de Moura Lopes, Francisco Eder/0000-0002-6146-156X	CNPqBrazilian National Council for Scientific and Technological Development [430204/2016-7]; CAPES-Coordination of Superior Level Staff Improvement	CNPqBrazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-Coordination of Superior Level Staff Improvement	KCTS received a grant from CNPqBrazilian National Council for Scientific and Technological Development (number 430204/2016-7 -http://cnpq.br).LPRT received a scholarship from CAPES-Coordination of Superior Level Staff Improvement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], REPROD FERTIL DEV; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 2014, EUROMET EMPIR CALL T, P1; Boutinaud M, 2019, ANIMAL, V13, pS52, DOI [10.1017/s1751731119000624, 10.1017/S1751731119000624]; Cebrian-Serrano A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169887; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHENG S, 1995, PCR METH APPL, V4, P294; Dehairs J, 2016, SCI REP, V6, P1, DOI [10.1035/srep28973, DOI 10.1035/SREP28973]; Eckhart L, 2012, FRONT BIOSCI-LANDMRK, V17, P2461, DOI 10.2741/4065; Eun K, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-018-0491-5; Feng XJ, 2015, TRANSGENIC RES, V24, P73, DOI 10.1007/s11248-014-9818-8; Frost MR, 1999, NUCLEIC ACIDS RES, V27, pi, DOI [10.1093/nar/27.15.e6-i, DOI 10.1093/NAR/27.15.E6-I]; Ismail B, 2010, J DAIRY SCI, V93, P4999, DOI 10.3168/jds.2010-3122; Jacquot Sylvie, 2019, Curr Protoc Mouse Biol, V9, pe65, DOI 10.1002/cpmo.65; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Li HW, 2011, ELECTROPHORESIS, V32, P394, DOI 10.1002/elps.201000392; Li JT, 2018, MBIO, V9, DOI 10.1128/mBio.00567-18; Lu R, 2018, TRANSGENIC RES, V27, P343, DOI 10.1007/s11248-018-0080-3; Luo J, 2018, J BIOTECHNOL, V281, P11, DOI 10.1016/j.jbiotec.2018.06.308; Luo Y, 2015, TRANSGENIC RES, V24, P875, DOI 10.1007/s11248-015-9898-0; Martins LT, 2016, CELL REPROGRAM, V18, P264, DOI 10.1089/cell.2015.0082; Moyer TC, 2015, METHOD CELL BIOL, V129, P19, DOI 10.1016/bs.mcb.2015.03.017; Perota A, 2019, XENOTRANSPLANTATION, V26, DOI 10.1111/xen.12524; Pierce KE, 2002, BIOTECHNIQUES, V32, P1106, DOI 10.2144/02325pf01; Ramos-Diaz R, 2015, CANCER CHEMOTH PHARM, V75, P1095, DOI 10.1007/s00280-015-2729-4; Saipin N, 2018, ANAT HISTOL EMBRYOL, V47, P187, DOI 10.1111/ahe.12339; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203011; Spiegel A, 2019, METHODS, V164, P49, DOI 10.1016/j.ymeth.2019.04.016; Tavares KCS, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017476; Thatcher SA, 2015, CLIN CHEM, V61, P89, DOI 10.1373/clinchem.2014.221374; Thomas HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114632; Thornhill AR, 2001, PRENATAL DIAG, V21, P490, DOI 10.1002/pd.109; Tsuchiya S, 2005, J ASSIST REPROD GEN, V22, P407, DOI 10.1007/s10815-005-7482-x; van der Burg M, 2011, LEUKEMIA, V25, P1467, DOI 10.1038/leu.2011.118; Yeung A, 2005, BIOTECHNIQUES, V38, P749, DOI 10.2144/05385RV01; Yin YJ, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1073-9; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282	39	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239435	10.1371/journal.pone.0239435	http://dx.doi.org/10.1371/journal.pone.0239435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946490	gold, Green Published			2022-12-26	WOS:000573851100088
J	Sondertoft, NB; Vogt, JK; Arumugam, M; Kristensen, M; Gobel, RJ; Fan, Y; Lyu, LW; Bahl, MI; Eriksen, C; Angquist, L; Frokiaer, H; Hansen, TH; Brix, S; Nielsen, HB; Hansen, T; Vestergaard, H; Gupta, R; Licht, TR; Lauritzen, L; Pedersen, O				Sondertoft, Nadja B.; Vogt, Josef K.; Arumugam, Manimozhiyan; Kristensen, Mette; Gobel, Rikke J.; Fan, Yong; Lyu, Liwei; Bahl, Martin, I; Eriksen, Carsten; Angquist, Lars; Frokiaer, Hanne; Hansen, Tue H.; Brix, Susanne; Nielsen, H. Bjorn; Hansen, Torben; Vestergaard, Henrik; Gupta, Ramneek; Licht, Tine R.; Lauritzen, Lotte; Pedersen, Oluf			The intestinal microbiome is a co-determinant of the postprandial plasma glucose response	PLOS ONE			English	Article							GUT MICROBIOME; TRANSIT-TIME; BIFIDOBACTERIA; METABOLISM; METAGENOME; SEQUENCE; HEALTHY	Elevated postprandial plasma glucose is a risk factor for development of type 2 diabetes and cardiovascular disease. We hypothesized that the inter-individual postprandial plasma glucose response varies partly depending on the intestinal microbiome composition and function. We analyzed data from Danish adults (n = 106), who were self-reported healthy and attended the baseline visit of two previously reported randomized controlled cross-over trials within the Gut, Grain and Greens project. Plasma glucose concentrations at five time points were measured before and during three hours after a standardized breakfast. Based on these data, we devised machine learning algorithms integrating bio-clinical, as well as shotgun-sequencing-derived taxa and functional potentials of the intestinal microbiome to predict individual postprandial glucose excursions. In thispost hocstudy, we found microbial and clinical features, which predicted up to 48% of the inter-individual variance of postprandial plasma glucose responses (Pearson correlation coefficient of measured vs. predicted values, R = 0.69, 95% CI: 0.45 to 0.84,p<0.001). The features were age, fasting serum triglycerides, systolic blood pressure, BMI, fasting total serum cholesterol, abundance ofBifidobacteriumgenus, richness of metagenomics species and abundance of a metagenomic species annotated toClostridialesat order level. A model based only on microbial features predicted up to 14% of the variance in postprandial plasma glucose excursions (R = 0.37, 95% CI: 0.02 to 0.64,p= 0.04). Adding fasting glycaemic measures to the model including microbial and bio-clinical features increased the predictive power to R = 0.78 (95% CI: 0.59 to 0.89,p<0.001), explaining more than 60% of the inter-individual variance of postprandial plasma glucose concentrations. The outcome of the study points to a potential role of the taxa and functional potentials of the intestinal microbiome. If validated in larger studies our findings may be included in future algorithms attempting to develop personalized nutrition, especially for prediction of individual blood glucose excursions in dys-glycaemic individuals.	[Sondertoft, Nadja B.; Vogt, Josef K.; Arumugam, Manimozhiyan; Gobel, Rikke J.; Fan, Yong; Lyu, Liwei; Angquist, Lars; Hansen, Tue H.; Hansen, Torben; Vestergaard, Henrik; Pedersen, Oluf] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Kristensen, Mette; Lauritzen, Lotte] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Bahl, Martin, I; Licht, Tine R.] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Eriksen, Carsten; Brix, Susanne] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Frokiaer, Hanne] Univ Copenhagen, Fac Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Nielsen, H. Bjorn] Clin Microbi AS, Copenhagen, Denmark; [Gupta, Ramneek] Tech Univ Denmark, Dept Hlth Technol, Lyngby, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Technical University of Denmark; Technical University of Denmark; University of Copenhagen; Technical University of Denmark	Sondertoft, NB; Pedersen, O (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.	nadja@sund.ku.dk; oluf@sund.ku.dk	Lyu, Liwei/GVS-2737-2022; Pedersen, Oluf/Z-1731-2019; Lauritzen, Lotte/F-2921-2013; Arumugam, Manimozhiyan/AAJ-2394-2020; Hansen, Tue Haldor/S-7724-2016; Arumugam, Manimozhiyan/E-1211-2011; Pedersen, Susanne Brix/B-3484-2009	Lyu, Liwei/0000-0002-7387-8557; Pedersen, Oluf/0000-0002-3321-3972; Lauritzen, Lotte/0000-0001-7184-5949; Arumugam, Manimozhiyan/0000-0002-0886-9101; Hansen, Tue Haldor/0000-0001-5948-8993; Arumugam, Manimozhiyan/0000-0002-0886-9101; Pedersen, Susanne Brix/0000-0001-8951-6705; Hansen, Torben/0000-0001-8748-3831; Bahl, Martin Iain/0000-0003-1579-8038; Angquist, Lars/0000-0002-9516-4424; Fan, Yong/0000-0003-4813-7017; Eriksen, Carsten/0000-0003-4400-3855; Vogt, Josef Korbinian/0000-0002-6472-381X; Licht, Tine Rask/0000-0002-6399-9574	Innovation Fund Denmark (Center for Gut, Grain and Greens (3G Center)) [11-116163/0603-00487B]; Novo Nordisk Foundation; Novo Nordisk Foundation [NNF18CC0034900]	Innovation Fund Denmark (Center for Gut, Grain and Greens (3G Center)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was supported by the Innovation Fund Denmark (grant no. 11-116163/0603-00487B; Center for Gut, Grain and Greens (3G Center)) and The Novo Nordisk Foundation. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen and is partly funded by an unrestricted donation from the Novo Nordisk Foundation (www.cbmr.ku.dk) (grant number NNF18CC0034900). The study sponsors and the employers had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson H, 2010, NEUROGASTROENT MOTIL, V22, P1164, DOI 10.1111/j.1365-2982.2010.01543.x; Allin KH, 2018, DIABETOLOGIA, V61, P810, DOI 10.1007/s00125-018-4550-1; [Anonymous], 2010, Can Commun Dis Rep, V36, P1, DOI [10.14745/ccdr.v36i00as2, 10.14745/ccdr.v36i00a05, 10.14745/ccdr.v36i00as3]; [Anonymous], 2014, CANC DISCOV, V4, pOF1; [Anonymous], 2018, LANG ENV STAT COMP; Biau G, 2016, TEST-SPAIN, V25, P197, DOI 10.1007/s11749-016-0481-7; Biltoft-Jensen A, 2009, BRIT J NUTR, V102, P1838, DOI 10.1017/S0007114509991292; Bordoni A, 2013, APPL MICROBIOL BIOT, V97, P8273, DOI 10.1007/s00253-013-5088-2; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Darzi Y, 2016, ISME J, V10, P1025, DOI 10.1038/ismej.2015.188; DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6; Ekstrom C.T., MESS MISCELLANEOUS E; Firouzi SA, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3604108; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gao RY, 2018, OBESITY, V26, P351, DOI 10.1002/oby.22088; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Hansen LBS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07019-x; Hua JP, 2005, BIOINFORMATICS, V21, P1509, DOI 10.1093/bioinformatics/bti171; Hulman A, 2018, DIABETES CARE, V41, P1740, DOI 10.2337/dc18-0279; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; LeDell E., 2018, DIM, V2, P17; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Maniruzzaman M, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0940-7; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mendes-Soares H, 2019, AM J CLIN NUTR, V110, P63, DOI 10.1093/ajcn/nqz028; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Organization WH, 2009, GLOB HLTH RISKS MORT; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Riedel CU, 2006, WORLD J GASTROENTERO, V12, P3729, DOI 10.3748/wjg.v12.i23.3729; Roager HM, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.93, 10.1038/NMICROBIOL.2016.93]; Roager HM, 2019, GUT, V68, P83, DOI 10.1136/gutjnl-2017-314786; Shafi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126048; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Vieira-Silva S, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.88, 10.1038/NMICROBIOL.2016.88]; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Waller PA, 2011, SCAND J GASTROENTERO, V46, P1057, DOI 10.3109/00365521.2011.584895; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Xiao JZ, 2003, J DAIRY SCI, V86, P2452, DOI 10.3168/jds.S0022-0302(03)73839-9; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zhou YH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00579	53	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238648	10.1371/journal.pone.0238648	http://dx.doi.org/10.1371/journal.pone.0238648			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32947608	Green Published, gold			2022-12-26	WOS:000573851100033
J	Stradomska, TJ; Syczewska, M; Jamroz, E; Pleskaczynska, A; Kruczek, P; Ciara, E; Tylki-Szymanska, A				Stradomska, Teresa Joanna; Syczewska, Malgorzata; Jamroz, Ewa; Pleskaczynska, Agata; Kruczek, Piotr; Ciara, Elzbieta; Tylki-Szymanska, Anna			Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders	PLOS ONE			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; BONE-MARROW-TRANSPLANTATION; ZELLWEGER SPECTRUM; MEMBRANE MICROVISCOSITY; CLINICAL-MANIFESTATIONS; BIOGENESIS DISORDERS; AXONAL DEGENERATION; OXIDATIVE STRESS; DIAGNOSIS; PLASMA	Peroxisomal disorders (PD) are a heterogeneous group of rare diseases caused by a defect in peroxisome biogenesis or a disruption of a peroxisomal function at a single enzyme or at transporter level. The main biochemical markers for PD are very long-chain fatty acids (VLCFA). The aim of the study was to investigate the correlation of basic diagnostic parameter, i.e. VLCFA, with disease severity, determined through the survival time. We performed a retrospective study in patients with PD (n = 31; aged 1 week-21 years). Evaluation of VLCFA results from patients were as follows: 15 patients with classical Zellweger syndrome (ZS), 3 patients with mild outcome of ZS, 9 individuals with D-Bifunctional Protein Deficiency (DBP), and no specified results in the case of 4 patients. Patients with classical ZS had higher VLCFA levels, compared to individuals with mild form of ZS and also to patients with DBP; forC26:0/C22:0:0.65 +/- 0.18; 0.11 +/- 0.09; 0.30 +/- 0.13(P< 0.001) and forC26:0:5.20 +/- 1.78; 0.76 +/- 0.46; 2.61 +/- 0.97[mg/mL] (P< 0.001) respectively. The only variable parameter, i.e. the one that determines the survival time of patients, wasC26:0(Chi(2)= 19,311,P< 0.0001). Correlation coefficient between survival time andC26:0level was statistically significant (r= -0.762), and the results showed that high levels ofC26:0were associated with short survival time. Conclusion VLCFA levels correlate with the severity of the clinical course of ZS, DBP and mild ZSD. The best predictive value for estimating the projected disease severity and survival time is a concentration of C26:0.	[Stradomska, Teresa Joanna] Childrens Mem Hlth Inst, Dept Biochem Radioimmunol & Expt Med, Warsaw, Poland; [Syczewska, Malgorzata] Childrens Mem Hlth Inst, Dept Pediat Rehabil, Warsaw, Poland; [Jamroz, Ewa] Med Univ Silesia, Clin Hosp 6, Dept Pediat & Neurol Dev Age, Katowice, Poland; [Pleskaczynska, Agata] Childrens Mem Hlth Inst, Dept Neonatol Pathol & Neonatal Intens Care Unit, Warsaw, Poland; [Kruczek, Piotr] Univ Childrens Hosp Cracow, Dept Neonatal Pathol & Intens Care Unit, Krakow, Poland; [Ciara, Elzbieta] Childrens Mem Hlth Inst, Dept Med Genet, Warsaw, Poland; [Tylki-Szymanska, Anna] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, Warsaw, Poland	Children's Memorial Health Institute; Children's Memorial Health Institute; Medical University Silesia; Children's Memorial Health Institute; Children's Memorial Health Institute; Children's Memorial Health Institute	Stradomska, TJ (corresponding author), Childrens Mem Hlth Inst, Dept Biochem Radioimmunol & Expt Med, Warsaw, Poland.	j.de.stradomska@gmail.com	Kruczek, Piotr/GQY-6382-2022	Ciara, Elzbieta/0000-0002-1065-7968; Stradomska, Teresa J/0000-0002-5585-413X				Bams-Mengerink AM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-174; Berendse K, 2016, J INHERIT METAB DIS, V39, P93, DOI 10.1007/s10545-015-9880-2; Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; Braverman NE, 2016, MOL GENET METAB, V117, P313, DOI 10.1016/j.ymgme.2015.12.009; BROWN FR, 1982, JOHNS HOPKINS MED J, V151, P344; Eichler FS, 2008, ANN NEUROL, V63, P729, DOI 10.1002/ana.21391; Ferdinandusse S, 2006, ANN NEUROL, V59, P92, DOI 10.1002/ana.20702; Fourcade S, 2008, HUM MOL GENET, V17, P1762, DOI 10.1093/hmg/ddn085; Fourcade S, 2014, BIOCHIMIE, V98, P143, DOI 10.1016/j.biochi.2013.09.012; Galea E, 2012, BBA-MOL BASIS DIS, V1822, P1475, DOI 10.1016/j.bbadis.2012.02.005; Gootjes J, 2002, NEUROLOGY, V59, P1746, DOI 10.1212/01.WNL.0000036609.14203.70; Gould SJ., 2001, METABOLIC MOL BASES, P3181; Hein S, 2008, HUM MOL GENET, V17, P1750, DOI 10.1093/hmg/ddn066; HO JK, 1995, J CLIN INVEST, V96, P1455, DOI 10.1172/JCI118182; Klouwer FCC, 2017, J INHERIT METAB DIS, V40, P875, DOI 10.1007/s10545-017-0064-0; Klouwer FCC, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0368-9; KNAZEK RA, 1983, J CLIN INVEST, V72, P245, DOI 10.1172/JCI110963; Kruska N, 2015, BBA-MOL BASIS DIS, V1852, P925, DOI 10.1016/j.bbadis.2015.01.005; Lipinski P, 2020, J APPL GENET, V61, P87, DOI 10.1007/s13353-019-00523-w; Lopez-Erauskin J, 2013, HUM MOL GENET, V22, P3296, DOI 10.1093/hmg/ddt186; Moser AB, 1999, ANN NEUROL, V45, P100, DOI 10.1002/1531-8249(199901)45:1<100::AID-ART16>3.0.CO;2-U; MOSER HW, 1981, NEUROLOGY, V31, P1241, DOI 10.1212/WNL.31.10.1241; Nury T, 2017, J STEROID BIOCHEM, V169, P123, DOI 10.1016/j.jsbmb.2016.03.037; Poll-The BT, 2004, AM J MED GENET A, V126A, P333, DOI 10.1002/ajmg.a.20664; Poll-The BT, 2012, BBA-MOL BASIS DIS, V1822, P1421, DOI 10.1016/j.bbadis.2012.03.011; Rahim RS, 2016, NEUROSCIENCE, V334, P201, DOI 10.1016/j.neuroscience.2016.08.001; Rydzanicz M, 2017, J APPL GENET, V58, P475, DOI 10.1007/s13353-017-0414-5; Shapiro E, 2000, LANCET, V356, P713, DOI 10.1016/S0140-6736(00)02629-5; Shimozawa N, 2007, J INHERIT METAB DIS, V30, P193, DOI 10.1007/s10545-007-0516-z; Stradomska TJ, 2014, FOLIA NEUROPATHOL, V52, P159, DOI 10.5114/fn.2014.43787; Stradomska TJ, 2009, FOLIA NEUROPATHOL, V47, P306; Stradomska Tresa J, 2018, Postepy Biochem, V64, P359, DOI 10.18388/pb.2018_150; Suzuki Y, 2000, J INHERIT METAB DIS, V23, P453, DOI 10.1023/A:1005656029200; Thoms S, 2009, TRENDS MOL MED, V15, P293, DOI 10.1016/j.molmed.2009.05.002; TYLKISZYMANSKA A, 1995, EUR J PEDIATR, V154, P867, DOI 10.1007/BF01959804; Van Veldhoven PP, 2010, J LIPID RES, V51, P2863, DOI 10.1194/jlr.R005959; Wanders RJA, 2014, BIOCHIMIE, V98, P36, DOI 10.1016/j.biochi.2013.08.022; WHITCOMB RW, 1988, J CLIN INVEST, V81, P185, DOI 10.1172/JCI113292; Zarrouk A, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/623257	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238796	10.1371/journal.pone.0238796	http://dx.doi.org/10.1371/journal.pone.0238796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946460	gold, Green Published			2022-12-26	WOS:000573851100025
J	Ganguly, S; Ghosh, D; Narayanaswamy, N; Govindaraju, T; Basu, G				Ganguly, Sudakshina; Ghosh, Debasis; Narayanaswamy, Nagarjun; Govindaraju, T.; Basu, Gautam			Dual DNA binding mode of a turn-on red fluorescent probe thiazole coumarin	PLOS ONE			English	Article							ETHIDIUM-BROMIDE; INTERCALATION; RECOGNITION	Turn-on fluorescent probes show enhanced emission upon DNA binding, advocating their importance in imaging cellular DNA. We have probed the DNA binding mode of thiazole-coumarin (TC) conjugate, a recently reported hemicyanine-based turn-on red fluorescent probe, using a number of biophysical techniques and a series of short oligonucleotides. TC exhibited increased fluorescence anisotropy and decreased absorbance (similar to 50%) at low [DNA]/[TC] ratio. Although the observed hypochromicity and the saturating value of [DNA base pair]:[TC] ratio is consistent with a previous study that suggested intercalation to be the DNA binding mode of TC, a distinctly different and previously unreported binding mode was observed at higher ratios of [DNA]:[TC]. With further addition of DNA, only oligonucleotides containing A(n)T(n) or (AT)(n) stretches showed further change-decreased hypochromicity, red shifted absorption peaks and concomitant fluorescence enhancement, saturating at about 1:1 [DNA]: [TC].H-1-NMR chemical shift perturbation patterns and H1'-H6/H8 NOE cross-peaks of the 1:1 complex indicated minor groove binding by TC. ITC showed the 1:1 DNA binding event to be endothermic (Delta H degrees similar to 2 kcal/mol) and entropy driven (Delta S degrees similar to 32 cal/mol/K). Taken together, the experimental data suggest a dual DNA binding mode by TC. At low [DNA]/[TC] ratio, the dominant mode is intercalation. This switches to minor groove binding at higher [DNA]/[TC], only for sequences containing A(n)T(n) or (AT)(n) stretches. Turn-on fluorescence results only in the previously unreported minor groove bound state. Our results allow a better understanding of DNA-ligand interaction for the newly reported turn-on probe TC.	[Ganguly, Sudakshina; Basu, Gautam] Bose Inst, Dept Biophys, Kolkata, India; [Ghosh, Debasis; Narayanaswamy, Nagarjun; Govindaraju, T.] Jawaharlal Nehru Ctr Adv Sci Res, New Chem Unit, Bioorgan Chem Lab, Bengaluru, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Basu, G (corresponding author), Bose Inst, Dept Biophys, Kolkata, India.	gautam@jcbose.ac.in		Narayanaswamy, Nagarjun/0000-0002-2474-5117				Amin KM, 2018, ARCH PHARM, V351, DOI 10.1002/ardp.201700199; Banerjee A, 2014, FEBS OPEN BIO, V4, P251, DOI 10.1016/j.fob.2014.02.006; Bhaduri S, 2018, BEILSTEIN J ORG CHEM, V14, P1051, DOI 10.3762/bjoc.14.93; Chaires JB, 1997, BIOPHYS CHEM, V64, P15, DOI 10.1016/S0301-4622(96)02205-3; Han FX, 2005, BIOCHEMISTRY-US, V44, P9785, DOI 10.1021/bi047374f; Hannah KC, 2005, BIOCHEMISTRY-US, V44, P15924, DOI 10.1021/bi051298e; Kubota Y, 2000, Nucleic Acids Symp Ser, P53; LARSSON A, 1994, J AM CHEM SOC, V116, P8459, DOI 10.1021/ja00098a004; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nafisi S, 2007, J MOL STRUCT, V827, P35, DOI 10.1016/j.molstruc.2006.05.004; Nakano T, 2010, POLYM J, V42, P103, DOI 10.1038/pj.2009.332; Narayanaswamy N, 2015, NUCLEIC ACIDS RES, V43, P8651, DOI 10.1093/nar/gkv875; Narayanaswamy N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06476; PERCZEL A, 1991, PROTEIN ENG, V4, P669, DOI 10.1093/protein/4.6.669; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; SADOWSKI J, 1994, J CHEM INF COMP SCI, V34, P1000, DOI 10.1021/ci00020a039; STOCKERT JC, 1983, J THEOR BIOL, V105, P461, DOI 10.1016/0022-5193(83)90187-X; Suseela YV, 2018, CHEM SOC REV, V47, P1098, DOI [10.1039/c7cs00774d, 10.1039/C7CS00774D]; Travers A, 2015, FEBS J, V282, P2279, DOI 10.1111/febs.13307; Trotta E, 1996, J BIOL CHEM, V271, P27608, DOI 10.1074/jbc.271.44.27608; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	22	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239145	10.1371/journal.pone.0239145	http://dx.doi.org/10.1371/journal.pone.0239145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941495	Green Published, gold			2022-12-26	WOS:000573848800046
J	Pan, YY; Wang, M; Wang, LB; Zhang, Q; Baloch, AR; He, HH; Xu, GQ; Soomro, J; Cui, Y; Yu, SJ				Pan, Yangyang; Wang, Meng; Wang, Libin; Zhang, Qian; Baloch, Abdul Rasheed; He, Honghong; Xu, Gengquan; Soomro, Jamila; Cui, Yan; Yu, Sijiu			Estrogen improves the development of yak (Bos grunniens) oocytes by targeting cumulus expansion and levels of oocyte-secreted factors duringin vitromaturation	PLOS ONE			English	Article							IN-VITRO MATURATION; BOVINE; EXPRESSION; COMPETENCE; EMBRYOS; GENES; CELLS; GDF9; FERTILIZATION; CAPACITATION	The estrogen-signalling pathway is critical for normal follicular development; however, little is known about its importance duringin vitromaturation (IVM) in large animals, particularly yaks (Bos grunniens). Through the present study, we aimed to determine the mechanisms underlying estrogen involvement in cumulus expansion and the subsequent development of cumulus-oocyte complexes (COCs). COCs were cultured in the maturation medium supplemented with different concentrations (10(-6)-10(-3)mM) of 17 beta-estradiol (E2) or its receptor antagonist, fulvestrant, and quantitative reverse-transcription polymerase chain reaction (qRT-PCR) and western blot were performed to determine the expression of cumulus-expansion related factors and oocyte-secreted factors (OSFs). The cumulus expansion of COCs was observed using an inverted microscope, and COCs developmental ability were judged by the evaluation of cleavage and blastulation rates per inseminated oocytes by IVF, and the number of cells in the blastocyst. Cumulus expansion increased with 10(-6)-10(-3)mM E2, but decreased with fulvestrant.HAS2,PTGS2,PTX3and OSFs expression increased in the 10(-6)-10(-3)mM E2 groups. Significantly higher cleavage and blastocyst rates were observed in the 10(-4)mM E2 group than in the fulvestrant and 0 mM E2 groups. Moreover, in the 10(-4)mM group, blastocysts at 7 days had higher cell counts than the other groups. In conclusion, the increase in cumulus expansion and subsequent oocyte development after the addition of E2 to IVM medium may have resulted from increased cumulus-expansion-related factor expression and OSF levels.	[Pan, Yangyang; Wang, Meng; Wang, Libin; Zhang, Qian; He, Honghong; Xu, Gengquan; Cui, Yan; Yu, Sijiu] Gansu Agr Univ, Coll Vet Med, Gansu Prov Livestock Embryo Engn Res Ctr, Lanzhou, Peoples R China; [Baloch, Abdul Rasheed] Zhengzhou Univ, Acad Med Sci, Natl Ctr Int Res Cell & Gene Therapy, Sino British Res Ctr Mol Oncol, Zhengzhou, Peoples R China; [Soomro, Jamila] Sindh Agr Univ, Fac Anim Husb & Vet Sci, Dept Vet Physiol & Biochem, Tandojam, Pakistan	Gansu Agricultural University; Zhengzhou University; Sindh Agricultural University	Yu, SJ (corresponding author), Gansu Agr Univ, Coll Vet Med, Gansu Prov Livestock Embryo Engn Res Ctr, Lanzhou, Peoples R China.	sijiuy@126.com	Baloch, Abdul Rasheed/ACE-1646-2022		Science and Technology Innovation Funds of Gansu Agricutural University [GAU-XKJS-2018-15]; National Natural Science Foundation of China [31702311]; Fuxi Foundation of Youth Talent at Gansu Agricultural University [Gaufx-02Y10]; Gansu Agricultural University [GSAU-RCZX201701]; Innovation Foundation in Colleges from Gansu Province [2018A-034, 2019B-081]	Science and Technology Innovation Funds of Gansu Agricutural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fuxi Foundation of Youth Talent at Gansu Agricultural University; Gansu Agricultural University; Innovation Foundation in Colleges from Gansu Province	This work was supported by the grants from Science and Technology Innovation Funds of Gansu Agricutural University (GAU-XKJS-2018-15), the National Natural Science Foundation of China (No. 31702311), the Fuxi Foundation of Youth Talent at Gansu Agricultural University (No. Gaufx-02Y10).Scientific research start-up funds for openly-recuited doctors, Gansu Agricultural University (No. GSAU-RCZX201701) and the Innovation Foundation in Colleges from Gansu Province (2018A-034 and 2019B-081).	[Anonymous], 2017, TRAITS URBAINS, V93, P16; Belli M, 2018, VITAM HORM, V107, P317, DOI 10.1016/bs.vh.2017.12.003; Blaha M, 2017, PROSTAG OTH LIPID M, V130, P38, DOI 10.1016/j.prostaglandins.2017.04.001; Caixeta ES, 2013, REPRODUCTION, V146, P27, DOI 10.1530/REP-13-0079; Chaubey GK, 2018, J CELL BIOCHEM, V119, P5750, DOI 10.1002/jcb.26688; Cillo F, 2007, REPRODUCTION, V134, P645, DOI 10.1530/REP-07-0182; Cox E, 2018, STATPEARLS; De-la King, 1997, ZYGOTE, V5, P309, DOI [10.1017/s0967199400003890, DOI 10.1017/S0967199400003890]; Diogenes MN, 2017, THERIOGENOLOGY, V102, P190, DOI 10.1016/j.theriogenology.2017.06.004; Diogenes MN, 2017, J ASSIST REPROD GEN, V34, P383, DOI 10.1007/s10815-016-0852-8; El-Magd MA, 2019, THERIOGENOLOGY, V126, P230, DOI 10.1016/j.theriogenology.2018.12.027; Foroughinia G, 2017, THERIOGENOLOGY, V91, P36, DOI 10.1016/j.theriogenology.2016.12.023; Franciosi F, 2016, ENDOCRINOLOGY, V157, P872, DOI 10.1210/en.2015-1727; Geyer J, 2017, J STEROID BIOCHEM, V172, P207, DOI 10.1016/j.jsbmb.2016.07.002; Han ZB, 2006, REPRODUCTION, V132, P749, DOI 10.1530/REP-06-0055; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Koo DB, 2002, BIOL REPROD, V67, P487, DOI 10.1095/biolreprod67.2.487; Lazzari G, 2002, BIOL REPROD, V67, P767, DOI 10.1095/biolreprod.102.004481; Lim W, 2016, J CELL PHYSIOL, V231, P2733, DOI 10.1002/jcp.25381; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes JS, 2019, THERIOGENOLOGY, V126, P222, DOI 10.1016/j.theriogenology.2018.12.010; Matzuk MM, 2002, SCIENCE, V296, P2178, DOI 10.1126/science.1071965; Moulavi F, 2018, THERIOGENOLOGY, V119, P259, DOI 10.1016/j.theriogenology.2018.07.010; Nagyova E, 2017, J PHYSIOL PHARMACOL, V68, P683; Nagyova E, 2012, Endocr Regul, V46, P225; Pan YY, 2015, LIVEST SCI, V182, P118, DOI 10.1016/j.livsci.2015.11.002; Pan YY, 2015, THERIOGENOLOGY, V84, P756, DOI 10.1016/j.theriogenology.2015.05.007; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; Parrish JJ, 2014, THERIOGENOLOGY, V81, P67, DOI 10.1016/j.theriogenology.2013.08.005; Pinto RFP, 2015, REPROD DOMEST ANIM, V50, P84, DOI 10.1111/rda.12452; Sarkar M, 2005, ANIM REPROD SCI, V90, P149, DOI 10.1016/j.anireprosci.2005.01.016; Sayasith K, 2008, ENDOCRINOLOGY, V149, P6213, DOI 10.1210/en.2008-0459; Sharma SC, 2000, J BIOL CHEM, V275, P33718, DOI 10.1074/jbc.M003555200; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Sugiura K, 2010, MOL ENDOCRINOL, V24, P2303, DOI 10.1210/me.2010-0260; Sugiura K, 2009, MOL REPROD DEV, V76, P537, DOI 10.1002/mrd.20971; TAKAHASHI Y, 1992, THERIOGENOLOGY, V37, P963, DOI 10.1016/0093-691X(92)90096-A; TSAFRIRI A, 1995, ADV EXP MED BIOL, V377, P121; Xiong XR, 2018, ANIM SCI J, V89, P298, DOI 10.1111/asj.12894; Yao XL, 2018, THERIOGENOLOGY, V114, P70, DOI 10.1016/j.theriogenology.2018.03.014; Yu SJ, 2001, ANIM REPROD SCI, V65, P67, DOI 10.1016/S0378-4320(00)00216-5; Zhang H, 2019, J STEROID BIOCHEM, V187, P58, DOI 10.1016/j.jsbmb.2018.11.001; Zhang K, 2010, REPRODUCTION, V140, P815, DOI 10.1530/REP-10-0190; Zi XD, 2012, GEN COMP ENDOCR, V175, P384, DOI 10.1016/j.ygcen.2011.12.004	45	4	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239151	10.1371/journal.pone.0239151	http://dx.doi.org/10.1371/journal.pone.0239151			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941516	gold, Green Published			2022-12-26	WOS:000573848800052
J	Veve, C; Chiabaut, N				Veve, Cyril; Chiabaut, Nicolas			Estimation of the shared mobility demand based on the daily regularity of the urban mobility and the similarity of individual trips	PLOS ONE			English	Article								Even if shared mobility services are encouraged by transportation policies, they remain underused and inefficient transportation modes because they struggle to find their customer base. This paper aims to estimate the potential demand for such services by focusing on individual trips and determining the number of passengers who perform similar trips. Contrary to existing papers, this study focuses on the demand without assuming any specific shared mobility system. The experiment performed on data coming from New York City conducts to cluster more than 85% of the trips. Consequently, shared mobility services such as ride-sharing can find their customer base and, at a long time, to a significantly reduce the number of cars flowing in the city. After a detailed analysis, commonalities in the clusters are identified: regular patterns from one day to the next exist in shared mobility demand. This regularity makes it possible to anticipate the potential shared mobility demand to help transportation suppliers to optimize their operations.	[Veve, Cyril; Chiabaut, Nicolas] Univ Lyon, Univ Gustave Eiffel, ENTPE, LICIT, Lyon, France	Universite Gustave-Eiffel	Chiabaut, N (corresponding author), Univ Lyon, Univ Gustave Eiffel, ENTPE, LICIT, Lyon, France.	nicolas.chiabaut@entpe.fr		Chiabaut, Nicolas/0000-0003-0450-4890; , Cyril/0000-0003-3336-1470				Abraham S, 2012, TRANSPORT RES C-EMER, V23, P109, DOI 10.1016/j.trc.2011.12.008; Agatz N, 2012, EUR J OPER RES, V223, P295, DOI 10.1016/j.ejor.2012.05.028; Akbarzadeh M, 2018, NAT HUM BEHAV, V2, P645, DOI 10.1038/s41562-018-0407-3; Chiabaut N, 2019, TRANSPORT FINDINGS; contributors O, 2017, CONTR; Creutzig F, 2015, SCIENCE, V350, P911, DOI 10.1126/science.aac8033; Duarte F, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aav9843; Erhardt GD, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau2670; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Furuhata M, 2013, TRANSPORT RES B-METH, V57, P28, DOI 10.1016/j.trb.2013.08.012; Giannotti F, 2011, VLDB J, V20, P695, DOI 10.1007/s00778-011-0244-8; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Ketabi R, 2018, 26TH ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2018), P544, DOI 10.1145/3274895.3274992; Lopez C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14237-8; NYC Department of Transportation, 2019, NEW YORK CIT MOB REP; Ramirez HG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225069; Ray JB, 2014, TRANSP RES AR TRA 5; Rayle L, 2016, TRANSPORT POLICY, V45, P168, DOI 10.1016/j.tranpol.2015.10.004; Santi P, 2014, P NATL ACAD SCI USA, V111, P13290, DOI 10.1073/pnas.1403657111; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Tachet R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42868; Tiakas E, 2006, INT DATABASE ENG APP, P185; Toohey K., 2015, SIGSPATIA, V7, P43, DOI [10.1145/2782759.2782767, DOI 10.1145/2782759.2782767]; van Kreveld M., 2007, P 15 ANN ACM INT S A, P44; Wang H., 2013, P 24 AUSTR DAT C, P13; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Wang X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096299, 10.1371/journal.pone.0085760]; Zhao K, 2015, SCI PEP, V5, P1	30	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238143	10.1371/journal.pone.0238143	http://dx.doi.org/10.1371/journal.pone.0238143			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941487	Green Published, gold			2022-12-26	WOS:000573848800103
J	Mellors, BL; Spear, AM; Howle, CR; Curtis, K; Macildowie, S; Dehghani, H				Mellors, Ben O. L.; Spear, Abigail M.; Howle, Christopher R.; Curtis, Kelly; Macildowie, Sara; Dehghani, Hamid			Machine learning utilising spectral derivative data improves cellular health classification through hyperspectral infra-red spectroscopy	PLOS ONE			English	Article							DEATH	The objective differentiation of facets of cellular metabolism is important for several clinical applications, including accurate definition of tumour boundaries and targeted wound debridement. To this end, spectral biomarkers to differentiate live and necrotic/apoptotic cells have been defined usingin vitromethods. The delineation of different cellular states using spectroscopic methods is difficult due to the complex nature of these biological processes. Sophisticated, objective classification methods will therefore be important for such differentiation. In this study, spectral data from healthy/traumatised cell samples using hyperspectral imaging between 2500-3500 nm were collected using a portable prototype device. Machine learning algorithms, in the form of clustering, have been performed on a variety of pre-processing data types including 'raw' unprocessed, smoothed resampling, background subtracted and spectral derivative. The resulting clusters were utilised as a diagnostic tool for the assessment of cellular health and quantified using both sensitivity and specificity to compare the different analysis methods. The raw data exhibited differences for one of the three different trauma types applied, although unable to accurately cluster all the traumatised samples due to signal contamination from the chemical insult. The background subtracted and smoothed data sets reduced the accuracy further, due to the apparent removal of key spectral features which exhibit cellular health. However, the spectral derivative data-types significantly improved the accuracy of clustering compared to other data types, with both sensitivity and specificity for the background subtracted data set being >94% highlighting its utility to account for unknown signal contamination while maintaining important cellular spectral features.	[Mellors, Ben O. L.] Univ Birmingham, Coll Engn & Phys Sci, Phys Sci Hlth Ctr Doctoral Training, Birmingham, W Midlands, England; [Mellors, Ben O. L.; Dehghani, Hamid] Univ Birmingham, Sch Comp Sci, Coll Engn & Phys Sci, Birmingham, W Midlands, England; [Spear, Abigail M.; Howle, Christopher R.; Curtis, Kelly; Macildowie, Sara] Def Sci & Technol Lab, Salisbury, Wilts, England	University of Birmingham; University of Birmingham; Defence Science & Technology Laboratory	Dehghani, H (corresponding author), Univ Birmingham, Sch Comp Sci, Coll Engn & Phys Sci, Birmingham, W Midlands, England.	h.dehghani@cs.bham.ac.uk		Dehghani, Hamid/0000-0003-4117-0412; Mellors, Ben/0000-0003-0510-2949	Engineering and Physical Sciences Research Council (EPSRC) [EP/L016346/1]; Protecting Our People programme at Dstl	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Protecting Our People programme at Dstl	The authors would like to acknowledge financial support from the Engineering and Physical Sciences Research Council (EPSRC) through a studentship form the Physical Sciences for Health Centre for Doctoral Training (EP/L016346/1), with co-funding from the Protecting Our People programme at Dstl.	[Anonymous], 2015, ISMP MSAL, V20, P1; [Anonymous], 2012, CLIN CANC RES, V18, pPR61; Assent I, 2012, WIRES DATA MIN KNOWL, V2, P340, DOI 10.1002/widm.1062; Benbow Maureen, 2016, Nurs Stand, V30, P40, DOI 10.7748/ns.30.27.40.s45; Birarda G, 2016, LAB CHIP, V16, P1644, DOI 10.1039/c5lc01460c; Bonnier F, 2012, ANALYST, V137, P322, DOI 10.1039/c1an15821j; BORNER MM, 1994, FEBS LETT, V353, P129, DOI 10.1016/0014-5793(94)01023-4; Castro P, 2018, 2018 SBFOTON INTERNATIONAL OPTICS AND PHOTONICS CONFERENCE (SBFOTON IOPC); Dehghani H, 2018, BIOMED OPT EXPRESS, V9, P4163, DOI 10.1364/BOE.9.004163; Dehghani H, 2010, PHYS MED BIOL, V55, P3381, DOI 10.1088/0031-9155/55/12/008; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Diakides NA, 2013, MEDICAL INFRARED IMAGING: PRINCIPLES AND PRACTICES; Diem M, 2012, SPECTROSC-INT J, V27, P463, DOI 10.1155/2012/848360; Ding C, 2004, P 21 INT C MACHINE L; Gerstner AOH, 2012, J BIOPHOTONICS, V5, P255, DOI 10.1002/jbio.201100081; Guo SX, 2020, J CHEMOMETR, V34, DOI 10.1002/cem.3202; Harding JR, 1998, P ANN INT IEEE EMBS, V20, P916, DOI 10.1109/IEMBS.1998.745591; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hobro AJ, 2017, VIB SPECTROSC, V91, P31, DOI 10.1016/j.vibspec.2016.10.012; Howle CR, 2016, PROC SPIE, V9703, DOI 10.1117/12.2213330; Howle CR, 2011, PROC SPIE, V8189, DOI 10.1117/12.898516; Jain AK., 1988, TECHNOMETRICS; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kavvadias V, 2013, 2013 35 ANN INT C IE; Kennedy GT, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.7.071615; MacQueen J, 1967, STATISTICS; Maitra S, 2008, APPL MULTIVAR STAT M, V79, P79; Marcsisin EJ, 2011, INFRARED SPECTROSCOP; Matthaus C, 2008, METHOD CELL BIOL, V89, P275, DOI 10.1016/S0091-679X(08)00610-9; Monstrey S, 2008, BURNS, V34, P761, DOI 10.1016/j.burns.2008.01.009; Moss DA, 2005, VIB SPECTROSC, V38, P185, DOI 10.1016/j.vibspec.2005.04.004; Raza K., 2018, TOUR UNSUPERVISED DE; Ruminski J, 2007, IEEE T BIO-MED ENG, V54, P303, DOI 10.1109/TBME.2006.886607; Selvan AN, 2017, METHODS MOL BIOL, V1618, P95, DOI 10.1007/978-1-4939-7051-3_10; Struyf A, 1997, COMPUT STAT DATA AN, V26, P17, DOI 10.1016/S0167-9473(97)00020-0; Teramoto S, 1999, JPN J PHARMACOL, V79, P33, DOI 10.1254/jjp.79.33; Thimsen E, 2017, NANOPHOTONICS-BERLIN, V6, P1043, DOI 10.1515/nanoph-2017-0039; Tsai F, 1998, REMOTE SENS ENVIRON, V66, P41, DOI 10.1016/S0034-4257(98)00032-7; Wahabzada M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186425; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Wrobel TP, 2018, ANAL CHEM, V90, P1444, DOI 10.1021/acs.analchem.7b05330; Yang Q, 2018, J IMAGING, V4, DOI 10.3390/jimaging4120144; Zelig U, 2009, BIOPHYS J, V97, P2107, DOI 10.1016/j.bpj.2009.07.026	44	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0238647	10.1371/journal.pone.0238647	http://dx.doi.org/10.1371/journal.pone.0238647			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931514	Green Published, gold			2022-12-26	WOS:000573375500020
J	Liu, SY; Gao, Y; Zhang, LP; Yin, Y; Zhang, WZ				Liu, Shiying; Gao, Yuan; Zhang, Liping; Yin, Yue; Zhang, Weizhen			Rspo1/Rspo3-LGR4 signaling inhibits hepatic cholesterol synthesis through the AMPK alpha-SREBP2 pathway	FASEB JOURNAL			English	Article						AMPK; cholesterol; LGR4; liver; R-spondins	LGR4; AMPK; METABOLISM; ABLATION	R-spondins (Rspos) are endogenous ligands of leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4). Rspos-LGR4 signaling plays important roles in embryogenesis, gastrointestinal homeostasis, and food intake. Here, we investigated the impacts of Rspos-LGR4 on hepatic cholesterol synthesis. Rspo1/3 andLgr4knockdown mice were used to investigate the impacts of Rspo1/3-LGR4 on hepatic cholesterol synthesis. AMPK alpha agonist, antagonist, and shRNA were used to explore the downstream targets of Rspos-LGR4 signaling. In our study, we reported that LGR4, Rspo1, and Rspo3 were highly expressed in hepatocytes and their expressions were sensitive to energy states. Rspo1 and Rspo3 reversed OA-induced cholesterol synthesis, accompanying with increased the phosphorylation of AMPK alpha Thr172, reduced SREBP2 nuclear translocation, andSrebf2mRNA expression. Conversely, hepatic LGR4 knockdown increased hepatic cholesterol synthesis and decreased the phosphorylation of AMPK alpha both in vitro and in vivo. Activation or inhibition of AMPK alpha significantly abolished the effects of LGR4 deficiency or Rspos, respectively, on cholesterol synthesis. Knockdown of AMPK alpha 1 or/and AMPK alpha 2 repressed Rspos-induced inhibition on cholesterol synthesis. Our study indicates that Rspo1/Rspo3-LGR4 signaling in hepatocytes suppresses cholesterol synthesis via the AMPK alpha-SREBP2 pathway.	[Liu, Shiying; Gao, Yuan; Yin, Yue; Zhang, Weizhen] Peking Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Zhang, Liping; Zhang, Weizhen] Univ Michigan, Med Ctr, Ann Arbor, MI USA	Peking University; University of Michigan System; University of Michigan	Yin, Y; Zhang, WZ (corresponding author), Peking Univ, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China.	yueyin@bjmu.edu.cn; weizhenzhang@bjmu.edu.cn			National Key R&D Program of China [2017YFC0908900]; National Natural Science Foundation of China [81730020, 81930015]; National Institutes of Health [1R01DK110273, R01DK112755]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Key R&D Program of China, Grant/Award Number: 2017YFC0908900; National Natural Science Foundation of China, Grant/Award Number: 81730020 and 81930015; National Institutes of Health, Grant/Award Number: 1R01DK110273 and R01DK112755	de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Dongiovanni P, 2015, J HEPATOL, V63, P705, DOI 10.1016/j.jhep.2015.05.006; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Li JY, 2014, ENDOCRINOLOGY, V155, P429, DOI 10.1210/en.2013-1550; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li ZR, 2019, AM J PHYSIOL-GASTR L, V316, pG123, DOI 10.1152/ajpgi.00056.2018; Li ZR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00131; Liu SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124951; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Natali F, 2007, J LIPID RES, V48, P1966, DOI 10.1194/jlr.M700051-JLR200; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Sun YK, 2015, BIOCHEM BIOPH RES CO, V464, P396, DOI 10.1016/j.bbrc.2015.06.066; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; Tang H, 2016, EBIOMEDICINE, V6, P139, DOI 10.1016/j.ebiom.2016.02.041; Wang F, 2014, J MOL ENDOCRINOL, V52, P133, DOI 10.1530/JME-13-0042; Wang JQ, 2013, NAT CELL BIOL, V15, P1455, DOI 10.1038/ncb2867; Yi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078144; Yoneda M, 2010, HEPATOL RES, V40, P566, DOI 10.1111/j.1872-034X.2010.00644.x; Zhou HM, 2018, J HEPATOL, V69, P99, DOI 10.1016/j.jhep.2018.01.036; Zou YY, 2017, OBESITY, V25, P252, DOI 10.1002/oby.21704	26	9	9	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14946	14959		10.1096/fj.202001234R	http://dx.doi.org/10.1096/fj.202001234R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32926477	Green Accepted, Green Published			2022-12-26	WOS:000570668600001
J	Zhao, D; Li, JQ; Xue, C; Feng, K; Liu, LP; Zeng, P; Wang, XL; Chen, YL; Li, LY; Zhang, ZS; Duan, YJ; Han, JH; Yang, XX				Zhao, Dan; Li, Jiaqi; Xue, Chao; Feng, Ke; Liu, Lipei; Zeng, Peng; Wang, Xiaolin; Chen, Yuanli; Li, Luyuan; Zhang, Zhisong; Duan, Yajun; Han, Jihong; Yang, Xiaoxiao			TL1A inhibits atherosclerosis in apoE-deficient mice by regulating the phenotype of vascular smooth muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; TL1A; vascular smooth muscle cell; phenotype; foam cell; calcification; ABC transporter; phenotype	ACTIVATION; EXPRESSION; RECEPTOR; LESIONS; ERK1/2; SWITCH	TNF ligand-related molecule 1A (TL1A) is a vascular endothelial growth inhibitor to reduce neovascularization. Lack of apoE a expression results in hypercholesterolemia and atherosclerosis. In this study, we determined the precise effects of TL1A on the development of atherosclerosis and the underlying mechanisms in apoE-deficient mice. After 12 weeks of pro-atherogenic high-fat diet feeding and TL1A treatment, mouse aorta, serum, and liver samples were collected and used to assess atherosclerotic lesions, fatty liver, and expression of related molecules. We found that TL1A treatment significantly reduced lesions and enhanced plaque stability. Mechanistically, TL1A inhibited formation of foam cells derived from vascular smooth muscle cells (VSMCs) but not macrophages by activating expression of ABC transporter A1 (ABCA1), ABCG1, and cholesterol efflux in a liver X receptor-dependent manner. TL1A reduced the transformation of VSMCs from contractile phenotype into synthetic phenotypes by activating expression of contractile marker alpha smooth muscle actin and inhibiting expression of synthetic marker osteopontin, or osteoblast-like phenotype by reducing calcification. In addition, TL1A ameliorated high-fat diet-induced lipid metabolic disorders in the liver. Taken together, our work shows that TL1A can inhibit the development of atherosclerosis by regulating VSMC/foam cell formation and switch of VSMC phenotypes and suggests further investigation of its potential for atherosclerosis treatment.	[Zhao, Dan; Li, Jiaqi; Xue, Chao; Feng, Ke; Liu, Lipei; Zeng, Peng; Wang, Xiaolin; Chen, Yuanli; Han, Jihong] Nankai Univ, State Key Lab Med Chem Biol, Minist Educ, Coll Life Sci,Key Lab Bioact Mat, Tianjin, Peoples R China; [Zhao, Dan; Duan, Yajun; Yang, Xiaoxiao] Hefei Univ Technol, Key Lab Metab & Regulat Major Dis, Anhui Higher Educ Inst, Coll Food & Biol Engn, Hefei, Peoples R China; [Li, Luyuan; Zhang, Zhisong] Nankai Univ, Coll Pharm, Tianjin, Peoples R China	Nankai University; Hefei University of Technology; Nankai University	Han, JH (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Minist Educ, Coll Life Sci,Key Lab Bioact Mat, Tianjin, Peoples R China.; Yang, XX (corresponding author), Hefei Univ Technol, Key Lab Metab & Regulat Major Dis, Anhui Higher Educ Inst, Coll Food & Biol Engn, Hefei, Peoples R China.	jihonhan2008@nankai.edu.cn; xiaoxiaoyang@hfut.edu.cn			International Science and Technology Cooperation Programs of China [2017YFE0110100]; National Natural Science Foundation of China (NSFC) [81803517, 81773727, 81973316, 81722046, 31770863]; Key Research and Development Program of Anhui Province [201904a07020007]; Fundamental Research Funds for the Central Universities	International Science and Technology Cooperation Programs of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Research and Development Program of Anhui Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the International Science and Technology Cooperation Programs of China Grant 2017YFE0110100 to (J. H., Y. D., X. Y., and Y. C.); National Natural Science Foundation of China (NSFC) Grants 81803517 (to X. Y.), 81773727 and 81973316 (to J. H.), 81722046 (to Y. D.), and 31770863 (to Y. C.); Key Research and Development Program of Anhui Province Grant 201904a07020007 (to J. H.); and the Fundamental Research Funds for the Central Universities (to X. Y., Y. D., and Y. C.).	Allahverdian S, 2018, CARDIOVASC RES, V114, P540, DOI 10.1093/cvr/cvy022; Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Allahverdian S, 2012, CARDIOVASC RES, V95, P165, DOI 10.1093/cvr/cvs094; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Chaabane C, 2014, CURR OPIN LIPIDOL, V25, P374, DOI 10.1097/MOL.0000000000000113; Chen YL, 2015, ARTERIOSCL THROM VAS, V35, P948, DOI 10.1161/ATVBAHA.114.305116; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Durham AL, 2018, CARDIOVASC RES, V114, P590, DOI 10.1093/cvr/cvy010; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Han H, 2018, BIOCHEM BIOPH RES CO, V506, P1040, DOI 10.1016/j.bbrc.2018.10.198; Hsu H, 2011, MUCOSAL IMMUNOL, V4, P368, DOI 10.1038/mi.2011.20; Kang YJ, 2005, CYTOKINE, V29, P229, DOI 10.1016/j.cyto.2004.12.001; Leopold JA, 2015, TRENDS CARDIOVAS MED, V25, P267, DOI 10.1016/j.tcm.2014.10.021; Li P, 2013, CIRC RES, V113, P1117, DOI 10.1161/CIRCRESAHA.113.301306; Liu LP, 2018, ARTERIOSCL THROM VAS, V38, P2382, DOI 10.1161/ATVBAHA.118.311546; Ma CR, 2018, BRIT J PHARMACOL, V175, P1486, DOI 10.1111/bph.14156; Ma J, 2019, J CARDIOVASC PHARM, V73, P105, DOI [10.1097/fjc.0000000000000642, 10.1097/FJC.0000000000000642]; McLaren JE, 2010, J IMMUNOL, V184, P5827, DOI 10.4049/jimmunol.0903782; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Sahoo S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153780; Schroeder F, 2005, LIPIDS, V40, P559, DOI 10.1007/s11745-005-1416-y; Shen LG, 2018, CYTOTECHNOLOGY, V70, P351, DOI 10.1007/s10616-017-0150-z; Sun L, 2017, ARTERIOSCL THROM VAS, V37, P1290, DOI 10.1161/ATVBAHA.117.309630; Tan Z, 2018, STEM CELLS DEV, V27, P534, DOI 10.1089/scd.2017.0244; Tu B, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.325; Wang Y, 2019, ARTERIOSCL THROM VAS, V39, P876, DOI 10.1161/ATVBAHA.119.312434; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wolf D, 2019, CIRC RES, V124, P315, DOI 10.1161/CIRCRESAHA.118.313591; Yang XX, 2016, J BIOL CHEM, V291, P15108, DOI 10.1074/jbc.M116.726737; Yurdagul A, 2016, BIOCHEM J, V473, P1281, DOI 10.1042/BJ20150844; Zhang JR, 2018, BIOMED PHARMACOTHER, V102, P711, DOI 10.1016/j.biopha.2018.03.120; Zhang K, 2016, ONCOTARGET, V7, P69436, DOI 10.18632/oncotarget.11683; Zhang L, 2016, BBA-MOL CELL BIOL L, V1861, P1180, DOI 10.1016/j.bbalip.2016.06.017; Zhao CY, 2010, J ENDOCRINOL, V204, P233, DOI 10.1677/JOE-09-0271	40	11	11	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16314	16327		10.1074/jbc.RA120.015486	http://dx.doi.org/10.1074/jbc.RA120.015486			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32963108	hybrid, Green Published			2022-12-26	WOS:000598519500012
J	Homayounieh, F; Zhang, EW; Babaei, R; Mobin, HK; Sharifian, M; Mohseni, I; Kuo, A; Arru, C; Kalra, MK; Digumarthy, SR				Homayounieh, Fatemeh; Zhang, Eric W.; Babaei, Rosa; Mobin, Hadi Karimi; Sharifian, Maedeh; Mohseni, Iman; Kuo, Anderson; Arru, Chiara; Kalra, Mannudeep K.; Digumarthy, Subba R.			Clinical and imaging features predict mortality in COVID-19 infection in Iran	PLOS ONE			English	Article							OUTCOMES; CT	The new coronavirus disease 2019 (COVID-19) pandemic has challenged many healthcare systems around the world. While most of the current understanding of the clinical features of COVID-19 is derived from Chinese studies, there is a relative paucity of reports from the remaining global health community. In this study, we analyze the clinical and radiologic factors that correlate with mortality odds in COVID-19 positive patients from a tertiary care center in Tehran, Iran. A retrospective cohort study of 90 patients with reverse transcriptase-polymerase chain reaction (RT-PCR) positive COVID-19 infection was conducted, analyzing demographics, co-morbidities, presenting symptoms, vital signs, laboratory values, chest radiograph findings, and chest CT features based on mortality. Chest radiograph was assessed using the Radiographic Assessment of Lung Edema (RALE) scoring system. Chest CTs were assessed according to the opacification pattern, distribution, and standardized severity score. Initial and follow-up Chest CTs were compared if available. Multiple logistic regression was used to generate a prediction model for mortality. The 90 patients included 59 men and 31 women (59.4 +/- 16.6 years), including 21 deceased and 69 surviving patients. Among clinical features, advanced age (p = 0.02), low oxygenation saturation (p<0.001), leukocytosis (p = 0.02), low lymphocyte fraction (p = 0.03), and low platelet count (p = 0.048) were associated with increased mortality. High RALE score on initial chest radiograph (p = 0.002), presence of pleural effusions on initial CT chest (p = 0.005), development of pleural effusions on follow-up CT chest (p = 0.04), and worsening lung severity score on follow-up CT Chest (p = 0.03) were associated with mortality. A two-factor logistic model using patient age and oxygen saturation was created, which demonstrates 89% accuracy and area under the ROC curve of 0.86 (p<0.0001). Specific demographic, clinical, and imaging features are associated with increased mortality in COVID-19 infections. Attention to these features can help optimize patient management.	[Homayounieh, Fatemeh; Zhang, Eric W.; Arru, Chiara; Kalra, Mannudeep K.; Digumarthy, Subba R.] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Div Thorac Imaging & Intervent, Boston, MA 02115 USA; [Babaei, Rosa; Mobin, Hadi Karimi; Sharifian, Maedeh; Mohseni, Iman] Univ Med Sci, Firoozgar Hosp, Dept Radiol, Tehran, Iran; [Kuo, Anderson] Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Div Cardiovasc Imaging, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Tehran University of Medical Sciences; Harvard University; Massachusetts General Hospital	Digumarthy, SR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Dept Radiol, Div Thorac Imaging & Intervent, Boston, MA 02115 USA.	sdigumarthy@mgh.harvard.edu		Arru, Chiara Daniela/0000-0002-2014-2802; Kuo, Anderson/0000-0002-5517-7984				Akl EA, 2021, RADIOLOGY, V298, pE63, DOI 10.1148/radiol.2020203173; Arabi YM, 2017, NEW ENGL J MED, V376, P584, DOI 10.1056/NEJMsr1408795; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Bialek S, 2020, MMWR-MORBID MORTAL W, V69, P422, DOI 10.15585/mmwr.mm6914e4; do Nascimento IB, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040941; Cao YH, 2020, J MED VIROL, V92, P1449, DOI 10.1002/jmv.25822; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686; Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230; Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Hope MD, 2020, LANCET, V395, P1189, DOI 10.1016/S0140-6736(20)30728-5; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Kotok D, 2020, J CRIT CARE, V56, P222, DOI 10.1016/j.jcrc.2020.01.012; Liang WH, 2020, EUROPEAN RESP J; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mahdavi A, 2020, ACAD RADIOL, V27, P1049, DOI 10.1016/j.acra.2020.04.031; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Radiological Society of North America, 2020, END SOC THOR RAD AM, DOI [10.1148/ryct.2020200152, DOI 10.1148/RYCT.2020200152]; Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756; Tan L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0148-4; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Warren MA, 2018, THORAX, V73, P840, DOI 10.1136/thoraxjnl-2017-211280; World Health Organization, 2020, WORLDS LEAD J PUBL N; World Health Organization, 2020, 122 WHO; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	36	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239519	10.1371/journal.pone.0239519	http://dx.doi.org/10.1371/journal.pone.0239519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970733	Green Published, gold			2022-12-26	WOS:000576265600093
J	Woolley, SA; Tsimnadis, ER; Lenghaus, C; Healy, PJ; Walker, K; Morton, A; Khatkar, MS; Elliott, A; Kaya, E; Hoerner, C; Priestman, DA; Shepherd, D; Platt, FM; Porebski, B; Willet, CE; O'Rourke, BA; Tammen, I				Woolley, Shernae A.; Tsimnadis, Emily R.; Lenghaus, Cor; Healy, Peter J.; Walker, Keith; Morton, Andrew; Khatkar, Mehar S.; Elliott, Annette; Kaya, Ecem; Hoerner, Clarisse; Priestman, David A.; Shepherd, Dawn; Platt, Frances M.; Porebski, Ben T.; Willet, Cali E.; O'Rourke, Brendon A.; Tammen, Imke			Molecular basis for a new bovine model of Niemann-Pick type C disease	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISORDER; SPHINGOMYELIN LIPIDOSIS; NPC1 PROTEIN; MOUSE MODEL; MUTATIONS; DIAGNOSIS; IDENTIFICATION; HETEROZYGOTES; TRAFFICKING; DEFICIENCY	Niemann-Pick type C disease is a lysosomal storage disease affecting primarily the nervous system that results in premature death. Here we present the first report and investigation of Niemann-Pick type C disease in Australian Angus/Angus-cross calves. After a preliminary diagnosis of Niemann-Pick type C, samples from two affected calves and two obligate carriers were analysed using single nucleotide polymorphism genotyping and homozygosity mapping, andNPC1was considered as a positional candidate gene. A likely causal missense variant on chromosome 24 in theNPC1gene (NM_174758.2:c.2969C>G) was identified by Sanger sequencing of cDNA. SIFT analysis, protein alignment and protein modelling predicted the variant to be deleterious to protein function. Segregation of the variant with disease was confirmed in two additional affected calves and two obligate carrier dams. Genotyping of 403 animals from the original herd identified an estimated allele frequency of 3.5%. The Niemann-Pick type C phenotype was additionally confirmed via biochemical analysis of Lysotracker Green, cholesterol, sphingosine and glycosphingolipids in fibroblast cell cultures originating from two affected calves. The identification of a novel missense variant for Niemann-Pick type C disease in Angus/Angus-cross cattle will enable improved breeding and management of this disease in at-risk populations. The results from this study offer a unique opportunity to further the knowledge of human Niemann-Pick type C disease through the potential availability of a bovine model of disease.	[Woolley, Shernae A.; Tsimnadis, Emily R.; Khatkar, Mehar S.; Tammen, Imke] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camden, NSW, Australia; [Walker, Keith; Elliott, Annette; O'Rourke, Brendon A.] Elizabeth Macarthur Agr Inst, NSW Dept Primary Ind, Menangle, NSW, Australia; [Kaya, Ecem; Hoerner, Clarisse; Priestman, David A.; Shepherd, Dawn; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford, England; [Porebski, Ben T.] Med Res Council Lab Mol Biol, Cambridge Biomed Campus, Cambridge, England; [Willet, Cali E.] Univ Sydney, Sydney Informat Hub Core Res Facil, Darlington, NSW, Australia	University of Sydney; NSW Department of Primary Industries; University of Oxford; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Sydney	Tammen, I (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camden, NSW, Australia.	imke.tammen@sydney.edu.au	Tammen, Imke/AFF-7998-2022; O'Rourke, Brendon/W-6589-2019	Tammen, Imke/0000-0002-5520-6597; O'Rourke, Brendon/0000-0001-6959-9398; Woolley, Shernae/0000-0003-2317-2916; Platt, Frances/0000-0001-7614-0403; Shepherd, Dawn/0000-0003-1304-6051	University of Sydney Faculty of Veterinary Science - Dorothy Minchin Bequest; University of Sydney Faculty of Veterinary Science; Australian Government Research Training Program (RTP) Scholarship; Australian Government; MRC [MC_U105178804] Funding Source: UKRI	University of Sydney Faculty of Veterinary Science - Dorothy Minchin Bequest; University of Sydney Faculty of Veterinary Science; Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Government(Australian GovernmentCGIAR); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the University of Sydney Faculty of Veterinary Science - Dorothy Minchin Bequest for IT, the University of Sydney Faculty of Veterinary Science honours project support for SAW and ERT and the Australian Government Research Training Program (RTP) Scholarship for SAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge and thank the producers for submitting samples, video recordings of affected animals and data associated with this case, as well as veterinarians Nerida Evans and Clem Watson for their assistance with collecting hair samples. The authors would like to acknowledge Professor John Hopwood for early functional experimentation of the bovine fibroblast cells. The authors would like to further acknowledge the Australian Genome Research Facility for conducting SNP genotyping and sequencing services. The authors acknowledge the assistance of resources from the National Computational Infrastructure (NCI Australia), an NCRIS enabled capability supported by the Australian Government for this study. The authors acknowledge the technical assistance provided by the Sydney Informatics Hub, a Core Research Facility of the University of Sydney and the use of the University of Sydney's high performance computing cluster, Artemis. The authors would like to thank Dr Julie Dennis and Dr Peter Kirkland for providing feedback on the paper during the draft stages.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aerts JMFG, 2011, J INHERIT METAB DIS, V34, P605, DOI 10.1007/s10545-011-9308-6; [Anonymous], 2007, PLOS ONE, V2, pe779; [Anonymous], 2012, NUCLEIC ACIDS RES, V40, pD71; BAKER HJ, 1987, VET PATHOL, V24, P386, DOI 10.1177/030098588702400504; Berg T, 1997, RES VET SCI, V63, P279, DOI 10.1016/S0034-5288(97)90034-5; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROWN DE, 1994, AM J PATHOL, V144, P1412; BUNDZA A, 1979, VET PATHOL, V16, P530, DOI 10.1177/030098587901600504; Case D.A., 2022, AMBER 2020; CHRISP CE, 1970, J AM VET MED ASSOC, V156, P616; Cibelli J, 2013, CELL STEM CELL, V12, P271, DOI 10.1016/j.stem.2013.01.004; CROCKER AC, 1958, MEDICINE, V37, P1, DOI 10.1097/00005792-195802000-00001; CROCKER AC, 1961, J NEUROCHEM, V7, P69, DOI 10.1111/j.1471-4159.1961.tb13499.x; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; D'Arcangelo G, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/3830424; Dang YL, 2014, GENE, V540, P153, DOI 10.1016/j.gene.2014.03.001; Deffieu MS, 2011, P NATL ACAD SCI USA, V108, P18932, DOI 10.1073/pnas.1110439108; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; DORLING PR, 1978, NEUROPATH APPL NEURO, V4, P285, DOI 10.1111/j.1365-2990.1978.tb00547.x; Dusendschon A, 1946, REUNIES; FINK JK, 1989, NEUROLOGY, V39, P1040, DOI 10.1212/WNL.39.8.1040; Greer WL, 1999, AM J HUM GENET, V65, P1252, DOI 10.1086/302620; Gurda BL, 2019, HUM MOL GENET, V28, pR119, DOI 10.1093/hmg/ddz127; HARTLEY WJ, 1975, AUST VET J, V51, P103, DOI 10.1111/j.1751-0813.1975.tb09422.x; HEALY PJ, 1995, AUST VET J, V72, P392, DOI 10.1111/j.1751-0813.1995.tb06178.x; HIGASHI Y, 1993, ACTA NEUROPATHOL, V85, P175; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; HUXTABLE CR, 1982, AUST VET J, V59, P50, DOI 10.1111/j.1751-0813.1982.tb02716.x; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jolly R D, 1970, N Z Vet J, V18, P228, DOI 10.1080/00480169.1970.33909; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kessell AE, 2011, AUST VET J, V89, P331, DOI 10.1111/j.1751-0813.2011.00817.x; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; KUWAMURA M, 1993, ACTA NEUROPATHOL, V85, P345, DOI 10.1007/BF00227733; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Li XC, 2017, P NATL ACAD SCI USA, V114, P9116, DOI 10.1073/pnas.1711716114; Lippert RA, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2431176; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Long T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13917-5; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Man WYN, 2007, PREV VET MED, V78, P262, DOI 10.1016/j.prevetmed.2006.10.010; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; McGovern MM, 2013, GENET MED, V15, P618, DOI 10.1038/gim.2013.4; Millat G, 2001, AM J HUM GENET, V68, P1373, DOI 10.1086/320606; MIYAWAKI S, 1982, J HERED, V73, P257, DOI 10.1093/oxfordjournals.jhered.a109635; MIYAWAKI S, 1986, J HERED, V77, P379, DOI 10.1093/oxfordjournals.jhered.a110265; MOLYNEUX RJ, 1995, J NAT PRODUCTS, V58, P878, DOI 10.1021/np50120a009; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Niemann A., 1914, JB KINDERHEILKD, V79, P1; Patterson MC, 2004, BBA-MOL CELL BIOL L, V1685, P77, DOI 10.1016/j.bbalip.2004.08.013; PENTCHEV PG, 1980, BIOCHIM BIOPHYS ACTA, V619, P669, DOI 10.1016/0005-2760(80)90116-2; Pflander U, 1946, SCHWEIZ MED WOCHENSC, P76; Pick L., 1927, MED KLIN, V23, P1483; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Saunders GK, 2008, VET PATHOL, V45, P201, DOI 10.1354/vp.45-2-201; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuchman EH, 2016, PEDIATR ENDOCR REV P, V13, P674; Scott C, 2004, BBA-MOL CELL BIOL L, V1685, P8, DOI 10.1016/j.bbalip.2004.08.006; Somers KL, 1999, MOL GENET METAB, V66, P117, DOI 10.1006/mgme.1998.2778; Somers KL, 2003, MOL GENET METAB, V79, P99, DOI 10.1016/S1096-7192(03)00074-X; Stein VM, 2012, J NEUROPATH EXP NEUR, V71, P434, DOI 10.1097/NEN.0b013e31825414a6; te Vruchte D, 2014, J CLIN INVEST, V124, P1320, DOI 10.1172/JCI72835; Tollersrud OK, 1997, EUR J BIOCHEM, V246, P410, DOI 10.1111/j.1432-1033.1997.00410.x; Vance JE, 2006, FEBS LETT, V580, P5518, DOI 10.1016/j.febslet.2006.06.008; Vanier MT, 2015, METHOD CELL BIOL, V126, P357, DOI 10.1016/bs.mcb.2014.10.028; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; VANIER MT, 1988, CLIN GENET, V33, P331; VANIER MT, 1991, BIOCHIM BIOPHYS ACTA, V1096, P328, DOI 10.1016/0925-4439(91)90069-L; VANIER MT, 1991, DEV NEUROSCI-BASEL, V13, P307, DOI 10.1159/000112178; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; VANIER MT, 1983, BIOCHIM BIOPHYS ACTA, V750, P178, DOI 10.1016/0005-2760(83)90218-7; Vapniarsky N, 2013, J COMP PATHOL, V149, P385, DOI 10.1016/j.jcpa.2013.01.011; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Wang N, 2017, HUM MUTAT, V38, P1491, DOI 10.1002/humu.23291; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WENGER DA, 1980, SCIENCE, V208, P1471, DOI 10.1126/science.7189903; WHITTEM JH, 1957, J PATHOL BACTERIOL, V74, P281, DOI 10.1002/path.1700740205; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yu XH, 2014, CLIN CHIM ACTA, V429, P69, DOI 10.1016/j.cca.2013.11.026; Zampieri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112503; ZITMAN D, 1978, CLIN CHIM ACTA, V86, P37, DOI 10.1016/0009-8981(78)90455-2	85	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238697	10.1371/journal.pone.0238697	http://dx.doi.org/10.1371/journal.pone.0238697			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970694	Green Published, gold			2022-12-26	WOS:000576265600030
J	Ishida, Y; Yamasaki, C; Iwanari, H; Yamashita, H; Ogawa, Y; Yanagi, A; Furukawa, S; Kojima, Y; Chayama, K; Kamiie, J; Tateno, C				Ishida, Yuji; Yamasaki, Chihiro; Iwanari, Hiroko; Yamashita, Hisahiko; Ogawa, Yuko; Yanagi, Ami; Furukawa, Suzue; Kojima, Yuha; Chayama, Kazuaki; Kamiie, Junichi; Tateno, Chise			Detection of acute toxicity of aflatoxin B1 to human hepatocytesin vitroandin vivousing chimeric mice with humanized livers	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; VITRIGEL MEMBRANE CHAMBER; HEPATITIS-B-VIRUS; MODEL; CYTOCHROME-P450; TROGLITAZONE; METABOLISM; HEPARG	Aflatoxin B1 (AFB1), a mycotoxin, is acutely hepatotoxic to many animals including humans. However, there are marked interspecies differences in sensitivity to AFB1-induced toxicity depending on bioactivation by cytochrome P450s (CYPs). In the present study, we examined the applicability of chimeric mice with humanized livers and derived fresh human hepatocytes forin vivoandvitrostudies on AFB1 cytotoxicity to human hepatocytes. Chimeric mice with highly humanized livers and SCID mice received daily injections of vehicle (corn oil), AFB1 (3 mg/kg), and carbon tetrachloride (50 mg/kg) for 2 days. Histological analysis revealed that AFB1 promoted hepatocyte vacuolation and inflammatory cell infiltration in the area containing human hepatocytes. A novel human alanine aminotransferase 1 specific enzyme-linked immunosorbent assay demonstrated the acute toxicity of AFB1 to human hepatocytes in the chimeric mouse livers. The sensitivity of cultured fresh human hepatocytes isolated from the humanized liver mice for AFB1 cytotoxicity was comparable to that of primary human hepatocytes. Long-term exposure to AFB1 (6 or 14 days) produced a more severe cytotoxicity. The half-maximal lethal concentration was 10 times lower in the 2-week treatment than after 2 days of exposure. Lastly, the significant reduction of AFB1 cytotoxicity by a pan-CYP inhibitor or transfection with CYP3A4 specific siRNA clearly suggested that bioactivation of AFB1 catalyzed by CYPs was essential for AFB1 cytotoxicity to the human hepatocytes in our mouse model. Collectively, our results implicate the humanized liver mice and derived fresh human hepatocytes are useful models for studies of AFB1 cytotoxicity to human hepatocytes.	[Ishida, Yuji; Yamasaki, Chihiro; Ogawa, Yuko; Yanagi, Ami; Furukawa, Suzue; Kojima, Yuha; Tateno, Chise] PhoenixBio Co Ltd, Dept Res & Dev, Higashihiroshima, Hiroshima, Japan; [Ishida, Yuji; Chayama, Kazuaki; Tateno, Chise] Hiroshima Univ, Res Ctr Hepatol & Gastroenterol, Hiroshima, Hiroshima, Japan; [Iwanari, Hiroko] Univ Tokyo, Res Ctr Adv Sci & Technol RCAST, Quantitat Biol & Med, Meguro Ku, Tokyo, Japan; [Yamashita, Hisahiko] Inst Immunol Co Ltd, Bunkyo Ku, Tokyo, Japan; [Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Appl Life Sci, Hiroshima, Hiroshima, Japan; [Kamiie, Junichi] Azabu Univ, Sch Vet Med, Lab Vet Pathol, Sagamihara, Kanagawa, Japan	PHOENIXBIO CO. LTD.; Hiroshima University; University of Tokyo; Hiroshima University; Azabu University	Tateno, C (corresponding author), PhoenixBio Co Ltd, Dept Res & Dev, Higashihiroshima, Hiroshima, Japan.; Tateno, C (corresponding author), Hiroshima Univ, Res Ctr Hepatol & Gastroenterol, Hiroshima, Hiroshima, Japan.	chise.mukaidani@phoenixbio.co.jp		Chayama, Kazuaki/0000-0002-5530-5341				[Anonymous], 2012, AFLATOXINS F, V100F, P225; CULLEN JM, 1987, CANCER RES, V47, P1913; Dohnal V, 2014, ARCH TOXICOL, V88, P1635, DOI 10.1007/s00204-014-1312-9; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V402, P121, DOI 10.1016/S0027-5107(97)00289-3; Guevara-Gonzalez RG, 2011, AFLATOXINS BIOCH MOL, DOI [10.5772/896, DOI 10.5772/896]; HAYES JD, 1991, PHARMACOL THERAPEUT, V50, P443, DOI 10.1016/0163-7258(91)90053-O; Ilic Z, 2010, TOXICOL APPL PHARM, V242, P241, DOI 10.1016/j.taap.2009.10.008; Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028; Ishikawa AT, 2017, TOXINS, V9, DOI 10.3390/toxins9110374; Kakuni M, 2014, INT J MOL SCI, V15, P58, DOI 10.3390/ijms15010058; Kakuni M, 2012, TOXICOL LETT, V214, P9, DOI 10.1016/j.toxlet.2012.08.001; Kensler TW, 2011, TOXICOL SCI, V120, pS28, DOI 10.1093/toxsci/kfq283; Kuna L, 2018, CURR DRUG METAB, V19, P830, DOI 10.2174/1389200219666180523095355; Marchese S, 2018, TOXINS, V10, DOI 10.3390/toxins10060214; Misik M, 2019, MUTAT RES-GEN TOX EN, V845, DOI 10.1016/j.mrgentox.2018.12.003; PRENDERGAST JA, 1967, TOXICOL APPL PHARM, V10, P270, DOI 10.1016/0041-008X(67)90110-X; Sanoh S, 2017, J TOXICOL SCI, V42, P589, DOI 10.2131/jts.42.589; Schulz-Utermoehl T, 2012, XENOBIOTICA, V42, P503, DOI 10.3109/00498254.2011.640716; Sugahara G, 2020, SEMIN LIVER DIS, V40, P189, DOI 10.1055/s-0040-1701444; Takaoka N, 2018, BIOCHEM PHARMACOL, V154, P28, DOI 10.1016/j.bcp.2018.04.017; Tateno C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142145; Tateno C, 2013, LAB INVEST, V93, P54, DOI 10.1038/labinvest.2012.158; Uchida M, 2018, DRUG METAB DISPOS, V46, P11, DOI 10.1124/dmd.117.075994; Uchida T, 2017, J GEN VIROL, V98, P1040, DOI 10.1099/jgv.0.000726; Van Ness KP, 1998, TOXICOL APPL PHARM, V152, P166, DOI 10.1006/taap.1998.8493; Watari R, 2019, BIOL PHARM BULL, V42, P348, DOI 10.1248/bpb.b18-00582; Watari R, 2018, J TOXICOL SCI, V43, P521, DOI 10.2131/jts.43.521; WOGAN GN, 1974, FOOD COSMET TOXICOL, V12, P681, DOI 10.1016/0015-6264(74)90239-9; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Xu D, 2015, J PHARMACOL EXP THER, V352, P274, DOI 10.1124/jpet.114.220798; Xu D, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001628; Yamasaki C, 2020, PLOS ONE, V15, pe0237809, DOI [10.1371/journal.pone.0237809, DOI 10.1371/J0URNAL.P0NE.0237809]; Yamasaki C, 2010, DRUG METAB PHARMACOK, V25, P539, DOI 10.2133/dmpk.DMPK-10-RG-047; Yokoyama Y, 2018, BIOL PHARM BULL, V41, P722, DOI 10.1248/bpb.b17-00913; Zeilinger K, 2016, EXP BIOL MED, V241, P1684, DOI 10.1177/1535370216657448; Zhou YT, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01093	37	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239540	10.1371/journal.pone.0239540	http://dx.doi.org/10.1371/journal.pone.0239540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966316	Green Published, gold			2022-12-26	WOS:000575688700038
J	Kubota, Y; Shiono, T; Kusumoto, B; Fujinuma, J				Kubota, Yasuhiro; Shiono, Takayuki; Kusumoto, Buntarou; Fujinuma, Junichi			Multiple drivers of the COVID-19 spread: The roles of climate, international mobility, and region-specific conditions	PLOS ONE			English	Article							DYNAMICS	Following its initial appearance in December 2019, coronavirus disease 2019 (COVID-19) quickly spread around the globe. Here, we evaluated the role of climate (temperature and precipitation), region-specific COVID-19 susceptibility (BCG vaccination factors, malaria incidence, and percentage of the population aged over 65 years), and human mobility (relative amounts of international visitors) in shaping the geographical patterns of COVID-19 case numbers across 1,020 countries/regions, and examined the sequential shift that occurred from December 2019 to June 30, 2020 in multiple drivers of the cumulative number of COVID-19 cases. Our regression model adequately explains the cumulative COVID-19 case numbers (per 1 million population). As the COVID-19 spread progressed, the explanatory power (R-2) of the model increased, reaching > 70% in April 2020. Climate, host mobility, and host susceptibility to COVID-19 largely explained the variance among COVID-19 case numbers across locations; the relative importance of host mobility and that of host susceptibility to COVID-19 were both greater than that of climate. Notably, the relative importance of these factors changed over time; the number of days from outbreak onset drove COVID-19 spread in the early stage, then human mobility accelerated the pandemic, and lastly climate (temperature) propelled the phase following disease expansion. Our findings demonstrate that the COVID-19 pandemic is deterministically driven by climate suitability, cross-border human mobility, and region-specific COVID-19 susceptibility. The identification of these multiple drivers of the COVID-19 outbreak trajectory, based on mapping the spread of COVID-19, will contribute to a better understanding of the COVID-19 disease transmission risk and inform long-term preventative measures against this disease.	[Kubota, Yasuhiro; Shiono, Takayuki; Fujinuma, Junichi] Univ Ryukyus, Fac Sci, Nishihara, Okinawa, Japan; [Kubota, Yasuhiro] Think Nat Inc, Nishihara, Okinawa, Japan; [Kusumoto, Buntarou] Univ Ryukyus, Univ Museum, Nishihara, Okinawa, Japan	University of the Ryukyus; University of the Ryukyus	Kubota, Y (corresponding author), Univ Ryukyus, Fac Sci, Nishihara, Okinawa, Japan.; Kubota, Y (corresponding author), Think Nat Inc, Nishihara, Okinawa, Japan.	Kubota.yasuhiro@gmail.com	Kusumoto, Buntarou/Y-3896-2018	Kusumoto, Buntarou/0000-0002-5091-3575; Kubota, Yasuhiro/0000-0002-5723-4962; Reis, AlessanRSS/0000-0001-8486-7469; Fujinuma, Junichi/0000-0001-9004-4709; Shiono, Takayuki/0000-0001-7253-7956				Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Araujo Miguel B., 2020, SPREAD SARS COV 2 CO, DOI [10.1101/2020.03.12.20034728, DOI 10.1101/2020.03.12.20034728]; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Baker R. E, 2020, SUSCEPTIBLE SUPPLY L, DOI [10.1101/2020.04.03.20052787, DOI 10.1101/2020.04.03.20052787]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Coelho MTP, 2020, EXPONENTIAL PHASE CO, DOI [10.1101/2020.04.02.20050773, DOI 10.1101/2020.04.02.20050773]; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174; Ficetola G.F., 2020, MEDRXIV, DOI [10.1101/2020.03.23.20040501., DOI 10.1016/j.ijantimicag.2020.105924]; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moriyama M, 2020, ANN REV VIROL, V7, DOI 10.1146/annurev-virology-012420-022445; Murray KA, 2018, ECOGRAPHY, V41, P1411, DOI 10.1111/ecog.03625; Murray KA, 2015, P NATL ACAD SCI USA, V112, P12746, DOI 10.1073/pnas.1507442112; Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020419; Pebesma E, 2018, R J, V10, P439; R Core Team, 2021, R LANGUAGE ENV STAT; Sajadi MM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11834; Sala G., 2020, MEDRXIV, DOI 10.1101/2020.03.30.20048165; Smith KF, 2007, ECOLOGY, V88, P1903, DOI 10.1890/06-1052.1; Townsend PA, 2014, MAPPING DIS TRANSMIS; Wells CR, 2020, P NATL ACAD SCI USA, V117, P7504, DOI 10.1073/pnas.2002616117; WHITTAKER R H, 1975, P385	23	27	28	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239385	10.1371/journal.pone.0239385	http://dx.doi.org/10.1371/journal.pone.0239385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966315	Green Published, gold, Green Submitted			2022-12-26	WOS:000575688700040
J	Zhao, LL; Richards, S; Turck, F; Kollmann, M				Zhao, Linlin; Richards, Sarah; Turck, Franziska; Kollmann, Markus			Information integration and decision making in flowering time control	PLOS ONE			English	Article							TEMPERATURE; ARABIDOPSIS; COLD; PHOTOSYNTHESIS; VERNALIZATION; MEMORY; MODEL; FLC	In order to successfully reproduce, plants must sense changes in their environment and flower at the correct time. Many plants utilize day length and vernalization, a mechanism for verifying that winter has occurred, to determine when to flower. Our study used available temperature and day length data from different climates to provide a general understanding how this information processing of environmental signals could have evolved in plants. For climates where temperature fluctuation correlations decayed exponentially, a simple stochastic model characterizing vernalization was able to reconstruct the switch-like behavior of the core flowering regulatory genes. For these and other climates, artificial neural networks were used to predict flowering gene expression patterns. For temperate plants, long-term cold temperature and short-term day length measurements were sufficient to produce robust flowering time decisions from the neural networks. Additionally, evolutionary simulations on neural networks confirmed that the combined signal of temperature and day length achieved the highest fitness relative to neural networks with access to only one of those inputs. We suggest that winter temperature memory is a well-adapted strategy for plants' detection of seasonal changes, and absolute day length is useful for the subsequent triggering of flowering.	[Zhao, Linlin; Kollmann, Markus] Heinrich Heine Univ Dusseldorf, Inst Math Modeling Biol Syst, Dusseldorf, Germany; [Richards, Sarah] Heinrich Heine Univ Dusseldorf, Inst Populat Genet, Dusseldorf, Germany; [Turck, Franziska] Max Planck Inst Plant Breeding Res, Cologne, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Max Planck Society	Zhao, LL; Kollmann, M (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Math Modeling Biol Syst, Dusseldorf, Germany.	linlin.zhao@hhu.de; markus.kollman@hhu.de		Zhao, Linlin/0000-0001-8086-2812	DFG (Deutsche Forschungsgemeinschaft) [KO3442-9]	DFG (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	M.K and F. T received the DFG (Deutsche Forschungsgemeinschaft) grant KO3442-9. https://www.dfg.de/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari KN, 2012, PLANT BREEDING, V131, P631, DOI 10.1111/j.1439-0523.2012.01996.x; Aikawa S, 2010, P NATL ACAD SCI USA, V107, P11632, DOI 10.1073/pnas.0914293107; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Angel A, 2015, P NATL ACAD SCI USA, V112, P4146, DOI 10.1073/pnas.1503100112; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; [Anonymous], 2004, HDB STOCHASTIC METHO; [Anonymous], INTERESTING CALCULAT; [Anonymous], SUNS DAYL GRAPH; Antoniou-Kourounioti RL, 2018, CELL SYST, V7, P643, DOI 10.1016/j.cels.2018.10.011; Bergstra J, 2010, THEANO CPU GPU MATH; Bratzel F, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0770-6; Chew YH, 2012, NEW PHYTOL, V194, P654, DOI 10.1111/j.1469-8137.2012.04069.x; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; David-Rus D, 2009, J THEOR BIOL, V258, P112, DOI 10.1016/j.jtbi.2008.12.021; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; Duncan S, 2015, ELIFE, V4, DOI 10.7554/eLife.06620; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Hepworth J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03065-7; Hyun Y, 2019, SCIENCE, V363, P409, DOI 10.1126/science.aau8197; Kelemen JZ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000332; MATLAB, 2014, MATLAB R2014A NAT; Mukhopadhyaya S, 2010, BIOSYSTEMS, V102, P49, DOI 10.1016/j.biosystems.2010.07.012; Nagano AJ, 2019, NAT PLANTS, V5, P74, DOI 10.1038/s41477-018-0338-z; NOAA, CLIM DAT ONL; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Risken H., 1989, FOKKER PLANCK EQUATI, DOI [10.1007/978-3-642-61544-3, DOI 10.1007/978-3-642-61544-3, 10.1007/978-3-642-61544-3_4]; Satake A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3303; Satake A, 2012, J THEOR BIOL, V302, P6, DOI 10.1016/j.jtbi.2012.02.009; Sedighi M, 2007, PHYS BIOL, V4, P246, DOI 10.1088/1478-3975/4/4/002; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Song YH, 2013, TRENDS PLANT SCI, V18, P575, DOI 10.1016/j.tplants.2013.05.003; Topham AT, 2017, P NATL ACAD SCI USA, V114, P6629, DOI 10.1073/pnas.1704745114; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Walczak Aleksandra M, 2012, Methods Mol Biol, V880, P273, DOI 10.1007/978-1-61779-833-7_13; Weigel D, 2012, PLANT PHYSIOL, V158, P2, DOI 10.1104/pp.111.189845; Weisstein EW, HERMITE POLYNOMIAL M; Whiting D, 2016, PLANT GROWTH FACTORS; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; WILSON D, 1969, NEW PHYTOL, V68, P1115, DOI 10.1111/j.1469-8137.1969.tb06511.x	40	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239417	10.1371/journal.pone.0239417	http://dx.doi.org/10.1371/journal.pone.0239417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966329	gold, Green Published			2022-12-26	WOS:000575688700023
J	Diaz-Ricaurte, JC; Serrano, FC; Guevara-Molina, EC; Araujo, C; Martins, M				Diaz-Ricaurte, Juan C.; Serrano, Filipe C.; Guevara-Molina, Estefany Caroline; Araujo, Cybele; Martins, Marcio			Does behavioral thermal tolerance predict distribution pattern and habitat use in two sympatric Neotropical frogs?	PLOS ONE			English	Article							CLIMATE-CHANGE; THERMOREGULATORY BEHAVIOR; WATER; ECOLOGY; TERRESTRIAL; PHYSIOLOGY; ABUNDANCE; SELECTION; ENERGY; BIODIVERSITY	Environmental temperatures are a major constraint on ectotherm abundance, influencing their distribution and natural history. Comparing thermal tolerances with environmental temperatures is a simple way to estimate thermal constraints on species distributions. We investigate the potential effects of behavioral thermal tolerance (i. e. Voluntary Thermal Maximum, VTMax) on anuran local (habitat) and regional distribution patterns and associated behavioral responses. We tested for differences in Voluntary Thermal Maximum (VTMax) of two sympatric frog species of the genusPhysalaemusin the Cerrado. We mapped the difference between VT(Max)and maximum daily temperature (VTMax-ETMax) and compared the abundance in open and non-open habitats for both species.Physalaemus nattererihad a significantly higher VT(Max)thanP.cuvieri. ForP.nattereri, the model including only period of day was chosen as the best to explain variation in the VT(Max)while forP.cuvieri, the null model was the best model. At the regional scale, VTMax-ET(Max)values were significantly different between species, withP.nattererimostly found in localities with maximum temperatures below its VT(Max)andP.cuvierishowing the reverse pattern. Regarding habitat use,P.cuvieriwas in general more abundant in open than in non-open habitats, whereasP.nattereriwas similarly abundant in these habitats. This difference seems to reflect their distribution patterns:P.cuvieriis more abundant in open and warmer habitats and occurs mostly in warmer areas in relation to its VTMax, whereasP.nattereritends to be abundant in both open and non-open (and cooler) areas and occurs mostly in cooler areas regarding its VTMax. Our study indicates that differences in behavioral thermal tolerance may be important in shaping local and regional distribution patterns. Furthermore, small-scale habitat use might reveal a link between behavioral thermal tolerance and natural history strategies.	[Diaz-Ricaurte, Juan C.] Escola Super Agr Luis Dequeiroz, Programa Posgrad Ecol Aplicada, Sao Paulo, Brazil; [Diaz-Ricaurte, Juan C.; Serrano, Filipe C.; Martins, Marcio] Univ Amazonia, Programa Biol, Grp Invest Biodiversidad Desarrollo Amazon BYDA, Semillero Invest Ecofisiol & Biogeog Vertebrados, Florencia, Caqueta, Colombia; [Diaz-Ricaurte, Juan C.] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, SP, Brazil; [Guevara-Molina, Estefany Caroline] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, SP, Brazil; [Araujo, Cybele] Inst Florestal, Secao Anim Silvestres, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Diaz-Ricaurte, JC (corresponding author), Escola Super Agr Luis Dequeiroz, Programa Posgrad Ecol Aplicada, Sao Paulo, Brazil.; Diaz-Ricaurte, JC (corresponding author), Univ Amazonia, Programa Biol, Grp Invest Biodiversidad Desarrollo Amazon BYDA, Semillero Invest Ecofisiol & Biogeog Vertebrados, Florencia, Caqueta, Colombia.; Diaz-Ricaurte, JC (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, SP, Brazil.	juan.diaz@usp.br	Diaz-Ricaurte, Juan C./AAI-6101-2020; Martins, Marcio/C-1150-2011; Serrano, Filipe A C/C-9627-2017	Diaz-Ricaurte, Juan C./0000-0002-4659-0865; Martins, Marcio/0000-0001-8108-6309; Serrano, Filipe A C/0000-0002-8568-678X; Guevara Molina, Estefany Caroline/0000-0003-4245-9058	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2018/14091-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [306961/2015-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MM thanks Fundacao de Amparo a Pesquisa do Estado de Sao Paulo for a grant (#2018/14091-8) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for a research fellowship (#306961/2015-6). JCDR and FCS thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2001, NATURE, V412, P499, DOI 10.1038/35087658; Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Anderson RCO, 2017, ECOL EVOL, V7, P9066, DOI 10.1002/ece3.3219; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Giaretta AA, 2006, J NAT HIST, V40, P2577, DOI 10.1080/00222930601130685; AQUINO L, 2004, IUCN RED LIST THREAT; Araujo CD, 2013, BIOTA NEOTROP, V13, P265, DOI 10.1590/S1676-06032013000100026; Artacho P, 2015, ECOL EVOL, V5, P3600, DOI 10.1002/ece3.1548; Barnes AD, 2015, FUNCT ECOL, V29, P1543, DOI 10.1111/1365-2435.12474; Bastos RP, 2003, STYLO GRAFICA EDITOR; BEUCHAT CA, 1984, J COMP PHYSIOL, V154, P579, DOI 10.1007/BF00684411; Blaustein Andrew R., 2010, Diversity, V2, P281; Brasileiro Cínthia Aguirre, 2005, Biota Neotrop., V5, P93, DOI 10.1590/S1676-06032005000300006; Brown GP, 2011, FUNCT ECOL, V25, P1339, DOI 10.1111/j.1365-2435.2011.01888.x; Buckley LB, 2008, ECOLOGY, V89, P48, DOI 10.1890/07-0845.1; Camacho A, 2018, J THERM BIOL, V73, P71, DOI 10.1016/j.jtherbio.2018.01.009; Camacho A, 2017, J THERM BIOL, V68, P63, DOI 10.1016/j.jtherbio.2017.03.010; Carey C, 2003, DIVERS DISTRIB, V9, P111, DOI 10.1046/j.1472-4642.2003.00011.x; Cechin Sonia Zanini, 2000, Revista Brasileira de Zoologia, V17, P729, DOI 10.1590/S0101-81752000000300017; Corn PS, 1994, MEASURING MONITORING, P109; Cowles RB, 1944, B AM MUS NAT HIST, V83, P263; CURRIE DJ, 1993, OIKOS, V67, P56, DOI 10.2307/3545095; De Candolle A.P., 1820, ESSAI ELEMENTAIRE GE; Duleba S, 2013, THESIS; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Freitas C, 2016, J ANIM ECOL, V85, P628, DOI 10.1111/1365-2656.12458; Frost DR, AMPHIBIAN SPECIES WO; Gouveia SF, 2014, GLOBAL ECOL BIOGEOGR, V23, P446, DOI 10.1111/geb.12114; Guevara-Molina EC, 2020, J THERM BIOL, V93, DOI 10.1016/j.jtherbio.2020.102721; HILLMAN PE, 1969, ECOLOGY, V50, P476, DOI 10.2307/1933903; Koppen W., 1948, CLIMATOLOGIA, DOI DOI 10.1079/SSR2005209; Lourenco LB, 2015, MOL PHYLOGENET EVOL, V92, P204, DOI 10.1016/j.ympev.2015.06.011; Lunghi E, 2016, J THERM BIOL, V60, P79, DOI 10.1016/j.jtherbio.2016.06.010; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Mazerolle MJ, 2019, PACKAGE AICCMODAVG; Melo A.C.G., 2011, PLANO MANEJO ESTACAO; Mijares A, 2010, IUCN RED LIST THREAT; Morin PJ, 2011, COMMUNITY ECOLOGY, 2ND EDITION, P1, DOI 10.1002/9781444341966; Motta J, 1999, THESIS; NASCIMENTO L. B, 2005, ARQ MUS NAC, V63, P297; Navas CA, 2008, COMP BIOCHEM PHYS A, V151, P344, DOI 10.1016/j.cbpa.2007.07.003; Oliveira TALD, 2012, THESIS; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pianka ER, 1986, ECOLOGY NATURAL HIST, V4887; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER WP, 1973, OECOLOGIA, V13, P1, DOI 10.1007/BF00379617; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Post E, 2008, P ROY SOC B-BIOL SCI, V275, P2005, DOI 10.1098/rspb.2008.0463; QGIS Development Team, QGIS GEOGR INF SYST; R Core Team, 2013, R LANG ENV STAT COMP; Ramalho Werther Pereira, 2014, Neotropical Biology and Conservation, V9, P147, DOI 10.4013/nbc.2014.93.04; Recoder RS, 2018, S AM J HERPETOL, V13, P249, DOI 10.2994/SAJH-D-17-00072.1; Rezende EL, 2014, FUNCT ECOL, V28, P799, DOI 10.1111/1365-2435.12268; Ribeiro JF, 1998, FITOFISIONOMIAS BIOM, P166; Sinclair BJ, 2016, ECOL LETT, V19, P1372, DOI 10.1111/ele.12686; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Stillman JH, 2019, PHYSIOLOGY, V34, P86, DOI 10.1152/physiol.00040.2018; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Thome MTC, 2006, THESIS; Tingley R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025979; Titon B, 2017, COMP BIOCHEM PHYS A, V208, P54, DOI 10.1016/j.cbpa.2017.03.012; Tracy CR, 2010, ECOLOGY, V91, P1477, DOI 10.1890/09-0839.1; TRACY CR, 1976, ECOL MONOGR, V46, P293, DOI 10.2307/1942256; Urbina-Cardona JN, 2006, BIOL CONSERV, V132, P61, DOI 10.1016/j.biocon.2006.03.014; Valdujo Paula Hanna, 2012, South American Journal of Herpetology, V7, P63; Wang YJ, 2006, FISH RES, V77, P220, DOI 10.1016/j.fishres.2005.08.011; Watling JI, 2015, LANDSCAPE ECOL, V30, P1449, DOI 10.1007/s10980-015-0198-0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Young JE, 2005, PHYSIOL BIOCHEM ZOOL, V78, P847, DOI 10.1086/432152	72	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239485	10.1371/journal.pone.0239485	http://dx.doi.org/10.1371/journal.pone.0239485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960914	gold, Green Published			2022-12-26	WOS:000575109500005
J	de Souza, DLL; Serrao, JE; Hansen, IA				Lino de Souza, Debora Linhares; Serrao, Jose Eduardo; Hansen, Immo Alex			Aquaporin expression in the alimentary canal of the honey beeApis melliferaL. (Hymenoptera: Apidae) and functional characterization of Am_Eglp 1	PLOS ONE			English	Article							GENE BIG BRAIN; WATER CHANNEL; MALPIGHIAN TUBULES; PROTEIN; MEMBRANE; ULTRASTRUCTURE; IDENTIFICATION; MIDGUT; ACT; BEE	Aquaporins (AQP) are a family of plasma membrane proteins responsible for water transport through cell membranes. They are differentially expressed in different parts of the alimentary canal of insects where they regulate water transport. These proteins have been studied in detail in some insects, but few data are available for aquaporins of the honey bee,Apis mellifera. We used quantitative PCR to study the expression of six putative aquaporin genes in forager honey bees. We found differential expression of all putative AQP genes in crop, midgut, ileum, rectum and Malpighian tubules. We found the entomoglyceroporinAm_Eglp 1expressed at extremely high levels in the midgut. We performed a functional characterization of Am_Eglp 1 using heterologous expression inXenopus laevisoocyte followed by water uptake assays. Our results confirmed that theAm_Eglp 1gene encodes a functional water transporter. This study shows that all putative honey bee aquaporin genes have complex expression patterns in the digestive and excretory organs of honey bee workers. Our results suggest that Am_Eglp 1 is the principal water transporter in the midgut ofA.melliferaworkers.	[Lino de Souza, Debora Linhares; Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Gera, Vicosa, MG, Brazil; [Hansen, Immo Alex] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	Universidade Federal de Vicosa; New Mexico State University	Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	immoh@nmsu.edu		Serrao, Jose Eduardo/0000-0002-0477-4252	Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.135613/2016-01]; CAPES [001]; CNPq [305165/2013-5, 303467.2018-7]; FAPEMIG [00598-16]	Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	We thank the Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for financial support through the Programa de Doutorado Sanduiche no Exterior (PDSE) process number 88881.135613/2016-01. We also thank the financial support of CAPES, grant number 001; CNPq (305165/2013-5 and 303467.2018-7); and FAPEMIG (00598-16).	[Anonymous], 2016, NUTR BUS J, V2016, P13; Azuma M, 2012, J INSECT PHYSIOL, V58, P523, DOI 10.1016/j.jinsphys.2012.01.007; Benoit JB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002517; Beyenbach KW, 2003, J EXP BIOL, V206, P3845, DOI 10.1242/jeb.00639; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cruz-Landim C, 1985, ANAIS ACAD CIENCIAS, V44, P28; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Doherty D, 1997, DEVELOPMENT, V124, P3881; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Drake LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep07795; Duchesne L, 2003, EUR J BIOCHEM, V270, P422, DOI 10.1046/j.1432-1033.2003.03389.x; Elsik CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-86; Finn RN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8814; Goncalves WG, 2014, MICROSC MICROANAL, V20, P285, DOI 10.1017/S143192761301372X; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; Herraiz A, 2011, J EXP BIOL, V214, P3630, DOI 10.1242/jeb.057406; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kataoka N, 2009, INSECT MOL BIOL, V18, P303, DOI 10.1111/j.1365-2583.2009.00871.x; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LeCaherec F, 1996, EUR J BIOCHEM, V241, P707, DOI 10.1111/j.1432-1033.1996.00707.x; LeCaherec F, 1997, CELL TISSUE RES, V290, P143, DOI 10.1007/s004410050916; de Souza DLL, 2020, J APICULT RES, V59, P178, DOI 10.1080/00218839.2019.1655181; Liu K, 2011, P NATL ACAD SCI USA, V108, P6062, DOI 10.1073/pnas.1102629108; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Maurizio A., 1975, HONEY COMPREHENSIVE, P77; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Nicolson SW, 1998, AM ZOOL, V38, P418; Oddo LP, 1999, APIDOLOGIE, V30, P57, DOI 10.1051/apido:19990107; Pashte V. V., 2015, Trends in Biosciences, V8, P3743; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philip BN, 2011, J EXP BIOL, V214, P848, DOI 10.1242/jeb.051276; Pienkowska JR, 2014, J MEMBRANE BIOL, V247, P239, DOI 10.1007/s00232-014-9629-0; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; RAO Y, 1990, NATURE, V345, P163, DOI 10.1038/345163a0; Savage DF, 2007, J MOL BIOL, V368, P607, DOI 10.1016/j.jmb.2007.02.070; Serrao JE, 2008, ANN ENTOMOL SOC AM, V101, P915, DOI 10.1603/0013-8746(2008)101[915:UOAMRO]2.0.CO;2; Serrao JE, 2014, PROTOPLASMA, V251, P1441, DOI 10.1007/s00709-014-0645-9; SMITH BL, 1991, J BIOL CHEM, V266, P6407; Snodgrass R.E., 1956, ANATOMY HONEY BEE; Spring JH, 2007, COMP BIOCHEM PHYS A, V148, P92, DOI 10.1016/j.cbpa.2006.12.022; Tatsumi K, 2009, FEBS LETT, V583, P2077, DOI 10.1016/j.febslet.2009.05.035; Team R.C., 2015, R LANG ENV STAT COMP; Tomkowiak E., 2010, ADV CELL BIOL, V2, P91, DOI DOI 10.2478/v10052-010-0005-7; Yanochko GM, 2002, J NEUROSCI, V22, P2530, DOI 10.1523/JNEUROSCI.22-07-02530.2002	49	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0236724	10.1371/journal.pone.0236724	http://dx.doi.org/10.1371/journal.pone.0236724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956406	gold, Green Published			2022-12-26	WOS:000574571500045
J	Ezemuoka, LC; Akorli, EA; Aboagye-Antwi, F; Akorli, J				Ezemuoka, Lilian Chiamaka; Akorli, Esinam Abla; Aboagye-Antwi, Fred; Akorli, Jewelna			Mosquito midgutEnterobacter cloacae andSerratia marcescensaffect the fitness of adult femaleAnopheles gambiaes.l.	PLOS ONE			English	Article							MICROBIOTA; BACTERIA	Some bacteria species found in the mosquito midgut have demonstrated their role in interrupting the development ofPlasmodiumwithin the midgut of theAnophelesmosquito and have been identified as potential candidates for novel bacteria-mediated disease control. However, to use these bacteria successfully in biocontrol mechanisms their effect on the fitness of the vector into which they have been introduced has to be evaluated. This study investigated the effect of two such bacteria candidates,Enterobacter cloacaeandSerratia marcescens, onAnopheles gambiaes.l. fitness. Pupae and larvae ofAnopheles gambiaes.l. mosquitoes were collected by dipping method and reared to adults. The effect of these bacteria on mosquito fitness was assessed by reintroducing isolates of each bacteria separately into antibiotic-treated female adult mosquitoes through sugar meal. Wild type (non-antibiotic-treated) mosquitoes and those antibiotic-treated with no bacteria reintroduction were used as controls. The mosquitoes were monitored on longevity/survival, fecundity, hatch rate, and larval survival. The antibiotic-treated adult mosquitoes had reduced life span with median survival of 14 days while the bacteria-reintroduced groups and the wild type survived to day 22 (p< 0.0001). Treatment withEnterobacterandSerratiadid not affect the average egg deposition (p>0.05) but they affected hatch rates positively (p= 0.008). There was, however, some evidence that suggestsEnterobactercould have a positive effect on larval development (p< 0.0001). With no observed negative effect on survival/longevity ofAnopheles gambiae, introducingE.cloacaeandS.marcescensin future bacteria-associated control strategies is unlikely to result in mosquitoes that will be outlived by the wild population. This, however, requires evaluations under field conditions.	[Ezemuoka, Lilian Chiamaka] Univ Ghana, African Reg Postgrad Programme Insect Sci ARPPIS, Legon, Accra, Ghana; [Akorli, Esinam Abla; Akorli, Jewelna] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Legon, Accra, Ghana; [Aboagye-Antwi, Fred] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Accra, Ghana; [Akorli, Jewelna] Univ Ghana, West African Ctr Cell Biol Infect Dis, Legon, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana; University of Ghana	Ezemuoka, LC (corresponding author), Univ Ghana, African Reg Postgrad Programme Insect Sci ARPPIS, Legon, Accra, Ghana.; Akorli, J (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Legon, Accra, Ghana.; Akorli, J (corresponding author), Univ Ghana, West African Ctr Cell Biol Infect Dis, Legon, Accra, Ghana.	lilianchiamaka298@gmail.com; jakorli@noguchi.ug.edu.gh	Akorli, Jewelna/ABC-4963-2021	Akorli, Jewelna/0000-0002-3972-0860; Akorli, Esinam/0000-0002-6916-6338; Chiamaka, Lilian/0000-0002-6367-3523	ARPPISDAAD, University of Ghana, M.Phil scholarship; WACCBIP-DELTAS Postdoctoral Fellowship [ACE02-WACCBIP, DE-15-007]	ARPPISDAAD, University of Ghana, M.Phil scholarship; WACCBIP-DELTAS Postdoctoral Fellowship	This research was funded by ARPPISDAAD, University of Ghana, M.Phil scholarship to Lilian Chiamaka Ezemuoka and partly supported by a WACCBIP-DELTAS Postdoctoral Fellowship, to Dr. Jewelna E. B. Akorli (ACE02-WACCBIP: Awandare; DE-15-007: Awandare). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akorli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157529; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Cirimotich CM, 2011, SUPPORTING ONLINE MA, V855; Coon KL., 2016, PARASIT VECTORS, V9, P1; Dennison NJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1468-2; Depraetere SA, 2008, FOOD CHEM, V107, P242, DOI 10.1016/j.foodchem.2007.08.023; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105; Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921; Gillies M.T., 1968, PUBLIC S AFRICAN I M, V55, P143; Gonzalez-ceron L, 2003, BACTERIA MIDGUTS FIE, P371; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hargreaves K, 2003, MED VET ENTOMOL, V17, P417, DOI 10.1111/j.1365-2915.2003.00460.x; Id ALW, 2020, IMPORTANCE VECTOR CO; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Klinkenberg E, 2008, IMPACT URBAN AGR MAL; Matthys B, 2006, J VECTOR ECOL, V31, P319, DOI 10.3376/1081-1710(2006)31[319:UALUAC]2.0.CO;2; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004; Riehle MA, 2007, INT J PARASITOL, V37, P595, DOI 10.1016/j.ijpara.2006.12.002; Sandrine E.Nsango, 2012, MIDGUT MICROBIOTA MA; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Straif SC, 1998, MIDGUT BACTERIA ANOP, P222; Tatem A, 2006, GLOBAL TRANSPORT NET; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; World Health Organization, 2019, MAL REP, pxi	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238931	10.1371/journal.pone.0238931	http://dx.doi.org/10.1371/journal.pone.0238931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946471	Green Published, gold			2022-12-26	WOS:000573851100065
J	Peterlin, B; Gualandi, F; Maver, A; Servidei, S; van der Maarel, SM; Lamy, F; Mejat, A; Evangelista, T; Ferlini, A				Peterlin, Borut; Gualandi, Francesca; Maver, Ales; Servidei, Serenella; van der Maarel, Silvere M.; Lamy, Francoise; Mejat, Alexander; Evangelista, Teresinha; Ferlini, Alessandra			Genetic testing offer for inherited neuromuscular diseases within the EURO-NMD reference network: A European survey study	PLOS ONE			English	Article							MOLECULAR DIAGNOSIS; SECONDARY FINDINGS; RARE DISEASES; EXOME; CHALLENGES; MYOPATHIES; DISORDERS; SYSTEMS	The genetic diagnostics of inherited neuromuscular diseases (NMDs) is challenging due to their clinical and genetic heterogeneity. We launched an online survey within the EURO-NMD European Reference Network (ERN) to collect information about the availability/distribution of genetic testing across 61 ERN health care providers (HCPs). A 17 items questionnaire was designed to address methods used, the number of genetic tests available, the clinical pathway to access genetic testing, the use of next-generation sequencing (NGS) and participation to quality assessment schemes (QAs). A remarkable number of HCPs (49%) offers >= 500 genetic tests per year, 43,6% offers 100-500 genetic tests per year, and 7,2% <= 100 per year. NGS is used by 94% of centres, Sanger sequencing by 84%, MLPA by 66% and Southern blotting by 36%. The majority of centres (60%) offer NGS for all patients that fulfil criteria for NMD of genetic origin. Pipelines for NGS vary amongst centres, even within the same national system. Referral of patients to genetic laboratories by specialists was frequently reported (58%), and 65% of centres participates in genetic testing QAs. We specifically evaluated how many centres cover SMA, DMD, Pompe, LGMDs, and TTR genes/diseases genetic diagnosis, since these rare diseases benefit from personalised therapies. We used the Orphanet EUGT numbers, provided by 82% of HCPs. SMA, DMD, LGMD, TTR and GAA genes are covered by EUGTs although with different numbers and modalities. The number of genetic tests for NMDs offered across HCPs National Health systems is quite high, including routine techniques and NGS. The number and type of tests offered and the clinical practices differ among centres. We provided evidence that survey tools might be useful to learn about the state-of-the-art of ERN health-related activities and to foster harmonisation and standardisation of the complex care for the rare disease patients in the EU.	[Peterlin, Borut; Maver, Ales] Univ Med Ctr Ljubljana, Clin Inst Med Genet, Ljubljana, Slovenia; [Gualandi, Francesca; Ferlini, Alessandra] Univ Hosp Ferrara, Unit Med Genet, Ferrara, Italy; [Servidei, Serenella] Fdn Policlin Univ A Gemelli IRCCS, Neurophysiopathol Unit, Rome, Italy; [van der Maarel, Silvere M.] Leiden Univ, Dept Human Genet, Med Ctr, Leiden, Netherlands; [Lamy, Francoise; Mejat, Alexander] AFM Telethon, Evry, France; [Evangelista, Teresinha] Sorbonne Univ, Neuromuscular Morphol Unit, Myol Inst, GHU Pitie Salpetriere, Paris, France	University Medical Centre Ljubljana; University of Ferrara; Arcispedale Sant'Anna; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Ferlini, A (corresponding author), Univ Hosp Ferrara, Unit Med Genet, Ferrara, Italy.; Evangelista, T (corresponding author), Sorbonne Univ, Neuromuscular Morphol Unit, Myol Inst, GHU Pitie Salpetriere, Paris, France.	t.evangelista@institut-myologie.org; fla@unife.it	Servidei, Serenella/ABC-4262-2021; Gualandi, Francesca/K-7513-2016	van der Maarel, Silvere/0000-0001-8103-711X; Gualandi, Francesca/0000-0001-9551-057X; FERLINI, ALESSANDRA/0000-0001-8385-9870; SERVIDEI, Serenella/0000-0001-8478-2799	 [739543]		All the authors of this publication are members of the European Reference Network for Rare Neuromuscular Diseases (EURO-NMD) Project ID No 739543. SS, SM ad BP and AF (Chair) are constituents of the Genetic Task. Alexander Mejat and Francoise Lamy (French Muscular Dystrophy Association AFM-Telethon) are kindly acknowledged as members of the EURO-NMD Genetic Task.	Ankala A, 2015, ANN NEUROL, V77, P206, DOI 10.1002/ana.24303; [Anonymous], 2017, PLASMONICS, V12, P1; Benarroch L, 2019, NEUROMUSCULAR DISORD, V29, P980, DOI 10.1016/j.nmd.2019.10.010; Brownstein CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r53; Burgunder JM, 2011, EUR J NEUROL, V18, P207, DOI 10.1111/j.1468-1331.2010.03069.x; Buske OJ, 2015, HUM MUTAT, V36, P931, DOI 10.1002/humu.22851; Chisholm C, 2018, GENET MED, V20, P365, DOI 10.1038/gim.2017.191; Cummings BB, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal5209; Dai Y, 2015, NEUROMUSCULAR DISORD, V25, P617, DOI 10.1016/j.nmd.2015.03.002; Deenen Johanna C W, 2015, J Neuromuscul Dis, V2, P73; Dias C, 2012, HUM MUTAT, V33, P614, DOI 10.1002/humu.22032; Finkel RS, 2017, NEW ENGL J MED, V377, P1723, DOI 10.1056/NEJMoa1702752; Gertz MA, 2019, EXPERT REV CLIN PHAR, V12, P701, DOI 10.1080/17512433.2019.1635008; Gonorazky HD, 2019, AM J HUM GENET, V104, P466, DOI 10.1016/j.ajhg.2019.01.012; Groisman IJ, 2017, EUR J HUM GENET, V25, P801, DOI 10.1038/ejhg.2017.64; Hehir-Kwa JY, 2015, EUR J HUM GENET, V23, P1601, DOI 10.1038/ejhg.2015.111; Hohenfellner K, 2019, MOL GENET METAB REP, V21, DOI 10.1016/j.ymgmr.2019.100514; Horaitis O, 2007, NAT GENET, V39, P425, DOI 10.1038/ng0407-425; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Lameire N, 1999, NEPHROL DIAL TRANSPL, V14, P3, DOI 10.1093/ndt/14.suppl_6.3; Lionel AC, 2018, GENET MED, V20, P435, DOI 10.1038/gim.2017.119; Manolio TA, 2013, GENET MED, V15, P258, DOI 10.1038/gim.2012.157; Pena LDM, 2018, GENET MED, V20, P464, DOI 10.1038/gim.2017.128; Pohjola P, 2016, EUR J HUM GENET, V24, P1547, DOI 10.1038/ejhg.2016.70; Rath A, 2012, HUM MUTAT, V33, P803, DOI 10.1002/humu.22078; Savarese M, 2016, NEUROLOGY, V87, P71, DOI 10.1212/WNL.0000000000002800; Sevy A, 2016, J NEUROL NEUROSUR PS, V87, P340, DOI 10.1136/jnnp-2014-309663; Tagliafico E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206855; Vears DF, 2018, EUR J HUM GENET, V26, P1743, DOI 10.1038/s41431-018-0239-7; Veltman JA, 2013, PERS MED, V10, P473, DOI 10.2217/pme.13.41; Verhaart IEC, 2019, NAT REV NEUROL, V15, P373, DOI 10.1038/s41582-019-0203-3; Webber EM, 2018, HUM MUTAT, V39, P1677, DOI 10.1002/humu.23631; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239329	10.1371/journal.pone.0239329	http://dx.doi.org/10.1371/journal.pone.0239329			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946487	Green Published, gold			2022-12-26	WOS:000573851100009
J	Alhajj, MN; Ariffin, Z; Celebic, A; Alkheraif, AA; Amran, AG; Ismail, IA				Alhajj, Mohammed Nasser; Ariffin, Zaihan; Celebic, Asja; Alkheraif, Abdulaziz A.; Amran, Abdullah G.; Ismail, Ibrahim A.			Perception of orofacial appearance among laypersons with diverse social and demographic status	PLOS ONE			English	Article							QUALITY-OF-LIFE; DENTAL AESTHETIC PERCEPTIONS; PSYCHOMETRIC PROPERTIES; FACIAL AESTHETICS; SMILE AESTHETICS; TOOTH COLOR; VERSION; SATISFACTION; VALIDATION; SCALE	Background The perception of dentofacial esthetics differs considerably between patients and dentists. Patient's expectations regarding his/her esthetics are important and should be assessed ahead of any planning of esthetic treatment. The aim of this study was to explore the differences in perception of orofacial appearance by laypersons with different social and demographic status. Materials and methods Self-administered questionnaires were distributed to 400 subjects. The questionnaire comprised three parts; the first part addressed the demographic variables. The second part queried about dental prosthesis, orthognathic or plastic surgery, and/or ongoing or previous orthodontic treatment. The third part included the Arabic version of the-8-item Orofacial Esthetic Scale (OES-Ar) whose responses were scored in the 5-point Likert scale. These scores were compared by different grouping factors (age, gender, marital status, and education) using non-parametric Mann-Whitney U and Kruskal Willis tests with 95% confidence interval (alpha > 0.05). Results A total of 268 questionnaires were eligible for analysis, representing 67% response rate. The satisfaction with facial profile appearance was the highest (4.0 +/- 1.1) followed by facial appearance (3.9 +/- 1.1), while the color of teeth was the least satisfying item (3.1 +/- 1.3). No significant differences were found between age groups for the mean summary score as well as for each item independently. No significant difference was found between both sexes except for the last item "overall impression". Married subjects rated one item (alignment of teeth) better than their counterparts. Positive perception of orofacial appearance increased significantly with the increase of education level, the perception of the oral health status, and the perception of the general health status. Conclusion Good oral health and/or high education level are significant determinants of more positive perception of orofacial esthetic appearance. Patients with these characteristics might be more concerned about their orofacial appearance, and this should be taken into consideration before planning any esthetic restorative dental treatment.	[Alhajj, Mohammed Nasser] Thamar Univ, Fac Dent, Dept Prosthodont, Dhamar, Yemen; [Ariffin, Zaihan] Univ Sains Malaysia, Sch Dent Sci, Prosthodont Unit, Heath Campus, Kelantan, Malaysia; [Celebic, Asja] Univ Zagreb, Fac Dent, Dept Removable Prosthodont, Zagreb, Croatia; [Alkheraif, Abdulaziz A.] King Saud Univ, Coll Appl Med Sci, Dent Hlth Dept, Dent Biomat Res Chair, Riyadh, Saudi Arabia; [Amran, Abdullah G.] Thamar Univ, Fac Dent, Dept Periodont, Dhamar, Yemen; [Ismail, Ibrahim A.] Univ Khartoum, Fac Dent, Dept Oral Rehabil, Khartoum, Sudan	Universiti Sains Malaysia; University of Zagreb; King Saud University; University of Khartoum	Alhajj, MN (corresponding author), Thamar Univ, Fac Dent, Dept Prosthodont, Dhamar, Yemen.	m.n.alhajj@hotmail.com	Alhajj, Mohammed Nasser/N-4943-2014	Alhajj, Mohammed Nasser/0000-0003-4477-3024	Deanship of Scientific Research, King Saud University	Deanship of Scientific Research, King Saud University(King Saud University)	The authors are grateful to the Deanship of Scientific Research, King Saud University for funding through the Vice Deanship of Scientific Research for Research Chairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afroz Shaista, 2013, J Indian Prosthodont Soc, V13, P455, DOI 10.1007/s13191-012-0247-1; Alhajj MN, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1046-0; Alhajj MN, 2017, J PROSTHODONT RES, V61, P290, DOI 10.1016/j.jpor.2016.10.004; [Anonymous], 2010, KABBALAH, V23, P249; Baubiniene Diana, 2009, Stomatologija, V11, P97; Bimbashi V, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0083-x; Bolas-Colvee B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201102; Campos LA, 2020, PEERJ, V8, DOI 10.7717/peerj.8814; Chen P, 2012, BRIT DENT J, V213, DOI 10.1038/sj.bdj.2012.1090; Chignell A, 2006, BRIT J AESTHET, V46, P406, DOI 10.1093/aesthj/ayl023; Cracel-Nogueira F, 2013, INT ORTHOD, V11, P432, DOI 10.1016/j.ortho.2013.09.007; Davis LG, 1998, J DENT, V26, P547, DOI 10.1016/S0300-5712(97)00031-6; Eli L, 2001, J PUBLIC HEALTH DENT, V61, P150, DOI 10.1111/j.1752-7325.2001.tb03382.x; Enabulele JE, 2017, AFRICAN J ORAL HLTH, V7, P1; Flores-Mir C, 2004, J Orthod, V31, P204, DOI 10.1179/146531204225022416; Fokas Effie, 2007, J MOD GREEK STUD, V27, P349; Gerritsen AE, 2008, INT J PROSTHODONT, V21, P169; Grosofsky A, 2003, PERCEPT MOTOR SKILL, V96, P43, DOI 10.2466/PMS.96.1.43-48; Hollister M C, 1993, J Dent Educ, V57, P901; International Whaling Commission, 2016, J CETACEAN RES MAN S, V17, P16; Isiekwe GI, 2016, AM J ORTHOD DENTOFAC, V150, P627, DOI 10.1016/j.ajodo.2016.03.025; Kavand G, 2012, J PUBLIC HEALTH DENT, V72, P164, DOI 10.1111/j.1752-7325.2011.00306.x; Klages U, 2004, EUR J ORTHODONT, V26, P507, DOI 10.1093/ejo/26.5.507; Krajicek DD., 1960, J PROSTHET DENT, V10, P205, DOI 10.1016/0022-3913(60)90041-X; Larsson P, 2021, J ORAL REHABIL, V48, P271, DOI 10.1111/joor.12965; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Mack MR, 1996, J PROSTHET DENT, V75, P169, DOI 10.1016/S0022-3913(96)90095-5; Matthias R E, 1993, Spec Care Dentist, V13, P53, DOI 10.1111/j.1754-4505.1993.tb01455.x; McLaren Edward A, 2002, J Calif Dent Assoc, V30, P839; Meng XX, 2007, J AGING HEALTH, V19, P778, DOI 10.1177/0898264307304373; Neophytou S, 2018, J ORAL REHABIL, V45, P932, DOI 10.1111/joor.12715; Panossian AJ, 2010, J ORAL MAXIL SURG, V68, P547, DOI 10.1016/j.joms.2009.09.021; Parrini S, 2016, AM J ORTHOD DENTOFAC, V150, P740, DOI 10.1016/j.ajodo.2016.06.022; Pavicic DK, 2017, INT J PROSTHODONT, V30, P156, DOI 10.11607/ijp.5070; Persic S, 2011, INT J PROSTHODONT, V24, P523; Pusic AL, 2013, CLIN PLAST SURG, V40, P249, DOI 10.1016/j.cps.2012.12.001; Reissmann DR, 2015, CLIN ORAL INVEST, V19, P1443, DOI 10.1007/s00784-014-1365-4; Reissmann DR, 2013, J DENT, V41, P581, DOI 10.1016/j.jdent.2013.05.007; Riley JL, 2012, J AM DENT ASSOC, V143, P1002, DOI 10.14219/jada.archive.2012.0329; Saffarpour Aida, 2016, J Dent (Tehran), V13, P85; Samorodnitzky-Naveh GR, 2007, J AM DENT ASSOC, V138, P805, DOI 10.14219/jada.archive.2007.0269; Sargozaie N, 2017, OPEN DENT J, V11, P485, DOI 10.2174/1874210601711010485; Sriphadungporn C, 2017, PROG ORTHOD, V18, DOI 10.1186/s40510-017-0162-4; N'Guyen-Van TL, 2019, INT J PROSTHODONT, V32, P137, DOI 10.11607/ijp.6002; Tin-Oo MM, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-6; Tortopidis D, 2007, J ESTHET RESTOR DENT, V19, P154, DOI 10.1111/j.1708-8240.2007.00089.x; Wagner I V, 1996, J Esthet Dent, V8, P199; Witt M, 2011, J AM DENT ASSOC, V142, P635, DOI 10.14219/jada.archive.2011.0245; Wolfart S, 2006, J ORAL REHABIL, V33, P489, DOI 10.1111/j.1365-2842.2005.01581.x; Wolfart S, 2006, INT J PROSTHODONT, V19, P449; Yin L, 2014, AM J ORTHOD DENTOFAC, V145, P750, DOI 10.1016/j.ajodo.2014.01.021; Zhao Y, 2013, J ORAL REHABIL, V40, P670, DOI 10.1111/joor.12077	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239232	10.1371/journal.pone.0239232	http://dx.doi.org/10.1371/journal.pone.0239232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941532	Green Published, gold			2022-12-26	WOS:000573848800104
J	Liu, JW; Li, J; Lin, G; Long, ZQ; Li, Q; Liu, B				Liu, Jingwei; Li, Jian; Lin, Gang; Long, Zhiqiang; Li, Qian; Liu, Bing			Risk factors of lobar lymph node metastases in non-primary tumor-bearing lobes among the patients of non-small-cell lung cancer	PLOS ONE			English	Article							VISCERAL PLEURAL INVASION; TNM CLASSIFICATION; STAGING PROJECT; INTERNATIONAL ASSOCIATION; ANATOMIC BASIS; N DESCRIPTORS; IMPACT; SPREAD; REVISION; SURGERY	Purpose Lobar lymph node metastases in non-primary tumor-bearing lobes (NTBL) are rarely reported. This study examined the risk factors of lobar lymph node metastasis in NTBL. Methods We retrospectively studied 301 patients with non-small-cell lung cancer (NSCLC) who underwent surgical pulmonary resection with systematic lymph node dissection plus extended lobar lymph node dissection of NTBL. Patients were classified into positive and negative NTBL groups. Unconditional logistic regression was used to identify the risk factors for lobar lymph node metastasis in NTBL. Results NTBL lobar lymph nodes were identified in 38 patients (12.6%). A higher proportion of adenocarcinomas occurred in the positive NTBL group compared to the negative NTBL group (73.7% vs. 46.4%,P= 0.01). Risk of NTBL lobar lymph node metastases was significantly elevated in the lower lobe of primary site compared to the upper lobe (OR = 2.61, 95% CI = 1.26-5.75,P= 0.01), and with adenocarcinomas compared to squamous cell carcinomas (OR = 2.75, 95% CI = 1.09-7.65,P= 0.04). No differences were observed when comparing left and right lobes. NTBL lobar lymph node metastasis was most often observed among patients with larger tumor size, N1/N2 nodal involvement, with lymph vascular invasion (LVI), and visceral pleural invasion (VPI). Conclusion NTBL lobar lymph node metastases occurred more often in patients with a primary NSCLC tumor in the lower lobe, with adenocarcinomas, larger tumor size, N1/N2 nodal involvement, LVI or VPI. Extended lymphadenectomy including NTBL nodes may be clinically advantageous when these risk factors are present.	[Liu, Jingwei; Li, Jian; Lin, Gang; Long, Zhiqiang] Peking Univ, Hosp 1, Dept Thorac Surg, Beijing, Peoples R China; [Li, Qian] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Liu, Bing] Peking Univ, Dept Thorac Surg 2, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing,Canc Hosp & Inst, Beijing, Peoples R China	Peking University; Icahn School of Medicine at Mount Sinai; Peking University	Liu, JW (corresponding author), Peking Univ, Hosp 1, Dept Thorac Surg, Beijing, Peoples R China.	jingweiliu5@126.com		Liu, Jingwei/0000-0001-9197-5118	Wu Jieping Medical Foundation [320.6799.15050]	Wu Jieping Medical Foundation	This study was supported by the grant (no. 320.6799.15050) from Wu Jieping Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, LANCET ONCOL, V16, pe158; Aoki T, 2015, J THORAC DIS, V7, pE326, DOI 10.3978/j.issn.2072-1439.2015.08.27; Asamura H, 2015, J THORAC ONCOL, V10, P1675, DOI 10.1097/JTO.0000000000000678; Backhus LM, 2016, J SURG RES, V200, P171, DOI 10.1016/j.jss.2015.06.048; De Leyn P, 2007, J THORAC ONCOL, V2, P357, DOI 10.1097/01.JTO.0000263722.22686.1c; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Detterbeck FC, 2016, J THORAC ONCOL, V11, P1433, DOI 10.1016/j.jtho.2016.06.028; Filosso PL, 2011, LUNG CANCER, V74, P25, DOI 10.1016/j.lungcan.2011.01.030; Gunluoglu MZ, 2011, ANN THORAC CARDIOVAS, V17, P229, DOI 10.5761/atcs.oa.09.01530; Hata E, 1994, Kyobu Geka, V47, P40; HEITZMAN ER, 1982, RADIOLOGY, V144, P3, DOI 10.1148/radiology.144.1.6283592; Hong QY, 2015, CANCER-AM CANCER SOC, V121, P3080, DOI 10.1002/cncr.29584; Imai K, 2013, SURG TODAY, V43, P249, DOI 10.1007/s00595-012-0237-2; Iyoda A, 2013, MOL CLIN ONCOL, V1, P437, DOI 10.3892/mco.2013.80; Iyoda A, 2009, J THORAC CARDIOV SUR, V138, P446, DOI 10.1016/j.jtcvs.2008.12.037; Karaman S, 2014, J CLIN INVEST, V124, P922, DOI 10.1172/JCI71606; Kawasaki K, 2015, ANN THORAC CARDIOVAS, V21, P217, DOI 10.5761/atcs.oa.14-00218; Kowalewski J, 2017, J THORAC DIS, V9, P4828, DOI 10.21037/jtd.2017.10.154; Kudo Y, 2012, LUNG CANCER, V78, P153, DOI 10.1016/j.lungcan.2012.08.004; Lee GD, 2016, EUR J CARDIO-THORAC, V49, P580, DOI 10.1093/ejcts/ezv134; Li H, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014800; Li N, 2018, THORAC CANCER, V9, P480, DOI 10.1111/1759-7714.12620; Maniwa T, 2016, SURG TODAY, V46, P699, DOI 10.1007/s00595-015-1268-2; Marra A, 2003, J THORAC CARDIOV SUR, V125, P543, DOI 10.1067/mtc.2003.322; Mollberg NM, 2014, ANN THORAC SURG, V97, P965, DOI 10.1016/j.athoracsur.2013.11.002; National Cancer Institute D, 2018, SURV EP END RES SEER; Neef H, 1999, Ann Ital Chir, V70, P857; Nomori H, 2010, J THORAC CARDIOV SUR, V139, P38, DOI 10.1016/j.jtcvs.2009.04.003; RIQUET M, 1994, SURG RADIOL ANAT, V16, P229, DOI 10.1007/BF01627676; RIQUET M, 1993, SURG RADIOL ANAT, V15, P271, DOI 10.1007/BF01627878; Riquet M, 2010, INTERACT CARDIOV TH, V11, P260, DOI 10.1510/icvts.2010.236349; Rouzaut A, 2007, J THORAC ONCOL, V2, P384, DOI 10.1097/01.JTO.0000268670.72249.ad; Rusch VW, 2007, J THORAC ONCOL, V2, P603, DOI 10.1097/JTO.0b013e31807ec803; Sakairi Y, 2014, ANN THORAC SURG, V97, P1694, DOI 10.1016/j.athoracsur.2013.12.015; Sato J, 1999, SURG TODAY, V29, P238; Schuchert MJ, 2011, ANN THORAC SURG, V91, P1059, DOI 10.1016/j.athoracsur.2010.11.038; Shields TLJ, 2000, GEN THORACIC SURG; Sung SY, 2018, ONCOLOGY-BASEL, V95, P156, DOI 10.1159/000488859; Topol M, 2009, ANN ANAT, V191, P568, DOI 10.1016/j.aanat.2009.08.008; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Tsubochi H, 2011, GEN THORAC CARDIOVAS, V59, P515, DOI 10.1007/s11748-010-0717-5; Wang Jian, 2018, Oncotarget, V9, P8133, DOI 10.18632/oncotarget.23550; Wang J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3106; Wu Nan, 2010, Zhonghua Yi Xue Za Zhi, V90, P1873; Yamanaka A, 2002, CHEST, V121, P112, DOI 10.1378/chest.121.1.112; Yanagawa N, 2013, EUR J CARDIO-THORAC, V44, pE200, DOI 10.1093/ejcts/ezt309; Yilmaz A, 2011, EUR J CARDIO-THORAC, V40, P664, DOI 10.1016/j.ejcts.2010.12.059; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Zhang YK, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1098-3; Zhao F, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3273-x	50	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239281	10.1371/journal.pone.0239281	http://dx.doi.org/10.1371/journal.pone.0239281			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941522	Green Published, gold			2022-12-26	WOS:000573848800003
J	Manyau, MCP; Mudzviti, T; Rusakaniko, S; Mberi, ET; Maponga, CC; Morse, GD				Manyau, Maudy C. P.; Mudzviti, Tinashe; Rusakaniko, Simbarashe; Mberi, Elson T.; Maponga, Charles C.; Morse, Gene D.			Survival of HIV-infected patients with high-grade non-Hodgkin's lymphomas: A retrospective study of experiences in Zimbabwe	PLOS ONE			English	Article							INTERNATIONAL PROGNOSTIC INDEX; B-CELL LYMPHOMA; AIDS-RELATED LYMPHOMA; ANTIRETROVIRAL THERAPY; POOLED ANALYSIS; RITUXIMAB; CHOP; COMBINATION; OUTCOMES; CYCLOPHOSPHAMIDE	Background Rituximab in combination with chemotherapy is now widely accepted as standard of care for AIDS-related lymphomas (ARLs) of B-cell origin. However, the clinical impact of rituximab in resource limited settings remains unknown. Different settings and patient heterogeneity may affect the effect of any given treatment. The study objectives were to determine if rituximab use was associated with improved 18-month overall survival (OS) of patients with ARLs and to identify correlates of 18-month OS. Methods A retrospective review of medical records of adult HIV infected patients treated for high-grade large cell non-Hodgkin's lymphoma with chemotherapy +/- rituximab between 2015-2017 was conducted. Vital status and disease progression/relapse at 18 months were determined. Survival functions were estimated using Kaplan-Meier methodology. Equality of survival functions were assessed using Log-rank tests and Cox regression analysis to identify risk factors for mortality. Results One hundred and twenty-four eligible medical records were identified. This was a cohort of black Africans with a median age of 42 (IQR: 33-47) and a 57% male gender distribution. Overall survival at 6, 12 and 18 months for the population was 75.9%, 44.0% and 30.6% respectively. Over the study period, 72.6% of patients were diagnosed with disease progression/ relapse. There was a higher rate of rituximab use in patients who were treated at a private institution and those with medical insurance. Rituximab use was not associated with a reduction in 18-month mortality [adjusted hazard ratio (aHR)1.28, (95% CI 0.63-2.60)]. Risk factors for 18-month mortality were male gender [aHR 1.89, (95% CI 1.04-3.43)], age 40+ years [aHR 2.49, (1.33-4.67)], receipt of <3 chemotherapy cycles [aHR 2.48, (95% CI 1.33-4.60)] and low socioeconomic status [aHR 2.44, (95% CI 1.28-4.67)]. Conclusions Predictors of mortality were male gender, older age, low socioeconomic status and receipt of a less than half of the recommended number of chemotherapy cycles. Rituximab use was not associated with an improvement in 18-month OS in Zimbabwean patients with ARLs.	[Manyau, Maudy C. P.; Mudzviti, Tinashe; Maponga, Charles C.] Univ Zimbabwe, Coll Hlth Sci, Sch Pharm, Harare, Zimbabwe; [Mudzviti, Tinashe] Newlands Clin, Harare, Zimbabwe; [Rusakaniko, Simbarashe] Univ Zimbabwe, Coll Hlth Sci, Dept Community Med, Harare, Zimbabwe; [Mberi, Elson T.] Univ Zimbabwe, Coll Hlth Sci, Dept Hematol, Harare, Zimbabwe; [Maponga, Charles C.; Morse, Gene D.] Univ Buffalo, Ctr Integrated Global Biomed Sci, Buffalo, NY USA; [Maponga, Charles C.; Morse, Gene D.] Univ Buffalo, Translat Pharmacol Res Core, Buffalo, NY USA	University of Zimbabwe; University of Zimbabwe; University of Zimbabwe; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Manyau, MCP (corresponding author), Univ Zimbabwe, Coll Hlth Sci, Sch Pharm, Harare, Zimbabwe.	pinky.manyau@gmail.com	Mudzviti, Tinashe/AAZ-5627-2020	Mudzviti, Tinashe/0000-0002-9817-7108; Manyau, Pinky/0000-0002-3772-1018	University at Buffalo -University of Zimbabwe HIV Research Training Program - Fogarty International Center [D43 TW010313]	University at Buffalo -University of Zimbabwe HIV Research Training Program - Fogarty International Center	This research was supported by the University at Buffalo -University of Zimbabwe HIV Research Training Program, funded by the Fogarty International Center under Award Number D43 TW010313. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health.	Andrews J, 2013, J CLIN EPIDEMIOL, V66, P719, DOI 10.1016/j.jclinepi.2012.03.013; Barta SK, 2014, HAEMATOLOGICA, V99, P1731, DOI 10.3324/haematol.2014.111112; Barta SK, 2013, BLOOD, V122, P3251, DOI 10.1182/blood-2013-04-498964; Bateganya MH, 2011, JAIDS-J ACQ IMM DEF, V56, P312, DOI 10.1097/QAI.0b013e31820c011a; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Best JH, 2005, VALUE HEALTH, V8, P462, DOI 10.1111/j.1524-4733.2005.00037.x; Boue F, 2006, J CLIN ONCOL, V24, P4123, DOI 10.1200/JCO.2005.05.4684; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Castillo JJ, 2012, AM J HEMATOL, V87, P330, DOI 10.1002/ajh.22275; Cingolani A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186549; de Witt P, 2013, JAIDS-J ACQ IMM DEF, V64, P66, DOI 10.1097/QAI.0b013e3182a03e9b; Gaur S, 2013, LYMPHOMA, DOI [10.1155/2013/290585, DOI 10.1155/2013/290585]; Gopal S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150445; HERMANS J, 1995, BLOOD, V86, P1460, DOI 10.1182/blood.V86.4.1460.bloodjournal8641460; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Kaplan LD, 2005, BLOOD, V106, P1538, DOI 10.1182/blood-2005-04-1437; Levine AM, 2013, J CLIN ONCOL, V31, P58, DOI 10.1200/JCO.2012.42.4648; Milligan MG, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00084; MoHCC, 2019, NAT CANC PREV CONTR; Mungati More, 2016, BMC Res Notes, V9, P302, DOI 10.1186/s13104-016-2101-8; Niu XL, 2013, CANCER MED-US, V2, P403, DOI 10.1002/cam4.84; Ribera JM, 2008, BRIT J HAEMATOL, V140, P411, DOI 10.1111/j.1365-2141.2007.06943.x; Sehn LH, 2005, BLOOD, V106, p147A; Silas OA, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0144-7; Simcock M, 2007, ANTIVIR THER, V12, P931; Sparano JA, 2010, BLOOD, V115, P3008, DOI 10.1182/blood-2009-08-231613; UNAIDS, 2019, UNAIDS ZIMB PROF; Weller I, 2009, AIDS, V23, P2029, DOI 10.1097/QAD.0b013e32832e531c; Wilder RB, 2002, CANCER-AM CANCER SOC, V94, P3083, DOI 10.1002/cncr.10583; World Bank, WORLD BANK DAT; ZNCR M, 2016, ZIMBABWE NATL REGIST	31	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239344	10.1371/journal.pone.0239344	http://dx.doi.org/10.1371/journal.pone.0239344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941540	gold, Green Published			2022-12-26	WOS:000573848800098
J	Soderholm, A; Newton, MS; Patrick, WM; Selmer, M				Soderholm, Annika; Newton, Matilda S.; Patrick, Wayne M.; Selmer, Maria			Structure and kinetics of indole-3-glycerol phosphate synthase from Pseudomonas aeruginosa: Decarboxylation is not essential for indole formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; decarboxylase; enzyme structure; enzyme mechanism; enzyme kinetics; biosynthesis; enzyme promiscuity; IGPS; tryptophan biosynthesis	INDOLEGLYCEROL-PHOSPHATE; STRUCTURE REFINEMENT; BIFUNCTIONAL ENZYME; CATALYTIC MECHANISM; ESCHERICHIA-COLI; BIOSYNTHESIS; ISOMERASE; FEATURES	In tryptophan biosynthesis, the reaction catalyzed by the enzyme indole-3-glycerol phosphate synthase (IGPS) starts with a condensation step in which the substrate's carboxylated phenyl group makes a nucleophilic attack to form the pyrrole ring of the indole, followed by a decarboxylation that restores the aromaticity of the phenyl. IGPS from Pseudomonas aeruginosa has the highest turnover number of all characterized IGPS enzymes, providing an excellent model system to test the necessity of the decarboxylation step. Since the 1960s, this step has been considered to be mechanistically essential based on studies of the IGPS-phosphoribosylanthranilate isomerase fusion protein from Escherichia coli. Here, we present the crystal structure of P. aeruginosa IGPS in complex with reduced CdRP, a nonreactive substrate analog, and using a sensitive discontinuous assay, we demonstrate weak promiscuous activity on the decarboxylated substrate 1-(phenylamino)-1-deoxyribulose-5-phosphate, with an similar to 1000x lower rate of IGP formation than from the native substrate. We also show that E. coli IGPS, at an even lower rate, can produce IGP from decarboxylated substrate. Our structure of P. aeruginosa IGPS has eight molecules in the asymmetric unit, of which seven contain ligand and one displays a previously unobserved conformation closer to the reactive state. One of the few nonconserved active-site residues, Phe(201) in P. aeruginosa IGPS, is by mutagenesis demonstrated to be important for the higher turnover of this enzyme on both substrates. Our results demonstrate that despite IGPS's classification as a carboxy-lyase (i.e. decarboxylase), decarboxylation is not a completely essential step in its catalysis.	[Soderholm, Annika; Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Newton, Matilda S.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Patrick, Wayne M.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Patrick, Wayne M.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Soderholm, Annika] Uppsala Univ, Dept Chem, Uppsala, Sweden; [Newton, Matilda S.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Newton, Matilda S.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA	Uppsala University; University of Otago; Victoria University Wellington; Victoria University Wellington; Uppsala University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Soderholm, A; Selmer, M (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	annika.soderholm@kemi.uu.se; maria.selmer@icm.uu.se		Selmer, Maria/0000-0001-9079-2774; Newton, Matilda/0000-0003-2213-3587	Knut and Alice Wallenberg Foundation; Swedish Research Council [2017-03827]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Knut and Alice Wallenberg Foundation and by Swedish Research Council Grant 2017-03827 (to M. S.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barden T. C., 2010, TOPICS HETEROCYCLIC, V26, P31; Cookson TVM, 2014, BIOCHEM J, V461, P87, DOI 10.1042/BJ20140209; Czekster CM, 2008, TETRAHEDRON LETT, V49, P5914, DOI 10.1016/j.tetlet.2008.07.149; Czekster CM, 2009, ARCH BIOCHEM BIOPHYS, V486, P19, DOI 10.1016/j.abb.2009.04.001; Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518; EBERHARD M, 1989, FEBS LETT, V245, P219, DOI 10.1016/0014-5793(89)80225-X; EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gerth ML, 2012, PROTEIN J, V31, P359, DOI 10.1007/s10930-012-9412-y; Hennig M, 2002, J MOL BIOL, V319, P757, DOI 10.1016/S0022-2836(02)00378-9; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; List F, 2011, CHEMBIOCHEM, V12, P1487, DOI 10.1002/cbic.201100082; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i; Newton M.M., 2015, THESIS; Newton MS, 2017, P NATL ACAD SCI USA, V114, P4727, DOI 10.1073/pnas.1618552114; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Parry R. J., 1972, CHEM HETEROCYCLIC CO, P1; Patrick WM, 2008, J MOL BIOL, V377, P323, DOI 10.1016/j.jmb.2008.01.043; Patrick WM, 2005, FEBS J, V272, P3684, DOI 10.1111/j.1742-4658.2005.04794.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schlee S, 2013, BIOCHEMISTRY-US, V52, P132, DOI 10.1021/bi301342j; Schneider B, 2005, BIOCHEMISTRY-US, V44, P16405, DOI 10.1021/bi051640n; SMITH OH, 1962, METHOD ENZYMOL, V5, P794, DOI 10.1016/S0076-6879(62)05315-X; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; Zaccardi MJ, 2014, PROTEIN SCI, V23, P302, DOI 10.1002/pro.2416; Zaccardi MJ, 2013, J BIOL CHEM, V288, P26350, DOI 10.1074/jbc.M113.487447; Zaccardi MJ, 2012, BIOCHEM BIOPH RES CO, V418, P324, DOI 10.1016/j.bbrc.2012.01.020	32	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					15948	15956		10.1074/jbc.RA120.014936	http://dx.doi.org/10.1074/jbc.RA120.014936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32928960	Green Published, hybrid			2022-12-26	WOS:000595657900014
J	Arnold, NS; Noren Hooten, N; Zhang, YQ; Lehrmann, E; Wood, W; Nunez, WC; Thorpe, RJ; Evans, MK; Dluzen, DF				Arnold, Nicole S.; Noren Hooten, Nicole; Zhang, Yongqing; Lehrmann, Elin; Wood, William, III; Nunez, Wendy Camejo; Thorpe, Roland J., Jr.; Evans, Michele K.; Dluzen, Douglas F.			The association between poverty and gene expression within peripheral blood mononuclear cells in a diverse Baltimore City cohort	PLOS ONE			English	Article							CONSERVED TRANSCRIPTIONAL RESPONSE; SOCIOECONOMIC-STATUS; UNITED-STATES; CARDIOVASCULAR-DISEASE; RACIAL-DIFFERENCES; LIFE EXPECTANCY; OLDER-ADULTS; MORTALITY; HEALTH; AFRICAN	Socioeconomic status (SES), living in poverty, and other social determinants of health contribute to health disparities in the United States. African American (AA) men living below poverty in Baltimore City have a higher incidence of mortality when compared to either white males or AA females living below poverty. Previous studies in our laboratory and elsewhere suggest that environmental conditions are associated with differential gene expression (DGE) patterns in peripheral blood mononuclear cells (PBMCs). DGE have also been associated with hypertension and cardiovascular disease (CVD) and correlate with race and sex. However, no studies have investigated how poverty status associates with DGE between male and female AAs and whites living in Baltimore City. We examined DGE in 52 AA and white participants of the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) cohort, who were living above or below 125% of the 2004 federal poverty line at time of sample collection. We performed a microarray to assess DGE patterns in PBMCs from these participants. AA males and females living in poverty had the most genes differentially-expressed compared with above poverty controls. Gene ontology (GO) analysis identified unique and overlapping pathways related to the endosome, single-stranded RNA binding, long-chain fatty-acyl-CoA biosynthesis, toll-like receptor signaling, and others within AA males and females living in poverty and compared with their above poverty controls. We performed RT-qPCR to validate top differentially-expressed genes in AA males. We found thatKLF6,DUSP2,RBM34, andCD19are expressed at significantly lower levels in AA males in poverty andKCTD12is higher compared to above poverty controls. This study serves as an additional link to better understand the gene expression response in peripheral blood mononuclear cells in those living in poverty.	[Arnold, Nicole S.; Nunez, Wendy Camejo; Dluzen, Douglas F.] Morgan State Univ, Dept Biol, Baltimore, MD 21239 USA; [Noren Hooten, Nicole; Evans, Michele K.] NIA, Lab Epidemiol & Populat Sci, NIH, Baltimore, MD 21224 USA; [Zhang, Yongqing; Lehrmann, Elin; Wood, William, III] NIA, Lab Genet & Genom, NIH, Baltimore, MD 21224 USA; [Thorpe, Roland J., Jr.] Johns Hopkins Univ, Program Res Mens Hlth, Hopkins Ctr Hlth Dispar Solut, Baltimore, MD USA	Morgan State University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University	Dluzen, DF (corresponding author), Morgan State Univ, Dept Biol, Baltimore, MD 21239 USA.	douglas.dluzen@morgan.edu	Noren Hooten, Nicole/J-5498-2019	Noren Hooten, Nicole/0000-0002-1683-3838; Arnold, Nicole/0000-0002-9084-755X; Lehrmann, Elin/0000-0002-9869-9475; Dluzen, Douglas/0000-0002-9426-5071	National Institute on Minority Health and Health Disparities RCMI@Morgan [5U54MD013376-8281]; National Institute on Aging Intramural Research Program [ZIAAG000519]; National Institute on Aging [K02AG05140, R01AG054363]; National Institute on Minority Health and Health Disparities [U54MD000214-6867]; National Institute of General Medical Science ASCEND [TL4GM118974]; National Institute of General Medical Science RISE [R25GM058904]	National Institute on Minority Health and Health Disparities RCMI@Morgan; National Institute on Aging Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of General Medical Science ASCEND; National Institute of General Medical Science RISE	This work was supported by the National Institute on Minority Health and Health Disparities RCMI@Morgan#5U54MD013376-8281.(DFD), National Institute on Aging Intramural Research Program (ZIAAG000519) (MKE), the National Institute on Aging K02AG05140 (RJT), R01AG054363 (RJT), the National Institute on Minority Health and Health Disparities U54MD000214-6867 (RJT), and the National Institute of General Medical Sciences ASCEND #TL4GM118974 and RISE #R25GM058904.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ahsan S., 2017, CURR PROTOC BIOINFOR, V57, DOI [10.1002/cpbi.24, DOI 10.1002/CPBI.24]; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; [Anonymous], 2020, MARYLAND POVERTY PRO; Barber S, 2016, AM J PUBLIC HEALTH, V106, P2219, DOI 10.2105/AJPH.2016.303471; Barnett DW, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0558-z; Beydoun MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3744-z; Brydon L, 2004, BRAIN BEHAV IMMUN, V18, P281, DOI 10.1016/j.bbi.2003.09.011; Castillo DC, 2012, CURR CARDIOVASC RISK, V6, P245, DOI 10.1007/s12170-012-0236-2; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Cole SW, 2020, P NATL ACAD SCI USA, V117, P4601, DOI 10.1073/pnas.1821367117; Cole SW, 2019, CURR OPIN BEHAV SCI, V28, P31, DOI 10.1016/j.cobeha.2019.01.008; Cole SW, 2015, PSYCHONEUROENDOCRINO, V62, P11, DOI 10.1016/j.psyneuen.2015.07.001; Davis SK, 2014, ETHNIC DIS, V24, P133; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Dluzen D. F., 2017, OXID MED CELL LONGEV, V2017, P12, DOI DOI 10.1155/2017/3984280; Dluzen DF, 2016, SCI REP-UK, V6, DOI 10.1038/srep35815; Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Dwyer-Lindgren L, 2017, JAMA INTERN MED, V177, P1003, DOI 10.1001/jamainternmed.2017.0918; Evans MK, 2010, ETHNIC DIS, V20, P267; Fiorito G, 2019, AGING-US, V11, P2045, DOI 10.18632/aging.101900; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Gallardo-Vara E, 2016, ANGIOGENESIS, V19, P155, DOI 10.1007/s10456-016-9495-8; Gaye A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187290; Giurgescu C, 2019, J URBAN HEALTH, V96, P23, DOI 10.1007/s11524-018-00341-1; Gleeson PA, 2014, SEMIN CELL DEV BIOL, V31, P64, DOI 10.1016/j.semcdb.2014.03.002; Glover LM, 2020, AM J HYPERTENS, V33, P84, DOI 10.1093/ajh/hpz133; Hajat A, 2011, AM J EPIDEMIOL, V173, P192, DOI 10.1093/aje/kwq348; Han B, 2018, AM J PREV MED, V54, P352, DOI 10.1016/j.amepre.2017.10.025; Jessica Semega MK, 2020, INCOME POVERTY US 20; Jimenez MP, 2019, SOC SCI MED, V241, DOI 10.1016/j.socscimed.2019.112574; Kershaw KN, 2015, CIRCULATION, V131, P141, DOI 10.1161/CIRCULATIONAHA.114.011345; Kim GD, 2020, FASEB J, V34, P3209, DOI 10.1096/fj.201902221R; Kim GD, 2019, FASEB J, V33, P10902, DOI 10.1096/fj.201900867RR; Kim GD, 2016, J BIOL CHEM, V291, P21271, DOI 10.1074/jbc.M116.738617; Klatte Marco, 2009, V479, P61, DOI 10.1007/978-1-59745-289-2_4; Kucharska-Newton AM, 2011, ANN EPIDEMIOL, V21, P572, DOI 10.1016/j.annepidem.2011.04.006; Li E, 2014, INT J ONCOL, V45, P587, DOI 10.3892/ijo.2014.2469; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood KG, 2018, PHYSIOL BEHAV, V188, P212, DOI 10.1016/j.physbeh.2018.02.016; Lu D, 2015, NAT IMMUNOL, V16, P1263, DOI 10.1038/ni.3278; Makaroun LK, 2017, JAMA INTERN MED, V177, P1745, DOI 10.1001/jamainternmed.2017.3903; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Miyake K, 2018, INT IMMUNOL, V30, P43, DOI 10.1093/intimm/dxy016; Mode NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154535; Mouchess ML, 2011, IMMUNITY, V35, P721, DOI 10.1016/j.immuni.2011.10.009; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; Ness RB, 2004, AM J EPIDEMIOL, V160, P1033, DOI 10.1093/aje/kwh325; Noren Hooten N, 2019, AGING-US, V11, P1189, DOI 10.18632/aging.101823; O'Donovan A, 2011, DIS MARKERS, V30, P123, DOI [10.3233/DMA-2011-0768, 10.1155/2011/560572]; Pool LR, 2018, JAMA-J AM MED ASSOC, V319, P1341, DOI 10.1001/jama.2018.2055; Roux AVD, 2007, REV EPIDEMIOL SANTE, V55, P13, DOI 10.1016/j.respe.2006.12.003; Ryu Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213186; Saydah S, 2010, PUBLIC HEALTH REP, V125, P377, DOI 10.1177/003335491012500306; Saydah SH, 2013, DIABETES CARE, V36, P49, DOI 10.2337/dc11-1864; Schultz WM, 2018, CIRCULATION, V137, P2166, DOI 10.1161/CIRCULATIONAHA.117.029652; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Shaked D, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00198; Shaked D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216338; Smith JA, 2017, EPIGENETICS-US, V12, P662, DOI 10.1080/15592294.2017.1341026; Snyder-Mackler N, 2016, SCIENCE, V354, P1041, DOI 10.1126/science.aah3580; Sonnenschein K, 2019, CARDIOVASC RES, V115, P1804, DOI 10.1093/cvr/cvz063; Sprung MR, 2019, J PUBLIC HEALTH RES, V8, P104, DOI 10.4081/jphr.2019.1643; Stanbery AG, 2020, P NATL ACAD SCI USA, V117, P3074, DOI 10.1073/pnas.1911579117; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Sweet DR, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00006; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Thames AD, 2019, PSYCHONEUROENDOCRINO, V106, P277, DOI 10.1016/j.psyneuen.2019.04.016; Thorpe RJ, 2012, ANN BEHAV MED, V43, P29, DOI 10.1007/s12160-011-9335-4; Wang BD, 2015, CLIN CANCER RES, V21, P4970, DOI 10.1158/1078-0432.CCR-14-1566; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0; Yang D, 2018, CARDIOVASC RES, V114, P1016, DOI 10.1093/cvr/cvy051; Zhang J, 2014, P NATL ACAD SCI USA, V111, P18637, DOI 10.1073/pnas.1415607112; Zonderman AB, 2016, JAMA INTERN MED, V176, P1394, DOI 10.1001/jamainternmed.2016.3649	75	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239654	10.1371/journal.pone.0239654	http://dx.doi.org/10.1371/journal.pone.0239654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970748	Green Submitted, gold, Green Published			2022-12-26	WOS:000576265600075
J	Pinto, N; Prokopec, SD; Ghasemi, F; Meens, J; Ruicci, KM; Khan, IM; Mundi, N; Patel, K; Han, MW; Yoo, J; Fung, K; MacNeil, D; Mymryk, JS; Datti, A; Barrett, JW; Boutros, PC; Ailles, L; Nichols, AC				Pinto, Nicole; Prokopec, Stephenie D.; Ghasemi, Farhad; Meens, Jalna; Ruicci, Kara M.; Khan, Imran M.; Mundi, Neil; Patel, Krupal; Han, Myung W.; Yoo, John; Fung, Kevin; MacNeil, Danielle; Mymryk, Joe S.; Datti, Alessandro; Barrett, John W.; Boutros, Paul C.; Ailles, Laurie; Nichols, Anthony C.			Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models	PLOS ONE			English	Article							GENETICS; TARGETS	Anaplastic thyroid cancer (ATC) is a rare, but nearly uniformly fatal disease that is typically resistant to chemotherapy and radiation. Alternative strategies to target this cancer at a molecular level are necessary in order to improve dismal outcomes for ATC patients. We examined the effects of flavopiridol, a CDK inhibitor, in a panel of ATC cell lines. When cell lines were treated over a ten-point concentration range, CAL62, KMH2 and BHT-101 cell lines had a sub micromolar half-maximal inhibitory concentration, while no effect was seen in the non-cancerous cell line IMR-90. Flavopiridol treatment resulted in decreased levels of the cell cycle proteins CDK9 and MCL1, and induced cell cycle arrest. Flavopiridol also decreased thein vitroability of ATC cells to form colonies and impeded migration using a transwell migration assay.In vivo, flavopiridol decreased tumor weight and tumor volume over time in a patient-derived xenograft model of ATC. Given the observedin vitroandin vivoactivity, flavopiridol warrants further investigation for treatment of ATC.	[Pinto, Nicole; Ghasemi, Farhad; Ruicci, Kara M.; Khan, Imran M.; Mundi, Neil; Patel, Krupal; Han, Myung W.; Yoo, John; Fung, Kevin; MacNeil, Danielle; Barrett, John W.; Nichols, Anthony C.] Western Univ, Dept Otolaryngol Head & Neck Surg, London, ON, Canada; [Pinto, Nicole] Western Univ, Dept Anat & Cell Biol, London, ON, Canada; [Prokopec, Stephenie D.; Boutros, Paul C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Meens, Jalna; Ailles, Laurie] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Yoo, John; Fung, Kevin; MacNeil, Danielle; Mymryk, Joe S.; Nichols, Anthony C.] Western Univ, Dept Oncol, London, ON, Canada; [Mymryk, Joe S.] Western Univ, Dept Microbiol & Immunol, London, ON, Canada; [Datti, Alessandro] Mt Sinai Hosp, Network Biol Collaborat Ctr, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Datti, Alessandro] Univ Perugia, Dept Agr Food & Environm Sci, Perugia, Italy; [Boutros, Paul C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Boutros, Paul C.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Boutros, Paul C.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA USA; [Boutros, Paul C.] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA USA; [Boutros, Paul C.] Univ Calif Los Angeles, Inst Precis Hlth, Los Angeles, CA USA; [Boutros, Paul C.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Perugia; University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Nichols, AC (corresponding author), Western Univ, Dept Otolaryngol Head & Neck Surg, London, ON, Canada.; Nichols, AC (corresponding author), Western Univ, Dept Oncol, London, ON, Canada.	Anthony.Nichols@lhsc.on.ca	Nichols, Anthony Charles/H-9595-2019; Khan, Mohammed I/I-9621-2017; Datti, Alessandro/ABA-1108-2021	Nichols, Anthony Charles/0000-0002-0760-980X; Khan, Mohammed I/0000-0003-3020-1324; Datti, Alessandro/0000-0001-6824-7382; Mundi, Neil/0000-0001-9328-8266; Patel, Krupal/0000-0002-2285-0386	Canadian Institutes of Health Research grant [MOP 377832]; NIH/NCI [P30CA016042]; Wolfe Surgical Research Professorship in the Biology of Head and Neck Cancers Fund	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wolfe Surgical Research Professorship in the Biology of Head and Neck Cancers Fund	This work was supported by Canadian Institutes of Health Research grant MOP 377832 to ACN and PCB, and the NIH/NCI award number P30CA016042 to PCB. ACN was also supported by the Wolfe Surgical Research Professorship in the Biology of Head and Neck Cancers Fund.	Abramoff MD., 2004, BIOPHOTONICS INT, V2004, P1; Akaishi J, 2011, THYROID, V21, P1183, DOI 10.1089/thy.2010.0332; [Anonymous], 2018, LANCET DIABETES ENDO, V6, P1, DOI DOI 10.1080/08927022.2018.1510179; Boffo S, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0704-8; Bose Prithviraj, 2013, Leuk Res Rep, V2, P12; FDA, 2014, ONCOLOGY TIMES, P1; Giuffrida D, 2000, ANAPLASTIC THYROID C, P1; Grande E, 2013, J RES MED SCI, P1; Guerra A, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S44; Kajiyama Y, 2004, FLAVOPIRIDOL RADIO S, P1; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Molinaro E, 2017, NAT REV ENDOCRINOL, V13, P644, DOI 10.1038/nrendo.2017.76; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; O'Neill JP, 2013, ORAL ONCOL, V49, P702, DOI 10.1016/j.oraloncology.2013.03.440; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Pernas S, 2018, THER ADV MED ONCOL, V10, DOI 10.1177/1758835918786451; Pinto N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207152; Pinto N, 2014, J ONCOL, V2014, DOI 10.1155/2014/936285; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Raju U, 2003, CANCER RES, P1; Rixe O, 2007, CLIN CANCER RES, V13, P7280, DOI 10.1158/1078-0432.CCR-07-2141; Rosove MH, 2013, NEW ENGL J MED, V368, P684, DOI 10.1056/NEJMc1215697; Ruicci KM, 2018, INT J CANCER, V61, P69, DOI [10.1002/ijc.32009, DOI 10.1002/IJC.3200930468243]; Shapiro GI, 1999, CLIN CANCER RES, P1; Smith N, 2015, J CLIN ENDOCR METAB, V100, P35, DOI 10.1210/jc.2014-2803; Subbiah V, 2018, J CLIN ONCOL, V36, P7, DOI 10.1200/JCO.2017.73.6785; Thangavel C, 2018, CLIN CANCER RES, V24, P1402, DOI 10.1158/1078-0432.CCR-17-2074; Xu Bin, 2016, ENDOCR PATHOL, P1, DOI 10.1007/s12022-015-9405-4; Zhang RR, 2011, LEUKEMIA LYMPHOMA, V52, P556, DOI 10.3109/10428194.2011.560694	30	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239315	10.1371/journal.pone.0239315	http://dx.doi.org/10.1371/journal.pone.0239315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970704	gold, Green Published			2022-12-26	WOS:000576265600038
J	Pott, LN; Austin, RM; Eller, AR; Hofman, CA; Sholts, SB				Pott, Laura N.; Austin, Rita M.; Eller, Andrea R.; Hofman, Courtney A.; Sholts, Sabrina B.			Population-level assessment of atlas occipitalization in artificially modified crania from pre-Hispanic Peru	PLOS ONE			English	Article							ATLANTOOCCIPITAL FUSION; VAULT MODIFICATION; TOMB 1; DEFORMATION; ANOMALIES; SKELETAL; PERIOD; RISK; PALEOPATHOLOGY; TUBERCULOSIS	Atlas occipitalization (AO) is a spinal anomaly, characterized by the fusion of the first cervical vertebra and occipital bone, with a complex etiology that can arise from congenital and environmental causes. AO has been reported in three regions of pre-Hispanic Peru in skeletal remains with artificial cranial modification (ACM), which involves the use of compression devices to permanently alter cranial shape and may have affected the fusion of the atlas and occipital bone. The aims of this study were to gain insights into AO's etiology by testing correlations between AO and ACM presence/type and geographic region as well as to characterize morphological variation associated with AO. We investigated the geographic distribution of AO and its potential relationship to ACM in a large sample of human crania from eight coastal and highland regions of pre-Hispanic Peru, held at the Smithsonian's National Museum of Natural History (n = 608, 1300-1500 CE). Eleven cases of AO were observed in three coastal regions-including two previously unreported regions-at an overall frequency of 1.8%. The frequency of AO did not differ significantly between crania with and without ACM, in general or by type, suggesting that ACM is not an etiological factor that influences AO in this sample. AO was observed at a significantly higher rate in the southern coastal region of Arequipa than in any other region. Genetic, dietary, and epidemiological conditions are evaluated as factors possibly shaping the geographic distribution of AO along the central and southern coasts of Peru.	[Pott, Laura N.; Austin, Rita M.; Hofman, Courtney A.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Pott, Laura N.; Austin, Rita M.; Hofman, Courtney A.] Univ Oklahoma, Labs Mol Anthropol & Microbiome Res, Norman, OK 73019 USA; [Austin, Rita M.; Eller, Andrea R.; Hofman, Courtney A.; Sholts, Sabrina B.] Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Smithsonian Institution; Smithsonian National Museum of Natural History	Sholts, SB (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Anthropol, Washington, DC 20560 USA.	sholtss@si.edu		Pott, Laura/0000-0003-0435-0983; Sholts, Sabrina/0000-0003-4168-0578; Eller, Andrea/0000-0001-8940-7568	Natural History Research Experiences NSF REU Site [NSF OCE-1560088]; Institute for Field Research Undergraduate Conference Travel Program; University of Oklahoma College of Arts and Sciences Student Travel Assistance Program; University of Oklahoma Honors College Undergraduate Research Opportunity Program	Natural History Research Experiences NSF REU Site; Institute for Field Research Undergraduate Conference Travel Program; University of Oklahoma College of Arts and Sciences Student Travel Assistance Program; University of Oklahoma Honors College Undergraduate Research Opportunity Program	Funding for this study was provided by the Natural History Research Experiences NSF REU Site (NSF OCE-1560088) (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1560088).The Institute for Field Research Undergraduate Conference Travel Program (https://www.saa.org/career-practice/awards/awards-detail/institute-forfield-research-annual-meeting-travel-award), University of Oklahoma College of Arts and Sciences Student Travel Assistance Program (http://www.ou.edu/cas/socialwork/current-students/resources/travel-support), and University of Oklahoma Honors College Undergraduate Research Opportunity Program (http://www.ou.edu/honors/undergraduate-research/urop) provided financial support for L.N.P. for the presentation of these results. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Motabagani MA, 2006, ANAT SCI INT, V81, P173, DOI 10.1111/j.1447-073x.2006.00129.x; Allison M. J., 1981, CHUNGARA, V7, P238; Allison Marvin J, 1984, PALEOPATHOLOGY ORIGI, P531; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; ANTON SC, 1989, AM J PHYS ANTHROPOL, V79, P253, DOI 10.1002/ajpa.1330790213; Aufderheide A. C., 1998, HUMAN PALEOPATHOLOGY; Baraybar JP, 1999, J ARCHAEOL SCI, V26, P471, DOI 10.1006/jasc.1998.0319; Barnes E, 1994, DEV DEFECTS AXIAL SK; Basic Z, 2014, INT J OSTEOARCHAEOL, V24, P540, DOI 10.1002/oa.2240; BJORK A, 1964, J DENT RES, V43, P353, DOI 10.1177/00220345640430030601; Blom DE, 2005, AM J PHYS ANTHROPOL, V127, P152, DOI 10.1002/ajpa.10431; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; BROTHWELL D, 1975, J ARCHAEOL SCI, V2, P75, DOI 10.1016/0305-4403(75)90048-5; Brown P., 1981, ARCHAEOL OCEAN, V16, P156; Buikstra J.E., 1994, STANDARDS DATA COLLE; CARTER CO, 1973, J MED GENET, V10, P209, DOI 10.1136/jmg.10.3.209; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V88, P323, DOI 10.1002/ajpa.1330880307; Copp AJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.7; Donoghue HD, 2019, ANN HUM BIOL, V46, P120, DOI 10.1080/03014460.2019.1624822; Erdil H., 2003, J ANAT SOC INDIA, V52, P125; Fehren-Schmitz L, 2014, P NATL ACAD SCI USA, V111, P9443, DOI 10.1073/pnas.1403466111; Fehren-Schmitz L, 2011, ANN HUM GENET, V75, P266, DOI 10.1111/j.1469-1809.2010.00620.x; Gerdau-Radonic K, 2015, J ARCHAEOL SCI-REP, V4, P371, DOI 10.1016/j.jasrep.2015.09.016; Gerszten PC, 2001, NEUROSURGERY, V48, P208, DOI 10.1097/00006123-200101000-00039; Gholve PA, 2007, J BONE JOINT SURG AM, V89A, P571, DOI 10.2106/JBJS.F.00527; Giuffra V, 2017, FOLIA MORPHOL, V76, P123, DOI 10.5603/FM.a2016.0039; Goodrich JT, 2010, WORLD NEUROSURG, V74, P81, DOI 10.1016/j.wneu.2010.08.018; Gopal K, 2015, INT J RES MED SCI, V3, P420, DOI [10.5455/2320-6012.ijrms20150207, DOI 10.5455/2320-6012.IJRMS20150207]; Guedes L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8304129; Guillen SE, 2012, GLOBAL HIST PALEOPAT, P312, DOI DOI 10.1093/ACPROF:OSOBL/9780195389807.003.0039; Haque S, 2012, RADIOGRAPHICS, V32, P557, DOI 10.1148/rg.322105143; Hrdlika A, 1920, ANTHROPOMETRY; Hrdlika A, 1914, 1913 NOTES PATHOLOGY; Hussien FH, 2009, INT J OSTEOARCHAEOL, V19, P613, DOI 10.1002/oa.984; Iwata A, 1998, J NEUROL SCI, V154, P229, DOI 10.1016/S0022-510X(97)00224-4; Jayanthi V, 2003, J ANAT SOC INDIA, V52, P71; Jimenez P, 2012, AM J PHYS ANTHROPOL, V147, P40, DOI 10.1002/ajpa.21625; KALLA AK, 1989, HUM GENET, V81, P105, DOI 10.1007/BF00293884; Kassim NM, 2010, BRATISL MED J, V111, P562; KATZ SH, 1974, SCIENCE, V184, P765, DOI 10.1126/science.184.4138.765; Keenleyside A, 2015, INT J OSTEOARCHAEOL, V25, P74, DOI 10.1002/oa.2264; Khamanarong Kimaporn, 2013, Acta Med Acad, V42, P41, DOI 10.5644/ama2006-124.69; Khudaverdyan AY, 2011, EUR J ANAT, V15, P162; Klaus HD, 2009, AM J PHYS ANTHROPOL, V139, P204, DOI 10.1002/ajpa.20973; KOHN LAP, 1993, AM J PHYS ANTHROPOL, V90, P147, DOI 10.1002/ajpa.1330900203; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Lau BT., 2008, INT J COMPUTING ICT, V2, P19; Masnicova S, 2003, INT J OSTEOARCHAEOL, V13, P266, DOI 10.1002/oa.684; MCRAE DL, 1953, AM J ROENTGENOL, V70, P23; MERBS CF, 1974, ARCTIC ANTHROPOL, V11, P12; MERBS CF, 1985, AM J PHYS ANTHROPOL, V67, P381, DOI 10.1002/ajpa.1330670410; Monte de la Paz J, 2015, DIARIO DE CAMPO, V10-11, P46; Morton DH, 2003, AM J MED GENET C, V121C, P5, DOI 10.1002/ajmg.c.20002; Mudaliar RP, 2013, J CLIN DIAGN RES, V7, P1835, DOI 10.7860/JCDR/2013/6611.3327; Mujica E, 1992, GACETA ARQUEOL ANDIN, V21, P81; Nagashima H, 2001, ARCH ORTHOP TRAUM SU, V121, P99, DOI 10.1007/s004020000164; Natsis K, 2017, SURG RADIOL ANAT, V39, P39, DOI 10.1007/s00276-016-1687-9; Nelson EA, 2020, INT J PALEOPATHOL, V29, P128, DOI 10.1016/j.ijpp.2019.12.006; O'Loughlin VD, 2004, AM J PHYS ANTHROPOL, V123, P146, DOI 10.1002/ajpa.10304; Obladen M, 2012, J CHILD NEUROL, V27, P672, DOI 10.1177/0883073811432749; Paine R.R., 2006, J ANTHROPOL SCI, V84, P125; Pechenkina EA, 2007, ANCIENT HLTH SKELETA, P92; Perez SI, 2007, J ARCHAEOL SCI, V34, P1649, DOI 10.1016/j.jas.2006.12.003; Pina Medina A, 1996, REV ESPANOLA CIRUGIA, V31, P146; Pomeroy E, 2010, INT J OSTEOARCHAEOL, V20, P317, DOI 10.1002/oa.1044; Ranade AV, 2007, NEUROANATOMY, V6, P32; Saini V, 2009, INT J ANATOMICAL VAR, V2, P65; SALO WL, 1994, P NATL ACAD SCI USA, V91, P2091, DOI 10.1073/pnas.91.6.2091; Scheuer L., 2004, DEV JUVENILE OSTEOLO; Schuenemann VJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006447; Senator M, 2012, INT J OSTEOARCHAEOL, V22, P749, DOI 10.1002/oa.1236; Sharma DK, 2017, J CLIN DIAGN RES, V11, pAC01, DOI 10.7860/JCDR/2017/26183.9999; Shaw GM, 2009, EPIDEMIOLOGY, V20, P714, DOI 10.1097/EDE.0b013e3181ac9fe7; Shaw GM, 1997, TERATOLOGY, V56, P295, DOI 10.1002/(SICI)1096-9926(199711)56:5<295::AID-TERA1>3.0.CO;2-X; Tiesler V., 2013, BIOARCHAEOLOGY ARTIF; Tiesler V, 2018, ENCY ARCHAEOLOGICAL, P1, DOI [10.1002/9781119188230.saseas0138, DOI 10.1002/9781119188230.SASEAS0138]; Torres-Rouff C, 2002, CURR ANTHROPOL, V43, P163, DOI 10.1086/338290; Tubbs RS, 2006, J NEUROSURG-SPINE, V4, P319, DOI 10.3171/spi.2006.4.4.319; VAKILI ST, 1985, AM J FOREN MED PATH, V6, P39, DOI 10.1097/00000433-198503000-00008; Velasco MC, 2018, CURR ANTHROPOL, V59, P98, DOI 10.1086/695986; Verano J., 2016, HOLES HEAD ART ARCHA; Verano JW, 1997, J WORLD PREHIST, V11, P237, DOI 10.1007/BF02221205; Verano JW, 1997, ANTIQUITY, V71, P670, DOI 10.1017/S0003598X00085392; Weiss P., 1984, B LIMA, V33, P17; Weiss P., 1961, OSTEOLOGIA CULTURAL; White T.D., 2005, HUMAN BONE MANUAL, DOI [DOI 10.1016/B978-0-12-088467-4.50018-1, 10.1016/B978-0-12-088467-4.50018-1]; Yazdy MM, 2011, PAEDIATR PERINAT EP, V25, P340, DOI 10.1111/j.1365-3016.2011.01198.x; Zaganjor I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151586; Zink A, 1994, ORIGINE SYPHILIS EUR, P202; 2019, NEW DISTRICTS, V20, P1	91	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239600	10.1371/journal.pone.0239600	http://dx.doi.org/10.1371/journal.pone.0239600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970756	Green Published, gold			2022-12-26	WOS:000576265600007
J	Dhawale, AK; Kumar, MA; Sinha, A				Dhawale, Ashni Kumar; Kumar, M. Ananda; Sinha, Anindya			Changing ecologies, shifting behaviours: Behavioural responses of a rainforest primate, the lion-tailed macaqueMacaca silenus, to a matrix of anthropogenic habitats in southern India	PLOS ONE			English	Article							UPPER BRAHMAPUTRA VALLEY; WESTERN-GHATS; MACACA-SILENUS; ACTIVITY PATTERNS; ACTIVITY BUDGETS; SOCIAL-BEHAVIOR; BONNET MACAQUES; ANAIMALAI HILLS; RHESUS MACAQUES; ANAMALAI HILLS	With the uncontrolled expansion of anthropogenic modifications of the environment, wildlife species are forced to interact with humans, often leading to conflict situations that have detrimental effects for both wildlife and humans. Such interactions are escalating globally, making it crucial for us to devise strategies for both, the management of conflict and the conservation of these often-threatened species. We studied a case of potentially detrimental human-wildlife interactions between an endemic, habitat-specialist primate, the lion-tailed macaqueMacaca silenusand resident human communities that has developed in recent years in the Western Ghats mountains of southern India. Primates provide useful model systems to understand the extent and nature of behavioural changes exhibited by wildlife in response to anthropogenic habitats with varying degrees of human influence. We documented behaviours, including foraging and intra-species social interactions, to examine the decisions made by the macaques as they exploited four human-modified habitats, which, for the purpose of this study, have been qualitatively characterised to include structural features of the habitat, type of food resources available and the presence of humans. Access to human-origin food, either cooked or packaged, acquired directly from homes or garbage pits, in the human-dominated habitat appeared to significantly reduce active foraging and searching for food, allowing them to engage in other behavioural activities, such as resting. Furthermore, patterns of reciprocated affiliation dissipated in certain human-dominated habitats, with individuals seeming to have adopted novel behavioural strategies, leading to altered social dynamics in the troop, possibly in response to provisioning. This study thus highlights the importance of understanding behavioural changes displayed by animals in response to human interactions; such knowledge could be crucial for the planning and implementation of management and conservation strategies for endangered species such as the lion-tailed macaque and possibly other wildlife in the increasingly anthropogenic landscapes of the tropical world.	[Dhawale, Ashni Kumar] Natl Ctr Biol Sci, WCS NCBS Programme, Wildlife Biol & Conservat, Bangalore, Karnataka, India; [Dhawale, Ashni Kumar; Sinha, Anindya] Natl Inst Adv Studies, Sch Nat & Engn Sci, Indian Inst Sci Campus, Bangalore, Karnataka, India; [Dhawale, Ashni Kumar] Univ Transdisciplinary Hlth Sci & Technol, Bangalore, Karnataka, India; [Kumar, M. Ananda] Nat Conservat Fdn, Mysore, Karnataka, India; [Sinha, Anindya] Indian Inst Sci Educ & Res Kolkata, Mohanpur, India; [Sinha, Anindya] Cotton Univ, Gauhati, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Indian Institute of Science Education & Research (IISER) - Kolkata	Dhawale, AK (corresponding author), Natl Ctr Biol Sci, WCS NCBS Programme, Wildlife Biol & Conservat, Bangalore, Karnataka, India.; Dhawale, AK (corresponding author), Natl Inst Adv Studies, Sch Nat & Engn Sci, Indian Inst Sci Campus, Bangalore, Karnataka, India.; Dhawale, AK (corresponding author), Univ Transdisciplinary Hlth Sci & Technol, Bangalore, Karnataka, India.	ashnidhawale@gmail.com		Sinha, Anindya/0000-0001-5623-711X; Dhawale, Ashni/0000-0002-7185-9870	National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India by the Department of Atomic Energy, Government of India; Tata Trusts, Mumbai, India; Science and Engineering Research Board of the Department of Science and Technology, Government of India	National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India by the Department of Atomic Energy, Government of India; Tata Trusts, Mumbai, India; Science and Engineering Research Board of the Department of Science and Technology, Government of India	Funding for this work was provided to AKD by core grants provided to the National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India by the Department of Atomic Energy, Government of India, and by a programme grant from the Tata Trusts, Mumbai, India. The funding sources covered logistic-and field-related expenses. AKD also received a monthly stipend from the abovementioned grants during the course of the study. AKD was supported for part of this work by a fellowship from a research grant awarded to AS by the Science and Engineering Research Board of the Department of Science and Technology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; ALTMANN J, 1988, AM J PRIMATOL, V15, P213, DOI 10.1002/ajp.1350150304; Baruch-Mordo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085122; Beckmann Jon P., 2008, Human-Wildlife Conflicts, V2, P168; Berman CM, 2007, INT J PRIMATOL, V28, P1123, DOI 10.1007/s10764-007-9199-4; BOCCIA ML, 1988, AM J PRIMATOL, V16, P123, DOI 10.1002/ajp.1350160203; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Campbell LAD, 2016, PRIMATES, V57, P309, DOI 10.1007/s10329-016-0540-4; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Deshpande A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22928-z; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dray S., 2017, J STAT SOFTW, V22, P4; El Alami A, 2012, AM J PRIMATOL, V74, P210, DOI 10.1002/ajp.21989; FORTHMANQUICK DL, 1988, ECOLOGY BEHAV FOOD E, P25; Fuentes A, 2007, INT J PRIMATOL, V28, P1143, DOI 10.1007/s10764-007-9184-y; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Hartig F., 2022, DHARMA RESIDUAL DIAG; HEMELRIJK CK, 1990, J THEOR BIOL, V143, P405, DOI 10.1016/S0022-5193(05)80036-0; Herve M, 2020, RVAIDEMEMOIRE TESTIN; Jaman MF, 2013, PRIMATES, V54, P49, DOI 10.1007/s10329-012-0330-6; Jeganathan P., 2018, Primate Conservation, V32, P205; Jeganathan P, 2018, CURR SCI INDIA, V114, P619, DOI 10.18520/cs/v114/i03/619-626; Kaburu SSK, 2019, AM J PHYS ANTHROPOL, V168, P92, DOI 10.1002/ajpa.23722; Krebs J. R., 1979, SOCIAL BEHAV COMMUNI, P225; Kumar A, 2013, ASIAN BIOTECHN DEV R, V15, P117; KURUP GU, 1993, INT J PRIMATOL, V14, P27, DOI 10.1007/BF02196501; Marechal L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155920; Marty PR, 2019, ANIM BEHAV, V150, P157, DOI 10.1016/j.anbehav.2019.02.010; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McKinney T, 2015, AM J PRIMATOL, V77, P715, DOI 10.1002/ajp.22395; McKinney T, 2011, AM J PRIMATOL, V73, P439, DOI 10.1002/ajp.20919; Muthuramkumar S, 2006, BIOTROPICA, V38, P143, DOI 10.1111/j.1744-7429.2006.00118.x; PEREIRA ME, 1985, NONHUMAN PRIMATE MOD, P00217; Pragatheesh A., 2011, Journal of Threatened Taxa, V3, P1656; Radhakrishna S, 2011, J BIOSCIENCES, V36, P749, DOI 10.1007/s12038-011-9145-7; Ram S, 2003, CURR SCI INDIA, V84, P780; RCore Team, 2020, R LANG ENV STAT COMP; Riley EP, 2007, INT J PRIMATOL, V28, P107, DOI 10.1007/s10764-006-9104-6; Schnepel B, 2016, THESIS; Seoraj-Pillai N, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010034; Sharma N, 2014, CONSERV BIOL, V28, P95, DOI 10.1111/cobi.12159; Sharma N, 2012, ORYX, V46, P308, DOI 10.1017/S0030605311001402; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Singh M, 2004, INT J PRIMATOL, V25, P847, DOI 10.1023/B:IJOP.0000029125.54747.ee; Singh M, 1997, MAMMALIA, V61, P17, DOI 10.1515/mamm.1997.61.1.17; Singh M, 2001, FOLIA PRIMATOL, V72, P278, DOI 10.1159/000049949; Singh M, 2002, AM J PRIMATOL, V57, P91, DOI 10.1002/ajp.10037; Singh M, 2011, PRIMATES, V52, P149, DOI 10.1007/s10329-011-0234-x; Singh M, 2006, J BIOSCIENCES, V31, P369, DOI 10.1007/BF02704110; Sinha A, 2005, J BIOSCIENCES, V30, P51, DOI 10.1007/BF02705150; Sinha A, 2005, CURR SCI INDIA, V89, P1166; Sinha A, 1998, PHILOS T ROY SOC B, V353, P619, DOI 10.1098/rstb.1998.0230; Sinha A., 2017, INT ENCY PRIMATOLOGY; Sinha A, 2013, DEV PRIMATOLOGY PROG, V43, P187; Sorace A, 2009, LANDSCAPE URBAN PLAN, V90, P111, DOI 10.1016/j.landurbplan.2008.10.019; Stephens D. W., 2008, FORAGING BEHAV ECOLO; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Thierry B, 2000, ETHOLOGY, V106, P713, DOI 10.1046/j.1439-0310.2000.00583.x; Tuomainen U, 2011, BIOL REV, V86, P640, DOI 10.1111/j.1469-185X.2010.00164.x; Umapathy G., 2000, Primate Report, V58, P67; van Noordwijk MA, 1999, PRIMATES, V40, P105, DOI 10.1007/BF02557705; van Schaik CP., 1989, COMP SOCIOECOLOGY BE, P195; Warren Y, 2011, DEV PRIMATOLOGY PROG, V35, P359; Yirga G, 2015, WILDLIFE RES, V42, P563, DOI 10.1071/WR14228; Zimmerer KS, 2004, AMBIO, V33, P520, DOI 10.1639/0044-7447(2004)033[0520:GAMTIT]2.0.CO;2	67	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238695	10.1371/journal.pone.0238695	http://dx.doi.org/10.1371/journal.pone.0238695			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966281	Green Published, gold			2022-12-26	WOS:000575688700045
J	Ribeiro, HV; Sunahara, AS; Sutton, J; Perc, M; Hanley, QS				Ribeiro, Haroldo, V; Sunahara, Andre S.; Sutton, Jack; Perc, Matjaz; Hanley, Quentin S.			City size and the spreading of COVID-19 in Brazil	PLOS ONE			English	Article							ORIGINS	The current outbreak of the coronavirus disease 2019 (COVID-19) is an unprecedented example of how fast an infectious disease can spread around the globe (especially in urban areas) and the enormous impact it causes on public health and socio-economic activities. Despite the recent surge of investigations about different aspects of the COVID-19 pandemic, we still know little about the effects of city size on the propagation of this disease in urban areas. Here we investigate how the number of cases and deaths by COVID-19 scale with the population of Brazilian cities. Our results indicate small towns are proportionally more affected by COVID-19 during the initial spread of the disease, such that the cumulative numbers of cases and deathsper capitainitially decrease with population size. However, during the long-term course of the pandemic, this urban advantage vanishes and large cities start to exhibit higher incidence of cases and deaths, such that every 1% rise in population is associated with a 0.14% increase in the number of fatalitiesper capitaafter about four months since the first two daily deaths. We argue that these patterns may be related to the existence of proportionally more health infrastructure in the largest cities and a lower proportion of older adults in large urban areas. We also find the initial growth rate of cases and deaths to be higher in large cities; however, these growth rates tend to decrease in large cities and to increase in small ones over time.	[Ribeiro, Haroldo, V; Sunahara, Andre S.] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Sutton, Jack; Hanley, Quentin S.] Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham, England; [Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, Maribor, Slovenia; [Perc, Matjaz] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Perc, Matjaz] Complex Sci Hub Vienna, Vienna, Austria	Universidade Estadual de Maringa; Nottingham Trent University; University of Maribor; China Medical University Taiwan; China Medical University Hospital - Taiwan	Ribeiro, HV (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.	hvr@dfi.uem.br	Perc, Matjaz/A-5148-2009; Smith, Jack/HHC-2369-2022; Ribeiro, Haroldo Valentin/C-8614-2012; Sutton, Jack/ABC-3261-2020	Perc, Matjaz/0000-0002-3087-541X; Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Sunahara, Andre Seiji/0000-0002-4666-9995; Reis, AlessanRSS/0000-0001-8486-7469; Hanley, Quentin/0000-0002-8189-9550; Sutton, Jack/0000-0002-7635-6578	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq [407690/2018-2, 303121/2018-1]; Slovenian Research Agency [J4-9302, J1-9112, P1-0403]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). H.V.R. thanks for the financial support of CNPq (Grant Nos. 407690/2018-2 and 303121/2018-1). M.P. acknowledges financial support of the Slovenian Research Agency (Grant Nos. J4-9302, J1-9112, and P1-0403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Soto R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023467; Antonio FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111015; Arabi YM, 2020, INTENS CARE MED, V46, P833, DOI 10.1007/s00134-020-05955-1; Batty M, 2013, NEW SCIENCE OF CITIES, P1; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Block P, 2020, NAT HUM BEHAV, V4, P588, DOI 10.1038/s41562-020-0898-6; Brandtner C, 2020, CREATURES STATE METR; Cardoso BHF, 2020, ARXIV200507791; Castro MC, 2019, LANCET, V394, P345, DOI 10.1016/S0140-6736(19)31243-7; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Delatorre E, 2020, TRACKING ONSET DATE; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Gao J, 2020, ARXIV200613853; Gao J, 2019, PHYS REP, V817, P1, DOI 10.1016/j.physrep.2019.05.002; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Heroy, 2020, ARXIV POPULATIONS EV; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; International Civil Aviation Organization, CIV AV STAT WORLD IC; Jiang LW, 2017, GLOBAL ENVIRON CHANG, V42, P193, DOI 10.1016/j.gloenvcha.2015.03.008; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Leitao JC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150649; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Melo HPM, 2014, SCI REP-UK, V4, DOI 10.1038/srep06239; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117; Rocha LEC, 2015, J URBAN HEALTH, V92, P785, DOI 10.1007/s11524-015-9976-x; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Souch JM, 2021, J RURAL HEALTH, V37, P188, DOI 10.1111/jrh.12450; Stier A., 2020, COVID 19 ATTACK RATE, DOI [10.1101/2020.03.22.20041004v2, DOI 10.1101/2020.03.22.20041004V2]; United Nations, WORLD URB PROSP URB; Vasconcelos GL, 2020, PEERJ, V8, DOI 10.7717/peerj.9421; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Walker PGT, 2020, SCIENCE, V369, P413, DOI 10.1126/science.abc0035; West G., 2017, SCALE UNIVERSAL LAWS; West R, 2020, NAT HUM BEHAV, V4, P451, DOI 10.1038/s41562-020-0887-9; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; World Health Organization, 2019, 209 WHO; Xiao KP, 2020, NATURE, V583, P286, DOI 10.1038/s41586-020-2313-x; Youn H, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0937	41	52	53	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239699	10.1371/journal.pone.0239699	http://dx.doi.org/10.1371/journal.pone.0239699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966344	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000575688700029
J	Nagy, L; Beke, F; Juhasz, L; Kovacs, T; Juhasz-Toth, E; Docsa, T; Toth, A; Gergely, P; Somsak, L; Bai, P				Nagy, Lilla; Beke, Ferenc; Juhasz, Laszlo; Kovacs, Tunde; Juhasz-Toth, Eva; Docsa, Tibor; Toth, Attila; Gergely, Pal; Somsak, Laszlo; Bai, Peter			Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells	PLOS ONE			English	Article							GLUCOPYRANOSYLIDENE-SPIRO-THIOHYDANTOIN; CYCLE PROGRESSION; PANCREATIC-ISLETS; PROLIFERATION; MECHANISMS; FR258900; ANALOGS; METABOLISM; EXPRESSION; PROTECTS	Type 2 diabetes mellitus (T2DM), one of the most common metabolic diseases, is characterized by insulin resistance and inadequate insulin secretion of beta cells. Glycogen phosphorylase (GP) is the key enzyme in glycogen breakdown, and contributes to hepatic glucose production during fasting or during insulin resistance. Pharmacological GP inhibitors are potential glucose lowering agents, which may be used in T2DM therapy. A natural product isolated from the cultured broth of the fungal strain No. 138354, called 2,3-bis(4-hydroxycinnamoyloxy)glutaric acid (FR258900), was discovered a decade ago.In vivostudies showed that FR258900 significantly reduced blood glucose levels in diabetic mice. We previously showed that GP inhibitors can potently enhance the function of beta cells. The purpose of this study was to assess whether an analogue of FR258900 can influence beta cell function. BF142 (Meso-Dimethyl 2,3-bis[(E)-3-(4-acetoxyphenyl)prop-2-enamido]butanedioate) treatment activated the glucose-stimulated insulin secretion pathway, as indicated by enhanced glycolysis, increased mitochondrial oxidation, significantly increased ATP production, and elevated calcium influx in MIN6 cells. Furthermore, BF142 induced mTORC1-specific phosphorylation of S6K, increased levels of PDX1 and insulin protein, and increased insulin secretion. Our data suggest that BF142 can influence beta cell function and can support the insulin producing ability of beta cells.	[Nagy, Lilla; Kovacs, Tunde; Docsa, Tibor; Gergely, Pal; Bai, Peter] Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary; [Beke, Ferenc; Juhasz, Laszlo; Juhasz-Toth, Eva; Somsak, Laszlo] Univ Debrecen, Fac Sci & Technol, Dept Organ Chem, Debrecen, Hungary; [Toth, Attila] Univ Debrecen, Fac Med, Dept Cardiol, Debrecen, Hungary; [Bai, Peter] MTA DE Lendulet Lab Cellular Metab, Debrecen, Hungary; [Bai, Peter] Univ Debrecen, Res Ctr Mol Med, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Bai, P (corresponding author), Univ Debrecen, Fac Med, Dept Med Chem, Debrecen, Hungary.; Bai, P (corresponding author), MTA DE Lendulet Lab Cellular Metab, Debrecen, Hungary.; Bai, P (corresponding author), Univ Debrecen, Res Ctr Mol Med, Debrecen, Hungary.	baip@med.unideb.hu	Juhász, László Dr./F-6396-2010; Tóth, Attila/F-4859-2010	Juhász, László Dr./0000-0002-7462-7944; Tóth, Attila/0000-0001-6503-3653	Hungarian Scientific Research Fund [K123975, GINOP-2.3.2-15-2016-00006, NKFIH-1150-6/2019, GINOP-2.3.2-15-2016-00008]; Magyar Tudomanyos Akademia [NKM-26/2019]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Magyar Tudomanyos Akademia	This work was supported by the Hungarian Scientific Research Fund grants K123975, GINOP-2.3.2-15-2016-00006, NKFIH-1150-6/2019 to PB, and grant GINOP-2.3.2-15-2016-00008 to LS, as well as, Magyar Tudomanyos Akademia grant NKM-26/2019 to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2013, AM J MANAG CARE, V19, pS43; Agius L, 2007, BEST PRACT RES CL EN, V21, P587, DOI 10.1016/j.beem.2007.09.001; Agius L, 2015, MOL ASPECTS MED, V46, P34, DOI 10.1016/j.mam.2015.09.002; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Baker DJ, 2005, DIABETES, V54, P2453, DOI 10.2337/diabetes.54.8.2453; Morales NB, 2012, COLOMB MEDICA, V43, P235; Blandino-Rosano M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16014; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Charvat TT, 2006, BIOORGAN MED CHEM, V14, P4552, DOI 10.1016/j.bmc.2006.02.030; Chau GC, 2017, J CELL BIOL, V216, P2091, DOI 10.1083/jcb.201701085; Czikora A, 2012, BRIT J PHARMACOL, V165, P1801, DOI 10.1111/j.1476-5381.2011.01645.x; Docsa T, 2015, CURR TOP MED CHEM, V15, P2390, DOI 10.2174/1568026615666150622091407; Docsa T, 2011, MOL MED REP, V4, P477, DOI 10.3892/mmr.2011.464; Doherty C, 2001, CABLE SATELL EUR, P14; Donnier-Marechal M, 2016, EXPERT OPIN THER PAT, V26, P199, DOI 10.1517/13543776.2016.1131268; Elghazi L, 2010, DIABETES, V59, P2390, DOI 10.2337/db09-0851; Fodor T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150232; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Furukawa S, 2005, J ANTIBIOT, V58, P497, DOI 10.1038/ja.2005.66; GRAF R, 1984, BASIC APPL HISTOCHEM, V28, P391; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Hayes JM, 2017, NAT PROD DRUG DISC, P29, DOI 10.1016/B978-0-12-809450-1.00002-8; Hayes JM, 2014, PHYTOCHEM REV, V13, P471, DOI 10.1007/s11101-014-9360-6; HELLMAN B, 1969, ENDOCRINOLOGY, V84, P1; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Juhasz L, 2014, CHEMPLUSCHEM, V79, P1558, DOI 10.1002/cplu.201402181; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kaneto H, 2015, INT J MOL SCI, V16, P6281, DOI 10.3390/ijms16036281; Kiviranta PH, 2008, BIOORGAN MED CHEM, V16, P8054, DOI 10.1016/j.bmc.2008.07.059; Liu H, 2009, DIABETES, V58, P663, DOI 10.2337/db07-1208; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Maedler K, 2017, J CELL BIOL; Malaisse WJ, 2016, DIABETOLOGIA, V59, P2489, DOI 10.1007/s00125-016-4092-3; MALAISSE WJ, 1977, BIOCHEM J, V164, P447, DOI 10.1042/bj1640447; MALAISSE WJ, 1992, METABOLISM, V41, P814, DOI 10.1016/0026-0495(92)90160-C; MALAISSE WJ, 1993, J CLIN INVEST, V91, P432, DOI 10.1172/JCI116219; Marton J., 2018, BIOCHIM BIOPHYS ACTA, V2, P30187; MCKENNIS H, 1958, J ORG CHEM, V23, P980, DOI 10.1021/jo01101a010; Miko E, 2018, BBA-BIOENERGETICS, V1859, P958, DOI 10.1016/j.bbabio.2018.04.002; Miko E, 2017, METHODS MOL BIOL, V1608, P185, DOI 10.1007/978-1-4939-6993-7_13; Mir-Coll J, 2016, DIABETOLOGIA, V59, P1012, DOI 10.1007/s00125-016-3871-1; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nagy L, 2018, BRIT J PHARMACOL, V175, P301, DOI 10.1111/bph.13819; Nagy L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069420; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Niclauss N, 2011, TRANSPLANTATION, V91, P714, DOI 10.1097/TP.0b013e31820c10c8; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Oikonomakos NG, 2002, BIOORGAN MED CHEM, V10, P261, DOI 10.1016/S0968-0896(01)00277-2; Osz E, 1999, BIOORG MED CHEM LETT, V9, P1385, DOI 10.1016/S0960-894X(99)00192-4; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Rath VL, 2000, CHEM BIOL, V7, P677, DOI 10.1016/S1074-5521(00)00004-1; Rhinesmith HS, 1938, ORG SYNTH, V18, P17; Sharma S, 1996, J BIOL CHEM, V271, P2294, DOI 10.1074/jbc.271.4.2294; Somsak L, 2008, CARBOHYD RES, V343, P2083, DOI 10.1016/j.carres.2008.01.045; Torres TP, 2011, J PHARMACOL EXP THER, V337, P610, DOI 10.1124/jpet.110.177899; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Varga G, 2013, BIOORG MED CHEM LETT, V23, P1789, DOI 10.1016/j.bmcl.2013.01.042; WENNER W, 1948, J ORG CHEM, V13, P26, DOI 10.1021/jo01159a004; Zahr E, 2007, TRANSPLANTATION, V84, P1576, DOI 10.1097/01.tp.0000296035.48728.28; [No title captured]	62	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0236081	10.1371/journal.pone.0236081	http://dx.doi.org/10.1371/journal.pone.0236081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960890	Green Published, gold			2022-12-26	WOS:000575109500024
J	Fujiwara, K; Masatsugu, T; Abe, A; Hirano, T; Sada, M				Fujiwara, Kenji; Masatsugu, Toshihiro; Abe, Atsushi; Hirano, Tatsuya; Sada, Masayuki			Preoperative diagnoses and identification rates of unexpected gallbladder cancer	PLOS ONE			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; CARCINOMA; MANAGEMENT	Background Unexpected gallbladder cancer (UGBC) is sometimes found in the resected gallbladder of patients during or after surgery. Some reports have indicated UGBC identification rates for all gallbladder surgeries, but scarce data are available for the UGBC identification rates for specific gallbladder diseases. The present study was performed to clarify UGBC rates and the factors suspicious for UGBC categorized according to preoperative diagnoses, in patients undergoing laparoscopic cholecystectomy (LSC). Methods We recorded data for all LSC surgeries performed in the Department of Surgery, Sada Hospital, Japan since 1991, and analyzed the 28-year data. We used the chi-square test and Kaplan-Meier analysis for this retrospective case-control study. Results The UGBC identification rate was 0.69% (63/9186 patients). The UGBC identification rates categorized according to the preoperative diagnoses were 1.3% (13/969) for acute cholecystitis, 2.4% (16/655) for benign tumor, 2.0% (28/1383) for chronic cholecystitis or cholecystitis, and 0.054% (3/5585) for cholecystolithiasis. The percentage of older patients (>= 60 years) was significantly higher in UGBCs compared with cases finally diagnosed as benign in each group categorized according to the preoperative diagnoses (p <= 0.0014), except for cholecystolithiasis. In cases pre-diagnosed as benign tumor, UGBCs were associated with higher rates of thickened gallbladder wall compared with benign tumor (69.2% vs. 27.9%, respectively; p = 0.0011). UGBCs pre-diagnosed as acute cholecystitis had higher T2-T4 rates (100% vs. 64.3%, respectively; p<0.05) and lower survival rates (p = 0.0149) than UGBCs pre-diagnosed with chronic cholecystitis. Conclusions UGBC identification rates depend on the preoperative diagnosis and range from 0.054% to 2.4%. Older age (>= 60 years) could be related to UGBC, and a pre-diagnosis of acute cholecystitis might indicate more advanced cancer compared with a pre-diagnosis of chronic cholecystitis.	[Fujiwara, Kenji; Masatsugu, Toshihiro; Abe, Atsushi; Hirano, Tatsuya; Sada, Masayuki] Sada Hosp, Dept Surg, Fukuoka, Japan; [Fujiwara, Kenji] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan	Kyushu University	Fujiwara, K (corresponding author), Sada Hosp, Dept Surg, Fukuoka, Japan.; Fujiwara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan.	kengdom@surg1.med.kyushu-u.ac.jp	Fujiwara, Kenji/AAI-8431-2021	Fujiwara, Kenji/0000-0001-5900-9382				Akyurek N, 2004, J HEPATO-BILIARY-PAN, V11, P357, DOI 10.1007/s00534-004-0910-y; Choi KS, 2015, WORLD J GASTROENTERO, V21, P1315, DOI 10.3748/wjg.v21.i4.1315; Clemente G, 2016, WORLD J GASTRO SURG, V8, P541, DOI 10.4240/wjgs.v8.i8.541; Contini S, 1999, SURG ENDOSC, V13, P264, DOI 10.1007/s004649900959; Dincel O, 2018, J CANCER RES THER, V14, P1325, DOI 10.4103/0973-1482.187301; Golse N, 2017, J VISC SURG, V154, P345, DOI 10.1016/j.jviscsurg.2017.06.004; Hu LS, 2013, ARCH IRAN MED, V16, P631, DOI 0131611/AIM.004; Kim JH, 2010, WORLD J SURG, V34, P114, DOI 10.1007/s00268-009-0279-9; Kim SH, 2017, INT J SURG, V45, P1, DOI 10.1016/j.ijsu.2017.07.046; Kwon AH, 2008, J SURG ONCOL, V97, P241, DOI 10.1002/jso.20944; Lee JM., 2018, DIS ABDOMEN PELVIS 2, P49, DOI 10.1007/978-3-319-75019-4_5; Liu KJM, 1997, SURGERY, V122, P748, DOI 10.1016/S0039-6060(97)90083-0; Lohe F, 2009, EUR J MED RES, V14, P345; Onoyama H, 1999, WORLD J SURG, V23, P708, DOI 10.1007/PL00012373; Silecchia Gianfranco, 2002, JSLS, V6, P339; Soreide K, 2019, BRIT J SURG, V106, P32, DOI 10.1002/bjs.11035; THORBJARNARSON B, 1960, ANN SURG, V151, P241, DOI 10.1097/00000658-196002000-00013; Weinstein D, 2002, ISRAEL MED ASSOC J, V4, P334; Xu Xie-qun, 2013, Chinese Medical Sciences Journal, V28, P102; Yamaguchi K, 1996, ARCH SURG-CHICAGO, V131, P981; Yokoe M, 2018, J HEPATO-BIL-PAN SCI, V25, P41, DOI 10.1002/jhbp.515; Zhong H, 2019, AM SURGEON, V85, P671; Zhu JQ, 2015, HEPATOB PANCREAT DIS, V14, P96, DOI 10.1016/S1499-3872(14)60292-7	23	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239178	10.1371/journal.pone.0239178	http://dx.doi.org/10.1371/journal.pone.0239178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946469	Green Published, gold			2022-12-26	WOS:000573851100045
J	Haynes, MS; Alder, KD; Bellamkonda, K; Kuzomunhu, L; Grauer, JN				Haynes, Monique S.; Alder, Kareme D.; Bellamkonda, Kirthi; Kuzomunhu, Lovemore; Grauer, Jonathan N.			Incidence, predictors, and timing of post-operative stroke following elective total hip arthroplasty and total knee arthroplasty	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; RISK-FACTORS; READMISSION; PREVALENCE; DATABASES; QUALITY; EVENTS; RATES	Background Postoperative stroke is a rare but potentially devastating complication following total hip arthroplasty (THA) and total knee arthroplasty (TKA). The purpose of the current study was to determine the incidence, independent risk factors, and timing of stroke following THA and TKA utilizing the National Surgical Quality Improvement (NSQIP) database. Methods Patients who underwent elective primary THA and TKA were identified in the 2005-2016 NSQIP database. Thirty-day postoperative strokes were identified, timing was characterized, and an incidence curve was created. Multivariate analyses determined the independent predictors of these strokes. Results Of 333,117 patients identified, 286 (0.09%) experienced a stroke. Given that THA vs TKA was not a univariate predictor of stroke, the two procedures were considered together. The majority (65%) of strokes occurred before discharge. Of the strokes observed, 25% occurred by postoperative day one, 50% by postoperative day two, and 75% by postoperative day nine. Independent risk factors for postoperative stroke were: age (60-69 years old odds ratio [OR] = 4.2; 70-79 years old OR = 8.1; <= 80 years old OR = 16.1), higher American Society of Anesthesiologists (ASA) score (ASA >= 3 OR = 1.7), and smoking [OR = 1.6). Conclusion The incidence of stroke after THA/TKA was low at 0.09%, with the majority occurring prior to discharge and half occurring by postoperative day two. Patients who were older, sicker, or who were smokers were at greater risk of postoperative stroke. These findings can be used to council patients and to optimize patient care.	[Haynes, Monique S.; Alder, Kareme D.; Bellamkonda, Kirthi; Grauer, Jonathan N.] Yale Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA; [Kuzomunhu, Lovemore] Univ Washington, Dept Surg, Seattle, WA USA	Yale University; University of Washington; University of Washington Seattle	Grauer, JN (corresponding author), Yale Sch Med, Dept Orthopaed & Rehabil, New Haven, CT 06510 USA.	jonathan.grauer@yale.edu		Grauer, Jonathan/0000-0002-2626-7278; Alder, Kareme/0000-0002-7796-4188	NIA NIH HHS [T35 AG049685] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alluri RK, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.10.49; Avram V, 2014, J ARTHROPLASTY, V29, P465, DOI 10.1016/j.arth.2013.07.039; Bateman BT, 2009, ANESTHESIOLOGY, V110, P231, DOI 10.1097/ALN.0b013e318194b5ff; Bohl DD, 2017, J ARTHROPLASTY, V32, P1991, DOI 10.1016/j.arth.2017.01.004; Bohl DD, 2016, J AM ACAD ORTHOP SUR, V24, P673, DOI 10.5435/JAAOS-D-15-00217; Faciszewski T, 1997, J BONE JOINT SURG AM, V79A, P1481, DOI 10.2106/00004623-199710000-00004; Jorgensen CC, 2016, THROMB RES, V138, P37, DOI 10.1016/j.thromres.2015.12.025; Kapadia BH, 2014, J ARTHROPLASTY, V29, P929, DOI 10.1016/j.arth.2013.09.017; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Minhas SV, 2016, CLIN ORTHOP RELAT R, V474, P611, DOI 10.1007/s11999-015-4496-2; Mortazavi SMJ, 2010, J BONE JOINT SURG AM, V92A, P2095, DOI 10.2106/JBJS.I.00940; Pedersen AB, 2014, BONE JOINT J, V96B, P479, DOI 10.1302/0301-620X.96B4.33209; Rasouli MR, 2016, J CLIN ANESTH, V34, P15, DOI 10.1016/j.jclinane.2016.03.034; Schairer WW, 2014, CLIN ORTHOP RELAT R, V472, P181, DOI 10.1007/s11999-013-3030-7; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Thornqvist C, 2014, ACTA ORTHOP, V85, P456, DOI 10.3109/17453674.2014.934184; Weiss A, 2015, JAMA SURG, V150, P815, DOI 10.1001/jamasurg.2015.0962	17	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239239	10.1371/journal.pone.0239239	http://dx.doi.org/10.1371/journal.pone.0239239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941539	Green Published, gold			2022-12-26	WOS:000573848800114
J	Naganuma, R; Yabe, I; Takeuchi, M; Morishita, K; Nakane, S; Takase, R; Takahashi-Iwata, I; Matsushima, M; Otsuki, M; Shiraishi, H; Sasaki, H				Naganuma, Ryoji; Yabe, Ichiro; Takeuchi, Megumi; Morishita, Kirari; Nakane, Shingo; Takase, Ryoken; Takahashi-Iwata, Ikuko; Matsushima, Masaaki; Otsuki, Mika; Shiraishi, Hideaki; Sasaki, Hidenao			Clinical factors affecting evoked magnetic fields in patients with Parkinson's disease	PLOS ONE			English	Article							INDUCED TRANSIENT POTENTIATION; RESPONSES; NERVE; HALLUCINATIONS; STIMULATION; MOVEMENT	Studies on evoked responses in Parkinson's disease (PD) may be useful for elucidating the etiology and quantitative evaluation of PD. However, in previous studies, the association between evoked responses and detailed motor symptoms or cognitive functions has not been clear. This study investigated the characteristics of the visual (VEF), auditory (AEF), and somatosensory (SEF) evoked magnetic fields in patients with Parkinson's disease (PD), and the correlations between evoked fields and the patient's clinical characteristics, motor symptoms, and cognitive functions. Twenty patients with PD and 10 healthy controls (HCs) were recruited as participants. We recorded VEF, AEF, and SEF, collected clinical characteristics, performed physical examinations, and administered 10 cognitive tests. We investigated differences in the latencies of the evoked fields between patients with PD and HCs. We also evaluated the correlation of the latencies with motor symptoms and cognitive functioning. There were significant differences between the two groups in 6 of the cognitive tests, all of which suggested mild cognitive impairment in patients with PD. The latencies of the VEF N75m, P100m, N145m, AEF P50m, P100m, and SEF P60m components were greater in the patients with PD than in the HCs. The latencies mainly correlated with medication and motor symptoms, less so with cognitive tests, with some elements of the correlations remaining significant after Bonferroni correction. In conclusion, the latencies of the VEF, AEF, and SEF were greater in PD patients than in HCs and were mainly correlated with medication and motor symptoms rather than cognitive functioning. Findings from this study suggest that evoked fields may reflect basal ganglia functioning and are candidates for assessing motor symptoms or the therapeutic effects of medication in patients with PD.	[Naganuma, Ryoji; Yabe, Ichiro; Takeuchi, Megumi; Takahashi-Iwata, Ikuko; Matsushima, Masaaki; Sasaki, Hidenao] Hokkaido Univ, Fac Med, Dept Neurol, Sapporo, Hokkaido, Japan; [Naganuma, Ryoji; Yabe, Ichiro; Takeuchi, Megumi; Takahashi-Iwata, Ikuko; Matsushima, Masaaki; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Morishita, Kirari] Hokkaido Univ Hosp, Div Lab & Transfus Med, Sapporo, Hokkaido, Japan; [Nakane, Shingo] Hokkaido Univ Hosp, Div Magnetoencephalog, Sapporo, Hokkaido, Japan; [Takase, Ryoken; Otsuki, Mika] Hokkaido Univ, Sch Med, Fac Hlth Sci, Grad Sch Hlth Sci,Dept Hlth Sci, Sapporo, Hokkaido, Japan; [Takase, Ryoken] Sapporo City Gen Hosp, Dept Radiat Technol, Sapporo, Hokkaido, Japan; [Shiraishi, Hideaki] Hokkaido Univ Hosp, Dept Pediat, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Sapporo City General Hospital; Hokkaido University	Yabe, I (corresponding author), Hokkaido Univ, Fac Med, Dept Neurol, Sapporo, Hokkaido, Japan.; Yabe, I (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.	yabe@med.hokudai.ac.jp		Naganuma, Ryoji/0000-0002-7720-0831; Matsushima, Masaaki/0000-0001-6585-3686	Ministry of Health, Welfare, and Labor, Japan; Ministry of Health, Welfare, and Labour, Japan	Ministry of Health, Welfare, and Labor, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Welfare, and Labour, Japan(Ministry of Health, Labour and Welfare, Japan)	IY received a grant by Ministry of Health, Welfare, and Labor, Japan (https://www.mhlw.go.jp/english/), there is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a Grant-in-Aid for the Research Committee of CNS Degenerative Diseases under Research on Measures for Intractable Diseases from the Ministry of Health, Welfare, and Labour, Japan. We thank Naoki Nishimoto, Ph.D., for advice regarding statistical analysis, Noriki Ochi for conducting MEG evaluations, Atsushi Shimojo for advice of MEG analysis, and Editage (www.editage.com) for English language editing.	[Anonymous], 1998, MED LETT DRUGS THER, V40, P25; [Anonymous], 2013, WOWR, V20, P1; BODISWOLLNER I, 1978, BRAIN, V101, P661, DOI 10.1093/brain/101.4.661; CALZETTI S, 1990, J NEUROL NEUROSUR PS, V53, P114, DOI 10.1136/jnnp.53.2.114; CHERON G, 1994, ELECTROEN CLIN NEURO, V92, P491, DOI 10.1016/0168-5597(94)90133-3; DAFNY N, 1975, EXP NEUROL, V49, P189, DOI 10.1016/0014-4886(75)90204-6; DESMEDT JE, 1985, ELECTROEN CLIN NEURO, V62, P1, DOI 10.1016/0168-5597(85)90030-9; Diederich NJ, 2009, NAT REV NEUROL, V5, P331, DOI 10.1038/nrneurol.2009.62; Drory VE, 1998, ACTA NEUROL SCAND, V97, P73; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujisawa Y, 2017, NAGOYA J MED SCI, V79, P147, DOI 10.18999/nagjms.79.2.147; Fujita K, 2006, JAPANESE VERSION WAI; Gittelman JX, 2013, JARO-J ASSOC RES OTO, V14, P719, DOI 10.1007/s10162-013-0405-0; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Japan Society for Higher Brain Dysfunction, 2014, STAND VERB PAIR LEAR; Japan Society for Higher Brain Dysfunction, 2003, VIS PERC TEST AG; Japan Society for Higher Brain Dysfunction Committee of Brain Function Test., 2006, CLIN ASS ATT CAT CLI; Kang SY, 2016, J MOV DISORD, V9, P35, DOI 10.14802/jmd.15038; Kuriki S, 1995, HEARING RES, V92, P47, DOI 10.1016/0378-5955(95)00195-6; Kurisaki H, 2009, J COGNITIVE NEUROSCI, V11, P220, DOI DOI 10.11253/NINCHISHINKEIKAGAKU.11.220; Maruyama T, 2000, Nihon Rinsho, V58, P2007; Matsui H, 2005, CLIN NEUROPHARMACOL, V28, P79, DOI 10.1097/01.wnf.0000157066.50948.65; Nagamine T, 1998, BRAIN RES, V791, P200, DOI 10.1016/S0006-8993(98)00095-X; Nakamura A, 1997, COGNITIVE BRAIN RES, V6, P9, DOI 10.1016/S0926-6410(97)00013-X; OKUDA B, 1995, ALZ DIS ASSOC DIS, V9, P68, DOI 10.1097/00002093-199509020-00002; Okuda B, 1992, Nihon Ronen Igakkai Zasshi, V29, P475; ONOFRJ M, 1986, J NEUROL NEUROSUR PS, V49, P1150, DOI 10.1136/jnnp.49.10.1150; Partington J. E., 1949, PSYCHOL SERVICE CTR, V1, P9; Pekkonen E, 1998, NEUROREPORT, V9, P2949, DOI 10.1097/00001756-199809140-00006; Postuma RB, 2015, MOVEMENT DISORD, V30, P1591, DOI 10.1002/mds.26424; Raven J.C., 1965, GUIDE USING COLOURED; ROSSINI PM, 1995, EVOKED POTENTIAL, V96, P236, DOI 10.1016/0168-5597(94)00292-M; ROSSINI PM, 1993, NEUROLOGY, V43, P2495, DOI 10.1212/WNL.43.12.2495; Rossini PM, 1998, CLIN NEUROSCI, V5, P121; Shigeto H, 1998, J NEUROL SCI, V156, P186, DOI 10.1016/S0022-510X(98)00026-4; Suzuki H., 2010, JPN J GERIAT PSYCHIA, V21, P198; Tachibana H, 1989, NEUROL MED, V31, P309; Tachibana H, 1988, JPN J CLIN PHYSL, V18, P429; Takeda M, 1993, Nihon Ronen Igakkai Zasshi, V30, P363; TAYLOR AE, 1986, BRAIN, V109, P845, DOI 10.1093/brain/109.5.845; Tinazzi M, 1999, J NEUROL SCI, V164, P163, DOI 10.1016/S0022-510X(99)00067-2; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tsutada T, 2003, CLIN ELECTROENCEPHAL, V45, P277; Uchiyama M, 2012, BRAIN, V135, P2458, DOI 10.1093/brain/aws126; Valeriani M, 1997, EVOKED POTENTIAL, V104, P60, DOI 10.1016/S0168-5597(96)96660-5; Virtanen J, 1998, EVOKED POTENTIAL, V108, P291, DOI 10.1016/S0168-5597(98)00006-9; 2013, HIST SPEAKING, V14, P29	49	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0232808	10.1371/journal.pone.0232808	http://dx.doi.org/10.1371/journal.pone.0232808			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941428	gold, Green Published, Green Submitted			2022-12-26	WOS:000573848800005
J	Nawka, MT; Hanning, U; Guerreiro, H; Flottmann, F; Van Horn, N; Buhk, JH; Fiehler, J; Frolich, AM				Nawka, Marie Teresa; Hanning, Uta; Guerreiro, Helena; Flottmann, Fabian; Van Horn, Noel; Buhk, Jan-Hendrik; Fiehler, Jens; Froelich, Andreas Maximilian			Feasibility of a customizable training environment for neurointerventional skills assessment	PLOS ONE			English	Article							THROMBECTOMY; MODEL	Objective To meet increasing demands to train neuroendovascular techniques, we developed a dedicated simulator applying individualized three-dimensional intracranial aneurysm models ('HANNES'; Hamburg Anatomic Neurointerventional Endovascular Simulator). We hypothesized that HANNES provides a realistic and reproducible training environment to practice coil embolization and to exemplify disparities between neurointerventionalists, thus objectively benchmarking operators at different levels of experience. Methods Six physicians with different degrees of neurointerventional procedural experience were recruited into a standardized training protocol comprising catheterization of two internal carotid artery (ICA) aneurysms and one basilar tip aneurysm, followed by introduction of one framing coil into each aneurysm and finally complete coil embolization of one determined ICA aneurysm. The level of difficulty increased with every aneurysm. Fluoroscopy was recorded and assessed for procedural characteristics and adverse events. Results Physicians were divided into inexperienced and experienced operators, depending on their experience with microcatheter handling. Mean overall catheterization times increased with difficulty of the aneurysm model. Inexperienced operators showed longer catheterization times (median; IQR: 47; 30-84s) than experienced operators (21; 13-58s, p = 0.011) and became significantly faster during the course of the attempts (rho = -0.493, p = 0.009) than the experienced physicians (rho = -0.318, p = 0.106). Number of dangerous maneuvers throughout all attempts was significantly higher for inexperienced operators (median; IQR: 1.0; 0.0-1.5) as compared to experienced operators (0.0; 0.0-1.0, p = 0.014). Conclusion HANNES represents a modular neurointerventional training environment for practicing aneurysm coil embolization in vitro. Objective procedural metrics correlate with operator experience, suggesting that the system could be useful for assessing operator proficiency.	[Nawka, Marie Teresa; Hanning, Uta; Guerreiro, Helena; Flottmann, Fabian; Van Horn, Noel; Buhk, Jan-Hendrik; Fiehler, Jens; Froelich, Andreas Maximilian] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Nawka, MT (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	m.nawka@uke.de	van Horn, Noel/AAW-5274-2020	van Horn, Noel/0000-0001-5764-1982; Hanning, Uta/0000-0002-7543-8555; Guerreiro, Helena/0000-0003-0221-8954	German Ministry for Education and Research (BMBF) [031L0068B]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Ministry for Education and Research (BMBF Grant 031L0068B). The sponsor encourages publication but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla AA, 2015, WORLD NEUROSURG, V83, P35, DOI 10.1016/j.wneu.2014.01.015; [Anonymous], 2018, PHYS TRAINING PROTOC; [Anonymous], 2019, VALIDATION STUDIES V; [Anonymous], 2019, EVALUATION MODULAR I; [Anonymous], 2013, SIMULATED DIAGNOSTIC; [Anonymous], 2018, UPDATE RAYMOND ROY O; [Anonymous], 2012, EFFECTIVENESS MECH E; [Anonymous], 2016, 3D PRINTING INTRACRA; [Anonymous], 2012, SIMULATOR BASED ANGI; [Anonymous], 2011, CEREBROVASCULAR BIOM; Bechstein M, 2021, CLIN NEURORADIOL, V31, P181, DOI 10.1007/s00062-019-00870-5; Bender MT, 2017, WORLD NEUROSURG, V106, P919, DOI [10.1016/J.WNEU.2017.07.074, 10.1016/j.wneu.2017.07.074]; Chan Y H, 2003, Singapore Med J, V44, P614; Chueh JY, 2013, STROKE, V44, P1396, DOI 10.1161/STROKEAHA.111.670463; Gruber A, 1997, MINIM INVAS NEUROSUR, V40, P121, DOI 10.1055/s-2008-1053431; Ihn YK, 2018, INTERV NEURORADIOL, V24, P237, DOI 10.1177/1591019918758493; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; Mokin M, 2015, J NEUROINTERV SURG, V7, P453, DOI 10.1136/neurintsurg-2014-011148; Reddy AS, 2021, J NEUROSURG, V134, P1190, DOI 10.3171/2020.1.JNS192732; Sorkin GC, 2014, NEUROSURGERY, V74, pS191, DOI 10.1227/NEU.0000000000000222; Sullivan S, 2018, J NEUROSURG-PEDIATR, V22, P672, DOI 10.3171/2018.6.PEDS17696; Wang JL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011103; Wortmann Nadine, 2019, T ADDITIVE MANUFACTU, V1, DOI [10.18416/AMMM.2019.1909S04T03, DOI 10.18416/AMMM.2019.1909S04T03]; Zhou G, 2017, NEUROSURG FOCUS, V42, DOI 10.3171/2017.3.FOCUS16450	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238952	10.1371/journal.pone.0238952	http://dx.doi.org/10.1371/journal.pone.0238952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941466	Green Published, gold			2022-12-26	WOS:000573848800064
J	Iwamiya, T; Segard, BD; Matsuoka, Y; Imamura, T				Iwamiya, Takahiro; Segard, Bertrand-David; Matsuoka, Yuimi; Imamura, Tomomi			Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis	PLOS ONE			English	Article							FACTOR RECEPTOR-BETA; CELL-ADHESION; MESENCHYMAL TRANSITION; MYOCARDIAL EDEMA; E-CADHERIN; ANGIOGENESIS; GROWTH; FIBROSIS; TISSUE; PROLIFERATION	Cardiovascular diseases are a leading cause of death worldwide. After an ischemic injury, the myocardium undergoes severe necrosis and apoptosis, leading to a dramatic degradation of function. Numerous studies have reported that cardiac fibroblasts (CFs) play a critical role in heart function even after injury. However, CFs present heterogeneous characteristics according to their development stage (i.e., fetal or adult), and the molecular mechanisms by which they maintain heart function are not fully understood. The aim of this study is to explore the hypothesis that a specific population of CFs can repair the injured myocardium in heart failure following ischemic infarction, and lead to a significant recovery of cardiac function. Flow cytometry analysis of CFs defined two subpopulations according to their relative expression of vascular cell adhesion molecule 1 (VCAM1). Whole-transcriptome analysis described distinct profiles for these groups, with a correlation between VCAM1 expression and lymphangiogenesis-related genes up-regulation. Vascular formation assays showed a significant stimulation of lymphatic cells network complexity by VCFs. Injection of human VCAM1-expressing CFs (VCFs) in postinfarct heart failure rat models (ligation of the left anterior descending artery) led to a significant restoration of the left ventricle contraction. Over the course of the experiment, left ventricular ejection fraction and fractional shortening increased by 16.65% +/- 5.64% and 10.43% +/- 6.02%, respectively, in VCF-treated rats. Histological examinations revealed that VCFs efficiently mobilized the lymphatic endothelial cells into the infarcted area. In conclusion, human CFs present heterogeneous expression of VCAM1 and lymphangiogenesis-promoting factors. VCFs restore the mechanical properties of ventricular walls by mobilizing lymphatic endothelial cells into the infarct when injected into a rat heart failure model. These results suggest a role of this specific population of CFs in the homeostasis of the lymphatic system in cardiac regeneration, providing new information for the study and therapy of cardiac diseases.	[Iwamiya, Takahiro; Segard, Bertrand-David; Matsuoka, Yuimi; Imamura, Tomomi] Metcela Inc, Res & Dev Dept, Kawasaki, Kanagawa, Japan; [Iwamiya, Takahiro] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Keio University	Iwamiya, T (corresponding author), Metcela Inc, Res & Dev Dept, Kawasaki, Kanagawa, Japan.; Iwamiya, T (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	t.iwamiya@metcela.com	Ségard, Bertrand-David/B-8251-2015	Ségard, Bertrand-David/0000-0001-8972-9786; Iwamiya, Takahiro/0000-0001-6616-1104	New Energy and Industrial Technology Development Organization (NEDO)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This research was funded by grants from New Energy and Industrial Technology Development Organization (NEDO), as described in the source of funding; research expenses and labor costs are paid from these grants. Therefore, the funder did not play a role in our study.	[Anonymous], 2012, REGEN MED S3, V7, pS14; Bernatchez PN, 2002, J CELL BIOCHEM, V85, P629, DOI 10.1002/jcb.10155; Blanton RM, 2019, AM J PHYSIOL-HEART C, V317, pH124, DOI 10.1152/ajpheart.00028.2019; Brakenhielm E, 2019, NAT REV CARDIOL, V16, P56, DOI 10.1038/s41569-018-0087-8; Breckwoldt K, 2016, BBA-MOL CELL RES, V1863, P1749, DOI 10.1016/j.bbamcr.2015.11.010; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Chen XX, 2016, BIOMED RES INT, V2016, P2016, DOI DOI 10.1155/2016/1654623; Christie JD, 2008, CRIT CARE MED, V36, P2794, DOI 10.1097/CCM.0b013e318186b843; Conroy KP, 2016, CELL TISSUE RES, V365, P511, DOI 10.1007/s00441-016-2407-9; Deschamps Anne M, 2005, Curr Heart Fail Rep, V2, P10, DOI 10.1007/s11897-005-0002-6; Diaz-Araya G, 2015, PHARMACOL RES, V101, P30, DOI 10.1016/j.phrs.2015.07.001; Djordjevic S, 2013, DRUG DISCOV TODAY, V18, P447, DOI 10.1016/j.drudis.2012.11.013; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; El-Chemaly Souheil, 2009, Lymphatic Research and Biology, V7, P197, DOI 10.1089/lrb.2009.0014; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; FUJISAKI H, 1995, J CLIN INVEST, V96, P1059, DOI 10.1172/JCI118092; Furtado MB, 2016, DEVELOPMENT, V143, P387, DOI 10.1242/dev.120576; Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Hall KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031794; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Huang Li-Hao, 2017, JACC Basic Transl Sci, V2, P477, DOI 10.1016/j.jacbts.2017.02.005; Ina K, 1997, AM J GASTROENTEROL, V92, P1342; Iseoka H, 2018, TISSUE ENG PT A, V24, P287, DOI [10.1089/ten.tea.2016.0535, 10.1089/ten.TEA.2016.0535]; Iwamiya T, 2016, REGEN THER, V4, P92, DOI 10.1016/j.reth.2016.01.005; Jamal S, 2002, J CLIN INVEST, V110, P443, DOI 10.1172/JCI200213729; Jimenez-Tellez N, 2019, WORLD J CARDIOL, V11, P221, DOI 10.4330/wjc.v11.i10.221; Jitariu AA, 2015, ARCH MED SCI, V11, P57, DOI 10.5114/aoms.2015.49217; Jurisic G, 2010, EXP CELL RES, V316, P2982, DOI 10.1016/j.yexcr.2010.06.013; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Kobayashi S, 2007, CANCER SCI, V98, P726, DOI 10.1111/j.1349-7006.2007.00439.x; Koga T, 1998, BRIT J PHARMACOL, V123, P1409, DOI 10.1038/sj.bjp.0701742; Krainock M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020027; Kumar A, 2016, TUMOR BIOL, V37, P11611, DOI 10.1007/s13277-016-5112-0; Kurashige C, 2014, FASEB J, V28, P1237, DOI 10.1096/fj.13-238998; KWEE L, 1995, DEVELOPMENT, V121, P489; LAINE GA, 1991, CIRC RES, V68, P1713, DOI 10.1161/01.RES.68.6.1713; LAINE GA, 1985, AM J PHYSIOL, V249, pH834, DOI 10.1152/ajpheart.1985.249.4.H834; Liu YW, 2018, NAT BIOTECHNOL, V36, P597, DOI 10.1038/nbt.4162; Magnusson PU, 2007, ARTERIOSCL THROM VAS, V27, P2142, DOI 10.1161/01.ATV.0000282198.60701.94; Masuda S, 2018, BIOMATERIALS, V166, P109, DOI 10.1016/j.biomaterials.2018.03.002; Matsuura K, 2011, BIOMATERIALS, V32, P7355, DOI 10.1016/j.biomaterials.2011.05.042; Matsuura K, 2009, J CLIN INVEST, V119, P2204, DOI 10.1172/JCI37456; Miyazaki H, 2014, CANCER SCI, V105, P1116, DOI 10.1111/cas.12476; Moore-Morris T, 2016, J MOL CELL CARDIOL, V91, P1, DOI 10.1016/j.yjmcc.2015.12.031; Morikawa M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021873; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Muraoka N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08626-y; Nassar Zeyad D, 2015, Oncoscience, V2, P635; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perkhofer L, 2016, STEM CELL RES, V17, P367, DOI 10.1016/j.scr.2016.08.007; Pop S, 2011, INT SPR SEM ELECT TE, P414, DOI 10.1109/ISSE.2011.6053898; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Saban MR, 2010, AM J PHYSIOL-RENAL, V299, pF1245, DOI 10.1152/ajprenal.00352.2010; Sanchez-Alonso S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02799; Shimizu Y, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009565; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; SIMMONS PJ, 1991, BLOOD, V78, P55; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Tahir AA, 2009, CANCER BIOL THER, V8, P2286; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tang H, 2002, J BIOL CHEM, V277, P5441, DOI 10.1074/jbc.M110673200; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Teo Z, 2017, ONCOGENE, V36, P6408, DOI 10.1038/onc.2017.244; Trincot CE, 2019, CIRC RES, V124, P101, DOI 10.1161/CIRCRESAHA.118.313835; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wang XW, 2015, J MOL CELL CARDIOL, V80, P101, DOI 10.1016/j.yjmcc.2015.01.001; Werner JH, 2019, TRANSL RES, V203, P73, DOI 10.1016/j.trsl.2018.07.012; Widyantoro B, 2010, CIRCULATION, V121, P2407, DOI 10.1161/CIRCULATIONAHA.110.938217; Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; YANG JT, 1995, DEVELOPMENT, V121, P549; Yu P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134666; Zamani M, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00147; Zhang EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103440; Zhang K, 2015, WORLD J GASTROENTERO, V21, P878, DOI 10.3748/wjg.v21.i3.878	81	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0237810	10.1371/journal.pone.0237810	http://dx.doi.org/10.1371/journal.pone.0237810			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936824	Green Published, gold			2022-12-26	WOS:000573658000035
J	Nio, Y; Ookawara, M; Yamasaki, M; Hanauer, G; Tohyama, K; Shibata, S; Sano, T; Shimizu, F; Anayama, H; Hazama, M; Matsuo, T				Nio, Yasunori; Ookawara, Mitsugi; Yamasaki, Midori; Hanauer, Guido; Tohyama, Kimio; Shibata, Sachio; Sano, Tomoya; Shimizu, Fumi; Anayama, Hisashi; Hazama, Masatoshi; Matsuo, Takanori			Ameliorative effect of phosphodiesterase 4 and 5 inhibitors in deoxycorticosterone acetate-salt hypertensive uni-nephrectomized KKA(y)mice	FASEB JOURNAL			English	Article						deoxycorticosterone acetate-salt hypertensive KKA(y)mouse; diabetic nephropathy; hypertension; phosphodiesterase 4; phosphodiesterase 5; uni-nephrectomy	PDE4 INHIBITORS; MOLECULAR-MECHANISMS; EJECTION FRACTION; HEART-FAILURE; RENAL INJURY; KIDNEY; ROFLUMILAST; RESVERATROL; PROGRESSION; SILDENAFIL	Diabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD). Hypertension increases kidney stress, which deteriorates function, and leads to peripheral renal vascular resistance. Long-term hypoperfusion promotes interstitial fibrosis and glomerular sclerosis, resulting in nephrosclerosis. Although hypertension and DN are frequent ESRD complications, relevant animal models remain unavailable. We generated a deoxycorticosterone acetate (DOCA)-salt hypertensive uni-nephrectomized (UNx) KKA(y)mouse model demonstrating hypertension, hyperglycemia, cardiac hypertrophy, kidney failure, increased urinary albumin creatinine ratio (UACR), and increased renal PDE4D and cardiac PDE5A mRNA levels. We hypothesized that the novel PDE4 selective inhibitor, compound A, and PDE5 inhibitor, sildenafil, exhibit nephroprotective, and cardioprotective effects in this new model. Compound A, sildenafil, and the angiotensin II receptor blocker, irbesartan, significantly reduced ventricular hypertrophy and pleural effusion volume. Meanwhile, compound A and sildenafil significantly suppressed the UACR, urinary kidney injury molecule-1, and monocyte chemoattractant protein-1 levels, as well as that of renal pro-fibrotic marker mRNAs, including collagen 1A1, fibronectin, and transforming growth factor-beta (TGF-beta). Moreover, compound A significantly suppressed TGF-beta-induced pro-fibrotic mRNA expression in vitro in all major kidney lesions, including within the glomerular mesangial region, podocytes, and epithelial region. Hence, PDE4 and PDE5 inhibitors may be promising treatments, in combination with irbesartan, for DN with hypertension as they demonstrate complementary mechanisms.	[Nio, Yasunori; Ookawara, Mitsugi; Yamasaki, Midori; Hazama, Masatoshi; Matsuo, Takanori] Takeda Pharmaceut Co Ltd, Extra Value Generat & Gen Med DDU, 26-1 Muraoka Higashi,2 Chome, Fujisawa, Kanagawa 2518555, Japan; [Hanauer, Guido] Takeda Pharmaceut Co Ltd, Takeda Pharmaceut Int AG, Fujisawa, Kanagawa, Japan; [Tohyama, Kimio; Shibata, Sachio] Takeda Pharmaceut Co Ltd, Drug Metab & Pharmacokinet Res Labs, Fujisawa, Kanagawa, Japan; [Sano, Tomoya; Shimizu, Fumi; Anayama, Hisashi] Takeda Pharmaceut Co Ltd, Drug Safety Res Labs, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Nio, Y (corresponding author), Takeda Pharmaceut Co Ltd, Extra Value Generat & Gen Med DDU, 26-1 Muraoka Higashi,2 Chome, Fujisawa, Kanagawa 2518555, Japan.	yasunori.nio@takeda.com	Nio, Yasunori/AFE-2456-2022		Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.)	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.)	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.)	Aoki M, 2000, J PHARMACOL EXP THER, V295, P255; Azevedo MF, 2014, ENDOCR REV, V35, P195, DOI 10.1210/er.2013-1053; Bae EH, 2012, KIDNEY BLOOD PRESS R, V36, P248, DOI 10.1159/000343414; Chertow GM, 2016, J AM SOC NEPHROL, V27, P40, DOI 10.1681/ASN.2015101125; Choi DE, 2009, AM J PHYSIOL-RENAL, V297, pF362, DOI 10.1152/ajprenal.90609.2008; Czirok S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10125-3; Fang L, 2013, NEPHROL DIAL TRANSPL, V28, P1751, DOI 10.1093/ndt/gfs391; Gentile G, 2014, EXPERT OPIN EMERG DR, V19, P571, DOI 10.1517/14728214.2014.979151; Giembycz MA, 2010, DRUG DES DEV THER, V4, P147; Gong KZ, 2011, MOL ENDOCRINOL, V25, P1794, DOI 10.1210/me.2011-1009; Guabiraba R, 2010, EUR J PHARMACOL, V633, P85, DOI 10.1016/j.ejphar.2010.01.021; Hajhosseiny R, 2014, EXPERT OPIN INV DRUG, V23, P511, DOI 10.1517/13543784.2014.892580; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Insel PA, 2012, BRIT J PHARMACOL, V166, P447, DOI 10.1111/j.1476-5381.2012.01847.x; Iordache AM, 2020, FOOD CHEM TOXICOL, V143, DOI 10.1016/j.fct.2020.111535; Jeong KH, 2009, AM J NEPHROL, V29, P274, DOI 10.1159/000158635; Kim KH, 2015, AM HEART J, V169, P813, DOI 10.1016/j.ahj.2015.03.018; Krishnan SM, 2019, CARDIOVASC RES, V115, P776, DOI 10.1093/cvr/cvy252; Leelahavanichkul A, 2010, KIDNEY INT, V78, P1136, DOI 10.1038/ki.2010.287; Liang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep28715; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Matyas C, 2017, EUR J HEART FAIL, V19, P326, DOI 10.1002/ejhf.711; Mehanna OM, 2018, ARCH PHYSIOL BIOCHEM, V124, P424, DOI 10.1080/13813455.2017.1419267; Mennuni S, 2014, J HUM HYPERTENS, V28, P74, DOI 10.1038/jhh.2013.55; Nio Y, 2017, FASEB J, V31, P5307, DOI 10.1096/fj.201700249R; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Peng HM, 2001, HYPERTENSION, V37, P974, DOI 10.1161/01.HYP.37.3.974; Pofi R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44584; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Radovits T, 2009, BRIT J PHARMACOL, V156, P909, DOI 10.1111/j.1476-5381.2008.00098.x; Randi EB, 2020, ANTIOXID REDOX SIGN, V32, P1155, DOI 10.1089/ars.2019.7868; Rodriguez-Iturbe B, 2005, KIDNEY INT, V68, P2131, DOI 10.1111/j.1523-1755.2005.00669.x; Ruzicka M, 2014, J HYPERTENS, V32, P1388, DOI 10.1097/HJH.0000000000000182; Sanz MJ, 2005, PHARMACOL THERAPEUT, V106, P269, DOI 10.1016/j.pharmthera.2004.12.001; Schinner E, 2015, INT J MOL SCI, V16, P2320, DOI 10.3390/ijms16022320; Sisson TH, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13753; Song K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159872; Tahara A, 2018, EUR J PHARMACOL, V830, P68, DOI 10.1016/j.ejphar.2018.04.024; Tian M, 2018, AM J PHYSIOL-RENAL, V315, pF558, DOI 10.1152/ajprenal.00137.2018; Togo S, 2009, AM J PHYSIOL-LUNG C, V296, pL959, DOI 10.1152/ajplung.00508.2007; Vollert S, 2012, DIABETOLOGIA, V55, P2779, DOI 10.1007/s00125-012-2632-z; Wouters EFM, 2012, J CLIN ENDOCR METAB, V97, pE1720, DOI 10.1210/jc.2011-2886; Xu M, 2020, AM J PHYSIOL-RENAL, V318, pF576, DOI 10.1152/ajprenal.00477.2019; Xu W, 2015, CLIN EXP PHARMACOL P, V42, P1075, DOI 10.1111/1440-1681.12459; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	45	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14997	15014		10.1096/fj.202001084R	http://dx.doi.org/10.1096/fj.202001084R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939821	Bronze			2022-12-26	WOS:000572318600001
J	Crosby, S; Younie, S; Williamson, I; Laird, K				Crosby, Sapphire; Younie, Sarah; Williamson, Iain; Laird, Katie			Evaluating approaches to designing effective Co-Created hand-hygiene interventions for children in India, Sierra Leone and the UK	PLOS ONE			English	Article							RISK; COMMUNITY	Effective and culturally appropriate hand-hygiene education is essential to promote health-related practices to control and prevent diseases such as Diarrhoea, Ebola and COVID-19. In this paper we outline and evaluate the Co-Creation processes underpinning a handwashing intervention for young children (A Germ's Journey) developed and delivered in India, Sierra Leone and the UK, and consider the implications surrounding Imperialist/Colonial discourse and the White Saviour Complex. The paper focuses both on the ways Co-Creation was conceptualised by our collaborators in all three countries and the catalysts and challenges encountered. Qualitative data have been drawn from in-depth interviews with five key stakeholders, focus group data from 37 teachers in Sierra Leone and responses to open-ended questionnaires completed by teachers in India (N = 66) and UK (N = 63). Data were analysed using thematic analysis and three themes, each with three constituent subthemes are presented. In the theme 'Representations of and Unique Approaches to Co-Creation' we explore the ways in which Co-Creation was constructed in relation to teamwork, innovative practice and more continuous models of evaluation. In 'Advantages of Co-Creation' we consider issues around shared ownership, improved outcomes and more meaningful insights alongside the mitigation of risks and short-circuiting of problems. In 'Challenges of Co-Creation' we discuss issues around timing and organisation, attracting and working with appropriate partners and understanding the importance of local context with inherent social, economic and structural barriers, especially in low-and-middle-income countries. We consider how theoretical elements of Co-Creation can inform effective international public health interventions; crucial during a global pandemic in which handwashing is the most effective method to control the transmission of COVID-19. Finally we reflect on some of the methodological challenges of our own work and in managing the potentially conflicting goals of the ethical and participatory values of Co-Creation with pragmatic considerations about ensuring an effective final 'product'.	[Crosby, Sapphire; Younie, Sarah] De Montfort Univ, Inst Res Criminol Commun Educ & Social Justice, Leicester, Leics, England; [Williamson, Iain] De Montfort Univ, Inst Psychol Sci, Leicester, Leics, England; [Laird, Katie] De Montfort Univ, Leicester Inst Pharmaceut Innovat, Infect Dis Res Grp, Leicester, Leics, England	De Montfort University; De Montfort University; De Montfort University	Crosby, S (corresponding author), De Montfort Univ, Inst Res Criminol Commun Educ & Social Justice, Leicester, Leics, England.	p13212007@my365.dmu.ac.uk		Younie, Sarah/0000-0001-8981-6476; Laird, Katie/0000-0001-7187-0415; Crosby, Sapphire/0000-0002-8423-2356	Faculty of Health and Life Sciences, De Montfort University	Faculty of Health and Life Sciences, De Montfort University	The authors received funding for this work from the Faculty of Health and Life Sciences, De Montfort University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; Allen R. L., 2001, EDUC THEORY, V51, DOI DOI 10.1111/J.1741-5446.2001.00467.X; [Anonymous], 2013, MUSLIM MAGAZINE, V4, P28; Aronson B.A., 2017, J CRITICAL THOUGHT P, V6, P36, DOI [10.31274/jctp-180810-83, DOI 10.31274/JCTP-180810-83]; Bendapudi N, 2003, J MARKETING, V67, P14, DOI 10.1509/jmkg.67.1.14.18592; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; British Educational Research Association [BERA], 2018, ETH GUID RES, V4th; Cairncross S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P771; Chandler D., 2003, ACTION RES, V1, P133, DOI [10.1177/14767503030012002, DOI 10.1177/14767503030012002]; Cole Teju, 2012, ATLANTIC; Crosby S, 2019, HLTH ED J, V79, P123; Crosby S, 2019, INT J EARLY YEARS ED, V27, P374, DOI 10.1080/09669760.2019.1628010; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Curtis V, 2011, LANCET INFECT DIS, V11, P312, DOI 10.1016/S1473-3099(10)70224-3; Dewey J., 1916, DEMOCRACY ED; Ehlen CG, 2015, COCREATION INNOVATIO, P111; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub3; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Freeman MC, 2013, AM J TROP MED HYG, V89, P875, DOI 10.4269/ajtmh.13-0237; Freiere P, 1972, PLACE PUBLICATION NO; Gao J, 2020, PLOS ONE, V15; Gillis A, 2002, RES NURSES METHODS I; Greenland K, 2013, TROPICAL MED INT HLT; Haque N, 2019, CAN GERIATR J, V22, P1, DOI 10.5770/cgj.22.266; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; hooks bell., 1994, TEACHING TRANSGRESS; Hopkins N, 2018, EDUC 3-13, V46, P433, DOI 10.1080/03004279.2018.1445477; Jansen S., 2017, 7 PRINCIPLES COMPLET; Kambil A, 1999, OUTLOOK, V2, P38; Kambil A, 1996, IS9621 STERN NYU, P1; Kumar R., 2011, RES METHODOLOGY STEP, V3rd; Laird K, 2017, GERMS JOURNEY DIRTY; Leask CF., 2019, RES INVOLV ENGAGEM, V5, P1, DOI [10.1186/s40900-018-0136-9, DOI 10.1186/S40900-018-0136-9]; Lombardo S, 2017, IND MARKET MANAG, V61, P155, DOI 10.1016/j.indmarman.2016.06.005; Lukman H., 2014, J ARG SCI, V15, P11; MacDonald C, CANADIAN J ACTION RE, V13, P34; Mcfadden SM, 2020, PLOS ONE, P1; McNiff J, 2014, ALL YOU NEED KNOW AC; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Reason P., 2008, SAGE HDB ACTION; Seidman Irving., 2019, INTERVIEWING QUALITA, V5th; The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209; UNICEF, 2019, DIARRH DIS; Vollman A.R., 2004, CANADIAN COMMUNITY P; WHO, 2019, INF PREV CONTR EV CL; Younie S, PLOS ONE	46	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239234	10.1371/journal.pone.0239234	http://dx.doi.org/10.1371/journal.pone.0239234			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU1BO	32931509	gold, Green Published			2022-12-26	WOS:000573375500029
J	Cheong, AT; Tong, SF; Chinna, K; Khoo, EM; Liew, SM				Cheong, Ai Theng; Tong, Seng Fah; Chinna, Karuthan; Khoo, Ee Ming; Liew, Su May			Gender differences in factors influencing intention to undergo cardiovascular disease health checks: A cross-sectional survey	PLOS ONE			English	Article							SEEKING BEHAVIOR; REASONED ACTION; SEX-DIFFERENCES; HELP-SEEKING; CARE; MEN; MASCULINITY; PREVENTION; ATTENDANCE; COUNTRIES	Background Undergo a health check for cardiovascular disease (CVD) is an important strategy to improve cardiovascular (CV) health. Men are reported to be less likely to undergo cardiovascular disease (CVD) health check than women. Gender difference could be one of the factors influencing health seeking behaviour of men and women. We aimed to identify gender differences in factors influencing the intention to undergo CVD health checks. Methods This was a cross-sectional survey using mall intercept interviews. Malaysians aged >= 30 years without known CVD were recruited. They were asked for their intention to undergo CVD health checks and associated factors. The factors included seven internal factors that were related to individuals' attitude, perception and preparedness for CVD health checks and two external factors that were related to external resources. Hierarchical ordinal regression analysis was used to evaluate the importance of the factors on intention to undergo CVD health checks, for men and women separately. Results 397 participants were recruited, 60% were women. For men, internal factors explained 31.6% of the variances in likeliness and 9.6% of the timeline to undergo CVD health checks, with 1.2% and 1.8% added respectively when external factors were sequentially included. For women, internal factors explained 18.9% and 22.1% of the variances, with 3.1% and 4.2% added with inclusion of the external factors. In men, perceived drawbacks of health checks was a significant negative factor associated with likeliness to undergo CVD health checks (coefficient = -1.093; 95%CI:-1.592 to -0.594), and timeline for checks (coefficient = -0.533; 95%CI:-0.975 to -0.091). In women, readiness to handle outcomes following health checks was significantly associated with likeliness to undergo the checks (coefficient = 0.575; 95%CI: 0.063 to 1.087), and timeline for checks (coefficient = 0.645; 95%CI: 0.162 to 1.128). Both external factors 1) influence by significant others (coefficient = 0.406; 95%CI: 0.013 to 0.800) and 2) external barriers (coefficient = -0.440; 95%CI:-0.869 to -0.011) were also significantly associated with likeliness to undergo CVD health checks in women. Conclusions Both men and women were influenced by internal factors in their intention to undergo CVD health checks, and women were also influenced by external factors. Interventions to encourage CVD health checks need to focus on internal factors and be gender sensitive.	[Cheong, Ai Theng] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia; [Tong, Seng Fah] Univ Kebangsaan Malaysia, Fac Med, Dept Family Med, Kuala Lumpur, Malaysia; [Chinna, Karuthan] Taylors Univ Malaysia, Fac Hlth & Med Sci, Sch Med, Subang Jaya, Malaysia; [Khoo, Ee Ming; Liew, Su May] Univ Malaya, Univ Malaya Primary Care Res Grp UMPCRG, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia	Universiti Putra Malaysia; Universiti Kebangsaan Malaysia; Universiti Malaya	Cheong, AT (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang, Selangor, Malaysia.	cheaitheng@upm.edu.my	KHOO, EE MING/B-8785-2010; Cheong, Ai Theng/H-9884-2014	KHOO, EE MING/0000-0003-3191-1264; Cheong, Ai Theng/0000-0002-3895-530X	University of Malaya Postgraduate Research Fund [PG049-2014A]	University of Malaya Postgraduate Research Fund(Universiti Malaya)	Financial support of this study was provided by University of Malaya Postgraduate Research Fund (PG049-2014A) via EMK. The funder have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. (URL of funder website: https://umresearch.um.edu.my/fundingopportunities-information).	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Aris T, 2015, NATL HLTH MORBIDITY, VII; Armitage CJ, 2002, BRIT J HEALTH PSYCH, V7, P299, DOI 10.1348/135910702760213698; Artac M, 2013, FAM PRACT, V30, P426, DOI 10.1093/fampra/cmt002; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Bunten A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-019-7889-4; Cheong AT, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-016-0579-8; Cheong AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201931; Cheong AT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188259; Cheong AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159438; Cook EJ, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0303-2; Cooke R, 2008, PSYCHOL HEALTH, V23, P745, DOI 10.1080/08870440701544437; CORNEY RH, 1990, J PSYCHOSOM RES, V34, P525, DOI 10.1016/0022-3999(90)90027-2; Courtenay W. H., 2003, International Journal of Men's Health, V2, P1, DOI 10.3149/jmh.0201.1; Dalton ARH, 2011, J PUBLIC HEALTH-UK, V33, P422, DOI 10.1093/pubmed/fdr034; Dryden R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-723; Fishbein M, 2008, MED DECIS MAKING, V28, P834, DOI 10.1177/0272989X08326092; Forster AS, 2016, J PUBLIC HEALTH-UK, V38, P552, DOI 10.1093/pubmed/fdv119; Gabriel S, 1999, J PERS SOC PSYCHOL, V77, P642, DOI 10.1037/0022-3514.77.3.642; Galdas Paul, 2007, J Health Serv Res Policy, V12, P223, DOI 10.1258/135581907782101552; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Hoy S., 2012, International Journal of Men's Health, V11, P202, DOI 10.3149/jmh.1103.202; Hozawa A, 2010, PREV MED, V51, P397, DOI 10.1016/j.ypmed.2010.08.017; Hsu HY, 2001, J ADV NURS, V35, P864, DOI 10.1046/j.1365-2648.2001.01924.x; Institute for Public Health (IPH), 2011, NAT HLTH MORB SURV 2, VIII; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Juel K, 2008, J PUBLIC HEALTH-UK, V30, P111, DOI 10.1093/pubmed/fdm072; Lee H, 2015, PREV MED, V70, P19, DOI 10.1016/j.ypmed.2014.11.007; Liang WC, 1999, AM J PREV MED, V17, P8, DOI 10.1016/S0749-3797(99)00040-9; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mahalik JR, 2007, SOC SCI MED, V64, P2201, DOI 10.1016/j.socscimed.2007.02.035; Men Keogh E., 2015, PAIN, V156, P2408, DOI [10.1097/j.pain.0000000000000328, DOI 10.1097/J.PAIN.0000000000000328]; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Noguchi R, 2019, HEALTH POLICY, V123, P360, DOI 10.1016/j.healthpol.2018.10.013; Osamor PE, 2016, INT J WOMENS HEALTH, V8, P191, DOI 10.2147/IJWH.S105483; Petter J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1379-0; Robertson S, 2006, HEALTH, V10, P175, DOI 10.1177/1363459306061787; Seah S. T. A., 2005, SMJ Singapore Medical Journal, V46, P210; SOCSO, SOCSO HLTH SCREEN PR; SOCSO, 2016, SOCSO HLTH SCREEN PR; Stoverinck MJM, 1996, J FAM PRACTICE, V43, P567; Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0; Van der Meer V, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-29; World Health Organization, 2016, PROJ MORT CAUS DEATH; Zikmund W.G., 2010, BUSINESS RES METHODS	48	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239679	10.1371/journal.pone.0239679	http://dx.doi.org/10.1371/journal.pone.0239679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970741	gold, Green Published, Green Accepted			2022-12-26	WOS:000576265600039
J	Rohr, AD; Schimmel, J; Liu, BY; Beerhues, L; Guggenberger, G; Winkelmann, T				Rohr, Annmarie-Deetja; Schimmel, Jessica; Liu, Benye; Beerhues, Ludger; Guggenberger, Georg; Winkelmann, Traud			Identification and validation of early genetic biomarkers for apple replant disease	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; FRUIT-TREES; SOIL; ETHYLENE; PLANT; PHYTOALEXINS; RESISTANCE; BIPHENYL; GROWTH; ROOTS	Apple replant disease (ARD) is a serious threat to producers of apple trees and fruits worldwide. The ARD etiology is not unraveled and managing options are either economically not applicable or environmentally harmful. Thus, interest is given in biomarkers that allow to indicate ARD situations at early time points in order to classify soils according to ARD severity but also to analyze the effectiveness to potential countermeasures. This study aimed at (i) identifying ARD biomarkers on the transcriptional level in root tissue by analyzing the expression of previously identified candidate genes in ARD soils of different origin and texture and (ii) testing the specificity of these marker genes to ARD. In vitro propagated M26 plantlets were submitted to a bio-test with three ARD soils, either untreated or disinfected by gamma-irradiation. Expression of seven candidate genes identified in a previous transcriptomic study was investigated by RT-qPCR in a time course experiment. Already three days after planting, a prominent upregulation of the phytoalexin biosynthesis genesbiphenyl synthase 3 (BIS3) and biphenyl 4-hydroxylase (B4Hb) was observed in the untreated ARD variants of all three soils. The phytoalexin composition in roots was comparable for all three soils and the total phytoalexin content correlated with the expression of BIS3 and B4Hb. The third promising candidate gene that was upregulated under ARD conditions was the ethylene-responsive transcription factor 1B-like (ERF1B). In a second experiment M26 plantlets were exposed to different abiotic stressors, namely heat, salt and nutrient starvation, and candidate gene expression was determined in the roots. The expression levels of BIS3 and B4Hb were highly and specifically upregulated in ARD soil, but not upon the abiotic stress conditions, whereas ERF1B also showed higher expression under heat stress. In conclusion, BIS3 and B4Hb are recommended as early ARD biomarkers due to their high expression levels and their high specificity.	[Rohr, Annmarie-Deetja; Winkelmann, Traud] Leibniz Univ Hannover, Inst Hort Prod Syst, Woody Plant & Propagat Physiol Sect, Hannover, Germany; [Schimmel, Jessica; Guggenberger, Georg] Leibniz Univ Hannover, Inst Soil Sci, Hannover, Germany; [Liu, Benye; Beerhues, Ludger] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Braunschweig, Germany	Leibniz University Hannover; Leibniz University Hannover; Braunschweig University of Technology	Rohr, AD (corresponding author), Leibniz Univ Hannover, Inst Hort Prod Syst, Woody Plant & Propagat Physiol Sect, Hannover, Germany.	rohr@baum.uni-hannover.de		Rohr, Annmarie-Deetja/0000-0003-0251-4657	German Research Foundation (DFG) [GRK1798, BE 1174/19-1]; German Federal Ministry of Research and Education [031B0025B]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Research and Education	The work of ADR and TW was funded by the German Research Foundation (DFG, www.dfg.de) via the research training group GRK1798 "Signaling at the Plant-Soil Interface" and a grant to BL and LB (BE 1174/19-1). It was also part of the project BonaRes-ORDIAmur (JS, GG) funded by the German Federal Ministry of Research and Education (www.bmbf.de) within the frame of the program BonaRes (grant no. 031B0025B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ACTA PETROLEI SINICA, V24, P57; Berrocal-Lobo M, 2004, MOL PLANT MICROBE IN, V17, P763, DOI 10.1094/MPMI.2004.17.7.763; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; BRAUN PG, 1991, CAN J PLANT PATHOL, V13, P291, DOI 10.1080/07060669109500914; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Chizzali C, 2013, TREES-STRUCT FUNCT, V27, P477, DOI 10.1007/s00468-012-0808-2; Chizzali C, 2012, BEILSTEIN J ORG CHEM, V8, P613, DOI 10.3762/bjoc.8.68; Chizzali C, 2012, PHYTOCHEMISTRY, V77, P179, DOI 10.1016/j.phytochem.2012.01.023; Demidchik V, 2002, PLANT J, V32, P799, DOI 10.1046/j.1365-313X.2002.01467.x; DUNN RA, 1972, PLANT DIS REP, V56, P577; Franke-Whittle IH, 2015, PLANT SOIL, V395, P317, DOI 10.1007/s11104-015-2562-x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; GELDART HG, 1994, ACTA HORTIC, P11; GLAZENER JA, 1978, PHYTOPATHOLOGY, V68, P111, DOI 10.1094/Phyto-68-111; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Grunewaldt-Stocker G, 2019, SCI HORTIC-AMSTERDAM, V243, P583, DOI 10.1016/j.scienta.2018.09.014; Gullino M. L., 1993, Acta Horticulturae, P35; HARGREAVES JA, 1980, PHYSIOL PLANT PATHOL, V16, P351, DOI 10.1016/S0048-4059(80)80007-5; Hewavitharana SS, 2016, PHYTOPATHOLOGY, V106, P1015, DOI 10.1094/PHYTO-12-15-0329-R; Hewavitharana SS, 2014, EUR J PLANT PATHOL, V140, P39, DOI 10.1007/s10658-014-0442-5; HOESTRA H., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P286; Hoestra H., 1968, THESIS; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Isutsa DK, 2000, HORTSCIENCE, V35, P262, DOI 10.21273/HORTSCI.35.2.262; JAFFEE BA, 1982, PLANT DIS, V66, P942, DOI 10.1094/PD-66-942; Jeandet P, 2014, MOLECULES, V19, P18033, DOI 10.3390/molecules191118033; JONKERS H, 1980, SCI HORTIC-AMSTERDAM, V13, P149, DOI 10.1016/0304-4238(80)90079-5; Khalil MNA, 2015, PLANT J, V83, P263, DOI 10.1111/tpj.12885; Khalil MNA, 2013, PHYTOCHEMISTRY, V96, P101, DOI 10.1016/j.phytochem.2013.09.003; Komisji ds Czlonkowie, 2004, FOLIA CARDIOLOGIC SA, V11, pA32; Konietschke F, 2015, J STAT SOFTW, V64; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mahnkopp F, 2018, SCI HORTIC-AMSTERDAM, V241, P167, DOI 10.1016/j.scienta.2018.06.076; MAI WF, 1981, PLANT DIS, V65, P859, DOI 10.1094/PD-65-859; Manici LM, 2015, PLANT PATHOL, V64, P843, DOI 10.1111/ppa.12315; Manici LM, 2013, APPL SOIL ECOL, V72, P207, DOI 10.1016/j.apsoil.2013.07.011; Mao K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00480; Mazzola M, 1999, PHYTOPATHOLOGY, V89, P920, DOI 10.1094/PHYTO.1999.89.10.920; Mazzola M, 2014, ACTA HORTIC, V1044, P105, DOI 10.17660/ActaHortic.2014.1044.11; Mazzola M, 1998, PHYTOPATHOLOGY, V88, P930, DOI 10.1094/PHYTO.1998.88.9.930; Mazzola M, 2015, PHYTOPATHOLOGY, V105, P460, DOI 10.1094/PHYTO-09-14-0247-R; Mazzola M, 2012, ANNU REV PHYTOPATHOL, V50, P45, DOI 10.1146/annurev-phyto-081211-173005; Muller M, 2015, PLANT PHYSIOL, V169, P32, DOI 10.1104/pp.15.00677; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Onate-Sanchez L, 2002, PLANT PHYSIOL, V128, P1313, DOI 10.1104/pp.010862; PETERSON AB, 1994, ACTA HORTIC, P19; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; R Core Team, 2018, R LANG ENV STAT COMP; Radl V, 2019, ENVIRON MICROBIOME, V14, DOI 10.1186/s40793-019-0346-2; Reim S, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01724; Shin SB, 2016, PHYSIOL MOL PLANT P, V94, P16, DOI 10.1016/j.pmpp.2016.03.003; Spath M, 2015, J PHYTOPATHOL, V163, P287, DOI 10.1111/jph.12318; Tewoldemedhin YT, 2011, SOIL BIOL BIOCHEM, V43, P1917, DOI 10.1016/j.soilbio.2011.05.014; Tewoldemedhin YT, 2011, EUR J PLANT PATHOL, V129, P637, DOI 10.1007/s10658-010-9728-4; Utkhede RS, 2006, ALLELOPATHY J, V18, P23; van Os GJ, 1999, EUR J PLANT PATHOL, V105, P791, DOI 10.1023/A:1008722517813; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANETTEN HD, 1994, PLANT CELL, V6, P1191; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Weiss S, 2017, TREE PHYSIOL, V37, P1672, DOI 10.1093/treephys/tpx108; Weiss S, 2017, SCI HORTIC-AMSTERDAM, V222, P111, DOI 10.1016/j.scienta.2017.05.012; Weiss S, 2017, PLANT MOL BIOL, V94, P303, DOI 10.1007/s11103-017-0608-6; Winkelmann T, 2019, CURR ISSUES MOL BIOL, V30, P89, DOI 10.21775/cimb.030.089; Yim B, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01604; Yim B, 2016, PLANT SOIL, V406, P389, DOI 10.1007/s11104-016-2876-3; Yim B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01224; Yim B, 2013, PLANT SOIL, V366, P617, DOI 10.1007/s11104-012-1454-6; Zhu YM, 2016, CAN J PLANT PATHOL, V38, P483, DOI 10.1080/07060661.2016.1260640	68	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238876	10.1371/journal.pone.0238876	http://dx.doi.org/10.1371/journal.pone.0238876			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970702	Green Published, gold			2022-12-26	WOS:000576265600009
J	Schori, JC; Steeves, TE; Murray, TJ				Schori, Jennifer C.; Steeves, Tammy E.; Murray, Tara J.			Designing monitoring protocols to measure population trends of threatened insects: A case study of the cryptic, flightless grasshopper Brachaspis robustus	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; METAPOPULATION; CONSERVATION; RESTORATION; DYNAMICS; ECOLOGY; HABITAT; SUCCESS; TRAPS	Statistically robust monitoring of threatened populations is essential for effective conservation management because the population trend data that monitoring generates is often used to make decisions about when and how to take action. Despite representing the highest proportion of threatened animals globally, the development of best practice methods for monitoring populations of threatened insects is relatively uncommon. Traditionally, population trend data for the Nationally Endangered New Zealand grasshopperBrachaspis robustushas been determined by counting all adults and nymphs seen on a single similar to 1.5 km transect searched once annually. This method lacks spatial and temporal replication, both of which are essential to overcome detection errors in highly cryptic species likeB.robustus. It also provides no information about changes in the grasshopper's distribution throughout its range. Here, we design and test new population density and site occupancy monitoring protocols by comparing a) comprehensive plot and transect searches at one site and b) transect searches at two sites representing two different habitats (gravel road and natural riverbed) occupied by the species across its remaining range. Using power analyses, we determined a) the number of transects, b) the number of repeated visits and c) the grasshopper demographic to count to accurately detect long term change in relative population density. To inform a monitoring protocol design to track trends in grasshopper distribution, we estimated the probability of detecting an individual with respect to a) search area, b) weather and c) the grasshopper demographic counted at each of the two sites. Density estimates from plots and transects did not differ significantly. Population density monitoring was found to be most informative when large adult females present in early summer were used to index population size. To detect a significant change in relative density with power > 0.8 at the gravel road habitat, at least seventeen spatial replicates (transects) and four temporal replicates (visits) were required. Density estimates at the natural braided river site performed poorly and likely require a much higher survey effort. Detection of grasshopper presence was highest (p(g)> 0.6) using a 100 m x 1 m transect at both sites in February under optimal (no cloud) conditions. At least three visits to a transect should be conducted per season for distribution monitoring. Monitoring protocols that inform the management of threatened species are crucial for better understanding and mitigation of the current global trends of insect decline. This study provides an exemplar of how appropriate monitoring protocols can be developed for threatened insect species.	[Schori, Jennifer C.; Steeves, Tammy E.] Univ Canterbury, Coll Sci, Sch Biol Sci, Christchurch, New Zealand; [Murray, Tara J.] Univ Canterbury, Coll Engn, Sch Forestry, Christchurch, New Zealand; [Murray, Tara J.] Biodivers Grp, Dept Conservat, Dunedin, New Zealand	University of Canterbury; University of Canterbury	Schori, JC (corresponding author), Univ Canterbury, Coll Sci, Sch Biol Sci, Christchurch, New Zealand.	jschori92@gmail.com		Schori, Jennifer/0000-0002-7119-3538	Environment Canterbury; Department of Conservation, New Zealand (Braided River Regional Initiative Fund); Forest and Bird (Stocker Scholarship); Forest and Bird (JS Watson Trust); New Zealand Federation of Graduate Women (Sadie Balkind Award); University of Canterbury Doctoral Scholarship	Environment Canterbury; Department of Conservation, New Zealand (Braided River Regional Initiative Fund); Forest and Bird (Stocker Scholarship); Forest and Bird (JS Watson Trust); New Zealand Federation of Graduate Women (Sadie Balkind Award); University of Canterbury Doctoral Scholarship	This research was funded by Environment Canterbury and the Department of Conservation, New Zealand (Braided River Regional Initiative Fund awarded to TJM), Forest and Bird (Stocker Scholarship and JS Watson Trust awarded to JCS) and the New Zealand Federation of Graduate Women (Sadie Balkind Award awarded to JCS). JCS was supported by the University of Canterbury Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Bates AJ, 2005, AQUAT CONSERV, V15, P159, DOI 10.1002/aqc.642; Bigelow RS, 1967, U CANTERBURY PUBLICA; Block WA, 2001, RESTOR ECOL, V9, P293, DOI 10.1046/j.1526-100x.2001.009003293.x; Bried JT, 2012, J INSECT CONSERV, V16, P489, DOI 10.1007/s10841-011-9435-2; Broder L, 2020, CONSERV BIOL, V34, P743, DOI 10.1111/cobi.13449; Caruso BS, 2006, ENVIRON MANAGE, V37, P840, DOI 10.1007/s00267-005-3103-9; Cook CN, 2010, FRONT ECOL ENVIRON, V8, P181, DOI 10.1890/090020; DEMPSTER JP, 1963, BIOL REV, V38, P490, DOI 10.1111/j.1469-185X.1963.tb00791.x; Dennis B, 2010, ECOLOGY, V91, P610, DOI 10.1890/08-1095.1; Department of Conservation, 2004, WOLDS PAST LEAS CONS; Ferreira SM, 1999, NEW ZEAL J ZOOL, V26, P229, DOI 10.1080/03014223.1999.9518192; Forsman A, 1999, ECOSCIENCE, V6, P35, DOI 10.1080/11956860.1999.11952202; Foucart A, 1998, J INSECT CONSERV, V2, P187, DOI 10.1023/A:1009691612698; Fountain ED, 2013, J INSECT CONSERV, V17, P737, DOI 10.1007/s10841-013-9557-9; Fraser I, 1999, 9901 DEP CONS; Gardiner Tim, 2005, Journal of Insect Conservation, V9, P151, DOI 10.1007/s10841-005-2854-1; Graves S., 2015, MULTCOMPVIEW VISUALI; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hallmann CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185809; Harker RJ, 2008, J INSECT CONSERV, V12, P125, DOI 10.1007/s10841-007-9068-7; Hohbein RR, 2018, WILDLIFE SOC B, V42, P597, DOI 10.1002/wsb.928; JUILLET JA, 1963, CAN J ZOOLOG, V41, P219, DOI 10.1139/z63-023; Knuff AK, 2019, METHODS ECOL EVOL, V10, P1820, DOI 10.1111/2041-210X.13258; Kral K, 2018, J INSECT CONSERV, V22, P1, DOI 10.1007/s10841-018-0046-z; Kuussaari M, 2015, BIOL CONSERV, V190, P51, DOI 10.1016/j.biocon.2015.05.011; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lyons JE, 2008, J WILDLIFE MANAGE, V72, P1683, DOI 10.2193/2008-141; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maloney R, 1992, BRACHASPIS ROBUSTUS; Matenaar D, 2014, J INSECT CONSERV, V18, P447, DOI 10.1007/s10841-014-9654-4; MATTHEWS R W, 1971, Michigan Entomologist, V4, P117; Morris SJ, 2005, SETTING MONITORING S; ODonnell C.F.J., 2016, MANAGEMENT RES PRIOR; Pascoe A., 1995, THESIS; Pellet J, 2008, J INSECT CONSERV, V12, P155, DOI 10.1007/s10841-007-9075-8; POLLARD E, 1977, BIOL CONSERV, V12, P115, DOI 10.1016/0006-3207(77)90065-9; Powney GD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08974-9; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Schorer J, 2020, J SPORT SCI, V38, P2208, DOI 10.1080/02640414.2020.1776923; SCHORI JC, 2020, THESIS; Schori JC, 2019, NEW ZEAL J ZOOL, V46, P149, DOI 10.1080/03014223.2018.1523201; Stelter C, 1997, J ANIM ECOL, V66, P508, DOI 10.2307/5945; Stringer IAN, 2012, NZ ENTOMOL, V35, P77, DOI 10.1080/00779962.2012.686309; Townsend A.J., 2008, NZ THREAT CLASSIFICA; TREWICK SA, 2014, NZ THREAT CLASSIFICA, V16; van Strien AJ, 2010, BASIC APPL ECOL, V11, P495, DOI 10.1016/j.baae.2010.05.003; Venables WN, 2002, MODERN; Weyer J, 2012, J INSECT CONSERV, V16, P379, DOI 10.1007/s10841-011-9423-6; WHITE EG, 1994, ECOLOGICAL RES MONIT; Zonneveld C, 2003, CONSERV BIOL, V17, P476, DOI 10.1046/j.1523-1739.2003.01516.x	54	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238636	10.1371/journal.pone.0238636	http://dx.doi.org/10.1371/journal.pone.0238636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970696	gold, Green Published			2022-12-26	WOS:000576265600006
J	Sosa-Moreno, A; Reinoso-Gonzalez, S; Mendez, MA				Sosa-Moreno, Andrea; Reinoso-Gonzalez, Sharon; Angel Mendez, Miguel			Anemia in women of reproductive age in Ecuador: Data from a national survey	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; PREVALENCE; HEMOGLOBIN; QUALITY; INCOME	Background Anemia is a condition characterized by a decline in the number of functional red blood cells or hemoglobin. Women of reproductive age from low- and middle-income countries are at higher risk of anemia, which could lead to prenatal, obstetric and perinatal complications. The aim of our study was to explore associations between anemia status and a set of demographic, socio-economic and reproductive factors, among Ecuadorian women of reproductive age (WRA). Methods We used data from non-pregnant, WRA (>= 12 and <= 49 years) women enrolled in the nationally representative cross-sectional Ecuadorian National Health and Nutrition Survey 2012 (ENSANUT-ECU 2012). Anemia and moderate-severe anemia were assessed using hemoglobin concentrations cutoffs of <12 g/dL and <11 g/dL, respectively. Logistic regression was used to obtain unadjusted and adjusted prevalence odds ratios (aOR). All analyzes were adjusted for multi-stage sampling, stratification and clustering. Results The study population included a subset of 7415 non-pregnant WRA. Mean hemoglobin concentration was 12.84 g/dL (95% CI = 12.8-12.9). The overall prevalence of anemia and moderate-severe anemia was 16.8% and 5.0%, respectively. Some factors were associated with an increase in anemia prevalence odds: living in Guayaquil (aOR 1.82, 95% CI 1.16-2.84) and Quito (aOR 1.84, 95% CI 1.17-2.90) compared to living in the rural Amazon, having given birth to more than four alive children compared with being nulliparous (aOR 1.85, 95% CI 1.00-3.43), currently taking contraceptives compared with former use (aOR 1.46, 95% CI 1.09-1.97). In addition, moderate-severe anemia was associated with age and region of residence. Conclusion In 2012, the prevalence of anemia among Ecuadorian WRA was considered a mild public health concern. However, we identified groups with higher anemia prevalence. Thus, emphasizing the importance of analyzing the prevalence in sub-populations of WRA and identifying populations where more frequent surveillance may be helpful.	[Sosa-Moreno, Andrea] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Reinoso-Gonzalez, Sharon; Angel Mendez, Miguel] Univ San Francisco Quito, Dept Ingn Quim, Grp Quim Computac & Teor, Colegio Ciencias & Ingenierias, Quito, Ecuador	University of Michigan System; University of Michigan	Sosa-Moreno, A (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	arsosa@umich.edu	Moreno, Andrea Sosa/ABG-2370-2020; Mendez, Miguel/M-2603-2019	Moreno, Andrea Sosa/0000-0002-4687-426X; Mendez, Miguel/0000-0001-9281-2644	Universidad San Francisco de Quito through the Grupo de Quimica Computacional y Teorica, (QCT); Instituto de Simulacion Computacional (ISC); USFQ Research Publication Fund	Universidad San Francisco de Quito through the Grupo de Quimica Computacional y Teorica, (QCT); Instituto de Simulacion Computacional (ISC); USFQ Research Publication Fund	The institutions, Universidad San Francisco de Quito through the Grupo de Quimica Computacional y Teorica, (QCT), the Instituto de Simulacion Computacional (ISC) and the USFQ Research Publication Fund supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, NCCN PRACT GUIDEL, V2017, P1, DOI DOI 10.1155/2017/2683789; [Anonymous], 2014, J NURS REGUL, V5, pS3; [Anonymous], 2012, ANN NIGERIAN MED, DOI DOI 10.4103/0331-3131.100213; [Anonymous], 2016, REPROD SYST SEX DISO, V5, pA20; [Anonymous], PREV AN WOM REPR AG; [Anonymous], 2013, GASTROENTEROL HEP S3, P1, DOI DOI 10.1017/S1743923X12000670; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Banco Central del Ecuador, 2019, REP POBR INGR DES JU; Bellamy C., 1998, STATE WORLDS CHILDRE; Bentley ME, 2003, EUR J CLIN NUTR, V57, P52, DOI 10.1038/sj.ejcn.1601504; Black L, 2008, VET THER, V9; Bora K, 2019, TROP MED INT HEALTH, V24, P829, DOI 10.1111/tmi.13240; CANIZARES C, 1988, BRAZ J MED BIOL RES, V21, P767; CDC. Centers for Disease Control and Prevention, 1998, REC PREV CONTR IR DE; Elzahaf R, 2016, INT J COMMUNITY MED, V3, P1915, DOI [10.18203/2394-6040.ijcmph20162065, DOI 10.18203/2394-6040.IJCMPH20162065]; Firquet A, 2017, GYNECOL ENDOCRINOL, V33, P503, DOI 10.1080/09513590.2017.1306736; Freire W, 2012, ENCUESTA NACL SALUD, V1; FREIRE WB, 1989, AM J CLIN NUTR, V50, P1442, DOI 10.1093/ajcn/50.6.1442; Freire WB, 2014, AM J CLIN NUTR, V100, p1636S, DOI 10.3945/ajcn.114.083766; Gautam S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218288; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; INEC, 2019, SER HIST CAN FAM BAS; INEC, 2020, CONT NAC; INEC, 2010, CENS POBL VIV; Kamruzzaman M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0211-4; Kusumi E, 2006, INT J HEMATOL, V84, P217, DOI 10.1532/IJH97.06097; Levy TS, 2016, ENCY FOOD HLTH, P156; Lopez C, 2013, EVALUACION USO INDIC; Meena K, 2019, ARTIF INTELL MED, V94, P138, DOI 10.1016/j.artmed.2019.02.005; Mujica-Coopman MF, 2015, FOOD NUTR BULL, V36, pS119, DOI 10.1177/0379572115585775; Nguyen PH, 2015, EUR J CLIN NUTR, V69, P107, DOI 10.1038/ejcn.2014.181; Pan American Health Organization, 2010, AN LAT AM CAR 2009 S; Percy L, 2017, OBSTET GYNAECOL, V19, P155, DOI 10.1111/tog.12368; Percy L, 2017, BEST PRACT RES CL OB, V40, P55, DOI 10.1016/j.bpobgyn.2016.09.007; Petry N, 2016, NUTRIENTS, V8, P11; Rahman MM, 2016, AM J CLIN NUTR, V103, P495, DOI 10.3945/ajcn.115.107896; Robinson SM, 2004, EUR J CLIN NUTR, V58, P1174, DOI 10.1038/sj.ejcn.1601946; Roser M., 2014, HUM DEV IND HDI; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Solovyova AV, 2018, CURRENT TOPICS ANEMI; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; The World Bank Group, ECUADOR; UNESCO, EC STAT; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; WHO, GLOB TARG 2015 IMPR; Wirth JP, AM J CLIN NUTR, P106; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2015, GLOB PREV AN 2011	49	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239585	10.1371/journal.pone.0239585	http://dx.doi.org/10.1371/journal.pone.0239585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970743	Green Published, gold			2022-12-26	WOS:000576265600083
J	Tanaka, S; De Tymowski, C; Assadi, M; Zappella, N; Jean-Baptiste, S; Robert, T; Peoc'h, K; Lortat-Jacob, B; Fontaine, L; Bouzid, D; Tran-Dinh, A; Tashk, P; Meilhac, O; Montravers, P				Tanaka, Sebastien; De Tymowski, Christian; Assadi, Maksud; Zappella, Nathalie; Jean-Baptiste, Sylvain; Robert, Tiphaine; Peoc'h, Katell; Lortat-Jacob, Brice; Fontaine, Lauriane; Bouzid, Donia; Tran-Dinh, Alexy; Tashk, Parvine; Meilhac, Olivier; Montravers, Philippe			Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; INFECTIOUS-DISEASES; IN-VIVO; CHOLESTEROL; METABOLISM; HDL; INFLAMMATION; GUIDELINES; MANAGEMENT; INJURY	Introduction Severe acute respiratory syndrome coronavirus2 has caused a global pandemic of coronavirus disease 2019 (COVID-19). High-density lipoproteins (HDLs), particles chiefly known for their reverse cholesterol transport function, also display pleiotropic properties, including anti-inflammatory or antioxidant functions. HDLs and low-density lipoproteins (LDLs) can neutralize lipopolysaccharides and increase bacterial clearance. HDL cholesterol (HDL-C) and LDL cholesterol (LDL-C) decrease during bacterial sepsis, and an association has been reported between low lipoprotein levels and poor patient outcomes. The goal of this study was to characterize the lipoprotein profiles of severe ICU patients hospitalized for COVID-19 pneumonia and to assess their changes during bacterial ventilator-associated pneumonia (VAP) superinfection. Methods A prospective study was conducted in a university hospital ICU. All consecutive patients admitted for COVID-19 pneumonia were included. Lipoprotein levels were assessed at admission and daily thereafter. The assessed outcomes were survival at 28 days and the incidence of VAP. Results A total of 48 patients were included. Upon admission, lipoprotein concentrations were low, typically under the reference values ([HDL-C] = 0.7[0.5-0.9] mmol/L; [LDL-C] = 1.8[1.3-2.3] mmol/L). A statistically significant increase in HDL-C and LDL-C over time during the ICU stay was found. There was no relationship between HDL-C and LDL-C concentrations and mortality on day 28 (log-rank p = 0.554 and p = 0.083, respectively). A comparison of alive and dead patients on day 28 did not reveal any differences in HDL-C and LDL-C concentrations over time. Bacterial VAP was frequent (64%). An association was observed between HDL-C and LDL-C concentrations on the day of the first VAP diagnosis and mortality ([HDL-C] = 0.6[0.5-0.9] mmol/L in survivors vs. [HDL-C] = 0.5[0.3-0.6] mmol/L in nonsurvivors, p = 0.036; [LDL-C] = 2.2[1.9-3.0] mmol/L in survivors vs. [LDL-C] = 1.3[0.9-2.0] mmol/L in nonsurvivors, p = 0.006). Conclusion HDL-C and LDL-C concentrations upon ICU admission are low in severe COVID-19 pneumonia patients but are not associated with poor outcomes. However, low lipoprotein concentrations in the case of bacterial superinfection during ICU hospitalization are associated with mortality, which reinforces the potential role of these particles during bacterial sepsis.	[Tanaka, Sebastien; De Tymowski, Christian; Assadi, Maksud; Zappella, Nathalie; Jean-Baptiste, Sylvain; Lortat-Jacob, Brice; Fontaine, Lauriane; Tran-Dinh, Alexy; Tashk, Parvine; Montravers, Philippe] Bichat Claude Bernard Hosp, Assistance Publ Hop Paris AP HP, Dept Anesthesiol & Crit Care Med, Paris, France; [Tanaka, Sebastien; Meilhac, Olivier] Reunion Isl Univ, French Inst Hlth & Med Res INSERM, CYROI Plateform, U1188,Diabet Atherothrombosis Reunion Indian Oce, St Denis De La Reunion, Reunion, France; [De Tymowski, Christian; Peoc'h, Katell] Ctr Res Inflammat, French Inst Hlth & Med Res INSERM U1149, Paris, France; [De Tymowski, Christian; Assadi, Maksud; Peoc'h, Katell; Bouzid, Donia; Montravers, Philippe] Univ Paris, UFR Denis Diderot, Paris, France; [Robert, Tiphaine; Peoc'h, Katell] Bichat Claude Bernard Hosp, Assistance Publ Hop Paris AP HP, Biochem Dept, Paris, France; [Bouzid, Donia] INSERM U1137 IAME, Paris, France; [Bouzid, Donia] Bichat Claude Bernard Hosp, Assistance Publ Hop Paris AP HP, Emergency Dept, Paris, France; [Tran-Dinh, Alexy] French Inst Hlth & Med Res INSERM U1148, Lab Vasc Translat Sci, Paris, France; [Meilhac, Olivier] Reunion Isl Univ Affiliated Hosp, St Denis De La Reunion, Reunion, France; [Montravers, Philippe] French Inst Hlth & Med Res INSERM U1152, Physiopathol & Epidemiol Resp Dis, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tanaka, S (corresponding author), Bichat Claude Bernard Hosp, Assistance Publ Hop Paris AP HP, Dept Anesthesiol & Crit Care Med, Paris, France.; Tanaka, S (corresponding author), Reunion Isl Univ, French Inst Hlth & Med Res INSERM, CYROI Plateform, U1188,Diabet Atherothrombosis Reunion Indian Oce, St Denis De La Reunion, Reunion, France.	sebastien.tanaka@aphp.fr	Bouzid, Donia/AAC-9054-2022; TRAN DINH, Alexy/AAD-1336-2022	Bouzid, Donia/0000-0002-7538-3320; de TYMOWSKI, Christian/0000-0001-6899-9912; Tran Dinh, Alexy/0000-0003-4361-5104				Alhazzani W, 2020, INTENS CARE MED, V46, P1977, DOI 10.1007/s00134-020-06227-8; [Anonymous], 2020, J THORAC ONCOL; [Anonymous], 2020, NEW ENGL J MED, DOI [DOI 10.1002/jmv.25685, DOI 10.1056/NEJMC2005203]; [Anonymous], 2020, N ENGL J MED; Baker J, 2010, J INFECT DIS, V201, P285, DOI 10.1086/649560; Barlage S, 2009, INTENS CARE MED, V35, P1877, DOI 10.1007/s00134-009-1609-y; Biswas HH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003904; Cao WJ, 2019, CLIN LAB, V65, P2377, DOI 10.7754/Clin.Lab.2019.190525; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cirstea M, 2017, J CRIT CARE, V38, P289, DOI 10.1016/j.jcrc.2016.11.041; Dudoignon E, 2020, CLIN INFECT DIS PUBL; Fan JL, 2020, METABOLISM, V107, DOI 10.1016/j.metabol.2020.154243; Gordon BR, 1996, CRIT CARE MED, V24, P584, DOI 10.1097/00003246-199604000-00006; Grasselli G, 2020, JAMA; Grunfeld C, 1999, J LIPID RES, V40, P245; Han SW, 2020, CANCER MED-US, V9, P6667, DOI 10.1002/cam4.3289; Hu X, 2020, CLIN CHIM ACTA INT J, V510, P105; Hu XZ, 2020, CLIN CHIM ACTA, V510, P105, DOI 10.1016/j.cca.2020.07.015; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kitchens RL, 2003, J LIPID RES, V44, P2339, DOI 10.1194/jlr.M300228-JLR200; Lee W, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00292-7; Levels JHM, 2001, INFECT IMMUN, V69, P2821, DOI 10.1128/IAI.69.5.2821-2828.2001; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Marin-Palma D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214245; McDonald MC, 2003, SHOCK, V20, P551, DOI 10.1097/01.shk.0000097249.97298.a3; Meilhac O, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040598; Merad M, 2020, NAT REV IMMUNOL; Pirillo A, 2015, HANDB EXP PHARMACOL, V224, P483, DOI 10.1007/978-3-319-09665-0_15; Rose H, 2008, ATHEROSCLEROSIS, V199, P79, DOI 10.1016/j.atherosclerosis.2007.10.018; Shor R, 2008, CLIN RES CARDIOL, V97, P227, DOI 10.1007/s00392-007-0611-z; Sorokin AV, 2020, FASEB J, V34, P9843, DOI 10.1096/fj.202001451; Tanaka S, 2020, ANESTHESIOLOGY; Tanaka S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02860-3; Tanaka S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0541-8; Tanaka S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0284-3; Theilmeier G, 2006, CIRCULATION, V114, P1403, DOI 10.1161/CIRCULATIONAHA.105.607135; Tran-Dinh A, 2013, BRIT J PHARMACOL, V169, P493, DOI 10.1111/bph.12174; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Walley KR, 2019, CRIT CARE MED, V47, P463, DOI 10.1097/CCM.0000000000003551; Wei X, 2020, J CLIN LIPIDOL; Wu AH, 2004, SHOCK, V21, P210, DOI 10.1097/01.shk.0000111661.09279.82; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037	45	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239573	10.1371/journal.pone.0239573	http://dx.doi.org/10.1371/journal.pone.0239573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970772	gold, Green Published			2022-12-26	WOS:000576265600014
J	Crupi, AP; Gregovich, DP; White, KS				Crupi, Anthony P.; Gregovich, David P.; White, Kevin S.			Steep and deep: Terrain and climate factors explain brown bear (Ursus arctos) alpine den site selection to guide heli-skiing management	PLOS ONE			English	Article							AMERICAN BLACK BEARS; GRIZZLY BEARS; BRITISH-COLUMBIA; AERIAL SURVEYS; BEHAVIORAL-RESPONSE; DENNING BEHAVIOR; POLAR BEARS; HABITAT USE; HIBERNATION; AVAILABILITY	Winter recreation and tourism continue to expand worldwide, and where these activities overlap with valuable wildlife habitat, there is greater potential for conservation concerns. Wildlife populations can be particularly vulnerable to disturbance in alpine habitats as helicopters and snowmachines are increasingly used to access remote backcountry terrain. Brown bears (Ursus arctos) have adapted hibernation strategies to survive this period when resources and energy reserves are limited, and disturbance could negatively impact fitness and survival. To help identify areas of potential conflict between helicopter skiing and denning brown bears in Alaska, we developed a model to predict alpine denning habitat and an associated data-based framework for mitigating disturbance activities. Following den emergence in spring, we conducted three annual aerial surveys (2015-2017) and used locations from three GPS-collared bears (2008-2014) to identify 89 brown bear dens above the forest line. We evaluated brown bear den site selection of land cover, terrain, and climate factors using resource selection function (RSF) models. Our top model supported the hypothesis that bears selected dens based on terrain and climate factors that maximized thermal efficiency. Brown bears selected den sites characterized by steep slopes at moderate elevations in smooth, well-drained topographies that promoted vegetation and deep snow. We used the RSF model to map relative probability of den selection and found 85% of dens occurred within terrain predicted as prime denning habitat. Brown bear exposure to helicopter disturbance was evident as moderate to high intensities of helicopter flight tracking data overlapped prime denning habitat, and we quantified where the risk of these impact was greatest. We also documented evidence of late season den abandonment due to disturbance from helicopter skiing. The results from this study provide valuable insights into bear denning habitat requirements in subalpine and alpine landscapes. Our quantitative framework can be used to support conservation planning for winter recreation industries operating in habitats occupied by denning brown bears.	[Crupi, Anthony P.; Gregovich, David P.; White, Kevin S.] Alaska Dept Fish & Game, Div Wildlife Conservat, Douglas, AK 99824 USA	Alaska Department of Fish & Game	Crupi, AP (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, Douglas, AK 99824 USA.	anthony.crupi@alaska.gov		Crupi, Anthony/0000-0003-2788-6238	Pittman-Robertson Federal Aid in Wildlife Restoration Act; State of Alaska Fish and Game Funds [AKW10-4.43]	Pittman-Robertson Federal Aid in Wildlife Restoration Act; State of Alaska Fish and Game Funds	Financial support was provided by the Pittman-Robertson Federal Aid in Wildlife Restoration Act and the State of Alaska Fish and Game Funds. AC was awarded grant number AKW10-4.43. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaska Department of Natural Resources, 2008, N SLOP AR LEAS SAL M; Andersen M, 2008, POLAR BIOL, V31, P501, DOI 10.1007/s00300-007-0376-x; [Anonymous], 2014, VEG MAP CLASS SO AL; [Anonymous], 2017, WEATHERSPARK; [Anonymous], 2017, USGS NAT MAP 3DEP DO; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; BAKER WL, 1992, LANDSCAPE ECOL, V7, P291, DOI 10.1007/BF00131258; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Becker EF, 2009, J AGR BIOL ENVIR ST, V14, P207, DOI 10.1198/jabes.2009.0013; Berman EE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215243; Beyer HL, 2013, GEOSPATIAL MODELING; Boelman NT, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaeec1; Boggs K, 2010, ARCT ANTARCT ALP RES, V42, P385, DOI 10.1657/1938-4246-42.4.385; Boulanger J, 2013, WILDLIFE BIOL, V19, P274, DOI 10.2981/12-088; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CAUGHLEY G, 1974, J WILDLIFE MANAGE, V38, P921, DOI 10.2307/3800067; Ciarniello LM, 2005, URSUS, V16, P47, DOI 10.2192/1537-6176(2005)016[0047:DBADSS]2.0.CO;2; Colt S, 2002, PNWGTR551 USDA FOR S; Commission for Environmental Cooperation, 2020, 2015 LAND COV N AM 3, V2.0; Connor T, 2018, ECOGRAPHY, V41, P1270, DOI 10.1111/ecog.03416; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Cote SD, 1996, WILDLIFE SOC B, V24, P681; Cote SD, 2013, J WILDLIFE MANAGE, V77, P1244, DOI 10.1002/jwmg.565; Craighead FC, 1972, WILDLIFE MONOGR, V32, P3; Crupi AP, 2017, SPATIAL RELATIONSHIP; Crupi AP, 2014, ADFGDWCWRR20142; Crupi AP, 2017, ADFGDWCWRR20171; Dadic R, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001261; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Ditmer MA, 2015, CURR BIOL, V25, P2278, DOI 10.1016/j.cub.2015.07.024; Elfstrom M, 2008, WILDLIFE BIOL, V14, P176, DOI 10.2981/0909-6396(2008)14[176:SODHBS]2.0.CO;2; Evans AL, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0140-6; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040520; Farley SD, 1995, CAN J ZOOL, V73, P2216, DOI 10.1139/z95-262; Flynn RW, 2012, ADFGDWCWRR201204 AL; FOLK G E JR, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P107; Freudiger D, 2017, WIRES WATER, V4, DOI 10.1002/wat2.1232; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Goldstein MI, 2010, J WILDLIFE MANAGE, V74, P35, DOI 10.2193/2008-490; GOODRICH LE, 1982, CAN GEOTECH J, V19, P421, DOI 10.1139/t82-047; Gottschalk TK, 2011, ECOL MODEL, V222, P3403, DOI 10.1016/j.ecolmodel.2011.07.008; Grimsdottir H, 2006, NAT HAZARDS, V39, P127, DOI 10.1007/s11069-005-5227-x; Grunewald T, 2014, CRYOSPHERE, V8, P2381, DOI 10.5194/tc-8-2381-2014; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Hagenstad M., 2018, EC CONTRIBUTIONS WIN; Harding L, 1980, INT C BEAR RES MAN, V4, P277, DOI 10.2307/3872881; HARDING LE, 1976, CAN J ZOOL, V54, P1357, DOI 10.1139/z76-153; Hellgren EC, 1998, URSUS-SERIES, V10, P467; Hilderbrand GV, 2000, J WILDLIFE MANAGE, V64, P178, DOI 10.2307/3802988; Hilderbrand GV, 2000, CAN FIELD NAT, V114, P498; Hodder DP, 2014, WILDLIFE BIOL, V20, P238, DOI 10.2981/wlb.00037; Huddart D, 2020, ADVENTURE TOURISM EN, P183, DOI [10.1007/978-3-030-18623-4_7, DOI 10.1007/978-3-030-18623-4_7]; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; Hurley K, 2004, BIENN S NO WILD SHEE, V14, P131; Immell D, 2013, URSUS, V24, P1; Jobbagy EG, 2000, GLOBAL ECOL BIOGEOGR, V9, P253, DOI 10.1046/j.1365-2699.2000.00162.x; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson CJ, 2005, WILDLIFE MONOGR, P1; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Keating KA, 2007, J WILDLIFE MANAGE, V71, P1344, DOI 10.2193/2006-359; Klein D.R., 1973, Publications natn Swedish Envir Prot Bd, V11, P377; Krebs J, 2007, J WILDLIFE MANAGE, V71, P2180, DOI 10.2193/2007-099; Larkin RP, 1996, 9621 US ARM CONSTR E; LENTFER J W, 1972, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series, V23, P125; Linnell JDC, 2000, WILDLIFE SOC B, V28, P400; Liston GE, 2006, J HYDROMETEOROL, V7, P1259, DOI 10.1175/JHM548.1; Lopez-Alfaro C, 2013, ECOL MODEL, V270, P1, DOI 10.1016/j.ecolmode1.2013.09.002; Manly B., 2002, RESOURCE SELECTION A, V2, DOI 10.1007/978-94-011-1558-2; MATTSON DJ, 1990, INT C BEAR, V8, P33; Mazza R, 2005, PNWGTR653 USDA FOR S; MCLELLAN BN, 1990, INT C BEAR, V8, P57; Miller SD, 1993, WILDLIFE TECHNICAL B, V11; MOORE ID, 1991, HYDROL PROCESS, V5, P1, DOI 10.1002/hyp.3360050102; Morris LR, 2016, APPL GEOGR, V76, P173, DOI 10.1016/j.apgeog.2016.09.025; Neteler M, 2013, OPEN SOURCE GIS GRAS; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Patthey P, 2008, J APPL ECOL, V45, P1704, DOI 10.1111/j.1365-2664.2008.01547.x; Pigeon KE, 2016, BEHAV ECOL SOCIOBIOL, V70, P1745, DOI 10.1007/s00265-016-2180-5; Pigeon KE, 2016, J WILDLIFE MANAGE, V80, P884, DOI 10.1002/jwmg.1069; Pigeon KE, 2014, J MAMMAL, V95, P559, DOI 10.1644/13-MAMM-A-137; POLLOCK KH, 1987, J WILDLIFE MANAGE, V51, P502, DOI 10.2307/3801040; Preatoni D, 2005, ACTA OECOL, V28, P189, DOI 10.1016/j.actao.2005.04.002; Proctor M.F., 2018, RESOURCE ROADS GRIZZ; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds H.V., 1976, IUCN Publs (New Series), VNo. 40, P403; Reynolds PE, 1986, INT C BEAR RES MANAG, V6, P169; Robbins CT, 2012, J MAMMAL, V93, P540, DOI 10.1644/11-MAMM-A-155.1; Rode KD, 2018, J MAMMAL, V99, P16, DOI 10.1093/jmammal/gyx181; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Sato CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064282; Schmidt JH, 2017, ECOL EVOL, V7, P4812, DOI 10.1002/ece3.2912; Schnabel D, 2019, FINAL COMMERICAL HEL; Schoen JW, 1987, INT C BEAR RES MANAG, V7, P293, DOI DOI 10.2307/3872636; Shanley CS, 2015, CLIMATIC CHANGE, V130, P155, DOI 10.1007/s10584-015-1355-9; Sorum MS, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2822; Spencer JM, 2011, NAT HAZARDS, V58, P31, DOI 10.1007/s11069-010-9641-3; Stapleton S, 2014, BIOL CONSERV, V170, P38, DOI 10.1016/j.biocon.2013.12.040; Stoen OG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196876; Sturm M, 1997, J GLACIOL, V43, P26, DOI 10.3189/S0022143000002781; Swenson JE, 1997, WILDLIFE BIOL, V3, P35, DOI 10.2981/wlb.1997.005; Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x; TIETJE WD, 1980, J WILDLIFE MANAGE, V44, P858, DOI 10.2307/3808314; Troyer WA, 1975, AERIAL SURVEY BROWN; USDOI Bureau of Land Management, 2020, REC DEC APPR HAIN AM; USDOI Fish and Wildlife Service, 2009, GUID EFF AN HEL US G, P18; VANDAELE LJ, 1990, INT C BEAR, V8, P257; Vroom GW., 1980, BEARS THEIR BIOL MAN, V4, P321, DOI [10.2307/3872887, DOI 10.2307/3872887]; Walcher M, 2019, WILD ENVIRON MED, V30, P251, DOI 10.1016/j.wem.2019.04.007; Wiens TS, 2008, ECOL MODEL, V212, P244, DOI 10.1016/j.ecolmodel.2007.10.005; Wilson TL, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00250.1; Zuur Alain F., 2009, P1	113	4	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238711	10.1371/journal.pone.0238711	http://dx.doi.org/10.1371/journal.pone.0238711			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966287	Green Published, gold			2022-12-26	WOS:000575688700013
J	Borges, L; Gorjao, R; Gray, SR; Martins, TR; Santos, VC; Momesso, CM; Pithon-Curi, TC; Hatanaka, E				Borges, Leandro; Gorjao, Renata; Gray, Stuart R.; Martins, Thais Reis; Santos, Vinicius Coneglian; Momesso, Cesar Miguel; Pithon-Curi, Tania Cristina; Hatanaka, Elaine			Lymphocyte activation after a high-intensity street dance class	PLOS ONE			English	Article							EXPRESSION; EXERCISE	Intense dance training leads to inflammation, which may impair the health and performance of the practitioners. Herein, we evaluate the effect of a single street dancing class on the profile of muscle enzymes, lymphocyte activation, and cell surface CD62L expression. We also investigated the correlation between muscle enzymes, adhesion molecules, and lymphocyte activation in dancers. Fifteen male participants (mean +/- standard error: age 22.4 +/- 1.08 years, body mass index 24.8 +/- 0.69 kg/m(2), body fat 12.3 +/- 1.52%), who were amateur dancers, had blood samples collected previously and subsequent to a high-intensity street dance class. After the class, dancers showed an increase in total lymphocyte count (2.0-fold), creatine kinase (CK)-NAC (4.87%), and CK-MB (3.36%). We also observed a decrease (2.5-fold) in reactive oxygen species (ROS) produced by lymphocytes, under phorbol myristate acetate-stimulated environments. Following the dance class, CD62L expression in lymphocytes decreased (51.42%), while there was a negative correlation between the intensity of the exercise and CD62L expression (r = -0.73; p = 0.01). Lymphocytes were less responsive to stimuli after a single bout of street dancing, indicating transient immunosuppression.	[Borges, Leandro; Gorjao, Renata; Martins, Thais Reis; Santos, Vinicius Coneglian; Momesso, Cesar Miguel; Pithon-Curi, Tania Cristina; Hatanaka, Elaine] Cruzeiro do Sul Univ, Inst Phys Act & Sport Sci ICAFE, Sao Paulo, SP, Brazil; [Gray, Stuart R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow	Borges, L (corresponding author), Cruzeiro do Sul Univ, Inst Phys Act & Sport Sci ICAFE, Sao Paulo, SP, Brazil.	sbleandro@yahoo.com.br	Momesso, Cesar Miguel/D-3281-2012; Pithon-Curi, Tania Cristina/AAB-9436-2021; Borges, Leandro/B-6257-2015; Hatanaka, Elaine/AFL-1791-2022; Gray, Stuart/L-2489-2017	Momesso, Cesar Miguel/0000-0001-6448-6028; Borges, Leandro/0000-0002-9755-2535; Hatanaka, Elaine/0000-0002-9716-1163; PITHON-CURI, TANIA CRISTINA/0000-0002-9714-9105; Gray, Stuart/0000-0001-8969-9636	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/21441-0, 2014/21185-1]; Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq) [306041/2011-1, 308700/2017-1]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88882.314890/2013-01]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cienti'fico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) under Grant [2011/21441-0 and 2014/21185-1] (EH); Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnologico (CNPq) under Grant [306041/2011-1 and 308700/2017-1] (EH); and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) under Grant [88882.314890/2013-01] (LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2015, SEMIN THROMB HEMOST, V41, P563, DOI 10.1055/s-0035-1556588; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Borges L, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/1684013; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P9; Campbell JP, 2009, BRAIN BEHAV IMMUN, V23, P767, DOI 10.1016/j.bbi.2009.02.011; Cottam DR, 2002, OBES SURG, V12, P230, DOI 10.1381/096089202762552674; Cronkite DA, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/1467538; de Moura NR, 2012, J STRENGTH COND RES, V26, P2507, DOI 10.1519/JSC.0b013e31823f29b5; Gambhir L, 2019, INT IMMUNOPHARMACOL, V67, P449, DOI 10.1016/j.intimp.2018.12.049; Gannon GA, 2001, EUR J APPL PHYSIOL, V84, P272, DOI 10.1007/s004210000374; Gleeson M, 2016, IMMUNOL CELL BIOL, V94, P124, DOI 10.1038/icb.2015.100; Koutedakis Y, 2004, SPORTS MED, V34, P651, DOI 10.2165/00007256-200434100-00003; Kruger K, 2007, EXERC IMMUNOL REV, V13, P37; Nielsen HB, 2003, SPORTS MED, V33, P853, DOI 10.2165/00007256-200333110-00005; Nielsen HG, 2004, SCAND J IMMUNOL, V60, P356, DOI 10.1111/j.0300-9475.2004.01486.x; Peat EE, 2010, BRIT J SPORT MED, V44, P573, DOI 10.1136/bjsm.2008.053306; Peschel T, 2007, EUR J CARDIOV PREV R, V14, P476, DOI 10.1097/HJR.0b013e328167239d; Riebe D, 2018, ACSMS GUIDELINES EXE, P111; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; van Eijk LT, 2007, CRIT CARE MED, V35, P1464, DOI 10.1097/01.CCM.0000266534.14262.E8; ZAMMIT VA, 1976, BIOCHEM J, V160, P447, DOI 10.1042/bj1600447	21	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239516	10.1371/journal.pone.0239516	http://dx.doi.org/10.1371/journal.pone.0239516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956398	gold, Green Accepted, Green Published			2022-12-26	WOS:000574571500046
J	Gad, H; Saraswathi, S; Al-Jarrah, B; Petropoulos, IN; Ponirakis, G; Khan, A; Singh, P; Al Khodor, S; Elawad, M; Almasri, W; Abdelrahman, H; Hussain, K; Hendaus, MA; Al-Mudahka, F; Abouhazima, K; McGrogan, P; Malik, RA; Akobeng, AK				Gad, Hoda; Saraswathi, Saras; Al-Jarrah, Bara; Petropoulos, Ioannis N.; Ponirakis, Georgios; Khan, Adnan; Singh, Parul; Al Khodor, Souhaila; Elawad, Mamoun; Almasri, Wesam; Abdelrahman, Hatim; Hussain, Khalid; Hendaus, Mohamed A.; Al-Mudahka, Fatma; Abouhazima, Khaled; McGrogan, Paraic; Malik, Rayaz A.; Akobeng, Anthony K.			Corneal confocal microscopy demonstrates minimal evidence of distal neuropathy in children with celiac disease	PLOS ONE			English	Article							NEUROLOGICAL DISORDERS; PERIPHERAL NEUROPATHY; DIABETIC-PATIENTS; NERVE TORTUOSITY; NONINVASIVE TEST; YOUNG-PATIENTS; DAMAGE; ATAXIA; WHORL	Objectives The aim of this study was to utilise corneal confocal microscopy to quantify corneal nerve morphology and establish the presence of sub-clinical small fibre damage and peripheral neuropathy in children with celiac disease. Methods This is a cross-sectional cohort study of twenty children with celiac disease and 20 healthy controls who underwent clinical and laboratory assessments and corneal confocal microscopy. Corneal nerve fiber density (no.mm(2)), corneal nerve branch density (no.mm(2)), corneal nerve fiber length (mm.mm(2)), corneal nerve fiber tortuosity and inferior whorl length (mm.mm(2)) were quantified manually. Results Corneal nerve fiber density (34.7 +/- 8.6 vs. 32.9 +/- 8.6;P= 0.5), corneal nerve branch density (47.2 +/- 24.5 vs. 47.3 +/- 20.0;P= 0.1) and corneal nerve fiber length (20.0 +/- 5.1 vs. 19.5 +/- 4.5;P= 0.8) did not differ between children with celiac disease and healthy controls. Corneal nerve fiber tortuosity (11.4 +/- 1.9 vs 13.5 +/- 3.0;P= 0.01) was significantly lower and inferior whorl length (20.0 +/- 5.5 vs 23.0 +/- 3.8;P= 0.06) showed a non-significant reduction in children with celiac disease compared to healthy controls. Inferior whorl length correlated significantly with corneal nerve fiber density (P = 0.005), corneal nerve branch density (P = 0.04), and corneal nerve fiber length (P = 0.002). Conclusion Corneal confocal microscopy demonstrates minimal evidence of neuropathy in children with celiac disease.	[Gad, Hoda; Petropoulos, Ioannis N.; Ponirakis, Georgios; Khan, Adnan; Malik, Rayaz A.] Weill Cornell Med Qatar, Dept Med, Doha, Qatar; [Saraswathi, Saras; Al-Jarrah, Bara; Elawad, Mamoun; Almasri, Wesam; Abdelrahman, Hatim; Al-Mudahka, Fatma; Abouhazima, Khaled; McGrogan, Paraic; Akobeng, Anthony K.] Sidra Med, Div Gastroenterol Hepatol & Nutr, Doha, Qatar; [Singh, Parul; Al Khodor, Souhaila] Sidra Med, Res Dept, Doha, Qatar; [Hussain, Khalid] Sidra Med, Div Endocrinol, Doha, Qatar; [Hendaus, Mohamed A.] Sidra Med, Gen Pediat Dept, Doha, Qatar; [Malik, Rayaz A.] Univ Manchester, Inst Cardiovasc Med, Manchester, Lancs, England	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Sidra Medical & Research Center; Sidra Medical & Research Center; Sidra Medical & Research Center; Sidra Medical & Research Center; University of Manchester	Malik, RA (corresponding author), Weill Cornell Med Qatar, Dept Med, Doha, Qatar.; Malik, RA (corresponding author), Univ Manchester, Inst Cardiovasc Med, Manchester, Lancs, England.	ram2045@qatar-med.cornell.edu	Malik, Rayaz/H-9231-2019	Malik, Rayaz/0000-0002-7188-8903	Sidra Internal Research Fund (SIRF); Biomedical Research Program grant from the Qatar National Research Fund (QNRF) [BMRP-5726113101]	Sidra Internal Research Fund (SIRF); Biomedical Research Program grant from the Qatar National Research Fund (QNRF)	This publication was made possible by a Sidra Internal Research Fund (SIRF) and a Biomedical Research Program [BMRP-5726113101] grant from the Qatar National Research Fund (QNRF). The statements made herein are solely the responsibility of the authors.	Alam U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180175; Anitua E, 2015, ACTA OPHTHALMOL, V93, pE605, DOI 10.1111/aos.12710; [Anonymous], 2007, FAM COURT REV, V45, P366, DOI 10.1111/j.1744-1617.2007.00152.x; [Anonymous], 2006, Drugs R D, V7, P305; [Anonymous], 2020, CLIN J SPORT MED, V29, pe111; [Anonymous], 2016, THE TOTAL AUDIENCE R; Brannagan TH, 2005, ARCH NEUROL-CHICAGO, V62, P1574, DOI 10.1001/archneur.62.10.1574; Casella G, 2016, MINERVA GASTROENTERO, V62, P197; Chin RL, 2003, NEUROLOGY, V60, P1581, DOI 10.1212/01.WNL.0000063307.84039.C7; Chin Russell L, 2004, J Clin Neuromuscul Dis, V5, P129, DOI 10.1097/00131402-200403000-00004; COOKE WT, 1966, BRAIN, V89, P663, DOI 10.1093/brain/89.4.663; COOKE WT, 1966, BRAIN, V89, P683, DOI 10.1093/brain/89.4.683; De Sousa EA, 2006, J NEUROL NEUROSUR PS, V77, P983, DOI 10.1136/jnnp.2006.091074; Deak EA, 2019, INVEST OPHTH VIS SCI, V60, P830, DOI 10.1167/iovs.18-24516; Edwards K, 2014, DIABETIC MED, V31, P1205, DOI 10.1111/dme.12466; Edwards K, 2017, J DIABETES COMPLICAT, V31, P1325, DOI 10.1016/j.jdiacomp.2017.04.025; Ferdousi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45116-z; Gad H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213319; Hadjivassiliou M, 2006, J NEUROL NEUROSUR PS, V77, P1262, DOI 10.1136/jnnp.2006.093534; Husby S, 2014, NAT REV GASTRO HEPAT, V11, P655, DOI 10.1038/nrgastro.2014.162; Jiang MS, 2016, BRIT J OPHTHALMOL, V100, P9, DOI 10.1136/bjophthalmol-2014-306038; Kakleas K, 2015, AUTOIMMUN REV, V14, P781, DOI 10.1016/j.autrev.2015.05.002; Kallinikos P, 2004, INVEST OPHTH VIS SCI, V45, P418, DOI 10.1167/iovs.03-0637; Kalteniece A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60422-7; Kalteniece A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21643-z; Kass-Iliyya L, 2017, EUR J NEUROSCI, V45, P232, DOI 10.1111/ejn.13481; Khan A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35298-3; Khan A, 2018, J DIABETES INVEST, V9, P1167, DOI 10.1111/jdi.12806; Khan A, 2017, STROKE, V48, P3012, DOI 10.1161/STROKEAHA.117.018289; Luostarinen L, 2003, J NEUROL NEUROSUR PS, V74, P490, DOI 10.1136/jnnp.74.4.490; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Mearns ES, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020380; Pacaud D, 2015, INVEST OPHTH VIS SCI, V56, P5636, DOI 10.1167/iovs.15-16995; Papanas N, 2015, J DIABETES INVEST, V6, P381, DOI 10.1111/jdi.12335; Perkins BA, 2018, DIABETOLOGIA, V61, P1856, DOI 10.1007/s00125-018-4653-8; Petropoulos IN, 2017, INVEST OPHTH VIS SCI, V58, P3677, DOI 10.1167/iovs.17-22050; Petropoulos IN, 2015, INVEST OPHTH VIS SCI, V56, P2498, DOI 10.1167/iovs.14-15919; Ponirakis G, 2019, ANN CLIN TRANSL NEUR, V6, P689, DOI 10.1002/acn3.746; Sankaranarayanan A, 2017, EARLY INTERV PSYCHIA, V11, P271, DOI 10.1111/eip.12258; Sellers EAC, 2013, DIABETIC MED, V30, P630, DOI 10.1111/dme.12125; Simonati A, 1998, NEUROPEDIATRICS, V29, P155, DOI 10.1055/s-2007-973553; Souayah N, 2008, EUR J NEUROL, V15, P1300, DOI 10.1111/j.1468-1331.2008.02305.x; Squintani G, 2009, RHEUMATOL INT, V29, P579, DOI 10.1007/s00296-008-0704-7; Szalai E, 2016, INVEST OPHTH VIS SCI, V57, P853, DOI 10.1167/iovs.15-18735; Tavakoli M, 2015, MUSCLE NERVE, V52, P363, DOI 10.1002/mus.24553; Tavakoli Mitra, 2013, J Diabetes Sci Technol, V7, P1179; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Thawani Sujata, 2017, J Clin Neuromuscul Dis, V19, P12, DOI 10.1097/CND.0000000000000174; Thawani SP, 2015, JAMA NEUROL, V72, P806, DOI 10.1001/jamaneurol.2015.0475; Tummanapalli SS, 2020, CURR EYE RES, V45, P921, DOI 10.1080/02713683.2019.1705984; Tuzun E, 2001, EUR NEUROL, V46, P157, DOI 10.1159/000050791; Utsunomiya T, 2015, INVEST OPHTH VIS SCI, V56, P5417, DOI 10.1167/iovs.15-16609; Xiong Q, 2018, DIABETES RES CLIN PR, V136, P85, DOI 10.1016/j.diabres.2017.11.026; Yan A, 2020, DIABETIC MED, V37, P326, DOI 10.1111/dme.13952; Zis P, 2019, POSTGRAD MED, V131, P496, DOI 10.1080/00325481.2019.1650609	55	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238859	10.1371/journal.pone.0238859	http://dx.doi.org/10.1371/journal.pone.0238859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956371	gold, Green Published			2022-12-26	WOS:000574571500034
J	Palin, MF; Lapointe, J; Gariepy, C; Beaudry, D; Kalbe, C				Palin, Marie-France; Lapointe, Jerome; Gariepy, Claude; Beaudry, Daniele; Kalbe, Claudia			Characterisation of intracellular molecular mechanisms modulated by carnosine in porcine myoblasts under basal and oxidative stress conditions	PLOS ONE			English	Article							BETA-ALANINE SUPPLEMENTATION; GROWTH-PERFORMANCE; CARCINOMA-CELLS; MEAT QUALITY; MUSCLE; PROLIFERATION; APOPTOSIS; CANCER; MTOR; HOMOCARNOSINE	Carnosine is a naturally occurring histidine-containing dipeptide present at high concentration in mammalian skeletal muscles. Carnosine was shown to affect muscle contraction, prevent the accumulation of oxidative metabolism by-products and act as an intracellular proton buffer maintaining the muscle acid-base balance. The present study was undertaken to gain additional knowledge about the intracellular mechanisms activated by carnosine in porcine myoblast cells under basal and oxidative stress conditions. Satellite cells were isolated from the skeletal muscles of 3 to 4 day-old piglets to study the effect of 0, 10, 25 and 50 mM carnosine pre-treatments in cells that were exposed (0.3 mM H2O2) or not to an H2O2-induced oxidative stress. Study results demonstrated that carnosine acts differently in myoblasts under oxidative stress and in basal conditions, the only exception being with the reduction of reactive oxygen species and protein carbonyls observed in both experimental conditions with carnosine pre-treatment. In oxidative stress conditions, carnosine pre-treatment increased the mRNA abundance of the nuclear factor, erythroid 2 like 2 (NEF2L2) transcription factor and several of its downstream genes known to reduce H2O2. Carnosine prevented the H2O2-mediated activation of p38 MAPK in oxidative stress conditions, whereas it triggered the activation of mTOR under basal conditions. Current results support the protective effect of carnosine against oxidative damage in porcine myoblast cells, an effect that would be mediated through the p38 MAPK intracellular signaling pathway. The activation of the mTOR signaling pathway under basal condition also suggest a role for carnosine in myoblasts proliferation, growth and survival.	[Palin, Marie-France; Lapointe, Jerome; Beaudry, Daniele] Agr & Agri Food Canada, Sherbrooke Res & Dev Ctr, Sherbrooke, PQ, Canada; [Gariepy, Claude] Agr & Agri Food Canada, St Hyacinthe Res & Dev Ctr, St Hyacinthe, PQ, Canada; [Kalbe, Claudia] Leibniz Inst Farm Anim Biol, Inst Muscle Biol & Growth, Dummerstorf, Germany	Agriculture & Agri Food Canada; Agriculture & Agri Food Canada; Forschungsinstitut fur Nutztierbiologie (FBN)	Palin, MF (corresponding author), Agr & Agri Food Canada, Sherbrooke Res & Dev Ctr, Sherbrooke, PQ, Canada.	mariefrance.palin@canada.ca			Agriculture and Agri-Food Canada A-Base Grant [J-001292]; Leibniz Institute of Farm Animal Biology (Zukunftsfonds)	Agriculture and Agri-Food Canada A-Base Grant(Agriculture & Agri Food Canada); Leibniz Institute of Farm Animal Biology (Zukunftsfonds)	This study was financially supported by Agriculture and Agri-Food Canada A-Base Grant J-001292 and by the Leibniz Institute of Farm Animal Biology (Zukunftsfonds). -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Alsheblak MM, 2016, EUR CYTOKINE NETW, V27, P6, DOI 10.1684/ecn.2016.0372; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2009, CAN COUNC AN CAR GUI; [Anonymous], 2016, CIRE ANTILLES GUYANE; Arzumanyan ES, 2010, NEUROCHEM J+, V4, P222, DOI 10.1134/S1819712410030104; BABIZHAYEV MA, 1994, BIOCHEM J, V304, P509, DOI 10.1042/bj3040509; Baek SH, 2014, STROKE, V45, P2438, DOI 10.1161/STROKEAHA.114.005183; Baguet A, 2010, EUR J APPL PHYSIOL, V108, P495, DOI 10.1007/s00421-009-1225-0; Bak MJ, 2014, INT J MOL MED, V34, P1516, DOI 10.3892/ijmm.2014.1972; Bao YH, 2015, ASIAN AUSTRAL J ANIM, V28, P1465, DOI 10.5713/ajas.14.0604; Bao Y, 2018, INTEGR CANCER THER, V17, P80, DOI 10.1177/1534735416684551; Boldyrev A, 2008, REJUV RES, V11, P821, DOI 10.1089/rej.2008.0716; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Choi SY, 1999, BBA-GEN SUBJECTS, V1472, P651, DOI 10.1016/S0304-4165(99)00189-0; Colzani M, 2016, CHEMMEDCHEM, V11, P1778, DOI 10.1002/cmdc.201500552; Cong JH, 2017, J SCI FOOD AGR, V97, P3733, DOI 10.1002/jsfa.8236; Corona C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017971; Cripps MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13649-w; D'Astous-Page J, 2017, MEAT SCI, V124, P84, DOI 10.1016/j.meatsci.2016.11.004; Derave W, 2007, J APPL PHYSIOL, V103, P1736, DOI 10.1152/japplphysiol.00397.2007; Dolan E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32636-3; Dutka TL, 2012, J APPL PHYSIOL, V112, P728, DOI 10.1152/japplphysiol.01331.2011; Fernyhough Melinda E, 2010, Int J Stem Cells, V3, P63; Gao H, 2015, J ZHEJIANG U SCI BIO, V16, P500; Gunzler W., 1985, HDB METHODS OXYGEN R, P285, DOI DOI 10.1201/9781351072922; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Hipkiss AR, 2014, AMINO ACIDS, V46, P327, DOI 10.1007/s00726-013-1627-5; Hipkiss AR, 2000, BIOGERONTOLOGY, V1, P217, DOI 10.1023/A:1010057412184; Horii Y, 2012, NEUROSCI LETT, V510, P1, DOI 10.1016/j.neulet.2011.12.058; Ibrahim W, 2008, INT J VITAM NUTR RES, V78, P230, DOI 10.1024/0300-9831.78.45.230; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Jia HJ, 2009, REGUL PEPTIDES, V154, P69, DOI 10.1016/j.regpep.2008.12.004; Jiang Q, 2017, ONCOTARGET, V8, P74820, DOI 10.18632/oncotarget.20426; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kefaloyianni E, 2006, CELL SIGNAL, V18, P2238, DOI 10.1016/j.cellsig.2006.05.004; Kobayashi T, 2014, IMMUNITY, V41, P375, DOI 10.1016/j.immuni.2014.08.011; KOHEN R, 1991, FREE RADICAL RES COM, V12-3, P179, DOI 10.3109/10715769109145784; Labrecque B, 2009, GENE, V443, P110, DOI 10.1016/j.gene.2009.04.026; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Maier AB, 2012, GERONTOLOGY, V58, P150, DOI 10.1159/000329784; Matsuyoshi Y, 2019, METHODS MOL BIOL, V1889, P81, DOI 10.1007/978-1-4939-8897-6_6; Mau M, 2008, IN VITRO CELL DEV-AN, V44, P1, DOI 10.1007/s11626-007-9069-6; Metzger K, 2020, IN VITRO CELL DEV-AN, V56, P193, DOI 10.1007/s11626-019-00428-2; Miceli V, 2018, MOL CELL ENDOCRINOL, V474, P105, DOI 10.1016/j.mce.2018.02.016; Nagasawa T, 2001, MOL CELL BIOCHEM, V225, P29, DOI 10.1023/A:1012256521840; Nanayakkara GK, 2019, ARCH BIOCHEM BIOPHYS, V662, P68, DOI 10.1016/j.abb.2018.12.002; Ommati MM, 2020, NUTR NEUROSCI, V23, P731, DOI 10.1080/1028415X.2018.1552399; Ommati MM, 2019, BIOL TRACE ELEM RES, V187, P151, DOI 10.1007/s12011-018-1358-2; Oppermann H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218972; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Patel H, 2016, MICROVASC RES, V103, P1, DOI 10.1016/j.mvr.2015.09.003; PAVLOV AR, 1993, BIOCHIM BIOPHYS ACTA, V1157, P304, DOI 10.1016/0304-4165(93)90114-N; Pfister F, 2011, CELL PHYSIOL BIOCHEM, V28, P125, DOI 10.1159/000331721; Renner C, 2010, NEUROL RES, V32, P101, DOI 10.1179/016164109X12518779082237; Rezzani R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215170; Riedl E, 2011, CELL PHYSIOL BIOCHEM, V28, P279, DOI 10.1159/000331740; Saunders B, 2017, BRIT J SPORT MED, V51, P658, DOI 10.1136/bjsports-2016-096396; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Shen Y, 2014, REGUL PEPTIDES, V192, P45, DOI 10.1016/j.regpep.2014.08.005; Shen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104632; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; Tchevkina E.M, 2012, PROTEIN PHOSPHORYLAT; Thornton KJ, 2019, J ANIM SCI, V97, P2258, DOI 10.1093/jas/skz081; Vishnyakova KS, 2014, MOL BIOL+, V48, P718, DOI 10.1134/S0026893314050161; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang ZW, 2014, J CANCER, V5, P382, DOI 10.7150/jca.8024; Zhao KX, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4348973; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; 2010, IARC MONOGR EVAL CAR, V94, pE286	77	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239496	10.1371/journal.pone.0239496	http://dx.doi.org/10.1371/journal.pone.0239496			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946513	Green Published, gold			2022-12-26	WOS:000573851100031
J	Alvendal, C; Mohanty, S; Bohm-Starke, N; Brauner, A				Alvendal, Cathrin; Mohanty, Soumitra; Bohm-Starke, Nina; Brauner, Annelie			Anti-biofilm activity of chlorhexidine digluconate againstCandida albicansvaginal isolates	PLOS ONE			English	Article							CANDIDA-ALBICANS; FLUCONAZOLE THERAPY; PERSISTER CELLS; TOLERABILITY; RESISTANCE; DEFENSE	Objectives Recurrent vulvovaginal candidiasis (RVVC) causes significant morbidity.Candida albicansis the main pathogen associated with both sporadic and recurrent candidiasis. Due to unsatisfactory treatment effect, the impact of chlorhexidine digluconate and fluconazole alone or in combination onC.albicansand biofilm was investigated. Methods VaginalC.albicansisolates from 18 patients with recurrent candidiasis and commensals from 19 asymptomatic women were isolated by culture. Crystal violet, XTT and colony forming unit assay were used to analyze the effect of chlorhexidine digluconate and fluconazole on growth of C. albicans, formation of new and already established, mature, biofilm. Results Fluconazole reduced the growth of planktonicC.albicans. However, in established biofilm, fluconazole had no effect on the candida cells and was not able to disperse and reduce the biofilm. By contrast, chlorhexidine digluconate had a direct killing effect onC.albicansgrown both planktonically and in biofilm. Chlorhexidine digluconate also dispersed mature biofilm and inhibited formation of new biofilm. No major differences were observed between commensal isolates and candida causing recurrent vulvovaginitis with respect to biofilm or growth after chlorhexidine digluconate treatment. Conclusion Biofilm is a problem in patients with recurrent vulvovaginal candidiasis reducing the effect of antifungal treatment. Development of new treatment strategies are urgently needed to decrease the recurrences. In already established biofilm, chlorhexidine digluconate dispersed the biofilm and was more effective in eradicating candida compared to fluconazole. Future treatment strategy may thus be a combination of chlorhexidine digluconate and fluconazole and prophylactic use of chlorhexidine digluconate to prevent biofilm formation and restrict infections.	[Alvendal, Cathrin; Bohm-Starke, Nina] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Obstet & Gynecol, Stockholm, Sweden; [Mohanty, Soumitra; Brauner, Annelie] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Div Clin Microbiol, Stockholm, Sweden; [Mohanty, Soumitra; Brauner, Annelie] Karolinska Univ Hosp, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Alvendal, C (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Obstet & Gynecol, Stockholm, Sweden.	cathrin.alvendal@sll.se		Mohanty, Soumitra/0000-0003-0919-5062	Karolinska Institutet, Stockholm, Sweden	Karolinska Institutet, Stockholm, Sweden	AB: The study was supported by Grants from the Karolinska Institutet, Stockholm, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Niaimi A, 2016, AM J INFECT CONTROL, V44, P996, DOI 10.1016/j.ajic.2016.02.036; [Anonymous], 2011, J NATL COMPR CANC NE, V9; Arendrup MC, 2012, CLIN MICROBIOL INFEC, V18, pE246, DOI 10.1111/j.1469-0691.2012.03880.x; Bandara HMHN, 2020, INT J PHARMACEUT, V578, DOI 10.1016/j.ijpharm.2020.119096; Brauner A, 2018, J MOL MED, V96, P537, DOI 10.1007/s00109-018-1637-6; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Burgess D, 2012, CAN J FILM STUD, V21, P2, DOI 10.3138/cjfs.21.1.2; Cauchie M, 2017, RES MICROBIOL, V168, P802, DOI 10.1016/j.resmic.2017.02.005; Cavalheiro M, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00028; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Conlon BP, 2015, ADV EXP MED BIOL, V831, P1, DOI 10.1007/978-3-319-09782-4_1; Dadar M, 2018, MICROB PATHOGENESIS, V117, P128, DOI 10.1016/j.micpath.2018.02.028; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Panariello BHD, 2018, J ORAL MICROBIOL, V10, DOI 10.1080/20002297.2018.1476644; Ellepola A, 2001, COPENHAGEN ORAL DIS, P11; Farmer MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002613; Fidel PL, 2007, AM J REPROD IMMUNOL, V57, P2, DOI 10.1111/j.1600-0897.2006.00450.x; Garcia-Perez JE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00538; Harriott MM, 2010, MICROBIOL-SGM, V156, P3635, DOI 10.1099/mic.0.039354-0; HOUANG ET, 1990, ANTIMICROB AGENTS CH, V34, P909, DOI 10.1128/AAC.34.5.909; Imbert C, 2006, MYCOPATHOLOGIA, V161, P147, DOI 10.1007/s11046-005-3085-4; Kalkanci A, 2013, J OBSTET GYNAECOL, V33, P378, DOI 10.3109/01443615.2013.767323; Kumar A, 2017, INT J MED MICROBIOL, V307, P481, DOI 10.1016/j.ijmm.2017.09.016; LaFleur MD, 2006, ANTIMICROB AGENTS CH, V50, P3839, DOI 10.1128/AAC.00684-06; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis Kim, 2012, Handb Exp Pharmacol, P121, DOI 10.1007/978-3-642-28951-4_8; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Marchaim D, 2012, OBSTET GYNECOL, V120, P1407, DOI [10.1097/AOG.0b013e31827307b2, http://10.1097/AOG.0b013e31827307b2]; Molteni B, 2004, CURR MED RES OPIN, V20, P849, DOI 10.1185/030079904125003692; Noverr MC, 2019, AM J OBSTET GYNECOL, V221, P169, DOI 10.1016/j.ajog.2019.04.017; Peters BM, 2014, INFECT IMMUN, V82, P532, DOI 10.1128/IAI.01417-13; Ramage G, 2002, J ANTIMICROB CHEMOTH, V49, P973, DOI 10.1093/jac/dkf049; Rosa MI, 2013, EUR J OBSTET GYN R B, V167, P132, DOI 10.1016/j.ejogrb.2012.12.001; Salim N, 2013, INT J ANTIMICROB AG, V41, P65, DOI 10.1016/j.ijantimicag.2012.08.014; SHUBAIR M, 1992, GYNECOL OBSTET INVES, V34, P229, DOI 10.1159/000292767; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD, 2016, AM J OBSTET GYNECOL, V214, P15, DOI 10.1016/j.ajog.2015.06.067; Sobel JD, 2004, NEW ENGL J MED, V351, P876, DOI 10.1056/NEJMoa033114; Swidsinski A, 2019, AM J OBSTET GYNECOL, V220, DOI 10.1016/j.ajog.2018.10.023; Varoni E, 2012, Minerva Stomatol, V61, P399; VAZQUEZ JA, 1994, J INFECT DIS, V170, P1566, DOI 10.1093/infdis/170.6.1566	41	4	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238428	10.1371/journal.pone.0238428	http://dx.doi.org/10.1371/journal.pone.0238428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941438	Green Published, gold			2022-12-26	WOS:000573848800109
J	Huang, JS; Pan, HB; Yang, TL; Hung, BH; Chiang, CL; Tsai, MY; Chou, CP				Huang, Jer-Shyung; Pan, Huay-Ben; Yang, Tsung-Lung; Hung, Bao-Hui; Chiang, Chia-Ling; Tsai, Meng-Yuan; Chou, Chen-Pin			Kinetic patterns of benign and malignant breast lesions on contrast enhanced digital mammogram	PLOS ONE			English	Article							MRI; CANCER; WOMEN; RISK	Purpose To evaluate the kinetic patterns of benign and malignant breast lesions using contrast-enhanced digital mammogram (CEDM). Methods Women with suspicious breast lesions on mammography or ultrasound were enrolled. Single-view mediolateral oblique (MLO) CEDM of an affected breast was acquired at 2, 3, 4, 7, and 10 min after injection of contrast agent. Three readers visually and semi-quantitatively analyzed the enhancement of suspicious lesions. The kinetic pattern of each lesion was classified as persistent, plateau, or washout over two time intervals, 2-4 min and 2-10 min, by comparing the signal intensity at the first time interval with that at the second. Results There were 73 malignant and 75 benign lesions in 148 patients (mean age: 52 years). Benign and malignant breast lesions showed the highest signal intensity at 3 min and 2 min, respectively. Average areas under receiver operating characteristic (ROC) curve for diagnostic accuracy based on lesion enhancement at different time points were 0.73 at 2 min, 0.72 at 3 min, 0.69 at 4 min, 0.67 at 7 min, and 0.64 at 10 min. Diagnostic performance was significantly better at 2, 3, and 4 min than at 7 and 10 min (all p < 0.05). A washout kinetic pattern was significantly associated with malignant lesions at 2-4 min and 2-10 min frames according to two of the three readers' interpretations (all p <= 0.001). Conclusion Applications of optimal time intervals and kinetic patterns show promise in differentiation of benign and malignant breast lesions on CEDM.	[Huang, Jer-Shyung; Pan, Huay-Ben; Yang, Tsung-Lung; Chiang, Chia-Ling; Tsai, Meng-Yuan; Chou, Chen-Pin] Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung, Taiwan; [Huang, Jer-Shyung; Pan, Huay-Ben; Yang, Tsung-Lung; Chiang, Chia-Ling; Tsai, Meng-Yuan] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Hung, Bao-Hui] Golden Hosp, Dept Radiol, Pingtung, Taiwan; [Chou, Chen-Pin] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Fooyin University	Chou, CP (corresponding author), Kaohsiung Vet Gen Hosp, Dept Radiol, Kaohsiung, Taiwan.; Chou, CP (corresponding author), Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.	chouchenpin@gmail.com		Tsai, Meng-Yuan/0000-0001-8596-3647; Yang, Tsung Lung/0000-0001-8532-1441	Kaohsiung Veterans General Hospital Research Found [KSVGH 108-158, KSVGH106-137]; Hologic Inc., Bedford, MA	Kaohsiung Veterans General Hospital Research Found; Hologic Inc., Bedford, MA	This work is directly supported by Kaohsiung Veterans General Hospital Research Found (KSVGH 108-158 and KSVGH106-137) and Hologic Inc., Bedford, MA. Hologic Inc. is a commercial company. The funders only provided support of the study in the form of research grant funding. None of authors received salary or other fees from funders. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development, or marketed products associated with this research to declare. The funders do not alter our adherence to PLOS ONE policies on sharing data and materials.	Bahl M, 2019, RADIOLOGY, V290, P298, DOI 10.1148/radiol.2018181788; Chou CP, 2015, EUR J RADIOL, V84, P2501, DOI 10.1016/j.ejrad.2015.09.019; Dromain C, 2011, EUR RADIOL, V21, P565, DOI 10.1007/s00330-010-1944-y; Hwang YS, 2018, ACTA RADIOL, V59, P893, DOI 10.1177/0284185117740760; Jochelson MS, 2017, EUR J RADIOL, V97, P37, DOI 10.1016/j.ejrad.2017.10.001; Jong RA, 2003, RADIOLOGY, V228, P842, DOI 10.1148/radiol.2283020961; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Liberman L, 2002, AM J ROENTGENOL, V179, P171, DOI 10.2214/ajr.179.1.1790171; Lobbes MBI, 2019, EUR RADIOL, V29, P6211, DOI 10.1007/s00330-019-06215-7; Macura KJ, 2006, RADIOGRAPHICS, V26, P1719, DOI 10.1148/rg.266065025; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; O'Flynn EAM, 2015, AM J ROENTGENOL, V204, pW141, DOI 10.2214/AJR.14.13636; Pan HB, 2018, J CHIN MED ASSOC, V81, P70, DOI 10.1016/j.jcma.2017.05.013; Patel MR, 1998, ACAD RADIOL, V5, P26, DOI 10.1016/S1076-6332(98)80008-1; Raza S, 2008, AM J ROENTGENOL, V191, P689, DOI 10.2214/AJR.07.3779; Sung JS, 2019, RADIOLOGY, V293, P81, DOI 10.1148/radiol.2019182660; Warner E, 2001, J CLIN ONCOL, V19, P3524, DOI 10.1200/JCO.2001.19.15.3524	17	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239271	10.1371/journal.pone.0239271	http://dx.doi.org/10.1371/journal.pone.0239271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941537	Green Published, gold			2022-12-26	WOS:000573848800051
J	Inaguma, D; Kitagawa, A; Yanagiya, R; Koseki, A; Iwamori, T; Kudo, M; Yuzawa, Y				Inaguma, Daijo; Kitagawa, Akimitsu; Yanagiya, Ryosuke; Koseki, Akira; Iwamori, Toshiya; Kudo, Michiharu; Yuzawa, Yukio			Increasing tendency of urine protein is a risk factor for rapid eGFR decline in patients with CKD: A machine learning-based prediction model by using a big database	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ARTIFICIAL-INTELLIGENCE; JAPANESE PATIENTS; OUTCOMES; COHORT; STAGE; NEPHROPATHY; PROGRESSION; MANAGEMENT; INJURY	Artificial intelligence is increasingly being adopted in medical fields to predict various outcomes. In particular, chronic kidney disease (CKD) is problematic because it often progresses to end-stage kidney disease. However, the trajectories of kidney function depend on individual patients. In this study, we propose a machine learning-based model to predict the rapid decline in kidney function among CKD patients by using a big hospital database constructed from the information of 118,584 patients derived from the electronic medical records system. The database included the estimated glomerular filtration rate (eGFR) of each patient, recorded at least twice over a period of 90 days. The data of 19,894 patients (16.8%) were observed to satisfy the CKD criteria. We characterized the rapid decline of kidney function by a decline of 30% or more in the eGFR within a period of two years and classified the available patients into two groups-those exhibiting rapid eGFR decline and those exhibiting non-rapid eGFR decline. Following this, we constructed predictive models based on two machine learning algorithms. Longitudinal laboratory data including urine protein, blood pressure, and hemoglobin were used as covariates. We used longitudinal statistics with a baseline corresponding to 90-, 180-, and 360-day windows prior to the baseline point. The longitudinal statistics included the exponentially smoothed average (ESA), where the weight was defined to be 0.9*(t/b), where t denotes the number of days prior to the baseline point and b denotes the decay parameter. In this study, b was taken to be 7 (7-day ESA). We used logistic regression (LR) and random forest (RF) algorithms based on Python code with scikit-learn library () for model creation. The areas under the curve for LR and RF were 0.71 and 0.73, respectively. The 7-day ESA of urine protein ranked within the first two places in terms of importance according to both models. Further, other features related to urine protein were likely to rank higher than the rest. The LR and RF models revealed that the degree of urine protein, especially if it exhibited an increasing tendency, served as a prominent risk factor associated with rapid eGFR decline.	[Inaguma, Daijo; Kitagawa, Akimitsu] Fujita Hlth Univ, Dept Internal Med, Bantane Hosp Nagoya, Nagoya, Aichi, Japan; [Yanagiya, Ryosuke] Fujita Hlth Univ, Div Med Informat Syst, Sch Med Toyoake, Toyoake, Aichi, Japan; [Koseki, Akira; Iwamori, Toshiya; Kudo, Michiharu] IBM Res Tokyo, Tokyo, Japan; [Yuzawa, Yukio] Fujita Hlth Univ, Dept Nephrol, Sch Med, Toyoake, Aichi, Japan	Fujita Health University; Fujita Health University; International Business Machines (IBM); Fujita Health University	Inaguma, D (corresponding author), Fujita Hlth Univ, Dept Internal Med, Bantane Hosp Nagoya, Nagoya, Aichi, Japan.	daijo@fujita-hu.ac.jp			IBM Research	IBM Research(International Business Machines (IBM))	IBM Research provided support for this study in the form of salaries for AK, TI and MK. The specific roles of these authors are articulated in the `author contributions' section.	Barbieri C, 2016, KIDNEY INT, V90, P422, DOI 10.1016/j.kint.2016.03.036; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Campbell GA, 2011, ADV CHRONIC KIDNEY D, V18, P420, DOI 10.1053/j.ackd.2011.10.006; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Chen TK, 2019, JAMA-J AM MED ASSOC, V322, P1294, DOI 10.1001/jama.2019.14745; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; De Nicola L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127071; Elhoseny M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46074-2; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Fiorentino M, 2018, CONTRIB NEPHROL, V193, P45, DOI 10.1159/000484962; Hamet P, 2017, METABOLISM, V69, pS36, DOI 10.1016/j.metabol.2017.01.011; Inaguma D, 2017, CLIN EXP NEPHROL, V21, P446, DOI 10.1007/s10157-016-1309-1; Iseki K, 2018, CLIN EXP NEPHROL, V22, P1331, DOI 10.1007/s10157-018-1587-x; Johnson KW, 2018, J AM COLL CARDIOL, V71, P2668, DOI 10.1016/j.jacc.2018.03.521; Kanda E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41663-7; Koyner JL, 2018, CRIT CARE MED, V46, P1070, DOI 10.1097/CCM.0000000000003123; Levey AS, 2014, AM J KIDNEY DIS, V64, P821, DOI 10.1053/j.ajkd.2014.07.030; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Liu YX, 2018, KIDNEY BLOOD PRESS R, V43, P1852, DOI 10.1159/000495818; Matsushita K, 2016, KIDNEY INT, V90, P1109, DOI 10.1016/j.kint.2016.08.003; Niel O, 2019, AM J KIDNEY DIS, V74, P803, DOI 10.1053/j.ajkd.2019.05.020; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Rosansky SJ, 2012, AM J NEPHROL, V36, P1, DOI 10.1159/000339327; Smart NA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007333.pub2; Toto RD, 2010, AM J KIDNEY DIS, V56, P896, DOI 10.1053/j.ajkd.2010.05.016; Wanner C, 2018, J AM SOC NEPHROL, V29, P2755, DOI 10.1681/ASN.2018010103; Xiao J, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1860-0; Xie Y, 2018, KIDNEY INT, V94, P567, DOI 10.1016/j.kint.2018.04.011; Xie Y, 2016, AM J KIDNEY DIS, V68, P219, DOI 10.1053/j.ajkd.2016.02.039; Yang W, 2014, AM J KIDNEY DIS, V63, P236, DOI 10.1053/j.ajkd.2013.08.028; Yu KH, 2018, NAT BIOMED ENG, V2, P719, DOI 10.1038/s41551-018-0305-z; Yu Z, 2019, AM J KIDNEY DIS, V74, P310, DOI 10.1053/j.ajkd.2019.02.015; Zhao J, 2019, MATH BIOSCI, V310, P24, DOI 10.1016/j.mbs.2019.02.001	33	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239262	10.1371/journal.pone.0239262	http://dx.doi.org/10.1371/journal.pone.0239262			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941535	gold, Green Published			2022-12-26	WOS:000573848800035
J	Khoshabi, P; Nejati, E; Ahmadi, SF; Chegini, A; Makui, A; Ghousi, R				Khoshabi, Pooya; Nejati, Erfan; Ahmadi, Seyyede Fatemeh; Chegini, Ali; Makui, Ahmad; Ghousi, Rouzbeh			Developing a Multi-Criteria Decision Making approach to compare types of classroom furniture considering mismatches for anthropometric measures of university students	PLOS ONE			English	Article							SCHOOL FURNITURE; FUZZY TOPSIS; DIMENSIONS; MATCH; DESIGN; VIKOR; RESOURCES; SELECTION; RELEVANT; SEAT	The mismatch between students' anthropometric measures and school furniture dimensions have been investigated in many countries. In Iran, collegians spend at least a quarter of the day hours at university in the sitting position, so it is essential to evaluate furniture mismatch among university students. In Iranian universities, the use of chairs with an attached table is widespread, while the study of mismatches in these chairs among the collegian community is rare. This study was aimed to compare and rank different classroom furniture types based on the mismatch between collegians' anthropometric measures and the dimensions of classroom furniture among Industrial Engineering students by developing a Multi-Criteria Decision Making approach in an integrated Methodology. The sample consisted of 111 participants (71 males, 40 females). Ten anthropometric measures were gathered, together with eight furniture dimensions for four types of chairs. Mismatch analyses were carried out using mismatch equations, and the Simple Additive Weighting method was used as a base method to solve the decision-making problem. The results indicated that Underneath Desk Height and Seat to Desk Clearance showed the highest levels of the match, while Seat Width presents the highest levels of low mismatch. According to the results, Type 1 and Type 3 were the best current classroom furniture. The Sensitivity Analysis was performed in two ways: changing the weights of criteria in nine scenarios and comparing the results with five other MCDM methods. The proposed MCDM approach can be used widely in furniture procurement processes and educational environments.	[Khoshabi, Pooya; Nejati, Erfan; Ahmadi, Seyyede Fatemeh; Chegini, Ali; Makui, Ahmad; Ghousi, Rouzbeh] Iran Univ Sci & Technol, Dept Ind Engn, Tehran, Iran	Iran University Science & Technology	Ghousi, R (corresponding author), Iran Univ Sci & Technol, Dept Ind Engn, Tehran, Iran.	ghousi@iust.ac.ir	Chegini, Ali/ABI-3779-2020; ghousi, rouzbeh/S-8982-2018; makui, ahmad/S-6038-2018	ghousi, rouzbeh/0000-0002-5839-5792; makui, ahmad/0000-0001-6249-530X; Nejati, Erfan/0000-0002-9032-4206; Ahmadi, Seyyede Fatemeh/0000-0001-8864-6401; Chegini, Ali/0000-0002-1448-3555				Agha SR, 2010, ERGONOMICS, V53, P344, DOI 10.1080/00140130903398366; Ahmadi M, 2017, INT J IND ERGONOM, V59, P54, DOI 10.1016/j.ergon.2017.03.002; Al-Hinai N., 2018, INT J MECH ENG ROBOT, V7, P534, DOI DOI 10.18178/IJMERR.7.5.534-543; [Anonymous], 2018, CANC DISCOV, V8, pOF6; Ashtiani B, 2009, APPL SOFT COMPUT, V9, P457, DOI 10.1016/j.asoc.2008.05.005; Assunu║ao A., 2013, INT J HUM FACTORS ER, V2, P66, DOI [DOI 10.1504/IJHFE.2013.055974, 10.1504/IJHFE.2013.055974]; Bahrampour S, 2020, INT J OCCUP SAF ERGO, V26, P429, DOI 10.1080/10803548.2018.1550912; Bana E Costa CA, 2005, INT SER OPER RES MAN, V78, P409, DOI 10.1007/0-387-23081-5_10; Biswas S., 2019, DECIS MAK APPL MANAG, V2, P138, DOI DOI 10.31181/DMAME1902040B; Bravo G, 2018, WORK, V60, P3, DOI 10.3233/WOR-182719; Castellucci HI, 2016, WORK, V53, P585, DOI 10.3233/WOR-152233; Castellucci HI, 2015, APPL ERGON, V46, P201, DOI 10.1016/j.apergo.2014.08.005; Castellucci HI, 2014, APPL ERGON, V45, P1123, DOI 10.1016/j.apergo.2014.01.012; Castellucci HI, 2010, APPL ERGON, V41, P563, DOI 10.1016/j.apergo.2009.12.001; Chiu MC, 2016, APPL ERGON, V54, P136, DOI 10.1016/j.apergo.2015.11.017; Clauser C. E., 1988, MEASURERS HDB US ARM; de Almeida A.T., 2015, MULTICRITERIA MULTIO; Deng Y, 2011, EXPERT SYST APPL, V38, P9854, DOI 10.1016/j.eswa.2011.02.017; Dianat I, 2013, APPL ERGON, V44, P101, DOI 10.1016/j.apergo.2012.05.004; Dobrosavljevi A., 2019, OPER RES ENG SCI THE, V2, P40, DOI [10.31181/oresta1903040d, DOI 10.31181/ORESTA1903040D]; EVANS WA, 1988, APPL ERGON, V19, P122, DOI 10.1016/0003-6870(88)90005-1; Fasulo L, 2019, APPL ERGON, V74, P233, DOI 10.1016/j.apergo.2018.08.021; Fazlollahtabar H, 2010, APPL ERGON, V42, P16, DOI 10.1016/j.apergo.2010.04.004; Figueira J, 2005, INT SER OPER RES MAN, V78, P1, DOI 10.1007/b100605; FISHBURN PC, 1967, NAV RES LOGIST Q, V14, P1, DOI 10.1002/nav.3800140102; Garcia-Acosta G, 2007, ERGONOMICS, V50, P1626, DOI 10.1080/00140130701587541; Gouvali MK, 2006, APPL ERGON, V37, P765, DOI 10.1016/j.apergo.2005.11.009; Greco S., 2016, MULTIPLE CRITERIA DE, V37; Halder P, 2018, J OCCUP HEALTH, V60, P64, DOI 10.1539/joh.16-0163-OA; Hsieh MC, 2018, INT J IND ERGONOM, V67, P171, DOI 10.1016/j.ergon.2018.05.004; Hwang C-L., 1981, MULTIPLE ATTRIBUTE D, V186, P58, DOI [DOI 10.1007/978-3-642-48318-9, 10.1007/978-3-642-48318-9]; JEONG BY, 1990, ERGONOMICS, V33, P1511, DOI 10.1080/00140139008925350; JUNG ES, 1991, ERGONOMICS, V34, P1351, DOI 10.1080/00140139108964875; Kahraman Y.R., 2002, ROBUST SENSITIVITY A; Klein JH, 1998, J OPER RES SOC, V49, P96, DOI 10.2307/3010661; Lee Y, 2018, INT J IND ERGONOM, V68, P260, DOI 10.1016/j.ergon.2018.08.010; Li H, 2020, APPL SOFT COMPUT, V91, DOI 10.1016/j.asoc.2020.106207; Macedo AC, 2015, HUM FACTORS, V57, P48, DOI 10.1177/0018720814533991; Mandel A.C, 1997, ERGON DES, V5, P28; McCormick E.J., 1982, HUMAN FACTORS ENG DE; Mihajlovic J., 2019, OPER RES ENG SCI, V2, P72, DOI [10.31181/oresta190247m, DOI 10.31181/ORESTA190247M]; Milanese S, 2004, ERGONOMICS, V47, P416, DOI 10.1080/0014013032000157841; Mohammadfam I, 2019, INT J IND ERGONOM, V74, DOI 10.1016/j.ergon.2019.102842; Mokdad M, 2002, INT J IND ERGONOM, V29, P331, DOI 10.1016/S0169-8141(01)00073-7; Mokhtarian MN, 2014, COMPUT IND ENG, V78, P213, DOI 10.1016/j.cie.2014.09.008; Molenbroek JFM, 2017, APPL ERGON, V65, P130, DOI 10.1016/j.apergo.2017.06.003; Mououdi MA, 1997, APPL ERGON, V28, P145, DOI 10.1016/S0003-6870(95)00059-3; Opricovic S, 2004, EUR J OPER RES, V156, P445, DOI 10.1016/s0377-2217(03)00020-1; Opricovic S., 1990, P 17 INT S OP RES SY; Opricovic S, 2011, EXPERT SYST APPL, V38, P12983, DOI 10.1016/j.eswa.2011.04.097; Orborne DJ, 1996, ERGONOMICS WORK HUMA; Oyewole SA, 2010, INT J IND ERGONOM, V40, P437, DOI 10.1016/j.ergon.2010.02.002; Pamucar D, 2015, EXPERT SYST APPL, V42, P3016, DOI 10.1016/j.eswa.2014.11.057; Panagiotopoulou G, 2004, APPL ERGON, V35, P121, DOI 10.1016/j.apergo.2003.11.002; Parcells C, 1999, J ADOLESCENT HEALTH, V24, P265, DOI 10.1016/S1054-139X(98)00113-X; Rossi D, 2019, ERGONOMICS, V62, P1301, DOI 10.1080/00140139.2019.1647349; Saaty T, 1980, ANAL HIERARCHY PROCE; Saaty T.L., 2013, DECISION MAKING ANAL, P1, DOI [10.1007/978-1-4614-7279-7_1, DOI 10.1007/978-1-4614-7279-7_1]; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Saaty TL, 2001, MANAG FOR ECOSYST, V3, P15; Sarin RK, 2013, ENCY OPERATIONS RES, V3rd, P1004, DOI [10.1007/978-1-4419-1153-7_644., DOI 10.1007/978-1-4419-1153-7_644]; Savanur CS, 2007, ERGONOMICS, V50, P1612, DOI 10.1080/00140130701587350; Stevic Z, 2020, COMPUT IND ENG, V140, DOI 10.1016/j.cie.2019.106231; Taifa IW, 2017, ENG SCI TECHNOL, V20, P232, DOI 10.1016/j.jestch.2016.08.004; Triantaphyllou E., 2000, MULTICRITERIA DECISI, VVolume 44; Ustinovichius L, 2007, CONTROL CYBERN, V36, P251; Wang WZ, 2018, INT J IND ERGONOM, V67, P242, DOI 10.1016/j.ergon.2018.06.002; Yanto, 2017, APPL ERGON, V62, P168, DOI 10.1016/j.apergo.2017.03.004; Zavadskas EK, 2012, ELEKTRON ELEKTROTECH, V122, P3, DOI 10.5755/j01.eee.122.6.1810; Zavadskas EK, 2010, TECHNOL ECON DEV ECO, V16, P159, DOI 10.3846/tede.2010.10	70	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239297	10.1371/journal.pone.0239297	http://dx.doi.org/10.1371/journal.pone.0239297			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941538	Green Published, gold			2022-12-26	WOS:000573848800021
J	Sanz-de-Galdeano, A; Terskaya, A; Upegui, A				Sanz-de-Galdeano, Anna; Terskaya, Anastasia; Upegui, Angie			Association of a genetic risk score with BMI along the life-cycle: Evidence from several US cohorts	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE; OBESITY; WEIGHT; BIRTH; ENVIRONMENT; ADOLESCENT; VARIANTS; AGE; SELECTION	We use data from the National Longitudinal Study of Adolescent to Adult Health and from the Health and Retirement Study to explore how the effect of individuals' genetic predisposition to higher BMI -measured by BMI polygenic scores- changes over the life-cycle for several cohorts. We find that the effect of BMI polygenic scores on BMI increases significantly as teenagers transition into adulthood (using the Add Health cohort, born 1974-83). However, this is not the case for individuals aged 55+ who were born in earlier HRS cohorts (1931-53), whose life-cycle pattern of genetic influence on BMI is remarkably stable as they move into old-age.	[Sanz-de-Galdeano, Anna; Upegui, Angie] Univ Alicante, FAE, Alicante, Spain; [Sanz-de-Galdeano, Anna] Inst Lab Econ, Bonn, Germany; [Sanz-de-Galdeano, Anna] CRES UPF, Barcelona, Spain; [Terskaya, Anastasia] Univ Navarra, Sch Econ & Business, Pamplona, Spain	Universitat d'Alacant; IZA Institute Labor Economics; University of Navarra	Sanz-de-Galdeano, A (corresponding author), Univ Alicante, FAE, Alicante, Spain.; Sanz-de-Galdeano, A (corresponding author), Inst Lab Econ, Bonn, Germany.; Sanz-de-Galdeano, A (corresponding author), CRES UPF, Barcelona, Spain.	anna.sanzdegaldeano@gmail.com			Spanish Ministry of Economy and Competitiveness [ECO2017-87069-P];  [PROMETEO/2019/037]	Spanish Ministry of Economy and Competitiveness(Spanish Government); 	Anna Sanz-de-Galdeano acknowledges financial support from PROMETEO/2019/037 and from the Spanish Ministry of Economy and Competitiveness Grant ECO2017-87069-P.	[Anonymous], 2013, MAN OV OB AD SYST EV; Barcellos SH, 2018, P NATL ACAD SCI USA, V115, pE9765, DOI 10.1073/pnas.1802909115; Belsky DW, 2014, BIODEMOGR SOC BIOL, V60, P137, DOI 10.1080/19485565.2014.946591; Belsky DW, 2012, ARCH PEDIAT ADOL MED, V166, P515, DOI 10.1001/archpediatrics.2012.131; Benjamin DJ, 2012, ANNU REV ECON, V4, P627, DOI 10.1146/annurev-economics-080511-110939; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Biroli P, 2015, GENETIC EC INTERACTI; Boardman JD, 2014, DEMOGRAPHY, V51, P119, DOI 10.1007/s13524-013-0259-4; Boardman JD, 2013, AM J PUBLIC HEALTH, V103, P64, DOI 10.2105/AJPH.2013.301355; Boardman JD, 2012, J THEOR POLIT, V24, P370, DOI 10.1177/0951629812437751; Bockerman P, 2019, HEALTH ECON, V28, P65, DOI 10.1002/hec.3828; Brunello G., 2008, RISE OBESITY ATLANTI; Brunello G, 2007, ECON HUM BIOL, V5, P1, DOI 10.1016/j.ehb.2006.11.002; Brunello G, 2020, J HEALTH ECON, V72, DOI 10.1016/j.jhealeco.2020.102349; Cawley J, 2004, J HUM RESOUR, V39, P451, DOI 10.2307/3559022; Cawley J, 2011, OXFORD HDB SOCIAL SC; Cawley J, 2015, J HEALTH ECON, V43, P244, DOI 10.1016/j.jhealeco.2015.03.001; Crosnoe R, 2008, SOC FORCES, V86, P1189; Cutler DM, 2003, J ECON PERSPECT, V17, P93, DOI 10.1257/089533003769204371; Day FR, 2017, NAT GENET, V49, P834, DOI 10.1038/ng.3841; de la Haye K, 2011, J ADOLESCENT HEALTH, V49, P421, DOI 10.1016/j.jadohealth.2011.02.008; Demerath EW, 2013, HUM HERED, V75, P175, DOI 10.1159/000351742; Domingue BW, 2018, P NATL ACAD SCI USA, V115, P702, DOI 10.1073/pnas.1711803115; Domingue BW, 2017, INT J EPIDEMIOL, V46, P1285, DOI 10.1093/ije/dyx041; Domingue BW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101596; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Firpo S, 2009, ECONOMETRICA, V77, P953, DOI 10.3982/ECTA6822; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Harris SE, 2017, AGING-US, V9, P2489, DOI 10.18632/aging.101333; JENCKS C, 1980, AM SOCIOL REV, V45, P723, DOI 10.2307/2094892; Jou C, 2014, NEW ENGL J MED, V370, P1874, DOI 10.1056/NEJMp1400613; Kasen S, 2008, INT J OBESITY, V32, P558, DOI 10.1038/sj.ijo.0803736; Khera AV, 2019, CELL, V177, P587, DOI 10.1016/j.cell.2019.03.028; Kuczmarski R. J., 2002, 2000 CDC GROWTH CHAR; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Liu H, 2015, AM SOCIOL REV, V80, P705, DOI 10.1177/0003122415590627; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Mendle J, 2019, J RES ADOLESCENCE, V29, P82, DOI 10.1111/jora.12371; Nagata JM, 2019, INT J EAT DISORDER, V52, P825, DOI 10.1002/eat.23083; OECD, 2017, OB UPD; Ong KK, 2012, J CLIN ENDOCR METAB, V97, P2844, DOI 10.1210/jc.2011-3445; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027135; Rokholm B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020816; Rosenquist JN, 2015, P NATL ACAD SCI USA, V112, P354, DOI 10.1073/pnas.1411893111; Sandholt CH, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.9; Sanz-de Galdeano A, 2019, 12375 IZA; Schaefer DR, 2014, AM J PUBLIC HEALTH, V104, P1223, DOI 10.2105/AJPH.2013.301768; Solorzano CMB, 2010, REPRODUCTION, V140, P399, DOI 10.1530/REP-10-0119; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Walter S, 2016, JAMA-J AM MED ASSOC, V316, P63, DOI 10.1001/jama.2016.8729; World Health Organization, 2000, WHO TECHN REP SER, P894; Yang WJ, 2007, EPIDEMIOL REV, V29, P49, DOI 10.1093/epirev/mxm004; Yao C, 2014, HUM MOL GENET, V23, P1947, DOI 10.1093/hmg/ddt582; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zajacova A, 2013, POPUL RES POLICY REV, V32, P311, DOI 10.1007/s11113-013-9273-x	60	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239067	10.1371/journal.pone.0239067	http://dx.doi.org/10.1371/journal.pone.0239067			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941506	Green Submitted, gold, Green Published			2022-12-26	WOS:000573848800088
J	Doheny, D; Sirkisoon, S; Carpenter, RL; Aguayo, NR; Regua, AT; Anguelov, M; Manore, SG; Arrigo, A; Abu Jalboush, S; Wong, GL; Yu, Y; Wagner, CJ; Chan, M; Ruiz, J; Thomas, A; Strowd, R; Lin, J; Lo, HW				Doheny, Daniel; Sirkisoon, Sherona; Carpenter, Richard L.; Aguayo, Noah Reeve; Regua, Angelina T.; Anguelov, Marlyn; Manore, Sara G.; Arrigo, Austin; Jalboush, Sara Abu; Wong, Grace L.; Yu, Yang; Wagner, Calvin J.; Chan, Michael; Ruiz, Jimmy; Thomas, Alexandra; Strowd, Roy; Lin, Jiayuh; Lo, Hui-Wen			Combined inhibition of JAK2-STAT3 and SMO-GLI1/tGLI1 pathways suppresses breast cancer stem cells, tumor growth, and metastasis	ONCOGENE			English	Article							SIGNALING PATHWAY; SONIC HEDGEHOG; THERAPEUTIC TARGET; GENE-EXPRESSION; FACTOR RECEPTOR; SPLICE VARIANT; UP-REGULATION; SELF-RENEWAL; STAT3; ACTIVATION	Triple-negative breast cancer (TNBC) and HER2-positive breast cancer are particularly aggressive and associated with unfavorable prognosis. TNBC lacks effective treatments. HER2-positive tumors have treatment options but often acquire resistance to HER2-targeted therapy after initial response. To address these challenges, we determined whether novel combinations of JAK2-STAT3 and SMO-GLI1/tGLI1 inhibitors synergistically target TNBC and HER2 breast cancer since these two pathways are concurrently activated in both tumor types and enriched in metastatic tumors. Herein, we show that novel combinations of JAK2 inhibitors (ruxolitinib and pacritinib) with SMO inhibitors (vismodegib and sonidegib) synergistically inhibited in vitro growth of TNBC and HER2-positive trastuzumab-resistant BT474-TtzmR cells. Synergy was also observed against breast cancer stem cells. To determine if the combination is efficacious in inhibiting metastasis, we treated mice with intracardially inoculated TNBC cells and found the combination to inhibit lung and liver metastases, and prolong host survival without toxicity. The combination inhibited orthotopic growth, VEGF-A expression, and tumor vasculature of both TNBC and HER2-positive trastuzumab-refractory breast cancer. Lung metastasis of orthotopic BT474-TtzmR xenografts was suppressed by the combination. Together, our results indicated that dual targeting of JAK2 and SMO resulted in synergistic suppression of breast cancer growth and metastasis, thereby supporting future clinical testing.	[Doheny, Daniel; Sirkisoon, Sherona; Carpenter, Richard L.; Aguayo, Noah Reeve; Regua, Angelina T.; Anguelov, Marlyn; Manore, Sara G.; Arrigo, Austin; Jalboush, Sara Abu; Wong, Grace L.; Yu, Yang; Wagner, Calvin J.; Lo, Hui-Wen] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27103 USA; [Chan, Michael; Ruiz, Jimmy; Thomas, Alexandra; Strowd, Roy; Lo, Hui-Wen] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Comprehens Canc Ctr, Winston Salem, NC 27103 USA; [Chan, Michael] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiat Oncol, Winston Salem, NC USA; [Ruiz, Jimmy; Thomas, Alexandra] Wake Forest Univ, Bowman Gray Sch Med, Dept Hematol & Oncol, Winston Salem, NC USA; [Strowd, Roy] Wake Forest Univ, Bowman Gray Sch Med, Dept Neurol, Winston Salem, NC 27103 USA; [Lin, Jiayuh] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Carpenter, Richard L.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, JH 308 1001 E 3rd St, Bloomington, IN 47405 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University System of Maryland; University of Maryland Baltimore; Indiana University System; Indiana University Bloomington	Lo, HW (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27103 USA.; Lo, HW (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Comprehens Canc Ctr, Winston Salem, NC 27103 USA.	hlo@wakehealth.edu		Manore, Sara/0000-0003-1962-5505; Regua, Angelina/0000-0003-2595-8242; Doheny, Daniel/0000-0002-1455-3090	NIH [R01NS087169, T32CA079448, R01NS087169-3S1, 1T32CA247819-01, P30CA012197, 1R01CA228137-01A1]; DoD [W81XWH-17-1-0044, W81XWH-19-1-0072, W81XWH-19-1-0753, W81XWH-20-1-0044]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense)	We would like to acknowledge the Massague laboratory for gifting the 231-BoM and 231-BrM breast cancer cell lines and Dr. Dihua Yu for gifting the BT474-TtzmR cell line. We acknowledge funding support for this project from NIH grants, R01NS087169 (HWL), T32CA079448 (RLC), R01NS087169-3S1 (HWL and SS), 1T32CA247819-01 (ATR), P30CA012197 (BP), 1R01CA228137-01A1 (HWL), as well as, DoD grants, W81XWH-17-1-0044 (HWL), W81XWH-19-1-0072 (HWL), W81XWH-19-1-0753 (HWL), and W81XWH-20-1-0044 (HWL and JL).	Ackerman Z, 2015, BIOL TRACE ELEM RES, V163, P169, DOI 10.1007/s12011-014-0110-9; Aditya Suruchi, 2013, Indian Dermatol Online J, V4, P365, DOI 10.4103/2229-5178.120685; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Mahmood S, 2018, DRUG DELIV TRANSL RE, V8, P1483, DOI 10.1007/s13346-018-0551-3; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Balko JM, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3001; Balko JM, 2014, CANCER DISCOV, V4, P232, DOI 10.1158/2159-8290.CD-13-0286; Baron JM, 2015, J ONCOL PHARM PRACT, V21, P132, DOI 10.1177/1078155214527144; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Carpenter RL, 2015, ONCOTARGET, V6, P22653, DOI 10.18632/oncotarget.4248; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Carpenter RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078836; Carpenter RL, 2013, J CARCINOG MUTAGEN, P2013; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Choi HJ, 2012, BBA-MOL CELL RES, V1823, P1082, DOI 10.1016/j.bbamcr.2012.03.015; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Foshay KM, 2008, STEM CELLS DEV, V17, P269, DOI 10.1089/scd.2007.0098; Gruber R, 2016, GASTROENTEROLOGY, V151, P526, DOI 10.1053/j.gastro.2016.05.006; Guo CC, 2012, P NATL ACAD SCI USA, V109, P17603, DOI 10.1073/pnas.1208807109; Han W, 2013, CANC HALLMARKS, V1, P28, DOI DOI 10.1166/CH.2013.1006; Hindley C, 2013, BIOCHEM J, V451, P135, DOI 10.1042/BJ20121627; Howie LJ, 2019, CLIN CANCER RES, V25, P2949, DOI 10.1158/1078-0432.CCR-18-3003; Howlader NNA, 2019, SEER CANC STAT REV 1, V2020, P1975; Hsu TH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04052-6; Jain S, 2017, ONCOTARGETS THER, V10, DOI 10.2147/OTT.S130910; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Kameda C, 2009, ANTICANCER RES, V29, P871; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KINZLER KW, 1988, NATURE, V332, P371, DOI 10.1038/332371a0; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Kuba S, 2014, JPN J CLIN ONCOL, V44, P1025, DOI 10.1093/jjco/hyu126; Kusaba T, 2006, ONCOL REP, V15, P1445; Lebert JM, 2018, CURR ONCOL, V25, pS142, DOI 10.3747/co.25.3954; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2009, CANCER RES, V69, P6790, DOI 10.1158/0008-5472.CAN-09-0886; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Loh CY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00048; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Merchant AA, 2010, CLIN CANCER RES, V16, P3130, DOI 10.1158/1078-0432.CCR-09-2846; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Okumura F, 2011, BBA-MOL CELL RES, V1813, P1784, DOI 10.1016/j.bbamcr.2011.05.013; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; Palmieri C, 2010, NAT REV CLIN ONCOL, V7, P561, DOI 10.1038/nrclinonc.2010.122; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Qin JJ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1206-z; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Rimkus TK, 2018, CANCER RES, V78, P2589, DOI 10.1158/0008-5472.CAN-17-2933; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Riobo-Del Galdo NA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040375; Ruiz-Borrego M, 2019, INVEST NEW DRUG, V37, P98, DOI 10.1007/s10637-018-0614-9; Ryan Q, 2008, ONCOLOGIST, V13, P1114, DOI 10.1634/theoncologist.2008-0816; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sirkisoon SR, 2020, ONCOGENE, V39, P64, DOI 10.1038/s41388-019-0959-3; Sirkisoon SR, 2018, ONCOGENE, V37, P2502, DOI 10.1038/s41388-018-0132-4; Snigdha K, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00085; Tavallai M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00142; Teperino R, 2014, SEMIN CELL DEV BIOL, V33, P81, DOI 10.1016/j.semcdb.2014.05.007; Wang T, 2015, ONCOTARGET, V6, P44191, DOI 10.18632/oncotarget.6176; Wang Y, 2018, CANCER LETT, V415, P117, DOI 10.1016/j.canlet.2017.12.003; Xie JW, 1997, CANCER RES, V57, P2369; Zaidi AH, 2013, CANCER INVEST, V31, P480, DOI 10.3109/07357907.2013.820317; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhu C, 2015, ACTA BIOCH BIOPH SIN, V47, P16, DOI 10.1093/abbs/gmu110; Zhu H, 2014, CANCER LETT, V343, P51, DOI 10.1016/j.canlet.2013.09.014	80	23	25	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2020	39	42					6589	6605		10.1038/s41388-020-01454-1	http://dx.doi.org/10.1038/s41388-020-01454-1		SEP 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA9HI	32929154	Green Accepted			2022-12-26	WOS:000569499000002
J	Hoffman, BU				Hoffman, Benjamin U.			Significant relaxation of SARS-CoV-2-targeted non-pharmaceutical interventions may result in profound mortality: A New York state modelling study	PLOS ONE			English	Article							CORONAVIRUS; CHINA	Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is the most significant global health crisis of the 21(st)century. The aim of this study was to develop a model to simulate the effect of undocumented infections, seasonal infectivity, immunity, and non-pharmaceutical interventions (NPIs) on the transmission, morbidity, and mortality of SARS-CoV-2 in New York State (NYS) based on data collected between March 4 and April 28, 2020. Simulations predict that undocumented infections significantly contribute to infectivity, NPIs are effective in reducing morbidity and mortality, and relaxation >50% of NPIs from initial lock-down levels may result in tens-of-thousands more deaths. Endemic infection is likely to occur in the absence of sustained immunity. As a result, until an effective vaccine or other effective pharmaceutical intervention is developed, the risks of significantly reducing NPIs should be carefully considered. This study employs modelling to simulate fundamental characteristics of SARS-CoV-2 transmission, which can help policymakers navigate combating this virus in the coming years.	[Hoffman, Benjamin U.] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Hoffman, Benjamin U.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Columbia University; University of California System; University of California San Francisco	Hoffman, BU (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA.; Hoffman, BU (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Benjamin.Hoffman@ucsf.edu	Hoffman, Benjamin U/ABD-4670-2020	Hoffman, Benjamin U/0000-0002-9831-4061	NIH MSTP training grant (National Institute of General Medical Sciences) [T32GM007367]	NIH MSTP training grant (National Institute of General Medical Sciences)	BUH was funded by a NIH MSTP training grant (National Institute of General Medical Sciences T32GM007367; https://www.nigms.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, NAT RESP ENT VIR SUR; [Anonymous], 2019, BMJ, V2020, pm792; [Anonymous], 2018, FLUVIEW INTERACTIVE; [Anonymous], 2019, QUICKFACTS US; [Anonymous], 2020, NEW YORK STATE STATE; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Chan Kwok-Hung, 2013, J Infect, V67, P130, DOI 10.1016/j.jinf.2013.03.015; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Cohen J.E., 1992, JAMA-J AM MED ASSOC, V268, P3381, DOI [10.1001/jama.1992.03490230111047, DOI 10.1001/JAMA.1992.03490230111047, 10.1017/S0950268800059896]; Coleman T.F., 1994, MATH PROGRAM, V67, P189, DOI DOI 10.1007/BF01582221; Cuomo A, 2020, NEW YORK STATE GOVER; Cuomo A.M., 2020, AMID ONGOING COVID 1; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Ficetola G.F., 2020, MEDRXIV, DOI [10.1101/2020.03.23.20040501., DOI 10.1016/j.ijantimicag.2020.105924]; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Governor Andrew M., 2020, CUOMO ANNOUNCES TEMP; Haffajee RL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006740; Health CaCoSFDoP, 2020, ORC1907 HLTH CACOSFD; Islam N., 2020, TEMPERATURE HUMIDITY, DOI 10.1101/2020.03.27.20045658; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Killerby ME, 2018, J CLIN VIROL, V101, P52, DOI 10.1016/j.jcv.2018.01.019; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Li Q., 2020, NEW ENGL J MED, V382, P1199; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; National Academies of Sciences E Medicine, 2020, RAP EXP CONS SARS CO; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Qi HC, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138778; Radcliffe J., 1977, J R STAT SOC SER C A, V26, P85, DOI [10.2307/2346882, DOI 10.1057/JORS.1977.92]; Richard AN, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20224; Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa038; Sajadi Mohammad M, 2020, SSRN, P3550308, DOI 10.2139/ssrn.3550308; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Tang B, 2020, INT J INFECT DIS, V95, P288, DOI 10.1016/j.ijid.2020.03.018; Wang J., 2020, SSRN ELECT J, DOI [10.2139/ssrn.3551767, DOI 10.2139/SSRN.3551767]; White-House, 2020, OP AM WASH DC; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239647	10.1371/journal.pone.0239647	http://dx.doi.org/10.1371/journal.pone.0239647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970745	gold, Green Published			2022-12-26	WOS:000576265600057
J	Rotejanaprasert, C; Lawpoolsri, S; Pan-ngum, W; Maude, RJ				Rotejanaprasert, Chawarat; Lawpoolsri, Saranath; Pan-ngum, Wirichada; Maude, Richard J.			Preliminary estimation of temporal and spatiotemporal dynamic measures of COVID-19 transmission in Thailand	PLOS ONE			English	Article							SERIAL INTERVAL; INFLUENZA; FRAMEWORK; NUMBER	Background As a new emerging infectious disease pandemic, there is an urgent need to understand the dynamics of COVID-19 in each country to inform planning of emergency measures to contain its spread. It is essential that appropriate disease control activities are planned and implemented in a timely manner. Thailand was one of the first countries outside China to be affected with subsequent importation and domestic spread in most provinces in the country. Method A key ingredient to guide planning and implementation of public health measures is a metric of transmissibility which represents the infectiousness of a disease. Ongoing policies can utilize this information to plan appropriately with updated estimates of disease transmissibility. Therefore we present descriptive analyses and preliminary statistical estimation of reproduction numbers over time and space to facilitate disease control activities in Thailand. Results The estimated basic reproduction number for COVID-19 during the study ranged from 2.23-5.90, with a mean of 3.75. We also tracked disease dynamics over time using temporal and spatiotemporal reproduction numbers. The results suggest that the outbreak was under control since the middle of April. After the boxing stadium and entertainment venues, the numbers of new cases had increased and spread across the country. Discussion Although various scenarios about assumptions were explored in this study, the real situation was difficult to determine given the limited data. More thorough mathematical modelling would be helpful to improve the estimation of transmissibility metrics for emergency preparedness as more epidemiological and clinical information about this new infection becomes available. However, the results can be used to guide interventions directly and to help parameterize models to predict the impact of these interventions.	[Rotejanaprasert, Chawarat; Lawpoolsri, Saranath; Pan-ngum, Wirichada; Maude, Richard J.] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Rotejanaprasert, Chawarat; Pan-ngum, Wirichada] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Lawpoolsri, Saranath] Mahidol Univ, Fac Trop Med, Ctr Excellence Biomed & Publ Hlth Informat BIOPH, Bangkok, Thailand; [Maude, Richard J.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA; [Maude, Richard J.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [Maude, Richard J.] Open Univ, Milton Keynes, Bucks, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Open University - UK	Rotejanaprasert, C (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand.; Rotejanaprasert, C (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.	chawarat.rot@mahidol.th	Maude, Richard James/AAV-3567-2020	Maude, Richard James/0000-0002-5355-0562; Lawpoolsri, Saranath/0000-0003-4841-7924; pan-ngum, wirichada/0000-0002-9839-5359	Faculty of Tropical Medicine, Mahidol University - Wellcome Trust [106698/Z/14/Z]	Faculty of Tropical Medicine, Mahidol University - Wellcome Trust	This research was supported in part by the Faculty of Tropical Medicine, Mahidol University and Mahidol-Oxford Tropical Medicine Research Unit is funded by the Wellcome Trust (106698/Z/14/Z). There was no additional external funding received for this study and the funding had no role in the design or analysis of the study, interpretation of results, or writing of the manuscript.	Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Billah MA, 2020, REPROD NUMBER COVID; Boelle PY, 2009, EUROSURVEILLANCE, V14, P10; Brauer F, 2008, LECT NOTES MATH, V1945, P19; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Du Zhanwei, 2020, medRxiv, DOI 10.1101/2020.04.23.20075796; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]; Farrington CP, 1996, J ROY STAT SOC A STA, V159, P547, DOI 10.2307/2983331; Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Griffin JM, 2020, RAPID REV AVAILABLE; Hebert-Dufresne L., 2020, MEDRXIV; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lawson A.B., 2016, HDB SPATIAL EPIDEMIO; Lawson AB, 2014, STAT PUBLIC POLICY, V1, P99, DOI 10.1080/2330443X.2014.970247; Li Jing, 2011, Comput Math Methods Med, V2011, P527610, DOI 10.1155/2011/527610; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Ma S, 2020, EPIDEMIOLOGICAL PARA; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; Nouvellet P, 2018, EPIDEMICS-NETH, V22, P29, DOI 10.1016/j.epidem.2017.02.012; Obadia T, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-147; Polonsky JA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0276; Richardson S, 2004, ENVIRON HEALTH PERSP, V112, P1016, DOI 10.1289/ehp.6740; Rotejanaprasert C, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0833-6; Rotejanaprasert C, 2014, STAT METHODS MED RES, V23, P531, DOI 10.1177/0962280214527382; Thailand WHO, 1 THAIL WHO; Thailand WHO, 37 THAIL WHO; Tindale L. C., 2020, MEDRXIV; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Wu Jianmin, 2022, Crit Rev Food Sci Nutr, V62, P783, DOI 10.1080/10408398.2020.1828813; Zhao S, 2020, MEDRXIV; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	41	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239645	10.1371/journal.pone.0239645	http://dx.doi.org/10.1371/journal.pone.0239645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970773	Green Accepted, Green Published, gold			2022-12-26	WOS:000576265600054
J	Horky, P; Venusova, E; Aulichova, T; Ridoskova, A; Skladanka, J; Skalickova, S				Horky, Pavel; Venusova, Eva; Aulichova, Tereza; Ridoskova, Andrea; Skladanka, Jiri; Skalickova, Sylvie			Usability of graphene oxide as a mycotoxin binder: In vitro study	PLOS ONE			English	Article							ANIMAL FEED; HUMIC-ACID; DEOXYNIVALENOL; DETOXIFICATION; CONTAMINATION; PERFORMANCE; ADSORPTION; EXTRACTION; AGENTS	Mycotoxin management in agriculture is an essential challenge for maintaining the health of both animals and humans. Choosing the right adsorbent is still a question for many breeders and an important criterion for feed manufacturers. New adsorbents are still being sought. Graphene oxide is a promising material in the field of nanotechnology, which excels in its adsorption properties. Presented in vitro study investigates graphene oxide for the binding of mycotoxins from crushed wheat. The results show that graphene oxide has an adsorption capacity for aflatoxin 0.045 mg/g, zearalenone 0.53 mg/g and deoxynivalenol 1.69 mg/g at 37 degrees C. In vitro simulation of crushed wheat digestion showed rapid adsorption during the gastric phase. Of the minerals, Mg, Cu and Zn were the most adsorbed. The applied dose of graphene oxide of 10 mg/g caused only a slight inhibition of the digestive enzymes alpha-amylase and trypsin compared to pepsin and gastric lipase. In vitro results indicated the suitability of graphene oxide in the adsorption of the aflatoxin, zearalenone and deoxynivalenol.	[Horky, Pavel; Venusova, Eva; Aulichova, Tereza; Skladanka, Jiri; Skalickova, Sylvie] Mendel Univ Brno, Fac AgriSci, Dept Anim Nutr & Forage Prod, Brno, Czech Republic; [Ridoskova, Andrea] Mendel Univ Brno, Fac AgriSci, Dept Chem & Biochem, Brno, Czech Republic; [Ridoskova, Andrea] Mendel Univ Brno, CEITEC Cent European Inst Technol, Brno, Czech Republic	Mendel University in Brno; Mendel University in Brno; Mendel University in Brno	Skalickova, S (corresponding author), Mendel Univ Brno, Fac AgriSci, Dept Anim Nutr & Forage Prod, Brno, Czech Republic.	sylvie.skalickova@gmail.com	Skladanka, Jiri/I-6115-2018; Horky, Pavel/D-1995-2013; Aulichová, Tereza/AAF-6105-2021; Ridošková, Andrea/AAK-4072-2021; Skalickova, Sylvie/E-8430-2012; Ridošková, Andrea/A-6765-2016	Horky, Pavel/0000-0001-6074-785X; Ridošková, Andrea/0000-0002-4650-6379; Skalickova, Sylvie/0000-0002-2808-001X; Ridošková, Andrea/0000-0002-4650-6379; Skladanka, Jiri/0000-0002-7179-7606; Venusova, Eva/0000-0003-1782-6338; Aulichova, Tereza/0000-0002-9965-6020	TACR [TJ02000062]	TACR	Pavel Horky TACR TJ02000062 Advanced materials as a tool for eliminating mycotoxins in feed https://www.tacr.cz The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, J CANC RES THER, V14, pS622; Avantaggiato G, 2005, FOOD ADDIT CONTAM A, V22, P379, DOI 10.1080/02652030500058312; Bai XJ, 2018, APPL SURF SCI, V430, P198, DOI 10.1016/j.apsusc.2017.06.055; Balaiah P., 2015, J NANOMED NANOTECHNO, V6, P1; Bilal M, 2019, CRIT REV BIOTECHNOL, V39, P202, DOI 10.1080/07388551.2018.1531822; Brodkorb A, 2019, NAT PROTOC, V14, P991, DOI 10.1038/s41596-018-0119-1; Di Gregorio MC, 2014, TOXIN REV, V33, P125, DOI 10.3109/15569543.2014.905604; Doll S, 2004, ARCH ANIM NUTR, V58, P311, DOI 10.1080/00039420412331273268; Elliott C., 2019, MYCOTOXIN RES, V36, P1, DOI [10.1007/s12550-019-00360-0, DOI 10.1007/S12550-019-00360-0]; Elliott CT, 2020, MYCOTOXIN RES, V36, P115, DOI 10.1007/s12550-019-00375-7; Feizy J, 2019, CHROMATOGRAPHIA, V82, P917, DOI 10.1007/s10337-019-03725-w; Fochesato AS, 2019, J APPL MICROBIOL, V126, P223, DOI 10.1111/jam.14101; Gonzalez-Arias CA, 2013, WORLD MYCOTOXIN J, V6, P167, DOI 10.3920/WMJ2012.1521; Horky P, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8090727; Horky P, 2016, ANN ANIM SCI, V16, P521, DOI 10.1515/aoas-2015-0085; Horky P, 2015, INT J ELECTROCHEM SC, V10, P6610; Huang KJ, 2012, MICROCHIM ACTA, V176, P327, DOI 10.1007/s00604-011-0719-8; Jampilek J., 2020, NANOCOMPOSITES SYNER; Ji JM, 2020, J HAZARD MATER, V381, DOI 10.1016/j.jhazmat.2019.120915; Kalji O, 2020, J COLLOID INTERF SCI, V567, P285, DOI 10.1016/j.jcis.2020.02.010; Karjiban R. A., 2018, TOXINS, V10; Kolawole O, 2019, TOXINS, V11, DOI 10.3390/toxins11110659; Kolosova A, 2012, FOOD ADDIT CONTAM A, V29, P1959, DOI 10.1080/19440049.2012.720035; Li DP, 2016, NANOSCALE, V8, P19491, DOI 10.1039/c6nr07249f; Liu S. J., 2018, ABSTR PAP AM CHEM SO, V256; Luo Y, 2020, TRENDS FOOD SCI TECH, V96, P127, DOI 10.1016/j.tifs.2019.12.012; Medina A, 2015, CURR OPIN FOOD SCI, V5, P99, DOI 10.1016/j.cofs.2015.11.002; Nadziakiewicza M, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100714; Nevrkla P, 2014, ACTA VET BRNO, V83, P321, DOI 10.2754/avb201483040321; Magnoli AP, 2019, CURR OPIN FOOD SCI, V29, P99, DOI 10.1016/j.cofs.2019.08.009; Paulick M, 2015, TOXINS, V7, P791, DOI 10.3390/toxins7030791; Pei SF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02479-z; Pereira CS, 2019, TOXINS, V11, DOI 10.3390/toxins11050290; Pinotti L, 2016, TOXINS, V8, DOI 10.3390/toxins8020045; Pirouz AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12341-3; Pirouz AA, 2018, TOXINS, V10, DOI 10.3390/toxins10090361; Sakata M, 2012, CHEM LETT, V41, P1625, DOI 10.1246/cl.2012.1625; Santos RR, 2011, FOOD ADDIT CONTAM A, V28, P1578, DOI 10.1080/19440049.2011.595014; Smith MC, 2016, TOXINS, V8, DOI 10.3390/toxins8040094; Streit E, 2012, TOXINS, V4, P788, DOI 10.3390/toxins4100788; Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8; van Rensburg CJ, 2006, POULTRY SCI, V85, P1576, DOI 10.1093/ps/85.9.1576; Vila-Donat P, 2018, FOOD CHEM TOXICOL, V114, P246, DOI 10.1016/j.fct.2018.02.044; Yang C, 2020, J HAZARD MATER, V389, DOI 10.1016/j.jhazmat.2020.122087; Zhang H, 2020, CATAL LETT, V150, P1244, DOI 10.1007/s10562-019-03055-4; Zhang X, 2012, CHINESE SCI BULL, V57, P3045, DOI 10.1007/s11434-012-5256-2; Zhu Y, 2016, ANIM FEED SCI TECH, V216, P19, DOI 10.1016/j.anifeedsci.2016.03.030	47	8	9	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239479	10.1371/journal.pone.0239479	http://dx.doi.org/10.1371/journal.pone.0239479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966310	Green Published, gold			2022-12-26	WOS:000575688700059
J	Powell, CD; Wilson, WM; Olesaningo, G; Manyama, M; Jamniczky, H; Spritz, R; Cross, JC; Lukowiak, K; Hallgrimsson, B; Gonzalez, PN				Powell, Christopher D.; Wilson, Warren M.; Olesaningo, Godwin; Manyama, Mange; Jamniczky, Heather; Spritz, Richard; Cross, James C.; Lukowiak, Kenneth; Hallgrimsson, Benedikt; Gonzalez, Paula N.			Lack of head sparing following third-trimester caloric restriction among Tanzanian Maasai	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; LATE PREGNANCY; FETAL-GROWTH; FOOD-INTAKE; IN-UTERO; HEALTH; QUESTIONNAIRE; CIRCUMFERENCE; PASTORALISTS; POPULATION	The reduction of food intake during pregnancy is part of many cultural and religious traditions around the world. The impact of such practices on fetal growth and development are poorly understood. Here, we examined the patterns of diet intake among Maasai pregnant women and assessed their effect on newborn morphometrics. We recruited 141 mother-infant pairs from Ngorongoro Conservation Area (NCA) in Northern Tanzania and quantified dietary intake and changes in maternal diet during pregnancy. We obtained measurements of body weight (BW) and head circumference (HC) at birth. We found that Maasai women significantly reduced their dietary intake during the third trimester, going from an average of 1601 kcal/day during the first two trimesters to 799 kcal/day in the final trimester. The greatest proportion of nutrient reduction was in carbohydrates. Overall, 40% of HC Z-scores of the NCA sample were more than 2 standard deviations below the WHO standard. Nearly a third of neonates classify as low birth weight (< 2500g). HC was smaller relative to BW in this cohort than predicted using the WHO standard. This contrasts markedly to a Tanzanian birth cohort obtained at the same time in an urban context in which only 12% of infants exhibited low weight, only two individuals had HC Z-scores < 2 and HC's relative to birth weight were larger than predicted using the WHO standards. The surprising lack of head sparing in the NCA cohort suggests that the impact of third trimester malnutrition bears further investigation in both animal models and human populations, especially as low HC is negatively associated with long term health outcomes.	[Powell, Christopher D.; Hallgrimsson, Benedikt] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Wilson, Warren M.; Jamniczky, Heather] Univ Calgary, Dept Anthropol & Archaeol, Calgary, AB, Canada; [Olesaningo, Godwin] Endulen Hosp, Ngorongoro Conservat Area, Mwanza, Tanzania; [Manyama, Mange] Catholic Univ Hlth & Allied Sci, Mwanza, Tanzania; [Manyama, Mange] Weill Cornell Med, Div Med Educ, Ar Rayyan, Qatar; [Jamniczky, Heather] Univ Calgary, McCaig Bone & Joint Inst, Calgary, AB, Canada; [Spritz, Richard] Univ Colorado, Sch Med, Dept Pediat, Denver, CO USA; [Spritz, Richard] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Denver, CO USA; [Cross, James C.] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB, Canada; [Cross, James C.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Cross, James C.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Lukowiak, Kenneth] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Gonzalez, Paula N.] Uiversidad Nacl Arturo Jauretche, Hosp El Cruce Dr Nestor Kirchner, CONICET, Unidad Ejecutora Estudios Neurociencias & Sistema, Buenos Aires, DF, Argentina	University of Calgary; University of Calgary; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Calgary; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Calgary; Alberta Childrens Hospital; University of Calgary; University of Calgary; University of Calgary; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gonzalez, PN (corresponding author), Uiversidad Nacl Arturo Jauretche, Hosp El Cruce Dr Nestor Kirchner, CONICET, Unidad Ejecutora Estudios Neurociencias & Sistema, Buenos Aires, DF, Argentina.	pgonzalez@fcnym.unlp.edu.ar	; Cross, James/F-4814-2011; Hallgrimsson, Benedikt/A-9616-2008	Jamniczky, Heather/0000-0002-2514-8226; Cross, James/0000-0003-0956-9378; gonzalez, paula/0000-0001-6335-7363; Hallgrimsson, Benedikt/0000-0002-7192-9103; Lukowiak, Ken/0000-0001-9028-1931; Wilson, Warren/0000-0002-0057-6873	National Institute of Dental and Craniofacial Research [1U01DE020054]; Natural Sciences of Engineering Research Council of Canada [238992-12]	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Natural Sciences of Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was supported by: National Institute of Dental and Craniofacial Research to RS and BH (Grant number: 1U01DE020054) https://www.nidcr.nih.gov/Natural Sciences of Engineering Research Council of Canada to BH (Grant number: 238992-12) http://www.nserccrsng.gc.ca/index_eng.asp No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, HYPERTENS RES, V30, P627, DOI 10.1291/hypres.30.627; [Anonymous], 2010, CROSSROADS PUBLICATI, V14, P9; Archie JG, 2006, AM J CLIN PATHOL, V126, P256, DOI 10.1309/FK9D5WBA1UEPT5BB; Baasher T, 1979, WHO EMRO TECHNICAL P, V2, P71; Baker J, 2010, AM J HUM BIOL, V22, P206, DOI 10.1002/ajhb.20979; Barbeito-Andres J, 2018, NEUROSCIENCE, V380, P14, DOI 10.1016/j.neuroscience.2018.03.049; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEATON GH, 1979, AM J CLIN NUTR, V32, P2546, DOI 10.1093/ajcn/32.12.2546; Beddada B, 1979, WHO EMRO TECHNICAL P, V2, P47; Bishop E, 2007, NOMAD PEOPLES, V11, P9, DOI 10.3167/np.2007.110202; Bloomfield FH, 2006, ARCH DIS CHILD-FETAL, V91, pF299, DOI 10.1136/adc.2005.076646; Boone RB, 2006, HUM ECOL, V34, P809, DOI 10.1007/s10745-006-9031-3; Borghi E, 2006, STAT MED, V25, P247, DOI 10.1002/sim.2227; Coast E, 2001, MAASAI DEMOGRAPHY; Cole JB, 2018, J ANAT, V232, P250, DOI 10.1111/joa.12748; COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9; Crawford M. A., 1993, Nutrition and Health (Bicester), V9, P81; Creswell J.W., 2018, QUAL INQ, V4; de Onis Mercedes, 2003, Forum Nutr, V56, P238; de Onis M, 2013, WORLD REV NUTR DIET, V106, P75, DOI 10.1159/000342550; DJAZAYERY A, 1992, ECOL FOOD NUTR, V28, P105, DOI 10.1080/03670244.1992.9991263; Eikenes L, 2012, PEDIATR RES, V72, P649, DOI 10.1038/pr.2012.129; El Shalazi H, 1979, WHO EMRO TECHNICAL P, V2, P100; Elvander C, 2012, ACTA OBSTET GYN SCAN, V91, P470, DOI 10.1111/j.1600-0412.2012.01358.x; FAO, 2001, REP JOINT FAO WHO UN; Ferland S, 2003, J REPROD MED, V48, P86; Galvin KA, 1994, AFRICAN PASTORALIST; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; Geraedts EJ, 2011, HORM RES PAEDIAT, V75, P213, DOI 10.1159/000321192; Gonzalez PN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152227; Henrichs J, 2010, DEV MED CHILD NEUROL, V52, P644, DOI 10.1111/j.1469-8749.2009.03513.x; Henrichs J, 2009, DEV PSYCHOBIOL, V51, P119, DOI 10.1002/dev.20351; HUNTER DJ, 1988, AM J EPIDEMIOL, V127, P1240, DOI 10.1093/oxfordjournals.aje.a114916; Hutter I, 1996, TROP MED INT HEALTH, V1, P399, DOI 10.1046/j.1365-3156.1996.d01-53.x; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Kigutha NH, 1997, AM J CLIN NUTR, V65, p68S; Kiserud T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002220; KRAMER MS, 1989, PEDIATRICS, V84, P717; Lagiou P, 2004, EUR J CLIN NUTR, V58, P231, DOI 10.1038/sj.ejcn.1601771; Lassale C, 2009, J HUM NUTR DIET, V22, P559, DOI 10.1111/j.1365-277X.2009.00990.x; LAWRENCE M, 1987, LANCET, V2, P1072, DOI 10.1016/S0140-6736(87)91492-9; Lennox J, 2017, GHRP, V2, P1, DOI [10.1186/s41256-017-0028-922., DOI 10.1186/S41256-017-0028-922]; Low FM, 2012, EVOL BIOL, V39, P650, DOI 10.1007/s11692-011-9157-0; Lukmanji Z., 2008, TANZANIA FOOD COMPOS; Martin H, 2014, AM J RES COMM, V2, P12; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; Merchant KM, 2001, BRIT J OBSTET GYNAEC, V108, P689, DOI 10.1111/j.1471-0528.2001.00181.x; Michels KB, 2005, AM J EPIDEMIOL, V161, P987, DOI 10.1093/aje/kwi115; Miller LC, 2016, PAEDIATR INT CHILD H, V36, P91, DOI 10.1080/20469047.2015.1133517; Moore SE, 1999, INT J EPIDEMIOL, V28, P1088, DOI 10.1093/ije/28.6.1088; Mpoke S, 1993, West J Nurs Res, V15, P298, DOI 10.1177/019394599301500303; Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735; NESTEL PS, 1989, ECOL FOOD NUTR, V23, P17, DOI 10.1080/03670244.1989.9991085; NICHTER M, 1983, HUM ORGAN, V42, P235, DOI 10.17730/humo.42.3.43081445235366lk; Peleg D, 1998, AM FAM PHYSICIAN, V58, P453; Peng YM, 2005, ACTA PAEDIATR, V94, P843, DOI 10.1080/08035250510027589; POOL R, 1987, SOC SCI MED, V25, P389, DOI 10.1016/0277-9536(87)90277-2; Powell CD, 2012, THESIS; PRENTICE AM, 1989, BRIT J NUTR, V62, P5, DOI 10.1079/BJN19890004; RAO M, 1985, ECOL FOOD NUTR, V16, P93, DOI 10.1080/03670244.1985.9990852; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Rock M, 2009, SOC SCI MED, V68, P991, DOI 10.1016/j.socscimed.2008.12.047; Rosenberg K, 2002, BJOG-INT J OBSTET GY, V109, P1199, DOI 10.1046/j.1471-0528.2002.00010.x; Rosenberg Karen, 1995, Evolutionary Anthropology, V4, P161, DOI 10.1002/evan.1360040506; Samuelsen GB, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.011; Savitri AI, 2014, BRIT J NUTR, V112, P1503, DOI 10.1017/S0007114514002219; SIBERT JR, 1978, BRIT MED J, V1, P1517, DOI 10.1136/bmj.1.6126.1517; Skull SA, 1997, MED J AUSTRALIA, V166, P412, DOI 10.5694/j.1326-5377.1997.tb123191.x; SOBELL J, 1989, AM J EPIDEMIOL, V130, P173, DOI 10.1093/oxfordjournals.aje.a115310; Solomon B, 1991, ILCA SYSTEMS STUDY; Spear Thomas, 1993, BEING MAASAI ETHNICI; Sutter K, 1997, Pediatr Nurs, V23, P485; THOMPSON FE, 1994, J NUTR, V124, pS2245, DOI 10.1093/jn/124.suppl_11.2245s; van Assema P, 2001, J HUM NUTR DIET, V14, P377, DOI 10.1046/j.1365-277X.2001.00310.x; van den Broek AJM, 2010, EARLY HUM DEV, V86, P379, DOI 10.1016/j.earlhumdev.2010.04.007; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; von Mitzlaff U, 1994, MAASAI WOMEN LIFE PA; Walker SP, 2007, EARLY HUM DEV, V83, P355, DOI 10.1016/j.earlhumdev.2006.07.006; Wang KCW, 2012, CLIN EXP PHARMACOL P, V39, P958, DOI 10.1111/j.1440-1681.2012.05743.x; Wang ST, 1998, PUBLIC HEALTH, V112, P331, DOI 10.1038/sj.ph.1900482; Wells JCK, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0067; Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; Yaroch AL, 2000, J AM DIET ASSOC, V100, P1050, DOI 10.1016/S0002-8223(00)00306-0; Young S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041934; Zinsstag J, 2006, TROP MED INT HEALTH, V11, P565, DOI 10.1111/j.1365-3156.2006.01615.x	89	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0237700	10.1371/journal.pone.0237700	http://dx.doi.org/10.1371/journal.pone.0237700			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966295	gold, Green Published			2022-12-26	WOS:000575688700014
J	Coughlan, G; Puthusseryppady, V; Lowry, E; Gillings, R; Spiers, H; Minihane, AM; Hornberger, M				Coughlan, Gillian; Puthusseryppady, Vaisakh; Lowry, Ellen; Gillings, Rachel; Spiers, Hugo; Minihane, Anne-Marie; Hornberger, Michael			Test-retest reliability of spatial navigation in adults at-risk of Alzheimer's disease	PLOS ONE			English	Article							ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; REY-OSTERRIETH; GENETIC-RISK; MEMORY; DEMENTIA; BRAIN; RECOMMENDATIONS; DEFICITS	The Virtual Supermarket Task (VST) and Sea Hero Quest detect high-genetic-risk Alzheimer`s disease (AD). We aimed to determine their test-retest reliability in a preclinical AD population. Over two time points, separated by an 18-month period, 59 cognitively healthy individuals underwent a neuropsychological and spatial navigation assessment. At baseline, participants were classified as low-genetic-risk of AD or high-genetic-risk of AD. We calculated two-way mixed effects intraclass correlation coefficients (ICC) for task parameters and used repeated measures ANOVAS to determine whether genetic risk or sex contributed to test-retest variability. The egocentric parameter of the VST measure showed the highest test-retest reliability (ICC = .72), followed by the SHQ distance travelled parameter (ICC = .50). Post hoc longitudinal analysis showed that boundary-based navigation predicts worsening episodic memory concerns in high-risk (F = 5.01,P =0.03), but in not low-risk, AD candidates. The VST and the Sea Hero Quest produced parameters with acceptable test-retest reliability. Further research in larger sample sizes is desirable.	[Coughlan, Gillian; Puthusseryppady, Vaisakh; Gillings, Rachel; Minihane, Anne-Marie; Hornberger, Michael] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Lowry, Ellen] Univ East Anglia, Dept Psychol, Norwich, Norfolk, England; [Spiers, Hugo] UCL, Inst Behav Neurosci, Dept Expt Psychol, London, England	University of East Anglia; University of East Anglia; University of London; University College London	Hornberger, M (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England.	m.hornberger@uea.ac.uk	Hornberger, Michael/C-9610-2011	Hornberger, Michael/0000-0002-2214-3788; Lowry, Ellen/0000-0003-4576-5018; Minihane, Anne Marie/0000-0001-9042-4226				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Allison SL, 2019, ARCH CLIN NEUROPSYCH, V34, P1138, DOI 10.1093/arclin/acz019; Allison SL, 2016, J ALZHEIMERS DIS, V52, P77, DOI 10.3233/JAD-150855; Amariglio Rebecca E, 2018, Alzheimers Dement (N Y), V4, P444, DOI 10.1016/j.trci.2018.08.005; [Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; Atri A, 2011, ARCH NEUROL-CHICAGO, V68, P599, DOI 10.1001/archneurol.2011.94; Bird CM, 2010, HIPPOCAMPUS, V20, P1154, DOI 10.1002/hipo.20715; Bird CM, 2003, BRIT J CLIN PSYCHOL, V42, P407, DOI 10.1348/014466503322528946; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Chabak Kelson D., 2020, Semiconductor Science and Technology, V35, DOI 10.1088/1361-6641/ab55fe; Chan D, 2016, JOVE-J VIS EXP, DOI 10.3791/54454; Contreras Joey A, 2017, Alzheimers Dement (Amst), V6, P40, DOI 10.1016/j.dadm.2016.12.004; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coughlan G, 2020, NEUROBIOL AGING, DOI [10.1101/771170, DOI 10.1101/771170]; Coughlan G, 2019, P NATL ACAD SCI USA, V116, P9285, DOI 10.1073/pnas.1901600116; Coughlan G, 2018, NAT REV NEUROL, V14, P496, DOI 10.1038/s41582-018-0031-x; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; Ferretti MT, 2018, NAT REV NEUROL, V14, P457, DOI 10.1038/s41582-018-0032-9; Fu HJ, 2017, NEURON, V93, P533, DOI 10.1016/j.neuron.2016.12.023; Goldberg Terry E, 2015, Alzheimers Dement (Amst), V1, P103, DOI 10.1016/j.dadm.2014.11.003; Hardcastle K, 2015, NEURON, V86, P827, DOI 10.1016/j.neuron.2015.03.039; Hubley AM, 2010, ARCH CLIN NEUROPSYCH, V25, P197, DOI 10.1093/arclin/acq003; Husain M, 2017, BRAIN, V140, P251, DOI 10.1093/brain/aww353; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; Kunz L, 2015, SCIENCE, V350, P430, DOI 10.1126/science.aac8128; Laczo J, 2017, PSYCHOPHARMACOLOGY, V234, P535, DOI 10.1007/s00213-016-4488-2; Lester AW, 2017, NEURON, V95, P1019, DOI 10.1016/j.neuron.2017.06.037; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; Matias-Guiu JA, 2017, INT PSYCHOGERIATR, V29, P105, DOI 10.1017/S1041610216001496; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; McNutt M, 2014, SCIENCE, V343, P231, DOI 10.1126/science.1250475; Mehta D, 2017, EXPERT OPIN INV DRUG, V26, P735, DOI 10.1080/13543784.2017.1323868; O'Neil-Pirozzi TM, 2012, BRAIN INJURY, V26, P1425, DOI 10.3109/02699052.2012.694561; RAWLINGS DB, 1992, CLIN NEUROPSYCHOL, V6, P415, DOI 10.1080/13854049208401868; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tu SC, 2017, J ALZHEIMERS DIS, V59, P883, DOI 10.3233/JAD-160592; Tu SC, 2015, CORTEX, V67, P83, DOI 10.1016/j.cortex.2015.03.016; Turgut M, 2015, QUAL QUANT, V49, P1997, DOI 10.1007/s11135-014-0086-8; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570	44	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239077	10.1371/journal.pone.0239077	http://dx.doi.org/10.1371/journal.pone.0239077			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NW6FH	32960930	Green Accepted, Green Published, gold			2022-12-26	WOS:000575109500026
J	Ochieng, JK; Kundu, ST; Bajaj, R; Rodriguez, BL; Fradette, JJ; Gibbons, DL				Ochieng, Joshua Kapere; Kundu, Samrat T.; Bajaj, Rakhee; Rodriguez, B. Leticia; Fradette, Jared J.; Gibbons, Don L.			MBIP (MAP3K12 binding inhibitory protein) drives NSCLC metastasis by JNK-dependent activation of MMPs	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; OVARIAN-CANCER CELLS; MATRIX METALLOPROTEINASES; LUNG-CANCER; ACETYLTRANSFERASE COMPLEX; PROMOTES INVASION; EXPRESSION; PATHWAY; GENOME; TARGET	Metastasis is the cause for 90% of cancer-related mortalities. Identification of genetic drivers promoting dissemination of tumor cells may provide opportunities for novel therapeutic strategies. We previously reported an in vivo gain-of-function screen that identified similar to 30 genes with a functional role in metastasis promotion and characterized detailed mechanistic functions of two hits. In this study, we characterized the contribution of one of the identified genes, MBIP (MAP3K12 binding inhibitory protein), towards driving tumor invasion and metastasis. We demonstrate that expression of MBIP significantly enhances the cellular proliferation, migration and invasion of NSCLC cells in vitro and metastasis in vivo. We functionally characterized that MBIP mediates activation of the JNK pathway and induces expression of matrix metalloproteinases (MMPs), which are necessary for the invasive and metastatic phenotype. Our findings establish a novel mechanistic role of MBIP as a driver of NSCLC progression and metastasis.	[Ochieng, Joshua Kapere; Kundu, Samrat T.; Bajaj, Rakhee; Rodriguez, B. Leticia; Fradette, Jared J.; Gibbons, Don L.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Gibbons, Don L.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kundu, ST; Gibbons, DL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Gibbons, DL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	skundu@mdanderson.org; dlgibbon@mdanderson.org		Gibbons, Don/0000-0003-2362-3094; Bajaj, Rakhee/0000-0002-9990-1655; Kundu, Samrat/0000-0002-0117-6986; Fradette, Jared/0000-0001-6712-2860; Kapere Ochieng, Joshua/0000-0001-5082-3353	DoD CDMRP Lung cancer research award [W81XWH-12-16294]; NIH/NCIK [K08 CA151651]; Jeane F Shelby Scholarship Fund; University of Texas MD Anderson Lung Cancer Moon Shots Program	DoD CDMRP Lung cancer research award; NIH/NCIK; Jeane F Shelby Scholarship Fund; University of Texas MD Anderson Lung Cancer Moon Shots Program	This work was supported by the DoD CDMRP Lung cancer research award W81XWH-12-16294 and NIH/NCIK K08 CA151651. DLG is an R. Lee Clark Fellow of the University of Texas MD Anderson Cancer Center, supported by the Jeane F Shelby Scholarship Fund. The work was also supported by the generous philanthropic contributions to The University of Texas MD Anderson Lung Cancer Moon Shots Program. We would like to thank Dr. Ignacio Wistuba's lab for technical support, Jared Fredette and Laura Gibson for technical assistance and the UTMDACC Department of Veterinary Medicine Facility.	Ahn YH, 2012, J CLIN INVEST, V122, P3170, DOI 10.1172/JCI63608; Bajaj R, 2020, ONCOGENE, V39, P5979, DOI 10.1038/s41388-020-01410-z; Basu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123979; Cheng CY, 2012, STEM CELL RES, V9, P9, DOI 10.1016/j.scr.2012.02.005; Choi Y, 2016, WORLD J GASTROENTERO, V22, P9141, DOI 10.3748/wjg.v22.i41.9141; Conlon GA, 2019, J PATHOL, V247, P629, DOI 10.1002/path.5225; Fukuyama K, 2000, J BIOL CHEM, V275, P21247, DOI 10.1074/jbc.M001488200; Gazon H, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02686; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Gibbons DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005401; Grzeskowiak CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04572-3; Guelman S, 2009, MOL CELL BIOL, V29, P1176, DOI 10.1128/MCB.01599-08; Harris T, 2011, CLIN CANCER RES, V17, P690, DOI 10.1158/1078-0432.CCR-10-1892; He WL, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4317-6; Inoue H, 2001, EMBO J, V20, P5421, DOI 10.1093/emboj/20.19.5421; Ispanovic E, 2006, AM J PHYSIOL-CELL PH, V291, pC579, DOI 10.1152/ajpcell.00300.2005; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Jendrzejewski J, 2016, THYROID, V26, P1276, DOI 10.1089/thy.2015.0665; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Konen JM, 2019, CANCERS, V11, DOI 10.3390/cancers11040462; Lee YH, 2014, TUMOR BIOL, V35, P7699, DOI 10.1007/s13277-014-2027-5; Levin PA, 2016, J THORAC ONCOL, V11, P1357, DOI 10.1016/j.jtho.2016.04.015; Li M, 2018, CHIN J INTEGR MED, V24, P40, DOI 10.1007/s11655-017-2805-1; Liotta L A, 1990, Semin Cancer Biol, V1, P99; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Martinotti S, 2020, METHODS MOL BIOL, V2109, P225, DOI 10.1007/7651_2019_259; McCawley LJ, 2000, MOL MED TODAY, V6, P149, DOI 10.1016/S1357-4310(00)01686-5; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; Naglich JG, 2001, CANCER RES, V61, P8480; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Peng DH, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaq1238; Sathyanesan A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05656-w; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sporn MB, 1996, LANCET, V347, P1377, DOI 10.1016/S0140-6736(96)91015-6; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Stanciu AE, 2017, CLIN LAB, V63, P1613, DOI 10.7754/Clin.Lab.2017.170339; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Suganuma T, 2010, CELL, V142, P726, DOI 10.1016/j.cell.2010.07.045; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Sulminoe A, 2007, LEUKEMIA RES, V31, P1437, DOI 10.1016/j.leukres.2007.01.015; Vincenti M P, 2001, Methods Mol Biol, V151, P121; Wang FQ, 2005, INT J CANCER, V114, P19, DOI 10.1002/ijc.20697; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zappa C, 2016, TRANSL LUNG CANCER R, V5, P288, DOI 10.21037/tlcr.2016.06.07; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493; Zhu J, 2019, AM J TRANSL RES, V11, P3862	47	5	5	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2020	39	43					6719	6732		10.1038/s41388-020-01463-0	http://dx.doi.org/10.1038/s41388-020-01463-0		SEP 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OF2UT	32963352	Green Accepted			2022-12-26	WOS:000572030400003
J	Wong, R; Bhattacharya, D				Wong, Rachel; Bhattacharya, Deepta			ZBTB38 is dispensable for antibody responses	PLOS ONE			English	Article							PLZF-RAR-ALPHA; MEMORY B; METHYLATED DNA; CIBZ; DIFFERENTIATION; EXPRESSION; CELLS; IDENTIFICATION; ASSOCIATION; INTERACTS	Members of the broad complex, tram track, bric-a-brac and zinc finger (BTB-ZF) family of transcription factors, such as BCL-6, ZBTB20, and ZBTB32, regulate antigen-specific B cell differentiation, plasma cell longevity, and the duration of antibody production. We found that ZBTB38, a different member of the BTB-ZF family that binds methylated DNA at CpG motifs, is highly expressed by germinal center B cells and plasma cells. To define the functional role of ZBTB38 in B cell responses, we generated mice conditionally deficient in this transcription factor. Germinal center B cells lacking ZBTB38 dysregulated very few genes relative to wild-type and heterozygous littermate controls. Accordingly, mice with hematopoietic-specific deletion ofZbtb38showed normal germinal center B cell numbers and antibody responses following immunization with hapten-protein conjugates. Memory B cells from these animals functioned normally in secondary recall responses. Despite expression of ZBTB38 in hematopoietic stem cells, progenitors and mature myeloid and lymphoid lineages were also present in normal numbers in mutant mice. These data demonstrate that ZBTB38 is dispensable for hematopoiesis and antibody responses. These conditional knockout mice may instead be useful in defining the functional importance of ZBTB38 in other cell types and contexts.	[Wong, Rachel] Washington Univ, Div Biol & Biomed Sci, St Louis, MO 63110 USA; [Wong, Rachel; Bhattacharya, Deepta] Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA	Washington University (WUSTL); University of Arizona	Bhattacharya, D (corresponding author), Univ Arizona, Dept Immunobiol, Tucson, AZ 85721 USA.	deeptab@email.arizona.edu			National Institutes of Health [R01AI099108]; National Science Foundation [DGE-1143954]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Institutes of Health (https://www.niaid.nih.gov/) grant R01AI099108 (D.B.). R.W. was supported by the National Science Foundation (https://www.nsfgrfp.org/) Graduate Research Fellowship Program (DGE-1143954). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2012, REGEN MED S3, V7, pS14; Chen J, 2019, PEERJ, V7, DOI 10.7717/peerj.6352; Chen J, 2018, GENE, V678, P8, DOI 10.1016/j.gene.2018.07.073; Chevrier S, 2014, IMMUNOL CELL BIOL, V92, P481, DOI 10.1038/icb.2014.20; Chevrier S, 2014, J EXP MED, V211, P827, DOI 10.1084/jem.20131831; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Chou C, 2014, NAT IMMUNOL, V15, P884, DOI 10.1038/ni.2943; de Dieuleveult M, 2018, EPIGENETICS INSIGHTS, V11, DOI 10.1177/2516865718811117; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hong SH, 1997, P NATL ACAD SCI USA, V94, P9028, DOI 10.1073/pnas.94.17.9028; Hudson NO, 2018, J BIOL CHEM, V293, P19835, DOI 10.1074/jbc.RA118.005147; Jash A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51860-z; Jash A, 2016, J IMMUNOL, V197, P1159, DOI 10.4049/jimmunol.1600882; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim JJ, 2012, HUM GENET, V131, P471, DOI 10.1007/s00439-011-1096-4; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kotoku T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34188; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miotto B, 2018, NUCLEIC ACIDS RES, V46, P4392, DOI 10.1093/nar/gky149; Miotto B, 2014, CELL REP, V7, P575, DOI 10.1016/j.celrep.2014.03.030; Nishii T, 2012, J BIOL CHEM, V287, P12417, DOI 10.1074/jbc.M111.333856; Ocsko T, 2018, BBA-GENE REGUL MECH, V1861, P1040, DOI 10.1016/j.bbagrm.2018.09.007; Oikawa Y, 2008, J BIOL CHEM, V283, P14242, DOI 10.1074/jbc.M802257200; Oikawa Y, 2011, CELL RES, V21, P1578, DOI 10.1038/cr.2011.90; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Sasai N, 2005, GENES CELLS, V10, P871, DOI 10.1111/j.1365-2443.2005.00885.x; Sasai N, 2010, NUCLEIC ACIDS RES, V38, P5015, DOI 10.1093/nar/gkq280; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Wang YN, 2014, J EXP MED, V211, P841, DOI 10.1084/jem.20131821; Wang Y, 2013, CLIN ENDOCRINOL, V79, P402, DOI 10.1111/cen.12145; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	48	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0235183	10.1371/journal.pone.0235183	http://dx.doi.org/10.1371/journal.pone.0235183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956421	Green Published, gold, Green Submitted			2022-12-26	WOS:000574571500030
J	Rosiak-Stec, K; Grot, D; Rieske, P				Rosiak-Stec, Kamila; Grot, Dagmara; Rieske, Piotr			Generation of induced neural stem cells with inducible IDH1(R132H)for analysis of glioma development and drug testing	PLOS ONE			English	Article							SUBVENTRICULAR ZONE; IDH1 MUTATION; MUTANT; INHIBITOR; R132H; PROLIFERATION; DIFFERENTIATION; DEHYDROGENASE; ASTROCYTOMAS; EXPRESSION	Mutation in isocitrate dehydrogenase 1 (IDH1(R132H)) occurs in various types of cancer, including low and high grade gliomas. Despite high incidence indicating its central role in tumor initiation and progression there are no targeted therapies directed against this oncogene available in the clinic. This is due to the limited understanding of the role of IDH1(R132H)in carcinogenesis, which is further propagated by the lack of appropriate experimental models. Moreover, properin vitromodels for analysis of gliomagenesis are required. In this study, we employed a Tet On system to generate human induced neural stem cells with doxycycline-inducible IDH1(R132H). Equivalent expression of both forms of IDH1 in the presented model remains similar to that described in tumor cells. Additional biochemical analyses further confirmed tightly controlled gene regulation at protein level. Formation of a functional mutant IDH1 enzyme was supported by the production of D-2-hydroxyglutarate (D2HG). All samples tested for MGMT promoter methylation status, including parental cells, proved to be partially methylated. Analysis of biological effect of IDH1(R132H)revealed that cells positive for oncogene showed reduced differentation efficiency and viability. Inhibition of mutant IDH1 with selective inhibitor efficiently suppressed D2HG production as well as reversed the effect of mutant IDH1 protein on cell viability. In summary, our model constitutes a valuable platform for studies on the molecular basis and the cell of origin of IDH-mutant glioma (e.g. by editing P53 in these cells and their derivatives), as well as a reliable experimental model for drug testing.	[Rosiak-Stec, Kamila; Grot, Dagmara; Rieske, Piotr] Med Univ Lodz, Dept Tumor Biol, Lodz, Poland	Medical University Lodz	Grot, D (corresponding author), Med Univ Lodz, Dept Tumor Biol, Lodz, Poland.	dagmara.grot@stud.umed.lodz.pl	; Rieske, Piotr/M-4821-2015	Rosiak, Kamila/0000-0002-7711-3519; Grot, Dagmara/0000-0002-3588-9140; Rieske, Piotr/0000-0002-2970-0970	National Science Center [2016/21/N/NZ3/03271]	National Science Center(National Science Centre, Poland)	This study was financially supported by the National Science Center Grant No. 2016/21/N/NZ3/03271. (KR) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; Bardella C, 2016, CANCER CELL, V30, P578, DOI 10.1016/j.ccell.2016.08.017; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Chesnelong C, 2014, NEURO-ONCOLOGY, V16, P686, DOI 10.1093/neuonc/not243; Christians A, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0817-0; Christians A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033449; Cui DM, 2016, INT J BIOCHEM CELL B, V73, P72, DOI 10.1016/j.biocel.2016.02.007; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Drozd AM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0112-3; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fan XL, 2019, FRONT MED-PRC, V13, P531, DOI 10.1007/s11684-019-0700-1; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Karpel-Massler G, 2019, CNS DRUGS, V33, P1155, DOI 10.1007/s40263-019-00684-6; Karpel-Massler G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00984-9; Lee JH, 2018, NATURE, V560, P243, DOI 10.1038/s41586-018-0389-3; Levallet G, 2019, J MOL DIAGN, V21, P695, DOI 10.1016/j.jmoldx.2019.03.007; Li F, 2015, MOL CELL, V60, P661, DOI 10.1016/j.molcel.2015.10.017; Li GZ, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/5975216; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Luchman HA, 2013, NEURO-ONCOLOGY, V15, P979, DOI 10.1093/neuonc/not064; McBrayer SK, 2018, CELL, V175, P101, DOI 10.1016/j.cell.2018.08.038; Mellinghoff IK, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.2003; Miller JJ, 2017, CANCER-AM CANCER SOC, V123, P4535, DOI 10.1002/cncr.31039; Modrek AS, 2017, CELL REP, V21, P1267, DOI 10.1016/j.celrep.2017.10.009; Molenaar RJ, 2018, ONCOGENE, V37, P1949, DOI 10.1038/s41388-017-0077-z; Molenaar RJ, 2015, CANCER RES, V75, P4790, DOI 10.1158/0008-5472.CAN-14-3603; Mondesir J, 2016, J BLOOD MED, V7, P171, DOI 10.2147/JBM.S70716; Nicolay B, 2017, NEURO-ONCOLOGY, V19, P79; Nie QM, 2015, MOL MED REP, V12, P6695, DOI 10.3892/mmr.2015.4241; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philip B, 2018, CELL REP, V23, P1553, DOI 10.1016/j.celrep.2018.03.133; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; Pinson H, 2020, J NEURO-ONCOL, V146, P55, DOI 10.1007/s11060-019-03334-5; Pirozzi CJ, 2017, MOL CANCER RES, V15, P507, DOI 10.1158/1541-7786.MCR-16-0485; Pusch S, 2017, ACTA NEUROPATHOL, V133, P629, DOI 10.1007/s00401-017-1677-y; Rieske P, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-54; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Rosiak K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154726; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Shao FJ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00048; Shi JL, 2015, TUMOR BIOL, V36, P655, DOI 10.1007/s13277-014-2644-z; Sulkowski PL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2463; Tateishi K, 2015, CANCER CELL, V28, P773, DOI 10.1016/j.ccell.2015.11.006; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wakimoto H, 2014, CLIN CANCER RES, V20, P2898, DOI 10.1158/1078-0432.CCR-13-3052; Walczak MP, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1097-0; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Watanabe T, 2009, AM J PATHOL, V174, P1149, DOI 10.2353/ajpath.2009.080958; Wei S, 2018, ONCOGENE, V37, P5160, DOI 10.1038/s41388-018-0334-9; Xia L, 2015, ONCOTARGET, V6, P17354, DOI 10.18632/oncotarget.4008; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang Y, 2019, CANCER RES, V79, P4994, DOI 10.1158/0008-5472.CAN-19-0054; Zhu J, 2013, J MOL NEUROSCI, V50, P165, DOI 10.1007/s12031-012-9890-6	54	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239325	10.1371/journal.pone.0239325	http://dx.doi.org/10.1371/journal.pone.0239325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946483	gold, Green Published			2022-12-26	WOS:000573851100013
J	Guo, YH; Feng, Y; Qu, F; Zhang, L; Yan, BY; Lv, JJ				Guo, Yanhui; Feng, Yi; Qu, Fuli; Zhang, Li; Yan, Bingyu; Lv, Jingjing			Prediction of hepatitis E using machine learning models	PLOS ONE			English	Article								Background Accurate and reliable predictions of infectious disease can be valuable to public health organizations that plan interventions to decrease or prevent disease transmission. A great variety of models have been developed for this task. However, for different data series, the performance of these models varies. Hepatitis E, as an acute liver disease, has been a major public health problem. Which model is more appropriate for predicting the incidence of hepatitis E? In this paper, three different methods are used and the performance of the three methods is compared. Methods Autoregressive integrated moving average(ARIMA), support vector machine(SVM) and long short-term memory(LSTM) recurrent neural network were adopted and compared. ARIMA was implemented by python with the help of statsmodels. SVM was accomplished by matlab with libSVM library. LSTM was designed by ourselves with Keras, a deep learning library. To tackle the problem of overfitting caused by limited training samples, we adopted dropout and regularization strategies in our LSTM model. Experimental data were obtained from the monthly incidence and cases number of hepatitis E from January 2005 to December 2017 in Shandong province, China. We selected data from July 2015 to December 2017 to validate the models, and the rest was taken as training set. Three metrics were applied to compare the performance of models, including root mean square error(RMSE), mean absolute percentage error(MAPE) and mean absolute error(MAE). Results By analyzing data, we tookARIMA(1, 1, 1),ARIMA(3, 1, 2) as monthly incidence prediction model and cases number prediction model, respectively. Cross-validation and grid search were used to optimize parameters of SVM. Penalty coefficientCand kernel function parametergwere set 8, 0.125 for incidence prediction, and 22, 0.01 for cases number prediction. LSTM has 4 nodes. Dropout and L2 regularization parameters were set 0.15, 0.001, respectively. By the metrics of RMSE, we obtained 0.022, 0.0204, 0.01 for incidence prediction, using ARIMA, SVM and LSTM. And we obtained 22.25, 20.0368, 11.75 for cases number prediction, using three models. For MAPE metrics, the results were 23.5%, 21.7%, 15.08%, and 23.6%, 21.44%, 13.6%, for incidence prediction and cases number prediction, respectively. For MAE metrics, the results were 0.018, 0.0167, 0.011 and 18.003, 16.5815, 9.984, for incidence prediction and cases number prediction, respectively. Conclusions Comparing ARIMA, SVM and LSTM, we found that nonlinear models(SVM, LSTM) outperform linear models(ARIMA). LSTM obtained the best performance in all three metrics of RSME, MAPE, MAE. Hence, LSTM is the most suitable for predicting hepatitis E monthly incidence and cases number.	[Guo, Yanhui; Qu, Fuli] Shandong Womens Univ, Sch Data & Comp Sci, Jinan, Shandong, Peoples R China; [Feng, Yi; Zhang, Li; Yan, Bingyu; Lv, Jingjing] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Shandong, Peoples R China; [Feng, Yi; Zhang, Li; Yan, Bingyu; Lv, Jingjing] Shandong Univ, Acad Prevent Med, Jinan, Shandong, Peoples R China	Shandong Womens University; Shandong University	Qu, F (corresponding author), Shandong Womens Univ, Sch Data & Comp Sci, Jinan, Shandong, Peoples R China.; Zhang, L (corresponding author), Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Infect Dis Control & Preven, Jinan, Shandong, Peoples R China.; Zhang, L (corresponding author), Shandong Univ, Acad Prevent Med, Jinan, Shandong, Peoples R China.	qufuli23@163.com; zl9127@163.com		Guo, Yanhui/0000-0002-5444-3822	ZhiFei Disease Prevention and Control Technology Research Fund Project [LYH2017-08]; Open Research Fund of Shandong Provincial Key Laboratory Of Infectious Disease Control and Prevention, Shandong Center for Disease Control and Prevention [2017KEYLAB01]; Shandong Medical Health Science and Technology Development Programs [2018WS309]; Science and Technology Project for the Universities of Shandong Province [J18KB171]; Discipline Talent Team Cultivation Program of Shandong Women's University [1904]; Shandong Women's University High level scientific research project Cultivation Fund [2019GSPGJ07]	ZhiFei Disease Prevention and Control Technology Research Fund Project; Open Research Fund of Shandong Provincial Key Laboratory Of Infectious Disease Control and Prevention, Shandong Center for Disease Control and Prevention; Shandong Medical Health Science and Technology Development Programs; Science and Technology Project for the Universities of Shandong Province; Discipline Talent Team Cultivation Program of Shandong Women's University; Shandong Women's University High level scientific research project Cultivation Fund	This work was supported by ZhiFei Disease Prevention and Control Technology Research Fund Project (No. LYH2017-08) to YF, Open Research Fund of Shandong Provincial Key Laboratory Of Infectious Disease Control and Prevention, Shandong Center for Disease Control and Prevention (No. 2017KEYLAB01) to YG, Shandong Medical Health Science and Technology Development Programs (No. 2018WS309) to YF, Science and Technology Project for the Universities of Shandong Province (No. J18KB171) to YG, Discipline Talent Team Cultivation Program of Shandong Women's University (No. 1904) to YG, and Shandong Women's University High level scientific research project Cultivation Fund (No. 2019GSPGJ07) to YG.	[Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Buczak AL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189988; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Drucker H, 1997, ADV NEUR IN, V9, P155; Fu R, 2016, 2016 31ST YOUTH ACADEMIC ANNUAL CONFERENCE OF CHINESE ASSOCIATION OF AUTOMATION (YAC), P324, DOI 10.1109/YAC.2016.7804912; Graves A, 2013, INT CONF ACOUST SPEE, P6645, DOI 10.1109/ICASSP.2013.6638947; HUNTER JS, 1986, J QUAL TECHNOL, V18, P203; Johansson MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33707; Khan S, 2016, BIOMED OPT EXPRESS, V7, P2249, DOI 10.1364/BOE.7.002249; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lee L, 2009, GLOBAL PUBLIC HLTH N, V185, DOI [10.1093/acprof:oso/9780199236626.003.009, DOI 10.1093/ACPROF:OSO/9780199236626.003.009]; Ling-zhi T, 2015, J SCI TEACHERS COLL, P10; Lu CJ, 2009, DECIS SUPPORT SYST, V47, P115, DOI 10.1016/j.dss.2009.02.001; Meyers LA, 2016, STAYING AHEAD CURVE; Mikolov T, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 1-2, P1045; Nelson DMQ, 2017, IEEE IJCNN, P1419, DOI 10.1109/IJCNN.2017.7966019; Organization WH, 2015, FACT SHEET RED IGN P; Pascanu R., 2013, INT C MACH LEARN, P1310; Poliseno L, 2012, SCI SIGNAL, V5, pre5; Ren H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-421; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Perez-Gracia MT, 2015, J CLIN TRANSL HEPATO, V3, P117, DOI 10.14218/JCTH.2015.00009; Wang Y, 2019, NANOMATER NANOTECHNO, V9, DOI 10.1177/1847980418825034; Yang SH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005607; Yang SH, 2015, P NATL ACAD SCI USA, V112, P14473, DOI 10.1073/pnas.1515373112	29	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0237750	10.1371/journal.pone.0237750	http://dx.doi.org/10.1371/journal.pone.0237750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941452	Green Published, gold			2022-12-26	WOS:000573848800082
J	Ma, L; Wu, JY; Qi, WL; Coulter, JA; Fang, Y; Li, XC; Liu, LJ; Jin, JJ; Niu, ZX; Yue, JL; Sun, WC				Ma, Li; Wu, Junyan; Qi, Weiliang; Coulter, Jeffrey A.; Fang, Yan; Li, Xuecai; Liu, Lijun; Jin, Jiaojiao; Niu, Zaoxia; Yue, Jinli; Sun, Wancang			Screening and verification of reference genes for analysis of gene expression in winter rapeseed (Brassica rapaL.) under abiotic stress	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; SYSTEMATIC VALIDATION; RT-PCR; NORMALIZATION; SELECTION; IDENTIFICATION	Winter rapeseed (Brassica rapaL.) is the main oilseed crop in northern China and can safely overwinter at 35 (i.e., Tianshui, China) to 48 degrees north latitude (i.e., Altai, Heilongjiang, Raohe, and Xinjiang, China). In order to identify stable reference genes to understand the molecular mechanisms of stress tolerance in winter rapeseed, internal reference genes of winter rapeseed under four abiotic stresses were analyzed using GeNorm, NormFinder, BestKeeper, and RefFinder software. The most stable combinations of internal reference genes were beta-actinandSANDin cold-stressed leaves,beta-actinandEF1ain cold-stressed roots,F-boxandSANDin high temperature-stressed leaves, andPP2AandRPLin high temperature-stressed roots,SANDandPP2Ain NaCl-stressed leaves,RPLandUBCin NaCl-stressed roots,RPLandPP2Ain PEG-stressed leaves, andPP2AandRPLin PEG-stressed roots. Expression profiles ofPXG3were used to verify these results. The stable reference genes identified in this study are useful tools for identifying stress-responsive genes to understand the molecular mechanisms of stress tolerance in winter rapeseed.	[Ma, Li; Wu, Junyan; Qi, Weiliang; Fang, Yan; Liu, Lijun; Jin, Jiaojiao; Niu, Zaoxia; Yue, Jinli; Sun, Wancang] Gansu Agr Univ, Gansu Prov Key Lab Aridl & Crop Sci, Lanzhou, Peoples R China; [Wu, Junyan; Qi, Weiliang; Li, Xuecai; Jin, Jiaojiao; Niu, Zaoxia; Yue, Jinli; Sun, Wancang] Gansu Agr Univ, Coll Agron, Lanzhou, Peoples R China; [Coulter, Jeffrey A.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA	Gansu Agricultural University; Gansu Agricultural University; University of Minnesota System; University of Minnesota Twin Cities	Sun, WC (corresponding author), Gansu Agr Univ, Gansu Prov Key Lab Aridl & Crop Sci, Lanzhou, Peoples R China.; Sun, WC (corresponding author), Gansu Agr Univ, Coll Agron, Lanzhou, Peoples R China.	18293121851@163.com		Coulter, Jeffrey/0000-0003-4609-4551	Gansu Agricultural University [GAU-KYQD-2019-17]; Utilization Technology of Rapeseed Heterosis and Creation of Strong Heterosis of China [2016YFD0101300]; Agriculture Research System of China [CARS-12]; Agriculture Research System of Gansu Province [GARS-TSZ-1]; National Natural Science Foundation of China [31860388]	Gansu Agricultural University; Utilization Technology of Rapeseed Heterosis and Creation of Strong Heterosis of China; Agriculture Research System of China; Agriculture Research System of Gansu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was financially supported by the Scientific research start-up funds for openly-recuited doctors of Gansu Agricultural University (GAU-KYQD-2019-17), the Utilization Technology of Rapeseed Heterosis and Creation of Strong Heterosis of China (2016YFD0101300), Agriculture Research System of China (CARS-12), and the Agriculture Research System of Gansu Province (GARS-TSZ-1), and the National Natural Science Foundation of China (31860388). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chai Q, 2014, AGRON SUSTAIN DEV, V34, P535, DOI 10.1007/s13593-013-0161-x; Chen Y, 2015, PHYSIOL PLANTARUM, V155, P138, DOI 10.1111/ppl.12302; Chen Y, 2015, PLANT CELL REP, V34, P1825, DOI 10.1007/s00299-015-1830-9; Delporte M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00651; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; [董小云 Dong Xiaoyun], 2018, [河南农业大学学报, Journal of Henan Agricultural University], V52, P313; Gan YT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6012; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gutierrez L, 2008, PLANT CELL, V20, P1734, DOI 10.1105/tpc.108.059774; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hlavackova I, 2013, INT J MOL SCI, V14, P8000, DOI 10.3390/ijms14048000; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Kanakachari M, 2016, APPL BIOCHEM BIOTECH, V178, P433, DOI 10.1007/s12010-015-1884-8; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Liu ZG, 2016, RUSS J PLANT PHYSL+, V63, P451, DOI 10.1134/S1021443716040099; Liu ZG, 2019, PLANT BREEDING, V138, P193, DOI 10.1111/pbr.12677; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064666; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Partridge M, 2009, PLANT PHYSIOL BIOCH, V47, P796, DOI 10.1016/j.plaphy.2009.04.005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qi JN, 2010, PLANT MOL BIOL REP, V28, P597, DOI 10.1007/s11105-010-0185-1; Rapacz M, 2012, ACTA PHYSIOL PLANT, V34, P1723, DOI 10.1007/s11738-012-0967-1; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Sang J, 2018, NUCLEIC ACIDS RES, V46, pD121, DOI 10.1093/nar/gkx875; Sgamma T, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0121-y; Silveira ED, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-84; Staiger CJ, 2000, ANNU REV PLANT PHYS, V51, P257, DOI 10.1146/annurev.arplant.51.1.257; Sun W, 2007, SCI AGR SIN; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tang X, 2017, PLANT METHODS, V13, DOI 10.1186/s13007-017-0238-7; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; [王治江 Wang Zhijiang], 2016, [干旱地区农业研究, Agricultural Research in the Arid Areas], V34, P243; Xiao D, 2012, FUNCT PLANT BIOL, V39, P342, DOI 10.1071/FP11246; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Zhou DongMei, 2014, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V22, P697; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	53	7	9	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0236577	10.1371/journal.pone.0236577	http://dx.doi.org/10.1371/journal.pone.0236577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941459	gold, Green Published			2022-12-26	WOS:000573848800016
J	Zhao, P; Tian, Y; Li, YK; Xu, GF; Tian, SB; Huang, ZC				Zhao, Ping; Tian, Yue; Li, Yongkui; Xu, Guofa; Tian, Subo; Huang, Zichen			Potato (Solanum tuberosumL.) tuber-root modeling method based on physical properties	PLOS ONE			English	Article							3-DIMENSIONAL ARCHITECTURE; SIMULATION-MODEL; DAMAGE; MAIZE; FIELD	The development of tuber-root models based on the physical properties of the root system of a plant is a prominent but complicated task. In this paper, a method for the construction of a 3D model of a potato tuber-root system is proposed, based on determining the characterization parameters of the potato tuber-root model. Three early maturing potato varieties, widely planted in Northeast China, were selected as the research objects. Their topological and geometric structures were analyzed to determine the model parameters. By actually digging potatoes in the field, field data measurement and statistical analysis of the parameters were performed, and a model parameter database was established. Based on the measured data, the root trajectory points were obtained by simulating the growth of the root tips. Then MATLAB was used to develop a system that would complete the construction of the potato tuber-root 3D visualization model. Finally, the accuracy of the model was verified experimentally. Case studies for the three different types indicated an acceptable performance of the proposed model, with a relative root mean square error of 6.81% and 15.32%, for the minimum and maximum values, respectively. The research results can be used to explore the interaction between the soil-tuber-root aggregates and the digging components, and provide a reference for the construction of root models of other tuber crops.	[Zhao, Ping; Tian, Yue; Li, Yongkui; Xu, Guofa; Tian, Subo] Shenyang Agr Univ, Coll Engn, Shenyang, Peoples R China; [Huang, Zichen] Kyoto Univ, Grad Sch Agr, Kyoto, Japan	Shenyang Agricultural University; Kyoto University	Tian, SB (corresponding author), Shenyang Agr Univ, Coll Engn, Shenyang, Peoples R China.; Huang, ZC (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	tiansubo@syau.edu.cn; huang.zichen.22c@kyoto-u.jp			National Natural Science Foundation of China (NSFC) [51505305]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The present work is financially supported the National Natural Science Foundation of China (NSFC) of Zhao Ping, and the grant mumber is 51505305. Zhao Ping had an important role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adeleke E, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10020206; Ammer C, 2005, TREES-STRUCT FUNCT, V19, P145, DOI 10.1007/s00468-004-0373-4; [Anonymous], 2006, B FARMACOS, V9, P93; Bentini M, 2006, BIOSYST ENG, V94, P75, DOI 10.1016/j.biosystemseng.2006.02.007; Bingham IJ, 2011, EUR J AGRON, V34, P181, DOI 10.1016/j.eja.2011.01.003; Celik HK, 2019, J FOOD PROCESS ENG, V42, DOI 10.1111/jfpe.13078; Charles-Dominique T, 2009, PLANT SOIL, V317, P61, DOI 10.1007/s11104-008-9788-9; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Despotovic M, 2016, RENEW SUST ENERG REV, V56, P246, DOI 10.1016/j.rser.2015.11.058; El-Sharkawy MA, 2004, PLANT MOL BIOL, V56, P481, DOI 10.1007/s11103-005-2270-7; Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025; Fang SQ, 2009, PLANT J, V60, P1096, DOI 10.1111/j.1365-313X.2009.04009.x; Fourcaud T, 2008, ANN BOT-LONDON, V101, P1053, DOI 10.1093/aob/mcn050; Heeraman DA, 1997, PLANT SOIL, V189, P167, DOI 10.1023/A:1004258818538; Joshi M, 2016, J PLANT PHYSIOL, V205, P113, DOI 10.1016/j.jplph.2016.08.014; Natsupakpong S, 2010, GRAPH MODELS, V72, P61, DOI 10.1016/j.gmod.2010.10.001; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; PAGES L, 1989, PLANT SOIL, V119, P147, DOI 10.1007/BF02370279; Peters R, 1996, POTATO RES, V39, P479, DOI 10.1007/BF02358463; Rymuza Katarzyna, 2014, Journal of Plant Protection Research, V54, P225, DOI 10.2478/jppr-2014-0034; Schwarz M, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001603; [田悦 Tian Yue], 2017, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V48, P737; Wishart J, 2013, PLANT SOIL, V368, P231, DOI 10.1007/s11104-012-1483-1; Wu J, 2015, PLANT SOIL, V387, P363, DOI 10.1007/s11104-014-2307-2; Xie J, 2009, THESIS; Yang HS, 2004, FIELD CROP RES, V87, P131, DOI 10.1016/j.fcr.2003.10.003; Yang L, 2020, IEEE ACCESS, V8, P23407, DOI 10.1109/ACCESS.2020.2970161; Yinjiang Jia, 2010, 2010 World Automation Congress (WAC 2010), P195; Zhang BG, 2003, PLANT GROWTH MODELING AND APPLICATIONS, PROCEEDINGS, P321; Zhang H, 2017, J INTEGR AGR, V16, P2924, DOI 10.1016/S2095-3119(17)61736-2	30	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239093	10.1371/journal.pone.0239093	http://dx.doi.org/10.1371/journal.pone.0239093			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941480	Green Published, gold			2022-12-26	WOS:000573848800075
J	Fan, SJ; Wang, J; Yu, GQ; Rong, FJ; Zhang, DW; Xu, CX; Du, J; Li, Z; Ouyang, G; Xiao, WH				Fan, Sijia; Wang, Jing; Yu, Guangqing; Rong, Fangjing; Zhang, Dawei; Xu, Chenxi; Du, Juan; Li, Zhi; Ouyang, Gang; Xiao, Wuhan			TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ubiquitylation (ubiquitination); hydroxyproline; DNA demethylation; protein-protein interaction; E3 ubiquitin ligase; TET1; TET2; TET3; PHD2; PHD3; pVHL	HYPOXIA-INDUCIBLE FACTORS; HIPPEL-LINDAU PROTEIN; PROLINE-HYDROXYLATION; HIF-ALPHA; VHL; HYPOMETHYLATION; EXPRESSION; 5-METHYLCYTOSINE; METHYLATION; DEMETHYLATION	Hypoxia-inducible factors are heterodimeric transcription factors that play a crucial role in a cell's ability to adapt to low oxygen. The von Hippel-Lindau tumor suppressor (pVHL) acts as a master regulator of HIF activity, and its targeting of prolyl hydroxylated HIF-alpha for proteasomal degradation under normoxia is thought to be a major mechanism for pVHL tumor suppression and cellular response to oxygen. Whether pVHL regulates other targets through a similar mechanism is largely unknown. Here, we identify TET2/3 as novel targets of pVHL. pVHL induces proteasomal degradation of TET2/3, resulting in reduced global 5-hydroxymethylcytosine levels. Conserved proline residues within the LAP/LAP-like motifs of these two proteins are hydroxylated by the prolyl hydroxylase enzymes (PHD2/EGLN1 and PHD3/EGLN3), which is prerequisite for pVHL-mediated degradation. Using zebrafish as a model, we determined that global 5-hydroxymethylcytosine levels are enhanced in vhl-null, egln1a/b-double-null, and egln3-null embryos. Therefore, we reveal a novel function for the PHD-pVHL pathway in regulating TET protein stability and activity. These data extend our understanding of how TET proteins are regulated and provide new insight into the mechanisms of pVHL in tumor suppression.	[Fan, Sijia; Wang, Jing; Yu, Guangqing; Rong, Fangjing; Zhang, Dawei; Xu, Chenxi; Du, Juan; Li, Zhi; Ouyang, Gang; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Beijing, Peoples R China; [Fan, Sijia; Wang, Jing; Yu, Guangqing; Rong, Fangjing; Li, Zhi; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Beijing, Peoples R China; [Wang, Jing; Ouyang, Gang; Xiao, Wuhan] Minist Agr, Key Lab Aquaculture Dis Control, Wuhan, Peoples R China; [Wang, Jing; Ouyang, Gang; Xiao, Wuhan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Jing; Ouyang, Gang; Xiao, Wuhan] Chinese Acad Sci, Innovat Acad Seed Design, Wuhan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Beijing, Peoples R China.; Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Beijing, Peoples R China.; Xiao, WH (corresponding author), Minist Agr, Key Lab Aquaculture Dis Control, Wuhan, Peoples R China.; Xiao, WH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Xiao, WH (corresponding author), Chinese Acad Sci, Innovat Acad Seed Design, Wuhan, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022		Chinese Academy of Sciences [XDA24010308]; National Natural Science Foundation of China [31830101, 31721005, 31671315]; MOST National Key Research and Development Program of China [2018YFD0900602]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST National Key Research and Development Program of China	This work was supported by the strategic priority research program of the Chinese Academy of Sciences Grant XDA24010308 (to W. X.), National Natural Science Foundation of China Grants 31830101, 31721005, and 31671315 (to W. X.), and MOST National Key Research and Development Program of China Grant 2018YFD0900602 (to W. X.).	Arias-Gonzalez L, 2013, NEOPLASIA, V15, P649, DOI 10.1593/neo.121896; Artemov AV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28795-y; Bauer C, 2015, J BIOL CHEM, V290, P4801, DOI 10.1074/jbc.M114.605881; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Chen Z, 2014, MOL CELL BIOL, V34, P1085, DOI 10.1128/MCB.00718-13; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Du J, 2015, J IMMUNOL, V195, P1782, DOI 10.4049/jimmunol.1500588; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Esteban MA, 2006, CANCER RES, V66, P3567, DOI 10.1158/0008-5472.CAN-05-2670; Friso S, 2013, CANCER EPIDEM BIOMAR, V22, P348, DOI 10.1158/1055-9965.EPI-12-0859; Gamper AM, 2012, MOL CELL, V45, P233, DOI 10.1016/j.molcel.2011.11.031; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Gossage L, 2015, NAT REV CANCER, V15, P55, DOI 10.1038/nrc3844; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JP, 2016, SCIENCE, V353, P929, DOI 10.1126/science.aad5755; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hattori M, 2015, EXP DERMATOL, V24, P841, DOI 10.1111/exd.12767; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jokilehto T, 2010, EXP CELL RES, V316, P1169, DOI 10.1016/j.yexcr.2010.02.012; Jung YS, 2012, CELL CYCLE, V11, P4462, DOI 10.4161/cc.22794; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Laukka T, 2016, J BIOL CHEM, V291, P4256, DOI 10.1074/jbc.M115.688762; Li C, 2015, CELL REP, V12, P1133, DOI 10.1016/j.celrep.2015.07.025; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lin GF, 2017, ONCOL LETT, V14, P6457, DOI 10.3892/ol.2017.7063; Liu QY, 2011, MOL CANCER THER, V10, P1113, DOI 10.1158/1535-7163.MCT-10-1010; Liu X, 2015, NUCLEIC ACIDS RES, V43, P5081, DOI 10.1093/nar/gkv379; Ludgate JL, 2013, GENE CHROMOSOME CANC, V52, P174, DOI 10.1002/gcc.22017; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mendoza-Perez J, 2016, CLIN CANCER RES, V22, P2074, DOI 10.1158/1078-0432.CCR-15-0977; Mills DB, 2018, ELIFE, V7, DOI 10.7554/eLife.31176; Moser SC, 2013, DEV CELL, V26, P381, DOI 10.1016/j.devcel.2013.06.014; Nakagawa T, 2015, MOL CELL, V57, P247, DOI 10.1016/j.molcel.2014.12.002; Noonan HR, 2016, DIS MODEL MECH, V9, P873, DOI 10.1242/dmm.024380; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Querbes W, 2011, BLOOD, V118, P1366; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Robinson CM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21524-5; Sajadian SO, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0213-6; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Shi FT, 2013, J BIOL CHEM, V288, P20776, DOI 10.1074/jbc.M113.460386; Skowronski K, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12400; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Tsai YP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0513-0; Wang JC, 2015, J SPINAL CORD MED, V38, P587, DOI 10.1179/2045772314Y.0000000271; Wang J, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx869; Wang J, 2014, MOL ENDOCRINOL, V28, P239, DOI 10.1210/me.2013-1258; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu MZ, 2015, CANCER RES, V75, P3912, DOI 10.1158/0008-5472.CAN-14-3208; Yang LB, 2016, CANCER CELL, V29, P922, DOI 10.1016/j.ccell.2016.05.003; Yu C, 2013, SCIENCE, V342, P1518, DOI 10.1126/science.1244587; Zhang J, 2018, SCIENCE, V361, P290, DOI 10.1126/science.aap8411; Zhang YW, 2017, MOL CELL, V65, P323, DOI 10.1016/j.molcel.2016.12.013; Zheng XN, 2014, GENE DEV, V28, P1429, DOI 10.1101/gad.242131.114	76	6	6	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16299	16313		10.1074/jbc.RA120.014538	http://dx.doi.org/10.1074/jbc.RA120.014538			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32963106	hybrid, Green Published			2022-12-26	WOS:000598519500011
J	Botey, AP; Robson, PJ; Hardwicke-Brown, AM; Rodehutskors, DM; O'Neill, BM; Stewart, DA				Botey, Anna Pujadas; Robson, Paula J.; Hardwicke-Brown, Adam M.; Rodehutskors, Dorothy M.; O'Neill, Barbara M.; Stewart, Douglas A.			From symptom to cancer diagnosis: Perspectives of patients and family members in Alberta, Canada	PLOS ONE			English	Article							SELF-ADVOCACY; RISK-FACTORS; DELAY; CARE; LITERACY; DISTRESS; BREAST; MODEL; TIME	Background Significant intervals from the identification of suspicious symptoms to a definitive diagnosis of cancer are common. Streamlining pathways to diagnosis may increase survival, quality of life post-treatment, and patient experience. Discussions of pathways to diagnosis from the perspective of patients and family members are crucial to advancing cancer diagnosis. Aim To examine the perspectives of a group of patients with cancer and family members in Alberta, Canada, on factors associated with timelines to diagnosis and overall experience. Methods A qualitative approach was used. In-depth, semi-structured interviews with patients with cancer (n = 18) and patient relatives (n = 5) were conducted and subjected to a thematic analysis. Findings Participants struggled emotionally in the diagnostic period. Relevant to their experience were: potentially avoidable delays, concerns about health status, and misunderstood investigation process. Participants emphasized the importance of their active involvement in the care process, and had unmet supportive care needs. Conclusion Psychosocial supports available to potential cancer patients and their families are minimal, and may be important for improved experiences before diagnosis. Access to other patients' lived experiences with the diagnostic process and with cancer, and an enhanced supportive role of family doctors might help improve experiences for patients and families in the interval before receiving a diagnosis of cancer, which may have a significant impact on wellbeing.	[Botey, Anna Pujadas; Stewart, Douglas A.] Alberta Hlth Serv, Canc Strateg Clin Network, Calgary, AB, Canada; [Botey, Anna Pujadas; Robson, Paula J.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Robson, Paula J.; Hardwicke-Brown, Adam M.; O'Neill, Barbara M.] Alberta Hlth Serv, Canc Strateg Clin Network, Edmonton, AB, Canada; [Rodehutskors, Dorothy M.] Alberta Hlth Serv, CancerControl Alberta, Calgary, AB, Canada; [Stewart, Douglas A.] Univ Calgary, Dept Oncol, Calgary, AB, Canada; [Stewart, Douglas A.] Univ Calgary, Dept Med, Calgary, AB, Canada	Alberta Health Services (AHS); University of Calgary; University of Alberta; Alberta Health Services (AHS); Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary	Botey, AP (corresponding author), Alberta Hlth Serv, Canc Strateg Clin Network, Calgary, AB, Canada.; Botey, AP (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	Anna.PujadasBotey@ahs.ca	; Robson, Paula/Q-3351-2017	Pujadas Botey, Anna/0000-0001-6661-4089; Robson, Paula/0000-0003-4640-1371				Alberta Health Services, 2018, COMPR BREAST CAR PRO; Allen L, 2020, CAN MED ASSOC J, V192, pE208, DOI 10.1503/cmaj.190728; [Anonymous], 2019, CAN CANC STAT 2019; [Anonymous], 2016, CAN FAM PHYSICIAN, V62, p[903, e659]; [Anonymous], 2016, CAN FAM PHYSICIAN, V62, p[903, e659]; Brocken P, 2015, PSYCHO-ONCOLOGY, V24, P433, DOI 10.1002/pon.3660; Brocken P, 2012, PSYCHO-ONCOLOGY, V21, P1, DOI 10.1002/pon.1929; Brousselle A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2390-1; Brown R, 2012, J CLIN ONCOL, V30, P857, DOI 10.1200/JCO.2011.37.7952; Butler J, 2013, HEALTH POLICY, V112, P148, DOI 10.1016/j.healthpol.2013.03.021; Coulter A, 2008, POLICY BRIEF ARE PAT; Creswell J.W., 2018, RES DESIGN, V5th; Denzin N., 2018, SAGE HDB QUALITATIVE; Easley J, 2017, CURR ONCOL, V24, P75, DOI 10.3747/co.24.3447; Gruman J, 2010, PATIENT EDUC COUNS, V78, P350, DOI 10.1016/j.pec.2010.02.002; Grunfeld E, 2016, CAN FAM PHYSICIAN, V62, P781; Hagan TL, 2017, ONCOL NURS FORUM, V44, P52, DOI 10.1188/17.ONF.52-59; Hagan TL, 2013, J ADV NURS, V69, P2348, DOI 10.1111/jan.12084; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Huber JT, 2012, LIBR QUART, V82, P429, DOI 10.1086/667438; Jonikas JA, 2013, COMMUNITY MENT HLT J, V49, P260, DOI 10.1007/s10597-011-9475-9; Kickbusch I, 2013, SOLID FACTS SERIES; Kim JOA, 2016, CLIN ONCOL-UK, V28, P750, DOI 10.1016/j.clon.2016.06.010; Lawler M, 2018, EUR J CANCER, V92, P88, DOI 10.1016/j.ejca.2018.01.074; Li X, 2013, INT J QUAL HEALTH C, V25, P197, DOI 10.1093/intqhc/mzt003; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; Maringe C, 2013, ACTA ONCOL, V52, P919, DOI 10.3109/0284186X.2013.764008; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miles A., 2017, TIMELY DIAGNOSIS COL, P103; Miles A, 2017, PSYCHO-ONCOLOGY, V26, P29, DOI 10.1002/pon.4093; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Moustakas C., 1994, PHENOMENOLOGICAL RES; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Nielsen-Bohlman L, 2004, HLTH LITERACY PRESCR; Patton MQ, 2015, QUALITATIVE RES EVAL, V4th ed; Prostate Cancer Centre Calgary, 2016, RAP ACC CLIN RAC; Quaife SL, 2014, BRIT J CANCER, V110, P12, DOI 10.1038/bjc.2013.684; Richards MA, 2009, BRIT J CANCER, V101, pS1, DOI 10.1038/sj.bjc.6605382; Rootman I, 2005, CAN J PUBLIC HEALTH, V96, pS62, DOI 10.1007/BF03403703; Saan, 2005, EUR HLTH FOR BADG 20; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Sikdar KC, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-016-1944-y; Statistics Canada, 2015, 10 LEADING CAUSES DE; Tremblay A, 2017, CAN J RESP CRIT CARE, V1, P180, DOI 10.1080/24745332.2017.1377055; VanManen M, 2014, DEV QUAL INQ, P1; Waldram JB, 2008, STUDIES THERAPEUTIC; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Weller D, 2012, BRIT J CANCER, V106, P1262, DOI 10.1038/bjc.2012.68; Weller D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009641; Wiljer D, 2012, J CANCER EDUC, V27, P494, DOI 10.1007/s13187-012-0345-0; Yuan Y, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1303-z	51	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239374	10.1371/journal.pone.0239374	http://dx.doi.org/10.1371/journal.pone.0239374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970713	gold, Green Published			2022-12-26	WOS:000576265600065
J	Groarke, JM; Berry, E; Graham-Wisener, L; McKenna-Plumley, PE; McGlinchey, E; Armour, C				Groarke, Jenny M.; Berry, Emma; Graham-Wisener, Lisa; McKenna-Plumley, Phoebe E.; McGlinchey, Emily; Armour, Cherie			Loneliness in the UK during the COVID-19 pandemic: Cross-sectional results from the COVID-19 Psychological Wellbeing Study	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; COGNITIVE-BEHAVIORAL THERAPY; QUESTIONNAIRE F-SOZU; SOCIAL-ISOLATION; MENTAL-HEALTH; OLDER-ADULTS; RISK-FACTORS; BRIEF FORM; QUARANTINE; PHQ-9	Objectives Loneliness is a significant public health issue. The COVID-19 pandemic has resulted in lockdown measures limiting social contact. The UK public are worried about the impact of these measures on mental health outcomes. Understanding the prevalence and predictors of loneliness at this time is a priority issue for research. Method The study employed a cross-sectional online survey design. Baseline data collected between March 23rd and April 24th 2020 from UK adults in the COVID-19 Psychological Wellbeing Study were analysed (N = 1964, 18-87 years, M = 37.11, SD = 12.86, 70% female). Logistic regression analysis examined the influence of sociodemographic, social, health and COVID-19 specific factors on loneliness. Results The prevalence of loneliness was 27% (530/1964). Risk factors for loneliness were younger age group (OR: 4.67-5.31), being separated or divorced (OR: 2.29), scores meeting clinical criteria for depression (OR: 1.74), greater emotion regulation difficulties (OR: 1.04), and poor quality sleep due to the COVID-19 crisis (OR: 1.30). Higher levels of social support (OR: 0.92), being married/co-habiting (OR: 0.35) and living with a greater number of adults (OR: 0.87) were protective factors. Conclusions Rates of loneliness during the initial phase of lockdown were high. Risk factors were not specific to the COVID-19 crisis. Findings suggest that supportive interventions to reduce loneliness should prioritise younger people and those with mental health symptoms. Improving emotion regulation and sleep quality, and increasing social support may be optimal initial targets to reduce the impact of COVID-19 regulations on mental health outcomes.	[Groarke, Jenny M.; Berry, Emma; Graham-Wisener, Lisa; McKenna-Plumley, Phoebe E.; Armour, Cherie] Queens Univ Belfast, Ctr Improving Hlth Related Qual Life CIHRQoL, Sch Psychol, Belfast, Antrim, North Ireland; [McGlinchey, Emily; Armour, Cherie] Queens Univ Belfast, Sch Psychol, Stress Trauma & Related Condit STARC Res Lab, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Groarke, JM (corresponding author), Queens Univ Belfast, Ctr Improving Hlth Related Qual Life CIHRQoL, Sch Psychol, Belfast, Antrim, North Ireland.	j.groarke@qub.ac.uk	McKenna-Plumley, Phoebe/AFT-2755-2022					[Anonymous], 2001, NEUROLOGY S3, V56, pA351; [Anonymous], 1996, PEAMIM, V66, P20; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2019, BMJ, V365, pl1494, DOI 10.1136/bmj.l149430940623; Armour C, 2020, PSYARXIV; Berking M, 2013, PSYCHOTHER PSYCHOSOM, V82, P234, DOI 10.1159/000348448; Beutel ME, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1262-x; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Bu F, 2020, WHO IS LONELY LOCKDO; Bu F., 2020, LONELINESS LOCKDOWN, DOI 10.1101/2020.05.29.210116657; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cohen-Mansfield J, 2016, INT PSYCHOGERIATR, V28, P557, DOI 10.1017/S1041610215001532; Cowan K, 2020, SURVEY RESULTS UNDER; Deckx L, 2014, EUR J ONCOL NURS, V18, P466, DOI 10.1016/j.ejon.2014.05.002; Devaraj S, 2020, 3603746 SPEC SCI RES; DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; Donovan NJ, 2020, AM J GERIATR PSYCHIA; Entstehung der Die, 2013, JUD BOHEM, V48, P5; Griffin SC, 2020, HEALTH PSYCHOL OPEN, V7, DOI 10.1177/2055102920913235; Hansen T, 2016, SOC INDIC RES, V129, P445, DOI 10.1007/s11205-015-1111-6; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; In Q, 2007, INTERNAL MED, V146, P317, DOI DOI 10.7326/0003-4819-146-5-200703060-00004; Jeste DV, 2021, ACAD PSYCHIATR, V45, P142, DOI 10.1007/s40596-020-01339-1; Jia R, 2020, MENTAL HLTH UK COVID, DOI [10.1101/2020.05.14.20102012, DOI 10.1101/2020.05.14.20102012]; Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X; Kantor BN, 2020, MENTAL HLTH OUTCOMES; Kaufman EA, 2016, J PSYCHOPATHOL BEHAV, V38, P443, DOI 10.1007/s10862-015-9529-3; Kertz S, 2013, CLIN PSYCHOL PSYCHOT, V20, P456, DOI 10.1002/cpp.1802; Killgore WDS, 2020, PSYCHIAT RES; Kliem S, 2015, J CLIN EPIDEMIOL, V68, P551, DOI 10.1016/j.jclinepi.2014.11.003; Kokou-Kpolou CK, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113128; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lasgaard M, 2016, SOC PSYCH PSYCH EPID, V51, P1373, DOI 10.1007/s00127-016-1279-3; Lee B, 2019, PSYCHIAT CLIN PSYCH, V29, P864, DOI 10.1080/24750573.2019.1691320; Lee EE, 2019, INT PSYCHOGERIATR, V31, P1447, DOI 10.1017/S1041610218002120; Lee PW, 2007, J AFFECT DISORDERS, V99, P139, DOI 10.1016/j.jad.2006.09.002; Li LZ, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113267; Lin ECL, 2010, AM J INFECT CONTROL, V38, P302, DOI 10.1016/j.ajic.2009.09.008; Lin MY, 2019, PSYCHOL ASSESSMENT, V31, P609, DOI 10.1037/pas0000686; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Losada-Baltar A, 2021, J GERONTOL B-PSYCHOL, V76, pE10, DOI 10.1093/geronb/gbaa048; Luchetti M, 2020, AM PSYCHOL, V75, P897, DOI 10.1037/amp0000690; Luo Y, 2012, SOC SCI MED, V74, P907, DOI 10.1016/j.socscimed.2011.11.028; Mann F, 2017, SOC PSYCH PSYCH EPID, V52, P627, DOI 10.1007/s00127-017-1392-y; Matthews T, 2016, SOC PSYCH PSYCH EPID, V51, P339, DOI 10.1007/s00127-016-1178-7; Menec VH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230673; Mujica-Mota RE, 2015, QUAL LIFE RES, V24, P909, DOI 10.1007/s11136-014-0820-7; Mullen RA, 2019, ANN FAM MED, V17, P108, DOI 10.1370/afm.2358; Murphy D, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1398001; Mushtaq R, 2014, J CLIN DIAGN RES, V8, pWE01, DOI 10.7860/JCDR/2014/10077.4828; Nyqvist F, 2017, SCAND J PUBLIC HEALT, V45, P411, DOI 10.1177/1403494817697511; Okruszek L, 2020, PSYARXIV; Peters M, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1103-3; Pinquart M, 2001, BASIC APPL SOC PSYCH, V23, P245, DOI 10.1207/S15324834BASP2304_2; Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156; Rosenberg M, 2020, DEPRESSION LONELINES; Rutter LA, 2017, J PSYCHOPATHOL BEHAV, V39, P140, DOI 10.1007/s10862-016-9571-9; Savikko N, 2005, ARCH GERONTOL GERIAT, V41, P223, DOI 10.1016/j.archger.2005.03.002; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shiovitz-Ezra S, 2010, INT PSYCHOGERIATR, V22, P455, DOI 10.1017/S1041610209991426; Shovestul B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229087; Silva CJ, 2015, CULT CIENC DEPORTE, V10, P227, DOI 10.12800/ccd.v10i30.591; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stickley Andrew, 2013, PLoS One, V8, pe67978, DOI 10.1371/journal.pone.0067978; Stickley A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191651; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Theeke LA, 2010, RES GERONTOL NURS, V3, P113, DOI 10.3928/19404921-20091103-99; Theeke LA, 2009, ARCH PSYCHIAT NURS, V23, P387, DOI 10.1016/j.apnu.2008.11.002; Titov Nickolai, 2011, Cognitive Behaviour Therapy, V40, P126, DOI 10.1080/16506073.2010.550059; Trauer JM, 2015, ANN INTERN MED, V163, P191, DOI 10.7326/M14-2841; Tull MT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113098; Victor CR, 2012, J PSYCHOL, V146, P85, DOI 10.1080/00223980.2011.613875; Victor CR, 2011, J PSYCHOL, DOI [10.1080/00223980.2011.613875?casa_token=FiyKOZi7o94AAAAA:Tdubr-aq-i4nihreqY0XIFltsz_d0ND26-vzHNS6g-U9Kn8xV1mOMxkIY8OXJTg1JOdoT9JcSDgc, DOI 10.1080/00223980.2011.613875?]; Voitsidis P, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113076; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wang JY, 2020, SOC PSYCH PSYCH EPID, V55, P811, DOI 10.1007/s00127-019-01734-6; Wong SY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-119; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Wortmann JH, 2016, PSYCHOL ASSESSMENT, V28, P1392, DOI 10.1037/pas0000260; Young JL, 2013, 2013 5TH IEEE INTERNATIONAL SYMPOSIUM ON MICROWAVE, ANTENNA, PROPAGATION AND EMC TECHNOLOGIES FOR WIRELESS COMMUNICATIONS (MAPE), P2, DOI 10.1109/MAPE.2013.6689923	83	316	317	16	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239698	10.1371/journal.pone.0239698	http://dx.doi.org/10.1371/journal.pone.0239698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970764	gold, Green Accepted, Green Published			2022-12-26	WOS:000576265600022
J	Kuo, FC; Chien, CC; Lee, MS; Wang, JW; Lin, PC; Lee, CH				Kuo, Feng-Chih; Chien, Chun-Chih; Lee, Mel S.; Wang, Jun-Wen; Lin, Po-Chun; Lee, Chen-Hsiang			Rapid diagnosis of periprosthetic joint infection from synovial fluid in blood culture bottles by direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry	PLOS ONE			English	Article							DESORPTION/IONIZATION-TIME; MICROBIAL IDENTIFICATION; MICROORGANISMS; PATHOGENS	Background The aim of this prospective study was to use direct matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) to rapidly diagnose periprosthetic joint infections (PJIs). Method Synovial fluid was taken from 77 patients (80 joints, 41 hips and 39 knees) who met the International Consensus Meeting criteria for PJI, and inoculated into blood culture bottles (BCBs) and onto conventional swabs. Positive blood cultures were analyzed using either direct or routine MALDI-TOF MS. Pathogen identification and the time to identification was recorded. Differences between groups were analyzed using the Kruskal-Wallis test and Bonferroni's post-hoc test. Results Direct and routine MALDI-TOF MS both detected 64 positive results (80%), compared to 47 (59%) by conventional swabs (p = 0.002). Direct MALDI-TOF MS identified 85.3% of the gram-positive organisms and 92.3% of the gram-negative organisms. No fungi were identified by direct MALDI-TOF MS. In 17 BCBs that were flagged positive, identification by direct MALDI-TOF MS failed. Among the positive results in the direct MALDI-TOF MS group,Staphylococcus aureusaccounted for 47%, followed byStaphylococcus epidermidis(17%),Escherichia coli(9%) andKlebsiella pneumoniae(9%). The median time to microorganism identification was significantly shorter with direct MALDI-TOF MS (12.7 h, IQR: 8.9-19.6 h) than with routine MALDI-TOF MS (39.5 h, IQR: 22.8-46.0 h) or swabs (44.4 h, IQR: 27.2-72.6 h) (p< 0.0001). In pairwise comparisons, there were significant differences in the time of microorganism identification between direct MALDI-TOF MS and routine MALDI-TOF MS (p < 0.0001) or swab culture (p < 0.0001). There was no significant difference between routine MALDI-TOF MS and swab culture (p = 0.0268). Conclusion Compared with current laboratory practice, direct MALDI-TOF MS shortened the time to microorganism identification and had superior results compared to conventional swabs, except for fungi. Further studies should investigate whether the earlier administration of appropriate antimicrobial agents can improve the treatment outcomes of PJIs.	[Kuo, Feng-Chih; Lee, Mel S.; Wang, Jun-Wen; Lin, Po-Chun] Kaohsiung Chang Gung Mem Hosp, Dept Orthopaed Surg, Kaohsiung, Taiwan; [Kuo, Feng-Chih; Lee, Mel S.; Wang, Jun-Wen; Lin, Po-Chun; Lee, Chen-Hsiang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chien, Chun-Chih] Kaohsiung Chang Gung Mem Hosp, Lab Med, Kaohsiung, Taiwan; [Lee, Chen-Hsiang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lee, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Lee, CH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan.	lee900@cgmh.org.tw		Kuo, Feng-Chih/0000-0001-5205-8333	Chang Gung Medical Research Program from Chang Gung Medical Foundation [CMRPG8F1402]	Chang Gung Medical Research Program from Chang Gung Medical Foundation	The Chang Gung Medical Research Program from Chang Gung Medical Foundation provided support for this study in the form of a grant awarded to FCK (CMRPG8F1402). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azrad M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3709-9; Bishop B, 2018, CLIN MICROBIOL INFEC, V24, P171, DOI 10.1016/j.cmi.2017.05.014; Buchan BW, 2012, J CLIN MICROBIOL, V50, P346, DOI 10.1128/JCM.05021-11; Chang YJ, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2842-6; Croxatto A, 2012, FEMS MICROBIOL REV, V36, P380, DOI 10.1111/j.1574-6976.2011.00298.x; Fink B, 2008, J BONE JOINT SURG BR, V90B, P874, DOI 10.1302/0301-620X.90B7.20417; Font-Vizcarra L, 2010, CLIN ORTHOP RELAT R, V468, P2238, DOI 10.1007/s11999-010-1254-3; French K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169332; Geller JA, 2016, J ARTHROPLASTY, V31, P1779, DOI 10.1016/j.arth.2016.02.014; Inigo M, 2016, J CLIN MICROBIOL, V54, P988, DOI 10.1128/JCM.02832-15; Kok J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023285; Kuo FC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1366-9; Li W, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01182; Lin JF, 2018, J MICROBIOL IMMUNOL, V51, P659, DOI 10.1016/j.jmii.2017.03.005; Minassian AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-233; Morgenthaler NG, 2015, INT J MICROBIOL, V2015, DOI 10.1155/2015/827416; Pan HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00481; Parvizi J, 2014, J ARTHROPLASTY, V29, P1331, DOI 10.1016/j.arth.2014.03.009; Peel TN, 2016, MBIO, V7, DOI 10.1128/mBio.01776-15; Peersman G, 2001, CLIN ORTHOP RELAT R, P15, DOI 10.1097/00003086-200111000-00003; Ruiz-Aragon J, 2018, ENFERM INFEC MICR CL, V36, P484, DOI 10.1016/j.eimc.2017.08.012; Segawa S, 2014, CLIN CHIM ACTA, V435, P59, DOI 10.1016/j.cca.2014.04.024; Siller-Ruiz M, 2017, ENFERM INFEC MICR CL, V35, P303, DOI 10.1016/j.eimc.2016.12.010; Tian YR, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00523; Wang MC, 2015, J MICROBIOL IMMUNOL, V48, P419, DOI 10.1016/j.jmii.2013.10.006; Yonetani S, 2016, INT J INFECT DIS, V52, P37, DOI 10.1016/j.ijid.2016.09.014; Zhou ML, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01824	27	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239290	10.1371/journal.pone.0239290	http://dx.doi.org/10.1371/journal.pone.0239290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970712	Green Published, gold			2022-12-26	WOS:000576265600016
J	Mboya, EA; Davies, ML; Horumpende, PG; Ngocho, JS				Mboya, Erick Alexander; Davies, Matthew Lee; Horumpende, Pius Gerald; Ngocho, James Samwel			Inadequate knowledge on appropriate antibiotics use among clients in the Moshi municipality Northern Tanzania	PLOS ONE			English	Article							DRUG-DISPENSING OUTLETS; SELF-MEDICATION; COMMUNITY; CONSUMPTION	Background Poor knowledge concerning appropriate antibiotic use significantly influences the misuse of antibiotics within the community, especially in developing countries where there are weaker health systems to regulate antibiotic dispensing. Antibiotic misuse leads to antibiotic resistance. This study assessed knowledge of appropriate antibiotic use among buyers in the Moshi municipality, Northern Tanzania. Methods We conducted a cross-sectional study in Moshi municipality between April and May 2017. Adults who bought antibiotics at drug outlets were invited to participate in the study. An exit interview was conducted with participants to collect their demographics and assess their knowledge concerning appropriate use of antibiotics. A logistic regression model was performed to determine factors associated with correct knowledge concerning antibiotic use. Results A total of 152 adults with a median age of 30.5 (IQR 25-42) years, were enrolled in the study. Slightly over half (n = 89, 58.6%), responded that they should stop antibiotics after finishing the dose as directed. Half (n = 77, 50.7%) thought that it was acceptable to share antibiotics with other individuals and over half of respondents (n = 95, 65.1%) thought that they should request the same antibiotics if they had used them to treat a similar illness in the past. Only 38 (25%) had adequate knowledge about the use of antibiotics. Sore throat and flu were respectively identified by 62.5% and 46.1% of respondents as conditions that can be treated with antibiotics. Higher levels of education (aOR = 4.11 95%CI = 1.44-11.71) and having health insurance (aOR = 9.05 95%CI = 3.35-24.45) were associated with better levels of knowledge concerning antibiotic use in various illnesses. Conclusion There is inadequate knowledge concerning the indications for antibiotics and their appropriate usage. Health promotion campaigns are needed to educate the population about appropriate antibiotic use and reduce their irrational use.	[Mboya, Erick Alexander] Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Davies, Matthew Lee] Newcastle Univ, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Horumpende, Pius Gerald] Mil Coll Med Sci, Infect Dis Inst, Dar Es Salaam, Tanzania; [Horumpende, Pius Gerald] Kilimanjaro Clin Res Inst, Kilimanjaro, Tanzania; [Ngocho, James Samwel] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Kilimanjaro, Tanzania	Muhimbili University of Health & Allied Sciences; Newcastle University - UK	Mboya, EA (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania.	alexandererick104@gmail.com		Horumpende, Pius/0000-0003-1241-6997; , Erick/0000-0002-3279-6256				Ali Iftikhar, 2016, Journal of Pharmacy Practice and Research, V46, P34, DOI 10.1002/jppr.1153; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2004, WORLDVIEWS, V8, P1, DOI DOI 10.1177/108471380400800102; Belkina T, 2014, J INFECT DEV COUNTR, V8, P424, DOI 10.3855/jidc.3866; Berzanskyte Ausra, 2006, International Journal of Occupational Medicine and Environmental Health, V19, P246, DOI [10.2478/v10001-006-0030-9, 10.2478/v10001-006-0030.9]; BOJALIL R, 1994, J CLIN EPIDEMIOL, V47, P147, DOI 10.1016/0895-4356(94)90019-1; Bradley CP, 2014, GEN PRACTICE UNCOMFO; Byrne MK, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7796-8; CDC U, 2013, ANTIBIOTIC RESISTANC; Center for Disease Dynamics Economics & Policy., 2015, STATE WORLDS ANTIBIO; Cordoba G, 2017, J ANTIMICROB CHEMOTH, V72, P305, DOI 10.1093/jac/dkw370; Desalegn AA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-170; Dillip A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0073-4; Nga DTT, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-6; Erku DA, 2016, DRUG HEALTHC PATIENT, V8, P65, DOI 10.2147/DHPS.S106948; Filippini M, 2013, EUR J HEALTH ECON, V14, P587, DOI 10.1007/s10198-012-0404-9; Finkelstein JA, 2003, PEDIATRICS, V112, P620, DOI 10.1542/peds.112.3.620; Fundacio Institut Catala de Farmacologia, 2018, BUTLLETI GROC, V31, P1; Gebeyehu E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138179; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Gwimile JJ, 2012, PAN AFR MED J, V12; Kalungia AC, 2016, EXPERT REV ANTI INFE, V7210, P20; Mbwambo G., 2017, African Journal of Microbiology Research, V11, P1018, DOI 10.5897/ajmr2017.8583; Minzi OM, 2013, DRUG HEALTHC PATIENT, V5, P5, DOI 10.2147/DHPS.S36409; Muscat M, 2006, SCAND J INFECT DIS, V38, P597, DOI 10.1080/00365540600606507; National Bureau of Statistics, 2018, TANZ FIG 2017; Pereko DD, 2015, SOUTH AFR J INFECT D, V30, P134, DOI 10.1080/23120053.2015.1107290; Poyongo BP, 2019, PHARMACISTS KNOWLEDG; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Shallcross LJ, 2014, J ANTIMICROB CHEMOTH, V69, P2883, DOI 10.1093/jac/dku346; Shet A, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0098-8; Smith RA, 2015, HEALTH COMMUN, V30, P309, DOI 10.1080/10410236.2014.943634; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Ventola C., 2019, INT J MED DEV CTRIES, V40, DOI [10.24911/ijmdc.51-1549060699, DOI 10.24911/IJMDC.51-1549060699]; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Zou XX, 2014, J HUAZHONG U SCI-MED, V34, P456, DOI 10.1007/s11596-014-1300-6	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239388	10.1371/journal.pone.0239388	http://dx.doi.org/10.1371/journal.pone.0239388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970720	gold, Green Published			2022-12-26	WOS:000576265600029
J	Yoon, JH; Cha, JY; Choi, YJ; Park, WS; Han, SS; Lee, KJ				Yoon, Ju-Hyun; Cha, Jung-Yul; Choi, Yoon Jeong; Park, Won-Se; Han, Sang-Sun; Lee, Kee-Joon			Simulation of miniscrew-root distance available for molar distalization depending on the miniscrew insertion angle and vertical facial type	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CORTICAL BONE; SAFE ZONES; MAXILLARY; PLACEMENT; THICKNESS; STABILITY; ANCHORAGE; MOVEMENT; CONTACT	Objective The purpose of this study was to evaluate the effects of miniscrew insertion angle and vertical facial type on the interradicular miniscrew-root distance available for molar distalization. Materials and methods Cone-beam computed tomography images of 60 adults with skeletal Class I occlusion exhibiting hyperdivergent (n = 20), normodivergent (n = 20), and hypodivergent (n = 20) facial types were used. Placement of a 6-mm long, 1.5-mm diameter, tapered miniscrew was simulated at a site 4 mm apical to the cementoenamel junction, with insertion angles of 0 degrees, 30 degrees, 45 degrees, and 60 degrees relative to the transverse occlusal plane. The shortest linear distance between the miniscrew and anterior root at four interradicular sites was measured: maxillary second premolar and first molar (Mx 5-6), maxillary first and second molars (Mx 6-7), mandibular second premolar and first molar (Mn 5-6), and mandibular first and second molars (Mn 6-7). Results Miniscrew-root distance significantly increased as the insertion angle increased from 0 degrees to 60 degrees. In the mandible, the distances significantly differed among vertical facial types, increasing in the following order: hyperdivergent, normodivergent, and hypodivergent. The minimum mean distance was found in the Mx 6-7 (30 degrees; 0.86 +/- 0.35 mm), and the maximum mean distance was found in the Mn 5-6 (60 degrees; 2.64 +/- 0.56 mm). The rates of miniscrews located buccally outside the root distalization path were up to 70% and 55% when the miniscrews were placed at 60 degrees insertion angles in the Mx 5-6 and Mn 5-6 regions, respectively. Conclusions Miniscrew-root distance increased significantly with the increased insertion angle, and the amount of increase was affected by the miniscrew placement site and vertical facial type. To ensure adequate distalization of the posterior segment, the miniscrew should be inserted at an angle in the interradicular area between the second premolar and first molar.	[Yoon, Ju-Hyun; Cha, Jung-Yul; Choi, Yoon Jeong; Lee, Kee-Joon] Yonsei Univ, Coll Dent, Inst Craniofacial Deform, Dept Orthodont, Seoul, South Korea; [Park, Won-Se] Yonsei Univ, Coll Dent, Dept Adv Gen Dent, Seoul, South Korea; [Han, Sang-Sun] Yonsei Univ, Coll Dent, Dept Oral & Maxillofacial Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, KJ (corresponding author), Yonsei Univ, Coll Dent, Inst Craniofacial Deform, Dept Orthodont, Seoul, South Korea.	orthojn@yuhs.ac	cha, jung yul/AGG-4402-2022; Lee, Kee-Joon/AAA-4090-2022	Han, Sang-Sun/0000-0003-1775-7862	faculty research grant of Yonsei University College of Dentistry [2017-0012]	faculty research grant of Yonsei University College of Dentistry	This study was supported by faculty research grant of Yonsei University College of Dentistry, Grant/Award Number:2017-0012 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albogha MH, 2019, ANGLE ORTHOD, V89, P235, DOI 10.2319/122017-873.1; [Anonymous], 2004, MOV DISORD S9, V19, pS1; Bae MJ, 2013, AM J ORTHOD DENTOFAC, V143, P893, DOI 10.1016/j.ajodo.2013.02.018; Cha BK, 2007, ANGLE ORTHOD, V77, P463, DOI 10.2319/0003-3219(2007)077[0463:SSAVFT]2.0.CO;2; Chaimanee P, 2011, ANGLE ORTHOD, V81, P397, DOI 10.2319/061710-111.1; Chen YH, 2008, CLIN ORAL IMPLAN RES, V19, P99, DOI 10.1111/j.1600-0501.2007.01418.x; Choi YJ, 2011, AM J ORTHOD DENTOFAC, V139, P823, DOI 10.1016/j.ajodo.2009.07.026; Deguchi T, 2006, AM J ORTHOD DENTOFAC, V129, DOI [10.1016/j.ajodo.2006.02.026, DOI 10.1016/J.AJODO.2006.02.026]; FROST HM, 1994, ANGLE ORTHOD, V64, P175; Guerrero ME, 2006, CLIN ORAL INVEST, V10, P1, DOI 10.1007/s00784-005-0031-2; HORN AJ, 1992, AM J ORTHOD DENTOFAC, V102, P180, DOI 10.1016/0889-5406(92)70031-5; Horner KA, 2012, AM J ORTHOD DENTOFAC, V142, P170, DOI 10.1016/j.ajodo.2012.03.021; Ingervall B, 1997, ANGLE ORTHOD, V67, P415; Isaac S., 1971, HDB RES EVALUATION; Julious SA, 2005, PHARM STAT, V4, P287, DOI 10.1002/pst.185; Kim H, 2011, AM J ORTHOD DENTOFAC, V139, P752, DOI 10.1016/j.ajodo.2009.06.042; Kim SJ, 2014, AM J ORTHOD DENTOFAC, V146, P190, DOI 10.1016/j.ajodo.2014.04.021; Kravitz ND, 2007, AM J ORTHOD DENTOFAC, V131, pS43, DOI 10.1016/j.ajodo.2006.04.027; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, pS68, DOI 10.1016/j.ajodo.2006.06.017; Lee KJ, 2009, AM J ORTHOD DENTOFAC, V135, P486, DOI 10.1016/j.ajodo.2007.05.019; Lim WH, 2007, CLIN ANAT, V20, P760, DOI 10.1002/ca.20513; Liou EJW, 2007, AM J ORTHOD DENTOFAC, V131, P352, DOI 10.1016/j.ajodo.2005.04.044; Liu HB, 2017, AM J ORTHOD DENTOFAC, V151, P500, DOI 10.1016/j.ajodo.2016.07.021; Maino B Giuliano, 2007, J Clin Orthod, V41, P762; Masumoto T, 2001, EUR J ORTHODONT, V23, P15, DOI 10.1093/ejo/23.1.15; Moon CH, 2010, AM J ORTHOD DENTOFAC, V138, P51, DOI 10.1016/j.ajodo.2008.08.032; Park H, 2001, USE MICROIMPLANT ORT; Park H S, 2001, J Clin Orthod, V35, P417; Park HS, 2005, ANGLE ORTHOD, V75, P602; Park HS, 2010, AM J ORTHOD DENTOFAC, V137, P200, DOI 10.1016/j.ajodo.2008.04.028; Poggio PM, 2006, ANGLE ORTHOD, V76, P191; Raji Seyed Hamid, 2014, Dent Res J (Isfahan), V11, P448; Riedel RA, 1952, ANGLE ORTHOD, V22, P142; Schnelle MA, 2004, ANGLE ORTHOD, V74, P832; Sella-Tunis T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24293-3; Tsunori M, 1998, ANGLE ORTHOD, V68, P557; Van Belle G, 2008, SAMPLE SIZE STAT RUL, V2nd, P27; Wilmes B, 2008, ANGLE ORTHOD, V78, P1065, DOI 10.2319/100707-484.1; Woodall N, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2010.08.017; Yamada K, 2009, ANGLE ORTHOD, V79, P78, DOI 10.2319/020408-68.1; Zhao LX, 2011, AM J ORTHOD DENTOFAC, V139, P628, DOI 10.1016/j.ajodo.2009.06.040	41	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239759	10.1371/journal.pone.0239759	http://dx.doi.org/10.1371/journal.pone.0239759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970759	Green Published, gold			2022-12-26	WOS:000576265600091
J	Kahlert, CR; Cipriani, M; Vernazza, P				Kahlert, C. R.; Cipriani, M.; Vernazza, P.			Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks-A proof-of-concept study	PLOS ONE			English	Article							SAFETY; MONOTHERAPY; EXPERIENCE; MANAGEMENT; BENEFITS	Objectives The aim of this proof-of-concept study is to test feasibility and efficacy of NVP plus Lamivudine (3TC) as novel simplified HIV maintenance dual therapy (DT) strategy. Methods Patients under combined antiretroviral treatment (cART) with fully suppressed HIV plasma viral load (pVL) >24 months-whereof >6 months on an NVP- containing regimen-were switched to oral NVP plus 3TC for 24 weeks. Patients could then decide whether to continue DT or return to the previous cART. HIV pVL was monitored monthly until week 144. The primary outcome was confirmed viral failure (RNA >100 copies/ml). Low-level detection of HIV-RNA in plasma was compared in each patient with pre-study viral load measurements. Results Twenty patients were included, switched to DT and all completed week 24. One patient decided thereafter to discontinue study participation for personal reasons. After a total of 144 observation weeks, none of the patients failed. The frequency of low- level HIV-RNA detection was not different from the period before randomization. Conclusions Our findings are surprising but given the nature of a proof-of-concept study, the results do not support the use of this dual regimen. However, as this dual HIV maintenance strategy was feasible and effective, over a period of 144 weeks, we suggest NVP plus 3TC warrants further evaluation as potential maintenance option in patients tolerating nevirapine. A properly sized multicentre non-inferiority trial is ongoing to further evaluate the value of this DT maintenance strategy.	[Kahlert, C. R.; Cipriani, M.; Vernazza, P.] Cantonal Hosp Sankt Gallen, Infect Dis & Hosp Epidemiol, St Gallen, Switzerland; [Kahlert, C. R.] Childrens Hosp Eastern Switzerland, Infect Dis & Hosp Epidemiol, St Gallen, Switzerland	Kantonsspital St. Gallen	Kahlert, CR (corresponding author), Cantonal Hosp Sankt Gallen, Infect Dis & Hosp Epidemiol, St Gallen, Switzerland.; Kahlert, CR (corresponding author), Childrens Hosp Eastern Switzerland, Infect Dis & Hosp Epidemiol, St Gallen, Switzerland.	christian.kahlert@kssg.ch	Kahlert, Christian/B-9659-2017	Kahlert, Christian/0000-0002-0784-3276				Calcagno A, 2014, CLIN PHARMACOKINET, V53, P891, DOI 10.1007/s40262-014-0171-0; Calmy A, 2009, ANTIVIR THER, V14, P931, DOI 10.3851/IMP1418; Gutmann C, 2010, AIDS, V24, P2347, DOI 10.1097/QAD.0b013e32833db9a1; Julia N, 2019, SWISS MED WKLY, V149, DOI 10.4414/smw.2019.20053; Kesselring AM, 2009, AIDS, V23, P1689, DOI 10.1097/QAD.0b013e32832d3b54; Podzamczer D, 2012, CURR HIV RES, V10, P513, DOI 10.2174/157016212802429820; Pollard RB, 1998, CLIN THER, V20, P1071, DOI 10.1016/S0149-2918(98)80105-7; Reliquet V, 2010, HIV CLIN TRIALS, V11, P110, DOI 10.1310/hct1102-110; Rodriguez-Arrondo F, 2009, CURR HIV RES, V7, P526, DOI 10.2174/157016209789346246; Ryscavage P, 2014, ANTIMICROB AGENTS CH, V58, P3585, DOI 10.1128/AAC.00076-14; Saag MS, 2018, JAMA-J AM MED ASSOC, V320, P379, DOI 10.1001/jama.2018.8431; Sarmati L, 2012, J ANTIMICROB CHEMOTH, V67, P2932, DOI 10.1093/jac/dks331; Vernazza P, 2007, AIDS, V21, P1309, DOI 10.1097/QAD.0b013e32814e6b1c; Wijting I, 2017, LANCET HIV, V4, pE547, DOI 10.1016/S2352-3018(17)30152-2; Wit FWNM, 2008, CLIN INFECT DIS, V46, P933, DOI 10.1086/528861	15	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0237770	10.1371/journal.pone.0237770	http://dx.doi.org/10.1371/journal.pone.0237770			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966293	Green Published, gold			2022-12-26	WOS:000575688700063
J	Sinha, S; Irani, UD; Manchaiah, V; Bhamla, MS				Sinha, Soham; Irani, Urvaksh D.; Manchaiah, Vinaya; Bhamla, M. Saad			LoCHAid: An ultra-low-cost hearing aid for age-related hearing loss	PLOS ONE			English	Article							HEALTH; TECHNOLOGIES; IMPAIRMENT; ADULTS	Hearing aids are the primary tool in non-medical rehabilitation for individuals with hearing loss. While the costs of the electronic components have reduced substantially, the cost of a hearing aid has risen steadily to the point that it has become unaffordable for the majority of the population with Age-Related Hearing Loss (ARHL) especially for those residing in low- and middle-income countries. Here, we present an ultra-low-cost, affordable and accessible hearing aid device ('LoCHAid'), specifically targeted towards treating ARHL in elderly patients. The LoCHAid components cost 98 cents (< $1) when purchased in bulk for 10,000 units and can be personalized for each user through a 3D-printable case. It is designed to be an over-the-counter (OTC) self-serviceable solution for elderly individuals with ARHL. Electroacoustic measurements show that the device meets most of the targets set out by the WHO Preferred Product Profile and Consumer Technology Association for hearing aids. The frequency response of the hearing aid shows selectable gain in the range of 4-8 kHz, and mild to moderate gain between 200-1000 Hz, and shows very limited total distortion (1%). Simulated gain measurements show that the LoCHAid is well fitted to a range of ARHL profiles for males and females between the ages of 60-79 years. Overall, the measurements show that the device offers the potential to benefit individuals with ARHL. Thus, our proposed design has the potential to address the challenge of affordable and accessible hearing technology for hearing impaired elderly individuals especially in low- and middle-income countries.	[Sinha, Soham; Bhamla, M. Saad] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Irani, Urvaksh D.] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA; [Manchaiah, Vinaya] Lamar Univ, Dept Speech & Hearing Sci, Beaumont, TX 77710 USA; [Sinha, Soham] Stanford Univ, Sch Bioengn, Palo Alto, CA 94304 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Texas State University System; Lamar University; Stanford University	Bhamla, MS (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	saabd@chbe.gatech.edu	Chan, Simmy/AAD-9046-2021; Bhamla, Saad/L-3174-2013	Sinha, Soham/0000-0001-8598-0543; Bhamla, Saad/0000-0002-9788-9920	Capita Foundation; National Science Foundation	Capita Foundation; National Science Foundation(National Science Foundation (NSF))	M.S.B. acknowledges funding support from Capita Foundation (2018 CFAR award). http://www.capitafoundation.org and National Science Foundation. 2020 CAREER Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank A. Dubey and S. Sekhar for initial LoCHAid prototype designs; Dr. A. Dockens, Dr. E. Burns of Lamar Audiology for assistance in audiological testing; Dr. R. A. Robinson Jr at the Georgia Tech School of Electrical and Computer Engineering guidance on filter design and frequency response; J. Eng for assistance on design of the custom PCB; Dr. P. S. Russo at Georgia Tech School of Materials Science and Engineering for assistance in testing device; Dr. Bradley McPherson and Bhavisha Parmar for helpful suggestions and advice; and finally the Bhamla Lab for invaluable feedback.	Aazh H, 2007, J AM ACAD AUDIOL, V18, P653, DOI 10.3766/jaaa.18.8.3; Aazh H, 2012, AM J AUDIOL, V21, P175, DOI 10.1044/1059-0889(2012/11-0008); [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2010, ELECT ANTIQUITY, V14, p[127, 128], DOI DOI 10.1177/1084713810385712; [Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2017, PREF PROF HEAR AID T; ANSI, 2014, SPEC HEAR AID CHAR, P552; Belenky M, 2011, SOLAR EAR LOW COST H; Bento RF, 2010, TRENDS AMPLIF, V14, P64, DOI 10.1177/1084713810380934; Bliss M, 2002, LANCET, V360, P1333, DOI 10.1016/S0140-6736(02)11330-4; Blustein J, 2016, AM J PUBLIC HEALTH, V106, P1032, DOI 10.2105/AJPH.2016.303176; Cheng CM, 2000, AUDIOLOGY, V39, P110; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Ciletti L, 2008, J AM ACAD AUDIOL, V19, P672, DOI 10.3766/jaaa.19.9.3; CTA, 2017, ANSI CTA STAND; Cybulski JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098781; Dillon H, 2011, PHONAK FOCUS, V40, P1; Holder JT, 2016, J AM ACAD AUDIOL, V27, P619, DOI 10.3766/jaaa.15027; Holube I, 2010, INT J AUDIOL, V49, P891, DOI 10.3109/14992027.2010.506889; Jilla Anna Marie, 2018, Semin Hear, V39, P135, DOI 10.1055/s-0038-1641740; Kujawa SG, 2006, J NEUROSCI, V26, P2115, DOI 10.1523/JNEUROSCI.4985-05.2006; Lewis JD, 2010, J ACOUST SOC AM, V127, P2521, DOI 10.1121/1.3327808; Limb CJ, 2010, TRENDS AMPLIF, V14, P63, DOI 10.1177/1084713810381273; Lin FR, 2016, JAMA-J AM MED ASSOC, V316, P819, DOI 10.1001/jama.2016.7916; Mainar AR, 2018, J ENERGY STORAGE, V15, P304, DOI 10.1016/j.est.2017.12.004; Manchaiah V., 2018, PERSPECTIVES ASIIA S, V3, P5, DOI DOI 10.1044/PERSP3.SIG7.5; Manchaiah V, 2017, CLIN INTERV AGING, V12, P859, DOI 10.2147/CIA.S135390; Maxim-Integrated, 2016, MICR AMPL AGC LOW NO; McCormack A, 2013, INT J AUDIOL, V52, P360, DOI 10.3109/14992027.2013.769066; McPherson B, 2005, DISABIL REHABIL, V27, P601, DOI 10.1080/09638280400019682; MCPHERSON B, 2004, COMMUN DISORD Q, V25, P219, DOI DOI 10.1177/15257401040250040601; McPherson B, 2014, DISABIL REHABIL-ASSI, V9, P360, DOI 10.3109/17483107.2014.907365; McPherson B, 2011, TRENDS AMPLIF, V15, P209, DOI 10.1177/1084713811424887; Reed NS, 2017, JAMA-J AM MED ASSOC, V318, P89, DOI 10.1001/jama.2017.6905; Ricketts TA, 2008, J SPEECH LANG HEAR R, V51, P160, DOI 10.1044/1092-4388(2008/012); Stenklev NC, 2004, INT J AUDIOL, V43, P295, DOI 10.1080/14992020400050039; United Nations Development Programme, 2019, GLOB MULT POV IND 20; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; Weinstein H, 2012, SOLAR CHARGER HEARIN; World Bank, 2019, GROSS NAT INC PER CA; World Health Organization, 2018, ADDR PREV HEAR LOSS; Xu K, 2018, PUBLIC SPENDING HLTH	43	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238922	10.1371/journal.pone.0238922	http://dx.doi.org/10.1371/journal.pone.0238922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966301	Green Published, gold			2022-12-26	WOS:000575688700022
J	Walters, KE; Martiny, JBH				Walters, Kendra E.; Martiny, Jennifer B. H.			Alpha-, beta-, and gamma-diversity of bacteria varies across habitats	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; PLANT DIVERSITY; SPECIES RICHNESS; SOIL; PATTERNS; FOREST; BIOGEOGRAPHY; TEMPERATURE; FERTILIZER; DYNAMICS	Bacteria are essential parts of ecosystems and are the most diverse organisms on the planet. Yet, we still do not know which habitats support the highest diversity of bacteria across multiple scales. We analyzed alpha-, beta-, and gamma-diversity of bacterial assemblages using 11,680 samples compiled by the Earth Microbiome Project. We found that soils contained the highest bacterial richness within a single sample (alpha-diversity), but sediment assemblages displayed the highest gamma-diversity. Sediment, biofilms/mats, and inland water exhibited the most variation in community composition among geographic locations (beta-diversity). Within soils, agricultural lands, hot deserts, grasslands, and shrublands contained the highest richness, while forests, cold deserts, and tundra biomes consistently harbored fewer bacterial species. Surprisingly, agricultural soils encompassed similar levels of beta-diversity as other soil biomes. These patterns were robust to the alpha- and beta- diversity metrics used and the taxonomic binning approach. Overall, the results support the idea that spatial environmental heterogeneity is an important driver of bacterial diversity.	[Walters, Kendra E.; Martiny, Jennifer B. H.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Walters, KE (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	ewalter@uci.edu		Walters, Kendra/0000-0003-2596-9435	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-SC0016410]; National Science Foundation Graduate Research Fellowship Program [DGE-1321846]; Ridge to Reef NSF Research Traineeship [DGE-1735040]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Ridge to Reef NSF Research Traineeship	Funding was provided by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research (DE-SC0016410; awarded to JBHM; https://www.energy.gov/science/ber/biological-andenvironmental-research).This work was supported by the Ridge to Reef NSF Research Traineeship, award DGE-1735040 (https://r2r.bio.uci.edu) and the National Science Foundation Graduate Research Fellowship Program (to KEW; under Grant No. DGE-1321846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; [Anonymous], 2020, LANCET RESP MED, V8, P1, DOI [10.1016/S2213-2600(19)30449-7, 10.1016/S22132600(19)30402-3]; [Anonymous], 2017, Hepatol Int, V11, P1, DOI 10.1007/s12072-016-9783-9; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2018, REGEN RECONSTR RESTO, V3, pX, DOI [10.22037/rrr.v3i4.24267., DOI 10.22037/RRR.V3I4.24267]; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Asakawa S, 2008, SOIL BIOL BIOCHEM, V40, P1322, DOI 10.1016/j.soilbio.2007.09.024; Bahram M, 2018, NATURE, V560, P233, DOI 10.1038/s41586-018-0386-6; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Campbell BJ, 2013, ISME J, V7, P210, DOI 10.1038/ismej.2012.93; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carson JK, 2010, APPL ENVIRON MICROB, V76, P3936, DOI 10.1128/AEM.03085-09; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Cheeke TE, 2015, MOL ECOL, V24, P2580, DOI 10.1111/mec.13178; Crump BC, 2012, ISME J, V6, P1629, DOI 10.1038/ismej.2012.9; Curd EE, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2079; Delgado-Baquerizo M, 2019, ECOSYSTEMS, V22, P1220, DOI 10.1007/s10021-018-0333-2; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Ding JL, 2016, APPL SOIL ECOL, V105, P187, DOI 10.1016/j.apsoil.2016.04.010; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2011, AM J BOT, V98, P439, DOI 10.3732/ajb.1000498; Freestone AL, 2006, ECOLOGY, V87, P2425, DOI 10.1890/0012-9658(2006)87[2425:DLAEHS]2.0.CO;2; Glassman SI, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00148-18; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Gorley C.K., 2006, GETTING STARTED PRIM; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hijmans RJ, 2015, RASTER GEOGRAPHIC DA; Holdridge L. R., 1967, Life zone ecology.; Ibarbalz FM, 2019, CELL, V179, P1084, DOI 10.1016/j.cell.2019.10.008; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Johnson M., 1974, J BIOGEOGR, V1, P149, DOI DOI 10.2307/3037964; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Lamb EG, 2011, PLANT SOIL, V338, P483, DOI 10.1007/s11104-010-0560-6; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Martiny JBH, 2018, TRENDS MICROBIOL, V26, P250, DOI 10.1016/j.tim.2018.02.010; Miletto M, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0128-z; Miller SR, 2009, APPL ENVIRON MICROB, V75, P4565, DOI 10.1128/AEM.02792-08; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Needham DM, 2017, ISME J, V11, P1614, DOI 10.1038/ismej.2017.29; Neufeld JD, 2005, APPL ENVIRON MICROB, V71, P5710, DOI 10.1128/AEM.71.10.5710-5718.2005; Nychka D., 2017, FIELDS TOOLS SPATIAL, DOI [10.5065/D6W957CT, DOI 10.5065/D6W957CT.R]; O'Brien SL, 2016, ENVIRON MICROBIOL, V18, P2039, DOI 10.1111/1462-2920.13231; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Philippot L, 2013, ISME J, V7, P1609, DOI 10.1038/ismej.2013.34; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; R Core T, 2017, LANG ENV STAT COMP; Ramirez GA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02969; Rintala H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-56; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Sharma SK, 2010, SUSTAIN AGR REV, V5, P317, DOI 10.1007/978-90-481-9513-8_11; Sharp CE, 2014, ISME J, V8, P1166, DOI 10.1038/ismej.2013.237; Soman C, 2017, PLANT SOIL, V413, P145, DOI 10.1007/s11104-016-3083-y; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Upchurch R, 2008, SOIL BIOL BIOCHEM, V40, P1294, DOI 10.1016/j.soilbio.2007.06.027; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433	70	39	39	10	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0233872	10.1371/journal.pone.0233872	http://dx.doi.org/10.1371/journal.pone.0233872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966309	Green Published, Green Submitted, gold			2022-12-26	WOS:000575688700034
J	Gordon, JL; Balsom, AA				Gordon, Jennifer L.; Balsom, Ashley A.			The psychological impact of fertility treatment suspensions during the COVID-19 pandemic	PLOS ONE			English	Article							INFERTILE WOMEN; DEFENSIVE PESSIMISM; SOCIAL SUPPORT; CHRONIC PAIN; PREVALENCE; ACCEPTANCE; ANXIETY; ADJUSTMENT; DEPRESSION; THERAPY	Purpose To examine the psychological impact of fertility treatment suspensions resulting from the COVID-19 pandemic and to clarify psychosocial predictors of better or worse mental health. Methods 92 women from Canada and the United States (ages 20-45 years) whose fertility treatments had been cancelled were recruited via social media. Participants completed a battery of questionnaires assessing depressive symptoms, perceived mental health impact, and change in quality of life related to treatment suspensions. Potential predictors of psychological outcomes were also examined, including several personality traits, aspects of social support, illness cognitions, and coping strategies. Results 52% of respondents endorsed clinical levels of depressive symptoms. On a 7-point scale, participants endorsed a significant decline in overall quality of life (M(SD) = -1.3(1.3), p < .0001) as well as a significant decline in mental health related to treatment suspensions on a scale from -5 to +5 (M(SD) = -2.1(2.1), p < .001). Several psychosocial variables were found to positively influence these outcomes: lower levels of defensive pessimism (r = -.25, p < .05), greater infertility acceptance (r = .51, p < .0001), better quality social support (r = .31, p < .01), more social support seeking (r = .35, p < .001) and less avoidance of infertility reminders (r = -.23, p = .029). Conclusion Fertility treatment suspensions have had a considerable negative impact on women's mental health and quality of life. However, these findings point to several protective psychosocial factors that can be fostered in the future to help women cope.	[Gordon, Jennifer L.; Balsom, Ashley A.] Univ Regina, Dept Psychol, Regina, SK, Canada	University of Regina	Gordon, JL (corresponding author), Univ Regina, Dept Psychol, Regina, SK, Canada.	jennifer.gordon@uregina.ca	Balsom, Ashley/AAS-1161-2020	Balsom, Ashley/0000-0002-1795-8093; Gordon, Jennifer/0000-0001-6401-6827	Saskatchewan Health Research Foundation [4577]; Canadian Institutes of Health Research, Tier II Canada Research Chair	Saskatchewan Health Research Foundation; Canadian Institutes of Health Research, Tier II Canada Research Chair(Canadian Institutes of Health Research (CIHR))	JLG: Saskatchewan Health Research Foundation, grant #4577, www.shrf.ca JLG: Canadian Institutes of Health Research, Tier II Canada Research Chair, https://cihr-irsc.gc.ca/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society for Reproductive Medicine, 2020, P STRATEGICA 9 INT A; Bromham D.R., 1989, J REPROD INFANT PSYC, V7, P195, DOI DOI 10.1080/02646838908403594; Bushnik T, 2012, HUM REPROD, V27, P738, DOI 10.1093/humrep/der465; Canadian Fertility Andrology Society Guidelines and Resources, 2020, CFAS COMM COVID 19; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Chen TH, 2004, HUM REPROD, V19, P2313, DOI 10.1093/humrep/deh414; DOMAR AD, 1993, J PSYCHOSOM OBST GYN, V14, P45; Driscoll MA, 2016, ANN BEHAV MED, V50, P272, DOI 10.1007/s12160-015-9750-z; Esteve R, 2007, ANN BEHAV MED, V33, P179, DOI 10.1007/BF02879899; Faramarzi M, 2008, J AFFECT DISORDERS, V108, P159, DOI 10.1016/j.jad.2007.09.002; HAYES SC, 1994, BEHAV ANALYST, V17, P289, DOI 10.1007/BF03392677; HYNES GJ, 1992, BRIT J MED PSYCHOL, V65, P269, DOI 10.1111/j.2044-8341.1992.tb01707.x; Kee BS, 2000, J ASSIST REPROD GEN, V17, P445; KEMP B, 2001, TOP SPINAL CORD INJU, V6, P116; Koszycki D, 2012, ARCH WOMEN MENT HLTH, V15, P193, DOI 10.1007/s00737-012-0277-z; Lauwerier E, 2010, INT J BEHAV MED, V17, P90, DOI 10.1007/s12529-009-9059-z; Lowe B, 2004, MED CARE, V42, P1194, DOI 10.1097/00005650-200412000-00006; Lund R, 2009, HUM REPROD, V24, P2810, DOI 10.1093/humrep/dep257; Martins MV, 2014, HUM REPROD, V29, P83, DOI 10.1093/humrep/det403; McCracken LA, 2008, HEALTH PSYCHOL, V27, P215, DOI 10.1037/0278-6133.27.2.215; Mindes EJ, 2003, SOC SCI MED, V56, P2165, DOI 10.1016/S0277-9536(02)00221-6; Myers LB, 1996, AM J FAM THER, V24, P9, DOI 10.1080/01926189508251012; Nelson CJ, 2008, J SEX MED, V5, P1907, DOI 10.1111/j.1743-6109.2008.00880.x; NOREM JK, 1986, J PERS SOC PSYCHOL, V51, P1208, DOI 10.1037/0022-3514.51.6.1208; Peterson BD, 2006, HUM REPROD, V21, P2443, DOI 10.1093/humrep/del145; Peterson BD, 2011, COGN BEHAV PRACT, V18, P577, DOI 10.1016/j.cbpra.2010.03.004; Ruiz F. J., 2012, INT J PSYCHOL PSYCHO, V12, P333, DOI DOI 10.1016/J.BETH.2011.07.004; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Spencer SM, 1996, PERS SOC PSYCHOL B, V22, P354, DOI 10.1177/0146167296224003; Turocy JM, 2020, EMOTIONAL IMPACT ASR; Van den Broeck U, 2010, PATIENT EDUC COUNS, V81, P422, DOI 10.1016/j.pec.2010.10.009; Viane I, 2003, PAIN, V106, P65, DOI 10.1016/S0304-3959(03)00291-4; Volgsten H, 2008, HUM REPROD, V23, P2056, DOI 10.1093/humrep/den154; Yu YJ, 2014, PSYCHIAT RES, V215, P401, DOI 10.1016/j.psychres.2013.10.032	34	27	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239253	10.1371/journal.pone.0239253	http://dx.doi.org/10.1371/journal.pone.0239253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946479	Green Published, gold			2022-12-26	WOS:000573851100030
J	Goutaudier, R; Coizet, V; Carcenac, C; Carnicella, S				Goutaudier, Raphael; Coizet, Veronique; Carcenac, Carole; Carnicella, Sebastien			Compound 21, a two-edged sword with both DREADD-selective and off-target outcomes in rats	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA; SUPERIOR COLLICULUS; DOPAMINE; CHEMOGENETICS; ACTIVATION; NEURONS; BEHAVIOR	Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) represent a technical revolution in integrative neuroscience. However, the first used ligands exhibited dose-dependent selectivity for their molecular target, leading to potential unspecific effects. Compound 21 (C21) was recently proposed as an alternative, butin vivocharacterization of its properties is not sufficient yet. Here, we evaluated its potency to selectively modulate the activity of nigral dopaminergic (DA) neurons through the canonical DREADD receptor hM4Di usingTH-Crerats. In males, 1 mg.kg(-1)of C21 strongly increased nigral neurons activity in control animals, indicative of a significant off-target effect. Reducing the dose to 0.5 mg.kg(-1)circumvented this unspecific effect, while activated the inhibitory DREADDs and selectively reduced nigral neurons firing. In females, 0.5 mg.kg(-1)of C21 induced a transient and residual off-target effect that may mitigated the inhibitory DREADDs-mediated effect. This study raises up the necessity to test selectivity and efficacy of chosen ligands for each new experimental condition.	[Goutaudier, Raphael; Coizet, Veronique; Carcenac, Carole; Carnicella, Sebastien] Univ Grenoble Alpes, Grenoble Inst Neurosci, U1216, INSERM, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Carnicella, S (corresponding author), Univ Grenoble Alpes, Grenoble Inst Neurosci, U1216, INSERM, Grenoble, France.	sebastien.carnicella@inserm.fr		Goutaudier, Raphael/0000-0003-3125-1307	Institut National de la Sante et de la Recherche Medicale (Inserm); Agence Nationale de la Recherche [ANR-16-CE16-0002]; Grenoble Alpes University	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Grenoble Alpes University	This work was supported by the Institut National de la Sante et de la Recherche Medicale (Inserm), the Agence Nationale de la Recherche (ANR-16-CE16-0002, to SC) and Grenoble Alpes University.	Aldrin-Kirk P, 2019, METHOD MOL BIOL, DOI [10.1007/978-1-4939-9065-8_4, DOI 10.1007/978-1-4939-9065-8_430706390]; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Beloate LN, 2016, J NEUROSCI, V36, P9949, DOI 10.1523/JNEUROSCI.0937-16.2016; Bonaventura J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12236-z; Brentzen S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00187; Campbell EJ, 2018, BRIT J PHARMACOL, V175, P994, DOI 10.1111/bph.14146; Chen X, 2015, ACS CHEM NEUROSCI, V6, P476, DOI 10.1021/cn500325v; Choleris E, 2018, NEUROSCI BIOBEHAV R, V85, P126, DOI 10.1016/j.neubiorev.2017.07.005; Coizet V, 2006, NEUROSCIENCE, V139, P1479, DOI 10.1016/j.neuroscience.2006.01.030; Coizet V, 2003, EUR J NEUROSCI, V17, P28, DOI 10.1046/j.1460-9568.2003.02415.x; Cornea-Hebert V, 1999, CORNEA HEBERT, V209, P187, DOI [10.1088/1741-2560/10/2/026010, DOI 10.1088/1741-2560/10/2/02601023428937]; Di Giovanni G, 1999, NEUROSCIENCE, V91, P587, DOI 10.1016/S0306-4522(98)00655-1; Dringenberg HC, 1998, N-S ARCH PHARMACOL, V358, P423, DOI 10.1007/PL00005274; Drui G, 2014, MOL PSYCHIATR, V19, P358, DOI 10.1038/mp.2013.3; Fink KB, 2007, PHARMACOL REV, V59, P360, DOI 10.1124/pr.107.07103; Girdhar A, 2018, IET IMAGE PROCESS, V12, P1, DOI 10.1049/iet-ipr.2017.0162; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Goutaudier R, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0171-19.2019; Jendryka M, 2019, SCI REP, V9, P1; Korotkova TM, 2002, NEUROSCI LETT, V320, P133, DOI 10.1016/S0304-3940(02)00050-2; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; MacLaren DAA, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0219-16.2016; Mahler SV, 2018, NEUROPSYCHOPHARMACOL, V43, P934, DOI 10.1038/npp.2017.299; Mahler SV, 2014, NAT NEUROSCI, V17, P577, DOI 10.1038/nn.3664; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Runegaard AH, 2019, PHARMACOL REV, V71, P123, DOI 10.1124/pr.117.013995; S BE, 2018, J CROHNS COLITIS, V12, pS049; Saloman JL, 2016, J NEUROSCI, V36, P10769, DOI 10.1523/JNEUROSCI.3480-15.2016; Thompson KJ, 2018, ACS PHARMACOL TRANSL, V1, P61, DOI 10.1021/acsptsci.8b00012; Ungless MA, 2012, TRENDS NEUROSCI, V35, P422, DOI 10.1016/j.tins.2012.02.003; Whissell PD, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00070; Xia F, 2017, ELIFE, V6, DOI 10.7554/eLife.27868	35	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238156	10.1371/journal.pone.0238156	http://dx.doi.org/10.1371/journal.pone.0238156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946510	Green Submitted, Green Published, gold			2022-12-26	WOS:000573851100022
J	Guido, I; Diehl, D; Olszok, NA; Bodenschatz, E				Guido, Isabella; Diehl, Douglas; Olszok, Nora Aleida; Bodenschatz, Eberhard			Cellular velocity, electrical persistence and sensing in developed and vegetative cells during electrotaxis	PLOS ONE			English	Article							DICTYOSTELIUM-DISCOIDEUM CELLS; DENSITY; CHEMOTAXIS; MIGRATION; MOTILITY; PROTEIN; FIELD; GALVANOTAXIS; ORIENTATION; EXPRESSION	Cells have the ability to detect electric fields and respond to them with directed migratory movement. Investigations identified genes and proteins that play important roles in defining the migration efficiency. Nevertheless, the sensing and transduction mechanisms underlying directed cell migration are still under discussion. We useDictyostelium discoideumcells as model system for studying eukaryotic cell migration in DC electric fields. We have defined the temporal electric persistence to characterize the memory that cells have in a varying electric field. In addition to imposing a directional bias, we observed that the electric field influences the cellular kinematics by accelerating the movement of cells along their paths. Moreover, the study of vegetative and briefly starved cells provided insight into the electrical sensing of cells. We found evidence that conditioned medium of starved cells was able to trigger the electrical sensing of vegetative cells that would otherwise not orient themselves in the electric field. This observation may be explained by the presence of the conditioned medium factor (CMF), a protein secreted by the cells, when they begin to starve. The results of this study give new insights into understanding the mechanism that triggers the electrical sensing and transduces the external stimulus into directed cell migration. Finally, the observed increased mobility of cells over time in an electric field could offer a novel perspective towards wound healing assays.	[Guido, Isabella; Diehl, Douglas; Olszok, Nora Aleida; Bodenschatz, Eberhard] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Bodenschatz, Eberhard] Georg August Univ Gottingen, Inst Dynam Complex Syst, Gottingen, Germany; [Bodenschatz, Eberhard] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY USA	Max Planck Society; University of Gottingen; Cornell University	Guido, I (corresponding author), Max Planck Inst Dynam & Self Org, Gottingen, Germany.	isabella.guido@ds.mpg.de		Guido, Isabella/0000-0002-1781-3767	MaxSynBio Consortium - Federal Ministry of Education and Research of Germany; MaxSynBio Consortium - Max Planck Society	MaxSynBio Consortium - Federal Ministry of Education and Research of Germany; MaxSynBio Consortium - Max Planck Society(Max Planck Society)	E.B. and I.G. Support from the MaxSynBio Consortium which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society. https://www.maxsynbio.mpg.de/13480/maxsynbio The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GM, 2013, CURR BIOL, V23, P560, DOI 10.1016/j.cub.2013.02.047; Beta C, 2008, LAB CHIP, V8, P1087, DOI 10.1039/b801331d; Clarke M, 1995, EXPERIENTIA, V51, P1124, DOI 10.1007/BF01944730; COOPER MS, 1984, P NATL ACAD SCI-BIOL, V81, P160, DOI 10.1073/pnas.81.1.160; Decave E, 2003, J CELL SCI, V116, P4331, DOI 10.1242/jcs.00726; Decave E, 2002, BIOPHYS J, V82, P2383, DOI 10.1016/S0006-3495(02)75583-5; Dineur E, 1891, B SEANCES SOC BELGE, V18, P113; Djamgoz MBA, 2001, J CELL SCI, V114, P2697; ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Gao RC, 2011, EUKARYOT CELL, V10, P1251, DOI 10.1128/EC.05066-11; Gao RC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab0562; GOMER RH, 1991, DEVELOPMENT, V112, P269; Gomer RH, 2011, DEV GROWTH DIFFER, V53, P482, DOI 10.1111/j.1440-169X.2010.01248.x; GUSTAFSSON P., 2012, PLOS ONE, V7, P1; Huang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21583; JAFFE LF, 1977, ANNU REV BIOPHYS BIO, V6, P445, DOI 10.1146/annurev.bb.06.060177.002305; JAIN R, 1994, J BIOL CHEM, V269, P9128; Li XF, 2002, J VASC RES, V39, P391, DOI 10.1159/000064517; Lin F, 2008, J IMMUNOL, V181, P2465, DOI 10.4049/jimmunol.181.4.2465; McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004; McCaig CD, 2009, J CELL SCI, V122, P4267, DOI 10.1242/jcs.023564; Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125; RAPP B, 1988, EUR BIOPHYS J BIOPHY, V16, P313, DOI 10.1007/BF00254068; ROBINSON KR, 1985, J CELL BIOL, V101, P2023, DOI 10.1083/jcb.101.6.2023; Sato MJ, 2007, BIOSYSTEMS, V88, P261, DOI 10.1016/j.biosystems.2006.06.008; Sato MJ, 2009, P NATL ACAD SCI USA, V106, P6667, DOI 10.1073/pnas.0809974106; Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248; Sheridan DM, 1996, J INVEST DERMATOL, V106, P642, DOI 10.1111/1523-1747.ep12345456; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Verwon M, 1896, ARCH GES PHYSL, V62, P415, DOI 10.1007/BF01790002; YUEN IS, 1995, J CELL BIOL, V129, P1251, DOI 10.1083/jcb.129.5.1251; YUEN IS, 1991, DEVELOPMENT, V113, P1375; Zhao M, 1997, CURR EYE RES, V16, P973, DOI 10.1076/ceyr.16.10.973.9014; Zhao M, 2002, J CELL BIOL, V157, P921, DOI 10.1083/jcb.200112070; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zouwail S, 2005, BIOCHEM J, V389, P207, DOI 10.1042/BJ20050085	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239379	10.1371/journal.pone.0239379	http://dx.doi.org/10.1371/journal.pone.0239379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946489	Green Published, gold, Green Submitted			2022-12-26	WOS:000573851100048
J	Shao, JJ; Ge, JF; Feng, XM; Zhao, CR				Shao, Jingjing; Ge, Jingfeng; Feng, Xiaomiao; Zhao, Chaoran			Study on the relationship between PM(2.5)concentration and intensive land use in Hebei Province based on a spatial regression model	PLOS ONE			English	Article							FINE PARTICULATE MATTER; AIR-POLLUTION; PM2.5; CHINA; HAZE; EXPANSION; HANGZHOU; CITIES; HEALTH; CITY	Based on 0.01 degrees x0.01 degrees grid data of PM(2.5)annual concentration and statistical yearbook data for 11 cities in Hebei Province from 2000 to 2015, the temporal and spatial distribution characteristics of PM(2.5)in the study area are analysed, the level of intensive land use in the area is evaluated, and decoupling theory and spatial regression are used to discuss the relationship between PM(2.5)concentration and intensive land use and the influence of intensive land use variables on PM(2.5)in Hebei Province. The results show that 1. In terms of time, the concentration of PM(2.5)in Hebei Province showed an overall upward trend from 2000 to 2015, with the highest in winter and the lowest in summer. The daily variations show double peaks at 8:00-10:00 and 21:00-0:00 and a single valley at 16:00-18:00. 2. In terms of space, the concentration of PM(2.5)in Hebei Province is high in the southeast and low in the northwest, and the pollution spillover initially decreases and then increases. 3. In the past 16 years, the level of intensive land use in Hebei Province has increased annually, but blind expansion still exists. 4. Decoupling theory and the spatial lag model show that land use intensity, land input level and land use structure are positively correlated with PM(2.5)concentration, land output benefit is negatively correlated with PM(2.5)concentration, and PM(2.5)concentration and land intensive use level have not yet been decoupled; thus, the relationship is not harmonious. This research can provide a scientific basis for reducing air pollution and promoting the development of urban land resources for intensive and sustainable development.	[Shao, Jingjing; Ge, Jingfeng; Zhao, Chaoran] Hebei Normal Univ, Coll Resources & Environm, Shijiazhuang, Hebei, Peoples R China; [Ge, Jingfeng] Hebei Normal Univ, Coll Resources & Environm, Hebei Key Lab Environm Change & Ecol Construct, Shijiazhuang, Hebei, Peoples R China; [Feng, Xiaomiao] Shijiazhuang Univ, Coll Resources & Environm, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Hebei Normal University	Ge, JF (corresponding author), Hebei Normal Univ, Coll Resources & Environm, Shijiazhuang, Hebei, Peoples R China.; Ge, JF (corresponding author), Hebei Normal Univ, Coll Resources & Environm, Hebei Key Lab Environm Change & Ecol Construct, Shijiazhuang, Hebei, Peoples R China.; Feng, XM (corresponding author), Shijiazhuang Univ, Coll Resources & Environm, Shijiazhuang, Hebei, Peoples R China.	gejingfeng@hebtu.edu.cn; fengxm0310@126.com			China Natural Science Foundation [41471090]; Hebei Natural Science Foundation [D2011205098]; Graduate Innovation Grant Program of Hebei Province [CXZZBS2019082]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hebei Natural Science Foundation(Natural Science Foundation of Hebei Province); Graduate Innovation Grant Program of Hebei Province	This research was supported by the China Natural Science Foundation (Fund No:41471090), the Hebei Natural Science Foundation (Fund No:D2011205098) and Graduate Innovation Grant Program of Hebei Province (Grant No. CXZZBS2019082). Jingfeng Ge is the owner of China Natural Science Foundation (Fund No:41471090) and the Hebei Natural Science Foundation (Fund No:D2011205098), Jingjing Shao is the owner of Graduate Innovation Grant Program of Hebei Province (Grant No. CXZZBS2019082).	[Anonymous], 2014, LANCET DIABETES ENDO, V2, P1, DOI 10.1016/S2213-8587(13)70164-5; [Anonymous], 2005, J MINIM INVASIVE GYN, V12, pS1; [Anonymous], 2015, DIABETES CARE S1, V38, P77; [Anonymous], 2017, CRIT CARE NURSE, V37, pe19; [Anonymous], 2010, SOFTWARE, V9, P13; ANSELIN L, 1989, ECON GEOGR, V65, P162, DOI 10.2307/143781; Chen HY, 2008, HABITAT INT, V32, P28, DOI 10.1016/j.habitatint.2007.06.005; [程兰 CHENG Lan], 2009, [生态学杂志, Chinese Journal of Ecology], V28, P2593; Deng Q., 2017, GEOLOGY ECOL LANDSCA, V1, P95, DOI [10.1080/24749508.2017.1332851, DOI 10.1080/24749508.2017.1332851]; Dong Chen-wei, 2017, Yingyong Shengtai Xuebao, V28, P231, DOI 10.13287/j.1001-9332.201701.022; Elhorst JP, 2010, SPAT ECON ANAL, V5, P9, DOI 10.1080/17421770903541772; [高健 Gao Jian], 2016, [科学通报, Chinese Science Bulletin], V61, P3002; Geary R.C., 1954, INC STAT, V5, P115, DOI [DOI 10.2307/2986645, 10.2307/2986645]; Green N, 2012, J AFR HIST, V53, P131, DOI 10.1017/S0021853712000230; Guan DB, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/2/024010; Huang P, 2015, INT J ENV RES PUB HE, V12, P6608, DOI 10.3390/ijerph120606608; Jansen RC, 2014, ADV ATMOS SCI, V31, P1427, DOI 10.1007/s00376-014-4042-2; Jian X., 2010, EC RES J, V45, P28; Jianhui X., 2010, RESOUCE DEV MARKET, V26, P291; Kaminski W, 2008, 2008 19 INT C SYST E; Kan HD, 2012, ENVIRON INT, V42, P10, DOI 10.1016/j.envint.2011.03.003; Khodeir M, 2012, ATMOS POLLUT RES, V3, P331, DOI 10.5094/APR.2012.037; Lee JH, 2015, SCI TOTAL ENVIRON, V514, P178, DOI 10.1016/j.scitotenv.2015.01.091; Li CH, 2011, CHINESE AGR SCI B; Li MN, 2014, ENVIRON POLLUT, V189, P85, DOI 10.1016/j.envpol.2014.02.024; Li Xue-mei, 2019, Journal of Ecology and Rural Environment, V35, P174, DOI 10.19741/j.issn.1673-4831.2017.0818; Liu H.J., 2015, CHINA IND EC, V5, P83, DOI DOI 10.19581/J.CNKI.CIEJOURNAL.2015.05.008; Miskell G, 2015, ENVIRON SCI TECHNOL, V49, P9004, DOI 10.1021/acs.est.5b00476; MORAN PAP, 1950, BIOMETRIKA, V37, P178, DOI 10.1093/biomet/37.1-2.178; Neuman M, 2005, J PLAN EDUC RES, V25, P11, DOI 10.1177/0739456X04270466; OECD, 2002, IND MEAS DEC ENV PRE; Pan Jing-hu, 2014, Shengtaixue Zazhi, V33, P3423; [彭佳雯 Peng Jiawen], 2011, [资源科学, Resources Science], V33, P626; Qian MJ, 2012, RESOURCE DEV MARKET, V28, P529; Song Y, 2019, ECOL INDIC, V102, P230, DOI 10.1016/j.ecolind.2019.02.044; Song YS, 2016, J CLEAN PROD, V112, P1312, DOI 10.1016/j.jclepro.2015.05.006; Ugarte MD, 2011, J R STAT SOC A STAT, V174, P513; [王婧 Wang Jing], 2014, [自然资源学报, Journal of Natural Resources], V29, P1271; Wang J, 2013, ATMOS ENVIRON, V68, P221, DOI 10.1016/j.atmosenv.2012.10.070; Wang SJ, 2017, J CLEAN PROD, V142, P1800, DOI 10.1016/j.jclepro.2016.11.104; [王跃思 Wang Yuesi], 2014, [地球科学进展, Advance in Earth Sciences], V29, P388; Westerlund J, 2014, ATMOS ENVIRON, V89, P22, DOI 10.1016/j.atmosenv.2014.02.015; Yan D., 2018, ATMOS ENVIRON, V183, P225, DOI [DOI 10.1016/J.ATMOSENV.2018.03.041, 10.1016/j.atmosenv.2018.03.041]; Yang LX, 2007, SCI TOTAL ENVIRON, V383, P164, DOI 10.1016/j.scitotenv.2007.04.042; Yang W., 1997, ADV EC GEOGRAPHY; [张恒德 Zhang Hengde], 2016, [环境科学学报, Acta Scientiae Circumstantiae], V36, P4340; Zhang Q, 2015, SCI TOTAL ENVIRON, V502, P578, DOI 10.1016/j.scitotenv.2014.09.079; Zhang YY, 2018, SCI TOTAL ENVIRON, V630, P72, DOI 10.1016/j.scitotenv.2018.02.151; Zhao N, 2017, J ARID METEOROLOGY, V35, P839; Zhou Y.X., 1999, URBAN GEOGR	50	13	14	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238547	10.1371/journal.pone.0238547	http://dx.doi.org/10.1371/journal.pone.0238547			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946497	gold, Green Published			2022-12-26	WOS:000573851100091
J	Carmelo, VAO; Kadarmideen, HN				Carmelo, Victor A. O.; Kadarmideen, Haja N.			Genetic variations (eQTLs) in muscle transcriptome and mitochondrial genes, and trans-eQTL molecular pathways in feed efficiency from Danish breeding pigs	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMS BIOLOGY; CANDIDATE GENES; LONGISSIMUS-DORSI; TRAITS; POLYMORPHISMS; EXPRESSION; GWAS; IDENTIFICATION; ARCHITECTURE	Feed efficiency (FE) is a key trait in pig production, as improvement in FE has positive economic and environmental impact. FE is a complex phenotype and testing animals for FE is costly. Therefore, there has been a desire to find functionally relevant single nucleotide polymorphisms (SNPs) as biomarkers, to improve our biological understanding of FE as well as accuracy of genomic prediction for FE. We have performed a cis- and trans- eQTL (expression quantitative trait loci) analysis, in a population of Danbred Durocs (N = 11) and Danbred Landrace (N = 27) using both a linear and ANOVA model based on muscle tissue RNA-seq. We analyzed a total of 1425x19179 or 2.7x10(7)Gene-SNP combinations in eQTL detection models for FE. The 1425 genes were from RNA-Seq based differential gene expression analyses using 25880 genes related to FE and additionally combined with mitochondrial genes. The 19179 SNPs were from applying stringent quality control and linkage disequilibrium filtering on genotype data using a GGP Porcine HD 70k SNP array. We applied 1000 fold bootstrapping and enrichment analysis to further validate and analyze our detected eQTLs. We identified 13 eQTLs with FDR < 0.1, affecting several genes found in previous studies of commercial pig breeds. Examples include MYO19, CPT1B, ACSL1, IER5L, CPT1A, SUCLA2, CSRNP1, PARK7 and MFF. The bootstrapping results showed statistically significant enrichment (p-value<2.2x10(-16)) of eQTLs with p-value < 0.01 in both cis and trans-eQTLs. Enrichment analysis of top trans-eQTLs revealed high enrichment for gene categories and gene ontologies associated with genomic context and expression regulation. This included transcription factors (p-value = 1.0x10(-13)), DNA-binding (GO:0003677, p-value = 8.9x10(-14)), DNA-binding transcription factor activity (GO:0003700,) nucleus gene (GO:0005634, p-value<2.2x10(-16)), negative regulation of expression (GO:0010629, p-value<2.2x10(-16)). These results would be useful for future genome assisted breeding of pigs to improve FE, and in the improved understanding of the functional mechanism of trans eQTLs.	[Carmelo, Victor A. O.; Kadarmideen, Haja N.] Tech Univ Denmark, Dept Appl Math & Comp Sci, Quantitat Genom Bioinformat & Computat Biol Grp, Lyngby, Denmark	Technical University of Denmark	Kadarmideen, HN (corresponding author), Tech Univ Denmark, Dept Appl Math & Comp Sci, Quantitat Genom Bioinformat & Computat Biol Grp, Lyngby, Denmark.	hajak@dtu.dk		Kadarmideen, Haja/0000-0001-6294-382X	Independent Research Fund Denmark (DFF) Technology and Production (FTP) grant [4184-00268B]	Independent Research Fund Denmark (DFF) Technology and Production (FTP) grant	VAOC were funded by the Independent Research Fund Denmark (DFF)(https://dff.dk/en) Technology and Production (FTP) grant (grant number: 4184-00268B). VAOC received partial Ph.D. stipends from the University of Copenhagen and Technical University of Denmark.	[Anonymous], 2015, CANC DISCOV, V5, pOF2; [Anonymous], 2017, ADDIT POLYM; Banerjee P, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00121; Becila S, 2010, EUR FOOD RES TECHNOL, V231, P485, DOI 10.1007/s00217-010-1296-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonder MJ, 2017, NAT GENET, V49, P131, DOI 10.1038/ng.3721; Bottje WG, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00306; Bryois J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004461; Canovas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035583; Carmelo V.A.O., 2020, BIORXIV; Carmelo VAO, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2291-2; Carmelo VAO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57182-4; Chen CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052433; Connor EE, 2010, FUNCT INTEGR GENOMIC, V10, P39, DOI 10.1007/s10142-009-0138-7; Ding RR, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00220; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drag M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192673; Do DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071509; Eya JC, 2011, AQUACULTURE, V321, P71, DOI 10.1016/j.aquaculture.2011.08.037; Cardoso TF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3986-x; Gallagher MD, 2018, AM J HUM GENET, V102, P717, DOI 10.1016/j.ajhg.2018.04.002; Gao Y, 2011, GENET MOL RES, V10, P779, DOI 10.4238/vol10-2gmr1170; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gilbert H, 2017, ANIMAL, V11, P1427, DOI 10.1017/S175173111600286X; Gondret F, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3639-0; Gonzalez-Prendes R, 2017, ANIM GENET, V48, P606, DOI 10.1111/age.12586; Hirschhorn JN, 2005, PEDIATR RES, V57, p74R, DOI 10.1203/01.PDR.0000159574.98964.87; Horodyska J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5175-y; Hu H, 2019, NUCLEIC ACIDS RES, V47, pD33, DOI 10.1093/nar/gky822; Hu Z-L, 2018, NUCLEIC ACIDS RES, V47, P1; Jegou M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146550; Johnson GCL, 2000, CURR OPIN GENET DEV, V10, P330, DOI 10.1016/S0959-437X(00)00075-7; Kadarmideen HN, 2008, IET SYST BIOL, V2, P423, DOI 10.1049/iet-syb:20070072; Kadarmideen HN, 2006, MAMM GENOME, V17, P548, DOI 10.1007/s00335-005-0169-x; Kadarmideen HN, 2011, MOL BIOSYST, V7, P235, DOI 10.1039/c0mb00190b; Kadarmideen HN, 2014, LIVEST SCI, V166, P232, DOI 10.1016/j.livsci.2014.04.028; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Kogelman LJA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0229-0; Lee T, 2014, ASIAN AUSTRAL J ANIM, V27, P303, DOI 10.5713/ajas.2013.13385; Li QG, 2012, MOL BIOL REP, V39, P8787, DOI 10.1007/s11033-012-1741-6; Li XJ, 2016, ANIM GENET, V47, P324, DOI 10.1111/age.12421; Liao C., 2019, BIORXIV; Liaubet L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-548; Linck E, 2019, MOL ECOL RESOUR, V19, P639, DOI 10.1111/1755-0998.12995; Liu XX, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0120-x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Pedersen BK, 2013, COMPR PHYSIOL, V3, P1337, DOI 10.1002/cphy.c120033; Perry KR, 2016, J ANIM SCI, V94, P67, DOI 10.2527/jas2016.94supplement467x; Ponsuksili S, 2014, INT J BIOL SCI, V10, P327, DOI 10.7150/ijbs.8134; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero IG, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-42; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sironen AI, 2010, J ANIM SCI, V88, P821, DOI 10.2527/jas.2009-2426; Steibel JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016766; Teissier M, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0400-3; Turner N, 2014, J ENDOCRINOL, V220, pT61, DOI 10.1530/JOE-13-0397; Velez-Irizarry D, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5386-2; Verardo LL, 2015, J APPL GENET, V56, P123, DOI 10.1007/s13353-014-0240-y; Veroneze R, 2013, J ANIM SCI, V91, P3493, DOI 10.2527/jas.2012-6052; Vincent A, 2015, J ANIM SCI, V93, P2745, DOI 10.2527/jas.2015-8928; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xu RX, 2014, ASIAN AUSTRAL J ANIM, V27, P1254, DOI 10.5713/ajas.2013.13772; Yang F, 2012, CHINESE SCI BULL, V57, P2733, DOI 10.1007/s11434-012-5328-3; Zhang XY, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00151; Zhang YJ, 2018, CELL STRESS CHAPERON, V23, P967, DOI 10.1007/s12192-018-0904-3	69	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239143	10.1371/journal.pone.0239143	http://dx.doi.org/10.1371/journal.pone.0239143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941478	Green Submitted, gold, Green Published			2022-12-26	WOS:000573848800037
J	De Pelsmaeker, N; Korslund, L; Steifetten, O				De Pelsmaeker, Nicolas; Korslund, Lars; Steifetten, Oyvind			Do bank voles (Myodes glareolus) trapped in live and lethal traps show differences in tick burden?	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; MOUSE APODEMUS-SYLVATICUS; LYME-DISEASE SPIROCHETE; IXODES-DAMMINI ACARI; HOME-RANGE SIZE; BORRELIA-BURGDORFERI; CLETHRIONOMYS-GLAREOLUS; CAPTURE MYOPATHY; RESERVOIR HOSTS; QUESTING ACTIVITY	In studies assessing tick abundance, the use of live traps to capture and euthanize rodent hosts is a commonly used method to determine their burden. However, captive animals can experience debilitating or fatal capture stress as a result prior to collection. An alternative method is the use of lethal traps, but this can potentially lead to tick drop-off between the time of capture and collection. In this study, in order to determine whether subjecting animals to capture stress is inevitable, we tested the difference in sheep tick (Ixodes ricinus) larval burdens between bank voles (Myodes glareolus) captured alive and euthanized, and lethally trapped bank voles. During 2017 and 2018, 1318 bank voles were captured using live (Ugglan Special no. 2) and lethal (Rapp2 Mousetrap) traps during two consecutive years over three seasons in two locations in Norway. Voles captured alive would remain captive until euthanized, while lethally trapped voles were killed instantly upon capture. Log-linear models, accounting for overdispersion, were used to determine whether trap type was influencing observed tick burden. Bank voles captured in lethal traps carried 5.7% more larvae compared to euthanized voles captured in live traps, but this difference was not significant (p = 0.420). Males were overall captured 2.7 times more frequently than females, and the sex ratio was equal in both trap types. This study shows that the use of lethal traps to determine tick burden of rodents is sufficiently reliable, without having to subject animals to potentially lethal stress, hereby reducing some ethical concerns of animal suffering and the results thereof, without compromising accuracy. Lethal trapping is also often more economical and practical, further favoring this collection method.	[De Pelsmaeker, Nicolas; Steifetten, Oyvind] Univ Southeastern Norway, Dept Nat Hlth & Environm, Bo, Norway; [Korslund, Lars] Univ Agder, Dept Nat Sci, Kristiansand, Norway	University of Agder	De Pelsmaeker, N (corresponding author), Univ Southeastern Norway, Dept Nat Hlth & Environm, Bo, Norway.	nicolas.de.pelsmaeker@usn.no	Korslund, Lars/AAF-1248-2021	Korslund, Lars/0000-0001-9825-1294; De Pelsmaeker, Nicolas/0000-0002-5908-040X				[Anonymous], 1991, AM J CLIN NUTR S, V55, p615S; Arthur DR, 1963, BRIT TICKS BRIT TICK; Bitam I, 2010, INT J INFECT DIS, V14, pE667, DOI 10.1016/j.ijid.2009.11.011; Blumstein Daniel T., 2015, Evolution Medicine and Public Health, P195, DOI 10.1093/emph/eov015; Bond ML, 1999, J MAMMAL, V80, P1243, DOI 10.2307/1383174; Bosson CO, 2012, J ZOOL, V288, P159, DOI 10.1111/j.1469-7998.2012.00941.x; Breed D, 2019, CONSERV PHYSIOL, V7, DOI 10.1093/conphys/coz027; BUJALSKA G, 1986, ACTA THERIOL, V31, P71, DOI 10.4098/AT.arch.86-6; Cole LC, 1946, PUBLIC HLTH REPORTS, V61; CRAINE NG, 1995, FOLIA PARASIT, V42, P73; CRAWLEY MC, 1969, OIKOS, V20, P310, DOI 10.2307/3543198; Dallas TA, 2012, J VECTOR ECOL, V37, P338, DOI 10.1111/j.1948-7134.2012.00236.x; Dantas-Torres F, 2013, VET PARASITOL, V192, P253, DOI 10.1016/j.vetpar.2012.09.034; DEBOER R, 1993, ZBL BAKT-INT J MED M, V279, P404; Delehanty B, 2009, GEN COMP ENDOCR, V160, P176, DOI 10.1016/j.ygcen.2008.11.011; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; DIZIJ A, 1995, PARASITE IMMUNOL, V17, P177, DOI 10.1111/j.1365-3024.1995.tb00887.x; DRUMMOND RO, 1967, ANN ENTOMOL SOC AM, V60, P439, DOI 10.1093/aesa/60.2.439; Estrada-Pena A, 2004, MED VET ENTOMOL, V18, P387, DOI 10.1111/j.0269-283X.2004.00523.x; GENTILE JR, 1987, WILDLIFE SOC B, V15, P490; Gern L, 1998, ZBL BAKT-INT J MED M, V287, P196; Gouveia K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066401; Gratz NG, 1957, J PARASITOL, V43; Gray JS, 2008, INT J MED MICROBIOL, V298, P19, DOI 10.1016/j.ijmm.2007.09.005; GRAY JS, 1982, B ENTOMOL RES, V72, P263, DOI 10.1017/S0007485300010567; GREENWOOD PJ, 1978, OIKOS, V31, P123, DOI 10.2307/3543393; Haapakoski M, 2010, POPUL ECOL, V52, P427, DOI 10.1007/s10144-010-0193-x; Haemig PD, 2008, SCAND J INFECT DIS, V40, P527, DOI 10.1080/00365540701805446; Handeland K, 2013, VET PARASITOL, V195, P142, DOI 10.1016/j.vetpar.2013.02.012; HANSSON L, 1987, OIKOS, V49, P161, DOI 10.2307/3566022; Harrison A, 2010, OIKOS, V119, P1099, DOI 10.1111/j.1600-0706.2009.18072.x; HART BL, 1990, NEUROSCI BIOBEHAV R, V14, P273, DOI 10.1016/S0149-7634(05)80038-7; Herraez P, 2007, J WILDLIFE DIS, V43, P770, DOI 10.7589/0090-3558-43.4.770; Hillyard P. D., 1996, TICKS N W EUROPE FIE; Humair PF, 1999, PARASITOLOGY, V118, P33, DOI 10.1017/S0031182098003564; Jouda F, 2004, J MED ENTOMOL, V41, P162, DOI 10.1603/0022-2585-41.2.162; Kemp DH., 1982, PHYSL TICKS, P119, DOI DOI 10.1016/B978-0-08-024937-7.50009-3; Kiffner C, 2011, PARASITOL RES, V108, P323, DOI 10.1007/s00436-010-2065-x; Knap N, 2009, VET PARASITOL, V164, P275, DOI 10.1016/j.vetpar.2009.06.001; KNULLE WILLI, 1966, J MED ENTOMOL, V2, P335, DOI 10.1093/jmedent/2.4.335; KORN H, 1986, OECOLOGIA, V68, P623, DOI 10.1007/BF00378782; Korslund L, 2018, ANN ZOOL FENN, V55, P247, DOI 10.5735/086.055.0607; LANE RS, 1991, J MED ENTOMOL, V28, P719, DOI 10.1093/jmedent/28.5.719; LAURANCE WF, 1987, AM MIDL NAT, V118, P1, DOI 10.2307/2425622; Letty J, 2000, ANIM CONSERV, V3, P211, DOI 10.1017/S1367943000000925; Lindsjo J, 2016, J WILDLIFE DIS, V52, pS65, DOI 10.7589/52.2S.S65; Lydecker HW, 2019, J MED ENTOMOL, V56, P1527, DOI 10.1093/jme/tjz094; MACIVOR KM, 1987, EXP APPL ACAROL, V3, P131, DOI 10.1007/BF01270475; MATUSCHKA FR, 1992, J INFECT DIS, V165, P479, DOI 10.1093/infdis/165.3.479; Meiners T, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.048; Mejlon HA, 1997, EXP APPL ACAROL, V21, P747, DOI 10.1023/A:1018421105231; Montane J, 2002, J VET MED A, V49, P93, DOI 10.1046/j.1439-0442.2002.jv409.x; Mooring MS, 1995, EXP APPL ACAROL, V19, P533, DOI 10.1007/BF00052923; Morand S, 2015, INTEGR ZOOL, V10, P409, DOI 10.1111/1749-4877.12143; Nadelman RB, 1997, NEW ENGL J MED, V337, P27, DOI 10.1056/NEJM199707033370105; Nakao M, 1996, J PARASITOL, V82, P669, DOI 10.2307/3283804; NILSSON A, 1978, OIKOS, V31, P313, DOI 10.2307/3543656; Pawelczyk A, 2004, INT J MED MICROBIOL, V293, P167, DOI 10.1016/S1433-1128(04)80033-0; Perret JL, 2000, PARASITOL RES, V86, P554, DOI 10.1007/s004360000209; Pichon B, 2005, VECTOR-BORNE ZOONOT, V5, P172, DOI 10.1089/vbz.2005.5.172; PIESMAN J, 1987, J CLIN MICROBIOL, V25, P557, DOI 10.1128/JCM.25.3.557-558.1987; PIESMAN J, 1991, J MED ENTOMOL, V28, P259, DOI 10.1093/jmedent/28.2.259; Pollock NB, 2012, PARASITOL RES, V111, P897, DOI 10.1007/s00436-012-2916-8; PUTMAN RJ, 1995, BIODIVERS CONSERV, V4, P903, DOI 10.1007/BF00056197; Qviller L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-179; R Development Core Team, 2019, R LANG ENV STAT CONP; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; RECHAV Y, 1982, J MED ENTOMOL, V19, P679, DOI 10.1093/jmedent/19.6.679; Scharlemann JPW, 2008, MED VET ENTOMOL, V22, P238, DOI 10.1111/j.1365-2915.2008.00734.x; Schutz KE, 2006, J WILDLIFE MANAGE, V70, P884, DOI 10.2193/0022-541X(2006)70[884:BAPROT]2.0.CO;2; Schwarz A, 2009, INT J HYG ENVIR HEAL, V212, P87, DOI 10.1016/j.ijheh.2007.12.001; SUTHERST RW, 1972, AUST J AGR RES, V23, P195, DOI 10.1071/AR9720195; TALLEKLINT L, 1994, J MED ENTOMOL, V31, P880, DOI 10.1093/jmedent/31.6.880; Vail SG, 2002, J MED ENTOMOL, V39, P842, DOI 10.1603/0022-2585-39.6.842; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; WILSON ML, 1984, YALE J BIOL MED, V57, P697; WILSON ML, 1985, ANN ENTOMOL SOC AM, V78, P172, DOI 10.1093/aesa/78.2.172; YEH MT, 1995, J MED ENTOMOL, V32, P853, DOI 10.1093/jmedent/32.6.853; ZETHOF TJJ, 1994, PHYSIOL BEHAV, V55, P109, DOI 10.1016/0031-9384(94)90017-5; Zuur Alain F., 2009, P1; 2008, TICKS BIOL DIS CONTR, P1	81	2	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239029	10.1371/journal.pone.0239029	http://dx.doi.org/10.1371/journal.pone.0239029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941509	gold, Green Published			2022-12-26	WOS:000573848800045
J	Kum-Nji, P; Meloy, L; Pierce, J; Ritter, A; Wheeler, R				Kum-Nji, Philip; Meloy, Linda; Pierce, John; Ritter, Amanda; Wheeler, Rachel			Group B streptococcal colonization: Prevalence and impact of smoking in women delivering term or near term neonates in a large tertiary care hospital in the southern United States	PLOS ONE			English	Article							TIME PCR ASSAY; RISK-FACTORS; CERVICAL-MUCUS; PREGNANT-WOMEN; TOBACCO-SMOKE; ANTIBIOTICS; CARRIAGE; EPIDEMIOLOGY; PATHOGENS; NICOTINE	Background and hypothesis The role of smoking as a risk factor for group B streptococcal (GBS) colonization in women during pregnancy has not been previously adequately explored. We hypothesized that women of term or near term neonates who smoked during pregnancy were more likely to have GBS colonization than their non-smoking counterparts. Methods The electronic health records (EHRs) of a convenience sample of women delivering in an inner-city university tertiary care center were reviewed. The outcome variable of interest was maternal GBS colonization during pregnancy. The primary independent variable of interest was tobacco smoking during pregnancy, determined from the EHRs by the number of cigarettes smoked during gestation. Descriptive statistics were conducted and categorical data were compared by the Fischer's exact test. Multiple logistic regression analysis was further conducted to determine the independent impact of tobacco smoke exposure on GBS colonization. Results The prevalence of maternal GBS colonization was 35% among the study population. In the univariate analyses, factors associated with maternal GBS colonization were tobacco smoking during pregnancy (P of trend <0.001), Race (P<0.001), maternal age <20 years (P = 0.006), low birthweight <2500 gm (P = 0.020), maternal drug use (P = 004), and gestational age <37 (P = 0.041). In a multiple logistic regression analysis, tobacco smoking during pregnancy remained the most significant predictor of GBS colonization. Women who smoked during pregnancy were more than twice more likely to be colonized than their non-smoking counterparts (OR = 2.6; 95% CI = 1.5-4.6; p<0.001). Maternal age was the only other significant predictor with younger mothers more than one and a half time more likely to be colonized than their older counterparts (OR = 1.65; 95% CI = 1.02-2.68; P = 0.04). Conclusion The prevalence of GBS colonization in this institution was consistent with recent national rates. Smoking and maternal age were identified as two independent risk factors for GBS colonization during pregnancy. Further studies are needed to confirm these findings.	[Kum-Nji, Philip; Meloy, Linda] Virginia Commonwealth Univ, Sch Med, Childrens Hosp Richmond, Richmond, VA 23284 USA; [Pierce, John] Lynchburg Womens Hlth, Lynchburg, VA USA; [Ritter, Amanda; Wheeler, Rachel] Virginia Commonwealth Univ, Sch Med, Dept Obstet & Gynecol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Kum-Nji, P (corresponding author), Virginia Commonwealth Univ, Sch Med, Childrens Hosp Richmond, Richmond, VA 23284 USA.	pkumnji@vcu.edu						Aloisio I, 2014, APPL MICROBIOL BIOT, V98, P6051, DOI 10.1007/s00253-014-5712-9; [Anonymous], 2019, CIRCULATION, V2019; [Anonymous], 2016, LANCET ONCOL, V17, pe198; ANTHONY BF, 1978, J INFECT DIS, V137, P524, DOI 10.1093/infdis/137.5.524; Ashkenazi-Hoffnung L, 2011, CLIN PEDIATR, V50, P827, DOI 10.1177/0009922811406260; Barcaite E, 2008, ACTA OBSTET GYN SCAN, V87, P260, DOI 10.1080/00016340801908759; Brook I, 2011, J DENT RES, V90, P704, DOI 10.1177/0022034510391794; Brook I, 2008, ANN OTO RHINOL LARYN, V117, P727, DOI 10.1177/000348940811701003; Brook I, 2010, INT J PEDIATR OTORHI, V74, P447, DOI 10.1016/j.ijporl.2010.01.006; Buckleys BS, 2012, DIABETES CARE S1, V29, P844; Busetti M, 2007, J CLIN PATHOL, V60, P1140, DOI 10.1136/jcp.2006.043489; Chaudhary M, 2017, PEDIATR INFECT DIS J, V36, P665, DOI 10.1097/INF.0000000000001514; Chen JC, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3216-4; Church DL, 2017, J CLIN MICROBIOL, V55, P2137, DOI 10.1128/JCM.00043-17; Darabi Roksana, 2017, Electron Physician, V9, P4399, DOI 10.19082/4399; Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; DILLON HC, 1982, J INFECT DIS, V145, P794, DOI 10.1093/infdis/145.6.794; El Ahmer OR, 1999, FEMS IMMUNOL MED MIC, V23, P27, DOI 10.1111/j.1574-695X.1999.tb01713.x; Gilbert GL, 2002, AUST NZ J OBSTET GYN, V42, P497, DOI 10.1111/j.0004-8666.2002.00497.x; Greenberg D, 2006, CLIN INFECT DIS, V42, P897, DOI 10.1086/500935; HELLBERG D, 1988, AM J OBSTET GYNECOL, V158, P910, DOI 10.1016/0002-9378(88)90093-2; Hiller Janet E, 2005, BMC Pregnancy Childbirth, V5, P12, DOI 10.1186/1471-2393-5-12; HOOGKAMPKORSTANJE JAA, 1982, J INFECT DIS, V145, P800, DOI 10.1093/infdis/145.6.800; Huneeus A, 2018, J PEDIATR ADOL GYNEC, V31, P411, DOI 10.1016/j.jpag.2018.01.003; Joachim A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-437; Kadanali A, 2005, INT J CLIN PRACT, V59, P437, DOI 10.1111/j.1368-5031.2005.00395.x; Kum-Nji P, 2006, PEDIATRICS, V117, P1745, DOI 10.1542/peds.2005-1886; Ledger WJ, 2013, BJOG-INT J OBSTET GY, V120, P1450, DOI 10.1111/1471-0528.12371; Lee SH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090282; Mathews, 2014, NATL VITAL STAT REP, V65, P1; MCCANN MF, 1992, CANCER EPIDEM BIOMAR, V1, P125; Meyn LA, 2002, AM J EPIDEMIOL, V155, P949, DOI 10.1093/aje/155.10.949; National Center for Health Statistics, 2016, VIT STAT BIRTH DAT F; Nelson TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-14943-3; Park JS, 2013, ANN LAB MED, V33, P39, DOI 10.3343/alm.2013.33.1.39; REGAN JA, 1991, OBSTET GYNECOL, V77, P604; Russell NJ, 2017, CLIN INFECT DIS, V65, pS100, DOI 10.1093/cid/cix658; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1; SCHUCHAT A, 1994, PEDIATR INFECT DIS J, V13, P623, DOI 10.1097/00006454-199407000-00008; Seale AC, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.67, 10.1038/NMICROBIOL.2016.67]; Seedat F, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1432-3; Shen P, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00434-17; Simons A. M., 1994, TOBACCO, V49, P186; Slotved HC, 2017, BMC, DOI [10.1186/s128al, DOI 10.1186/S128AL]; Terry Richard R., 1999, Journal of the American Osteopathic Association, V99, P571; Turrentine MA, 2013, BJOG-INT J OBSTET GY, V120, P1453, DOI 10.1111/1471-0528.12372; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Voss M, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0204-8; Wohl DL, 2015, J AM BOARD FAM MED, V28, P82, DOI 10.3122/jabfm.2015.01.140017	49	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239294	10.1371/journal.pone.0239294	http://dx.doi.org/10.1371/journal.pone.0239294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941502	gold, Green Published			2022-12-26	WOS:000573848800022
J	Nsiah-Asamoah, C; Doku, DT; Agblorti, S				Nsiah-Asamoah, Christiana; Doku, David Teye; Agblorti, Samuel			Mothers' and Grandmothers' misconceptions and socio-cultural factors as barriers to exclusive breastfeeding: A qualitative study involving Health Workers in two rural districts of Ghana	PLOS ONE			English	Article							COUNTRIES	Background Education on exclusive breastfeeding (EBF) practices is usually given in the form of health talks by health workers (HWs). The need for HWs to be well-informed about cultural practices and misconceptions that act as barriers to EBF has been documented in literature. This information can guide HWs in developing interventions such as health talks which are culturally sensitive. However, this has not been explored from the perspectives of HWs in Ghana. In this paper, we report mothers' and grandmothers' misconceptions and cultural practices that are barriers to EBF in two rural districts in Ghana from the perspectives of Community Health Workers and Community Health Volunteers. Methods We used qualitative data collected in the Kwahu Afram Plains South and North Districts of Ghana through nine focus group discussions (FGDs) among HWs and followed the data saturation principle. All FGDs were audio-taped, transcribed verbatim and translated from local dialects to English. The emerging themes were used in writing a narrative account, guided by the principles of the thematic analysis. Results Our main findings included mothers' and grandmothers' perceptions that HWs themselves do not practice EBF. Mothers had the perception that grandmothers did not practice EBF but their children grew well, and gestures of babies suggested their readiness to start eating. Misconceptions revealed included beliefs that breastmilk is watery in nature and does not satisfy infants. Another misconception was that babies gain weight faster when not exclusively breastfed but fed on infant formulas. A custom of giving corn flour mixed with water or light porridge during the first few days after birth to welcome newborns was also reported. Conclusions The reports of the HWs revealed that several socio-cultural factors and misconceptions of mothers and grandmothers negatively influence EBF practices of mothers. Findings from this study highlight the need for HWs to provide culturally appropriate counselling services on breastfeeding not only to mothers but also to grandmothers and fathers in order to promote EBF and reap its benefits.	[Nsiah-Asamoah, Christiana] Univ Cape Coast, Dept Clin Nutr & Dietet, Cape Coast, Ghana; [Doku, David Teye; Agblorti, Samuel] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana	University of Cape Coast; University of Cape Coast	Nsiah-Asamoah, C (corresponding author), Univ Cape Coast, Dept Clin Nutr & Dietet, Cape Coast, Ghana.	cbuxton@ucc.edu.gh	Agblorti, Samuel Kofi Miledzi/O-1111-2018	Agblorti, Samuel Kofi Miledzi/0000-0002-9579-1575; Nsiah-Asamoah, Christiana/0000-0001-7470-0876				Aborigo RA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-76; Agunbiade OM, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-5; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2009, POSTGRADUATE J AESTH, V6, P1; Aseyo RE, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0318-4; Balogun OO, 2015, MATERN CHILD NUTR, V11, P433, DOI 10.1111/mcn.12180; Bhanderi DJ, 2019, J FAM MED PRIM CARE, V8, P54, DOI 10.4103/jfmpc.jfmpc_329_18; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bravi F, 2016, AM J CLIN NUTR, V104, P646, DOI 10.3945/ajcn.115.120881; Cai XD, 2012, INT BREASTFEED J, V7, DOI 10.1186/1746-4358-7-12; Dachew BA, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-11; DaCosta S, 2012, PEEL REGIONCA; District Planning Co-Ordinating Unit, 2017, KWAH AFR PLAINS N DI; District Planning Co-Ordinating Unit, 2017, KWAH AFR PLAINS S DI; Edmond K, 2016, LANCET GLOB HEALTH, V4, pE266, DOI 10.1016/S2214-109X(16)00040-1; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF International, 2003, DEM HLTH SURV; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF International, 2008, DEM HLTH SURV; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF International, 2015, DEM HLTH SURV; Hassan NE, 2018, EGYPT PEDIATR ASSO, V66, P9, DOI 10.1016/j.epag.2018.01.001; Hornell A, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.20823; Kavle JA, 2017, PUBLIC HEALTH NUTR, V20, P3120, DOI 10.1017/S1368980017002531; Khatun H, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0186-5; Kronborg H, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-243; Kwasi Ofosu D, 2012, ASSESSING SPATIAL DI; Mogre V, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0071-z; Morgenroth T, 2015, REV GEN PSYCHOL, V19, P465, DOI 10.1037/gpr0000059; Moyo G., 2020, CURR DEV NUTR, V4, P249; Radzyminski S, 2015, J PERINAT EDUC, V24, P102, DOI 10.1891/1058-1243.24.2.102; Russell CG, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2801-y; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Shankar Kanagasabapathy, 2015, International Journal of Biomedical and Advance Research, V6, P484; Swigart TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180185; Talbert AW, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0069-6; Tampah-Naah AM, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-13; Tekaly G, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1284-7; Thepha T, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0148-y; Thet MM, 2016, APPETITE, V96, P62, DOI 10.1016/j.appet.2015.08.044; UNICEF, 2016, 1 HOUR LIF MAK CAS I; Vareilles G, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0554-3; Walsh AM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0793-4; Wanjohi M, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-016-0092-7; World Health Organisation, 2011, PROM PROP FEED INF Y; Zhang PP, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2625-1; 2015, XENOTRANSPLANTATION, V22	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239278	10.1371/journal.pone.0239278	http://dx.doi.org/10.1371/journal.pone.0239278			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941500	Green Published, gold			2022-12-26	WOS:000573848800058
J	Pacheco-Barrios, K; Cardenas-Rojas, A; Giannoni-Luza, S; Fregni, F				Pacheco-Barrios, Kevin; Cardenas-Rojas, Alejandra; Giannoni-Luza, Stefano; Fregni, Felipe			COVID-19 pandemic and Farr's law: A global comparison and prediction of outbreak acceleration and deceleration rates	PLOS ONE			English	Article								The COVID-19 outbreak has forced most of the global population to lock-down and has put in check the health services all over the world. Current predictive models are complex, region-dependent, and might not be generalized to other countries. However, a 150-year old epidemics law promulgated by William Farr might be useful as a simple arithmetical model (percent increase [R1] and acceleration [R2] of new cases and deaths) to provide a first sight of the epidemic behavior and to detect regions with high predicted dynamics. Thus, this study tested Farr's Law assumptions by modeling COVID-19 data of new cases and deaths. COVID-19 data until April 10, 2020, was extracted from available countries, including income, urban index, and population characteristics. Farr's law first (R-1) and second ratio (R-2) were calculated. We constructed epidemic curves and predictive models for the available countries and performed ecological correlation analysis between R(1)and R(2)with demographic data. We extracted data from 210 countries, and it was possible to estimate the ratios of 170 of them. Around 42 center dot 94% of the countries were in an initial acceleration phase, while 23 center dot 5% already crossed the peak. We predicted a reduction close to zero with wide confidence intervals for 56 countries until June 10 (high-income countries from Asia and Oceania, with strict political actions). There was a significant association between high R(1)of deaths and high urban index. Farr's law seems to be a useful model to give an overview of COVID-19 pandemic dynamics. The countries with high dynamics are from Africa and Latin America. Thus, this is a call to urgently prioritize actions in those countries to intensify surveillance, to re-allocate resources, and to build healthcare capacities based on multi-nation collaboration to limit onward transmission and to reduce the future impact on these regions in an eventual second wave.	[Pacheco-Barrios, Kevin; Cardenas-Rojas, Alejandra; Giannoni-Luza, Stefano; Fregni, Felipe] Harvard Med Sch, Spaulding Res Inst, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Pacheco-Barrios, Kevin; Cardenas-Rojas, Alejandra; Giannoni-Luza, Stefano; Fregni, Felipe] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Pacheco-Barrios, Kevin] Univ San Ignacio de Loyola, Unidad Invest Generac & Sintesis Evidencias Salud, Lima, Peru; [Fregni, Felipe] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Universidad San Ignacio de Loyola; Harvard University; Harvard T.H. Chan School of Public Health	Fregni, F (corresponding author), Harvard Med Sch, Spaulding Res Inst, Spaulding Rehabil Hosp, Boston, MA 02115 USA.; Fregni, F (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA.; Fregni, F (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	ffregni@hsph.harvard.edu	Pacheco-Barrios, Kevin/N-8216-2016; Cardenas-Rojas, Alejandra/AAK-6507-2020	Pacheco-Barrios, Kevin/0000-0002-7166-2816; Cardenas-Rojas, Alejandra/0000-0002-8464-6866; Giannoni-Luza, Stefano/0000-0001-7413-4501	NIH [R01 AT009491-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	FF is funded by NIH grant R01 AT009491-01A1 (https://www.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; [Anonymous], 2020, NAT ENERGY, V5, P1, DOI 10.1038/s41560-020-0552-6; [Anonymous], 2020, LANCET INFECT DIS, V20, P192, DOI [10.1016/S1473-3099(20)30483-7, DOI 10.1016/S1473-3099(20)30483-7, DOI 10.1056/NEJMoa2021756]; Velasquez RMA, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109924; BREGMAN DJ, 1990, JAMA-J AM MED ASSOC, V263, P1522, DOI 10.1001/jama.263.11.1522; Covid C, 2020, COV C; Darakjy Salima, 2014, Inj Epidemiol, V1, P31; Fanelli D, 2020, CHAOS SOLITON FRACT, V134, DOI 10.1016/j.chaos.2020.109761; Fullman N, 2018, LANCET, V391, P2236, DOI [10.1016/S0140-6736(18)30994-2, 10.1016/s0140-6736(18)30994-2]; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Greenaway C, 2017, HDB MIGRATION SECURI; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; Institute for Health Metrics and Evaluation, 2020, COV 19 PROJ; J B, 1915, BMJ-BRIT MED J, V2, P250, DOI [10.1136/bmj.2.2850.250, DOI 10.1136/BMJ.2.2850.250]; Jia ZW, 2020, LANCET INFECT DIS, V20, P757, DOI 10.1016/S1473-3099(20)30258-9; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Maxmen A, 2020, NATURE, V580, P173, DOI 10.1038/d41586-020-00983-9; Moore M, 2016, IDENTIFYING FUTURE D; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Nsoesie EO, 2014, INFLUENZA OTHER RESP, V8, P309, DOI 10.1111/irv.12226; Otto-Zimmermann K, 2012, LOCAL ENVIRON, V17, P511, DOI 10.1080/13549839.2012.686564; Paakkari L, 2020, LANCET PUBLIC HEALTH, V5, pE249, DOI 10.1016/S2468-2667(20)30086-4; Quinn SC, 2014, BIOSECUR BIOTERROR, V12, P263, DOI 10.1089/bsp.2014.0032; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Romero TH, 2020, AR CNE, P24; Sánchez-Moreno Francisco, 2014, Rev. perú. med. exp. salud publica, V31, P747; Santillana M, 2018, INFECT DIS MODEL, V3, P1, DOI 10.1016/j.idm.2018.03.001; Stevens GA, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002116, 10.1371/journal.pmed.1002056]; Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545; Tuite AR, 2020, LANCET INFECT DIS, V20, P537, DOI 10.1016/S1473-3099(20)30227-9; World Health Organization, 2021, NOV COR 2019 NCOV SI; Worldometer, 2020, COVID 19 COR PAND 20; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328	36	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239175	10.1371/journal.pone.0239175	http://dx.doi.org/10.1371/journal.pone.0239175			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941485	Green Published, gold			2022-12-26	WOS:000573848800020
J	Pathirana, J; Texeira, L; Munian, H; Nakwa, F; Mayet, I; Maposa, I; Groome, MJ; Boppana, S; Madhi, SA				Pathirana, Jayani; Texeira, Leanne; Munian, Hannah; Nakwa, Firdose; Mayet, Ismail; Maposa, Innocent; Groome, Michelle J.; Boppana, Suresh; Madhi, Shabir A.			Neurological and growth outcomes in South African children with congenital cytomegalovirus: A cohort study	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; INFANTS BORN; FOLLOW-UP; INFECTION; PREVALENCE	Objectives To assess neurological sequelae and growth in the first 12 months of life in a cohort of congenital cytomegalovirus (cCMV) infected infants compared to cCMV uninfected infants. Study design This was a prospective matched cohort study conducted in Soweto, South Africa where forty-six confirmed cCMV cases were matched on HIV-exposure, gender and gestational age (+/- two weeks) to 84 cCMV-uninfected controls in a 1:2 ratio. Cases and controls were followed up until 12 months of age to assess anthropometry, hearing and neurodevelopmental outcomes. Results Thirty-four (73.9%) cCMV cases and 74 (88.1%) controls, completed all assessments at 12 months age. At 12 months, one cCMV case had died, none of the children in either group had SNHL and neurodevelopmental delay was present in a similar percentage of cCMV cases (n = 2; 6%) and controls (n = 1, 4%; OR 1.09, 95% CI 0.04-27.84, p = 0.958). Anthropometry did not differ between cases and controls overall throughout the follow up period. HIV-exposed cases had smaller head circumference for age at 6 and 12 months when compared with HIV-exposed controls. Conclusion By 12 months of age, there was no evidence of a difference in neurological sequelae between cCMV infected South African children and cCMV uninfected children in this study. Further follow-up is warranted to detect late-onset hearing loss and neurodevelopmental delay beyond 12 months of age.	[Pathirana, Jayani; Groome, Michelle J.; Madhi, Shabir A.] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Pathirana, Jayani; Groome, Michelle J.; Madhi, Shabir A.] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Fac Hlth Sci, Dept Sci & Technol, Johannesburg, South Africa; [Texeira, Leanne; Munian, Hannah] Chris Hani Baragwanath Acad Hosp CHBAH, Dept Speech Therapy & Audiol STA, Johannesburg, South Africa; [Nakwa, Firdose] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Dept Paediat,Chris Hani Baragwanath Acad Hosp, Johannesburg, South Africa; [Mayet, Ismail] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med,Dept Ophthalmol, St Johns Eye Hosp,Chris Hani Baragwanath Acad Hos, Johannesburg, South Africa; [Maposa, Innocent] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Johannesburg, South Africa; [Boppana, Suresh] Univ Alabama Birmingham, Sch Med, Dept Pediat, Birmingham, AL USA; [Boppana, Suresh] Univ Alabama Birmingham, Sch Med, Dept Microbiol, Birmingham, AL 35294 USA	University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Pathirana, J (corresponding author), Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, Fac Hlth Sci, Johannesburg, South Africa.; Pathirana, J (corresponding author), Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Fac Hlth Sci, Dept Sci & Technol, Johannesburg, South Africa.	jayani.c@hotmail.com	de Lima, Antonio Marcos Oliveira/AAT-2148-2021; Groome, Michelle Jennifer/AAI-9967-2021	Groome, Michelle Jennifer/0000-0001-5893-3725; Mayet, Ismail/0000-0003-1720-941X; Maposa, Innocent/0000-0002-3448-4096; Madhi, Shabir/0000-0002-7629-0636	South African Medical Research Council; South African Research Chairs Initiative (SARChI) [UID 64797]	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); South African Research Chairs Initiative (SARChI)	SAM received funding for this study from the South African Medical Research Council and The South African Research Chairs Initiative (SARChI), Grant number: UID 64797. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nrf.ac.za/division/rcce/instruments/research-chairs.	American Speech Language Hearing Association, 2015, AUD INF SER; Bartlett AW, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1938; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bayley N., 2019, BAYLEY SCALES INFANT; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007; Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629; Boppana SB, 2011, NEW ENGL J MED, V364, P2111, DOI 10.1056/NEJMoa1006561; Britt WJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080405; Capretti MG, 2014, BRAIN DEV-JPN, V36, P203, DOI 10.1016/j.braindev.2013.04.001; Dangor Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123014; Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544; Filteau S, 2009, TROP MED INT HEALTH, V14, P276, DOI 10.1111/j.1365-3156.2009.02220.x; Fowler KB, 1996, J PEDIAT, V135, P60; Ghekiere S, 2012, J PEDIAT OPHTH STRAB, V49, P274, DOI 10.3928/01913913-20120710-03; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; Kaye S, 2008, J INFECT DIS, V197, P1307, DOI 10.1086/586715; Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Koyano S, 2018, PEDIATR INT, V60, P57, DOI 10.1111/ped.13433; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Manuela K, 2018, SWISS MED WKLY, V148, DOI 10.4414/smw.2018.14627; Mussi-Pinhata MM, 2018, J INFECT DIS, V218, P1200, DOI 10.1093/infdis/jiy321; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Pathirana J, 2019, CLIN INFECT DIS; Rosenthal LS, 2009, PEDIATR INFECT DIS J, V28, P515, DOI 10.1097/INF.0b013e318198c724; SCHOUB BD, 1993, S AFR MED J, V83, P108; WHO, 2006, CHILD GROWTH STAND L; Yamamoto AY, 2011, PEDIATR INFECT DIS J, V30, P1043, DOI 10.1097/INF.0b013e31822d9640; Zavattoni M, 2014, J MED VIROL, V86, P2163, DOI 10.1002/jmv.23954	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238102	10.1371/journal.pone.0238102	http://dx.doi.org/10.1371/journal.pone.0238102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941484	gold, Green Published			2022-12-26	WOS:000573848800059
J	Queiroz, APS; Freitas, MCC; Silva, JRA; Lima, AB; Sawada, L; Monteiro, RFM; de Freitas, ACGA; Maues, LAL; Arruda, AC; Silva, MN; Maia, CSF; Fontes, EA; Nascimento, JLM; Arruda, MSP; Bastos, GNT				Santos Queiroz, Amanda Pamela; Costa Freitas, Manolo Cleiton; Silva, Jose Rogerio A.; Lima, Anderson Bentes; Sawada, Leila; Monteiro, Rayan Fidel Martins; Gomes Albuquerque de Freitas, Ana Carolina; Loureiro Maues, Luis Antonio; Arruda, Alberto Cardoso; Silva, Milton Nascimento; Ferraz Maia, Cristiane Socorro; Fontes-Junior, Eneas Andrade; Nascimento, Jose Luiz M.; Arruda, Mara Silvia P.; Bastos, Gilmara N. T.			Pellucidin A promotes antinociceptive activity by peripheral mechanisms inhibiting COX-2 and NOS: In vivo and in silico study	PLOS ONE			English	Article							NITRIC-OXIDE; TYROSINASE; EVOLUTION; ANALOGS; MODELS	Peperomia pellucida(PP) belongs to thePeperomia genus, which has a pantropic distribution. PP is used to treat a wide range of symptoms and diseases, such as pain, inflammation, and hypertension. Intriguingly, PP extract is used by different tropical countries for its anti-inflammatory and antinociceptive effects. In fact, these outcomes have been shown in animal models, though the exact bioactive products of PP that exert such results are yet to be discovered. To determine and elucidate the mechanism of action of one of these compounds, we evaluated the antinociceptive effect of the novel dimeric ArC2 compound, Pellucidin A by usingin vivoandin silicomodels. Animals were then subjected to chemical, biphasic and thermal models of pain. Pellucidin A induced an antinociceptive effect against chemical-induced pain in mice, demonstrated by the decrease of the number of writhes, reaching a reduction of 43% and 65% in animals treated with 1 and 5 mg/kg of Pellucidin A, respectively. In the biphasic response (central and peripheral), animals treated with Pellucidin A showed a significant reduction of the licking time exclusively during the second phase (inflammatory phase). In the hot-plate test, Pellucidin A did not have any impact on the latency time of the treated animals. Moreover,in vivoandin silicoresults show that Pellucidin A's mechanism of action in the inflammatory pain occurs most likely through interaction with the nitric oxide (NO) pathway. Our results demonstrate that the antinociceptive activities of Pellucidin A operate under mechanism(s) of peripheral action, involving inflammatory mediators. This work provides insightful novel evidence of the biological properties of Pellucidin A, and leads to a better understanding of its mechanism of action, pointing to potential pharmacological use.	[Santos Queiroz, Amanda Pamela; Lima, Anderson Bentes; Sawada, Leila; Monteiro, Rayan Fidel Martins; Loureiro Maues, Luis Antonio; Bastos, Gilmara N. T.] Univ Fed Para, Inst Ciencias Biol, Lab Neuroinflamacao, Belem, Para, Brazil; [Costa Freitas, Manolo Cleiton; Arruda, Alberto Cardoso; Silva, Milton Nascimento; Arruda, Mara Silvia P.] Univ Fed Para, Inst Ciencias Exatas & Nat, Lab Cent Extracao, Belem, Para, Brazil; [Costa Freitas, Manolo Cleiton] Univ Fed Para, Campus Univ Marajo Breves, Breves, Para, Brazil; [Silva, Jose Rogerio A.; Gomes Albuquerque de Freitas, Ana Carolina] Univ Fed Para, Inst Ciencias Exatas & Nat, Lab Planejamento & Desenvolvimento Farmacos, Belem, Para, Brazil; [Lima, Anderson Bentes] Univ Estado Para, Lab Morfofisiol Aplicada Saude, Belem, Para, Brazil; [Silva, Milton Nascimento] Univ Fed Para, Inst Ciencias Exatas & Nat, Lab Cromatog Liquida, Belem, Para, Brazil; [Ferraz Maia, Cristiane Socorro; Fontes-Junior, Eneas Andrade] Univ Fed Para, Fac Farm, Lab Farmacol Inflamacao & Comportamento, Belem, Para, Brazil; [Nascimento, Jose Luiz M.] Univ Fed Para, Inst Ciencias Biol, Lab Neuroquim Mol & Celular, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para; Universidade do Estado do Para (UEPA); Universidade Federal do Para; Universidade Federal do Para; Universidade Federal do Para	Bastos, GNT (corresponding author), Univ Fed Para, Inst Ciencias Biol, Lab Neuroinflamacao, Belem, Para, Brazil.	bastosgnt@gmail.cnm	Maia, Cristiane/E-7217-2016; ARRUDA, MARA SILVIA/AAO-5663-2021; Silva, Jose/P-8942-2014; Fontes-Júnior, Enéas Andrade/R-6372-2018; Fontes-Júnior, Enéas Andrade/ABF-8064-2020	Maia, Cristiane/0000-0003-4493-7375; Silva, Jose/0000-0003-2310-5107; Fontes-Júnior, Enéas Andrade/0000-0002-6186-9581; Monteiro, Rayan/0000-0001-6642-4488; do Nascimento, jose/0000-0003-3647-9124	National Council of Scientific and Technological Development (CNPq); CAPES; Fundacao Amazo<^>nia Paraense de Amparo a Pesquisa (FAPESPa)	National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Amazo<^>nia Paraense de Amparo a Pesquisa (FAPESPa)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA))	The authors received funding for National Council of Scientific and Technological Development (CNPq), CAPES and Fundacao Amazo<^>nia Paraense de Amparo a Pesquisa (FAPESPa).	Adeoluwa OA, 2014, J ETHNOPHARMACOL, V156, P353, DOI 10.1016/j.jep.2014.08.040; Alves NSF, 2019, J ETHNOPHARMACOL, V232, P90, DOI 10.1016/j.jep.2018.12.021; [Anonymous], 2011, MOL CELLULAR PROTEOM, V10, pR110; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2010, NEPHROL THER, V6, pS27; Arrigoni-Blank MD, 2004, J ETHNOPHARMACOL, V91, P215, DOI 10.1016/j.jep.2003.12.030; Aziba PI, 2001, FITOTERAPIA, V72, P57, DOI 10.1016/S0367-326X(00)00249-5; Bayma JD, 2000, PHYTOCHEMISTRY, V55, P779; Brasil EM, 2017, CHEM BIOL DRUG DES, V90, P804, DOI 10.1111/cbdd.13001; Ciancetta A, 2014, J CHEM INF MODEL, V54, P2243, DOI 10.1021/ci5002857; Coe Felix G., 1997, Journal of Ethnobiology, V17, P171; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Fantini J, 2014, ACS CHEM NEUROSCI, V5, P216, DOI 10.1021/cn400183w; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gehlhaar D. K., 1998, Evolutionary Programming VII. 7th International Conference, EP98. Proceedings, P449, DOI 10.1007/BFb0040797; Kidd BL, 2001, BRIT J ANAESTH, V87, P3, DOI 10.1093/bja/87.1.3; Kim SF, 2011, NITRIC OXIDE-BIOL CH, V25, P255, DOI 10.1016/j.niox.2011.07.002; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LaBuda CJ, 2006, EUR J PAIN, V10, P505, DOI 10.1016/j.ejpain.2005.07.004; Lima CR, 2014, MOLECULES, V19, P9591, DOI 10.3390/molecules19079591; Menegatti R, 2006, BIOORGAN MED CHEM, V14, P632, DOI 10.1016/j.bmc.2005.08.042; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; NGADJUI B T, 1987, Fitoterapia, V58, P340; Nwokocha C. R., 2012, MED AROMAT PLANTS, V1, P1, DOI [10.4172/2167-0412.1000105, DOI 10.4172/2167-0412.1000105]; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Rawendra RDS, 2014, J AGR FOOD CHEM, V62, P12178, DOI 10.1021/jf504734g; Rosenfeld RJ, CONFORMATIONAL CHANG, DOI [10.1021/bi026313j, DOI 10.1021/BI026313J]; Samain MS, 2009, PLANT SYST EVOL, V278, P1, DOI 10.1007/s00606-008-0113-0; Sanchez-Mateo CC, 2006, J ETHNOPHARMACOL, V107, P1, DOI 10.1016/j.jep.2006.01.032; Srebro D, 2016, ACTA NEUROBIOL EXP, V76, P110, DOI 10.21307/ane-2017-010; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; ul-Haq Z, 2011, J COMPUT AID MOL DES, V25, P81, DOI 10.1007/s10822-010-9404-y; Wei Lee Seong, 2011, Acta Med Iran, V49, P670; Xu S, 2006, J NAT PROD, V69, P247, DOI 10.1021/np050457s; 2015, STRATEGIC COMMENTS, V21, pE20	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238834	10.1371/journal.pone.0238834	http://dx.doi.org/10.1371/journal.pone.0238834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941458	gold, Green Published			2022-12-26	WOS:000573848800061
J	Chorus, C; Sandorf, ED; Mouter, N				Chorus, Caspar; Sandorf, Erlend Dancke; Mouter, Niek			Diabolical dilemmas of COVID-19: An empirical study into Dutch society's trade-offs between health impacts and other effects of the lockdown	PLOS ONE			English	Article							DISCRETE-CHOICE; MODEL; PREFERENCES; VALUATION; CITIZEN; TIME	We report and interpret preferences of a sample of the Dutch adult population for different strategies to end the so-called 'intelligent lockdown' which their government had put in place in response to the COVID-19 pandemic. Using a discrete choice experiment, we invited participants to make a series of choices between policy scenarios aimed at relaxing the lockdown, which were specified not in terms of their nature (e.g. whether or not to allow schools to re-open) but in terms of their effects along seven dimensions. These included health-related effects, but also impacts on the economy, education, and personal income. From the observed choices, we were able to infer the implicit trade-offs made by the Dutch between these policy effects. For example, we find that the average citizen, in order to avoid one fatality directly or indirectly related to COVID-19, is willing to accept a lasting lag in the educational performance of 18 children, or a lasting (>3 years) and substantial (>15%) reduction in net income of 77 households. We explore heterogeneity across individuals in terms of these trade-offs by means of latent class analysis. Our results suggest that most citizens are willing to trade-off health-related and other effects of the lockdown, implying a consequentialist ethical perspective. Somewhat surprisingly, we find that the elderly, known to be at relatively high risk of being affected by the virus, are relatively reluctant to sacrifice economic pain and educational disadvantages for the younger generation, to avoid fatalities. We also identify a so-called taboo trade-off aversion amongst a substantial share of our sample, being an aversion to accept morally problematic policies that simultaneously imply higher fatality numbers and lower taxes. We explain various ways in which our results can be of value to policy makers in the context of the COVID-19 and future pandemics.	[Chorus, Caspar; Mouter, Niek] Delft Univ Technol, Fac Technol, Dept Engn Syst & Serv, Delft, Netherlands; [Sandorf, Erlend Dancke] Univ Stirling, Stirling Management Sch, Econ Div, Stirling, Scotland	Delft University of Technology; University of Stirling	Chorus, C (corresponding author), Delft Univ Technol, Fac Technol, Dept Engn Syst & Serv, Delft, Netherlands.	c.g.chorus@tudelft.nl	Sandorf, Erlend Dancke/AAO-4012-2021	Chorus, Caspar/0000-0002-6380-4853; Sandorf, Erlend Dancke/0000-0001-7521-4773	European Union's Horizon 2020 research and innovation program under the European Research Council Consolidator grant [BEHAVE724431]; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [793163]; TU Delft Covid-19 Response fund	European Union's Horizon 2020 research and innovation program under the European Research Council Consolidator grant; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; TU Delft Covid-19 Response fund	Caspar Chorus acknowledges funding from the European Union's Horizon 2020 research and innovation program under the European Research Council Consolidator grant BEHAVE724431. Erlend Dancke Sandorf acknowledges funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 793163 (INSPiRE). The TU Delft Covid-19 Response fund sponsored our data collection effort.	Aditya A., 2020, BUSINESS WORLD; [Anonymous], 2020, NAT MED, V26, P1, DOI 10.1038/s41591-019-0740-8; [Anonymous], 2020, TELEGRAAF; [Anonymous], 2019, NL TIMES        0206; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA, DOI 10.1089/dia.2020.2525.abstracts; [Anonymous], 2012, MORT RISK VAL ENV HL; [Anonymous], 2020, GUARDIAN 1026; Arrow K.J., 1993, REPORT NOAA PANEL CO, V58; Belot M, 2020, 13230 IZA; Ben-Akiva ME., 1985, DISCRETE CHOICE ANAL; Carson RT, 2007, ENVIRON RESOUR ECON, V37, P181, DOI 10.1007/s10640-007-9124-5; Carson RT, 2014, J ASSOC ENVIRON RESO, V1, P171, DOI 10.1086/676450; Chorus CG, 2018, J CHOICE MODEL, V27, P37, DOI 10.1016/j.jocm.2017.09.002; Chorus CG, 2020, NEDERLANDERS MAKEN B; CNN, 2020, CNN; CPB, 2020, SCEN COR CRIS; Daly A, 2012, TRANSPORT RES B-METH, V46, P333, DOI 10.1016/j.trb.2011.10.008; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; de Blaeij A, 2003, ACCIDENT ANAL PREV, V35, P973, DOI 10.1016/S0001-4575(02)00105-7; Dutch Health Care Authority, 2020, HER ZORG EENV REK MA; Fiske AP, 1997, POLIT PSYCHOL, V18, P255, DOI 10.1111/0162-895X.00058; Frimpong Jemima A., 2020, FINANCIAL INCENTIVES; Greene WH, 2003, TRANSPORT RES B-METH, V37, P681, DOI 10.1016/S0191-2615(02)00046-2; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Hainmueller J, 2015, P NATL ACAD SCI USA, V112, P2395, DOI 10.1073/pnas.1416587112; HAUSMAN JA, 1995, J PUBLIC ECON, V56, P1, DOI 10.1016/0047-2727(93)01415-7; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hensher DA, 2009, TRANSPORT RES A-POL, V43, P692, DOI 10.1016/j.tra.2009.06.001; Hoyos D, 2010, ECOL ECON, V69, P1595, DOI 10.1016/j.ecolecon.2010.04.011; Johnston RJ, 2017, J ASSOC ENVIRON RESO, V4, P319, DOI 10.1086/691697; Jonker M.F., WORKING PAPER; Lancsar E, 2008, PHARMACOECONOMICS, V26, P661, DOI 10.2165/00019053-200826080-00004; Lancsar E, 2020, J HEALTH ECON, V70, DOI 10.1016/j.jhealeco.2020.102303; Liebe U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199923; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; McFadden D., 2017, CONTINGENT VALUATION; Mouter N., WORKING PAPER; Mouter N, 2017, TRANSPORT RES A-POL, V106, P333, DOI 10.1016/j.tra.2017.10.003; Mouter N, 2016, TRANSPORT RES A-POL, V91, P317, DOI 10.1016/j.tra.2016.02.014; Netherlands Youth Institute, 2020, FACTAND FIG; NIBUD, 2020, VIJFD NED ERV INK; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Pellegrini A., 2020, WORKING PAPER; Reckers-Droog V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198761; Rijksoverheid, 2020, VID PERSC COR; Rijkswaterstaat, STEUNP EC EXP; RIVM, 2020, 2020 RIJKS VOLKSG MI; Scarpa R, 2008, AUST J AGR RESOUR EC, V52, P253, DOI 10.1111/j.1467-8489.2007.00436.x; Skedgel C, 2015, MED DECIS MAKING, V35, P94, DOI 10.1177/0272989X14547915; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Travisi CM, 2008, ECOL ECON, V67, P598, DOI 10.1016/j.ecolecon.2008.01.011; van de Wetering L, 2015, PHARMACOECONOMICS, V33, P1289, DOI 10.1007/s40273-015-0311-x; Wiertz C., 2020, PREDICTED ADOPTION R, DOI [10.2139/ssrn.3589199, DOI 10.2139/SSRN.3589199]	53	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238683	10.1371/journal.pone.0238683	http://dx.doi.org/10.1371/journal.pone.0238683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936815	gold, Green Published			2022-12-26	WOS:000573658000036
J	Dhaka, P; Malik, SVS; Yadav, JP; Kumar, M; Barbuddhe, SB; Rawool, DB				Dhaka, Pankaj; Malik, Satya Veer Singh; Yadav, Jay Prakash; Kumar, Manesh; Barbuddhe, Sukhadeo B.; Rawool, Deepak B.			Apparent prevalence and risk factors of coxiellosis (Q fever) among dairy herds in India	PLOS ONE			English	Article							BURNETII INFECTION; SEROPREVALENCE; CATTLE; EXPOSURE	Coxiella burnetiiis a highly infectious zoonotic pathogen infecting wide range of mammals, including humans. In the present study, a total of 711 blood samples from bovines [cattle (n = 543) and buffaloes (n = 168)] from eight farms at different geographical locations in India were screened forC.burnetiitargeting theIS1111and thecom1genes. The anti-C.burnetiiantibodies in serum samples were detected using indirect-ELISA kits. Also, a total of 21 parameters pertaining to animal health and farm management were identified to assess their role as possible risk factors for coxiellosis among the targeted farms. The apparent prevalence (positive for PCR and/or ELISA) for coxiellosis was reported to be 24.5% in cattle and 8.9% in buffaloes. In cattle, the detection rate ofC.burnetiiemploying theIS1111gene (8.5%) was found to be significantly higher (p<0.05) as compared to thecom1(6.5%) gene. The seropositivity by ELISA was higher among cattle (17.7%) than in buffaloes (8.3%). Further, on univariable analysis of risk factors, species (cattle) (OR:3.31; 95%CI:1.88-5.82), inadequate floor spacing (OR:1.64; 95%CI:1.10-2.43), mastitis (OR:2.35, 95%CI:1.45-3.81) and reproductive disorders (OR:2.54; 95%CI:1.67-3.85) were significantly (p<0.05) having high odds for coxiellosis. The multivariable logistic regression analysis of the animal level risk factors revealed that species and age were found to be significantly associated with coxiellosis. However, since the number of screened farms is limited; further research is needed with a higher number of animals to confirm the farm level odds ratio of risk factors. Quarantine and biosecurity measures including farm hygiene operations were observed to be inadequate and also the lack of awareness about coxiellosis among the farm workers. In absence of vaccination program for coxiellosis in India, robust surveillance, farm biosecurity measures and the awareness for the disease among risk groups can play an important role in the disease prevention and subsequent transmission of the pathogen.	[Dhaka, Pankaj; Malik, Satya Veer Singh; Yadav, Jay Prakash; Kumar, Manesh; Rawool, Deepak B.] ICAR Indian Vet Res Inst, Div Vet Publ Hlth, Bareilly, Uttar Pradesh, India; [Barbuddhe, Sukhadeo B.; Rawool, Deepak B.] ICAR Natl Res Ctr Meat, Hyderabad, Telangana, India; [Dhaka, Pankaj] Guru Angad Dev Vet & Anim Sci Univ, Sch Publ Hlth & Zoonoses, Coll Vet Sci, Ludhiana, Punjab, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Meat; Guru Angad Dev Veterinary & Animal Sciences University (GADVASU)	Rawool, DB (corresponding author), ICAR Indian Vet Res Inst, Div Vet Publ Hlth, Bareilly, Uttar Pradesh, India.; Rawool, DB (corresponding author), ICAR Natl Res Ctr Meat, Hyderabad, Telangana, India.	deepak.rawool@yahoo.com	Dhaka, Pankaj/I-1460-2016; YADAV, JAY/AAE-6997-2021	YADAV, JAY/0000-0002-0238-7638; Dhaka, Pankaj/0000-0001-9402-8263; MALIK, SATYA VEER SINGH/0000-0002-0619-2192; Rawool, Deepak Bhiwa/0000-0002-6173-4708				Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Agger JF, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-80; Alvarez J, 2012, VET J, V194, P102, DOI 10.1016/j.tvjl.2012.02.022; [Anonymous], 2012, Mapping of poverty and likely zoonoses hotspots; Arricau-Bouvery N, 2005, VACCINE, V23, P4392, DOI 10.1016/j.vaccine.2005.04.010; Barkallah M, 2018, COMP IMMUNOL MICROB, V57, P15, DOI 10.1016/j.cimid.2018.02.001; Barlow J, 2008, VET RES, V39, DOI 10.1051/vetres:2007060; Barlozzari G, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268819002115; Bouvery NA, 2003, VET RES, V34, P423, DOI 10.1051/vetres:2003017; Candela MG, 2017, EPIDEMIOL INFECT, V145, P478, DOI [10.1017/S0950268816002454, 10.1017/s0950268816002454]; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; Dhaka P, 2019, J INFECT PUBLIC HEAL, V12, P190, DOI 10.1016/j.jiph.2018.10.001; Eldin C, 2017, CLIN MICROBIOL REV, V30, P115, DOI 10.1128/CMR.00045-16; Freick M, 2017, REPROD DOMEST ANIM, V52, P160, DOI 10.1111/rda.12878; Galluzzo P, 2019, VET ITAL, V55, P247, DOI 10.12834/VetIt.1391.7602.2; Givens MD, 2018, ANIMAL, V12, pS165, DOI [10.1017/s1751731118000708, 10.1017/S1751731118000708]; Guatteo R, 2011, VET MICROBIOL, V149, P1, DOI 10.1016/j.vetmic.2010.10.007; Hermans T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096607; Kargar M, 2015, ZAHEDAN J RES MED SC, P17, DOI [10.17795/zjrms988, DOI 10.17795/ZJRMS988]; Kersh GJ, 2012, J WILDLIFE DIS, V48, P201, DOI 10.7589/0090-3558-48.1.201; Keshavamurthy R, 2019, PREV VET MED, V166, P16, DOI 10.1016/j.prevetmed.2019.03.003; Khademi P, 2019, COMP IMMUNOL MICROB, V67, DOI 10.1016/j.cimid.2019.101368; Klee SR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-2; Klemmer J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192188; McCaughey C, 2010, EPIDEMIOL INFECT, V138, P21, DOI 10.1017/S0950268809002854; Menadi SE, 2020, TROP ANIM HEALTH PRO, V52, P935, DOI 10.1007/s11250-019-02083-x; Nahed H. G., 2012, The Journal of American Science, V8, P619; Nokhodian Z, 2017, ACTA TROP, V169, P107, DOI 10.1016/j.actatropica.2017.02.002; Ortega-Mora LM, 2012, VET REC, V170, P257, DOI 10.1136/vr.e1592; Park JH, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e245; Paul S, 2012, PREV VET MED, V107, P57, DOI 10.1016/j.prevetmed.2012.05.015; Perugini AG, 2009, RES VET SCI, V87, P189, DOI 10.1016/j.rvsc.2009.01.005; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Rousset E, 2009, APPL ENVIRON MICROB, V75, P428, DOI 10.1128/AEM.00690-08; Schimmer B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042364; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; Shome R, 2019, ACTA TROP, V194, P41, DOI 10.1016/j.actatropica.2019.03.022; Vaidya VM, 2010, COMP IMMUNOL MICROB, V33, P307, DOI 10.1016/j.cimid.2008.10.006; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; Wardrop NA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005032; Zhang GQ, 1998, J CLIN MICROBIOL, V36, P77, DOI 10.1128/JCM.36.1.77-80.1998	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239260	10.1371/journal.pone.0239260	http://dx.doi.org/10.1371/journal.pone.0239260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931511	Green Published, gold			2022-12-26	WOS:000573375500005
J	Katul, GG; Mrad, A; Bonetti, S; Manoli, G; Parolari, AJ				Katul, Gabriel G.; Mrad, Assaad; Bonetti, Sara; Manoli, Gabriele; Parolari, Anthony J.			Global convergence of COVID-19 basic reproduction number and estimation from early-time SIR dynamics	PLOS ONE			English	Article							TRANSMISSION DYNAMICS; PERSPECTIVES; WUHAN	The SIR ('susceptible-infectious-recovered') formulation is used to uncover the generic spread mechanisms observed by COVID-19 dynamics globally, especially in the early phases of infectious spread. During this early period, potential controls were not effectively put in place or enforced in many countries. Hence, the early phases of COVID-19 spread in countries where controls were weak offer a unique perspective on the ensemble-behavior of COVID-19 basic reproduction numberR(o)inferred from SIR formulation. The work here shows that there is global convergence (i.e., across many nations) to an uncontrolledR(o)= 4.5 that describes the early time spread of COVID-19. This value is in agreement with independent estimates from other sources reviewed here and adds to the growing consensus that the early estimate ofR(o)= 2.2 adopted by the World Health Organization is low. A reconciliation between power-law and exponential growth predictions is also featured within the confines of the SIR formulation. The effects of testing ramp-up and the role of 'super-spreaders' on the inference ofR(o)are analyzed using idealized scenarios. Implications for evaluating potential control strategies from this uncontrolledR(o)are briefly discussed in the context of the maximum possible infected fraction of the population (needed to assess health care capacity) and mortality (especially in the USA given diverging projections). Model results indicate that if intervention measures still result inR(o)> 2.7 within 44 days after first infection, intervention is unlikely to be effective in general for COVID-19.	[Katul, Gabriel G.; Mrad, Assaad] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Katul, Gabriel G.] Duke Univ, Dept Civil & Environm Engn, Durham, NC 27706 USA; [Bonetti, Sara] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Bonetti, Sara] UCL, Bartlett Sch Environm Energy & Resources, London, England; [Manoli, Gabriele] UCL, Dept Civil Environm & Geomat Engn, London, England; [Parolari, Anthony J.] Marquette Univ, Dept Civil Construct & Environm Engn, Milwaukee, WI 53233 USA	Duke University; Duke University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; University College London; University of London; University College London; Marquette University	Katul, GG (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.; Katul, GG (corresponding author), Duke Univ, Dept Civil & Environm Engn, Durham, NC 27706 USA.	gaby@duke.edu	Mrad, Assaad/P-7020-2019; Katul, Gabriel G/A-7210-2008	Mrad, Assaad/0000-0003-4922-4446; Katul, Gabriel G/0000-0001-9768-3693; Bonetti, Sara/0000-0001-8856-3438; Manoli, Gabriele/0000-0002-9245-2877				Alimohamadi Yousef, 2020, J Prev Med Public Health, V53, P151, DOI 10.3961/jpmph.20.076; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Barbour A., 1990, STOCHASTIC PROCESSES, P86; Blackwood JC., 2018, LETT BIOMATH, V5, P195, DOI [10.30707/LiB5.1Blackwood, DOI 10.30707/LIB5.1BLACKWOOD]; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Cao Z., 2020, ESTIMATING EFFECTIVE, DOI [10.1101/2020.01.27.20018952, DOI 10.1101/2020.01.27.20018952]; Delamater PL, 2019, EMERG INFECT DIS, V25, P1, DOI 10.3201/eid2501.171901; Dietz K, 2002, MATH BIOSCI, V180, P1, DOI 10.1016/S0025-5564(02)00122-0; Fuentes MA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158104; Haushofer J, 2020, SCIENCE, V368, P1063, DOI 10.1126/science.abb6144; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Imai N., 2020, 3 IMP COLL LOND, DOI [10.25561/77148, DOI 10.25561/77148]; Keeling MJ, 2009, BRIT MED BULL, V92, P33, DOI 10.1093/bmb/ldp038; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; Keeling MJ, 2000, J THEOR BIOL, V203, P51, DOI 10.1006/jtbi.1999.1064; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Layne SP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb1469; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Liu QH, 2018, P NATL ACAD SCI USA, V115, P12680, DOI 10.1073/pnas.1811115115; Liu T., 2020, TRANSMISSION DYNAMIC, DOI 10.1101/2020.01.25.919787; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Majumder Maimuna S, 2020, SSRN, P3524675, DOI 10.2139/ssrn.3524675; Meyerowitz-Katz G, 2020, INT J INFECT DIS, V101, P138, DOI 10.1016/j.ijid.2020.09.1464; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; minutephysics, 2020, MIN TELL WERE BEAT C; Murray J. D., 2007, MATH BIOL, V17; Newman M., 2018, HEGELS INTERPRETATIO; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ng TC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55574-0; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Read J. M., 2020, MEDRXIV, DOI 10.1101/2020.01.23.20018549; Ridenhour B, 2018, AM J PUBLIC HEALTH, V108, pS455; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Roques L, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9050097; Roser M, 2020, WHY DID RENEWABLES B; Ross R, 1916, P R SOC LOND A-CONTA, V92, P204, DOI 10.1098/rspa.1916.0007; Sanche S, 2020, ARXIV200203268; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; SHEN M, 2020, BIORXIV, DOI [10.1101/2020.01.23.916726, DOI 10.1101/2020.01.23.916726]; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Singer H.M, 2020, ARXIV200311997, P1; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Walters CE, 2018, EPIDEMICS-NETH, V25, P1, DOI 10.1016/j.epidem.2018.05.007; WHO, 2019, REP WHO CHIN JOINT M; Wodarz D, 2020, PATTERNS COVID19 EPI; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; You C, 2020, INT J HYG ENVIR HEAL, V228, DOI 10.1016/j.ijheh.2020.113555; Yuan J, 2020, INT J INFECT DIS, V95, P311, DOI 10.1016/j.ijid.2020.03.050; Zhang KK, 2020, CHARACTERIZING TRANS, DOI 10.1101/2020.02.24.20026773; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	57	42	43	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239800	10.1371/journal.pone.0239800	http://dx.doi.org/10.1371/journal.pone.0239800			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970786	Green Published, gold, Green Submitted			2022-12-26	WOS:000576265600062
J	Dadjo, C; Nyende, AB; Yao, N; Kiplangat, N; Assogbadjo, AE				Dadjo, Colombe; Nyende, Aggrey B.; Yao, Nasser; Kiplangat, Ngeno; Assogbadjo, Achille E.			Genome-wide genetic diversity and population structure ofGarcinia kola(Heckel) in Benin using DArT-Seq technology	PLOS ONE			English	Article							MAP; CONSTRUCTION; SELECTION	Garcinia kola(Heckel) is a versatile tree indigenous to West and Central Africa. All parts of the tree have value in traditional medicine. Natural populations of the species have declined over the years due to overexploitation. Assessment of genetic diversity and population structure ofG.kolais important for its management and conservation. The present study investigates the genetic diversity and population structureof G.kolapopulations in Benin using ultra-high-throughput diversity array technology (DArT) single nucleotide polymorphism (SNP) markers. From the 102 accessions sampled, two were excluded from the final dataset owing to poor genotyping coverage. A total of 43,736 SNPs were reported, of which 12,585 were used for analyses after screening with quality control parameters including Minor allele frequency (>= 0.05), call rate (>= 80%), reproducibility (>= 95%), and polymorphic information content (>= 1%). Analysis revealed low genetic diversity with expected heterozygosity per population ranging from 0.196 to 0.228. Pairwise F-statistics (F-ST) revealed low levels of genetic differentiation between populations while an Analysis of molecular variance (AMOVA) indicated that the majority of variation (97.86%) was within populations. Population structure analysis through clustering and discriminant analysis on principal component revealed two admixed clusters, implying little genetic structure. However, the model-based maximum likelihood in Admixture indicated only one genetic cluster. The present study indicated low genetic diversity ofG.kola, and interventions are needed to be tailored towards its conservation.	[Dadjo, Colombe] Pan African Univ, Inst Basic Sci Technol & Innovat, Nairobi, Kenya; [Dadjo, Colombe; Assogbadjo, Achille E.] Univ Abomey Calavi, Fac Agron Sci, Lab Appl Ecol, Cotonou, Benin; [Nyende, Aggrey B.] Jomo Kenyatta Univ Agr & Technol, Inst Biotechnol Res, Nairobi, Kenya; [Yao, Nasser] Int Livestock Res Inst, Biosci Eastern & Cent Africa, Nairobi, Kenya; [Kiplangat, Ngeno] Egerton Univ, Dept Anim Sci, Anim Breeding & Genom Grp, Egerton, Kenya	University of Abomey Calavi; Jomo Kenyatta University of Agriculture & Technology; CGIAR; International Livestock Research Institute (ILRI); Egerton University	Dadjo, C (corresponding author), Pan African Univ, Inst Basic Sci Technol & Innovat, Nairobi, Kenya.; Dadjo, C (corresponding author), Univ Abomey Calavi, Fac Agron Sci, Lab Appl Ecol, Cotonou, Benin.	dadjocolombe@gmail.com		Dadjo, Colombe/0000-0003-1310-2949	Pan African University-African Union scholarship	Pan African University-African Union scholarship	The research was funded through the Pan African University-African Union scholarship awarded to Colombe Dadjo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Zaitoun SY, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1475-2; Adedokun MO, 2007, IJSER, V8, P37; Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Akoegninou A, 2006, FLORE ANAL BENIN, DOI DOI 10.1007/s11056-010-9214-z; Al-Breiki RD, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5044-8; Alam M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203465; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Baral K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092587; Barnaud A, 2008, CAH AGRIC, V17, P178; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Branch CL, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170057; Deschamps Stephane, 2012, Biology (Basel), V1, P460, DOI 10.3390/biology1030460; Diversity Arrays Technology P/L, 2020, INTR KDC COMP APPL; Eltaher S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00076; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Freeland J. R., 2011, MOL ECOLOGY; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Hanaoka S, 2013, BASIC MOL TECHNIQUES; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Iwu MM, 1993, HDB AFRICAN MED PLAN, P223; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Li FG, 2005, BOT BULL ACAD SINICA, V46, P155; Li RJ, 2016, GENETICA, V144, P535, DOI 10.1007/s10709-016-9921-2; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Mohan M, 1997, MOL BREEDING, V3, P87, DOI 10.1023/A:1009651919792; Ndjiondjop MN, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01748; Neuenschwander P, 2011, PROTECTION NATURE AF; Odunayo J., 2019, AM J MOL BIOL, V9, P41, DOI DOI 10.4236/AJMB.2019.92004; Perrier X, 2014, DARWIN SOFTWARE; R Core Team, 2020, R LANG ENV STAT COMP; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ren RS, 2015, MOL GENET GENOMICS, V290, P1457, DOI 10.1007/s00438-015-0997-7; Sansaloni C, 2011, BMC P S7, V5, pP54, DOI 10.1186/1753-6561-5-S7-P54; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1978, VARIABILITY NATURAL; Xiao LQ, 2006, ANN BOT-LONDON, V97, P807, DOI 10.1093/aob/mcl039; ZENG ZB, 1994, GENETICS, V136, P1457	42	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238984	10.1371/journal.pone.0238984	http://dx.doi.org/10.1371/journal.pone.0238984			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966312	Green Published, gold			2022-12-26	WOS:000575688700057
J	Jin, GG; Yan, MY; Liu, KD; Yao, K; Chen, HY; Zhang, CJ; Yi, Y; Reddy, K; Gorja, DR; Laster, KV; Guo, ZP; Dong, ZG				Jin, Guoguo; Yan, Mingyang; Liu, Kangdong; Yao, Ke; Chen, Hanyong; Zhang, Chengjuan; Yi, Yang; Reddy, Kanamata; Gorja, Dhilli Rao; Laster, Kyle Vaughn; Guo, Zhiping; Dong, Zigang			Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer	ONCOGENE			English	Article							RIBOSOMAL S6 KINASE; PROTEIN; ACTIVATION; FAMILY; PHOSPHORYLATION; MAPK	Colon cancer is the most aggressive tumor in both men and women globally. As many the chemotherapeutic regimens have adverse side effects and contribute to the resistance and recurrence, therefore, finding novel therapeutic targets and developing effective agents are urgent. Based on the TCGA and GTEx database analysis, RSK1 and MSK2 were found abnormal expressed in colon cancer. RSK1 and MSK2 were overexpressed in colon cancer tissues confirmed by western blot and IHC. After knocking down RSK1 or MSK2, cell proliferation and anchorage-independent cell growth were markedly inhibited. Using a computer docking model, we identified a novel dual-target inhibitor, APIO-EE-07, that could block both RSK1 and MSK2 kinase activity in a dose-dependent manner. APIO-EE-07 inhibited cell growth and induced apoptosis and also increased expression of Bax as well as cleaved caspase-3 and -PARP in colon cancer cells by downregulating RSK1 and MSK2 downstream targets, including CREB and ATF1. Furthermore, APIO-EE-07 decreased tumor volume and weight in human patient-derived xenografts tumors implanted in SCID mice. In summary, our results demonstrate that RSK1 and MSK2 are the potential targets for the treatment of colon cancer. APIO-EE-07, a novel dual-target inhibitor of RSK1 and MSK2, can suppress the growth of colon cancer by attenuating RSK1 and MSK2 signaling.	[Jin, Guoguo; Guo, Zhiping] Henan Luoyang Orthoped Hosp, Zhengzhou, Henan, Peoples R China; [Jin, Guoguo; Yan, Mingyang; Liu, Kangdong; Gorja, Dhilli Rao; Laster, Kyle Vaughn; Dong, Zigang] China US Henan Hormel Canc Inst, Zhengzhou, Peoples R China; [Jin, Guoguo; Liu, Kangdong] Zhengzhou Univ, Henan Prov Cooperat Innovat Ctr Canc Chemoprevent, Zhengzhou, Henan, Peoples R China; [Liu, Kangdong; Dong, Zigang] Zhengzhou Univ, Coll Med, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou, Henan, Peoples R China; [Yao, Ke; Chen, Hanyong; Reddy, Kanamata] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Zhang, Chengjuan] Zhengzhou Univ, Affiliated Tumor Hosp, Ctr Bio Repository, Zhengzhou, Henan, Peoples R China; [Yi, Yang] Henan Univ Chinese Med, Sch Basic Med Sci, Dept Pathol & Pathophysiol, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University; University of Minnesota System; Zhengzhou University; Henan University of Traditional Chinese Medicine	Guo, ZP (corresponding author), Henan Luoyang Orthoped Hosp, Zhengzhou, Henan, Peoples R China.; Dong, ZG (corresponding author), China US Henan Hormel Canc Inst, Zhengzhou, Peoples R China.; Dong, ZG (corresponding author), Zhengzhou Univ, Coll Med, Sch Basic Med Sci, Dept Pathophysiol, Zhengzhou, Henan, Peoples R China.	Zhiping74@hotmail.com; zgdong@hci-cn.org			Key Science and Technology Program of Henan Province, China [182102310125]; Key program of TCM research in Henan Province, China [2018ZY1016, 2019ZY1037]	Key Science and Technology Program of Henan Province, China; Key program of TCM research in Henan Province, China	This work was supported by the Key Science and Technology Program of Henan Province, China (182102310125) and the Key program of TCM research in Henan Province, China (2018ZY1016, 2019ZY1037).	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; [Anonymous], 2019, SCHROD SUIT 2019; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bode AM, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0055-0; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Clark DE, 2005, CANCER RES, V65, P3108; De Cesare D, 1998, P NATL ACAD SCI USA, V95, P12202, DOI 10.1073/pnas.95.21.12202; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Giselle R, 2002, MOL CELL BIOL, V8, P2871; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Houles T, 2018, SEMIN CANCER BIOL, V48, P53, DOI 10.1016/j.semcancer.2017.04.016; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Jideh B, 2018, MED J AUSTRALIA, V208, P483, DOI 10.5694/mja18.00279; Jin GG, 2017, ONCOTARGET, V8, P53387, DOI 10.18632/oncotarget.18508; Lara R, 2013, CANCER RES, V73, P5301, DOI 10.1158/0008-5472.CAN-12-4448; Lee YT, 2018, EUR J PHARMACOL, V834, P188, DOI 10.1016/j.ejphar.2018.07.034; Liu HY, 2014, NEUROCHEM RES, V39, P2479, DOI 10.1007/s11064-014-1452-6; Liu KD, 2011, J BIOL CHEM, V286, P2057, DOI 10.1074/jbc.M110.147306; Ludwik KA, 2016, MOL CANCER THER, V15, P2598, DOI 10.1158/1535-7163.MCT-16-0106; Markad SB, 2014, ORG LETT, V16, P5470, DOI 10.1021/ol502721r; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Reyskens KMSE, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00056; Rodriguez-Antona C, 2010, ENDOCR-RELAT CANCER, V17, P7, DOI 10.1677/ERC-08-0304; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Smith JA, 2005, CANCER RES, V65, P1027; Strelkov IS, 2002, CANCER RES, V62, P75; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Xian W, 2009, CANCER RES, V69, P2244, DOI 10.1158/0008-5472.CAN-08-3398; Yao K, 2014, CANCER PREV RES, V7, P958, DOI 10.1158/1940-6207.CAPR-14-0126; Ye D, 2019, J MOL NEUROSCI, V68, P475, DOI 10.1007/s12031-019-01309-9	35	3	3	2	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2020	39	43					6733	6746		10.1038/s41388-020-01467-w	http://dx.doi.org/10.1038/s41388-020-01467-w		SEP 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OF2UT	32963350				2022-12-26	WOS:000572030400002
J	Opito, R; Mpagi, J; Bwayo, D; Okello, F; Mugisha, K; Napyo, A				Opito, Ronald; Mpagi, Joseph; Bwayo, Denis; Okello, Francis; Mugisha, Kenneth; Napyo, Agnes			Treatment outcome of the implementation of HIV test and treat policy at The AIDs Support Organization (TASO) Tororo clinic, Eastern Uganda: A retrospective cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY	Background Uganda has been making progress towards universal HIV test and treat since 2013 and the 2016 test and treat policy was expanded from the 2013 guidelines. The expanded policy was rolled out in 2017 across the country. The treatment outcomes of this new policy have not yet been assessed at program level. The objective of this study was to determine the treatment outcome of the HIV test and treat policy in TASO Tororo Clinic, Eastern Uganda. Methodology This was a retrospective cohort study using secondary data. The study involved 580 clients who were newly diagnosed HIV positive in TASO Tororo clinic between June 2017 and May 2018, who were then followed up for ART initiation, retention in care, viral load monitoring and viral load suppression. The data was analyzed using Stat 14.0 version statistical software application. Results Of the 580 clients, 93.1%(540) were adults aged >= 20 years. The uptake of test and treat was at 92.4%(536) and 12 months retention was at 78.7% (422). The factors associated with retention in care were a) being counselled before ART initiation, AOR 2.41 (95%CI, 1.56-3.71), b) having a treatment supporter, AOR 1.57 (95%CI, 1.02-2.43) and having an opportunistic infection, AOR 2.99 (95%CI:1.21-7.41). The viral load coverage was 52.4% (221) and viral load suppression rate was 89.1% (197) of clients monitored. Age <20 years was the only identified factor associated with vial load non suppression, AOR 7.35 (95% CI = 2.23-24.24). Conclusion This study found high uptake of ART under test and treat policy, with very low viral load coverage, and a high viral load suppression rate among those monitored. The study therefore highlights a need to differentiate viral load testing based on the population needs and ensure each client testing positive receives pre-ART initiation counselling so as to improve retention in care.	[Opito, Ronald; Okello, Francis; Napyo, Agnes] Busitema Univ, Dept Publ Hlth, Mbale, Uganda; [Opito, Ronald; Mugisha, Kenneth] AIDs Support Org TASO, Directorate Program Management & Capac Dev, Kampala, Uganda; [Mpagi, Joseph] Busitema Univ, Dept Microbiol, Mbale, Uganda; [Bwayo, Denis] Busitema Univ, Dept Internal Med, Mbale, Uganda		Opito, R (corresponding author), Busitema Univ, Dept Publ Hlth, Mbale, Uganda.; Opito, R (corresponding author), AIDs Support Org TASO, Directorate Program Management & Capac Dev, Kampala, Uganda.	dropitoroni@gmail.com		Opito, Ronald/0000-0002-6183-6851				[Anonymous], 2019, Nat Rev Dis Primers, V5, P19, DOI 10.1038/s41572-019-0075-2; [Anonymous], 2016, CONS GUID PREV TREAT; [Anonymous], 2015, GEOLOGIYA GEOFIZIKA, V5, P9; [Anonymous], 2018, TOXICOL ANAL CLIN, V30, P1; [Anonymous], 2015, CANC DISCOV, V6, P6; Ayele W, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2176-5; Brown Lillian B., 2019, FACTORS PREDICTIVE S, P1; Bulage L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2428-3; Burch LS, 2016, LANCET PUBLIC HEALTH, V1, pE26, DOI 10.1016/S2468-2667(16)30002-0; Kadima J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200242; Lertpiriyasuwat Cheewanan, 2017, Journal of the Medical Association of Thailand, V100, P944; Mayanja Y, 2018, AIDS BEHAV, V22, P1053, DOI 10.1007/s10461-017-1973-5; Miller M.A., 2010, P GAT COMP ENV WORKS; Ministry of Health U, 2019, UG POP BAS HIV IMP A; Moyo F, 2016, CLIN EPIDEMIOL, V8, P37, DOI 10.2147/CLEP.S93014; Musa BM, 2019, F1000RESEARCH, P1; Nabukeera-Barungi N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1265-5; Petersen M, 2017, JAMA-J AM MED ASSOC, V317, P2196, DOI 10.1001/jama.2017.5705; Rufu A, 2018, PUBLIC HEALTH ACTION, V8, P145, DOI 10.5588/pha.18.0030; Schwartz SR, 2017, J INT AIDS SOC, V20, P43, DOI 10.1002/jia2.25003; Ssebunya R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2550-2; Suguitan Jr AL, 2011, PLOS ONE, V6; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; Uganda Ministry of Health, 2013, ADD NAT ANT TREATM G; UNAIDS, 2019, JOINT UN PROGR HIV A; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364	27	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239087	10.1371/journal.pone.0239087	http://dx.doi.org/10.1371/journal.pone.0239087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960927	gold, Green Published			2022-12-26	WOS:000575109500002
J	Cao, Q; Liu, L; Hu, YG; Jiang, N; Wang, YJ; Chen, JL; Zhou, Q; Guo, RQ				Cao, Quan; Liu, Lian; Hu, Yugang; Jiang, Nan; Wang, Yijia; Chen, Jinling; Zhou, Qing; Guo, Ruiqiang			Irradiation of carotid baroreceptor with low-intensity pulsed ultrasound exerts different metabolic protection in perirenal, epididymal white adipose tissue and interscapular brown adipose tissue of obese rats	FASEB JOURNAL			English	Article						AMP-activated protein kinase; peroxisome proliferator-activated receptor; autonomic nervous system; obesity	SYMPATHETIC ACTIVATION; DEVELOPMENTAL ORIGIN; FAT; ADIPOCYTES; INSULIN; LIPOLYSIS; PROTEIN; HEALTH; RESISTANCE; TARGET	This study was designed to clarify whether the irradiation of carotid baroreceptor (CB) with low-intensity pulsed ultrasound (LIPUS) protects against obesity by rebalancing the autonomic nervous system (ANS). Obesity was induced using a high-fat diet (HFD) for 8 weeks in Sprague-Dawley rats. Irradiation with LIPUS was daily (20 minutes a day) applied to the right CB. In our study, LIPUS significantly ameliorated metabolic disorders in obese rats. LIPUS partly restored norepinephrine (NE) and acetylcholine (ACH) levels in the perirenal white adipose tissue (PWAT), epididymal white adipose tissue (EWAT), interscapular brown adipose tissue (IBAT), and plasma of obese rats. LIPUS partially rectified the dysregulated AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor (PPAR) alpha/gamma pathway in the PWAT, EWAT, and IBAT of obese rats. PPAR gamma and PPAR gamma target genes respond more sensitively to HFD and LIPUS in PWAT and EWAT than in IBAT. NE, ACH, uncoupling protein-1, phosphorylated AMPK, PPAR alpha, and PPAR alpha target genes respond more sensitively to HFD and LIPUS in IBAT than in PWAT and EWAT. Conclusion: LIPUS irradiation of CB exerts different metabolic protection in PWAT, EWAT, and IBAT by rebalancing the ANS and rectifying the AMPK/PPAR alpha/gamma pathway in obese rats.	[Cao, Quan; Hu, Yugang; Jiang, Nan; Wang, Yijia; Chen, Jinling; Zhou, Qing; Guo, Ruiqiang] Wuhan Univ, Renmin Hosp, Dept Ultrasound Imaging, Echo Lab, 238 Jiefang Rd, Wuhan 430060, Peoples R China; [Cao, Quan; Hu, Yugang; Jiang, Nan; Wang, Yijia; Chen, Jinling; Zhou, Qing; Guo, Ruiqiang] Wuhan Univ, Renmin Hosp, Dept Ultrasound Imaging, 3D Printing & AI Lab, Wuhan, Peoples R China; [Liu, Lian] Wuhan Univ, Renmin Hosp, Dept Anesthesiol, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Zhou, Q; Guo, RQ (corresponding author), Wuhan Univ, Renmin Hosp, Dept Ultrasound Imaging, Echo Lab, 238 Jiefang Rd, Wuhan 430060, Peoples R China.	qingzhou@whu.edu.cn; ruiqiangwhrm@whu.edu.cn			National Natural Science Foundation of China [81971624]; Wuhan Municipal Science and Technology Bureau [2019020701011477]; Fundamental Research Funds for the Central Universities [2042019kf0089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Municipal Science and Technology Bureau; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 81971624, Recipient: Qing Zhou), Wuhan Municipal Science and Technology Bureau (No. 2019020701011477, Recipient: Qing Zhou), and Fundamental Research Funds for the Central Universities (No. 2042019kf0089, Recipient: Nan Jiang)	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Beech DJ, 2019, ARTERIOSCL THROM VAS, V39, P2228, DOI 10.1161/ATVBAHA.119.313348; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Campioli E, 2011, OBESITY, V19, P703, DOI 10.1038/oby.2010.244; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao Q, 2019, J LIPID RES, V60, P1212, DOI [10.1194/jlr.M091256, 10.1194/jlr.m091256]; Chakravarthy MV, 2009, J LIPID RES, V50, P630, DOI 10.1194/jlr.M800379-JLR200; Chouchani ET, 2019, CELL METAB, V29, P27, DOI 10.1016/j.cmet.2018.11.002; Chu DT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13093; Chu DT, 2017, HORM METAB RES, V49, P276, DOI 10.1055/s-0043-100384; Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004; Deng JL, 2020, AUTOPHAGY, V16, P451, DOI 10.1080/15548627.2019.1628537; Deshpande SS, 2019, ENDOCRINOLOGY, V160, P220, DOI 10.1210/en.2018-00569; Ding L, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2006-0; Chu DT, 2017, BIOCHIMIE, V138, P102, DOI 10.1016/j.biochi.2017.04.017; Chu DT, 2017, J PHYSIOL BIOCHEM, V73, P1, DOI 10.1007/s13105-016-0536-y; Dutta-Roy AK, 2000, CELL MOL LIFE SCI, V57, P1360, DOI 10.1007/PL00000621; Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014; Frayn KN, 2010, ACTA PHYSIOL, V199, P509, DOI 10.1111/j.1748-1716.2010.02128.x; Fucho R, 2017, FASEB J, V31, P1263, DOI 10.1096/fj.201601156R; Gamboa A, 2014, HYPERTENSION, V64, P867, DOI 10.1161/HYPERTENSIONAHA.114.03738; Garretson JT, 2016, MOL METAB, V5, P626, DOI 10.1016/j.molmet.2016.06.013; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Giordano A, 2014, EUR J ENDOCRINOL, V170, pR159, DOI 10.1530/EJE-13-0945; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Granger AJ, 2017, CURR OPIN NEUROBIOL, V45, P85, DOI 10.1016/j.conb.2017.04.007; Greenberg AS, 2011, EMBO J, V30, P4337, DOI 10.1038/emboj.2011.371; Hashimoto M, 2019, FASEB J, V33, P8069, DOI 10.1096/fj.201802147RR; Jura M, 2016, BIOCHIMIE, V124, P124, DOI 10.1016/j.biochi.2015.05.006; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kotzbeck P, 2018, J LIPID RES, V59, P784, DOI 10.1194/jlr.M079665; Lainez NM, 2019, ENDOCRINOLOGY, V160, P2719, DOI 10.1210/en.2019-00487; Lambert GW, 2010, PHARMACOL THERAPEUT, V126, P159, DOI 10.1016/j.pharmthera.2010.02.002; Landsberg L, 2012, OBES REV, V13, P97, DOI 10.1111/j.1467-789X.2012.01040.x; Li L, 2019, MOL ASPECTS MED, V68, P60, DOI 10.1016/j.mam.2019.07.005; Lim JX, 2013, FASEB J, V27, P4757, DOI 10.1096/fj.13-232702; Lim K, 2013, HYPERTENSION, V61, P628, DOI 10.1161/HYPERTENSIONAHA.111.00705; Marin-Royo G, 2019, FASEB J, V33, P12060, DOI 10.1096/fj.201900347RR; Messina G, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00137; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; O'Brien PD, 2017, LANCET NEUROL, V16, P465, DOI 10.1016/S1474-4422(17)30084-4; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Qi M, 2017, THERANOSTICS, V7, P4498, DOI 10.7150/thno.17949; Reilly SM, 2017, NAT REV ENDOCRINOL, V13, P633, DOI 10.1038/nrendo.2017.90; Scheja L, 2019, NAT REV ENDOCRINOL, V15, P507, DOI 10.1038/s41574-019-0230-6; Schreiber R, 2015, P NATL ACAD SCI USA, V112, P13850, DOI 10.1073/pnas.1516004112; Seals DR, 2004, DIABETES, V53, P276, DOI 10.2337/diabetes.53.2.276; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Silva AZ, 2018, LIFE SCI, V211, P147, DOI 10.1016/j.lfs.2018.09.027; Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Straznicky NE, 2009, DIABETES, V58, P1126, DOI 10.2337/db08-1595; Tabuchi Y, 2007, CANCER LETT, V246, P149, DOI 10.1016/j.canlet.2006.02.011; Thomas D, 2017, METABOLISM, V72, P120, DOI 10.1016/j.metabol.2017.04.005; Toczylowski K, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2060-7; Unger RH, 2001, FASEB J, V15, P312, DOI 10.1096/fj.00-0590; Vekic J, 2019, METABOLISM, V92, P71, DOI 10.1016/j.metabol.2018.11.005; Victor RG, 2015, NAT REV CARDIOL, V12, P451, DOI 10.1038/nrcardio.2015.96; Villarroya F, 2017, NAT REV ENDOCRINOL, V13, P26, DOI 10.1038/nrendo.2016.136; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Wang J, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-019-0750-1; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Xiong XQ, 2014, ACTA PHYSIOL, V210, P468, DOI 10.1111/apha.12182; Xue RQ, 2017, J CELL MOL MED, V21, P58, DOI 10.1111/jcmm.12938; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zhu YB, 2015, OBESITY, V23, P1014, DOI 10.1002/oby.21062; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	72	1	1	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15431	15447		10.1096/fj.202001550R	http://dx.doi.org/10.1096/fj.202001550R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32954572				2022-12-26	WOS:000573726700001
J	Hu, Y; Yang, QY; Kou, J; Sun, CB; Li, HL				Hu, Yang; Yang, Qingyang; Kou, Jue; Sun, Chunbao; Li, Hongliang			Aggregation mechanism of colloidal kaolinite in aqueous solutions with electrolyte and surfactants	PLOS ONE			English	Article							HYDROPHOBIC AGGLOMERATION; FLOCCULATION; SUSPENSIONS; PARTICLES; SURFACES	In this study, the effect of surfactants and electrolytes on stability of kaolinite dispersions was analyzed by measuring suspension transmittance, zeta potential, and adsorption. It was experimentally found that the compression of kaolinite electric double layer caused by NaCl addition may reduce the electrostatic repulse force to facilitate the aggregation of kaolinite particles. Surfactant facilitate the aggregation of kaolinite particles mainly through the adsorption of it on the surface of kaolinite to generate hydrophobic force. Compared to anionic surfactant, the cationic surfactant has a better flocculation effect because it can be used in a wide pH range and its adsorption can reduce the electrostatic repulse force between kaolinite particles.	[Hu, Yang; Yang, Qingyang; Kou, Jue; Sun, Chunbao] Univ Sci & Technol Beijing, Sch Civil & Resources Engn, Beijing, Peoples R China; [Li, Hongliang] Taiyuan Univ Technol, Coll Min Engn, Taiyuan, Peoples R China	University of Science & Technology Beijing; Taiyuan University of Technology	Li, HL (corresponding author), Taiyuan Univ Technol, Coll Min Engn, Taiyuan, Peoples R China.	lihongliang222@126.com			National Natural Science Foundation of China [51804021, 51804213]; China Scholarships Council (CSC) [201906935041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarships Council (CSC)	National Natural Science Foundation of China (project No. 51804021 and No. 51804213) and China Scholarships Council (CSC) under project No. 201906935041.	Alkan M, 2005, MICROPOR MESOPOR MAT, V83, P51, DOI 10.1016/j.micromeso.2005.03.011; Barani K, 2018, J MATER RES TECHNOL, V7, P142, DOI 10.1016/j.jmrt.2017.05.010; Bergaya F., 2006, HDB CLAY SCI, P141; BRINDLEY GW, 1945, NATURE, V156, P661, DOI 10.1038/156661b0; C Hiemenz P., 1997, PRINCIPLES COLLOID S, P525; Dwari RK, 2019, INT J MIN SCI TECHNO, V29, P745, DOI 10.1016/j.ijmst.2019.06.001; Honaker RQ, 2005, COAL PREP, V25, P81, DOI 10.1080/07349340590927413; Hu Y, 2013, COLLOID SURFACE A, V434, P281, DOI 10.1016/j.colsurfa.2013.05.074; Kang X, 2019, APPL CLAY SCI, V176, P38, DOI 10.1016/j.clay.2019.04.024; Kinoshita T, 2017, APPL CLAY SCI, V148, P11, DOI 10.1016/j.clay.2017.07.024; Kirdponpattara S, 2013, J COLLOID INTERF SCI, V397, P169, DOI 10.1016/j.jcis.2013.01.033; Lee BJ, 2012, WATER RES, V46, P5696, DOI 10.1016/j.watres.2012.07.056; Li HL, 2020, INT J MIN MET MATER, V27, P857, DOI 10.1007/s12613-020-2078-0; Li J, 2013, COLLOID SURFACE A, V428, P100, DOI 10.1016/j.colsurfa.2013.03.034; Liu D, 2018, POWDER TECHNOL, V326, P228, DOI 10.1016/j.powtec.2017.11.070; Liu LY, 2019, APPL SURF SCI, V470, P27, DOI 10.1016/j.apsusc.2018.11.104; Lu SC, 2005, STUD INTERF SCI, V20, P172; Mietta F, 2009, J COLLOID INTERF SCI, V336, P134, DOI 10.1016/j.jcis.2009.03.044; Nasser MS, 2011, CHEM ENG RES DES, V89, P768, DOI 10.1016/j.cherd.2010.08.015; NOVICH BE, 1984, CLAY CLAY MINER, V32, P400, DOI 10.1346/CCMN.1984.0320508; SONG SX, 1994, J COLLOID INTERF SCI, V166, P35, DOI 10.1006/jcis.1994.1268; Yi H, 2017, J DISPER SCI TECHNOL, V38, P1336, DOI 10.1080/01932691.2016.1237366; Zbik MS, 2009, J COLLOID INTERF SCI, V339, P110, DOI 10.1016/j.jcis.2009.07.038; Zhu XY, 2016, APPL CLAY SCI, V124, P127, DOI 10.1016/j.clay.2016.01.033; Zou WJ, 2020, COLLOID SURFACE A, V585, DOI 10.1016/j.colsurfa.2019.124055	25	5	5	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238350	10.1371/journal.pone.0238350	http://dx.doi.org/10.1371/journal.pone.0238350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956346	gold, Green Published			2022-12-26	WOS:000574571500002
J	Martucciello, S; Turturo, MG; Bilio, M; Cioffi, S; Chen, L; Baldini, A; Illingworth, E				Martucciello, Stefania; Turturo, Maria Giuseppina; Bilio, Marchesa; Cioffi, Sara; Chen, Li; Baldini, Antonio; Illingworth, Elizabeth			A dual role forTbx1in cardiac lymphangiogenesis through genetic interaction withVegfr3	FASEB JOURNAL			English	Article						cardiac; genetic interaction; lymphatic vessel; mouse model; Tbx1; Vegfr3	2ND HEART; TBX1; VEGFR3; ANGIOGENESIS; EXPRESSION; GROWTH; CELLS; CRE; ENDOTHELIUM; LYMPHATICS	The transcription factorTBX1is the major gene implicated in 22q11.2 deletion syndrome (22q11.2DS). The complex clinical phenotype includes vascular anomalies and a recent report presented new cases of primary lymphedema in 22q11.2DS patients. We have previously shown that TBX1 is required for systemic lymphatic vessel development in prenatal mice and it is critical for their survival postnatally. Using loss-of-function genetics and transgenesis in the mouse, we show here a strong genetic interaction betweenTbx1andVegfr3in cardiac lymphangiogenesis. Intriguingly, we found that different aspects of the cardiac lymphatic phenotype inTbx1-Vegfr3compound heterozygotes were regulated independently by the two genes, withTbx1primarily regulating vessel numbers andVegfr3vessel morphology. Consistent with this observation,Tbx1(Cre)-activated expression of aVegfr3transgene rescued partially the cardiac lymphatic abnormalities in compound heterozygotes. Through time-controlled genetic experiments, we show thatTbx1is activated and required in cardiac lymphatic endothelial cell (LEC) progenitors between E10.5 and E11.5. Furthermore, we found that it is also required later in development for the growth of the cardiac lymphatics. Finally, our study revealed a differential sensitivity between ventral and dorsal cardiac lymphatics to the effects of alteredTbx1andVegfr3gene dosage, and we show that this likely results from an earlier requirement forTbx1in ventral cardiac LEC progenitors.	[Martucciello, Stefania] IRCCS Neuromed, Pozzilli, Italy; [Martucciello, Stefania; Illingworth, Elizabeth] Univ Salerno, Dept Chem & Biol, Via Giovanni Paolo II 132, I-84084 Fisciano, Italy; [Turturo, Maria Giuseppina; Bilio, Marchesa; Cioffi, Sara; Baldini, Antonio] CNR, Inst Genet & Biophys ABT, Naples, Italy; [Chen, Li] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Baldini, Antonio] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy	IRCCS Neuromed; University of Salerno; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Houston System; University of Houston; University of Naples Federico II	Illingworth, E (corresponding author), Univ Salerno, Dept Chem & Biol, Via Giovanni Paolo II 132, I-84084 Fisciano, Italy.	eillingworth@unisa.it	CIOFFI, Sara/GWZ-9079-2022; Baldini, Antonio/M-2355-2015	CIOFFI, Sara/0000-0003-3197-6578; MARTUCCIELLO, STEFANIA/0000-0002-3720-1442; Baldini, Antonio/0000-0002-5330-0256	Fondation Leducq [15CVD01]; Ministero della Salute (Ministry of Health, Italy) [RF-2011-02347197, 20179J2P9J]; Fondation Jerome Lejeune (Jerome Lejeune Foundation) [1685]	Fondation Leducq(Leducq Foundation); Ministero della Salute (Ministry of Health, Italy)(Ministry of Health, Italy); Fondation Jerome Lejeune (Jerome Lejeune Foundation)	Fondation Leducq, Grant/Award Number: 15CVD01; Ministero della Salute (Ministry of Health, Italy), Grant/Award Number: RF-2011-02347197 and 20179J2P9J; Fondation Jerome Lejeune (Jerome Lejeune Foundation), Grant/Award Number: 1685	Alfano D, 2019, HUM MOL GENET, V28, P2295, DOI 10.1093/hmg/ddz058; Benedito R, 2012, NATURE, V484, P110, DOI 10.1038/nature10908; Chen L, 2010, J CELL BIOL, V189, P417, DOI 10.1083/jcb.200912037; Cioffi S, 2014, HUM MOL GENET, V23, P78, DOI 10.1093/hmg/ddt400; Connell FC, 2009, HUM GENET, V124, P625, DOI 10.1007/s00439-008-0586-5; Cortes C, 2018, CIRC RES, V122, P142, DOI 10.1161/CIRCRESAHA.117.310838; Diogo R, 2015, NATURE, V520, P466, DOI 10.1038/nature14435; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Ehlers ML, 2014, CELL REP, V8, P1639, DOI 10.1016/j.celrep.2014.08.035; Flaht-Zabost A, 2014, ANAT REC, V297, P1115, DOI 10.1002/ar.22912; Gordon K, 2013, CIRC RES, V112, P956, DOI 10.1161/CIRCRESAHA.113.300350; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Henri O, 2016, CIRCULATION, V133, P1484, DOI 10.1161/CIRCULATIONAHA.115.020143; Huynh T, 2007, GENESIS, V45, P470, DOI 10.1002/dvg.20317; Ishikawa Y, 2007, HISTOPATHOLOGY, V51, P345, DOI 10.1111/j.1365-2559.2007.02785.x; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Lioux G, 2020, DEV CELL, V52, P350, DOI 10.1016/j.devcel.2019.12.006; Mahadevan A, 2014, DEV CELL, V31, P690, DOI 10.1016/j.devcel.2014.11.002; Mansir T, 1999, GENET COUNSEL, V10, P67; Martinez-Corral I, 2015, CIRC RES, V116, P1649, DOI 10.1161/CIRCRESAHA.116.306170; Maruyama K, 2019, DEV BIOL, V452, P134, DOI 10.1016/j.ydbio.2019.05.002; Megason SG, 2002, DEVELOPMENT, V129, P2087; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Pichol-Thievend C, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.160184; Rana MS, 2014, CIRC RES, V115, P790, DOI 10.1161/CIRCRESAHA.115.305020; Reuter MS, 2019, GENET MED, V21, P1001, DOI 10.1038/s41436-018-0260-9; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stanczuk L, 2015, CELL REP, V10, P1708, DOI 10.1016/j.celrep.2015.02.026; Stone OA, 2019, DEV CELL, V50, P247, DOI 10.1016/j.devcel.2019.04.034; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Theveniau-Ruissy M, 2016, DEV DYNAM, V245, P445, DOI 10.1002/dvdy.24380; Unolt M, 2018, EUR J MED GENET, V61, P411, DOI 10.1016/j.ejmg.2018.02.006; Unolt M, 2018, AM J MED GENET A, V176, P2087, DOI 10.1002/ajmg.a.38662; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Xu HS, 2005, DEVELOPMENT, V132, P4387, DOI 10.1242/dev.02018; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Yang Y, 2014, J CLIN INVEST, V124, P888, DOI 10.1172/JCI71609; Zarkada G, 2015, P NATL ACAD SCI USA, V112, P761, DOI 10.1073/pnas.1423278112	44	5	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15062	15079		10.1096/fj.201902202R	http://dx.doi.org/10.1096/fj.201902202R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32951265	hybrid, Green Submitted			2022-12-26	WOS:000573725500001
J	Zhu, YQ; Pan, XS; Du, N; Li, KY; Hu, YM; Wang, LL; Zhang, J; Liu, YY; Zuo, LQ; Meng, XM; Hu, CM; Wu, X; Jin, J; Wu, WY; Chen, XT; Wu, FR; Huang, Y				Zhu, Yueqin; Pan, Xuesheng; Du, Na; Li, Kuayue; Hu, Yamin; Wang, Lili; Zhang, Jin; Liu, Yanyi; Zuo, Longquan; Meng, Xiaoming; Hu, Chengmu; Wu, Xian; Jin, Juan; Wu, Wenyong; Chen, Xiangtao; Wu, Fanrong; Huang, Yan			ASIC1a regulates miR-350/SPRY2 by N-6-methyladenosine to promote liver fibrosis	FASEB JOURNAL			English	Article						ASIC1a; HSC; SPRY2; METTL3; miR-350	SENSING ION CHANNELS; HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; NUCLEAR-RNA; INDUCED ACTIVATION; METHYLATION; EXPRESSION; PROLIFERATION; TRANSDUCTION; MICRORNA	As a reversible scar repair reaction, liver fibrosis can be blocked or even reversed by proper intervention during its formation. Our work suggests that acid-sensitive ion channel 1a (ASIC1a) participates in liver fibrosis and presents a novel mechanism involving m(6)A modification and miR-350/SPRY2. We demonstrated that the expression of ASIC1a was significantly increased in liver tissue of patients with liver fibrosis and animal models of liver fibrosis, as well as PDGF-BB-induced activated HSC-T6. After downregulating the expression of ASIC1a, the degree of liver fibrosis is reduced and HSC activation was inhibited, the level of m(6)A modification and miR-350 expression were also reduced. The results of dual luciferase reporter assay showed that miR-350 can bind to the target gene SPRY2 and inhibit its expression. We also found that METTL3 can regulate the extent of m(6)A modification of pri-miR-350 by binding to DGCR8. In addition, silencing or blocking the expression of ASIC1a can reduce the expression of PI3K/AKT and ERK signaling pathway-related proteins in activated HSCs. Taken together, we demonstrated that ASIC1a regulates the processing of miR-350 through METTL3-dependent m(6)A modification, and mature miR-350 targets SPRY2 and further promotes liver fibrosis through the PI3K/KT and ERK pathways.	[Zhu, Yueqin; Pan, Xuesheng; Du, Na; Li, Kuayue; Hu, Yamin; Wang, Lili; Zhang, Jin; Liu, Yanyi; Meng, Xiaoming; Hu, Chengmu; Wu, Xian; Chen, Xiangtao; Wu, Fanrong; Huang, Yan] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Anhui Prov Lab Inflammatory & Immun Dis, Hefei 230032, Peoples R China; [Zuo, Longquan] Hosp Armed Police Anhui Prov, Dept Pharm, Hefei 230041, Peoples R China; [Jin, Juan] Anhui Med Univ, Sch Basic Med Sci, Dept Pharmacol, Hefei 230032, Peoples R China; [Wu, Wenyong] Anhui Med Univ, Affiliated Hosp 1, Dept Gen Surg, Hefei 230022, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Huang, Y (corresponding author), Anhui Med Univ, Sch Pharm, Hefei, Anhui, Peoples R China.	aydhy@126.com		Huang, Yan/0000-0002-6587-6607	Outstanding youth project of Anhui natural science foundation [1908085J30]; 2019 anhui medical university basic and clinical cooperative research promotion project [2019xkjT015]; School-level Young Talents Supporting Plan [0601037104]; 2018 Young Talents Double Training Project Subsidy [0601037206]	Outstanding youth project of Anhui natural science foundation; 2019 anhui medical university basic and clinical cooperative research promotion project; School-level Young Talents Supporting Plan; 2018 Young Talents Double Training Project Subsidy	Outstanding youth project of Anhui natural science foundation, Grant/Award Number: 1908085J30; 2019 anhui medical university basic and clinical cooperative research promotion project, Grant/Award Number: 2019xkjT015; School-level Young Talents Supporting Plan, Grant/Award Number: 0601037104; 2018 Young Talents Double Training Project Subsidy, Grant/Award Number: 0601037206	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Alexander IE, 1996, HUM GENE THER, V7, P841, DOI 10.1089/hum.1996.7.7-841; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Chai S, 2010, J BIOL CHEM, V285, P13002, DOI 10.1074/jbc.M109.086041; Chassagnon IR, 2017, P NATL ACAD SCI USA, V114, P3750, DOI 10.1073/pnas.1614728114; Chen MN, 2018, HEPATOLOGY, V67, P2254, DOI 10.1002/hep.29683; Chen YZ, 2019, CELL DEATH DIFFER, V26, P1832, DOI 10.1038/s41418-018-0250-0; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Dibas A, 2018, CURR EYE RES, V43, P921, DOI 10.1080/02713683.2018.1454478; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Duan B, 2007, J NEUROSCI, V27, P11139, DOI 10.1523/JNEUROSCI.3364-07.2007; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gao ML, 2012, EMBO MOL MED, V4, P776, DOI 10.1002/emmm.201100944; Ge YZ, 2013, BBA-MOL BASIS DIS, V1832, P1, DOI 10.1016/j.bbadis.2012.09.004; Gregory NS, 2018, NEUROSCIENCE, V386, P166, DOI 10.1016/j.neuroscience.2018.06.033; Han B, 2020, NANOTOXICOLOGY, V14, P1, DOI 10.1080/17435390.2019.1661041; He Y, 2018, CELL PHYSIOL BIOCHEM, V47, P1465, DOI 10.1159/000490839; Hu JF, 2015, CLIN SCI, V129, P305, DOI 10.1042/CS20140012; Huang C, 2010, J PHARM PHARMACOL, V62, P223, DOI 10.1211/jpp.62.02.0010; Huang HL, 2019, NATURE, V567, P414, DOI 10.1038/s41586-019-1016-7; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jin C, 2017, ONCOTARGET, V8, P25977, DOI 10.18632/oncotarget.10774; Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965; Knuckles P, 2017, NAT STRUCT MOL BIOL, V24, P561, DOI 10.1038/nsmb.3419; Li MH, 2010, J CEREBR BLOOD F MET, V30, P1247, DOI 10.1038/jcbfm.2010.30; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu ML, 2017, ONCOTARGET, V8, P8283, DOI 10.18632/oncotarget.14164; Liu Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25386-9; Lu QL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10116-0; Luo SK, 2014, P NATL ACAD SCI USA, V111, P13834, DOI 10.1073/pnas.1412742111; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; Paik YH, 2009, GUT, V58, P1517, DOI 10.1136/gut.2008.157420; Pan XY, 2019, THERANOSTICS, V9, P4308, DOI 10.7150/thno.32710; Patel R, 2013, J CLIN INVEST, V123, P1157, DOI 10.1172/JCI63672; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Peng Y, 2014, AM J PHYSIOL-GASTR L, V306, pG253, DOI 10.1152/ajpgi.00471.2012; Pereira BLB, 2015, NUTRIENTS, V7, P9640, DOI 10.3390/nu7115493; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Qu NF, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6638-5; Rivera-Barahona A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06420-8; Samadaian N, 2018, PATHOL RES PRACT, V214, P2018, DOI 10.1016/j.prp.2018.09.019; Sanchez A, 2008, ONCOGENE, V27, P4969, DOI 10.1038/onc.2008.129; Sui J, 2018, CHEM-BIOL INTERACT, V280, P77, DOI 10.1016/j.cbi.2017.12.020; Tao L, 2018, ARCH TOXICOL, V92, P2935, DOI 10.1007/s00204-018-2278-9; Tsay HC, 2019, J HEPATOL, V70, P722, DOI 10.1016/j.jhep.2018.12.016; Wang H, 2015, BIOCHEM BIOPH RES CO, V468, P758, DOI 10.1016/j.bbrc.2015.11.029; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wang YH, 2019, TOXICOL LETT, V300, P1, DOI 10.1016/j.toxlet.2018.10.003; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wu FR, 2014, MOL CELL BIOCHEM, V395, P199, DOI 10.1007/s11010-014-2125-0; Wu KM, 2016, CLIN SCI, V130, P1469, DOI 10.1042/CS20160334; Xiao FL, 2018, CELL BIOL INT, V42, P1370, DOI 10.1002/cbin.11022; Xiao S, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0097-8; Xin X, 2014, FRONT BIOSCI-LANDMRK, V19, P1418, DOI 10.2741/4292; Yu H, 2018, J BIOMOL STRUCT DYN, V36, P2558, DOI 10.1080/07391102.2017.1363087; Yu XW, 2015, GLIA, V63, P483, DOI 10.1002/glia.22766; Zhang F, 2014, MOL CELL ENDOCRINOL, V382, P197, DOI 10.1016/j.mce.2013.09.020; Zhang YH, 2017, LAB INVEST, V97, P53, DOI 10.1038/labinvest.2016.127; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zuo LQ, 2019, J CELL MOL MED, V23, P3940, DOI 10.1111/jcmm.14275	68	12	14	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14371	14388		10.1096/fj.202001337R	http://dx.doi.org/10.1096/fj.202001337R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32949431				2022-12-26	WOS:000572425000001
J	Coelho, FC; Lana, RM; Cruz, OG; Villela, DAM; Bastos, LS; Piontti, APY; Davis, JT; Vespignani, A; Codeco, CT; Gomes, MFC				Coelho, Flavio C.; Lana, Raquel M.; Cruz, Oswaldo G.; Villela, Daniel A. M.; Bastos, Leonardo S.; Piontti, Ana Pastore Y.; Davis, Jessica T.; Vespignani, Alessandro; Codeco, Claudia T.; Gomes, Marcelo F. C.			Assessing the spread of COVID-19 in Brazil: Mobility, morbidity and social vulnerability	PLOS ONE			English	Article								Brazil detected community transmission of COVID-19 on March 13, 2020. In this study we identified which areas in the country were the most vulnerable for COVID-19, both in terms of the risk of arrival of cases, the risk of sustained transmission and their social vulnerability. Probabilistic models were used to calculate the probability of COVID-19 spread from Sao Paulo and Rio de Janeiro, the initial hotspots, using mobility data from the pre-epidemic period, while multivariate cluster analysis of socio-economic indices was done to identify areas with similar social vulnerability. The results consist of a series of maps of effective distance, outbreak probability, hospital capacity and social vulnerability. They show areas in the North and Northeast with high risk of COVID-19 outbreak that are also highly socially vulnerable. Later, these areas would be found the most severely affected. The maps produced were sent to health authorities to aid in their efforts to prioritize actions such as resource allocation to mitigate the effects of the pandemic. In the discussion, we address how predictions compared to the observed dynamics of the disease.	[Coelho, Flavio C.] Fundacao Getulio Vargas, Escola Matemat Aplicada, Rio De Janeiro, Brazil; [Coelho, Flavio C.; Lana, Raquel M.; Cruz, Oswaldo G.; Villela, Daniel A. M.; Bastos, Leonardo S.; Codeco, Claudia T.; Gomes, Marcelo F. C.] Nucleo Metodos Anal Vigilancia Saude Publ, Rio De Janeiro, Brazil; [Lana, Raquel M.; Cruz, Oswaldo G.; Villela, Daniel A. M.; Bastos, Leonardo S.; Codeco, Claudia T.; Gomes, Marcelo F. C.] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil; [Bastos, Leonardo S.] London Sch Hyg & Trop Med, London, England; [Piontti, Ana Pastore Y.; Davis, Jessica T.; Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Vespignani, Alessandro] ISI Fdn, Turin, Italy	Escola de Pos-Graduacao em Economia (EPGE); Getulio Vargas Foundation; Fundacao Oswaldo Cruz; University of London; London School of Hygiene & Tropical Medicine; Northeastern University	Codeco, CT (corresponding author), Nucleo Metodos Anal Vigilancia Saude Publ, Rio De Janeiro, Brazil.; Codeco, CT (corresponding author), Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil.	claudia.codeco@fiocruz.br	Ferreira da Costa Gomes, Marcelo/K-4469-2013; Coelho, Flavio/L-1089-2018	Ferreira da Costa Gomes, Marcelo/0000-0003-4693-5402; codeco, claudia torres/0000-0003-1174-178X; Bastos, Leonardo/0000-0002-1406-0122; Coelho, Flavio/0000-0003-3868-4391				Abbott Sam, 2020, Wellcome Open Res, V5, P17, DOI 10.12688/wellcomeopenres.15718.1; Allen L. J., 2008, MATH EPIDEMIOLOGY, V1945; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2020, CAPITAIS SP RJ TEM T; [Anonymous], 2020, MINISTERIO SAUDE CON; [Anonymous], 2020, BRASIL CONFIRMA TRAN; [Anonymous], 2017, CLUSTER CLUSTER ANAL; [Anonymous], 2020, LANCET, V395, P922, DOI 10.1016/S0140-6736(20)30644-9; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Chinazzi M, 2020, ESTIMATING RISK SUST, P11; Codeco CT, 2012, CAD SAUDE PUBLICA, V28, P1325, DOI 10.1590/S0102-311X2012000700011; Gautreau A, 2008, J THEOR BIOL, V251, P509, DOI 10.1016/j.jtbi.2007.12.001; IBGE Instituto Brasileiro de Geografia e Estatistica, 2010, CENS DEM 2010 RES GE; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li R., 2020, SUBSTANTIAL UNDOCUME; Liu T, 2020, BIORXIV; Ministerio da Saude, 2020, NOT CAS PEL NOV COR; Ministerio da Saude, 2020, LINH TMP COR; Ministerio da Saude, 2020, DATASUS INF SAUD RED; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Wei T, 2017, R PACKAGE CORRPLOT V; World Health Organization (WHO), 2020, COR DIS COVID 19 OUT, DOI DOI 10.1016/S0140-6736(20)30566-3	23	36	37	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238214	10.1371/journal.pone.0238214	http://dx.doi.org/10.1371/journal.pone.0238214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946442	gold, Green Published			2022-12-26	WOS:000573851100062
J	Silvestri, E; Senese, R; De Matteis, R; Cioffi, F; Moreno, M; Lanni, A; Gentile, A; Busiello, RA; Salzano, AM; Scaloni, A; de Lange, P; Goglia, F; Lombardi, A				Silvestri, Elena; Senese, Rosalba; De Matteis, Rita; Cioffi, Federica; Moreno, Maria; Lanni, Antonia; Gentile, Alessandra; Busiello, Rosa Anna; Salzano, Anna Maria; Scaloni, Andrea; de Lange, Pieter; Goglia, Fernando; Lombardi, Assunta			Absence of uncoupling protein 3 at thermoneutrality influences brown adipose tissue mitochondrial functionality in mice	FASEB JOURNAL			English	Article						metabolism; oxidative stress; respiratory chain	BLUE NATIVE-PAGE; GLYCEROL-3-PHOSPHATE DEHYDROGENASE; SUPEROXIDE-PRODUCTION; RESPIRATORY-CHAIN; SKELETAL-MUSCLE; THYROID-HORMONE; UCP3; THERMOGENESIS; OBESITY; ELECTROPHORESIS	The physiological role played by uncoupling protein 3 (UCP3) in brown adipose tissue (BAT) has not been fully elucidated so far. In the present study, we evaluated the impact of the absence of UCP3 on BAT mitochondrial functionality and morphology. To this purpose, wild type (WT) and UCP3 Knockout (KO) female mice were housed at thermoneutrality (30 degrees C), a condition in which BAT contributes to energy homeostasis independently of its cold-induced thermogenic function. BAT mitochondria from UCP3 KO mice presented a lower ability to oxidize the fatty acids and glycerol-3-phosphate, and an enhanced oxidative stress as revealed by enhanced mitochondrial electron leak, lipid hydroperoxide levels, and induction of antioxidant mitochondrial enzymatic capacity. The absence of UCP3 also influenced the mitochondrial super-molecular protein aggregation, an important feature for fatty acid oxidation rate as well as for adequate cristae organization and mitochondrial shape. Indeed, electron microscopy revealed alterations in mitochondrial morphology in brown adipocytes from KO mice. In the whole, data here reported show that the absence of UCP3 results in a significant alteration of BAT mitochondrial physiology and morphology. These observations could also help to clarify some aspects of the association between metabolic disorders associated with low UCP3 levels, as previously reported in human studies.	[Silvestri, Elena; Cioffi, Federica; Moreno, Maria; Goglia, Fernando] Univ Sannio, Dept Sci & Technol, Via Sanctis, I-82100 Benevento, Italy; [Senese, Rosalba; Lanni, Antonia; de Lange, Pieter] Univ Campania Luigi Vanvitelli, Dept Environm Biol & Pharmaceut Sci & Technol, Caserta, Italy; [De Matteis, Rita] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Gentile, Alessandra; Busiello, Rosa Anna; Lombardi, Assunta] Univ Naples Federico II, Dept Biol, Naples, Italy; [Salzano, Anna Maria; Scaloni, Andrea] CNR, ISPAAM, Prote & Mass Spectrometry Lab, Naples, Italy	University of Sannio; Universita della Campania Vanvitelli; University of Urbino; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR)	Goglia, F (corresponding author), Univ Sannio, Dept Sci & Technol, Via Sanctis, I-82100 Benevento, Italy.; Lombardi, A (corresponding author), Univ Naples Federico II, Complesso Univ Monte St Angelo, Dept Biol, Edificio 7, I-80126 Naples, Italy.	goglia@unisannio.it; assunta.lombardi@unina.it	de Lange, Pieter/GXA-3052-2022; Salzano, Anna Maria/C-7139-2012	Salzano, Anna Maria/0000-0001-7192-8760; SENESE, Rosalba/0000-0003-1571-0980; MORENO, Maria/0000-0002-6218-5501; Scaloni, Andrea/0000-0001-9362-8515; Silvestri, Elena/0000-0002-0592-9033; GENTILE, ALESSANDRA/0000-0002-5790-8533	University of Sannio Research Grants; University of Urbino Grants; Department of Biology University of Naples Federico II (Ricerca di Base)	University of Sannio Research Grants; University of Urbino Grants; Department of Biology University of Naples Federico II (Ricerca di Base)	This study was funded by University of Sannio Research Grants, University of Urbino Grants and by the Department of Biology University of Naples Federico II (Ricerca di Base)	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Arioli S, 2009, MICROBIOL-SGM, V155, P1953, DOI 10.1099/mic.0.024737-0; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bloor ID, 2014, HORM BEHAV, V66, P95, DOI 10.1016/j.yhbeh.2014.02.007; Boss Olivier, 2012, Front Endocrinol (Lausanne), V3, P14, DOI 10.3389/fendo.2012.00014; BUKOWIEC.LJ, 1974, BIOCHIM BIOPHYS ACTA, V348, P115, DOI 10.1016/0005-2760(74)90097-6; Busiello RA, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00036; Cadenas S, 2018, BBA-BIOENERGETICS, V1859, P940, DOI 10.1016/j.bbabio.2018.05.019; Calderon-Dominguez M, 2016, ADIPOCYTE, V5, P98, DOI 10.1080/21623945.2015.1122857; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Clark AM, 2009, ANAL CHEM, V81, P2350, DOI 10.1021/ac8026965; de Lange P, 2001, ENDOCRINOLOGY, V142, P3414, DOI 10.1210/en.142.8.3414; De Marchi U, 2011, J BIOL CHEM, V286, P32533, DOI 10.1074/jbc.M110.216044; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; GARRIB A, 1986, J BIOL CHEM, V261, P8042; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Gonzalez-Hurtado E, 2018, MOL METAB, V7, P45, DOI 10.1016/j.molmet.2017.11.004; He JY, 2018, P NATL ACAD SCI USA, V115, P2988, DOI 10.1073/pnas.1722086115; HEATH RL, 1976, ANAL BIOCHEM, V76, P184, DOI 10.1016/0003-2697(76)90277-3; Hilse KE, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00747; Hilse KE, 2016, BBA-BIOENERGETICS, V1857, P72, DOI 10.1016/j.bbabio.2015.10.011; Lenaz G, 2012, ADV EXP MED BIOL, V748, P107, DOI 10.1007/978-1-4614-3573-0_5; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lombardi A, 2009, J PROTEOMICS, V72, P708, DOI 10.1016/j.jprot.2009.02.007; Lombardi A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080916; Lombardi A, 2010, J BIOL CHEM, V285, P16599, DOI 10.1074/jbc.M110.102699; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Masand R, 2018, CELL METAB, V27, P616, DOI 10.1016/j.cmet.2018.01.018; McBride S, 2019, ARCH BIOCHEM BIOPHYS, V663, P239, DOI 10.1016/j.abb.2019.01.018; Mills EM, 2004, J MOL MED, V82, P787, DOI 10.1007/s00109-004-0591-7; Mills EM, 2003, NATURE, V426, P403, DOI 10.1038/426403a; Miwa S, 2005, BBA-BIOENERGETICS, V1709, P214, DOI 10.1016/j.bbabio.2005.08.003; Miwa S, 2003, BIOCHEM SOC T, V31, P1300; Motloch LJ, 2016, J MEMBRANE BIOL, V249, P577, DOI 10.1007/s00232-016-9913-2; MRAEK T, 2014, BIOCHIM BIOPHYS ACTA, V1837, P98; MRAEK T, 2013, BIOCH BIOPHYS ACTA B, V1827, P401, DOI DOI 10.1016/j.bbabio.2012.11.014; Nau K, 2008, J COMP PHYSIOL B, V178, P269, DOI 10.1007/s00360-007-0219-7; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Ozcan C, 2013, AM J PHYSIOL-HEART C, V304, pH1192, DOI 10.1152/ajpheart.00592.2012; Perrino C, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000086; Pohl EE, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00470; Quintana-Cabrera R, 2018, BIOCHEM BIOPH RES CO, V500, P94, DOI 10.1016/j.bbrc.2017.04.088; Rauchova H, 2003, ACTA BIOCHIM POL, V50, P405; Reitman ML, 2018, FEBS LETT, V592, P2098, DOI 10.1002/1873-3468.13070; Riley CL, 2016, J PHYSIOL-LONDON, V594, P7455, DOI 10.1113/JP272971; Rodriguez-Cuenca S, 2002, J BIOL CHEM, V277, P42958, DOI 10.1074/jbc.M207229200; Salzano AM, 2013, J PROTEOMICS, V94, P240, DOI 10.1016/j.jprot.2013.09.007; Schagger H, 1995, METHOD ENZYMOL, V260, P190, DOI 10.1016/0076-6879(95)60137-6; Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572; Schrauwen P, 2005, ACTA PHYSIOL SCAND, V183, P273, DOI 10.1111/j.1365-201X.2004.01393.x; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Sprague JE, 2004, BIOCHEM PHARMACOL, V68, P1339, DOI 10.1016/j.bcp.2004.03.049; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Valle A, 2007, CELL PHYSIOL BIOCHEM, V19, P195, DOI 10.1159/000099207; Vrbacky M, 2007, BBA-BIOENERGETICS, V1767, P989, DOI 10.1016/j.bbabio.2007.05.002; Zerbetto E, 1997, ELECTROPHORESIS, V18, P2059, DOI 10.1002/elps.1150181131	62	5	5	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15146	15163		10.1096/fj.202000995R	http://dx.doi.org/10.1096/fj.202000995R		SEP 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32946628				2022-12-26	WOS:000572282400001
J	Tanios, S; Eyles, A; Corkrey, R; Tegg, RS; Thangavel, T; Wilson, CR				Tanios, Sabine; Eyles, Alieta; Corkrey, Ross; Tegg, Robert S.; Thangavel, Tamilarasan; Wilson, Calum R.			Quantifying risk factors associated with light-induced potato tuber greening in retail stores	PLOS ONE			English	Article							BLUE-LIGHT; CHLOROPHYLL; ACCUMULATION; METABOLISM; RESPONSES	Light conditions in retail stores may contribute to potato greening. In this study, we aimed to develop a potato tuber greening risk rating model for retail stores based on light quality and intensity parameters. This was achieved by firstly exposing three potato varieties (Nicola, Maranca and Kennebec) to seven specific light wavelengths (370, 420, 450, 530, 630, 660 and 735 nm) to determine the tuber greening propensity. Detailed light quality and intensity measurements from 25 retail stores were then combined with the greening propensity data to develop a tuber greening risk rating model. Our study showed that maximum greening occurred under blue light (450 nm), while 53%, 65% and 75% less occurred under green (530 nm), red (660 nm) and orange (630 nm) light, respectively. Greening risk, which varied between stores, was found to be related to light intensity level, and partially explained potato stock loss in stores. Our results from this study suggested that other in-store management practices, including lighting duration, average potato turnover, and light protection during non-retail periods, likely influence tuber greening risk.	[Tanios, Sabine; Eyles, Alieta; Wilson, Calum R.] Univ Tasmania, New Town Res Labs, Tasmanian Inst Agr, ARC Training Ctr Innovat Hort Prod, New Town, Tas, Australia; [Tanios, Sabine; Eyles, Alieta; Tegg, Robert S.; Thangavel, Tamilarasan; Wilson, Calum R.] Univ Tasmania, New Town Res Labs, Tasmanian Inst Agr, New Town, Tas, Australia; [Corkrey, Ross] Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia	University of Tasmania; University of Tasmania; University of Tasmania	Wilson, CR (corresponding author), Univ Tasmania, New Town Res Labs, Tasmanian Inst Agr, ARC Training Ctr Innovat Hort Prod, New Town, Tas, Australia.; Wilson, CR (corresponding author), Univ Tasmania, New Town Res Labs, Tasmanian Inst Agr, New Town, Tas, Australia.	calum.wilson@utas.edu.au		Wilson, Calum/0000-0001-5434-3816; Thangavel, Tamilarasan/0000-0002-8800-0990; Tanios, Sabine/0000-0003-1420-412X	Australian Research Council's Industrial Transformation Training Centres scheme [IC140100024]	Australian Research Council's Industrial Transformation Training Centres scheme(Australian Research Council)	CRW and ST received funding from the Australian Research Council's Industrial Transformation Training Centres scheme under Grant IC140100024 (htpps://arc.gov.au). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2017, LEUKEMIA RES, V54, P55; ANSTIS PJP, 1973, NEW PHYTOL, V72, P449, DOI 10.1111/j.1469-8137.1973.tb04394.x; Bamberg J, 2015, AM J POTATO RES, V92, P435, DOI 10.1007/s12230-015-9454-8; Edwards E. J., 1997, THESIS; Fernqvist F, 2009, ACTA HORTIC, V831, P313, DOI 10.17660/ActaHortic.2009.831.37; Grunenfelder L, 2006, POSTHARVEST BIOL TEC, V40, P73, DOI 10.1016/j.postharvbio.2005.12.018; Hogewoning SW, 2010, J EXP BOT, V61, P3107, DOI 10.1093/jxb/erq132; KAMIYA A, 1983, PLANT CELL PHYSIOL, V24, P799, DOI 10.1093/oxfordjournals.pcp.a076580; Liljemark A., 1960, AM POTATO J, V28, P589; Olsen NL, 2018, AM J POTATO RES, V95, P123, DOI 10.1007/s12230-017-9616-y; Ouzounis T, 2015, HORTSCIENCE, V50, P1128, DOI 10.21273/HORTSCI.50.8.1128; PATIL BC, 1971, J FOOD SCI, V36, P474, DOI 10.1111/j.1365-2621.1971.tb06391.x; Percival G, 1999, J SCI FOOD AGR, V79, P1305, DOI [10.1002/(SICI)1097-0010(19990715)79:10<1305::AID-JSFA368>3.3.CO;2-I, 10.1002/(SICI)1097-0010(19990715)79:10&lt;1305::AID-JSFA368&gt;3.0.CO;2-R]; PETERMANN JB, 1985, PLANT SCI, V39, P105, DOI 10.1016/0168-9452(85)90100-1; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Roni MZK, 2017, HORTICULTURAE, V3, DOI 10.3390/horticulturae3040050; Tanios S, 2020, NEW PHYTOL, V225, P1273, DOI 10.1111/nph.16334; Tanios S, 2018, AM J POTATO RES, V95, P248, DOI 10.1007/s12230-018-9648-y; Tran LH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030641; VIRGIN HI, 1992, PHYSIOL PLANTARUM, V86, P587, DOI [10.1034/j.1399-3054.1992.860413.x, 10.1111/j.1399-3054.1992.tb02174.x]; Wang H, 2009, J PHOTOCH PHOTOBIO B, V96, P30, DOI 10.1016/j.jphotobiol.2009.03.010; YAMAGUCHI M, 1960, AM POTATO J, V37, P229; Zheng L, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00917	24	3	3	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0235522	10.1371/journal.pone.0235522	http://dx.doi.org/10.1371/journal.pone.0235522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946481	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000573851100016
J	Behrens, NE; Wertheimer, A; Love, MB; Klotz, SA; Ahmad, N				Behrens, Nicole E.; Wertheimer, Anne; Love, Maria B.; Klotz, Stephen A.; Ahmad, Nafees			Evaluation of HIV-specific T-cell responses in HIV-infected older patients with controlled viremia on long-term antiretroviral therapy	PLOS ONE			English	Article							VIRAL LOAD; PERIPHERAL-BLOOD; DECAY KINETICS; CD4; TYPE-1; ACTIVATION; INITIATION; IDENTIFICATION; DYSREGULATION; REPLICATION	HIV-infected older individuals may have a diminished immune response because of exhaustion/immune aging of T-cells. Therefore, we have investigated HIV-specific CD4 and CD8 T-cell responses in 100 HIV-infected patients (HIV+) who have aged on long-term antiretroviral therapy (ART) and achieved controlled viremia (mostly undetectable viral load; 92 patients with <20 to <40 HIV RNA copies/mL and 8 <60 to <100) and improved CD4 T-cell counts. We show that the median frequencies of HIV-specific CD4(+)and CD8(+)IFN-gamma T-cells were higher in HIV(+)than uninfected individuals (HIV-), including increasing levels of IFN-gamma produced by CD4(+)T-cells and decreasing levels by CD8(+)T-cells with increasing CD4 T-cell counts in HIV+. No correlation was found between T-cell responses and varying levels of undetectable viremia. HIV-specific TNF-alpha made by CD8(+)T-cells was higher in HIV(+)than HIV-, including decreasing levels with increasing CD4 T-cell counts in HIV+. Furthermore, the CD8(+)T-cell mediators, CD107a and Granzyme-B, were higher in HIV(+)than HIV-, and decreased with increasing CD4 T-cell counts in HIV+. Remarkably, HIV-specific CD8 T-cells produced decreasing levels of IFN-gamma with increasing age of HIV+, including decreased levels of CD107a and Granzyme-B in older HIV+. However, HIV-specific CD8(+)T-cells produced increasing levels of TNF-alpha with increasing age of the HIV+, suggesting continued inflammation. In conclusion, HIV(+)with controlled viremia on long-term ART and with higher CD4 T-cell counts showed reduced HIV-specific CD8 T-cell responses as compared to those with lower CD4 T-cell counts, and older HIV(+)exhibited decreasing levels of CD8 T-cell responses with increasing age.	[Behrens, Nicole E.; Wertheimer, Anne; Love, Maria B.; Ahmad, Nafees] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, Tucson, AZ 85721 USA; [Wertheimer, Anne; Klotz, Stephen A.] Univ Arizona, Hlth Sci Ctr, Dept Med, Tucson, AZ USA; [Wertheimer, Anne] Univ Arizona, Hlth Sci Ctr, Coll Med, Tucson, AZ USA; [Wertheimer, Anne] Univ Arizona, Hlth Sci Ctr, Bio5 Inst, Tucson, AZ USA	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences	Ahmad, N (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, Tucson, AZ 85721 USA.	nafees@email.arizona.edu	Wertheimer, Anne/ABF-7802-2021	Ahmad, Nafees/0000-0001-7717-9115	Arizona Biomedical Research Commission, Arizona Department of Health Services [ADHS14-082984]	Arizona Biomedical Research Commission, Arizona Department of Health Services	The work presented in this manuscript was supported by a grant to NA from the Arizona Biomedical Research Commission, Arizona Department of Health Services (ADHS14-082984). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work presented in this manuscript was supported by a grant to NA from the Arizona Biomedical Research Commission, Arizona Department of Health Services (ADHS14-082984). The authors thank all patients for their participation in this study. The authors also thank Shannon Smith for patient recruitment and sample collection and David Harris for PBMC isolation and storage at the Biorepository.	Adland E, 2018, AIDS, V32, P1413, DOI [10.1097/QAD.0000000000001844, 10.1097/qad.0000000000001844]; Alatrakchi N, 2005, AIDS, V19, P25, DOI 10.1097/00002030-200501030-00003; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; [Anonymous], 2018, CMCLR, V4, P17; Moro-Garcia MA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00107; Appay V, 2002, TRENDS IMMUNOL, V23, P580, DOI 10.1016/S1471-4906(02)02338-4; Balamurugan A, 2013, J VIROL, V87, P8726, DOI 10.1128/JVI.01040-13; Bauernfeind F, 2016, J IMMUNOL, V197, P2900, DOI 10.4049/jimmunol.1501336; Behrens NE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199101; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Chevalier MF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00395; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Clayton KL, 2018, NAT IMMUNOL, V19, P475, DOI 10.1038/s41590-018-0085-3; Couturier J, 2014, VIROLOGY, V462, P175, DOI 10.1016/j.virol.2014.06.008; Critchfield JW, 2007, J VIROL, V81, P5460, DOI 10.1128/JVI.02535-06; Demers KR, 2013, IMMUNOL REV, V254, P190, DOI 10.1111/imr.12069; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Frater J, 2014, AIDS, V28, P699, DOI 10.1097/QAD.0000000000000130; Freel SA, 2010, J VIROL, V84, P4998, DOI 10.1128/JVI.00138-10; Gomez-Mora E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184433; Haynes L, 2004, J IMMUNOL, V172, P5194, DOI 10.4049/jimmunol.172.9.5194; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Hong HS, 2010, J VIROL, V84, P1183, DOI 10.1128/JVI.01675-09; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Lederman MM, 2011, J INFECT DIS, V204, P1217, DOI 10.1093/infdis/jir507; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Lifson AR, 2017, AIDS, V31, P953, DOI 10.1097/QAD.0000000000001417; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Malhotra U, 2007, J VIROL, V81, P5225, DOI 10.1128/JVI.02564-06; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; Nikolich-Zugich J, 2005, J EXP MED, V201, P837, DOI 10.1084/jem.20050341; Ogg GS, 1999, J VIROL, V73, P797, DOI 10.1128/JVI.73.1.797-800.1999; Ostrowski SR, 2005, J INFECT DIS, V191, P348, DOI 10.1086/427340; Oxenius A, 2002, AIDS, V16, P2317, DOI 10.1097/00002030-200211220-00012; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Perreau M, 2013, CURR OPIN HIV AIDS, V8, P333, DOI 10.1097/COH.0b013e328361faf4; Pettersen FO, 2010, CLIN EXP IMMUNOL, V161, P315, DOI 10.1111/j.1365-2249.2010.04179.x; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Ranasinghe S, 2012, J VIROL, V86, P277, DOI 10.1128/JVI.05577-11; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Riou C, 2012, J IMMUNOL, V188, P2198, DOI 10.4049/jimmunol.1102813; RIVIERE Y, 1995, AIDS RES HUM RETROV, V11, P903, DOI 10.1089/aid.1995.11.903; Roff SR, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00498; Salti SM, 2011, J IMMUNOL, V187, P6301, DOI 10.4049/jimmunol.1100891; Schieffer M, 2014, J VIROL, V88, P7357, DOI 10.1128/JVI.00728-14; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Wood KL, 2009, FRONT BIOSCI-LANDMRK, V14, P3771, DOI [10.2741/3487, 10.2735/3487]; Yue FY, 2017, J VIROL, V91, DOI 10.1128/JVI.02233-16; Zheng B, 1997, IMMUNOL REV, V160, P63, DOI 10.1111/j.1600-065X.1997.tb01028.x; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	55	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0236320	10.1371/journal.pone.0236320	http://dx.doi.org/10.1371/journal.pone.0236320			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941433	Green Published, gold			2022-12-26	WOS:000573848800054
J	Braun, A; Evdokimov, D; Frank, J; Sommer, C; Uceyler, N				Braun, Alexandra; Evdokimov, Dimitar; Frank, Johanna; Sommer, Claudia; Ueceyler, Nurcan			MiR103a-3p and miR107 are related to adaptive coping in a cluster of fibromyalgia patients	PLOS ONE			English	Article							GENE-EXPRESSION; GERMAN VERSION; DEPRESSION; INFLAMMATION; CHILDHOOD; CRITERIA; NERVE; MIRNA	Background MicroRNA (miRNA) mainly inhibit post-transcriptional gene expression of specific targets and may modulate disease severity. Objective We aimed to identify miRNA signatures distinguishing patient clusters with fibromyalgia syndrome (FMS). Subjects and methods We previously determined four FMS patient clusters labelled "maladaptive", "adaptive", "vulnerable", and "resilient". Here, we cluster-wise assessed relative gene expression of miR103a-3p, miR107, miR130a-3p, and miR125a-5p in white blood cell (WBC) RNA of 31 FMS patients and 16 healthy controls. Sum scores of pain-, stress-, and resilience-related questionnaires were correlated with miRNA relative gene expression. A cluster-specific speculative model of a miRNA-mediated regulatory cycle was proposed, and its potential targets verified by the online tool "target scan human". Results One-way ANOVA revealed lower gene expression of miR103a-3p, miR107, and miR130a-3p in FMS patients compared to controls (p < 0.05). Follow-up post-hoc tests indicated the highest peak of gene expression of miR103a-3p for the adaptive cluster (p < 0.05), i.e. in patients with low disability in all symptom categories. Gene expression of miR103a-3p correlated with FMS related disability and miR107 with the score "physical abuse" of the trauma questionnaire (p < 0.05). Target scan identified sucrose non-fermentable serine/threonine protein kinase, nuclear factor kappa-b, cyclin dependent kinase, and toll-like receptor 4 as genetic targets of the miR103a/107 miRNA family. Conclusion We show an association between upregulated gene expression of miR103a, tendentially of miR107, and adaptive coping in FMS patients. Validation of this pair of miRNA may enable to identify a somatic resilience factor in FMS.	[Braun, Alexandra; Evdokimov, Dimitar; Frank, Johanna; Sommer, Claudia; Ueceyler, Nurcan] Univ Wurzburg, Dept Neurol, Wurzburg, Germany	University of Wurzburg	Braun, A (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.	Braun_A5@ukw.de			Evangelisches Studienwerk e.V. - Else Kroner-Fresenius-Stiftung [2014_A129]	Evangelisches Studienwerk e.V. - Else Kroner-Fresenius-Stiftung	A.B. was funded by Evangelisches Studienwerk e.V. (available from: https://www.evstudienwerk.de/english/doctoral.html) and the study is part of her doctoral thesis in the framework of the German graduate program DoloRes (available from: http://www.dolo-res.de/).The funding was the salary for her thesis therefore no grant number is available. The study was in part funded by Else Kroner-Fresenius-Stiftung (available from: https://www.ekfs.de/en).N.U. was the recipient of the grant with the grant number 2014_A129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Agarwal V, 2014, TARGETSCANHUMAN 2014; Ahonen MA, 2019, MOL CELL ENDOCRINOL, V479, P110, DOI 10.1016/j.mce.2018.09.007; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; Bjersing JL, 2015, RHEUMATOL INT, V35, P635, DOI 10.1007/s00296-014-3139-3; Bjersing JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078762; Bleckmann A, 2015, MOL ONCOL, V9, P155, DOI 10.1016/j.molonc.2014.07.023; Bohn D, 2013, J TRAUMA DISSOCIATIO, V14, P342, DOI 10.1080/15299732.2012.736930; Braun A, 2020, CLUSTERING FIB UNPUB, DOI [10.1101/2020.07.08.20148130, DOI 10.1101/2020.07.08.20148130]; Eisenberger NI, 2017, NEUROPSYCHOPHARMACOL, V42, P242, DOI 10.1038/npp.2016.141; Evdokimov D, 2019, ANN NEUROL, V86, P504, DOI 10.1002/ana.25565; Foley NH, 2012, J LEUKOCYTE BIOL, V92, P521, DOI 10.1189/jlb.0312160; Goldberg RT, 1999, DISABIL REHABIL, V21, P23, DOI 10.1080/096382899298061; Gutierrez H, 2011, TRENDS NEUROSCI, V34, P316, DOI 10.1016/j.tins.2011.03.001; Hauser W, 2011, ARTHRIT CARE RES, V63, P808, DOI 10.1002/acr.20328; Husain MI, 2017, J PSYCHOPHARMACOL, V31, P1137, DOI 10.1177/0269881117725711; Ji RR, 2016, SCIENCE, V354, P572, DOI 10.1126/science.aaf8924; Kiecolt-Glaser JK, 2015, AM J PSYCHIAT, V172, P1075, DOI 10.1176/appi.ajp.2015.15020152; Kopriva SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067760; Laux L., 1981, STATE TRAIT ANGSTINV; Leinders M, 2016, EXP NEUROL, V283, P276, DOI 10.1016/j.expneurol.2016.06.025; Leinders M, 2016, PAIN, V157, P2493, DOI 10.1097/j.pain.0000000000000668; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu QL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10116-0; Masotti A, 2017, MOL NEUROBIOL, V54, P7129, DOI 10.1007/s12035-016-0235-2; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Meyer TD, 2001, DIAGNOSTICA, V47, P208, DOI 10.1026//0012-1924.47.4.208; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Moncini S, 2017, MOL NEUROBIOL, V54, P4329, DOI 10.1007/s12035-016-0002-4; Offenbaecher M, 2000, J RHEUMATOL, V27, P1984; Olivieri F, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-11; Sarnico I, 2012, BRAIN RES, V1476, P203, DOI 10.1016/j.brainres.2012.04.013; Sommer C, 2018, PAIN, V159, P595, DOI 10.1097/j.pain.0000000000001122; Sommer C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-104; Song YQ, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0164-1; Tuarp J., 2000, QUINTESSENZ, V51, P721; Uceyler N, 2015, J NEUROL, V262, P203, DOI 10.1007/s00415-014-7556-8; Van der Auwera S, 2019, NEUROPSYCHOPHARMACOL; Varma G, 2017, NEUROTOXICOLOGY, V62, P207, DOI 10.1016/j.neuro.2017.07.002; Wang S., 2017, EL COMP EMC BEIJ 201, V4, P1; Wingenfeld K., 2010, PSYCHOTHER PSYCHOSOM, V60, pe13, DOI [DOI 10.1055/S-0030-1253494, 10.1055/s-0030-1253494]; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	43	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239286	10.1371/journal.pone.0239286	http://dx.doi.org/10.1371/journal.pone.0239286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941517	Green Published, gold			2022-12-26	WOS:000573848800002
J	Frolov, NS; Pitsik, EN; Maksimenko, VA; Grubov, VV; Kiselev, AR; Wang, Z; Hramov, AE				Frolov, Nikita S.; Pitsik, Elena N.; Maksimenko, Vladimir A.; Grubov, Vadim V.; Kiselev, Anton R.; Wang, Zhen; Hramov, Alexander E.			Age-related slowing down in the motor initiation in elderly adults	PLOS ONE			English	Article							COMPENSATORY MECHANISMS; HIPPOCAMPAL-FORMATION; OSCILLATIONS REFLECT; OLDER-ADULTS; BRAIN; THETA; EEG; IMAGERY; CONNECTIVITY; PERFORMANCE	Age-related changes in the human brain functioning crucially affect the motor system, causing increased reaction time, low ability to control and execute movements, difficulties in learning new motor skills. The lifestyle and lowered daily activity of elderly adults, along with the deficit of motor and cognitive brain functions, might lead to the developed ambidexterity, i.e., the loss of dominant limb advances. Despite the broad knowledge about the changes in cortical activity directly related to the motor execution, less is known about age-related differences in the motor initiation phase. We hypothesize that the latter strongly influences the behavioral characteristics, such as reaction time, the accuracy of motor performance, etc. Here, we compare the neuronal processes underlying the motor initiation phase preceding fine motor task execution between elderly and young subjects. Based on the results of the whole-scalp sensor-level electroencephalography (EEG) analysis, we demonstrate that the age-related slowing down in the motor initiation before the dominant hand movements is accompanied by the increased theta activation within sensorimotor area and reconfiguration of the theta-band functional connectivity in elderly adults.	[Frolov, Nikita S.; Pitsik, Elena N.; Maksimenko, Vladimir A.; Grubov, Vadim V.; Hramov, Alexander E.] Innopolis Univ, Neurosci & Cognit Technol Lab, Innopolis, The Republic Of, Russia; [Grubov, Vadim V.; Kiselev, Anton R.; Hramov, Alexander E.] Saratov State Med Univ, Saratov, Russia; [Wang, Zhen] Northwestern Polytech Univ, Xian, Shaanxi, Peoples R China	Innopolis University; Razumovsky Saratov State Medical University; Northwestern Polytechnical University	Frolov, NS (corresponding author), Innopolis Univ, Neurosci & Cognit Technol Lab, Innopolis, The Republic Of, Russia.	n.frolov@innopolis.ru	Kiselev, Anton/F-4785-2011; Grubov, Vadim/N-3511-2016; Hramov, Alexander/C-5600-2008; Frolov, Nikita/A-1166-2015; Pitsik, Elena/F-6902-2019	Kiselev, Anton/0000-0003-3967-3950; Grubov, Vadim/0000-0003-2491-2592; Hramov, Alexander/0000-0003-2787-2530; Frolov, Nikita/0000-0002-2788-1907; Pitsik, Elena/0000-0003-1850-2394	Council on grants of the President of the Russian Federation [MK-2080.2020.2, NSh2594.2020.2]; Russian Foundation for Basic Research [19-5255001]	Council on grants of the President of the Russian Federation; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	NF received funding for this work from the Council on grants of the President of the Russian Federation (Grant No. MK-2080.2020.2). AH received funding for this work from the Russian Foundation for Basic Research (Grant No. 19-5255001) and the Council on grants of the President of the Russian Federation (Grant No. NSh2594.2020.2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; [Anonymous], 2013, EC J WATCH, V10, pA1; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Berchicci M, 2012, NEUROIMAGE, V62, P1750, DOI 10.1016/j.neuroimage.2012.06.031; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; Caplan JB, 2003, J NEUROSCI, V23, P4726; Carmeli E, 2003, J GERONTOL A-BIOL, V58, P146, DOI 10.1093/gerona/58.2.M146; Carp J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029411; Cruikshank LC, 2012, J NEUROPHYSIOL, V107, P65, DOI 10.1152/jn.00893.2010; Dahan A, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00238; Dushanova J, 2014, ADV MED SCI-POLAND, V59, P61, DOI 10.1016/j.advms.2013.08.002; Fernandez-Ruiz J, 2018, NEUROIMAGE, V165, P92, DOI 10.1016/j.neuroimage.2017.10.001; Frolov N, EEG DATASET ANAL AGE; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Gruzelier J, 2009, COGN PROCESS, V10, pS101, DOI 10.1007/s10339-008-0248-5; Hall SD, 2011, NEUROIMAGE, V56, P1506, DOI 10.1016/j.neuroimage.2011.02.025; Hall SD, 2010, HUM BRAIN MAPP, V31, P581, DOI 10.1002/hbm.20889; Hamedi M, 2016, NEURAL COMPUT, V28, P999, DOI 10.1162/NECO_a_00838; Heinrichs-Graham E, 2016, NEUROIMAGE, V134, P514, DOI 10.1016/j.neuroimage.2016.04.032; Heinrichs-Graham E, 2016, J COGNITIVE NEUROSCI, V28, P1039, DOI 10.1162/jocn_a_00948; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Ikkai A, 2011, NEUROPSYCHOLOGIA, V49, P1428, DOI 10.1016/j.neuropsychologia.2010.12.020; JASP Team, 2020, JASP VERS 0 12; Kalisch T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000090; Kardos Z, 2014, NEUROSCIENCE, V273, P152, DOI 10.1016/j.neuroscience.2014.04.071; Kuhn AA, 2004, BRAIN, V127, P735, DOI 10.1093/brain/awh106; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Leisman G, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00094; Liu LQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187911; Maes C, 2017, NEUROSCI BIOBEHAV R, V75, P234, DOI 10.1016/j.neubiorev.2017.01.052; Maksimenko VA, 2018, NONLINEAR DYNAM, V91, P2803, DOI 10.1007/s11071-018-4047-y; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Nuwer MR, 1998, ELECTROEN CLIN NEURO, V106, P259, DOI 10.1016/S0013-4694(97)00106-5; Oddie SD, 1998, NEUROSCI BIOBEHAV R, V22, P221, DOI 10.1016/S0149-7634(97)00003-1; Papegaaij S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00028; Perfetti B, 2011, J NEUROPHYSIOL, V105, P18, DOI 10.1152/jn.00778.2010; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pitsik E, 2020, CHAOS, V30, DOI 10.1063/1.5136246; PRICHEP LS, 1994, NEUROBIOL AGING, V15, P85, DOI 10.1016/0197-4580(94)90147-3; Quentin R, 2019, NAT NEUROSCI, V22, P686, DOI 10.1038/s41593-019-0386-3; Reiner M, 2018, NEUROSCIENCE, V378, P198, DOI 10.1016/j.neuroscience.2017.07.022; Reiner M, 2014, BIOL PSYCHOL, V95, P45, DOI 10.1016/j.biopsycho.2013.10.010; Reuter-Lorenz PA, 2014, NEUROPSYCHOL REV, V24, P355, DOI 10.1007/s11065-014-9270-9; Riecker A, 2006, NEUROIMAGE, V32, P1345, DOI 10.1016/j.neuroimage.2006.05.021; Rossiter HE, 2014, NEUROIMAGE, V91, P360, DOI 10.1016/j.neuroimage.2014.01.012; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Sepp S, 2019, EDUC PSYCHOL REV, P1; Smith CD, 1999, NEUROLOGY, V53, P1458, DOI 10.1212/WNL.53.7.1458; Sorond FA, 2015, J GERONTOL A-BIOL, V70, P1526, DOI 10.1093/gerona/glv130; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stomrud E, 2010, NEUROBIOL AGING, V31, P215, DOI 10.1016/j.neurobiolaging.2008.03.025; Tomassini A, 2017, ELIFE, V6, DOI 10.7554/eLife.25618; Tombini M, 2009, NEUROIMAGE, V47, P1735, DOI 10.1016/j.neuroimage.2009.04.046; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Ward NS, 2006, AGEING RES REV, V5, P239, DOI 10.1016/j.arr.2006.04.003; Xifra-Porxas A, 2019, NEUROIMAGE, V201, DOI 10.1016/j.neuroimage.2019.116037; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	63	12	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0233942	10.1371/journal.pone.0233942	http://dx.doi.org/10.1371/journal.pone.0233942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32937652	Green Submitted, Green Published, gold			2022-12-26	WOS:000573658000009
J	Lawes, JC; Rijksen, EJT; Brander, RW; Franklin, RC; Daw, S				Lawes, Jasmin C.; Rijksen, Eveline J. T.; Brander, Robert W.; Franklin, Richard C.; Daw, Shane			Dying to help: Fatal bystander rescues in Australian coastal environments	PLOS ONE			English	Article							RIP CURRENT FATALITIES; SEA-BREEZE; BEACHES; RESUSCITATION; DEATHS; MEN	Bystanders who drown during a rescue attempt in aquatic waterways are becoming an increasingly important issue within drowning prevention. In the Australian context, the majority of these incidents occur in coastal water ways. This study documents and characterizes bystander rescuer fatalities within Australian coastal waterways that occurred between 1 July 2004 and 30 June 2019 in order to provide suggestions for future public safety interventions involving bystander rescuers. Data was sourced through Surf Life Saving Australia's (SLSA) Coastal Fatality Database, which collates information from multiple sources. Sixty-seven bystander rescuer fatalities in coastal waterways were reported during the 15-year period, an average of 4.5 per year, which is a significant proportion of the five fatalities previously reported across all Australian waterways. The majority of coastal bystander rescuer fatality incidents occurred in the state of New South Wales (49%), at beaches (64%), in regional or remote areas (71%), more than 1 km from the nearest lifesaving service (78%), during summer (45%), in the afternoon (72%), in the presence of rip currents (73%), and did not involve the use of flotation devices to assist rescue (97%). The majority of coastal bystander rescuer victims were Australian residents (88%) born in Australia/Oceania (68%), males (81%), aged between 30-44 years old (36%), visitors to the location (55%), either family (69%) or friends (15%) of the rescuee(s), and were attempting to rescue someone younger than 18 years old (64%). Our results suggest future safety intervention approaches should target males, parents and carers visiting beach locations in regional locations during holiday times and should focus on the importance of flotation devices when enacting a rescue and further educating visitors about the rip current hazard. Future research should examine the psychology of bystander rescue situations and evaluate the effectiveness of different safety intervention approaches.	[Lawes, Jasmin C.; Rijksen, Eveline J. T.; Daw, Shane] Surf Life Saving Australia, Sydney, NSW, Australia; [Lawes, Jasmin C.; Brander, Robert W.] UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Lawes, Jasmin C.; Franklin, Richard C.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia	University of New South Wales Sydney; James Cook University	Lawes, JC (corresponding author), Surf Life Saving Australia, Sydney, NSW, Australia.; Lawes, JC (corresponding author), UNSW Sydney, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.; Lawes, JC (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia.	jlawes@slsa.asn.au	Brander, Robert/GZH-3081-2022; Lawes, Jasmin/S-2025-2019	Lawes, Jasmin/0000-0002-6652-3053; Daw, Shane/0000-0003-0904-3632; Brander, Robert/0000-0002-7268-2587				Arozarena I, 2015, NAT HAZARDS, V77, P753, DOI 10.1007/s11069-015-1626-9; Attard A, 2015, ACCIDENT ANAL PREV, V82, P70, DOI 10.1016/j.aap.2015.05.017; Australia RLSS, 2019, ROYAL LIF SAV NAT DR; Australian Bureau of Statistics, 2019, AUSTR DEM STAT; Barlas B, 2016, NAT HAZARDS, V80, P811, DOI 10.1007/s11069-015-1998-x; Brander RW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212349; Brannstrom C, 2015, APPL GEOGR, V56, P61, DOI 10.1016/j.apgeog.2014.10.011; Brighton B, 2013, NAT HAZARD EARTH SYS, V13, P1069, DOI 10.5194/nhess-13-1069-2013; Brookes A., 2004, AUSTR J OUTDOOR ED, V8, P44; Castelle B, 2016, EARTH-SCI REV, V163, P1, DOI 10.1016/j.earscirev.2016.09.008; Cooney N., 2019, COASTAL SAFETY BRIEF; Franklin R, 2014, DROWNING PREVENTION, P419; Franklin RC, 2010, INJURY PREV, V16, pA81, DOI 10.1136/ip.2010.029215.294; Franklin RC, 2019, AUST NZ J PUBL HEAL, V43, P477, DOI 10.1111/1753-6405.12900; Franklin RC, 2011, J PAEDIATR CHILD H, V47, P44, DOI 10.1111/j.1440-1754.2010.01889.x; French MT, 2015, ECON INQ, V53, P745, DOI 10.1111/ecin.12157; Gensini VA, 2010, NAT HAZARDS, V54, P159, DOI 10.1007/s11069-009-9458-0; Health AGDo, 2019, DOCT LOC 2016; Houser C, 2017, NAT HAZARD EARTH SYS, V17, P1003, DOI 10.5194/nhess-17-1003-2017; Howland J, 1996, AM J PUBLIC HEALTH, V86, P93, DOI 10.2105/AJPH.86.1.93; Leggat PA, 2009, J TRAVEL MED, V16, P243, DOI 10.1111/j.1708-8305.2009.00302.x; MacCool J., 2008, INT J AQUAT RES ED, V2, DOI [10.25035/ijare.02.01.02, DOI 10.25035/IJARE.02.01.02]; Mackie IJ, 1999, MED J AUSTRALIA, V171, P587, DOI 10.5694/j.1326-5377.1999.tb123808.x; Masselink G, 1998, MAR GEOL, V146, P115, DOI 10.1016/S0025-3227(97)00121-7; Masselink G, 2001, J COASTAL RES, V17, P173; Matthews B, 2014, SAFETY SCI, V62, P312, DOI 10.1016/j.ssci.2013.09.003; McKay C, 2014, TOURISM MANAGE, V45, P71, DOI 10.1016/j.tourman.2014.03.007; Menard AD, 2018, NAT HAZARDS, V94, P953, DOI 10.1007/s11069-018-3424-7; Moran K, 2010, INT J AQUAT RES ED, V4, P115, DOI [10.25035/ijare.04.02.03, DOI 10.25035/IJARE.04.02.03]; Moran K., 2013, INT J AQUAT RES ED, V7, P290; Moran K, 2017, INT J INJ CONTROL SA, V24, P396, DOI 10.1080/17457300.2016.1224904; Moran K, 2011, ANN LEIS RES, V14, P260, DOI 10.1080/11745398.2011.615719; Optimal therapy report, 2009, CAN AGENCY DRUGS TEC, V3, pe0101; Orlowski JP, 2001, PEDIATR CLIN N AM, V48, P627, DOI 10.1016/S0031-3955(05)70331-X; Pearn JH, 2012, INT J AQUAT RES ED, V6, DOI 10.25035/ijare.06.04.07; Pearn JH., 2009, INT J AQUAT RES ED, V3, DOI [10.25035/ijare.03.03.09, DOI 10.25035/IJARE.03.03.09]; Peden AE, 2020, J PAEDIATR CHILD H, V56, P450, DOI 10.1111/jpc.14668; Peden AE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6256-1; Pidgeon S., 2018, 10 YEAR NATL STUDY O; Short AD, 2007, J COASTAL RES, P7; Short AD, 2007, AUSTR BEACH SAFETY M; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; SLSA, 2016, NAT COAST SAF REP 20; Surf Life Saving Australia, 2019, NAT COAST SAF REP; Surf Life Saving Australia (SLSA), 2018, NAT COAST SAF REP 20; Szpilman D, 2014, RESUSCITATION, V85, P1149, DOI 10.1016/j.resuscitation.2014.05.034; Turgut A, 2012, J SAFETY RES, V43, P129, DOI 10.1016/j.jsr.2012.05.001; Venema AM, 2010, RESUSCITATION, V81, P434, DOI 10.1016/j.resuscitation.2010.01.005; WHO, 2020, DROWN FACT SHEET WHO; WHO, 2017, PREV DROWN IMPL GUID; Wilks J., 2003, J HOSP TOUR MANAG, V10, P79; Willcox-Pidgeon SM, 2020, INJURY PREVENTION; World Health Organization (WHO), 2014, GLOB REP DROWN PREV; 2015, SEWAGE DISPOSAL CLOV, V0015, pE631	54	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238317	10.1371/journal.pone.0238317	http://dx.doi.org/10.1371/journal.pone.0238317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936817	gold, Green Published, Green Accepted			2022-12-26	WOS:000573658000010
J	Harke, NN; Radtke, JP; Hadaschik, BA; Bach, C; Berger, FP; Blana, A; Borgmann, H; Distler, FA; Edeling, S; Egner, T; Engels, CL; Farzat, M; Haese, A; Hein, R; Kuczyk, MA; Manseck, A; Moritz, R; Musch, M; Peters, I; Pokupic, S; Rocco, B; Schneider, A; Schumann, A; Schwentner, C; Sighinolfi, CM; Buse, S; Stolzenburg, JU; Truss, MC; Waldner, M; Wulfing, C; Zimmermanns, V; Witt, JH; Wagner, C				Harke, Nina N.; Radtke, Jan P.; Hadaschik, Boris A.; Bach, Christian; Berger, Frank P.; Blana, Andreas; Borgmann, Hendrik; Distler, Florian A.; Edeling, Sebastian; Egner, Tobias; Engels, Christina L.; Farzat, Mahmoud; Haese, Alexander; Hein, Rainer; Kuczyk, Markus A.; Manseck, Andreas; Moritz, Rudolf; Musch, Michael; Peters, Inga; Pokupic, Sasa; Rocco, Bernardo; Schneider, Andreas; Schumann, Andre; Schwentner, Christian; Sighinolfi, Chiara M.; Buse, Stephan; Stolzenburg, Jens-Uwe; Truss, Michael C.; Waldner, Michael; Wuelfing, Christian; Zimmermanns, Volker; Witt, Joern H.; Wagner, Christian			To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic	PLOS ONE			English	Article							IMPACT; SMOKE	Introduction After the outbreak of COVID-19 unprecedented changes in the healthcare systems worldwide were necessary resulting in a reduction of urological capacities with postponements of consultations and surgeries. Material and methods An email was sent to 66 urological hospitals with focus on robotic surgery (RS) including a link to a questionnaire (e.g. bed/staff capacity, surgical caseload, protection measures during RS) that covered three time points: a representative baseline week prior to COVID-19, the week of March 16(th)-22(nd)and April 20(th)-26(th)2020. The results were evaluated using descriptive analyses. Results 27 out of 66 questionnaires were analyzed (response rate: 41%). We found a decrease of 11% in hospital beds and 25% in OR capacity with equal reductions for endourological, open and robotic procedures. Primary surgical treatment of urolithiasis and benign prostate syndrome (BPS) but also of testicular and penile cancer dropped by at least 50% while the decrease of surgeries for prostate, renal and urothelial cancer (TUR-B and cystectomies) ranged from 15 to 37%. The use of personal protection equipment (PPE), screening of staff and patients and protection during RS was unevenly distributed in the different centers-however, the number of COVID-19 patients and urologists did not reach double digits. Conclusion The German urological landscape has changed since the outbreak of COVID-19 with a significant shift of high priority surgeries but also continuation of elective surgical treatments. While screening and staff protection is employed heterogeneously, the number of infected German urologists stays low.	[Harke, Nina N.; Kuczyk, Markus A.; Peters, Inga] Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany; [Radtke, Jan P.; Hadaschik, Boris A.] Univ Duisburg Essen, Dept Urol, Essen, Germany; [Bach, Christian] Rhein Westfal TH Aachen, Dept Urol, Aachen, Germany; [Berger, Frank P.] Univ Jena, Dept Urol, Jena, Germany; [Blana, Andreas] Furth Hosp, Dept Urol, Furth, Germany; [Borgmann, Hendrik] Johannes Gutenberg Univ Mainz, Dept Urol, Med Ctr, Mainz, Germany; [Distler, Florian A.] Paracelsus Med Univ, Dept Urol, Nurnberg, Germany; [Edeling, Sebastian] Da Vinci Zentrum, Dept Urol, Hannover, Germany; [Egner, Tobias] Klinikum Wurzburg Mitte, Dept Urol, Wurzburg, Germany; [Engels, Christina L.] Municipal Hosp Karlsruhe, Dept Urol, Karlsruhe, Germany; [Farzat, Mahmoud] Diakonie Klinikum, Dept Urol, Siegen, Germany; [Haese, Alexander] Univ Clin Hamburg Eppendorf, Martini Klin, Prostate Canc Ctr, Hamburg, Germany; [Hein, Rainer] Klinikum Magdeburg, Dept Urol, Magdeburg, Germany; [Manseck, Andreas] Klinikum Ingolstadt, Dept Urol, Ingolstadt, Germany; [Moritz, Rudolf] Ruhr Univ Bochum, Marien Hosp, Dept Urol, Herne, Germany; [Musch, Michael] Kliniken Essen Mitte, Dept Urol Pediat Urol & Urol Oncol, Essen, Germany; [Pokupic, Sasa] Asklepios Klinikum Harburg, Dept Urol, Hamburg, Germany; [Rocco, Bernardo; Sighinolfi, Chiara M.] Univ Modena & Reggio Emilia, Dept Urol, Modena, Italy; [Schneider, Andreas] Main Kinzig Kliniken Standort Gelnhausen, Dept Urol, Gelnhausen, Germany; [Schumann, Andre] Martin Luther Univ Halle Wittenberg, Dept Urol & Kidney Transplantat, Halle, Saale, Germany; [Schwentner, Christian] Diakonieklinikum Stuttgart, Dept Urol, Stuttgart, Germany; [Buse, Stephan] Alfried Krupp Hosp, Dept Urol & Urol Oncol, Essen, Germany; [Stolzenburg, Jens-Uwe] Univ Leipzig, Dept Urol, Leipzig, Germany; [Truss, Michael C.] Klinikum Dortmund, Dept Urol, Dortmund, Germany; [Waldner, Michael] St Elisabeth Krankenhaus Koln Hohenlind, Dept Urol, Cologne, Germany; [Wuelfing, Christian] Asklepios Klin Altona, Dept Urol, Hamburg, Germany; [Zimmermanns, Volker] Siloah St Trudpert Klinikum, Dept Urol, Pforzheim, Germany; [Witt, Joern H.; Wagner, Christian] St Antonius Hosp Gronau, Prostate Ctr Northwest, Dept Urol Pediat Urol & Urol Oncol, Gronau, Germany	Hannover Medical School; University of Duisburg Essen; RWTH Aachen University; Friedrich Schiller University of Jena; Johannes Gutenberg University of Mainz; Municipal Hospital Karlsruhe; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ruhr University Bochum; St. Marien Hospital; Kliniken Essen-Mitte; Universita di Modena e Reggio Emilia; Martin Luther University Halle Wittenberg; Alfried Krupp Hospital; Leipzig University; Klinikum Dortmund; Asklepios Klinik Altona	Harke, NN (corresponding author), Hannover Med Sch, Dept Urol & Urol Oncol, Hannover, Germany.	harkenina@gmail.com		Harke, Nina N./0000-0002-6154-7101				[Anonymous], 2013, Jt Comm Perspect, V33, P12; [Anonymous], 1991, JB BERLINER MUSEEN, V33, P47; [Anonymous], 2004, OBESITY RES S2, p51S; FERENCZY A, 1990, OBSTET GYNECOL, V75, P114; Francis N, 2020, SURG ENDOSC, V34, P2327, DOI 10.1007/s00464-020-07565-w; Garcia S, 2020, J AM COLL CARDIOL, V75, P2871, DOI 10.1016/j.jacc.2020.04.011; Gravas S, 2020, EUR UROL FOCUS, V6, P1104, DOI 10.1016/j.euf.2020.06.006; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Kwak HD, 2016, OCCUP ENVIRON MED, V73, P857, DOI 10.1136/oemed-2016-103724; Lei S, 2020, ECLINICALMEDICINE, V2020, DOI 10.1016/j.eclinm.2020.100363; Lei Shaoqing, 2020, EClinicalMedicine, V21, P100331, DOI 10.1016/j.eclinm.2020.100331; Mantica G, 2020, PUBLIC HEALTH, V183, P40, DOI 10.1016/j.puhe.2020.04.046; Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746; Novara G, 2020, BJU INT, V126, P245, DOI 10.1111/bju.15107; Nunoo-Mensah JW, 2020, CLIN COLORECTAL CANC, V19, P178, DOI 10.1016/j.clcc.2020.05.011; Oderda M, 2020, EUR UROL, V78, P124, DOI 10.1016/j.eururo.2020.04.036; Paffenholz P, 2020, EUR UROL FOCUS, V6, P1111, DOI 10.1016/j.euf.2020.06.001; Patriti A, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00314-3; Porter J, 2020, BJU INT, V126, P225, DOI 10.1111/bju.15105; Ribal MJ, 2020, EUR UROL, V78, P21, DOI 10.1016/j.eururo.2020.04.056; Rocco B, 2021, BJU INT, V127, P56, DOI 10.1111/bju.15149; Rodriguez-Leor Oriol, 2020, JACC Case Rep, V2, P1625, DOI 10.1016/j.jaccas.2020.04.011; Sobel D, 2020, UROLOGY, V141, P1, DOI 10.1016/j.urology.2020.04.083; Teoh JYC, 2020, EUR UROL, V78, P265, DOI 10.1016/j.eururo.2020.05.025; Wallis CJD, 2020, EUR UROL, V78, P29, DOI 10.1016/j.eururo.2020.04.063; Wurnschimmel C, 2020, BJU INT, V126, P252, DOI 10.1111/bju.15115; Zheng MH, 2020, ANN SURG, V272, pE5, DOI 10.1097/SLA.0000000000003924	29	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239027	10.1371/journal.pone.0239027	http://dx.doi.org/10.1371/journal.pone.0239027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931510	gold, Green Published			2022-12-26	WOS:000573375500010
J	Ornaghi, S; Callegari, C; Milazzo, R; La Milia, L; Brunetti, F; Lubrano, C; Tasca, C; Livio, S; Savasi, VM; Cetin, I; Vergani, P				Ornaghi, Sara; Callegari, Clelia; Milazzo, Roberta; La Milia, Laura; Brunetti, Federica; Lubrano, Chiara; Tasca, Chiara; Livio, Stefania; Savasi, Valeria Maria; Cetin, Irene; Vergani, Patrizia			Performance of an extended triage questionnaire to detect suspected cases of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in obstetric patients: Experience from two large teaching hospitals in Lombardy, Northern Italy	PLOS ONE			English	Article							SYMPTOMATIC PREGNANT-WOMEN; COVID-19	Objectives 1. To assess the performance of an extended questionnaire in identifying cases of SARS-CoV-2 infection among obstetric patients. 2. To evaluate the rate of infection among healthcare workers involved in women's care. Study design A prospective cohort study of obstetric patients admitted to MBBM Foundation and Buzzi Hospital (Lombardy, Northern Italy) from March 16(th)to May 22(nd), 2020. Women were screened on admission by a questionnaire investigating major and minor symptoms of infection and high-risk contacts in the last 14 days. SARS-CoV-2 assessment was performed by RT-PCR on nasopharyngeal swabs. Till April 7(th), a targeted SARS-CoV-2 testing triggered by a positive questionnaire was used; from April 8(th), a universal testing approach was implemented. Results There were 1,177 women screened by the questionnaire, which yielded a positive result in 130 (11.0%) cases. SARS-CoV-2 RT-PCR was performed in 865 (73.5%) patients, identifying 51 (5.9%) infections. During the first period, there were 29 infected mothers, 4 (13.8%) of whom had a negative questionnaire. After universal testing implementation, there were 22 (3%, 95% CI 1.94% - 4.04%) infected mothers, 13 (59.1%) of whom had a negative questionnaire; rate of infection among asymptomatic women was 1.9%. Six of the 17 SARS-CoV-2-positive women with a negative questionnaire reported symptoms more than 14 but within 30 days before admission. Isolated olfactory or taste disorders were identified in 15.7% of infected patients. Rate of infection among healthcare workers was 5.8%. Conclusions An exhaustive triage questionnaire can effectively discriminate women at low risk of SARS-CoV-2 infection in the context of a targeted and a universal viral testing approach. In 15.7% of infected women, correct classification as a suspected case of infection was due to investigation of olfactory and taste disorders. Extension of the assessed time-frame to 30 days may be worth considering to increase the questionnaire's performance.	[Ornaghi, Sara; Callegari, Clelia; La Milia, Laura; Brunetti, Federica; Vergani, Patrizia] San Gerardo Hosp, MBBM Fdn, Div Obstet, Dept Obstet & Gynecol, Monza, Italy; [Ornaghi, Sara; La Milia, Laura; Brunetti, Federica; Vergani, Patrizia] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Milazzo, Roberta; Lubrano, Chiara; Tasca, Chiara; Livio, Stefania; Savasi, Valeria Maria; Cetin, Irene] Univ Milan, Dept Clin & Biol Sci, Milan, Italy; [Milazzo, Roberta; Lubrano, Chiara; Tasca, Chiara; Livio, Stefania; Cetin, Irene] Buzzi Childrens Hosp, ASST Fatebenefratelli Sacco, Dept Woman Mother & Neonate, Milan, Italy; [Savasi, Valeria Maria] Sacco Hosp, Dept Woman Mother & Neonate, ASST Fatebenefratelli Sacco, Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Milan; University of Milan; Luigi Sacco Hospital	Ornaghi, S (corresponding author), San Gerardo Hosp, MBBM Fdn, Div Obstet, Dept Obstet & Gynecol, Monza, Italy.; Ornaghi, S (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Monza, Italy.	sara.ornaghi@unimib.it	Ornaghi, Sara/K-4261-2018; Ornaghi, Sara/GXW-2481-2022; cetin, irene/K-6112-2016	Ornaghi, Sara/0000-0001-6898-7217; cetin, irene/0000-0002-9217-3034				Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bahado-Singh R., 2020, TRIAGE L D POSTPARTU; Breslin N, 2020, AM J OBSTET GYNECOL, DOI [10.1016/j.ajogmf.2020.100118, DOI 10.1016/J.AJOGMF.2020.100118]; Buonsenso D, 2020, LANCET RESP MED, V8, pE27, DOI 10.1016/S2213-2600(20)30120-X; Chan KH, 2004, EMERG INFECT DIS, V10, P294, DOI 10.3201/eid1002.030610; Control KCfD, 2020, FIND INV AN RE POS C; Dipartimento Protezione Civile, 2020, COVID 19 IT MON SIT; Duffy CR, 2020, OBSTET GYNECOL, V136, P229, DOI 10.1097/AOG.0000000000003984; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Gautier JF, 2020, OBESITY, V28, P848, DOI 10.1002/oby.22809; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Heatlh Emergencies Preparedness and Response WHO Global, 2020, ADV US MASKS CONT CO, P16; Hopkins C, 2020, RHINOLOGY, V58, P295, DOI 10.4193/Rhin20.116; Hunter E, 2020, LANCET, V395, pE77, DOI 10.1016/S0140-6736(20)30970-3; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Joseph A., 2020, WE DONT ACTUALLY HAV; Joynt GM, 2020, LANCET INFECT DIS, V20, P635, DOI 10.1016/S1473-3099(20)30237-1; Kalafat E, 2020, ULTRASOUND OBST GYN, V55, P835, DOI 10.1002/uog.22034; Khalil A, 2020, AM J OBSTET GYNECOL, V223, P296, DOI 10.1016/j.ajog.2020.05.005; Khalil A, 2021, LANCET INFECT DIS, V21, P23, DOI 10.1016/S1473-3099(20)30403-5; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Menni C, 2020, LANCET, V395, pE107, DOI 10.1016/S0140-6736(20)31281-2; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Metz TD, 2020, OBSTET GYNECOL, V136, P227, DOI 10.1097/AOG.0000000000003972; Miller ES, 2020, OBSTET GYNECOL, V136, P232, DOI 10.1097/AOG.0000000000003983; Moro F, 2020, ULTRASOUND OBST GYN, V55, P593, DOI 10.1002/uog.22028; Naqvi M, 2020, OBSTET GYNECOL, V136, P235, DOI 10.1097/AOG.0000000000003987; New York City Department of Public Health, 2020, COR DIS 2019 COVID 1; Oza S, 2017, EMERG INFECT DIS, V23, P1792, DOI 10.3201/eid2311.170171; Poon LC, 2020, ULTRASOUND OBST GYN, V55, P848, DOI 10.1002/uog.22061; Poon LC, 2020, ULTRASOUND OBST GYN, V55, P700, DOI 10.1002/uog.22013; Ralli M, 2020, EUR REV MED PHARMACO, V24, P3440, DOI 10.26355/eurrev_202004_20797; Savasi VM, 2020, OBSTET GYNECOL, V136, P252, DOI 10.1097/AOG.0000000000003979; Sutton D, 2020, NEW ENGL J MED, V382, P2163, DOI 10.1056/NEJMc2009316; Tassis B, 2020, INT J GYNECOL OBSTET, V150, P124, DOI 10.1002/ijgo.13191; Vaira LA, 2020, BRIT J ORAL MAX SURG, V58, P615, DOI 10.1016/j.bjoms.2020.04.024; Vintzileos WS, 2020, AM J OBSTET GYNECOL, V223, P284, DOI 10.1016/j.ajog.2020.04.024; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Yang RR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10182	41	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239173	10.1371/journal.pone.0239173	http://dx.doi.org/10.1371/journal.pone.0239173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931524	Green Published, gold			2022-12-26	WOS:000573375500016
J	Mori, S; Ai, T; Otomo, Y				Mori, Shusuke; Ai, Tomohiko; Otomo, Yasuhiro			Characteristics, laboratories, and prognosis of severe COVID-19 in the Tokyo metropolitan area: A retrospective case series	PLOS ONE			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION	The impact of the COVID-19 pandemic has been immense, while the epidemiology and pathophysiology remain unclear. Despite many casualties in many countries, there have been less than 1,000 deaths in Japan as of end of June, 2020. In this study, we analyzed the cases of COVID-19 patients admitted to our institution located in the Tokyo metropolitan area where the survival rate is higher than those in other cities in the world. Medical records of COVID-19 patients that were admitted to a single Japanese tertiary university hospital in the Tokyo metropolitan area between March 10th and June 2nd, 2020 were retrospectively reviewed. The identified COVID-19 cases were subdivided into two groups (severe and mild) depending on the need for mechanical ventilation. Those in the severe group required mechanical ventilation as opposed to those in the mild group. The data were analyzed using nonparametric tests expressed by median [interquartile range (IQR)]. A total of 45 COVID-19 patients were included, consisting of 22 severe cases (Group S) and 23 mild cases (Group M). Male sex (Group S, 95.5% vs. Group M, 56.5%, p<0.01), high body mass index (Group S, 24.89 [22.44-27.15] vs. Group M, 21.43 [19.05-23.75], p<0.01), and hyperlipidemia (Group S, 36.4% vs. Group M, 0%, p<0.01) were more seen in Group S. Five (22.7%) cases in Group S underwent extracorporeal membranous oxygenation (ECMO). On admission, lymphopenia, decreased albumin, and elevated fibrinogen, lactate dehydrogenase, transaminases, creatine kinase, C-reactive protein, and procalcitonin were observed in Group S. The median ICU and hospital stay were 13.5 [10.3-22.3] days and 23.0 [16.3-30.5] days, respectively, in Group S. As of June 28th, 2020, in Group S, 19 (86.4%) patients have survived, of which 17 (77.3%) were discharged, and 2 are still in treatments. Three died of multiple organ failure. All 23 patients in Group M have recovered. Male sex, high body mass index, and hyperlipidemia can be risk factors for severe COVID-19 pneumonia, and its overall short-term survival rate was between 77.3% and 86.4% in this study.	[Mori, Shusuke; Ai, Tomohiko; Otomo, Yasuhiro] Tokyo Med & Dent Univ, Dept Acute Crit Care & Disaster Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Mori, S (corresponding author), Tokyo Med & Dent Univ, Dept Acute Crit Care & Disaster Med, Tokyo, Japan.	shunasu@yahoo.co.jp		Ai, Tomohiko/0000-0003-0376-0227				Aiolfi A, 2020, ANN THORAC SURG, V110, pE413, DOI 10.1016/j.athoracsur.2020.04.011; Akel T, 2020, THROMB RES, V193, P79, DOI 10.1016/j.thromres.2020.05.033; Allen HL, 2020, JAMA-J AM MED ASSOC, V324, P135, DOI 10.1001/jama.2020.10553; [Anonymous], 2020, LANCET, V395, pE102, DOI 10.1016/S0140-6736(20)31290-3; [Anonymous], 2020, ASAIO J, DOI DOI 10.1097/MAT.0000000000001193; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Baj J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061753; Barrasa H, 2020, ANAESTH CRIT CARE PA, V39, P553, DOI 10.1016/j.accpm.2020.04.001; Conway MJ, 2020, J MED VIROL, V92, P1629, DOI 10.1002/jmv.25751; Crump A, 2020, QJM-INT J MED, V113, P455, DOI 10.1093/qjmed/hcaa181; Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012; Du BX, 2020, INFLAMMATION, V43, P1110, DOI 10.1007/s10753-020-01198-w; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Forster P, 2020, P NATL ACAD SCI USA, V117, P9241, DOI 10.1073/pnas.2004999117; Harvey MJ, 2015, APPL HEALTH ECON HEA, V13, P341, DOI 10.1007/s40258-015-0170-9; HAYDEN WR, 1993, AM J NEURORADIOL, V14, P604; Heidary F, 2020, J ANTIBIOT, V73, P593, DOI 10.1038/s41429-020-0336-z; Hernandez AV, 2020, ANN INTERN MED, V173, P287, DOI 10.7326/M20-2496; Iwabuchi K, 2020, J INFECT CHEMOTHER, V26, P625, DOI 10.1016/j.jiac.2020.04.007; Ledford H, 2020, NATURE, V582, P160, DOI 10.1038/d41586-020-01695-w; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Vega JML, 2020, EMERG RADIOL, V27, P727, DOI 10.1007/s10140-020-01806-0; Ma AJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03007-0; MacLaren G, 2020, JAMA-J AM MED ASSOC, V323, P1245, DOI 10.1001/jama.2020.2342; Mazzoni A, 2020, J CLIN INVEST, V130, P4694, DOI [10.1172/JCI138554., 10.1172/JCI138554]; Mishra V, 2010, EUR J CARDIO-THORAC, V37, P339, DOI 10.1016/j.ejcts.2009.06.059; Miyasaka M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012661; National Institute of Infectious Diseases of Japan, 2020, MAN DET PATH 2019 NC; Organization for Economic Cooperation and Development, 2017, HLTH SPEND IND, DOI [10.1787/8643de7--en, DOI 10.1787/8643DE7--EN, 10.1787/8643de7e-en, DOI 10.1787/8643DE7E-EN]; Panagopoulos P, 2021, J CHEMOTHERAPY, V33, P193, DOI 10.1080/1120009X.2020.1775424; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rubin EJ, 2020, NEW ENGL J MED, V382, P2464, DOI 10.1056/NEJMe2020822; Ryu S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020006; Sharma A, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106054; Spiro JE, 2020, INFECTION, V48, P941, DOI 10.1007/s15010-020-01457-w; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; ten Doesschate T, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04389-w; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Ucpinar BA, 2020, J INFECT PUBLIC HEAL, V13, P887, DOI 10.1016/j.jiph.2020.05.012; WHO, COR DIS COVID 19 202; Yang X, 2020, CRIT CARE MED, V48, P1289, DOI 10.1097/CCM.0000000000004447; Zeng YC, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2840-8; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	43	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239644	10.1371/journal.pone.0239644	http://dx.doi.org/10.1371/journal.pone.0239644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970757	Green Published, gold			2022-12-26	WOS:000576265600055
J	Chandramouleeswaran, PM; Guha, M; Shimonosono, M; Whelan, KA; Maekawa, H; Sachdeva, UM; Ruthel, G; Mukherjee, S; Engel, N; Gonzalez, MV; Garifallou, J; Ohashi, S; Klein-Szanto, AJ; Mesaros, CA; Blair, IA; da Silva, RP; Hakonarson, H; Noguchi, E; Baur, JA; Nakagawa, H				Chandramouleeswaran, Prasanna M.; Guha, Manti; Shimonosono, Masataka; Whelan, Kelly A.; Maekawa, Hisatsugu; Sachdeva, Uma M.; Ruthel, Gordon; Mukherjee, Sarmistha; Engel, Noah; Gonzalez, Michael, V; Garifallou, James; Ohashi, Shinya; Klein-Szanto, Andres J.; Mesaros, Clementina A.; Blair, Ian A.; da Silva, Renata Pellegrino; Hakonarson, Hakon; Noguchi, Eishi; Baur, Joseph A.; Nakagawa, Hiroshi			Autophagy mitigates ethanol-induced mitochondrial dysfunction and oxidative stress in esophageal keratinocytes	PLOS ONE			English	Article							PROTEIN-KINASE; CELL-DEATH; ALCOHOL; LIVER; TRANSIT; DNA; MECHANISM; APOPTOSIS; SYSTEM; DAMAGE	During alcohol consumption, the esophageal mucosa is directly exposed to high concentrations of ethanol (EtOH). We therefore investigated the response of normal human esophageal epithelial cell lines EPC1, EPC2 and EPC3 to acute EtOH exposure. While these cells were able to tolerate 2% EtOH for 8 h in both three-dimensional organoids and monolayer culture conditions, RNA sequencing suggested that EtOH induced mitochondrial dysfunction. With EtOH treatment, EPC1 and EPC2 cells also demonstrated decreased mitochondrial ATPB protein expression by immunofluorescence and swollen mitochondria lacking intact cristae by transmission electron microscopy. Mitochondrial membrane potential (Delta psi m) was decreased in a subset of EPC1 and EPC2 cells stained with Delta psi m-sensitive dye MitoTracker Deep Red. In EPC2, EtOH decreased ATP level while impairing mitochondrial respiration and electron transportation chain functions, as determined by ATP fluorometric assay, respirometry, and liquid chromatography-mass spectrometry. Additionally, EPC2 cells demonstrated enhanced oxidative stress by flow cytometry for mitochondrial superoxide (MitoSOX), which was antagonized by the mitochondria-specific antioxidant MitoCP. Concurrently, EPC1 and EPC2 cells underwent autophagy following EtOH exposure, as evidenced by flow cytometry for Cyto-ID, which detects autophagic vesicles, and immunoblots demonstrating induction of the lipidated and cleaved form of LC3B and downregulation of SQSTM1/p62. In EPC1 and EPC2, pharmacological inhibition of autophagy flux by chloroquine increased mitochondrial oxidative stress while decreasing cell viability. In EPC2, autophagy induction was coupled with phosphorylation of AMP activated protein kinase (AMPK), a cellular energy sensor responding to low ATP levels, and dephosphorylation of downstream substrates of mechanistic Target of Rapamycin Complex (mTORC)-1 signaling. Pharmacological AMPK activation by AICAR decreased EtOH-induced reduction of Delta psi m and ATP in EPC2. Taken together, acute EtOH exposure leads to mitochondrial dysfunction and oxidative stress in esophageal keratinocytes, where the AMPK-mTORC1 axis may serve as a regulatory mechanism to activate autophagy to provide cytoprotection against EtOH-induced cell injury.	[Chandramouleeswaran, Prasanna M.; Engel, Noah] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Guha, Manti; Shimonosono, Masataka; Maekawa, Hisatsugu; Sachdeva, Uma M.; Nakagawa, Hiroshi] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA; [Whelan, Kelly A.] Temple Univ, Fels Inst Canc Res & Mol Biol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Sachdeva, Uma M.] Massachusetts Gen Hosp, Div Thorac Surg, Boston, MA 02114 USA; [Ruthel, Gordon] Univ Penn, Dept Biomed Sci, Mari Lowe Ctr Comparat Oncol, Sch Vet Med, Philadelphia, PA 19104 USA; [Mukherjee, Sarmistha; Baur, Joseph A.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mukherjee, Sarmistha; Baur, Joseph A.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Gonzalez, Michael, V; Garifallou, James; da Silva, Renata Pellegrino; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Ohashi, Shinya] Kyoto Univ, Grad Sch Med, Dept Therapeut Oncol, Sakyo Ku, Kyoto, Japan; [Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Histopathol Facil, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Mesaros, Clementina A.; Blair, Ian A.] Univ Penn, Translat Biomarkers Core, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [Noguchi, Eishi] Drexel Univ, Dept Biochem & Mol Biol, Coll Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Massachusetts General Hospital; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Kyoto University; Fox Chase Cancer Center; University of Pennsylvania; Drexel University	Nakagawa, H (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.	hn2360@cumc.columbia.edu	Ruthel, Gordon/GYU-9133-2022; Ohashi, Shinya/AAD-8920-2022; Noguchi, Eishi/AAF-3986-2021; Noguchi, Eishi/E-7283-2013	Engel, Noah/0000-0001-7785-1899; Noguchi, Eishi/0000-0001-5470-5127; Ruthel, Gordon/0000-0001-9193-5589	NIH [K01DK103953, R01DK121159, P01CA098101, U54CA163004, R01DK114436, R01AA026297, P30DK050306, P30ES013508]; University of Pennsylvania Center of Excellence in Environmental Toxicology [P30CA013696]; W. W. Smith Charitable Trust [C0608]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center of Excellence in Environmental Toxicology; W. W. Smith Charitable Trust	This study was supported by the following NIH (https://www.nih.gov/) Grants: K01DK103953 and R01DK121159 (KAW), P01CA098101 (HN), U54CA163004 (HN), R01DK114436 (HN), and R01AA026297 (PMC, MS, MG, and HN), P30DK050306, P30ES013508 University of Pennsylvania Center of Excellence in Environmental Toxicology (HN, CAM, IB), P30CA013696. EN is a recipient of the W. W. Smith Charitable Trust (http://www.wwsmithcharitabletrust.org/)grant (#C0608). No funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Amanuma Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14142; [Anonymous], 2013, FARMERS 1, V29, P15; Bailey SM, 2001, ALCOHOL CLIN EXP RES, V25, P726, DOI 10.1111/j.1530-0277.2001.tb02273.x; Balbo S, 2012, CANCER EPIDEM BIOMAR, V21, P601, DOI 10.1158/1055-9965.EPI-11-1175; Brooks PJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000050; Butura A, 2009, J HEPATOL, V50, P572, DOI 10.1016/j.jhep.2008.10.020; Celestini V, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0336-0; Chao XJ, 2018, GASTROENTEROLOGY, V155, P865, DOI 10.1053/j.gastro.2018.05.027; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; Fan HJ, 2019, CARCINOGENESIS, V40, P669, DOI 10.1093/carcin/bgy160; Farkas A, 2003, ARCH DERMATOL RES, V295, P56, DOI 10.1007/s00403-003-0399-2; Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59; FISHER RS, 1982, J NUCL MED, V23, P878; Fugitive Literacies Collective, 2020, ENGLISH ED, V52, pN3; Garaycoechea JI, 2018, NATURE, V553, P171, DOI 10.1038/nature25154; Goyal A, 2017, ULTRAFAST NEXT GENER; Green PD, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061509; Guo LL, 2016, RAPID COMMUN MASS SP, V30, P1835, DOI 10.1002/rcm.7667; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Harada H, 2003, MOL CANCER RES, V1, P729; Hoek JB, 2002, GASTROENTEROLOGY, V122, P2049, DOI 10.1053/gast.2002.33613; HOLLOWAY RH, 1989, DIGEST DIS SCI, V34, P905, DOI 10.1007/BF01540277; Ido Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035092; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; JORGENSEN F, 1992, J NUCL MED, V33, P2106; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; Kasagi Y, 2018, CELL MOL GASTROENTER, V5, P333, DOI 10.1016/j.jcmgh.2017.12.013; KHARBANDA S, 1993, BIOCHEM PHARMACOL, V45, P675, DOI 10.1016/0006-2952(93)90142-J; Kholmukhamedov A, 2013, SHOCK, V39, P543, DOI 10.1097/SHK.0b013e318292300d; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Lu YK, 2008, HEPATOLOGY, V47, P1483, DOI 10.1002/hep.22222; Mansouri A, 2001, J PHARMACOL EXP THER, V298, P737; Maurer AH, 2015, J NUCL MED, V56, P1229, DOI 10.2967/jnumed.112.114314; MORIMOTO M, 1995, HEPATOLOGY, V21, P1610, DOI 10.1016/0270-9139(95)90466-2; Qi XM, 2013, ACTA PHARMACOL SIN, V34, P1229, DOI 10.1038/aps.2013.62; Rabinovitch RC, 2017, CELL REP, V21, P1, DOI 10.1016/j.celrep.2017.09.026; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Sims CA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120182; Tanaka K, 2016, AM J CANCER RES, V6, P781; Thomes PG, 2015, ALCOHOL CLIN EXP RES, V39, P2354, DOI 10.1111/acer.12904; Trefely S, 2018, RAPID COMMUN MASS SP, V32, P1163, DOI 10.1002/rcm.8159; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Whelan KA, 2017, ONCOGENE, V36, P4843, DOI 10.1038/onc.2017.102; Whelan KA, 2018, CELL MOL GASTROENTER, V5, P461, DOI 10.1016/j.jcmgh.2018.01.011; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Yukawa Y, 2014, AM J CANCER RES, V4, P279; Zhao BZ, 2016, GENES DIS, V3, P82, DOI 10.1016/j.gendis.2015.12.002; Zhong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091308; 2016, AM J PHYSL RENAL PHY, V310, pG205	56	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239625	10.1371/journal.pone.0239625	http://dx.doi.org/10.1371/journal.pone.0239625			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966340	gold, Green Published			2022-12-26	WOS:000575688700044
J	Franca, AD; Schallig, HDFH; Soares, LS; Pompilio, MA; Tozetti, IA; Bonin, CM; Dorval, MEMC				Franca, Adriana de Oliveira; Schallig, Henk D. F. H.; Soares, Luana Silva; Pompilio, Mauricio Antonio; Tozetti, Ines Aparecida; Bonin, Camila Mareti; Cavalheiros Dorval, Maria Elizabeth Moraes			Cytokine profile inLeishmania-positive blood donors	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; INTERFERON-GAMMA; IFN-GAMMA; T-CELLS; RESISTANCE; INFECTION; INTERLEUKIN-10; INDUCTION; IL-10; IL-27	Serum levels of interleukin 2 (IL-2), interleukin 4 (IL-4), interleukin 6 (IL-6), interleukin 10 (IL-10), interleukin 17 (IL-17), interferon gamma (IFN-gamma), tumor necrosis factor alpha (TNF-alpha), and interleukin 1 beta (IL-1 beta), cytokines involved in the immune response, were investigated in 75Leishmania-positive blood donors living in endemic areas. Based on their status in 2011 and 2015, the subjects were clustered into three groups: positive for at least one diagnostic method in both years, but lacking clinical progression to disease (G1); positive on at least one method in 2011 but negative in 2015 (G2); negative on all methods in both years (G3). Donors were interviewed for sociodemographic data collection and underwent clinical evaluation and laboratory tests. Serum cytokines were quantified using a CBA Flex set (BD Biosciences). Significant differences were found for all the cytokines evaluated, with lower concentrations in consistentlyLeishmania-negative individuals. The exception was IFN-gamma, with similar levels among all donors. No changes consistent with active disease were observed in the laboratory results forLeishmania-positive donors who underwent clinical evaluation, none of whom progressed to disease. This suggests that infection control is associated with serum IL-17 levels. Resolution ofLeishmaniainfection in positive donors may be related to high levels of IL-17 and low levels of IL-10, highlighting the role played by IL-17 in asymptomaticLeishmania-infected individuals.	[Franca, Adriana de Oliveira; Cavalheiros Dorval, Maria Elizabeth Moraes] Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Lab Clin Parasitol, Campo Grande, MS, Brazil; [Schallig, Henk D. F. H.] Univ Catolica Dom Bosco, Lab Immunol, Campo Grande, MS, Brazil; [Soares, Luana Silva] Univ Fed Mato Grosso do Sul, Helio Mandetta Sch Med, Campo Grande, MS, Brazil; [Pompilio, Mauricio Antonio; Tozetti, Ines Aparecida; Bonin, Camila Mareti] Univ Fed Mato Grosso do Sul, Inst Biosci, Lab Immunobiol, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Catolica Dom Bosco (UCDB); Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Franca, AD (corresponding author), Univ Fed Mato Grosso do Sul, Grad Program Infect & Parasit Dis, Lab Clin Parasitol, Campo Grande, MS, Brazil.	dricaseal@hotmail.com		Franca, Adriana de Oliveira/0000-0002-4994-1958	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT/MS) [114/2014, SIAFEM:023670, 23/200.262/2014]; Universidade Federal de Mato Grosso do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT/MS)(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Universidade Federal de Mato Grosso do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Author who received award: MECD The work received financial support from the Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT/MS), https://www.fundect.ms.gov.br/Termo de outorga: 114/2014; SIAFEM:023670; Processo:23/200.262/2014.email:projetos@fundect.ms.gov.br Author who feceived award: IAT This study was conducted with support from the Universidade Federal de Mato Grosso do Sul and financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES). https://ppgdip.ufms.br/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gama MEA, 2013, REV SOC BRAS MED TRO, V46, P741, DOI 10.1590/0037-8682-0203-2013; Costa ASA, 2012, MEM I OSWALDO CRUZ, V107, P735, DOI 10.1590/S0074-02762012000600005; Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017; Banerjee A, 2016, CELL IMMUNOL, V309, P37, DOI 10.1016/j.cellimm.2016.07.004; BELOSEVIC M, 1990, J IMMUNOL, V145, P831; Bhattacharya P, 2013, REV SOC BRAS MED TRO, V46, P128, DOI 10.1590/0037-8682-0022-2012; Bittar RC, 2007, MEM I OSWALDO CRUZ, V102, P625, DOI 10.1590/S0074-02762007005000069; Carvalho E.M., 2005, GAZ MED BAHIA, V75, P24; CARVALHO EM, 1985, J CLIN INVEST, V76, P2066, DOI 10.1172/JCI112209; Costa DL, 2013, PATHOG GLOB HEALTH, V107, P78, DOI 10.1179/2047773213Y.0000000078; dos Santos PL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004375; Franca AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198199; Gama MEA, 2004, BRAZ J MED BIOL RES, V37, P129, DOI 10.1590/S0100-879X2004000100018; Hailu A, 2004, AM J TROP MED HYG, V71, P561, DOI 10.4269/ajtmh.2004.71.561; HOLADAY BJ, 1993, J INFECT DIS, V167, P411, DOI 10.1093/infdis/167.2.411; Ibarra-Meneses AV, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.021; Juttler E, 2007, MOL CELL NEUROSCI, V34, P612, DOI 10.1016/j.mcn.2007.01.004; Khoshdel A, 2009, BRAZ J INFECT DIS, V13, P44, DOI 10.1590/S1413-86702009000100010; Kopf M, 1996, J EXP MED, V184, P1127, DOI 10.1084/jem.184.3.1127; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Nascimento MSL, 2015, J INFECT DIS, V211, P1015, DOI 10.1093/infdis/jiu531; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Nylen S, 2007, J EXP MED, V204, P805, DOI 10.1084/jem.20061141; Peruhype-Magalhaes V, 2006, CLIN EXP IMMUNOL, V146, P124, DOI 10.1111/j.1365-2249.2006.03171.x; Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x; Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813; Quirino GFS, 2016, INFECT IMMUN, V84, P2289, DOI 10.1128/IAI.00283-16; RAZIUDDIN S, 1994, J INFECT DIS, V170, P1037, DOI 10.1093/infdis/170.4.1037; Terrazas C, 2016, FASEB J, V30, P1135, DOI 10.1096/fj.15-277202; TUMANG MCT, 1994, J IMMUNOL, V153, P768; WHO, 2017, GLOB HLTH OBS GHO DA; Yoshimura T, 2006, J IMMUNOL, V177, P5377, DOI 10.4049/jimmunol.177.8.5377	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238933	10.1371/journal.pone.0238933	http://dx.doi.org/10.1371/journal.pone.0238933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966326	gold, Green Published			2022-12-26	WOS:000575688700041
J	Sumit, AF; Das, A; Miraj, IH; Bhowmick, D				Sumit, Ahmed Faisal; Das, Anindya; Miraj, Ishtiaq Hossain; Bhowmick, Debasish			Association between chronic obstructive pulmonary disease (COPD) and occupational exposures: A hospital based quantitative cross-sectional study among the Bangladeshi population	PLOS ONE			English	Article							HEART-DISEASES; AIR-POLLUTION; LUNG-FUNCTION; BURDEN; PREVALENCE; COHORT; DUSTS; GASES; FUMES	The association between chronic obstructive pulmonary disease (COPD) and occupational exposures are less studied in Bangladeshi context, despite the fact that occupational exposures are serious public health concerns in Bangladesh. Therefore, this study aimed to evaluate this association considering demographic, health and smoking characteristics of Bangladeshi population. This was a hospital-based quantitative study including 373 participants who were assessed for COPD through spirometry testing. Assessment of occupational exposures was based on both self-reporting by respondents and ALOHA based job exposure matrix (JEM). Here, among the self-reported exposed group (n = 189), 104 participants (55%) were found with COPD compared to 23 participants (12.5%) in unexposed group (n = 184) that differed significantly (p = 0.00). Similarly, among the JEM measured low (n = 103) and high exposed group (n = 236), 23.3% and 41.5% of the participants were found with COPD respectively; compared to unexposed group (14.7%; n = 34), that differed significantly also (p = 0.00). Likewise, participants with longer self-reported occupational exposures (>8 years) showed significantly (p = 0.00) higher proportions of COPD (79.5%) compared to 40.4% in shorter exposure group (1-8 years). Similarly, significant (p = 0.00) higher cases of COPD were observed among the longer cumulative exposure years (>9 years) group than the shorter cumulative exposure years (1-9 years) group in JEM. While combining smoking and occupational exposure, the chance of developing COPD among the current, former and non-smokers of exposed group were 7.4, 7.2 and 12.7 times higher respectively than unexposed group. Furthermore, logistic analysis revealed that after adjustments for confounding risk factors, the chance of developing COPD among the self-reported exposure group was 6.3 times higher (ORs: 6.3, p = 0.00) than unexposed group; and JEM exposure group has odds of 2.8 and 1.1 respectively (p<0.05) for high and low exposures. Further studies are needed to reinforce this association between COPD and occupational exposure in Bangladesh.	[Sumit, Ahmed Faisal; Das, Anindya] Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh; [Miraj, Ishtiaq Hossain] Univ Dhaka, Dept Econ, Dhaka, Bangladesh; [Bhowmick, Debasish] Dhaka Med Coll Hosp, Dept Resp Med, Dhaka, Bangladesh	University of Dhaka; University of Dhaka; Dhaka Medical College	Sumit, AF (corresponding author), Univ Dhaka, Dept Genet Engn & Biotechnol, Dhaka, Bangladesh.	ahmedfaisalsumit@du.ac.bd		Bhowmick, Dr. Debasish/0000-0001-5546-2470; SUMIT, AHMED/0000-0002-8856-9079; Das, Anindya/0000-0003-4142-1517				Alam DS, 2015, COPD, V12, P658, DOI 10.3109/15412555.2015.1041101; Alim MA, 2014, ENVIRON HEALTH PREV, V19, P126, DOI 10.1007/s12199-013-0364-4; Biswas RS, 2016, CHATTAGRAM MAA O SHI, V15, P8, DOI [10.3329/cmoshmcj.v15i1.28753, DOI 10.3329/CMOSHMCJ.V15I1.28753]; Blanc PD, 2019, AM J RESP CRIT CARE, V199, P1312, DOI 10.1164/rccm.201904-0717ST; Caillaud D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-302; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; de Meer G., 2004, ENV HLTH, V3, P1, DOI [10.1186/1476-069X-3-1, DOI 10.1186/1476-069X-3-1]; Doney B, 2019, AM J IND MED, V62, P393, DOI 10.1002/ajim.22958; Eriksson B, 2013, RESP MED, V107, P98, DOI 10.1016/j.rmed.2012.09.011; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Govender N, 2011, THORAX, V66, P597, DOI 10.1136/thx.2010.149468; Hossain M. A., 2016, BIORESEARCH COMMUNIC, V2, P158; International Standard Classification of Occupations, 1990, ISCO88 ILO; Islam MS, 2017, JORDAN J CIV ENG, V11, P267; Islam R, 2016, INT J PUB HLTH SAFE, V1, P102; Jaen Angeles, 2006, Environ Health, V5, P2, DOI 10.1186/1476-069X-5-2; Janson C, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00561-2019; Kurth L, 2017, OCCUP ENVIRON MED, V74, P290, DOI 10.1136/oemed-2016-103753; Lopez-Campos JL, 2020, ARCH BRONCONEUMOL, V56, P65, DOI 10.1016/j.arbres.2019.06.001; Matheson MC, 2005, THORAX, V60, P645, DOI 10.1136/thx.2004.035170; Mehta AJ, 2012, AM J RESP CRIT CARE, V185, P1292, DOI 10.1164/rccm.201110-1917OC; Miah S.J., 2014, IOSR J ENV SCI TOXIC, V8, P57, DOI DOI 10.9790/2402-08155767; MILLER A, 1992, AM REV RESPIR DIS, V146, P1368, DOI 10.1164/ajrccm/146.5_Pt_1.1368b; Minov J., 2013, Macedonian Journal of Medical Sciences, V6, P397; Mustafa Mahfuz, 2014, Health, V6, P2144, DOI 10.4236/health.2014.616249; Pallasaho P, 2014, COPD, V11, P88, DOI 10.3109/15412555.2013.830095; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Perret J, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA1111; Schirnhofer L, 2007, CHEST, V131, P29, DOI 10.1378/chest.06-0365; Shanmugananth E., 2019, Research Journal of Pharmacy and Technology, V12, P5285, DOI 10.5958/0974-360X.2019.00915.6; Siddharthan T, 2018, AM J RESP CRIT CARE, V197, P611, DOI 10.1164/rccm.201709-1861OC; Sim YS, 2017, TUBERC RESPIR DIS, V80, P105, DOI 10.4046/trd.2017.80.2.105; Sutradhar I, 2019, CUREUS J MED SCIENCE, V11, DOI 10.7759/cureus.3970; Trupin L, 2003, EUR RESPIR J, V22, P462, DOI 10.1183/09031936.03.00094203; Vandevoorde J, 2006, EUR RESPIR J, V27, P378, DOI 10.1183/09031936.06.00036005; Wang C, 2018, LANCET, V391, P1706, DOI [10.1016/s0140-6736(18)30841-9, 10.1016/S0140-6736(18)30841-9]; World Health Organization, CHRON OBSTR PULM DIS; Zhou YM, 2013, COPD, V10, P567, DOI 10.3109/15412555.2013.781579	38	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239602	10.1371/journal.pone.0239602	http://dx.doi.org/10.1371/journal.pone.0239602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966342	gold, Green Published			2022-12-26	WOS:000575688700015
J	Xie, CC; Gonzalez-Bello, C; Li, ZM; Bai, FM; Hu, ZW; Zhang, W; Li, ZM				Xie, Congcong; Gonzalez-Bello, Concepcion; Li, Zhi-Min; Bai, Fumei; Hu, Ziwei; Zhang, Wei; Li, Zhimin			Kinetic and structural insights into enzymatic mechanism of succinic semialdehyde dehydrogenase fromCyanothecesp. ATCC51142	PLOS ONE			English	Article							COFACTOR	As a ubiquitous enzyme, succinic semialdehyde dehydrogenase contributes significantly in many pathways including the tricarboxylic acid cycle and other metabolic processes such as detoxifying the accumulated succinic semialdehyde and surviving in nutrient-limiting conditions. Here thecce4228gene encoding succinic semialdehyde dehydrogenase fromCyanothecesp. ATCC51142 was cloned and the homogenous recombinant cce4228 protein was obtained by Ni-NTA affinity chromatography. Biochemical characterization revealed that cce4228 protein displayed optimal activity at presence of metal ions in basic condition. Although the binding affinity of cce4228 protein with NAD(+)was about 50-fold lower than that of cce4228 with NADP(+), the catalytic efficiency of cce4228 protein towards succinic semialdehyde with saturated concentration of NADP(+)is same as that with saturated concentration of NAD(+)as its cofactors. Meanwhile, the catalytic activity of cce4228 was competitively inhibited by succinic semialdehyde substrate. Kinetic and structural analysis demonstrated that the conserved Cys262 and Glu228 residues were crucial for the catalytic activity of cce4228 protein and the Ser157 and Lys154 residues were determinants of cofactor preference.	[Xie, Congcong; Li, Zhi-Min; Bai, Fumei; Hu, Ziwei; Zhang, Wei; Li, Zhimin] Jiangxi Agr Univ, Coll Biosci & Bioengn, Jiangxi Key Lab Conservat & Utilizat Fungal Resou, Nanchang, Jiangxi, Peoples R China; [Gonzalez-Bello, Concepcion] Jiangxi Agr Univ, Coll Sci, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University	Li, ZM (corresponding author), Jiangxi Agr Univ, Coll Biosci & Bioengn, Jiangxi Key Lab Conservat & Utilizat Fungal Resou, Nanchang, Jiangxi, Peoples R China.	zhiminli@jxau.edu.cn	GONZALEZ-BELLO, CONCEPCION/M-2436-2014; Li, Zhimin/A-9671-2011	GONZALEZ-BELLO, CONCEPCION/0000-0001-6439-553X; Li, Zhimin/0000-0001-7036-9282	Natural Science Foundation of Jiangxi Province [20161ACB21012]; National Natural Science Foundation of China [31860249]	Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by Natural Science Foundation of Jiangxi Province (20161ACB21012) and National Natural Science Foundation of China (31860249).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anna-Kaisa Niemi a Candida Brownb, 2014, MOL GENETICS METABOL, DOI [10.1016/j.ymgmr.2014.02.005, DOI 10.1016/J.YMGMR.2014.02.005]; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bouche N, 2003, P NATL ACAD SCI USA, V100, P6843, DOI 10.1073/pnas.1037532100; de Carvalho LPS, 2011, ARCH BIOCHEM BIOPHYS, V509, P90, DOI 10.1016/j.abb.2011.01.023; Do Nascimento M, 2019, ALGAL RES, V43, DOI 10.1016/j.algal.2019.101652; DONNELLY MI, 1981, EUR J BIOCHEM, V113, P555, DOI 10.1111/j.1432-1033.1981.tb05098.x; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; Green LS, 2000, J BACTERIOL, V182, P2838, DOI 10.1128/JB.182.10.2838-2844.2000; Jang EH, 2014, MOL CELLS, V37, P719, DOI 10.14348/molcells.2014.0162; Kim KJ, 2011, ANTIOXID REDOX SIGN, V15, P691, DOI 10.1089/ars.2010.3470; Kim YG, 2009, EMBO J, V28, P959, DOI 10.1038/emboj.2009.40; Knoot CJ, 2018, J BIOL CHEM, V293, P5044, DOI 10.1074/jbc.R117.815886; Lin CY, 2015, J CHILD NEUROL, V30, P486, DOI 10.1177/0883073814544365; Malaspina P, 2016, NEUROCHEM INT, V99, P72, DOI 10.1016/j.neuint.2016.06.009; Murphy TC, 2003, J NEUROCHEM, V86, P298, DOI 10.1046/j.1471-4159.2003.01839.x; Park J, 2013, J BIOL CHEM, V288, P15760, DOI 10.1074/jbc.M113.460428; Park SA, 2014, J MICROBIOL BIOTECHN, V24, P954, DOI 10.4014/jmb.1402.02054; Rigsby RE, 2016, BIOCHEM MOL BIOL EDU, V44, P433, DOI 10.1002/bmb.20966; Schneider BL, 2012, J BACTERIOL, V194, P4080, DOI 10.1128/JB.05063-11; STANIER RY, 1977, ANNU REV MICROBIOL, V31, P225, DOI 10.1146/annurev.mi.31.100177.001301; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Toyokura K, 2011, PLANT CELL PHYSIOL, V52, P1340, DOI 10.1093/pcp/pcr079; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; Vanlerberghe GC, 1999, PLANT PHYSIOL, V121, P793, DOI 10.1104/pp.121.3.793; Wang XQ, 2018, INT J BIOL MACROMOL, V108, P615, DOI 10.1016/j.ijbiomac.2017.12.059; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; [谢琮琮 Xie Congcong], 2019, [微生物学通报, Microbiology China], V46, P2933; Xiong W, 2014, MOL MICROBIOL, V93, P786, DOI 10.1111/mmi.12699; Yuan ZN, 2013, J STRUCT BIOL, V182, P125, DOI 10.1016/j.jsb.2013.03.001; Zhang SY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01972; Zhang SY, 2011, SCIENCE, V334, P1551, DOI 10.1126/science.1210858; Zheng HY, 2013, PROTEINS, V81, P1031, DOI 10.1002/prot.24227	33	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239372	10.1371/journal.pone.0239372	http://dx.doi.org/10.1371/journal.pone.0239372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966327	Green Published, gold			2022-12-26	WOS:000575688700018
J	Kang, HJ; Lee, HH; Jung, SE; Park, KS; Joo-Hyun, O; Jeon, YW; Choi, BO; Cho, SG				Kang, Hye Jin; Lee, Han Hee; Jung, Seung-Eun; Park, Kyung-Sin; Joo-Hyun, O.; Jeon, Young-Woo; Choi, Byung-Ock; Cho, Seok-Goo			Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NON-HODGKINS-LYMPHOMA; ELDERLY-PATIENTS; PLUS RITUXIMAB; THERAPY; INDEX	Purpose The optimal treatment for primary gastric diffuse large B-cell lymphoma (PG-DLBCL) is still unknown. We evaluated unfavorable prognostic factors and pattern of failure in PG-DLBCL to determine the optimal treatment strategy. Methods Between April 2001 and November 2018, 120 patients with complete remission following rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) chemotherapy were retrospectively reviewed. According to the Lugano staging system, 80 patients (66.7%) had localized disease and 40 patients (33.3%) had advanced disease. A total of 93 (77.5%) patients had single gastric lesion and 27 (22.5%) patients had multiple gastric lesions. Ninety patients (75%) were treated with R-CHOP chemotherapy alone and 30 patients (25%) received R-CHOP chemotherapy with additional local treatment for gastric lesions. Results The 5-year locoregional failure-free survival (LRFS), progression-free survival (PFS), and overall survival (OS) rates in patients treated with R-CHOP chemotherapy with local treatment were 100%, 100%, and 100%, respectively, whereas the LRFS, PFS, and OS rates in patients treated with R-CHOP chemotherapy alone were 86.3%, 78.2%, and 87.4%, respectively (p= 0.031,p= 0.095, andp= 0.025, respectively). During the follow-up period, 17 patients (14.2%) had disease recurrence. Only 3 of the 17 patients had relapse in a completely new site without relapse in the initial involved site. All, except 2, cases of local recurrence included gastric failure. In the multivariate analysis, performance status and number of gastric lesions were independent prognostic factors for treatment outcome. Conclusions Patients with complete remission following R-CHOP chemotherapy showed a good prognosis. The main pattern of failure in patients with PG-DLBCL was local recurrence, especially in the stomach. Patients who received local treatment for gastric lesions showed improved gastric control. Therefore, in patients with unfavorable prognostic factors, we recommend R-CHOP chemotherapy with additional local treatment for gastric lesions.	[Kang, Hye Jin; Choi, Byung-Ock] Catholic Univ Korea, Catholic Univ Lymphoma Grp, Seoul St Marys Hosp, Coll Med,Dept Radiat Oncol, Seoul, South Korea; [Lee, Han Hee] Catholic Univ Korea, Catholic Univ Lymphoma Grp, Seoul St Marys Hosp, Dept Gastroenterol,Coll Med, Seoul, South Korea; [Jung, Seung-Eun] Catholic Univ Korea, Catholic Univ Lymphoma Grp, Seoul St Marys Hosp, Dept Radiol,Coll Med, Seoul, South Korea; [Park, Kyung-Sin] Catholic Univ Korea, Catholic Univ Lymphoma Grp, Seoul St Marys Hosp, Dept Pathol,Coll Med, Seoul, South Korea; [Joo-Hyun, O.] Catholic Univ Korea, Catholic Univ Lymphoma Grp, Seoul St Marys Hosp, Dept Nucl Med,Coll Med, Seoul, South Korea; [Jeon, Young-Woo] Catholic Univ Korea, Catholic Univ Lymphoma Grp, Yeouido St Marys Hosp, Dept Hematol,Coll Med, Seoul, South Korea; [Cho, Seok-Goo] Catholic Univ Korea, Catholic Univ Lymphoma Grp, Seoul St Marys Hosp, Dept Hematol,Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Choi, BO (corresponding author), Catholic Univ Korea, Catholic Univ Lymphoma Grp, Seoul St Marys Hosp, Coll Med,Dept Radiat Oncol, Seoul, South Korea.; Cho, SG (corresponding author), Catholic Univ Korea, Catholic Univ Lymphoma Grp, Seoul St Marys Hosp, Dept Hematol,Coll Med, Seoul, South Korea.	choibo67@catholic.ac.kr; chosg@catholic.ac.kr	Lee, Han Hee/AAB-7987-2022	Lee, Han Hee/0000-0002-8244-374X				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Cortelazzo S, 1999, ANN ONCOL, V10, P1433, DOI 10.1023/A:1008351427601; DAMORE F, 1991, EUR J CANCER, V27, P1201, DOI 10.1016/0277-5379(91)90081-N; Ferreri AJM, 1999, ONCOLOGY-BASEL, V56, P274, DOI 10.1159/000011978; Ferreri AJM, 2007, CRIT REV ONCOL HEMAT, V63, P65, DOI 10.1016/j.critrevonc.2007.01.003; Fischbach W, 2011, Z GASTROENTEROL, V49, P430, DOI 10.1055/s-0029-1246012; Ghimire P, 2011, WORLD J GASTROENTERO, V17, P697, DOI 10.3748/wjg.v17.i6.697; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Horning SJ, 2004, J CLIN ONCOL, V22, P3032, DOI 10.1200/JCO.2004.06.088; Ishikawa E, 2018, CANCER MED-US, V7, P3510, DOI 10.1002/cam4.1595; Jegadeesh N, 2015, INT J RADIAT ONCOL, V92, P107, DOI 10.1016/j.ijrobp.2015.01.025; Koch P, 2005, J CLIN ONCOL, V23, P7050, DOI 10.1200/JCO.2005.04.031; Lin TL, 2012, ANN HEMATOL, V91, P1383, DOI 10.1007/s00277-012-1463-9; Liu X, 2016, INT J RADIAT ONCOL, V95, P712, DOI 10.1016/j.ijrobp.2016.01.027; Liu YZ, 2019, LEUKEMIA LYMPHOMA, V60, P934, DOI 10.1080/10428194.2018.1515942; Juarez-Salcedo LM, 2018, CANCER CONTROL, V25, DOI 10.1177/1073274818778256; Newton R, 1997, INT J CANCER, V72, P923, DOI 10.1002/(SICI)1097-0215(19970917)72:6<923::AID-IJC1>3.0.CO;2-R; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; ROHATINER A, 1994, ANN ONCOL, V5, P397, DOI 10.1093/oxfordjournals.annonc.a058869; Shi Z, 2013, INT J RADIAT ONCOL, V86, P569, DOI 10.1016/j.ijrobp.2013.02.007; Tomita N, 2013, BRIT J HAEMATOL, V161, P383, DOI 10.1111/bjh.12281; Yoon SS, 2004, ANN SURG, V240, P28, DOI 10.1097/01.sla.0000129356.81281.0c; Zhang J, 2012, LEUKEMIA LYMPHOMA, V53, P2175, DOI 10.3109/10428194.2012.680451	26	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0238807	10.1371/journal.pone.0238807	http://dx.doi.org/10.1371/journal.pone.0238807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960887	Green Published, gold			2022-12-26	WOS:000575109500032
J	Havton, LA; Biscola, NP; Christe, KL; Colman, RJ				Havton, Leif A.; Biscola, Natalia P.; Christe, Kari L.; Colman, Ricki J.			Ketamine-induced neuromuscular reactivity is associated with aging in female rhesus macaques	PLOS ONE			English	Article							MACACA-MULATTA; INTRAMUSCULAR KETAMINE; ANESTHESIA; SEDATION; PHARMACODYNAMICS; TOLERANCE; MENOPAUSE; CHILDREN; NEURONS; STRESS	Rhesus macaques represent an important species for translational and pre-clinical research studies across a multitude of disease and injury models, including aging. Ketamine anesthesia is used in humans and non-human primates but may be associated with adverse effects, including neuromuscular reactions. The effects of aging on ketamine adverse effects is not well characterized. Urodynamic recordings and electromyography (EMG) studies were performed in aged (>20 years old) and adult (3.9-14.9 years old) female rhesus macaques under an equal and light plane of sedation by constant rate infusion (CRI) of ketamine. A total of 4 of 41 adult subjects (9.7%) showed clinical signs of ketamine-induced abnormal neuromuscular reactivity, whereas a larger portion of 14 of 26 aged subjects showed similar ketamine-induced neuromuscular reactivity (53.8%;P< 0.001). The ketamine CRI rate was 19.8 +/- 0.9 mg/kg/h in adults and lower in aged subjects at 16.5 +/- 1.4 mg/kg/h (P<0.05). The ketamine CRI rate was negatively correlated with age (r = -0.30,P<0.05, n = 64). The incidence of ketamine reactivity or CRI rate was not different between aged pre-and post-menopausal females. EMG recordings during neuromuscular reactivity showed coordinated activation of multiple muscles, suggesting a central nervous system (CNS) mechanism for ketamine-associated neuromuscular reactivity. The incidence of ketamine-induced neuromuscular reactivity is age related but not affected by the estrous cycle in female rhesus macaques. A coordinated activation of multiple muscles, innervated by different peripheral nerves, suggests that ketamine-induced neuromuscular reactivity originates in the CNS.	[Havton, Leif A.; Biscola, Natalia P.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Havton, Leif A.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Havton, Leif A.] James J Peters Vet Adm Med Ctr, VA RR&D Natl Ctr Med Consequences Spinal Cord Inj, Bronx, NY 10468 USA; [Christe, Kari L.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA USA; [Colman, Ricki J.] UW Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Colman, Ricki J.] UW Madison, Dept Cell & Regenerat Biol, Madison, WI USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Havton, LA (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Havton, LA (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Havton, LA (corresponding author), James J Peters Vet Adm Med Ctr, VA RR&D Natl Ctr Med Consequences Spinal Cord Inj, Bronx, NY 10468 USA.	leif.havton@mssm.edu	Christe, Kari/AAD-5929-2022	Colman, Ricki/0000-0001-9706-0525	Department of Defense Spinal Cord Injury Research Program [SC090273]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Institutes of Health (NIH) Office of the Director [P51 OD011107]; NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant [UL1TR001881]; NIH [R01AG040178]; NCRR/ORIP grants [P51RR000167/P51OD011106]	Department of Defense Spinal Cord Injury Research Program; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; National Institutes of Health (NIH) Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR/ORIP grants	The studies were supported by Department of Defense Spinal Cord Injury Research Program (SC090273) (LAH), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (LAH), the National Institutes of Health (NIH) Office of the Director (P51 OD011107) to the California National Primate Research Center/UC Davis, and the NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant (UL1TR001881) (LAH). Funding for the UW portion of this study was provided by NIH grant R01AG040178 (RJC) and was made possible in part by NCRR/ORIP grants P51RR000167/P51OD011106 to the Wisconsin National Primate Research Center, University of WisconsinMadison.	Authier S, 2006, J AM ASSOC LAB ANIM, V45, P73; Bertrand HGMJ, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0721-9; BREE MM, 1967, ANESTH ANAL CURR RES, V46, P596; Chang HH, 2016, EXP NEUROL, V285, P190, DOI 10.1016/j.expneurol.2016.05.026; Christe KL, 2013, COMPARATIVE MED, V63, P445; Gad PN, 2018, J NEUROPHYSIOL, V119, P1521, DOI 10.1152/jn.00840.2017; Gad PN, 2017, J MED PRIMATOL, V46, P359, DOI 10.1111/jmp.12287; Gazzaley AH, 1996, P NATL ACAD SCI USA, V93, P3121, DOI 10.1073/pnas.93.7.3121; Ghoniem GM, 1996, J UROLOGY, V156, P233, DOI 10.1016/S0022-5347(01)66007-5; Gilardi KVK, 1997, BIOL REPROD, V57, P335, DOI 10.1095/biolreprod57.2.335; Havton LA, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113033; Hof PR, 2002, BRAIN RES, V928, P175, DOI 10.1016/S0006-8993(01)03345-5; KHAN MS, 1988, POSTGRAD MED J, V64, P833, DOI 10.1136/pgmj.64.756.833-a; Lee VK, 2010, J AM ASSOC LAB ANIM, V49, P57; MACDONALD JF, 1987, J NEUROPHYSIOL, V58, P251, DOI 10.1152/jn.1987.58.2.251; Marland S, 2013, CNS NEUROSCI THER, V19, P381, DOI 10.1111/cns.12072; McGlone RG, 2004, EMERG MED J, V21, P290, DOI 10.1136/emj.2002.003772; Mion G, 2013, CNS NEUROSCI THER, V19, P370, DOI 10.1111/cns.12099; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Peltoniemi MA, 2016, CLIN PHARMACOKINET, V55, P1059, DOI 10.1007/s40262-016-0383-6; Pouget P, 2010, PSYCHOPHARMACOLOGY, V209, P313, DOI 10.1007/s00213-010-1797-8; Quibell R, 2011, J PAIN SYMPTOM MANAG, V41, P640, DOI 10.1016/j.jpainsymman.2011.01.001; Rakesh G, 2017, EXPERT REV NEUROTHER, V17, P777, DOI 10.1080/14737175.2017.1341310; Settle TL, 2010, J MED PRIMATOL, V39, P50, DOI 10.1111/j.1600-0684.2009.00393.x; Simmons HA, 2016, VET PATHOL, V53, P399, DOI 10.1177/0300985815620628; STEELMAN R, 1991, Anesthesia Progress, V38, P50; SUSSMAN DR, 1974, ANESTHESIOLOGY, V40, P459, DOI 10.1097/00000542-197405000-00012; Tobias JD, 2000, CRIT CARE MED, V28, P2122, DOI 10.1097/00003246-200006000-00079; Vardy JM, 2008, EMERG MED J, V25, P579, DOI 10.1136/emj.2007.056200; Walker ML, 2008, BIOL REPROD, V79, P398, DOI 10.1095/biolreprod.108.068536; WENK GL, 1991, NEUROBIOL AGING, V12, P93, DOI 10.1016/0197-4580(91)90047-N; Winterborn AN, 2008, J MED PRIMATOL, V37, P116, DOI 10.1111/j.1600-0684.2007.00234.x	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0236430	10.1371/journal.pone.0236430	http://dx.doi.org/10.1371/journal.pone.0236430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956357	gold, Green Published			2022-12-26	WOS:000574571500036
J	Kisaka, S; Makumbi, FE; Majalija, S; Bangirana, A; Thumbi, SM				Kisaka, Stevens; Makumbi, Fredrick E.; Majalija, Samuel; Bangirana, Alexander; Thumbi, S. M.			Epidemiology and preclinical management of dog bites among humans in Wakiso and Kampala districts, Uganda: Implications for prevention of dog bites and rabies	PLOS ONE			English	Article							INJURIES; PROPHYLAXIS	In rabies endemic areas, appropriate management of dog bites is critical in human rabies prevention. Victims must immediately wash bite wound for 15 minutes with water, soap, and a disinfectant before seeking medical care. This study investigated the epidemiology of dog bites and the determinants of compliance to these pre-clinical guidelines requirements among dog bite victims from high rabies-burden areas of Wakiso and Kampala, Uganda. An explanatory sequential mixed-methods study design was used. Quantitative data were collected from 376 dog-bite patients at two healthcare facilities. Qualitative data were also collected through 13 in-depth interviews with patients, healthcare workers, herbalists, and veterinarians. Qualitative data were analyzed using a deductive thematic approach. Generalized linear models were used to determine factors associated with compliance. Nearly half (190, 51%) of the patients were from Wakiso District and 293 (77.9%) had grade II wounds. Most of the wounds (171, 45.5%) were on the legs. Two-thirds of the bites occurred in public places. Only 70 (19%) of the bite patients had complied with pre-clinical guidelines. Nearly half of the patients had applied substances that were not recommended e.g. herbs (47/193), antiseptics (46/193), "black stone" (25/193), and unknown creams (10/193). Factors negatively associated with compliance included: being aged 15 years or older, adjPR = 0.70 (0.47-0.92) and knowing the dog owner, adjPR = 0.65 (0.36-0.93). However, attainment of secondary or higher education, adjPR = 1.76 (1.24-3.79), being in employment, adjPR = 1.48 (1.09-2.31), perception that the dog was sick, adjPR = 1.47 (1.02-2.72) and knowledge about the dog's subsequent victim(s) adjPR = 0.35 (0.17-0.70) were positively associated with compliance. High occurrence of dog bites in public places by free-roaming dogs suggests the need for deliberate promotion of responsible dog ownership. Additionally, targeted health education may be required to improve the low compliance to pre-clinical guidelines.	[Kisaka, Stevens; Thumbi, S. M.] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Kisaka, Stevens; Makumbi, Fredrick E.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kisaka, Stevens; Majalija, Samuel] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda; [Bangirana, Alexander] Mulago Natl Referral Hosp, Dept Emergency Med, Kampala, Uganda; [Thumbi, S. M.] Washington State Univ, Rabies Free Africa, Pullman, WA 99164 USA; [Thumbi, S. M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	University of Nairobi; Makerere University; Makerere University; Mulago National Referral Hospital; Washington State University; Washington State University	Kisaka, S (corresponding author), Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya.; Kisaka, S (corresponding author), Makerere Univ, Sch Publ Hlth, Kampala, Uganda.; Kisaka, S (corresponding author), Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Kampala, Uganda.	bmkstevens@gmail.com	Majalija, Samuel/AAC-3932-2021	Kisaka, Stevens/0000-0001-7848-316X	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [B 8606.R02]; Sida [54100113]; DELTAS Africa Initiative [107768/Z/15/Z]; Deutscher Akademischer Austauschdienst (DAAD); African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK); UK government	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; DELTAS Africa Initiative; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government	This research was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-B 8606.R02), Sida (Grant No:54100113), the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z) and Deutscher Akademischer Austauschdienst (DAAD). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) and the UK government. Stevens Kisaka is a CARTA PhD fellow. The statements made and views expressed are solely the responsibility of the Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar SA, 2012, ANN AFR MED, V11, P108, DOI 10.4103/1596-3519.93534; Aghahowa SE, 2010, VACCINE, V28, P4847, DOI 10.1016/j.vaccine.2010.04.004; Agrawal Aviral, 2017, Int J Clin Pediatr Dent, V10, P67, DOI 10.5005/jp-journals-10005-1410; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2013, DOKUMENT, V3, P4; [Anonymous], 2014, J CLIN DIAGN RES, V8; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; [Anonymous], 2017, EUR J TRANSL MYOL, V27, p7X; [Anonymous], 2013, LANCET ONCOL, V14, pe168; Beyene TJ, 2018, ZOONOSES PUBLIC HLTH, V65, P443, DOI 10.1111/zph.12458; Bula-Rudas FJ, 2018, HUMAN ANIMAL BITES; Calverton M, 2018, UG DEM HLTH SURV 200; Diallo MK, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3928-0; Fevre EM, 2005, TROP MED INT HEALTH, V10, P790, DOI 10.1111/j.1365-3156.2005.01447.x; Georges K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-85; Gilchrist J, 2008, INJURY PREV, V14, P296, DOI 10.1136/ip.2007.016220; Gogtay NJ, 2014, INDIAN J MED RES, V139, P459; Guo C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35158-0; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Herbert Mrudu, 2012, J Infect Public Health, V5, P374, DOI 10.1016/j.jiph.2012.05.002; Hergert M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002059; Inche Zainal Abidin S, 2014, ADV EPIDEMIOLOGY, V2014, P1, DOI 10.1155/2014/793286; Jain Piyush, 2014, J Family Med Prim Care, V3, P355, DOI 10.4103/2249-4863.148107; Kabeta T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003867; Lembo T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001388; Liu QY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005663; MAAIF UBOS, 2010, NAT LIV CENS REP 200; Mannion CJ, 2016, BRIT J HOSP MED, V77, pC165, DOI 10.12968/hmed.2016.77.10.C165; MoH, 2016, INJ DISTR HLTH INF S; Morgan M, 2007, BMJ-BRIT MED J, V334, P413, DOI 10.1136/bmj.39105.659919.BE; Organization WH, 2018, WHO EXP CONS RAB 3 R; Oxford Dictionary, 2018, PRACTICE; Penjor K, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4926-y; Penjor K, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6559-x; Permpalung N, 2013, VACCINE, V31, P4079, DOI 10.1016/j.vaccine.2013.06.083; Salomao C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005787; Shantavasinkul P, 2011, ADV VIRUS RES, V79, P291, DOI 10.1016/B978-0-12-387040-7.00013-5; Sharma S, 2016, ANN MED HEALTH SCI R, V6, P115, DOI 10.4103/2141-9248.181836; Tenzin, 2011, VACCINE, V29, P4094, DOI 10.1016/j.vaccine.2011.03.106; Tepsumethanon V, 2004, CLIN INFECT DIS, V39, P278, DOI 10.1086/421556; Tipping G, 1995, HLTH CARE SEEKING BE; Tschopp R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004471; Wallace RM, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0306-2; Wambura G, 2019, VACCINE, V37, pA28, DOI 10.1016/j.vaccine.2019.05.035; Westgarth C, 2018, J EPIDEMIOL COMMUN H, V72, P331, DOI 10.1136/jech-2017-209330; WHO, 2013, WHO TECH REP SER, V982, P1; WHO, 2012, CURR WHO GUID RAB PR; Wilde H, 2007, VACCINE, V25, P7605, DOI 10.1016/j.vaccine.2007.08.054; Wilde H, 2016, VACCINE, V34, P187, DOI 10.1016/j.vaccine.2015.11.036	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239090	10.1371/journal.pone.0239090	http://dx.doi.org/10.1371/journal.pone.0239090			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956373	Green Submitted, Green Published, gold			2022-12-26	WOS:000574571500019
J	Cheng, S; Kerr, KF; Thiessen-Philbrook, H; Coca, SG; Parikh, CR				Cheng, Si; Kerr, Kathleen F.; Thiessen-Philbrook, Heather; Coca, Steven G.; Parikh, Chirag R.			BioPETsurv: Methodology and open source software to evaluate biomarkers for prognostic enrichment of time-to-event clinical trials	PLOS ONE			English	Article							PREDICTIVE BIOMARKERS; PROGRESSION	Biomarkers can be used to enrich a clinical trial for patients at higher risk for an outcome, a strategy termed "prognostic enrichment." Methodology is needed to evaluate biomarkers for prognostic enrichment of trials with time-to-event endpoints such as survival. Key considerations when considering prognostic enrichment include: clinical trial sample size; the number of patients one must screen to enroll the trial; and total patient screening costs and total per-patient trial costs. The Biomarker Prognostic Enrichment Tool for Survival Outcomes (BioPETsurv) is a suite of methods for estimating these elements to evaluate a prognostic enrichment biomarker and/or plan a prognostically enriched clinical trial with a time-to-event primary endpoint. BioPETsurv allows investigators to analyze data on a candidate biomarker and potentially censored survival times. Alternatively, BioPETsurv can simulate data to match a particular clinical setting. BioPETsurv's data simulator enables investigators to explore the potential utility of a prognostic enrichment biomarker for their clinical setting. Results demonstrate that both modestly prognostic and strongly prognostic biomarkers can improve trial metrics such as reducing sample size or trial costs. In addition to the quantitative analysis provided by BioPETsurv, investigators should consider the generalizability of trial results and evaluate the ethics of trial eligibility criteria. BioPETsurv is freely available as a package for theRstatistical computing platform, and as a webtool at www.prognosticenrichment.com/surv.	[Cheng, Si; Kerr, Kathleen F.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Thiessen-Philbrook, Heather; Parikh, Chirag R.] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21218 USA; [Coca, Steven G.] Icahn Sch Med Mt Sinai, Dept Med, Div Nephrol, New York, NY 10029 USA	University of Washington; University of Washington Seattle; Johns Hopkins University; Icahn School of Medicine at Mount Sinai	Parikh, CR (corresponding author), Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21218 USA.	chirag.parikh@jhmi.edu		Thiessen Philbrook, Heather/0000-0003-2067-0514	NIH [R01-HL-085757, K24-DK090203, P30-DK-079310, R01 DK115562, UO1 DK106962, R01 HL085757, R01 DK112258, U01 OH011326, U01-DK-082185]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding statement. NIH (R01-HL-085757 to CRP) funded the TRIBE-AKI Consortium. CRP is supported by NIH grant K24-DK090203 and the P30-DK-079310 O'Brien Kidney Center Grant. SGC has salary support from NIH grants R01 DK115562, UO1 DK106962, R01 HL085757, R01 DK112258, and U01 OH011326. SGC and CRP are members of the NIH-sponsored Assessment, Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury (ASSESS-AKI) Consortium (U01-DK-082185). The funding agencies did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of CRP and SGC are articulated in the `author contributions' section SGC received consulting fees from Goldfinch Bio, CHF Solutions, Quark Biopharma, Janssen Pharmaceuticals, Takeda Pharmaceuticals, and Relypsa. These organizations did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of SGC are articulated in the `author contributions' section.	Administration USFaD, 2014, GUIDANCE IND FDA STA; Ayas NT, 2019, LUNG, V197, P459, DOI 10.1007/s00408-019-00237-0; Biomarker Qualification Review Team (BQRT), BIOM QUAL REV TOT KI; Biro Peter, 2010, PARI J, V11, P22; Chen JJ, 2015, BIOMARK MED, V9, P1121, DOI 10.2217/bmm.15.84; Chen YC, 2018, PHARM STAT, V17, P105, DOI 10.1002/pst.1842; Greenberg JH, 2018, J AM SOC NEPHROL, V29, P1549, DOI 10.1681/ASN.2017090989; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Kerr KF, 2017, CLIN TRIALS, V14, P629, DOI 10.1177/1740774517723588; Li YY, 2013, J ENVIRON MANAGE, V119, P143, DOI 10.1016/j.jenvman.2013.02.004; Nadkarni GN, 2018, KIDNEY INT, V93, P1409, DOI 10.1016/j.kint.2018.01.026; Parikh CR, 2020, AM J KIDNEY DIS, V75, P187, DOI 10.1053/j.ajkd.2019.06.011; Parikh CR, 2016, KIDNEY INT, V89, P1372, DOI 10.1016/j.kint.2016.02.027; Perez-Gracia JL, 2017, CANCER TREAT REV, V53, P79, DOI 10.1016/j.ctrv.2016.12.005; Satagopan JM, 2015, GENET EPIDEMIOL, V39, P509, DOI 10.1002/gepi.21917; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Simon Richard, 2006, Cancer Biomarkers, V2, P89; Song X, 2020, BIOSTATISTICS, DOI [10.1093/biostatistics/kxaa018, DOI 10.1093/BIOSTATISTICS/KXAA01832424421]; Stanski NL, 2020, NAT REV NEPHROL, V16, P20, DOI 10.1038/s41581-019-0199-3; Stanton BC, 2014, NAT CHEM BIOL, V10, P99, DOI 10.1038/nchembio.1411; Taieb J, 2019, DRUGS, V79, P1375, DOI 10.1007/s40265-019-01165-2; Temple R, 2010, CLIN PHARMACOL THER, V88, P774, DOI 10.1038/clpt.2010.233; Tofte N, 2020, LANCET DIABETES ENDO, V8, P301, DOI 10.1016/S2213-8587(20)30026-7; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Wang SJ, 2007, PHARM STAT, V6, P227, DOI 10.1002/pst.300	25	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239486	10.1371/journal.pone.0239486	http://dx.doi.org/10.1371/journal.pone.0239486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946505	gold, Green Published			2022-12-26	WOS:000573851100021
J	Conde, BE; Aragaki, S; Ticktin, T; Fonseca, AS; Yazbek, PB; Sauini, T; Rodrigues, E				Conde, Bruno Esteves; Aragaki, Sonia; Ticktin, Tamara; Fonseca, Amanda Surerus; Yazbek, Priscila Baptistella; Sauini, Thamara; Rodrigues, Eliana			Evaluation of conservation status of plants in Brazil's Atlantic forest: An ethnoecological approach withQuilombolacommunities in Serra do Mar State Park	PLOS ONE			English	Article							DIVERSITY; GRADIENT; AREA	The Atlantic Forest is considered the fourth most important biodiversity hotspot. Although almost 96% of its original area has been devastated, a large part of its remaining conserved area is inhabited by traditional communities. This research focused on twoQuilombolacommunities who reside within the Nucleo Picinguaba of the Serra do Mar State Park, State of Sao Paulo, Brazil. The objective was to use a combination of ethnoecological and ecological approaches to select priority species for which to develop participatory conservation and sustainable management plans in protected areas in Brazil. We collaborated with community members to collect ethnobotanical and ethnoecological data and then measured the abundance of native species in local forests through phytosociological sampling. We used this information to assess the degree of threat to useful species using the Conservation Priority Index, adding an additional layer of analysis based on habitat successional categories. We then overlayed those useful species identified as highest risk locally with those federally listed as threatened or endangered. Based on this, we identified three species as priority for the development of sustainable management plans:Virola bicuhyba,Cedrella fissilisandPlinia edulis.	[Conde, Bruno Esteves] Univ Fed Sao Paulo, Dept Biol Sci, Postgrad Program Chem Biol, Sao Paulo, Brazil; [Conde, Bruno Esteves] Ctr Univ Estacio Sa, Juiz De Fora, MG, Brazil; [Aragaki, Sonia] Inst Bot Sao Paulo, Sao Paulo, Brazil; [Ticktin, Tamara] Univ Hawaii Manoa, Bot Dept, Honolulu, HI USA; [Fonseca, Amanda Surerus] Ctr Ensino Super Juiz Fora, Juiz De Fora, MG, Brazil; [Yazbek, Priscila Baptistella; Sauini, Thamara] Univ Fed Sao Paulo, Ctr Ethnobot & Ethnopharmacol Studies, Dept Environm Sci, Sao Paulo, Brazil; [Rodrigues, Eliana] Univ Fed Sao Paulo, Dept Environm Sci, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Instituto de Botanica - Sao Paulo; University of Hawaii System; University of Hawaii Manoa; Centro de Ensino Superior de Juiz de Fora (CES/JF); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Conde, BE (corresponding author), Univ Fed Sao Paulo, Dept Biol Sci, Postgrad Program Chem Biol, Sao Paulo, Brazil.; Conde, BE (corresponding author), Ctr Univ Estacio Sa, Juiz De Fora, MG, Brazil.	bcondebio@hotmail.com	Rodrigues, Eliana/B-5839-2013; Conde, Bruno/I-3681-2016	Rodrigues, Eliana/0000-0001-8847-6676; Conde, Bruno/0000-0002-7542-2828	FAPESP - BIOTA PROGRAM [2015/12046-0]; CNPq [400802/2016-3]	FAPESP - BIOTA PROGRAM(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FAPESP - BIOTA PROGRAM (case number 2015/12046-0) and CNPq -Universal 2016 (case number 400802/2016-3).	AbSaber A. N, 2003, OS DOMINIOS NATUREZA; Albuquerque UP, MEIO AMBIENTE DESENV, V13, P277; [Anonymous], 2020, NAT PHYS, V16, P1, DOI 10.1038/s41567-019-0781-4; [Anonymous], COMUNIDADES TRADICIO; [Anonymous], 2008, BIODIVERSIDADE BRASI; [Anonymous], J PAN AFR STUD; [Anonymous], THESIS; [Anonymous], 2016, FLORA BRASILIENSIS O; [Anonymous], 2007, REL PED REC AR QUIL, P55; Araujo E.L., 2010, METODOS TECNICAS PES, P223; BARSTOW M, 2018, CEDRELA FISSILIS, DOI DOI 10.2305/IUCN.UK.2018-1.RLTS.T33928A68080477.EN; Bernard H.R., 1988, RES METHODS CULTURAL; CASTRO L. H. S., 2015, THESIS; Catharino Eduardo Luís Martins, 2006, Biota Neotrop., V6, P0, DOI 10.1590/S1676-06032006000200004; CNCFlora, PLIN ED LIST VERM FL; CNCFlora, LIST VERM FLOR BRAS; CNCFlora, VIR BIC LIST VERM FL; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Conde BE, 2016, THESIS; Conde BE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187599; Cunha MC, 2001, BIODIVERSIDADE AMAZO; de Oliveira RLC, 2007, ENVIRON MONIT ASSESS, V132, P189, DOI 10.1007/s10661-006-9528-7; DZEREFOS CM, 2001, BIODIVERS CONSERV, V10, P1875, DOI DOI 10.1023/A:1013177628331; Ferreti ARA, 2003, SEM REST FLOR CUR 20, P1; FUNDART, 2014, QUIL PREF MUN UB; GANDOLFI S., 1995, REV BRAS BIOL, V55, P753; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Hanazaki Natalia, 2018, Rodriguésia, V69, P1587, DOI 10.1590/2175-7860201869409; Hanazaki N., 2003, BIOTEMAS FLORIAN POL, V16, P23, DOI DOI 10.5007/%25x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hoermann S, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P199, DOI 10.1109/ICVR.2015.7358575; International Union for Conservation of Nature (IUCN), 2019, RED LIST THREAT PLAN; Joly Carlos Alfredo, 2012, Biota Neotrop., V12, P125, DOI 10.1590/S1676-06032012000100012; Mander J.J., 1997, TRADE WILDLIFE MEDIC; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; de Lucena RFP, 2012, J ENVIRON MANAGE, V96, P106, DOI 10.1016/j.jenvman.2011.09.001; Peralta RL, 2012, THESIS; Barretto Eduardo Hortal Pereira, 2015, Hoehnea, V42, P445, DOI 10.1590/2236-8906-72/2014; Posey DA, 1990, AMAZONIA ADEUS; Sauini T, 2019, THESIS; Crepaldi MOS, 2010, BIODIVERS CONSERV, V19, P37, DOI 10.1007/s10531-009-9700-9; Souza AD, 2017, ACTA BOT BRAS, V31, P169, DOI 10.1590/0102-33062017abb0027; Stehmann J. R., 2009, PLANTAS FLORESTA ATL; Tabarelli M., 1999, Revista Brasileira de Biologia, V59, P251, DOI 10.1590/S0034-71081999000200009; Ticktin T, 2018, CONSERV BIOL, V32, P1085, DOI 10.1111/cobi.13152; Ticktin T, 2011, NON-TIMBER FOREST PRODUCTS IN THE GLOBAL CONTEXT, P149, DOI 10.1007/978-3-642-17983-9_7; Yazbek P, 2018, THESIS; Yazbek PB, 2019, J ETHNOPHARMACOL, V244, DOI 10.1016/j.jep.2019.112123	49	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238914	10.1371/journal.pone.0238914	http://dx.doi.org/10.1371/journal.pone.0238914			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946472	gold, Green Published			2022-12-26	WOS:000573851100011
J	Ilic, I; Orsolic, N; Rodak, E; Odeh, D; Lovric, M; Mujkic, R; Azdajic, MD; Grgic, A; Levak, MT; Vargek, M; Dmitrovic, B; Belovari, T				Ilic, Ivana; Orsolic, Nada; Rodak, Edi; Odeh, Dyana; Lovric, Marko; Mujkic, Robert; Azdajic, Marija Delas; Grgic, Andela; Levak, Maja Tolusic; Vargek, Martin; Dmitrovic, Branko; Belovari, Tatjana			The effect of high-fat diet and 13-cis retinoic acid application on lipid profile, glycemic response and oxidative stress in female Lewis rats	PLOS ONE			English	Article							13-CIS-RETINOIC ACID; INSULIN-RESISTANCE; REGULATES OBESITY; ADIPOSE-TISSUE; ORAL TREATMENT; WEIGHT-GAIN; METABOLISM; GLUCOSE; LIVER; INFLAMMATION	Vitamin A and its metabolites are key regulators of the development of adipose tissue and associated metabolic complications. The aim of this study was to determine the effect of high fat diet and 13-cis retinoic acid (13 cRA) application on metabolic parameters, adipogenic and inflammatory indicators in female Lewis rats. Female rats of Lewis strain were fed standard laboratory diet (STD) and high fat diet (HFD, 45% of saturated fatty acids) during 30 days. The groups were divided into additional 3 groups (6 rats each): two experimental groups that received 13 cRA orally on a daily basis during 30 days (7.5 mg/kg and 15 mg/kg, respectively) and the control group that was given sunflower oil. Animals were sacrificed after 60 days. Feeding of Lewis rats with chronic HFD diet with 13 cRA supplementation increased weight gain, adiposity index, dyslipidaemia, hyperleptinaemia, insulin resistance, VLDL concentrations, oxidative stress and atherogenic indices. Administration of 13 cRA in Lewis rats fed STD did not change the weight of the animals, but it slightly increased the atherogenic parameters. 13 cRA and HFD affect metabolic parameters, glucose and lipid metabolism in Lewis rats and its administration has a completely different effect on metabolism in rats fed STD, highlighting the complex role of vitamin A supplementation in obesity. Other factors, such as genetics, age, sex, adipose tissue distribution, also must be taken into consideration.	[Ilic, Ivana; Mujkic, Robert; Grgic, Andela; Dmitrovic, Branko] Josip Juraj Strossmayer Univ Osijek, Fac Dent Med & Hlth, Dept Anat Histol Embryol Pathol Anat & Pathol His, Osijek, Croatia; [Ilic, Ivana; Rodak, Edi; Lovric, Marko; Levak, Maja Tolusic; Belovari, Tatjana] Josip Juraj Strossmayer Univ Osijek, Fac Med Osijek, Dept Histol & Embryol, Osijek, Croatia; [Orsolic, Nada; Odeh, Dyana] Univ Zagreb, Fac Sci Zagreb, Dept Anim Physiol, Zagreb, Croatia; [Azdajic, Marija Delas] Sestre Milosrdnice Univ Hosp Ctr, Dept Dermatol & Venereol, Zagreb, Croatia; [Levak, Maja Tolusic] Univ Hosp Osijek, Dept Dermatol & Venereol, Osijek, Croatia; [Vargek, Martin] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria; [Dmitrovic, Branko] Univ Hosp Osijek, Clin Inst Pathol & Forens Med, Osijek, Croatia	University of JJ Strossmayer Osijek; University of JJ Strossmayer Osijek; University of Zagreb; University of Zagreb; Medical University of Graz	Ilic, I (corresponding author), Josip Juraj Strossmayer Univ Osijek, Fac Dent Med & Hlth, Dept Anat Histol Embryol Pathol Anat & Pathol His, Osijek, Croatia.; Ilic, I (corresponding author), Josip Juraj Strossmayer Univ Osijek, Fac Med Osijek, Dept Histol & Embryol, Osijek, Croatia.	ilic.ivana2212@gmail.com	Delaš Aždajić, Marija/R-8470-2019; Delaš Aždajić, Marija/U-4713-2019; Odeh, Dyana/AAY-5158-2021; Odeh, Dyana/AAU-9279-2021	Delaš Aždajić, Marija/0000-0003-3619-0216; Delaš Aždajić, Marija/0000-0003-3619-0216; Odeh, Dyana/0000-0002-6182-755X; Mujkic, Robert/0000-0002-8799-521X	Faculty of Dental Medicine and Health [VIF-2018-FDMZOS-O4, IP1 2019]; Faculty of Dental Medicine	Faculty of Dental Medicine and Health; Faculty of Dental Medicine	This work was supported in part by Faculty of Dental Medicine and Health under grants ID: VIF-2018-FDMZOS-O4 and ID: IP1 2019. There was no additional external funding received for this study. Faculty of Dental Medicine and Health did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Akyol M, 2005, AM J CLIN DERMATOL, V6, P175, DOI 10.2165/00128071-200506030-00004; ATGIE C, 1993, AM J PHYSIOL, V265, pC1674, DOI 10.1152/ajpcell.1993.265.6.C1674; Auberval N, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-130; BARTH JH, 1993, BRIT J DERMATOL, V129, P704, DOI 10.1111/j.1365-2133.1993.tb03336.x; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Behiry EG, 2019, ENDOCR METAB IMMUNE, V19, P676, DOI 10.2174/1871530319666190121123535; Blaner WS, 2001, J AM ACAD DERMATOL, V45, pS129, DOI 10.1067/mjd.2001.113714; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Borrayo G, 2018, ACTA ENDOCRINOL-BUCH, V14, P261, DOI 10.4183/aeb.2018.261; Bowe JE, 2014, J ENDOCRINOL, V222, pG13, DOI 10.1530/JOE-14-0182; Brzovic-Saric V, 2015, MOL VIS, V21, P649; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Carre N, 2014, BIOCHIMIE, V97, P16, DOI 10.1016/j.biochi.2013.09.023; Cisneros FJ, 2005, J APPL TOXICOL, V25, P470, DOI 10.1002/jat.1082; Crawford M, 2019, LIPIDS, V54, P119, DOI 10.1002/lipd.12131; de Oliveira MR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/140267; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Faran SA, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55090579; Ferguson SA, 2006, BASIC CLIN PHARMACOL, V98, P582, DOI 10.1111/j.1742-7843.2006.pto_359.x; Ferguson SA, 2005, FOOD CHEM TOXICOL, V43, P1289, DOI 10.1016/j.fct.2005.02.016; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Forbat E, 2018, J DERMATOL TREAT, V29, P698, DOI 10.1080/09546634.2018.1445194; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Garcia OP, 2012, P NUTR SOC, V71, P290, DOI 10.1017/S0029665112000079; Geng C, 2017, SCI CHINA LIFE SCI, V60, P1234, DOI [10.1007/s11, 10.1007/s11427-016-9027-6]; Granados N, 2013, INT J OBESITY, V37, P1169, DOI 10.1038/ijo.2012.190; He YH, 2011, J NUTR, V141, P1938, DOI 10.3945/jn.111.141762; Heliovaara MK, 2007, METABOLISM, V56, P786, DOI 10.1016/j.metabol.2007.02.002; Huang BW, 2004, DIABETES OBES METAB, V6, P120, DOI 10.1111/j.1462-8902.2004.00323.x; Hyatt GA, 1997, INVEST OPHTH VIS SCI, V38, P1471; Jeyakumar SM, 2008, BIOCHEM BIOPH RES CO, V370, P243, DOI 10.1016/j.bbrc.2008.03.073; Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7; Jeyakumar SM, 2015, EXP PHYSIOL, V100, P1352, DOI 10.1113/EP085027; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; KIM YB, 1995, BIOCHEM BIOPH RES CO, V208, P1092, DOI 10.1006/bbrc.1995.1446; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahalle Namita, 2014, Indian J Endocrinol Metab, V18, P48, DOI 10.4103/2230-8210.126532; Marques C, 2016, ADIPOCYTE, V5, P11, DOI 10.1080/21623945.2015.1061723; Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Napoli JL, 1996, FASEB J, V10, P993, DOI 10.1096/fasebj.10.9.8801182; Noeman SA, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-17; Obregon MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00479; Orsolic N, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8060156; Parra P, 2008, J NUTR BIOCHEM, V19, P109, DOI 10.1016/j.jnutbio.2007.01.009; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; Peelman F, 2004, PROG LIPID RES, V43, P283, DOI 10.1016/j.plipres.2004.03.001; Pertynska-Marczewska M, 2004, CYTOKINE, V28, P35, DOI 10.1016/j.cyto.2004.06.006; Poston WSC, 1999, ATHEROSCLEROSIS, V146, P201, DOI 10.1016/S0021-9150(99)00258-0; Ramli NS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1200-3; Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379; SAFONOVA I, 1994, MOL CELL ENDOCRINOL, V104, P201, DOI 10.1016/0303-7207(94)90123-6; SAMOKYSZYN VM, 1990, METHOD ENZYMOL, V190, P281; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Scherberich JE, 2003, INT J CLIN PHARM TH, V41, P459; Schuitmaker JJ, 1996, J PHOTOCH PHOTOBIO B, V34, P3, DOI 10.1016/1011-1344(96)07342-3; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Seo DC, 2017, PREV MED, V97, P100, DOI 10.1016/j.ypmed.2017.01.012; Shurtz-Swirski R, 2001, DIABETES CARE, V24, P104, DOI 10.2337/diacare.24.1.104; Snel M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/983814; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Wong SK, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0123-9; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Zarei L, 2019, VET RES FORUM, V10, P133, DOI 10.30466/vrf.2019.74079.1996; Zhang M, 2015, J PHARMACOL SCI, V127, P430, DOI 10.1016/j.jphs.2015.03.001; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081	71	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238600	10.1371/journal.pone.0238600	http://dx.doi.org/10.1371/journal.pone.0238600			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32947606	gold, Green Published			2022-12-26	WOS:000573851100039
J	Hanson, A; Elpek, K; Duong, E; Shallberg, L; Fan, M; Johnson, C; Wallace, M; Mabry, GR; Sazinsky, S; Pepper, L; Shu, CJ; Sathyanarayanan, S; Zuerndorfer, S; Simpson, T; Gostissa, M; Briskin, M; Law, D; Michaelson, J; Harvey, CJ				Hanson, Amanda; Elpek, Kutlu; Duong, Ellen; Shallberg, Lindsey; Fan, Martin; Johnson, Calvin; Wallace, Matthew; Mabry, George R.; Sazinsky, Stephen; Pepper, Lauren; Shu, Chengyi J.; Sathyanarayanan, Sriram; Zuerndorfer, Sarah; Simpson, Tyler; Gostissa, Monica; Briskin, Michael; Law, Deborah; Michaelson, Jennifer; Harvey, Christopher J.			ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; CTLA-4 BLOCKADE; LIGAND; RESPONSES; THERAPY; MICROENVIRONMENT; EXPRESSION; EFFICACY; H4/ICOS; PATHWAY	Immunotherapy checkpoint inhibitors, such as antibodies targeting PD-1 and CTLA-4, have demonstrated the potential of harnessing the immune system to treat cancer. However, despite encouraging results particularly with respect to survival, only a minority of patients benefit from these therapies. In clinical studies aimed at understanding changes in the immune system following immunotherapy treatment, ICOS (Inducible T cell CO-Stimulator) was shown to be significantly up-regulated on CD4+ T cells and this was associated with clinical activity, indicating that ICOS stimulatory activity may be beneficial in the treatment of solid tumors. In this report, we describe the generation of specific, species cross-reactive, agonist antibodies to ICOS, including the humanized clinical candidate, JTX-2011 (vopratelimab). Preclinical studies suggest that the ICOS stimulating antibodies require Fc receptor cross-linking for optimal agonistic activity. Notably, the ICOS antibodies do not exhibit superagonist properties but rather require T cell receptor (TCR)-mediated upregulation of ICOS for agonist activity. Treatment with the ICOS antibodies results in robust anti-tumor benefit and long-term protection in preclinical syngeneic mouse tumor models. Additional benefit is observed when the ICOS antibodies are administered in combination with anti-PD-1 and anti-CTLA-4 therapies. Based on the preclinical data, JTX-2011 is currently being developed in the clinical setting for the treatment of solid tumors.	[Hanson, Amanda; Elpek, Kutlu; Duong, Ellen; Shallberg, Lindsey; Fan, Martin; Johnson, Calvin; Simpson, Tyler; Michaelson, Jennifer; Harvey, Christopher J.] Jounce Therapeut Inc, Preclin Sci, Cambridge, MA 02139 USA; [Wallace, Matthew; Mabry, George R.; Sazinsky, Stephen; Pepper, Lauren; Zuerndorfer, Sarah] Jounce Therapeut Inc, Prot Sci, Cambridge, MA USA; [Shu, Chengyi J.; Sathyanarayanan, Sriram] Jounce Therapeut Inc, Translat Sci, Cambridge, MA USA; [Gostissa, Monica] Jounce Therapeut Inc, Pharmacol, Cambridge, MA USA; [Briskin, Michael; Law, Deborah] Jounce Therapeut Inc, Res, Cambridge, MA USA		Harvey, CJ (corresponding author), Jounce Therapeut Inc, Preclin Sci, Cambridge, MA 02139 USA.	charvey@jouncetx.com		Shallberg, Lindsey/0000-0001-6573-7327	Jounce Therapeutics	Jounce Therapeutics	This study was funded by Jounce Therapeutics. The funder provided support in the form of salaries for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ara G, 2003, INT J CANCER, V103, P501, DOI 10.1002/ijc.10831; Arimura Y, 2002, INT IMMUNOL, V14, P555, DOI 10.1093/intimm/dxf022; Carthon BC, 2010, CLIN CANCER RES, V16, P2861, DOI 10.1158/1078-0432.CCR-10-0569; Chattopadhyay K, 2006, J IMMUNOL, V177, P3920, DOI 10.4049/jimmunol.177.6.3920; Dahan R, 2016, CANCER CELL, V29, P820, DOI 10.1016/j.ccell.2016.05.001; Eastwood D, 2013, BRIT J CLIN PHARMACO, V76, P299, DOI 10.1111/bcp.12165; Faget J, 2012, CANCER RES, V72, P6130, DOI 10.1158/0008-5472.CAN-12-2409; Fan XZ, 2014, J EXP MED, V211, P715, DOI 10.1084/jem.20130590; Feito MJ, 2003, EUR J IMMUNOL, V33, P204, DOI 10.1002/immu.200390023; Fos C, 2008, J IMMUNOL, V181, P1969, DOI 10.4049/jimmunol.181.3.1969; Fu TH, 2011, CANCER RES, V71, P5445, DOI 10.1158/0008-5472.CAN-11-1138; Furness AJS, 2014, TRENDS IMMUNOL, V35, P290, DOI 10.1016/j.it.2014.05.002; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Huang XM, 2014, CANCER SCI, V105, P150, DOI 10.1111/cas.12327; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Maazi H, 2015, IMMUNITY, V42, P538, DOI 10.1016/j.immuni.2015.02.007; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Metzger TC, 2016, CANCER RES, V76, P3684, DOI 10.1158/0008-5472.CAN-15-3412; Nagashima H, 2018, J ALLERGY CLIN IMMUN, V141, P1939, DOI 10.1016/j.jaci.2018.01.028; Okamoto N, 2003, BIOCHEM BIOPH RES CO, V310, P691, DOI 10.1016/j.bbrc.2003.09.065; Quezada SA, 2019, CLIN CANCER RES, V25, P1130, DOI 10.1158/1078-0432.CCR-18-2509; Seo Y, 2014, ONCOL REP, V31, P2115, DOI 10.3892/or.2014.3077; Sharma A, 2019, CLIN CANCER RES, V25, P1233, DOI 10.1158/1078-0432.CCR-18-0762; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Simpson TR, 2010, CURR OPIN IMMUNOL, V22, P326, DOI 10.1016/j.coi.2010.01.001; Stebbings R, 2013, J IMMUNOTOXICOL, V10, P75, DOI 10.3109/1547691X.2012.711783; Suh WK, 2004, J IMMUNOL, V172, P5917, DOI 10.4049/jimmunol.172.10.5917; The Lancet Global Health, 2018, LANCET GLOB HLTH, V6, pE593; Trehu E, 2019, KEYSTONE S CANC IMMU; Velders MP, 1998, BRIT J CANCER, V78, P478, DOI 10.1038/bjc.1998.518; Vidric M, 2005, J IMMUNOL, V175, P7288, DOI 10.4049/jimmunol.175.11.7288; Waibler Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001708; Wallin JJ, 2001, J IMMUNOL, V167, P132, DOI 10.4049/jimmunol.167.1.132; Watanabe R, 2006, J IMMUNOL, V177, P1085, DOI 10.4049/jimmunol.177.2.1085; Yao S, 2011, IMMUNITY, V34, P729, DOI 10.1016/j.immuni.2011.03.014; Zamarin D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14340	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239595	10.1371/journal.pone.0239595	http://dx.doi.org/10.1371/journal.pone.0239595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970735	Green Published, gold			2022-12-26	WOS:000576265600089
J	Choi, JA; Park, YM; Han, K; Lee, J; Yun, JS; Ko, SH				Choi, Jin A.; Park, Yong-Moon; Han, Kyungdo; Lee, Jiyoung; Yun, Jae-Seung; Ko, Seung-Hyun			Fasting plasma glucose level and the risk of open angle glaucoma: Nationwide population-based cohort study in Korea	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; INTRAOCULAR-PRESSURE; ENVIRONMENT; HEALTH	Background The level of fasting plasma glucose (FPG) is positively associated with intraocular pressure. Diabetes causes early structural changes of retina, especially on ganglion cell layer. In this regard, the FPG level itself may also show an independent association with open angle glaucoma (OAG) development in general population. Herein, we investigate the association of the FPG level with the incidence of OAG. Methods Using nationally representative data from the Korean National Health Insurance System, 374,376 subjects >= 40 years of age without OAG who underwent health examinations from 2009 to 2013 were enrolled and followed to the end of 2014. Incident cases of OAG using the International Classification of Diseases 10 codes and medication information were analyzed based on the levels of FPG. Results Subjects with the highest FPG level (>= 160 mg/dL), compared with the lowest level (<80 mg/dL), showed a higher hazard ratio (HR) [2.189; 95% confidence interval (CI): 1.779-2.695;Pfor trend < 0.001] for OAG after adjustments for age and sex. This result persisted after further adjustments for the presence of type 2 diabetes, current smoking, drinking, and exercise habits, diastolic blood pressure, body mass index (BMI), and total cholesterol level (HR: 1.588; 95% CI: 1.268-1.989;Pfor trend < 0.001). The positive association between the FPG level and the incidence of OAG was distinct in subjects 40-64 years of age, those with a BMI <25 kg/m(2), and those without hypertension (HR 2.022; 95% CI: 1.494-2.736;Pfor trend Pfor trend < 0.001: HR 1.706; 95% CI: 1.180-2.467;Pfor trend <0.001, respectively). Conclusions This nationwide population-based cohort study showed that the fasting glucose was associated with an increased risk of OAG. These findings suggest that subjects with high FPG levels require special attention when screening for glaucoma.	[Choi, Jin A.; Lee, Jiyoung] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, St Vincents Hosp, Seoul, South Korea; [Park, Yong-Moon] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Han, Kyungdo] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea; [Yun, Jae-Seung; Ko, Seung-Hyun] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,St Vincents Hosp, Seoul, South Korea	Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Soongsil University; Catholic University of Korea	Ko, SH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab,St Vincents Hosp, Seoul, South Korea.	kosh@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Ko, Seung-Hyun/0000-0003-3703-1479	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI18C0275]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (Grant Number: HI18C0275, Recipient: SHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Bae EH, 2019, HYPERTENSION, V74, P880, DOI 10.1161/HYPERTENSIONAHA.119.13422; Blackwell B, 2002, AM J OPHTHALMOL, V134, P499; Brannick B, 2016, EXP BIOL MED, V241, P1323, DOI 10.1177/1535370216654227; Choi JA, 2015, OPHTHALMOLOGY, V122, P976, DOI 10.1016/j.ophtha.2015.01.001; Chopra V, 2008, OPHTHALMOLOGY, V115, P227, DOI 10.1016/j.ophtha.2007.04.049; Chrysostomou V, 2010, OPHTHALMIC RES, V44, P173, DOI 10.1159/000316478; Clermont AC, 2007, MICROCIRCULATION, V14, P49, DOI 10.1080/10739680601072164; Cohen E, 2017, J GLAUCOMA, V26, P652, DOI 10.1097/IJG.0000000000000700; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; de Voogd S, 2006, OPHTHALMOLOGY, V113, P1827, DOI 10.1016/j.ophtha.2006.03.063; DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493; Dimitrova G, 2017, INVEST OPHTH VIS SCI, V58, P190, DOI 10.1167/iovs.16-20531; Downs JC, 2008, OPTOMETRY VISION SCI, V85, P425, DOI 10.1097/OPX.0b013e31817841cb; Fleming C, 2005, ANN FAM MED, V3, P167, DOI 10.1370/afm.293; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Haffner Steven M, 2004, Diabetes Care, V27 Suppl 1, pS68; Jeganathan VSE, 2008, DIABETES CARE, V31, P1905, DOI 10.2337/dc08-0342; Jonas JB, 2017, LANCET, V390, P2183, DOI 10.1016/S0140-6736(17)31469-1; Jung Y, 2018, DIABETES METAB, V44, P328, DOI 10.1016/j.diabet.2017.09.007; Kanamori A, 2004, CURR EYE RES, V28, P47, DOI 10.1076/ceyr.28.1.47.23487; Kim BY, 2019, DIABETES METAB J, V43, P487, DOI 10.4093/dmj.2019.0067; Kim H, 2019, AM J HYPERTENS, V32, P308, DOI 10.1093/ajh/hpy186; Kim HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38283; Kim MJ, 2014, ACTA OPHTHALMOL, V92, pe507, DOI 10.1111/aos.12327; Ko SH, 2018, DIABETES METAB J, V42, P93, DOI 10.4093/dmj.2018.42.2.93; Lee YH, 2016, DIABETES METAB J, V40, P79, DOI 10.4093/dmj.2016.40.1.79; Maul EA, 2010, OPHTHALMOLOGY, V117, P1665, DOI 10.1016/j.ophtha.2009.11.001; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Mitsumatsu T, 2018, DIABETES, V67, DOI 10.2337/db18-602-P; Na KI, 2019, J GLAUCOMA, V28, P111, DOI 10.1097/IJG.0000000000001134; Nguyen TT, 2007, DIABETES CARE, V30, P2708, DOI 10.2337/dc07-0732; Park HYL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07890-6; Park S, 2019, J GASTROENTEROL, V54, P881, DOI 10.1007/s00535-019-01589-3; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Rim TH, 2017, J HYPERTENS, V35, P729, DOI 10.1097/HJH.0000000000001225; Sase K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00425; Sato T, 2002, INVEST OPHTH VIS SCI, V43, P170; Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Unnikrishnan R, 2017, DIABETES, V66, P1432, DOI 10.2337/db16-0766; Verma A, 2009, EYE, V23, P1824, DOI 10.1038/eye.2009.184; Wasserman DH, 2018, CIRC RES, V122, P1135, DOI 10.1161/CIRCRESAHA.118.311912; Wygnanski-Jaffe T, 2015, INT J OPHTHALMOL-CHI, V8, P403, DOI 10.3980/j.issn.2222-3959.2015.02.34; Yi SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08498-6; Zhao D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112460; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239529	10.1371/journal.pone.0239529	http://dx.doi.org/10.1371/journal.pone.0239529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966328	Green Published, gold			2022-12-26	WOS:000575688700009
J	Scheuren, AC; Kuhn, GA; Muller, R				Scheuren, Ariane C.; Kuhn, Gisela A.; Mueller, Ralph			Effects of long-term in vivo micro-CT imaging on hallmarks of osteopenia and frailty in aging mice	PLOS ONE			English	Article							PROXIMAL TIBIA; COMPUTED TOMOGRAPHY; BONE ARCHITECTURE; TRABECULAR BONE; INBRED STRAINS; CORTICAL BONE; RADIATION; INDEX; ADULTS; RISK	In vivomicro-CT has already been used to monitor microstructural changes of bone in mice of different ages and in models of age-related diseases such as osteoporosis. However, as aging is accompanied by frailty and subsequent increased sensitivity to external stimuli such as handling and anesthesia, the extent to which longitudinal imaging can be applied in aging studies remains unclear. Consequently, the potential of monitoring individual mice during the entire aging process-from healthy to frail status-has not yet been exploited. In this study, we assessed the effects of long-termin vivomicro-CT imaging-consisting of 11 imaging sessions over 20 weeks-on hallmarks of aging both on a local (i.e., static and dynamic bone morphometry) and systemic (i.e., frailty index (FI) and body weight) level at various stages of the aging process. Furthermore, using a premature aging model (PolgA((D257A/D257A))), we assessed whether these effects differ between genotypes. The 6(th)caudal vertebrae of 4 groups of mice (PolgA((D257A/D257A))and PolgA((+/+))) were monitored byin vivomicro-CT every 2 weeks. One group was subjected to 11 scans between weeks 20 and 40 of age, whereas the other groups were subjected to 5 scans between weeks 26-34, 32-40 and 40-46, respectively. The long-term monitoring approach showed small but significant changes in the static bone morphometric parameters compared to the other groups. However, no interaction effect between groups and genotype was found, suggesting that PolgA mutation does not render bone more or less susceptible to long-term micro-CT imaging. The differences between groups observed in the static morphometric parameters were less pronounced in the dynamic morphometric parameters. Moreover, the body weight and FI were not affected by more frequent imaging sessions. Finally, we observed that longitudinal designs including baseline measurements at young adult age are more powerful at detecting effects ofin vivomicro-CT imaging on hallmarks of aging than cross-sectional comparisons between multiple groups of aged mice subjected to fewer imaging sessions.	[Scheuren, Ariane C.; Kuhn, Gisela A.; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Muller, R (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	ram@ethz.ch	Müller, Ralph/A-1198-2008	Müller, Ralph/0000-0002-5811-7725	European Cooperation in Science and Technology (COST Action) [BM1402]; European Research Council (ERC Advanced MechAGE ERC-2016-ADG) [741883]	European Cooperation in Science and Technology (COST Action)(European Cooperation in Science and Technology (COST)); European Research Council (ERC Advanced MechAGE ERC-2016-ADG)(European Research Council (ERC))	This manuscript is based upon work supported by the European Cooperation in Science and Technology (COST Action BM1402: MouseAGE) and the European Research Council (ERC Advanced MechAGE ERC-2016-ADG-741883).	[Anonymous], 2018, CANC DISCOV, V8, pOF6; [Anonymous], 2017, HEMONC TODAY, V18, P46; Banga S, 2019, MECH AGEING DEV, V179, P1, DOI 10.1016/j.mad.2019.01.008; Barth HD, 2010, BONE, V46, P1475, DOI 10.1016/j.bone.2010.02.025; BELL EG, 1969, RADIOLOGY, V92, P1083, DOI 10.1148/92.5.1083; Bellantuono I, 2020, NAT PROTOC, V15, P540, DOI 10.1038/s41596-019-0256-1; Bellantuono I, 2018, NATURE, V554, P293, DOI 10.1038/d41586-018-01668-0; Birkhold AI, 2014, BONE, V66, P15, DOI 10.1016/j.bone.2014.05.013; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Brouwers JEM, 2007, J ORTHOP RES, V25, P1325, DOI 10.1002/jor.20439; Buie HR, 2008, J BONE MINER RES, V23, P2048, DOI 10.1359/JBMR.080808; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Currey JD, 1997, J ORTHOP RES, V15, P111, DOI 10.1002/jor.1100150116; Dall'Ara E, 2016, MECH AGEING DEV, V160, P93, DOI 10.1016/j.mad.2016.08.001; Department of Economic and Social Affairs PD, 2020, STESASERA444 DEP EC; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; ERIKSEN EF, 1986, ENDOCR REV, V7, P379, DOI 10.1210/edrv-7-4-379; Fang X, 2012, J NUTR HEALTH AGING, V16, P903, DOI 10.1007/s12603-012-0368-6; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feridooni HA, 2015, J GERONTOL A-BIOL, V70, P686, DOI 10.1093/gerona/glu161; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Friese MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209283; Geurts J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58385-w; Hildebrandt IJ, 2008, ILAR J, V49, P17, DOI 10.1093/ilar.49.1.17; Hohlbaum K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179588; Jones DM, 2004, J AM GERIATR SOC, V52, P1929, DOI 10.1111/j.1532-5415.2004.52521.x; Kane AE, 2016, CLIN INTERV AGING, V11, P1519, DOI 10.2147/CIA.S105714; Kennedy CC, 2014, OSTEOPOROSIS INT, V25, P2825, DOI 10.1007/s00198-014-2828-9; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lambers FM, 2015, J BIOMECH, V48, P1179, DOI 10.1016/j.jbiomech.2014.11.020; Lambers FM, 2011, BONE, V49, P1340, DOI 10.1016/j.bone.2011.08.035; Laperre K, 2011, BONE, V49, P613, DOI 10.1016/j.bone.2011.06.031; Levchuk A, 2014, CLIN BIOMECH, V29, P355, DOI 10.1016/j.clinbiomech.2013.12.019; Li XM, 2014, ANESTHESIOLOGY, V121, P79, DOI 10.1097/ALN.0000000000000191; Longo AB, 2016, CALCIFIED TISSUE INT, V98, P631, DOI 10.1007/s00223-016-0113-y; Mustafy T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207323; Pacheco R, 2013, CURR OSTEOPOROS REP, V11, P299, DOI 10.1007/s11914-013-0174-z; Pendleton MM, 2019, BONE, V128, DOI 10.1016/j.bone.2019.115043; Razi H, 2015, ACTA BIOMATER, V13, P301, DOI 10.1016/j.actbio.2014.11.021; Robey PG, 1999, AGING SKELETON, P145; Rockwood K, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43068; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Scheuren AC, 2020, J CACHEXIA SARCOPENI, V11, P1121, DOI 10.1002/jcsm.12588; Schulte FA, 2011, BONE, V48, P433, DOI 10.1016/j.bone.2010.10.007; Tremoleda JL, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-44; Tremoleda JL, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-11; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; von Zglinicki T, 2016, MECH AGEING DEV, V160, P34, DOI 10.1016/j.mad.2016.07.004; Wehrle E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53822-x; Whitehead JC, 2014, J GERONTOL A-BIOL, V69, P621, DOI 10.1093/gerona/glt136; Willey JS, 2010, BONE, V46, P101, DOI 10.1016/j.bone.2009.09.002; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Xu H, 2014, J ALZHEIMERS DIS, V39, P29, DOI 10.3233/JAD-130902; Yang HS, 2014, BONE, V66, P131, DOI 10.1016/j.bone.2014.05.019	56	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239534	10.1371/journal.pone.0239534	http://dx.doi.org/10.1371/journal.pone.0239534			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966306	gold, Green Published, Green Submitted			2022-12-26	WOS:000575688700028
J	Bekele, T; Rahman, B; Rawstorne, P				Bekele, Tolesa; Rahman, Bayzidur; Rawstorne, Patrick			The effect of access to water, sanitation and handwashing facilities on child growth indicators: Evidence from the Ethiopia Demographic and Health Survey 2016	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; NUTRITIONAL INTERVENTIONS; HYGIENE; ENTEROPATHY; UNDERNUTRITION; MALNUTRITION; MORTALITY; DIARRHEA; DISEASE; QUALITY	Introduction Poor access to water, sanitation, and handwashing (WASH) facilities frequently contribute to child growth failure. The role of access to WASH facilities on child growth outcomes in Ethiopia is largely unknown. The aim of this study was to determine individual and combined effects of access to WASH facilities on child growth outcomes. Methods Data for this analysis was sourced from the recent Ethiopia Demographic and Health Survey (EDHS) 2016. A multivariable logistic regression model was applied to identify the separate and combined association of access to WASH facilities with child growth outcomes. Odds ratio (OR) and 95% confidence interval (CI) were estimated. Statistical significance was declared at p < 0.05. Results Included in the analyses were data for children 0-59 months of age, which amounted to valid data for 9588 children with a height-for-age z-score (HAZ), 9752 children with a weight-for-age z-score (WAZ) and 9607 children with a weight-for-height z-score (WHZ). Children with access to improved combined sanitation with handwashing facilities had 29% lower odds of linear growth failure (stunting) (adjusted odds ratio (AOR) = 0.71; 95% CI: 0.51-0.99) compared with those with unimproved. Children with access to combined improved WASH facilities were 33% less likely to have linear growth failure (AOR = 0.67; 95% CI: 0.45-0.98). Access to improved handwashing alone reduced the odds of being underweight by 17% (AOR = 0.83; 95% CI: 0.71-0.98) compared with unimproved. Improved water and sanitation separately as well as combined WASH were not associated with decreased odds of underweight and wasting. Conclusions Combined access to improved water, sanitation and handwashing was associated with reduced child linear growth failure. Further research with robust methods is needed to examine whether combined WASH practices have synergistic effect on child growth outcomes.	[Rahman, Bayzidur; Rawstorne, Patrick] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Bekele, Tolesa] Ambo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Oromia, Ethiopia	University of New South Wales Sydney; Ambo University	Bekele, T (corresponding author), Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia.; Bekele, T (corresponding author), Ambo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Oromia, Ethiopia.	t.okuba@unsw.edu.au			University of New South Wales (UNSW), Australia	University of New South Wales (UNSW), Australia	The authors are grateful to The University of New South Wales (UNSW), Australia for providing PhD scholarship for the primary author. The data used in this study were taken from DHS Archive and the authors acknowledge the DHS Program for allowing us to use the dataset. The analysis and interpretation of the findings in this study are the responsibility of the authors and do not necessarily reflect the view of the DHS Program.	[Anonymous], 2015, CANC DISCOV, V5, pOF2; [Anonymous], 2016, PEDIATRICS, V138; [Anonymous], 2010, DRUG DISCOV TODAY-TE, V7, pe1; Arnold B, 2009, INT J EPIDEMIOL, V38, P1651, DOI 10.1093/ije/dyp241; Arnold BF, 2010, P NATL ACAD SCI USA, V107, P22605, DOI 10.1073/pnas.1008944107; Biran A, 2008, TROP MED INT HEALTH, V13, P278, DOI 10.1111/j.1365-3156.2007.02001.x; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boyle EH, 2017, IPUMS DEMOGRAPHIC HL, DOI [10.18128/D080.V4.1.NICHD, DOI 10.18128/D080.V4.1.NICHD]; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Chase C., 2016, MULTISECTORAL APPROA; Checkley W, 2004, LANCET, V363, P112, DOI 10.1016/S0140-6736(03)15261-0; Clasen T, 2014, TROP MED INT HEALTH, V19, P884, DOI 10.1111/tmi.12330; Cumming O, 2016, MATERN CHILD NUTR, V12, P91, DOI 10.1111/mcn.12258; Dangour AD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009382.pub2; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Dearden KA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4033-1; Eldridge S, 2008, BMJ-BRIT MED J, V336, P876, DOI 10.1136/bmj.39517.495764.25; Fenn B, 2012, PUBLIC HEALTH NUTR, V15, P1746, DOI 10.1017/S1368980012001115; Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Frozanfar MK, 2016, NAGOYA J MED SCI, V78, P41; Gera T, 2018, INDIAN PEDIATR, V55, P381, DOI 10.1007/s13312-018-1279-3; Haile D, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0587-9; Hug L., 2020, LEVELS TRENDS CHILD; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Langford R, 2011, AM J HUM BIOL, V23, P621, DOI 10.1002/ajhb.21189; Lin A, 2013, AM J TROP MED HYG, V89, P130, DOI 10.4269/ajtmh.12-0629; Luby SP, 2018, LANCET GLOB HEALTH, V6, pE302, DOI 10.1016/S2214-109X(17)30490-4; Merchant AT, 2003, EUR J CLIN NUTR, V57, P1562, DOI 10.1038/sj.ejcn.1601725; Ngure FM, 2014, ANN NY ACAD SCI, V1308, P118, DOI 10.1111/nyas.12330; Null C, 2018, LANCET GLOB HEALTH, V6, pE316, DOI 10.1016/S2214-109X(18)30005-6; Osgood-Zimmerman A, 2018, NATURE, V555, P41, DOI 10.1038/nature25760; Poda GG, 2017, INT J QUAL HEALTH C, V29, P901, DOI 10.1093/intqhc/mzx129; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Roth DE, 2017, LANCET GLOB HEALTH, V5, pE1249, DOI 10.1016/S2214-109X(17)30418-7; Rutstein SO, 2000, B WORLD HEALTH ORGAN, V78, P1256; Shrestha SK, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-2010-9; Syed S, 2016, J PEDIATR GASTR NUTR, V63, P6, DOI 10.1097/MPG.0000000000001147; UNICEF, 1990, UNICEF POL REV; Wang YX, 2012, APPL MECH MATER, V192, P29, DOI 10.4028/www.scientific.net/AMM.192.29; WHO/UNICEF, 2015, PROGR DRINKING WATER; WHO UNICEF USAID, 2015, IMPR NUTR OUTC BETT; WHO UNICEFUSAID AEDUCDAVIS IFPRI, 2010, IND ASS INF YOUNG CH; Wolf J, 2019, INT J EPIDEMIOL, V48, P1204, DOI 10.1093/ije/dyy253; World Health Organization, 2010, NUTR LANDSC INF SYST, DOI 10.1159/000362780.Interpretation; WORLD HEALTH ORGANIZATION (WHO); UNITED NATIONS CHILDREN'S FUND (UNICEF), 2017, PROGR DRINK WAT SAN, DOI DOI 10.1111/TMI.12329; World-Bank, 2017, ETH COUNTR OV; World-Bank, 2015, IN LED AFR MIN COUNC; Yisak H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0535-0	49	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239313	10.1371/journal.pone.0239313	http://dx.doi.org/10.1371/journal.pone.0239313			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960921	gold, Green Published			2022-12-26	WOS:000575109500043
J	Hada, A; Dutta, TK; Singh, N; Singh, B; Rai, V; Singh, NK; Rao, U				Hada, Alkesh; Dutta, Tushar K.; Singh, Nisha; Singh, Balwant; Rai, Vandna; Singh, Nagendra K.; Rao, Uma			A genome-wide association study in Indian wild rice accessions for resistance to the root-knot nematode Meloidogyne graminicola	PLOS ONE			English	Article							SMALL GTPASE RAC; ORYZA-SATIVA; DISEASE RESISTANCE; CULTIVATED RICE; DEFENSE RESPONSES; CYST-NEMATODE; GENE FLOW; RUFIPOGON; EXPRESSION; REVEALS	Rice root-knot nematode (RRKN),Meloidogyne graminicolais one of the major biotic constraints in rice-growing countries of Southeast Asia. Host plant resistance is an environmentally-friendly and cost-effective mean to mitigate RRKN damage to rice. Considering the limited availability of genetic resources in the Asian rice (Oryza sativa) cultivars, exploration of novel sources and genetic basis of RRKN resistance is necessary. We screened 272 diverse wild rice accessions (O.nivara,O.rufipogon,O.sativaf.spontanea) to identify genotypes resistant to RRKN. We dissected the genetic basis of RRKN resistance using a genome-wide association study with SNPs (singlenucleotidepolymorphism) genotyped by 50K "OsSNPnks" genic Affymetrix chip. Population structure analysis revealed that these accessions were stratified into three major sub-populations. Overall, 40 resistant accessions (nematode gall number and multiplication factor/MF < 2) were identified, with 17 novel SNPs being significantly associated with phenotypic traits such as number of galls, egg masses, eggs/egg mass and MF per plant. SNPs were localized to the quantitative trait loci (QTL) on chromosome 1, 2, 3, 4, 6, 10 and 11 harboring the candidate genes including NBS-LRR, Cf2/Cf5 resistance protein, MYB, bZIP, ARF, SCARECROW and WRKY transcription factors. Expression of these identified genes was significantly (P< 0.01) upregulated in RRKN-infected plants compared to mock-inoculated plants at 7 days after inoculation. The identified SNPs enrich the repository of candidate genes for future marker-assisted breeding program to alleviate the damage of RRKN in rice.	[Hada, Alkesh; Dutta, Tushar K.; Rao, Uma] ICAR Indian Agr Res Inst, Div Nematol, New Delhi, India; [Singh, Nisha; Singh, Balwant; Rai, Vandna; Singh, Nagendra K.] ICAR Natl Inst Plant Biotechnol, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Dutta, TK; Rao, U (corresponding author), ICAR Indian Agr Res Inst, Div Nematol, New Delhi, India.	nemaiari@gmail.com; umarao@iari.res.in	Dutta, Tushar/AAC-5382-2020; Singh, Nisha/AAS-5583-2020	Dutta, Tushar/0000-0002-0278-1707; Singh, Nisha/0000-0002-1950-815X; HADA, ALKESH/0000-0003-2618-7072; Davies, Keith/0000-0001-6060-2394	Department of Biotechnology, Govt. of India [BT/PR18924/COE/34/48/2017, IARI:ORP:NEM:09:04]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	UR received a grant. Grant number: BT/PR18924/COE/34/48/2017 Funder full name: Department of Biotechnology, Govt. of India URL of funder website: http://dbtindia.gov.in/IARI Outreach Project (IARI:ORP:NEM:09:04) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwer MA, 2018, J EXP BOT, V69, P1805, DOI 10.1093/jxb/ery019; Banaticla-Hilario MCN, 2013, GENET RESOUR CROP EV, V60, P1899, DOI 10.1007/s10722-013-9965-4; Bouzroud S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193517; BRAR DS, 2003, MONOGRAPH GENUS ORYZ, P283; Bridge John, 2005, P87, DOI 10.1079/9780851997278.0087; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Butardo VM, 2016, INT REV CEL MOL BIO, V323, P31, DOI 10.1016/bs.ircmb.2015.12.003; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Civan P, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.164, 10.1038/NPLANTS.2015.164]; De Waele D, 2007, ANNU REV PHYTOPATHOL, V45, P457, DOI 10.1146/annurev.phyto.45.062806.094438; DeYoung BJ, 2006, NAT IMMUNOL, V7, P1243, DOI 10.1038/ni1410; Dimkpa SON, 2016, J EXP BOT, V67, P1191, DOI 10.1093/jxb/erv470; Dutta T. K., 2014, African Journal of Microbiology Research, V8, P1245; Dutta TK, 2012, AFR J MICROBIOL RES, V6, P6016, DOI 10.5897/AJMR12.707; Dutta TK, 2011, NEMATOLOGY, V13, P509, DOI 10.1163/138855410X528262; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Lawilao JG, 2019, NEMATOLOGY, V21, P401, DOI 10.1163/15685411-00003222; Galeng-Lawilao J, 2018, BMC GENET, V19, DOI 10.1186/s12863-018-0656-1; Goff KE, 2007, GENE REGUL SYST BIO, V1, P167; Huang GZ, 2006, MOL PLANT MICROBE IN, V19, P463, DOI 10.1094/MPMI-19-0463; Jena M., 2013, ORYZA, V50, P132; Jones MP, 1997, EUPHYTICA, V94, P237, DOI 10.1023/A:1002969932224; Juliana P, 2018, THEOR APPL GENET, V131, P1405, DOI 10.1007/s00122-018-3086-6; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kim H, 2016, RICE, V9, DOI 10.1186/s12284-016-0119-0; Krattinger SG, 2016, NEW PHYTOL, V212, P320, DOI 10.1111/nph.14097; Kumari C, 2017, INDIAN J GENET PL BR, V77, P42, DOI 10.5958/0975-6906.2017.00006.2; Kumari C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22846; Kyndt T., 2014, ANNU REV PHYTOPATHOL, V52, p7 1; Kyndt T, 2016, J EXP BOT, V67, P4559, DOI 10.1093/jxb/erw230; Lahari Z, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2427-0; Lee WY, 2003, PHYSIOL PLANTARUM, V119, P573, DOI 10.1046/j.1399-3054.2003.00215.x; Li DY, 2008, J EXP BOT, V59, P2133, DOI 10.1093/jxb/ern072; Li XL, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02110; Lim CW, 2015, MOL PLANT MICROBE IN, V28, P825, DOI 10.1094/MPMI-10-14-0313-R; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Lorieux M, 2003, THEOR APPL GENET, V107, P691, DOI 10.1007/s00122-003-1285-1; Mantelin S, 2017, MOL PLANT PATHOL, V18, P3, DOI 10.1111/mpp.12394; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Mayrose M, 2006, MOL PLANT PATHOL, V7, P593, DOI [10.1111/j.1364-3703.2006.00364.x, 10.1111/J.1364-3703.2006.00364.X]; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Milligan SB, 1998, PLANT CELL, V10, P1307, DOI 10.1105/tpc.10.8.1307; Moeder W, 2005, MOL PLANT MICROBE IN, V18, P116, DOI 10.1094/MPMI-18-0116; Monaghan J, 2010, PLANT CELL PHYSIOL, V51, P742, DOI 10.1093/pcp/pcq038; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Cabasan MTN, 2018, TROP PLANT PATHOL, V43, P230, DOI 10.1007/s40858-018-0210-8; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Pariyar Shree R, 2016, Phytopathology, V106, P1128, DOI 10.1094/PHYTO-02-16-0054-FI; Plowright RA, 1999, NEMATOLOGY, V1, P745, DOI 10.1163/156854199508775; Pritchard JK, 2000, GENETICS, V155, P945; Rakshit S, 2007, THEOR APPL GENET, V114, P731, DOI 10.1007/s00122-006-0473-1; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Rohilla M, 2020, MOL GENET GENOMICS, V295, P1211, DOI 10.1007/s00438-020-01690-w; Sanchez EN, 2013, SYST SYST ENG SER, P9; SANO H, 1994, P NATL ACAD SCI USA, V91, P10556, DOI 10.1073/pnas.91.22.10556; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shrestha R, 2007, NEW PHYTOL, V176, P665, DOI 10.1111/j.1469-8137.2007.02185.x; Singh B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00123; Singh N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00972; Singh N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11600; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sun CQ, 2001, THEOR APPL GENET, V102, P157, DOI 10.1007/s001220051631; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tripathy K, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay058; Tsuda K, 2015, NEW PHYTOL, V206, P932, DOI 10.1111/nph.13286; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Warmerdam S, 2019, MOL PLANT PATHOL, V20, P137, DOI 10.1111/mpp.12745; Warmerdam S, 2018, NEW PHYTOL, V218, P724, DOI 10.1111/nph.15034; Ye JR, 2019, MOL PLANT, V12, P360, DOI 10.1016/j.molp.2018.10.005; Zhang HY, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01214; Zhang HJ, 2016, J EXP BOT, V67, P131, DOI 10.1093/jxb/erv448; Zhang YL, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1918-4; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou BJ, 2017, PLANT PHYSIOL, V173, P1371, DOI 10.1104/pp.16.01190; Zhou HF, 2008, THEOR APPL GENET, V117, P1181, DOI 10.1007/s00122-008-0855-7	76	8	8	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239085	10.1371/journal.pone.0239085	http://dx.doi.org/10.1371/journal.pone.0239085			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960916	Green Submitted, Green Published, gold			2022-12-26	WOS:000575109500007
J	Keppley, LJW; Walker, SJ; Gademsey, AN; Smith, JP; Keller, SR; Kester, M; Fox, TE				Keppley, Laura J. W.; Walker, Susan J.; Gademsey, Alexis N.; Smith, Jason P.; Keller, Susanna R.; Kester, Mark; Fox, Todd E.			Nervonic acid limits weight gain in a mouse model of diet-induced obesity	FASEB JOURNAL			English	Article						ceramide; fatty acid oxidation; obesity; omega-9; sphingolipids	FATTY-ACIDS; LIPID-METABOLISM; ADIPOSE-TISSUE; PLASMA; LIVER; PHOSPHOLIPIDS; ADIPOCYTES; CARNITINE; RISK; RATS	Lipid perturbations contribute to detrimental outcomes in obesity. We previously demonstrated that nervonic acid, a C24:1 omega-9 fatty acid, predominantly acylated to sphingolipids, including ceramides, are selectively reduced in a mouse model of obesity. It is currently unknown if deficiency of nervonic acid-sphingolipid metabolites contribute to complications of obesity. Mice were fed a standard diet, a high fat diet, or these diets supplemented isocalorically with nervonic acid. The primary objective was to determine if dietary nervonic acid content alters the metabolic phenotype in mice fed a high fat diet. Furthermore, we investigated if nervonic acid alters markers of impaired fatty acid oxidation in the liver. We observed that a nervonic acid-enriched isocaloric diet reduced weight gain and adiposity in mice fed a high fat diet. The nervonic acid enrichment led to increased C24:1-ceramides and improved several metabolic parameters including blood glucose levels, and insulin and glucose tolerance. Mechanistically, nervonic acid supplementation increased PPAR alpha and PGC1 alpha expression and improved the acylcarnitine profile in liver. These alterations indicate improved energy metabolism through increased beta-oxidation of fatty acids. Taken together, increasing dietary nervonic acid improves metabolic parameters in mice fed a high fat diet. Strategies that prevent deficiency of, or restore, nervonic acid may represent an effective strategy to treat obesity and obesity-related complications.	[Keppley, Laura J. W.; Walker, Susan J.; Gademsey, Alexis N.; Smith, Jason P.; Kester, Mark; Fox, Todd E.] Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,1215 Pinn Hall,POB 800735, Charlottesville, VA 22908 USA; [Keller, Susanna R.] Univ Virginia, Med Endocrinol & Metab, Charlottesville, VA USA; [Fox, Todd E.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Fox, TE (corresponding author), Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,1215 Pinn Hall,POB 800735, Charlottesville, VA 22908 USA.	tfox@virginia.edu	Kester, Mark/ABG-4615-2020		University of Virginia; National Institute of Health [EY018336]	University of Virginia; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	University of Virginia; National Institute of Health, Grant/Award Number: EY018336	An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Anroedh S, 2018, J LIPID RES, V59, P1729, DOI 10.1194/jlr.P081281; Bandet CL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030479; Cazzola R, 2011, J NUTR BIOCHEM, V22, P388, DOI 10.1016/j.jnutbio.2010.03.007; Chaurasia B, 2019, SCIENCE, V365, P386, DOI 10.1126/science.aav3722; Cheng CF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113447; CHRISTOPHERSEN B, 1983, LIPIDS, V18, P137, DOI 10.1007/BF02536108; Delgado GE, 2017, J CLIN LIPIDOL, V11, P126, DOI 10.1016/j.jacl.2016.10.015; DEWAILLY P, 1978, LIPIDS, V13, P301, DOI 10.1007/BF02533676; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Fox TE, 2010, ADV EXP MED BIOL, V688, P206; Giesbertz P, 2015, J LIPID RES, V56, P2029, DOI 10.1194/jlr.D061721; Gosejacob D, 2016, J BIOL CHEM, V291, P6989, DOI 10.1074/jbc.M115.691212; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Hack A, 2006, PEDIATR RES, V60, P93, DOI 10.1203/01.pdr.0000219479.95410.79; Hammad SS, 2017, LIPIDS, V52, P803, DOI 10.1007/s11745-017-4291-9; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; HARDWICK JP, 2009, PPAR RES, V2009, DOI [10.1155/2009/952734, DOI 10.1155/2009/952734]; HULAN HW, 1977, CAN J PHYSIOL PHARM, V55, P258, DOI 10.1139/y77-037; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Karlsson M, 2006, OBESITY, V14, P1931, DOI 10.1038/oby.2006.225; Kojima M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-77; Lambert Johana M., 2018, Advances in Biological Regulation, V70, P19, DOI 10.1016/j.jbior.2018.10.002; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Law BA, 2018, FASEB J, V32, P1403, DOI 10.1096/fj.201700300R; Matsuzaka T, 2020, HEPATOLOGY, V71, P1609, DOI 10.1002/hep.30953; Meikle PJ, 2017, NAT REV ENDOCRINOL, V13, P79, DOI 10.1038/nrendo.2016.169; Mwinyi J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175776; Oda E, 2005, INT HEART J, V46, P975, DOI 10.1536/ihj.46.975; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Othman A, 2015, DIABETES, V64, P1035, DOI 10.2337/db14-1325; Palomer X, 2018, TRENDS ENDOCRIN MET, V29, P178, DOI 10.1016/j.tem.2017.11.009; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Pearson JM, 2020, MOL CANCER RES, V18, P352, DOI 10.1158/1541-7786.MCR-19-0619; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Pickens CA, 2015, PROSTAG LEUKOTR ESS, V95, P31, DOI 10.1016/j.plefa.2014.12.001; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Schooneman MG, 2013, DIABETES, V62, P1, DOI 10.2337/db12-0466; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Yamazaki Y, 2014, J OLEO SCI, V63, P527, DOI 10.5650/jos.ess13226; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004	45	10	10	9	52	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15314	15326		10.1096/fj.202000525R	http://dx.doi.org/10.1096/fj.202000525R		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959931	Green Accepted			2022-12-26	WOS:000573862400001
J	Aserese, AD; Atenafu, A; Sisay, M; Sorrie, MB; Yirdaw, BW; Zegeye, MK				Aserese, Addisalem Damtie; Atenafu, Azeb; Sisay, Mekonnen; Sorrie, Muluken Bekele; Yirdaw, Birhanu Wubale; Zegeye, Martha Kassahun			Adequate vitamin A rich food consumption and associated factors among lactating mothers visiting child immunization and post-natal clinic at health institutions in Gondar Town, Northwest Ethiopia	PLOS ONE			English	Article							WOMEN; DEFICIENCY; AREA	Background Vitamin A deficiency is highly prevalent in low-income countries and is a major public health problem worldwide. Lactating mothers are the most vulnerable population group to vitamin A deficiency. Despite this, there is limited study on vitamin A-rich food consumption by lactating mothers in Ethiopia. Therefore, this study aimed to assess adequate vitamin A rich food consumption and associated factors among lactating mothers visiting child immunization and postnatal care centers in health institutions of Gondar Town. Methods An Institution-based cross-sectional study design was employed at a health institution in Gondar Town from February to March 2019, and included 631 study participants. Simple random sampling followed by a systematic sampling technique was used to select participants. The data were collected using the Helen Keller International Food Frequency Questionnaire, entered using Epi-Info 7 statistical software and exported to STATA version 14 for analysis. A multivariable logistic regression analysis was used to identify factors associated with the outcome variable and variables with p-value Result A total of 624 lactating mothers participated in the study giving a response rate of 98.89%. The study shows adequate consumption of vitamin A-rich food was 38.94% (95% CI: 35%- 43%). Predictors such as attending college diploma and above (AOR = 2.26, 95% CI; 1.02-4.99), having household family size <= 3 (AOR = 4.04, 95% CI; 1.60-10.17), being in higher economic class (AOR = 1.93, 95% CI; 1.18-3.14), having dietary diversity score of >= 5 (AOR = 1.59, 95% CI; 1.09-2.32) and meal frequency of >= 4 (AOR = 1.64, 95% CI; 1.09-2.32) were statistically significant. Conclusion and recommendation The majority of respondents had inadequate consumption of foods rich in vitamin A. Educational status, family size, wealth index, dietary diversity, and meal frequency were found to be factors that affect adequate consumption of vitamin A-rich foods. Encouraging and educating lactating mothers to consume foods rich in vitamin A is crucial.	[Aserese, Addisalem Damtie; Sorrie, Muluken Bekele] Arbaminch Univ, Arba Minch, Ethiopia; [Atenafu, Azeb; Sisay, Mekonnen; Yirdaw, Birhanu Wubale] Univ Gondar, Gondar, Ethiopia; [Zegeye, Martha Kassahun] Ambo Univ, Ambo, Ethiopia	Arba Minch University; University of Gondar; Ambo University	Aserese, AD (corresponding author), Arbaminch Univ, Arba Minch, Ethiopia.	addis2010ec@gmail.com		Yirdaw, Birhanu Wubale/0000-0003-0378-7630; Bekele, Muluken/0000-0002-3464-2584				Abebe H, 2014, ETHIOP J HEALTH SCI, V24, P219, DOI 10.4314/ejhs.v24i3.5; African E, 2001, IRON VITAMIN A STATU; Ahmed F, 2003, PUBLIC HEALTH NUTR, V6, P447, DOI 10.1079/PHN2002454; [Anonymous], 2009, WHO GLOBAL DATABASE; [Anonymous], 2018, GONDAR TOWN HLTH BUR; Azage T, 2008, NUTR COUNTRY PROFILE; Brzovi Zdenka, 2016, PROLEGOMENA, V15, P21; Database WHO, 2005, GLOB PREV VIT A DEF; Demissie T, 2010, FOOD NUTR BULL, V31, P234, DOI 10.1177/156482651003100206; Dijkhuizen MA, 2001, AM J CLIN NUTR, V73, P786; Ettyang GA, 2003, ANN NUTR METAB, V47, P276, DOI 10.1159/000072400; FAO F., 2016, MIN DIET DIV WOM GUI, P82; FDRE, 2015, NAT NUTR PROGR ETH; Greiner T., 2013, VITAMIN A MOVING FOO, P1; Haidar J., 2016, VITAMIN A DEFICIENCY; Hailu AA., 2017, ETHIOPIAN NATL MICRO; Henjum S, 2015, PUBLIC HEALTH NUTR, V18, P3201, DOI 10.1017/S1368980015000671; Kominiarek MA, 2016, MED CLIN N AM, V100, P1199, DOI 10.1016/j.mcna.2016.06.004; McLaren D., 2001, SIGHT LIFE MANUAL VI; Miller M, 2002, P 20 INT VIT A CONS, P2867; Ncube TN, 2001, EUR J CLIN NUTR, V55, P229, DOI 10.1038/sj.ejcn.1601138; Nti C. A., 2012, Food and Public Health, V2, P219; Persson V., 2001, VITAMIN A INTAKE STA; Ramakrishnan U, 1999, J NUTR, V129, P2021, DOI 10.1093/jn/129.11.2021; Samba C, 2013, J HEALTH POPUL NUTR, V31, P28; Sommer A., 1995, VITAMIN A DEFICENCY; Subcommittee on the tenth edition of the recommended dietary allowances food and nutrition board commission on life sciences National Research Council, 1989, REC DIET ALL; Ulak M, PREVALENCE VITAMIN A, P4; USAID, 2015, ESS NUTR ACT ESS HYG; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; World Health Organization, 2008, IND ASS INF YOUNG CH	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239308	10.1371/journal.pone.0239308	http://dx.doi.org/10.1371/journal.pone.0239308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956396	gold, Green Published			2022-12-26	WOS:000574571500032
J	Rodriguez, BL; Vega-Soto, EE; Kennedy, CS; Nguyen, MH; Cederna, PS; Larkin, LM				Rodriguez, Brittany L.; Vega-Soto, Emmanuel E.; Kennedy, Christopher S.; Nguyen, Matthew H.; Cederna, Paul S.; Larkin, Lisa M.			A tissue engineering approach for repairing craniofacial volumetric muscle loss in a sheep following a 2, 4, and 6-month recovery	PLOS ONE			English	Article							SKELETAL-MUSCLE; RAT; IMPLANTATION; CONSTRUCTS; DIFFERENTIATION; HETEROGENEITY; DENERVATION; FIBERS; INJURY; FORCE	Volumetric muscle loss (VML) is the loss of skeletal muscle that results in significant and persistent impairment of function. The unique characteristics of craniofacial muscle compared trunk and limb skeletal muscle, including differences in gene expression, satellite cell phenotype, and regenerative capacity, suggest that VML injuries may affect craniofacial muscle more severely. However, despite these notable differences, there are currently no animal models of craniofacial VML. In a previous sheep hindlimb VML study, we showed that our lab's tissue engineered skeletal muscle units (SMUs) were able to restore muscle force production to a level that was statistically indistinguishable from the uninjured contralateral muscle. Thus, the goals of this study were to: 1) develop a model of craniofacial VML in a large animal model and 2) to evaluate the efficacy of our SMUs in repairing a 30% VML in the ovine zygomaticus major muscle. Overall, there was no significant difference in functional recovery between the SMU-treated group and the unrepaired control. Despite the use of the same injury and repair model used in our previous study, results showed differences in pathophysiology between craniofacial and hindlimb VML. Specifically, the craniofacial model was affected by concomitant denervation and ischemia injuries that were not exhibited in the hindlimb model. While clinically realistic, the additional ischemia and denervation likely created an injury that was too severe for our SMUs to repair. This study highlights the importance of balancing the use of a clinically realistic model while also maintaining control over variables related to the severity of the injury. These variables include the volume of muscle removed, the location of the VML injury, and the geometry of the injury, as these affect both the muscle's ability to self-regenerate as well as the probability of success of the treatment.	[Rodriguez, Brittany L.; Cederna, Paul S.; Larkin, Lisa M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Vega-Soto, Emmanuel E.; Kennedy, Christopher S.; Nguyen, Matthew H.; Larkin, Lisa M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Cederna, Paul S.] Univ Michigan, Dept Plast Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Larkin, LM (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.; Larkin, LM (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	llarkin@umich.edu		Nguyen, Matthew/0000-0002-4846-2058	National Institutes of Health, National Institute for Arthritis and Musculoskeletal and Skin Diseases [1R01AR067744-01]; NIH by the Michigan Integrative Musculoskeletal Health Core Center	National Institutes of Health, National Institute for Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH by the Michigan Integrative Musculoskeletal Health Core Center	This work was funded by the National Institutes of Health, National Institute for Arthritis and Musculoskeletal and Skin Diseases (https://www.niams.nih.gov/grants-funding) received by LL (Grant number:1R01AR067744-01), as well as NIH P30 support provided by the Michigan Integrative Musculoskeletal Health Core Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animals CftUotGftCaUoL, 2010, GUIDE CARE USE LAB A, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; [Anonymous], 1986, AM J PHYSIOL, V250, pH822; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Carlson BM, 2014, EUR J TRANSL MYOL, V24, P5, DOI 10.4081/ejtm.2014.3293; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Corona BT, 2015, CELLS TISSUES ORGANS, V202, P180, DOI 10.1159/000443925; Corona BT, 2014, TISSUE ENG PT A, V20, P705, DOI 10.1089/ten.TEA.2012.0761; DALBIS A, 1994, EUR J BIOCHEM, V223, P249, DOI 10.1111/j.1432-1033.1994.tb18989.x; Dennis RG, 2000, IN VITRO CELL DEV-AN, V36, P327; Farber SJ, 2019, MIL MED, V184, pE236, DOI 10.1093/milmed/usz103; Foltan R, 2008, MED HYPOTHESES, V71, P572, DOI 10.1016/j.mehy.2008.05.010; Garg K, 2015, J ORTHOP RES, V33, P40, DOI 10.1002/jor.22730; Garland CB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00453; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Geiger PC, 2001, J APPL PHYSIOL, V90, P1196, DOI 10.1152/jappl.2001.90.4.1196; Gordon T, 2016, EXP NEUROL, V285, P24, DOI 10.1016/j.expneurol.2016.08.019; Greising SM, 2019, TISSUE ENG PART B-RE, V25, P510, DOI [10.1089/ten.teb.2019.0207, 10.1089/ten.TEB.2019.0207]; Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007; Happak W, 1997, ANAT RECORD, V249, P276, DOI 10.1002/(SICI)1097-0185(199710)249:2<276::AID-AR15>3.0.CO;2-L; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Hwang K, 2018, J CRANIOFAC SURG, V29, P1378, DOI 10.1097/SCS.0000000000004585; LABBE R, 1987, J VASC SURG, V6, P152, DOI 10.1067/mva.1987.avs0060152; Larkin LM, 2011, AM J PHYSIOL-REG I, V301, pR1400, DOI 10.1152/ajpregu.00093.2011; Larkin LM, 1998, J GERONTOL A-BIOL, V53, pB252, DOI 10.1093/gerona/53A.4.B252; Larson AA, 2018, CELLS TISSUES ORGANS, V205, P197, DOI 10.1159/000490884; Laschke MW, 2016, BIOTECHNOL ADV, V34, P112, DOI 10.1016/j.biotechadv.2015.12.004; Lee L, 2019, MIL MED, V184, pE247, DOI 10.1093/milmed/usz059; LEEUW T, 1994, DIFFERENTIATION, V55, P193, DOI 10.1046/j.1432-0436.1994.5530193.x; Lew TA, 2010, J ORAL MAXIL SURG, V68, P3, DOI 10.1016/j.joms.2009.06.006; Lewis MP, 2001, EUR J ORAL SCI, V109, P209, DOI 10.1034/j.1600-0722.2001.00021.x; Mahalingam VD, 2015, TISSUE ENG PART C-ME, V21, P548, DOI [10.1089/ten.tec.2014.0542, 10.1089/ten.TEC.2014.0542]; Mahalingam VD, 2015, TISSUE ENG PT A, V21, P1047, DOI [10.1089/ten.tea.2014.0422, 10.1089/ten.TEA.2014.0422]; Mao JJ, 2010, TISSUE ENG PART B-RE, V16, P257, DOI [10.1089/ten.teb.2009.0496, 10.1089/ten.TEB.2009.0496]; Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24; Mintz EL, 2020, TISSUE ENG PT A, V26, P140, DOI [10.1089/ten.tea.2019.0126, 10.1089/ten.TEA.2019.0126]; Noden DM, 2006, DEV DYNAM, V235, P1194, DOI 10.1002/dvdy.20697; Novakova SS, 2020, TISSUE ENG PT A, V26, P837, DOI [10.1089/ten.tea.2019.0288, 10.1089/ten.TEA.2019.0288]; Novakova SS, 2018, J ORTHOP RES, V36, P289, DOI 10.1002/jor.23642; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Rodriguez BL, 2020, TISSUE ENG PT A, V26, P167, DOI [10.1089/ten.tea.2019.0087, 10.1089/ten.TEA.2019.0087]; Rodriguez BL, 2019, REGEN ENG TRANSL MED, V5, P86, DOI 10.1007/s40883-018-0078-7; Surgeons ASoP, 2018, 2018 NATL PLASTIC SU; Syverud BC, 2018, TISSUE ENG PART C-ME, V24, P263, DOI [10.1089/ten.tec.2017.0406, 10.1089/ten.TEC.2017.0406]; Syverud BC, 2018, TISSUE ENG PART C-ME, V24, P32, DOI [10.1089/ten.TEC.2017.0316, 10.1089/ten.tec.2017.0316]; Syverud BC, 2017, TISSUE ENG PART C-ME, V23, P616, DOI [10.1089/ten.tec.2017.0284, 10.1089/ten.TEC.2017.0284]; Syverud BC, 2016, TISSUE ENG PT A, V22, P480, DOI [10.1089/ten.tea.2015.0545, 10.1089/ten.TEA.2015.0545]; van den Elzen MEP, 2012, J CRANIO MAXILL SURG, V40, P777, DOI 10.1016/j.jcms.2012.02.010; van der Meulen JH, 2003, PLAST RECONSTR SURG, V112, P1336, DOI 10.1097/01.PRS.0000081464.98718.E3; VanDusen KW, 2014, TISSUE ENG PT A, V20, P2920, DOI [10.1089/ten.tea.2014.0060, 10.1089/ten.TEA.2014.0060]; VanSwearingen JM, 1999, AESTHET PLAST SURG, V23, P416, DOI 10.1007/s002669900312; Versnel SL, 2010, J PLAST RECONSTR AES, V63, P1642, DOI 10.1016/j.bjps.2009.10.018; Williams ML, 2013, J TISSUE ENG REGEN M, V7, P434, DOI 10.1002/term.537; Wisdom KM, 2015, BIOMECH MODEL MECHAN, V14, P195, DOI 10.1007/s10237-014-0607-3; 2014, INTERV CARDIOL REV, V9, P89	55	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239152	10.1371/journal.pone.0239152	http://dx.doi.org/10.1371/journal.pone.0239152			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956427	gold, Green Published			2022-12-26	WOS:000574571500043
J	de la Torre, CM; Grossman, JH; Bobko, AA; Bennewitz, MF				de la Torre, Celia Martinez; Grossman, Jasmine H.; Bobko, Andrey A.; Bennewitz, Margaret F.			Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time	PLOS ONE			English	Article							MAGNETIC-PROPERTIES; THERMAL-DECOMPOSITION; CONTRAST AGENTS; STEM-CELLS; MRI; NANOCRYSTALS; OLEYLAMINE; MAMMOGRAPHY; PEGYLATION; NUCLEATION	Manganese oxide (MnO) nanoparticles (NPs) can serve as robust pH-sensitive contrast agents for magnetic resonance imaging (MRI) due to Mn2+ release at low pH, which generates a similar to 30 fold change in T-1 relaxivity. Strategies to control NP size, composition, and Mn2+ dissolution rates are essential to improve diagnostic performance of pH-responsive MnO NPs. We are the first to demonstrate that MnO NP size and composition can be tuned by the temperature ramping rate and aging time used during thermal decomposition of manganese(II) acetylacetonate. Two different temperature ramping rates (10 degrees C/min and 20 degrees C/min) were applied to reach 300 degrees C and NPs were aged at that temperature for 5, 15, or 30 min. A faster ramping rate and shorter aging time produced the smallest NPs of similar to 23 nm. Shorter aging times created a mixture of MnO and Mn3O4 NPs, whereas longer aging times formed MnO. Our results indicate that a 20 degrees C/min ramp rate with an aging time of 30 min was the ideal temperature condition to form the smallest pure MnO NPs of similar to 32 nm. However, Mn2+ dissolution rates at low pH were unaffected by synthesis conditions. Although Mn2+ production was high at pH 5 mimicking endosomes inside cells, minimal Mn2+ was released at pH 6.5 and 7.4, which mimic the tumor extracellular space and blood, respectively. To further elucidate the effects of NP composition and size on Mn2+ release and MRI contrast, the ideal MnO NP formulation (similar to 32 nm) was compared with smaller MnO and Mn3O4 NPs. Small MnO NPs produced the highest amount of Mn2+ at acidic pH with maximum T-1 MRI signal; Mn3O4 NPs generated the lowest MRI signal. MnO NPs encapsulated within poly(lactide-co-glycolide) (PLGA) retained significantly higher Mn2+ release and MRI signal compared to PLGA Mn3O4 NPs. Therefore, MnO instead of Mn3O4 should be targeted intracellularly to maximize MRI contrast.	[de la Torre, Celia Martinez; Grossman, Jasmine H.; Bennewitz, Margaret F.] West Virginia Univ, Dept Chem & Biomed Engn, Morgantown, WV 26506 USA; [Bobko, Andrey A.] West Virginia Univ, Dept Biochem, Morgantown, WV 26506 USA; [Bobko, Andrey A.] West Virginia Univ, In Vivo Multifunct Magnet Resonance Ctr, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Bennewitz, MF (corresponding author), West Virginia Univ, Dept Chem & Biomed Engn, Morgantown, WV 26506 USA.	margaret.bennewitz@mail.wvu.edu		Bennewitz, Margaret/0000-0002-2519-1603; Martinez De La Torre, Celia/0000-0002-5088-3839	WVU Chemical and Biomedical Engineering Department startup funds; National Institute of General Medical Sciences [P20GM121322]; NIH [U54GM104942]	WVU Chemical and Biomedical Engineering Department startup funds; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by WVU Chemical and Biomedical Engineering Department startup funds awarded to MFB and National Institute of General Medical Sciences in the form of a NIH-NIGMS grant awarded to AAB (P20GM121322). The Bruker ICON MRI machine was also supported by a NIH grant (U54GM104942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, WEATHER, V66, pi, DOI 10.1002/wea.699; [Anonymous], 2014, DIABETES CARE, V1, pS14; [Anonymous], 2015, CONCURR COMPUT PRACT, V27, pi; [Anonymous], 2013, INT UROGYNECOL J S1, V24, pS1; Antoni H, 2017, PHYS CHEM CHEM PHYS, V19, P18434, DOI 10.1039/c7cp02717f; Bennewitz MF, 2012, MOL IMAGING BIOL, V14, P676, DOI 10.1007/s11307-012-0553-3; Bennewitz MF, 2011, ACS NANO, V5, P3438, DOI 10.1021/nn1019779; Bennewitz MF, 2009, NEUROTHERAPEUTICS, V6, P323, DOI 10.1016/j.nurt.2009.01.018; Bock NA, 2008, NMR BIOMED, V21, P473, DOI 10.1002/nbm.1211; Chen YF, 2007, J AM CHEM SOC, V129, P10937, DOI 10.1021/ja073023n; Chen Y, 2012, BIOMATERIALS, V33, P7126, DOI 10.1016/j.biomaterials.2012.06.059; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Chhour P, 2014, ACS NANO, V8, P9143, DOI 10.1021/nn502730q; Douglas FJ, 2014, NANOSCALE, V6, P172, DOI 10.1039/c3nr04832b; Duan BC, 2018, ACS BIOMATER SCI ENG, V4, P3047, DOI 10.1021/acsbiomaterials.8b00287; Fang Y, 2017, DRUG DELIV, V24, P22, DOI 10.1080/10717544.2017.1388451; Felton C, 2014, DRUG METAB REV, V46, P142, DOI 10.3109/03602532.2013.876429; Gale EM, 2016, J AM CHEM SOC, V138, P15861, DOI 10.1021/jacs.6b10898; Godunov EB, 2018, INORG MATER+, V54, P66, DOI 10.1134/S002016851801003X; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Hinds KA, 2003, BLOOD, V102, P867, DOI 10.1182/blood-2002-12-3669; Hsu JC, 2018, NANOSCALE, V10, P17236, DOI 10.1039/c8nr03741h; Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/NNM.11.19, 10.2217/nnm.11.19]; Koylu MZ, 2009, MOLECULES, V14, P1537, DOI 10.3390/molecules14041537; Kuhl CK, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0937-7; Louie A, 2013, J MAGN RESON IMAGING, V38, P530, DOI 10.1002/jmri.24298; McCall RL, 2013, JOVE-J VIS EXP, DOI 10.3791/51015; Mourdikoudis S, 2013, CHEM MATER, V25, P1465, DOI 10.1021/cm4000476; Moya C, 2015, PHYS CHEM CHEM PHYS, V17, P13143, DOI 10.1039/c5cp01052g; Na HB, 2007, ANGEW CHEM INT EDIT, V46, P5397, DOI 10.1002/anie.200604775; Nofiele JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058617; Nolis GM, 2018, INORG CHEM, V57, P12900, DOI 10.1021/acs.inorgchem.8b02124; Othman E, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0793-1; Park M, 2011, CHEM MATER, V23, P3318, DOI 10.1021/cm200414c; Pinc J, 2017, CHEM PAP, V71, P1031, DOI 10.1007/s11696-016-0023-5; Polte J, 2015, CRYSTENGCOMM, V17, P6809, DOI 10.1039/c5ce01014d; Riedl CC, 2015, J CLIN ONCOL, V33, P1128, DOI 10.1200/JCO.2014.56.8626; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Salazar-Alvarez G, 2007, J AM CHEM SOC, V129, P9102, DOI 10.1021/ja0714282; Schladt TD, 2009, CHEM MATER, V21, P3183, DOI 10.1021/cm900663t; Seo WS, 2004, ANGEW CHEM INT EDIT, V43, P1115, DOI 10.1002/anie.200352400; Sesen F.E., 2017, J CHEM TECH APPL, V1, P1, DOI DOI 10.35841/CHEMICAL-TECHNOLOGY.1.1.26-27; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; Shapiro EM, 2005, MAGNET RESON MED, V53, P329, DOI 10.1002/mrm.20342; Shapiro EM, 2008, MAGN RESON MED, V60, P265, DOI 10.1002/mrm.21631; Shi Yupeng, 2018, Nanotheranostics, V2, P403, DOI 10.7150/ntno.28046; SukJS Xu Q, 2016, ADV DRUG DELIV REV A, V99, P28, DOI DOI 10.1016/j.addr.2015.09.012; Thanh NTK, 2014, CHEM REV, V114, P7610, DOI 10.1021/cr400544s; Tu CQ, 2011, ANN BIOMED ENG, V39, P1335, DOI 10.1007/s10439-011-0270-0; van Schooneveld MM, 2010, CONTRAST MEDIA MOL I, V5, P231, DOI 10.1002/cmmi.376; Xu ZC, 2009, CHEM MATER, V21, P1778, DOI 10.1021/cm802978z; Yin M, 2003, J AM CHEM SOC, V125, P10180, DOI 10.1021/ja0362656; Zhang HW, 2014, NANOSCALE, V6, P5918, DOI 10.1039/c4nr00761a; Zhang TR, 2007, NANO LETT, V7, P3203, DOI 10.1021/nl071928t; Zheng MT, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-166	55	7	7	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239034	10.1371/journal.pone.0239034	http://dx.doi.org/10.1371/journal.pone.0239034			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946514	Green Published, gold			2022-12-26	WOS:000573851100079
J	Parlin, AF; Stratton, SM; Culley, TM; Guerra, PA				Parlin, Adam F.; Stratton, Samuel M.; Culley, Theresa M.; Guerra, Patrick A.			A laboratory-based study examining the properties of silk fabric to evaluate its potential as a protective barrier for personal protective equipment and as a functional material for face coverings during the COVID-19 pandemic	PLOS ONE			English	Article							CONTACT-ANGLE MEASUREMENTS; N95 RESPIRATOR; FILTRATION PERFORMANCE; RESISTANCE; PROTEINS; COCOON; MASKS	The worldwide shortage of single-use N95 respirators and surgical masks due to the COVID-19 pandemic has forced many health care personnel to use their existing equipment for as long as possible. In many cases, workers cover respirators with available masks in an attempt to extend their effectiveness against the virus. Due to low mask supplies, many people instead are using face coverings improvised from common fabrics. Our goal was to determine what fabrics would be most effective in both practices. Under laboratory conditions, we examined the hydrophobicity of fabrics (cotton, polyester, silk), as measured by their resistance to the penetration of small and aerosolized water droplets, an important transmission avenue for the virus causing COVID-19. We also examined the breathability of these fabrics and their ability to maintain hydrophobicity despite undergoing repeated cleaning. Laboratory-based tests were conducted when fabrics were fashioned as an overlaying barrier for respirators and when constructed as face coverings. When used as material in these two situations, silk was more effective at impeding the penetration and absorption of droplets due to its greater hydrophobicity relative to other tested fabrics. We found that silk face coverings repelled droplets in spray tests as well as disposable single-use surgical masks, and silk face coverings have the added advantage over masks such that they can be sterilized for immediate reuse. We show that silk is a hydrophobic barrier to droplets, can be more breathable than other fabrics that trap humidity, and are re-useable via cleaning. We suggest that silk can serve as an effective material for making hydrophobic barriers that protect respirators, and silk can now be tested under clinical conditions to verify its efficacy for this function. Although respirators are still the most appropriate form of protection, silk face coverings possess properties that make them capable of repelling droplets.	[Parlin, Adam F.; Stratton, Samuel M.; Culley, Theresa M.; Guerra, Patrick A.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Guerra, PA (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	patrick.guerra@uc.edu		Stratton, Samuel/0000-0002-3685-1961				[Anonymous], 2019, R LANG ENV STAT COMP; Asadi S, 2020, AEROSOL SCI TECH, V54, P635, DOI 10.1080/02786826.2020.1749229; Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P1911, DOI 10.1001/jama.2020.4770; Bayardo R., 2008, RIPS, V1, P17; Borkow G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011295; Center for Disease Control National Center for Immunization and Respiratory Diseases (NCIRD) Division of Viral Diseases, 2020, DIV VIR DIS REC REG; Centers for Disease Control and Prevention [internet], UND DIFF; Chen FJ, 2012, J R SOC INTERFACE, V9, P2299, DOI 10.1098/rsif.2011.0887; COOPER DW, 1983, AM IND HYG ASSOC J, V44, P720, DOI 10.1202/0002-8894(1983)044<0720:CMFERP>2.3.CO;2; Danks HV, 2004, EUR J ENTOMOL, V101, P433, DOI 10.14411/eje.2004.062; Dato VM, 2006, EMERG INFECT DIS, V12, P1033, DOI 10.3201/eid1206.051468; Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43; Dong ZM, 2016, INSECT BIOCHEM MOLEC, V75, P24, DOI 10.1016/j.ibmb.2016.05.005; El-Atab N, 2020, ACS NANO, V14, P7659, DOI 10.1021/acsnano.0c03976; Fischer RJ, 2020, EMERG INFECT DIS, V26, P2253, DOI 10.3201/eid2609.201524; GENNADIOS A, 1994, J FOOD ENG, V21, P395, DOI 10.1016/0260-8774(94)90062-0; Guerra PA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62547-1; Guerra PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174023; GWOSDOW AR, 1986, TEXT RES J, V56, P574, DOI 10.1177/004051758605600909; Horrocks NPC, 2013, COMP BIOCHEM PHYS A, V164, P645, DOI 10.1016/j.cbpa.2013.01.023; Ippolito M, 2020, PULMONOLOGY, V26, P204, DOI 10.1016/j.pulmoe.2020.04.009; Kaltenboeck A, 2020, MAYO CLIN PROC, V95, P1132, DOI 10.1016/j.mayocp.2020.04.014; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1; Kunz RI, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8175701; Lamour G, 2010, J CHEM EDUC, V87, P1403, DOI 10.1021/ed100468u; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Li Y, 2006, AM J IND MED, V49, P1056, DOI 10.1002/ajim.20395; Lindsley WG, 2015, J OCCUP ENVIRON HYG, V12, P509, DOI 10.1080/15459624.2015.1018518; Lindsley WG, 2013, AEROSOL SCI TECH, V47, P937, DOI 10.1080/02786826.2013.803019; MADAN GL, 1978, TEXT RES J, V48, P662, DOI 10.1177/004051757804801108; NIELSEN R, 1987, AM IND HYG ASSOC J, V48, P639, DOI 10.1202/0002-8894(1987)048<0639:TEOTAH>2.0.CO;2; Nileback L, 2017, ACS APPL MATER INTER, V9, P31634, DOI 10.1021/acsami.7b10874; Papierowska E, 2018, TREES-STRUCT FUNCT, V32, P1253, DOI 10.1007/s00468-018-1707-y; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; Rhim JW, 2006, LWT-FOOD SCI TECHNOL, V39, P806, DOI 10.1016/j.lwt.2005.05.008; Roberge RJ, 2012, ANN OCCUP HYG, V56, P102, DOI 10.1093/annhyg/mer069; Roberge Raymond J, 2008, J Public Health Manag Pract, V14, pE19, DOI 10.1097/01.PHH.0000311904.41691.fd; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shakya KM, 2017, J EXPO SCI ENV EPID, V27, P352, DOI 10.1038/jes.2016.42; Sharabaty T., 2008, INDIAN J FIBRE TEXT, V33, P419; Singh CP, 2014, CELL MICROBIOL, V16, P1354, DOI 10.1111/cmi.12294; Sinkule EJ, 2013, ANN OCCUP HYG, V57, P384, DOI 10.1093/annhyg/mes068; Sotirchos ES, 2019, JAMA NEUROL, V76, P507, DOI 10.1001/jamaneurol.2018.4720; Strasser BJ, 2020, LANCET, V396, P19, DOI 10.1016/S0140-6736(20)31207-1; Sun MX, 2017, ACTA BIOMATER, V51, P408, DOI 10.1016/j.actbio.2017.01.022; Sun WX, 2013, 2013 INTERNATIONAL CONFERENCE ON INFORMATION TECHNOLOGY AND APPLICATIONS (ITA), P30, DOI 10.1109/ITA.2013.13; Tang JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059970; Tehrani-Bagha AR, 2019, ADV COLLOID INTERFAC, V268, P114, DOI 10.1016/j.cis.2019.03.006; VANDERKLOOT WG, 1953, BEHAVIOUR, V5, P157, DOI 10.1163/156853953X00096; VANDERKLOOT WG, 1953, BEHAVIOUR, V5, P141, DOI 10.1163/156853953X00087; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0016018; Wang CY, 2016, NANO RES, V9, P2590, DOI 10.1007/s12274-016-1145-3; World Health Organization, 2020, ADVICE USE MASKS CON; Zhou L, 2003, FEBS LETT, V554, P337, DOI 10.1016/S0014-5793(03)01184-0	56	17	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239531	10.1371/journal.pone.0239531	http://dx.doi.org/10.1371/journal.pone.0239531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946526	Green Published, gold			2022-12-26	WOS:000573851100046
J	Park, HJ; Jo, DS; Choi, H; Bae, JE; Park, NY; Kim, JB; Choi, JY; Kim, YH; Oh, GS; Chang, JH; Kim, HJ; Cho, DH				Park, Hyun Jun; Jo, Doo Sin; Choi, Hyunjung; Bae, Ji-Eun; Park, Na Yeon; Kim, Joon Bum; Choi, Ji Yeon; Kim, Yong Hwan; Oh, Gyeong Seok; Chang, Jeong Ho; Kim, Hyoung-June; Cho, Dong-Hyung			Melasolv induces melanosome autophagy to inhibit pigmentation in B16F1 cells	PLOS ONE			English	Article							PROTEIN; DEGRADATION; MELANOGENESIS; MELANOCYTES; UBIQUITIN; MECHANISM; TFEB; LC3	The melanosome is a specialized membrane-bound organelle that is involved in melanin synthesis, storage, and transportation. In contrast to melanosome biogenesis, the processes underlying melanosome degradation remain largely unknown. Autophagy is a process that promotes degradation of intracellular components' cooperative process between autophagosomes and lysosomes, and its role for process of melanosome degradation remains unclear. Here, we assessed the regulation of autophagy and its contributions to depigmentation associated with Melasolv (3,4,5-trimethoxycinnamate thymol ester). B16F1 cells-treated with Melasolv suppressed the alpha-MSH-stimulated increase of melanin content and resulted in the activation of autophagy. However, introduction of bafilomycin A1 strongly suppressed melanosome degradation in Melasolv-treated cells. Furthermore, inhibition of autophagy by ATG5 resulted in significant suppression of Melasolv-mediated depigmentation in alpha-MSH-treated cells. Taken together, our results suggest that treatment with Melasolv inhibits skin pigmentation by promoting melanosome degradation via autophagy activation.	[Park, Hyun Jun; Park, Na Yeon; Kim, Joon Bum; Choi, Ji Yeon; Kim, Yong Hwan; Oh, Gyeong Seok; Cho, Dong-Hyung] Kyungpook Natl Univ, Sch Life Sci, Daegu, South Korea; [Jo, Doo Sin; Bae, Ji-Eun] Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea; [Choi, Hyunjung; Kim, Hyoung-June] AmorePacific Corp, R&D Unit, Yongin, Gyeonggi Do, South Korea; [Chang, Jeong Ho] Kyungpook Natl Univ, Dept Biol Educ, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Cho, DH (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Daegu, South Korea.; Kim, HJ (corresponding author), AmorePacific Corp, R&D Unit, Yongin, Gyeonggi Do, South Korea.	leojune@amorepacific.com; dhcho@knu.ac.kr			Amorepacific corporation; National Research Foundation	Amorepacific corporation; National Research Foundation	The Study was funded by Amorepacific corporation and National Research Foundation. The funder provided support in the form of salaries for authors [HC and H-JK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ambrosio AL, 2016, P NATL ACAD SCI USA, V113, P5622, DOI 10.1073/pnas.1600108113; Anding AL, 2018, CURR BIOL, V28, P287, DOI 10.1016/j.cub.2017.11.064; Cho DH, 2020, MOL CELLS, V43, P10, DOI 10.14348/molcells.2020.2329; D'Alba L, 2019, PHYSIOL REV, V99, P1, DOI 10.1152/physrev.00059.2017; D'Mello SAN, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071144; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Feng YC, 2017, AUTOPHAGY, V13, P1617, DOI 10.1080/15548627.2017.1356553; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Hsiao JJ, 2014, ARCH BIOCHEM BIOPHYS, V563, P28, DOI 10.1016/j.abb.2014.07.019; Hu GD, 2019, CHINESE CHEM LETT, V30, P1704, DOI 10.1016/j.cclet.2019.06.039; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Hwang JA, 2017, BIOL PHARM BULL, V40, P535, DOI 10.1248/bpb.b16-00834; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang HH, 2003, CHEM PHARM BULL, V51, P1085; Kim ES, 2013, FEBS LETT, V587, P3955, DOI 10.1016/j.febslet.2013.10.027; Kim NH, 2017, PIGM CELL MELANOMA R, V30, P521, DOI 10.1111/pcmr.12605; Kim PS, 2018, BIOCHEM BIOPH RES CO, V503, P309, DOI 10.1016/j.bbrc.2018.06.021; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lee JH, 2017, SKIN PHARMACOL PHYS, V30, P190, DOI 10.1159/000477356; Levy F, 2005, MOL BIOL CELL, V16, P1777, DOI 10.1091/mbc.E04-09-0803; Li Y, 2017, AUTOPHAGY, V13, P1995, DOI 10.1080/15548627.2017.1371394; Luzikov VN, 1999, FEBS LETT, V448, P201, DOI 10.1016/S0014-5793(99)00344-0; Mardakheh FK, 2010, MOL CELL BIOL, V30, P5672, DOI 10.1128/MCB.00878-10; Murase D, 2013, J INVEST DERMATOL, V133, P2416, DOI 10.1038/jid.2013.165; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Pillaiyar T, 2018, J MED CHEM, V61, P7395, DOI 10.1021/acs.jmedchem.7b00967; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Slade L, 2017, MOL CANCER RES, V15, P1637, DOI 10.1158/1541-7786.MCR-17-0320; Wasmeier C, 2008, J CELL SCI, V121, P3995, DOI 10.1242/jcs.040667; Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284	34	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239019	10.1371/journal.pone.0239019	http://dx.doi.org/10.1371/journal.pone.0239019			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941497	Green Published, gold			2022-12-26	WOS:000573848800077
J	Umemura, T; Mashita, S; Kawamura, T				Umemura, Toshitaka; Mashita, Shinichi; Kawamura, Takahiko			Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTRACEREBRAL HEMORRHAGE; BRAIN MICROBLEEDS; PREDICTING STROKE; RISK-FACTOR; WARFARIN; METAANALYSIS	Objective Cerebral microbleeds (CMBs) are a magnetic resonance imaging (MRI) marker for cerebral small vessel disease. Existing CMBs and those that newly develop are associated with the risks of stroke incidence and recurrence. The purpose of the present study was to investigate the association of oral anticoagulant (OAC) use and the development of new CMBs in cardioembolic stroke patients with atrial fibrillation. Subjects and methods We prospectively followed cardioembolic stroke patients with atrial fibrillation who had been hospitalized in the stroke center of our hospital, had been prescribed anticoagulants at discharge, and underwent repeated brain MRI with an interval of at least one year from the baseline MRI. Assessing the presence, number and location of CMBs using T2*-weighted gradient-recalled echo MRI, we used logistic regression models to investigate the associations between OAC use and the incidence of new CMBs. We also examined associations of subsequent stroke with OACs and CMBs during the follow-up. Results A total of 81 patients, consisting of 45 patients receiving direct oral anticoagulants (DOACs) and 36 patients receiving warfarin (WF), were analyzed in the present study. Baseline CMBs were observed in 19/81 patients (23.5%) and new CMBs in 18/81 patients (22.2%) on follow-up MRI (median interval, 34 months). Of the 31 new CMBs, 25 (80.6%) developed in the lobar location and 6 (19.4%) in the deep or infratentorial location. New CMBs occurred in 4 patients (10.0%) taking DOACsalone, in 10 patients (35.7%) taking WF alone, in 3 patients (37.5%) taking WF plus antiplatelet agents and in 1 patient (20.0%) taking DOAC plus antiplatelet agent. Regarding location, the new CMBs were the lobar type in 7 of the 10 patients taking WF alone, as well as in 3 of the 4 patients taking DOACs alone. In multivariate analysis, the presence of CMBs at baseline and WF use (vs. DOAC use) were associated with new CMBs (CMB presence at baseline: OR 4.16, 95% CI 1.19-14.44; WF use: OR 3.38, 95% CI 1.02-11.42). The presence of >= 2 CMBs at baseline was related to a higher risk of subsequent stroke (OR 7.25, 95% CI 1.01-52.35, P = 0.048). Conclusion Our findings suggest that DOAC compared with WF use at discharge is associated with a lower incidence of new CMBs in cardioembolic stroke patients with atrial fibrillation. Further prospective studies in the clinical setting are needed to confirm our exploratory data.	[Umemura, Toshitaka] Chubu Rosai Hosp, Dept Neurol, Japan Org Occupat Hlth & Safety, Nagoya, Aichi, Japan; [Mashita, Shinichi] Chubu Rosai Hosp, Dept Radiol, Japan Org Occupat Hlth & Safety Nagoya, Nagoya, Aichi, Japan; [Kawamura, Takahiko] Chubu Rosai Hosp, Prevent Med Ctr, Dept Diabet & Endocrine Internal Med, Japan Org Occupat Hlth & Safety Nagoya, Nagoya, Aichi, Japan		Kawamura, T (corresponding author), Chubu Rosai Hosp, Prevent Med Ctr, Dept Diabet & Endocrine Internal Med, Japan Org Occupat Hlth & Safety Nagoya, Nagoya, Aichi, Japan.	t.umemura@bg7.so-net.ne.jp						Bokura H, 2011, STROKE, V42, P1867, DOI 10.1161/STROKEAHA.110.601922; Charidimou A, 2017, NEUROLOGY, V89, P2317, DOI 10.1212/WNL.0000000000004704; Charidimou A, 2013, STROKE, V44, P995, DOI 10.1161/STROKEAHA.111.000038; Cordonnier C, 2007, BRAIN, V130, P1988, DOI 10.1093/brain/awl387; Cordonnier C, 2009, STROKE, V40, P94, DOI 10.1161/STROKEAHA.108.526996; Diener HC, 2016, STROKE, V47, P904, DOI 10.1161/STROKEAHA.115.011150; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fazekas F, 1991, J NEUROIMAGING, V1, P27; Fisher M, 2010, STROKE, V41, P2782, DOI 10.1161/STROKEAHA.110.593657; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Lee SH, 2009, NEUROLOGY, V72, P171, DOI 10.1212/01.wnl.0000339060.11702.dd; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lovelock CE, 2010, STROKE, V41, P1222, DOI 10.1161/STROKEAHA.109.572594; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Saito T, 2015, J STROKE CEREBROVASC, V24, P1373, DOI 10.1016/j.jstrokecerebrovasdis.2015.02.018; Seiffge DJ, 2019, ANN NEUROL, V85, P823, DOI 10.1002/ana.25489; Siegbahn A, 2016, THROMB HAEMOSTASIS, V115, P921, DOI 10.1160/TH15-07-0529; Soo Y, 2019, J NEUROL NEUROSUR PS, V90, P428, DOI 10.1136/jnnp-2018-319104; Soo Y, 2018, J NEUROL NEUROSUR PS, V89, P680, DOI 10.1136/jnnp-2017-317151; Umemura T, 2012, AM J HYPERTENS, V25, P430, DOI 10.1038/ajh.2011.254; van Etten ES, 2014, STROKE, V45, P2280, DOI 10.1161/STROKEAHA.114.005151; Viswanathan A, 2006, STROKE, V37, P550, DOI 10.1161/01.STR.0000199847.96188.12; Wilson D, 2019, LANCET NEUROL, V18, P653, DOI 10.1016/S1474-4422(19)30197-8; Wilson D, 2018, LANCET NEUROL, V17, P539, DOI 10.1016/S1474-4422(18)30145-5; Yokoyama M, 2019, J STROKE CEREBROVASC, V28, P1918, DOI 10.1016/j.jstrokecerebrovasdis.2019.03.050	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238456	10.1371/journal.pone.0238456	http://dx.doi.org/10.1371/journal.pone.0238456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941455	gold, Green Published			2022-12-26	WOS:000573848800043
J	Okada, C; Takimoto, H				Okada, Chika; Takimoto, Hidemi			Development of a screening method for determining sodium intake based on the Dietary Reference Intakes for Japanese, 2020: A cross-sectional analysis of the National Health and Nutrition Survey, Japan	PLOS ONE			English	Article							PROCESSED FOOD; SALT	Background Although assessing nutrient intake through dietary surveys is desirable, it can be effort- and time-intensive. We aimed to develop a brief screening method for determining sodium intake in order to raise public awareness regarding the Dietary Reference Intakes for Japanese (DRI-J) 2020. Methods Using data from the 2015 National Health and Nutrition Survey, we compared dietary behaviours obtained from a self-administered questionnaire according to sodium intake, which was assessed from one-day dietary records by a semi-weighed method. Participants were divided into 4 groups based on the reference values of sodium (salt equivalent) shown in the DRI-J. We also randomly divided the participants into development and validation groups, and used logistic regression analysis to identify predictive factors for sex-specific DRI-J (<7.5 g/day in men and <6.5 g/day in women) and above-average intakes (>= 10 g/day in men and women). Results Among the 6,172 Japanese individuals aged >= 20 years old, participants with lower sodium intake were found to use nutrition labels and had a lower frequency of eating out than those with higher intakes (Pfor difference < .001). Our final model for predicting sodium intake included adjusted sex, age, dietary behaviours, and consumption of mainly processed foods. In the development group, areas under the receiver operating characteristics curves were 0.747 and 0.741 for adherence to sex-specific DRI-J and above-average intake, respectively. The corresponding values in the validation group were 0.734 and 0.730, respectively. Conclusions This method could easily identify sodium intake using dietary behaviours and specific food consumption, and is expected to be widely useful for health and nutrition education in Japan.	[Okada, Chika; Takimoto, Hidemi] Natl Inst Biomed Innovat Hlth & Nutr, Dept Nutr Epidemiol & Shokuiku, Natl Inst Hlth & Nutr, Tokyo, Japan	National Institute of Health & Nutrition - Japan	Takimoto, H (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Dept Nutr Epidemiol & Shokuiku, Natl Inst Hlth & Nutr, Tokyo, Japan.	thidemi@nibiohn.go.jp	Takimoto, Hidemi/ABC-6850-2020; , 瀧本秀美/AAH-9938-2020	Takimoto, Hidemi/0000-0002-2751-8710; 	Ministry of Health, Labour, and Welfare in Japan	Ministry of Health, Labour, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Health, Labour, and Welfare in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CANC DISCOV, V3, pOF14; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; Campbell N, 2014, J CLIN HYPERTENS, V16, P619, DOI 10.1111/jch.12379; Cappuccio FP, 2007, BMJ-BRIT MED J, V334, P859, DOI 10.1136/bmj.39175.364954.BE; Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3; Hollander M, 2014, NONPARAMETRIC STAT M; Martinez FJ, 2008, COPD, V5, P85, DOI 10.1080/15412550801940721; Ministry of Health Labor and Welfare, 2020, DIET REF INT JAP; Ministry of Health Labour and Welfare, 2015, DIET REF INT JAP 201, P2015; Ministry of Health Labour and Welfare., 2016, ANN REP NAT HLTH NUT; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Nghiem N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3102-1; Okada E, 2018, ASIA PAC J CLIN NUTR, V27, P1120, DOI 10.6133/apjcn.042018.06; Okuda N, 2014, HYPERTENS RES, V37, P467, DOI 10.1038/hr.2013.149; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; The Council for Science and Technology Ministry of Education Culture Sports and Technology, 2010, STAND TABL FOOD COMP; Trevena H, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2743-4; Trieu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130247; Wang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043834; Watanabe S, 2009, ASIA PAC J CLIN NUTR, V18, P532; Wijnhoven HAH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196406; World Health Organization, GUID SOD INT AD CHIL	22	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0235749	10.1371/journal.pone.0235749	http://dx.doi.org/10.1371/journal.pone.0235749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931497	Green Published, gold			2022-12-26	WOS:000573375500006
J	Zhong, C; Yu, Q; Jia, WT; Yu, X; Yu, DD; Yang, M; Wang, LN; Ling, CQ; Zhu, LQ				Zhong, Chen; Yu, Qin; Jia, Wentao; Yu, Xin; Yu, Dandan; Yang, Ming; Wang, Lina; Ling, Changquan; Zhu, Liqing			Mechanism for enhanced transduction of hematopoietic cells by recombinant adeno-associated virus serotype 6 vectors	FASEB JOURNAL			English	Article						gene delivery; hematopoietic stem; progenitor cells; proteasome inhibitor; reactive oxygen species; shikonin	HIGH-EFFICIENCY TRANSDUCTION; GENE-THERAPY; IN-VITRO; TRANSGENE EXPRESSION; STEM; TRANSPLANTATION; INDUCTION; SHIKONIN; EFFICACY; MOUSE	Hematopoietic gene delivery, such as hematopoietic stem/progenitor cells (HSPCs), is a promising treatment for both inherited and acquired diseases, such as hemophilia. Recently, a combined strategy to achieve more than 90% transduction efficiency was documented using recombinant adeno-associated virus serotype 6 (rAAV6) vectors. However, the mechanisms of enhanced vector transduction efficiency in hematopoietic cells are largely unknown. In this manuscript, we first reported that proteasome inhibitors, which are well-known to facilitate rAAV intracellular trafficking in various cell types, are not effective in hematopoietic cells. From the screening of small molecules derived from traditional Chinese medicine, we demonstrated that shikonin, a potential reactive oxygen species (ROS) generator, significantly increased the in vitro and ex vivo transgene expression mediated by rAAV6 vectors in hematopoietic cells, including human cord blood-derived CD34 + HSPCs. Shikonin mainly targeted vector intracellular trafficking, instead of host cell entry or endonuclear single to double strand vector DNA transition, in a vector serotype-dependent manner. Moreover, a ROS scavenger completely prevented the capability of shikonin to enhance rAAV6 vector-mediated transgene expression. Taken together, these studies expand our understanding of rAAV6-mediated transduction in hematopoietic cells and are informative for improving rAAV6-based treatment of blood diseases.	[Zhong, Chen; Yu, Dandan; Zhu, Liqing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Clin Lab, Wenzhou 325000, Zhejiang, Peoples R China; [Zhong, Chen; Yang, Ming] Fudan Univ, Sch Life Sci, Zhongshan Hosp, State Key Lab Genet Engn, Shanghai, Peoples R China; [Yu, Qin; Ling, Changquan] Shanghai Univ Tradit Chinese Med, Grad Sch, 1200 Cailun Rd, Shanghai 201203, Peoples R China; [Jia, Wentao; Yu, Xin; Wang, Lina; Ling, Changquan] Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, 168 Changhai Rd, Shanghai 200433, Peoples R China	Wenzhou Medical University; Fudan University; Shanghai University of Traditional Chinese Medicine; Naval Medical University	Zhu, LQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Clin Lab, Wenzhou 325000, Zhejiang, Peoples R China.; Ling, CQ (corresponding author), Shanghai Univ Tradit Chinese Med, Grad Sch, 1200 Cailun Rd, Shanghai 201203, Peoples R China.; Wang, LN; Ling, CQ (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Tradit Chinese Med, 168 Changhai Rd, Shanghai 200433, Peoples R China.	rena1022@163.com; lingchangquan@hotmail.com; wzzhuliqing@126.com			National Natural Science Foundation of China (NSFC) [81430101, 81774244]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81430101 and 81774244	Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Basaiyye SS, 2019, J INTEGR MED-JIM, V17, P221, DOI 10.1016/j.joim.2019.03.004; Brown N, 2017, HUM GENE THER, V28, P450, DOI 10.1089/hum.2017.038; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; de Sio FRS, 2006, BLOOD, V107, P4257, DOI 10.1182/blood-2005-10-4047; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Fleischer T, 2016, J INTEGR MED-JIM, V14, P322, DOI 10.1016/S2095-4964(16)60270-4; Gaudet D, 2016, HUM GENE THER, V27, P916, DOI 10.1089/hum.2015.158; Hoy SM, 2019, DRUGS, V79, P1255, DOI 10.1007/s40265-019-01162-5; Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4; Li M, 2017, BLOOD, V130, P1041, DOI 10.1182/blood-2016-12-755967; Ling C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35495; Ling C, 2014, HUM GENE THER, V25, P1023, DOI 10.1089/hum.2014.099; Lu JM, 2017, CEREB CORTEX, V27, P3842, DOI 10.1093/cercor/bhx082; Mantel C, 2012, BLOOD, V120, P2589, DOI 10.1182/blood-2012-01-404004; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Mitchell AM, 2013, J VIROL, V87, P13035, DOI 10.1128/JVI.01826-13; Mitchell AM, 2013, J VIROL, V87, P4571, DOI 10.1128/JVI.03443-12; Monahan PE, 2010, MOL THER, V18, P1907, DOI 10.1038/mt.2010.170; Morgan RA, 2017, CELL STEM CELL, V21, P574, DOI 10.1016/j.stem.2017.10.010; Naldini L, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809958; Nienhuis AW, 2017, MOL THER, V25, P1163, DOI 10.1016/j.ymthe.2017.03.033; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Settharaksa S, 2019, J INTEGR MED-JIM, V17, P351, DOI 10.1016/j.joim.2019.05.003; Smith KA, 2017, REDOX BIOL, V13, P228, DOI 10.1016/j.redox.2017.05.020; Song LJ, 2013, CYTOTHERAPY, V15, P986, DOI 10.1016/j.jcyt.2013.04.003; Song LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058757; Su J, 2015, BIOMATERIALS, V70, P84, DOI 10.1016/j.biomaterials.2015.08.004; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Wang LN, 2014, J INTEGR MED-JIM, V12, P20, DOI 10.1016/S2095-4964(14)60003-0; Wang RB, 2012, EXPERT OPIN THER PAT, V22, P977, DOI 10.1517/13543776.2012.709237; Weller ML, 2010, NAT MED, V16, P662, DOI 10.1038/nm.2145; Wheeler MD, 2000, HEPATOLOGY, V32, P1050, DOI 10.1053/jhep.2000.19339; Zhang FL, 2011, GENE THER, V18, P128, DOI 10.1038/gt.2010.120; Zheng QY, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100920; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	38	2	2	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12379	12391		10.1096/fj.201902875R	http://dx.doi.org/10.1096/fj.201902875R		JUL 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32960474				2022-12-26	WOS:000556424300001
J	Bugger, H; Gollmer, J; Pregartner, G; Wunsch, G; Berghold, A; Zirlik, A; von Lewinski, D				Bugger, Heiko; Gollmer, Johannes; Pregartner, Gudrun; Wuensch, Gerit; Berghold, Andrea; Zirlik, Andreas; von Lewinski, Dirk			Complications and mortality of cardiovascular emergency admissions during COVID-19 associated restrictive measures	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; INFECTION	While hospital admissions for myocardial infarction (MI) and pulmonary embolism (PE) are decreased during the COVID-19 pandemic, controversy remains about respective complication and mortality rates. This study evaluated admission rates, complications, and intrahospital mortality for selected life-threatening cardiovascular emergencies (MI, PE, and acute aortic dissection (AAD)) during COVID-19-associated restrictive social measures (RM) in Styria, Austria. By screening a patient information system for International Statistical Classification of Diseases and Related Health Problems (ICD) diagnosis codes covering more than 85% of acute hospital admissions in the state of Styria (similar to 1.24 million inhabitants), we retrospectively identified patients with admission diagnoses for MI (I21, I22), PE (I26), and AAD (I71). Rates of complications such as cardiogenic shock and cardiopulmonary resuscitation, treatment escalations (thrombolysis for PE), and mortality were analyzed by patient chart review during 6 weeks following onset of COVID-19 associated RM, and during respective time frames in the years 2016 to 2019. 1,668 patients were included. Cumulative admissions for MI, PE and AAD decreased (RR 0.77; p<0.001) during RM compared to previous years. In contrast, intrahospital mortality increased by 65% (RR 1.65; p = 0.041), mainly driven by mortality following MI (RR 1.80; p = 0.042). PE patients received more frequently thrombolysis treatment (RR 3.63; p = 0.006), while rates of cardiogenic shock and cardiopulmonary resuscitation remained unchanged. Of 226 patients hospitalized during RM, 81 patients with suspected COVID-19 disease were screened for SARS-CoV-2 infection with only 5 testing positive. Thus, cumulative hospital admissions for cardiovascular emergencies decreased during COVID-19 associated RM while intrahospital mortality increased.	[Bugger, Heiko; Gollmer, Johannes; Zirlik, Andreas; von Lewinski, Dirk] Med Univ Graz, Div Cardiol, Graz, Austria; [Pregartner, Gudrun; Wuensch, Gerit; Berghold, Andrea] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria	Medical University of Graz; Medical University of Graz	von Lewinski, D (corresponding author), Med Univ Graz, Div Cardiol, Graz, Austria.	dirk.von-lewinski@medunigraz.at	Bugger, Heiko/ABA-4180-2021; Zirlik, Andreas/A-6400-2011	Zirlik, Andreas/0000-0001-6290-3297; Gollmer, Johannes/0000-0002-8734-6359; Bugger, Heiko/0000-0002-3524-0405				Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418; Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Benzakoun J, 2020, EUR J HEART FAIL, V22, P1046, DOI 10.1002/ejhf.1916; Bompard F, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01365-2020; Bram JT, 2020, J PEDIATR ORTHOPED, V40, P373, DOI 10.1097/BPO.0000000000001600; Bunce PE, 2011, CLIN INFECT DIS, V52, pE14, DOI 10.1093/cid/ciq125; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409; Dinmohamed AG, 2020, LANCET ONCOL, V21, P750, DOI 10.1016/S1470-2045(20)30265-5; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Holt A, 2020, EUR HEART J, V41, P3072, DOI 10.1093/eurheartj/ehaa494; Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393; Kiblboeck D, 2020, WIEN KLIN WOCHENSCHR, V132, P362, DOI 10.1007/s00508-020-01698-7; Kim IC, 2020, EUR HEART J, V41, P1859, DOI 10.1093/eurheartj/ehaa288; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Lazzerini M, 2020, LANCET CHILD ADOLESC, V4, pE10, DOI 10.1016/S2352-4642(20)30108-5; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1131, DOI [10.1515/cclm-2020-0198, 10.1515/cclm-2020-1761]; Madjid M, 2020, JAMA CARDIOL, V5, P831, DOI 10.1001/jamacardio.2020.1286; Metzler B, 2020, EUR HEART J, V41, P1852, DOI 10.1093/eurheartj/ehaa314; Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9; Nopp S, 2020, RES PRACT THROMB HAE, V4, P835, DOI 10.1002/rth2.12391; Poissy J, 2020, CIRCULATION, V142, P184, DOI 10.1161/CIRCULATIONAHA.120.047430; Rath D, 2020, CLIN RES CARDIOL, V109, P1491, DOI 10.1007/s00392-020-01683-0; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Sakelliadis EI, 2020, FORENSIC SCI INT, V313, DOI 10.1016/j.forsciint.2020.110365; Scholz KH, 2020, CLIN RES CARDIOL, V109, P1511, DOI 10.1007/s00392-020-01703-z; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Solomon MD, 2020, NEW ENGL J MED, V383, P691, DOI 10.1056/NEJMc2015630; Tam CCF, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.006631; Tan W, 2020, CARDIOL RES, V11, P256, DOI 10.14740/cr1096; Taza F, 2020, BMJ CASE REP, V13, DOI 10.1136/bcr-2020-236561; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Vejpongsa P, 2019, AM J MED, V132, P1173, DOI 10.1016/j.amjmed.2019.05.002; Wilson SJ, 2020, CIRC-CARDIOVASC INTE, V13, DOI 10.1161/CIRCINTERVENTIONS.120.009438; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	37	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239801	10.1371/journal.pone.0239801	http://dx.doi.org/10.1371/journal.pone.0239801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970774	gold, Green Published			2022-12-26	WOS:000576265600058
J	Christensen, SR; Pilling, EB; Eyring, JB; Dickerson, G; Sloan, CD; Magnusson, BM				Christensen, Sarah R.; Pilling, Emily B.; Eyring, J. B.; Dickerson, Grace; Sloan, Chantel D.; Magnusson, Brianna M.			Political and personal reactions to COVID-19 during initial weeks of social distancing in the United States	PLOS ONE			English	Article								Objective To examine perceptions, behaviors, and impacts surrounding COVID-19 early in the pandemic response. Materials and methods A cross-sectional survey of 1,030 U.S. adults was administered on March 31st, 2020. This survey examined attitudes toward media, government, and community responses to COVID-19 by political ideology and sociodemographic factors. Knowledge, anxieties, and impacts of COVID-19 were also assessed. Results Conservatives were more likely to report that COVID-19 was receiving too much media coverage and people were generally overreacting; liberals were more likely to report the government had not done enough in response to the pandemic. Females and those with lower income experienced more COVID-19 related economic anxieties. Those working and with children at home reported higher social, home, and work disruption. Social distancing behaviors were more common among liberals and were associated with increases in depressive symptoms. General knowledge about COVID-19 was widely exhibited across the sample, however, Black and Hispanic respondents were less likely to correctly answer questions about the availability of a vaccine and modes of transmission. Conclusions Public health experts should consider the political climate in crafting messaging that appeals to the values of those across the political spectrum. Research on the COVID-19 pandemic should continue to monitor the effects of social distancing on mental health and among vulnerable populations.	[Christensen, Sarah R.; Pilling, Emily B.; Eyring, J. B.; Dickerson, Grace; Sloan, Chantel D.; Magnusson, Brianna M.] Brigham Young Univ, Coll Life Sci, Dept Publ Hlth, Provo, UT 84602 USA	Brigham Young University	Magnusson, BM (corresponding author), Brigham Young Univ, Coll Life Sci, Dept Publ Hlth, Provo, UT 84602 USA.	Brianna.Magnusson@byu.edu	Sloan-Aagard, Chantel/GWC-7572-2022; Magnusson, Brianna M./AAB-4055-2019	Magnusson, Brianna M./0000-0001-6389-8186; Eyring, J. B./0000-0002-4416-6673				Ad Fontes Media, 2020, MED BIAS CHART VERS; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bianchi SM, 2012, SOC FORCES, V91, P55, DOI 10.1093/sf/sos120; Centers for Disease Control and Prevention, 2021, INT INF PREV CONTR G; Doherty C., 2014, POLITICAL POLARIZATI; Edison Research, 2019, WOM EC ANX; Fiorina MP, 2008, ANNU REV POLIT SCI, V11, P563, DOI 10.1146/annurev.polisci.11.053106.153836; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Leigh-Hunt N, 2017, PUBLIC HEALTH, V152, P157, DOI 10.1016/j.puhe.2017.07.035; Leiserowitz A., 2011, GLOBAL WARMINGS 6 AM; Littlefield RS, 2007, J APPL COMMUN RES, V35, P26, DOI 10.1080/00909880601065664; Malka A, 2010, SOC JUSTICE RES, V23, P156, DOI 10.1007/s11211-010-0114-3; Newman Nic, 2019, REUTERS I DIGITAL NE; Pratt, 2020, THE CHICAGO TRIBUNE; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Reynolds B, 2008, HEALTH PROMOT PRACT, V9, p13S, DOI 10.1177/1524839908325267; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; SAGE Working Group on Vaccine Hesitancy, 2018, VACC HES SURV QUEST; Talevi D, 2020, RIV PSICHIATR, V55, P137, DOI 10.1708/3382.33569; U.S. Census Bureau, 2019, FAM PRES OWN CHILDR; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729	23	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239693	10.1371/journal.pone.0239693	http://dx.doi.org/10.1371/journal.pone.0239693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970761	Green Published, gold			2022-12-26	WOS:000576265600015
J	Hebert, L; Hillman, P; Baker, C; Brown, M; Ashley-Koch, A; Hixson, JE; Morrison, AC; Northrup, H; Au, KS				Hebert, Luke; Hillman, Paul; Baker, Craig; Brown, Michael; Ashley-Koch, Allison; Hixson, James E.; Morrison, Alanna C.; Northrup, Hope; Au, Kit Sing			Burden of rare deleterious variants in WNT signaling genes among 511 myelomeningocele patients	PLOS ONE			English	Article							PLANAR CELL POLARITY; NEURAL-TUBE DEFECTS; PROTEIN PHOSPHATASE 2A; BETA-CATENIN; IDENTIFICATION; CILIA; PHOSPHORYLATION; EXPRESSION; MUTATIONS; CLOSURE	Genes in the noncanonical WNT signaling pathway controlling planar cell polarity have been linked to the neural tube defect myelomeningocele. We hypothesized that some genes in the WNT signaling network have a higher mutational burden in myelomeningocele subjects than in reference subjects in gnomAD. Exome sequencing data from 511 myelomeningocele subjects was obtained in-house and data from 29,940 ethnically matched subjects was provided by version 2 of the publicly available Genome Aggregation Database. To compare mutational burden, we collapsed rare deleterious variants across each of 523 human WNT signaling genes in case and reference populations. Ten WNT signaling genes were disrupted with a higher mutational burden among Mexican American myelomeningocele subjects compared to reference subjects (Fishers exact test, P <= 0.05) and seven different genes were disrupted among individuals of European ancestry compared to reference subjects. Gene ontology enrichment analyses indicate that genes disrupted only in the Mexican American population play a role in planar cell polarity whereas genes identified in both populations are important for the regulation of canonical WNT signaling. In summary, evidence for WNT signaling genes that may contribute to myelomeningocele in humans is presented and discussed.	[Hebert, Luke; Hillman, Paul; Baker, Craig; Northrup, Hope; Au, Kit Sing] Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Pediat, Div Med Genet, McGovern Med Sch, Houston, TX 77030 USA; [Brown, Michael; Hixson, James E.; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston UTHlth, Human Genet Ctr, Dept Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX USA; [Ashley-Koch, Allison] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Ashley-Koch, Allison] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC USA; [Baker, Craig] Univ Nebraska Med Ctr, Munroe Meyer Inst, Omaha, NE USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Duke University; Duke University; University of Nebraska System; University of Nebraska Medical Center	Au, KS (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Pediat, Div Med Genet, McGovern Med Sch, Houston, TX 77030 USA.	Kit-Sing.Au@uth.tmc.edu		Hillman, Paul/0000-0002-9356-7887; Au, Kit Sing/0000-0002-2694-5833	National Institute of Health's Eunice Kennedy Shriver National Institute of Child Health & Human Development [5R01HD073434, 5P01HD035946]; 2019 International Neural Tube Defects Conference at Boston, MA [NIH R13 HD 100191]	National Institute of Health's Eunice Kennedy Shriver National Institute of Child Health & Human Development; 2019 International Neural Tube Defects Conference at Boston, MA	For exome sequencing, the National Institute of Health's Eunice Kennedy Shriver National Institute of Child Health & Human Development awarded Kit-Sing Au (KA) the grant numbered 5R01HD073434 (https://urldefense.proofpoint.com/v2/url?u=https-3A__project reporter.nih.gov_project-5Finfo-5Fdescription. cfm-3Fprojectnumber-3D5R01HD0734342D05&d=DwIGaQ&c=bKRySV-ouEg_AT-w2QWsTdd9X__KYh9Eq2fdmQDVZgw&r= VkWBAnv-bUNSziZvFEP1ll8maq8XQJ0rSgEH0uBTc0&m=TR2cQ3DpEHWj9jZOxbu PdU9ftRv5wfV4D8TMg_m6wgw&s=IU6EML_ vdznk-0qm7pgyXx66fW2xBT7YpzLVI_7r7v0&e=). For subject recruitment, the National Institute of Health's Eunice Kennedy Shriver National Institute of Child Health & Human Development awarded Hope Northrup (HN) the grant numbered 5P01HD035946 (https://urldefense.proofpoint.com/v2/url?u=https-3A__report.nih.gov_ categorical-5Fspending-5Fproject-5Flisting.aspx3FFY-3D2009-26ARRA-3DN-26DCat-3DSpina-2BBifida&d=DwIGaQ&c=bKRySV-ouEg_ATw2QWsTdd9X__KYh9Eq2fdmQDVZgw&r= VkWBAnv-bUNSziZvFEP1ll8maq8XQJ0rSgEH0uBTc0&m=TR2cQ3DpEHWj9jZOxbu PdU9ftRv5wfV4D8TMg_m6wgw&s=8305l-7yq Es3TXp5AdF2w9l7FKDEGOG0zkGhdytuDlc&e=). LH received travel support for attending the 2019 International Neural Tube Defects Conference at Boston, MA to allow display and discussion of the data with grant number NIH R13 HD 100191. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agopian AJ, 2013, BIRTH DEFECTS RES A, V97, P42, DOI 10.1002/bdra.23100; Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Allache R, 2015, BIRTH DEFECTS RES A; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Angers S, 2006, NAT LETT, V443, P3; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; [Anonymous], 2012, REGEN MED S3, V7, pS14; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Au KS, 2008, BIRTH DEFECTS RES A, V82, P692, DOI 10.1002/bdra.20499; Canfield MA, 2014, AM J PUBLIC HEALTH, V104, P1999; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Copp AJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.7; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dai D, 2011, J INVEST DERMATOL, V131, P302, DOI 10.1038/jid.2010.306; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Guo MH, 2018, AM J HUM GENET, V103, P522, DOI 10.1016/j.ajhg.2018.08.016; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Henderson DJ, 2018, CURR OPIN CELL BIOL, V55, P96, DOI 10.1016/j.ceb.2018.06.011; Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130; Higa LA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-5; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Ishida M, 2018, CLIN GENET, V93, P870, DOI 10.1111/cge.13189; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P824, DOI 10.1002/bdra.23079; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katoh M, 2003, INT J MOL MED, V11, P249; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Krupp DR, 2012, BIRTH DEFECTS RES A, V94, P683, DOI 10.1002/bdra.23040; Lei YP, 2015, HUM MUTAT, V36, P342, DOI 10.1002/humu.22750; Leoyklang P, 2008, CLIN GENET, V73, P373, DOI 10.1111/j.1399-0004.2008.00975.x; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Nikolopoulou E, 2017, DEVELOPMENT, V144, P552, DOI 10.1242/dev.145904; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Paulson AF, 2014, CELL ADHES MIGR, V8, P19, DOI 10.4161/cam.27839; Peters T, 2014, PEDIATR DERMATOL, V31, P220, DOI 10.1111/pde.12267; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Rentzsch P, 2019, NUCLEIC ACIDS RES, V47, pD886, DOI 10.1093/nar/gky1016; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Salbaum JM, 2010, BIRTH DEFECTS RES A, V88, P601, DOI 10.1002/bdra.20680; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Skalka N, 2013, ONCOGENE, V32, P2836, DOI 10.1038/onc.2012.308; Steinhart Z, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146589; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wang K, 2013, NEURO-ONCOLOGY, V15, P578, DOI 10.1093/neuonc/not004; Wang MQ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101198; Wen S, 2010, AM J MED GENET A, V152A, P299, DOI 10.1002/ajmg.a.33230; WOOLF CM, 1975, SOC BIOL, V22, P216, DOI 10.1080/19485565.1975.9988169; Wu J, 2017, DEV CELL, V40, P423, DOI 10.1016/j.devcel.2017.02.023; Yang W, 2017, CELL RES, V27, P1466, DOI 10.1038/cr.2017.127; Yang YZ, 2015, ANNU REV CELL DEV BI, V31, P623, DOI 10.1146/annurev-cellbio-100814-125315; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015; Zaganjor I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151586	68	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239083	10.1371/journal.pone.0239083	http://dx.doi.org/10.1371/journal.pone.0239083			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970752	Green Published, gold, Green Submitted			2022-12-26	WOS:000576265600049
J	Zhang, W; Abdelrasoul, GN; Savchenko, O; Abdrabou, A; Wang, ZX; Chen, J				Zhang, Wei; Abdelrasoul, Gaser N.; Savchenko, Oleksandra; Abdrabou, Abdalla; Wang, Zhixiang; Chen, Jie			Ultrasound-assisted magnetic nanoparticle-based gene delivery	PLOS ONE			English	Article							INTENSITY PULSED ULTRASOUND; NONVIRAL VECTORS; STIMULATION; CELLS	Targeted gene delivery is important in biomedical research and applications. In this paper, we synergistically combine non-viral chemical materials, magnetic nanoparticles (MNPs), and a physical technique, low-intensity pulsed ultrasound (LIPUS), to achieve efficient and targeted gene delivery. The MNPs are iron oxide super-paramagnetic nanoparticles, coated with polyethyleneimine (PEI), which makes a high positive surface charge and is favorable for the binding of genetic materials. Due to the paramagnetic properties of the MNPs, the application of an external magnetic field increases transfection efficiency while LIPUS stimulation enhances cell viability and permeability. We found that stimulation at the intensity of 30 mW/cm(2)for 10 minutes yields optimal results with a minimal adverse effect on the cells. By combining the effect of the external magnetic field and LIPUS, the genetic material (GFP or Cherry Red plasmid) can enter the cells. The flow cytometry results showed that by using just a magnetic field to direct the genetic material, the transfection efficiency on HEK 293 cells that were treated by our MNPs was 56.1%. Coupled with LIPUS stimulation, it increased to 61.5% or 19% higher than the positive control (Lipofectamine 2000). Besides, compared with the positive control, our method showed less toxicity. Cell viability after transfection was 63.61%, which is 19% higher than the standard transfection technique. In conclusion, we designed a new gene-delivery method that is affordable, targeted, shows low-toxicity, yet high transfection efficiency, compared to other conventional approaches.	[Zhang, Wei; Abdelrasoul, Gaser N.; Chen, Jie] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Savchenko, Oleksandra; Chen, Jie] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Abdrabou, Abdalla; Wang, Zhixiang] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Chen, J (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada.; Chen, J (corresponding author), Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.	jc65@ualberta.ca			MITACS Canada Foundation for Innovation	MITACS Canada Foundation for Innovation	MITACS Canada Foundation for Innovation.	[Anonymous], 2011, ULTRASONICS FUNDAMEN; Bajpai VK, 2019, ACS APPL MATER INTER, V11, P43949, DOI 10.1021/acsami.9b16989; Baker KG, 2001, PHYS THER, V81, P1351, DOI 10.1093/ptj/81.7.1351; Belguise-Valladier P, 2001, CYTOTECHNOLOGY, V35, P197, DOI 10.1023/A:1013133605406; Chen J., 2015, GOOGLE PATENTS; Davidson JM, 2008, J INVEST DERMATOL, V128, P1360, DOI 10.1038/jid.2008.128; Davis ME, 2002, CURR OPIN BIOTECH, V13, P128, DOI 10.1016/S0958-1669(02)00294-X; Dobson J, 2006, GENE THER, V13, P283, DOI 10.1038/sj.gt.3302720; Elsabahy M, 2011, CURR DRUG DELIV, V8, P235, DOI 10.2174/156720111795256174; Evans CH, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001493; He C, 2013, CELL MOL BIOENG, V6, P266, DOI 10.1007/s12195-013-0279-6; Huang DG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69430-z; Jiang XX, 2019, IEEE T BIO-MED ENG, V66, P2704, DOI 10.1109/TBME.2018.2889669; Jin WY, 2018, J BIOMED NANOTECHNOL, V14, P1654, DOI 10.1166/jbn.2018.2604; Khanna A, 2009, BRIT MED BULL, V89, P169, DOI 10.1093/bmb/ldn040; Khosravi D. K., 2010, CALCIUM BASED NONVIR; Kumar MNVR, 2004, EXPERT OPIN BIOL TH, V4, P1213, DOI 10.1517/14712598.4.8.1213; Li ZY, 2020, J CONTROL RELEASE, V322, P622, DOI 10.1016/j.jconrel.2020.03.021; Lin GT, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071057; Liu Y, 2012, ULTRASOUND MED BIOL, V38, P876, DOI 10.1016/j.ultrasmedbio.2012.01.006; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Malizos KN, 2006, INJURY, V37, pS56, DOI 10.1016/j.injury.2006.02.037; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nguyen AH, 2018, APPL NANOSCI, V8, P811, DOI 10.1007/s13204-018-0775-z; Pounder NM, 2008, ULTRASONICS, V48, P330, DOI 10.1016/j.ultras.2008.02.005; Rahmani S, 2019, INT J PHARMACEUT, V560, P306, DOI 10.1016/j.ijpharm.2019.02.016; Roy I, 2003, INT J PHARMACEUT, V250, P25, DOI 10.1016/S0378-5173(02)00452-0; Savchenko O, 2017, SCI REP-UK, V7, DOI 10.1038/srep42003; Semple SC, 2005, J PHARMACOL EXP THER, V312, P1020, DOI 10.1124/jpet.104.078113; Shukla S, 2019, ACS APPL MATER INTER, V11, P18165, DOI 10.1021/acsami.9b02857; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; ter Haar G, 1999, Eur J Ultrasound, V9, P3; Villate-Beitia I, 2017, INT J PHARMACEUT, V521, P130, DOI 10.1016/j.ijpharm.2017.02.016; Vinogradov SV, 2002, ADV DRUG DELIVER REV, V54, P135, DOI 10.1016/S0169-409X(01)00245-9; Wang WW, 2013, CURR PHARM BIOTECHNO, V14, P46; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Xin ZC, 2016, TRANSL ANDROL UROL, V5, P255, DOI 10.21037/tau.2016.02.04; Xing JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187048; Xu P, 2012, BIOTECHNOL LETT, V34, P1965, DOI 10.1007/s10529-012-0984-6; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485; Zhao YP, 2014, ULTRASONICS, V54, P1439, DOI 10.1016/j.ultras.2014.04.025; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239633	10.1371/journal.pone.0239633	http://dx.doi.org/10.1371/journal.pone.0239633			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970723	Green Published, Green Submitted, gold			2022-12-26	WOS:000576265600095
J	Rayner, JE; Duffy, DL; Smit, DJ; Jagirdar, K; Lee, KJ; De'Ambrosis, B; Smithers, BM; McMeniman, EK; McInerney-Leo, AM; Schaider, H; Stark, MS; Soyer, HP; Sturm, RA				Rayner, Jenna E.; Duffy, David L.; Smit, Darren J.; Jagirdar, Kasturee; Lee, Katie J.; De'Ambrosis, Brian; Smithers, B. Mark; McMeniman, Erin K.; McInerney-Leo, Aideen M.; Schaider, Helmut; Stark, Mitchell S.; Soyer, H. Peter; Sturm, Richard A.			Germline and somatic albinism variants in amelanotic/hypomelanotic melanoma: Increased carriage of TYR and OCA2 variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OCULOCUTANEOUS ALBINISM; AMELANOTIC MELANOMA; P-GENE; PIGMENTATION; MUTATION; CANCER; COLOR; RISK; SUSCEPTIBILITY	Amelanotic/hypomelanotic melanoma is a clinicopathologic subtype with absent or minimal melanin. This study assessed previously reported coding variants in albinism genes (TYR,OCA2,TYRP1,SLC45A2,SLC24A5,LRMDA)and common intronic, regulatory variants ofOCA2in individuals with amelanotic/hypomelanotic melanoma, pigmented melanoma cases and controls. Exome sequencing was available for 28 individuals with amelanotic/hypomelanotic melanoma and 303 individuals with pigmented melanoma, which were compared to whole exome data from 1144 Australian controls. Microarray genotyping was available for a further 17 amelanotic/hypomelanotic melanoma, 86 pigmented melanoma, 147 melanoma cases (pigmentation unknown) and 652 unaffected controls. Rare deleterious variants inTYR/OCA1 were more common in amelanotic/hypomelanotic melanoma cases than pigmented melanoma cases (set mixed model association testsP= 0.0088). TheOCA2hypomorphic allele p.V443I was more common in melanoma cases (1.8%) than controls (1.0%,(XP)-P-2= 0.02), and more so in amelanotic/hypomelanotic melanoma (4.4%,(XP)-P-2= 0.007). No amelanotic/hypomelanotic melanoma cases carried an eye and skin darkening haplotype ofOCA2(including rs7174027), present in 7.1% of pigmented melanoma cases (P= 0.0005) and 9.4% controls. Variants inTYRandOCA2may play a role in amelanotic/hypomelanotic melanoma susceptibility. We suggest that somatic loss of function at these loci could contribute to the loss of tumor pigmentation, consistent with this we found a higher rate of somatic mutation inTYR/OCA2in amelanotic/hypomelanotic melanoma vs pigmented melanoma samples (28.6% vs 3.0%;P= 0.021) from The Cancer Genome Atlas Skin Cutaneous Melanoma collection.	[Rayner, Jenna E.; Duffy, David L.; Smit, Darren J.; Jagirdar, Kasturee; Lee, Katie J.; McMeniman, Erin K.; McInerney-Leo, Aideen M.; Schaider, Helmut; Stark, Mitchell S.; Soyer, H. Peter; Sturm, Richard A.] Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia; [Duffy, David L.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [De'Ambrosis, Brian; McMeniman, Erin K.; Soyer, H. Peter] Princess Alexandra Hosp, Dermatol Dept, Brisbane, Qld, Australia; [De'Ambrosis, Brian] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [De'Ambrosis, Brian] South East Dermatol, Brisbane, Qld, Australia; [Smithers, B. Mark] Univ Queensland, Sch Med, Queensland Melanoma Project, Brisbane, Qld, Australia	University of Queensland; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Sturm, RA (corresponding author), Univ Queensland, Diamantina Inst, Dermatol Res Ctr, Brisbane, Qld, Australia.	r.sturm@uq.edu.au	Soyer, H. Peter/W-3791-2017; Smithers, Bernard Mark/F-2060-2010; McInerney-Leo, Aideen M/D-8302-2016; Stark, Mitchell/K-6794-2019; Duffy, David/B-7392-2013	Soyer, H. Peter/0000-0002-4770-561X; Smithers, Bernard Mark/0000-0002-8333-8685; McInerney-Leo, Aideen M/0000-0002-0059-5732; Stark, Mitchell/0000-0002-4510-2161; Jagirdar, Kasturee/0000-0001-8761-132X; Duffy, David/0000-0001-7227-632X; De'Ambrosis, Brian/0000-0001-5189-8701; Schaider, Helmut/0000-0003-3195-2517; SMIT, Darren/0000-0002-3288-3659; Lee, Katie/0000-0002-9000-3226	National Health and Medical Research Council (NHMRC) [APP1062935]; Centre of Research Excellence for the Study of Naevi [APP1099021]; NHMRC Practitioner Fellowship [APP1137127]; NHMRC [APP1106491, APP1158111]; Queensland Genomics, Queensland Government, Round 1 Demonstration Project grant	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Centre of Research Excellence for the Study of Naevi; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Queensland Genomics, Queensland Government, Round 1 Demonstration Project grant	This work was supported by the National Health and Medical Research Council (NHMRC; https://www.nhmrc.gov.au/) Project (APP1062935), the Centre of Research Excellence for the Study of Naevi (APP1099021), an NHMRC Practitioner Fellowship (APP1137127) to HPS, and NHMRC Fellowships (APP1106491 and APP1158111) to MSS and AML. Funding for WES was provided by Queensland Genomics, Queensland Government, Round 1 Demonstration Project grant (https://queenslandgenomics.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2013, J DERMATOL SCI, V69, P167, DOI 10.1016/j.jdermsci.2012.10.016; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ainger SA, 2017, DERMATOLOGY, V233, P1, DOI 10.1159/000468538; Akahoshi K, 2004, AM J MED GENET A, V126A, P290, DOI 10.1002/ajmg.a.20580; Akahoshi K, 2001, AM J MED GENET, V104, P299, DOI 10.1002/ajmg.10095; Amos CI, 2011, HUM MOL GENET, V20, P5012, DOI 10.1093/hmg/ddr415; Chen H, 2019, AM J HUM GENET, V104, P260, DOI 10.1016/j.ajhg.2018.12.012; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cust AE, 2018, PHOTOCH PHOTOBIO SCI, V17, P1853, DOI 10.1039/c7pp00411g; Daley GM, 2017, EXP DERMATOL, V26, P730, DOI 10.1111/exd.13114; Robles-Espinoza CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12064; Donnelly MP, 2012, HUM GENET, V131, P683, DOI 10.1007/s00439-011-1110-x; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Duffy DL, 2020, J INVEST DERMATOL, V140, P498, DOI 10.1016/j.jid.2019.05.032; Duffy DL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06649-5; Duffy DL, 2010, AM J HUM GENET, V87, P6, DOI 10.1016/j.ajhg.2010.05.017; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Duffy DL, 1997, AM J HUM GENET, V61, pA197; Ehrhart F, 2019, WORLD J BIOL PSYCHIA, V20, P670, DOI 10.1080/15622975.2018.1439594; Fernandez LP, 2009, EXP DERMATOL, V18, P634, DOI 10.1111/j.1600-0625.2009.00846.x; Ghiorzo P, 2009, MELANOMA RES, V19, P142, DOI 10.1097/CMR.0b013e32832a1e18; Goldstein AM, 2017, HUM MOL GENET, V26, P4886, DOI 10.1093/hmg/ddx368; Gong HZ, 2019, MELANOMA RES, V29, P221, DOI 10.1097/CMR.0000000000000571; Graf J, 2005, HUM MUTAT, V25, P278, DOI 10.1002/humu.20143; Gronskov K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37272-5; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Guedj M, 2008, HUM MUTAT, V29, P1154, DOI 10.1002/humu.20823; Hawkes JE, 2013, J DERMATOL SCI, V69, P30, DOI 10.1016/j.jdermsci.2012.09.016; Huang KL, 2018, CELL, V173, P355, DOI 10.1016/j.cell.2018.03.039; Jagirdar K, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12253; Jannot AS, 2005, EUR J HUM GENET, V13, P913, DOI 10.1038/sj.ejhg.5201415; Johanson HC, 2010, J HUM GENET, V55, P103, DOI 10.1038/jhg.2009.130; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lacaze P, 2019, EUR J HUM GENET, V27, P308, DOI 10.1038/s41431-018-0279-z; Laino AM, 2018, BRIT J DERMATOL, V178, P1119, DOI 10.1111/bjd.16323; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lasseaux E, 2018, PIGM CELL MELANOMA R, V31, P466, DOI 10.1111/pcmr.12688; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Martinez-Garcia M, 2013, J DERMATOL, V40, P319, DOI 10.1111/1346-8138.12170; Montoliu L, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12167; Nathan V, 2019, PIGM CELL MELANOMA R, V32, P854, DOI 10.1111/pcmr.12804; Norman CS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04401-5; Park S, 2015, MOL CELL BIOCHEM, V403, P61, DOI 10.1007/s11010-015-2337-y; Pavan WJ, 2019, ANNU REV GENOM HUM G, V20, P41, DOI 10.1146/annurev-genom-083118-015230; Pizzichetta MA, 2017, BRIT J DERMATOL, V177, P538, DOI 10.1111/bjd.15093; Pizzichetta MA, 2004, BRIT J DERMATOL, V150, P1117, DOI 10.1111/j.1365-2133.2004.05928.x; Potjer TP, 2019, INT J CANCER, V144, P2453, DOI 10.1002/ijc.31984; R Core Team, 2016, R A LANGUAGE AND ENV; Rayner JE, 2019, J EUR ACAD DERMATOL, V33, P1076, DOI 10.1111/jdv.15446; Ribero S, 2017, BRIT J DERMATOL, V177, pE333, DOI 10.1111/bjd.15687; Ripley WNVaBD, 2002, MODERN APPL STAT S; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shain AH, 2018, CANCER CELL, V34, P45, DOI 10.1016/j.ccell.2018.06.005; Stark MS, 2018, J INVEST DERMATOL, V138, P1636, DOI 10.1016/j.jid.2018.02.012; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sturm RA, 2014, J INVEST DERMATOL, V134, P141, DOI 10.1038/jid.2013.272; Sturm RA, 2009, PIGM CELL MELANOMA R, V22, P544, DOI 10.1111/j.1755-148X.2009.00606.x; Sviderskaya EV, 1997, J INVEST DERMATOL, V108, P30, DOI 10.1111/1523-1747.ep12285621; Vernali S, 2017, JAMA DERMATOL, V153, P1026, DOI 10.1001/jamadermatol.2017.2444; Visser M, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12210; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhang MF, 2013, HUM MOL GENET, V22, P2948, DOI 10.1093/hmg/ddt142; Zhang TW, 2018, GENOME RES, V28, P1621, DOI 10.1101/gr.233304.117	66	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238529	10.1371/journal.pone.0238529	http://dx.doi.org/10.1371/journal.pone.0238529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966289	gold, Green Published			2022-12-26	WOS:000575688700025
J	Shaw, NP; Jackson, T; Orchard, J				Shaw, Nolan Peter; Jackson, Tyler; Orchard, Jeff			Biological batch normalisation: How intrinsic plasticity improves learning in deep neural networks	PLOS ONE			English	Article							ALGORITHM	In this work, we present a local intrinsic rule that we developed, dubbed IP, inspired by the Infomax rule. Like Infomax, this rule works by controlling the gain and bias of a neuron to regulate its rate of fire. We discuss the biological plausibility of the IP rule and compare it to batch normalisation. We demonstrate that the IP rule improves learning in deep networks, and provides networks with considerable robustness to increases in synaptic learning rates. We also sample the error gradients during learning and show that the IP rule substantially increases the size of the gradients over the course of learning. This suggests that the IP rule solves the vanishing gradient problem. Supplementary analysis is provided to derive the equilibrium solutions that the neuronal gain and bias converge to using our IP rule. An analysis demonstrates that the IP rule results in neuronal information potential similar to that of Infomax, when tested on a fixed input distribution. We also show that batch normalisation also improves information potential, suggesting that this may be a cause for the efficacy of batch normalisation-an open problem at the time of this writing.	[Shaw, Nolan Peter; Jackson, Tyler; Orchard, Jeff] Univ Waterloo, David R Cheriton Sch Comp Sci, Waterloo, ON, Canada	University of Waterloo	Shaw, NP (corresponding author), Univ Waterloo, David R Cheriton Sch Comp Sci, Waterloo, ON, Canada.	nolan.shaw@uwaterloo.ca		Shaw, Nolan/0000-0002-4576-5504				BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Erdogmus D, 2002, IEEE T SIGNAL PROCES, V50, P1780, DOI 10.1109/TSP.2002.1011217; Furui S, 2012, IEEE SIGNAL PROC MAG, V29, P16, DOI 10.1109/MSP.2012.2209906; HEBB D. O., 1949; Ioffe S., 2015, INT C ONMACHINE LEAR, V37, P448, DOI DOI 10.1007/S13398-014-0173-7.2; Kingma DP., 2014, ADAM METHOD STOCHAST; Kohler J., 2018, STAT-US, V1050, P27; Krizhevsky A, 2009, THESIS U TORONTO TOR; Krizhevsky A, 2014, CIFAR 10 DATASET, V55; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062894; Lin, 2015, ARXIV150204156; OJA E, 1982, J MATH BIOL, V15, P267, DOI 10.1007/BF00275687; Santurkar S, 2018, ADV NEUR IN, V31; Schrauwen B, 2008, NEUROCOMPUTING, V71, P1159, DOI 10.1016/j.neucom.2007.12.020; Shannon C. E., 1949, MATH THEORY COMMUNIC; Steil JJ, 2007, NEURAL NETWORKS, V20, P353, DOI 10.1016/j.neunet.2007.04.011; Triesch J, 2005, LECT NOTES COMPUT SC, V3696, P65, DOI 10.1007/11550822_11; Triesch J., 2005, ADV NEURAL INFORM PR, V17, P1417, DOI DOI 10.1162/NEC0.2007.19.4.885; Werbos P., 1982, SYSTEM MODELING OPTI, V2, P762, DOI [10.1007/BFb0006203, DOI 10.1007/BFB0006203]; Whittington JCR, 2017, NEURAL COMPUT, V29, P1229, DOI 10.1162/NECO_a_00949; Zhang W, 2003, NAT REV NEUROSCI, V4, P885, DOI 10.1038/nrn1248	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238454	10.1371/journal.pone.0238454	http://dx.doi.org/10.1371/journal.pone.0238454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966302	gold, Green Published			2022-12-26	WOS:000575688700048
J	Timmerman, CA; Marchal, P; Denamiel, M; Couvreur, C; Cresson, P				Timmerman, Charles-Andre; Marchal, Paul; Denamiel, Margaux; Couvreur, Clemence; Cresson, Pierre			Seasonal and ontogenetic variation of whiting diet in the Eastern English Channel and the Southern North Sea	PLOS ONE			English	Article							NITROGEN STABLE-ISOTOPES; MERLANGIUS-MERLANGUS; TROPHIC LEVEL; FUNCTIONAL DIVERSITY; STOMACH CONTENT; GADUS-MORHUA; BODY-SIZE; FOOD WEBS; FISH; CARBON	An accurate description of trophic interactions is crucial to understand ecosystem functioning and sustainably manage marine ecosystems exploitation. Carbon and nitrogen stable isotopes were coupled with stomach content analyses to investigate whiting (Merlangius merlangus, Linnaeus, 1758) feeding behavior in the Eastern English Channel and Southern North Sea. Whiting juveniles and adults were sampled in autumn and winter to investigate both ontogenetic and seasonal changes. In addition, queen scallops (Aequipecten opercularis) samples were collected along with fish to be used as isotopic benthic baseline. Results indicated an ontogenetic diet change from crustaceans to fish and cephalopods. In autumn, delta N-15 values generally increased with fish size while in winter, a decrease of delta N-15 values with fish size was observed, as a potential result of spatial variation in baseline delta N-15 values. In winter, a nutrient-poor period, an increase in feeding intensity was observed, especially on the copepodTemora longicornis. This study provides further insights into whiting trophic ecology in relation to ontogenetic and seasonal variations, and it confirms the importance of combining several trophic analysis methods to understand ecosystem functioning.	[Timmerman, Charles-Andre; Marchal, Paul; Denamiel, Margaux; Couvreur, Clemence; Cresson, Pierre] IFREMER, HMMN, Ctr Manche Mer Nord, Boulogne Sur Mer, France	Ifremer	Timmerman, CA (corresponding author), IFREMER, HMMN, Ctr Manche Mer Nord, Boulogne Sur Mer, France.	charles.andre.timmerman@ifremer.fr	Cresson, Pierre/D-8402-2012	Cresson, Pierre/0000-0002-3485-4261; Marchal, Paul/0000-0003-2047-4599; Timmerman, Charles-Andre/0000-0001-7307-7090	European Marine Fisheries Fund; France Filiere Peche (2017-2020 VARITROPH project); French government; Region Hauts-de-France; Ifremer	European Marine Fisheries Fund; France Filiere Peche (2017-2020 VARITROPH project); French government; Region Hauts-de-France(Region Hauts-de-France); Ifremer	CAT received a PhD grant through a project funded by European Marine Fisheries Fund and France Filiere Peche (2017-2020 VARITROPH project; PI:PC). All coauthors are supported by grant from the French government, the Region Hauts-de-France and Ifremer under the framework of the project CPER MARCO 2015-2020 The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Akima H., 2020, AKIMA INTERPOLATION; Ankjaero T, 2012, MAR ECOL PROG SER, V461, P197, DOI 10.3354/meps09871; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2010, LIMINA REV INVESTIGA, VI, P15; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Becker R.A., 2018, MAPDATA EXTRAMAP DAT; BOTTCHER J, 1990, J HYDROL, V114, P413, DOI 10.1016/0022-1694(90)90068-9; Breton E, 2000, J PLANKTON RES, V22, P1423, DOI 10.1093/plankt/22.8.1423; Brodziak J, 2002, B MAR SCI, V70, P589; Brunsdon C, 2014, GISTOOLS SOME FURTHE; Buchheister A, 2010, CAN J FISH AQUAT SCI, V67, P445, DOI 10.1139/F09-196; Buckland A, 2017, FISH RES, V196, P126, DOI 10.1016/j.fishres.2017.08.003; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Cachera M, 2017, J SEA RES, V120, P60, DOI 10.1016/j.seares.2016.08.004; Carpentier A, 2009, CHANNEL HABITAT ATLA; Clegg T, 2018, ECOLOGY, V99, P2712, DOI 10.1002/ecy.2523; Coll M, 2016, ECOL INDIC, V60, P947, DOI 10.1016/j.ecolind.2015.08.048; Cormon X, 2015, THESIS; Cresson P, 2020, PROG OCEANOGR, V186, DOI 10.1016/j.pocean.2020.102343; Cresson P, 2017, MAR POLLUT BULL, V123, P279, DOI 10.1016/j.marpolbul.2017.08.046; Cresson P, 2014, J EXP MAR BIOL ECOL, V452, P54, DOI 10.1016/j.jembe.2013.11.014; DAUVIN JC, 1989, J MAR BIOL ASSOC UK, V69, P589, DOI 10.1017/S002531540003099X; del Rio CM, 2012, J MAMMAL, V93, P353, DOI 10.1644/11-MAMM-S-165.1; Demain DK, 2011, J FISH BIOL, V79, P89, DOI 10.1111/j.1095-8649.2011.02997.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dessier A, 2018, PROG OCEANOGR, V166, P121, DOI 10.1016/j.pocean.2017.10.009; Di Pane J, 2020, J SEA RES, V157, DOI 10.1016/j.seares.2020.101848; Fox CJ, 2012, MAR ECOL PROG SER, V462, P205, DOI 10.3354/meps09748; Fox J., 2019, R COMPANION APPL REG, VThird; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Garcia SM, 2003, ECOSYSTEM APPROACH F; Giraldo C, 2017, LIMNOL OCEANOGR, V62, P2213, DOI 10.1002/lno.10561; Girardin R, 2018, ESTUAR COAST SHELF S, V201, P208, DOI 10.1016/j.ecss.2016.10.016; Graham BS, 2007, MAR BIOL, V150, P647, DOI 10.1007/s00227-006-0360-y; Guelinckx J, 2007, MAR ECOL PROG SER, V341, P205, DOI 10.3354/meps341205; Harmelin-Vivien M, 2012, CYBIUM, V36, P323; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; HISLOP JRG, 1991, ICES J MAR SCI, V48, P139, DOI 10.1093/icesjms/48.2.139; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; ICES-International Council for the Exploration of the Sea, 2004, MAN INT BOTT TRAWL S; Iwamoto T., 1990, FAO SPECIES CATALOGU, V10; Jennings S, 2003, MAR BIOL, V142, P1131, DOI 10.1007/s00227-003-1020-0; Jennings S, 2015, ICES J MAR SCI, V72, P2289, DOI 10.1093/icesjms/fsv120; Kinzig A. P., 2002, FUNCTIONAL CONSEQUEN; Kopp D, 2015, PROG OCEANOGR, V130, P157, DOI 10.1016/j.pocean.2014.11.001; Lauerburg RAM, 2015, J FISH BIOL, V86, P1729, DOI 10.1111/jfb.12682; Lefebvre S, 2009, MAR ECOL PROG SER, V390, P27, DOI 10.3354/meps08187; Lenz PH, 2005, BIOL BULL-US, V209, P75, DOI 10.2307/3593143; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Mancinelli G, 2013, ESTUAR COAST SHELF S, V135, P77, DOI 10.1016/j.ecss.2013.04.004; MARIOTTI A, 1982, CAN J SOIL SCI, V62, P227, DOI 10.4141/cjss82-027; Marsh JM, 2017, DEEP-SEA RES PT II, V135, P78, DOI 10.1016/j.dsr2.2016.07.010; Matley JK, 2016, RAPID COMMUN MASS SP, V30, P29, DOI 10.1002/rcm.7406; Maucorps A, 1969, SCI PECHE, V186, P1; Maxwell TAD, 2006, OECOLOGIA, V150, P282, DOI 10.1007/s00442-006-0520-2; McClelland JW, 1997, LIMNOL OCEANOGR, V42, P930, DOI 10.4319/lo.1997.42.5.0930; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Moison M, 2012, AQUAT BIOL, V16, P149, DOI 10.3354/ab00438; Morris DJ, 2018, EARTH SYST SCI DATA, V10, P27, DOI 10.5194/essd-10-27-2018; Nakazawa T, 2015, POPUL ECOL, V57, P347, DOI 10.1007/s10144-014-0448-z; Nielsen JM, 2019, MAR ECOL PROG SER, V632, P1, DOI 10.3354/meps13188; Nielsen JM, 2018, METHODS ECOL EVOL, V9, P278, DOI 10.1111/2041-210X.12869; Olivier P, 2019, ECOGRAPHY, V42, P2107, DOI 10.1111/ecog.04461; Pinnegar JK, 1999, FUNCT ECOL, V13, P225, DOI 10.1046/j.1365-2435.1999.00301.x; Pinnegar JK, 2003, J FISH BIOL, V63, P197, DOI 10.1111/j.1095-8649.2003.00204.x; Polito MJ, 2019, LIMNOL OCEANOGR-METH, V17, P292, DOI 10.1002/lom3.10314; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2003, ECOLOGY, V84, P1298, DOI 10.1890/0012-9658(2003)084[1298:IVITTO]2.0.CO;2; Potapov AM, 2019, AM NAT, V194, P823, DOI 10.1086/705811; Rault J, 2017, J FISH BIOL, V91, P1449, DOI 10.1111/jfb.13470; Reddin CJ, 2018, FUNCT ECOL, V32, P904, DOI 10.1111/1365-2435.13026; ROBB AP, 1980, J FISH BIOL, V16, P199, DOI 10.1111/j.1095-8649.1980.tb03699.x; Romanuk TN, 2011, GLOBAL ECOL BIOGEOGR, V20, P231, DOI 10.1111/j.1466-8238.2010.00579.x; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Ross SD, 2016, J FISH BIOL, V88, P1965, DOI 10.1111/jfb.12959; Rudolf VHW, 2013, ECOLOGY, V94, P1046, DOI 10.1890/12-0378.1; Sanchez-Hernandez J, 2019, BIOL REV, V94, P539, DOI 10.1111/brv.12468; Serrano R, 2007, CHEMOSPHERE, V69, P1075, DOI 10.1016/j.chemosphere.2007.04.034; Spitz J, 2010, ICES J MAR SCI, V67, P909, DOI 10.1093/icesjms/fsq008; Tappin AD, 2015, MAR POLLUT BULL, V95, P529, DOI 10.1016/j.marpolbul.2014.12.012; Telsnig JID, 2019, J ANIM ECOL, V88, P405, DOI 10.1111/1365-2656.12929; Tilman D, 2014, ANNU REV ECOL EVOL S, V45, P471, DOI 10.1146/annurev-ecolsys-120213-091917; Travers-Trolet M., 2017, CGFS2017 CRUISE, DOI [10.17600/17002200, DOI 10.17600/17002200]; Travers-Trolet M, 2019, ECOL MODEL, V410, DOI 10.1016/j.ecolmodel.2019.108800; Trueman CN, 2017, METHODS ECOL EVOL, V8, P232, DOI 10.1111/2041-210X.12651; Vander Zanden MJ, 1998, T AM FISH SOC, V127, P729, DOI 10.1577/1548-8659(1998)127<0729:AOSITT>2.0.CO;2; Verin Y, 2018, IBTS 2018 CRUISE THA, DOI [10.17600/18000003, DOI 10.17600/18000003]; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Woodward G, 2009, FRESHWATER BIOL, V54, P2171, DOI 10.1111/j.1365-2427.2008.02081.x; Yokoyama H, 2006, AQUACULTURE, V254, P411, DOI 10.1016/j.aquaculture.2005.10.024; Zuur A.F., 2007, ANAL ECOLOGICAL DATA, P672, DOI DOI 10.1007/978-0-387-45972-1	97	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239436	10.1371/journal.pone.0239436	http://dx.doi.org/10.1371/journal.pone.0239436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966332	Green Submitted, Green Published, gold			2022-12-26	WOS:000575688700056
J	Cardona-Arias, JA; Correa, JCC; Higuita-Gutierrez, LF				Cardona-Arias, Jaiberth Antonio; Correa, Juan Carlos Catano; Higuita-Gutierrez, Luis Felipe			Prevalence of hepatitis B/C viruses and associated factors in key groups attending a health services institution in Colombia, 2019	PLOS ONE			English	Article							C VIRUS; VIRAL-HEPATITIS; NATURAL-HISTORY; SEX WORKERS; INFECTION; EPIDEMIOLOGY; PEOPLE; HIV	Both hepatitis B virus (HBV) and hepatitis C virus (HCV) are major sources of morbidity and mortality worldwide; however, their prevalence in key groups in Colombia is not yet known. We aimed to analyse the prevalence of HBV and HCV and its associated factors in key groups who were treated at an institution providing health services in Colombia during 2019. This was a multiple-group ecological study that included 2,624 subjects from the general population, 1,100 men who have had sex with men (MSM), 1,061 homeless individuals, 380 sex workers, 260 vulnerable young people, 202 drug users, 41 inmates and 103 people from the lesbian, gay, bisexual and transgender community. Prevalence of infection with a 95% confidence interval and its associated factors was calculated for each group. Confounding variables were assessed using logistical regression and SPSS 25.0 software. Prevalence of HBV and HCV in the general population was 0.15% and 0.27%, respectively; 0.27% and 2.09% in MSM; 0.37% and 2.17% amongst homeless individuals; 0.26% and 0.0% amongst sex workers; 0.39% and 0.0% amongst vulnerable youth; and 5.94% and 45.54 amongst injecting drug users. In the multivariate HBV model, the explanatory variables included the study group, city of origin and the type of health affiliation; for HCV they were group, origin, sex, age group, health affiliation, use of drugs and hallucinogen use during sexual intercourse. A high prevalence of HBV and HCV were evidenced for both viral infections, which was, consequently, much higher within the key groups. The main associated factors that were identified related to origin and type of health affiliation and demonstrated a double vulnerability, that is, belonging to groups that are discriminated and excluded from many health policies and living under unfavourable socioeconomic conditions that prevent proper affiliation and health care.	[Cardona-Arias, Jaiberth Antonio; Higuita-Gutierrez, Luis Felipe] Univ Antioquia, Sch Microbiol, Medellin, Antioquia, Colombia; [Correa, Juan Carlos Catano] Univ Antioquia, Internal Med Infect Dis Sect, Medellin, Antioquia, Colombia; [Higuita-Gutierrez, Luis Felipe] Cooperat Univ Colombia, Fac Med, Medellin, Antioquia, Colombia	Universidad de Antioquia; Universidad de Antioquia; Universidad Cooperativa de Colombia	Cardona-Arias, JA (corresponding author), Univ Antioquia, Sch Microbiol, Medellin, Antioquia, Colombia.	jaiberth.cardona@udea.edu.co	Cardona, Jaiberth/GZL-3892-2022	Higuita-Gutierrez, Luis Felipe/0000-0003-1361-3124; Cardona Arias, Jaiberth/0000-0002-7101-929X	 [05239]		Grant Gilead subvention 05239 "A call to action from the promotion of health and prevention of HIV-HBV-HCV infection" The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad S, 2017, NEFROLOGIA, V37, P158, DOI 10.1016/j.nefro.2016.10.003; Rios-Ocampo WA, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0206-z; Alonso M, 2015, INT J PUBLIC HEALTH, V60, P789, DOI 10.1007/s00038-015-0708-5; Alvarado-Mora MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018888; [Anonymous], 2017, GLOB HEP REP 2017, P2017; [Anonymous], 2018, LANCET DIABETES ENDO, V6, P1, DOI DOI 10.1080/08927022.2018.1510179; Baden R, 2014, J INFECT DIS, V209, pS81, DOI 10.1093/infdis/jiu057; Behzadifar M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8175-1; Beijer U, 2012, LANCET INFECT DIS, V12, P859, DOI 10.1016/S1473-3099(12)70177-9; Bradshaw D, 2013, CURR OPIN INFECT DIS, V26, P66, DOI 10.1097/QCO.0b013e32835c2120; Callejas-Rojo Fabián, 2017, CES Med., V31, P27, DOI 10.21615/cesmedicina.31.1.3; Camejo MI, 2003, REV SAUDE PUBL, V37, P339, DOI 10.1590/S0034-89102003000300012; Cheung RC, 2002, J CLIN GASTROENTEROL, V34, P476, DOI 10.1097/00004836-200204000-00021; Cooke GS, 2019, LANCET GASTROENTEROL, V4, P135, DOI 10.1016/S2468-1253(18)30270-X; Dogbe EE, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.119.5263; Dostor, 2019, EL DOSTOR J, V10, P9; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; EI-Ghitany EM, 2013, J VIROL METHODS, V194, P190, DOI 10.1016/j.jviromet.2013.08.026; European Centre for Disease Prevention and Control, 2016, SYST REV HEP B C PRE; FAIRLEY CK, 1990, MED J AUSTRALIA, V153, P271, DOI 10.5694/j.1326-5377.1990.tb136899.x; Farooq A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188066; Gorgos L, 2013, INFECT DIS CLIN N AM, V27, P811, DOI 10.1016/j.idc.2013.08.002; HYAMS KC, 1992, J MED VIROL, V37, P127, DOI 10.1002/jmv.1890370210; Indolfi G, 2019, LANCET GASTROENTEROL, V4, P466, DOI 10.1016/S2468-1253(19)30042-1; Leon P, 1999, Rev Panam Salud Publica, V5, P144, DOI 10.1590/S1020-49891999000300002; Jaramillo CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181643; Mateu-Gelabert P, 2018, CURR HIV-AIDS REP, V15, P324, DOI 10.1007/s11904-018-0406-z; Matos Marcos André de, 2017, Rev. Saúde Pública, V51, P65, DOI [10.1590/s1518-8787.2017051006540, 10.1590/S1518-8787.2017051006540]; Ruiz Mendoza Leyand, 2018, rev.udcaactual.divulg.cient., V21, P297, DOI 10.31910/rudca.v21.n2.2018.969; Organizacion Mundial de la Salud (OMS), 2019, DAT MAS REC PON REL; Organizacion Mundial de la Salud (OMS), 2017, DAT MAS REC PON REL; Pando MA, 2006, AM J TROP MED HYG, V74, P233, DOI 10.4269/ajtmh.2006.74.233; Bedoya JAP, 2012, REV SAUDE PUBL, V46, P950, DOI 10.1590/S0034-89102012000600004; Randrianirina F, 2008, J VIROL METHODS, V151, P294, DOI 10.1016/j.jviromet.2008.03.019; Rustgi VK, 2007, J GASTROENTEROL, V42, P513, DOI 10.1007/s00535-007-2064-6; Silva MBS, 2010, MEM I OSWALDO CRUZ, V105, P299, DOI 10.1590/S0074-02762010000300009; Toro-Tobon D, 2018, INT J DRUG POLICY, V60, P56, DOI 10.1016/j.drugpo.2018.07.002; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012	38	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0238655	10.1371/journal.pone.0238655	http://dx.doi.org/10.1371/journal.pone.0238655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NW6FH	32960901	gold, Green Published			2022-12-26	WOS:000575109500012
J	Chang, YD; Li, CH; Tsai, CH; Cheng, YW; Kang, JJ; Lee, CC				Chang, Yu-Di; Li, Ching-Hao; Tsai, Chi-Hao; Cheng, Yu-Wen; Kang, Jaw-Jou; Lee, Chen-Chen			Aryl hydrocarbon receptor deficiency enhanced airway inflammation and remodeling in a murine chronic asthma model	FASEB JOURNAL			English	Article						airway remodeling; allergy; aryl hydrocarbon receptor; epithelial-mesenchymal transition	T-CELLS; DIOXIN RECEPTOR; DENDRITIC CELLS; ACTIVATION; EXPRESSION; INDUCTION; GENDER	The aryl hydrocarbon receptor (AhR) is a ligand-dependent-activated transcriptional factor that regulates the metabolism of xenobiotic and endogenous compounds. Recent studies have shown that AhR is a novel master regulator of the mucosal immune system, including lungs and intestine. To elucidate the role of AhR in chronic severe asthma, AhR wild-type and knockout mice (AhR(-/-)) were sensitized and challenged with ovalbumin for 4 weeks. To uncover the underlying mechanisms, inflammatory cells profile and cytokines production were analyzed in bronchial lavage fluid (BALF) and lung tissue. Compared to wild-type mice, AhR(-/-)mice had exacerbated asthma symptoms, including airway inflammation, mucus production, airway hyperresponsiveness, and airway remodeling. BALF monocytes, neutrophils, eosinophils, and lymphocytes were all enhanced in OVA-immunized AhR(-/-)mice. In OVA-immunized AhR(-/-)mice, T helper (Th) 17 cell-specific cytokine IL-17A, as well as airway remodeling factors, including epithelial-mesenchymal transition (EMT) markers and vascular endothelial growth factor (VEGF), were all enhanced in lung tissue. Moreover, human cohort studies showed that AhR gene expression in bronchial epithelial cells decreases in severe asthma patients. Loss of AhR leads to worsening of allergic asthma symptoms, indicating its importance in maintaining normal lung function and mediating disease severity.	[Chang, Yu-Di; Lee, Chen-Chen] China Med Univ, Sch Med, Dept Microbiol & Immunol, Taichung, Taiwan; [Li, Ching-Hao] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei, Taiwan; [Tsai, Chi-Hao; Kang, Jaw-Jou] Natl Yang Min Univ, Sch Pharmaceut Sci, 155,Sect 2,Linong St, Taipei 112, Taiwan; [Cheng, Yu-Wen] Taipei Med Univ, Sch Pharm, Taipei, Taiwan	China Medical University Taiwan; Taipei Medical University; Taipei Medical University	Kang, JJ (corresponding author), Natl Yang Min Univ, Sch Pharmaceut Sci, 155,Sect 2,Linong St, Taipei 112, Taiwan.; Lee, CC (corresponding author), China Med Univ, Coll Med, Sch Med, Dept Microbiol & Immunol, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.	jjkang@ym.edu.tw; leechenchen@mail.cmu.edu.tw			China Medical University [CMU108-S-28, CMU108-MF-78, CMU107-S-30, CMU106-S-12]; Ministry of Science, and Technology, Taiwan [MOST 104-2320-B-039-002]; "Drug Development Centre, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	China Medical University(China Medical University); Ministry of Science, and Technology, Taiwan(Ministry of Science and Technology, Taiwan); "Drug Development Centre, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	The work was supported by China Medical University (CMU108-S-28, CMU108-MF-78, CMU107-S-30, and CMU106-S-12), Ministry of Science, and Technology, Taiwan (MOST 104-2320-B-039-002). This work was financially supported by the "Drug Development Centre, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Antczak A, 1997, EUR RESPIR J, V10, P1235, DOI 10.1183/09031936.97.10061235; Bel EH, 2011, THORAX, V66, P910, DOI 10.1136/thx.2010.153643; Bonds RS, 2013, CURR OPIN ALLERGY CL, V13, P92, DOI 10.1097/ACI.0b013e32835a6dd6; Brandt EB, 2013, J ALLERGY CLIN IMMUN, V132, P1194, DOI 10.1016/j.jaci.2013.06.048; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; DENIS M, 1988, BIOCHEM BIOPH RES CO, V155, P801, DOI 10.1016/S0006-291X(88)80566-7; Dong B, 2011, BBA-GEN SUBJECTS, V1810, P427, DOI 10.1016/j.bbagen.2010.11.007; Goettel JA, 2016, CELL REP, V17, P1318, DOI 10.1016/j.celrep.2016.09.082; Goleva E, 2007, J ALLERGY CLIN IMMUN, V120, P1065, DOI 10.1016/j.jaci.2007.07.042; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Haarmann-Stemmann T, 2006, BIOL CHEM, V387, P1195, DOI 10.1515/BC.2006.147; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Jaeger C, 2017, J BIOL RHYTHM, V32, P109, DOI 10.1177/0748730417696786; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kaye J, 2016, P NATL ACAD SCI USA, V113, pE6145, DOI 10.1073/pnas.1607843113; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kupczyk M, 2012, J INTERN MED, V272, P121, DOI 10.1111/j.1365-2796.2012.02558.x; Laffont S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01069; Larigot Lucie, 2018, Biochim Open, V7, P1, DOI 10.1016/j.biopen.2018.05.001; Lee CC, 2016, CANCER LETT, V376, P211, DOI 10.1016/j.canlet.2016.03.052; Lee CC, 2010, BRIT J PHARMACOL, V161, P1496, DOI 10.1111/j.1476-5381.2010.00972.x; Leung DYM, 2003, J ALLERGY CLIN IMMUN, V111, P3, DOI 10.1067/mai.2003.97; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Milara J, 2013, THORAX, V68, P410, DOI 10.1136/thoraxjnl-2012-201761; Modena BD, 2014, AM J RESP CRIT CARE, V190, P1363, DOI 10.1164/rccm.201406-1099OC; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Reddy AT, 2012, JOVE-J VIS EXP, DOI 10.3791/3771; Saleh D, 1998, FASEB J, V12, P929, DOI 10.1096/fasebj.12.11.929; Sathish V, 2015, PHARMACOL THERAPEUT, V150, P94, DOI 10.1016/j.pharmthera.2015.01.007; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Thatcher TH, 2016, IMMUNOLOGY, V147, P41, DOI 10.1111/imm.12540; Voraphani N, 2014, MUCOSAL IMMUNOL, V7, P1175, DOI 10.1038/mi.2014.6; Wang CN, 2019, BRIT J PHARMACOL, V176, P1122, DOI 10.1111/bph.14596; Weng CM, 2018, ALLERGY, V73, P2192, DOI 10.1111/all.13462; Wilson SR, 2013, J PHARMACOL EXP THER, V345, P419, DOI 10.1124/jpet.113.203786; Xu T, 2015, J IMMUNOL, V195, P5539, DOI 10.4049/jimmunol.1501198; Zhang SJ, 2015, TOXICOL APPL PHARM, V286, P92, DOI 10.1016/j.taap.2015.03.023	43	9	9	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15300	15313		10.1096/fj.202001529R	http://dx.doi.org/10.1096/fj.202001529R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959404				2022-12-26	WOS:000573859700001
J	Nguyen, DH; Vo, TNN; Nguyen, NT; Ching, YC; Thi, TTH				Nguyen, Dai Hai; Vo, Thanh Nguyet Nguyen; Nguyen, Ngoc Tung; Ching, Yern Chee; Hoang Thi, Thai Thanh			Comparison of biogenic silver nanoparticles formed byMomordica charantiaandPsidium guajavaleaf extract and antifungal evaluation	PLOS ONE			English	Article							L. LEAF	Exploiting plant extracts to form metallic nanoparticles has been becoming the promising alternative routes of chemical and physical methods owing to environmentally friendly and abundantly renewable resources. In this study,Momordica charantiaandPsidium guajavaleaf extract (MC.broth and PG.broth) are exploited to fabricate two kinds of biogenic silver nanoparticles (MC.AgNPs and PG.AgNPs). Phytoconstituent screening is performed to identify the categories of natural compounds in MC.broth and PG.broth. Both extracts contain wealthy polyphenols which play a role of reducing agent to turn silver (I) ions into silver nuclei. Trace alkaloids, rich saponins and other oxygen-containing compounds creating the organic corona surrounding nanoparticles act as stabilizing agents. MC.AgNPs and PG.AgNPs are characterized by UV-vis and FTIR spectrophotometry, EDS and TEM techniques. FTIR spectra indicate the presence of O-H, C = O, C-O-C and C = C groups on the surface of silver nanoparticles which is corresponded with three elements of C, O and Ag found in EDS analysis. TEM micrographs show the spherical morphology of MC.AgNPs and PG.AgNPs. MC.AgNPs were 17.0 nm distributed in narrow range of 5-29 nm, while the average size of PG.AgNPs were 25.7 nm in the range of 5-53 nm. Further, MC.AgNPs and PG.AgNPs exhibit their effectively inhibitory ability againstA.niger,A.flavusandF.oxysporumas dose-dependence. Altogether, MC.AgNPs and PG.AgNPs will have much potential in scaled up production and become the promising fungicides for agricultural applications.	[Nguyen, Dai Hai; Vo, Thanh Nguyet Nguyen] Vietnam Acad Sci & Technol, Inst Appl Mat Sci, Ho Chi Minh City, Vietnam; [Nguyen, Dai Hai] Vietnam Acad Sci & Technol, Grad Univ Sci & Technol, Hanoi, Vietnam; [Vo, Thanh Nguyet Nguyen; Hoang Thi, Thai Thanh] Ton Duc Thang Univ, Fac Sci Appl, Biomat & Nanotechnol Res Grp, Ho Chi Minh City, Vietnam; [Nguyen, Ngoc Tung] Vietnam Acad Sci & Technol, Ctr Res & Technol Transfer, Hanoi, Vietnam; [Ching, Yern Chee] Univ Malaya, Dept Chem Engn, Fac Engn, Kuala Lumpur, Malaysia	Vietnam Academy of Science & Technology (VAST); Vietnam Academy of Science & Technology (VAST); Ton Duc Thang University; Universiti Malaya	Thi, TTH (corresponding author), Ton Duc Thang Univ, Fac Sci Appl, Biomat & Nanotechnol Res Grp, Ho Chi Minh City, Vietnam.	hoangthithaithanh@tdtu.edu.vn	Hoang Thi, Thai Thanh/L-5117-2019; Ching, Chee Yern/D-6881-2011; Hoang, Thi Thai Thanh/GPS-6261-2022	Hoang Thi, Thai Thanh/0000-0002-2245-9029; Ching, Chee Yern/0000-0002-1611-1341; Nguyen, Dai Hai/0000-0003-3501-7390				a R-M, 2020, J CLIN MED, V9; Anjali Das CG, 2020, BIOCATALYSIS AGR BIO, V2020, P101593; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 2019, BRAIN STIMUL MAR; Bhagyashree SB, 2016, J PHARMACOGN PHYTOCH, V5, P345; Chen F, 2019, INT J BIOL MACROMOL, V138, P673, DOI 10.1016/j.ijbiomac.2019.07.129; Nguyen DH, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10030542; Das P, 2019, J MICROBIOL METH, V167, DOI 10.1016/j.mimet.2019.105766; Diaz-de-Cerio E, 2016, J FUNCT FOODS, V22, P376, DOI 10.1016/j.jff.2016.01.040; Diaz-de-Cerio E, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/250919; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Farooqi AA, 2018, FOOD CHEM TOXICOL, V119, P98, DOI 10.1016/j.fct.2018.05.024; Hong T, 2020, POLYMERS-BASEL, V12, DOI 10.3390/polym12081772; Jebril S, 2020, MATER CHEM PHYS, V248, DOI 10.1016/j.matchemphys.2020.122898; Jia S, 2017, INT J MOL SCI, V18; Kalimuthu K, 2020, MICROCHEM J, V152, DOI 10.1016/j.microc.2019.104296; Kim H, 2019, J CONTROL RELEASE, V303, P55, DOI 10.1016/j.jconrel.2019.04.003; Kim Sang Woo, 2012, Mycobiology, V40, P53, DOI 10.5941/MYCO.2012.40.1.053; Koduru JR, 2018, ADV COLLOID INTERFAC, V256, P326, DOI 10.1016/j.cis.2018.03.001; Kubola J, 2008, FOOD CHEM, V110, P881, DOI 10.1016/j.foodchem.2008.02.076; Leesberg, 2012, THE NEW HOLLSTEIN, V1, plvi; Mashwani ZUR, 2016, ADV COLLOID INTERFAC, V234, P132, DOI 10.1016/j.cis.2016.04.008; Medici S, 2019, J MED CHEM, V62, P5923, DOI 10.1021/acs.jmedchem.8b01439; Le NTT, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10072505; Le NTT, 2021, J CLUST SCI, V32, P601, DOI 10.1007/s10876-020-01823-6; Thi PL, 2018, MAT SCI ENG C-MATER, V92, P52, DOI 10.1016/j.msec.2018.06.037; Prakash A., 2011, J BIOMATERIALS NANOB, V02, P155, DOI [10.4236/jbnb.2011.22020, DOI 10.4236/JBNB.2011.22020]; Rahimi M, 2020, CARBOHYD POLYM, V231, DOI 10.1016/j.carbpol.2019.115696; Siddhanta S, 2015, SOFT MATTER, V11, P7241, DOI 10.1039/c5sm01896j; Stensberg MC, 2011, NANOMEDICINE-UK, V6, P879, DOI [10.2217/nnm.11.78, 10.2217/NNM.11.78]; Stepien G, 2018, ACS APPL MATER INTER, V10, P4548, DOI 10.1021/acsami.7b18648; Wang JL, 2020, WATER RES, V176, DOI 10.1016/j.watres.2020.115722; Zhang F, 2016, INT J BIOL MACROMOL, V92, P246, DOI 10.1016/j.ijbiomac.2016.06.101	33	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239360	10.1371/journal.pone.0239360	http://dx.doi.org/10.1371/journal.pone.0239360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960911	Green Published, gold			2022-12-26	WOS:000575109500006
J	Lantz, ME; Cui, AXX; Cuddy, LL				Lantz, Michael E.; Cui, Anja-Xiaoxing; Cuddy, Lola L.			The role of duration and frequency of occurrence in perceived pitch structure	PLOS ONE			English	Article							WORD SEGMENTATION; TIME PERCEPTION; RECOGNITION MEMORY; TONAL HIERARCHIES; OVER-ESTIMATION; NUMEROSITY; NUMBER; MUSIC; REPRESENTATION; INFORMATION	Introduction To survive, organisms need to organize perceptual input into coherent, usable structures. Research has illuminated the potential role of frequency of occurrence and duration as cues to extract statistical regularities from our environment. Musical stimuli provide a unique opportunity to study how these cues are used to organize auditory input into higher level perceptual entities, i.e., pitch structure, and to assess the influence of cognitive schema. Methods To examine the relative importance of these two cues in pitch structure perception, we constructed novel tone sequences in which frequency of occurrence and duration cues were pitted against each other. We assessed perceived pitch structure in musically trained and untrained listeners using a probe tone paradigm. Results In all experiments, a 3-tiered hierarchy of pitch structure emerged, with highest ratings for tones of longer duration, next highest for shorter, more frequent tones and lowest for probe tones that did not occur in the sequence. The hierarchy did not reflect assimilation to Western tonal schema. Discussion Our results argue against theories positing the same mechanism for the processing of duration and frequency of occurrence, and that duration is weighted preferentially. We further suggest that the organization of perceptual information will proceed according to whatever information is relevant, available, and most easily acquired.	[Lantz, Michael E.; Cui, Anja-Xiaoxing; Cuddy, Lola L.] Queens Univ, Dept Psychol, Kingston, ON, Canada; [Cui, Anja-Xiaoxing] Univ British Columbia, Sch Mus, Vancouver, BC, Canada	Queens University - Canada; University of British Columbia	Cui, AXX (corresponding author), Queens Univ, Dept Psychol, Kingston, ON, Canada.; Cui, AXX (corresponding author), Univ British Columbia, Sch Mus, Vancouver, BC, Canada.	anja.cui@ubc.ca		Cui, Anja-Xiaoxing/0000-0002-5003-6867	NSERC [333-2010-RGPIN]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by NSERC (https://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant 333-2010-RGPIN to L. L. C. The funder played no role in any aspect of the study.	ANDERSON RC, 1978, AM EDUC RES J, V15, P433, DOI 10.2307/1162496; [Anonymous], 2003, BIODRUGS, V17, P212; [Anonymous], 2003, OFFICIAL J EUR UNION, V13, pL37; [Anonymous], 1984, PANTHEON INT Z KUNST, V2, P131; [Anonymous], 2010, B CONSTITUTIONAL CAS, V1, P96; [Anonymous], 1998, POLITICAL THEORY, V26, P56; Archer SL, 2016, J EXP CHILD PSYCHOL, V148, P131, DOI 10.1016/j.jecp.2016.04.004; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Basso G, 1996, NEUROREPORT, V7, P2111, DOI 10.1097/00001756-199609020-00009; Batchelor S, 2015, LEARN INSTR, V40, P79, DOI 10.1016/j.learninstruc.2015.09.005; Ben-Haim MS, 2014, J EXP PSYCHOL HUMAN, V40, P24, DOI 10.1037/a0033583; BHARUCHA JJ, 1984, COGNITIVE PSYCHOL, V16, P485, DOI 10.1016/0010-0285(84)90018-5; BHARUCHA JJ, 1984, J EXP PSYCHOL GEN, V113, P421, DOI 10.1037/0096-3445.113.3.421; BOLTZ M, 1991, MEM COGNITION, V19, P239, DOI 10.3758/BF03211148; BOLTZ MG, 1993, PERCEPT PSYCHOPHYS, V53, P585, DOI 10.3758/BF03211736; Breukelaar JWC, 1998, J EXP PSYCHOL ANIM B, V24, P84, DOI 10.1037/0097-7403.24.1.84; BREWER WF, 1981, COGNITIVE PSYCHOL, V13, P207, DOI 10.1016/0010-0285(81)90008-6; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; CASTELLANO MA, 1984, J EXP PSYCHOL GEN, V113, P394, DOI 10.1037/0096-3445.113.3.394; Chesney DL, 2012, ATTEN PERCEPT PSYCHO, V74, P1104, DOI 10.3758/s13414-012-0349-1; Chun J, 2018, SCAND J PSYCHOL, V59, P252, DOI 10.1111/sjop.12445; Crollen V, 2012, ACTA PSYCHOL, V140, P246, DOI 10.1016/j.actpsy.2012.05.003; Crollen V, 2011, EXP PSYCHOL, V58, P39, DOI 10.1027/1618-3169/a000064; CUDDY LL, 1987, PERCEPT PSYCHOPHYS, V41, P609, DOI 10.3758/BF03210493; Cuddy LL., 1991, PSYCHOMUS, V10, P107; Cui AX, 2015, COGN PROCESS, V16, P211, DOI 10.1007/s10339-015-0651-7; Das A., 2011, PROCEDIA SOCIAL BEHA, V28, P333; DAWE LA, 1995, PERCEPT PSYCHOPHYS, V57, P905, DOI 10.3758/BF03206805; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Dormal V, 2016, NEUROPSYCHOLOGIA, V85, P272, DOI 10.1016/j.neuropsychologia.2016.03.033; Dormal V, 2012, HUM BRAIN MAPP, V33, P1490, DOI 10.1002/hbm.21300; Droit-Volet S, 2003, J EXP CHILD PSYCHOL, V84, P63, DOI 10.1016/S0022-0965(02)00180-7; Ellis RJ, 2009, J EXP PSYCHOL HUMAN, V35, P264, DOI 10.1037/a0013482; Ergincan F, 1993, MIDIPLAY; Fornaciai M, 2017, NEUROIMAGE, V157, P429, DOI 10.1016/j.neuroimage.2017.05.069; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gauldin R, 1997, HARMONIC PRACTICE TO; GHATALA ES, 1973, J EXP CHILD PSYCHOL, V16, P495, DOI 10.1016/0022-0965(73)90010-6; Gibbon J, 2014, ANIMAL COGNITION, V1st, P465; Haley KL, 2014, APHASIOLOGY, V28, P320, DOI 10.1080/02687038.2013.855702; Hannula MM, 2005, LEARN INSTR, V15, P237, DOI 10.1016/j.learninstruc.2005.04.005; Hannula-Sormunen MM, 2015, MATH THINK LEARN, V17, P155, DOI 10.1080/10986065.2015.1016814; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; HASHER L, 1977, J VERB LEARN VERB BE, V16, P173, DOI 10.1016/S0022-5371(77)80045-5; Haut MW, 2001, NEUROPSYCHOLOGY, V15, P568, DOI 10.1037//0894-4105.15.4.568; Hendershott G, 1990, CAKEWALK PROFESSIONA; HERSHMAN D. P., 1995, PSYCHOMUSICOLOGY, V14, P4; Houston DM, 2000, PSYCHON B REV, V7, P504, DOI 10.3758/BF03214363; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; JASP Team, 2019, JASP VERS 0 11 1; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041496; JONES MR, 1982, PERCEPT PSYCHOPHYS, V32, P211, DOI 10.3758/BF03206225; Jusczyk PW, 1999, COGNITIVE PSYCHOL, V39, P159, DOI 10.1006/cogp.1999.0716; Kahneman D., 1973, ATTENTION EFFORT; Kersey AJ, 2017, J NEUROSCI, V37, P512, DOI [10.1523/JNEUROSCI.0065-16.2016, 10.1523/JNEUROSCI.0065-16.2017]; KNOPOFF L, 1983, J MUSIC THEORY, V27, P75, DOI 10.2307/843561; Krumhansl Carol L, 2001, COGNITIVE FDN MUSICA; Krumhansl CL, 2003, ANN NY ACAD SCI, V999, P414, DOI 10.1196/annals.1284.052; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; KRUMHANSL CL, 1986, MUSIC PERCEPT, V4, P153; Krumhansl CL, 2001, ANN NY ACAD SCI, V930, P77, DOI 10.1111/j.1749-6632.2001.tb05726.x; KRUMHANSL CL, 1979, J EXP PSYCHOL HUMAN, V5, P579, DOI 10.1037/0096-1523.5.4.579; KRUMHANSL CL, 1982, MEM COGNITION, V10, P243, DOI 10.3758/BF03197636; Krumhansl CL, 2010, INMUSIC PERCEPTION, P51, DOI [10.1068/p6560, DOI 10.1068/P6560]; Lantz ME, 2014, PSYCHOL MUSIC, V42, P580, DOI 10.1177/0305735613483847; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lerdahl, 2004, TONAL PITCH SPACE; LOFTUS GR, 1985, J EXP PSYCHOL HUMAN, V11, P1, DOI 10.1037/0096-1523.11.1.1; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; MECK WH, 1985, J EXP PSYCHOL ANIM B, V11, P591, DOI 10.1037/0097-7403.11.4.591; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Medical Advisory Secretariat, 2010, Ont Health Technol Assess Ser, V10, P1; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Naparstek S, 2010, J EXP PSYCHOL LEARN, V36, P1053, DOI 10.1037/a0019766; NAVEHBENJAMIN M, 1986, J EXP PSYCHOL LEARN, V12, P378, DOI 10.1037/0278-7393.12.3.378; Onoe H, 2001, NEUROIMAGE, V13, P37, DOI 10.1006/nimg.2000.0670; ORAM N, 1995, PSYCHOL RES-PSYCH FO, V57, P103; Paquette S, 2018, ANN NY ACAD SCI, V1423, P329, DOI 10.1111/nyas.13666; Park J, 2018, DEV COGN NEUROS-NETH, V30, P333, DOI 10.1016/j.dcn.2017.02.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Peretz I, 2015, PHILOS T R SOC B, V370, P68, DOI 10.1098/rstb.2014.0090; Pesenti M, 2003, NEUROIMAGE, V19; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Piston W, 1987, REVISED M DEVOTO, V5th; POTTER MC, 1969, J EXP PSYCHOL, V81, P10, DOI 10.1037/h0027470; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; Prince JB, 2014, J EXP PSYCHOL HUMAN, V40, P2073, DOI 10.1037/a0037730; Prince JB, 2009, J EXP PSYCHOL HUMAN, V35, P1598, DOI 10.1037/a0016456; Raman R, 2016, MUSIC PERCEPT, V33, P367, DOI 10.1525/mp.2016.33.3.367; REYNOLDS JK, 1992, APPL COGNITIVE PSYCH, V6, P279, DOI 10.1002/acp.2350060402; Roitman JD, 2007, ACTA PSYCHOL, V124, P296, DOI 10.1016/j.actpsy.2006.03.008; ROSE RJ, 1976, J EXP PSYCHOL-HUM L, V2, P142; Rosenthal MA, 2016, MUSIC PERCEPT, V33, P601, DOI 10.1525/MP.2016.33.5.601; Saffran JR, 2003, CURR DIR PSYCHOL SCI, V12, P110, DOI 10.1111/1467-8721.01243; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; SANDEL MJ, 1984, POLIT THEORY, V12, P81, DOI 10.1177/0090591784012001005; Schenker H., 1980, HARMONY; SHAFFER WO, 1972, J EXP PSYCHOL, V92, P292, DOI 10.1037/h0032076; Skagerlund K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00500; Smith NA, 2004, J EXP PSYCHOL HUMAN, V30, P268, DOI 10.1037/0096-1523.30.2.268; Temperley David, 2004, COGNITION BASIC MUSI; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; THOMPSON WF, 1992, PSYCHOL RES-PSYCH FO, V54, P60, DOI 10.1007/BF00937134; Tobia MJ, 2012, NEUROIMAGE, V63, P1730, DOI 10.1016/j.neuroimage.2012.08.017; TODD MPM, 1994, J NEW MUSIC RES, V23, P25, DOI 10.1080/09298219408570647; Toiviainen P, 2003, PERCEPTION, V32, P741, DOI 10.1068/p3312; Trainor LJ, 2000, PERCEPT PSYCHOPHYS, V62, P333, DOI 10.3758/BF03205553; Volet SD, 2008, Q J EXP PSYCHOL, V61, P1827, DOI 10.1080/17470210701743643; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Walsh V, 2003, TRENDS COGN SCI, V7, P335, DOI 10.1016/S1364-6613(03)00166-9; Youngblood James., 1958, J MUSIC THEORY, V2, P24, DOI DOI 10.2307/842928; ZACKS RT, 1982, J EXP PSYCHOL-HUM L, V8, P106, DOI 10.1037/0278-7393.8.2.106	114	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239582	10.1371/journal.pone.0239582	http://dx.doi.org/10.1371/journal.pone.0239582			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NV8NR	32956428	Green Published, gold			2022-12-26	WOS:000574571500026
J	Platt, L; Xu, A; Giddy, J; Bogart, LM; Boulle, A; Parker, RA; Losina, E; Bassett, IV				Platt, Laura; Xu, Ai; Giddy, Janet; Bogart, Laura M.; Boulle, Andrew; Parker, Robert A.; Losina, Elena; Bassett, Ingrid, V			Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; FOLLOW-UP; MORTALITY; LINKAGE; DURBAN; TB	Background Predicting long-term care trajectories at the time of HIV diagnosis may allow targeted interventions. Our objective was to uncover distinct CD4-based trajectories and determine baseline demographic, clinical, and contextual factors associated with trajectory membership. Methods We used data from the Sizanani trial (NCT01188941), in which adults were enrolled prior to HIV testing in Durban, South Africa from August 2010-January 2013. We ascertained CD4 counts from the National Health Laboratory Service over 5y follow-up. We used group-based statistical modeling to identify groups with similar CD4 count trajectories and Bayesian information criteria to determine distinct CD4 trajectories. We evaluated baseline factors that predict membership in specific trajectories using multinomial logistic regression. We examined calendar year of participant enrollment, age, gender, cohabitation, TB positivity, self-identified barriers to care, and ART initiation within 3 months of diagnosis. Results 688 participants had longitudinal data available. Group-based trajectory modeling identified four distinct trajectories: one with consistently low CD4 counts (21%), one with low CD4 counts that increased over time (22%), one with moderate CD4 counts that remained stable (41%), and one with high CD4 counts that increased over time (16%). Those with higher CD4 counts at diagnosis were younger, less likely to have TB, and less likely to identify barriers to care. Those in the least favorable trajectory (consistently low CD4 count) were least likely to start ART within 3 months. Conclusions One-fifth of people newly-diagnosed with HIV presented with low CD4 counts that failed to rise over time. Less than 40% were in a trajectory characterized by increasing CD4 counts. Patients in more favorable trajectories were younger, less likely to have TB, and less likely to report barriers to healthcare. Better understanding barriers to early care engagement and ART initiation will be necessary to improve long-term clinical outcomes.	[Platt, Laura; Bassett, Ingrid, V] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Platt, Laura; Parker, Robert A.; Bassett, Ingrid, V] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Xu, Ai; Parker, Robert A.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Giddy, Janet] McCord Hosp, Durban, South Africa; [Bogart, Laura M.] RAND Corp, Santa Monica, CA USA; [Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Boulle, Andrew] Prov Govt Western Cape, Dept Hlth, Cape Town, South Africa; [Parker, Robert A.; Losina, Elena; Bassett, Ingrid, V] Harvard Med Sch, Boston, MA 02115 USA; [Parker, Robert A.; Losina, Elena; Bassett, Ingrid, V] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; RAND Corporation; University of Cape Town; Harvard University; Harvard Medical School; Harvard University; Boston University	Bassett, IV (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.; Bassett, IV (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Bassett, IV (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Bassett, IV (corresponding author), Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA.	ibassett@mgh.harvard.edu	Bassett, Ingrid V./ABI-7674-2020; Boulle, Andrew/C-1413-2008	Bassett, Ingrid V./0000-0001-6920-6080; Boulle, Andrew/0000-0002-7713-8062	National Institute of Mental Health [R01MH090326, R01MH108427]; National Institute of Allergy and Infectious Diseases [T32AI007433, K24AI141036]; Weissman Family MGH Research Scholar	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Weissman Family MGH Research Scholar	This publication was made possible by Grant Numbers R01MH090326 (IVB) and R01MH108427 (IVB) from the National Institute of Mental Health (www.nimh.nih.org) and by Grant Numbers T32AI007433 (LRP) and K24AI141036 (IVB) from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.org), as well as funding from Weissman Family MGH Research Scholar (IVB). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Bassett IV, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4373-9; Bassett IV, 2016, JAIDS-J ACQ IMM DEF, V73, P154, DOI 10.1097/QAI.0000000000001025; Bassett IV, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-390; Bassett IV, 2012, JAIDS-J ACQ IMM DEF, V59, P25, DOI 10.1097/QAI.0b013e31823d3aba; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Cornell M, 2014, JAIDS-J ACQ IMM DEF, V67, pE67, DOI 10.1097/QAI.0000000000000269; Craw JA, 2008, JAIDS-J ACQ IMM DEF, V47, P597, DOI 10.1097/QAI.0b013e3181684c51; Drain PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055305; Fomundam HN, 2017, SAMJ S AFR MED J, V107, P1058, DOI [10.7196/SAMJ.2017.v107i12.12358, 10.7196/samj.2017.v107i12.12358]; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Haber N, 2016, CURR OPIN HIV AIDS, V11, P102, DOI 10.1097/COH.0000000000000212; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; McNairy ML, 2012, AIDS, V26, P1735, DOI 10.1097/QAD.0b013e328355d67b; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mody A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002959; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Powers KA, 2017, JAIDS-J ACQ IMM DEF, V74, pS88, DOI 10.1097/QAI.0000000000001234; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sherman GG, 2014, SAMJ S AFR MED J, V104, P235, DOI [10.7196/SAMJ.7598, 10.7196/samj.7598]; UNAIDS, 2018, UNAIDS COUNTRY PROFI; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238975	10.1371/journal.pone.0238975	http://dx.doi.org/10.1371/journal.pone.0238975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956380	gold, Green Published			2022-12-26	WOS:000574571500038
J	Itokawa, K; Sekizuka, T; Hashino, M; Tanaka, R; Kuroda, M				Itokawa, Kentaro; Sekizuka, Tsuyoshi; Hashino, Masanori; Tanaka, Rina; Kuroda, Makoto			Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR	PLOS ONE			English	Article								Since December 2019, the coronavirus disease 2019 (COVID-19) caused by a novel coronavirus SARS-CoV-2 has rapidly spread to almost every nation in the world. Soon after the pandemic was recognized by epidemiologists, a group of biologists comprising the ARTIC Network, has devised a multiplexed polymerase chain reaction (PCR) protocol and primer set for targeted whole-genome amplification of SARS-CoV-2. The ARTIC primer set amplifies 98 amplicons, which are separated only in two PCRs, across a nearly entire viral genome. The original primer set and protocol showed a fairly small amplification bias when clinical samples with relatively high viral loads were used. However, as sample's viral load become low, rapid decrease in abundances of several amplicons were seen. In this report, we will show that dimer formations between some primers are the major cause of coverage bias in the multiplex PCR. Based on this, we propose 12 alternative primers in total in the ARTIC primer set that were predicted to be involved in 14 primer interactions. The resulting primer set, version N1 (NIID-1), exhibits improved overall coverage compared to the ARTIC Network's original (V1) and modified (V3) primer set.	[Itokawa, Kentaro; Sekizuka, Tsuyoshi; Hashino, Masanori; Tanaka, Rina; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Itokawa, K (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan.	itokawa@nih.go.jp		Itokawa, Kentaro/0000-0003-1300-9883; Kuroda, Makoto/0000-0002-0487-4405	Japan Agency for Medical Research and Development (AMED) [JP19fk0108103, JP19fk0108104]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This study was supported by a Grant-in Aid from the Japan Agency for Medical Research and Development (AMED) under Grant number JP19fk0108103 and JP19fk0108104. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, METHODS MOL BIOL, DOI DOI 10.1007/978-1-4939-2438-7_1; Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88; Grubaugh ND, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-018-1618-7; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hunter JD, 2007, COMPUT SCI ENG, DOI [10.1109/MCSE.2007.74, DOI 10.1109/MCSE.2007.74]; Itokawa K, 2020, NCOV 2019 SEQUENCING, DOI [10.17504/protocols.io.bd9fi93n, DOI 10.17504/PROTOCOLS.IO.BD9FI93N]; Itokawa K, 2020, BIORXIV 2020 2020 03, DOI [10.1101/2020.03.10.985150, DOI 10.1101/2020.03.10.985150]; Johnston AD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36612-9; Kim YH, 2008, BIOTECHNIQUES, V44, P495, DOI 10.2144/000112705; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Loman NJ., HCOV 2019 NCOV 2019; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Quick J., 2020, PROTOCOLSIO, DOI [10.17504/protocols.io.bbmuik6w.https://doi.org/10.17504/protocols.io.bbmuik6w, DOI 10.17504/PROTOCOLS.IO.BBMUIK6W.HTTPS://DOI.ORG/10.17504/PROTOCOLS.IO.BBMUIK6W]; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core team, 2014, R A LANGUAGE AND ENV; Robinson M, 2011, EDGER DIFFERENTIAL E, V23, P2887; Sekizuka T, 2020, HAPLOTYPE NETWORKS S, DOI 10.1101/2020.03.23.20041970; Shirato K, 2020, JPN J INFECT DIS, V73, P304, DOI 10.7883/yoken.JJID.2020.061; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	22	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239403	10.1371/journal.pone.0239403	http://dx.doi.org/10.1371/journal.pone.0239403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946527	gold, Green Published, Green Submitted			2022-12-26	WOS:000573851100012
J	Sunata, K; Terai, H; Seki, H; Mitsuhashi, M; Kagoshima, Y; Nakayama, S; Wakabayashi, K; Muraoka, K; Suzuki, Y; Suzuki, Y				Sunata, Keeya; Terai, Hideki; Seki, Hatsuho; Mitsuhashi, Masatsugu; Kagoshima, Yuka; Nakayama, Sohei; Wakabayashi, Kenichiro; Muraoka, Kaori; Suzuki, Yukio; Suzuki, Yusuke			Analysis of clinical outcomes in elderly patients with impaired swallowing function	PLOS ONE			English	Article							PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; COMMUNITY-ACQUIRED PNEUMONIA; ASPIRATION PNEUMONIA; MANAGEMENT; MULTICENTER; SURVIVAL; SOCIETY; FOOD; CARE	Japan is the world's leading aging society, and increasing medical expenses for elderly people is an urgent issue. Since aspiration pneumonia in elderly people with impaired swallowing function is a huge problem in Japan, their expected long-term clinical course should be clarified. Accordingly, we collected data from 991 elderly (>= 75 years old) patients whose swallowing function was evaluated by Kitasato Institute Hospital's speech therapists (January 1, 2010 to December 31, 2017). We analyzed the relationship between swallowing function and the subjects' long-term prognosis. To clarify the prognostic factors of patients with dysphagia, we obtained their clinical information (age, gender, activities of daily living, nutritional status, availability of alternative feeding pathways such as percutaneous endoscopic gastrostomy, and cognitive function). We confirmed 372 death cases and stratified the cases into three groups using Fujishima's swallowing ability grade, which is used to predict elderly people's real-world life expectancy. Results showed the median survival days were 331 and 952 days in Groups I (Grades 1-3,n= 308) and II (Grades 4-6,n= 153), respectively, whereas the median survival days for Group III (Grades 7-10,n= 530) could not be calculated. We conducted a multivariate analysis using the Cox proportional hazards model with Group I, which revealed that initial grade and percutaneous endoscopic gastrostomy were significant prognostic factors for the subjects' long-term survival. Nevertheless, further discussion is necessary, particularly to determine advanced care planning regarding indications for alternative feeding pathways in elderly patients with severe dysphagia, since percutaneous endoscopic gastrostomy could significantly prolong their survival.	[Sunata, Keeya; Terai, Hideki; Nakayama, Sohei; Suzuki, Yukio; Suzuki, Yusuke] Kitasato Univ, Kitasato Inst Hosp, Dept Resp Med, Minato Ku, Tokyo, Japan; [Sunata, Keeya] Keio Univ, Sch Med, Div Pulm Med, Dept Med,Shinjuku Ku, Tokyo, Japan; [Seki, Hatsuho; Kagoshima, Yuka; Muraoka, Kaori] Kitasato Univ, Dept Rehabil, Kitasato Inst Hosp, Minato Ku, Tokyo, Japan; [Mitsuhashi, Masatsugu; Wakabayashi, Kenichiro] Kitasato Univ, Dept Otolaryngol, Kitasato Inst Hosp, Minato Ku, Tokyo, Japan; [Suzuki, Yukio] Kitasato Univ, Dept Pharmacol, Minato Ku, Tokyo, Japan	Kitasato University; Keio University; Kitasato University; Kitasato University; Kitasato University	Terai, H; Suzuki, Y (corresponding author), Kitasato Univ, Kitasato Inst Hosp, Dept Resp Med, Minato Ku, Tokyo, Japan.	hidekit926@gmail.com; yusuke-s@insti.kitasato-u.ac.jp		Nakayama, Sohei/0000-0002-6487-0422; Terai, Hideki/0000-0002-1118-1930	Health Care Science Institute; Foundation for Total Health Promotion	Health Care Science Institute; Foundation for Total Health Promotion(Foundation for Total Health Promotion)	This study was supported by a research grant from the Health Care Science Institute to H.T. and a research grant from the Foundation for Total Health Promotion to H.T. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch X, 2012, EUR J INTERN MED, V23, P720, DOI 10.1016/j.ejim.2012.08.006; Bureau S, 2013, STAT HDB JAP; Bureau S, 2016, E STAT; Cilloniz C, 2016, EXPERT REV RESP MED, V10, P1211, DOI 10.1080/17476348.2016.1240037; DeLegge MH, 2005, GASTROINTEST ENDOSC, V62, P952, DOI 10.1016/j.gie.2005.08.024; Faverio P, 2014, EUR J INTERN MED, V25, P312, DOI 10.1016/j.ejim.2013.12.001; Finucane TE, 1996, LANCET, V348, P1421, DOI 10.1016/S0140-6736(96)03369-7; Fujishima I, 1993, REHABILITATION SWALL; Ganzini L, 2003, NEW ENGL J MED, V349, P359, DOI 10.1056/NEJMsa035086; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Higaki F, 2008, AM J GASTROENTEROL, V103, P1011, DOI 10.1111/j.1572-0241.2007.01719.x; Komiya K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38097; Komiya K, 2013, RESPIROLOGY, V18, P514, DOI 10.1111/resp.12029; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; Marik PE, 2001, NEW ENGL J MED, V344, P665, DOI 10.1056/NEJM200103013440908; Matsushita S, 1999, Nihon Ronen Igakkai Zasshi, V36, P45; Mikasa K, 2016, J INFECT CHEMOTHER, V22, pS1, DOI 10.1016/j.jiac.2015.12.019; Ministry of Health LaWIBRD, HEIS 29 NEND IR NO D; Muramatsu N, 2011, GERONTOLOGIST, V51, P425, DOI 10.1093/geront/gnr067; Suzuki Y, 2010, WORLD J GASTROENTERO, V16, P5084, DOI 10.3748/wjg.v16.i40.5084; Takenoshita S, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0662-6; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; Teramoto S, 2015, RESPIR INVESTIG, V53, P178, DOI 10.1016/j.resinv.2015.01.003; Wax JW, 2018, J AM GERIATR SOC, V66, P441, DOI 10.1111/jgs.15200	24	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239440	10.1371/journal.pone.0239440	http://dx.doi.org/10.1371/journal.pone.0239440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946492	Green Published, gold			2022-12-26	WOS:000573851100003
J	Fatima, N; Gromnicova, R; Loughlin, J; Sharrack, B; Male, D				Fatima, Nayab; Gromnicova, Radka; Loughlin, Jane; Sharrack, Basil; Male, David			Gold nanocarriers for transport of oligonucleotides across brain endothelial cells	PLOS ONE			English	Article							CELLULAR UPTAKE; NANOPARTICLES; DELIVERY; BARRIER; SIZE; THERAPY	Treatment of diseases that affect the CNS by gene therapy requires delivery of oligonucleotides to target cells within the brain. As the blood brain barrier prevents movement of large biomolecules, current approaches involve direct injection of the oligonucleotides, which is invasive and may have only a localised effect. The aim of this study was to investigate the potential of 2 nm galactose-coated gold nanoparticles (NP-Gal) as a delivery system of oligonucleotides across brain endothelium. DNA oligonucleotides of different types were attached to NP-Gal by the place exchange reaction and were characterised by EMSA (electrophoretic mobility shift assay). Several nanoparticle formulations were created, with single- or double-stranded (20nt or 40nt) DNA oligonucleotides, or with different amounts of DNA attached to the carriers. These nanocarriers were applied to transwell cultures of human brain endothelium in vitro (hCMEC/D3 cell-line) or to a 3D-hydrogel model of the blood-brain barrier including astrocytes. Transfer rates were measured by quantitative electron microscopy for the nanoparticles and qPCR for DNA. Despite the increase in nanoparticle size caused by attachment of oligonucleotides to the NP-Gal carrier, the rates of endocytosis and transcytosis of nanoparticles were both considerably increased when they carried an oligonucleotide cargo. Carriers with 40nt dsDNA were most efficient, accumulating in vesicles, in the cytosol and beneath the basal membrane of the endothelium. The oligonucleotide cargo remained attached to the nanocarriers during transcytosis and the transport rate across the endothelial cells was increased at least 50fold compared with free DNA. The nanoparticles entered the extracellular matrix and were taken up by the astrocytes in biologically functional amounts. Attachment of DNA confers a strong negative charge to the nanoparticles which may explain the enhanced binding to the endothelium and transcytosis by both vesicular transport and the transmembrane/cytosol pathway. These gold nanoparticles have the potential to transport therapeutic amounts of nucleic acids into the CNS.	[Fatima, Nayab; Gromnicova, Radka; Loughlin, Jane; Male, David] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes, Bucks, England; [Sharrack, Basil] Univ Sheffield, NIHR Translat Neurosci BRC, Acad Dept Neurosci & Sheffield, Sheffield Teaching Hosp,NHS Fdn Trust, Sheffield, S Yorkshire, England	Open University - UK; Oxford University Hospitals NHS Foundation Trust; University of Sheffield	Male, D (corresponding author), Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes, Bucks, England.	David.Male@open.ac.uk		Loughlin, Alison/0000-0003-4769-3740; Male, David/0000-0002-1242-3137	Open University; Sheffield Hospital Trust	Open University; Sheffield Hospital Trust	NF was supported by a post-graduate studentship from the Open University and funding from Sheffield Hospital Trust. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Bartczak D, 2012, NANOSCALE, V4, P4470, DOI 10.1039/c2nr31064c; Behzadi S, 2017, CHEM SOC REV, V46, P4218, DOI 10.1039/c6cs00636a; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Crawford L, 2016, J CONTROL RELEASE, V240, P251, DOI 10.1016/j.jconrel.2015.12.041; Dabrowska M, 2020, METHODS MOL BIOL, V2056, P269, DOI 10.1007/978-1-4939-9784-8_17; Deverman BE, 2018, NAT REV DRUG DISCOV, V17, P641, DOI 10.1038/nrd.2018.110; Ding Y, 2014, MOL THER, V22, P1075, DOI 10.1038/mt.2014.30; Dong XY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00156; Enea M, 2019, NANOTOXICOLOGY, V13, P990, DOI 10.1080/17435390.2019.1621398; EU Directive, 2002, OFF J EUR COMMUN, V12, pL189; Evers MM, 2015, ADV DRUG DELIVER REV, V87, P90, DOI 10.1016/j.addr.2015.03.008; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Gromnicova R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161610; Gromnicova R, 2016, NANOMEDICINE-UK, V11, P617, DOI 10.2217/nnm.15.215; Gromnicova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081043; Jiang Y, 2015, ACS NANO, V9, P9986, DOI 10.1021/acsnano.5b03521; Juliano RL, 2016, NUCLEIC ACIDS RES, V44, P6518, DOI 10.1093/nar/gkw236; Kempe H, 2015, MOL BIOL CELL, V26, P797, DOI 10.1091/mbc.E14-08-1296; Li Y, 2010, J PHYS CHEM B, V114, P2749, DOI 10.1021/jp904550b; Male D, 2016, INT REV NEUROBIOL, V130, P155, DOI 10.1016/bs.irn.2016.05.003; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Sela H, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0133-1; Shilo M, 2014, NANOSCALE, V6, P2146, DOI 10.1039/c3nr04878k; Sreekanthreddy Peddagangannagari, 2015, F1000Res, V4, P1279, DOI 10.12688/f1000research.7142.2; Teleanu DM, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9030371; Vales G, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10020271; Van Lehn RC, 2013, NANO LETT, V13, P4060, DOI 10.1021/nl401365n; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Wei GT, 1999, J CHROMATOGR A, V836, P253, DOI 10.1016/S0021-9673(99)00069-2; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; WILLIAMS V, 1980, NEUROSCIENCE, V5, P1151, DOI 10.1016/0306-4522(80)90194-3; Wurster CD, 2018, THERAPEUTIC ADV NEUR, V11	36	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0236611	10.1371/journal.pone.0236611	http://dx.doi.org/10.1371/journal.pone.0236611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941446	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000573848800012
J	Zhang, JL; Wong, CC; Leung, KT; Wu, F; Zhou, YH; Tong, JHM; Chan, RCK; Li, H; Wang, YF; Yan, H; Liu, LP; Wu, WKK; Chan, MWY; Cheng, ASL; Yu, J; Wong, NA; Lo, KW; To, KF; Kang, W				Zhang, Jinglin; Wong, Chi Chun; Leung, Kam Tong; Wu, Feng; Zhou, Yuhang; Tong, Joanna H. M.; Chan, Ronald C. K.; Li, Hui; Wang, Yifei; Yan, Huan; Liu, Liping; Wu, William K. K.; Chan, Michael W. Y.; Cheng, Alfred S. L.; Yu, Jun; Wong, Nathalie; Lo, Kwok Wai; To, Ka Fai; Kang, Wei			FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; GENE AMPLIFICATION; FGFR2 GENE; CROSS-TALK; PATHWAYS; AZD4547; OVEREXPRESSION; EFFICACY; HEDGEHOG; WNT	Fibroblast growth factor receptor type 2 (FGFR2) has emerged as a key oncogenic factor that regulates gastric cancer (GC) progression, but the underlying mechanism of FGF-FGFR2 signaling pathway remains largely unknown. To identify the potential molecular mechanisms of the oncogenic FGFR2 in gastric carcinogenesis and convey a novel therapeutic strategy, we profiled the FGFR alterations and analyzed their clinical associations in TCGA and Hong Kong GC cohorts. We found that FGFR2 overexpression in GC cell lines and primary tumors predicted poor survival and was associated with advanced stages of GC. Functionally, growth abilities and cell cycle progression of GC were inhibited by inactivation of ERK-MAPK signal transduction after FGFR2 knockdown, while apoptosis was promoted. Meanwhile, the first-line anti-cancer drug sensitivity was enhanced. RNA-seq analysis further revealed that YAP1 signaling serves as a significant downstream modulator and mediates the oncogenic signaling of FGFR2. When stimulating FGFR2 by rhFGF18, we observed intensified F-actin, nuclear accumulation of YAP1, and overexpression of YAP1 targets, but these effects were attenuated by either FGFR2 depletion or AZD4547 administration. Additionally, the FGF18-FGFR2 signaling upregulated YAP1 expression through activating c-Jun, an effector of MAPK signaling. In our cohort, 28.94% of GC cases were characterized as FGFR2, c-Jun, and YAP1 co-positive and demonstrated worse clinical outcomes. Remarkably, we also found that co-targeting FGFR2 and YAP1 by AZD4547 and Verteporfin synergistically enhanced the antitumor effects in vitro and in vivo. In conclusion, we have identified the oncogenic FGF-FGFR2 regulates YAP1 signaling in GC. The findings also highlight the translational potential of FGFR2-c-Jun-YAP1 axis, which may serve as a prognostic biomarker and therapeutic target for GC.	[Zhang, Jinglin; Wu, Feng; Zhou, Yuhang; Tong, Joanna H. M.; Chan, Ronald C. K.; Li, Hui; Wang, Yifei; Yan, Huan; Lo, Kwok Wai; To, Ka Fai; Kang, Wei] Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab Translat Oncol, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jinglin; Wong, Chi Chun; Zhou, Yuhang; Tong, Joanna H. M.; Li, Hui; Wang, Yifei; Yan, Huan; Yu, Jun; To, Ka Fai; Kang, Wei] Chinese Univ Hong Kong, State Key Lab Digest Dis, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Zhang, Jinglin; Zhou, Yuhang; Tong, Joanna H. M.; Li, Hui; Wang, Yifei; Yan, Huan; Wong, Nathalie; Lo, Kwok Wai; To, Ka Fai; Kang, Wei] Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Leung, Kam Tong] Chinese Univ Hong Kong, Dept Pediat, Hong Kong, Peoples R China; [Liu, Liping] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen, Guangdong, Peoples R China; [Wu, William K. K.] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Hong Kong, Hong Kong, Peoples R China; [Chan, Michael W. Y.] Natl Chung Cheng Univ, Dept Life Sci, Chiayi, Taiwan; [Cheng, Alfred S. L.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Wong, Nathalie] Chinese Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Jinan University; Chinese University of Hong Kong; National Chung Cheng University; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	To, KF; Kang, W (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab Translat Oncol, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.; To, KF; Kang, W (corresponding author), Chinese Univ Hong Kong, State Key Lab Digest Dis, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.; To, KF; Kang, W (corresponding author), Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.	kfto@cuhk.edu.hk; weikang@cuhk.edu.hk	Leung, Kam Tong/I-8569-2017; wu, william/HII-5817-2022; KANG, Wei/C-5451-2016; Wu, William K.K./A-3277-2009	Leung, Kam Tong/0000-0002-7695-2513; KANG, Wei/0000-0002-4651-677X; Wu, William K.K./0000-0002-5662-5240; Chan, Michael/0000-0003-0314-2437; , Huan/0000-0003-3370-0479; Wong, Chi Chun/0000-0003-1362-3541	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 14100019, 14118518]; CUHK Direct Grant for Research from The Chinese University of Hong Kong [2019.001]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); CUHK Direct Grant for Research from The Chinese University of Hong Kong	We thank the TCGA Research Network (http://ca ncergenome.nih.gov/), The UCSC Cancer Genomics Browser (https:// genome-cancer.ucsc.edu/), NCI Center for Cancer Genomics Office (http://gdc.nci.nih.gov/), and JASPAR 2020 database (http://jaspar.genereg.net/) for the gastric cancer dataset and analysis. We also appreciate the technical support from Core Utilities of Cancer Genomics and Pathobiology of Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong. The manuscript is under the support of Research Grants Council of the Hong Kong Special Administrative Region, China [Project No.: CUHK 14100019 and 14118518 (for GRF projects)], and CUHK Direct Grant for Research (2019.001) from The Chinese University of Hong Kong.	Ahn S, 2016, MODERN PATHOL, V29, P1095, DOI 10.1038/modpathol.2016.96; Babina IS, 2017, NAT REV CANCER, V17, P318, DOI 10.1038/nrc.2017.8; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bosetti C, 2008, ANN ONCOL, V19, P631, DOI 10.1093/annonc/mdm597; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brooks AN, 2012, CLIN CANCER RES, V18, P1855, DOI 10.1158/1078-0432.CCR-11-0699; Chang JJ, 2015, ONCOTARGET, V6, P2009, DOI 10.18632/oncotarget.2987; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Dudka AA, 2010, CANCER RES, V70, P3391, DOI 10.1158/0008-5472.CAN-09-3033; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Hu B, 2012, J GASTROINTEST ONCOL, V3, P251, DOI 10.3978/j.issn.2078-6891.2012.021; Huang TT, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0493-7; Jang J, 2017, TRANSL ONCOL, V10, P469, DOI 10.1016/j.tranon.2017.03.001; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang W, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0134-0; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katoh M, 2006, INT J ONCOL, V29, P163; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Kim HS, 2019, J CANCER, V10, P20, DOI 10.7150/jca.28204; Lau WM, 2018, MOL CANCER THER, V17, P232, DOI 10.1158/1535-7163.MCT-17-0367; Leung WK, 2018, GASTROENTEROLOGY, V155, P67, DOI 10.1053/j.gastro.2018.03.028; Liao RG, 2013, CANCER RES, V73, P5195, DOI 10.1158/0008-5472.CAN-12-3950; Matsuda Y, 2012, MOL CANCER THER, V11, P2010, DOI 10.1158/1535-7163.MCT-12-0243; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Mitsuno Y, 2001, GUT, V49, P18, DOI 10.1136/gut.49.1.18; Ohta H, 2009, BRIT J CANCER, V100, P389, DOI 10.1038/sj.bjc.6604846; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; Shoji H, 2015, ANTICANCER RES, V35, P5055; Su X, 2014, BRIT J CANCER, V110, P967, DOI 10.1038/bjc.2013.802; Sun D, 2016, ONCOTARGET, V7, P81062, DOI 10.18632/oncotarget.13188; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Tsang Michael, 2004, Sci STKE, V2004, ppe17, DOI 10.1126/stke.2282004pe17; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Van Cutsem E, 2017, ANN ONCOL, V28, P1316, DOI 10.1093/annonc/mdx107; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Yanai K, 2008, CANCER LETT, V263, P145, DOI 10.1016/j.canlet.2007.12.030; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Zhang JL, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060637; Zhang JL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071576; Zhang JL, 2019, ONCOGENE, V38, P33, DOI 10.1038/s41388-018-0430-x	48	14	16	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2020	39	43					6647	6663		10.1038/s41388-020-01458-x	http://dx.doi.org/10.1038/s41388-020-01458-x		SEP 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OF2UT	32934314	hybrid, Green Published			2022-12-26	WOS:000571179500001
J	Chen, V; Bruno, AE; Britt, LL; Hernandez, CC; Gimenez, LE; Peisley, A; Cone, RD; Millhauser, GL				Chen, Valerie; Bruno, Antonio E.; Britt, Laura L.; Hernandez, Ciria C.; Gimenez, Luis E.; Peisley, Alys; Cone, Roger D.; Millhauser, Glenn L.			Membrane orientation and oligomerization of the melanocortin receptor accessory protein 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transmembrane domain; metabolic regulation; G protein&#8211; coupled receptor (GPCR); obesity; membrane protein; accessory protein; melanocortin receptor; membrane threading	BLUE NATIVE ELECTROPHORESIS; DUAL-TOPOLOGY; MRAP2; IDENTIFICATION; MUTATIONS; TRANSPORT; RESIDUES; REGIONS; PACKING; MOTIFS	The melanocortin receptor accessory protein 2 (MRAP2) plays a pivotal role in the regulation of several G protein-coupled receptors that are essential for energy balance and food intake. MRAP2 loss-of-function results in obesity in mammals. MRAP2 and its homolog MRAP1 have an unusual membrane topology and are the only known eukaryotic proteins that thread into the membrane in both orientations. In this study, we demonstrate that the conserved polybasic motif that dictates the membrane topology and dimerization of MRAP1 does not control the membrane orientation and dimerization of MRAP2. We also show that MRAP2 dimerizes through its transmembrane domain and can form higher-order oligomers that arrange MRAP2 monomers in a parallel orientation. Investigating the molecular details of MRAP2 structure is essential for understanding the mechanism by which it regulates G protein-coupled receptors and will aid in elucidating the pathways involved in metabolic dysfunction.	[Chen, Valerie; Bruno, Antonio E.; Britt, Laura L.; Millhauser, Glenn L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Hernandez, Ciria C.; Gimenez, Luis E.; Peisley, Alys; Cone, Roger D.] Univ Michigan, Life Sci Inst, Ann Arbor, MI USA; [Hernandez, Ciria C.; Gimenez, Luis E.; Peisley, Alys; Cone, Roger D.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI USA	University of California System; University of California Santa Cruz; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Millhauser, GL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.	glennm@ucsc.edu		Peisley, Alys/0000-0002-8999-5440; Cone, Roger/0000-0003-3333-5651; Diaz Gimenez, Luis Eduardo/0000-0002-0110-2135	National Institutes of Health [R01DK110403, R01DK070332]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01DK110403 (to G. L. M.) and R01DK070332 (to R. D. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Asai M, 2013, SCIENCE, V341, P275, DOI 10.1126/science.1233000; Baron M, 2019, NAT MED, V25, P1733, DOI 10.1038/s41591-019-0622-0; Bruschetta G, 2018, MOL METAB, V18, P79, DOI 10.1016/j.molmet.2018.09.010; Bugge K, 2016, FEBS J, V283, P4424, DOI 10.1111/febs.13793; Chaly AL, 2016, ELIFE, V5, DOI 10.7554/eLife.12397; Chan LF, 2009, P NATL ACAD SCI USA, V106, P6146, DOI 10.1073/pnas.0809918106; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Geets E, 2016, MOL GENET METAB, V117, P383, DOI 10.1016/j.ymgme.2016.01.003; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hilaire S, 2001, J BIOL CHEM, V276, P42182, DOI 10.1074/jbc.M107323200; Hinkle PM, 2009, MOL CELL ENDOCRINOL, V300, P25, DOI 10.1016/j.mce.2008.10.041; Malik S, 2015, J BIOL CHEM, V290, P27972, DOI 10.1074/jbc.M115.668491; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rouault AAJ, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax4569; Rouault AAJ, 2017, BBA-MOL CELL RES, V1864, P2322, DOI 10.1016/j.bbamcr.2017.09.008; Schonnop L, 2016, OBESITY, V24, P1976, DOI 10.1002/oby.21576; Sebag JA, 2007, P NATL ACAD SCI USA, V104, P20244, DOI 10.1073/pnas.0708916105; Sebag JA, 2013, SCIENCE, V341, P278, DOI 10.1126/science.1232995; Sebag JA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000593; Sebag JA, 2009, J BIOL CHEM, V284, P610, DOI 10.1074/jbc.M804413200; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Srisai D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00747-6; Swanton E, 2005, P NATL ACAD SCI USA, V102, P4342, DOI 10.1073/pnas.0407287102; Teese MG, 2015, BIOCHEMISTRY-US, V54, P5125, DOI 10.1021/acs.biochem.5b00495; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200	33	7	7	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16370	16379		10.1074/jbc.RA120.015482	http://dx.doi.org/10.1074/jbc.RA120.015482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32943551	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000598519500016
J	Villalba, B; Johnson, KA				Villalba, Brian; Johnson, Kenneth A.			Rate-limiting pyrophosphate release by hepatitis C virus polymerase NS5B improves fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatitis C virus (HCV); NS5B; enzyme kinetics; RNA polymerase; polymerase fidelity; viral polymerase; pre-steady-state kinetics	REPLICATION; RNA; RESISTANCE; EXPLORER; EXCISION	The hepatitis C virus RNA-dependent RNA polymerase NS5B is responsible for the replication of the viral genome. Previous studies have uncovered NTP-mediated excision mechanisms that may be responsible for aiding in maintaining fidelity (the frequency of incorrect incorporation events relative to correct), but little is known about the fidelity of NS5B. In this study, we used transient-state kinetics to examine the mechanistic basis for polymerase fidelity. We observe a wide range of efficiency for incorporation of various mismatched base pairs and have uncovered a mechanism in which the rate constant for pyrophosphate release is slowed for certain misincorporation events. This results in an increase in fidelity against these specific misincorporations. Furthermore, we discover that some mismatches are highly unfavorable and cannot be observed under the conditions used here. The calculated fidelity of NS5B ranges between 10(-4)-10(-9) for different mismatches.	[Johnson, Kenneth A.] Univ Texas Austin, Inst Cell Biol, Austin, TX 78712 USA; Univ Texas Austin, Inst Mol Biol, Austin, TX 78712 USA; [Villalba, Brian] MoMa Therapeut, Cambridge, MA USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Johnson, KA (corresponding author), Univ Texas Austin, Inst Cell Biol, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu		Johnson, Kenneth/0000-0002-6575-2823; Villalba, Brian/0000-0002-4826-5652	NIAID [1R01AI110577]; Welch Foundation [F-1604]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation)	This work was supported by NIAID Grant 1R01AI110577 (to K. A. J.) and the Welch Foundation Grant F-1604 (to K. A. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Davis JS, 2020, MED J AUSTRALIA, V213, P86, DOI 10.5694/mja2.50673; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; FONG TL, 1991, J CLIN INVEST, V88, P1058, DOI 10.1172/JCI115368; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056; Hanes JW, 2006, J BIOL CHEM, V281, P36241, DOI 10.1074/jbc.M607965200; Jin ZN, 2013, P NATL ACAD SCI USA, V110, pE348, DOI 10.1073/pnas.1214924110; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kellinger MW, 2010, P NATL ACAD SCI USA, V107, P7734, DOI 10.1073/pnas.0913946107; Li A, 2016, J BIOL CHEM, V291, P26554, DOI 10.1074/jbc.M116.753152; Lin L, 2009, J MED VIROL, V81, P1569, DOI 10.1002/jmv.21510; Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200; Powdrill MH, 2011, P NATL ACAD SCI USA, V108, P20509, DOI 10.1073/pnas.1105797108; Revie D, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-346; Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Selisko B, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020059; Svarovskaia ES, 2014, CLIN INFECT DIS, V59, P1666, DOI 10.1093/cid/ciu697; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Villalba B, 2020, J BIOL CHEM, V295, P10112, DOI 10.1074/jbc.RA120.013422	25	3	3	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16436	16444		10.1074/jbc.RA120.015394	http://dx.doi.org/10.1074/jbc.RA120.015394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32938715	Green Published, hybrid			2022-12-26	WOS:000598519500021
J	Gitore, WA; Ali, MM; Yoseph, A; Mangesha, AE; Debiso, AT				Gitore, Wondwosen Abera; Ali, Musa Mohammed; Yoseph, Amanuel; Mangesha, Adane Ermias; Debiso, Alemu Tamiso			Prevalence of soil-transmitted helminthes and its association with water, sanitation, hygiene among schoolchildren and barriers for schools level prevention in technology villages of Hawassa University: Mixed design	PLOS ONE			English	Article							CHILDREN; INFECTIONS; TOWN	Background Soil-transmitted helminths (STH) remain one of the most common causes of morbidity among children in Ethiopia. Assessment of the magnitude of STH and its association with water, sanitation, and hygiene (WASH) and identify barriers for school-level prevention assist public health planners to prioritize promotion strategies and is a basic step for intervention. However, there is a lack of evidence on the prevalence of STH and its association with WASH and barriers for school-level prevention among schoolchildren. Objective To assess the prevalence of STH and its association with WASH and identify barriers for school level prevention in technology village of Hawassa University; 2019. Methods An institution-based analytical cross-sectional study was conducted on a sample of 1080 schoolchildren from September 5 to October 15, 2019. A two-stage cluster and purposive sampling technique were used to draw the study participants. A pretested, structured questionnaire, observation checklist, and in-depth interview were used to collect the data. Two grams of stool samples were collected from each study participant and examined using direct wet mount and Kato-Katz technique. Data were entered into Epi Info version 7 and analyzed using SPSS version 25. Both bi-variable and multivariable logistic regression analyses were done. Qualitative data were analyzed using thematic content analysis method by Atlas-Ti software and presented in narratives. Results The overall prevalence of STHs was 23.1% (95% CI = 21.4, 27.6). The identified predictors of STHs were large family size (AOR = 2.03; 95% CI = 1.53-3.99), absence of separate toilet room for male and female (AOR = 3.33; 95% CI = 1.91-5.79), toilet not easy to clean (AOR = 2.17; 95% CI = 1.44-3.33), inadequate knowledge about STHs (AOR = 2.08; 95% CI = 1.07-3.44) and children who had travelled greater than 100 meters to access toilet (AOR = 3.45; 95% CI = 2.24-8.92). These results were supported by the individual, institutional, socio-economic and cultural qualitative results. Conclusion The STHs was moderate public health concerns. Reinforcing the existing fragile water, sanitation and hygiene programs and regular deworming of schoolchildren may support to reduce the burden of STHs. Also, increasing modern family planning methods utilization to decrease family size is recommended.	[Gitore, Wondwosen Abera; Ali, Musa Mohammed] Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia; [Yoseph, Amanuel; Debiso, Alemu Tamiso] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia; [Mangesha, Adane Ermias] Hawassa Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Hawassa, Ethiopia	Hawassa University; Hawassa University; Hawassa University	Gitore, WA (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Med Lab Sci, Hawassa, Ethiopia.	aberawondwosen@yahoo.com	Ali, Musa/AAO-1172-2021	Ali, Musa/0000-0001-7786-3400				Abate Abraraw, 2013, ISRN Parasitol, V2013, P757451, DOI 10.5402/2013/757451; Abdi M, 2017, J INFECT PUBLIC HEAL, V10, P84, DOI 10.1016/j.jiph.2016.02.009; Abera A, 2014, ASIAN PAC J TROP MED, V7, P525, DOI 10.1016/S1995-7645(14)60088-2; Alelign Tilahun, 2015, J Parasitol Res, V2015, P641602, DOI 10.1155/2015/641602; [Anonymous], 2016, EUR J ORAL IMPLANTOL, V9, pS173; Ayalew A., 2011, J PARASITOL VECTOR B, V3, P75; Creswell J.W., 2018, QUAL INQ, V4; Davis EL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006195; Ethiopia Federal Ministry of Health, 2016, NAT NEGL TROP DIS MA, VSecond; Francis L, 2012, INT J ENV RES PUB HE, V9, P2910, DOI 10.3390/ijerph9082910; Getaneh Amde, 2010, BMC Res Notes, V3, P90, DOI 10.1186/1756-0500-3-90; Ghiwot Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109793; Girum Tadesse, 2005, Ethiopian Journal of Health Development, V19, P140; Haileamlak A, 2015, ETHIOP J HLTH SCI, V15, P107; Health(FMoH). F. M. o. H, 2016, NAT MAST PLAN NEGL T, VSecond; Heydari A, 2003, PREVALENCE INTESTINA; Jaran AS, 2016, E MEDITERR HEALTH J, V22, P756, DOI 10.26719/2016.22.10.756; Legesse L, 2010, ETHIOP J HEALTH DEV, V24, P191; Lewetegn M, 2015, PREVALENCE INTESTINA, DOI [10.11648/j.ijbmr.20190701.11, DOI 10.11648/J.IJBMR.20190701.11]; Mandomando IM, 2007, AM J TROP MED HYG, V76, P522, DOI 10.4269/ajtmh.2007.76.522; Mathewos Biniam, 2014, BMC Res Notes, V7, P88, DOI 10.1186/1756-0500-7-88; Mekonnen B, 2014, J TROPICAL DIS, V2, P132, DOI DOI 10.4172/2329-891X.1000132; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-27; Sanchez AL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002378; Seid M, 2015, NO ETHIOPIA ACTA PAR, V6, P29; Sergio Juraci Vieira, 2009, Cad. Saúde Pública, V25, P1093, DOI 10.1590/S0102-311X2009000500016; Shrestha A, 2012, KATHMANDU U MED J, V10, P62, DOI 10.3126/kumj.v10i1.6904; Sidama Zone Administration, 2018, ANN AGR CLIM CHANG R; Sidama Zone Administration, 2018, ANN HLTH HLTH REL RE; Sidama Zone Administration, 2018, DISTR BAS FOC REP DE; Simon Adane, 2018, KNOWLEDGE ATTI UNPUB, DOI [10.1186/s12879-019-4253-3, DOI 10.1186/S12879-019-4253-3]; Sowemimo OA, 2011, J HELMINTHOL, V85, P234, DOI 10.1017/S0022149X10000489; Teshale Tsega, 2018, BMC Res Notes, V11, P444, DOI 10.1186/s13104-018-3556-6; Uhuo A. C., 2011, Advances in Applied Science Research, V2, P257; Wale M., 2014, J PARASITOL VECTOR B, V6, P156, DOI [10.5897/JPVB2014.0159, DOI 10.5897/JPVB2014.0159]; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wongstitwilairoong B, 2007, AM J TROP MED HYG, V76, P345, DOI 10.4269/ajtmh.2007.76.345; Workineh Lemma, 2018, J PARASITOLOGY RES, DOI [10.1155/2020/2521750, DOI 10.1155/2020/2521750]; World Health Organization, 2017, FACT SHEET SOIL TRAN; World Health Organization, 2016, WHO TECHN REP SER; World Health Organization (WHO), 2016, SOIL TRANSM HELM EL; Yami A, 2011, ETHIOP J HEALTH SCI, V21, P167	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239557	10.1371/journal.pone.0239557	http://dx.doi.org/10.1371/journal.pone.0239557			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970747	Green Published, gold			2022-12-26	WOS:000576265600037
J	Grimaldo, E; Herrmann, B; Jacques, N; Vollstad, J; Su, B				Grimaldo, Eduardo; Herrmann, Bent; Jacques, Nadine; Vollstad, Jorgen; Su, Biao			Effect of mechanical properties of monofilament twines on the catch efficiency of biodegradable gillnets	PLOS ONE			English	Article							COD GADUS-MORHUA; FISHING PERFORMANCE; SIZE SELECTION; NETS	Gillnets made of the biodegradable resin polybutylene succinate co-adipate-co-terephthalate were tested under commercial fishing conditions to compare their fishing performance with that of conventional nylon polyamide (PA) gillnets. Both types of gillnets were made of 0.55 mm o monofilaments. However, since the biodegradable nets are weaker than nylon PA nets when using the same monofilament diameter, we also used biodegradable nets made of 0.60 mm o monofilament that had a similar tensile strength to the 0.55 mm o nylon PA nets. The relative catch efficiency of the different gillnet types was evaluated over the 2018 autumn fishing season for saithe and cod in northern Norway. For cod, both biodegradable gillnets (0.55 and 0.60 mm) had a significantly lower catch efficiency compared to the traditional nylon PA net (0.55 mm) with estimated catch efficiencies of 62.38% (CI: 50.55-74.04) and 54.96% (CI: 35.42-73.52) compared with the nylon PA net, respectively. Similarly for saithe, both biodegradable gillnets (0.55 and 0.60 mm) had a lower estimated catch efficiency compared to the traditional nylon PA net (0.55 mm) with estimated catch efficiencies of 83.40% (71.34-94.86) and 83.87% (66.36-104.92), compared with the nylon PA net, respectively. Tensile strength does not explain the differences in catch efficiency between the two gillnet types, since increasing the twine diameter of the biodegradable gillnets (to match the strength of nylon PA gillnets) did not yield similar catch efficiencies. However, the elasticity and stiffness of the materials may be responsible for the differences in catch efficiency between the nylon PA and biodegradable gillnets.	[Grimaldo, Eduardo; Vollstad, Jorgen] SINTEF Ocean, Dept Fisheries Technol, Trondheim, Norway; [Herrmann, Bent] SINTEF Ocean, Dept Fisheries Technol, Hirtshals, Denmark; [Herrmann, Bent; Jacques, Nadine] Arctic Univ Norway UiT, Tromso, Norway; [Su, Biao] SINTEF Ocean, Dept Aquaculture Technol, Trondheim, Norway	SINTEF; SINTEF; UiT The Arctic University of Tromso; SINTEF	Grimaldo, E (corresponding author), SINTEF Ocean, Dept Fisheries Technol, Trondheim, Norway.	Eduardo.Grimaldo@sintef.no		Grimaldo, Eduardo/0000-0003-2690-9477; Jacques, Nadine/0000-0001-6981-3825	Regional Research Council of Northern Norway [282512]; Norwegian Directorate of Fisheries	Regional Research Council of Northern Norway; Norwegian Directorate of Fisheries	This study was financed by the Regional Research Council of Northern Norway(project no. 282512) and the Norwegian Directorate of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; [Anonymous], 18062002 ISO; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Deshpande P. C., 2020, RESOUR CONSERV RECY, V5, DOI [10.1016/j.rcrx.2019.100024, DOI 10.1016/J.RCRX.2019.100024]; FAO, 2018, M SUSTAINABLE DEV GO; Fisheries Directorate, 2020, FISH VESS PERM; Fisheries Directorate of Norway, 2020, CAT LIC; Grati F, 2015, FISH RES, V164, P170, DOI 10.1016/j.fishres.2014.11.014; Grimaldo E, 2019, FISH RES, V213, P67, DOI 10.1016/j.fishres.2019.01.003; Grimaldo E, 2018, MAR COAST FISH, V10, P619, DOI 10.1002/mcf2.10058; Grimaldo E, 2018, ICES J MAR SCI, V75, P2245, DOI 10.1093/icesjms/fsy108; Hareide NR, 2005, 2005N07 ICES; Herrmann B, 2018, FISH RES, V207, P49, DOI 10.1016/j.fishres.2018.05.028; Herrmann B, 2017, FISH RES, V185, P153, DOI 10.1016/j.fishres.2016.09.013; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Herrmann B, 2016, MAR COAST FISH, V8, P277, DOI 10.1080/19425120.2016.1161682; Herrmann B, 2015, ICES J MAR SCI, V72, P686, DOI 10.1093/icesjms/fsu124; Katsanevakis S, 2006, FISH RES, V81, P229, DOI 10.1016/j.fishres.2006.07.002; Kim M.K., 2017, US Patent application publication, Patent No. [US 2017/0112111A1, 20170112111, US2017/0112111A1]; Kim S, 2016, ANIM CONSERV, V19, P309, DOI 10.1111/acv.12256; Kim S, 2020, TURK J FISH AQUAT SC, V20, P127, DOI 10.4194/1303-2712-v20_2_05; Kim S, 2014, FISHERIES SCI, V80, P887, DOI 10.1007/s12562-014-0785-z; Kim S, 2014, TURK J FISH AQUAT SC, V14, P21, DOI 10.4194/1303-2712-v14_1_03; Large PA, 2009, ICES J MAR SCI, V66, P323, DOI 10.1093/icesjms/fsn220; 김성훈, 2013, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V49, P218, DOI 10.3796/KSFT.2012.49.3.218; Macfadyen G., 2009, FAO Fisheries and Aquaculture Technical Paper; Norwegian Fisheries Directorate, 2019, LOST FISH GEARS GHOS; 박성욱, 2007, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V43, P281; SCHAEFER MB, 1957, J FISH RES BOARD CAN, V14, P669, DOI 10.1139/f57-025; Sekiguchi T, 2011, POLYM DEGRAD STABIL, V96, P1397, DOI 10.1016/j.polymdegradstab.2011.03.004; Su B, 2019, PAPER OMAE2019 95350; Sundt P, 2018, M1052 NORW ENV AG, P181; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Urbanek AK, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0448-4; Veiga-Malta T, 2019, OCEAN COAST MANAGE, V177, P148, DOI 10.1016/j.ocecoaman.2019.05.009; Wileman D., 1996, MANUAL METHODS MEASU; 배봉성, 2013, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V49, P95, DOI 10.3796/KSFT.2013.49.2.095; 배봉성, 2012, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V48, P310, DOI 10.3796/KSFT.2012.48.4.310; 박성욱, 2008, [Journal of the Korean Society of Fisheries and Ocean Technology, 수산해양기술연구], V44, P265	40	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0234224	10.1371/journal.pone.0234224	http://dx.doi.org/10.1371/journal.pone.0234224			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970682	gold, Green Published, Green Submitted			2022-12-26	WOS:000576265600100
J	Loureiro, LO; Engstrom, MD; Lim, BK				Loureiro, Livia O.; Engstrom, Mark D.; Lim, Burton K.			Does evolution of echolocation calls and morphology inMolossusresult from convergence or stasis?	PLOS ONE			English	Article							PHYLOGENETIC SIGNAL; SPECIES-DIVERSITY; GENETIC-EVIDENCE; BODY-SIZE; BATS; MOLOSSIDAE; CHIROPTERA; LINEAGES; DIVERSIFICATION; ADAPTATION	Although many processes of diversification have been described to explain variation of morphological traits within clades that have obvious differentiation among taxa, not much is known about these patterns in complexes of cryptic species.Molossusis a genus of bats that is mainly Neotropical, occurring from the southeastern United States to southern Argentina, including the Caribbean islands.Molossuscomprises some groups of species that are morphologically similar but phylogenetically divergent, and other groups of species that are genetically similar but morphologically distinct. This contrast allows investigation of unequal trait diversification and the evolution of morphological and behavioural characters. In this study, we assessed the role of phylogenetic history in a genus of bat with three cryptic species complexes, and evaluated if morphology and behavior are evolving concertedly. The Genotype by Sequence genomic approach was used to build a species-level phylogenetic tree forMolossusand to estimate the ancestral states of morphological and echolocation call characters. We measured the correlation of phylogenetic distances to morphological and echolocation distances, and tested the relationship between morphology and behavior when the effect of phylogeny is removed. Morphology evolved via a mosaic of convergence and stasis, whereas call design was influenced exclusively through local adaptation and convergent evolution. Furthermore, the frequency of echolocation calls is negatively correlated with the size of the bat, but other characters do not seem to be evolving in concert. We hypothesize that slight variation in both morphology and behaviour among species of the genus might result from niche specialization, and that traits evolve to avoid competition for resources in similar environments.	[Loureiro, Livia O.] Hosp Sick Children, Ctr Appl Genom, SickKids Learning Inst, Toronto, ON, Canada; [Loureiro, Livia O.; Engstrom, Mark D.; Lim, Burton K.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON, Canada; [Loureiro, Livia O.; Engstrom, Mark D.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Ontario Museum; University of Toronto	Loureiro, LO (corresponding author), Hosp Sick Children, Ctr Appl Genom, SickKids Learning Inst, Toronto, ON, Canada.; Loureiro, LO (corresponding author), Royal Ontario Museum, Dept Nat Hist, Toronto, ON, Canada.; Loureiro, LO (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	livia.loureiro@sickkids.ca		Loureiro, Livia/0000-0003-0098-7901	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) [99999.011880/2013-09]; Royal Ontario Museum; Ecuambiente Consulting Group; Conservation International; Academy of Natural Sciences, Philadelphia	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Royal Ontario Museum; Ecuambiente Consulting Group; Conservation International; Academy of Natural Sciences, Philadelphia	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) #99999.011880/2013-09 to LOL. Neotropical fieldwork has been primarily funded by the Royal Ontario Museum with additional financial support in Ecuador by Ecuambiente Consulting Group and in Guyana by Conservation International and funding through the Academy of Natural Sciences, Philadelphia to BKL and MDE.	ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Ammerman LK, 2012, J MAMMAL, V93, P12, DOI 10.1644/11-MAMM-A-103.1; [Anonymous], 2019, PLAST RECONSTR SURG, V143, p1S; ARCHIE JW, 1985, SYST ZOOL, V34, P326, DOI 10.2307/2413151; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bioacoustics Research Program, 2014, RAV PRO INT SOUND AN; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Burns LE, 2014, CONSERV GENET, V15, P1371, DOI 10.1007/s10592-014-0623-y; CHURCHER CHARLES S., 1959, JOUR MAMMAL, V40, P513, DOI 10.2307/1376267; Churchill M, 2016, CURR BIOL, V26, P2144, DOI 10.1016/j.cub.2016.06.004; Collen A., 2012, THESIS; Darwin C., 1872, P374; Davies KTJ, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-2; Dolan P.G., 1989, Texas Tech University Museum Special Publications, P1; Eger JL, 2007, MAMMALS S AM, P399; Eldredge N, 2005, PALEOBIOLOGY, V31, P133, DOI 10.1666/0094-8373(2005)031[0133:TDOES]2.0.CO;2; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; Ewer R.F, 1974, CARNIVORES; Feng J, PROG NAT SCI, V19, P673; Fenton BM, 2011, BIOTROPICA, V30, P314; Feulner PGD, 2006, MOL PHYLOGENET EVOL, V39, P198, DOI 10.1016/j.ympev.2005.09.008; Foote M, 2002, ANNU REV ECOL SYST, V62, P504; Freckleton RP, 2000, FUNCT ECOL, V14, P129, DOI 10.1046/j.1365-2435.2000.00400.x; FREEMAN PW, 1988, BIOL J LINN SOC, V33, P249, DOI 10.1111/j.1095-8312.1988.tb00811.x; Gager Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150780; Garcia-Cruz J, 2006, SYST BOT, V31, P302, DOI 10.1600/036364406777585739; Gregorin R, 2016, CLADISTICS, V32, P2, DOI 10.1111/cla.12117; GRIFFIN DR, 1958, SCIENCE, V128, P145, DOI 10.1126/science.128.3316.145; Harmon LJ, 2015, AM NAT, V185, P584, DOI 10.1086/680859; Harvey P. H., 1991, COMP METHOD EVOLUTIO; Holland BR, 2010, SYST BIOL, V59, P433, DOI 10.1093/sysbio/syq023; Hone DWE, 2012, LETHAIA, V45, P139, DOI 10.1111/j.1502-3931.2011.00300.x; Houston R.D., 2004, ECHOLOCATION BATS DO; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jakobsen L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00089; Jakobsen L, 2013, NATURE, V493, P93, DOI 10.1038/nature11664; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Jones G, 1999, J EXP BIOL, V202, P3359; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Jung K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085279; KALKO EKV, 1993, BEHAV ECOL SOCIOBIOL, V33, P415; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Keck F, 2016, ECOL EVOL, V6, P2774, DOI 10.1002/ece3.2051; Keogh H, 1979, ATLAS HAIR SO AFRICA; Kossl M, 2016, J MAMM EVOL, V3, P40; Lavoue S, 2012, ICHTHYOL RES, V59, P104, DOI 10.1007/s10228-011-0258-7; Lim BK, 2008, J MAMM EVOL, V15, P79, DOI 10.1007/s10914-007-9068-0; Lim BK, 2017, J MAMMAL, V98, P986, DOI 10.1093/jmammal/gyw147; Lopez-Gonzalez C, 2001, J MAMMAL, V82, P760, DOI 10.1644/1545-1542(2001)082<0760:TSOMBJ>2.0.CO;2; Loureiro LO, 2020, ECOL EVOL, V10, P389, DOI 10.1002/ece3.5903; Loureiro LO, 2019, ACTA CHIROPTEROL, V21, P51, DOI 10.3161/15081109ACC2019.21.1.004; Loureiro LO, 2018, DATA BRIEF, V18, P1609, DOI 10.1016/j.dib.2018.04.088; Loureiro LO, 2018, MAMM BIOL, V90, P10, DOI 10.1016/j.mambio.2018.01.008; Loureiro LO, 2018, ZOOSYSTEMA, V40, P425, DOI 10.5252/zoosystema2018v40a18; Lucas P.W., 1979, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1979, P486; Maddison W.P., 2018, MESQUITE; Mahler DL, 2017, AM NAT, V190, pS13, DOI 10.1086/692648; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; MARQUES S A, 1986, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V2, P159; Marx FG, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140434; McLean BS, 2018, EVOLUTION, V72, P473, DOI 10.1111/evo.13422; Measey GJ, 2009, ZOOLOGY, V112, P217, DOI 10.1016/j.zool.2008.09.005; Melville J, 2001, J EXP ZOOL, V291, P339, DOI 10.1002/jez.1133; Michalak P, 2001, P NATL ACAD SCI USA, V98, P13195, DOI 10.1073/pnas.231478298; MICKEVICH MF, 1976, SYST ZOOL, V25, P260, DOI 10.2307/2412494; Miller JR, 2012, BIOACOUSTICS, V21, P193, DOI 10.1080/09524622.2012.675176; Mora EC, 2004, J COMP PHYSIOL A, V190, P561, DOI 10.1007/s00359-004-0519-2; Muchlinski MN, 2008, ANAT REC, V291, P1221, DOI 10.1002/ar.20742; Nagalingum NS, 2007, SYST BOT, V32, P16, DOI 10.1600/036364407780360256; NEUWEILER G, 1989, TRENDS ECOL EVOL, V4, P160, DOI 10.1016/0169-5347(89)90120-1; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Packert M, 2003, EVOLUTION, V57, P616; Peters G., 1989, P14; Peterson R.L., 1995, Faune de Madagascar, V84, P1; Pfenninger M, 2003, MOL ECOL, V12, P2731, DOI 10.1046/j.1365-294X.2003.01943.x; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Pye J. David, 1993, Bioacoustics, V4, P271; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Ramirez-Barahona S, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1098; Remagnino P, 2017, COMPUTATIONAL BOT, P11, DOI [10.1007/978-3-662-53745-9_2, DOI 10.1007/978-3-662-53745-9_2]; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Riesch R, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0705-1; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; ROSENZWEIG ML, 1968, AM MIDL NAT, V80, P299, DOI 10.2307/2423529; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schnitzler HU, 1998, BATS PHYLOGENY MORPH; Schnitzler HU, 2009, SCI YORK, V51, P557; Seifert B, 2009, MYRMECOL NEWS, V12, P149; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Silva-Taboada G, 1979, MURCIELAGOS CUBA; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; Smith KL, 2011, EVOLUTION, V65, P976, DOI 10.1111/j.1558-5646.2010.01211.x; Stange M, 2018, SYST BIOL, V67, P681, DOI 10.1093/sysbio/syy006; Stoffberg S, 2011, J MAMM EVOL, V18, P117, DOI 10.1007/s10914-011-9158-x; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; STURMBAUER C, 1993, MOL BIOL EVOL, V10, P751; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Taylor P., 2019, HDB MAMMALS WORLD, V9; Taylor PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041744; Thiagavel J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02532-x; Thiagavel J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00959-2; von Cramon-Taubadel N, 2009, AM J PHYS ANTHROPOL, V140, P205, DOI 10.1002/ajpa.21041; Wagner HC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30890-z; Wainwright CP, 1994, ECOLOGICAL MORPHOLOG	107	0	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238261	10.1371/journal.pone.0238261	http://dx.doi.org/10.1371/journal.pone.0238261			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970683	gold, Green Published			2022-12-26	WOS:000576265600087
J	Misztak, P; Panczyszyn-Trzewik, P; Nowak, G; Sowa-Kucma, M				Misztak, Paulina; Panczyszyn-Trzewik, Patrycja; Nowak, Gabriel; Sowa-Kucma, Magdalena			Epigenetic marks and their relationship with BDNF in the brain of suicide victims	PLOS ONE			English	Article							HISTONE ACETYLATION; MECP2 PHOSPHORYLATION; VAL66MET POLYMORPHISM; DEPRESSIVE-DISORDERS; MAJOR DEPRESSION; DNA METHYLATION; RISK-FACTORS; EXPRESSION; STRESS; HIPPOCAMPUS	Background Suicide is a common phenomenon affecting people of all ages. There is a strong relationship between suicidal ideation and depressive disorders. Increasing number of studies suggest that epigenetic modifications in certain brain areas are the main mechanism through which environmental and genetic factors interact with each other contributing to the development of mental disorders. To verify this hypothesis, some epigenetic marks: H3K9/14ac, HDAC2/3, H3K27me2 and Sin3a, as well as p-S421-MeCP2/MeCP2 were examined. On the other hand, BDNF protein level were studied. Materials and methods Western blot analysis were performed in the frontal cortex (FCx) and hippocampus (HP) of suicide victims (n = 14) and non-suicidal controls (n = 8). The differences between groups and correlations between selected proteins were evaluated using Mann-Whitney U-test and Spearman's rank correlation. Results Statistically significant decrease in H3K9/14ac (FCx:down arrow similar to 23%;HP:down arrow similar to 33%) combined with increase in HDAC3 (FCx:up arrow similar to 103%;HP:up arrow similar to 85% in HP) protein levels in suicides compared to the controls was shown. These alterations were accompanied by an increase in H3K27me2 (FCx:up arrow 45%;HP:up arrow similar to 59%) and Sin3a (HP:up arrow 50%) levels and decrease in p-S421-MeCP2/MeCP2 protein ratio (HP:down arrow similar to 55%;FCx:down arrow similar to 27%). Moreover, reduced BDNF protein level (FCx:down arrow similar to 43%;HP:down arrow similar to 28%) in suicides was observed. On the other hand, some significant correlations (e.g. between H3K9/14ac and HDAC2 or between BDNF and p-S421-MeCP2/MeCP2) were demonstrated. Conclusions Our findings confirm the role of epigenetic component and BDNF protein in suicidal behavior. Lowered BDNF protein level in suicides is probably due to decrease in histone acetylation and increased level of factors related with deacetylation and methylation processes, including MeCP2 factor, which may operate bidirectionally (an activator or inhibitor of transcription).	[Misztak, Paulina; Panczyszyn-Trzewik, Patrycja; Nowak, Gabriel; Sowa-Kucma, Magdalena] Polish Acad Sci, Maj Inst Pharmacol, Dept Neurobiol, Krakow, Poland; [Misztak, Paulina; Nowak, Gabriel] Jagiellonian Univ, Chair Pharmacobiol, Med Coll, Krakow, Poland; [Panczyszyn-Trzewik, Patrycja; Sowa-Kucma, Magdalena] Rzeszow Univ, Inst Med Sci, Dept Human Physiol, Med Coll, Rzeszow, Poland	Polish Academy of Sciences; Maj Institute of Pharmacology of the Polish Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Rzeszow	Sowa-Kucma, M (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Neurobiol, Krakow, Poland.; Sowa-Kucma, M (corresponding author), Rzeszow Univ, Inst Med Sci, Dept Human Physiol, Med Coll, Rzeszow, Poland.	msowa@ur.edu.pl		Sowa-Kucma, Magdalena/0000-0001-5956-7229; Misztak, Paulina/0000-0002-7232-3162; Panczyszyn-Trzewik, Patrycja/0000-0001-8760-7494; Nowak, Gabriel/0000-0002-3000-7938	National Science Centre [UMO-2013/09/D/NZ7/02520]; Medical College of Rzeszow University (Rzeszow, Poland)	National Science Centre(National Science Centre, Poland); Medical College of Rzeszow University (Rzeszow, Poland)	The study was partially supported by grant from the National Science Centre (contract UMO-2013/09/D/NZ7/02520 to M. Sowa-Kucma) and funds of the Medical College of Rzeszow University (Rzeszow, Poland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors appreciate the immense contribution of people (or their families) who donated brain tissue for research purposes. We would also like to thank the staff of Department of Forensic Medicine, Jagiellonian University Medical College and Institute of Forensic Research in Krakow for tissue acquisition during autopsy.	[Anonymous], 2016, LANCET ONCOL, V17, pe198; Ausio J, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0214-5; Banerjee R, 2013, CLIN MED INSIGHTS-PA, V6, P1, DOI 10.4137/CMPath.S12530; Bani-Fatemi A, 2016, NEUROPSYCHOBIOLOGY, V73, P10, DOI 10.1159/000441191; Gonzalez-Castro TB, 2017, J PSYCHIATR RES, V94, P208, DOI 10.1016/j.jpsychires.2017.07.020; Bello O, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00245; Bjorkholm C, 2016, NEUROPHARMACOLOGY, V102, P72, DOI 10.1016/j.neuropharm.2015.10.034; Block SG, 2014, ASIAN J PSYCHIATR, V12, P7, DOI 10.1016/j.ajp.2014.09.001; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chandramohan Y, 2008, EUR J NEUROSCI, V27, P2701, DOI 10.1111/j.1460-9568.2008.06230.x; Chen KW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030571; Cieslik K, 2011, PHARMACOL REP, V63, P537; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Covington HE, 2011, NEUROSCI LETT, V493, P122, DOI 10.1016/j.neulet.2011.02.022; Covington HE, 2009, J NEUROSCI, V29, P11451, DOI 10.1523/JNEUROSCI.1758-09.2009; Damen D, 2013, BIOL CHEM, V394, P1595, DOI 10.1515/hsz-2013-0193; Deng JV, 2018, NEUROSCIENCE, V369, P212, DOI 10.1016/j.neuroscience.2017.11.016; Eisen RB, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0179-z; Ernst C, 2009, ARCH GEN PSYCHIAT, V66, P22, DOI 10.1001/archpsyc.66.1.22; Ferland CL, 2011, NEUROSCIENCE, V174, P104, DOI 10.1016/j.neuroscience.2010.10.077; Fiori LM, 2011, INT J NEUROPSYCHOPH, V14, P595, DOI 10.1017/S1461145710001574; Gates LA, 2017, J BIOL CHEM, V292, P14456, DOI 10.1074/jbc.M117.802074; Gili M, 2019, J AFFECT DISORDERS, V245, P152, DOI 10.1016/j.jad.2018.10.115; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Hing B, 2018, AM J MED GENET B, V177, P143, DOI 10.1002/ajmg.b.32616; Hing B, 2012, BIOL PSYCHIAT, V71, P618, DOI 10.1016/j.biopsych.2011.11.030; Hobara T, 2010, J PSYCHIATR RES, V44, P263, DOI 10.1016/j.jpsychires.2009.08.015; Hollis F, 2011, HORM BEHAV, V59, P331, DOI 10.1016/j.yhbeh.2010.09.005; Hutchinson AN, 2012, J NEUROSCI, V32, P14355, DOI 10.1523/JNEUROSCI.2156-12.2012; Hutchinson AN, 2012, NEUROPSYCHOPHARMACOL, V37, P321, DOI 10.1038/npp.2011.190; Jamaladdin S, 2014, P NATL ACAD SCI USA, V111, P9840, DOI 10.1073/pnas.1321330111; Januar V, 2015, INT J EPIDEMIOL, V44, P1364, DOI 10.1093/ije/dyu273; Jokinen J, 2018, ACTA PSYCHIAT SCAND, V137, P287, DOI 10.1111/acps.12842; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Karpova NN, 2014, NEUROPHARMACOLOGY, V76, P709, DOI 10.1016/j.neuropharm.2013.04.002; Kishi T, 2018, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00308; Kouter K, 2019, J AFFECT DISORDERS, V253, P419, DOI 10.1016/j.jad.2019.04.077; Labonte B, 2012, ARCH GEN PSYCHIAT, V69, P722, DOI 10.1001/archgenpsychiatry.2011.2287; Lee BH, 2010, J AFFECT DISORDERS, V125, P369, DOI 10.1016/j.jad.2010.01.074; Liu D, 2014, EXP BIOL MED, V239, P330, DOI 10.1177/1535370213513987; Lutz PE, 2017, MOL PSYCHIATR, V22, P1395, DOI 10.1038/mp.2017.141; Maheu ME, 2013, J PSYCHIATR RES, V47, P384, DOI 10.1016/j.jpsychires.2012.11.013; Mandelli L, 2013, NEUROSCI BIOBEHAV R, V37, P2375, DOI 10.1016/j.neubiorev.2013.07.011; Maussion G, 2014, EPIGENETICS-US, V9, P1061, DOI 10.4161/epi.29068; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Misztak P, 2018, PHARMACOL REP, V70, P398, DOI 10.1016/j.pharep.2017.08.001; Morris MJ, 2013, J NEUROSCI, V33, P6401, DOI 10.1523/JNEUROSCI.1001-12.2013; Mullins N, 2019, AM J PSYCHIAT, V176, P651, DOI 10.1176/appi.ajp.2019.18080957; Murphy TM, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.249; Nakagawa Y, 2019, J ORAL SCI, V61, P516, DOI 10.2334/josnusd.18-0409; O'Rourke N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187632; Otsuka I, 2019, NEUROPSYCHOPHARMACOL, V44, P2119, DOI 10.1038/s41386-019-0506-5; Policicchio S, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0752-7; Poulter MO, 2008, BIOL PSYCHIAT, V64, P645, DOI 10.1016/j.biopsych.2008.05.028; Radley JJ, 2011, STRESS, V14, P481, DOI 10.3109/10253890.2011.604751; Rafalo-Ulinska A, 2016, J PSYCHIATR RES, V83, P220, DOI 10.1016/j.jpsychires.2016.09.008; Reul JMHM, 2007, PSYCHONEUROENDOCRINO, V32, pS21, DOI 10.1016/j.psyneuen.2007.03.016; Roy B, 2017, NEUROSCI BIOBEHAV R, V72, P10, DOI 10.1016/j.neubiorev.2016.10.031; Salas-Magana M, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.706; Schneider E, 2015, CYTOGENET GENOME RES, V146, P19, DOI 10.1159/000435778; Sonal A, 2018, ASIAN J PSYCHIATR, V33, P128, DOI 10.1016/j.ajp.2018.03.004; Sowa-Kucma M, 2008, J NEURAL TRANSM, V115, P1621, DOI 10.1007/s00702-008-0115-7; Sowa-Kucma M, 2013, J AFFECT DISORDERS, V151, P924, DOI 10.1016/j.jad.2013.08.009; Strawbridge RJ, 2019, EBIOMEDICINE, V41, P517, DOI 10.1016/j.ebiom.2019.02.005; Sun HS, 2013, NEUROPSYCHOPHARMACOL, V38, P124, DOI 10.1038/npp.2012.73; Tripp A, 2012, AM J PSYCHIAT, V169, P1194, DOI 10.1176/appi.ajp.2012.12020248; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Turecki G, 2014, NAT REV NEUROSCI, V15, P802, DOI 10.1038/nrn3839; Youssef MM, 2018, INT J NEUROPSYCHOPH, V21, P528, DOI 10.1093/ijnp/pyy008; Zaletel I, 2017, REV NEUROSCIENCE, V28, P675, DOI 10.1515/revneuro-2016-0072; Zhao MZ, 2018, J AFFECT DISORDERS, V227, P226, DOI 10.1016/j.jad.2017.10.024; Zheng Y, 2016, EPIGENETICS-US, V11, P150, DOI 10.1080/15592294.2016.1146850	75	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239335	10.1371/journal.pone.0239335	http://dx.doi.org/10.1371/journal.pone.0239335			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970734	Green Published, gold			2022-12-26	WOS:000576265600021
J	Park, Y; Cho, KJ				Park, Yuli; Cho, Kyong Jin			Outcome of phacoemulsification in patients with open-angle glaucoma after selective laser trabeculoplasty	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE CONTROL; TRABECULAR MESHWORK; CATARACT-SURGERY; REDUCTION; EYES	Purpose To investigate the outcome of phacoemulsification in selective laser trabeculoplasty (SLT)-treated eyes. Methods This retrospective study included patients who had open angle glaucoma (OAG) with previous SLT who underwent phacoemulsification. We evaluated intraocular pressure (IOP), length of glaucoma control without treatment, and antiglaucoma medication or surgery. SLT-treated eyes that did not receive phacoemulsification were retrospectively chosen as a control. We investigated factors related to outcome of phacoemulsification by multivariate analysis. Results 42 eyes with previous SLT that underwent phacoemulsification and 40 controls were retrospectively evaluated. Phacoemulsification was performed 52 +/- 15 months after SLT. After a mean follow-up of 74 +/- 21 months, mean IOP was significantly decreased in the phaco group by 2.2 +/- 2.7 mmHg (p< 0.001). In the SLT group, mean IOP was decreased by 0.8 +/- 2.8 mmHg (p< 0.001). 9 eyes (16.7%) in the phaco group and 11 eyes (19.0%) of the SLT group needed topical treatment, and no eye needed glaucoma surgery in both groups. The factor related to success was higher baseline IOP (p= 0.002). Conclusion Prior SLT didn't negatively influence phacoemulsification in patients with OAG. Phacoemulsification lowered IOP effectively and safely in OAG patients who were treated with SLT.	[Park, Yuli; Cho, Kyong Jin] Dankook Univ, Dankook Univ Hosp, Coll Med, Dept Ophthalmol, Cheonan, South Korea; [Cho, Kyong Jin] Dankook Univ, Beckman Laser Inst Korea, Cheonan, South Korea	Dankook University; Dankook University Hospital; Dankook University	Cho, KJ (corresponding author), Dankook Univ, Dankook Univ Hosp, Coll Med, Dept Ophthalmol, Cheonan, South Korea.; Cho, KJ (corresponding author), Dankook Univ, Beckman Laser Inst Korea, Cheonan, South Korea.	perfectcure@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2019R1I1A3A01059102]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	KJC received the award. - This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2019R1I1A3A01059102). -http://english.moe.go.kr/main.do?s=english -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P731, DOI 10.1001/archophthalmol.2010.85; Ansari Ejaz, 2013, J Curr Glaucoma Pract, V7, P17, DOI 10.5005/jp-journals-10008-1131; Asrani S, 2000, J GLAUCOMA, V9, P134; Berdahl JP, 2009, MIDDLE EAST AFR J OP, V16, P119, DOI 10.4103/0974-9233.56222; Chen PP, 2015, OPHTHALMOLOGY, V122, P1294, DOI 10.1016/j.ophtha.2015.03.021; Cvenkel B, 2003, LASER SURG MED, V33, P204, DOI 10.1002/lsm.10203; Kramer TR, 2001, OPHTHALMOLOGY, V108, P773, DOI 10.1016/S0161-6420(00)00660-6; Lai JSM, 2006, J GLAUCOMA, V15, P47, DOI 10.1097/01.ijg.0000196619.34368.0a; LATINA MA, 1995, EXP EYE RES, V60, P359, DOI 10.1016/S0014-4835(05)80093-4; Latina Mark A, 2002, Curr Opin Ophthalmol, V13, P94, DOI 10.1097/00055735-200204000-00007; Liu CJL, 2011, J GLAUCOMA, V20, P566, DOI 10.1097/IJG.0b013e3181efe1e9; Longo A, 2015, EYE, V29, P1347, DOI 10.1038/eye.2015.108; Majstruk L, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1157-3; Mathalone N, 2005, J CATARACT REFR SURG, V31, P479, DOI 10.1016/j.jcrs.2004.06.046; McAlinden C, 2014, EYE, V28, P249, DOI 10.1038/eye.2013.267; Melamed S, 2003, ARCH OPHTHALMOL-CHIC, V121, P957, DOI 10.1001/archopht.121.7.957; Mierzejewski Andrzej, 2008, Klin Oczna, V110, P11; Nagar M, 2009, BRIT J OPHTHALMOL, V93, P497, DOI 10.1136/bjo.2008.148510; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Sharpe RA, 2018, INT J OPHTHALMOL-CHI, V11, P71, DOI 10.18240/ijo.2018.01.13; Slabaugh MA, 2014, AM J OPHTHALMOL, V157, P26, DOI 10.1016/j.ajo.2013.08.023; Strenk SA, 2010, J CATARACT REFR SURG, V36, P235, DOI 10.1016/j.jcrs.2009.08.029; Tran VT, 2015, INT OPHTHALMOL, V35, P209, DOI 10.1007/s10792-014-9934-8; Tu KL, 2007, MOL VIS, V13, P1130; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; VANBUSKIRK EM, 1984, OPHTHALMOLOGY, V91, P1005; Wang N, 2003, INVEST OPHTH VIS SCI, V44, P1977, DOI 10.1167/iovs.02-0631; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Xu HP, 2011, INVEST OPHTH VIS SCI, V52, P249, DOI 10.1167/iovs.10-6001	30	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238394	10.1371/journal.pone.0238394	http://dx.doi.org/10.1371/journal.pone.0238394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970691	Green Published, gold			2022-12-26	WOS:000576265600043
J	Lee, BH; Hwang, YJ; Kim, JW				Lee, Byung Hoon; Hwang, Yoon Joon; Kim, Jin Woo			Delayed phase computed tomography angiography ASPECTS predicts clinical outcome and final infarct volume	PLOS ONE			English	Article							INDIVIDUAL PATIENT DATA; EARLY CT SCORE; ISCHEMIC-STROKE; SOURCE IMAGES; ENDOVASCULAR THROMBECTOMY; PERFUSION; RECANALIZATION; EXTENT; THROMBOLYSIS; METAANALYSIS	Background and purpose Non-contrast computed tomography (NCCT) Alberta Stroke Program Early CT Score (ASPECTS) and assessment of collateral flow with multiphase computed tomography angiography (CTA) have been investigated as predictors of clinical outcome in patients with acute ischemic stroke. This study assessed the value of multiphase CTA ASPECTS in predicting final infarction core and clinical outcome in patients undergoing endovascular treatment of acute ischemic stroke. Methods We retrospectively studied consecutive patients who underwent multiphase CTA prior to endovascular treatment of acute stroke due to anterior circulation large artery occlusion. Multiphase CTA and final diffusion-weighted imaging (DWI) scans were evaluated by two independent observers for NCCT ASPECTS, acute phase CTA (CTA-AP) ASPECTS, delayed phase CTA (CTA-DP) ASPECTS, and final DWI ASPECTS. Modified Rankin Scale score <= 2 at 3 months was considered a favorable outcome. Results A total of 74 patients were analyzed. We found that CTA-DP ASPECTS (r= 0.82; 95% CI, 0.73-0.91; p < 0.001) correlated with final DWI ASPECTS better than NCCT ASPECTS (r= 0.49; 95% CI, 0.39-0.59) and CTA-AP ASPECTS (r= 0.71; 95% CI, 0.64-0.78). Interobserver agreement was higher for CTA-DP ASPECTS (k= 0.84). Good CTA-DP ASPECTS was an independent predictor of favorable outcome (odds ratio, 8.71; 95% CI, 3.71-17.3; p < 0.001). Conclusion CTA-DP ASPECTS is a reliable predictor of final infarction core and neurological outcome.	[Lee, Byung Hoon; Hwang, Yoon Joon] Inje Univ, Ilsan Paik Hosp, Dept Radiol, Goyang, South Korea; [Kim, Jin Woo] Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea	Inje University; Yonsei University; Yonsei University Health System	Kim, JW (corresponding author), Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.	sunny-cocktail@hanmail.net		Lee, Byunghoon/0000-0003-4481-7859; Kim, Jin woo/0000-0003-3155-0569				Albers GW, 2018, NEW ENGL J MED, V378, P708, DOI 10.1056/NEJMoa1713973; Aviv RI, 2007, CLIN RADIOL, V62, P447, DOI 10.1016/j.crad.2006.11.019; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Campbell BCV, 2016, STROKE, V47, P798, DOI 10.1161/STROKEAHA.115.012360; Coutts SB, 2004, STROKE, V35, P2472, DOI 10.1161/01.STR.0000145330.14928.2a; Dzialowski I, 2006, STROKE, V37, P973, DOI 10.1161/01.STR.0000206215.62441.56; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Hwang YH, 2015, AM J NEURORADIOL, V36, P495, DOI 10.3174/ajnr.A4151; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Kawiorski MM, 2016, NEURORADIOLOGY, V58, P487, DOI 10.1007/s00234-016-1652-7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lansberg MG, 2017, ANN NEUROL, V81, P849, DOI 10.1002/ana.24953; Lev MH, 1999, RADIOLOGY, V213, P150, DOI 10.1148/radiology.213.1.r99oc10150; Lev MH, 2001, STROKE, V32, P2021, DOI 10.1161/hs0901.095680; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Menon BK, 2015, STROKE, V46, P1453, DOI 10.1161/STROKEAHA.115.009160; Menon BK, 2015, RADIOLOGY, V275, P510, DOI 10.1148/radiol.15142256; Menon BK, 2011, NEUROIMAG CLIN N AM, V21, P407, DOI 10.1016/j.nic.2011.01.007; Nambiar V, 2014, AM J NEURORADIOL, V35, P884, DOI 10.3174/ajnr.A3817; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Sallustio F, 2017, AM J NEURORADIOL, V38, P1569, DOI 10.3174/ajnr.A5264; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schramm P, 2002, STROKE, V33, P2426, DOI 10.1161/01.STR.0000032244.03134.37; Smit EJ, 2013, STROKE, V44, P2194, DOI 10.1161/STROKEAHA.111.000675	29	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239510	10.1371/journal.pone.0239510	http://dx.doi.org/10.1371/journal.pone.0239510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960912	Green Published, gold			2022-12-26	WOS:000575109500044
J	Ricker, M; Gutierrez-Garcia, G; Juarez-Guerrero, D; Evans, MEK				Ricker, Martin; Gutierrez-Garcia, Genaro; Juarez-Guerrero, David; Evans, Margaret E. K.			Statistical age determination of tree rings	PLOS ONE			English	Article							GROWTH; CLIMATE; FREQUENCY; SERIES	Dendrochronology, the study of annual rings formed by trees and woody plants, has important applications in research of climate and environmental phenomena of the past. Since its inception in the late 19(th)century, dendrochronology has not had a way to quantify uncertainty about the years assigned to each ring (dating). There are, however, many woody species and sites where it is difficult or impossible to delimit annual ring boundaries and verify them with crossdating, especially in the lowland tropics. Rather than ignoring dating uncertainty or discarding such samples as useless, we present for the first time a probabilistic approach to assign expected ages with a confidence interval. It is proven that the cumulative age in a tree-ring time series advances by an amount equal to the probability that a putative growth boundary is truly annual. Confidence curves for the tree stem radius as a function of uncertain ages are determined. A sensitivity analysis shows the effect of uncertainty of the probability that a recognizable boundary is annual, as well as of the number of expected missing boundaries. Furthermore, we derive a probabilistic version of the mean sensitivity of a dendrochronological time series, which quantifies a tree's sensitivity to environmental variation over time, as well as probabilistic versions of the autocorrelation and process standard deviation. A computer code inMathematicais provided, with sample input files, as supporting information. Further research is necessary to analyze frequency patterns of false and missing boundaries for different species and sites.	[Ricker, Martin; Juarez-Guerrero, David] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico; [Gutierrez-Garcia, Genaro] Univ Nacl Autonoma Mexico, Inst Geol, Dept Ciencias Ambientales & Suelo, Mexico City, DF, Mexico; [Evans, Margaret E. K.] Univ Arizona, Tree Ring Bldg, Tucson, AZ USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Arizona	Ricker, M (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City, DF, Mexico.	mricker@ib.unam.mx	Gutierrez-Garcia, Genaro/C-2413-2009	Gutierrez-Garcia, Genaro/0000-0003-2299-1194	Office of Research, Discovery & Innovation (RDI); UA Global, University of Arizona; United States Forest Service	Office of Research, Discovery & Innovation (RDI); UA Global, University of Arizona; United States Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	Our discussion about probabilistic age determination started at a meeting to establish a North American Forest Inventory and Tree-Ring Data Network, with funding from the Office of Research, Discovery & Innovation (RDI) and UA Global, University of Arizona, as well as the United States Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, J PHYS CHEM SOLIDS, V94, P1; [Anonymous], 2008, CANC S8, V113, pi; Baker JCA, 2017, TREES-STRUCT FUNCT, V31, P1999, DOI 10.1007/s00468-017-1604-9; Black BA, 2016, GLOBAL CHANGE BIOL, V22, P2582, DOI 10.1111/gcb.13256; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Bunn AG, 2013, DENDROCHRONOLOGIA, V31, P250, DOI 10.1016/j.dendro.2013.01.004; Cook ER, 1992, METHODS DENDROCHRONO; Copenheaver CA, 2006, FOREST ECOL MANAG, V236, P348, DOI 10.1016/j.foreco.2006.09.020; Brandes AFD, 2016, ACTA BOT BRAS, V30, P383, DOI 10.1590/0102-33062016abb0101; DOUGLASS A. E., 1941, JOUR FOREST, V39, P825; Douglass AE, 1920, ECOLOGY, V1, P24, DOI 10.2307/1929253; Douglass AE, 1936, USITC PUBL, V289; Fritts HC, 2001, TREE RINGS CLIMATE; Grundmann BM, 2008, DENDROCHRONOLOGIA, V26, P109, DOI 10.1016/j.dendro.2008.05.002; Gutierrez-Garcia G., 2014, THESIS; Hamming R. W, 1991, ART PROBABILITY SCIE; HOGG RV, 1993, PROBABILITY STAT INF; Kulahci M, 2008, INTRO TIME SERIES AN; Loader NJ, 2019, J QUATERNARY SCI, V34, P475, DOI 10.1002/jqs.3115; Lorimer CG, 1999, PLANT ECOL, V143, P189, DOI 10.1023/A:1009847819158; Makinen H, 2008, EUR J FOREST RES, V127, P235, DOI 10.1007/s10342-007-0199-x; Metsaranta JM, 2018, FOREST ECOL MANAG, V429, P57, DOI 10.1016/j.foreco.2018.06.040; Morrongiello JR, 2012, NAT CLIM CHANGE, V2, P849, DOI [10.1038/NCLIMATE1616, 10.1038/nclimate1616]; Ohashi S, 2009, TREES-STRUCT FUNCT, V23, P813, DOI 10.1007/s00468-009-0322-3; Pons TL, 2011, TREES-STRUCT FUNCT, V25, P83, DOI 10.1007/s00468-010-0527-5; Ricker M, 1999, ECOL ECON, V31, P439, DOI 10.1016/S0921-8009(99)00068-3; Schongart J, 2017, ECOL STUD-ANAL SYNTH, V231, P35, DOI 10.1007/978-3-319-61669-8_3; Seselj M, 2017, AM J PHYS ANTHROPOL, V163, P531, DOI 10.1002/ajpa.23228; Silva MD, 2019, BIOL REV, V94, P1161, DOI 10.1111/brv.12495; Sokal R. R., 2012, BIOMETRY; Speer JH, 2010, FUNDAMENTALS TREE RI; St George S, 2013, GEOPHYS RES LETT, V40, P3727, DOI 10.1002/grl.50743; Strackee J., 1992, Dendrochronologia, P121; Vaganov E. A., 2006, GROWTH DYNAMICS CONI; Vieira S, 2005, P NATL ACAD SCI USA, V102, P18502, DOI 10.1073/pnas.0505966102; Woodward HN, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P195; WORBES M, 1989, ECOLOGY, V70, P503, DOI 10.2307/1937554; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018	38	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239052	10.1371/journal.pone.0239052	http://dx.doi.org/10.1371/journal.pone.0239052			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960924	Green Published, gold			2022-12-26	WOS:000575109500031
J	Robbins, AS; Pathak, SR; Webber, BJ; Erich, RA; Escobar, JD; Simon, AA; Stahlman, SL; Gambino-Shirley, KJ				Robbins, Anthony S.; Pathak, Sonal R.; Webber, Bryant J.; Erich, Roger A.; Escobar, James D.; Simon, Alisa A.; Stahlman, Shauna L.; Gambino-Shirley, Kelly J.			Malignancy in US Air Force fighter pilots and other officers, 1986-2017: A retrospective cohort study	PLOS ONE			English	Article							AIRLINE CABIN CREW; CANCER INCIDENCE; RADIATION-EXPOSURE; UNITED-STATES; HEALTH; ENVIRONMENT; MORTALITY; PERSONNEL; AVIATORS; REGISTRY	Objective This study sought to determine the incidence rates of cancer, overall and by site, among active component U.S. Air Force fighter pilots, and to compare the rates with those in other active component Air Force officers. Methods Using a matched retrospective cohort design, U.S. Air Force fighter pilots were compared with other commissioned officers who entered active component service between 1 January 1986 and 31 December 2006. The cohort was followed for cancer diagnoses in TRICARE and the Veterans Health Administration from 1 October 1995 through 31 December 2017. Fighter pilots and non-fighter pilot officers were compared after matching on sex, age at first observation (15 age groups), and age at last observation (15 age groups). Sex-stratified overall and site-specific cancer rates were compared with matched Poisson regression to determine incidence rate ratios with 95% confidence intervals. Results During 1,412,590 person-years of follow-up, among the study population of 88,432 service members (4,949 fighter pilots and 83,483 matched officers), 977 incident cancer cases were diagnosed (86 in fighter pilots and 891 in matched officers). Male fighter pilots and matched officers had similar rates of all malignant cancers (RR = 1.04; 95% CI: 0.83-1.31) and of each cancer site. Female fighter pilots and matched officers also had similar rates of all malignant cancers (RR = 0.99; 95% CI: 0.25-4.04). Discussion In the active component U.S. Air Force, fighter pilots and their officer peers had similar overall and site-specific cancer rates.	[Robbins, Anthony S.; Webber, Bryant J.; Escobar, James D.; Simon, Alisa A.; Gambino-Shirley, Kelly J.] US Air Force Sch Aerosp Med, Publ Hlth & Prevent Med Dept, Wright Patterson AFB, OH USA; [Pathak, Sonal R.] DataRev LLC, Atlanta, GA USA; [Pathak, Sonal R.] Solut Innovat Technol Inc, Fairborn, OH USA; [Erich, Roger A.] US Air Force Sch Aerosp Med, Aerosp Med Dept, Wright Patterson AFB, OH USA; [Stahlman, Shauna L.] Armed Forces Hlth Surveillance Branch, Silver Spring, MD USA		Robbins, AS (corresponding author), US Air Force Sch Aerosp Med, Publ Hlth & Prevent Med Dept, Wright Patterson AFB, OH USA.	anthony.robbins.5@us.af.mil	Webber, Bryant/ABI-7744-2020	Webber, Bryant/0000-0002-2099-2671				Air Force Personnel Center, NTR; [Anonymous], 2019, CA-CANCER J CLIN, DOI [DOI 10.3322/CAAC.21551, DOI 10.3322/caac.21551]; Ballard T, 2000, AVIAT SPACE ENVIR MD, V71, P216; Band PR, 1996, AM J EPIDEMIOL, V143, P137; Department of Veterans Affairs, NTR; Erich R, 2016, MIL MED, V181, P821, DOI 10.7205/MILMED-D-15-00310; Grayson JK, 1996, AVIAT SPACE ENVIR MD, V67, P1152; Grayson JK, 1996, AVIAT SPACE ENVIR MD, V67, P101; Gudmundsdottir EM, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0295-4; Hammar N, 2002, AVIAT SPACE ENVIR MD, V73, P2; Laughrey MS, 2003, AVIAT SPACE ENVIR MD, V74, P851; Lea CS, 2014, MIL MED, V179, P247, DOI 10.7205/MILMED-D-13-00356; Lee Terrence, 2016, MSMR, V23, P23; Linnersjo A, 2003, OCCUP ENVIRON MED, V60, P810, DOI 10.1136/oem.60.11.810; Nakagawara VBMR., 2007, OPTICAL RAD TRANSMIT; National Cancer Institute, NTR; Pukkala E, 2002, BRIT MED J, V325, P567, DOI 10.1136/bmj.325.7364.567; Rogers D, 2011, AVIAT SPACE ENVIR MD, V82, P1067, DOI 10.3357/ASEM.3090.2011; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Schoenfeld AJ, 2018, JAMA SURG, V153, P679, DOI 10.1001/jamasurg.2018.0480; Sihver L, 2015, RADIAT PROT DOSIM, V164, P477, DOI 10.1093/rpd/ncv330; U.S. Air Force, NTR; U.S. Department of Defense, NTR; Ward E, 2004, CA-CANCER J CLIN, V54, P78, DOI 10.3322/canjclin.54.2.78; Webber BJ, 2019, ARMED FORCES MSMR, V26, P18; Wollschlager D, 2018, J EXPO SCI ENV EPID, V28, P275, DOI 10.1038/jes.2017.21; Yamane GK, 2003, AVIAT SPACE ENVIR MD, V74, P846; Zhu KM, 2009, CANCER EPIDEM BIOMAR, V18, P1740, DOI 10.1158/1055-9965.EPI-09-0041; Zullig LL, 2017, MIL MED, V182, pE1883, DOI 10.7205/MILMED-D-16-00371	29	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239437	10.1371/journal.pone.0239437	http://dx.doi.org/10.1371/journal.pone.0239437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960918	gold, Green Published			2022-12-26	WOS:000575109500037
J	Dalen, T; Aune, TK; Hjelde, GH; Ettema, G; Sandbakk, O; McGhie, D				Dalen, Terje; Aune, Tore Kristian; Hjelde, Geir Havard; Ettema, Gertjan; Sandbakk, Oyvind; McGhie, David			Player load in male elite soccer: Comparisons of patterns between matches and positions	PLOS ONE			English	Article							TRAINING LOAD; PERFORMANCE; ACCELERATION; FATIGUE; DECELERATION; VARIABILITY; PROFILES; DEMANDS; TEAM	Our primary aim was to explore the development of player load throughout match time (i.e., the pattern) using moving 5-min windows in an elite soccer team and our secondary aim was to compare player load patterns between different positions within the same team. The dataset included domestic home matches (n = 34) over three seasons for a Norwegian Elite League team. Player movements (mean +/- SD age 25.5 +/- 4.2 years, height 183.6 +/- 6.6 cm, body mass 78.9 +/- 7.4 kg) were recorded at 20 Hz using body-worn sensors. Data for each variable (player load, player load per meter, total distance, accelerations, decelerations, sprint distance, high-intensity running distance) were averaged within positions in each match, converted to z-scores and averaged across all matches, yielding one time series for each variable for each position. Pattern similarity between positions was assessed with cross-correlations. Overall, we observed a distinct pattern in player load throughout match time, which also occurred in the majority of individual matches. The pattern shows peaks at regular intervals (similar to 15 min), each followed by a period of lower load, declining until the next peak. The same pattern was evident in player load per meter. The cross-correlation analyses support the visual evidence, with correlations ranging 0.88-0.97 (p <.001) in all position pairs. In contrast, no specific patterns were discernible in total distance, accelerations, decelerations, sprint distance and high-intensity running distance, with cross-correlations ranging 0.65-0.89 (p <.001), 0.32-0.64 (p <.005), 0.18-0.65 (p <.005 in nine position pairs), 0.02-0.38 (p <.05 in three pairs) and 0.01-0.52 (p <.05 in three pairs), respectively. This study demonstrated similarity in player load patterns between both matches and positions in elite soccer competition, which could indicate a physical "pacing pattern" employed by the team.	[Dalen, Terje; Aune, Tore Kristian] Nord Univ, Dept Phys Educ & Sport Sci, Levanger, Norway; [Hjelde, Geir Havard] Rosenborg FC, Trondheim, Norway; [Ettema, Gertjan; Sandbakk, Oyvind; McGhie, David] Norwegian Univ Sci & Technol, Ctr Elite Sports Res, Dept Neuromed & Movement Sci, Trondheim, Norway	Nord University; Norwegian University of Science & Technology (NTNU)	Dalen, T (corresponding author), Nord Univ, Dept Phys Educ & Sport Sci, Levanger, Norway.	terje.dalen@nord.no		Dalen, Terje/0000-0002-3073-4182	Rosenborg FC	Rosenborg FC	The funder (Rosenborg FC) provided support in the form of salaries for author [G.H.H.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akenhead R, 2013, J SCI MED SPORT, V16, P556, DOI 10.1016/j.jsams.2012.12.005; Barrett S, 2016, J SCI MED SPORT, V19, P810, DOI 10.1016/j.jsams.2015.12.514; Barrett S, 2016, INT J SPORT PHYSIOL, V11, P135, DOI 10.1123/ijspp.2014-0582; Barrett S, 2014, INT J SPORT PHYSIOL, V9, P945, DOI 10.1123/ijspp.2013-0418; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Bradley PS, 2010, J STRENGTH COND RES, V24, P2343, DOI 10.1519/JSC.0b013e3181aeb1b3; Bradley PS, 2009, J SPORT SCI, V27, P159, DOI 10.1080/02640410802512775; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Carling C, 2016, J SPORT SCI, V34, P2215, DOI 10.1080/02640414.2016.1176228; Carling C, 2013, SPORTS MED, V43, P655, DOI 10.1007/s40279-013-0055-8; Casamichana D, 2013, J STRENGTH COND RES, V27, P369, DOI 10.1519/JSC.0b013e3182548af1; Dalen T, 2019, EUR J SPORT SCI, V19, P1015, DOI 10.1080/17461391.2019.1566403; Dalen T, 2018, OPEN ACCESS J SPORTS, V9, P107, DOI 10.2147/OAJSM.S167347; Dalen T, 2016, J STRENGTH COND RES, V30, P351, DOI 10.1519/JSC.0000000000001063; Drust B, 2007, SPORTS MED, V37, P783, DOI 10.2165/00007256-200737090-00003; Gaudino P, 2015, INT J SPORT PHYSIOL, V10, P860, DOI 10.1123/ijspp.2014-0518; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Haken H, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19010018; Harper DJ, 2019, SPORTS MED, V49, P1923, DOI 10.1007/s40279-019-01170-1; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Ingebrigtsen J, 2015, EUR J SPORT SCI, V15, P101, DOI 10.1080/17461391.2014.933879; Ingebrigtsen J, 2012, J SPORT SCI, V30, P1337, DOI 10.1080/02640414.2012.711484; Krustrup P., 2009, P 6 WORLD C SCI FOOT, P205; Mallo J, 2008, J SPORT MED PHYS FIT, V48, P166; Mohr M, 2005, J SPORT SCI, V23, P593, DOI 10.1080/02640410400021286; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Rebelo A, 2012, INT J SPORTS MED, V33, P297, DOI 10.1055/s-0031-1297952; Santos FP, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18040152; Schmidt R. A., 1996, ADV MOTOR LEARNING C, P195; Scott BR, 2013, INT J SPORT PHYSIOL, V8, P195, DOI 10.1123/ijspp.8.2.195; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Varley MC, 2012, INT J SPORT PHYSIOL, V7, P183, DOI 10.1123/ijspp.7.2.183; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6; Wehbe GM, 2014, J STRENGTH COND RES, V28, P834, DOI 10.1519/JSC.0b013e3182a35dd1	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239162	10.1371/journal.pone.0239162	http://dx.doi.org/10.1371/journal.pone.0239162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956408	gold, Green Published			2022-12-26	WOS:000574571500005
J	Hu, ZY; Du, DP				Hu, Zhiyong; Du, Dongping			A new analytical framework for missing data imputation and classification with uncertainty: Missing data imputation and heart failure readmission prediction	PLOS ONE			English	Article							PATIENT; MODELS	Background The wide adoption of electronic health records (EHR) system has provided vast opportunities to advance health care services. However, the prevalence of missing values in EHR system poses a great challenge on data analysis to support clinical decision-making. The objective of this study is to develop a new methodological framework that can address the missing data challenge and provide a reliable tool to predict the hospital readmission among Heart Failure patients. Methods We used Gaussian Process Latent Variable Model (GPLVM) to impute the missing values. Specifically, a lower dimensional embedding was learned from a small complete dataset and then used to impute the missing values in the incomplete dataset. The GPLVM-based missing data imputation can provide both the mean estimate and the uncertainty associated with the mean estimate. To incorporate the uncertainty in prediction, a constrained support vector machine (cSVM) was developed to obtain robust predictions. We first sampled multiple datasets from the distributions of input uncertainty and trained a support vector machine for each dataset. Then an optimal classifier was identified by selecting the support vectors that maximize the separation margin of a newly sampled dataset and minimize the similarity with the pre-trained support vectors. Results The proposed model was derived and validated using Physionet MIMIC-III clinical database. The GPLVM imputation provided normalized mean absolute errors of 0.11 and 0.12 respectively when 20% and 30% of instances contained missing values, and the confidence bounds of the estimations captures 97% of the true values. The cSVM model provided an average Area Under Curve of 0.68, which improves the prediction accuracy by 7% as compared to some existing classifiers. Conclusions The proposed method provides accurate imputation of missing values and has a better prediction performance as compared to existing models that can only deal with deterministic inputs.	[Hu, Zhiyong; Du, Dongping] Texas Tech Univ, Dept Ind Mfg & Syst Engn, Lubbock, TX 79409 USA	Texas Tech University System; Texas Tech University	Du, DP (corresponding author), Texas Tech Univ, Dept Ind Mfg & Syst Engn, Lubbock, TX 79409 USA.	dongping.du@ttu.edu			National Science Foundation [CMMI-1728338]	National Science Foundation(National Science Foundation (NSF))	DD receives funding from National Science Foundation (https://www.nsf.gov/) with grant number CMMI-1728338 for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; Awan SE, 2019, ESC HEART FAIL, V6, P428, DOI 10.1002/ehf2.12419; Beaulieu-Jones BK, 2018, JMIR MED INF, V6, DOI 10.2196/medinform.8960; Blei DM, 2017, J AM STAT ASSOC, V112, P859, DOI 10.1080/01621459.2017.1285773; Bradford C, 2017, RES SOC ADMIN PHARM, V13, P1070, DOI 10.1016/j.sapharm.2016.11.002; Brown SES, 2013, MED CARE, V51, P706, DOI 10.1097/MLR.0b013e318293c2fa; Calvert J, 2017, J MED ECON, V20, P646, DOI 10.1080/13696998.2017.1307203; Choi Youngduck, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P41; Codella J, 2019, 2019 IEEE INT C HEAL, P1, DOI DOI 10.1109/ICHI.2019.8904779; Frizzell JD, 2017, JAMA CARDIOL, V2, P204, DOI 10.1001/jamacardio.2016.3956; Gordon G., 2012, OPTIMIZATION, V10, P725; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hersh WR, 2013, MED CARE, V51, pS30, DOI 10.1097/MLR.0b013e31829b1dbd; Hosein FS, 2013, CRIT CARE, V17, DOI 10.1186/cc12747; Huang K, 2019, ARXIV190405342; Jiang J, 2019, AAAI SPRING S COMB M; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Lawrence ND, 2004, ADV NEUR IN, V16, P329; Li HX, 2013, INFORM SCIENCES, V221, P60, DOI 10.1016/j.ins.2012.09.041; Lin Y.-W., 2019, PLOS ONE, V14; Mazumder R, 2010, J MACH LEARN RES, V11, P2287; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Mortazavi BJ, 2016, CIRC-CARDIOVASC QUAL, V9, P629, DOI 10.1161/CIRCOUTCOMES.116.003039; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; O'Connor CM, 2017, JACC-HEART FAIL, V5, P393, DOI 10.1016/j.jchf.2017.03.011; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Qin B, 2011, KNOWL-BASED SYST, V24, P1151, DOI 10.1016/j.knosys.2011.04.011; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; Sundararaman A, 2018, BIG DATA RES, V13, P65, DOI 10.1016/j.bdr.2018.05.004; Titsias M, 2010, P 13 INT C ART INT S; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Wellner B, 2017, JMIR MED INF, V5, DOI 10.2196/medinform.8680	35	9	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0237724	10.1371/journal.pone.0237724	http://dx.doi.org/10.1371/journal.pone.0237724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956366	gold, Green Published			2022-12-26	WOS:000574571500033
J	Li, J; Yu, TT; Yan, HC; Qiao, YQ; Wang, LC; Zhang, T; Li, Q; Zhou, YH; Liu, DW				Li, Jing; Yu, Ting-Ting; Yan, Hui-Chun; Qiao, Yi-Qiang; Wang, Lin-Chuan; Zhang, Ting; Li, Qian; Zhou, Yan-Heng; Liu, Da-Wei			T cells participate in bone remodeling during the rapid palatal expansion	FASEB JOURNAL			English	Article						bone formation; immunity; orthodontics; osteoclasts	OSTEOCLAST DIFFERENTIATION; MIDPALATAL SUTURE; IFN-GAMMA; RANKL; DESTRUCTION; ALPHA; RUNX2	Palatal expansion has been widely used for the treatment of transverse discrepancy or maxillae hypoplasia, but the biological mechanism of bone formation during this procedure is largely unknown. Osteoclasts, which could be regulated by T cells and other components of the immune system, play a crucial role in force-induced bone remodeling. However, whether T cells participate in the palatal expansion process remains to be determined. In this study, we conducted the tooth borne rapid palatal expansion model on the mouse, and detect whether the helper T cells (Th) and regulatory T cells (Treg) could affect osteoclasts and further bone formation. After bonding open spring palatal expanders for 3-day, 5-day, 7-day, and retention for 28-day, micro-computed tomography scanning, histologic, and immunofluorescence staining were conducted to evaluate how osteoclasts were regulated by T cells during the bone remodeling process. We revealed that the increased osteoclast number was downregulated at the end of the early stage of rapid palatal expansion. Type 1 helper T (Th1) cells and Type 17 helper T (Th17) cells increased initially and promoted osteoclastogenesis. Thereafter, the regulatory T (Treg) cells emerged and maintained a relatively high level at the late stage of the experiment to downregulate the osteoclast number by inhibiting Th1 and Th17 cells, which governed the new bone formation. In conclusion, orchestrated T cells are able to regulate osteoclasts at the early stage of rapid palatal expansion and further facilitate bone formation during retention. This study identifies that T cells participate in the palatal expansion procedure by regulating osteoclasts and implies the potential possibility for clinically modulating T cells to improve the palatal expansion efficacy.	[Li, Jing; Yu, Ting-Ting; Yan, Hui-Chun; Zhang, Ting; Li, Qian; Zhou, Yan-Heng; Liu, Da-Wei] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China; [Li, Jing; Yu, Ting-Ting; Yan, Hui-Chun; Zhang, Ting; Li, Qian; Zhou, Yan-Heng; Liu, Da-Wei] Natl Clin Res Ctr Oral Dis, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Li, Jing; Yu, Ting-Ting; Yan, Hui-Chun; Zhang, Ting; Li, Qian; Zhou, Yan-Heng; Liu, Da-Wei] Beijing Key Lab Digital Stomatol, Beijing, Peoples R China; [Qiao, Yi-Qiang] Zhengzhou Univ, Affiliated Hosp 1, Dept Stomatol, Zhengzhou, Peoples R China; [Wang, Lin-Chuan] Univ Rochester, Eastman Inst Oral Hlth, Rochester, NY USA	Peking University; Zhengzhou University; University of Rochester	Zhou, YH; Liu, DW (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 Zhongguancun South Ave, Beijing 100081, Peoples R China.	yanhengzhou@vip.163.com; liudawei@bjmu.edu.cn	, 许开源 18362929861 赛德阳光口腔/AFX-1820-2022; Zhou, Yanheng/ABG-5432-2021	Zhou, Yanheng/0000-0002-5610-9967	National Science Foundation of China [81970909, 51903003]; National Natural Science Foundation of China [U1704187]; Natural Science Foundation of Beijing [7192290]; Young Scientists Fund [20110203, 20170109]; Peking University Medicine Seed Fund for Interdisciplinary Research [BMU2018MX007]; Peking University Medicine Fund of Fostering Young Scholars' Scientific & Technological Innovation [BMU2018PYB009]; Fundamental Research Funds for the Central Universities	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Young Scientists Fund; Peking University Medicine Seed Fund for Interdisciplinary Research; Peking University Medicine Fund of Fostering Young Scholars' Scientific & Technological Innovation; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Science Foundation of China, Grant/Award Number: 81970909 and 51903003; National Natural Science Foundation of China, Grant/Award Number: U1704187; Natural Science Foundation of Beijing, Grant/Award Number: 7192290; Young Scientists Fund, Grant/Award Number: 20110203 and 20170109; Peking University Medicine Seed Fund for Interdisciplinary Research, Grant/Award Number: BMU2018MX007; Peking University Medicine Fund of Fostering Young Scholars' Scientific & Technological Innovation, Grant/Award Number: BMU2018PYB009; Fundamental Research Funds for the Central Universities	Adamopoulos IE, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2936; Ayon Haro E R, 2011, J Periodontal Res, V46, P361, DOI 10.1111/j.1600-0765.2011.01352.x; Fuhrer RS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44959-w; Gao YH, 2007, J CLIN INVEST, V117, P122, DOI 10.1172/JCI30074; Hayakawa T, 2015, MOL MED REP, V12, P5879, DOI 10.3892/mmr.2015.4141; He D, 2015, J DENT RES, V94, P1286, DOI 10.1177/0022034515589714; He D, 2015, J DENT RES, V94, P129, DOI 10.1177/0022034514553817; He DQ, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01607-9; HORTON JE, 1972, SCIENCE, V177, P793, DOI 10.1126/science.177.4051.793; Hou B, 2007, BONE, V40, P1483, DOI 10.1016/j.bone.2007.01.019; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kawane T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31853-0; Kelchtermans H, 2009, ANN RHEUM DIS, V68, P744, DOI 10.1136/ard.2007.086066; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Krishnan V, 2006, AM J ORTHOD DENTOFAC, V129, P1, DOI DOI 10.1016/J.AJ0D0.2005.10.007; Li MY, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12697; Li WL, 2020, J CELL PHYSIOL, V235, P5972, DOI 10.1002/jcp.29522; Liu F, 2017, J DENT RES, V96, P694, DOI 10.1177/0022034517690388; Liu SSY, 2011, AM J ORTHOD DENTOFAC, V139, P446, DOI 10.1016/j.ajodo.2009.03.056; Liu SSY, 2010, EUR J ORTHODONT, V32, P371, DOI 10.1093/ejo/cjp103; Liu Y, 2017, J DENT RES, V96, P586, DOI 10.1177/0022034516685527; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Marahleh A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02925; Maruyama T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10526; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; MURRAY JMG, 1971, J DENT RES, V50, P1654, DOI 10.1177/00220345710500065101; Potempa J, 2017, NAT REV RHEUMATOL, V13, P606, DOI 10.1038/nrrheum.2017.132; Rody WJ, 2001, AM J ORTHOD DENTOFAC, V120, P477, DOI 10.1067/mod.2001.118623; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shin H, 2019, KOREAN J ORTHOD, V49, P360, DOI 10.4041/kjod.2019.49.6.360; STARNBACH H, 1966, ANGLE ORTHOD, V36, P152; Suzuki N, 2008, INT J MOL MED, V21, P291; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Walsh MC, 2018, NAT REV RHEUMATOL, V14, P146, DOI 10.1038/nrrheum.2017.213; Wise GE, 2008, J DENT RES, V87, P414, DOI 10.1177/154405910808700509; Wu BH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177159; Wu SH, 2012, INT J MED SCI, V9, P801, DOI 10.7150/ijms.4838; Yan Y, 2015, J DENT RES, V94, P1463, DOI 10.1177/0022034515595003; Yu MC, 2018, EMBO REP, V19, P156, DOI 10.15252/embr.201744421; Zaiss MM, 2010, J IMMUNOL, V184, P7238, DOI 10.4049/jimmunol.0903841; Zhao H, 2015, NAT CELL BIOL, V17, P386, DOI 10.1038/ncb3139	44	5	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15327	15337		10.1096/fj.202001078R	http://dx.doi.org/10.1096/fj.202001078R		SEP 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32951236				2022-12-26	WOS:000572346100001
J	Endalew, DA; Moti, D; Mohammed, N; Redi, S; Alemu, BW				Endalew, Daniel Adane; Moti, Dureti; Mohammed, Nuru; Redi, Sebaba; Alemu, Biresaw Wassihun			Knowledge and practice of cervical cancer screening and associated factors among reproductive age group women in districts of Gurage zone, Southern Ethiopia. A cross-sectional study	PLOS ONE			English	Article							ATTITUDE	Background Cervical cancer is a malignant tumor of the lower-most part of the uterus and major cause of morbidity and mortality among women's in the world. Its high mortality rate in the globe can be reduced through comprehensive approaches' that include; primary prevention, early diagnosis, effective screening, and treatment packages. This study was aimed to assess the knowledge and practice of cervical cancer screening and its associated factors among reproductive age group women in districts of Gurage zone, Southern Ethiopia, 2019. Methods A community-based cross-sectional study design was conducted from March 1-30, 2019. A total of 268 respondents were selected using a systematic sampling technique. Data was collected using pretested, semi-structured, and interviewer-administered questionnaires. Data were entered into Epi data version 3.1software and exported to SPSS 24 for analysis. Bivariate and multivariate analyses with a 95% confidence level was done and variables (P <0.05) were deemed statistically significant. Result A total of 260 respondents participated in the study with a response rate of 97%. About 3.8% of the respondents had experiences cervical cancer screening and 26.2% of respondents had good knowledge. Early age at first sex [AOR = 6.05 (95%CI; 1.167-31.36)], having information about cervical cancer [(AOR = 10.2 (95% CI 1.9-96.4)], and multiple sexual partners [AOR = 3.96 (95% CI; 1.48-10.58)] were factors affecting the practice of cervical cancer screening. Being uneducated [AOR = 15.5 (95%CI; 3.82-62.967)], family history of cervical cancer [AOR = 14.158 (95%CI;3.88-51.7)], having plans to screen for cervical cancer [AOR = 0.352 (95%CI;.175-.710)], menarcheal age [AOR = 2.63 (95%CI;1.28-5.37)] and age at first sex [AOR = 3.17 (95%CI;1.283-7.837)] were factors affecting knowledge of cervical screening. Conclusion The study findings indicate that respondents' practice and knowledge of cervical cancer is mainly affected by early age at first sex, having information about cervical cancer, multiple sexual partners, Educational status, family history of cervical cancer, having plans to screen for cervical cancer, age at first sex and age of menarche. Therefore, all concerned bodies need to focus on women in the reproductive age group to increase the level of knowledge and practice of cervical cancer screening through appropriate interventions.	[Endalew, Daniel Adane; Moti, Dureti; Mohammed, Nuru; Redi, Sebaba] Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia; [Alemu, Biresaw Wassihun] Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia	Arba Minch University	Endalew, DA (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia.	danieladane178@yahoo.com		Endalew, daniel/0000-0002-3540-4844	Wolkite University	Wolkite University	This paper was funded by Wolkite University, but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and none of the authors received a salary from any of this fund.	Adeyemi M, 2011, FACTORS AFFECTING CE; Alemayehu Y, 2008, CANC THREAT ETHIOPIA; [Anonymous], 2013, PARTY SCH SINICA, V05, P47; Bingham A, 2003, SALUD PUBLICA MEXICO, V45, pS408; Deresse M, 2018, STUDY KNOWLEDGE ATTI; Dhendup T, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-44; Ezem BU, 2007, ANN AFR MED, V6, P94, DOI 10.4103/1596-3519.55727; Gebrie MH., 2015, J DIABETES METAB, V6, P569; Getahun F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-2; Gichangi P, 2003, INT J GYNECOL CANCER, V13, P827, DOI 10.1111/j.1525-1438.2003.13612.x; Habtu Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4203-2; John J, 2011, THESIS; LOUTFI A, 1992, ETHIOPIAN MED J, V30, P13; McCarey C, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-45; Ncube B, 2015, N AM J MED SCI, V7, P104, DOI 10.4103/1947-2714.153922; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Olumide O, 2014, KNOWLEDGE ATTITUDE F; Tadele N, 2015, ETHIOP J HEALTH SCI, V25, P53, DOI 10.4314/ejhs.v25i1.8; Tebeu PM, 2008, INT J GYNECOL CANCER, V18, P761, DOI 10.1111/j.1525-1438.2007.01066.x; Tekle T, 2020, CANCER MANAG RES, V12, P993, DOI 10.2147/CMAR.S240364; Tilahun T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4564-x; Tsegaye S, 2015, THESIS; WHO, 2013, COMP CERV CANC PREV; World Health Organization, 2015, WHO GUID SCREEN TREA; World Health Organization, 2018, CANC TODAY; World Health Organization (WHO), 2010, HUM PAP REL CANC; 2007, NEW YORK BLADE  0907, V11, P7	27	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238869	10.1371/journal.pone.0238869	http://dx.doi.org/10.1371/journal.pone.0238869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946461	Green Published, gold			2022-12-26	WOS:000573851100085
J	Ul Alam, MN; Chowdhury, UF				Ul Alam, Md Nafis; Chowdhury, Umar Faruq			Short k-mer abundance profiles yield robust machine learning features and accurate classifiers for RNA viruses	PLOS ONE			English	Article							EXPRESSION; CLASSIFICATION; PREDICTION; GENOMES; VERSION	High-throughput sequencing technologies have greatly enabled the study of genomics, transcriptomics and metagenomics. Automated annotation and classification of the vast amounts of generated sequence data has become paramount for facilitating biological sciences. Genomes of viruses can be radically different from all life, both in terms of molecular structure and primary sequence. Alignment-based and profile-based searches are commonly employed for characterization of assembled viral contigs from high-throughput sequencing data. Recent attempts have highlighted the use of machine learning models for the task, but these models rely entirely on DNA genomes and owing to the intrinsic genomic complexity of viruses, RNA viruses have gone completely overlooked. Here, we present a novel short k-mer based sequence scoring method that generates robust sequence information for training machine learning classifiers. We trained 18 classifiers for the task of distinguishing viral RNA from human transcripts. We challenged our models with very stringent testing protocols across different species and evaluated performance against BLASTn, BLASTx and HMMER3 searches. For clean sequence data retrieved from curated databases, our models display near perfect accuracy, outperforming all similar attempts previously reported. On de novo assemblies of raw RNA-Seq data from cells subjected to Ebola virus, the area under the ROC curve varied from 0.6 to 0.86 depending on the software used for assembly. Our classifier was able to properly classify the majority of the false hits generated by BLAST and HMMER3 searches on the same data. The outstanding performance metrics of our model lays the groundwork for robust machine learning methods for the automated annotation of sequence data.	[Ul Alam, Md Nafis; Chowdhury, Umar Faruq] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh	University of Dhaka	Ul Alam, MN (corresponding author), Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh.	nafees3176@outlook.com		Chowdhury, Umar Faruq/0000-0001-5088-4658; Alam, Md Nafis Ul/0000-0003-3088-5279				Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; AGOL VI, 1974, BIOSYSTEMS, V6, P113, DOI 10.1016/0303-2647(74)90003-3; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrientos-Somarribas M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18341-7; Bleidorn C, 2016, SYST BIODIVERS, V14, P1, DOI 10.1080/14772000.2015.1099575; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Bushmanova E., 2018, RNASPADES NOVO TRANS; Bzhalava Z, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2340-x; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chang Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0596-2; Chaudhary N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116106; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Duffy S, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000003; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Holzer M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz039; Hoff KJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-217; Jaspers E, 2004, APPL ENVIRON MICROB, V70, P4831, DOI 10.1128/AEM.70.8.4831-4839.2004; Kannan S., 2016, SHANNON INFORM OPTIM, P39230; KOONIN EV, 1991, VIRUS GENES, V5, P273, DOI 10.1007/BF00568977; Krishnamurthy SR, 2017, VIRUS RES, V239, P136, DOI 10.1016/j.virusres.2017.02.002; Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; Liu JT, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004772; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Peng Y, 2013, BIOINFORMATICS, V29, P326, DOI 10.1093/bioinformatics/btt219; Polson SW, 2011, ISME J, V5, P165, DOI 10.1038/ismej.2010.81; Ren J, 2020, QUANT BIOL, V8, P64, DOI 10.1007/s40484-019-0187-4; Ren J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0283-5; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rosani U, 2017, VIRUS RES, V239, P33, DOI 10.1016/j.virusres.2016.10.009; Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7; Skewes-Cox P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105067; Song WC, 2019, NUCLEIC ACIDS RES, V47, pW74, DOI 10.1093/nar/gkz380; Tampuu A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222271; Williamson KE, 2017, ANNU REV VIROL, V4, P201, DOI 10.1146/annurev-virology-101416-041639; Wommack K.E., 2011, METAGENOMIC CONTRAST; Wommack K. Eric, 2009, V502, P279, DOI 10.1007/978-1-60327-565-1_16; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077	47	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239381	10.1371/journal.pone.0239381	http://dx.doi.org/10.1371/journal.pone.0239381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946529	Green Submitted, Green Published, gold			2022-12-26	WOS:000573851100053
J	Williams, GM; Wang, Y; Suman, DS; Unlu, I; Gaugler, R				Williams, Gregory M.; Wang, Yi; Suman, Devi S.; Unlu, Isik; Gaugler, Randy			The development of autonomous unmanned aircraft systems for mosquito control	PLOS ONE			English	Article							SPRAY SYSTEM; AERIAL; PESTICIDES; SIMULATION; DRIFT	We constructed an electric multi-rotor autonomous unmanned aerial system (UAS) to perform mosquito control activities. The UAS can be equipped with any of four modules for spraying larvicides, dropping larvicide tablets, spreading larvicide granules, and ultra-low volume spraying of adulticides. The larvicide module sprayed 124 mu m drops at 591 mL/min over a 14 m swath for a total application rate of 1.6 L/ha. The tablet module was able to repeatedly deliver 40-gram larvicide tablets within 1.1 m of the target site. The granular spreader covered a 6 m swath and treated 0.76 ha in 13 min at an average rate of 1.8 kg/ha. The adulticide module produced 16 mu m drops with an average deposition of 2.6 drops/mm(2). UAS pesticide applications were made at rates prescribed for conventional aircraft, limited only by the payload capacity and flight time. Despite those limitations, this system can deliver pesticides with much greater precision than conventional aircraft, potentially reducing pesticide use. In smaller, congested environments or in programs with limited resources, UAS may be a preferable alternative to conventional aircraft.	[Williams, Gregory M.] Hudson Reg Hlth Commiss, Secaucus, NJ 07094 USA; [Williams, Gregory M.; Wang, Yi; Unlu, Isik; Gaugler, Randy] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08854 USA; [Suman, Devi S.] Zool Survey India, Kolkata, India	Rutgers State University New Brunswick; Zoological survey of India	Williams, GM (corresponding author), Hudson Reg Hlth Commiss, Secaucus, NJ 07094 USA.; Williams, GM (corresponding author), Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ 08854 USA.	gwilliams@hudsonregionalhealth.org	Williams, Gregory/ABD-8038-2020	Williams, Gregory/0000-0001-9760-6831	USDA National Institute of Food and Agriculture Hatch project through the New Jersey Agricultural Experiment Station, Hatch project [1020755, NJ08530]; Rutgers Center for Unmanned Aircraft; Northeastern Mosquito Control Association	USDA National Institute of Food and Agriculture Hatch project through the New Jersey Agricultural Experiment Station, Hatch project; Rutgers Center for Unmanned Aircraft; Northeastern Mosquito Control Association	This work was supported by the USDA National Institute of Food and Agriculture Hatch project accession number 1020755 through the New Jersey Agricultural Experiment Station, Hatch project NJ08530, the Rutgers Center for Unmanned Aircraft and the Northeastern Mosquito Control Association's McColgan Grant-in-Aid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar D, 2019, QGROUNDCONTROL SOFTW; Arterburn D, 2017, FINAL REPORT FAA UAS; Benzon GL, 1980, P 26 ANN M NE MOSQ C; Bird SL, 1996, J ENVIRON QUAL, V25, P1095, DOI 10.2134/jeq1996.00472425002500050024x; Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x; BROWN JR, 1993, J AM MOSQUITO CONTR, V9, P32; Buettner J, 2018, AMCA LEGISLATIVE REG; Carroll MK, 1979, THESIS; Case E, 2020, J MED ENTOMOL, V57, P1588, DOI 10.1093/jme/tjaa078; Clayson PJ, 2010, J AM MOSQUITO CONTR, V26, P229, DOI 10.2987/10-5999.1; Cope Stanton E, 2008, US Army Med Dep J, P9; DJI Science and Technology, 2019, EL SAF PROT SKIES DR; DJI Science and Technology, 2017, AGR MG 1; European Commission, 2016, COMM DEL REG EU 2016, P1; Faraji A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152069; Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P304, DOI 10.2987/13-6334R.1; FENG JC, 1989, WEED TECHNOL, V3, P275, DOI 10.1017/S0890037X00031808; Fritz BK, 2011, T ASABE, V54, P57; Gonzalez-de-Santos P, 2017, PRECIS AGRIC, V18, P574, DOI 10.1007/s11119-016-9476-3; Griffith JA, 2002, ECOL APPL, V12, P1702, DOI 10.1890/1051-0761(2002)012[1702:IALNAS]2.0.CO;2; Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858; Hanlon M, 2004, NEW ATLAS; Huang Y, 2009, APPL ENG AGRIC, V25, P803; Huang Y., 2014, J AGR SCI-CAMBRIDGE, V7, P148, DOI [10.5539/jas.v7n1p148, DOI 10.5539/JAS.V7N1P148]; Iost FH, 2020, J ECON ENTOMOL, V113, P1, DOI 10.1093/jee/toz268; KANIUKA R, 1985, AGR RES, V33, P8; Kimball P, 2016, WING BEATS, V27, P23; Lee Jaeone, 2018, [Journal of Korea Academia-Industrial cooperation Society, 한국산학기술학회논문지], V19, P63, DOI 10.5762/KAIS.2018.19.4.63; Manoj KS, 2016, SMALL UNMANNED AERIA; Miller J W, 2005, REPORT DEV OPERATION; MIYAHARA M, 1993, WEED TURFGRASS SCI, V13, P185; Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305; National Transportation Safety Board, 2016, CEN16FA158 NTSB; O'Meara G.F., 1976, P303; Oborne M., 2019, MISSION PLANNER SOFT; PIMENTEL D, 1995, J AGR ENVIRON ETHIC, V8, P17, DOI 10.1007/BF02286399; Pradelli C, 2014, 6 ABC ACTION NE 0825; SAS institute Inc, 2020, SAS STAT 15 1 US GUI; Stocklin V, 2017, German patent, Patent No. [DE102017010319A1, 102017010319]; Swift Navigation, 2019, PIKS MULT SUMM; TEDDERS WL, 1986, J ECON ENTOMOL, V79, P709, DOI 10.1093/jee/79.3.709; U-Blox AG, 2012, LEA 6 SER PROD SUMM; Whitmyre G. Jr., 1973, Proceedings, New Jersey Mosquito Extermination Association, V60, P44; Williams GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110035; Yang FB, 2018, ENERGIES, V11, DOI 10.3390/en11092399; Zhai J., 2019, INT PEST CONT, V61, P3; ZHU H, 1994, T ASAE, V37, P1401, DOI 10.13031/2013.28220; 2015, GERONTOLOGIST, V55, P1	48	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0235548	10.1371/journal.pone.0235548	http://dx.doi.org/10.1371/journal.pone.0235548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946475	Green Published, gold			2022-12-26	WOS:000573851100054
J	Blaix, C; Moonen, AC				Blaix, Cian; Moonen, Anna-Camilla			Structural field margin characteristics affect the functional traits of herbaceous vegetation	PLOS ONE			English	Article							MANAGEMENT; FARMLAND; BIODIVERSITY; DIVERSITY	Background Field margins are ecologically important to an agroecosystem as they are a source of biodiversity. They can be composed of a diverse flora which may offer resources to a wide range of insects and birds. The vegetation composition of field margins is determined by soil characteristics, management, and landscape structures. However, little is known about the effect of individual field margin components such as ditches, grass strips, shrubs and trees, and the overall margin's complexity, on the vegetation composition and its functional effect and response traits. Methods This paper reports on the effects of field margin component typology (ditches, grass strips, shrubs, trees, and vehicle tracks) and complexity (the number of components), on the herbaceous vegetation of field margins. Forty field margins were sampled in 2016 in a 200 ha. organic mixed arable livestock farm. Results The factor which was identified as having the most effect on vegetation composition was adjacent land-use type, which reflected the margins' management regime. However, field margin components were found to affect vegetation response and effect traits. Tree components had less grassweeds than vehicle tracks while more complex field margins also had less grassweeds than simple field margins near cropped fields, most likely due to the lower availability in light and less disturbance from vehicles. Simple grassy margins produced a high proportion of hymenoptera flowers. Discussion These results highlight the importance of field margin components in maintaining a high diversity of vegetation typologies differing in effect traits that are relevant for the provisioning of ecosystem services, such as supporting pollen and nectar requirements of beneficial insects, as well as their importance in determining the presence of weed species that could potentially invade the cropped fields.	[Blaix, Cian; Moonen, Anna-Camilla] Scuola Super Sant Anna, Inst Life Sci, Grp Agroecol, Pisa, Italy	Scuola Superiore Sant'Anna	Blaix, C (corresponding author), Scuola Super Sant Anna, Inst Life Sci, Grp Agroecol, Pisa, Italy.	cianblaix@gmail.com		MOONEN, Anna Camilla/0000-0002-4472-1665; Blaix, Cian/0000-0002-2525-8150	Scuola Superiore Sant'Anna in Pisa in the International PhD Programme on Agrobiodiversity	Scuola Superiore Sant'Anna in Pisa in the International PhD Programme on Agrobiodiversity	Cian Blaix received a PhD grant from the Scuola Superiore Sant'Anna in Pisa in the International PhD Programme on Agrobiodiversity.	Aavik T, 2008, APPL VEG SCI, V11, P375, DOI 10.3170/2008-7-18486; Aavik T, 2010, AGR ECOSYST ENVIRON, V135, P178, DOI 10.1016/j.agee.2009.09.005; Albert CH, 2010, J ECOL, V98, P604, DOI 10.1111/j.1365-2745.2010.01651.x; Alexander SA, 2002, J NEMATOL, V34, P130; Alignier A, 2015, AGR ECOSYST ENVIRON, V211, P164, DOI 10.1016/j.agee.2015.06.008; [Anonymous], 2017, KIDNEY INT S113, V76, pS1; Audigier V, 2016, ADV DATA ANAL CLASSI, V10, P5, DOI 10.1007/s11634-014-0195-1; Backman JPC, 2002, AGR ECOSYST ENVIRON, V89, P53, DOI 10.1016/S0167-8809(01)00318-8; Barberi P, 2018, WEED RES, V58, P76, DOI 10.1111/wre.12283; Batary P, 2011, P ROY SOC B-BIOL SCI, V278, P1894, DOI 10.1098/rspb.2010.1923; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bocci G, 2015, METHODS ECOL EVOL, V6, P347, DOI 10.1111/2041-210X.12327; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Cirujeda A, 2019, WEED RES; Colloff MJ, 2013, BIOL CONTROL, V67, P170, DOI 10.1016/j.biocontrol.2013.07.017; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; ELLENBERG H, 1974, Scripta Geobotanica, V9, P1; Fanelli G, 2006, SISTEMA AMBIENTALE T, P505; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; GRIME JP, 1974, NATURE, V250, P26, DOI 10.1038/250026a0; Gross N, 2009, FUNCT ECOL, V23, P1167, DOI 10.1111/j.1365-2435.2009.01591.x; Haenke S, 2009, J APPL ECOL, V46, P1106, DOI 10.1111/j.1365-2664.2009.01685.x; HASLETT JR, 1989, OECOLOGIA, V78, P433, DOI 10.1007/BF00378732; Hoft A, 2006, J PLANT DIS PROTECT, P517; Josse J, 2016, J STAT SOFTW, V70; Julve P, 2015, INDEX BOT ECOLOGIQUE; Kevan P. G., 1998, COLOR VISION PERSPEC, P163; Klecka J, 2018, PEERJ, V6, DOI 10.7717/peerj.6025; Kleijn D, 1997, J APPL ECOL, V34, P1413, DOI 10.2307/2405258; Koster J, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2363-8; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Lavorel S, 2013, J ECOL, V101, P4, DOI 10.1111/1365-2745.12031; Lavorel S, 2011, J ECOL, V99, P135, DOI 10.1111/j.1365-2745.2010.01753.x; Maier Marco., 2014, DIRICHLETREG DIRICHL, P125; Marshall EJR, 2002, AGR ECOSYST ENVIRON, V89, P5, DOI 10.1016/S0167-8809(01)00315-2; Muller H, 1881, ALPENBLUMEN IHRE BEF; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Orlowski G, 2014, BIRD STUDY, V61, P484, DOI 10.1080/00063657.2014.954984; Pasek JE, 1988, AGR ECOSYST ENVIRON, V22/23, P16; Pfiffner L, 2000, AGR ECOSYST ENVIRON, V78, P215, DOI 10.1016/S0167-8809(99)00130-9; Pierce S, 2017, FUNCT ECOL, V31, P444, DOI 10.1111/1365-2435.12722; Pignatti S., 2005, BRAUN BLANQUETIA, V39, P1; R Foundation for Statistical Computing, 2018, R LANG ENV STAT COMP; Ranaldo M, WEED RES; Rosado BHP, 2017, FUNCT ECOL, V31, P1969, DOI 10.1111/1365-2435.12894; Schmitz J, 2014, AGR ECOSYST ENVIRON, V193, P60, DOI 10.1016/j.agee.2014.04.025; Speight MCD, 2015, DATABASE EUROPEAN SY; Storkey J, 2015, WEED RES, V55, P206, DOI 10.1111/wre.12126; Storkey J, 2013, J ECOL, V101, P38, DOI 10.1111/1365-2745.12020; Sutherland JP, 1999, ENTOMOL EXP APPL, V93, P157, DOI 10.1023/A:1003844307934; Sweet TM, 2017, J EDUC BEHAV STAT, V42, P107, DOI 10.3102/1076998616659752; Van Geert A, 2010, J ECOL, V98, P178, DOI 10.1111/j.1365-2745.2009.01600.x; Van Halder I, 2007, PLANTATION FORESTS B, P225; Vehtari A, 2017, STAT COMPUT, V27, P1433, DOI 10.1007/s11222-016-9709-3; White GC I, 2000, BLOOD COAGULATION FI, V11, pS53, DOI 10.1097/00001721-200004001-00012; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wood SA, 2015, TRENDS ECOL EVOL, V30, P531, DOI 10.1016/j.tree.2015.06.013	60	2	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238916	10.1371/journal.pone.0238916	http://dx.doi.org/10.1371/journal.pone.0238916			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941477	Green Published, gold			2022-12-26	WOS:000573848800006
J	Huang, QB; Sun, Y; Zhai, W; Ma, X; Shen, DL; Du, SL; You, BS; Niu, YJ; Huang, CP; Zhang, X; Chang, C				Huang, Qingbo; Sun, Yin; Zhai, Wei; Ma, Xin; Shen, Donglai; Du, Songliang; You, Bosen; Niu, Yuanjie; Huang, Chi-Ping; Zhang, Xu; Chang, Chawnshang			Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner	ONCOGENE			English	Article							HYPOXIA-INDUCIBLE FACTORS; TUMOR-SUPPRESSOR PROTEIN; CANCER; PROGRESSION; AXIS	Recent studies indicated that the androgen receptor (AR) plays important roles in modulating metastasis of VHL-mutant clear cell renal cell carcinoma (ccRCC). However, the precise mechanisms of AR roles in VHL wild-type (VHL-wt) ccRCC, remain unclear. Here we found that AR interacted with VHL to modulate the metastasis of VHL-wt ccRCC via an oxygen-dependent manner. Mechanism dissection revealed that AR could transcriptionally suppress the miR-185-5p expression in the presence of functional VHL-wt protein under a normoxic condition, which might then result in increasing the expression of VEGF-A and VEGF-C via targeting the 3 ' UTR of mRNAs at a post-transcriptional level. In contrast, under a hypoxic condition, AR could increase miR-185-5p expression to suppress VEGF-C expression, yet this miR-185-5p effect on VEGF-A was reversed via AR's positive regulation on the HIF2 alpha-increased VEGF-A expression that resulted in increasing VEGF-A in the VHL-wt RCC cells. These distinct AR functions under different oxygen conditions may involve the VHL-impacted ubiquitination and nuclear localization of AR. The differential regulation of VEGF-A vs VEGF-C by AR may then result in differential impacts on the ccRCC metastatic destinations of VHL-wt ccRCC cells under different oxygen conditions. These finer mechanisms may help in the development of a novel therapy to better suppress the ccRCC progression under different oxygenization conditions.	[Huang, Qingbo; Ma, Xin; Shen, Donglai; Du, Songliang; Zhang, Xu] Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing 100853, Peoples R China; [Huang, Qingbo; Sun, Yin; Zhai, Wei; You, Bosen; Niu, Yuanjie; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Huang, Qingbo; Sun, Yin; Zhai, Wei; You, Bosen; Niu, Yuanjie; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Huang, Qingbo; Sun, Yin; Zhai, Wei; You, Bosen; Niu, Yuanjie; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Huang, Qingbo; Sun, Yin; Zhai, Wei; You, Bosen; Niu, Yuanjie; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA; [Zhai, Wei] Jiao Tong Univ, Renji Hosp, Dept Urol, Shanghai 200127, Peoples R China; [Huang, Chi-Ping; Chang, Chawnshang] China Med Univ Hosp, Dept Urol, Sex Hormone Res Ctr, Taichung 404, Taiwan	Chinese People's Liberation Army General Hospital; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Shanghai Jiao Tong University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Zhang, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Urol, Beijing 100853, Peoples R China.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Dept Radiat Oncol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.; Chang, C (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14642 USA.; Chang, C (corresponding author), China Med Univ Hosp, Dept Urol, Sex Hormone Res Ctr, Taichung 404, Taiwan.	xzhang@foxmail.com; chang@urmc.rochester.edu	zhang, xu/GYE-3558-2022; You, Bosen/AHC-2523-2022	Chang, Chawnshang/0000-0001-8510-3516; Huang, Qingbo/0000-0003-2894-0187; Zhai, Wei/0000-0001-6274-6404	George Whipple Professorship Endowment; Beijing Natural Science Foundation [7194319]; National Nature Science Foundation [81972389]	George Whipple Professorship Endowment; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by George Whipple Professorship Endowment, and Beijing Natural Science Foundation (No. 7194319), and National Nature Science Foundation (No. 81972389).	Arjumand W, 2012, TUMOR BIOL, V33, P9, DOI 10.1007/s13277-011-0257-3; Baran N, 2017, CLIN CANCER RES, V23, P2382, DOI 10.1158/1078-0432.CCR-16-0895; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Bukowski RM, 1997, CANCER-AM CANCER SOC, V80, P1198, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H; Chen SL, 2013, BIOCHEM J, V456, P55, DOI 10.1042/BJ20121711; Chen Y, 2015, ONCOTARGET, V6, P31203, DOI 10.18632/oncotarget.4522; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Coffey K, 2012, J ENDOCRINOL, V215, P221, DOI 10.1530/JOE-12-0238; Gossage L, 2010, NAT REV CLIN ONCOL, V7, P277, DOI 10.1038/nrclinonc.2010.42; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; He DL, 2014, CANCER RES, V74, P4420, DOI 10.1158/0008-5472.CAN-13-2681; Huang QB, 2014, ONCOTARGET, V5, P3066, DOI 10.18632/oncotarget.1827; Huang QB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00701-6; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Oudard S, 2007, ANN ONCOL, V18, P25, DOI 10.1093/annonc/mdm411; Petrova V, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0011-9; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Qu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041504; Sayeed A, 2012, J CELL PHYSIOL, V227, P751, DOI 10.1002/jcp.22784; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Wang J, 2014, MOL ENDOCRINOL, V28, P239, DOI 10.1210/me.2013-1258; Wong SC, 2018, MOL CANCER THER, V17, P140, DOI 10.1158/1535-7163.MCT-17-0471; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Yang OCY, 2013, KIDNEY INT, V84, P667, DOI 10.1038/ki.2013.245; Zhai W, 2016, ONCOGENE, V35, P4866, DOI 10.1038/onc.2016.19	31	3	3	4	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2020	39	43					6677	6691		10.1038/s41388-020-01455-0	http://dx.doi.org/10.1038/s41388-020-01455-0		SEP 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OF2UT	32943729				2022-12-26	WOS:000571161500002
J	Chapagain, D; Wallis, LJ; Range, F; Affenzeller, N; Serra, J; Viranyi, Z				Chapagain, Durga; Wallis, Lisa J.; Range, Friederike; Affenzeller, Nadja; Serra, Jessica; Viranyi, Zsofia			Behavioural and cognitive changes in aged pet dogs: No effects of an enriched diet and lifelong training	PLOS ONE			English	Article							LONG-TERM TREATMENT; PERSONALITY-TRAITS; CANINE MODEL; BEAGLE DOG; INDIVIDUAL-DIFFERENCES; FORTIFIED FOOD; WORKING-MEMORY; DYSFUNCTION; ANTIOXIDANTS; SUPPLEMENTATION	Dogs demonstrate behavioural changes and cognitive decline during aging. Compared to laboratory dogs, little is known about aging in pet dogs exposed to different environments and nutrition. In this study, we examined the effects of age, an enriched diet and lifelong training on different behavioural and cognitive measures in 119 pet dogs (>6yrs). Dogs were maintained on either an enriched diet or a control diet for one year. Lifelong training was calculated using a questionnaire where owners filled in their dog's training experiences to date. Before commencing the diet and after one year of dietary treatment, they were tested in the Modified Vienna Canine Cognitive Battery (MVCCB) consisting of 11 subtests to examine correlated individual differences in a set of tasks measuring general, social and physical cognition and related behaviours. Fourty two behavioural variables were coded and were subjected to principle component analyses for variable reduction. Twelve subtest level components and two Z-transformed variables were subjected to exploratory factor analysis which resulted in six final factors: Problem solving, Trainability, Sociability, Boldness, Activity-independence and Dependency. Problem solving, Sociability, Boldness, and Dependency showed a linear decline with age, suggesting that the MVCCB can be used as a tool to measure behavioural and cognitive decline in aged pet dogs. An enriched diet and lifelong training had no effect on these factors, calling attention to the fact that the real world impact of nutritional and other interventions in possibly counteracting the effects of aging, should be further investigated in pet dogs living under diverse conditions, in order to understand their ultimate effects.	[Chapagain, Durga; Range, Friederike; Viranyi, Zsofia] Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab,Comparat Cognit,Med Univ Vienna, Vienna, Austria; [Chapagain, Durga; Range, Friederike] Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Domesticat Lab, Vienna, Austria; [Wallis, Lisa J.] Univ Liverpool, Inst Infect Vet & Ecol Sci, Dept Livestock & One Hlth, Liverpool, Merseyside, England; [Wallis, Lisa J.] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Affenzeller, Nadja] Univ Vet Med Vienna, Dept Clin Compan Anim & Horses, Vienna, Austria; [Serra, Jessica] Royal Canin Res Ctr, Aimargues, France	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Veterinary Medicine Vienna; University of Liverpool; Eotvos Lorand University; University of Veterinary Medicine Vienna	Chapagain, D (corresponding author), Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Clever Dog Lab,Comparat Cognit,Med Univ Vienna, Vienna, Austria.; Chapagain, D (corresponding author), Univ Vet Med Vienna, Konrad Lorenz Inst Ethol, Domesticat Lab, Vienna, Austria.	durgachapagain1@gmail.com	Wallis, Lisa/GVS-6425-2022	Wallis, Lisa/0000-0003-3931-3250; Range, Friederike/0000-0003-3127-5536; Chapagain, Durga/0000-0001-6595-2406	Royal Canin, Aimargues, France [FA 3721 4007]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [680040]	Royal Canin, Aimargues, France; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC))	This research was fully funded by Royal Canin, Aimargues, France (Project Number: FA 3721 4007). JS was an employee with Royal Canin, Aimargues, France. The funders had no role in study design, data collection and analysis, and decision to publish. Lisa J. Wallis was additionally supported by funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (Grant Agreement No. 680040).	Adams B, 2000, PROG NEURO-PSYCHOPH, V24, P675, DOI 10.1016/S0278-5846(00)00101-9; Allemand M, 2007, J PERS, V75, P323, DOI 10.1111/j.1467-6494.2006.00441.x; [Anonymous], 2012, M100S22 CLIN LAB STA; [Anonymous], 2000, PDA J PHARM SCI TECH, V54, P1; [Anonymous], 2014, APPL GEOMATICS; Arden R, 2016, CURR DIR PSYCHOL SCI, V25, P307, DOI 10.1177/0963721416667718; Arden R, 2016, INTELLIGENCE, V55, P79, DOI 10.1016/j.intell.2016.01.008; Bamidis PD, 2014, NEUROSCI BIOBEHAV R, V44, P206, DOI 10.1016/j.neubiorev.2014.03.019; Bensky MK, 2013, ADV STUD BEHAV, V45, P209, DOI 10.1016/B978-0-12-407186-5.00005-7; Bray EE, 2017, ANIM COGN, V20, P923, DOI 10.1007/s10071-017-1112-8; Brickman AM., 2009, HDB NEUROSCIENCE AGI, V1, P175, DOI [10.1016/B978-008045046-9.00745-2, DOI 10.1016/B978, DOI 10.1016/B978-008045046-9.00745-2]; Bullock T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01290; Carriere JSA, 2010, PSYCHOL AGING, V25, P569, DOI 10.1037/a0019363; Carstensen L.L., 2006, HDB PSYCHOL AGING, P343, DOI DOI 10.1016/B978-012101264-9/50018-5; Chapagain D, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02217; Chapagain D, 2018, GERONTOLOGY, V64, P165, DOI 10.1159/000481621; Chapagain D, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00100; Chopik WJ, 2019, J RES PERS, V79, P94, DOI 10.1016/j.jrp.2019.01.005; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Coren S, 1999, INTELLIGENCE DOGS GU; Cotman CW, 2002, NEUROBIOL AGING, V23, P809, DOI 10.1016/S0197-4580(02)00073-8; Council NR, 2006, NUTR REQ DOGS CATS, DOI [10.17226/10668 ., DOI 10.17226/10668]; Craik FIM, 2010, PSYCHOL AGING, V25, P968, DOI 10.1037/a0020276; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; Denapoli JS, 1658, EFFECT DIETARY PROTE; DeYoung CG, 2009, CAMBRIDGE HANDBOOK OF PERSONALITY PSYCHOLOGY, P323; Dodd CE, 2003, VET MED-US, V98, P396; Fisk JE, 1996, PSYCHOL AGING, V11, P316, DOI 10.1037/0882-7974.11.2.316; Fusco D, 2007, CLIN INTERV AGING, V2, P377; GAGNON S, 1993, ANIM LEARN BEHAV, V21, P246, DOI 10.3758/BF03197989; Geda YE, 2010, ARCH NEUROL-CHICAGO, V67, P80, DOI 10.1001/archneurol.2009.297; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gonzalez-Martinez A, 2013, VET J, V198, P176, DOI 10.1016/j.tvjl.2013.07.004; Griffin AS, 2015, COGNITION PERSONALIT, P1; Gross J, 1997, EMOTION AGING EXPERI, P590; Head E, 2009, EXP NEUROL, V220, P171, DOI 10.1016/j.expneurol.2009.08.014; Head E, 2013, BBA-MOL BASIS DIS, V1832, P1384, DOI 10.1016/j.bbadis.2013.03.016; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Joseph JA, 2005, AM J CLIN NUTR, V81, p313S, DOI 10.1093/ajcn/81.1.313S; Kaeberlein M, 2016, MAMM GENOME, V27, P279, DOI 10.1007/s00335-016-9638-7; Kalmijn S, 2004, NEUROLOGY, V62, P275, DOI 10.1212/01.WNL.0000103860.75218.A5; Kubinyi E, 2009, BEHAV PROCESS, V81, P392, DOI 10.1016/j.beproc.2009.04.004; L?decke D., 2018, SJSTATS STAT FUNCTIO; Landsberg G., 2013, HDB BEHAV PROBLEMS D; Landsberg GM, 2011, VET CLIN N AM-SMALL, V41, P565, DOI 10.1016/j.cvsm.2011.03.017; Luchsinger JA, 2003, ARCH NEUROL-CHICAGO, V60, P203, DOI 10.1001/archneur.60.2.203; Luchsinger JA, 2007, CURR NEUROL NEUROSCI, V7, P366, DOI 10.1007/s11910-007-0057-8; MacLean EL, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00236; MacLean EL, 2017, ANIM BEHAV, V126, P41, DOI 10.1016/j.anbehav.2017.01.005; Madari A, 2015, APPL ANIM BEHAV SCI, V171, P138, DOI 10.1016/j.applanim.2015.08.034; McMillan FD, 2003, J AM ANIM HOSP ASSOC, V39, P227, DOI 10.5326/0390227; Menchetti L, 2018, ANIMALS, V8, DOI 10.3390/ani8060080; Milgram NW, 2004, EXP GERONTOL, V39, P753, DOI 10.1016/j.exger.2004.01.007; Milgram NW, 1999, LEARN MEMORY, V6, P54; Milgram NW, 2002, NEUROBIOL AGING, V23, P737, DOI 10.1016/S0197-4580(02)00020-9; Milgram NW, 2002, NEUROSCI BIOBEHAV R, V26, P679, DOI 10.1016/S0149-7634(02)00039-8; MILGRAM NW, 1994, BEHAV NEUROSCI, V108, P57, DOI 10.1037/0735-7044.108.1.57; Milgram NW, 2005, NEUROBIOL AGING, V26, P77, DOI 10.1016/j.neurobiolaging.2004.02.014; Mongillo P, 2013, PHYSIOL BEHAV, V120, P64, DOI 10.1016/j.physbeh.2013.07.011; Mongillo P, 2010, ANIM BEHAV, V80, P1057, DOI 10.1016/j.anbehav.2010.09.014; Neilson JC, 2001, J AM VET MED ASSOC, V218, P1787, DOI 10.2460/javma.2001.218.1787; Opii W, 2008, NEUROBIOL AGING, V29, P51, DOI 10.1016/j.neurobiolaging.2006.09.012; Ortega RM, 2002, J NUTR, V132, P2065, DOI 10.1093/jn/132.7.2065; Osetla MC, 2008, J VET BEHAV, V3, P41, DOI 10.1016/j.jveb.2007.08.003; Oswald Wolf D, 2006, Eur J Ageing, V3, P179, DOI 10.1007/s10433-006-0035-z; Pan YL, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00127; Pan YL, 2018, BRIT J NUTR, V119, P349, DOI [10.1017/s0007114517003464, 10.1017/S0007114517003464]; Pan YL, 2010, BRIT J NUTR, V103, P1746, DOI 10.1017/S0007114510000097; Pop V, 2010, J NEUROSCI, V30, P9831, DOI 10.1523/JNEUROSCI.6194-09.2010; R Core Team, 2013, R LANG ENV STAT COMP; Rhodes MG, 2004, PSYCHOL AGING, V19, P482, DOI 10.1037/0882-7974.19.3.482; Riemer S, 2018, APPL ANIM BEHAV SCI, V206, P87, DOI 10.1016/j.applanim.2018.05.016; Rosado B, 2012, VET J, V194, P189, DOI 10.1016/j.tvjl.2012.03.025; Rosado B, 2012, VET J, V194, P196, DOI 10.1016/j.tvjl.2012.03.023; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Salthouse TA, 2001, INTELLIGENCE, V29, P93, DOI 10.1016/S0160-2896(00)00040-4; Salvin HE, 2011, J VET BEHAV, V6, P313, DOI 10.1016/j.jveb.2011.04.004; Salvin HE, 2011, VET J, V188, P331, DOI 10.1016/j.tvjl.2010.05.014; Salvin HE, 2010, VET J, V184, P277, DOI 10.1016/j.tvjl.2009.11.007; Shatil E, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00008; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Siwak CT, 2005, PROG NEURO-PSYCHOPH, V29, P461, DOI 10.1016/j.pnpbp.2004.12.011; Siwak CT, 2002, PHYSIOL BEHAV, V75, P65, DOI 10.1016/S0031-9384(01)00632-1; Snigdha S, 2016, NEUROBIOL AGING, V37, P171, DOI 10.1016/j.neurobiolaging.2015.09.015; Starling MJ, 2013, VET J, V197, P868, DOI 10.1016/j.tvjl.2013.05.019; Stewart L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135176; Streiner DL, 2003, J PERS ASSESS, V80, P217, DOI 10.1207/S15327752JPA8003_01; Studzinski CM, 2006, NEUROBIOL LEARN MEM, V86, P197, DOI 10.1016/j.nlm.2006.02.005; Svartberg K, 2005, APPL ANIM BEHAV SCI, V91, P103, DOI 10.1016/j.applanim.2004.08.030; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Szabo D, 2016, J VET BEHAV, V11, P86, DOI 10.1016/j.jveb.2015.08.003; Tapp PD, 2003, LEARN MEMORY, V10, P148, DOI 10.1101/lm.56503; Tapp PD, 2003, LEARN MEMORY, V10, P64, DOI 10.1101/lm.54403; Turcsan B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195448; Turcsan B, 2011, APPL ANIM BEHAV SCI, V132, P61, DOI 10.1016/j.applanim.2011.03.006; Valenzuela M, 2009, INDIAN J PSYCHIAT, V51, pS16; van Horik JO, 2016, ANIM BEHAV, V114, P189, DOI 10.1016/j.anbehav.2016.02.006; VAUGHAN LC, 1990, VET REC, V126, P379; Wallis L, 2014, FRONTIERS PSYCHOL, P71; Wallis LJ, 2020, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00493; Wallis LJ, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00200; Wallis LJ, 2016, AGE, V38, DOI 10.1007/s11357-015-9866-x; Wallis LJ, 2016, THESIS; Wasylyshyn C, 2011, PSYCHOL AGING, V26, P15, DOI 10.1037/a0020912; Weiler JA, 2008, LEARN MEMORY, V15, P190, DOI 10.1101/lm.890408	109	8	8	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238517	10.1371/journal.pone.0238517	http://dx.doi.org/10.1371/journal.pone.0238517			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU5BZ	32936808	gold, Green Published			2022-12-26	WOS:000573658000013
J	Galistu, A; D'Aquila, PS				Galistu, Adriana; D'Aquila, Paolo S.			Memantine effects on ingestion microstructure and the effect of administration time: A within-subject study	PLOS ONE			English	Article							MEDIATED BEHAVIORAL ACTIVATION; NMDA-RECEPTOR ANTAGONIST; SUCROSE CONCENTRATION; RATS LICKING; EATING-DISORDER; DOPAMINE; FOOD; RESPONSES; PIMOZIDE; BRAIN	In a between-subject comparison of two memantine administration schedules we observed that treatment with the NMDA receptor antagonist memantine before testing sessions reduced ingestion of a 10% sucrose solution in rats, due to reduced licking burst size, thus suggesting a blunted hedonic response. Conversely, daily post-session administration reduced burst number, indicating a reduced level of behavioural activation, likely due to the development of conditioned taste aversion (CTA). In this study, the effect of pre-session and post-session memantine administration was investigated within-subjects. Memantine was administered in daily intraperitoneal injections for 13 days, on alternate days, either 1-h before-"before testing" sessions-or immediately after a 30-min session-"after testing" sessions. The effects on the microstructure of licking for a 10% sucrose solution were examined in the course of treatment and for 21 days after treatment discontinuation. The results show reduced burst size in the "before testing" sessions, without effects on the intra-burst lick rate, an index of motoric effects. Moreover, burst number was reduced since the third session of both administration conditions until the end of treatment. Interestingly, the effect of memantine of reducing the activation of ingestive behaviour was less pronounced in this study with respect to that observed with the previous study post-session administration schedule, in spite of the longer treatment. This apparent paradox might be explained if one considers these effects as instances of a memory-related effect, such as the development of CTA. In the framework of this hypothesis, the "before testing" sessions, not being followed by memantine administration, can be considered as extinction sessions performed every other day. Moreover, the animals treated with memantine at the highest dose failed to recover to pre-treatment ingestion levels 21 days after treatment discontinuation, while the animals treated after testing sessions in the previously published study showed a complete recovery well before the 15(th)day test. Within the same interpretative framework, this might depend by the reduced number and frequency of the extinction trials-i.e. the number of the sessions run after treatment discontinuation-in the present study. These results provide further support to the conclusion that memantine administration before sessions reduce burst size, an effect which is likely due to blockade of NMDA receptors occurring during behavioural testing. The observation that this effect can be obtained even in absence of a reduced intra-burst lick rate, which rules out the involvement of motor impairment, provides an important piece of evidence in support to the interpretation of this effect as a blunted hedonic response. Moreover, these results provide further evidence that burst number reduction is due to a memory-related effect induced by memantine administration after sessions.	[Galistu, Adriana; D'Aquila, Paolo S.] Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy	University of Sassari	D'Aquila, PS (corresponding author), Univ Sassari, Dipartimento Sci Biomed, Sassari, Italy.	dsfpaolo@uniss.it	D'Aquila, Paolo S./H-5389-2011	D'Aquila, Paolo S./0000-0002-7885-9988	Fondazione di Sardegna [U500.2013/AI.424.MGB]; University of Sassari Research Fund	Fondazione di Sardegna(Fondazione Banco di Sardegna); University of Sassari Research Fund	This work was supported by the Fondazione di Sardegna (U500.2013/AI.424.MGB to PSD) and by the University of Sassari Research Fund 2019 (PSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 1997, NEUROBIOL LEARN MEM, V68, P189, DOI 10.1006/nlme.1997.3773; Bisaga A, 2008, EUR NEUROPSYCHOPHARM, V18, P794, DOI 10.1016/j.euroneuro.2008.05.004; Brennan BP, 2008, INT J EAT DISORDER, V41, P520, DOI 10.1002/eat.20541; Carletti R, 2017, CURR OPIN PHARMACOL, V35, P94, DOI 10.1016/j.coph.2017.07.008; Chen HSV, 2006, J NEUROCHEM, V97, P1611, DOI 10.1111/j.1471-4159.2006.03991.x; D'Aquila PS, 2020, PHYSIOL BEHAV, V224, DOI 10.1016/j.physbeh.2020.113032; D'Aquila PS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177705; D'Aquila PS, 2010, NEUROPHARMACOLOGY, V58, P1085, DOI 10.1016/j.neuropharm.2010.01.017; DAVIS JD, 1989, ANN NY ACAD SCI, V575, P106; DAVIS JD, 1992, BEHAV NEUROSCI, V106, P217, DOI 10.1037/0735-7044.106.1.217; De Chiara L, 2014, RIV PSICHIATR, V49, P192, DOI 10.1708/1600.17462; Dwyer DM, 2012, Q J EXP PSYCHOL, V65, P371, DOI 10.1080/17470218.2011.652969; Foltin RW, 2008, PSYCHOPHARMACOLOGY, V199, P583, DOI 10.1007/s00213-008-1178-8; FOWLER SC, 1992, BEHAV NEUROSCI, V106, P386, DOI 10.1037/0735-7044.106.2.386; Freeman CR, 2018, FRONT BIOSCI-LANDMRK, V23, P2255, DOI 10.2741/4704; Galistu A, 2020, PSYCHOPHARMACOLOGY, V237, P103, DOI 10.1007/s00213-019-05348-3; Galistu A, 2013, PSYCHOPHARMACOLOGY, V229, P357, DOI 10.1007/s00213-013-3110-0; GRAMLING SE, 1986, PHARMACOL BIOCHEM BE, V25, P219, DOI 10.1016/0091-3057(86)90256-X; GRAMLING SE, 1984, PHARMACOL BIOCHEM BE, V21, P617, DOI 10.1016/S0091-3057(84)80047-7; Hermanussen M, 2005, ECON HUM BIOL, V3, P329, DOI 10.1016/j.ehb.2005.04.001; Higgs S, 1998, PSYCHOPHARMACOLOGY, V139, P342, DOI 10.1007/s002130050725; JACKSON A, 1989, NEUROPHARMACOLOGY, V28, P459, DOI 10.1016/0028-3908(89)90079-8; Johnson AW, 2018, LEARN MOTIV, V61, P85, DOI 10.1016/j.lmot.2017.07.001; Johnson AW, 2018, INT J DEV NEUROSCI, V64, P38, DOI 10.1016/j.ijdevneu.2017.06.012; Lu S, 2018, ANN CLIN PSYCHIATRY, V30, P234; Lydall ES, 2010, PSYCHOPHARMACOLOGY, V209, P153, DOI 10.1007/s00213-010-1779-x; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Popik P, 2011, AMINO ACIDS, V40, P477, DOI 10.1007/s00726-010-0659-3; Robbins TW, 2007, PSYCHOPHARMACOLOGY, V191, P433, DOI 10.1007/s00213-006-0528-7; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; SCHNEIDER LH, 1990, EUR J PHARMACOL, V186, P61, DOI 10.1016/0014-2999(90)94060-B; Smith GP, 2001, APPETITE, V36, P84, DOI 10.1006/appe.2000.0371; Smith KL, 2015, NEUROPSYCHOPHARMACOL, V40, P1163, DOI 10.1038/npp.2014.299; SPANAGEL R, 1994, EUR J PHARMACOL, V262, P21, DOI 10.1016/0014-2999(94)90023-X; Spector AC, 1998, BEHAV NEUROSCI, V112, P678, DOI 10.1037/0735-7044.112.3.678; Traverso LM, 2012, PHARMACOL BIOCHEM BE, V100, P645, DOI 10.1016/j.pbb.2011.11.012; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Vardigan JD, 2010, PHARMACOL BIOCHEM BE, V95, P223, DOI 10.1016/j.pbb.2010.01.010; Wenzel A, 1997, J NEUROCHEM, V68, P469	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0239270	10.1371/journal.pone.0239270	http://dx.doi.org/10.1371/journal.pone.0239270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936829	Green Published, gold			2022-12-26	WOS:000573658000025
J	Ren, HW; Zuo, SK; Hou, YY; Shang, WL; Liu, N; Yin, ZM				Ren, Huiwen; Zuo, Shengkai; Hou, Yayan; Shang, Wenlong; Liu, Na; Yin, Zhuming			Inhibition of alpha 1-adrenoceptor reduces TGF-beta 1-induced epithelial-to-mesenchymal transition and attenuates UUO-induced renal fibrosis in mice	FASEB JOURNAL			English	Article						epithelia-mesenchymal transition; renal fibrosis; sympathetic nerve activity; tamsulosin; transforming growth factor-beta 1; alpha 1-adrenoceptor	PROTEIN-KINASE; ANGIOTENSIN-II; ADENOSINE A(1); KIDNEY; P38; ACTIVATION; CELLS; TRANSDIFFERENTIATION; PHOSPHORYLATION; NOREPINEPHRINE	Renal fibrosis is a common pathological hallmark of chronic kidney disease (CKD). Renal sympathetic nerve activity is elevated in patients and experimental animals with CKD and contributes to renal interstitial fibrosis in obstructive nephropathy. However, the mechanisms underlying sympathetic overactivation in renal fibrosis remain unknown. Norepinephrine (NE), the main sympathetic neurotransmitter, was found to promote TGF-beta 1-induced epithelial-mesenchymal transition (EMT) and fibrotic gene expression in the human renal proximal epithelial cell line HK-2. Using both genetic and pharmacological approaches, we identified that NE binds G alpha q-coupled alpha 1-adrenoceptor (alpha 1-AR) to enhance EMT of HK-2 cells by activating p38/Smad3 signaling. Inhibition of p38 diminished the NE-exaggerated EMT process and increased the fibrotic gene expression in TGF-beta 1-treated HK-2 cells. Moreover, the pharmacological blockade of alpha 1-AR reduced the kidney injury and renal fibrosis in a unilateral ureteral obstruction mouse model by suppressing EMT in the kidneys. Thus, sympathetic overactivation facilitates EMT of renal epithelial cells and fibrosis via the alpha 1-AR/p38/Smad3 signaling pathway, and alpha 1-AR inhibition may be a promising approach toward treating renal fibrosis.	[Ren, Huiwen; Zuo, Shengkai; Hou, Yayan; Shang, Wenlong; Liu, Na] Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, Tianjin Key Lab Inflammat Biol, Tianjin, Peoples R China; [Yin, Zhuming] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Oncoplast Surg, Tianjin, Peoples R China; [Yin, Zhuming] Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Yin, Zhuming] Sino Russian Joint Res Ctr Oncoplast Breast Surg, Tianjin, Peoples R China; [Yin, Zhuming] Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin, Peoples R China; [Yin, Zhuming] Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Yin, Zhuming] Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Ren, HW (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Pharmacol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China.	renhuiwen@tmu.edu.cn	Zuo, Shengkai/GVO-9978-2022	Zuo, Shengkai/0000-0003-0040-4470	National Natural Science Foundation of China [81703591, 81703167]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grants 81703591 and 81703167)	Bariety J, 2003, NEPHROL DIAL TRANSPL, V18, P1777, DOI 10.1093/ndt/gfg231; Burnstock G, 2017, AUTON NEUROSCI-BASIC, V204, P4, DOI 10.1016/j.autneu.2016.05.007; Chen JH, 2015, AM J TRANSL RES, V7, P1553; Cho BR, 2018, DRUG DES DEV THER, V12, P1855, DOI 10.2147/DDDT.S164049; Das NA, 2020, CELL SIGNAL, V68, DOI 10.1016/j.cellsig.2019.109506; Falke LL, 2015, NAT REV NEPHROL, V11, P233, DOI 10.1038/nrneph.2014.246; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Furukawa F, 2003, HEPATOLOGY, V38, P879, DOI 10.1053/jhep.2003.50384; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Haddad L, 2018, J MATERN-FETAL NEO M, V31, P191, DOI 10.1080/14767058.2017.1280017; Hayes SA, 2003, ONCOGENE, V22, P4841, DOI 10.1038/sj.onc.1206730; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; Ichikawa H, 2013, ANN ANAT, V195, P50, DOI 10.1016/j.aanat.2012.05.004; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kamato D, 2017, CELL MOL LIFE SCI, V74, P1379, DOI 10.1007/s00018-016-2405-9; Kim J, 2015, KIDNEY INT, V87, P350, DOI 10.1038/ki.2014.300; Kim J, 2013, J AM SOC NEPHROL, V24, P229, DOI 10.1681/ASN.2012070678; Klein IHHT, 2003, J AM SOC NEPHROL, V14, P3239, DOI 10.1097/01.ASN.0000098687.01005.A5; Klein JD, 2006, AM J PHYSIOL-RENAL, V291, pF952, DOI 10.1152/ajprenal.00173.2006; Kohno M, 2014, CHEM BIOL, V21, P1522, DOI 10.1016/j.chembiol.2014.09.008; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Li QJ, 2018, LIFE SCI, V207, P1, DOI 10.1016/j.lfs.2018.05.003; Lohse MJ, 2015, J MOL MED, V93, P955, DOI 10.1007/s00109-015-1323-x; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Ma TT, 2019, ADV EXP MED BIOL, V1165, P347, DOI 10.1007/978-981-13-8871-2_16; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Moon JA, 2006, KIDNEY INT, V70, P1234, DOI 10.1038/sj.ki.5001775; Nishi EE, 2015, EXP PHYSIOL, V100, P479, DOI 10.1113/expphysiol.2014.079889; Nonogaki K, 2017, NEUROSCI LETT, V638, P35, DOI 10.1016/j.neulet.2016.12.008; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Pereira MMC, 1998, BRIT J PHARMACOL, V125, P697, DOI 10.1038/sj.bjp.0702128; Piascik MT, 2001, J PHARMACOL EXP THER, V298, P403; Puhl SL, 2016, BRIT J PHARMACOL, V173, P88, DOI 10.1111/bph.13339; Robinson AJ, 2001, BRIT J PHARMACOL, V133, P1378, DOI 10.1038/sj.bjp.0704200; Seccia TM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003888; Shen N, 2013, KIDNEY INT, V84, P64, DOI 10.1038/ki.2013.82; Shimizu T, 1999, EXP CELL RES, V251, P424, DOI 10.1006/excr.1999.4582; Song S, 2018, J MOL ENDOCRINOL, V61, P101, DOI 10.1530/JME-18-0069; Spencer BH, 2018, PHARMACOLOGY, V102, P17, DOI 10.1159/000488713; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257; Veelken R, 2008, J AM SOC NEPHROL, V19, P1371, DOI 10.1681/ASN.2007050552; Vongwiwatana A, 2005, AM J TRANSPLANT, V5, P1367, DOI 10.1111/j.1600-6143.2005.00843.x; Wang YY, 2018, DIABETES, V67, P1748, DOI 10.2337/db17-1521; Wasilewska A, 2011, PEDIATR NEPHROL, V26, P579, DOI 10.1007/s00467-011-1773-5; Yamaguchi Y, 2009, AM J KIDNEY DIS, V54, P653, DOI 10.1053/j.ajkd.2009.05.009; Yan JD, 2009, ACTA PHARMACOL SIN, V30, P994, DOI 10.1038/aps.2009.56; Yan R, 2019, J CELL BIOCHEM, V120, P6998, DOI 10.1002/jcb.27937; Yang JW, 2002, J AM SOC NEPHROL, V13, P2464, DOI 10.1097/01.ASN.0000031827.16102.C1; Yoshida S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00008; Yoshinaga T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167848; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zoccali C, 2002, HYPERTENSION, V40, P41, DOI 10.1161/01.HYP.0000022063.50739.60; Zuo SK, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708237	56	6	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14892	14904		10.1096/fj.202000737RRR	http://dx.doi.org/10.1096/fj.202000737RRR		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939891	Bronze			2022-12-26	WOS:000570944300001
J	Salinero, AE; Robison, LS; Gannon, OJ; Riccio, D; Mansour, F; Abi-Ghanem, C; Zuloaga, KL				Salinero, Abigail E.; Robison, Lisa S.; Gannon, Olivia J.; Riccio, David; Mansour, Febronia; Abi-Ghanem, Charly; Zuloaga, Kristen L.			Sex-specific effects of high-fat diet on cognitive impairment in a mouse model of VCID	FASEB JOURNAL			English	Article						cerebral blood flow; diet-induced obesity; prediabetes; sex; vascular contributions to cognitive impairment and dementia	CAROTID-ARTERY OCCLUSION; BLOOD-FLOW; GLUCOSE-TOLERANCE; ALZHEIMER-DISEASE; HORMONE-THERAPY; VISCERAL FAT; OBESITY; ESTROGEN; DEMENTIA; MIDLIFE	Mid-life metabolic disease (ie, obesity, diabetes, and prediabetes) causes vascular dysfunction and is a risk factor for vascular contributions to cognitive impairment and dementia (VCID), particularly in women. Using middle-aged mice, we modeled metabolic disease (obesity/prediabetes) via chronic high-fat (HF) diet and modeled VCID via unilateral common carotid artery occlusion. VCID impaired spatial memory in both sexes, but episodic-like memory in females only. HF diet caused greater weight gain and glucose intolerance in middle-aged females than males. HF diet alone impaired episodic-like memory in both sexes, but spatial memory in females only. Finally, the combination of HF diet and VCID elicited cognitive impairments in all tests, in both sexes. Sex-specific correlations were found between metabolic outcomes and memory. Notably, both visceral fat and the pro-inflammatory cytokine tumor necrosis factor alpha correlated with spatial memory deficits in middle-aged females, but not males. Overall, our data show that HF diet causes greater metabolic impairment and a wider array of cognitive deficits in middle-aged females than males. The combination of HF diet with VCID elicits deficits across multiple cognitive domains in both sexes. Our data are in line with clinical data, which shows that mid-life metabolic disease increases VCID risk, particularly in females.	[Salinero, Abigail E.; Robison, Lisa S.; Gannon, Olivia J.; Riccio, David; Mansour, Febronia; Abi-Ghanem, Charly; Zuloaga, Kristen L.] Albany Med Coll, Dept Neurosci & Expt Therapeut, 47 New Scotland Ave,MC-136, Albany, NY 12208 USA	Albany Medical College	Zuloaga, KL (corresponding author), Albany Med Coll, Dept Neurosci & Expt Therapeut, 47 New Scotland Ave,MC-136, Albany, NY 12208 USA.	zuloagk@amc.edu		Robison, Lisa/0000-0002-5110-9183	American Heart Association (AHA) [16SDG2719001]; HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS) [R01NS110749]; HHS \ NIH \ National Institute on Aging (NIA) [R01NS110749]	American Heart Association (AHA)(American Heart Association); HHS \ NIH \ National Institute of Neurological Disorders and Stroke (NINDS); HHS \ NIH \ National Institute on Aging (NIA)	American Heart Association (AHA), Grant/Award Number: 16SDG2719001; HHS vertical bar NIH vertical bar National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS110749; HHS vertical bar NIH vertical bar National Institute on Aging (NIA), Grant/Award Number: R01NS110749	Ahnstedt H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00659; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; CDC, 2017, NAT DIAB STAT REP 20, V2018; Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588; Cora MC, 2015, TOXICOL PATHOL, V43, P776, DOI 10.1177/0192623315570339; Cui D, 2019, NEUROREPORT, V30, P441, DOI 10.1097/WNR.0000000000001224; Curb JD, 1999, NEUROLOGY, V52, P971, DOI 10.1212/WNL.52.5.971; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Deutsch C, 2009, MICROVASC RES, V78, P100, DOI 10.1016/j.mvr.2009.04.004; Dominguez R, 2018, J STROKE CEREBROVASC, V27, P1743, DOI 10.1016/j.jstrokecerebrovasdis.2018.01.030; Dong S, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1351; Dow CA, 2015, APPL PHYSIOL NUTR ME, V40, P711, DOI 10.1139/apnm-2015-0006; Dybjer E, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0318-3; Dye L, 2017, P NUTR SOC, V76, P443, DOI 10.1017/S0029665117002014; Eringa EC, 2013, REV ENDOCR METAB DIS, V14, P39, DOI 10.1007/s11154-013-9239-7; Gannon OJ, 2019, NEUROCHEM INT, V127, P38, DOI 10.1016/j.neuint.2018.11.014; Geroldi C, 2005, ARCH NEUROL-CHICAGO, V62, P1067, DOI 10.1001/archneur.62.7.1067; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Gruzdeva O, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0856-8; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Johnson LA, 2016, EBIOMEDICINE, V3, P26, DOI 10.1016/j.ebiom.2015.12.008; Kaya E, 2008, MATURITAS, V59, P72, DOI 10.1016/j.maturitas.2007.10.004; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim JH, 2017, GLIA, V65, P1471, DOI 10.1002/glia.23174; Kim KW, 2017, INT J OBESITY, V41, P683, DOI 10.1038/ijo.2017.13; Koellhoffer EC, 2013, TRANSL STROKE RES, V4, P390, DOI 10.1007/s12975-012-0230-5; Liang MJ, 2019, J MAGN RESON IMAGING, V49, P1105, DOI 10.1002/jmri.26290; Lovejoy JC, 2008, INT J OBESITY, V32, P949, DOI 10.1038/ijo.2008.25; Lynch CM, 2013, STROKE, V44, P3195, DOI 10.1161/STROKEAHA.113.001366; Marseglia A, 2019, ALZHEIMERS DEMENT, V15, P25, DOI 10.1016/j.jalz.2018.06.3060; Marseglia A, 2018, J GERONTOL A-BIOL, V73, P400, DOI 10.1093/gerona/glx112; Matin N, 2016, AM J PHYSIOL-HEART C, V310, pH1321, DOI 10.1152/ajpheart.00890.2015; McCrimmon RJ, 2012, LANCET, V379, P2291, DOI 10.1016/S0140-6736(12)60360-2; Mikkola TS, 2017, J CLIN ENDOCR METAB, V102, P870, DOI 10.1210/jc.2016-3590; Miller VM, 2017, AM J PHYSIOL-HEART C, V313, pH1013, DOI 10.1152/ajpheart.00383.2017; OHKURA T, 1995, MENOPAUSE, V2, P13; Petrault O, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104536; Pires PW, 2018, MICROCIRCULATION, V25, DOI 10.1111/micc.12460; Pirimoglu ZM, 2011, CLIMACTERIC, V14, P453, DOI 10.3109/13697137.2010.539723; Pistell PJ, 2010, J NEUROIMMUNOL, V219, P25, DOI 10.1016/j.jneuroim.2009.11.010; Polycarpou A, 2016, AM J PHYSIOL-HEART C, V311, pH972, DOI 10.1152/ajpheart.00197.2016; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Robison LS, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0391-19.2019; Robison LS, 2019, BRAIN RES, V1710, P43, DOI 10.1016/j.brainres.2018.12.030; Rodriguez-Flores M, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-2; Ronan L, 2016, NEUROBIOL AGING, V47, P63, DOI 10.1016/j.neurobiolaging.2016.07.010; Rosano GMC, 2007, CLIMACTERIC, V10, P19, DOI 10.1080/13697130601114917; Salinero AE, 2018, INT J OBESITY, V42, P1088, DOI 10.1038/s41366-018-0023-3; Scheja L, 2019, NAT REV ENDOCRINOL, V15, P507, DOI 10.1038/s41574-019-0230-6; Selvarajah D, 2016, DIABETES VASC DIS RE, V13, P367, DOI 10.1177/1479164116644404; Simpson E, 1999, ENDOCR-RELAT CANCER, V6, P131, DOI 10.1677/erc.0.0060131; Takechi R, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00399; Thambisetty M, 2013, NEUROBIOL AGING, V34, P2271, DOI 10.1016/j.neurobiolaging.2013.03.025; Toppala S, 2019, J ALZHEIMERS DIS, V72, P215, DOI 10.3233/JAD-190691; van Bussel FCG, 2016, DIABETES, V65, P2404, DOI 10.2337/db16-0128; Wang LX, 2016, EXP NEUROL, V283, P353, DOI 10.1016/j.expneurol.2016.07.006; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P103, DOI 10.2174/156720507780362047; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16; Xue M, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100944; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Yamashiro K, 2014, EUR J NEUROL, V21, P667, DOI 10.1111/ene.12374; Yoshizaki K, 2008, EXP NEUROL, V210, P585, DOI 10.1016/j.expneurol.2007.12.005; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zhang Y, 2017, ENDOCRINE, V56, P65, DOI 10.1007/s12020-016-1197-x; Zhu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep42660; Zuloaga KL, 2016, J CEREBR BLOOD F MET, V36, P1257, DOI 10.1177/0271678X15616400; Zuloaga KL, 2015, TRANSL STROKE RES, V6, P390, DOI 10.1007/s12975-015-0412-z	67	7	7	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15108	15122		10.1096/fj.202000085R	http://dx.doi.org/10.1096/fj.202000085R		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939871	Green Accepted, Bronze			2022-12-26	WOS:000571367000001
J	Szulc, B; Sosicka, P; Maszczak-Seneczko, D; Skurska, E; Shauchuk, A; Olczak, T; Freeze, HH; Olczak, M				Szulc, Bozena; Sosicka, Paulina; Maszczak-Seneczko, Dorota; Skurska, Edyta; Shauchuk, Auhen; Olczak, Teresa; Freeze, Hudson H.; Olczak, Mariusz			Biosynthesis of GlcNAc-rich N- and O-glycans in the Golgi apparatus does not require the nucleotide sugar transporter SLC35A3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; nucleotide sugar transporter; N-glycan; O-glycan; UDP&#8211; N-acetylglucosamine; Golgi apparatus; glycobiology; glycoconjugate; glycoprotein biosynthesis; Golgi; transporter; CRISPR; Cas; membrane transport; post-translational modification (PTM)	UDP-GALACTOSE TRANSPORTER; CELL MUTANT DEFICIENT; ACETYLGLUCOSAMINE TRANSPORTER; MOLECULAR-CLONING; GLYCOSYLATION; EXPRESSION; MUTATIONS; COMPLEXES; DEFECT; GENE	Nucleotide sugar transporters, encoded by the SLC35 gene family, deliver nucleotide sugars throughout the cell for various glycosyltransferase-catalyzed glycosylation reactions. GlcNAc, in the form of UDP-GlcNAc, and galactose, as UDP-Gal, are delivered into the Golgi apparatus by SLC35A3 and SLC35A2 transporters, respectively. However, although the UDP-Gal transporting activity of SLC35A2 has been clearly demonstrated, UDP-GlcNAc delivery by SLC35A3 is not fully understood. Therefore, we analyzed a panel of CHO, HEK293T, and HepG2 cell lines including WT cells, SLC35A2 knockouts, SLC35A3 knockouts, and double-knockout cells. Cells lacking SLC35A2 displayed significant changes in N- and O-glycan synthesis. However, in SLC35A3-knockout CHO cells, only limited changes were observed; GlcNAc was still incorporated into N-glycans, but complex type N-glycan branching was impaired, although UDP-GlcNAc transport into Golgi vesicles was not decreased. In SLC35A3-knockout HEK293T cells, UDP-GlcNAc transport was significantly decreased but not completely abolished. However, N-glycan branching was not impaired in these cells. In CHO and HEK293T cells, the effect of SLC35A3 deficiency on N-glycan branching was potentiated in the absence of SLC35A2. Moreover, in SLC35A3-knockout HEK293T and HepG2 cells, GlcNAc was still incorporated into O-glycans. However, in the case of HepG2 cells, no qualitative changes in N-glycans between WT and SLC35A3 knockout cells nor between SLC35A2 knockout and double-knockout cells were observed. These findings suggest that SLC35A3 may not be the primary UDP-GlcNAc transporter and/or different mechanisms of UDP-GlcNAc transport into the Golgi apparatus may exist.	[Szulc, Bozena; Sosicka, Paulina; Maszczak-Seneczko, Dorota; Skurska, Edyta; Shauchuk, Auhen; Olczak, Teresa; Olczak, Mariusz] Univ Wroclaw, Fac Biotechnol, Wroclaw, Poland; [Sosicka, Paulina; Freeze, Hudson H.] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA USA	University of Wroclaw; Sanford Burnham Prebys Medical Discovery Institute	Olczak, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Wroclaw, Poland.	mariusz.olczak@uwr.edu.pl		Skurska, Edyta/0000-0002-8170-6616; Olczak, Mariusz/0000-0001-8629-6364; Szulc, Bozena/0000-0002-7782-9592; Olczak, Teresa/0000-0002-6140-8144; Maszczak-Seneczko, Dorota/0000-0002-5112-7920	National Science Center (Krakow, Poland) [2014/15/B/NZ3/00372, 2017/27/N/NZ3/00369]; Rocket Fund; National Institutes of Health [R01DK099551]	National Science Center (Krakow, Poland)(National Science Centre, Poland); Rocket Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Science Center (Krakow, Poland) Grants 2014/15/B/NZ3/00372 (to M. O.) and 2017/27/N/NZ3/00369 (to B. S.), funds from the Rocket Fund, and National Institutes of Health Grant R01DK099551 (to H. H. F). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abeijon C, 1996, P NATL ACAD SCI USA, V93, P5963, DOI 10.1073/pnas.93.12.5963; Toscanini MA, 2019, J BIOL CHEM, V294, P10042, DOI 10.1074/jbc.RA119.008827; Ahuja S, 2019, ELIFE, V8, DOI 10.7554/eLife.45221; Andersen PK, 2007, MOL MEMBR BIOL, V24, P519, DOI 10.1080/09687680701459877; Baptista CG, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0601-7; Bazan B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207521; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; Bruneel A, 2018, ELECTROPHORESIS, V39, P3123, DOI 10.1002/elps.201800021; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; Ebert B, 2018, NAT PLANTS, V4, P792, DOI 10.1038/s41477-018-0235-5; Edmondson AC, 2017, AM J MED GENET A, V173, P2758, DOI 10.1002/ajmg.a.38374; Edvardson S, 2013, J MED GENET, V50, P733, DOI 10.1136/jmedgenet-2013-101753; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; Guillen E, 1999, J BIOL CHEM, V274, P6641, DOI 10.1074/jbc.274.10.6641; Hadley B, 2019, COMPUT STRUCT BIOTEC, V17, P1123, DOI 10.1016/j.csbj.2019.08.002; HARA T, 1989, J BIOCHEM-TOKYO, V106, P236, DOI 10.1093/oxfordjournals.jbchem.a122838; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Ishida N, 1996, J BIOCHEM, V120, P1074; Ishida N, 2005, GENOMICS, V85, P106, DOI 10.1016/j.ygeno.2004.09.010; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Khoder-Agha F, 2019, CELL MOL LIFE SCI, V76, P1821, DOI 10.1007/s00018-019-03032-5; Kim S, 2001, GLYCOCONJUGATE J, V18, P623, DOI 10.1023/A:1020691619908; Kudelka MR, 2016, NAT METHODS, V13, P81, DOI [10.1038/NMETH.3675, 10.1038/nmeth.3675]; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Marini C, 2017, AM J MED GENET A, V173, P1119, DOI 10.1002/ajmg.a.38112; Maszczak-Seneczko D, 2016, METHODS MOL BIOL, V1496, P133, DOI 10.1007/978-1-4939-6463-5_11; Maszczak-Seneczko D, 2015, J BIOL CHEM, V290, P15475, DOI 10.1074/jbc.M115.636670; Maszczak-Seneczko D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.460543; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Maszczak-Seneczko D, 2011, ACTA BIOCHIM POL, V58, P413; Maszczak-Seneczko D, 2011, GLYCOCONJUGATE J, V28, P481, DOI 10.1007/s10719-011-9348-z; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; McDonald AG, 2014, J CELL SCI, V127, P5014, DOI 10.1242/jcs.151878; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Ng BG, 2019, HUM MUTAT, V40, P908, DOI 10.1002/humu.23731; Nji E, 2019, NAT STRUCT MOL BIOL, V26, P415, DOI 10.1038/s41594-019-0225-y; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Olczak M, 2013, BIOCHEM BIOPH RES CO, V434, P473, DOI 10.1016/j.bbrc.2013.03.098; Parker JL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12673-w; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; ROPP PA, 1991, J BIOL CHEM, V266, P23863; Song ZW, 2013, MOL ASPECTS MED, V34, P590, DOI 10.1016/j.mam.2012.12.004; Sosicka P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020276; Sosicka P, 2017, BBA-MOL CELL RES, V1864, P825, DOI 10.1016/j.bbamcr.2017.02.002; Sosicka P, 2014, BIOCHEM BIOPH RES CO, V454, P486, DOI 10.1016/j.bbrc.2014.10.098; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Varki A, 2017, ESSENTIALS GLYCOBIOL, V2015-2017; Yoshioka S, 1997, J BIOCHEM, V122, P691	52	9	9	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16445	16463		10.1074/jbc.RA119.012362	http://dx.doi.org/10.1074/jbc.RA119.012362			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32938718	Green Published, hybrid			2022-12-26	WOS:000598519500022
J	Yamasaki, T; Kohda, D				Yamasaki, Takahiro; Kohda, Daisuke			Uncoupling the hydrolysis of lipid-linked oligosaccharide from the oligosaccharyl transfer reaction by point mutations in yeast oligosaccharyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); epitope tag; free N-glycan (FNG); glycoprotein biosynthesis; membrane enzyme; N-linked glycosylation; oligosaccharyltransferase (OST); Saccharomyces cerevisiae; site-directed mutagenesis; substrate specificity; oligosaccharyltransferase; free oligosaccharide (fOS)	RETICULUM-ASSOCIATED DEGRADATION; N-GLYCOSYLATION; PROTEIN GLYCOSYLATION; STT3 PROTEIN; COMPLEX; SUBUNITS; OST3P; GENERATION; VERSATILE; ANTIBODY	Oligosaccharyltransferase (OST) is responsible for the first step in the N-linked glycosylation, transferring an oligosaccharide chain onto asparagine residues to create glycoproteins. In the absence of an acceptor asparagine, OST hydrolyzes the oligosaccharide donor, releasing free N-glycans (FNGs) into the lumen of the endoplasmic reticulum (ER). Here, we established a purification method for mutated OSTs using a high-affinity epitope tag attached to the catalytic subunit Stt3, from yeast cells co-expressing the WT OST to support growth. The purified OST protein with mutations is useful for wide-ranging biochemical experiments. We assessed the effects of mutations in the Stt3 subunit on the two enzymatic activities in vitro, as well as their effects on the N-glycan attachment and FNG content levels in yeast cells. We found that mutations in the first DXD motif increased the FNG generation activity relative to the oligosaccharyl transfer activity, both in vitro and in vivo, whereas mutations in the DK motif had the opposite effect; the decoupling of the two activities may facilitate future deconvolution of the reaction mechanism. The isolation of the mutated OSTs also enabled us to identify different enzymatic properties in OST complexes containing either the Ost3 or Ost6 subunit and to find a 15-residue peptide as a better-quality substrate than shorter peptides. This toolbox of mutants, substrates, and methods will be useful for investigations of the molecular basis and physiological roles of the OST enzymes in yeast and other organisms.	[Yamasaki, Takahiro; Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Fukuoka, Japan	Kyushu University	Kohda, D (corresponding author), Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Fukuoka, Japan.	kohda@bioreg.kyushu-u.ac.jp		Yamasaki, Takahiro/0000-0002-3102-9952; Kohda, Daisuke/0000-0001-8234-3776	Japan Society for the Promotion of Science KAKENHI [JP24370047, JP26119001, JP26119002]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants JP24370047, JP26119001, and JP26119002 (to D. K.)	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bai L, 2018, NATURE, V555, P328, DOI 10.1038/nature25755; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Chantret I, 2011, J BIOL CHEM, V286, P41786, DOI 10.1074/jbc.M111.251371; Chavan M, 2006, P NATL ACAD SCI USA, V103, P8947, DOI 10.1073/pnas.0603262103; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Dwivedi R, 2013, BIOPOLYMERS, V99, P772, DOI 10.1002/bip.22296; Einhauer A, 2001, J CHROMATOGR A, V921, P25, DOI 10.1016/S0021-9673(01)00831-7; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Harada Y, 2015, GLYCOBIOLOGY, V25, P1196, DOI 10.1093/glycob/cwv055; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Igura M, 2011, GLYCOBIOLOGY, V21, P575, DOI 10.1093/glycob/cwq196; Karaoglu D, 1997, J BIOL CHEM, V272, P32513, DOI 10.1074/jbc.272.51.32513; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; Kohda D, 2018, ADV EXP MED BIOL, V1104, P171, DOI 10.1007/978-981-13-2158-0_9; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Li GT, 2005, J BIOL CHEM, V280, P1864, DOI 10.1074/jbc.M410969200; Locatelli-Hoops SC, 2013, BBA-PROTEINS PROTEOM, V1834, P2045, DOI 10.1016/j.bbapap.2013.06.003; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu H, 2018, P NATL ACAD SCI USA, V115, P9557, DOI 10.1073/pnas.1806034115; Matsumoto S, 2017, BIOCHEMISTRY-US, V56, P602, DOI 10.1021/acs.biochem.6b01089; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Niu GT, 2020, FEBS OPEN BIO, V10, P468, DOI 10.1002/2211-5463.12804; Nothaft H, 2009, P NATL ACAD SCI USA, V106, P15019, DOI 10.1073/pnas.0903078106; Poljak K, 2018, MOL CELL PROTEOMICS, V17, P32, DOI 10.1074/mcp.RA117.000096; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Shrimal S, 2019, MOL BIOL CELL, V30, P2626, DOI 10.1091/mbc.E19-06-0330; Shrimal S, 2019, GLYCOBIOLOGY, V29, P288, DOI 10.1093/glycob/cwy093; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Spirig U, 1997, MOL GEN GENET, V256, P628, DOI 10.1007/s004380050611; Widlund PO, 2005, YEAST, V22, P769, DOI 10.1002/yea.1244; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Yamasaki T, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3186	42	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16072	16085		10.1074/jbc.RA120.015013	http://dx.doi.org/10.1074/jbc.RA120.015013			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32938717	Green Published, hybrid			2022-12-26	WOS:000595657900023
J	Hao, FC; Sun, LJ; Zhao, FJ				Hao, Fuchang; Sun, Lijuan; Zhao, Fajun			Borehole diameter shrinkage rule considering rheological properties and its effect on gas extraction	PLOS ONE			English	Article							WEAK ROCK; CREEP; MODEL; COAL; STABILITY; MECHANISM; DAMAGE	To study the shrinkage rule of borehole diameter and its effect on gas extraction, a visco-elastoplastic model for boreholes considering strain softening and the dilatancy characteristic was established to obtain the expressions of the coal stress, variation in diameter, and pressure relief range. The stress distribution and pressure relief effect of the boreholes in soft and hard coal seams were comparatively analyzed. The shrinkage rule of the borehole diameter was studied. The reasons for the rapid reduction in the extraction concentration of the borehole in soft coal seams were described. A technology of improving the gas extraction effect in soft coal seams was developed. The research results showed that the radius of the plastic softening zone is 0.405 m for a borehole in a soft coal seam and 0.224 m for that in a hard coal seam. This indicates that the borehole in a soft coal seam has a better pressure relief effect. The boreholes in both hard and soft coal seams will incur a shrinkage phenomenon; however, the soft coal seam has low strength and a weak ability to resist damage, and thus the surrounding coal will have a more intense creep deformation, leading to an instability failure during a short period of time and thus, a blocking of the extraction channel, thereby causing a rapid reduction in the gas extraction concentration. The borehole in a hard coal seam also shows a shrinkage phenomenon, but remains in a stable state without a blockage; thus, high-concentration gas can be extracted from this borehole for a long period of time. The geo-stress and coal strength are the two main factors controlling the amplitude of borehole shrinkage. From an increase in stress, the borehole in a hard coal seam shows a more intense creep deformation in a deep mine, which may lead to blockage. The key to improving the gas extraction effect in soft coal seams is to maintain a smooth extraction channel. The full screen pipe is installed through the drill pipe to retain an extraction channel, leading to an average gas extraction increase from 0.043 m(3)/min to 0.12 m(3)/min, an increase of 2.77 times. These research results are consistent with actual production, and can provide theoretical guidance for determining the gas extraction parameters.	[Hao, Fuchang; Sun, Lijuan; Zhao, Fajun] Henan Polytech Univ, State Key Lab Cultivat Base Gas Geol & Gas Contro, Jiaozuo, Henan, Peoples R China; [Hao, Fuchang; Zhao, Fajun] Collaborat Innovat Ctr Coal Safety Prod Henan Pro, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University	Hao, FC (corresponding author), Henan Polytech Univ, State Key Lab Cultivat Base Gas Geol & Gas Contro, Jiaozuo, Henan, Peoples R China.; Hao, FC (corresponding author), Collaborat Innovat Ctr Coal Safety Prod Henan Pro, Jiaozuo, Henan, Peoples R China.	haofuchang@163.com			National Natural Science Funds of China [51604092]; Henan Provincial Natural Science Founs [182300410128]; Henan Province Science and Technology Project [182102310828]; Fundamental Research Funds for the Universities of Henan Province	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Henan Provincial Natural Science Founs; Henan Province Science and Technology Project; Fundamental Research Funds for the Universities of Henan Province	This work was funded by the National Natural Science Funds of China (No. 51604092), the Henan Provincial Natural Science Founs (No. 182300410128), and the Henan Province Science and Technology Project (No. 182102310828), and the Fundamental Research Funds for the Universities of Henan Province.	Al-Ajmi AM, 2006, INT J ROCK MECH MIN, V43, P1200, DOI 10.1016/j.ijrmms.2006.04.001; AUBERTIN M, 1991, ROCK MECH ROCK ENG, V24, P81, DOI 10.1007/BF01032500; Bai JF, 2020, INT J BIOL MACROMOL, V142, P1, DOI 10.1016/j.ijbiomac.2019.12.001; Duan MK, 2020, ARAB J GEOSCI, V13, DOI 10.1007/s12517-020-5249-4; Duan MK, 2020, TRANSPORT POROUS MED, V131, P1007, DOI 10.1007/s11242-019-01375-y; Duan MK, 2020, J NAT GAS SCI ENG, V73, P1; Fabre G, 2006, INT J ROCK MECH MIN, V43, P950, DOI 10.1016/j.ijrmms.2006.02.004; Gao H, 2016, J NAT GAS SCI ENG, V36, P1276, DOI 10.1016/j.jngse.2016.02.035; Garcia HE, 2013, ENERGY, V52, P17, DOI 10.1016/j.energy.2012.11.032; Haimson B, 2007, INT J ROCK MECH MIN, V44, P157, DOI 10.1016/j.ijrmms.2006.06.002; HAYHURST DR, 1972, J MECH PHYS SOLIDS, V20, P381, DOI 10.1016/0022-5096(72)90015-4; Kanfar MF, 2015, INT J ROCK MECH MIN, V78, P36, DOI 10.1016/j.ijrmms.2015.04.024; Li YS, 2000, INT J ROCK MECH MIN, V37, P467, DOI 10.1016/S1365-1609(99)00073-8; Liu C, 2016, J NAT GAS SCI ENG, V36, P1303, DOI 10.1016/j.jngse.2016.03.026; Liu T, 2017, J NAT GAS SCI ENG, V44, P233, DOI 10.1016/j.jngse.2017.04.026; Liu T, 2016, GREENH GASES, V6, P597, DOI 10.1002/ghg.1591; Nawrocki PA, 1998, INT J ROCK MECH MIN, V35, P991, DOI 10.1016/S0148-9062(98)00012-6; Schoenball M, 2014, INT J ROCK MECH MIN, V70, P400, DOI 10.1016/j.ijrmms.2014.05.012; Sone H, 2014, INT J ROCK MECH MIN, V69, P120, DOI 10.1016/j.ijrmms.2014.04.002; STILLE H, 1989, INT J ROCK MECH MIN, V26, P99, DOI 10.1016/0148-9062(89)90530-5; Wang GJ, 2004, INT J ROCK MECH MIN, V41, P364, DOI 10.1016/j.ijrmms.2003.12.078; Wang HN, 2010, ACTA MECH, V210, P315, DOI 10.1007/s00707-009-0208-x; Wang YL, 2003, J PETROL SCI ENG, V38, P187, DOI 10.1016/S0920-4105(03)00032-9; Whittles DN, 2007, INT J COAL GEOL, V71, P313, DOI 10.1016/j.coal.2006.11.004; Yang WD, 2014, ROCK MECH ROCK ENG, V47, P1211, DOI 10.1007/s00603-013-0478-4; Yang WD, 2014, INT J ROCK MECH MIN, V66, P169, DOI 10.1016/j.ijrmms.2014.01.002; Zare-Reisabadi MR, 2012, INT J ROCK MECH MIN, V56, P77, DOI 10.1016/j.ijrmms.2012.07.018; Zhang HT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232182; Zhang WD, 2015, J PETROL SCI ENG, V129, P29, DOI 10.1016/j.petrol.2014.08.021; [周福宝 Zhou Fubao], 2016, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V45, P433	30	2	2	9	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239016	10.1371/journal.pone.0239016	http://dx.doi.org/10.1371/journal.pone.0239016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970705	Green Published, gold			2022-12-26	WOS:000576265600076
J	Iwuji, C; Chimukuche, RS; Zuma, T; Plazy, M; Larmarange, J; Orne-Gliemann, J; Siedner, M; Shahmanesh, M; Seeley, J				Iwuji, Collins; Chimukuche, Rujeko Samanthia; Zuma, Thembelihle; Plazy, Melanie; Larmarange, Joseph; Orne-Gliemann, Joanna; Siedner, Mark; Shahmanesh, Maryam; Seeley, Janet			Test but not treat: Community members' experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa	PLOS ONE			English	Article							QUALITATIVE RESEARCH; HIV; PREVENTION; INITIATION; INFECTION; CARE	Introduction Antiretroviral therapy (ART) has revolutionised the care of HIV-positive individuals resulting in marked decreases in morbidity and mortality, and markedly reduced transmission to sexual partners. However, these benefits can only be realised if individuals are aware of their HIV-positive status, initiated and retained on suppressive lifelong ART. Framed using the socio-ecological model, the present study explores factors contributing to poor ART uptake among community members despite high acceptance of HIV-testing within a Treatment as Prevention (TasP) trial. In this paper we identify barriers and facilitators to treatment across different levels of the socio-ecological framework covering individual, community and health system components. Methods This research was embedded within a cluster-randomised trial (ClinicalTrials.gov, number NCT01509508) of HIV treatment as Prevention in rural KwaZulu-Natal, South Africa. Data were collected between January 2013 and July 2014 from resident community members. Ten participants contributed to repeat in-depth interviews whilst 42 participants took part in repeat focus group discussions. Data from individual interviews and focus group discussions were triangulated using community walks to give insights into community members' perception of the barriers and facilitators of ART uptake. We used thematic analysis guided by a socio-ecological framework to analyse participants' narratives from both individual interviews and focus group discussions. Results Barriers and facilitators operating at the individual, community and health system levels influence ART uptake. Stigma was an over-arching barrier, across all three levels and expressed variably as fear of HIV disclosure, concerns about segregated HIV clinical services and negative community religious perceptions. Other barriers were individual (substance misuse, fear of ART side effects), community (alternative health beliefs). Facilitators cited by participants included individual (expectations of improved health and longer life expectancy following ART, single tablet regimens), community (availability of ART in the community through mobile trial facilities) and health system factors (fast and efficient service provided by friendly staff). Discussion We identified multiple barriers to achieving universal ART uptake. To enhance uptake in HIV care services, and achieve the full benefits of ART requires interventions that tackle persistent HIV stigma, and offer people with HIV respectful, convenient and efficient services. These interventions require evaluation in appropriately designed studies.	[Iwuji, Collins] Univ Sussex, Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Falmer, England; [Iwuji, Collins; Chimukuche, Rujeko Samanthia; Zuma, Thembelihle; Siedner, Mark; Shahmanesh, Maryam; Seeley, Janet] Africa Hlth Res Inst, Berea, Kwazulu Natal, South Africa; [Plazy, Melanie; Orne-Gliemann, Joanna] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, Bordeaux, France; [Larmarange, Joseph] Ctr Populat & Dev Ceped, Inst Rech Dev IRD, Paris, France; [Siedner, Mark] Harvard Med Sch, Boston, MA 02115 USA; [Shahmanesh, Maryam] UCL, Inst Global Hlth, London, England; [Seeley, Janet] London Sch Hyg & Trop Med, London, England	University of Brighton; University of Sussex; Africa Health Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Harvard University; Harvard Medical School; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Iwuji, C (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Dept Global Hlth & Infect, Falmer, England.; Iwuji, C (corresponding author), Africa Hlth Res Inst, Berea, Kwazulu Natal, South Africa.	c.iwuji@bsms.ac.uk	Iwuji, Collins/AAS-3246-2020; Larmarange, Joseph/I-5889-2015; Chidawanyika, Rujeko/AAU-9737-2020	Larmarange, Joseph/0000-0001-7097-700X; Chidawanyika, Rujeko/0000-0002-4890-2105; Iwuji, Collins/0000-0003-2045-1717; Seeley, Janet/0000-0002-0583-5272; PLAZY, Melanie/0000-0002-8971-6878	French National Agency for Aids and Viral Hepatitis Research (ANRS) [ANRS 12249]; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH [81151938]; International Initiative for Impact Evaluation, Inc. (3ie); Bill & Melinda Gates Foundation; Wellcome Trust; Academy of Medical Sciences, Grand Challenges Research Fund Networking Grant; HIV-Drug Resistance Elimination and Management (HDREAM) Network	French National Agency for Aids and Viral Hepatitis Research (ANRS)(ANRSFrench National Research Agency (ANR)); Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH; International Initiative for Impact Evaluation, Inc. (3ie); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust(Wellcome TrustEuropean Commission); Academy of Medical Sciences, Grand Challenges Research Fund Networking Grant; HIV-Drug Resistance Elimination and Management (HDREAM) Network	The French National Agency for Aids and Viral Hepatitis Research (ANRS) is the sponsor and co-funder of the trial; http://www.anrs.fr (ANRS 12249). The study received additional support from the Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH; https://www.giz.de/en/html/index.html (81151938). The research was also co-funded by the International Initiative for Impact Evaluation, Inc. (3ie), a grantee of the Bill & Melinda Gates Foundation; http://www.3ieimpact.org.The trial is conducted with the support of Merck & Co. Inc and Gilead Sciences that provided the Atripla (R) drug supply. The Africa Health Research Institute receives core funding from the Wellcome Trust, https://wellcome.ac.uk/which provides the platform for the population-and clinic based research at the Centre. The analysis addressed within this manuscript was funded by the Academy of Medical Sciences, Grand Challenges Research Fund Networking Grant; https://acmedsci.ac.uk, awarded to Deenan Pillay and Collins Iwuji in support of the HIV-Drug Resistance Elimination and Management (HDREAM) Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayieko J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202990; Bajunirwe F, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9619684; Bond V, 2019, HEALTH PLACE, V55, P87, DOI 10.1016/j.healthplace.2018.11.006; Bond V, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25117; Bor J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178249; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Chamie G, 2016, LANCET HIV, V3, pE111, DOI 10.1016/S2352-3018(15)00251-9; Chimbindi N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203193; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Grimsrud A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19984; Havlir D, 2018, 22 INT AIDS C 23 27; Havlir DV, 2019, NEW ENGL J MED, V381, P219, DOI 10.1056/NEJMoa1809866; Hayes B, 2017, FOOLPROOF, AND OTHER MATHEMATICAL MEDITATIONS, P71; Hayes R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-57; Hayes RJ, 2019, NEW ENGL J MED, V381, P207, DOI 10.1056/NEJMoa1814556; Hosegood V, 2009, DEMOGR RES, V20, P279, DOI 10.4054/DemRes.2009.20.13; Iwuji CC, 2015, J AIDS CLIN RES, P6; Iwuji CC, 2018, LANCET HIV, V5, pE116, DOI 10.1016/S2352-3018(17)30205-9; Iwuji CC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002107; Karim SSA, 2019, NEW ENGL J MED, V381, P286, DOI 10.1056/NEJMe1907279; Kawuma R, 2018, AJAR-AFR J AIDS RES, V17, P217, DOI 10.2989/16085906.2018.1490785; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Latkin CA, 2013, AM PSYCHOL, V68, P210, DOI 10.1037/a0032704; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Makhema J, 2019, NEW ENGL J MED, V381, P230, DOI 10.1056/NEJMoa1812281; Makhema MJ, 2018, 22 INT AIDS C 23 27; Musante K, 2010, PARTICIPANT OBSERVAT; Musheke M, 2013, AIDS PATIENT CARE ST, V27, P231, DOI 10.1089/apc.2012.0341; Orne-Gliemann J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1344-y; Pantelic M, 2015, AIDS BEHAV, V19, P137, DOI 10.1007/s10461-014-0852-6; Perriat D, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25048; Petersen M, 2017, JAMA-J AM MED ASSOC, V317, P2196, DOI 10.1001/jama.2017.5705; Petty NJ, 2012, MANUAL THER, V17, P378, DOI 10.1016/j.math.2012.03.004; Plazy M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20913; Probst C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017955; Ritchie J., 2013, QUALITATIVE RES PRAC; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Schwitters A, 2015, GLOB HEALTH-SCI PRAC, V3, P109, DOI 10.9745/GHSP-D-14-00145; Seeley J, 2019, AIDS BEHAV, V23, P929, DOI 10.1007/s10461-018-2335-7; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Szaflarski M, 2013, CURR HIV-AIDS REP, V10, P324, DOI 10.1007/s11904-013-0175-7; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; World health organisation (WHO), 2019, UN HLTH COV UHC; Yakob B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2830-6; Zou J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-75; Zuma T, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00073	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239513	10.1371/journal.pone.0239513	http://dx.doi.org/10.1371/journal.pone.0239513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970730	Green Published, Green Accepted, gold			2022-12-26	WOS:000576265600094
J	Tsukada, K; Matsumoto, Y; Shimada, M				Tsukada, Kaima; Matsumoto, Yoshihisa; Shimada, Mikio			Linker region is required for efficient nuclear localization of polynucleotide kinase phosphatase	PLOS ONE			English	Article							PROTEIN-KINASE; DNA; REPAIR; XRCC1; PNKP; KINASE/PHOSPHATASE; PHOSPHORYLATION; MUTATIONS; SEQUENCE; TRANSLOCATION	Polynucleotide kinase phosphatase (PNKP) is a DNA repair factor with dual enzymatic functions,i.e., phosphorylation of 5'-end and dephosphorylation of 3'-end, which are prerequisites for DNA ligation and, thus, is involved in multiple DNA repair pathways,i.e., base excision repair, single-strand break repair and double-strand break repair through non-homologous end joining. Mutations in PNKP gene causes inherited diseases, such as microcephaly and seizure (MCSZ) by neural developmental failure and ataxia with oculomotor apraxia 4 (AOA4) and Charcot-Marie-Tooth disease 2B2 (CMT2B2) by neurodegeneration. PNKP consists of the Forkhead-associated (FHA) domain, linker region, phosphatase domain and kinase domain. Although the functional importance of PNKP interaction with XRCC1 and XRCC4 through the FHA domain and that of phosphatase and kinase enzyme activities have been well established, little is known about the function of linker region. In this study, we identified a functional putative nuclear localization signal (NLS) of PNKP located in the linker region, and showed that lysine 138 (K138), arginine 139 (R139) and arginine 141 (R141) residues therein are critically important for nuclear localization. Furthermore, double mutant of K138A and R35A, the latter of which mutates arginine 35, central amino acid of FHA domain, showed additive effect on nuclear localization, indicating that the FHA domain as well as the NLS is important for PNKP nuclear localization. Thus, this study revealed two distinct mechanisms regulating nuclear localization and subnuclear distribution of PNKP. These findings would contribute to deeper understanding of a variety of DNA repair pathway,i.e., base excision repair, single-strand break repair and double-strand break repair.	[Tsukada, Kaima; Matsumoto, Yoshihisa; Shimada, Mikio] Tokyo Inst Technol, Inst Innovat Res, Lab Adv Nucl Energy, Tokyo, Japan	Tokyo Institute of Technology	Shimada, M (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Lab Adv Nucl Energy, Tokyo, Japan.	mshimada@lane.iir.titech.ac.jp	Shimada, Mikio/E-1565-2015; Matsumoto, Yoshihisa/G-3430-2017	Shimada, Mikio/0000-0003-1980-9187; Matsumoto, Yoshihisa/0000-0002-0758-290X; Tsukada, Kaima/0000-0002-6725-9514	Uehara Memorial Foundation; Takeda Science Foundation; Kato Memorial Bioscience Foundation; Japan Atomic Energy Agency; Chubu Electric Power; Japan Society for the Promotion of Science [20J13601, 15H02817, 17K20042, 20H04334]; Tokyo Tech ACEEES; Tokyo Tech ToTAL	Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kato Memorial Bioscience Foundation; Japan Atomic Energy Agency(Japan Atomic Energy Agency); Chubu Electric Power; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tokyo Tech ACEEES; Tokyo Tech ToTAL	This work was supported by The Uehara Memorial Foundation (to MS), Takeda Science Foundation (to MS), Kato Memorial Bioscience Foundation (to MS), Japan Atomic Energy Agency (to MS), Chubu Electric Power (to MS), Grants-inAid for Scientific Research from Japan Society for the Promotion of Science (20J13601 to KT, 15H02817, 17K20042 and 20H04334 to YM), Tokyo Tech ACEEES (to KT), and Tokyo Tech ToTAL (to KT).	Ali AAE, 2009, NUCLEIC ACIDS RES, V37, P1701, DOI 10.1093/nar/gkn1086; [Anonymous], 2015, TRANSPLANTATION DIRE, V1, pe2, DOI 10.1097/TXD.0000000000000509; [Anonymous], 1999, STATE ADM TRADITIONA, V4, P387; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Bras J, 2015, AM J HUM GENET, V96, P474, DOI 10.1016/j.ajhg.2015.01.005; Breslin C, 2009, MOL CELL BIOL, V29, P4653, DOI 10.1128/MCB.00677-09; Caldecott KW, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102664; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chalasani SL, 2018, DNA REPAIR, V68, P12, DOI 10.1016/j.dnarep.2018.05.002; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; Dumitrache LC, 2017, MECH AGEING DEV, V161, P121, DOI 10.1016/j.mad.2016.04.009; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fukuchi M, 2015, BIOCHEM BIOPH RES CO, V461, P687, DOI 10.1016/j.bbrc.2015.04.093; Hanssen-Bauer A, 2012, DNA REPAIR, V11, P357, DOI 10.1016/j.dnarep.2012.01.001; Hanzlikova H, 2018, MOL CELL, V71, P319, DOI 10.1016/j.molcel.2018.06.004; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; IIDA K, 1992, CELL STRUCT FUNCT, V17, P39, DOI 10.1247/csf.17.39; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Kalasova I, 2020, NUCL ACIDS RES, DOI 10.1093/nar/gkaa489; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kamdar RP, 2010, J RADIAT RES, V51, P303, DOI 10.1269/jrr.09146; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Kirby TW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13405; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Koike M, 1999, EXP CELL RES, V250, P401, DOI 10.1006/excr.1999.4507; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; LaVallee J, 2019, FEBS LETT, V593, P107, DOI 10.1002/1873-3468.13288; Leal A, 2018, NEUROGENETICS, V19, P215, DOI 10.1007/s10048-018-0555-7; Lee Y, 2009, NAT NEUROSCI, V12, P973, DOI 10.1038/nn.2375; Liu QY, 2010, CELL RES, V20, P948, DOI 10.1038/cr.2010.89; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; MORELAND RB, 1987, MOL CELL BIOL, V7, P4048, DOI 10.1128/MCB.7.11.4048; Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374; Parsons JL, 2012, NUCLEIC ACIDS RES, V40, P11404, DOI 10.1093/nar/gks909; Paucar M, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000049; Segal-Raz H, 2011, EMBO REP, V12, P713, DOI 10.1038/embor.2011.96; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Shimada M, 2015, EMBO J, V34, P2465, DOI 10.15252/embj.201591363; Zolner AE, 2011, NUCLEIC ACIDS RES, V39, P9224, DOI 10.1093/nar/gkr647	44	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239404	10.1371/journal.pone.0239404	http://dx.doi.org/10.1371/journal.pone.0239404			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970693	Green Published, gold			2022-12-26	WOS:000576265600061
J	Yashiro, T; Yura, S; Tobita, A; Toyoda, Y; Kasakura, K; Nishiyama, C				Yashiro, Takuya; Yura, Shiori; Tobita, Akari; Toyoda, Yuki; Kasakura, Kazumi; Nishiyama, Chiharu			Pterostilbene reduces colonic inflammation by suppressing dendritic cell activation and promoting regulatory T cell development	FASEB JOURNAL			English	Article						colitis; immunosuppression; pterostilbene; resveratrol	TRANSCRIPTIONAL REGULATION; EXPRESSION; RECEPTOR; KINASE; RESVERATROL; CALCINEURIN; INHIBITORS; SUBSTRATE; DISEASES; COLITIS	Dendritic cells (DCs) and T cells play important roles in immune regulation, and modulating their function is an approach for developing preventive or therapeutic strategies against immune disorders. Herein, the effect of pterostilbene (PSB) (3 ',5 '-dimethoxy-resveratrol)-a resveratrol-related polyphenol found in blueberries-on immune regulation was evaluated. Using an in vitro co-culture system, PSB was found to exert the strongest inhibitory effect among all tested resveratrol derivatives on DC-mediated T cell proliferation; moreover, PSB treatment decreased the Th1 and Th17 populations and increased the regulatory T cell (Treg) population. Upon co-stimulation with anti-CD3 and anti-CD28 antibodies, PSB inhibited CD4(+)T cell proliferation and differentiation into Th1 cells. Additionally, PSB acted on DCs to suppress the lipopolysaccharide-induced transactivation of genes encoding antigen presentation-related molecules and inflammatory cytokines by attenuating the DNA-binding ability of the transcription factor PU.1. Furthermore, PSB promoted DC-mediated Foxp3(+)Treg differentiation, and PU.1 knockdown increased DC-induced Treg activity. Oral administration of PSB alleviated the symptoms of dextran sulfate sodium-induced colitis and decreased tumor necrosis factor-alpha expression in mice. Thus, PSB treatment ameliorates colonic inflammation.	[Yashiro, Takuya; Yura, Shiori; Tobita, Akari; Toyoda, Yuki; Kasakura, Kazumi; Nishiyama, Chiharu] Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Tokyo, Japan	Tokyo University of Science	Yashiro, T (corresponding author), Tokyo Univ Sci, Fac Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, 6-3-1 Niijuku, Tokyo 1258585, Japan.	tyashiro@rs.tus.ac.jp	Nishiyama, Chiharu/GPW-9372-2022		MEXT; Tokyo Biochemical Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Takeda Science Foundation; Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists) [10792];  [19K05884];  [17K15275]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; Tojuro Iijima Foundation for Food Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was supported by a Grant-in-Aid for Challenging Exploratory Research (CN), Grant-in-Aid for Scientific Research (C) (TY; 19K05884), Grant-in-Aid for Young Scientists (B) (TY; 17K15275), the MEXT-Supported Program for the Strategic Research Foundation at Private Universities (Translational Research Center, Tokyo University of Science), the Tokyo Biochemical Research Foundation (CN), the Tojuro Iijima Foundation for Food Science and Technology (CN and TY), and the Takeda Science Foundation (CN). TY was supported by Research Fellowships of the Japanese Society for the Promotion of Science for Young Scientists (JSPS Research Fellowships for Young Scientists #10792)	Chang GM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9872073; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; Fonseca-Camarillo G, 2015, INFLAMM BOWEL DIS, V21, P2188, DOI 10.1097/MIB.0000000000000477; Fukai T, 2009, BIOCHEM BIOPH RES CO, V388, P102, DOI 10.1016/j.bbrc.2009.07.126; Gibson DJ, 2013, INFLAMM BOWEL DIS, V19, P2716, DOI 10.1097/MIB.0b013e31829ed7df; Guttman-Yassky E, 2017, CURR OPIN IMMUNOL, V48, P68, DOI 10.1016/j.coi.2017.08.008; Hamdorf M, 2011, STEM CELLS, V29, P297, DOI 10.1002/stem.564; Hawse WF, 2017, J IMMUNOL, V199, P589, DOI 10.4049/jimmunol.1700369; Inaba K, 2020, J IMMUNOL, V205, P822, DOI 10.4049/jimmunol.1901008; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Kanada S, 2011, BLOOD, V117, P2211, DOI 10.1182/blood-2010-06-291898; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Kessler Sean P, 2015, Int J Cell Biol, V2015, P745237, DOI 10.1155/2015/745237; Kitamura N, 2012, J ALLERGY CLIN IMMUN, V129, P814, DOI 10.1016/j.jaci.2011.10.019; Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Maeda K, 2006, BLOOD, V108, P262, DOI 10.1182/blood-2005-07-2878; Malaguarnera L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050946; Nunes S, 2018, NUTR RES REV, V31, P85, DOI 10.1017/S095442241700021X; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; Palanki MSS, 2002, CURR MED CHEM, V9, P219, DOI 10.2174/0929867023371265; Rimando AM, 2005, J AGR FOOD CHEM, V53, P3403, DOI 10.1021/jf0580364; Ruhlmann A, 1997, IMMUNOBIOLOGY, V198, P192; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; van Panhuys N, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00006; Waldner M, 2016, BRIT J CLIN PHARMACO, V82, P1158, DOI 10.1111/bcp.12893; Wang C, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104442; Yao Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23051148; Yashiro T, 2019, FASEB J, V33, P11481, DOI 10.1096/fj.201900379RR; Yashiro T, 2018, J IMMUNOL, V201, P3677, DOI 10.4049/jimmunol.1800492; Yashiro T, 2016, SCI REP-UK, V6, DOI 10.1038/srep34825; Yashiro T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137699; Yashiro T, 2012, ATHEROSCLEROSIS, V220, P369, DOI 10.1016/j.atherosclerosis.2011.11.006; Zhang J, 1999, J IMMUNOL, V162, P3819; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	40	11	11	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14810	14819		10.1096/fj.202001502R	http://dx.doi.org/10.1096/fj.202001502R		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32964554	hybrid			2022-12-26	WOS:000573907800001
J	Barr, WA; Sheth, RB; Kwon, J; Cho, J; Glickman, JW; Hart, F; Chatterji, OK; Scopino, K; Voelkel-Meiman, K; Krizanc, D; Thayer, KM; Weir, MP				Barr, William A.; Sheth, Ruchi B.; Kwon, Jack; Cho, Jungwoo; Glickman, Jacob W.; Hart, Felix; Chatterji, Om K.; Scopino, Kristen; Voelkel-Meiman, Karen; Krizanc, Daniel; Thayer, Kelly M.; Weir, Michael P.			GCN sensitive protein translation in yeast	PLOS ONE			English	Article							DIRECTED CROSS-LINKING; CODON USAGE BIAS; MESSENGER-RNA; RIBOSOME-FOOTPRINT; IN-VIVO; SITE; EFFICIENCY; SEQUENCE; OPTIMALITY; EXPRESSION	Levels of protein translation by ribosomes are governed both by features of the translation machinery as well as sequence properties of the mRNAs themselves. We focus here on a striking three-nucleotide periodicity, characterized by overrepresentation of GCN codons and underrepresentation of G at the second position of codons, that is observed in Open Reading Frames (ORFs) of mRNAs. Our examination of mRNA sequences inSaccharomyces cerevisiaerevealed that this periodicity is particularly pronounced in the initial codons-the ramp region-of ORFs of genes with high protein expression. It is also found in mRNA sequences immediately following non-standard AUG start sites, located upstream or downstream of the standard annotated start sites of genes. To explore the possible influences of the ramp GCN periodicity on translation efficiency, we tested edited ramps with accentuated or depressed periodicity in two test genes,SKN7andHMT1. Greater conformance to (GCN)(n)was found to significantly depress translation, whereas disrupting conformance had neutral or positive effects on translation. Our recent Molecular Dynamics analysis of a subsystem of translocating ribosomes in yeast revealed an interaction surface that H-bonds to the +1 codon that is about to enter the ribosome decoding center A site. The surface, comprised of 16S/18S rRNA C1054 and A1196 (E.colinumbering) and R146 of ribosomal protein Rps3, preferentially interacts with GCN codons, and we hypothesize that modulation of this mRNA-ribosome interaction may underlie GCN-mediated regulation of protein translation. Integration of our expression studies with large-scale reporter studies of ramp sequence variants suggests a model in which theC1054-A1196-R146 (CAR) interaction surface can act as both an accelerator and braking system for ribosome translation.	[Barr, William A.; Sheth, Ruchi B.; Kwon, Jack; Cho, Jungwoo; Glickman, Jacob W.; Hart, Felix; Chatterji, Om K.; Scopino, Kristen; Weir, Michael P.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Voelkel-Meiman, Karen] Wesleyan Univ, Dept Mol Biol & Biochem, Middletown, CT 06457 USA; [Krizanc, Daniel; Thayer, Kelly M.] Wesleyan Univ, Dept Math & Comp Sci, Middletown, CT 06457 USA; [Krizanc, Daniel; Thayer, Kelly M.; Weir, Michael P.] Wesleyan Univ, Dept Chem, Middletown, CT 06457 USA; [Thayer, Kelly M.] Wesleyan Univ, Coll Integrat Sci, Middletown, CT USA; [Barr, William A.] Rockefeller Univ, Lab Mol Metab, 1230 York Ave, New York, NY 10021 USA; [Glickman, Jacob W.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Wesleyan University; Wesleyan University; Wesleyan University; Wesleyan University; Wesleyan University; Rockefeller University; Icahn School of Medicine at Mount Sinai	Weir, MP (corresponding author), Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA.; Weir, MP (corresponding author), Wesleyan Univ, Dept Chem, Middletown, CT 06457 USA.	mweir@wesleyan.edu		Kwon, Han/0000-0001-7851-7956; Barr, William/0000-0001-6723-7684	National Institutes of Health [GM120719, GM128102]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MPW GM120719 National Institutes of Health https://www.nih.gov KMT GM128102 National Institutes of Health https://www.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2016, ELIFE, V5, DOI 10.7554/eLife.14874; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Buchanan BW, 2016, JOVE-J VIS EXP, DOI 10.3791/53975; Crook ZR, 2020, TRENDS BIOCHEM SCI, V45, P332, DOI 10.1016/j.tibs.2019.12.008; Cuperus JT, 2017, GENOME RES, V27, P2015, DOI 10.1101/gr.224964.117; CURRAN JF, 1994, J MOL BIOL, V235, P389, DOI 10.1016/S0022-2836(05)80046-4; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Ding YL, 2014, NATURE, V505, P696, DOI 10.1038/nature12756; DONTSOVA O, 1992, EMBO J, V11, P3105, DOI 10.1002/j.1460-2075.1992.tb05383.x; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Fournier CT, 2012, J PROTEOME RES, V11, P5712, DOI 10.1021/pr300538f; Fredrick K, 2010, CELL, V141, P227, DOI 10.1016/j.cell.2010.03.033; Frumkin I, 2018, P NATL ACAD SCI USA, V115, pE4940, DOI 10.1073/pnas.1719375115; Gamble CE, 2016, CELL, V166, P679, DOI 10.1016/j.cell.2016.05.070; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Harigaya Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3749-8; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hsin J, 2008, CURRENT PROTOCOLS IN, P14, DOI [10.1002/0471250953.bi0814s24, DOI 10.1002/0471250953.BI0814S24]; Humphrey W., 1986, J MOL GRAPHICS, V14, P33, DOI [10.1016/0263-7855(96)00018-5, DOI 10.1016/0263-7855(96)00018-5]; Ingolia NT, 2016, CELL, V165, P22, DOI 10.1016/j.cell.2016.02.066; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LAGUNEZOTERO J, 1992, J BIOMOL STRUCT DYN, V10, P455, DOI 10.1080/07391102.1992.10508662; Lin YZ, 2019, NUCLEIC ACIDS RES, V47, P9358, DOI 10.1093/nar/gkz681; Lv FJ, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.37; Lycette BE, 2016, J PROTEOME RES, V15, P2891, DOI 10.1021/acs.jproteome.5b00996; Mao YH, 2014, NUCLEIC ACIDS RES, V42, P4813, DOI 10.1093/nar/gku159; Mendoza L, 1998, BIOSYSTEMS, V46, P293, DOI 10.1016/S0303-2647(98)00009-4; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; RINKEAPPEL J, 1991, EMBO J, V10, P2195, DOI 10.1002/j.1460-2075.1991.tb07755.x; Scopino K, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060849; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Taylor SC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/361590; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tran JR, 2012, METHODS MOL BIOL, V832, P505, DOI 10.1007/978-1-61779-474-2_36; TRIFONOV EN, 1987, J MOL BIOL, V194, P643, DOI 10.1016/0022-2836(87)90241-5; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Verma M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13810-1; Wan J, 2018, RESEARCH-CHINA, V2018, DOI 10.1155/2018/7089174; Weinberg DE, 2016, CELL REP, V14, P1787, DOI 10.1016/j.celrep.2016.01.043; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Young BD, 2012, BIOCHEMISTRY-US, V51, P5091, DOI 10.1021/bi300186g; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; 2018, CURR OPIN TOXICOL, V10	52	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0233197	10.1371/journal.pone.0233197	http://dx.doi.org/10.1371/journal.pone.0233197			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946445	Green Published, gold, Green Submitted			2022-12-26	WOS:000573851100038
J	Luo, CY; Natividad, RJ; Lalli, ML; Asthagiri, AR				Luo, Catherine Y.; Natividad, Robert J.; Lalli, Mark L.; Asthagiri, Anand R.			Multivariate relationships among nucleus and Golgi properties during fibrillar migration are robust to and unchanged by epithelial-to-mesenchymal transition	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; TGF-BETA; CELL; BOOTSTRAP; SURVIVAL; CONTACT; EMT	Epithelial-to-mesenchymal transition (EMT) and maturation of a fibrillar tumor microenvironment play important roles in breast cancer progression. A better understanding of how these events promote cancer cell migration and invasion could help identify new strategies to curb metastasis. The nucleus and Golgi affect migration in a microenvironment-dependent manner. Nucleus size and mechanics influence the ability of a cell to squeeze through confined tumor microenvironments. Golgi positioning determines front-rear polarity necessary for migration. While the roles of individual attributes of nucleus and Golgi in migration are being clarified, how their manifold features are inter-related and work together remains to be understood at a systems level. Here, to elucidate relationships among nucleus and Golgi properties, we quantified twelve morphological and positional properties of these organelles during fibrillar migration of human mammary epithelial cells. Principal component analysis (PCA) reduced the twelve-dimensional space of measured properties to three principal components that capture 75% of the variations in organelle features. Unexpectedly, nucleus and Golgi properties that co-varied in a PCA model built with data from untreated cells were largely similar to co-variations identified using data from TGF beta-treated cells. Thus, while TGF beta-mediated EMT significantly alters gene expression and motile phenotype, it did not significantly affect the relationships among nucleus size, aspect ratio and orientation with migration direction and among Golgi size and nucleus-Golgi separation distance. Indeed, in a combined PCA model incorporating data from untreated and TGF beta-treated cells, scores of individual cells occupy overlapping regions in principal component space, indicating that TGF beta-mediated EMT does not promote a unique "Golgi-nucleus phenotype" during fibrillar migration. These results suggest that migration along spatially-confined fiber-like tracks employs a conserved nucleus-Golgi arrangement that is independent of EMT state.	[Luo, Catherine Y.; Natividad, Robert J.; Asthagiri, Anand R.] Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA; [Lalli, Mark L.; Asthagiri, Anand R.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA; [Asthagiri, Anand R.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Northeastern University; Northeastern University; Northeastern University	Asthagiri, AR (corresponding author), Northeastern Univ, Dept Bioengn, Boston, MA 02115 USA.; Asthagiri, AR (corresponding author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.; Asthagiri, AR (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	a.asthagiri@neu.edu		Luo, Catherine/0000-0001-5382-3893	National Institutes of Health [1R21CA246150]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant 1R21CA246150 to A.R.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Asthagiri lab, including Emily Gong, Alex Hruska and Dan Milano, for helpful discussions. This work was supported by the National Institutes of Health grant 1R21CA246150 to A.R.A.	Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Babamoradi H, 2013, CHEMOMETR INTELL LAB, V120, P97, DOI 10.1016/j.chemolab.2012.10.007; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545; Gritsenko PG, 2012, J PATHOL, V226, P185, DOI 10.1002/path.3031; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Kushiro K, 2012, LANGMUIR, V28, P4357, DOI 10.1021/la204872c; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Milano DF, 2016, BIOPHYS J, V111, P1569, DOI 10.1016/j.bpj.2016.08.037; Milano DF, 2016, BIOPHYS J, V110, P1886, DOI 10.1016/j.bpj.2016.02.040; Miller MA, 2013, P NATL ACAD SCI USA, V110, pE2074, DOI 10.1073/pnas.1222387110; Natividad RJ, 2018, BIOPHYS J, V115, P2067, DOI 10.1016/j.bpj.2018.10.006; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Roweis S, 1998, ADV NEUR IN, V10, P626; Sidani M, 2006, J MAMMARY GLAND BIOL, V11, P151, DOI 10.1007/s10911-006-9021-5; Tan XC, 2017, J CLIN INVEST, V127, P117, DOI 10.1172/JCI88736; Timmerman ME, 2007, BRIT J MATH STAT PSY, V60, P295, DOI 10.1348/000711006X109636; Van Ginkel JR, 2014, J STAT COMPUT SIM, V84, P2298, DOI 10.1080/00949655.2013.788654; Wickert LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep20139; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; YOUNG FW, 1978, PSYCHOMETRIKA, V43, P279, DOI 10.1007/BF02293871	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239188	10.1371/journal.pone.0239188	http://dx.doi.org/10.1371/journal.pone.0239188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946467	gold, Green Published			2022-12-26	WOS:000573851100050
J	Monari, S; Ferri, M; Vannini, M; Sisti, L; Marchese, P; Ehrnell, M; Xanthakis, E; Celli, A; Tassoni, A				Monari, Stefania; Ferri, Maura; Vannini, Micaela; Sisti, Laura; Marchese, Paola; Ehrnell, Maria; Xanthakis, Epameinondas; Celli, Annamaria; Tassoni, Annalisa			Cascade strategies for the full valorisation of Garganega white grape pomace towards bioactive extracts and bio-based materials	PLOS ONE			English	Article							BY-PRODUCTS; ANTIOXIDANT; POLYPHENOLS; COMPOSITES; FIBERS; FOOD; VALORIZATION; DEGRADATION; ASSAY; RED	Agro-waste reduction and reuse are among the current main social challenges. In this perspective, the present research was aimed at the complete valorisation of Garganega grape pomace by recovering bioactive phenol extracts and by testing the solid fibre extract residues in composite formulation for packaging applications. The pomace was derived from white wine production, therefore, respect to red pomace, it was promptly removed from must after pressing, and its exploitation can be particularly interesting and valuable as still rich in active compounds. Phenol extracts were obtained both via solvent-based and pressurised liquid extractions and their phytochemical compositions were compared in terms of total amount of phenols, flavonoids, flavanols, anthocyanins, hydroxycinnamic acids, and reducing sugars. Antioxidant activity and detailed phenol profiles were also achieved. The highest phenol yield was obtained via solvent-based extraction with 75% acetone (v/v), solid/liquid ratio 1:5, 2h incubation at 50 degrees C (77.9 gGAeq/kgDW). The fibrous solid residue of the extraction was characterized via thermogravimetric analysis and used for composite preparation by melt mixing with the renewable and biodegradable PHBV polymer through a green approach (solvent-less process). The composites resulted thermally stable at high temperatures, showing initial degradation processes only at temperatures higher than 250 degrees C. Differential scanning calorimetry analyses were carried out to study melting and crystallization phenomena, while mechanical properties were investigated by tensile tests. The materials finally showed properties similar to those of the matrix. The bio-composites can be considered as an alternative to plain PHBV, since they are less expensive and eco-friendlier thanks to a reduced polymeric content, and they could represent a suitable way for full agro-waste exploitation.	[Monari, Stefania; Ferri, Maura; Tassoni, Annalisa] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy; [Ferri, Maura; Vannini, Micaela; Sisti, Laura; Marchese, Paola; Celli, Annamaria] Univ Bologna, Dept Civil Chem Environm & Mat Engn, Bologna, Italy; [Ehrnell, Maria; Xanthakis, Epameinondas] RISE Res Inst Sweden, Dept Agr & Food, Gothenburg, Sweden	University of Bologna; University of Bologna; RISE Research Institutes of Sweden	Tassoni, A (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy.; Vannini, M (corresponding author), Univ Bologna, Dept Civil Chem Environm & Mat Engn, Bologna, Italy.	micaela.vannini@unibo.it; annalisa.tassoni2@unibo.it	Celli, Annamaria/K-7631-2013; TASSONI, ANNALISA/G-3981-2012	Celli, Annamaria/0000-0002-5974-1642; FERRI, MAURA/0000-0001-5428-4369; TASSONI, ANNALISA/0000-0002-3541-4030	European Union's Horizon 2020 research and innovation programme [688338]	European Union's Horizon 2020 research and innovation programme	This work was supported by the NoAW project ("Innovative approaches to turn agricultural waste into ecological and economic assets"), founded by the European Union ' s Horizon 2020 research and innovation programme (grant agreement No 688338) to EX, AC, AT. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2020, SCI TOTAL ENVIRON, V719, DOI 10.1016/j.scitotenv.2020.137315; Amutio M, 2012, FUEL, V95, P305, DOI 10.1016/j.fuel.2011.10.008; Aoyagi Y, 2002, POLYM DEGRAD STABIL, V76, P53, DOI 10.1016/S0141-3910(01)00265-8; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Balla VK, 2019, COMPOS PART B-ENG, V174, DOI 10.1016/j.compositesb.2019.106956; Benyahya S, 2014, IND CROP PROD, V53, P296, DOI 10.1016/j.indcrop.2013.12.045; Berthet MA, 2015, COMPOS PART A-APPL S, V72, P139, DOI 10.1016/j.compositesa.2015.02.006; Bledzki AK, 2010, COMPOS SCI TECHNOL, V70, P1687, DOI 10.1016/j.compscitech.2010.06.005; Considine JA, 2014, COMPLETE GUIDE QUALI; Deng Q, 2011, FOOD RES INT, V44, P2712, DOI 10.1016/j.foodres.2011.05.026; FAOSTAT, 2017, FOOD AGR DAT; Ferri M, 2009, PROTEOMICS, V9, P610, DOI 10.1002/pmic.200800386; Ferri M, 2020, J ADV RES, V24, P1, DOI 10.1016/j.jare.2020.02.015; Ferri M, 2017, NEW BIOTECHNOL, V39, P51, DOI 10.1016/j.nbt.2017.07.002; Ferri M, 2016, NEW BIOTECHNOL, V33, P338, DOI 10.1016/j.nbt.2015.12.004; Ferri M, 2013, J FOOD COMPOS ANAL, V30, P94, DOI 10.1016/j.jfca.2013.02.004; Fontana AR, 2013, J AGR FOOD CHEM, V61, P8987, DOI 10.1021/jf402586f; Garcia-Lomillo J, 2017, COMPR REV FOOD SCI F, V16, P3, DOI 10.1111/1541-4337.12238; Gonzalez-Centeno MR, 2013, J AGR FOOD CHEM, V61, P11579, DOI 10.1021/jf403168k; Gowman A, 2018, ACS OMEGA, V3, P15205, DOI 10.1021/acsomega.8b01675; Gowman AC, 2019, BIORESOURCES, V14, P10047, DOI 10.15376/biores.14.4.Gowman; Gullon P, 2018, SCI TOTAL ENVIRON, V624, P225, DOI 10.1016/j.scitotenv.2017.12.036; Hassaini L, 2017, POLYM TEST, V59, P430, DOI 10.1016/j.polymertesting.2017.03.004; Hogan S, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-71; Jayaprakasha GK, 2003, FOOD RES INT, V36, P117, DOI 10.1016/S0963-9969(02)00116-3; Kalli E, 2018, BIORESOUR BIOPROCESS, V5, DOI 10.1186/s40643-018-0232-6; Kawalec M, 2008, MACROMOL SYMP, V272, P63, DOI 10.1002/masy.200851208; Sanchez-Safont EL, 2016, J RENEW MATER, V4, P123, DOI 10.7569/JRM.2015.634127; Lucarini M, 2018, MOLECULES, V23, DOI 10.3390/molecules23081888; Madeddu C, 2021, WASTE BIOMASS VALORI, V12, P1143, DOI 10.1007/s12649-020-01082-6; Mantell C, 2003, ENG LIFE SCI, V3, P38, DOI 10.1002/elsc.200390004; Martins IM, 2016, FOOD RES INT, V89, P533, DOI 10.1016/j.foodres.2016.09.009; MCMURROUGH I, 1978, ANAL BIOCHEM, V91, P92, DOI 10.1016/0003-2697(78)90819-9; Moliner C., 2017, CHEM ENG T, V57, P1417, DOI DOI 10.3303/CET1757237; Muhlack RA, 2018, WASTE MANAGE, V72, P99, DOI 10.1016/j.wasman.2017.11.011; Mustafa A, 2011, ANAL CHIM ACTA, V703, P8, DOI 10.1016/j.aca.2011.07.018; Muthuraj R, 2017, J APPL POLYM SCI, V134, DOI 10.1002/app.44860; Nackz M, 2004, J CHROMATOGR A, V1054, P93; Nanni A, 2020, J APPL POLYM SCI, V137, DOI 10.1002/app.48869; Nanni A, 2018, POLYM DEGRAD STABIL, V149, P9, DOI 10.1016/j.polymdegradstab.2018.01.012; Pinelo M, 2005, J AGR FOOD CHEM, V53, P2111, DOI 10.1021/jf0488110; Pinta D, 2018, CROPS PROD, V111, P379, DOI DOI 10.1016/J.INDCROP.2017.10.038; Rasines-Perea Zurine, 2018, Diseases, V6, DOI 10.3390/diseases6030060; Righetti MC, 2019, MATERIALS, V12, DOI 10.3390/ma12060990; Rivera-Briso AL, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10070732; Saccani A, 2019, POLYM COMPOSITE, V40, P1378, DOI 10.1002/pc.24870; Saccani A, 2018, J APPL POLYM SCI, V135, DOI 10.1002/app.46234; Shi J, 2003, J FOOD AGRIC ENVIRON, V1, P42; Sirohi R, 2020, BIORESOURCE TECHNOL, V314, DOI 10.1016/j.biortech.2020.123771; Sisti L, 2018, J ENVIRON CHEM ENG, V6, P4452, DOI 10.1016/j.jece.2018.06.066; Sisti L, 2016, IND CROP PROD, V81, P56, DOI 10.1016/j.indcrop.2015.11.045; Spitalsky Z, 2006, POLYM DEGRAD STABIL, V91, P856, DOI 10.1016/j.polymdegradstab.2005.06.019; Stefan MB, 2014, FOOD ANAL METHOD, V7, P326, DOI 10.1007/s12161-013-9630-8; Tassoni A, 2019, WASTES SOLUTIONS TRE, P440; Tassoni A, 2020, MOLECULES, V25, DOI 10.3390/molecules25061383; Teixeira A, 2014, INT J MOL SCI, V15, P15638, DOI 10.3390/ijms150915638; Torres-Giner S, 2018, FOOD PACKAGING SHELF, V17, P39, DOI 10.1016/j.fpsl.2018.05.002; Totaro G, 2018, COMPOS PART B-ENG, V139, P195, DOI 10.1016/j.compositesb.2017.11.055; Vaisanen T, 2017, J CLEAN PROD, V149, P582, DOI 10.1016/j.jclepro.2017.02.132; 2019, CAN J KIDNEY HLTH DI, V6, P1	60	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239629	10.1371/journal.pone.0239629	http://dx.doi.org/10.1371/journal.pone.0239629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946525	Green Published, gold			2022-12-26	WOS:000573851100059
J	Alawad, KA; Al-Subhi, AM; Alsaafani, MA; Alraddadi, TM				Alawad, Kamal Aldien; Al-Subhi, Abdullah M.; Alsaafani, Mohammed A.; Alraddadi, Turki M.			Decadal variability and recent summer warming amplification of the sea surface temperature in the Red Sea	PLOS ONE			English	Article							ATLANTIC MULTIDECADAL OSCILLATION; EVENTS; LAND	Under climate change, regional Sea Surface Temperature (SST) changes are a crucial factor affecting marine ecosystems, which thrive only within a certain thermal limit. Thirty-seven years of monthly gridded Optimum Interpolation SST data from 1982 to 2017 were used to investigate the decadal variability of this parameter in the Red Sea during the summer season, in relation to large-scale climate variability. We identified a non-uniform warming trend beginning around the mid-1990s over the whole basin, with a predominant amplified warming over the northern half (0.04 degrees C year(-1)), which is approximately four times higher than the global warming trend, but much weaker warming over southern end (0.01 degrees C year(-1)). It was found that the Atlantic Multi-Decadal Oscillation (AMO) and the Silk Road Pattern (SRP) are shaping the RS SST, since their phase shift concurs with the timing of the significant non-uniform warming over the basin. The AMO triggers the SRP-related vertical and horizontal temperature advection that leads to opposite changes in the SST. We suggest that warming is amplified over the basin due to an overlap with global warming signals. Our results have important implications for interannual and decadal SST predictions based on the predictability of AMO and SRP patterns.	[Alawad, Kamal Aldien; Al-Subhi, Abdullah M.; Alsaafani, Mohammed A.; Alraddadi, Turki M.] King Abdulaziz Univ, Fac Marine Sci, Marine Phys Dept, Jeddah, Saudi Arabia; [Alawad, Kamal Aldien] Sudan Meteorol Author, Weather Forecast Div, Khartoum, Sudan	King Abdulaziz University	Alawad, KA (corresponding author), King Abdulaziz Univ, Fac Marine Sci, Marine Phys Dept, Jeddah, Saudi Arabia.; Alawad, KA (corresponding author), Sudan Meteorol Author, Weather Forecast Div, Khartoum, Sudan.	kmohamad0001@stu.kau.edu.sa	Alawad, Kamal Aldien/AAJ-1768-2021; Alraddadi, Turki/AAS-4202-2021; Alsaafani, Mohammed A/I-6557-2013; Al-Subhi, Abdullah/AAP-4404-2020; alraddadi, turki/GLR-0705-2022	Alawad, Kamal Aldien/0000-0002-6236-8981; Alraddadi, Turki/0000-0002-9433-7477; Alsaafani, Mohammed A/0000-0002-0307-5353; Al-Subhi, Abdullah/0000-0001-6292-9884; 	Deanship of Graduate Studies (DGS)-King Abdulaziz University-Saudi Arabia; HPC Center (Azizi Supercomputer)-King Abdulaziz University-Saudi Arabia	Deanship of Graduate Studies (DGS)-King Abdulaziz University-Saudi Arabia; HPC Center (Azizi Supercomputer)-King Abdulaziz University-Saudi Arabia	The Deanship of Graduate Studies (DGS) and HPC Center (Azizi Supercomputer)-King Abdulaziz University-Saudi Arabia provided PhD scholarship and material support, making their high performance computer available to analyze and plot the results, respectively.	Abdulla CP, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12132090; Al Senafi F, 2015, INT J CLIMATOL, V35, P4509, DOI 10.1002/joc.4302; Al-Subhi A.M., 2017, SIGNATURES TROPICAL; Alawad KA, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12142227; Alawad KA, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11192224; [Anonymous], 2007, EUR J NUCL MED MOL I; [Anonymous], 2008, CANC S8, V113, pi; [Anonymous], 2003, EUROPEAN J NUCL MED, V30, pBP23; Attada R, 2019, CLIM DYNAM, V52, P3389, DOI 10.1007/s00382-018-4333-x; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Boer GJ, 2011, CLIM DYNAM, V37, P2253, DOI 10.1007/s00382-011-1112-3; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Chaidez V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08146-z; Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029; Ding QH, 2005, J CLIMATE, V18, P3483, DOI 10.1175/JCLI3473.1; Dong BW, 2009, J CLIMATE, V22, P3079, DOI 10.1175/2009JCLI2652.1; Eladawy A, 2017, OCEANOLOGIA, V59, P213, DOI 10.1016/j.oceano.2017.01.002; Enfield DB, 2001, GEOPHYS RES LETT, V28, P2077, DOI 10.1029/2000GL012745; Goudie A.S., 2006, DESERT DUST GLOBAL S; Hamidi M, 2014, AEOLIAN RES, V13, P59, DOI 10.1016/j.aeolia.2014.02.002; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hong XW, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7909; Hong XW, 2016, J CLIMATE, V29, P3753, DOI 10.1175/JCLI-D-15-0541.1; IPCC, 2014, CLIM CHANG 2013 THE; Joshi MM, 2013, CLIMATIC CHANGE, V117, P951, DOI 10.1007/s10584-013-0715-6; Karnauskas KB, 2018, J GEOPHYS RES-OCEANS, V123, P5824, DOI 10.1029/2017JC013320; Krokos G, 2019, GEOPHYS RES LETT, V46, P3454, DOI 10.1029/2018GL081397; Lluch-Cota SE, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P149; MIDDLETON NJ, 1986, J CLIMATOL, V6, P183, DOI 10.1002/joc.3370060207; Nasrallah HA, 2004, J ARID ENVIRON, V56, P357, DOI 10.1016/S0140-1963(03)00007-7; Notaro M, 2015, J GEOPHYS RES-ATMOS, V120, P10229, DOI 10.1002/2015JD023855; Notaro M, 2013, J GEOPHYS RES-ATMOS, V118, P6028, DOI 10.1002/jgrd.50346; Nykjaer L, 2009, CLIM RES, V39, P11, DOI 10.3354/cr00794; Osman EO, 2018, GLOBAL CHANGE BIOL, V24, pE474, DOI 10.1111/gcb.13895; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Raitsos DE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047984; Raitsos DE, 2015, GEOPHYS RES LETT, V42, P855, DOI 10.1002/2014GL062882; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Rodwell MJ, 2001, J CLIMATE, V14, P3192, DOI 10.1175/1520-0442(2001)014<3192:SAASM>2.0.CO;2; Roik A, 2016, CORAL REEFS, V35, P681, DOI 10.1007/s00338-015-1383-y; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Shaltout M., 2019, OCEANOLOGIA; Shao Y, 2001, J GEOPHYS RES-ATMOS, V106, P20239, DOI 10.1029/2001JD900171; Skliris N, 2012, OCEAN DYNAM, V62, P13, DOI 10.1007/s10236-011-0493-5; Sun XQ, 2019, ADV ATMOS SCI, V36, P811, DOI 10.1007/s00376-019-8169-z; Xie SP, 2015, NAT CLIM CHANGE, V5, P921, DOI [10.1038/nclimate2689, 10.1038/NCLIMATE2689]; Yasui S, 2010, J CLIMATE, V23, P2093, DOI 10.1175/2009JCLI3323.1; Yu Y, 2016, J GEOPHYS RES-ATMOS, V121, P289, DOI 10.1002/2015JD024063; Yu Y, 2015, J GEOPHYS RES-ATMOS, V120, P1739, DOI 10.1002/2014JD022611; Yu Y, 2013, J GEOPHYS RES-ATMOS, V118, P13253, DOI 10.1002/2013JD020677	50	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0237436	10.1371/journal.pone.0237436	http://dx.doi.org/10.1371/journal.pone.0237436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941427	gold, Green Published			2022-12-26	WOS:000573848800029
J	Martinez-Perez, PA; Hyndman, TH; Fleming, PA				Martinez-Perez, Pedro A.; Hyndman, Timothy H.; Fleming, Patricia A.			Haematology and blood chemistry in free-ranging quokkas (Setonix brachyurus): Reference intervals and assessing the effects of site, sampling time, and infectious agents	PLOS ONE			English	Article							CANINE DIROFILARIAL HEMOGLOBINURIA; NORTHERN JARRAH FOREST; ROTTNEST-ISLAND QUOKKA; I PROVIRAL DNA; SPONTANEOUS PROLIFERATIONS; AUSTRALIAN MARSUPIALS; FLOWER CELLS; ADVIA 120; SERUM; VALUES	Quokkas (Setonix brachyurus) are small macropodid marsupials from Western Australia, which are identified as of conservation concern. Studies on their blood analytes exist but involve small sample sizes and are associated with very little information concerning the health of the animals. Blood was collected from free-ranging quokkas from Rottnest Island (n = 113) and mainland (n = 37) Western Australia, between September 2010 and December 2011, to establish haematology and blood chemistry reference intervals. Differences in haematology and blood chemistry between sites (Rottnest Island v mainland) were significant for haematology (HMT,p= 0.003), blood chemistry (BLC,p= 0.001) and peripheral blood cell morphology (PBCM,p= 0.001). Except for alkaline phosphatase, all blood chemistry analytes were higher in mainland animals. There were also differences with time of year in HMT (p= 0.001), BLC (p= 0.001) and PBCM (p= 0.001) for Rottnest Island quokkas. A small sample of captive animals (n = 8) were opportunistically sampled for plasma concentrations of vitamin E and were found to be deficient compared with wild-caught animals. Fifty-eight of the 150 quokkas were also tested for the presence ofSalmonella, microfilariae,Macropodid herpesvirus-6,Theileriaspp.,Babesiaspp., trypanosomes,Cryptococcusspp. and other saprophytic fungi. All eight infectious agents were detected in this study. Infectious agents were detected in 24 of these 58 quokkas (41%), with more than one infectious agent detected for all 24 individuals.Salmonellawere detected concurrently with microfilariae in 8 of these 24 quokkas, and this mixed infection was associated with lower values across all haematological analytes, withSalmonellahaving the greater involvement in the decreased haematological values (p< 0.05). There was no evidence for an effect of sex on HMT, BLC and PBCM. Our data provide important haematological and blood chemistry reference intervals for free-ranging quokkas. We applied novel methods of analyses to HMT and BLC that can be used more broadly, aiding identification of potential disease in wildlife.	[Martinez-Perez, Pedro A.; Hyndman, Timothy H.] Murdoch Univ, Sch Vet Med, Murdoch, WA, Australia; [Fleming, Patricia A.] Murdoch Univ, Harry Butler Inst, Murdoch, WA, Australia; [Martinez-Perez, Pedro A.] Ngee Ann Polytech, Sch Life Sci & Chem Technol, Singapore, Singapore	Murdoch University; Murdoch University	Hyndman, TH (corresponding author), Murdoch Univ, Sch Vet Med, Murdoch, WA, Australia.	t.hyndman@murdoch.edu.au	Martinez, Pedro/ABG-8790-2020	Martinez, Pedro/0000-0002-8433-1944	Holsworth Wildlife Research Endowment [14020]	Holsworth Wildlife Research Endowment	Funding of this research was contributed to by the Holsworth Wildlife Research Endowment, 14020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley MR, 2010, NEW ZEAL VET J, V58, P218, DOI 10.1080/00480169.2010.68868; [Anonymous], 1908, CURRENT LIT      MAR, V44, P295; [Anonymous], 2003, ASIA PULSE      1010, V12, P11; Arundel J., 1977, BIOL MARSUPIALS, P141; ATTWOOD HD, 1973, J COMP PATHOL, V83, P569, DOI 10.1016/0021-9975(73)90014-5; Bain KT, 2015, ECOLOGY QUOKKA SETON; BARKER S, 1974, COMP BIOCHEM PHYSIOL, V49, P147, DOI 10.1016/0300-9629(74)90550-7; BARKER S, 1961, AUST J BIOL SCI, V14, P646, DOI 10.1071/BI9610646; BARTHOLOMEW GEORGE A., 1956, PHYSIOL ZOOL, V29, P26; Behnke J. M., 1999, Parasitology International, V48, P183, DOI 10.1016/S1383-5769(99)00014-8; Bennett MD, 2008, VET CLIN PATH, V37, P221, DOI 10.1111/j.1939-165X.2008.00040.x; Bennett MD, 2007, VET CLIN PATH, V36, P348, DOI 10.1111/j.1939-165X.2007.tb00439.x; Billiards SS, 1999, COMP HAEMATOL INT, V9, P86, DOI 10.1007/s005800050016; Bordes F, 2011, IMPACT MULTIPLE INFE; Bourges-Abella N, 2011, VET CLIN PATH, V40, P303, DOI 10.1111/j.1939-165X.2011.00333.x; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Briggs C, 2009, INT J LAB HEMATOL, V31, P48, DOI 10.1111/j.1751-553X.2007.01002.x; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bryant GL, 2012, J WILDLIFE DIS, V48, P282, DOI 10.7589/0090-3558-48.2.282; Burbidge AA, 2020, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2020-1.RLTS.T20165A166611530.en, DOI 10.2305/IUCN.UK.2020-1.RLTS.T20165A166611530.EN]; CANFIELD PJ, 1990, J COMP PATHOL, V103, P147, DOI 10.1016/S0021-9975(08)80171-5; CANFIELD PJ, 1990, J COMP PATHOL, V103, P135, DOI 10.1016/S0021-9975(08)80170-3; Cattet MRL, 2003, J WILDLIFE DIS, V39, P649, DOI 10.7589/0090-3558-39.3.649; Clark P., 2006, Comparative Clinical Pathology, V14, P191, DOI 10.1007/s00580-006-0597-3; Clark P., 2006, Comparative Clinical Pathology, V15, P82, DOI 10.1007/s00580-006-0619-1; Clark P., 2004, HAEMATOLOGY AUSTR MA; Clarke J, 2013, J WILDLIFE DIS, V49, P831, DOI 10.7589/2011-12-345; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COX FEG, 2001, PARASITOLOGY, V122, pS2, DOI DOI 10.1017/S003118200001698X; Dawson R, 2012, J ZOOL, V288, P267, DOI 10.1111/j.1469-7998.2012.00952.x; Dundas SJ, 2018, AUST MAMMAL, V40, P26, DOI 10.1071/AM16033; DWINGER RH, 1994, VET PARASITOL, V54, P353, DOI 10.1016/0304-4017(94)90002-7; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Geffre A, 2011, J VET DIAGN INVEST, V23, P343, DOI 10.1177/104063871102300225; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvey J.W., 2012, VET HEMATOLOGY DIAGN, P328, DOI 10.1016/C2009-0-39565-3; Hawkey CM, 1975, COMP MAMMALIAN HAEMA, P218; Hayward MW, 2005, WILDLIFE RES, V32, P15, DOI 10.1071/WR03051; Institute CaLS, 2008, EP28A3C CLSI, P28; ISHIHARA K, 1981, JPN J VET SCI, V43, P1; Jefferies R, 2007, VET PARASITOL, V144, P20, DOI 10.1016/j.vetpar.2006.09.022; JONES MEE, 1990, GEN COMP ENDOCR, V77, P75, DOI 10.1016/0016-6480(90)90208-4; KAKULAS B, 1983, Journal of the Royal Society of Western Australia, V66, P52; KAKULAS B. A., 1963, AUSTRALIAN JOUR SCI, V25, P313; KAKULAS BA, 1966, ANN NY ACAD SCI, V138, P90; KAKULAS BA, 1961, NATURE, V191, P402, DOI 10.1038/191402a0; KAKULAS BA, 1963, NATURE, V198, P673, DOI 10.1038/198673a0; KALDOR I, 1986, COMP BIOCHEM PHYS A, V84, P691, DOI 10.1016/0300-9629(86)90389-0; King JM, 2010, GEN COMP ENDOCR, V167, P60, DOI 10.1016/j.ygcen.2010.02.018; KITAGAWA H, 1989, JPN J VET SCI, V51, P703; Kitchener D.J., 1995, MAMMALS AUSTR, P401; LEWIS JH, 1968, COMP BIOCHEM PHYSIOL, V25, P1129, DOI 10.1016/0010-406X(68)90601-4; Martinez-Perez P, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10040585; McInnes LM, 2011, PARASITOLOGY, V138, P59, DOI 10.1017/S0031182010000971; Mckenzie S., 2002, Comparative Clinical Pathology, V11, P229, DOI 10.1007/s005800200024; MCMURRAY CH, 1979, J CHROMATOGR, V178, P525, DOI 10.1016/S0021-9673(00)92511-1; Meintker L, 2013, AM J CLIN PATHOL, V139, P641, DOI 10.1309/AJCP7D8ECZRXGWCG; Meteorology ABo, 2020, MET ABO CLIM STAT AU; MILLER T, 1979, J ENDOCRINOL, V82, P159, DOI 10.1677/joe.0.0820159; Munson L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002545; Nielsen NO, 2006, T ROY SOC TROP MED H, V100, P543, DOI 10.1016/j.trstmh.2005.08.016; Pacioni C, 2013, J WILDLIFE DIS, V49, P816, DOI 10.7589/2011-09-275; de Oliveira MDP, 2010, J CLIN VIROL, V48, P288, DOI 10.1016/j.jcv.2010.05.005; Phillips V, 2016, DEMOGRAPHICS ECOLOGY; Poole HL, 2014, WILDLIFE RES, V41, P510, DOI 10.1071/WR14083; Quinn PJ, 2011, VET MICROBIOLOGY MIC, P357; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Reese TA, 2016, J VIROL, V90, P5534, DOI 10.1128/JVI.01865-15; Robert KA, 2013, J WILDLIFE MANAGEMEN; Sacher RA, 1999, BRIT J HAEMATOL, V105, P758, DOI 10.1046/j.1365-2141.1999.01408.x; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHIELD J, 1971, J ZOOL, V165, P343; Shield JW, 1958, ASPECTS FIELD ECOLOG; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; STAIB F, 1987, ZBL BAKT-INT J MED M, V266, P167; Stirrat SC, 2003, WILDLIFE RES, V30, P59, DOI 10.1071/WR01041; Su LB, 2014, INFECT IMMUN, V82, P3855, DOI 10.1128/IAI.02023-14; Superina M, 2008, J WILDLIFE DIS, V44, P902, DOI 10.7589/0090-3558-44.4.902; TACHIBANA N, 1992, INT J CANCER, V51, P593, DOI 10.1002/ijc.2910510415; Teare JA., 2002, INT SPECIES INFORM S; Tennant BC, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P379, DOI 10.1016/B978-0-12-370491-7.00013-1; Tezuka K, 2014, BLOOD, V123, P346, DOI 10.1182/blood-2013-06-508861; Thrall M. A., 2012, Veterinary hematology and clinical chemistry, P75; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Vaughan RJ, 2009, J ZOO WILDLIFE MED, V40, P276, DOI 10.1638/2008-0058.1; Vogelnest L, 2010, MED AUSTR MAMMALS, P133; Wahid S., 1962, Journal of Helminthology, V36, P207, DOI 10.1017/S0022149X00022483; Weber DK, 2002, J WILDLIFE DIS, V38, P576, DOI 10.7589/0090-3558-38.3.576; Weiser G., 2012, Veterinary hematology and clinical chemistry, P127; Welles EG, 2009, VET CLIN PATH, V38, P20, DOI 10.1111/j.1939-165X.2008.00084.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wiedmeyer CE, 2002, AM J VET RES, V63, P1083, DOI 10.2460/ajvr.2002.63.1083; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; YAMAGUCHI K, 1988, BRIT J HAEMATOL, V68, P169, DOI 10.1111/j.1365-2141.1988.tb06185.x; Yen P. K. F., 1983, THESIS; ZIEGLER C, 1991, J VET MED B, V38, P123, DOI 10.1111/j.1439-0450.1991.tb00855.x	99	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239060	10.1371/journal.pone.0239060	http://dx.doi.org/10.1371/journal.pone.0239060			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941511	Green Published, gold			2022-12-26	WOS:000573848800089
J	Tokunaga, S; Ehrhart, EJ; Monnet, E				Tokunaga, Satoshi; Ehrhart, E. J.; Monnet, Eric			Histological and mechanical comparisons of arytenoid cartilage between 4 brachycephalic and 8 non-brachycephalic dogs: A pilot study	PLOS ONE			English	Article							AIRWAY-OBSTRUCTION SYNDROME; CAUDAL SOFT PALATE; COMPUTED-TOMOGRAPHY; LARYNGEAL COLLAPSE; DIMENSIONS; ANATOMY	Brachycephalic airway syndrome (BAS) is a well-established cause of respiratory distress in dogs. BAS without surgical correction results in eventual laryngeal collapse. Arytenoid lateralization has been used to treat severe laryngeal collapse with some highly variable results. Chondromalacia and decreased stiffness of the arytenoid cartilage has been postulated a source of failure after arytenoid lateralization but no report of the histological characteristics and mechanical strength of arytenoid cartilage in brachycephalic dogs has been reported. Here we report histological and mechanical features in arytenoid cartilage of brachycephalic dogs. We identified the arytenoid cartilage in brachycephalic dogs presented degenerative histological characteristics and decreased load to failure and stiffness compared to that in non-brachycephalic dogs. Together, these observations suggest that degenerative condition of arytenoid cartilage in brachycephalic dogs could contribute to chondromalacia and mechanical weakness of arytenoid cartilage and result in cause of failure after arytenoid lateralization.	[Tokunaga, Satoshi; Monnet, Eric] Colorado State Univ, Coll Vet Med & Biomed Sci, Clin Sci, Ft Collins, CO 80523 USA; [Ehrhart, E. J.] Ethos Diagnost Sci, San Diego, CA USA	Colorado State University	Monnet, E (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Clin Sci, Ft Collins, CO 80523 USA.	Eric.Monnet@ColoState.EDU			Lulu foundation at Colorado State University	Lulu foundation at Colorado State University	This study was supported and funded by Lulu foundation at Colorado State University to EM. E.J. Ehrhart is an employee of Ethos Diagnostic Science. The Lulu Foundation provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPLEJOHN KL, 1988, HISTOCHEMISTRY, V89, P185, DOI 10.1007/BF00489922; Danieli MV, 2014, CLINICS, V69, P694, DOI 10.6061/clinics/2014(10)08; Dupre G, 2010, MECH DIS SMALL ANIMA, P298; Dupre G, 2016, VET CLIN N AM-SMALL, V46, P691, DOI 10.1016/j.cvsm.2016.02.002; Dupre G, 2013, SMALL ANIMAL SOFT TISSUE SURGERY, P167; Evans H.E., 2013, MILLERS ANATOMY DOG; Fenner JVH, 2020, VET SURG, V49, P53, DOI 10.1111/vsu.13297; HARVEY CE, 1989, J SMALL ANIM PRACT, V30, P184, DOI 10.1111/j.1748-5827.1989.tb01531.x; Heidenreich D, 2016, VET SURG, V45, P83, DOI 10.1111/vsu.12418; Henao-Murillo L, 2021, CARTILAGE, V13, p1501S, DOI 10.1177/1947603519885005; HENDRICKS JC, 1992, VET CLIN N AM-SMALL, V22, P1145, DOI 10.1016/S0195-5616(92)50306-0; Lorinson D, 1997, CANINE PRACT, V22, P18; Meola SD, 2013, TOP COMPANION ANIM M, V28, P91, DOI 10.1053/j.tcam.2013.06.004; O'Driscoll SW, 2001, TISSUE ENG, V7, P313, DOI 10.1089/10763270152044170; Pichetto M, 2015, ANAT REC, V298, P618, DOI 10.1002/ar.23054; Pichetto M, 2011, ANAT REC, V294, P1267, DOI 10.1002/ar.21417; Pink JJ, 2006, J SMALL ANIM PRACT, V47, P131, DOI 10.1111/j.1748-5827.2006.00056.x; Ree JJ, 2016, CAN VET J, V57, P976; Rutherford L, 2017, VET RADIOL ULTRASOUN, V58, P634, DOI 10.1111/vru.12526; Szarko M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-231; Torrez CV, 2006, J SMALL ANIM PRACT, V47, P150, DOI 10.1111/j.1748-5827.2006.00059.x; Trappler Michelle, 2011, Compend Contin Educ Vet, V33, pE1; Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504; Wetzel J, 2010, ACVS COLL SCI WEEK; White RN, 2012, J SMALL ANIM PRACT, V53, P44, DOI 10.1111/j.1748-5827.2011.01156.x; WYLLIE AH, 1987, J PATHOL, V153, P313, DOI 10.1002/path.1711530404	26	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239223	10.1371/journal.pone.0239223	http://dx.doi.org/10.1371/journal.pone.0239223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941546	gold, Green Published			2022-12-26	WOS:000573848800100
J	Grimmer, M; Zeiss, J; Weigand, F; Zhao, GP; Lamm, S; Steil, M; Heller, A				Grimmer, Martin; Zeiss, Julian; Weigand, Florian; Zhao, Guoping; Lamm, Sascha; Steil, Martin; Heller, Adrian			Lower limb joint biomechanics-based identification of gait transitions in between level walking and stair ambulation	PLOS ONE			English	Article							DESCENT; ASCENT; KINEMATICS; KINETICS	Lower limb exoskeletons and lower limb prostheses have the potential to reduce gait limitations during stair ambulation. To develop robotic assistance devices, the biomechanics of stair ambulation and the required transitions to level walking have to be understood. This study aimed to identify the timing of these transitions, to determine if transition phases exist and how long they last, and to investigate if there exists a joint-related order and timing for the start and end of the transitions. Therefore, this study analyzed the kinematics and kinetics of both transitions between level walking and stair ascent, and between level walking and stair descent (12 subjects, 25.4 yrs, 74.6 kg). We found that transitions primarily start within the stance phase and end within the swing phase. Transition phases exist for each limb, all joints (hip, knee, ankle), and types of transitions. They have a mean duration of half of one stride and they do not last longer than one stride. The duration of the transition phase for all joints of a single limb in aggregate is less than 35% of one stride in all but one case. The distal joints initialize stair ascent, while the proximal joints primarily initialize the stair descent transitions. In general, the distal joints complete the transitions first. We believe that energy- and balance-related processes are responsible for the joint-specific transition timing. Regarding the existence of a transition phase for all joints and transitions, we believe that lower limb exoskeleton or prosthetic control concepts should account for these transitions in order to improve the smoothness of the transition and to thus increase the user comfort, safety, and user experience. Our gait data and the identified transition timings can provide a reference for the design and the performance of stair ambulation- related control concepts.	[Grimmer, Martin; Zhao, Guoping] Tech Univ Darmstadt, Inst Sports Sci, Darmstadt, Hesse, Germany; [Zeiss, Julian; Weigand, Florian] Tech Univ Darmstadt, Inst Automat Control & Mechatron, Darmstadt, Hesse, Germany; [Lamm, Sascha; Steil, Martin; Heller, Adrian] Tech Univ Darmstadt, Darmstadt, Hesse, Germany	Technical University of Darmstadt; Technical University of Darmstadt; Technical University of Darmstadt	Grimmer, M (corresponding author), Tech Univ Darmstadt, Inst Sports Sci, Darmstadt, Hesse, Germany.	grimmer@sport.tu-darmstadt.de	Weigand, Florian/GPF-4030-2022	Weigand, Florian/0000-0001-6580-7153; Zeiss, Julian/0000-0001-9406-0167; Grimmer, Martin/0000-0003-1921-1433	German Science Foundation (DFG) [GR 4689/3-1, KO 1876/15-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	The funding for J.Z. was provided by the German Science Foundation (DFG, www.dfg.de) under the grant number KO 1876/15-1. Funding for M.G. was provided by the German Science Foundation (DFG) under the grant number GR 4689/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors received no specific funding for this work.	Aldridge JM, 2012, GAIT POSTURE, V36, P291, DOI 10.1016/j.gaitpost.2012.03.013; [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; Bulea TC, 2014, J REHABIL RES DEV, V51, P1077, DOI 10.1682/JRRD.2013.12.0257; Chumanov ES, 2008, CLIN BIOMECH, V23, P1260, DOI 10.1016/j.clinbiomech.2008.07.011; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Diaz Jean P, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P1817, DOI 10.1109/EMBC.2018.8512614; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Farris RJ, 2012, IEEE ENG MED BIO, P1908, DOI 10.1109/EMBC.2012.6346326; Grimmer M, 2020, FRONT ROBOT AI, V7, DOI 10.3389/frobt.2020.00013; Grimmer M, 2019, FRONT NEUROROBOTICS, V13, DOI 10.3389/fnbot.2019.00057; Grimmer M, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-018-0458-8; Grimmer M, 2014, TR AUGM HUM PERF, V2, P105, DOI 10.1007/978-94-017-8932-5__5; Grimmer M, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0286-7; Hamner SR, 2010, J BIOMECH, V43, P2709, DOI 10.1016/j.jbiomech.2010.06.025; Jang J, 2016, 2016 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS (IROS 2016), P5658, DOI 10.1109/IROS.2016.7759832; Joudzadeh P, 2017, RSI INT CONF ROBOT M, P76; Kang J, 2002, EUR J APPL PHYSIOL, V86, P503, DOI 10.1007/s00421-002-0583-7; Krausz NE, 2015, IEEE T BIO-MED ENG, V62, P2576, DOI 10.1109/TBME.2015.2448457; Lawson BE, 2013, IEEE T NEUR SYS REH, V21, P466, DOI 10.1109/TNSRE.2012.2225640; Ledoux ED, 2017, IEEE T NEUR SYS REH, V25, P917, DOI 10.1109/TNSRE.2017.2656467; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Muller R, 2014, J BIOMECH, V47, P2286, DOI 10.1016/j.jbiomech.2014.04.041; Nadeau S, 2003, CLIN BIOMECH, V18, P950, DOI 10.1016/S0268-0033(03)00179-7; Peng JS, 2016, J BIOMECH, V49, P528, DOI 10.1016/j.jbiomech.2015.12.041; Protopapadaki A, 2007, CLIN BIOMECH, V22, P203, DOI 10.1016/j.clinbiomech.2006.09.010; Purath Janet, 2004, Can J Nurs Res, V36, P76; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; Schmidt K, 2017, FRONT NEUROROBOTICS, V11, DOI 10.3389/fnbot.2017.00057; SCHUTZ RW, 1987, RES Q EXERCISE SPORT, V58, P132, DOI 10.1080/02701367.1987.10605437; Sinclair J, 2013, J HUM KINET, V39, P25, DOI 10.2478/hukin-2013-0065; Tokur D, 2020, HUM MOVEMENT SCI, V69, DOI 10.1016/j.humov.2019.102546; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Winter D.A., 2009, DEPRESS ANXIETY, VFourth, DOI [10.1002/9780470549148, DOI 10.1002/DA.22895]	33	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0239148	10.1371/journal.pone.0239148	http://dx.doi.org/10.1371/journal.pone.0239148			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936793	gold, Green Published			2022-12-26	WOS:000573658000021
J	Lee, J; Lee, JC; Kim, HW; Kim, J; Hwang, JH				Lee, Jongchan; Lee, Jong-chan; Kim, Hyoung Woo; Kim, Jaihwan; Hwang, Jin-Hyeok			Postoperative muscle mass restoration as a prognostic factor in patients with resected pancreatic cancer	PLOS ONE			English	Article							NUTRITIONAL-STATUS; SURVIVAL; SARCOPENIA; INDEX; CHEMOTHERAPY; GEMCITABINE; EXERCISE; THERAPY; SURGERY	Background Recent studies have found that muscle depletion may be a prognostic predictor in patients with pancreatic cancer (PC). However, in these studies, limited data were used to assess the relationship between the serial change in body composition and outcomes after PC resection. Hence, we evaluated the changes in body composition during the perioperative period in patients with PC and their association with the overall survival (OS). Methods A total of 89 patients with PC who received surgery with curative intent between 2006 and 2015 were included in this study retrospectively. These patients underwent serial computed tomography (CT) scans: preoperatively, immediately after surgery (4 weeks), and 12 and 24 weeks after resection. The muscle and visceral fat areas were measured at the third lumbar vertebra level on cross-sectional CT images using sliceOmatic V5.0 program (TomoVision, Canada). The body composition ratio was determined by dividing the post-resection body composition at each point (4, 12, and 24 weeks) by the pre-resection body composition. Patients were divided into two groups-higher and lower groups-based on this body composition ratio (skeletal muscle mass ratio [SMR], visceral fat mass ratio [VFR]). The OS was compared between the two groups using the log-rank test. Results The median age of patients was 63 (27-84) years, and the baseline body mass index was 23.0 (17.0-35.8) kg/m(2). In the comparison of the SMR, there was no significant difference in the OS between the two groups at 4 and 12 weeks (4 weeks,P= 0.488; 12 weeks,P= 0.397). However, the higher group showed a longer OS than the lower group at 24 weeks (39 vs. 20 months,P= 0.008). Similarly, in the VFR, there was no significant difference in the OS between the two groups at 4 and 12 weeks (4 weeks,P= 0.732; 12 weeks,P= 0.060). However, the OS was longer in the higher group at 24 weeks (35 vs. 22 months,P= 0.023). When we analyzed the effect of muscle restoration at 24 weeks after resection on the OS by gender, there was no significant difference between the OS and SMR in the male group (P= 0.213), but a significant difference was noted in the female group (P= 0.002). In the multivariate Cox regression analysis, the SMR at 24 weeks after resection was significantly associated with the OS (P= 0.023) but not VFR at 24 weeks. In 69 patients without recurrence at 6 months, the SMR at 24 weeks was related to longer OS but without statistical significance (P= 0.07). Conclusions This study suggests that the restoration of muscle mass at 24 weeks after resection may be an independent prognostic factor for survival in patients with resected PC.	[Lee, Jongchan; Lee, Jong-chan; Kim, Jaihwan; Hwang, Jin-Hyeok] Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea; [Kim, Hyoung Woo] Chungbuk Natl Univ Hosp, Coll Med, Dept Internal Med, Cheongju, South Korea	Seoul National University (SNU); Chungbuk National University; Chungbuk National University Hospital	Hwang, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Bundang Hosp, Seongnam, South Korea.	woltoong@snu.ac.kr		Kim, Hyoung Woo/0000-0002-5135-7355; Hwang, Jin-Hyeok/0000-0002-5643-8461				Akahori T, 2015, WORLD J SURG, V39, P2975, DOI 10.1007/s00268-015-3205-3; Choi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139749; Christensen JF, 2014, ANN ONCOL, V25, P947, DOI 10.1093/annonc/mdt551; Cooper AB, 2015, ANN SURG ONCOL, V22, P2416, DOI 10.1245/s10434-014-4285-2; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dalal S, 2012, J PAIN SYMPTOM MANAG, V44, P181, DOI 10.1016/j.jpainsymman.2011.09.010; Delitto D, 2017, SURGERY, V161, P930, DOI 10.1016/j.surg.2016.09.038; Di Sebastiano KM, 2013, BRIT J NUTR, V109, P302, DOI 10.1017/S0007114512001067; Elliott JA, 2017, ANN SURG, V266, P822, DOI 10.1097/SLA.0000000000002398; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; Ferrone CR, 2008, J GASTROINTEST SURG, V12, P701, DOI 10.1007/s11605-007-0384-8; Grande AJ, 2015, J CACHEXIA SARCOPENI, V6, P208, DOI 10.1002/jcsm.12055; Johnston AJ, 2015, CELL, V162, P1365, DOI 10.1016/j.cell.2015.08.031; Jung HW, 2015, SUPPORT CARE CANCER, V23, P687, DOI 10.1007/s00520-014-2418-6; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Malietzis G, 2016, ANN SURG ONCOL, V23, P2539, DOI 10.1245/s10434-016-5188-1; Meza-Junco J, 2013, J CLIN GASTROENTEROL, V47, P861, DOI 10.1097/MCG.0b013e318293a825; Mintziras I, 2018, INT J SURG, V59, P19, DOI 10.1016/j.ijsu.2018.09.014; Mishra SI, 2015, ONCOL NURS FORUM, V42, pE33, DOI 10.1188/15.ONF.E33-E53; Miyamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129742; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Oldervoll LM, 2011, ONCOLOGIST, V16, P1649, DOI 10.1634/theoncologist.2011-0133; ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231; Roubenoff R, 2001, CAN J APPL PHYSIOL, V26, P78, DOI 10.1139/h01-006; Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stene GB, 2015, ACTA ONCOL, V54, P340, DOI 10.3109/0284186X.2014.953259; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Ueno H, 2009, BRIT J CANCER, V101, P908, DOI 10.1038/sj.bjc.6605256; Wakabayashi H, 2016, AM J PHYS MED REHAB, V95, pE84, DOI 10.1097/PHM.0000000000000458	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238649	10.1371/journal.pone.0238649	http://dx.doi.org/10.1371/journal.pone.0238649			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936836	gold, Green Published			2022-12-26	WOS:000573658000030
J	Weiner, AB; Jan, S; Jain-Poster, K; Ko, OS; Desai, AS; Kundu, SD				Weiner, Adam B.; Jan, Stephen; Jain-Poster, Ketan; Ko, Oliver S.; Desai, Anuj S.; Kundu, Shilajit D.			Insurance coverage, stage at diagnosis, and time to treatment following dependent coverage and Medicaid expansion for men with testicular cancer	PLOS ONE			English	Article							AFFORDABLE CARE ACT; HEALTH-INSURANCE; YOUNG-ADULTS; EARLY IMPACT; ACCESS; ADOLESCENTS; MANAGEMENT	Introduction We sought to assess the impact of Affordable Care Act Dependent Care Expansion (ACA-DCE), which allowed dependent coverage for adults aged 19-25, and Medicaid expansion on outcomes for men with testicular cancer. Methods Using a US-based cancer registry, we performed adjusted difference-in-difference (DID) analyses comparing outcomes between men aged 19-25 (n = 8,026) and 26-64 (n = 33,303) pre- (2007-2009) and post-ACA-DCE (2011-2016) and between men in states that expanded Medicaid (n = 2,296) to men in those that did not (n = 2,265)pre- (2011-2013) and post-Medicaid expansion (2015-2016). Results In ACA-DCE analysis, rates of uninsurance decreased (DID -5.64, 95% confidence interval [CI] -7.23 to -4.04%, p<0.001) among patients aged 19-25 relative to older patients aged 26-64. There was no significant DID in advanced stage at diagnosis (stage >= II; p = 0.6) or orchiectomy more than 14 days after diagnosis (p = 0.6). For patients who received chemotherapy or radiotherapy as their first course of treatment, treatment greater than 60 days after diagnosis decreased (DID -4.84%, 95% CI -8.22 to -1.45%, p = 0.005) among patients aged 19-25 relative to patients aged 26-64. In Medicaid expansion states, rates of uninsurance decreased (DID -4.20%, 95% CI -7.67 to -0.73%, p = 0.018) while patients receiving chemotherapy or radiotherapy greater than 60 days after diagnosis decreased (DID -8.76, 95% CI -17.13 to -0.38%, p = 0.040) compared to rates in non-expansion states. No significant DIDs were seen for stage (p = 0.8) or time to orchiectomy (p = 0.1). Conclusions Men with testicular cancer had lower uninsurance rates and decreased time to delivery of chemotherapy or radiotherapy following ACA-DCE and Medicaid expansions. Time to orchiectomy and stage at diagnosis did not change following either insurance expansion.	[Weiner, Adam B.; Jain-Poster, Ketan; Ko, Oliver S.; Desai, Anuj S.; Kundu, Shilajit D.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA; [Jan, Stephen] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	Northwestern University; Feinberg School of Medicine; University System of Maryland; University of Maryland Baltimore	Kundu, SD (corresponding author), Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA.	Shilajit.Kundu@nm.org	Jan, Stephen/AAG-3333-2021		2019 Urology Care Foundation Residency Research Award Program; Russell Scott, Jr., MD Urology Research Fund	2019 Urology Care Foundation Residency Research Award Program; Russell Scott, Jr., MD Urology Research Fund	This work was supported in part by the 2019 Urology Care Foundation Residency Research Award Program and the Russell Scott, Jr., MD Urology Research Fund (ABW). https://www.auanet.org/research/research-funding/auafunding/residency-research-awards/residency-research-awards-fellows The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolescent and Young Adult Oncology Program Review Group, 2006, CLOS GAP RES CAR IMP; Agarwal A, 2019, INT J RADIAT ONCOL, V105, P25, DOI 10.1016/j.ijrobp.2019.05.033; Berchick E, 2018, WHO ARE UNINSURED MO; Bilimoria KY, 2009, J CLIN ONCOL, V27, P4177, DOI 10.1200/JCO.2008.21.7018; Bleyer A, 2008, NAT REV CANCER, V8, P288, DOI 10.1038/nrc2349; Boffa DJ, 2017, JAMA ONCOL, V3, P1722, DOI 10.1001/jamaoncol.2016.6905; Cantor JC, 2012, HEALTH SERV RES, V47, P1773, DOI 10.1111/j.1475-6773.2012.01458.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Dong W, 2016, ONCOL LETT, V11, P1361, DOI 10.3892/ol.2015.4065; Edge SB, 2010, AJCC CANC STAGING MA; Gray PJ, 2015, CANCER-AM CANCER SOC, V121, P681, DOI 10.1002/cncr.29094; Han X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198771; Han XS, 2016, J ADOLESCENT HEALTH, V59, P648, DOI 10.1016/j.jadohealth.2016.07.027; Han XS, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw058; Howlader N NA, 2019, SEER CANC STAT REV C; Kamel MH, 2016, UROLOGY, V87, P140, DOI 10.1016/j.urology.2015.06.059; Loehrer AP, 2017, JAMA SURG, V152, P734, DOI 10.1001/jamasurg.2017.0461; Loehrer AP, 2015, J AM COLL SURGEONS, V221, P1015, DOI 10.1016/j.jamcollsurg.2015.09.010; Mesquita-Neto JWB, 2020, AM J SURG, V219, P181, DOI 10.1016/j.amjsurg.2019.06.023; Miller S, 2017, NEW ENGL J MED, V376, P947, DOI 10.1056/NEJMsa1612890; Nogueira LM, 2019, JNCI CANCER SPECT, V3, DOI 10.1093/jncics/pkz001; Parsons HM, 2016, CANCER-AM CANCER SOC, V122, P1766, DOI 10.1002/cncr.29982; Robbins AS, 2014, CANCER-AM CANCER SOC, V120, P1212, DOI 10.1002/cncr.28568; Rosenberg AR, 2015, CANCER-AM CANCER SOC, V121, P1279, DOI 10.1002/cncr.29187; Sommers BD, 2013, HEALTH AFFAIR, V32, P165, DOI 10.1377/hlthaff.2012.0552; Weiner AB, 2020, CANCER-AM CANCER SOC, V126, P3229, DOI 10.1002/cncr.32930	27	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238813	10.1371/journal.pone.0238813	http://dx.doi.org/10.1371/journal.pone.0238813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936794	Green Published, gold			2022-12-26	WOS:000573658000012
J	Xylaki, M; Boumpoureka, I; Kokotou, MG; Marras, T; Papadimitriou, G; Kloukina, I; Magrioti, V; Kokotos, G; Vekrellis, K; Emmanouilidou, E				Xylaki, Mary; Boumpoureka, Ioanna; Kokotou, Maroula G.; Marras, Theodoros; Papadimitriou, Georgia; Kloukina, Ismini; Magrioti, Victoria; Kokotos, George; Vekrellis, Kostas; Emmanouilidou, Evangelia			Changes in the cellular fatty acid profile drive the proteasomal degradation of alpha-synuclein and enhance neuronal survival	FASEB JOURNAL			English	Article						alpha-synuclein; arachidonic acid; degradation; oligomers; Parkinson's disease; phospholipase A(2); proteasome	CHAPERONE-MEDIATED AUTOPHAGY; PHOSPHOLIPASE A(2); ARACHIDONIC-ACID; MEMBRANE INTERACTIONS; SNARE COMPLEX; BINDING; MUTANT; TOXICITY; NEURODEGENERATION; OLIGOMERIZATION	Parkinson's disease is biochemically characterized by the deposition of aberrant aggregated alpha-synuclein in the affected neurons. The aggregation properties of alpha-synuclein greatly depend on its affinity to bind cellular membranes via a dynamic interaction with specific lipid moieties. In particular, alpha-synuclein can interact with arachidonic acid (AA), a polyunsaturated fatty acid, in a manner that promotes the formation of alpha-helix enriched assemblies. In a cellular context, AA is released from membrane phospholipids by phospholipase A(2)(PLA(2)). To investigate the impact of PLA(2)activity on alpha-synuclein aggregation, we have applied selective PLA(2)inhibitors to a SH-SY5Y cellular model where the expression of human wild-type alpha-synuclein is correlated with a gradual accumulation of soluble oligomers and subsequent cell death. We have found that pharmacological and genetic inhibition of GIVA cPLA(2)resulted in a dramatic decrease of intracellular oligomeric and monomeric alpha-synuclein significantly promoting cell survival. Our data suggest that alterations in the levels of free fatty acids, and especially AA and adrenic acid, promote the formation of alpha-synuclein conformers which are more susceptible to proteasomal degradation. This mechanism is active only in living cells and is generic since it does not depend on the absolute quantity of alpha-synuclein, the presence of disease-linked point mutations, the expression system or the type of cells. Our findings indicate that the alpha-synuclein-fatty acid interaction can be a critical determinant of the conformation and fate of alpha-synuclein in the cell interior and, as such, cPLA(2)inhibitors could serve to alleviate the intracellular, potentially pathological, alpha-synuclein burden.	[Xylaki, Mary; Boumpoureka, Ioanna; Kloukina, Ismini; Vekrellis, Kostas; Emmanouilidou, Evangelia] Acad Athens, Biomed Res Fdn, Ctr Basic Res, Athens, Greece; [Kokotou, Maroula G.; Magrioti, Victoria; Kokotos, George] Natl & Kapodistrian Univ Athens, Dept Chem, Organ Chem Lab, Athens, Greece; [Marras, Theodoros; Papadimitriou, Georgia; Emmanouilidou, Evangelia] Natl & Kapodistrian Univ Athens, Dept Chem, Biochem Lab, Athens 15784, Greece; [Xylaki, Mary] Univ Med Ctr Goettingen, Dept Expt Neurodegenerat, Ctr Biostruct Imaging Neurodegenerat BIN, G ettingen, Germany	Academy of Athens; National & Kapodistrian University of Athens; National & Kapodistrian University of Athens	Emmanouilidou, E (corresponding author), Natl & Kapodistrian Univ Athens, Dept Chem, Biochem Lab, Athens 15784, Greece.	eemman@chem.uoa.gr	Emmanouilidou, Evangelia/ACP-6562-2022	Xylaki, Mary/0000-0002-7892-8621	General Secretariat for Research and Technology (GSRT); Fondation Sante; Hellenic Foundation of Research and Innovation [1065]; SARG NKUA [16672]	General Secretariat for Research and Technology (GSRT)(Greek Ministry of Development-GSRT); Fondation Sante; Hellenic Foundation of Research and Innovation; SARG NKUA	General Secretariat for Research and Technology (GSRT), Grant/Award Number: COOPERATION II; Fondation Sante; Hellenic Foundation of Research and Innovation, Grant/Award Number: SemiSynPD, No. 1065; SARG NKUA, Grant/Award Number: 16672	Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Alza NP, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00175; Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bate C, 2015, BIOMOLECULES, V5, P178, DOI 10.3390/biom5010178; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Calo L, 2016, MOVEMENT DISORD, V31, P169, DOI 10.1002/mds.26479; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Cliffe R, 2019, CELL REP, V26, P2140, DOI 10.1016/j.celrep.2019.01.096; Connell E, 2007, EMBO REP, V8, P414, DOI 10.1038/sj.embor.7400935; Corbett Grant T, 2015, Mov Disord, V30, P1870, DOI 10.1002/mds.26361; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Darios F, 2010, EMBO REP, V11, P528, DOI 10.1038/embor.2010.66; Dedaki C, 2019, J MED CHEM, V62, P2916, DOI 10.1021/acs.jmedchem.8b01216; Dehay B, 2016, MOVEMENT DISORD, V31, P882, DOI 10.1002/mds.26568; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Drombosky KW, 2018, NEUROBIOL DIS, V120, P126, DOI 10.1016/j.nbd.2018.08.019; Emmanouilidou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022225; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Galvagnion C, 2017, J PARKINSON DIS, V7, P433, DOI 10.3233/JPD-171103; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Guerrero-Munoz MJ, 2014, NEUROBIOL DIS, V71, P14, DOI 10.1016/j.nbd.2014.08.008; Gustafsson G, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1018-z; Helwig M, 2016, BRAIN, V139, P856, DOI 10.1093/brain/awv376; Hirohata M, 2008, NEUROPHARMACOLOGY, V54, P620, DOI 10.1016/j.neuropharm.2007.11.010; HORROCKS LA, 1989, ANN NY ACAD SCI, V559, P17; Iljina M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33928; Illes-Toth E, 2015, BIOCHEM J, V468, P485, DOI 10.1042/BJ20150159; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kapaki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081654; Karampetsou M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15813-8; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Killinger BA, 2019, NPJ PARKINSONS DIS, V5, DOI 10.1038/s41531-019-0095-3; Kim KH, 2019, TOXINS, V11, DOI 10.3390/toxins11060358; Kokotou MG, 2020, MOLECULES, V25, DOI 10.3390/molecules25071548; Kokotou MG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07330-5; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Lee JT, 2008, HUM MOL GENET, V17, P906, DOI 10.1093/hmg/ddm363; Magrioti V, 2013, BIOORGAN MED CHEM, V21, P5823, DOI 10.1016/j.bmc.2013.07.010; Malada-Edelstein YF, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0811-z; MASUDA M, 1987, J IMMUNOL METHODS, V96, P225, DOI 10.1016/0022-1759(87)90318-8; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Melachroinou K, 2013, NEUROBIOL AGING, V34, P2853, DOI 10.1016/j.neurobiolaging.2013.06.006; Miki Y, 2017, NEUROSCI LETT, V645, P40, DOI 10.1016/j.neulet.2017.02.027; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mohite GM, 2018, BIOCHEMISTRY-US, V57, P5183, DOI 10.1021/acs.biochem.8b00314; Monge P, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040542; Mor DE, 2016, NEUROBIOL DIS, V88, P66, DOI 10.1016/j.nbd.2015.12.018; Mori A, 2019, P NATL ACAD SCI USA, V116, P20689, DOI 10.1073/pnas.1902958116; Nussbaum RL, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024109; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Pham CLL, 2013, BIOSCIENCE REP, V33, P807, DOI 10.1042/BSR20130092; Rott R, 2011, P NATL ACAD SCI USA, V108, P18666, DOI 10.1073/pnas.1105725108; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Schaeffer EL, 2011, PROG NEURO-PSYCHOPH, V35, P1612, DOI 10.1016/j.pnpbp.2011.05.001; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Shahmoradian SH, 2019, NAT NEUROSCI, V22, P1099, DOI 10.1038/s41593-019-0423-2; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sousa VL, 2009, MOL BIOL CELL, V20, P3725, DOI 10.1091/mbc.E08-03-0302; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Stefanis L, 2019, J NEUROCHEM, V150, P577, DOI 10.1111/jnc.14704; Tan C, 2016, MOL NEUROBIOL, V53, P3854, DOI 10.1007/s12035-015-9314-z; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Ugalde CL, 2019, J BIOL CHEM, V294, P9016, DOI 10.1074/jbc.REV119.007500; Vekrellis K, 2009, J NEUROCHEM, V109, P1348, DOI 10.1111/j.1471-4159.2009.06054.x; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wong YC, 2017, NAT MED, V23, P151, DOI 10.1038/nm.4269; Xilouri M, 2016, AUTOPHAGY, V12, P2230, DOI 10.1080/15548627.2016.1214777; Ximerakis M, 2014, FASEB J, V28, P3146, DOI 10.1096/fj.13-245852; Ye M, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.49; Ysselstein D, 2015, NEUROBIOL DIS, V79, P150, DOI 10.1016/j.nbd.2015.04.007	77	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15123	15145		10.1096/fj.202001344R	http://dx.doi.org/10.1096/fj.202001344R		SEP 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931072				2022-12-26	WOS:000570777700001
J	Zhang, WJ; Xu, S; Shi, L; Zhu, ZZ; Xie, XY				Zhang, Wenjing; Xu, Shuai; Shi, Laner; Zhu, Zhangzhi; Xie, Xinying			Construction and analysis of a competing endogenous RNA network to reveal potential prognostic biomarkers for Oral Floor Squamous Cell Carcinoma	PLOS ONE			English	Article							SOLUBLE BETAGLYCAN; BETA RECEPTOR; EXPRESSION; GENE; GROWTH; CERNA	Background Patients diagnosed with Oral Floor Squamous Cell Carcinoma (OFSCC) face considerable challenges in physiology and psychology. This study explored prognostic signatures to predict prognosis in OFSCC through a detailed transcriptomic analysis. Method We built an interactive competing endogenous RNA (ceRNA) network that included lncRNAs, miRNAs and mRNAs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were used to predict the gene functions and regulatory pathways of mRNAs. Least absolute shrinkage and selection operator algorithm (LASSO) analysis and Cox regression analysis were used to screen prognosis factors. The Kaplan-Meier method was used to analyze the survival rate of prognosis factors. Risk score was used to assess the reliability of the prediction model. Results A specific ceRNA network consisting of 56 mRNAs, 16 miRNAs and 31 lncRNAs was established. Three key genes (HOXC13, TGFBR3, KLHL40) and 4 clinical factors (age, gender, TNM, and clinical stage) were identified and effectively predicted the for survival time. The expression of a gene signature was validated in two external validation cohorts. The signature (areas under the curve of 3 and 5 years were 0.977 and 0.982, respectively) showed high prognostic accuracy in the complete TCGA cohort. Conclusions Our study successfully developed an extensive ceRNA network for OFSCC and further identified a 3-mRNA and 4-clinical-factor signature, which may serve as a biomarker.	[Zhang, Wenjing] Southern Med Univ, Affiliated Hosp 3, Dept Hlth Management Ctr, Guangzhou, Guangdong, Peoples R China; [Zhang, Wenjing; Shi, Laner] Guangzhou Univ Tradit Chinese Med, Dept Coll Clin Med 1, Guangzhou, Guangdong, Peoples R China; [Xu, Shuai] Guangzhou Univ Chinese Med, Shenzhen Baoan Tradit Chinese Med Hosp, Endocrine Dept, Shenzhen, Guangdong, Peoples R China; [Zhu, Zhangzhi] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Endocrine Dept, Guangzhou, Guangdong, Peoples R China; [Xie, Xinying] Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Gen Dept, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Zhu, ZZ (corresponding author), Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Endocrine Dept, Guangzhou, Guangdong, Peoples R China.; Xie, XY (corresponding author), Guangzhou Univ Tradit Chinese Med, Affiliated Hosp 1, Gen Dept, Guangzhou, Guangdong, Peoples R China.	ssunshine0514@163.com; xiexinying2012@sina.com						Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Alhamzawi R, 2018, MATH BIOSCI, V303, P75, DOI 10.1016/j.mbs.2018.06.004; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; [Anonymous], 2015, NUCLEIC ACIDS RES, V43, pD204; Bandyopadhyay A, 1999, CANCER RES, V59, P5041; Bandyopadhyay A, 2005, PROSTATE, V63, P81, DOI 10.1002/pros.20166; Bandyopadhyay A, 2002, CANCER RES, V62, P4690; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bhosale PG, 2017, TRANSL ONCOL, V10, P396, DOI 10.1016/j.tranon.2017.03.008; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Copland JA, 2003, ONCOGENE, V22, P8053, DOI 10.1038/sj.onc.1206835; Ellington TD, 2020, MMWR-MORBID MORTAL W, V69, P433, DOI 10.15585/mmwr.mm6915a1; Garg A, 2014, J CLIN INVEST, V124, P3529, DOI 10.1172/JCI74994; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Ren SG, 2018, IEEE T PATTERN ANAL, V40, P2992, DOI 10.1109/TPAMI.2017.2776267; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rundqvist HC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223024; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schmidt BL, 2004, J ORAL MAXIL SURG, V62, P1055, DOI 10.1016/j.joms.2004.03.010; Turley RS, 2007, CANCER RES, V67, P1090, DOI 10.1158/0008-5472.CAN-06-3117; Waldmann P, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2743-3; Wang YF, 2016, TRENDS GENET, V32, P211, DOI 10.1016/j.tig.2016.02.001; Wei ZX, 2019, BIOMED PHARMACOTHER, V119, DOI 10.1016/j.biopha.2019.109365; Yang SJ, 2018, J CELL BIOCHEM, V119, P6953, DOI 10.1002/jcb.26902; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141042; Zhou L, 2017, STAT BIOSCI, V9, P431, DOI 10.1007/s12561-016-9170-z	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0238420	10.1371/journal.pone.0238420	http://dx.doi.org/10.1371/journal.pone.0238420			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931492	gold, Green Published			2022-12-26	WOS:000573375500026
J	Bhatia, M; Thakur, J; Suyal, S; Oniel, R; Chakraborty, R; Pradhan, S; Sharma, M; Sengupta, S; Laxman, S; Masakapalli, SK; Bachhawat, AK				Bhatia, Muskan; Thakur, Jyotika; Suyal, Shradha; Oniel, Ruchika; Chakraborty, Rahul; Pradhan, Shalini; Sharma, Monika; Sengupta, Shantanu; Laxman, Sunil; Masakapalli, Shyam Kumar; Bachhawat, Anand Kumar			Allosteric inhibition of MTHFR prevents futile SAM cycling and maintains nucleotide pools in one-carbon metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						methionine; allosteric regulation; S-adenosylmethionine (SAM); Saccharomyces cerevisiae; AMP; feedback insensitive; futile cycle; MTHFR; nucleotide depletion	METHYLENETETRAHYDROFOLATE REDUCTASE; S-ADENOSYLMETHIONINE; SACCHAROMYCES-CEREVISIAE; FUMARATE REDUCTASE; ESCHERICHIA-COLI; FLUX ANALYSIS; YEAST; GENE; 5,10-METHYLENETETRAHYDROFOLATE; ANAEROBIOSIS	Methylenetetrahydrofolate reductase (MTHFR) links the folate cycle to the methionine cycle in one-carbon metabolism. The enzyme is known to be allosterically inhibited by SAM for decades, but the importance of this regulatory control to one-carbon metabolism has never been adequately understood. To shed light on this issue, we exchanged selected amino acid residues in a highly conserved stretch within the regulatory region of yeast MTHFR to create a series of feedback-insensitive, deregulated mutants. These were exploited to investigate the impact of defective allosteric regulation on one-carbon metabolism. We observed a strong growth defect in the presence of methionine. Biochemical and metabolite analysis revealed that both the folate and methionine cycles were affected in these mutants, as was the transsulfuration pathway, leading also to a disruption in redox homeostasis. The major consequences, however, appeared to be in the depletion of nucleotides. C-13 isotope labeling and metabolic studies revealed that the deregulated MTHFR cells undergo continuous transmethylation of homocysteine by methyltetrahydrofolate (CH3THF) to form methionine. This reaction also drives SAM formation and further depletes ATP reserves. SAM was then cycled back to methionine, leading to futile cycles of SAM synthesis and recycling and explaining the necessity for MTHFR to be regulated by SAM. The study has yielded valuable new insights into the regulation of one-carbon metabolism, and the mutants appear as powerful new tools to further dissect out the intersection of one-carbon metabolism with various pathways both in yeasts and in humans.	[Bhatia, Muskan; Suyal, Shradha; Bachhawat, Anand Kumar] Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, Punjab, India; [Sharma, Monika] Indian Inst Sci Educ & Res, Dept Chem Sci, Mohali, Punjab, India; [Thakur, Jyotika; Masakapalli, Shyam Kumar] Indian Inst Technol Mandi, Sch Basic Sci, BioX Ctr, Kamand, Himachal Prades, India; [Oniel, Ruchika; Laxman, Sunil] Inst Stem Cell Sci & Regenerat Med inStem, NCBS TIFR Campus, Bangalore, Karnataka, India; [Chakraborty, Rahul; Pradhan, Shalini; Sengupta, Shantanu] Inst Genom & Integrat Biol, Council Sci & Ind Res, New Delhi, India	Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Bachhawat, AK (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mohali, Punjab, India.	anand@iisermohali.ac.in	Masakapalli, Shyam/ABD-9712-2020; Sharma, Monika/S-2525-2019; Laxman, Sunil/F-9886-2018	Masakapalli, Shyam/0000-0003-1988-5569; Sharma, Monika/0000-0001-9864-3298; Laxman, Sunil/0000-0002-0861-5080; Suyal, Shradha/0000-0001-5286-1599	Indian Council of Medical Research, India (ICMR) [JRF-2013/HRD-64 (33138)]; Indian Institute of Science Education and Research Mohali; Ministry of Human Resource Development (MHRD); IMPRINT; Department of Science and Technology of the Government of India [CRG/2018/000190]; MHRD-IMPRINT Project [7801 IITM/IMPRINT/AD/169]; Department of Biotechnology, Ministry of Science and Technology, India (DBT) [BT/PR13446/COE/34/30/2015]; Department of Science and Technology for an INSPIRE Award and Research Grant [IFA14-CH-165]	Indian Council of Medical Research, India (ICMR)(Indian Council of Medical Research (ICMR)); Indian Institute of Science Education and Research Mohali; Ministry of Human Resource Development (MHRD)(Ministry of Human Resource Development (MHRD), Government of India); IMPRINT; Department of Science and Technology of the Government of India(Department of Science & Technology (India)); MHRD-IMPRINT Project; Department of Biotechnology, Ministry of Science and Technology, India (DBT); Department of Science and Technology for an INSPIRE Award and Research Grant(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines)	M. B. is a recipient of Indian Council of Medical Research, India (ICMR) Fellowship JRF-2013/HRD-64 (33138), and S. S. acknowledges fellowship support from Indian Institute of Science Education and Research Mohali for her doctoral work. J. T. acknowledges fellowship support from Ministry of Human Resource Development (MHRD) and IMPRINT. This work was supported by Grant-in-Aid CRG/2018/000190 from the Department of Science and Technology of the Government of India (to A. K. B.) S. K. Macknowledges the support of MHRD-IMPRINT Project 7801 IITM/IMPRINT/AD/169. S. L. acknowledges support from Department of Biotechnology, Ministry of Science and Technology, India (DBT) Grant BT/PR13446/COE/34/30/2015. M. S. acknowledges Department of Science and Technology for an INSPIRE Award and Research Grant IFA14-CH-165.	Antoniewicz MR, 2007, METAB ENG, V9, P277, DOI 10.1016/j.ymben.2007.01.003; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burda P, 2015, HUM MUTAT, V36, P611, DOI 10.1002/humu.22779; Camarasa C, 2007, YEAST, V24, P391, DOI 10.1002/yea.1467; Chan SY, 2003, J BIOL CHEM, V278, P43051, DOI 10.1074/jbc.M308696200; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Enomoto K, 2002, FEMS MICROBIOL LETT, V215, P103; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Froese DS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04735-2; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; Guthrie C., 1991, GUIDE YEAST GENETICS, P194; Hayakawa K, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0935-6; Jain M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23806-4; Jyoti P, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00091-20; Kanarek N, 2018, NATURE, V559, P632, DOI 10.1038/s41586-018-0316-7; Kato M, 2019, CELL, V177, P711, DOI 10.1016/j.cell.2019.02.044; KUTZBACH C, 1967, BIOCHIM BIOPHYS ACTA, V139, P217, DOI 10.1016/0005-2744(67)90140-4; KUTZBACH C, 1971, BIOCHIM BIOPHYS ACTA, V250, P459, DOI 10.1016/0005-2744(71)90247-6; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Lopez-Lopez E, 2013, PHARMACOGENOMICS J, V13, P498, DOI 10.1038/tpj.2012.44; Masakapalli SK, 2014, PLANT J, V78, P964, DOI 10.1111/tpj.12522; MATTHEWS RG, 1979, BIOCHEMISTRY-US, V18, P4845, DOI 10.1021/bi00589a012; Matthews RG, 1998, EUR J PEDIATR, V157, pS54, DOI 10.1007/PL00014305; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Murin R, 2017, GEN PHYSIOL BIOPHYS, V36, P513, DOI 10.4149/gpb_2017031; Raymond RK, 1999, ARCH BIOCHEM BIOPHYS, V372, P300, DOI 10.1006/abbi.1999.1498; Rebora K, 2001, MOL CELL BIOL, V21, P7901, DOI 10.1128/MCB.21.23.7901-7912.2001; Roje S, 2002, J BIOL CHEM, V277, P4056, DOI 10.1074/jbc.M110651200; Rosenblatt DS., 1995, METABOLIC MOL BASES, P3111; Rummel T, 2007, J Inherit Metab Dis, V30, P401, DOI 10.1007/s10545-007-0445-x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SELHUB J, 1992, AM J CLIN NUTR, V55, P131, DOI 10.1093/ajcn/55.1.131; Shree M, 2018, METABOLITES, V8, DOI 10.3390/metabo8040066; SUMNER J, 1986, J BIOL CHEM, V261, P7697; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMAS D, 1991, EMBO J, V10, P547, DOI 10.1002/j.1460-2075.1991.tb07981.x; Trimmer EE, 2001, BIOCHEMISTRY-US, V40, P6216, DOI 10.1021/bi002790v; Trimmer EE, 2013, CURR PHARM DESIGN, V19, P2574; Walvekar Adhish, 2018, Wellcome Open Res, V3, P122, DOI 10.12688/wellcomeopenres.14832.1; Wang HL, 2018, J BIOL REG HOMEOS AG, V32, P1255; White WH, 2001, J BIOL CHEM, V276, P10794, DOI 10.1074/jbc.M009804200; Yadav S, 2020, G3-GENES GENOM GENET, V10, P371, DOI 10.1534/g3.119.400606; Ye CQ, 2017, MOL CELL, V66, P180, DOI 10.1016/j.molcel.2017.02.026; Zhang J, 2016, ACS SYNTH BIOL, V5, P1546, DOI 10.1021/acssynbio.6b00135	50	6	7	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16037	16057		10.1074/jbc.RA120.015129	http://dx.doi.org/10.1074/jbc.RA120.015129			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32934008	Green Published, hybrid			2022-12-26	WOS:000595657900021
J	Khmelev, VN; Shalunov, AV; Nesterov, VA				Khmelev, Vladimir N.; Shalunov, Andrey, V; Nesterov, Viktor A.			Improving the separation efficient of particles smaller than 2.5 micrometer by combining ultrasonic agglomeration and swirling flow techniques	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; ACOUSTIC AGGLOMERATION; ULTRAFINE PARTICLES; CYCLONE; FINE; COAGULATION; MORTALITY; MICRON; HEALTH; INLET	The method for increasing the separation efficiency of particles smaller than 2.5 micrometers by combined ultrasonic agglomeration and swirling flow technique is proposed in the article. The swirling flow creates areas with an increased concentration of particles on the outer radius of the vortex. The ultrasonic exposure on these areas leads to more efficient agglomeration and the formation of agglomerates of many times larger than the original particles. The resulting agglomerates are easily separated from the gas flow. The design of the agglomerator was developed. The vortex velocity is determined, at which ultrasonic exposure on the swirling flow increases the average particle sized(32)= 2.5 micrometer to 4.5 times. The ultrasonic exposure on a rectilinear flow can increase the particle size no more than 1.6 times for comparison. The proposed method is compared with inertial gas clearing in a cyclone. It was found that the proposed combined method allows increasing the cleaning efficiency from 46% to 85% at ultrasonic exposure on the swirling flow in the agglomerator and cyclone.	[Khmelev, Vladimir N.; Shalunov, Andrey, V; Nesterov, Viktor A.] Altay State Tech Univ, Dept Methods & Tools Measurement & Automat, Biysk Technol Inst, Biisk, Altai Krai, Russia	Polzunov Altai State Technical University	Nesterov, VA (corresponding author), Altay State Tech Univ, Dept Methods & Tools Measurement & Automat, Biysk Technol Inst, Biisk, Altai Krai, Russia.	nva@u-sonic.ru	Nesterov, Viktor A/U-9508-2018; Shalunov, Andrey V/L-2276-2016; Vladimir, Khmelev/B-5629-2017	Nesterov, Viktor A/0000-0002-6140-5699; Shalunov, Andrey V/0000-0002-5299-9931; Vladimir, Khmelev/0000-0001-7089-3578	Russian Science Foundation [19-19-00121]	Russian Science Foundation(Russian Science Foundation (RSF))	The study was carried out by a grant from the Russian Science Foundation. (project No. 19-19-00121). Khmelev V.N. and co-authors (Shalunov A.V. and Nesterov V.A.) are grantees	Brandt O, 1936, KOLLOID Z, V77, P103, DOI 10.1007/BF01422153; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Cereska A, 2016, J VIBROENG, V18, P2004, DOI 10.21595/jve.2016.16983; DESARABIA ERF, 1986, J SOUND VIB, V110, P413, DOI 10.1016/S0022-460X(86)80144-4; Dong SZ, 2006, J AEROSOL SCI, V37, P540, DOI 10.1016/j.jaerosci.2005.05.008; Furuyama A, 2009, ARCH TOXICOL, V83, P429, DOI 10.1007/s00204-008-0371-1; Gallego-Juarez JA, 1999, ENVIRON SCI TECHNOL, V33, P3843, DOI 10.1021/es990002n; Gallego-Juarez JA, 2010, PHYSCS PROC, V3, P35, DOI 10.1016/j.phpro.2010.01.006; Gonzalez I, 2003, J AEROSOL SCI, V34, P1611, DOI 10.1016/S0021-8502(03)00190-3; Halonen JI, 2009, EPIDEMIOLOGY, V20, P143, DOI 10.1097/EDE.0b013e31818c7237; Hsiao TC, 2015, J AEROSOL SCI, V86, P1, DOI 10.1016/j.jaerosci.2015.03.005; Khmelev Vladimir N., 2013, 2013 14th International Conference of Young Specialists on Micro/Nanotechnologies and Electron Devices (EDM), P166, DOI 10.1109/EDM.2013.6641966; Khmelev VN, 2018, INT CONF SEMINAR, P327; Khmelev VN, 2016, ARCH ACOUST, V41, P757, DOI 10.1515/aoa-2016-0073; Khmelev VN, 2016, INT CONF SEMINAR, P251, DOI 10.1109/EDM.2016.7538735; Khmelev VN, 2015, INT CONF SEMINAR, P224, DOI 10.1109/EDM.2015.7184532; Kim T-S, 2006, Patent, Patent No. [US7422615B2, B01D 45/12, 7422615]; Kudryashova O, 2012, PHOTODETECTORS, P341, DOI 10.5772/35215; Kudryashova OB, 2010, KEY ENG MAT, V437, P179, DOI 10.4028/www.scientific.net/KEM.437.179; Liu JZ, 2011, J ENVIRON SCI, V23, P1845, DOI 10.1016/S1001-0742(10)60652-3; Lu MS, 2019, RSC ADV, V9, P5224, DOI 10.1039/c8ra09581g; Mazyan WI, 2017, J AEROSOL SCI, V110, P36, DOI 10.1016/j.jaerosci.2017.05.007; Mednikov E.P., 1965, APPL MECH MAT, V34, P1087; Misiulia D, 2017, POWDER TECHNOL, V305, P48, DOI 10.1016/j.powtec.2016.09.050; Nowak K, 2019, IOP CONF SER-MAT SCI, V603, DOI 10.1088/1757-899X/603/5/052096; Oliveira RAF, 2019, CHEM ENG PROCESS, V145, DOI 10.1016/j.cep.2019.107667; Patterson HS, 1931, NATURE, V127, P667, DOI 10.1038/127667a0; Penttinen P, 2001, EUR RESPIR J, V17, P428, DOI 10.1183/09031936.01.17304280; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Riera E, 2015, PHYSCS PROC, V63, P67, DOI 10.1016/j.phpro.2015.03.011; Ruckerl Regina, 2007, Part Fibre Toxicol, V4, P1, DOI 10.1186/1743-8977-4-1; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Salcedo RL, 2003, IND ENG CHEM RES, V42, P145, DOI 10.1021/ie020195e; Seya K, 1957, ULTR S P EL MAT, P583, DOI [10.1109/ULTSYM.1975.196591, DOI 10.1109/ULTSYM.1975.196591]; Shirokova N.L., 1973, PHYS PRINCIPLES ULTR, V2, P475; SONG L, 1994, J VIB ACOUST, V116, P208, DOI 10.1115/1.2930414; Surmen A, 2011, POWDER TECHNOL, V207, P1, DOI 10.1016/j.powtec.2010.10.002; TIMOSHENKO V, 1976, ULTRASONICS, V14, P218, DOI 10.1016/0041-624X(76)90021-4; Titov SS, 2014, C P 1 INT C ATM DUST, P261; Xie B, 2018, POWDER TECHNOL, V339, P695, DOI 10.1016/j.powtec.2018.07.103; Xiong ZY, 2014, AEROSOL AIR QUAL RES, V14, P1055, DOI 10.4209/aaqr.2013.09.0298; Yang JX, 2013, SEP PURIF TECHNOL, V105, P15, DOI 10.1016/j.seppur.2012.12.020; Yu ZK, 2020, SEP PURIF TECHNOL, V248, DOI 10.1016/j.seppur.2020.117098	43	1	1	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239593	10.1371/journal.pone.0239593	http://dx.doi.org/10.1371/journal.pone.0239593			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970754	Green Published, gold			2022-12-26	WOS:000576265600088
J	Xiong, JT; Liu, SG; Hu, K; Xiong, YX; Wang, PY; Xiong, L				Xiong, Jingting; Liu, Shiguo; Hu, Kai; Xiong, Yinxiang; Wang, Pengyun; Xiong, Liang			Study of reference intervals for free triiodothyronine, free thyroxine, and thyroid-stimulating hormone in an elderly Chinese Han population	PLOS ONE			English	Article							IFCC WORKING GROUP; FUNCTION TESTS; STANDARDIZATION; DIAGNOSIS; DISEASE; AGE	The clinical manifestations of thyroid diseases in elderly patients are often atypical. This study aimed to establish reference intervals for thyroid function in the elderly in order to help diagnose thyroid diseases in this population. A total of 5345 healthy individuals were examined and divided into three groups according to their age: 4297 individuals aged < 65 years (19-64), 719 individuals aged between 65 and 79 years, and 329 individuals aged between 80 and 100 years. Levels of free triiodothyronine (FT3), free thyroxine (FT4), thyroid-stimulating hormone (TSH), thyroid peroxidase antibody, and thyroglobulin antibody were measured in these subjects by using a fully automated analyzer. The following free triiodothyronine, free thyroxine, and thyroid-stimulating hormone reference intervals were obtained from each age group: For individuals aged < 65 years (19-64 years), FT3, FT4, and TSH were 3.40-6.44, 10.26-19.25 pmol/L and 0.50-4.81 mu IU/mL, respectively. For individuals aged between 65 and 79 years, FT3, FT4 and TSH ranged between 3.01-5.91, 10.04-19.76 pmol/L, and 0.54-5.51 mu IU/mL, respectively. For individuals aged between 80 and 100 years, FT3, FT4, and TSH varied between 2.82-5.57, 9.79-21.22 pmol/L, 0.31-6.28 mu IU/mL respectively. FT3 concentration was lower and the concentrations of FT4 and TSH were higher in individuals aged >= 65 years than in those aged <65 years (P<0.0001; P = 0.0039; P<0.0001, respectively). In conclusion, establishment of a reference interval would allow clinicians to diagnose diseases more accurately and easily.	[Xiong, Jingting; Xiong, Yinxiang; Wang, Pengyun; Xiong, Liang] Huazhong Univ Sci & Technol, Liyuan Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Hubei, Peoples R China; [Liu, Shiguo] Jianghan Univ, Dept Lab Med, Hubei 3 Peoples Hosp, Wuhan, Hubei, Peoples R China; [Hu, Kai] Puai Hosp, Dept Dermatol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Jianghan University	Wang, PY; Xiong, L (corresponding author), Huazhong Univ Sci & Technol, Liyuan Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Hubei, Peoples R China.	wpy0110@126.com; xionglianghust@163.com			Training Plan of Young and Middle-Aged Backbone Talents of Medicine of Health and Family Planning Commission of Wuhan, Hubei Province, China	Training Plan of Young and Middle-Aged Backbone Talents of Medicine of Health and Family Planning Commission of Wuhan, Hubei Province, China	This work was supported by grants from the Training Plan of Young and Middle-Aged Backbone Talents of Medicine of Health and Family Planning Commission of Wuhan, Hubei Province, China (2017).	Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Cappola AR, 2019, JAMA-J AM MED ASSOC, V322, P1961, DOI 10.1001/jama.2019.14728; Ceresini Graziano, 2010, Acta Biomed, V81 Suppl 1, P31; Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110; Chaker L, 2016, THYROID, V26, P1195, DOI 10.1089/thy.2016.0133; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Demers LM, 2003, CLIN ENDOCRINOL, V58, P138, DOI 10.1046/j.1365-2265.2003.01681.x; Hennessey JV, 2015, INT J CLIN PRACT, V69, P771, DOI 10.1111/ijcp.12619; HERRMANN J, 1981, KLIN WOCHENSCHR, V59, P315, DOI 10.1007/BF01525000; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Jonklaas J, 2019, LANCET DIABETES ENDO, V7, P473, DOI 10.1016/S2213-8587(18)30371-1; Kahapola-Arachchige KM, 2012, CLIN ENDOCRINOL, V77, P773, DOI 10.1111/j.1365-2265.2012.04463.x; Leung AM, 2014, NAT REV ENDOCRINOL, V10, P136, DOI 10.1038/nrendo.2013.251; MARIOTTI S, 1993, J CLIN ENDOCR METAB, V77, P1130, DOI 10.1210/jc.77.5.1130; Mitrou P, 2011, MATURITAS, V70, P5, DOI 10.1016/j.maturitas.2011.05.016; Over R, 2010, J CLIN ENDOCR METAB, V95, P3675, DOI 10.1210/jc.2010-0281; Park SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190738; Tabatabaie V, 2013, CURR OPIN ENDOCRINOL, V20, P455, DOI 10.1097/01.med.0000433055.99570.52; Thienpont LM, 2014, EUR THYROID J, V3, P109, DOI 10.1159/000358270; Thienpont LM, 2010, CLIN CHEM, V56, P912, DOI 10.1373/clinchem.2009.140194; Thienpont LM, 2010, CLIN CHEM, V56, P902, DOI 10.1373/clinchem.2009.140178; Zhai XD, 2018, THYROID, V28, P1571, DOI 10.1089/thy.2017.0715; Zimmermann MB, 2015, LANCET DIABETES ENDO, V3, P286, DOI 10.1016/S2213-8587(14)70225-6	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239579	10.1371/journal.pone.0239579	http://dx.doi.org/10.1371/journal.pone.0239579			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970739	Green Published, gold			2022-12-26	WOS:000576265600018
J	Tu, MY; Chiang, KT; Cheng, CC; Li, FL; Wen, YH; Lin, SH; Lai, CY				Tu, Min-Yu; Chiang, Kwo-Tsao; Cheng, Chao-Chien; Li, Fang-Ling; Wen, Yu-His; Lin, Sing-Hong; Lai, Chung-Yu			Comparison of hypobaric hypoxia symptoms between a recalled exposure and a current exposure	PLOS ONE			English	Article							DECOMPRESSION-SICKNESS; MILITARY AIRCRAFT	Background Aircrew members are required to attend hypoxia awareness training regularly to strengthen their memory of their personal hypoxia symptoms by undergoing training inside a hypobaric chamber. The aim of this study was to examine the association between hypoxia symptoms experienced during two training sessions that were 4 years apart. Methods This was a crossover study to compare hypoxia symptoms and self-reported physiological effects of trapped gas between a previous training session and a current training session in an altitude chamber. The subjects were military crew members who undertook a 25,000-feet refresher training course in 2018. We used a structured questionnaire to obtain the target information before and during hypoxia exposure. Data were analyzed using SPSS software. Results A total of 341 trainees participated in this survey and completely filled out the questionnaire. Gastrointestinal tract discomfort caused by the expansion of trapped gas was the main physiological reaction during the previous and current training sessions. Frequently reported symptoms were poor concentration (30.5%), impaired cognitive function (20.5%), visual disturbances (16.4%), hot flashes (15.8%), and paresthesia (12.6%) during both exposures. However, the proportions of participants reporting poor concentration (P= 0.378) and visual disturbances (P= 0.594) were not significantly different between the recalled and current training sessions. The five most common symptoms among the subjects with less than 1,000 flight hours were poor concentration (29.8%), visual disturbance (27.3%), impaired cognitive function (14.9%), dizziness/lightheadedness (11.6%), and hot flashes (9.9%), which overlapped substantially with the symptoms reported by other subjects. The occurrence of those five most common symptoms in the group with more than 1,000 flight hours did not significantly differ between the recalled training session and the current training session. Conclusions The most common hypoxia symptoms reported were similar between the recalled and current training sessions in an environment with a low oxygen concentration. This finding was also clearly affected by the duration of flight experience. Moreover, GI effects of the expansion of trapped gas were commonly observed at low atmospheric pressure.	[Tu, Min-Yu; Chiang, Kwo-Tsao; Cheng, Chao-Chien; Wen, Yu-His; Lin, Sing-Hong] Kaohsiung Armed Forces Gen Hosp, Aviat Physiol Res Lab, Gangshan Branch, Kaohsiung, Taiwan; [Tu, Min-Yu] Meiho Univ, Dept Hlth Business Adm, Neipu Township, Pingtung County, Taiwan; [Tu, Min-Yu] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Tu, Min-Yu] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan; [Tu, Min-Yu; Chiang, Kwo-Tsao] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Li, Fang-Ling] Triserv Gen Hosp, Natl Def Med Ctr, Dept Psychiat, Beitou Branch, Taipei, Taiwan; [Lai, Chung-Yu] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Chung Hsing University; National Chung Hsing University; National Sun Yat Sen University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Lai, CY (corresponding author), Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan.	multi0912@gmail.com		Lai, Chung-Yu/0000-0002-7524-3010	Medical Affairs Bureau Ministry of National Defense, Taiwan,ROC [MAB-107-107]	Medical Affairs Bureau Ministry of National Defense, Taiwan,ROC	Financial support of this study was from Medical Affairs Bureau Ministry of National Defense, Taiwan,ROC (MAB-107-107).	[Anonymous], 1992, ARABICA, V39, P1; Artino AR, 2006, AVIAT SPACE ENVIR MD, V77, P857; Cable GG, 2003, AVIAT SPACE ENVIR MD, V74, P169; Dille RJ., 2002, FUNDAMENTALS AEROSPA, P1; Files DS, 2005, AVIAT SPACE ENVIR MD, V76, P523; Fraley E., 1993, 7 INT S AV PHYS COL, P664; Griva K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174277; Johnston BJ, 2012, AVIAT SPACE ENVIR MD, V83, P962, DOI 10.3357/ASEM.3172.2012; Neuhaus C, 2014, PSYCHOL RES BEHAV MA, V7, P297, DOI 10.2147/PRBM.S51844; Nishi S, 2011, MIL MED, V176, P79, DOI 10.7205/MILMED-D-09-00213; Pickard J.S., 2002, FUNDAMENTALS AEROSPA, V3rd ed., P19; Pilmanis AA, 2004, AVIAT SPACE ENVIR MD, V75, P749; RAYMAN RB, 1983, AVIAT SPACE ENVIR MD, V54, P357; Rice GM, 2003, AVIAT SPACE ENVIR MD, V74, P56; SAMPSON JB, 1980, AVIAT SPACE ENVIR MD, V51, P872; Sausen KP, 2001, AVIAT SPACE ENVIR MD, V72, P539; Singh B, 2010, AVIAT SPACE ENVIR MD, V81, P857, DOI 10.3357/ASEM.2640.2010; Smith A, 2005, AVIAT SPACE ENVIR MD, V76, P794; Smith AM, 2008, AVIAT SPACE ENVIR MD, V79, P54, DOI 10.3357/ASEM.2013.2008; Temme LA, 2010, AVIAT SPACE ENVIR MD, V81, P654, DOI 10.3357/ASEM.2690.2010; USAF, AFPAM11403 USAF; VACCHIANO CA, 2004, AVIAT SPACE ENV MED, V75, pB56; Vargo AK, 2017, AEROSP MED HUM PERFO, V88, P252; Webb JT, 2011, AVIAT SPACE ENVIR MD, V82, pA1, DOI 10.3357/ASEM.2576.2011; Woodrow AD, 2011, AVIAT SPACE ENVIR MD, V82, P1143, DOI 10.3357/ASEM.2987.2011	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239194	10.1371/journal.pone.0239194	http://dx.doi.org/10.1371/journal.pone.0239194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966320	gold, Green Published			2022-12-26	WOS:000575688700051
J	Crandall, H; Kapusta, A; Killpack, J; Heyrend, C; Nilsson, K; Dickey, M; Daly, JA; Ampofo, K; Pavia, AT; Mulvey, MA; Yandell, M; Hulten, KG; Blaschke, AJ				Crandall, Hillary; Kapusta, Aurelie; Killpack, Jarrett; Heyrend, Carly; Nilsson, Kody; Dickey, Mandy; Daly, Judy A.; Ampofo, Krow; Pavia, Andrew T.; Mulvey, Matthew A.; Yandell, Mark; Hulten, Kristina G.; Blaschke, Anne J.			Clinical and molecular epidemiology of invasiveStaphylococcus aureusinfection in Utah children; continued dominance of MSSA over MRSA	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; METHICILLIN-RESISTANT; VIRULENCE DETERMINANT; 3-YEAR SURVEILLANCE; UNITED-STATES; USA300 CLONE; INFECTIONS; PNEUMONIA; EMERGENCE	Background InvasiveStaphylococcus aureusinfections are a common cause of morbidity and mortality in children. In the early 2000's the proportion of infections due the methicillin-resistantS.aureus(MRSA) increased rapidly. We described the clinical and molecular epidemiology of invasiveS.aureusdisease in a pediatric population. Methods We prospectively identified children in Utah with invasiveS.aureusinfections. Medical records were reviewed to determine diagnosis and clinical characteristics. Isolates were genotyped using multi-locus sequence typing. The presence of genes encoding the Panton-Valentine leukocidin (PVL) was determined using polymerase chain reaction. Results Over a 4-year period between January 2009 and December 2012, we identified 357 children, hospitalized at Primary Children's Hospital, with invasiveS.aureusinfections and isolates available for the study. Methicillin-susceptibleS.aureus(MSSA) caused 79% of disease, while MRSA caused only 21% of disease. Mortality associated with invasiveS.aureusinfection was 3.6%. The most common diagnoses were osteoarticular infections (38%) followed by central line associated blood stream infections (19%) and pneumonia (12%). We identified 41 multi-locus sequence types. The majority of isolates belonged to 6 predominant clonal complexes (CC5, CC8, CC15, CC30, CC45, CC59). PVL was present in a minority (16%) of isolates, of which most were ST8 MRSA. Conclusions MSSA was the primary cause of invasiveS.aureusinfections at our institution throughout the study period. A limited number of predominant strains accounted for the majority of invasive disease. The classic virulence factor PVL was uncommon in MSSA isolates. Further study is needed to improve our understanding ofS.aureusvirulence and disease pathogenesis.	[Crandall, Hillary] Univ Utah, Dept Pediat, Div Pediat Crit Care, Salt Lake City, UT 84112 USA; [Kapusta, Aurelie; Killpack, Jarrett; Nilsson, Kody; Ampofo, Krow; Pavia, Andrew T.; Blaschke, Anne J.] Univ Utah, Dept Pediat, Div Pediat Infect Dis, Salt Lake City, UT USA; [Kapusta, Aurelie; Yandell, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Heyrend, Carly; Dickey, Mandy; Daly, Judy A.] Primary Childrens Med Ctr, Salt Lake City, UT USA; [Daly, Judy A.; Mulvey, Matthew A.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Yandell, Mark] Univ Utah, Dept Human Genet, USTAR Ctr Genet Discovery, Salt Lake City, UT USA; [Hulten, Kristina G.] Baylor Coll Med, Dept Pediat, Div Pediat Infect Dis, Houston, TX 77030 USA; [Kapusta, Aurelie] IDbyDNA, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Baylor College of Medicine	Crandall, H (corresponding author), Univ Utah, Dept Pediat, Div Pediat Crit Care, Salt Lake City, UT 84112 USA.	hillary.crandall@hsc.utah.edu	Blaschke, Anne/GOJ-7946-2022	Kapusta, Aurelie/0000-0002-4131-903X; Crandall, Hillary/0000-0002-5392-8457	Thrasher Research Fund; Early Career Award; Eunice Kennedy Shriver National Institute for Child Health and Human Development [K12HD047349-13]	Thrasher Research Fund; Early Career Award; Eunice Kennedy Shriver National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Thrasher Research Fund, Early Career Award and the Eunice Kennedy Shriver National Institute for Child Health and Human Development [K12HD047349-13] to HC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Buckingham SC, 2004, PEDIATR INFECT DIS J, V23, P619, DOI 10.1097/01.inf.0000131981.67342.c4; Carrel M, 2015, EMERG INFECT DIS, V21, P1973, DOI 10.3201/eid2111.150452; Carrillo-Marquez MA, 2011, PEDIATR INFECT DIS J, V30, P545, DOI 10.1097/INF.0b013e31821618be; Carrillo-Marquez MA, 2009, PEDIATR INFECT DIS J, V28, P1076, DOI 10.1097/INF.0b013e3181adbcfe; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Crawford SE, 2005, PEDIATR INFECT DIS J, V24, P459, DOI 10.1097/01.inf.0000164170.67897.97; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; Dantes R, 2013, JAMA INTERN MED, V173, P1970, DOI 10.1001/jamainternmed.2013.10423; David MZ, 2017, CURR TOP MICROBIOL, V409, P325, DOI 10.1007/82_2017_42; David MZ, 2015, J CLIN MICROBIOL, V53, P2486, DOI 10.1128/JCM.00096-15; David MZ, 2014, CLIN INFECT DIS, V59, P798, DOI 10.1093/cid/ciu410; Day CT, 2014, PEDIATR INFECT DIS J, V33, P98, DOI 10.1097/INF.0b013e3182a5f9a8; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feudtner C, 2002, PEDIATRICS, V109, P656, DOI 10.1542/peds.109.4.656; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gonzalez BE, 2005, PEDIATRICS, V115, P642, DOI 10.1542/peds.2004-2300; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Hulten KG, 2006, PEDIATR INFECT DIS J, V25, P349, DOI 10.1097/01.inf.0000207404.50143.1e; Hulten KG, 2018, PEDIATR INFECT DIS J, V37, P235, DOI 10.1097/INF.0000000000001753; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; Iwamoto M, 2013, PEDIATRICS, V132, pE817, DOI 10.1542/peds.2013-1112; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Kaya H, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00612-17; Kechrid A, 2011, CLIN MICROBIOL INFEC, V17, P1020, DOI 10.1111/j.1469-0691.2010.03367.x; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobayashi SD, 2011, J INFECT DIS, V204, P937, DOI 10.1093/infdis/jir441; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; McCaskill ML, 2007, PEDIATR INFECT DIS J, V26, P1122, DOI 10.1097/INF.0b013e31814536e0; McGavin MJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00048; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; Pasquale TR, 2013, INT J INFECT DIS, V17, pE398, DOI 10.1016/j.ijid.2012.12.013; Perez-Montarelo D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02210; Prevention CfDCa, 2011, TOX SHOCK SYNDR OTH; Shore AC, 2014, J CLIN MICROBIOL, V52, P859, DOI 10.1128/JCM.02799-13; Strauss L, 2017, P NATL ACAD SCI USA, V114, pE10596, DOI 10.1073/pnas.1702472114; Sutter DE, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3099; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053	50	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238991	10.1371/journal.pone.0238991	http://dx.doi.org/10.1371/journal.pone.0238991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946486	Green Published, gold			2022-12-26	WOS:000573851100017
J	Jeffres, CA; Holmes, EJ; Sommer, TR; Katz, JVE				Jeffres, Carson A.; Holmes, Eric J.; Sommer, Ted R.; Katz, Jacob V. E.			Detrital food web contributes to aquatic ecosystem productivity and rapid salmon growth in a managed floodplain	PLOS ONE			English	Article							JUVENILE CHINOOK SALMON; FRESH-WATER; SACRAMENTO RIVER; ORGANIC-CARBON; ALGAL BIOMASS; HABITAT USE; CALIFORNIA; METHANE; PHYTOPLANKTON; TEMPERATURE	Similar to many large river valleys globally, the Sacramento River Valley has been extensively drained and leveed, hydrologically divorcing river channels from most floodplains. Today, the former floodplain is extensively managed for agriculture. Lack of access to inundated floodplains is recognized as a significant contributing factor in the decline of native Chinook Salmon(Oncorhynchus tshawytscha). We observed differences in salmon growth rate, invertebrate density, and carbon source in food webs from three aquatic habitat types-leveed river channels, perennial drainage canals in the floodplain, and agricultural floodplain wetlands. Over 23 days (17 February to 11 March, 2016) food web structure and juvenile Chinook Salmon growth rates were studied within the three aquatic habitat types. Zooplankton densities on the floodplain wetland were 53x more abundant, on average, than in the river. Juvenile Chinook Salmon raised on the floodplain wetland grew at 0.92 mm/day, 5x faster than fish raised in the adjacent river habitat (0.18 mm/day). Two aquatic-ecosystem modeling methods were used to partition the sources of carbon (detrital or photosynthetic) within the different habitats. Both modeling approaches found that carbon in the floodplain wetland food web was sourced primarily from detrital sources through heterotrophic pathways, while carbon in the river was primarily photosynthetic and sourced from in situ autotrophic production. Hydrologic conditions typifying the ephemerally inundated floodplain-shallower depths, warmer water, longer water residence times and predominantly detrital carbon sources compared to deeper, colder, swifter water and a predominantly algal-based carbon source in the adjacent river channel-appear to facilitate the dramatically higher rates of food web production observed in the floodplain. These results suggest that hydrologic patterns associated with seasonal flooding facilitate river food webs to access floodplain carbon sources that contribute to highly productive heterotrophic energy pathways important to the production of fisheries resources.	[Jeffres, Carson A.; Holmes, Eric J.] Univ Calif Davis, Ctr Watershed Sci Davis, Davis, CA 95616 USA; [Sommer, Ted R.] Calif Dept Water Resources West Sacramento, West Sacramento, CA USA; [Katz, Jacob V. E.] Calif Trout San Francisco, San Francisco, CA USA	University of California System; University of California Davis	Jeffres, CA (corresponding author), Univ Calif Davis, Ctr Watershed Sci Davis, Davis, CA 95616 USA.	cajeffres@ucdavis.edu		Jeffres, Carson/0000-0001-6532-6851	California Department of Water Resources [4600011527];  [2012-0043]	California Department of Water Resources; 	CJ received grant #4600011527 from California Department of Water Resources, JK received funding from California Water Foundation (http://www.californiawaterfoundation.org/), grant #2012-0043. TS is in an employee of California Department of Water Resources and was a collaborator in study design and manuscript writing.	Ahearn DS, 2006, FRESHWATER BIOL, V51, P1417, DOI 10.1111/j.1365-2427.2006.01580.x; ANDERSEN T, 1991, LIMNOL OCEANOGR, V36, P807, DOI 10.4319/lo.1991.36.4.0807; [Anonymous], 2001, HARVARD HLTH LETT, V26, P6; Appling A., 2018, STREAMMETABOLIZER MO; Bastviken D, 2003, ECOLOGY, V84, P969, DOI 10.1890/0012-9658(2003)084[0969:MAASOC]2.0.CO;2; Basu BK, 1996, LIMNOL OCEANOGR, V41, P1572; BAYLEY P B, 1991, Regulated Rivers Research and Management, V6, P75, DOI 10.1002/rrr.3450060203; Benigno GM, 2008, HYDROBIOLOGIA, V600, P297, DOI 10.1007/s10750-007-9239-2; Cloern J, 1996, OCEANOGRAPHIC LIT RE, V7, P691; Conrad JL, 2016, N AM J FISH MANAGE, V36, P30, DOI 10.1080/02755947.2015.1111276; Corline NJ, 2017, WETL ECOL MANAG, V25, P533, DOI 10.1007/s11273-017-9534-2; Deines P, 2007, ENVIRON MICROBIOL, V9, P1126, DOI 10.1111/j.1462-2920.2006.01235.x; Foott JS, 2004, CALIF FISH GAME, V90, P71; Fry B., 1989, STABLE ISOTOPES ECOL, P196, DOI [DOI 10.1007/978-1-4612-3498-2, DOI 10.1007/978-1-4612-3498-2_12]; Goertler P, 2018, T AM FISH SOC, V147, P287, DOI 10.1002/tafs.10028; Grosholz E, 2006, HYDROBIOLOGIA, V568, P91, DOI 10.1007/s10750-006-0029-z; Hanak E., 2011, MANAGING CALIFORNIAS; Holtgrieve GW, 2010, LIMNOL OCEANOGR, V55, P1047, DOI 10.4319/lo.2010.55.3.1047; Inamine M, 2010, US SOC DAMS 30 C SAC; Jeffres CA, 2008, ENVIRON BIOL FISH, V83, P449, DOI 10.1007/s10641-008-9367-1; Junk W, 1986, FLOOD PULSE CONCEPT; Junk WJ, 2008, 4 WORLD FISH C; Karanovic I., 2012, CRUSTACEA OSTRACODA; Katz JVE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177409; Limm MP, 2009, ENVIRON BIOL FISH, V85, P141, DOI 10.1007/s10641-009-9473-8; Lopez CB, 2006, ECOSYSTEMS, V9, P422, DOI 10.1007/s10021-005-0113-7; Lusardi RA, 2020, CANADIAN J FISHERIES, P1; Merritt R. W., 2008, INTRO AQUATIC INSECT; Mladenov N, 2005, WETLANDS, V25, P622, DOI 10.1672/0277-5212(2005)025[0622:EOAFOD]2.0.CO;2; Muller-Solger AB, 2002, LIMNOL OCEANOGR, V47, P1468; Murase J, 2007, ENVIRON MICROBIOL, V9, P3025, DOI 10.1111/j.1462-2920.2007.01414.x; Opperman JJ, 2009, SCIENCE, V326, P1487, DOI 10.1126/science.1178256; Palijan G, 2012, MICROB ECOL, V64, P39, DOI 10.1007/s00248-012-0016-z; Richter BD, 2003, ECOL APPL, V13, P206, DOI 10.1890/1051-0761(2003)013[0206:ESWMMR]2.0.CO;2; Robertson AI, 1999, MAR FRESHWATER RES, V50, P813, DOI 10.1071/MF99112; Sanseverino AM, 2012, METHANE CARBON SUPPO; SCHOENBERG SA, 1984, OIKOS, V42, P291, DOI 10.2307/3544397; Sommer TR, 2005, N AM J FISH MANAGE, V25, P1493, DOI 10.1577/M04-208.1; Sommer TR, 2004, AQUAT CONSERV, V14, P247, DOI 10.1002/aqc.620; Sommer TR, 2001, CAN J FISH AQUAT SCI, V58, P325, DOI 10.1139/cjfas-58-2-325; Thorp JH, 2010, AQUAT ECOL SER, P1; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; WHITE PA, 1991, MICROBIAL ECOL, V21, P99, DOI 10.1007/BF02539147	43	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0216019	10.1371/journal.pone.0216019	http://dx.doi.org/10.1371/journal.pone.0216019			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946438	Green Published, gold			2022-12-26	WOS:000573851100087
J	Rojo-Arreola, L; Garcia-Carreno, F; Romero, R; Dominguez, LD				Rojo-Arreola, Liliana; Garcia-Carreno, Fernando; Romero, Rogelio; Dominguez, Luis Diaz			Proteolytic profile of larval developmental stages ofPenaeus vannamei: An activity and mRNA expression approach	PLOS ONE			English	Article							SHRIMP LITOPENAEUS-VANNAMEI; CATHEPSIN-D; MOLECULAR CHARACTERIZATION; PROTEOMIC ANALYSIS; DIGESTIVE ENZYMES; MIDGUT GLAND; FAT-BODY; PROTEASE; METAMORPHOSIS; PURIFICATION	In arthropods, the cleavage of specific proteins by peptidases has pivotal roles in multiple physiological processes including oogenesis, immunity, nutrition, and parasitic infection. These enzymes are also key players in the larval development, and well-described triggers of molting and metamorphosis. In this work the peptidase complement throughout the larvae development ofPenaeus vannameiwas quantified at the transcript and activity level using qPCR and fluorogenic substrates designed to be hydrolyzed by class-specific peptidases respectively, providing a detailed identification of the proteolytic repertoire inP.vannameilarvae. Significant changes in the peptidase activity profile were observed. During the lecithotrophic naupliar instars, the dominant peptidase activity and expression derive from cysteine peptidases, suggesting that enzymes of this class hydrolyze the protein components of yolk as the primary amino acid source. At the first feeding instar, zoea, dominant serine peptidase activity was found where trypsin activity is particularly high, supporting previous observations that during zoea the breakdown of food protein is primarily enzymatic. At decapodid stages the peptidase expression and activity is more diverse indicating that a multienzyme network achieves food digestion. Our results suggest that proteolytic enzymes fulfill specific functions duringP.vannameilarval development.	[Rojo-Arreola, Liliana] CONACyT Ctr Invest Biol Noroeste, Mexico City, DF, Mexico; [Garcia-Carreno, Fernando; Romero, Rogelio; Dominguez, Luis Diaz] Ctr Invest Biol Noroeste, Mexico City, DF, Mexico	CIBNOR - Centro de Investigaciones Biologicas del Noroeste	Rojo-Arreola, L (corresponding author), CONACyT Ctr Invest Biol Noroeste, Mexico City, DF, Mexico.	lrojo@cibnor.mx		Rojo-Arreola, Liliana/0000-0002-4163-0506	CONACYT [716372, 853957]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB 2015-01-256318]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologi ' a (CONACYT, grant number CB 2015-01-256318) to LRA; LDD and RR hold a CONACYT graduate scholarship (grant numbers 716372 and 853957 respectively).	Ahn JE, 2009, J INSECT PHYSIOL, V55, P678, DOI 10.1016/j.jinsphys.2009.04.016; Alipour H, 2017, ELECTRON J BIOTECHN, V29, P47, DOI 10.1016/j.ejbt.2017.06.007; Andres M, 2010, J EXP MAR BIOL ECOL, DOI [10.1016/j.jembe.2010.02.003, DOI 10.1016/J.JEMBE.2010.02.003]; Anger K., 2001, CRUSTACEAN ISS, DOI [10.1651/0278-0372(2005)025, DOI 10.1651/0278-0372(2005)025]; Anger K, 2006, INVERTEBR REPROD DEV, V49, P175, DOI 10.1080/07924259.2006.9652207; [Anonymous], 2020, J CLIN ENDOCRINOL ME, V105, pe32; [Anonymous], 2013, HDB PROT ENZ VOLS 1; [Anonymous], 2019, MONTHLY NEWSLETTER M; Aoki H, 2004, J COMP PHYSIOL B, V174, P59, DOI 10.1007/s00360-003-0389-x; Aoki H, 2003, PROTEIN EXPRES PURIF, V31, P213, DOI 10.1016/S1046-5928(03)00196-7; Lage LPA, 2017, AQUACULTURE, V479, P142, DOI 10.1016/j.aquaculture.2017.05.030; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Borges-Veloso A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-123; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandao AD, 2014, ARTHROPOD STRUCT DEV, V43, P511, DOI 10.1016/j.asd.2014.05.001; Broehan G, 2010, INSECT BIOCHEM MOLEC, V40, P274, DOI 10.1016/j.ibmb.2009.10.009; Bustin Stephen, 2017, Biomol Detect Quantif, V14, P19, DOI 10.1016/j.bdq.2017.11.001; Cai XY, 2014, GENE, V542, P232, DOI 10.1016/j.gene.2014.03.012; Cheong SPS, 2015, INTEGR COMP BIOL, V55, P878, DOI 10.1093/icb/icv066; Chikate YR, 2016, PESTIC BIOCHEM PHYS, V133, P44, DOI 10.1016/j.pestbp.2016.03.006; Cho WL, 1999, J BIOL CHEM, V274, P13311, DOI 10.1074/jbc.274.19.13311; COOK HL, 1969, T AM FISH SOC, V98, P751, DOI 10.1577/1548-8659(1969)98[751:TCOLPS]2.0.CO;2; Dall W, 1991, ADV MAR BIOL, DOI [10.1016/S0065-2881(08)60174-1, DOI 10.1016/S0065-2881(08)60174-1]; del Toro MDN, 2011, AQUACULTURE, V317, P99, DOI 10.1016/j.aquaculture.2011.03.035; Cesar JRD, 2006, AQUACULTURE, V261, P688, DOI 10.1016/j.aquaculture.2006.08.003; Dvorak J, 2008, BIOCHIMIE, V90, P345, DOI 10.1016/j.biochi.2007.08.013; Estrela A, 2007, COMP BIOCHEM PHYS B, V148, P410, DOI 10.1016/j.cbpb.2007.07.009; Fialho E, 2005, ARCH BIOCHEM BIOPHYS, V436, P246, DOI 10.1016/j.abb.2005.01.005; Gao Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01220-6; Gao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144350; Garcia-Orozco KD, 2002, COMP BIOCHEM PHYS B, V133, P361, DOI 10.1016/S1096-4959(02)00152-5; Geier G, 1998, EUR J BIOCHEM, V253, P796, DOI 10.1046/j.1432-1327.1998.2530796.x; Glanemann C, 2003, APPL MICROBIOL BIOT, V61, P61, DOI 10.1007/s00253-002-1191-5; Gui ZZ, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-49; Guo SY, 2018, INSECT MOL BIOL, V27, P724, DOI 10.1111/imb.12511; Hambrook JR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007393; Havird JC, 2016, INTEGR COMP BIOL, V56, P1170, DOI 10.1093/icb/icw003; Hernandez-Cortes P, 1997, J FOOD BIOCHEM, V21, P497, DOI 10.1111/j.1745-4514.1997.tb00202.x; Hernandez-Cortes P, 2017, BIOL BULL-US, V232, P2, DOI 10.1086/691381; Horn M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002766; Hu KJ, 2007, COMP BIOCHEM PHYS B, V146, P69, DOI 10.1016/j.cbpb.2006.09.010; Jia QQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep07535; Kang TH, 2017, GENE, V617, P1, DOI 10.1016/j.gene.2017.03.035; Lemos D, 1999, MAR BIOL, V135, P653, DOI 10.1007/s002270050666; Leyria J, 2018, J INSECT PHYSIOL, V105, P28, DOI 10.1016/j.jinsphys.2018.01.002; Li YD, 2015, COMP BIOCHEM PHYS D, V13, P1, DOI 10.1016/j.cbd.2014.10.002; Liu HW, 2017, INSECT MOL BIOL, V26, P507, DOI 10.1111/imb.12312; Liu HW, 2018, J PROTEOMICS, V173, P115, DOI 10.1016/j.jprot.2017.11.027; Liu J, 2006, INSECT MOL BIOL, V15, P823, DOI 10.1111/j.1365-2583.2006.00686.x; LOVETT DL, 1989, J MORPHOL, V201, P253, DOI 10.1002/jmor.1052010305; LOVETT DL, 1990, BIOL BULL, V178, P160, DOI 10.2307/1541974; Martynov AG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1306-x; Mrak P, 2017, ARTHROPOD STRUCT DEV, V46, P77, DOI 10.1016/j.asd.2016.11.001; Muhlia-Almazan A, 2002, COMP BIOCHEM PHYS B, V133, P383, DOI 10.1016/S1096-4959(02)00163-X; Perkin L, 2016, PEERJ, V4, DOI 10.7717/peerj.1581; Poulin E, 2001, J EXP MAR BIOL ECOL, V257, P109, DOI 10.1016/S0022-0981(00)00332-4; Qu MB, 2014, J PROTEOME RES, V13, P2931, DOI 10.1021/pr5000957; Rojo L, 2010, MAR BIOTECHNOL, V12, P696, DOI 10.1007/s10126-010-9257-3; Rojo-Arreola L, 2019, AQUACULTURE, V500, P18, DOI 10.1016/j.aquaculture.2018.10.002; Saborowski R, 2006, MAR BIOL, V149, P865, DOI 10.1007/s00227-005-0240-x; Saikhedkar N, 2015, INSECT BIOCHEM MOLEC, V64, P51, DOI 10.1016/j.ibmb.2015.07.005; Sainz JC, 2004, J CRUSTACEAN BIOL, V24, P266, DOI 10.1651/C-2423; Sainz JC, 2004, COMP BIOCHEM PHYS B, V138, P155, DOI 10.1016/j.cbpc.2004.03.002; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031; Sojka D, 2016, TRENDS PARASITOL, V32, P708, DOI 10.1016/j.pt.2016.05.015; Stephens A, 2012, COMP BIOCHEM PHYS B, V161, P32, DOI 10.1016/j.cbpb.2011.09.004; Sun YX, 2018, DEV COMP IMMUNOL, V78, P114, DOI 10.1016/j.dci.2017.09.019; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VOGT G, 1989, HISTOCHEMISTRY, V91, P373, DOI 10.1007/BF00493824; Vogt G, 2019, J MORPHOL, V280, P1405, DOI 10.1002/jmor.21040; Wei JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106201; Wei JK, 2014, COMP BIOCHEM PHYS D, V11, P37, DOI 10.1016/j.cbd.2014.07.001; Wei Z, 2007, DEV GROWTH DIFFER, V49, P611, DOI 10.1111/j.1440-169X.2007.00957.x; Yu J, 2012, BIOCHEM BIOPH RES CO, V425, P113, DOI 10.1016/j.bbrc.2012.07.068	76	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239413	10.1371/journal.pone.0239413	http://dx.doi.org/10.1371/journal.pone.0239413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946520	Green Published, gold			2022-12-26	WOS:000573851100037
J	Firouzmandi, M; Vasei, F; Giti, R; Sadeghi, H				Firouzmandi, Maryam; Vasei, Fateme; Giti, Rashin; Sadeghi, Hadis			Effect of silver diamine fluoride and proanthocyanidin on resistance of carious dentin to acid challenges	PLOS ONE			English	Article							GRAPE SEED EXTRACT; PRIMARY TEETH; ROOT CARIES; MECHANICAL-PROPERTIES; ORGANIC MATRIX; IN-VITRO; REMINERALIZATION; COLLAGEN; STIFFNESS; DEMINERALIZATION	The aim of this study was to evaluate the effect of silver diamine fluoride and grape seed extract on the microstructure and mechanical properties of carious dentin following exposure to acidic challenge. Ninety-eight molars with occlusal caries were used. In the control group the specimens were kept in distilled water. In the GSE group, the specimens were immersed in 6.5% grape seed extract solution for 30 minutes. In the SDF group, the specimens were immersed in 30% SDF solution for 4 minutes. In the GSE+SDF group, the specimens were immersed in 6.5% grape seed extract solution for 30 minutes and then exposed to 30% SDF solution for 4 minutes. All the groups underwent pH cycling model for 8 days. Microhardness measurements were taken at the baseline before surface treatments and after pH cycling. Elastic modulus was measured, after pH cycling. In the control group, the final hardness was significantly lower than the initial hardness (P = 0.001). In the SDF group, the final hardness was significantly higher than the initial hardness (P < 0.001). There was no significant difference between the initial and final hardness values in the GSE and GSE + SDF groups (p = 0.92, p = 0.07). The H-1-H(0)in the SDF group was significantly higher than the other groups (P<0.05). Moreover, elastic modulus of the experimental groups except GSE+SDF group was significantly higher than control. The highest mean elastic modulus was detected in the SDF group (P<0.001). The use of SDF and GSE prior to the acid challenge improved mechanical properties. Microstructural investigation, using scanning electron microscope showed dentin structure protection against acid challenges with SDF treatment and collagen matrix stabilization with GSE treatment. However combined use of these agents was not beneficious.	[Firouzmandi, Maryam] Shiraz Univ Med Sci, Oral & Dent Dis Res Ctr, Sch Dent, Dept Operat Dent, Shiraz, Iran; [Vasei, Fateme] Shiraz Univ Med Sci, Sch Dent, Dept Operat Dent, Shiraz, Iran; [Giti, Rashin] Shiraz Univ Med Sci, Sch Dent, Dept Prosthodont, Shiraz, Iran; [Sadeghi, Hadis] Shiraz Univ Med Sci, Sch Dent, Student Res Comm, Shiraz, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Vasei, F (corresponding author), Shiraz Univ Med Sci, Sch Dent, Dept Operat Dent, Shiraz, Iran.	Fvj_anjell@yahoo.com	Giti, Rashin/H-5270-2016; firouzmandi, maryam/H-5759-2016	Giti, Rashin/0000-0003-1091-9574; firouzmandi, maryam/0000-0002-5510-0506; Vasei, Fateme/0000-0002-7800-3995	Shiraz University of Medical Sciences [8794123]	Shiraz University of Medical Sciences	This study was supported by the vice chancellor for research of Shiraz University of Medical Sciences (Grant#8794123).	Aydin B, 2019, DENT MATER, V35, P328, DOI 10.1016/j.dental.2018.11.029; Balalaie A, 2018, DENT MATER J, V37, P173, DOI 10.4012/dmj.2017-062; Banerjee A, 2017, BRIT DENT J, V223, P215, DOI 10.1038/sj.bdj.2017.672; Bedran-Russo AK, 2013, AM J DENT, V26, P244; Bedran-Russo AKB, 2008, J BIOMED MATER RES B, V86B, P330, DOI 10.1002/jmb.b.31022; Bedran-Russo AKB, 2007, J BIOMED MATER RES B, V80B, P268, DOI 10.1002/jbm.b.30593; Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593; Cai J, 2019, ACTA BIOMATER, V88, P491, DOI 10.1016/j.actbio.2019.02.020; Carrilho MR, 2009, J BIOMED MATER RES B, V90B, P373, DOI 10.1002/jbm.b.31295; Castellan CS, 2010, J DENT, V38, P431, DOI 10.1016/j.jdent.2010.02.002; Chen A., 2012, J CAN DENT ASSOC, V20, P1; Chu CH, 2008, J DENT, V36, P387, DOI 10.1016/j.jdent.2008.02.013; Chu CH, 2002, J DENT RES, V81, P767, DOI 10.1177/0810767; Dos Santos PH, 2011, J BIOMECH, V44, P1691, DOI 10.1016/j.jbiomech.2011.03.030; Epasinghe DJ, 2015, AUST DENT J, V60, P463, DOI 10.1111/adj.12249; Epasinghe DJ, 2017, MAT SCI ENG C-MATER, V73, P293, DOI 10.1016/j.msec.2016.11.078; Firouzmandi Maryam, 2019, Eur J Dent, V13, P255, DOI 10.1055/s-0039-1693237; Frencken J E, 2016, Adv Dent Res, V28, P46, DOI 10.1177/0022034516639272; FUSAYAMA T, 1966, J DENT RES, V45, P1033, DOI 10.1177/00220345660450040401; Hara AT, 2005, CARIES RES, V39, P134, DOI 10.1159/000083159; Hara AT, 2003, CARIES RES, V37, P339, DOI 10.1159/000072165; Hiraishi N, 2011, J DENT, V39, P391, DOI 10.1016/j.jdent.2011.03.002; Isenburg JC, 2004, BIOMATERIALS, V25, P3293, DOI 10.1016/j.biomaterials.2003.10.001; Ito S, 2005, J BIOMED MATER RES B, V72B, P109, DOI 10.1002/jbm.b.30130; Jenson Larry, 2007, J Calif Dent Assoc, V35, P714; Kaushik Roy, 2013, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V4, P1271; Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13, DOI 10.1177/154411130301400103; KLETER GA, 1994, J DENT RES, V73, P1523, DOI 10.1177/00220345940730090701; Lee Y., 2012, SOL CELLS, V22, P2; Listl S, 2015, J DENT RES, V94, P1355, DOI 10.1177/0022034515602879; Liu Y, 2011, ADV MATER, V23, P975, DOI 10.1002/adma.201003882; Llodra JC, 2005, J DENT RES, V84, P721, DOI 10.1177/154405910508400807; Lou YL, 2011, J DENT, V39, P612, DOI 10.1016/j.jdent.2011.06.008; Marshall GW, 2001, J DENT RES, V80, P1768, DOI 10.1177/00220345010800081701; Mazzoni A, 2013, DENT MATER, V29, P1040, DOI 10.1016/j.dental.2013.07.010; Mei ML, 2018, J DENT RES, V97, P751, DOI 10.1177/0022034518774783; Mei ML, 2017, J DENT RES, V96, P1122, DOI 10.1177/0022034517709738; Mei ML, 2014, J DENT, V42, P395, DOI 10.1016/j.jdent.2013.12.007; Mei ML, 2014, J DENT, V42, P329, DOI 10.1016/j.jdent.2013.11.018; Mei ML, 2013, J DENT, V41, P809, DOI 10.1016/j.jdent.2013.06.009; Mei ML, 2012, DENT MATER, V28, P903, DOI 10.1016/j.dental.2012.04.011; Mei ML, 2013, MED ORAL PATOL ORAL, V18, pE824, DOI 10.4317/medoral.18831; Omidi S, 2018, GREEN CHEM LETT REV, V11, P544, DOI 10.1080/17518253.2018.1546410; Punyanirun K, 2018, J DENT, V69, P55, DOI 10.1016/j.jdent.2017.09.005; Quock RL, 2012, OPER DENT, V37, P610, DOI 10.2341/11-344-L; Reynolds EC, 2008, J DENT RES, V87, P344, DOI 10.1177/154405910808700420; Rosenblatt A, 2009, J DENT RES, V88, P116, DOI 10.1177/0022034508329406; Seseogullari-Dirihan R, 2015, DENT MATER, V31, P941, DOI 10.1016/j.dental.2015.05.002; Sun J, 2014, J MATER CHEM B, V2, P4544, DOI 10.1039/c4tb00451e; Tan HP, 2010, J DENT RES, V89, P1086, DOI 10.1177/0022034510375825; Tang CF, 2013, ARCH ORAL BIOL, V58, P1769, DOI 10.1016/j.archoralbio.2013.09.007; Tsao R, 2010, NUTRIENTS, V2, P1231, DOI 10.3390/nu2121231; Vollenweider M, 2007, ACTA BIOMATER, V3, P936, DOI 10.1016/j.actbio.2007.04.003; Wang JL, 2013, DIAM RELAT MATER, V31, P15, DOI 10.1016/j.diamond.2012.10.006; White D J, 1995, Adv Dent Res, V9, P175; Xie Q, 2008, J DENT, V36, P900, DOI 10.1016/j.jdent.2008.07.011; Yao P, 2018, J IND ENG CHEM, V58, P74, DOI 10.1016/j.jiec.2017.09.009; Zhang W, 2013, CARIES RES, V47, P284, DOI 10.1159/000346620	58	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238590	10.1371/journal.pone.0238590	http://dx.doi.org/10.1371/journal.pone.0238590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941456	gold, Green Published			2022-12-26	WOS:000573848800004
J	Husted, KLS; Dandanell, S; Petersen, J; Dela, F; Helge, JW				Husted, Karina L. S.; Dandanell, Sune; Petersen, Janne; Dela, Flemming; Helge, Jorn W.			The effectiveness of body age-based intervention in workplace health promotion: Results of a cohort study on 9851 Danish employees	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BIOLOGICAL AGE; MORTALITY; SMOKING; STATEMENT; WOMEN; TIME	Introduction The aging population emphasize the need for effective health promotion interventions. The workplace is a prioritized setting for health promotion to reach widely within a population. Body age can be used as a health-risk estimate and as a motivational tool to change health behavior. In this study we investigate body age-based intervention including motivational interview and its effect on health, when applied to real life workplace health promotion. Material and methods Body age-based intervention was performed in 90 companies on 9851 Danish employees from 2011-2017. Metabolic risk factors were assessed, body age score was determined and an individualized motivational interview was conducted at baseline and follow-up. Change in body age score, single risk factors, smoking habits and metabolic syndrome were analyzed. The body age score is a composite score comprising 11 weighted variables. A body age score <= 0 is preferred, as this elicit a younger/healthier or equal body age compared to chronological age. Results At 1.3 year follow-up the unhealthiest employees were less likely to participate. Within follow-up participants (39%, n = 3843) body age had improved by a decline in mean body age score of -0.6 and -0.7 years for men and women, respectively (p<0.001). Number of employees with metabolic syndrome had decreased from 646 at baseline to 557 at follow-up (p = 0.005) and 42% of smokers had quit smoking (p<0.001). Conclusion On the basis of this study, we suggest that body age assessment motivates to participate in workplace health promotion, affect high risk behavior such as smoking thus have potential in public health promotion.	[Husted, Karina L. S.; Dandanell, Sune; Dela, Flemming; Helge, Jorn W.] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Copenhagen, Denmark; [Husted, Karina L. S.] Univ Coll Copenhagen, Dept Physiotherapy & Occupat Therapy, Copenhagen, Denmark; [Petersen, Janne] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Petersen, Janne] Bispebjerg & Frederiksberg Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark; [Dela, Flemming] Bispebjerg Hosp, Dept Geriatr, Copenhagen, Denmark	University of Copenhagen; University College Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital	Husted, KLS (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, Copenhagen, Denmark.; Husted, KLS (corresponding author), Univ Coll Copenhagen, Dept Physiotherapy & Occupat Therapy, Copenhagen, Denmark.	karinalu@sund.ku.dk	Dela, Flemming/AAU-1691-2021; Helge, Jørn Wulff/I-7096-2012	Dela, Flemming/0000-0001-9970-9535; Helge, Jørn Wulff/0000-0001-9724-5423; Husted, Karina Louise Skov/0000-0002-9280-1694	Copenhagen Center for Health Technology; Center for Healthy Aging; University College Copenhagen	Copenhagen Center for Health Technology; Center for Healthy Aging; University College Copenhagen	This work was supported by the Copenhagen Center for Health Technology; the Center for Healthy Aging and University College Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrante JP, 2008, PREV MED, V46, P247, DOI 10.1016/j.ypmed.2007.09.007; Blair SN, 2012, SCAND J MED SCI SPOR, V22, pE24, DOI 10.1111/j.1600-0838.2012.01462.x; Butler CC, 1999, BRIT J GEN PRACT, V49, P611; Carone G, 2016, PENSION REFORMS EU E, DOI 10.2765/620267; Danish Health Authority, 2016, FALD RYGN DANM GEAT; Ekblom-Bak E, 2014, SCAND J MED SCI SPOR, V24, P319, DOI 10.1111/sms.12014; Emmons KM, 2001, AM J PREV MED, V20, P68, DOI 10.1016/S0749-3797(00)00254-3; EU-OSHA, 2012, MOT EMPL PART WORKPL; European Commission, 2017, 065 EUR COMM DIR GEN; Ezzati M, 2003, LANCET, V362, P847, DOI 10.1016/S0140-6736(03)14338-3; Goffaux J, 2005, SOUTH MED J, V98, P985, DOI 10.1097/01.smj.0000182178.22607.47; Hwang GS, 2012, ASIA-PAC J PUBLIC HE, V24, P82, DOI 10.1177/1010539510370991; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Jia LP, 2017, CLIN INTERV AGING, V12, P759, DOI 10.2147/CIA.S134921; Jorgensen MB, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-56; Jorgensen MB, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010516; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kang YG, 2018, CLIN INTERV AGING, V13, P429, DOI 10.2147/CIA.S157014; Kavanagh T, 2003, J AM COLL CARDIOL, V42, P2139, DOI 10.1016/j.jacc.2003.07.028; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Kouwenhoven-Pasmooij TA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5633-0; Krogsboll LT, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7191; Laukkanen R, 2011, POLAR BODY AGE SCI B; Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233; Liukkonen M, 2017, SAF HEALTH WORK-KR, V8, P393, DOI [10.1016/j.shaw.2017.03.003, 10.1016/j.shaw.2017.03.003.]; Lowsky DJ, 2014, J GERONTOL A-BIOL, V69, P640, DOI 10.1093/gerona/glt162; Nes BM, 2020, MED SCI SPORT EXER, V52, P1440, DOI 10.1249/MSS.0000000000002352; Prior JO, 2005, PREV MED, V40, P259, DOI 10.1016/j.ypmed.2004.05.032; REAVEN GM, 1993, ANNU REV MED, V44, P121, DOI 10.1146/annurev.me.44.020193.001005; Robroek SJW, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-26; SCHAEFER EJ, 1994, J LIPID RES, V35, P871; Soler RE, 2010, AM J PREV MED, V38, pS237, DOI 10.1016/j.amepre.2009.10.030; Soria R, 2006, BRIT J GEN PRACT, V56, P768; TRUELSEN T, 1994, STROKE, V25, P802, DOI 10.1161/01.STR.25.4.802; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weng SF, 2013, ADDICTION, V108, P307, DOI 10.1111/add.12015; WHO, 2009, WHO WORKPL HLTH PROM	39	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239337	10.1371/journal.pone.0239337	http://dx.doi.org/10.1371/journal.pone.0239337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941507	gold, Green Published			2022-12-26	WOS:000573848800026
J	Rao, HM; Ahmad, S; Madni, A; Ahmad, I; Shahzad, MN				Rao, Huma; Ahmad, Saeed; Madni, Asadullah; Ahmad, Imtiaz; Shahzad, Muhammad Nadeem			Single-step extraction for simultaneous quantification of desvenlafaxine and alprazolam in human spiked plasma by RP-HPLC	PLOS ONE			English	Article							PURE POWDER; PRODUCTS	Desvenlafaxine (DES) and Alprazolam (ALP) are the drugs commonly prescribed together for the treatment of Major Depressive Disorders (MDD). A literature survey revealed, there is no method for the simultaneous determination of these two drugs. The purpose of this research was to develop and validate a simple, accurate, precise, robust, and isocratic RP-HPLC method for simultaneous determination of DES and ALP in human spiked plasma using UV-detector in short analysis time. The method utilized Hypersil BDS C18 (250 mmx4.6 mm, 5 mu m) through an isocratic mode of elution using HPLC grade acetonitrile and 0.02M KH(2)PO(4)buffer (65:35) and 0.1% Tri Fluoro Acetic acid (TFA) with pH 4.00 adjusted with 1M KOH. The flow rate was 1.00 mLmin(-1)and elution of the drugs was monitored at 230nm. The elution time of DES and ALP was 4.011 and 5.182 minutes respectively. The method was linear for the concentration range 10-150 mu gmL(-1)for DES and 5.0-75.0 mu gmL(-1)for ALP. According to the validation results, the method is sensitive with Limit of Detection (LOD) 4.740 mu gmL(-1)and Limit of Quantification (LOQ) of 14.365 mu gmL(-1)for DES and LOD 1.891 mu gmL(-1)& LOQ 5.730 mu gmL(-1)for ALP. The reproducibility of results with minute deliberate variations in method parameters has proven that the method is robust. The data from stability studies show a non-significant change in drugs solutions for 2 months. The optimized method was validated as per International Conference for Harmonisation (ICH) Q2(R1) guidelines. This method can be used for the estimation of DES and ALP in plasma and can evaluate pharmacokinetic parameters of both drugs simultaneously.	[Rao, Huma; Ahmad, Saeed; Madni, Asadullah; Ahmad, Imtiaz; Shahzad, Muhammad Nadeem] Islamia Univ Bahawalpur, Fac Pharm, Bahawalpur, Pakistan	Islamia University of Bahawalpur	Rao, HM; Ahmad, S; Madni, A (corresponding author), Islamia Univ Bahawalpur, Fac Pharm, Bahawalpur, Pakistan.	humarao80@gmail.com; rsahmed_iub@yahoo.com; asadullah.madni@iub.edu.pk	Rao, Huma/HHS-0521-2022	Madni, Prof. Dr. M. Asadullah/0000-0002-0388-9867	Higher Education Commission	Higher Education Commission(Ministry of Higher Education & Scientific Research (MHESR))	Higher Education Commission has awarded scholarship to author Huma Rao as a stipend/fellowship for the student. It does not include funds for the research project and/or research article publication fee etc.	Alajarin M, 2007, TETRAHEDRON LETT, V48, P3495, DOI 10.1016/j.tetlet.2007.03.121; [Anonymous], 2015, CORSALUD; [Anonymous], 2014, CANC DISCOV, V4, pOF1; BIRKENHAGER TK, 1995, INT CLIN PSYCHOPHARM, V10, P181, DOI 10.1097/00004850-199510030-00008; Dorgan J.F., 2010, BREAST CANC RES, V12, pR98; Dunlop Boadie W, 2008, Prim Care Companion J Clin Psychiatry, V10, P222; Gonsalves AR, 2010, ARKIVOC, P128, DOI 10.3998/ark.5550190.0011.513; Guideline IHT, 2005, INT C HARM GEN SWITZ INT C HARM GEN SWITZ; Hanysova L, 2005, CHEM PAP, V59, P99; Jain J.Chaudhry, 2018, GLOBAL J PHARM ED RE, V5, P26; Kancharla PK, 2016, BIOMED CHROMATOGR, V30, P249, DOI 10.1002/bmc.3542; Kumar K. A. Mohanakrishna, 2011, INT J CHEMTECH RES, V3, P161; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Loscalzo LM, 2008, EUR J PHARMACOL, V580, P306, DOI 10.1016/j.ejphar.2007.11.011; Mallikarjuna R., 2013, INDIAN J RES PHARM B, V1, P525; Moussa B.A., 2011, J CHEM PHARM RES, V3, P425; Nudelman NS, 2002, J PHARMACEUT BIOMED, V30, P887, DOI 10.1016/S0731-7085(02)00351-5; Patel RB, 2009, EURASIAN J ANAL CHEM, V4, P76, DOI 10.12973/ejac.2009.00052a; Patel RB, 2009, ANAL LETT, V42, P1588, DOI 10.1080/00032710902994165; Pawar Shubhangi M, 2012, J Pharm Anal, V2, P264, DOI 10.1016/j.jpha.2012.02.009; Perez-Lozano P, 2004, J PHARMACEUT BIOMED, V34, P979, DOI 10.1016/j.jpba.2003.12.012; Sultana N., 2012, J CHROMATOGR SEP TEC, V3, P1; Tulja R.G. Gowri, 2011, J PHARM RES, V4, P358; Valenstein M, 2004, AM J PSYCHIAT, V161, P654, DOI 10.1176/appi.ajp.161.4.654; van Marwijk H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007139.pub2; Verster JC, 2004, CNS DRUG REV, V10, P45; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Zamorski MA, 2002, AM FAM PHYSICIAN, V66, P1477	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238954	10.1371/journal.pone.0238954	http://dx.doi.org/10.1371/journal.pone.0238954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941505	Green Published, gold			2022-12-26	WOS:000573848800066
J	Palmer, RF; Jaen, CR; Perales, RB; Rincon, R; Forster, JN; Miller, CS				Palmer, Raymond F.; Jaen, Carlos R.; Perales, Roger B.; Rincon, Rodolfo; Forster, Jacqueline N.; Miller, Claudia S.			Three questions for identifying chemically intolerant individuals in clinical and epidemiological populations: The Brief Environmental Exposure and Sensitivity Inventory (BREESI)	PLOS ONE			English	Article							FOOD ALLERGY; PREVALENCE	The Quick Environmental Exposure and Sensitivity Inventory (QEESI) is a validated questionnaire used worldwide to assess intolerances to chemicals, foods, and drugs, and has emerged as the gold standard for assessing chemical intolerance (CI). Despite a reported prevalence of 8-33%, epidemiological studies and routine primary care clinics rarely assess CI. To help address this gap, we developed the Brief Environmental Exposure and Sensitivity Inventory (BREESI)-a 3-item CI screening tool. We tested the BREESI's potential to predict whether an individual is likely to be classified as chemically intolerant if administered the 50-item QEESI. We recruited 293 participants from a university-based primary care clinic and through online participation. The statistical sensitivity, specificity, and positive and negative predictive values of the BREESI were calculated against the validated QEESI. Ninety percent (90%) of participants answering "yes" to all three items on the BREESI fit the QEESI criteria for beingvery suggestiveof CI based upon their chemical intolerance and symptom scores (positive predictive value = 90%). For participants endorsing two items, 93% were classified as eithervery suggestive(39%)or suggestive(54%) of CI (positive predictive value = 87%). Of those endorsing only one item, 13% were classified asvery suggestiveof CI, and 70% assuggestive. Of those answering "No" to all of the BREESI items, 95% were classified asnot suggestiveof CI (i.e., negative predictive value = 95%). The BREESI is a versatile screening tool for assessing potential CI useful for clinical and epidemiological applications, based upon individuals' past adverse responses in a variety of settings. Just as health care professionals routinely inquire about latex allergy to prevent adverse reactions, the BREESI provides an essential screen for CI. Together, the BREESI and QEESI provide new diagnostic tools that may help predict and prevent future adverse reactions to chemicals, foods, and drugs.	[Palmer, Raymond F.; Jaen, Carlos R.; Perales, Roger B.; Rincon, Rodolfo; Forster, Jacqueline N.; Miller, Claudia S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Palmer, RF (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Family & Community Med, San Antonio, TX 78229 USA.	palmerr@uthscsa.edu		Jaen, Carlos Roberto/0000-0001-5904-4719; palmer, ray/0000-0001-6621-9038	Marilyn Brachman Hoffman Foundation, Fort Worth, Texas	Marilyn Brachman Hoffman Foundation, Fort Worth, Texas	Marilyn Brachman Hoffman Foundation, Fort Worth, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SAS 9 4 STAT REF; Ashford N., 1998, CHEM EXPOSURES LOW L; Azuma K, 2020, INT J HYG ENVIR HEAL, V225, DOI 10.1016/j.ijheh.2020.113470; Azuma K, 2015, ARCH ENVIRON OCCUP H, V70, P341, DOI 10.1080/19338244.2014.926855; Bell IR, 2013, WOMEN HEALTH, VSecond, P1379, DOI DOI 10.1016/B978-0-12-384978-6.00094-7; Caress SM, 2004, AM J PUBLIC HEALTH, V94, P746, DOI 10.2105/AJPH.94.5.746; Dantoft MT, 2015, CURRENT RHEUMATOLOGY, V2, P167; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Genuis SJ, 2010, SCI TOTAL ENVIRON, V408, P6047, DOI 10.1016/j.scitotenv.2010.08.047; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hojo S, 2018, INT J HYG ENVIR HEAL, V221, P1085, DOI 10.1016/j.ijheh.2018.08.001; Hojo Sachiko, 2009, Environmental Health and Preventive Medicine, V14, P267, DOI 10.1007/s12199-009-0095-8; Jeon BH., 2012, KOREAN J OCCUPATIONA, V24, P96; Katerndahl DA, 2012, ANN FAM MED, V10, P357, DOI 10.1370/afm.1346; Kreutzer R, 1999, AM J EPIDEMIOL, V150, P1; Blanco EL, 2016, MED CLIN-BARCELONA, V146, P108, DOI 10.1016/j.medcli.2015.09.016; Macy E., 2018, DRUG ALLERGY TESTING, P165, DOI [10.1016/B978-0-323-48551-7.00016-X ., DOI 10.1016/B978-0-323-48551-7.00016-X]; Macy E, 2012, ANN ALLERG ASTHMA IM, V108, P88, DOI 10.1016/j.anai.2011.11.006; Miller CS, 1999, TOXICOL IND HEALTH, V15, P386, DOI 10.1191/074823399678846862; Miller CS, 1999, TOXICOL IND HEALTH, V15, P370, DOI 10.1177/074823379901500311; Miller CS, 2001, ANN NY ACAD SCI, V933, P1, DOI 10.1017/CBO9780511666452.002; Miller CS, 1997, ENVIRON HEALTH PERSP, V105, P445, DOI 10.2307/3433351; Miller CS., 2001, TOXICANT INDUCED LOS, P85; Miller CS, 1997, ARCH ENV HLTH, V50, P119; Nettleman Mary, 2015, Trans Am Clin Climatol Assoc, V126, P237; Nordin S, 2010, INT ARCH OCC ENV HEA, V83, P95, DOI 10.1007/s00420-009-0427-4; Omer HMRB, 2014, DRUG SAFETY, V37, P1037, DOI 10.1007/s40264-014-0236-x; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Skovbjerg S, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/304314; Steinemann A, 2018, J OCCUP ENVIRON MED, V60, pE152, DOI 10.1097/JOM.0000000000001272; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00307; YOUNG E, 1994, LANCET, V343, P1127, DOI 10.1016/S0140-6736(94)90234-8; Yun MJ, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-32	35	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238296	10.1371/journal.pone.0238296	http://dx.doi.org/10.1371/journal.pone.0238296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936802	gold, Green Published			2022-12-26	WOS:000573658000004
J	Mehner, C; Miller, E; Hockla, A; Coban, M; Weroha, SJ; Radisky, DC; Radisky, ES				Mehner, Christine; Miller, Erin; Hockla, Alexandra; Coban, Mathew; Weroha, S. John; Radisky, Derek C.; Radisky, Evette S.			Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma	ONCOGENE			English	Article							INHIBITOR KAZAL TYPE-1; TRYPSIN-INHIBITOR; MONOCLONAL-ANTIBODY; ANOIKIS RESISTANCE; INTERLEUKIN-6; SPINK1; CANCER; EXPRESSION; PROGNOSIS; IL-6	A major clinical challenge of ovarian cancer is the development of malignant ascites accompanied by widespread peritoneal metastasis. In ovarian clear cell carcinoma (OCCC), a challenging subtype of ovarian cancer, this problem is compounded by near-universal primary chemoresistance; patients with advanced stage OCCC thus lack effective therapies and face extremely poor survival rates. Here we show that tumor-cell-expressed serine protease inhibitor Kazal type 1 (SPINK1) is a key driver of OCCC progression and metastasis. Using cell culture models of human OCCC, we find that shRNA silencing of SPINK1 sensitizes tumor cells to anoikis and inhibits proliferation. Knockdown of SPINK1 in OCCC cells also profoundly suppresses peritoneal metastasis in mouse implantation models of human OCCC. We next identify a novel autocrine signaling axis in OCCC cells whereby tumor-cell-produced interleukin-6 (IL-6) regulates SPINK1 expression to stimulate a common protumorigenic gene expression pattern leading to anoikis resistance and proliferation of OCCC cells. We further demonstrate that this signaling pathway can be successfully interrupted with the IL-6R alpha inhibitor tocilizumab, sensitizing cells to anoikis in vitro and reducing metastasis in vivo. These results suggest that clinical trials of IL-6 pathway inhibitors in OCCC may be warranted, and that SPINK1 might offer a candidate predictive biomarker in this population.	[Mehner, Christine] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN USA; [Mehner, Christine; Miller, Erin; Hockla, Alexandra; Coban, Mathew; Radisky, Derek C.; Radisky, Evette S.] Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA; [Weroha, S. John] Mayo Clin, Div Med Oncol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Radisky, ES (corresponding author), Mayo Clin, Dept Canc Biol, Ctr Comprehens Canc, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Coban, Matt/AAH-7053-2019	Coban, Matt/0000-0001-6396-6759; Radisky, Evette/0000-0003-3121-109X	NCI NIH HHS [R21 CA226302, P50 CA136393, R21 CA177865, R01 CA154387] Funding Source: Medline; U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI) [R01CA154387, P50CA136393, R21CA177865] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)		Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Al-Quteimat OM, 2014, J ONCOL PHARM PRACT, V20, P369, DOI 10.1177/1078155213506244; Angevin E, 2014, CLIN CANCER RES, V20, P2192, DOI 10.1158/1078-0432.CCR-13-2200; Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Ateeq B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001498; Cepeda D, 2013, EMBO MOL MED, V5, P1067, DOI 10.1002/emmm.201202341; Chan JK, 2008, GYNECOL ONCOL, V109, P370, DOI 10.1016/j.ygyno.2008.02.006; Chandler RL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7118; Chen F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06860-4; Cichon MA, 2015, CANCER INFORM, V14, P1, DOI 10.4137/CIN.S18965; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Dijkgraaf EM, 2015, ANN ONCOL, V26, P2141, DOI 10.1093/annonc/mdv309; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; HALILA H, 1987, BRIT J CANCER, V56, P153, DOI 10.1038/bjc.1987.175; Hirano G, 2011, INT J ONCOL, V38, P893, DOI 10.3892/ijo.2011.938; Howlader NNA, 2020, SEER CANC STAT REV; HUHTALA ML, 1982, J BIOL CHEM, V257, P13713; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Itkonen O, 2014, CLIN CHIM ACTA, V431, P260, DOI 10.1016/j.cca.2014.02.014; Kawabata A, 2017, GYNECOL ONCOL, V146, P609, DOI 10.1016/j.ygyno.2017.06.027; Kereszturi E, 2009, GUT, V58, P545, DOI 10.1136/gut.2008.164947; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Lamontagne J, 2010, J VIROL, V84, P907, DOI 10.1128/JVI.01249-09; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lu XY, 2008, APOPTOSIS, V13, P483, DOI 10.1007/s10495-008-0193-x; Ma H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38362-0; Marzec K, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00162; Mehner C, 2015, ONCOTARGET, V6, P35737, DOI 10.18632/oncotarget.5927; Mitra AK, 2016, TUMOR METASTASIS, P43, DOI 10.5772/64700; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Paju A, 2004, CLIN CANCER RES, V10, P4761, DOI 10.1158/1078-0432.CCR-0204-03; Pectasides D, 2006, ONCOLOGIST, V11, P1089, DOI 10.1634/theoncologist.11-10-1089; Portolano N, 2014, JOVE-J VIS EXP, DOI 10.3791/51897; Rasanen K, 2016, MOL CARCINOGEN, V55, P2010, DOI 10.1002/mc.22447; Rasanen K, 2016, CLIN CHEM, V62, P449, DOI 10.1373/clinchem.2015.241513; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Soon WW, 2011, EMBO MOL MED, V3, P451, DOI 10.1002/emmm.201100150; Stany MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021121; Stenman UH, 2002, CLIN CHEM, V48, P1206; Stenman UH, 2011, ASIAN J ANDROL, V13, P628, DOI 10.1038/aja.2011.45; Sugiyama T, 1998, CANCER LETT, V128, P211, DOI 10.1016/S0304-3835(98)00065-2; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016; WATSON JM, 1990, CANCER RES, V50, P6959; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yanaihara N, 2016, MOL CARCINOGEN, V55, P832, DOI 10.1002/mc.22325; YASUDA T, 1993, GENE, V131, P275; YASUDA T, 1990, BIOL CHEM H-S, V371, P95; Yuniati L, 2019, J CELL PHYSIOL, V234, P5379, DOI 10.1002/jcp.27407	54	8	8	2	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 15	2020	39	42					6606	6618		10.1038/s41388-020-01451-4	http://dx.doi.org/10.1038/s41388-020-01451-4		SEP 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OA9HI	32929152	Green Accepted			2022-12-26	WOS:000569499000001
J	Rivera, RR; Lin, ME; Bornhop, EC; Chun, J				Rivera, Richard R.; Lin, Mu-En; Bornhop, Emily C.; Chun, Jerold			Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain	FASEB JOURNAL			English	Article						conditional knockout; LPA; PSNL; Schwann cells; neurons	LYSOPHOSPHATIDIC ACID LPA; MULTIPLE-SCLEROSIS; RECEPTOR GENE; SPINAL-CORD; INJURY; MODEL; ROLES; DISRUPTION; MECHANISMS; MORPHOLOGY	LPA(1)is one of six known receptors (LPA(1-6)) for lysophosphatidic acid (LPA). ConstitutiveLpar1null mutant mice have been instrumental in identifying roles for LPA-LPA(1)signaling in neurobiological processes, brain development, and behavior, as well as modeling human neurological diseases like neuropathic pain. ConstitutiveLpar1null mutant mice are protected from partial sciatic nerve ligation (PSNL)-induced neuropathic pain, however, the cell types that are functionally responsible for mediating this protective effect are unknown. Here, we report the generation of anLpar1(flox/flox)conditional null mutant mouse that allows for cre-mediated conditional deletion, combined with a PSNL pain model.Lpar1(flox/flox)mice were crossed withcretransgenic lines driven by neural gene promoters fornestin(all neural cells),synapsin(neurons), orP0(Schwann cells).CD11b-cretransgenic mice were also used to deleteLpar1in microglia. PSNL-initiated pain responses were reduced following cre-mediatedLpar1deletion with all three neural promoters as well as theCD11bpromoter, supporting involvement of Schwann cells, central and/or peripheral neurons, and microglia in mediating pain. Interestingly, rescue responses were nonidentical, implicating distinct roles forLpar1-expressing cell types. Our results with a newLpar1conditional mouse mutant expand an understanding of LPA(1)signaling in the PSNL model of neuropathic pain.	[Rivera, Richard R.; Bornhop, Emily C.; Chun, Jerold] Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, 10901 N Torrey Pines Rd, La Jolla, CA 90237 USA; [Lin, Mu-En] Scripps Res Inst, Dept Mol Biol, Dorris Neurosci Ctr, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Lin, Mu-En] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Lin, Mu-En] RevMAb Biosci, San Francisco, CA USA	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; University of California System; University of California San Diego	Chun, J (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Degenerat Dis Program, 10901 N Torrey Pines Rd, La Jolla, CA 90237 USA.	jchun@sbpdiscovery.org			HHS | NIH | National Institute of Mental Health (NIMH) [R01MH051699]; Amira Pharmaceuticals	HHS | NIH | National Institute of Mental Health (NIMH); Amira Pharmaceuticals	HHS | NIH | National Institute of Mental Health (NIMH), Grant/Award Number: R01MH051699; Amira Pharmaceuticals	Anliker B, 2013, GLIA, V61, P2009, DOI 10.1002/glia.22572; Blaho VA, 2018, TRENDS PHARMACOL SCI, V39, P953, DOI 10.1016/j.tips.2018.08.006; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Callaerts-Vegh Z, 2012, GENES BRAIN BEHAV, V11, P1009, DOI 10.1111/j.1601-183X.2012.00840.x; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chrencik JE, 2015, CELL, V161, P1633, DOI 10.1016/j.cell.2015.06.002; Chun J., 2014, LYSOPHOSPHOLIPID REC; Chun J, 2019, ANNU REV PHARMACOL, V59, P149, DOI 10.1146/annurev-pharmtox-010818-021358; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; D'Mello R, 2008, BRIT J ANAESTH, V101, P8, DOI 10.1093/bja/aen088; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Dubin AE, 2010, J NEUROSCI, V30, P7300, DOI 10.1523/JNEUROSCI.6151-09.2010; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Estivill-Torrus G, 2008, CEREB CORTEX, V18, P938, DOI 10.1093/cercor/bhm132; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Fincher J, 2014, DEV NEUROSCI-BASEL, V36, P443, DOI 10.1159/000364858; Fukushima N, 2000, DEV BIOL, V228, P6, DOI 10.1006/dbio.2000.9930; Fukushima N, 2002, MOL CELL NEUROSCI, V20, P271, DOI 10.1006/mcne.2002.1123; Gennero I, 2011, BONE, V49, P395, DOI 10.1016/j.bone.2011.04.018; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Harrison SM, 2003, MOL CELL NEUROSCI, V24, P1170, DOI 10.1016/j.mcn.2003.09.001; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kihara Y, 2014, BRIT J PHARMACOL, V171, P3575, DOI 10.1111/bph.12678; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lim TKY, 2015, J NEUROSCI, V35, P3346, DOI 10.1523/JNEUROSCI.4040-14.2015; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Lummis NC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2011; Ma L, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-29; Ma L, 2010, J NEUROCHEM, V115, P643, DOI 10.1111/j.1471-4159.2010.06955.x; Ma L, 2010, J PHARMACOL EXP THER, V333, P540, DOI 10.1124/jpet.109.164830; Ma L, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-64; Matas-Rico E, 2008, MOL CELL NEUROSCI, V39, P342, DOI 10.1016/j.mcn.2008.07.014; Mirendil H, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.33; Moller T, 2001, J BIOL CHEM, V276, P25946, DOI 10.1074/jbc.M102691200; SCHUMACHER KA, 1979, THROMB HAEMOSTASIS, V42, P631; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Suckau O, 2019, DEV DYNAM, V248, P375, DOI 10.1002/dvdy.23; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Ueda H, 2018, PAIN, V159, P2170, DOI 10.1097/j.pain.0000000000001316; Ueda H, 2017, PAIN, V158, pS55, DOI 10.1097/j.pain.0000000000000813; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Weiner JA, 2001, J NEUROSCI, V21, P7069, DOI 10.1523/JNEUROSCI.21-18-07069.2001; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	54	7	7	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2020	34	7					8833	8842		10.1096/fj.202000317R	http://dx.doi.org/10.1096/fj.202000317R		JUN 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MG8UN	32929779	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000541772400001
J	Choubey, A; Girdhar, K; Kar, AK; Kushwaha, S; Yadav, MK; Ghosh, D; Mondal, P				Choubey, Abhinav; Girdhar, Khyati; Kar, Aditya K.; Kushwaha, Shaivya; Yadav, Manoj Kumar; Ghosh, Debabrata; Mondal, Prosenjit			Low-dose naltrexone rescues inflammation and insulin resistance associated with hyperinsulinemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						low-dose naltrexone; SIRT1; NF-&#954; B; insulin resistance; sirtuin 1 (SIRT1); Toll-like receptor 4 (TLR4); insulin; cytokine induction; hyperinsulinemia; inflammation	NF-KAPPA-B; ALTERNATIVE ACTIVATION; NEUROPATHIC PAIN; PROTEIN; CELLS; GENE; TIME	The incidence of diabetes, obesity, and metabolic diseases has reached an epidemic status worldwide. Insulin resistance is a common link in the development of these conditions, and hyperinsulinemia is a central hallmark of peripheral insulin resistance. However, how hyperinsulinemia leads to systemic insulin resistance is less clear. We now provide evidence that hyperinsulinemia promotes the release of soluble pro-inflammatory mediators from macrophages that lead to systemic insulin resistance. Our observations suggest that hyperinsulinemia induces sirtuin1 (SIRT1) repression and stimulates NF-kappa B p65 nuclear translocation and transactivation of NF-kappa B to promote the extracellular release of pro-inflammatory mediators. We further showed that low-dose naltrexone (LDN) abrogates hyperinsulinemia-mediated SIRT1 repression and prevents NF-kappa B p65 nuclear translocation. This, in turn, attenuates the hyperinsulinemia-induced release of pro-inflammatory cytokines and reinstates insulin sensitivity both in in vitro and in vivo diet-induced hyperinsulinemic mouse model. Notably, our data indicate that Sirt1 knockdown or inhibition blunts the anti-inflammatory properties of LDN in vitro. Using numerous complementary in silico and in vitro experimental approaches, we demonstrated that LDN can bind to SIRT1 and increase its deacetylase activity. Together, these data support a critical role of SIRT1 in inflammation and insulin resistance in hyperinsulinemia. LDN improves hyperinsulinemia-induced insulin resistance by reorienting macrophages toward anti-inflammation. Thus, LDN treatment may provide a novel therapeutic approach against hyperinsulinemia-associated insulin resistance.	[Choubey, Abhinav; Girdhar, Khyati; Mondal, Prosenjit] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India; [Choubey, Abhinav; Girdhar, Khyati; Mondal, Prosenjit] Indian Inst Technol Mandi, BioX Ctr, Mandi, Himachal Prades, India; [Kar, Aditya K.; Kushwaha, Shaivya; Ghosh, Debabrata] CSIR Indian Inst Toxicol Res CSIR IITR, Lucknow, Uttar Pradesh, India; [Yadav, Manoj Kumar] SRM Univ, Dept Bioinformat, Delhi NCR, Sonipat, Haryana, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); SRM University Haryana	Mondal, P (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India.; Mondal, P (corresponding author), Indian Inst Technol Mandi, BioX Ctr, Mandi, Himachal Prades, India.	prosenjit@iitmandi.ac.in	Kar, Aditya/GLU-5509-2022; Girdhar, Khyati/CAF-5110-2022; Yadav, Manoj Kumar/ABE-7732-2020	Girdhar, Khyati/0000-0002-2293-1864; Yadav, Manoj Kumar/0000-0003-3219-0171; Choubey, Abhinav/0000-0002-6025-6820; MONDAL, PROSENJIT/0000-0001-8566-249X	Science and Engineering Research Board (SERB) [ECR/2015/000165]	Science and Engineering Research Board (SERB)	This work was supported by Science and Engineering Research Board (SERB), Grant ECR/2015/000165 (to P. M.).	Bai WL, 2016, CELL CYCLE, V15, P3337, DOI 10.1080/15384101.2016.1237170; Bluher M, 2012, DIABETES METAB J, V36, P317, DOI 10.4093/dmj.2012.36.5.317; Cabanas H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02545; Cant R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00809; Cheng F, 2009, AM J PHYSIOL-REG I, V297, pR844, DOI 10.1152/ajpregu.00311.2009; Cohen L, 1998, NATURE, V395, P292, DOI 10.1038/26254; Cornish JW, 1997, J SUBST ABUSE TREAT, V14, P529, DOI 10.1016/S0740-5472(97)00020-2; Daniel PV, 2019, FEBS LETT, V593, P3084, DOI 10.1002/1873-3468.13538; Dogra S, 2019, NANOMED-NANOTECHNOL, V17, P210, DOI 10.1016/j.nano.2019.01.013; Fisher E, 2017, ACS CHEM NEUROSCI, V8, P2088, DOI 10.1021/acschemneuro.7b00228; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hutchinson MR, 2008, EUR J NEUROSCI, V28, P20, DOI 10.1111/j.1460-9568.2008.06321.x; International Diabetes Foundation, 2009, IDF DIABETES ATLAS; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kao JH, 2015, BRIT J PHARMACOL, V172, P630, DOI 10.1111/bph.12790; Kappert K, 2008, BIOCHEM BIOPH RES CO, V365, P503, DOI 10.1016/j.bbrc.2007.11.006; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma MC, 2018, J CARDIOTHORAC SURG, V13, DOI 10.1186/s13019-018-0718-5; NANKERVIS A, 1985, DIABETOLOGIA, V28, P427, DOI 10.1007/BF00280885; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Oser CB, 2007, J STUD ALCOHOL DRUGS, V68, P852, DOI 10.15288/jsad.2007.68.852; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Sbraccia P, 1996, DIABETOLOGIA, V39, P220, DOI 10.1007/BF00403966; Shin KC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01232-w; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Tanaka K, 2019, LIFE SCI, V224, P232, DOI 10.1016/j.lfs.2019.03.069; Toljan Karlo, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6040082; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wang X, 2016, BRIT J PHARMACOL, V173, P856, DOI 10.1111/bph.13394; Weerts EM, 2008, NEUROPSYCHOPHARMACOL, V33, P653, DOI 10.1038/sj.npp.1301440; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Younger J, 2014, CLIN RHEUMATOL, V33, P451, DOI 10.1007/s10067-014-2517-2	39	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16359	16369		10.1074/jbc.RA120.013484	http://dx.doi.org/10.1074/jbc.RA120.013484			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32943552	hybrid, Green Published			2022-12-26	WOS:000598519500015
J	Guo, XY; Liu, YS; Gao, XD; Kinoshita, T; Fujita, M				Guo, Xin-Yu; Liu, Yi-Shi; Gao, Xiao-Dong; Kinoshita, Taroh; Fujita, Morihisa			Calnexin mediates the maturation of GPI-anchors through ER retention	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic reticulum; glycosylphosphatidylinositol; lipid remodeling; protein folding; glycosylphosphatidylinositol (GPI anchor); glycobiology; endoplasmic reticulum (ER); ER quality control	QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; INOSITOL DEACYLATION; PROTEINS; CALRETICULIN; ERP57; TRANSPORT; BINDING; LECTIN; PGAP1	The protein folding and lipid moiety status of glycosylphosphatidylinositol-anchored proteins (GPI-APs) are monitored in the endoplasmic reticulum (ER), with calnexin playing dual roles in the maturation of GPI-APs. In the present study, we investigated the functions of calnexin in the quality control and lipid remodeling of GPI-APs in the ER. By directly binding the N-glycan on proteins, calnexin was observed to efficiently retain GPI-APs in the ER until they were correctly folded. In addition, sufficient ER retention time was crucial for GPI-inositol deacylation, which is mediated by post-GPI attachment protein 1 (PGAP1). Once the calnexin/calreticulin cycle was disrupted, misfolded and inositol-acylated GPI-APs could not be retained in the ER and were exposed on the plasma membrane. In calnexin/calreticulin-deficient cells, endogenous GPI-anchored alkaline phosphatase was expressed on the cell surface, but its activity was significantly decreased. ER stress induced surface expression of misfolded GPI-APs, but proper GPI-inositol deacylation occurred due to the extended time that they were retained in the ER. Our results indicate that calnexin-mediated ER quality control systems for GPI-APs are necessary for both protein folding and GPI-inositol deacylation.	[Guo, Xin-Yu; Liu, Yi-Shi; Gao, Xiao-Dong; Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China; [Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan; [Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan	Jiangnan University; Osaka University; Osaka University	Fujita, M (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Jiangsu, Peoples R China.	fujita@jiangnan.edu.cn	Kinoshita, Taroh/C-7353-2009		National Natural Science Foundation of China [31770853]; Program of Introducing Talents of Discipline to Universities [111-2-06]; National First-Class Discipline Program of Light Industry Technology and Engineering Grant [LITE2018-015]; Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions; International Joint Research Laboratory for Investigation of Glycoprotein Biosynthesis at Jiangnan University; Research Institute for Microbial Diseases, Osaka University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); National First-Class Discipline Program of Light Industry Technology and Engineering Grant; Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions; International Joint Research Laboratory for Investigation of Glycoprotein Biosynthesis at Jiangnan University; Research Institute for Microbial Diseases, Osaka University	This work was supported by National Natural Science Foundation of China Grant 31770853, Program of Introducing Talents of Discipline to Universities Grant 111-2-06, National First-Class Discipline Program of Light Industry Technology and Engineering Grant LITE2018-015, the Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions, the International Joint Research Laboratory for Investigation of Glycoprotein Biosynthesis at Jiangnan University, and a grant for a Joint Research Project of the Research Institute for Microbial Diseases, Osaka University.	Cannon KS, 1996, J BIOL CHEM, V271, P14280, DOI 10.1074/jbc.271.24.14280; Chen R, 1998, P NATL ACAD SCI USA, V95, P9512, DOI 10.1073/pnas.95.16.9512; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Ferguson M. A. J., 2009, ESSENTIALS GLYCOBIOL, P137; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Granzow M, 2015, MOL CELL PROBE, V29, P323, DOI 10.1016/j.mcp.2015.05.012; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirata T, 2015, MOL BIOL CELL, V26, P3071, DOI 10.1091/mbc.E14-11-1568; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Ikezawa H, 2002, BIOL PHARM BULL, V25, P409, DOI 10.1248/bpb.25.409; Ishida Y, 2003, J BIOCHEM, V134, P63, DOI 10.1093/jb/mvg114; Kettwig M, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0602-7; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kozlov G, 2017, STRUCTURE, V25, P1415, DOI 10.1016/j.str.2017.07.010; Leach MR, 2004, J BIOL CHEM, V279, P9072, DOI 10.1074/jbc.M310788200; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Liu YS, 2018, J CELL BIOL, V217, P585, DOI 10.1083/jcb.201706135; Maeda Y, 2008, NAT CELL BIOL, V10, P1135, DOI 10.1038/ncb1773; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; McConville MJ, 2000, MOL MEMBR BIOL, V17, P1; McKean DM, 2012, BIOL OPEN, V1, P874, DOI 10.1242/bio.20121982; MENON AK, 1994, METHOD ENZYMOL, V230, P418; Muniz M, 2016, J LIPID RES, V57, P352, DOI 10.1194/jlr.R062760; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Pollock S, 2004, EMBO J, V23, P1020, DOI 10.1038/sj.emboj.7600119; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; SECKLER R, 1992, FASEB J, V6, P2545, DOI 10.1096/fasebj.6.8.1592207; Sikorska N, 2016, J CELL BIOL, V213, P693, DOI 10.1083/jcb.201602010; Spiro RG, 1996, J BIOL CHEM, V271, P11588, DOI 10.1074/jbc.271.19.11588; Sun ZH, 2019, J CELL BIOL, V218, P3171, DOI 10.1083/jcb.201906047; Swanton E, 2003, EMBO J, V22, P2948, DOI 10.1093/emboj/cdg300; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Tiede A, 1999, BIOL CHEM, V380, P503, DOI 10.1515/BC.1999.066; Trychta KA, 2018, CELL REP, V25, P1829, DOI 10.1016/j.celrep.2018.10.055; Ueda Y, 2007, J BIOL CHEM, V282, P30373, DOI 10.1074/jbc.M705601200; Vassilakos A, 1998, BIOCHEMISTRY-US, V37, P3480, DOI 10.1021/bi972465g; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Zavodszky E, 2019, ELIFE, V8, DOI 10.7554/eLife.46740; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354; Zoltewicz JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006191	52	8	8	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16393	16410		10.1074/jbc.RA120.015577	http://dx.doi.org/10.1074/jbc.RA120.015577			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32967966	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000598519500018
J	Kadkhodayi-Kholghi, N; Bhatt, JS; Gor, J; McDermott, LC; Gale, DP; Perkins, SJ				Kadkhodayi-Kholghi, Nilufar; Bhatt, Jayesh S.; Gor, Jayesh; McDermott, Lindsay C.; Gale, Daniel P.; Perkins, Stephen J.			The solution structure of the complement deregulator FHR5 reveals a compact dimer and provides new insights into CFHR5 nephropathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						analytical ultracentrifugation; atomistic modeling; FHR5; complement; molecular dynamics; molecular modeling; Monte Carlo simulations; small-angle X-ray scattering analytical ultracentrifugation; complement; molecular dynamics; small-angle X-ray scattering (SAXS)	MEMBRANE COFACTOR PROTEIN; HEMOLYTIC-UREMIC SYNDROME; FACTOR-H; NEUTRON-SCATTERING; FACTOR-I; X-RAY; COMPONENT; MUTATION; ULTRACENTRIFUGATION; MACROMOLECULES	The human complement Factor H-related 5 protein (FHR5) antagonizes the main circulating complement regulator Factor H, resulting in the deregulation of complement activation. FHR5 normally contains nine short complement regulator (SCR) domains, but a FHR5 mutant has been identified with a duplicated N-terminal SCR-1/2 domain pair that causes CFHR5 nephropathy. To understand how this duplication causes disease, we characterized the solution structure of native FHR5 by analytical ultracentrifugation and small-angle X-ray scattering. Sedimentation velocity and X-ray scattering indicated that FHR5 was dimeric, with a radius of gyration (R-g) of 5.5 +/- 0.2 nm and a maximum protein length of 20 nm for its 18 domains. This result indicated that FHR5 was even more compact than the main regulator Factor H, which showed an overall length of 26-29 nm for its 20 SCR domains. Atomistic modeling for FHR5 generated a library of 250,000 physically realistic trial arrangements of SCR domains for scattering curve fits. Only compact domain structures in this library fit well to the scattering data, and these structures readily accommodated the extra SCR-1/2 domain pair present in CFHR5 nephropathy. This model indicated that mutant FHR5 can form oligomers that possess additional binding sites for C3b in FHR5. We conclude that the deregulation of complement regulation by the FHR5 mutant can be rationalized by the enhanced binding of FHR5 oligomers to C3b deposited on host cell surfaces. Our FHR5 structures thus explained key features of the mechanism and pathology of CFHR5 nephropathy.	[Kadkhodayi-Kholghi, Nilufar; Bhatt, Jayesh S.; Gor, Jayesh; Perkins, Stephen J.] UCL, Div Biosci, Dept Struct & Mol Biol, London, England; [McDermott, Lindsay C.] Univ Bedfordshire, Sch Life Sci, Luton, Beds, England; [Gale, Daniel P.] UCL, Royal Free Hosp, UCL Dept Renal Med, London, England	University of London; University College London; University of Bedfordshire; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Perkins, SJ (corresponding author), UCL, Div Biosci, Dept Struct & Mol Biol, London, England.	s.perkins@ucl.ac.uk	Gale, Daniel/D-5594-2013	Gale, Daniel/0000-0002-9170-1579; Gor, Jayesh/0000-0002-1654-1392; Kadkhodayi-Kholghi, Nilufar/0000-0001-6239-957X; Perkins, Stephen/0000-0001-9218-9805; McDermott, Lindsay C./0000-0003-4723-6056	Rosetrees Trust for Medical Research [M187]; UCL Impact Studentship; Medical Research Council Clinician Scientist Fellowship; Engineering and Physical Sciences Research Council (EPSRC) [EP/K039121/1]; National Science Foundation (NSF) [CHE-1265821]; EPSRC [EP/K039121/1] Funding Source: UKRI; MRC [G1002528] Funding Source: UKRI	Rosetrees Trust for Medical Research(Rosetrees Trust); UCL Impact Studentship; Medical Research Council Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Science Foundation (NSF)(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	N. K. K. was supported by the Rosetrees Trust for Medical Research (reference M187) and a UCL Impact Studentship. D. P. G. was supported by a Medical Research Council Clinician Scientist Fellowship. J. S. B. and S. J. P. were supported by a joint Engineering and Physical Sciences Research Council (EPSRC) (EP/K039121/1) and National Science Foundation (NSF) (CHE-1265821) grant for the CCP-SAS project.	Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; Athanasiou Y, 2011, CLIN J AM SOC NEPHRO, V6, P1436, DOI 10.2215/CJN.09541010; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Chen Q, 2014, J CLIN INVEST, V124, P145, DOI 10.1172/JCI71866; Curtis JE, 2012, COMPUT PHYS COMMUN, V183, P382, DOI 10.1016/j.cpc.2011.09.010; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; de Jorge EG, 2013, P NATL ACAD SCI USA, V110, P4685, DOI 10.1073/pnas.1219260110; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; Glatter O., 1982, SMALL ANGLE X RAY SC; Holers VM, 2013, J CLIN INVEST, V123, P2357, DOI 10.1172/JCI69684; Holmes LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060352; Hui GK, 2015, BIOCHEM J, V471, P167, DOI 10.1042/BJ20150612; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jozsi M, 2014, METHODS MOL BIOL, V1100, P225, DOI 10.1007/978-1-62703-724-2_18; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; MacKerell A. D., 1998, ENCY COMPUTATIONAL C; Makou E, 2012, J MOL BIOL, V424, P295, DOI 10.1016/j.jmb.2012.09.013; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Murphy B, 2002, AM J KIDNEY DIS, V39, P24, DOI 10.1053/ajkd.2002.29873; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Osborne AJ, 2018, J BIOL CHEM, V293, P17166, DOI 10.1074/jbc.RA118.004767; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2002, J MOL BIOL, V316, P217, DOI 10.1006/jmbi.2001.5337; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins SJ, 2016, J APPL CRYSTALLOGR, V49, P1861, DOI 10.1107/S160057671601517X; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; Perkins SJ, 2011, METHODS, V54, P181, DOI 10.1016/j.ymeth.2011.01.004; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rodriguez E, 2014, BIOSCIENCE REP, V34, P635, DOI 10.1042/BSR20140117; Ruseva MM, 2016, IMMUNOBIOLOGY, V221, P1167, DOI 10.1016/j.imbio.2016.06.098; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19; Tortajada A, 2013, J CLIN INVEST, V123, P2434, DOI 10.1172/JCI68280; van Beek AE, 2016, IMMUNOBIOLOGY, V221, P1182, DOI 10.1016/j.imbio.2016.06.130; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wright DW, 2015, J APPL CRYSTALLOGR, V48, P953, DOI 10.1107/S1600576715007062	52	2	2	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16342	16358		10.1074/jbc.RA120.015132	http://dx.doi.org/10.1074/jbc.RA120.015132			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32928961	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000598519500014
J	Ceron, K; Santana, DJ; Valente-Neto, F				Ceron, Karoline; Santana, Diego J.; Valente-Neto, Francisco			Seasonal patterns of ecological uniqueness of anuran metacommunities along different ecoregions in Western Brazil	PLOS ONE			English	Article							BETA-DIVERSITY; COMPREHENSIVE FRAMEWORK; SITE CONTRIBUTIONS; GRAN-CHACO; COMMUNITIES; BIODIVERSITY; STREAMS; FOREST; VEGETATION; SELECTION	Beta diversity can be portioned into local contributions to beta diversity (LCBD), which represents the degree of community composition uniqueness of a site compared to regionally sampled sites. LCBD can fluctuate among seasons and ecoregions according to site characteristics, species dispersal abilities, and biotic interactions. In this context, we examined anuran seasonal patterns of LCBD in different ecoregions of Western Brazil, and assessed their correlation with species richness and if environmental (climatic variables, pond area and ecoregions) and/or spatial predictors (spatial configuration of sampling sites captured by distance-based Moran's Eigenvector Maps) would drive patterns of LCBD. We sampled anurans in 19 ponds in different ecoregions in the Mato Grosso do Sul state, Western Brazil, during one dry and one rainy season. We found that LCBD patterns were similar between seasons with sites tending to contribute in the same way for community composition uniqueness during the dry and rainy season. Among studied ecoregions, Cerrado showed higher LCBD values in both seasons. In addition, LCBD was negatively correlated with species richness in the dry season. We also found that LCBD variation was explained by ecoregion in the dry season, but in the rainy season both environmental and spatial global models were non-significant. Our results reinforce the compositional uniqueness of the Cerrado ecoregion when compared to the other ecoregions in both seasons, which may be caused by the presence of species with different requirements that tolerate different conditions caused by seasonality.	[Ceron, Karoline; Santana, Diego J.; Valente-Neto, Francisco] Univ Fed Mato Grosso do Sul, Programa Posgrad Ecol & Conservacao, Inst Biociencias, Campo Grande, MS, Brazil; [Santana, Diego J.] Univ Fed Mato Grosso do Sul, Inst Biociencias, Campo Grande, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul	Ceron, K (corresponding author), Univ Fed Mato Grosso do Sul, Programa Posgrad Ecol & Conservacao, Inst Biociencias, Campo Grande, MS, Brazil.	adenomera@gmail.com	Neto, Francisco Valente/M-3991-2014; Ceron, Karoline/N-1788-2019; Santana, Diego/G-5257-2012	Neto, Francisco Valente/0000-0002-5298-3753; Ceron, Karoline/0000-0003-2354-3756; Santana, Diego/0000-0002-8789-3061	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [311492/2017-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88882.317337/201901]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	KC is grateful to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001 for her scholarship. DJS thanks CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) for his research fellowship (311492/2017-7). FVN was supported by grant number 88882.317337/201901, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001.	Almeida-Gomes M, 2016, BIOTROPICA, V48, P365, DOI 10.1111/btp.12285; Almeida-Gomes M, 2016, BIOL CONSERV, V195, P89, DOI 10.1016/j.biocon.2015.12.025; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Cantidio LS, 2019, ECOGRAPHY, V42, P1887, DOI 10.1111/ecog.04564; Castro E, 2019, HYDROBIOLOGIA, V842, P219, DOI 10.1007/s10750-019-04037-8; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Cordova-Tapia F, 2018, ECOL FRESHW FISH, V27, P522, DOI 10.1111/eff.12366; da Silva FR, 2014, PLOS ONE, V9; da Silva PG, 2018, DIVERS DISTRIB, V24, P1674, DOI 10.1111/ddi.12785; Delatorre M, 2015, FRESHWATER BIOL, V60, P2197, DOI 10.1111/fwb.12648; Dinerstein E., 1995, CONSERVATION ASSESSM; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Dray S, 2009, PACKFOR FORWARD SELE, P46; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Duellman W., 1986, BIOL AMPHIBIANS; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Giaretta Ariovaldo A., 2004, Herpetozoa, V16, P115; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Harris MB, 2005, CONSERV BIOL, V19, P714, DOI 10.1111/j.1523-1739.2005.00708.x; He K, 2009, ECOL INFORM, V4, P93, DOI 10.1016/j.ecoinf.2009.01.003; HEDGES SB, 2008, ZOOTAXA 0331, P1; Heino J, 2017, OECOLOGIA, V183, P151, DOI 10.1007/s00442-016-3754-7; Hijmans R. J., 2016, R PACKAGE VERSION, V2, P5; Kong H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174582; Krasnov BR, 2019, PARASITOLOGY, V146, P653, DOI 10.1017/S0031182018001944; Landeiro VL, 2018, DIVERS DISTRIB, V24, P966, DOI 10.1111/ddi.12734; Leao-Pires TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196066; Legendre P, 2019, FOR ECOSYST, V6, DOI 10.1186/s40663-019-0164-4; Legendre P, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2728; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lion MB, 2014, DIVERS DISTRIB, V20, P1245, DOI 10.1111/ddi.12228; Michelin G, 2020, ANIM BIODIV CONSERV, V43, P169, DOI 10.32800/abc.2020.43.0169; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Mouquet N, 2003, AM NAT, V162, P544, DOI 10.1086/378857; Mouquet N, 2013, ECOL LETT, V16, P1, DOI 10.1111/ele.12014; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nori J, 2016, DIVERS DISTRIB, V22, P1212, DOI 10.1111/ddi.12497; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Oliveira PS, 2002, CERRADOS BRAZIL ECOL; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pennington RT, 2009, ANNU REV ECOL EVOL S, V40, P437, DOI 10.1146/annurev.ecolsys.110308.120327; Pott Arnildo, 2004, Wetlands Ecology and Management, V12, P547, DOI 10.1007/s11273-005-1754-1; Prado DE, 1992, NAT DYN SAVANNA BOUN, V5; Qiao XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17043; R Core Team, 2021, R LANGUAGE ENV STAT; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ruhi A, 2017, CONSERV BIOL, V31, P1459, DOI 10.1111/cobi.12906; Santana HS, 2015, BRAZ J BIOL, V75, P144, DOI 10.1590/1519-6984.09213; Scarabotti PA, 2011, ECOL FRESHW FISH, V20, P605, DOI 10.1111/j.1600-0633.2011.00510.x; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Scott Jr N. J., 1994, MEASURING MONITORING, P118; Silva FR da, 2007, BIOTA NEOTROPICA, V7; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Spichiger R, 2004, J BIOGEOGR, V31, P1489, DOI 10.1111/j.1365-2699.2004.01071.x; Strassburg BBN, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0099; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Tolonen KE, 2018, AQUAT ECOL, V52, P17, DOI 10.1007/s10452-017-9642-3; Tolonen KE, 2017, FRESHWATER BIOL, V62, P1, DOI 10.1111/fwb.12832; Tonkin JD, 2016, FRESHWATER BIOL, V61, P607, DOI 10.1111/fwb.12728; Vad CF, 2017, BIOL CONSERV, V209, P253, DOI 10.1016/j.biocon.2017.02.025; Valdujo Paula Hanna, 2012, South American Journal of Herpetology, V7, P63; Valente-Neto F, 2020, HYDROBIOLOGIA, V847, P617, DOI 10.1007/s10750-019-04125-9; Valenzuela-Sanchez A, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0132-y; Varpe O, 2017, INTEGR COMP BIOL, V57, P943, DOI 10.1093/icb/icx123; Wells K. D., 2007, ECOLOGY BEHAV AMPHIB, DOI [10. 7208/chicago/9780226893334. 001. 0001, DOI 10.7208/CHICAG0/9780226893334.001.0001, DOI 10.7208/CHICAGO/9780226893334.001.0001]; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Zak MR, 2004, BIOL CONSERV, V120, P589, DOI 10.1016/j.biocon.2004.03.034; Zhang M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00161; Zimmerman BL, 1994, AUDIO STRIP TRANSECT, P92	81	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239874	10.1371/journal.pone.0239874	http://dx.doi.org/10.1371/journal.pone.0239874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970785	gold, Green Published			2022-12-26	WOS:000576265600102
J	Gabrieli, D; Schumm, SN; Vigilante, NF; Parvesse, B; Meaney, DF				Gabrieli, David; Schumm, Samantha N.; Vigilante, Nicholas F.; Parvesse, Brandon; Meaney, David F.			Neurodegeneration exposes firing rate dependent effects on oscillation dynamics in computational neural networks	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; DIFFUSE AXONAL INJURY; VISUAL-CORTEX; FUNCTIONAL CONNECTIVITY; COGNITIVE IMPAIRMENT; SYNAPTIC PLASTICITY; RECEPTIVE-FIELD; MODEL; INFLAMMATION	Traumatic brain injury (TBI) can lead to neurodegeneration in the injured circuitry, either through primary structural damage to the neuron or secondary effects that disrupt key cellular processes. Moreover, traumatic injuries can preferentially impact subpopulations of neurons, but the functional network effects of these targeted degeneration profiles remain unclear. Although isolating the consequences of complex injury dynamics and long-term recovery of the circuit can be difficult to control experimentally, computational networks can be a powerful tool to analyze the consequences of injury. Here, we use the Izhikevich spiking neuron model to create networks representative of cortical tissue. After an initial settling period with spike-timing-dependent plasticity (STDP), networks developed rhythmic oscillations similar to those seenin vivo. As neurons were sequentially removed from the network, population activity rate and oscillation dynamics were significantly reduced. In a successive period of network restructuring with STDP, network activity levels returned to baseline for some injury levels and oscillation dynamics significantly improved. We next explored the role that specific neurons have in the creation and termination of oscillation dynamics. We determined that oscillations initiate from activation of low firing rate neurons with limited structural inputs. To terminate oscillations, high activity excitatory neurons with strong input connectivity activate downstream inhibitory circuitry. Finally, we confirm the excitatory neuron population role through targeted neurodegeneration. These results suggest targeted neurodegeneration can play a key role in the oscillation dynamics after injury.	[Gabrieli, David; Schumm, Samantha N.; Vigilante, Nicholas F.; Parvesse, Brandon; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Meaney, David F.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Meaney, DF (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Meaney, DF (corresponding author), Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA.	dmeaney@seas.upenn.edu		Schumm, Samantha/0000-0003-4399-5362; Meaney, David/0000-0002-0954-4122; Vigilante, Nicholas/0000-0003-0540-4816	Paul G. Allen Family Foundation; National Institutes of Health [RO1 NS088176]	Paul G. Allen Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Paul G. Allen Family Foundation: received by DM, https://www.pgafamilyfoundation.org/National Institutes of Health, received by DM, grant number RO1 NS088176, https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; [Anonymous], 2008, DTSCH ARZTEBL, V105, pC301; [Anonymous], 2017, EUR J TRANSL MYOL, V27, p7X; [Anonymous], 2017, MORBIDITY MORTALITY, V66, P1; [Anonymous], 2013, NEUROLOGY S3, V80, pS1, DOI [10.1212/WNL.06013e3182872e90, DOI 10.1212/WNL.06013E3182872E90]; Atlan LS, 2019, J NEUROTRAUM, V36, P2558, DOI 10.1089/neu.2017.5574; Barth BB, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9090428; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bozer ALH, 2017, J INTEGR NEUROSCI, V16, P107, DOI 10.3233/JIN-170011; Brette R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004114; Briggs Farran, 2005, Thalamus & Related Systems, V3, P133, DOI 10.1017/S1472928807000131; Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Cavdar S, 2014, NEUROSCI BULL, V30, P451, DOI 10.1007/s12264-013-1402-3; Clayton MS, 2015, TRENDS COGN SCI, V19, P188, DOI 10.1016/j.tics.2015.02.004; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Crone JS, 2018, J NEUROSCI RES, V96, P671, DOI 10.1002/jnr.24115; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Dayan P, 2001, COMPUTATIONAL NEUROS; Effenberger F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004420; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; FERSTER D, 1992, J NEUROSCI, V12, P1262; Folweiler KA, 2018, J NEUROTRAUM, V35, P1304, DOI 10.1089/neu.2017.5350; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Gilbert N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197419; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Hanslmayr S, 2016, TRENDS NEUROSCI, V39, P16, DOI 10.1016/j.tins.2015.11.004; Hausser M, 2001, CURR BIOL, V11, pR10, DOI 10.1016/S0960-9822(00)00034-8; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2004, CEREB CORTEX, V14, P933, DOI 10.1093/cercor/bhh053; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lu JT, 2007, J NEUROSCI, V27, P9711, DOI 10.1523/JNEUROSCI.2513-07.2007; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Maller JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37905-9; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Nicolelis M, 2007, METHODS NEURAL ENSEM, DOI DOI 10.1201/9781420006414; OTIS TS, 1992, J NEUROPHYSIOL, V67, P227, DOI 10.1152/jn.1992.67.1.227; Paterno R, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0762-x; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Pena RFO, 2018, J COMPUT NEUROSCI, V45, P1, DOI 10.1007/s10827-018-0688-6; Radnikow G, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00001; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rodrigues FA, 2016, PHYS REP, V610, P1, DOI 10.1016/j.physrep.2015.10.008; Roeper J, 2013, TRENDS NEUROSCI, V36, P336, DOI 10.1016/j.tins.2013.03.003; Saigal Rajiv, 2014, Neurosurgery, V75 Suppl 4, pS149, DOI 10.1227/NEU.0000000000000497; Schumm SN, 2020, FRONT COMPUT NEUROSC, V14, DOI 10.3389/fncom.2020.00018; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00073, 10.3389/fneur.2015.00240]; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Soriano J, 2008, P NATL ACAD SCI USA, V105, P13758, DOI 10.1073/pnas.0707492105; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stephens JA, 2018, DEV NEUROREHABIL, V21, P423, DOI 10.1080/17518423.2017.1338777; Stoelzel CR, 2008, J NEUROSCI, V28, P5018, DOI 10.1523/JNEUROSCI.4726-07.2008; SWADLOW HA, 1985, J NEUROPHYSIOL, V54, P168, DOI 10.1152/jn.1985.54.1.168; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Tzounopoulos T, 2007, NEURON, V54, P291, DOI 10.1016/j.neuron.2007.03.026; van der Horn HJ, 2016, BRAIN IMAGING BEHAV, V10, P1243, DOI 10.1007/s11682-015-9489-y; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Volman V, 2011, P NATL ACAD SCI USA, V108, P15402, DOI 10.1073/pnas.1112066108; Wang WH, 2018, J NEUROTRAUM, V35, P2306, DOI 10.1089/neu.2018.5688; Wiles L, 2017, SCI REP-UK, V7, DOI 10.1038/srep44006; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; WOODSON W, 1989, J COMP NEUROL, V280, P254, DOI 10.1002/cne.902800207; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	95	6	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0234749	10.1371/journal.pone.0234749	http://dx.doi.org/10.1371/journal.pone.0234749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966291	Green Submitted, gold, Green Published			2022-12-26	WOS:000575688700055
J	Stockly, OR; Wolfe, AE; Carrougher, GJ; Stewart, BT; Gibran, NS; Wolf, SE; McMullen, K; Bamer, AM; Kowalske, K; Cioffi, WG; Zafonte, R; Schneider, JC; Ryan, CM				Stockly, Olivia R.; Wolfe, Audrey E.; Carrougher, Gretchen J.; Stewart, Barclay T.; Gibran, Nicole S.; Wolf, Steven E.; McMullen, Kara; Bamer, Alyssa M.; Kowalske, Karen; Cioffi, William G.; Zafonte, Ross; Schneider, Jeffrey C.; Ryan, Colleen M.			Inhalation injury is associated with long-term employment outcomes in the burn population: Findings from a cross-sectional examination of the Burn Model System National Database	PLOS ONE			English	Article							QUALITY-OF-LIFE; SMOKE-INHALATION; HEALTH; SURVIVORS; BRONCHIECTASIS; SATISFACTION; PNEUMONIA; MORTALITY; DIAGNOSIS; WORK	Introduction Inhalation injuries carry significant acute care burden including prolonged ventilator days and length of stay. However, few studies have examined post-acute outcomes of inhalation injury survivors. This study compares the long-term outcomes of burn survivors with and without inhalation injury. Methods Data collected by the Burn Model System National Database from 1993 to 2019 were analyzed. Demographic and clinical characteristics for adult burn survivors with and without inhalation injury were examined. Outcomes included employment status, Short Form-12/Veterans Rand-12 Physical Composite Score (SF-12/VR-12 PCS), Short Form-12/Veterans Rand-12 Mental Composite Score (SF-12/VR-12 MCS), and Satisfaction With Life Scale (SWLS) at 24 months post-injury. Regression models were used to assess the impacts of sociodemographic and clinical covariates on long-term outcome measures. All models controlled for demographic and clinical characteristics. Results Data from 1,871 individuals were analyzed (208 with inhalation injury; 1,663 without inhalation injury). The inhalation injury population had a median age of 40.1 years, 68.8% were male, and 69% were White, non-Hispanic. Individuals that sustained an inhalation injury had larger burn size, more operations, and longer lengths of hospital stay (p<0.001). Individuals with inhalation injury were less likely to be employed at 24 months post-injury compared to survivors without inhalation injury (OR = 0.63, p = 0.028). There were no significant differences in PCS, MCS, or SWLS scores between groups in adjusted regression analyses. Conclusions Burn survivors with inhalation injury were significantly less likely to be employed at 24 months post-injury compared to survivors without inhalation injury. However, other health-related quality of life outcomes were similar between groups. This study suggests distinct long-term outcomes in adult burn survivors with inhalation injury which may inform future resource allocation and treatment paradigms.	[Stockly, Olivia R.; Wolfe, Audrey E.; Zafonte, Ross; Schneider, Jeffrey C.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA; [Carrougher, Gretchen J.; Stewart, Barclay T.; Gibran, Nicole S.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Stewart, Barclay T.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Wolf, Steven E.] Univ Texas Med Branch, Dept Surg, Galveston, TX 77555 USA; [McMullen, Kara; Bamer, Alyssa M.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Kowalske, Karen] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Cioffi, William G.] Brown Univ, Rhode Isl Hosp, Dept Surg, Providence, RI 02903 USA; [Ryan, Colleen M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA; [Ryan, Colleen M.] Shriners Hosp Children Boston, Boston, MA USA	Harvard University; Spaulding Rehabilitation Hospital; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Medical Branch Galveston; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Schneider, JC (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA 02129 USA.	jcschneider@partners.org	Schneider, Jeffrey/AAO-2126-2020	Stewart, Barclay/0000-0002-8099-9218; Wolf, Steven/0000-0003-2972-3440	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): NIDILRR grant [90DPBU0001]	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): NIDILRR grant(United States Department of Health & Human Services)	The contents of this manuscript were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR): NIDILRR grant number 90DPBU0001. This grant was awarded to J.C.S. NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS and one should not assume endorsement by the Federal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Burn Association, 2017, NAT BURN REP 2017 UP; Amtmann D, 2020, ARCH PHYS MED REHAB, V101, pS63, DOI 10.1016/j.apmr.2017.09.119; Amtmann D, 2019, ASSESSMENT, V26, P695, DOI 10.1177/1073191117693921; Barrett LW, 2019, BURNS TRAUMA, V7, DOI 10.1186/s41038-019-0163-2; Bienvenu OJ, 2018, INTENS CARE MED, V44, P38, DOI 10.1007/s00134-017-5009-4; Bourbeau J, 1996, EUR RESPIR J, V9, P1470, DOI 10.1183/09031936.96.09071470; Carrougher GJ, 2020, ARCH PHYS MED REHAB, V101, pS71, DOI 10.1016/j.apmr.2019.09.009; Chacko J, 2012, INDIAN J CRIT CARE M, V16, P93, DOI 10.4103/0972-5229.99120; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dries DJ, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-31; Dyster-Aas J, 2004, BURNS, V30, P839, DOI 10.1016/j.burns.2004.05.010; Edelman DA, 2006, J BURN CARE RES, V27, P848, DOI 10.1097/01.BCR.0000245493.26814.CE; Espinoza LF, 2019, ARCH PHYS MED REHAB, V100, P2015, DOI 10.1016/j.apmr.2019.06.007; Fauerbach JA, 2001, J BURN CARE REHABIL, V22, P26, DOI 10.1097/00004630-200101000-00007; Fauerbach JA, 2007, J BURN CARE RES, V28, P587, DOI 10.1097/BCR.0B013E318093E470; FOGARTY PW, 1991, THORAX, V46, P914, DOI 10.1136/thx.46.12.914; Friedstat JS, 2017, CLIN PLAST SURG, V44, P911, DOI 10.1016/j.cps.2017.05.023; Gayat E, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1922-8; Giannoni-Pastor A, 2016, J BURN CARE RES, V37, pE79, DOI 10.1097/BCR.0000000000000226; Gornet MF, 2018, SPINE J, V18, P1292, DOI 10.1016/j.spinee.2018.02.023; Goverman J, 2016, BURNS, V42, P1067, DOI 10.1016/j.burns.2016.01.018; Goverman J, 2017, J BURN CARE RES, V38, pE240, DOI 10.1097/BCR.0000000000000361; Hall JP, 2013, DISABIL HEALTH J, V6, P100, DOI 10.1016/j.dhjo.2012.11.001; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Holavanahalli RK, 2016, J BURN CARE RES, V37, P243, DOI 10.1097/BCR.0000000000000257; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Huzar TF, 2011, EXPERT REV RESP MED, V5, P663, DOI [10.1586/ers.11.61, 10.1586/ERS.11.61]; JIN RL, 1995, CAN MED ASSOC J, V153, P529; Jones SW, 2017, CLIN PLAST SURG, V44, P505, DOI 10.1016/j.cps.2017.02.009; Kadri SS, 2016, CHEST, V150, P1260, DOI 10.1016/j.chest.2016.06.008; Kelter BM, 2020, BURNS, V46, P493, DOI 10.1016/j.burns.2019.10.017; Kim Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185195; Konig C, 2019, QUAL LIFE RES, V28, P637, DOI 10.1007/s11136-018-2028-8; Lezotte DC, 2007, ARCH PHYS MED REHAB, V88, pS7, DOI 10.1016/j.apmr.2007.09.011; lqbal SU, VETERANS RAND 12 ITE; Mason ST, 2012, J BURN CARE RES, V33, P101, DOI 10.1097/BCR.0b013e3182374439; National Academies of Science Engineering and Medicine, 2019, IMPL CAL WILDF HLTH; Palmieri TL, 2009, J BURN CARE RES, V30, P201, DOI 10.1097/BCR.0b013e3181923e93; Rosenberg M, 2015, BURNS, V41, P721, DOI 10.1016/j.burns.2015.01.013; Sasannejad C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2626-z; Schneider JC, 2011, J BURN CARE RES, V32, P294, DOI 10.1097/BCR.0b013e31820aaf56; Sheridan RL, 2016, NEW ENGL J MED, V375, P464, DOI 10.1056/NEJMra1601128; SHIMAZU T, 1987, ANN SURG, V206, P89, DOI 10.1097/00000658-198707000-00014; SHIRANI KZ, 1987, ANN SURG, V205, P82, DOI 10.1097/00000658-198701000-00015; SLUTZKER AD, 1989, CHEST, V95, P1349, DOI 10.1378/chest.95.6.1349; Stergiou-Kita M, 2014, J OCCUP REHABIL, V24, P173, DOI 10.1007/s10926-013-9463-8; TASAKA S, 1995, RESPIRATION, V62, P40; Toon MH, 2010, CRIT CARE RESUSC, V12, P53; Walker PF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1077-4; Ware J, 2000, LINCOLN; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weldring T, 2013, HEALTH SERV INSIGHTS, V6, P61, DOI 10.4137/HSI.S11093; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Wise B, 2015, CAN FAM PHYSICIAN, V61, P47; Witt CE, 2017, J AM COLL SURGEONS, V225, pS56, DOI 10.1016/j.jamcollsurg.2017.07.111; Woodson LC, 2009, J BURN CARE RES, V30, P143, DOI 10.1097/BCR.0b013e3181923b71	56	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239556	10.1371/journal.pone.0239556	http://dx.doi.org/10.1371/journal.pone.0239556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966317	Green Published, gold			2022-12-26	WOS:000575688700060
J	Crandall, SG; Gold, KM; Jimenez-Gasco, MD; Filgueiras, CC; Willett, DS				Crandall, Sharifa G.; Gold, Kaitlin M.; Jimenez-Gasco, Maria del Mar; Filgueiras, Camila C.; Willett, Denis S.			A multi-omics approach to solving problems in plant disease ecology	PLOS ONE			English	Review							LEAF OPTICAL-PROPERTIES; SALICYLIC-ACID; IMAGING SPECTROSCOPY; FUNCTIONAL GENOMICS; HYPERSPECTRAL SENSORS; METABOLOMICS; RESISTANCE; EVOLUTION; PHYTOPATHOLOGY; CLASSIFICATION	The swift rise of omics-approaches allows for investigating microbial diversity and plant-microbe interactions across diverse ecological communities and spatio-temporal scales. The environment, however, is rapidly changing. The introduction of invasive species and the effects of climate change have particular impact on emerging plant diseases and managing current epidemics. It is critical, therefore, to take a holistic approach to understand how and why pathogenesis occurs in order to effectively manage for diseases given the synergies of changing environmental conditions. A multi-omics approach allows for a detailed picture of plant-microbial interactions and can ultimately allow us to build predictive models for how microbes and plants will respond to stress under environmental change. This article is designed as a primer for those interested in integrating -omic approaches into their plant disease research. We review -omics technologies salient to pathology including metabolomics, genomics, metagenomics, volatilomics, and spectranomics, and present cases where multi-omics have been successfully used for plant disease ecology. We then discuss additional limitations and pitfalls to be wary of prior to conducting an integrated research project as well as provide information about promising future directions.	[Crandall, Sharifa G.; Jimenez-Gasco, Maria del Mar] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Gold, Kaitlin M.] Cornell Univ, Plant Pathol & Plant Microbe Biol Sect, Cornell AgriTech, Geneva, NY USA; [Filgueiras, Camila C.; Willett, Denis S.] Cornell Univ, Cornell AgriTech, Appl Chem Ecol Technol, Geneva, NY 14456 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; Cornell University	Willett, DS (corresponding author), Cornell Univ, Cornell AgriTech, Appl Chem Ecol Technol, Geneva, NY 14456 USA.	deniswillett@cornell.edu	Jimenez-Gasco, Maria del Mar/A-9701-2011	Jimenez-Gasco, Maria del Mar/0000-0001-7329-0211	Microbiome Center at Huck Institutes of Life Sciences at The Pennsylvania State University	Microbiome Center at Huck Institutes of Life Sciences at The Pennsylvania State University	We would like to thank the Microbiome Center at Huck Institutes of Life Sciences at The Pennsylvania State University for providing resources and support for this article. Bo Holladay (yadalloh@gmail.com) provided artwork for this project.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Agrios G. N., 2005, PLANT PATHOL, V5th, P79; Agrios GN., 2009, PLANT PATHOGENS DIS; Ahmad I, 2020, BIOL CONTROL, V144, DOI 10.1016/j.biocontrol.2019.104167; Ali A, 2018, PHYSIOL MOL PLANT P, V104, P15, DOI 10.1016/j.pmpp.2018.08.001; Allwood JW, 2008, PHYSIOL PLANTARUM, V132, P117, DOI 10.1111/j.1399-3054.2007.01001.x; [Anonymous], 2012, NUCL ACIDS RES, V41, pD43; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2011, J NATL COMPR CANC NE, V9; Arens N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01377; Asner GP, 2009, FRONT ECOL ENVIRON, V7, P269, DOI 10.1890/070152; Asner GP, 2016, GLOB ECOL CONSERV, V8, P212, DOI 10.1016/j.gecco.2016.09.010; Aylward FO, 2017, P NATL ACAD SCI USA, V114, P11446, DOI 10.1073/pnas.1714821114; Bailly A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01638; Baldwin IT, 2006, SCIENCE, V311, P812, DOI 10.1126/science.1118446; Barone Amalia, 2008, Int J Plant Genomics, V2008, P820274, DOI 10.1155/2008/820274; Bartels B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00471; Barth A, 2000, PROG BIOPHYS MOL BIO, V74, P141, DOI 10.1016/S0079-6107(00)00021-3; Bever JD, 2015, ANNU REV ECOL EVOL S, V46, P305, DOI 10.1146/annurev-ecolsys-112414-054306; Bezemer TM, 2005, TRENDS ECOL EVOL, V20, P617, DOI 10.1016/j.tree.2005.08.006; Bicchi Carlo, 2012, Methods Mol Biol, V918, P289, DOI 10.1007/978-1-61779-995-2_15; Bienkowski D, 2019, COMPUT ELECTRON AGR, V167, DOI 10.1016/j.compag.2019.105056; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; Bonanomi G, 2018, ANNU REV PHYTOPATHOL, V56, P1, DOI 10.1146/annurev-phyto-080615-100046; BURDON JJ, 1991, AUST J ECOL, V16, P423, DOI 10.1111/j.1442-9993.1991.tb01072.x; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Caarls L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00170; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Carter GA, 2001, AM J BOT, V88, P677, DOI 10.2307/2657068; Castrillo G, 2017, NATURE, V543, P513, DOI 10.1038/nature21417; Ceresini PC, 2019, MOL PLANT PATHOL, V20, P155, DOI 10.1111/mpp.12747; Chandrashekara C., 2012, ECO FRIENDLY INNOVAT, P241, DOI DOI 10.13140/2.1.5173.7608; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Couture JJ, 2018, PLANT DIS, V102, P2233, DOI 10.1094/PDIS-01-18-0054-RE; Couture JJ, 2016, METHODS ECOL EVOL, V7, P1402, DOI 10.1111/2041-210X.12596; Cumeras R, 2018, VOLATILE ORGANIC COM, P23; CURRAN PJ, 1989, REMOTE SENS ENVIRON, V30, P271, DOI 10.1016/0034-4257(89)90069-2; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; de Vries S, 2020, NEW PHYTOL, V226, P1256, DOI 10.1111/nph.16458; Dell B., 1989, JARRAH FOREST, P67; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dunn WB, 2013, METABOLOMICS, V9, pS44, DOI 10.1007/s11306-012-0434-4; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fadiji AE, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00467; Fallon B, 2020, TREE PHYSIOL, V40, P377, DOI 10.1093/treephys/tpaa005; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Filgueiras CC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235851; Filgueiras CC, 2017, BIOCONTROL SCI TECHN, V27, P833, DOI 10.1080/09583157.2017.1349874; Filgueiras CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep36484; Filgueiras CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154712; Fisher JB, 2016, GLOBAL CHANGE BIOL, V22, P2596, DOI 10.1111/gcb.13264; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Friesen Nikolai, 2006, Aliso, V22, P372; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Galla SJ, 2016, MOL ECOL, V25, P5267, DOI 10.1111/mec.13837; Gao BC, 1996, REMOTE SENS ENVIRON, V58, P257, DOI 10.1016/S0034-4257(96)00067-3; Ge YF, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0450-8; Gilbert GS, 2010, EVOL APPL, V3, P144, DOI 10.1111/j.1752-4571.2009.00107.x; Gillon D, 1999, OECOLOGIA, V118, P173, DOI 10.1007/s004420050716; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gold KM, 2020, PHYTOPATHOLOGY, V110, P29; Gold K. M., 2019, U.S. Patent App., Patent No. [16/251,415, 16251415]; Gold KM, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12020286; Gold KM, 2019, PLANT SCI; Griffiths WJ, 2010, ANGEW CHEM INT EDIT, V49, P5426, DOI 10.1002/anie.200905579; Grunwald S., 2016, ENV SOIL LANDSCAPE M; Hall R, 2002, PLANT METABOLOMICS M; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; HANDELSMAN J, 2007, COMMITTEE METAGENOMI; Harrison JG, 2020, ENVIRON MICROBIOL, V22, P2107, DOI 10.1111/1462-2920.14968; HATFIELD JL, 1993, CROP PROT, V12, P403, DOI 10.1016/0261-2194(93)90001-Y; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Hennessy Rosanna C, 2017, BMC Res Notes, V10, P376, DOI 10.1186/s13104-017-2704-8; Hiddink GA, 2010, SUSTAIN AGR REV, V4, P119, DOI 10.1007/978-90-481-8741-6_5; Hieter P, 1997, SCIENCE, V278, P601, DOI 10.1126/science.278.5338.601; Holopainen JK, 2012, ADV EXP MED BIOL, V739, P17, DOI 10.1007/978-1-4614-1704-0_2; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Innes R, 2018, CELL, V173, P1314, DOI 10.1016/j.cell.2018.05.034; Insam H, 2010, BIOL FERT SOILS, V46, P199, DOI 10.1007/s00374-010-0442-3; Irie M, 2014, METABOLOMICS, V10, P473, DOI 10.1007/s11306-013-0588-8; JACKSON RD, 1986, ANNU REV PHYTOPATHOL, V24, P265, DOI 10.1146/annurev.py.24.090186.001405; Jacquemoud S, 1995, REMOTE SENS ENVIRON, V54, P180, DOI 10.1016/0034-4257(95)00170-0; Jeger MJ, 2014, EUR J PLANT PATHOL, V138, P513, DOI 10.1007/s10658-013-0325-1; Jia Q, 2020, SYMBIOSIS, V80, P103, DOI 10.1007/s13199-019-00663-x; Johnson CH, 2016, NAT REV MOL CELL BIO, V17, P451, DOI 10.1038/nrm.2016.25; Johnson SR, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00022; Jud W, 2018, PLANT METHODS, V14, DOI 10.1186/s13007-018-0378-4; Khare E, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02732; Klessig DF, 2018, MOL PLANT MICROBE IN, V31, P871, DOI [10.1094/MPMI-03-18-0067-CR, 10.1094/mpmi-03-18-0067-cr]; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kohl J, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00845; Kokaly RF, 2015, INT J APPL EARTH OBS, V43, P55, DOI 10.1016/j.jag.2015.01.010; Kokaly RF, 2009, REMOTE SENS ENVIRON, V113, pS78, DOI 10.1016/j.rse.2008.10.018; Kumar D., 2015, ELUCIDATION ABIOTIC, P329; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Kusajima M, 2018, BIOSCI BIOTECH BIOCH, V82, P1522, DOI 10.1080/09168451.2018.1480350; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin RP, 2015, ANNU REV PHYTOPATHOL, V53, P199, DOI 10.1146/annurev-phyto-080614-120357; Li Y, 2013, PHYSIOL MOL PLANT P, V83, P51, DOI 10.1016/j.pmpp.2013.05.001; Lindeberg M, 2012, ANNU REV PHYTOPATHOL, V50, P111, DOI 10.1146/annurev-phyto-081211-173022; Liu XJ, 2017, TRENDS BIOCHEM SCI, V42, P274, DOI 10.1016/j.tibs.2017.01.004; Lu H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00238; Lu W, 2008, J CHROMATOGR B, V871, P236, DOI 10.1016/j.jchromb.2008.04.031; Ma LJ, 2013, ANNU REV MICROBIOL, V67, P399, DOI 10.1146/annurev-micro-092412-155650; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mahdi JG, 2006, CELL PROLIFERAT, V39, P147, DOI 10.1111/j.1365-2184.2006.00377.x; Mahlein AK, 2018, ANNU REV PHYTOPATHOL, V56, P535, DOI 10.1146/annurev-phyto-080417-050100; Mahlein AK, 2019, CURR OPIN PLANT BIOL, V50, P156, DOI 10.1016/j.pbi.2019.06.007; Mahlein AK, 2016, PLANT DIS, V100, P241, DOI 10.1094/PDIS-03-15-0340-FE; Majchrzak T, 2020, TRENDS PLANT SCI, V25, P302, DOI 10.1016/j.tplants.2019.12.005; Martins RC, 2019, EPIA C ART INT, P156; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McKusick VA, 1987, NEW DISCIPLINE NEW N; Meacham-Hensold K, 2020, J EXP BOT, V71, P2312, DOI 10.1093/jxb/eraa068; Meacham-Hensold K, 2019, REMOTE SENS ENVIRON, V231, DOI 10.1016/j.rse.2019.04.029; Meireles JE, 2020, NEW PHYTOL, V228, P485, DOI 10.1111/nph.16771; Mhlongo MI, 2017, BIOCHEM BIOPH RES CO, V482, P1498, DOI 10.1016/j.bbrc.2016.12.063; Mhlongo MI, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00112; Moller M, 2017, NAT REV MICROBIOL, V15, P756, DOI 10.1038/nrmicro.2017.76; NAGARAJAN S, 1984, PHYTOPATHOLOGY, V74, P585, DOI 10.1094/Phyto-74-585; NCBI Resource Coordinators, 2013, NUCL ACIDS RES, V42, pD7; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Ni J, 2010, PROC SPIE, V7752, DOI 10.1117/12.888400; NILSSON HE, 1995, CAN J PLANT PATHOL, V17, P154, DOI 10.1080/07060669509500707; Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022; Nobrega MA, 2004, J PHYSIOL-LONDON, V554, P31, DOI 10.1113/jphysiol.2003.050948; Noctor G, 2015, PHYTOCHEMISTRY, V112, P33, DOI 10.1016/j.phytochem.2014.09.002; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Oliver DJ, 2002, METAB ENG, V4, P98, DOI 10.1006/mben.2001.0212; OREN R, 1986, OECOLOGIA, V70, P187, DOI 10.1007/BF00379238; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Parthasarathy S, 2017, ANN PHYTOMEDICINE, V6, P55, DOI 10.21276/ap.2017.6.2.4; Pascale A, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01741; Poppe S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005055; Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935; RASKIN I, 1992, ANNU REV PLANT PHYS, V43, P439, DOI 10.1146/annurev.pp.43.060192.002255; Rizzo DM, 2002, PLANT DIS, V86, P205, DOI 10.1094/PDIS.2002.86.3.205; Roberts Lee D, 2012, Curr Protoc Mol Biol, VChapter 30, DOI 10.1002/0471142727.mb3002s98; Rosenkranz M, 2001, ELS, P1; Rumpf T, 2010, COMPUT ELECTRON AGR, V74, P91, DOI 10.1016/j.compag.2010.06.009; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211; Sarrocco S, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00107; Sauter H, 1991, METABOLIC PROFILING; Schlatter D, 2017, PHYTOPATHOLOGY, V107, P1284, DOI 10.1094/PHYTO-03-17-0111-RVW; Schrimpe-Rutledge AC, 2016, J AM SOC MASS SPECTR, V27, P1897, DOI 10.1007/s13361-016-1469-y; Sebastien M, 2015, BIOL CONTROL, V89, P98, DOI 10.1016/j.biocontrol.2015.06.003; Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304; Serbin SP, 2019, NEW PHYTOL, V224, P1557, DOI 10.1111/nph.16123; Serbin SP, 2012, J EXP BOT, V63, P489, DOI 10.1093/jxb/err294; Sheibani-Tezerji R, 2015, MBIO, V6, DOI 10.1128/mBio.00621-15; Singh A, 2015, ECOL APPL, V25, P2180, DOI [10.1890/14-2098.1.sm, 10.1890/14-2098.1]; Solden L, 2016, CURR OPIN MICROBIOL, V31, P217, DOI 10.1016/j.mib.2016.04.020; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Stukenbrock EH, 2011, GENOME RES, V21, P2157, DOI 10.1101/gr.118851.110; Sud M, 2016, NUCLEIC ACIDS RES, V44, pD463, DOI 10.1093/nar/gkv1042; Sudisha J, 2012, PROG BIOL CONTROL, V12, P379, DOI 10.1007/978-94-007-1933-0_17; Sumner LW, 2003, PHYTOCHEMISTRY, V62, P817, DOI 10.1016/S0031-9422(02)00708-2; Sumner LW, 2018, ANN PLANT REV ONLINE, P343; Sundin GW, 2016, PHYTOPATHOLOGY, V106, P1071, DOI 10.1094/PHYTO-03-16-0117-FI; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Townsend PA, 2003, IEEE T GEOSCI REMOTE, V41, P1347, DOI 10.1109/TGRS.2003.813205; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Ustin SL, 2004, BIOSCIENCE, V54, P523, DOI 10.1641/0006-3568(2004)054[0523:UISTSE]2.0.CO;2; Ustin SL, 2010, NEW PHYTOL, V186, P795, DOI 10.1111/j.1469-8137.2010.03284.x; Valent B, 2019, MOL PLANT PATHOL, V20, P173, DOI 10.1111/mpp.12778; van Bruggen AHC, 2016, PEST MANAG SCI, V72, P30, DOI 10.1002/ps.4145; van Dam NM, 2016, TRENDS PLANT SCI, V21, P256, DOI 10.1016/j.tplants.2016.01.008; VanInsberghe D, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0253; Vergara Diaz O, 2019, HIGH THROUGHPUT PHEN; Vukicevich E, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0385-7; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Ward JL, 2007, FEBS J, V274, P1126, DOI 10.1111/j.1742-4658.2007.05675.x; Weissenbach J, 2016, CR BIOL, V339, P231, DOI 10.1016/j.crvi.2016.05.002; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wu D, 2008, T ASABE, V51, P1133, DOI 10.13031/2013.24504; Xie CQ, 2017, COMPUT ELECTRON AGR, V135, P154, DOI 10.1016/j.compag.2016.12.015; Xu GY, 2017, NATURE, V545, P491, DOI 10.1038/nature22372; Xu GY, 2017, NATURE, V545, P487, DOI 10.1038/nature22371; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174; Yendrek CR, 2017, PLANT PHYSIOL, V173, P614, DOI 10.1104/pp.16.01447; Yurgel ME, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006409; Zanne AE, 2020, BIOL REV, V95, P409, DOI 10.1111/brv.12570; Zarco-Tejada PJ, 2018, NAT PLANTS, V4, P432, DOI 10.1038/s41477-018-0189-7; Zhai SL, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/47/475105	189	18	19	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0237975	10.1371/journal.pone.0237975	http://dx.doi.org/10.1371/journal.pone.0237975			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960892	gold, Green Published			2022-12-26	WOS:000575109500039
J	Lin, SR; Wen, YC; Yeh, HL; Jiang, KC; Chen, WH; Mokgautsi, N; Huang, J; Chen, WY; Liu, YN				Lin, Shian-Ren; Wen, Yu-Ching; Yeh, Hsiu-Lien; Jiang, Kuo-Ching; Chen, Wei-Hao; Mokgautsi, Ntlotlang; Huang, Jiaoti; Chen, Wei-Yu; Liu, Yen-Nien			EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; MITOCHONDRIAL-DNA CONTENT; ANDROGEN RECEPTOR; STEM-CELLS; EXPRESSION; ACTIVATION; MECHANISMS; STAT3; ADENOCARCINOMAS; LOCALIZATION	Neuroendocrine (NE) differentiation is a well-recognized phenotypic change of prostate cancer after androgen deprivation therapy (ADT), and it ultimately develops into an aggressive subset of this disease. However, the contribution of signaling pathways that lead to metabolic disorders and NE differentiation of prostate cancer remains unclear. In this study, we identified that ADT induced upregulation of the succinate-CoA ligase GDP-forming beta subunit (SUCLG2), which regulates succinate metabolism and NE differentiation of prostate cancer. We demonstrated a connection that upregulation of epidermal growth factor receptor (EGFR)-leukemia inhibitory factor receptor (LIFR) signaling induced SUCLG2 expression in prostate cancer cells. The LIFR is upregulated by nuclear EGFR, which acts as a transcriptional regulator, directly binds to theLIFRpromoter, and drives NE differentiation and glycolysis of prostate cancer. LIFR upregulation is associated with SUCLG2, which increased succinate synthesis and enzymatic activities of mitochondrial nucleoside diphosphate kinase (NDPK) in prostate cancer cells. Knockdown of SUCLG2 suppressed NE differentiation in cultured cells and reduced prostate tumor growth in a xenograft model. Analysis of prostate tissue samples showed increased intensity of nuclear EGFR associated with the LIFR and SUCLG2 in castration-resistant prostate cancer tumors. Our study provides a mechanism whereby ADT upregulates EGFR-LIFR signaling that activates SUCLG2, which subsequently stimulates the metabolic changes associated with NE differentiation and aggressive prostate cancer phenotype.	[Lin, Shian-Ren; Jiang, Kuo-Ching; Chen, Wei-Hao; Mokgautsi, Ntlotlang; Liu, Yen-Nien] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan; [Wen, Yu-Ching] Taipei Med Univ, Wan Fang Hosp, Dept Urol, Taipei, Taiwan; [Wen, Yu-Ching] Taipei Med Univ, Sch Med, Dept Urol, Coll Med, Taipei, Taiwan; [Yeh, Hsiu-Lien] Natl Tsing Hua Univ, Inst Informat Syst & Applicat, Hsinchu, Taiwan; [Huang, Jiaoti; Liu, Yen-Nien] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Chen, Wei-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Chen, Wei-Yu] Taipei Med Univ, Sch Med, Dept Pathol, Coll Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; National Tsing Hua University; Duke University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Liu, YN (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan.; Liu, YN (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.; Chen, WY (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan.; Chen, WY (corresponding author), Taipei Med Univ, Sch Med, Dept Pathol, Coll Med, Taipei, Taiwan.	1047@tmu.edu.tw; liuy@tmu.edu.tw	Lin, Shian-Ren/AAR-6238-2020; Liu, Yen-Nien/AAW-4698-2021	Lin, Shian-Ren/0000-0002-4160-2361; 	Ministry of Science and Technology of Taiwan [MOST108-2320-B-038-047, MOST 109-2314-B-038-105, MOST109-2326-B-038-001-MY3]; Taipei Medical University-Wan Fang Hospital [109TMU-WFH-01]; National Health Research Institute of Taiwan [NHRI-EX109-10702BI]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Wan Fang Hospital; National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan)	This work was jointly supported by grants from the Ministry of Science and Technology of Taiwan (MOST108-2320-B-038-047) to WYC, (MOST 109-2314-B-038-105) to YCW, and (MOST109-2326-B-038-001-MY3) to YNL, Taipei Medical University-Wan Fang Hospital (109TMU-WFH-01) to WYC, and the National Health Research Institute of Taiwan (NHRI-EX109-10702BI) to YNL.	Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; Cortes MA, 2012, CARCINOGENESIS, V33, P1169, DOI 10.1093/carcin/bgs139; Angelescu R, 2013, ENDOSC ULTRASOUND, V2, P86, DOI [10.4103/2303-9027.117692, 10.7178/eus.05.005]; Beltran H, 2019, CLIN CANCER RES, V25, P6916, DOI 10.1158/1078-0432.CCR-19-1423; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Brand TM, 2013, RADIOTHER ONCOL, V108, P370, DOI 10.1016/j.radonc.2013.06.010; Brand TM, 2011, DISCOV MED, V12, P419; Bressy C, 2018, CANCER RES, V78, P909, DOI 10.1158/0008-5472.CAN-15-2790; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Cai CM, 2009, CANCER RES, V69, P5202, DOI 10.1158/0008-5472.CAN-09-0026; Chang YS, 2015, CANCER RES, V75, P3077, DOI 10.1158/0008-5472.CAN-14-3380; Chen L, 2020, GUT, V69, P630, DOI 10.1136/gutjnl-2019-318325; Chiarugi P, 2014, SEMIN ONCOL, V41, P267, DOI 10.1053/j.seminoncol.2014.03.004; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Choueiri TK, 2009, CANCER, V115, P981, DOI 10.1002/cncr.24064; Chua CY, 2016, ONCOGENE, V35, P738, DOI 10.1038/onc.2015.131; Dai C, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030452; Day KC, 2017, CANCER RES, V77, P74, DOI 10.1158/0008-5472.CAN-16-1656; DISANTAGNESE PA, 1992, HUM PATHOL, V23, P287; Dobolyi A, 2015, J BIOENERG BIOMEMBR, V47, P33, DOI 10.1007/s10863-014-9586-4; Dobolyi A, 2015, BRAIN STRUCT FUNCT, V220, P135, DOI 10.1007/s00429-013-0643-2; Dziennis S, 2008, REV NEUROSCIENCE, V19, P341; Egan Kathryn, 2010, J Clin Med Res, V2, P225, DOI 10.4021/jocmr443w; Faraco CCF, 2018, J STRUCT BIOL, V202, P61, DOI 10.1016/j.jsb.2017.12.007; Gagliano-Juca T, 2018, J CLIN ENDOCR METAB, V103, P3900, DOI 10.1210/jc.2018-01068; Heidenreich A, 2014, EUR UROL, V65, P467, DOI 10.1016/j.eururo.2013.11.002; Hoshino M, 2007, PATHOBIOLOGY, V74, P15, DOI 10.1159/000101047; Hsing AW, 2007, AM J CLIN NUTR, V86, p843S, DOI 10.1093/ajcn/86.3.843S; Huang JT, 2006, PROSTATE, V66, P1399, DOI 10.1002/pros.20434; Humez S, 2006, ENDOCR-RELAT CANCER, V13, P181, DOI 10.1677/erc.1.01079; Kharmate G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154967; Kim J, 2019, CELL METAB, V30, P434, DOI 10.1016/j.cmet.2019.08.013; Kim MM, 2004, CLIN CANCER RES, V10, P8512, DOI 10.1158/1078-0432.CCR-04-0734; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Li QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06067-7; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu YN, 2019, CLIN CANCER RES, V25, P4128, DOI 10.1158/1078-0432.CCR-18-3239; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; Marcoux N, 2019, J CLIN ONCOL, V37, P278, DOI 10.1200/JCO.18.01585; Martin-Orozco RM, 2007, NEOPLASIA, V9, P614, DOI 10.1593/neo.07337; Miller C, 2011, BBA-MOL BASIS DIS, V1812, P625, DOI 10.1016/j.bbadis.2011.01.013; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Nicola NA, 2015, CYTOKINE GROWTH F R, V26, P533, DOI 10.1016/j.cytogfr.2015.07.001; Onishi K, 2015, DEVELOPMENT, V142, P2230, DOI 10.1242/dev.117598; Papouchado B, 2005, MODERN PATHOL, V18, P1329, DOI 10.1038/modpathol.3800427; Peraldo-Neia C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-31; Read J, 2017, EUR J CANCER, V70, P62, DOI 10.1016/j.ejca.2016.10.017; Rimawi MF, 2010, CANCER-AM CANCER SOC, V116, P1234, DOI 10.1002/cncr.24816; Rooney JP, 2015, METHODS MOL BIOL, V1241, P23, DOI 10.1007/978-1-4939-1875-1_3; Sasaki T, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120565; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Shah T, 2006, J NEUROENDOCRINOL, V18, P355, DOI 10.1111/j.1365-2826.2006.01425.x; Shao JL, 2019, CANCER LETT, V451, P110, DOI 10.1016/j.canlet.2019.02.042; Spiotto MT, 2000, PROSTATE, V42, P88, DOI 10.1002/(SICI)1097-0045(20000201)42:2<88::AID-PROS2>3.0.CO;2-P; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Thomas R, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00800; Timofeeva OA, 2012, J BIOL CHEM, V287, P14192, DOI 10.1074/jbc.M111.323899; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Tsai YC, 2017, CANCER LETT, V384, P1, DOI 10.1016/j.canlet.2016.10.014; Vlachostergios PJ, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00006; Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715; Wang Y, 2006, BRIT J CANCER, V95, P1087, DOI 10.1038/sj.bjc.6603377; Williamson SR, 2011, MODERN PATHOL, V24, P1120, DOI 10.1038/modpathol.2011.56; Wu HX, 2018, BBA-MOL BASIS DIS, V1864, P2769, DOI 10.1016/j.bbadis.2018.05.004; Xu RH, 2005, CANCER RES, V65, P613; Xue Y, 1997, AM J PATHOL, V151, P1759; Zhang XQ, 2003, ONCOGENE, V22, P6704, DOI 10.1038/sj.onc.1206764	73	15	15	2	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 29	2020	39	44					6757	6775		10.1038/s41388-020-01468-9	http://dx.doi.org/10.1038/s41388-020-01468-9		SEP 2020	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OH9QS	32963351				2022-12-26	WOS:000572030400001
J	Nutricionist, ACT; Procianoy, RS; Roesch, LFW; Corso, AL; Dobbler, PT; Silveira, RC				Terrazzan Nutricionist, Ana Carolina; Procianoy, Renato S.; Wurdig Roesch, Luiz Fernando; Corso, Andrea Lucia; Dobbler, Priscila Thiago; Silveira, Rita C.			Meconium microbiome and its relation to neonatal growth and head circumference catch-up in preterm infants	PLOS ONE			English	Article							BRAIN-INJURY; NEURODEVELOPMENT; MECHANISMS; BACTERIA; ILLNESS	The purpose was identify an association between meconium microbiome, extra-uterine growth restriction, and head circumference catch-up. Materials and methods: Prospective study with preterm infants born <33 weeks gestational age (GA), admitted at Neonatal Unit and attending the Follow-Up Preterm Program of a tertiary hospital. Excluded out born infants; presence of congenital malformations or genetic syndromes; congenital infections; HIV-positive mothers; and newborns whose parents or legal guardians did not authorize participation. Approved by the institution's ethics committee. Conducted 16S rRNA sequencing using PGM Ion Torrent meconium samples for microbiota analysis. Results: Included 63 newborns, GA 30 +/- 2.3 weeks, mean weight 1375.80 +/- 462.6 grams, 68.3% adequate weight for GA at birth.Polynucleobacter(p = 0.0163), Gp1 (p = 0.018), andPrevotella(p = 0.038) appeared in greater abundance in meconium of preterm infants with adequate birth weight for GA. Thirty (47.6%) children reached head circumference catch-up before 6 months CA and 33 (52.4%) after 6 months CA.Salmonella(p<0.001),Flavobacterium(p = 0.026), andBurkholderia(p = 0.026) were found to be more abundant in meconium in the group of newborns who achieved catch-up prior to 6th month CA. Conclusion: Meconium microbiome abundance was related to adequacy of weight for GA. Meconium microbiome differs between children who achieve head circumference catch-up by the 6th month of corrected age or after this period.	[Terrazzan Nutricionist, Ana Carolina; Silveira, Rita C.] Fed Univ Rio Grande do Sul UFRGS, Postgrad Program Child & Adolescent Hlth PPGSCA, Porto Alegre, RS, Brazil; [Procianoy, Renato S.; Corso, Andrea Lucia; Silveira, Rita C.] Hosp Clin Porto Alegre, Neonatal Intens Care Unit, Porto Alegre, RS, Brazil; [Wurdig Roesch, Luiz Fernando; Dobbler, Priscila Thiago] Biotec Fed Univ Pampa, Interdisciplinary Ctr Biotechnol Res, CIP, Sao Gabriel, RS, Brazil	Universidade Federal do Rio Grande do Sul	Silveira, RC (corresponding author), Fed Univ Rio Grande do Sul UFRGS, Postgrad Program Child & Adolescent Hlth PPGSCA, Porto Alegre, RS, Brazil.; Silveira, RC (corresponding author), Hosp Clin Porto Alegre, Neonatal Intens Care Unit, Porto Alegre, RS, Brazil.	drarita.c.s@gmail.com	Dobbler, Priscila Caroline Thiago/E-4387-2018; Dal Corso, Andrea/A-5745-2008; Roesch, Luiz F W/D-2838-2009; Roesch, Luiz/GRS-4638-2022; Procianoy, Renato/I-5133-2014	Dobbler, Priscila Caroline Thiago/0000-0002-7681-5463; Dal Corso, Andrea/0000-0003-1186-5133; Roesch, Luiz F W/0000-0003-1450-8828; SILVEIRA, RITA DE CASSIA/0000-0002-2982-2652; Corso, Andrea Lucia/0000-0003-1118-1145; Procianoy, Renato/0000-0001-8297-4164				Ardissone AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090784; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; Belfort MB, 2011, PEDIATRICS, V128, pE899, DOI 10.1542/peds.2011-0282; Cai SL, 2020, CHILD NERV SYST, V36, P2997, DOI 10.1007/s00381-020-04633-3; Caporaso JG, 2010, NAT METHODS NATURE M; Cheong JLY, 2020, J NEURAL TRANSM, V127, P1, DOI 10.1007/s00702-019-02121-w; Collin MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21589; DiBartolomeo ME, 2016, CLIN THER, V38, P733, DOI 10.1016/j.clinthera.2016.02.003; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Guaraldi Federica, 2012, Front Cell Infect Microbiol, V2, P94, DOI 10.3389/fcimb.2012.00094; Henderickx JGE, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00085; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Hortensius LM, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00961; Itani T, 2017, ANAEROBE, V43, P4, DOI 10.1016/j.anaerobe.2016.11.001; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Korpela K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20827-x; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lu J, 2019, DEV PSYCHOBIOL, V61, P739, DOI 10.1002/dev.21806; Lu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23692-w; Lu L, 2018, CURR PATHOBIOL REP, V6, P15, DOI 10.1007/s40139-018-0159-9; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Nataro JP, 2017, VACCINE, V35, P6807, DOI 10.1016/j.vaccine.2017.05.035; Niccolai E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010156; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Petherick A, 2010, NATURE, V468, pS5, DOI 10.1038/468S5a; Pylro VS, 2016, MICROB ECOL, V72, P443, DOI 10.1007/s00248-016-0785-x; Pylro VS, 2014, MICROB ECOL, V67, P237, DOI 10.1007/s00248-013-0302-4; Ramel SE, 2012, NEONATOLOGY, V102, P19, DOI 10.1159/000336127; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Robertson RC, 2019, TRENDS MICROBIOL, V27, P131, DOI 10.1016/j.tim.2018.09.008; Rogers GB, 2016, MOL PSYCHIATR, V21, P738, DOI 10.1038/mp.2016.50; Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8; Ruiz L, 2016, J PEDIATR GASTR NUTR, V63, pE193, DOI 10.1097/MPG.0000000000001196; Turroni F, 2020, ITAL J PEDIATR, V46, DOI 10.1186/s13052-020-0781-0; Varal IG, 2018, PAK J MED SCI, V34, P1502, DOI 10.12669/pjms.346.16107; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Wejryd E, 2019, ACTA PAEDIATR, V108, P62, DOI 10.1111/apa.14497	54	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238632	10.1371/journal.pone.0238632	http://dx.doi.org/10.1371/journal.pone.0238632			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956415	Green Published, gold			2022-12-26	WOS:000574571500007
J	Brothers, RM; Stephens, BY; Akins, JD; Fadel, PJ				Brothers, R. Matthew; Stephens, Brandi Y.; Akins, John D.; Fadel, Paul J.			Influence of sex on heightened vasoconstrictor mechanisms in the non-Hispanic black population	FASEB JOURNAL			English	Article						cardiovascular disease; hypertension; non-Hispanic black women; vasoconstriction; vascular function	CUTANEOUS MICROVASCULAR FUNCTION; CEREBRAL VASODILATORY CAPACITY; CREATINE-KINASE ACTIVITY; NITRIC-OXIDE SYNTHASE; HIGH BLOOD-PRESSURE; RACIAL-DIFFERENCES; AFRICAN-AMERICANS; ENDOTHELIAL DYSFUNCTION; ETHNIC-DIFFERENCES; GENDER-DIFFERENCES	Cardiovascular disease (CVD) affects individuals of all races and ethnicities; however, its prevalence is highest in non-Hispanic black individuals (BL) relative to other populations. While previous research has provided valuable insight into elevated CVD risk in the BL population, this work has been almost exclusively conducted in men. This is alarming given that BL women suffer from CVD at an equivalent rate to BL men and each has a greater prevalence when compared to all other ethnicities, regardless of sex. The importance of investigating sex differences in mechanisms of cardiovascular function is highlighted by the National Institute of Health requiring sex to be considered as a biological variable in research studies to better our "understanding of key sex influences on health processes and outcomes." The mechanism(s) responsible for the elevated CVD risk in BL women remains unclear and is likely multifactorial. Limited studies in BL women suggest that, while impaired vasodilator capacity is involved, heightened vasoconstrictor tone and/or responsiveness may also contribute. Within this mini-review, we will discuss potential mechanisms of elevated rates of hypertension and other CVDs in BL individuals with a particular focus on young, otherwise healthy, college-aged women. To stimulate academic thought and future research, we will also discuss potential mechanisms for impaired vascular function in BL women, as well as possible divergent mechanisms between BL men and women based on either preliminary data or plausible speculation extending from findings in the existing literature. Last, we will conclude with potential future research directions aimed at better understanding the elevated risk for hypertension and CVD in BL women.	[Brothers, R. Matthew; Stephens, Brandi Y.; Akins, John D.; Fadel, Paul J.] Univ Texas Arlington, Dept Kinesiol, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Brothers, RM (corresponding author), Univ Texas Arlington, Dept Kinesiol, Coll Nursing & Hlth Innovat, 500 W Nedderman,MAC 147, Arlington, TX 76019 USA.	matthew.brothers@uta.edu	Akins, John/GVN-2915-2022	Stephens, Brandi/0000-0002-1624-8778; Fadel, Paul/0000-0002-0115-0743	College of Nursing and Health Innovation at University of Texas at Arlington	College of Nursing and Health Innovation at University of Texas at Arlington	The College of Nursing and Health Innovation at University of Texas at Arlington, Grant/Award Number: Start-up funds	Abate NI, 2001, HYPERTENSION, V38, P379, DOI 10.1161/01.HYP.38.3.379; Adefurin A, 2013, HYPERTENSION, V61, P915, DOI 10.1161/HYPERTENSIONAHA.111.00854; Alonso D, 2003, HEART FAIL REV, V8, P107, DOI 10.1023/A:1022155206928; Apple FS, 2003, CLIN CHEM, V49, P1331, DOI 10.1373/49.8.1331; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; Barbosa TC, 2018, AM J PHYSIOL-HEART C, V315, pH1316, DOI 10.1152/ajpheart.00387.2018; Barrett-O'Keefe Z, 2013, CLIN SCI, V124, P413, DOI 10.1042/CS20120424; Bourque SL, 2011, AM J PHYSIOL-REG I, V300, pR1288, DOI 10.1152/ajpregu.00397.2010; Brewster LM, 2010, AM J PHYSIOL-HEART C, V299, pH431, DOI 10.1152/ajpheart.00919.2009; Brewster LM, 2006, CIRCULATION, V114, P2034, DOI 10.1161/CIRCULATIONAHA.105.584490; Brewster LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032471; Brothers RM, 2019, AM J PHYSIOL-HEART C, V317, pH777, DOI 10.1152/ajpheart.00126.2019; Brownlow BN, 2019, CURR PSYCHIAT REP, V21, DOI 10.1007/s11920-019-1098-9; CALHOUN DA, 1993, HYPERTENSION, V22, P801, DOI 10.1161/01.HYP.22.6.801; CALHOUN DA, 1992, AM J MED SCI, V304, P306, DOI 10.1097/00000441-199211000-00008; CALHOUN DA, 1994, J HYPERTENS, V12, P1291; Campia U, 2004, CIRCULATION, V109, P3191, DOI 10.1161/01.CIR.0000130590.24107.D3; Campia U, 2002, J AM COLL CARDIOL, V40, P754, DOI 10.1016/S0735-1097(02)02015-6; Candler WH, 1997, MIL MED, V162, P788, DOI 10.1093/milmed/162.12.788; Cardillo C, 1998, HYPERTENSION, V31, P1235, DOI 10.1161/01.HYP.31.6.1235; Cardillo C, 1999, CIRCULATION, V99, P90, DOI 10.1161/01.CIR.99.1.90; Chen DA, 2009, HYPERTENS RES, V32, P559, DOI 10.1038/hr.2009.59; Choi S, 2014, KIDNEY RES CLIN PRAC, V33, P19, DOI 10.1016/j.krcp.2013.12.001; Christmas KM, 2018, MICROVASC RES, V115, P52, DOI 10.1016/j.mvr.2017.08.005; Clark R, 1999, AM PSYCHOL, V54, P805, DOI 10.1037/0003-066X.54.10.805; Couto GK, 2014, EXP PHYSIOL, V99, P1427, DOI 10.1113/expphysiol.2014.079236; D'Angelo G, 2006, AM J PHYSIOL-HEART C, V290, pH1251, DOI 10.1152/ajpheart.00203.2005; Davern PJ, 2009, HYPERTENSION, V54, P1262, DOI 10.1161/HYPERTENSIONAHA.109.139741; Dawes M, 1997, CIRCULATION, V95, P2293, DOI 10.1161/01.CIR.95.9.2293; De Matteo R, 2006, AM J HYPERTENS, V19, P396, DOI 10.1016/j.amjhyper.2005.09.024; Deo SH, 2015, AM J PHYSIOL-HEART C, V308, pH548, DOI 10.1152/ajpheart.00784.2014; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Dow CA, 2017, EXP PHYSIOL, V102, P1133, DOI 10.1113/EP086454; Drew RC, 2020, AM J PHYSIOL-REG I, V318, pR234, DOI 10.1152/ajpregu.00091.2019; du Plooy CS, 2015, J AMINO ACIDS, V2015, P481517; DuPont JJ, 2011, J APPL PHYSIOL, V111, P1561, DOI 10.1152/japplphysiol.00419.2011; Ergul A, 1999, J CARDIOVASC PHARM, V34, P327, DOI 10.1097/00005344-199909000-00002; Ergul A, 1998, J PHARMACOL EXP THER, V285, P511; Ergul S, 1996, HYPERTENSION, V28, P652, DOI 10.1161/01.HYP.28.4.652; Evans RR, 1996, AM J CARDIOL, V78, P486, DOI 10.1016/S0002-9149(96)00344-X; Feairheller DL, 2011, CTS-CLIN TRANSL SCI, V4, P32, DOI 10.1111/j.1752-8062.2011.00264.x; Ferrario CM, 2006, J RENIN-ANGIO-ALDO S, V7, P3, DOI 10.3317/jraas.2006.003; Fisher JP, 2009, AUTON NEUROSCI-BASIC, V148, P5, DOI 10.1016/j.autneu.2009.02.003; Fonkoue IT, 2017, J APPL PHYSL 1985; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Freedman RR, 2000, HYPERTENSION, V35, P795, DOI 10.1161/01.HYP.35.3.795; FREEDMAN RR, 1987, CIRC RES, V61, P581, DOI 10.1161/01.RES.61.4.581; Frierson GM, 2013, ETHNIC DIS, V23, P35; Gupta AK, 2010, AM J HYPERTENS, V23, P1023, DOI 10.1038/ajh.2010.105; Harshfield GA, 2002, AM J HYPERTENS, V15, P903, DOI 10.1016/S0895-7061(02)02994-1; Hart EC, 2012, J PHYSIOL-LONDON, V590, P2069, DOI 10.1113/jphysiol.2011.224642; HAYNES WG, 1995, CLIN SCI, V88, P509, DOI 10.1042/cs0880509; Heffernan KS, 2008, AM J PHYSIOL-HEART C, V295, pH2380, DOI 10.1152/ajpheart.00902.2008; Hinds K, 2010, HYPERTENSION, V56, P75, DOI 10.1161/HYPERTENSIONAHA.110.150011; Holowatz LA, 2006, J PHYSIOL-LONDON, V574, P573, DOI 10.1113/jphysiol.2006.108993; Holowatz LA, 2011, J PHYSIOL-LONDON, V589, P4787, DOI 10.1113/jphysiol.2011.212100; Houghton JL, 2002, J AM COLL CARDIOL, V39, P1314, DOI 10.1016/S0735-1097(02)01781-3; Hurr C, 2018, EXP PHYSIOL, V103, P343, DOI 10.1113/EP086776; Hurr C, 2015, EXP PHYSIOL, V100, P1030, DOI 10.1113/EP085269; Hurr C, 2015, EXP PHYSIOL, V100, P35, DOI 10.1113/expphysiol.2014.082362; ISHIKAWA K, 1994, P NATL ACAD SCI USA, V91, P4892, DOI 10.1073/pnas.91.11.4892; Jain S, 2004, BIOL PSYCHOL, V65, P89, DOI 10.1016/S0301-0511(03)00111-X; Jarvis SS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00086; Jeong JH, 2019, J CLIN HYPERTENS, V21, P1191, DOI 10.1111/jch.13625; Johnsen SH, 2011, J HYPERTENS, V29, P36, DOI 10.1097/HJH.0b013e32834068e0; JOHNSON JA, 1995, J CARDIOVASC PHARM, V25, P90, DOI 10.1097/00005344-199501000-00015; Kalinowski L, 2004, CIRCULATION, V109, P2511, DOI 10.1161/01.CIR.0000129087.81352.7A; Karamat FA, 2014, HYPERTENSION, V63, P68, DOI 10.1161/HYPERTENSIONAHA.113.01352; Kitada K, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/731970; Kneale BJ, 2000, J AM COLL CARDIOL, V36, P1233, DOI 10.1016/S0735-1097(00)00849-4; Lackland DT, 2014, AM J MED SCI, V348, P135, DOI 10.1097/MAJ.0000000000000308; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; Macedo FN, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00265; Marinos A, 2017, J AM HEART ASSOC, V6, DOI [10.1161/jaha.117.006971, 10.1161/JAHA.117.006971]; Mata-Greenwood E, 2008, REPROD SCI, V15, P9, DOI 10.1177/1933719107312160; MATURI MF, 1989, J CLIN INVEST, V83, P1217, DOI 10.1172/JCI114004; Mayorov DN, 2003, HYPERTENSION, V41, P1168, DOI 10.1161/01.HYP.0000064574.29317.45; Melikian N, 2007, HYPERTENSION, V49, P873, DOI 10.1161/01.HYP.0000258405.25330.80; Nishida Y, 1998, J HYPERTENS, V16, P1611, DOI 10.1097/00004872-199816110-00007; Nishiyama SK, 2017, J APPL PHYSIOL, V122, P354, DOI 10.1152/japplphysiol.00772.2016; Okada Y, 2016, HYPERTENSION, V67, P951, DOI 10.1161/HYPERTENSIONAHA.115.06700; Okada Y, 2012, HYPERTENSION, V60, P842, DOI 10.1161/HYPERTENSIONAHA.112.195313; Oudman I, 2013, J HYPERTENS, V31, P1025, DOI 10.1097/HJH.0b013e32835f5c29; Patik JC, 2018, AM J PHYSIOL-HEART C, V315, pH1063, DOI 10.1152/ajpheart.00142.2018; Perregaux D, 2000, HYPERTENSION, V36, P866, DOI 10.1161/01.HYP.36.5.866; Ray CA, 1985, J APPL PHYSIOL, V92, P2002; Schmieder RE, 1996, J HYPERTENS, V14, P1201, DOI 10.1097/00004872-199610000-00008; SEEDAT YK, 1989, J HYPERTENS, V7, P515, DOI 10.1097/00004872-198907000-00001; Sherwood A, 2017, J HYPERTENS, V35, P975, DOI 10.1097/HJH.0000000000001266; Stanhewicz AE, 2012, J APPL PHYSIOL, V112, P791, DOI 10.1152/japplphysiol.01257.2011; Stauffer BL, 2010, AM J PHYSIOL-REG I, V298, pR261, DOI 10.1152/ajpregu.00626.2009; Stein CM, 2000, HYPERTENSION, V36, P945, DOI 10.1161/01.HYP.36.6.945; Stephens DP, 2004, AM J PHYSIOL-HEART C, V287, pH1404, DOI 10.1152/ajpheart.00061.2004; Taherzadeh Z, 2016, AM J HYPERTENS, V29, P170, DOI 10.1093/ajh/hpv078; Tawakol A, 2019, J AM COLL CARDIOL, V73, P3243, DOI 10.1016/j.jacc.2019.04.042; Thomas KS, 2006, PSYCHOSOM MED, V68, P692, DOI 10.1097/01.psy.0000238214.80871.e6; Treiber FA, 2002, PSYCHOSOM MED, V64, P707, DOI 10.1097/01.PSY.0000021952.59258.1C; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Vranish JR, 2018, HYPERTENSION, V71, P192, DOI 10.1161/HYPERTENSIONAHA.117.10229; WATKINS LL, 1995, LIFE SCI, V57, P1411, DOI 10.1016/0024-3205(95)02103-P; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; YANG ZH, 1990, CIRCULATION, V82, P188, DOI 10.1161/01.CIR.82.1.188; Zou MH, 2004, ENDOTHELIUM-J ENDOTH, V11, P89, DOI 10.1080/10623320490482619	103	2	2	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14073	14082		10.1096/fj.202001405R	http://dx.doi.org/10.1096/fj.202001405R		SEP 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32949436				2022-12-26	WOS:000572345300001
J	Madani, A; Mallick, I; Guy, A; Crauste, C; Durand, T; Fourquet, P; Audebert, S; Camoin, L; Canaan, S; Cavalier, JF				Madani, Abdeldjalil; Mallick, Ivy; Guy, Alexandre; Crauste, Celine; Durand, Thierry; Fourquet, Patrick; Audebert, Stephane; Camoin, Luc; Canaan, Stephane; Cavalier, Jean Francois			Dissecting the antibacterial activity of oxadiazolone-core derivatives againstMycobacterium abscessus	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS GROWTH; NONTUBERCULOUS MYCOBACTERIA; DRUG-RESISTANCE; ANTIGEN 85C; IN-VITRO; TRIACYLGLYCEROL; INFECTIONS; DISRUPTION; COMPLEX; GENE	Mycobacterium abscessus (M.abscessus), a rapidly growing mycobacterium, is an emergent opportunistic pathogen responsible for chronic bronchopulmonary infections in individuals with respiratory diseases such as cystic fibrosis. Most treatments ofM.abscessuspulmonary infections are poorly effective due to the intrinsic resistance of this bacteria against a broad range of antibiotics including anti-tuberculosis agents. Consequently, the number of drugs that are efficient againstM.abscessusremains limited. In this context, 19 oxadiazolone (OX) derivatives have been investigated for their antibacterial activity against both the rough (R) and smooth (S) variants ofM.abscessus. SeveralOXsimpair extracellularM.abscessusgrowth with moderated minimal inhibitory concentrations (MIC), or act intracellularly by inhibitingM.abscessusgrowth inside infected macrophages with MIC values similar to those of imipenem. Such promising results prompted us to identify the potential target enzymes of the sole extra and intracellular inhibitor ofM.abscessusgrowth,i.e., compoundiBpPPOX,viaactivity-based protein profiling combined with mass spectrometry. This approach led to the identification of 21 potential protein candidates being mostly involved inM.abscessuslipid metabolism and/or in cell wall biosynthesis. Among them, the Ag85C protein has been confirmed as a vulnerable target ofiBpPPOX. This study clearly emphasizes the potential of theOXderivatives to inhibit the extracellular and/or intracellular growth ofM.abscessusby targeting various enzymes potentially involved in many physiological processes of this most drug-resistant mycobacterial species.	[Madani, Abdeldjalil; Mallick, Ivy; Canaan, Stephane; Cavalier, Jean Francois] Aix Marseille Univ, Inst Microbiol Mediterranee, LISM, CNRS, FR-3479 Marseille, France; [Mallick, Ivy] Aix Marseille Univ, IHU Mediterranee Infect, Marseille, France; [Guy, Alexandre; Crauste, Celine; Durand, Thierry] Univ Montpellier, ENSCM, CNRS, IBMM, Montpellier, France; [Fourquet, Patrick; Audebert, Stephane; Camoin, Luc] Aix Marseille Univ, Inst Paoli Calmettes, Marseille Proteom, INSERM,CNRS,CRCM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Cavalier, JF (corresponding author), Aix Marseille Univ, Inst Microbiol Mediterranee, LISM, CNRS, FR-3479 Marseille, France.	jfcavalier@imm.cnrs.fr	Cavalier, JF/ABB-6445-2020	Cavalier, JF/0000-0003-0864-8314; Crauste, Celine/0000-0002-5714-8749; Audebert, Stephane/0000-0002-9409-2588; Camoin, Luc/0000-0002-1230-4787	CNRS; Aix Marseille University; Agence Nationale de la Recherche [ANR-19-CE44-0011]; Association Gregory Lemarchal; Vaincre la Mucoviscidose [RF20160501651]; IHU Mediterrane e Infection (Marseille, France); Institut Paoli-Calmettes; Centre de Recherche en Cancerologie de Marseille; IBISA (Infrastructures Biologie Sante et Agronomie); Canceropole PACA; ProvenceAlpes-Cote d'Azur Region; Institut PaoliCalmettes; Fonds Europeen de Developpement Regional (FEDER)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix Marseille University; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Gregory Lemarchal; Vaincre la Mucoviscidose; IHU Mediterrane e Infection (Marseille, France); Institut Paoli-Calmettes; Centre de Recherche en Cancerologie de Marseille; IBISA (Infrastructures Biologie Sante et Agronomie); Canceropole PACA(Region Grand-Est); ProvenceAlpes-Cote d'Azur Region(Region Provence-Alpes-Cote d'Azur); Institut PaoliCalmettes; Fonds Europeen de Developpement Regional (FEDER)(European Commission)	This work was supported by the CNRS, Aix Marseille University and by the grant ANR-19-CE44-0011 from the Agence Nationale de la Recherche (https://anr.fr/).AM was supported by a PhD fellowship from the Association Gregory Lemarchal and Vaincre la Mucoviscidose (https://www.vaincrelamuco.org/) (project no RF20160501651). A. M. received a financial support from the IHU Mediterrane e Infection (Marseille, France). Proteomics analyses were supported by the Institut Paoli-Calmettes and the Centre de Recherche en Cancerologie de Marseille. Proteomic analyses were done using the mass spectrometry facility of Marseille Proteomics (marseille-proteomique.univ-amu.fr) supported by IBISA (Infrastructures Biologie Sante et Agronomie), the Canceropole PACA, the ProvenceAlpes-Cote d'Azur Region, the Institut PaoliCalmettes, and Fonds Europeen de Developpement Regional (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, J ADOLESCENT HEALT S, V61, pS1; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Bernut A, 2014, P NATL ACAD SCI USA, V111, pE943, DOI 10.1073/pnas.1321390111; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Caire-Brandli I, 2014, INFECT IMMUN, V82, P476, DOI 10.1128/IAI.01196-13; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; Chinese Society for Colposcopy and Cervical Pathology of China Healthy Birth Science Association, 2017, ZHONG GUO FU CHAN KE, V18, P190; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; Claeys TA, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00739-17; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Dedieu L, 2013, BIOCHIMIE, V95, P66, DOI 10.1016/j.biochi.2012.07.008; Delorme V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046493; Floto RA, 2016, THORAX, V71, P88, DOI 10.1136/thoraxjnl-2015-207983; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Hawke D, 1987, APPL BIOSYSTEMS B, V28; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Johansen MD, 2020, NAT REV MICROBIOL, V18, P392, DOI 10.1038/s41579-020-0331-1; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Le Run E, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01915-18; Lee MR, 2015, EMERG INFECT DIS, V21, P1638, DOI [10.3201/eid2109.141634, 10.3201/2109.141634]; Lefebvre AL, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02440-16; Lehmann J, 2016, MEDCHEMCOMM, V7, P1797, DOI 10.1039/c6md00231e; Lehmann J, 2018, ANGEW CHEM INT EDIT, V57, P348, DOI 10.1002/anie.201709365; Luthra S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02179; Madani A, 2019, ACS INFECT DIS, V5, P1597, DOI 10.1021/acsinfecdis.9b00172; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Pawlik A, 2013, MOL MICROBIOL, V90, P612, DOI 10.1111/mmi.12387; Nguyen PC, 2018, BIOORG CHEM, V81, P414, DOI 10.1016/j.bioorg.2018.08.025; Nguyen PC, 2018, INT J ANTIMICROB AG, V51, P651, DOI 10.1016/j.ijantimicag.2017.12.001; Nguyen PC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11843-4; Porvaznik I, 2017, ADV EXP MED BIOL, V944, P19, DOI 10.1007/5584_2016_45; Ravindran MS, 2014, MOL CELL PROTEOMICS, V13, P435, DOI 10.1074/mcp.M113.029942; Rybniker J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8659; Sacchettini JC, 2000, TRENDS MICROBIOL, V8, P441, DOI 10.1016/S0966-842X(00)01843-6; Santucci P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45164-5; Santucci P, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00394-18; Santucci P, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00122; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh S, 2014, CLIN MICROBIOL INFEC, V20, pO1124, DOI 10.1111/1469-0691.12780; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tallman KR, 2016, ACS INFECT DIS, V2, P48, DOI 10.1021/acsinfecdis.6b00135; Viljoen A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00069; Viljoen A, 2018, J BIOL CHEM, V293, P2755, DOI 10.1074/jbc.RA117.000760; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Warrier T, 2012, ANTIMICROB AGENTS CH, V56, P1735, DOI 10.1128/AAC.05742-11	52	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238178	10.1371/journal.pone.0238178	http://dx.doi.org/10.1371/journal.pone.0238178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946441	Green Published, gold			2022-12-26	WOS:000573851100072
J	Chou, YT; Li, CH; Shen, WC; Yang, YC; Lu, FH; Wu, JS; Chang, CJ				Chou, Yu-Tsung; Li, Chung-Hao; Shen, Wei-Chen; Yang, Yi-Ching; Lu, Feng-Hwa; Wu, Jin-Shang; Chang, Chih-Jen			Association of sleep quality and sleep duration with serum uric acid levels in adults	PLOS ONE			English	Article							FATTY LIVER-DISEASE; METABOLIC SYNDROME; CIGARETTE-SMOKING; OXIDATIVE STRESS; INCIDENT GOUT; WEIGHT-GAIN; FOLLOW-UP; RISK; HYPERURICEMIA; PREVALENCE	Objective To date, the association between sleep duration or sleep quality and hyperuricemia has remained unclear. In addition, sleep duration and quality were not considered concomitantly in previous studies. Thus, this study was aimed toward an examination of the association of sleep duration and quality with uric acid level in a Taiwanese population. Methods A total of 4,555 patients aged >= 18 years were enrolled in this study. The sleep duration was classified into three groups: short (<7 h), normal (7-9 h), and long (>= 9 h). The Pittsburgh Sleep Quality Index (PSQI) was used to evaluate sleep quality, and poor sleep quality was defined as a global PSQI score of >5. Results Poor sleepers were younger and had lower body mass index, blood pressure, uric acid, blood sugar, cholesterol, creatinine level, shorter sleep duration, and engaged in less exercise but had a higher white blood cell count and prevalence of smoking as compared to good sleepers. There were also differences in body mass index, blood pressure, uric acid, blood sugar, lipid profiles, and sleep quality among subjects with different sleep durations. After adjusting for other variables, poor sleep quality was associated with lower uric acid levels. In addition, short sleep duration was positively associated with higher uric acid levels. Conclusions Poor sleep quality was related to lower uric acid levels, whereas short sleep duration was associated with higher uric acid levels.	[Chou, Yu-Tsung; Li, Chung-Hao; Shen, Wei-Chen; Yang, Yi-Ching; Lu, Feng-Hwa; Wu, Jin-Shang; Chang, Chih-Jen] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Family Med, Tainan, Taiwan; [Chou, Yu-Tsung; Li, Chung-Hao] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Hlth Management Ctr, Tainan, Taiwan; [Yang, Yi-Ching; Lu, Feng-Hwa; Wu, Jin-Shang] Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan, Taiwan; [Wu, Jin-Shang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Family Med,Dou Liou Branch, Douliu City, Yunlin, Taiwan; [Chang, Chih-Jen] Chia Yi Christian Hosp, Dept Family Med, Ditmanson Med Fdn, Chiayi, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Wu, JS; Chang, CJ (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Family Med, Tainan, Taiwan.; Wu, JS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Family Med, Tainan, Taiwan.; Wu, JS (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Family Med,Dou Liou Branch, Douliu City, Yunlin, Taiwan.; Chang, CJ (corresponding author), Chia Yi Christian Hosp, Dept Family Med, Ditmanson Med Fdn, Chiayi, Taiwan.	jins@mail.ncku.edu.tw; changcj.ncku@gmail.com	Chou, Yu-tsung/AAV-1165-2021	Chou, Yu-Tsung/0000-0001-9505-2230; LI, CHUNG-HAO/0000-0001-5062-8128	National Cheng Kung University Hospital, Taiwan [NCKUH10903022]	National Cheng Kung University Hospital, Taiwan	This research was funded by the National Cheng Kung University Hospital, Taiwan (NCKUH10903022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams B, 2012, MED HYPOTHESES, V78, P349, DOI 10.1016/j.mehy.2011.10.029; Ali N, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1026-2; Alvarez-Lario B, 2011, QJM-INT J MED, V104, P1015, DOI 10.1093/qjmed/hcr159; Alvarez-Lario B, 2010, RHEUMATOLOGY, V49, P2010, DOI 10.1093/rheumatology/keq204; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2015, J SPEC OPER MED, V15, P129; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2015, BMJ, V2015, ph1887; Arora T, 2011, DIABETES CARE, V34, P2317, DOI 10.2337/dc11-0647; Bandaru P, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/604715; Beyl RN, 2016, AM J MED, V129, P1153, DOI 10.1016/j.amjmed.2016.06.040; Borghi C, 2014, EXPERT REV CARDIOVAS, V12, P1219, DOI 10.1586/14779072.2014.957675; Borst SE, 2004, ENDOCRINE, V23, P177, DOI 10.1385/ENDO:23:2-3:177; Bowman GL, 2010, J ALZHEIMERS DIS, V19, P1331, DOI 10.3233/JAD-2010-1330; Brocato J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008590; Chang HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169577; Chaput JP, 2009, SLEEP MED, V10, P919, DOI 10.1016/j.sleep.2008.09.016; Chen XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094084; Chiou WK, 2010, J EPIDEMIOL, V20, P219, DOI 10.2188/jea.JE20090078; Chou YT, 2018, OBES RES CLIN PRACT, V12, P500, DOI 10.1016/j.orcp.2018.05.002; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Cui LF, 2017, MOD RHEUMATOL, V27, P1066, DOI 10.1080/14397595.2017.1300117; Cutler RG, 2015, CURR TOP MED CHEM, V15, P2233, DOI 10.2174/1568026615666150610143234; EFSA FEEDAP, 2014, EFSA J, V12, P1, DOI DOI 10.2903/j.efsa.2014.3547; El Ridi R, 2017, J ADV RES, V8, P487, DOI 10.1016/j.jare.2017.03.003; Fabbrini E, 2014, DIABETES, V63, P976, DOI 10.2337/db13-1396; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; He WL, 2019, J CLIN NEUROSCI, V69, P155, DOI 10.1016/j.jocn.2019.08.004; Hill VM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005206; Irwin M, 1999, J CLIN ENDOCR METAB, V84, P1979, DOI 10.1210/jc.84.6.1979; Juraschek SP, 2014, ATHEROSCLEROSIS, V233, P623, DOI 10.1016/j.atherosclerosis.2014.01.026; Kanagasabai T, 2015, SLEEP, V38, P1905, DOI 10.5665/sleep.5238; Karis E, 2014, SOUTH MED J, V107, P235, DOI 10.1097/SMJ.0000000000000082; Kim CW, 2013, J HEPATOL, V59, P351, DOI 10.1016/j.jhep.2013.03.035; Kim CE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5557-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu WJ, 2019, J PUBLIC HEALTH-UK, V41, pE158, DOI 10.1093/pubmed/fdy135; Madhavan R, 2013, IEEE ROBOT AUTOM MAG, V20, P19, DOI 10.1109/MRA.2013.2279233; Medic G, 2017, NAT SCI SLEEP, V9, P151, DOI 10.2147/NSS.S134864; Mirrakhimov AE, 2013, MED HYPOTHESES, V81, P749, DOI 10.1016/j.mehy.2013.07.042; Miyake T, 2015, J GASTROENTEROL, V50, P583, DOI 10.1007/s00535-014-0989-0; National High Blood Pressure Education Program, 2004, 7 NAT HEART LUNG BLO; Noone DG, 2013, J PEDIATR-US, V162, P128, DOI 10.1016/j.jpeds.2012.06.008; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Ok EJ, 2018, KOREAN J FAM MED, V39, P295, DOI 10.4082/kjfm.17.0034; Okubo N, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-562; Pan Z, 2020, ENDOCRINE, V69, P286, DOI 10.1007/s12020-020-02281-w; Papandreou C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040761; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Qiu L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-664; Roughley MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0610-9; Saag KG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1907; Sakuta H, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.598; Sattui SE, 2014, RHEUM DIS CLIN N AM, V40, P251, DOI 10.1016/j.rdc.2014.01.005; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Schretlen DJ, 2007, NEUROPSYCHOLOGY, V21, P136, DOI 10.1037/0894-4105.21.1.136; Seetho IW, 2015, CHRON RESP DIS, V12, P238, DOI 10.1177/1479972315586197; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Shani M, 2016, J CLIN ENDOCR METAB, V101, P3772, DOI 10.1210/jc.2016-2107; Shen L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003620; Tanaka K, 2015, ENVIRON HEALTH PREV, V20, P347, DOI 10.1007/s12199-015-0473-3; Teng GG, 2016, ARTHRIT CARE RES, V68, P1135, DOI 10.1002/acr.22821; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; Viazzi F, 2014, HIGH BLOOD PRESS CAR, V21, P189, DOI 10.1007/s40292-014-0042-7; Wan YF, 2014, ARCH MED RES, V45, P132, DOI 10.1016/j.arcmed.2013.11.006; Wang WQ, 2015, RHEUMATOLOGY, V54, P91, DOI 10.1093/rheumatology/keu304; Watanabe M, 2010, SLEEP, V33, P161, DOI 10.1093/sleep/33.2.161; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Zhao K, 2017, NEUROSCI LETT, V657, P102, DOI 10.1016/j.neulet.2017.08.015; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	75	12	12	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239185	10.1371/journal.pone.0239185	http://dx.doi.org/10.1371/journal.pone.0239185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941519	gold, Green Published			2022-12-26	WOS:000573848800084
J	Ogawa, C; Tsuchiya, K; Maeda, K				Ogawa, Chie; Tsuchiya, Ken; Maeda, Kunimi			High serum magnesium levels are associated with favorable prognoses in diabetic hemodialysis patients, retrospective observational study	PLOS ONE			English	Article							DIETARY MAGNESIUM; MORTALITY; HYPOMAGNESEMIA; PREDICTOR; SAMPLE	Background Recent studies have found hypomagnesemia is linked to a heightened risk of cardiovascular events and mortality in hemodialysis (HD) patients; however, the level of serum magnesium (s-Mg) necessary for promoting overall health in these patients and the effects of s-Mg in diabetes HD patients remains to be clarified. Methods HD outpatients (n = 148 under, age <= 70 y) were followed over a 6-y period. They were divided into four groups according to their average s-Mg during the first year (L; low level, H; high level) and if they had DM or not (non-DM). The endpoint was mortality and hospitalization for decline of Activities of Daily Living (death/hospitalization). A receiver operating characteristics curve was used in diagnostic tests to identify s-Mg associated with this endpoint. Kaplan-Meier, log-rank test, and a Cox proportional hazards model were used to evaluate prognoses. Fisher's exact test and multiple regressions examined the causes of the endpoints between the four groups and the factors predictive of s-Mg. Results s-Mg at 2.7 mg/dL was associated with death/hospitalization. The 5-y survival rate was 38.1%, 86.7%, 73.2% and 87.5%, in the DM/Mg(L), DM/Mg(H), non-DM/Mg(L) and non-DM/Mg(H) groups, respectively (P< 0.001). The Cox proportional hazards model showed significantly lower risk in other groups compared with that in the DM/Mg(L) group [DM/Mg(H); hazard ratio (HR): 0.22, 95% confidence interval (CI): 0.05-0.97,P= 0.046, non-DM/Mg(L); HR: 0.32, 95% CI: 0.15-0.68,P= 0.003, non-DM/Mg(H); HR: 0.17, 95% CI: 0.06-0.44,P< 0.001]. The frequency of the different causes of the endpoints for each group was not significant; s-Mg only associated with age in the DM group. Conclusions s-Mg greater than 2.7 mg/dL associated with a favorable prognosis in HD patients with DM, suggesting that s-Mg is a factor independent of diabetes.	[Ogawa, Chie; Maeda, Kunimi] Maeda Inst Renal Res, Kawasaki, Kanagawa, Japan; [Ogawa, Chie; Tsuchiya, Ken; Maeda, Kunimi] Biomarker Soc INC, Kawasaki, Kanagawa, Japan; [Tsuchiya, Ken] Tokyo Womens Med Univ, Dept Blood Purificat, Tokyo, Japan	Tokyo Women's Medical University	Ogawa, C (corresponding author), Maeda Inst Renal Res, Kawasaki, Kanagawa, Japan.; Ogawa, C (corresponding author), Biomarker Soc INC, Kawasaki, Kanagawa, Japan.	tato.ogawa@gmail.com			Maeda Institute of Renal Research	Maeda Institute of Renal Research	We received financial or material support from the Maeda Institute of Renal Research. C. Ogawa and K. Maeda received a salary from the Maeda Institute of Renal Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ago R, 2016, HEMODIAL INT, V20, P580, DOI 10.1111/hdi.12437; BRANNAN PG, 1976, J CLIN INVEST, V57, P1412, DOI 10.1172/JCI108410; Del Giorno R, 2018, CLIN EXP NEPHROL, V22, P620, DOI 10.1007/s10157-017-1494-6; Elin RJ, 2010, MAGNESIUM RES, V23, pS194, DOI 10.1684/mrh.2010.0213; Ford ES, 2003, J NUTR, V133, P2879, DOI 10.1093/jn/133.9.2879; Geiger H, 2012, CLIN KIDNEY J, V5, P25, DOI 10.1093/ndtplus/sfr165; Grober U, 2015, NUTRIENTS, V7, P8199, DOI 10.3390/nu7095388; Hruby A, 2014, DIABETES CARE, V37, P419, DOI 10.2337/dc13-1397; Jackson SE, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121901; King DE, 2005, J AM COLL NUTR, V24, P166, DOI 10.1080/07315724.2005.10719461; Kircelli F, 2012, NEPHROL DIAL TRANSPL, V27, P514, DOI 10.1093/ndt/gfr321; Lacson E, 2015, AM J KIDNEY DIS, V66, P1056, DOI 10.1053/j.ajkd.2015.06.014; LAKATOS E, 1988, BIOMETRICS, V44, P229, DOI 10.2307/2531910; Liu JL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122867; Nakashima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143656; Pham PCT, 2007, CLIN J AM SOC NEPHRO, V2, P366, DOI 10.2215/CJN.02960906; Sakaguchi Y, 2018, J AM SOC NEPHROL, V29, P991, DOI 10.1681/ASN.2017080849; Sakaguchi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116273; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Selim GN, 2017, INT J ARTIF ORGANS, V40, P542, DOI 10.5301/ijao.5000611; Shimohata H, 2019, HEMODIAL INT, V23, P369, DOI 10.1111/hdi.12759; SHINZATO T, 1994, NEPHRON, V67, P280, DOI 10.1159/000187980; Turgut F, 2008, INT UROL NEPHROL, V40, P1075, DOI 10.1007/s11255-008-9410-3; Vormann J, 2016, AIMS PUBLIC HEALTH, V3, P329, DOI 10.3934/publichealth.2016.2.329; Wang S, 2002, ARCH PATHOL LAB MED, V126, P947; Weisinger JR, 1998, LANCET, V352, P391, DOI 10.1016/S0140-6736(97)10535-9; Yorifuji M, 2018, HEMODIAL INT, V22, P342, DOI 10.1111/hdi.12625; Yu L, 2017, BLOOD PURIFICAT, V43, P31, DOI 10.1159/000451052	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238763	10.1371/journal.pone.0238763	http://dx.doi.org/10.1371/journal.pone.0238763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941454	gold, Green Published			2022-12-26	WOS:000573848800033
J	Rossi, F; Josey, B; Sayitoglu, EC; Potens, R; Sultu, T; Duru, AD; Beljanski, V				Rossi, Fiorella; Josey, Benjamin; Sayitoglu, Ece Canan; Potens, Renee; Sultu, Tolga; Duru, Adil Doganay; Beljanski, Vladimir			Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; BIOLOGY	Zika virus (ZIKV) is a single-stranded RNA virus belonging to the family Flaviviridae. ZIKV predominantly enters cells using the TAM-family protein tyrosine kinase receptor AXL, which is expressed on a range of cell types, including neural progenitor cells, keratinocytes, dendritic cells, and osteoblasts. ZIKV infections have been associated with fetal brain damage, which prompted the World Health Organization to declare a public health emergency in 2016. ZIKV infection has also been linked to birth defects in other organs. Several studies have reported congenital heart defects (CHD) in ZIKV infected infants and cardiovascular complications in adults infected with ZIKV. To develop a better understanding of potential causes for these pathologies at a cellular level, we characterized ZIKV infection of human fetal cardiac mesenchymal stromal cells (fcMSCs), a cell type that is known to contribute to both embryological development as well as adult cardiac physiology. Total RNA, supernatants, and/or cells were collected at various time points post-infection to evaluate ZIKV replication, cell death, and antiviral responses. We found that ZIKV productively infected fcMSCs with peak (similar to 70%) viral mRNA detected at 48 h. Use of an antibody blocking the AXL receptor decreased ZIKV infection (by similar to 50%), indicating that the receptor is responsible to a large extent for viral entry into the cell. ZIKV also altered protein expression of several mesenchymal cell markers, which suggests that ZIKV could affect fcMSCs' differentiation process. Gene expression analysis of fcMSCs exposed to ZIKV at 6, 12, and 24 h post-infection revealed up-regulation of genes/pathways associated with interferon-stimulated antiviral responses. Stimulation of TLR3 (using poly I:C) or TLR7 (using Imiquimod) prior to ZIKV infection suppressed viral replication in a dose-dependent manner. Overall, fcMSCs can be a target for ZIKV infection, potentially resulting in CHD during embryological development and/or cardiovascular issues in ZIKV infected adults.	[Rossi, Fiorella; Josey, Benjamin; Sayitoglu, Ece Canan; Potens, Renee; Duru, Adil Doganay; Beljanski, Vladimir] Nova Southeastern Univ, NSU Cell Therapy Inst, Dr Kiran C Patel Coll Allopath Med, Ft Lauderdale, FL 33314 USA; [Sultu, Tolga] Bogazici Univ, Dept Mol Biol & Genet, Istanbul, Turkey; [Duru, Adil Doganay] Karolinska Inst, Dept Med Solna, Sci Life Lab, Stockholm, Sweden	Nova Southeastern University; Bogazici University; Karolinska Institutet	Beljanski, V (corresponding author), Nova Southeastern Univ, NSU Cell Therapy Inst, Dr Kiran C Patel Coll Allopath Med, Ft Lauderdale, FL 33314 USA.	vbeljanski@nova.edu	Sutlu, Tolga/E-1190-2012	Sutlu, Tolga/0000-0002-7813-8734; Duru, Adil/0000-0002-5844-913X; Sayitoglu, Ece Canan/0000-0002-7588-1338; Beljanski, Vladimir/0000-0002-2005-1628	Zika Research Grant Initiative, Florida Department of Health [7ZK13]	Zika Research Grant Initiative, Florida Department of Health	This study was supported by the Zika Research Grant Initiative, Florida Department of Health (http://www.floridahealth.gov/) in the form of a grant awarded to VB and ADD (7ZK13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla LF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0938-2; Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802; Angelidou A, 2018, NEONATOLOGY, V113, P177, DOI 10.1159/000484656; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2019, CIRCULATION, V2019; Axelrod H, 2014, ONCOTARGET, V5, P1, DOI 10.18632/oncotarget.2422; Beys-da-Silva WO, 2019, MOL NEUROBIOL, V56, P4708, DOI 10.1007/s12035-018-1417-x; Bowen JR, 2018, VIRUS RES, V254, P21, DOI 10.1016/j.virusres.2017.08.018; Brade T, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a013847; de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085; Doppler SA, 2017, J THORAC DIS, V9, pS36, DOI 10.21037/jtd.2017.03.122; El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296; Gittenberger-De Groot AC, 2005, PEDIATR RES, V57, P169, DOI 10.1203/01.PDR.0000148710.69159.61; Gordon-Lipkin E, 2019, J DEV BEHAV PEDIATR, V40, P387, DOI 10.1097/DBP.0000000000000665; Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hwang NS, 2009, WIRES SYST BIOL MED, V1, P97, DOI 10.1002/wsbm.26; Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Ljung K, 2019, STEM CELLS DEV, V28, P310, DOI 10.1089/scd.2018.0198; Mansson-Broberg A, 2016, STEM CELL REP, V6, P607, DOI 10.1016/j.stemcr.2016.02.014; Minhas AM, 2017, CUREUS, V9, DOI 10.7759/cureus.1399; Monguio-Tortajada M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01577; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Moraes DA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0359-3; Mumtaz N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35422-3; Neo SY, 2020, J CLIN INVEST, V130, P1185, DOI 10.1172/JCI128895; Ojha CR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208543; Orofino DHG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006362; Paolino M, 2016, CANCERS, V8, DOI 10.3390/cancers8100097; Resiere D, 2018, J CLIN VIROL, V98, P8, DOI 10.1016/j.jcv.2017.11.002; Santana MB, 2019, CLIN MICROBIOL INFEC, V25, P1043, DOI 10.1016/j.cmi.2019.03.020; Serman TM, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100970; Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019; Strange DP, 2019, MBIO, V10, DOI 10.1128/mBio.01372-19; Sturzu AC, 2011, CIRC RES, V108, P353, DOI 10.1161/CIRCRESAHA.110.227066; Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Waggoner JJ, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx103; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049; Yadav S, 2016, J TRANSL INTERN MED, V4, P42, DOI 10.1515/jtim-2016-0009; Zhang B, 2010, CANCER RES, V70, P6407, DOI 10.1158/0008-5472.CAN-10-1544; Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114; Zhu CJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1090-3	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239238	10.1371/journal.pone.0239238	http://dx.doi.org/10.1371/journal.pone.0239238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941515	gold, Green Published			2022-12-26	WOS:000573848800112
J	Catala, M; Prats, C; Lopez, D; Cardona, PJ; Alonso, S				Catala, Marti; Prats, Clara; Lopez, Daniel; Cardona, Pere-Joan; Alonso, Sergio			A reaction-diffusion model to understand granulomas formation inside secondary lobule during tuberculosis infection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MACROPHAGES; MECHANISMS	Mycobacterium tuberculosis(Mtb) is the causative agent for tuberculosis, the most extended infectious disease around the world. When Mtb enters inside the pulmonary alveolus it is rapidly phagocytosed by the alveolar macrophage. Although this controls the majority of inhaled microorganisms, in this case, Mtb survives inside the macrophage and multiplies. A posterior chemokine and cytokine cascade generated by the irruption of monocytes, neutrophils and posteriorly, by T-cells, does not necessarily stop the growth of the granuloma. Interestingly, the encapsulation process built by fibroblasts is able to surround the lesion and stop its growing. The success of this last process determines if the host enters in an asymptomatic latent state or continues into a life-threatening and infective active tuberculosis disease (TB). Understanding such dichotomic process is challenging, and computational modeling can bring new ideas. Thus, we have modeled the different stages of the infection, first in a single alveolus (a sac with a radius of 0.15 millimeters) and, second, inside a secondary lobule (a compartment of the lungs of around 3 cm(3)). We have employed stochastic reaction-diffusion equations to model the interactions among the cells and the diffusive transport to neighboring alveolus. The whole set of equations have successfully described the encapsulation process and determine that the size of the lesions depends on its position on the secondary lobule. We conclude that size and shape of the secondary lobule are the relevant variables to control the lesions, and, therefore, to avoid the evolution towards TB development. As lesions appear near to interlobular connective tissue they are easily controlled and their growth is drastically stopped, in this sense secondary lobules with a more flattened shape could control better the lesion.	[Catala, Marti; Prats, Clara; Lopez, Daniel; Alonso, Sergio] Univ Politecn Cataluna, Dept Phys, Barcelona, Catalonia, Spain; [Catala, Marti; Prats, Clara; Cardona, Pere-Joan] Fundacio Inst Invest Ciencies Salut Germans Tria, Comparat Med & Bioimage Ctr Catalonia CMCiB, Badalona, Catalonia, Spain; [Cardona, Pere-Joan] Univ Autanoma Barcelona UAB, Fundacio Inst Germans Trias & Pujol IGTP, Expt TB Unit UTE, Badalona, Catalonia, Spain; [Cardona, Pere-Joan] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain	Universitat Politecnica de Catalunya; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Prats, C (corresponding author), Univ Politecn Cataluna, Dept Phys, Barcelona, Catalonia, Spain.; Prats, C (corresponding author), Fundacio Inst Invest Ciencies Salut Germans Tria, Comparat Med & Bioimage Ctr Catalonia CMCiB, Badalona, Catalonia, Spain.	clara.prats@upc.edu	Alonso, Sergio/L-6177-2014; Alonso, Sergio/GVR-8346-2022; Codina, Daniel Lopez/L-5309-2014; Prats, Clara/L-4797-2014; Cardona, Pere-Joan/A-5258-2011	Alonso, Sergio/0000-0002-3989-8757; Codina, Daniel Lopez/0000-0002-0408-4526; Prats, Clara/0000-0002-1398-7559; Cardona, Pere-Joan/0000-0001-5623-7873; Catala, Marti/0000-0003-3308-9905	La Caixa Foundation [100010434, LCF/PR/GN17/50300003]; Agencia de Gesto d'Ajuts Universitaris i de Recerca AGAUR, Grup Unitat de Tuberculosi Experimental [2017-SGR-500]; Ministerio de Ciencia, Innovacion y Universidades; FEDER [PGC2018-095456-B-I00]	La Caixa Foundation(La Caixa Foundation); Agencia de Gesto d'Ajuts Universitaris i de Recerca AGAUR, Grup Unitat de Tuberculosi Experimental; Ministerio de Ciencia, Innovacion y Universidades(Spanish Government); FEDER(European Commission)	CP, PJC and MC received funding from La Caixa Foundation (ID 100010434), under agreement LCF/PR/GN17/50300003; PJC received funding from Agencia de Gesto d'Ajuts Universitaris i de Recerca AGAUR), Grup Unitat de Tuberculosi Experimental, 2017-SGR-500; CP, DL, SA, MC received funding from Ministerio de Ciencia, Innovacion y Universidades and FEDER, with the project PGC2018-095456-B-I00.	[Anonymous], 1994, PUBL HLTH EM WHO GLO; [Anonymous], 2006, PLOS CLIN TRIALS, V1, pe33, DOI 10.1371/journal.pctr.0010033; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Bru A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012985; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2018, ENFERM INFEC MICR CL, V36, P38, DOI 10.1016/j.eimc.2017.10.015; Cardona PJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00556; Cardona PJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00354; Cardona PJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00612; Cardona PJ., 2018, CURR OPIN SYST BIOL, V12, P53, DOI [10.1016/j.coisb.2018.10.004, DOI 10.1016/J.COISB.2018.10.004]; Catala M, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007772; CHAPMAN EH, 1981, J CLIN PATHOL, V34, P1083, DOI 10.1136/jcp.34.10.1083; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Furth R, 1920, Z PHYS, V2, P244, DOI 10.1007/BF01328731; Gammack D, 2004, J MATH BIOL, V48, P218, DOI 10.1007/s00285-003-0232-8; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Haefner J.W, 2005, MODELING BIOL SYSTEM; Hao WR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148738; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Krombach F, 1997, ENVIRON HEALTH PERSP, V105, P1261, DOI 10.2307/3433544; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Marino S, 2016, COMPUTATION, V4, DOI 10.3390/computation4040039; Marzo E, 2014, TUBERCULOSIS, V94, P55, DOI 10.1016/j.tube.2013.09.004; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Prats C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00033; Ramos-Kichik V, 2009, TUBERCULOSIS, V89, P29, DOI 10.1016/j.tube.2008.09.009; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Riley LK, 2015, AM FAM PHYSICIAN, V92, P1004; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Saladin KS, 2011, HUMAN ANATOMY; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Tak T, 2013, J LEUKOCYTE BIOL, V94, P595, DOI 10.1189/jlb.1112571; TINGBEALL HP, 1993, BLOOD, V81, P2774; Todar K., 2008, TODARS ONLINE TXB BA; Verrall AJ, 2014, IMMUNOLOGY, V141, P506, DOI 10.1111/imm.12223; Warsinske HC, 2017, J THEOR BIOL, V429, P1, DOI 10.1016/j.jtbi.2017.06.017; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; WHO, 2015, WORLD HEAL ORGAN, V58, P7250; World Health Organization, 2018, GLOB TUB REP 2018; Ziraldo C, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01477	44	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0239289	10.1371/journal.pone.0239289	http://dx.doi.org/10.1371/journal.pone.0239289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936814	Green Published, gold			2022-12-26	WOS:000573658000017
J	Inoue, H; Todo, Y				Inoue, Hiroyasu; Todo, Yasuyuki			The propagation of economic impacts through supply chains: The case of a mega-city lockdown to prevent the spread of COVID-19	PLOS ONE			English	Article							SHOCKS; MODEL	This study quantifies the economic effect of a possible lockdown of Tokyo to prevent the spread of COVID-19. The negative effect of such a lockdown may propagate to other regions through supply chains because of supply and demand shortages. Applying an agent-based model to the actual supply chains of nearly 1.6 million firms in Japan, we simulate what would happen to production activities outside Tokyo if production activities that are not essential to citizens' survival in Tokyo were shut down for a certain period. We find that if Tokyo were locked down for a month, the indirect effect on other regions would be twice as large as the direct effect on Tokyo, leading to a total production loss of 27 trillion yen in Japan or 5.2% of the country's annual GDP. Although the production that would be shut down in Tokyo accounts for 21% of the total production in Japan, the lockdown would result in an 86% reduction of the daily production in Japan after one month.	[Inoue, Hiroyasu] Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo, Japan; [Todo, Yasuyuki] Waseda Univ, Grad Sch Econ, Tokyo, Japan	University of Hyogo; Waseda University	Inoue, H (corresponding author), Univ Hyogo, Grad Sch Simulat Studies, Kobe, Hyogo, Japan.	inoue@sim.u-hyogo.ac.jp		Inoue, Hiroyasu/0000-0003-1639-4801	Japan Society for the Promotion of the Science [JP18K04615, JP18H03642]	Japan Society for the Promotion of the Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	JP18K04615 (awarded to HI) JP18H03642 (awarded to YT) Japan Society for the Promotion of the Science https://www.jsps.go.jp/english/e-grants/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi A.-L., 2016, NETWORK SCI; Barrot JN, 2016, Q J ECON, V131, P1543, DOI 10.1093/qje/qjw018; Boehm CE, 2019, REV ECON STAT, V101, P60, DOI 10.1162/rest_a_00750; Bonadio Barthelemy, 2020, NBER WORKING PAPER S, V7224; Burt RS, 2004, AM J SOCIOL, V110, P349, DOI 10.1086/421787; Carvalho V. M., 2016, SUPPLY CHAIN DISRUPT; Center CR, 2020, COR COVID 19 GLOB CA; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Colon C., 2019, TRANSPORTATION SUPPL; Fujiwara Y, 2010, EUR PHYS J B, V77, P565, DOI 10.1140/epjb/e2010-00275-2; Guan DB, 2020, NAT HUM BEHAV, V4, P577, DOI 10.1038/s41562-020-0896-8; Hallegatte S, 2008, RISK ANAL, V28, P779, DOI 10.1111/j.1539-6924.2008.01046.x; Inoue H, 2019, NAT SUSTAIN, V2, P841, DOI 10.1038/s41893-019-0351-x; Inoue H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213648; Kashiwagi Y, 2018, E1810 WINPEC, pE1810; McCann F, 2020, 20203 CENTR BANK IR; McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; OECD, 2020, COR WORLD EC RISK OE; Otto C, 2017, J ECON DYN CONTROL, V83, P232, DOI 10.1016/j.jedc.2017.08.001; The Ministry of Internal Affairs and Communications, 2015, 2015 UPD INP OUTP TA; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499	23	64	65	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239251	10.1371/journal.pone.0239251	http://dx.doi.org/10.1371/journal.pone.0239251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU1BO	32931506	gold, Green Submitted, Green Published			2022-12-26	WOS:000573375500011
J	Meguro, S; Zhuang, XZ; Kirisako, H; Nakatogawa, H				Meguro, Sota; Zhuang, Xizhen; Kirisako, Hiromi; Nakatogawa, Hitoshi			Pex3 confines pexophagy receptor activity of Atg36 to peroxisomes by regulating Hrr25-mediated phosphorylation and proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						yeast; Saccharomyces cerevisiae; selective autophagy; pexophagy; peroxisome; proteasome; Atg36; Pex3; Hrr25; protein phosphorylation; autophagy; protein degradation	SELECTIVE AUTOPHAGY; MOLECULAR-MECHANISMS; CARGO RECOGNITION; ALPHA-MANNOSIDASE; TAGS PEROXISOMES; PROTEIN; PATHWAYS; TRANSPORT; IMAGE; YEAST	In macroautophagy (hereafter autophagy), cytoplasmic molecules and organelles are randomly or selectively sequestered within double-membrane vesicles called autophagosomes and delivered to lysosomes or vacuoles for degradation. In selective autophagy, the specificity of degradation targets is determined by autophagy receptors. In the budding yeast Saccharomyces cerevisiae, autophagy receptors interact with specific targets and Atg11, resulting in the recruitment of a protein complex that initiates autophagosome formation. Previous studies have revealed that autophagy receptors are regulated by posttranslational modifications. In selective autophagy of peroxisomes (pexophagy), the receptor Atg36 localizes to peroxisomes by binding to the peroxisomal membrane protein Pex3. We previously reported that Atg36 is phosphorylated by Hrr25 (casein kinase 1 delta), increasing the Atg36-Atg11 interaction and thereby stimulating pexophagy initiation. However, the regulatory mechanisms underlying Atg36 phosphorylation are unknown. Here, we show that Atg36 phosphorylation is abolished in cells lacking Pex3 or expressing a Pex3 mutant defective in the interaction with Atg36, suggesting that the interaction with Pex3 is essential for the Hrr25-mediated phosphorylation of Atg36. Using recombinant proteins, we further demonstrated that Pex3 directly promotes Atg36 phosphorylation by Hrr25. A co-immunoprecipitation analysis revealed that the interaction of Atg36 with Hrr25 depends on Pex3. These results suggest that Pex3 increases the Atg36-Hrr25 interaction and thereby stimulates Atg36 phosphorylation on the peroxisomal membrane. In addition, we found that Pex3 binding protects Atg36 from proteasomal degradation. Thus, Pex3 confines Atg36 activity to the peroxisome by enhancing its phosphorylation and stability on this organelle.	[Meguro, Sota; Zhuang, Xizhen; Kirisako, Hiromi; Nakatogawa, Hitoshi] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology	Nakatogawa, H (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan.	hnakatogawa@bio.titech.ac.jp	Nakatogawa, Hitoshi/D-5155-2015	Nakatogawa, Hitoshi/0000-0002-5828-0741	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25111003, 17H01430, 19H05708]; Tokyo Tech Fund; STAR Grant	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Tech Fund; STAR Grant	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grants 25111003, 17H01430, and 19H05708 (to H. N.). Support was also provided by Tokyo Tech Fund with a STAR Grant (to H.N).	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Brachmann CB, 1998, YEAST, V14, P115; Burnett SF, 2015, J BIOL CHEM, V290, P8623, DOI 10.1074/jbc.M114.619338; Cho DH, 2018, MOL CELLS, V41, P55, DOI 10.14348/molcells.2018.2245; Conway O, 2020, J MOL BIOL, V432, P2483, DOI 10.1016/j.jmb.2019.10.013; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Farre JC, 2019, EMBO REP, V20, DOI 10.15252/embr.201846864; Farre JC, 2016, NAT REV MOL CELL BIO, V17, P537, DOI 10.1038/nrm.2016.74; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Harada K, 2019, ELIFE, V8, DOI 10.7554/eLife.43088; HOHFELD J, 1991, J CELL BIOL, V114, P1167, DOI 10.1083/jcb.114.6.1167; Honsho M, 2016, BBA-MOL CELL RES, V1863, P984, DOI 10.1016/j.bbamcr.2015.09.032; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kageyama T, 2009, BIOCHEM BIOPH RES CO, V378, P551, DOI 10.1016/j.bbrc.2008.11.084; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kotani T, 2018, P NATL ACAD SCI USA, V115, P10363, DOI 10.1073/pnas.1806727115; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506; Mochida K, 2014, FEBS LETT, V588, P3862, DOI 10.1016/j.febslet.2014.09.032; Motley AM, 2012, EMBO J, V31, P2852, DOI 10.1038/emboj.2012.151; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2020, NAT REV MOL CELL BIO, V21, P439, DOI 10.1038/s41580-020-0241-0; Nazarko TY, 2014, J CELL BIOL, V204, P541, DOI 10.1083/jcb.201307050; Nuttall JM, 2014, AUTOPHAGY, V10, P835, DOI 10.4161/auto.28259; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Pfaffenwimmer T, 2014, EMBO REP, V15, P862, DOI 10.15252/embr.201438932; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Suzuki K, 2010, J BIOL CHEM, V285, P30019, DOI 10.1074/jbc.M110.143511; Tanaka C, 2014, J CELL BIOL, V207, P91, DOI 10.1083/jcb.201402128; Turco E, 2019, MOL CELL, V74, P330, DOI 10.1016/j.molcel.2019.01.035; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906; Zientara-Rytter K, 2020, J MOL BIOL, V432, P104, DOI 10.1016/j.jmb.2019.06.017; Zientara-Rytter K, 2018, AUTOPHAGY, V14, P368, DOI 10.1080/15548627.2017.1413521	42	3	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16292	16298		10.1074/jbc.RA120.013565	http://dx.doi.org/10.1074/jbc.RA120.013565			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32958557	hybrid, Green Published			2022-12-26	WOS:000598519500010
J	Fontenot, CR; Tasnim, H; Valdes, KA; Popescu, CV; Ding, HG				Fontenot, Chelsey R.; Tasnim, Homyra; Valdes, Kathryn A.; Popescu, Codrina V.; Ding, Huangen			Ferric uptake regulator (Fur) reversibly binds a [2Fe-2S] cluster to sense intracellular iron homeostasis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron homeostasis; iron&#8211; sulfur cluster; ferric uptake regulator (Fur); iron&#8211; sulfur protein; iron metabolism; repressor protein; Escherichia coli (E; coli); Mossbauer spectroscopy; electron paramagnetic resonance (EPR); intracellular iron homeostasis; IscA	ELECTRON-PARAMAGNETIC-RESONANCE; MOSSBAUER-SPECTROSCOPY; INTACT MITOCHONDRIA; CRYSTAL-STRUCTURE; SULFUR CLUSTERS; PROTEIN; BIOGENESIS; GENE; SITE; INDUCTION	The ferric uptake regulator (Fur) is a global transcription factor that regulates intracellular iron homeostasis in bacteria. The current hypothesis states that when the intracellular "free" iron concentration is elevated, Fur binds ferrous iron, and the iron-bound Fur represses the genes encoding for iron uptake systems and stimulates the genes encoding for iron storage proteins. However, the "iron-bound" Fur has never been isolated from any bacteria. Here we report that the Escherichia coli Fur has a bright red color when expressed in E. coli mutant cells containing an elevated intracellular free iron content because of deletion of the iron-sulfur cluster assembly proteins IscA and SufA. The acid-labile iron and sulfide content analyses in conjunction with the EPR and Mossbauer spectroscopy measurements and the site-directed mutagenesis studies show that the red Fur protein binds a [2Fe-2S] cluster via conserved cysteine residues. The occupancy of the [2Fe-2S] cluster in Fur protein is similar to 31% in the E. coli iscA/sufA mutant cells and is decreased to similar to 4% in WT E. coli cells. Depletion of the intracellular free iron content using the membrane-permeable iron chelator 2,2 '-dipyridyl effectively removes the [2Fe-2S] cluster from Fur in E. coli cells, suggesting that Fur senses the intracellular free iron content via reversible binding of a [2Fe-2S] cluster. The binding of the [2Fe-2S] cluster in Fur appears to be highly conserved, because the Fur homolog from Hemophilus influenzae expressed in E. coli cells also reversibly binds a [2Fe-2S] cluster to sense intracellular iron homeostasis.	[Fontenot, Chelsey R.; Tasnim, Homyra; Ding, Huangen] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Valdes, Kathryn A.; Popescu, Codrina V.] Univ St Thomas, Dept Chem, St Paul, MN USA	Louisiana State University System; Louisiana State University; University of St Thomas Minnesota	Ding, HG (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	hding@lsu.edu		Tasnim, Homyra/0000-0001-5191-1021; Ding, Huangen/0000-0002-4815-7336	National Institutes of Health [R15GM129564]; Louis Stokes Alliance for Minority Participation Bridge to Doctorate program at Louisiana State University from NSF; College of Arts and Sciences at University of Saint Thomas (MN); Collaborative Research Grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louis Stokes Alliance for Minority Participation Bridge to Doctorate program at Louisiana State University from NSF; College of Arts and Sciences at University of Saint Thomas (MN); Collaborative Research Grant	This work was supported by National Institutes of Health Grant R15GM129564. C. R. F. was supported by The Louis Stokes Alliance for Minority Participation Bridge to Doctorate program at Louisiana State University from NSF. The Mossbauer spectroscopy work was funded by start-up funds from The College of Arts and Sciences at University of Saint Thomas (MN) to C. V. P. and a Collaborative Research Grant to K. A. V. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Althaus EW, 1999, BIOCHEMISTRY-US, V38, P6559, DOI 10.1021/bi982788s; Andrews S, 2013, METAL IONS LIFE SCI, V12, P203, DOI 10.1007/978-94-007-5561-1_7; Beauchene NA, 2017, P NATL ACAD SCI USA, V114, P12261, DOI 10.1073/pnas.1707189114; Belmonte L, 2017, J CHEM INF MODEL, V57, P3162, DOI 10.1021/acs.jcim.7b00468; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Cheng ZS, 2017, J BIOL CHEM, V292, P3146, DOI 10.1074/jbc.M116.766774; COWART RE, 1993, ANAL BIOCHEM, V211, P151, DOI 10.1006/abio.1993.1246; COY M, 1994, BIOMETALS, V7, P292; Cutone A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31872; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Fillat MF, 2014, ARCH BIOCHEM BIOPHYS, V546, P41, DOI 10.1016/j.abb.2014.01.029; Gutlich P, 2011, MOSSBAUER SPECTROSCOPY AND TRANSITION METAL CHEMISTRY: FUNDAMENTALS AND APPLICATIONS, P1; HAMED MY, 1993, J INORG BIOCHEM, V50, P193, DOI 10.1016/0162-0134(93)80025-5; Hider RC, 2013, DALTON T, V42, P3220, DOI 10.1039/c2dt32149a; Hohle TH, 2016, MOL MICROBIOL, V101, P152, DOI 10.1111/mmi.13381; Hudder BN, 2007, J BIOL INORG CHEM, V12, P1029, DOI 10.1007/s00775-007-0275-1; Jacquamet L, 2000, J AM CHEM SOC, V122, P394, DOI 10.1021/ja991932+; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Katigbak J, 2012, J PHYS CHEM LETT, V3, P3503, DOI 10.1021/jz301689b; Landry AP, 2013, DALTON T, V42, P3100, DOI 10.1039/c2dt32000b; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Li HR, 2011, J BIOL CHEM, V286, P867, DOI 10.1074/jbc.M110.184176; Li LT, 2012, J BIOL CHEM, V287, P35709, DOI 10.1074/jbc.M112.395533; Lillig CH, 2005, P NATL ACAD SCI USA, V102, P8168, DOI 10.1073/pnas.0500735102; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mettert EL, 2014, J BACTERIOL, V196, P4315, DOI 10.1128/JB.01975-14; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Mills SA, 2005, BIOCHEMISTRY-US, V44, P13553, DOI 10.1021/bi0507579; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Nader S, 2019, BIOMETALS, V32, P501, DOI 10.1007/s10534-019-00201-8; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Pandelia ME, 2015, BBA-MOL CELL RES, V1853, P1395, DOI 10.1016/j.bbamcr.2014.12.005; Pecqueur L, 2006, J BIOL CHEM, V281, P21286, DOI 10.1074/jbc.M601278200; Perard J, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0095-6; Pi HL, 2017, P NATL ACAD SCI USA, V114, P12785, DOI 10.1073/pnas.1713008114; Pinochet-Barros A, 2018, ANTIOXID REDOX SIGN, V29, P1858, DOI 10.1089/ars.2017.7359; Popescu CV, 1998, P NATL ACAD SCI USA, V95, P13431, DOI 10.1073/pnas.95.23.13431; Rietzschel N, 2015, MOL CELL BIOL, V35, P370, DOI 10.1128/MCB.01033-14; Roncarati D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12593; Rouault TA, 2017, J BIOL CHEM, V292, P12744, DOI 10.1074/jbc.R117.789537; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Seo SW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5910; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Tan GQ, 2012, BIOMETALS, V25, P1177, DOI 10.1007/s10534-012-9580-4; Tan GQ, 2009, BIOCHEM J, V420, P463, DOI 10.1042/BJ20090206; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Wofford JD, 2019, J BIOL CHEM, V294, P50, DOI 10.1074/jbc.RA118.005233; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; Yang J, 2015, J BIOL CHEM, V290, P14226, DOI 10.1074/jbc.M115.654269; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264; Zhu JW, 2018, BIOINFORMATICS, V34, P263, DOI 10.1093/bioinformatics/bty278	57	19	19	5	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15454	15463		10.1074/jbc.RA120.014814	http://dx.doi.org/10.1074/jbc.RA120.014814			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32928958	Green Published, hybrid			2022-12-26	WOS:000594361600003
J	Ali, SA; Abbasi, Z; Shahid, B; Moin, G; Hambidge, KM; Krebs, NF; Westcott, JE; McClure, EM; Goldenberg, RL; Saleem, S				Ali, Sumera Aziz; Abbasi, Zahid; Shahid, Babar; Moin, Ghazal; Hambidge, K. Michael; Krebs, Nancy F.; Westcott, Jamie E.; McClure, Elizabeth M.; Goldenberg, Robert L.; Saleem, Sarah			Prevalence and determinants of anemia among women of reproductive age in Thatta Pakistan: Findings from a cross-sectional study	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; PREGNANT-WOMEN; MATERNAL ANEMIA; HEMOGLOBIN CONCENTRATION; NONPREGNANT WOMEN; RISK-FACTORS; ABSORPTION; IMPACT; DIET	Background Anemia is a major public health concern among women of reproductive age leading to high maternal mortality in low- and middle-income countries. Of the prior studies conducted in Pakistan, most focused on large urban areas and did not explore the determinants of anemia among women of reproductive age (WRA) across socio-demographic, dietary, reproductive, and biological domains. Thus, we aimed to study the prevalence and determinants of anemia among WRA in rural Pakistan. Methods We conducted a cross-sectional study in the Thatta district of Pakistan from September 2018 to January 2019 and enrolled 150 non-pregnant, married women. Data collectors administered a structured questionnaire to collect sociodemographic, reproductive and dietary data from women, who also provided stool and blood samples. We classified all WRA as anemic if their hemoglobin was <12.0 g/dl. We performed logistic regression analysis to calculate adjusted odds ratios (aOR) and their respective 95% CIs to assess the determinants of anemia. Results In our study, 61.3% of the enrolled women were anemic. In the multivariable analysis, we found that factors such as serum iron levels of less than 50 mu g/dl (aOR: 7.17; 95% CI (2.94, 17.47)), history of breastfeeding (aOR: 2.43; 95% CI (1.04, 5.72)), living in a katcha house (aOR: 6.61; 95% CI (2.21, 19.87)), no consumption of meat (aOR: 4.18; 95% CI (1.66, 9.96)) were significantly associated with anemia among WRA. A history of more than one abortion (aOR: 0.06; 95% CI (0.01, 0.33) appeared protective for its association with anemia. Conclusion Our findings demonstrate a high burden of anemia and its complex determinants among WRA in rural Pakistan. A combination of nutritional and educational strategies should be designed to encourage rural women to consume iron-rich foods in their diet with an access to adequate food. Breastfeeding women should be encouraged to consume extra calories with sufficient intake of the food to continue exclusive breastfeeding and reserve the iron stores through amenorrhea to prevent themselves from becoming anemic.	[Ali, Sumera Aziz] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Abbasi, Zahid; Shahid, Babar; Moin, Ghazal; Saleem, Sarah] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Hambidge, K. Michael; Krebs, Nancy F.; Westcott, Jamie E.] Univ Colorado, Sect Nutr, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [McClure, Elizabeth M.] Reg Triangulate Inst Int, Res Triangle Pk, NC USA; [Goldenberg, Robert L.] Columbia Univ, Dept Obstet & Gynecol, New York, NY USA	Columbia University; Aga Khan University; University of Colorado System; University of Colorado Anschutz Medical Campus; Columbia University	Ali, SA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	sa3778@cumc.columbia.edu		Shahid, Babar/0000-0001-9478-2098	University of ColoradoDenver USA \ Anschutz Medical Campus; University of Colorado-Denver USA \ Anschutz Medical Campus	University of ColoradoDenver USA \ Anschutz Medical Campus; University of Colorado-Denver USA \ Anschutz Medical Campus	The primary and only source of funding for this study was the University of ColoradoDenver USA vertical bar Anschutz Medical Campus. Neither my instituion (Aga Khan University), nor any other organization provided any funding for this crosssectional study The funders had no role in study design, data collection and analysis, except they reviewed and approved the protocol of the study and provided feedback and comments on the final manuscript and approved the manuscript for publication. No author received salary for this cross-sectional study. The authors "Sumera Aziz Ali and Zahid Abbasi" received a proportion of their salary for the main and primary Women First study, but not for this cross-sectional study. The primary Women First study was funded by University of Colorado-Denver USA vertical bar Anschutz Medical Campus. We received funding for this study from the University of Colorado-Denver USA vertical bar Anschutz Medical Campus.	Ahmad M, 2013, INT J SOCIOLOGY SOCI; Akinlaja O., 2016, OBSTET GYNE COL INT, V4; AlSayes F, 2011, J MED LAB DIAGNOSIS, V2, P5; Amin OM, 2000, J MICROBIOL METH, V39, P127, DOI 10.1016/S0167-7012(99)00108-6; Anjum Anam, 2015, Punjab University Journal of Zoology, V30, P15; [Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; [Anonymous], 2004, J PROSTHET ORTHOT; [Anonymous], 2006, INFOFISH INT, V2, P71; [Anonymous], 2007, OFFICIAL J EUROPEAN; [Anonymous], 2012, KIDNEY INT, V2, ps1; Ayong L, 2019, METHODS MOL BIOL, V2013, P73, DOI 10.1007/978-1-4939-9550-9_5; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Bentley ME, 2003, EUR J CLIN NUTR, V57, P52, DOI 10.1038/sj.ejcn.1601504; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Bhandary S, 2011, JGPEMN, V2, P21; Bhargava A, 2001, J NUTR, V131, P758, DOI 10.1093/jn/131.3.758; Bose CL, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S1; Cappellini MD, 2015, SEMINARS HEMATOLOGY; Chowdhury S., 2014, MED TODAY, V26, P49, DOI [10.3329/medtoday.v26i1.21314, DOI 10.3329/MEDTODAY.V26I1.21314]; Devanesan S, 2019, J INFECT PUBLIC HEAL, V12, P585, DOI 10.1016/j.jiph.2019.02.018; Dewey KG, 2001, J NUTR, V131, P262, DOI 10.1093/jn/131.2.262; Gebremedhin S, 2011, ETHIOP J HEALTH DEV, V25, P22; Ghose B, 2016, PEERJ, V4, DOI 10.7717/peerj.1945; Goudar SS, 2012, INT J GYNECOL OBSTET, V118, P190, DOI 10.1016/j.ijgo.2012.04.022; Habib MA, 2018, ASIA PAC J CLIN NUTR, V27, P195, DOI 10.6133/apjcn.042017.14; Hambidge KM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102534; Hambidge KM, 2019, AM J CLIN NUTR, V109, P457, DOI 10.1093/ajcn/nqy228; Harding KL, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12478; Harvey LJ, 2005, BRIT J NUTR, V94, P557, DOI 10.1079/BJN20051493; Hassan U, 2013, PAKISTAN ARMED FORCE, V63, P266; Heath ALM, 2002, BEST PRACT RES CL HA, V15, P225, DOI 10.1053/beha.2002.0208; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Irfan Ullah, 2013, International Journal of Biosciences (IJB), V3, P77; Kamruzzaman M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0211-4; Lander RL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071560; Liabsuetrakul T, 2011, J HEALTH POPUL NUTR, V29, P218, DOI 10.3329/jhpn.v29i3.7869; Mardani M, 2017, J MATERN-FETAL NEO M, V30, P826, DOI 10.1080/14767058.2016.1187126; MARTINEZTORRES C, 1971, AM J CLIN NUTR, V24, P531; Medicine Io Lactation NRCSoND Lactation IoMSoNd Lactation IoMSo Resources USH Administration S, 1991, NUTR LACT; Milman N, 2017, AM J CLIN NUTR, V106, p1655S, DOI 10.3945/ajcn.117.156000; Milman N, 2011, ANN HEMATOL, V90, P1247, DOI 10.1007/s00277-011-1279-z; Ministry of National Services Regulation and Coordination (MoNHSR&C) GoP, 2018, NAT NUTR SURV; Monarrez-Espino J, 2001, SALUD PUBLICA MEXICO, V43, P392, DOI 10.1590/S0036-36342001000500002; MONSEN ER, 1988, J AM DIET ASSOC, V88, P786; Namaste SML, 2017, AM J CLIN NUTR, V106, p333S, DOI 10.3945/ajcn.116.142273; National Institute of Population Studies, 2017, PAK DEM HLTH SURV 20; Nguyen PH, 2015, EUR J CLIN NUTR, V69, P107, DOI 10.1038/ejcn.2014.181; Ouedraogo S, 2013, AM J TROP MED HYG, V88, P292, DOI 10.4269/ajtmh.12-0195; Parks S, 2019, BJOG-INT J OBSTET GY, V126, P737, DOI 10.1111/1471-0528.15585; Pasricha SR, 2008, AM J TROP MED HYG, V78, P375, DOI 10.4269/ajtmh.2008.78.375; Preet K., 2018, INT J RES MED SCI, V6, P628; Rozi S., 2016, OPEN J EPIDEMIOL, V6, P95; Senaviratna N. A. M. R., 2019, ASIAN J PROBAB STAT, V5, P1, DOI [10.9734/ajpas/2019/v5i230132, DOI 10.9734/AJPAS/2019/V5I230132]; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Thomson CA, 2011, J AM DIET ASSOC, V111, P532, DOI 10.1016/j.jada.2011.01.017; Uche-Nwachi EO, 2010, AFR HEALTH SCI, V10, P66; Waninge A, MEASURING PHYS FITNE, V31, P38; World Health Organization, 2011, SER FERR CONC ASS IR; World Health Organization, 2015, GLOB PREV AN 2011, V2017; Young SL, 2010, AM J TROP MED HYG, V83, P144, DOI 10.4269/ajtmh.2010.09-0442	60	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239320	10.1371/journal.pone.0239320	http://dx.doi.org/10.1371/journal.pone.0239320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970719	gold, Green Published			2022-12-26	WOS:000576265600002
J	Charlie-Silva, I; Feitosa, NM; Gomes, JMM; Hoyos, DCD; Mattioli, CC; Eto, SF; Fernandes, DC; Belo, MAD; Silva, JD; de Barros, ALB; Correa, JD; de Menezes, GB; Fukushima, HCS; Castro, TFD; Borra, RC; Pierezan, F; de Melo, NFS; Fraceto, LF				Charlie-Silva, Ives; Feitosa, Natalia Martins; Mendonca Gomes, Juliana Moreira; de Melo Hoyos, Daniela Chemim; Mattioli, Cristiano Campos; Eto, Silas Fernandes; Fernandes, Dayanne Carla; de Andrade Belo, Marco Antonio; Silva, Juliana de Oliveira; Branco de Barros, Andre Luis; Correa Junior, Jose Dias; de Menezes, Gustavo Batista; Silva Fukushima, Hirla Costa; Dias Castro, Tassia Flavia; Borra, Ricardo Carneiro; Pierezan, Felipe; Silva de Melo, Nathalie Ferreira; Fraceto, Leonardo Fernandes			Potential of mucoadhesive nanocapsules in drug release and toxicology in zebrafish	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; RAINBOW-TROUT; BENZOCAINE; NANOPARTICLES; VALIDATION; EFFICACY; FISH	Mucoadhesive polymeric nanocapsules have attracted interest of researchers from different fields from natural sciences because of their ability to interact with the mucosa and increase drug permeation. Anesthesia by immersion causes absorption through the skin and gills of fish, so it is important to evaluate the exposure of these organs to drug nanosystems. Benzocaine (BENZ) is one of the most popular anesthetic agents used in fish anesthesia, but it has drawbacks because of its low bioavailability, resulting in weak absorption after immersion. Here we describe method developed for preparing and characterizing chitosan-coated PLGA mucoadhesive nanoparticles containing BENZ (NPMAs) for zebrafish immersion anesthesia. We determined the lowest effective concentration, characterized the interaction of the mucoadhesive system with fish, measured the anesthetic efficacy, and evaluated possible toxic effects in embryos and adults exposed to the nanoformulations. This study opens perspectives for using nanoformulations prepared with BENZ in aquaculture, allowing reduction of dosage as well as promoting more effective anesthesia and improved interaction with the mucoadhesive system of fish.	[Charlie-Silva, Ives] Univ Sao Paulo ICB USP, Dept Pharmacol, Sao Paulo, SP, Brazil; [Feitosa, Natalia Martins] Univ Fed Rio de Janeiro UFRJ, Inst Biodiversidade & Sustentabilidade NUPEM, Lab Integrad Biociencias Translacionais LIBT, Macae, RJ, Brazil; [Mendonca Gomes, Juliana Moreira; Correa Junior, Jose Dias; de Menezes, Gustavo Batista] ICB UFMG, Dept Morphol, Belo Horizonte, MG, Brazil; [de Melo Hoyos, Daniela Chemim] Univ Fed Minas Gerais, Aquiculture Lab Laqua, Belo Horizonte, MG, Brazil; [Mattioli, Cristiano Campos; de Andrade Belo, Marco Antonio] Sao Paulo State Univ, Dept Prevent Vet Med, Jaboticabal, SP, Brazil; [Eto, Silas Fernandes] Fed Univ Roraima UFRR, Dept Postgrad Hlth SciencesPROCISA, Boa Vista, Parana, Brazil; [Fernandes, Dayanne Carla] Sao Paulo State Univ, Inst Chem, UNESP, Araraquara, SP, Brazil; [de Andrade Belo, Marco Antonio] Brasil Univ, Lab Anim Pharmacol & Toxicol, Descalvado, SP, Brazil; [Silva, Juliana de Oliveira; Branco de Barros, Andre Luis] Univ Fed Minas Gerais, Dept Clin & Toxicol Anal, Fac Pharm, Belo Horizonte, MG, Brazil; [Silva Fukushima, Hirla Costa; Dias Castro, Tassia Flavia; Borra, Ricardo Carneiro] Univ Fed Sao Carlos, Lab Appl Immunol, Sao Carlos, SP, Brazil; [Pierezan, Felipe] Univ Fed Minas Gerais, Dept Clin & Vet Surg, Sch Vet Med, Belo Horizonte, MG, Brazil; [Silva de Melo, Nathalie Ferreira] Fac Med Sao Leopoldo Mandic, Araras, SP, Brazil; [Fraceto, Leonardo Fernandes] Sao Paulo State Univ, Inst Sci & Technol Sorocaba, Sorocaba, SP, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade Federal de Roraima; Universidade Estadual Paulista; Universidade Federal de Minas Gerais; Universidade Federal de Sao Carlos; Universidade Federal de Minas Gerais; Faculdade Sao Leopoldo Mandic; Universidade Estadual Paulista	Charlie-Silva, I (corresponding author), Univ Sao Paulo ICB USP, Dept Pharmacol, Sao Paulo, SP, Brazil.	charliesilva4@hotmail.com	Feitosa, Natalia M/B-6991-2013; de Barros, Andre Luis/O-2615-2017; Fraceto, Leonardo/C-4468-2012; Gomes, Juliana Moreira Mendonça/AAG-8391-2019; Belo, Marco/H-2183-2013; Mattioli, Cristiano/AAJ-7662-2020; Fraceto, Leonardo Fernandes/ABF-2797-2021; Corrêa, José Dias/P-3815-2019; FAPESP, CDMF/J-3591-2015	de Barros, Andre Luis/0000-0002-7641-6585; Belo, Marco/0000-0001-5845-3940; Mattioli, Cristiano/0000-0002-4271-5309; Fraceto, Leonardo Fernandes/0000-0002-2827-2038; Corrêa, José Dias/0000-0002-8623-8524; Fernandes, Dayanne Carla/0000-0003-2037-1397; Chemim de Melo Hoyos, Daniela/0000-0001-6196-2404; FAPESP, CDMF/0000-0002-4464-0937; Charlie-Silva, Ives/0000-0002-7572-2767; Moreira Mendonca Gomes, Juliana/0000-0002-5444-5764	Sao Paulo Research Foundation [2013/25971-9, 2018/07098-0, 2019/19939-1]; Minas Gerais Research Foundation [APQ-02913-17]; National Council for Scientific and Technological Development [301473/2016-1, 477816/2013-4]; Coordination for Improvement of Higher Education Personnel	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Minas Gerais Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for Improvement of Higher Education Personnel	Financial and material support was provided through the Sao Paulo Research Foundation (#2013/25971-9 for author MAdAB, #2018/07098-0 and #2019/19939-1 for author ICS), by the Minas Gerais Research Foundation (#APQ-02913-17 for author JDCJ), by the National Council for Scientific and Technological Development (#301473/2016-1 for author JDCJ, #477816/2013-4 for author MAdAB), and by the Coordination for Improvement of Higher Education Personnel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nemrawi NK, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010028; ALLEN JL, 1988, PROG FISH CULT, V50, P59, DOI 10.1577/1548-8640(1988)050&lt;0059:ROBIRT&gt;2.3.CO;2; Anderson W, 2013, J COLLOID INTERF SCI, V405, P322, DOI 10.1016/j.jcis.2013.02.030; [Anonymous], 2016, J NANOBIOTECHNOLOGY; Barboza FM, 2014, SCI WORLD J, DOI 10.1155/2014/268107; Bolasina SN, 2017, AQUACULT REP, V6, P56, DOI 10.1016/j.aqrep.2017.04.002; Brox S, 2016, ENVIRON SCI TECHNOL, V50, P10264, DOI 10.1021/acs.est.6b04325; Charlie-Silva I, 2018, FISH SHELLFISH IMMUN; Charlie-Silva I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41312-z; Clemente-Napimoga JT, 2012, LIFE SCI, V90, P944, DOI 10.1016/j.lfs.2012.04.035; Demare P, 2012, J CHEM EDUC, V89, P147, DOI 10.1021/ed100838a; Dudhani AR, 2010, CARBOHYD POLYM, V81, P243, DOI 10.1016/j.carbpol.2010.02.026; Ehrlich O, 2019, ZEBRAFISH, V16, P451, DOI 10.1089/zeb.2019.1737; Eto SF, 2018, FISH SHELLFISH IMMUN, V76, P153, DOI 10.1016/j.fsi.2018.02.048; Fabiani BM, 2013, ACTA SCI ANIM SCI; Gholipourkanani H, 2015, J FISH AQUAT SCI; Gilderhus PA, 1987, N AM J FISH MANAGE; Gomez D, 2013, FISH SHELLFISH IMMUN, V35, P1729, DOI 10.1016/j.fsi.2013.09.032; Grillo R, 2014, INT J ENV SCI TECHNO; Grillo R, 2010, J DRUG TARGET, V18, P688, DOI 10.3109/10611861003649738; Grillo R, 2009, LAT AM J PHARM, V28, P393; Heo GJ, 2010, VET ANAESTH ANALG, V37, P132, DOI 10.1111/j.1467-2995.2009.00510.x; Khair-ul-Bariyah S, 2020, MINI-REV MED CHEM, V20, P3, DOI 10.2174/1389557519666190913145423; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; Marques PE, 2015, NAT PROTOC, V10, P258, DOI 10.1038/nprot.2015.006; Melo NFS de, 2017, J NANOSCI NANOTECHNO; Moraes CM, 2009, MATER SCI ENG B-ADV, V165, P243, DOI 10.1016/j.mseb.2009.06.011; Nangia S, 2012, LANGMUIR, V28, P17666, DOI 10.1021/la303449d; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL, P2002, DOI 10.1017/S0016672303216384; Oberdorster G, 2009, J NANOSCI NANOTECHNO, V9, P4996, DOI 10.1166/jnn.2009.GR02; OECD, 1995, GUID TEST CHEM, DOI [10.1787/9789264069787-en, DOI 10.1787/9789264203709-EN]; Olt J, 2016, J PHYSIOL-LONDON, V594, P5427, DOI 10.1113/JP271794; Readman GD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06917-2; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; Shaikh R, 2011, J PHARM BIOALLIED SC, V3, P89, DOI 10.4103/0975-7406.76478; de Melo NFS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161796; de Melo NFS, 2014, COLLOID SURFACE B, V121, P66, DOI 10.1016/j.colsurfb.2014.05.035; De Melo NFS, 2012, J PHARM SCI-US, V101, P1157, DOI 10.1002/jps.22829; de Melo NFS, 2011, PHARM RES-DORDR, V28, P1984, DOI 10.1007/s11095-011-0425-6; Simovic S, 2015, NANOMED-NANOTECHNOL, V11, P1169, DOI 10.1016/j.nano.2015.02.016; Sosnik A, 2015, BIOTECHNOL ADV, V33, P1380, DOI 10.1016/j.biotechadv.2015.01.003; Torchilin VP, 2014, NAT REV DRUG DISCOV, V13, P813, DOI 10.1038/nrd4333; Wang YF, 2017, F1000RESEARCH; WEDEMEYER G, 1970, J FISH RES BOARD CAN, V27, P909, DOI 10.1139/f70-097; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wynd BM, 2017, ZEBRAFISH, V14, P1, DOI 10.1089/zeb.2016.1289	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238823	10.1371/journal.pone.0238823	http://dx.doi.org/10.1371/journal.pone.0238823			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970684	Green Published, gold			2022-12-26	WOS:000576265600090
J	Masen, MA; Chung, A; Dawczyk, JU; Dunning, Z; Edwards, L; Guyott, C; Hall, TAG; Januszewski, RC; Jiang, SL; Jobanputra, RD; Karunaseelan, KJ; Kalogeropoulos, N; Lima, MR; Castillo, CSM; Mohammed, IK; Murali, M; Paszkiewicz, FP; Plotczyk, M; Pruncu, CI; Rodgers, E; Russell, F; Silversides, R; Stoddart, JC; Tan, ZC; Uribe, D; Yap, KK; Zhou, X; Vaidyanathan, R				Masen, Marc A.; Chung, Aaron; Dawczyk, Joanna U.; Dunning, Zach; Edwards, Lydia; Guyott, Christopher; Hall, Thomas A. G.; Januszewski, Rachel C.; Jiang, Shaoli; Jobanputra, Rikeen D.; Karunaseelan, Kabelan J.; Kalogeropoulos, Nikolaos; Lima, Maria R.; Castillo, C. Sebastian Mancero; Mohammed, Idris K.; Murali, Manoj; Paszkiewicz, Filip P.; Plotczyk, Magdalena; Pruncu, Catalin, I; Rodgers, Euan; Russell, Felix; Silversides, Richard; Stoddart, Jennifer C.; Tan, Zhengchu; Uribe, David; Yap, Kian K.; Zhou, Xue; Vaidyanathan, Ravi			Evaluating lubricant performance to reduce COVID-19 PPE-related skin injury	PLOS ONE			English	Article							FRICTION; HYDRATION; OILS	Background Healthcare workers around the world are experiencing skin injury due to the extended use of personal protective equipment (PPE) during the COVID-19 pandemic. These injuries are the result of high shear stresses acting on the skin, caused by friction with the PPE. This study aims to provide a practical lubricating solution for frontline medical staff working a 4+ hours shift wearing PPE. Methods A literature review into skin friction and skin lubrication was conducted to identify products and substances that can reduce friction. We evaluated the lubricating performance of commercially available products in vivo using a custom-built tribometer. Findings Most lubricants provide a strong initial friction reduction, but only few products provide lubrication that lasts for four hours. The response of skin to friction is a complex interplay between the lubricating properties and durability of the film deposited on the surface and the response of skin to the lubricating substance, which include epidermal absorption, occlusion, and water retention. Interpretation Talcum powder, a petrolatum-lanolin mixture, and a coconut oil-cocoa butter-beeswax mixture showed excellent long-lasting low friction. Moisturising the skin results in excessive friction, and the use of products that are aimed at 'moisturising without leaving a non-greasy feel' should be prevented. Most investigated dressings also demonstrate excellent performance.	[Masen, Marc A.; Chung, Aaron; Dawczyk, Joanna U.; Edwards, Lydia; Guyott, Christopher; Hall, Thomas A. G.; Januszewski, Rachel C.; Jiang, Shaoli; Jobanputra, Rikeen D.; Karunaseelan, Kabelan J.; Kalogeropoulos, Nikolaos; Lima, Maria R.; Castillo, C. Sebastian Mancero; Mohammed, Idris K.; Murali, Manoj; Paszkiewicz, Filip P.; Pruncu, Catalin, I; Rodgers, Euan; Russell, Felix; Silversides, Richard; Stoddart, Jennifer C.; Tan, Zhengchu; Uribe, David; Yap, Kian K.; Zhou, Xue; Vaidyanathan, Ravi] Imperial Coll London, Dept Mech Engn, London, England; [Dunning, Zach] Coventry Univ, Dept Mfg Engn, Coventry, W Midlands, England; [Jiang, Shaoli] Wuhan Univ Technol, Wuhan, Peoples R China; [Plotczyk, Magdalena] Imperial Coll London, Dept Bioengn, London, England; [Zhou, Xue] Southwest Jiaotong Univ, Chengdu, Peoples R China	Imperial College London; Coventry University; Wuhan University of Technology; Imperial College London; Southwest Jiaotong University	Masen, MA (corresponding author), Imperial Coll London, Dept Mech Engn, London, England.	m.masen@imperial.ac.uk	Hall, Thomas/ABG-5042-2021; Raposo de Lima, Maria/AAD-4624-2022; Pruncu, Catalin/A-6880-2018; Jobanputra, Rikeen/AAD-6817-2021	Raposo de Lima, Maria/0000-0002-6032-3042; Pruncu, Catalin/0000-0002-4926-2189; Masen, Marc/0000-0002-9423-7193; Mancero Castillo, Carlos Sebastian/0000-0001-6020-4695; Hall, Thomas/0000-0001-6695-1130; Plotczyk, Magdalena/0000-0002-2676-1671; Vaidyanathan, Ravi/0000-0002-9625-4544; Yap, Kian Kun/0000-0001-5368-1063; Chung, Aaron/0000-0002-1467-2153; Uribe, David/0000-0002-3839-6771; Jobanputra, Rikeen/0000-0001-8600-8422	Imperial College COVID-19 response fund; MRC [UKDRI-7003] Funding Source: UKRI	Imperial College COVID-19 response fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Imperial College COVID-19 response fund for funding this study.	Adams MJ, 2007, TRIBOL LETT, V26, P239, DOI 10.1007/s11249-007-9206-0; [Anonymous], 2017, INT J COMMUN SYST, V30, pe2999; [Anonymous], 2020, CLIN DIABETOLOGY, V9, P1; Bader DL, 2019, CLIN BIOMECH, V67, P70, DOI 10.1016/j.clinbiomech.2019.04.018; Brill AK, 2017, RESPIROLOGY, V22, P1343, DOI 10.1111/resp.13074; DEACON RF, 1958, PROC R SOC LON SER-A, V243, P464, DOI 10.1098/rspa.1958.0013; Falloon SS, 2019, P I MECH ENG H, V233, P35, DOI 10.1177/0954411918802756; Foo CCI, 2006, CONTACT DERMATITIS, V55, P291, DOI 10.1111/j.1600-0536.2006.00953.x; Gefen A, 2020, WOUND MANAGEMENT PRE, V66; Gefen Amit, 2020, J Wound Care, V29, pS1, DOI 10.12968/jowc.2020.29.Sup2a.S1; Gerhardt LC, 2008, J R SOC INTERFACE, V5, P1317, DOI 10.1098/rsif.2008.0034; Hendriks CP, 2010, TRIBOL LETT, V37, P361, DOI 10.1007/s11249-009-9530-7; Klaassen M, 2020, COLLOID SURFACE B, V189, DOI 10.1016/j.colsurfb.2020.110883; Kuilenburg J van, 2013, P IMECHE J, V227, P347; Loden M, 2012, CLIN DERMATOL, V30, P286, DOI 10.1016/j.clindermatol.2011.08.015; Lu R, 2020, LANCET, V395, P565574; Lynde C W, 2001, Skin Therapy Lett, V6, P3; Manorama A, 2013, CLIN BIOMECH, V28, P574, DOI 10.1016/j.clinbiomech.2013.04.001; Oomens C. W. J., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P171, DOI 10.1080/1025584031000121034; Patzelt A, 2012, SKIN RES TECHNOL, V18, P364, DOI 10.1111/j.1600-0846.2011.00578.x; Rawlings A V, 2004, Dermatol Ther, V17 Suppl 1, P49, DOI 10.1111/j.1396-0296.2004.04S1006.x; Recalcati S, 2020, J EUR ACAD DERMATOL, V34, pE212, DOI 10.1111/jdv.16387; REICHEL SM, 1958, JAMA-J AM MED ASSOC, V166, P762, DOI 10.1001/jama.1958.62990070004010a; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stamatas GN, 2008, J DERMATOL SCI, V50, P135, DOI 10.1016/j.jdermsci.2007.11.006; Veijgen NK, 2013, TRIBOL LETT, V49, P251, DOI 10.1007/s11249-012-0062-1; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117; Zhou Nuo-Ya, 2020, Int J Dermatol Venereol, DOI 10.1097/JD9.0000000000000085; Zulkowski K, 2017, ADV SKIN WOUND CARE, V30, P372, DOI 10.1097/01.ASW.0000521048.64537.6e	29	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239363	10.1371/journal.pone.0239363	http://dx.doi.org/10.1371/journal.pone.0239363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970710	gold, Green Published			2022-12-26	WOS:000576265600047
J	Du, M				Du, Marvin			Windows of opportunity for daily physical activity	PLOS ONE			English	Article							AIR-POLLUTION; WALKABILITY; MORTALITY	Air pollution is a serious concern to people who want to engage in physical activities to improve and maintain their health. However, air quality data collected at the nearest monitoring site may not be the best source of information because the data may be incomplete (e.g., some pollutants are not monitored) or not representative. This paper puts forward a method that uses air quality data from a large area to derive a diurnal profile of air quality variation for that area and identify the time window in which the air quality is typically the best during a day. If people exercise in that time window then they can minimize their exposure to air pollution. Three years' worth of air quality data in five California counties were analyzed to identify the general pattern of diurnal variation of air quality. The analysis shows the pattern of air quality variation is very similar among those five counties which represent diverse geographical and meteorological conditions. The analysis further reveals that in California air quality is generally the best in early mornings; as such, people should exercise in the early morning if their daily schedule allows it. A similar analysis can be performed for other areas to help people choose the best time window to exercise.	[Du, Marvin] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Du, M (corresponding author), Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA.	marvin.du@berkeley.edu						Andersen ZJ, 2015, ENVIRON HEALTH PERSP, V123, P557, DOI 10.1289/ehp.1408698; Bentley R, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP2080, 10.1289/ehp2080]; CARB, 2021, ANN NETW PLAN COV MO; Cepeda M, 2017, LANCET PUBLIC HEALTH, V2, pE23, DOI 10.1016/S2468-2667(16)30021-4; Giles LV, 2014, SPORTS MED, V44, P223, DOI 10.1007/s40279-013-0108-z; Giorgini P, 2016, J CARDIOPULM REHABIL, V36, P84, DOI 10.1097/HCR.0000000000000139; Hankey S, 2017, ENVIRON HEALTH PERSP, V125, P527, DOI 10.1289/EHP442; Marshall JD, 2009, ENVIRON HEALTH PERSP, V117, P1752, DOI 10.1289/ehp.0900595; Reis RS, 2013, AM J PREV MED, V45, P269, DOI 10.1016/j.amepre.2013.04.020; Roberts JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090143; Sun J, 2015, J AIR WASTE MANAGE, V65, P611, DOI 10.1080/10962247.2015.1033068; Sundquist K, 2011, SOC SCI MED, V72, P1266, DOI 10.1016/j.socscimed.2011.03.004; Tainio M, 2016, PREV MED, V87, P233, DOI 10.1016/j.ypmed.2016.02.002; U.S. EPA, 1992, EPA454R92019; Yu HJ, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0592-x	15	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238713	10.1371/journal.pone.0238713	http://dx.doi.org/10.1371/journal.pone.0238713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966318	gold, Green Published			2022-12-26	WOS:000575688700004
J	Riboli, A; Coratella, G; Rampichini, S; Ce, E; Esposito, F				Riboli, Andrea; Coratella, Giuseppe; Rampichini, Susanna; Ce, Emiliano; Esposito, Fabio			Area per player in small-sided games to replicate the external load and estimated physiological match demands in elite soccer players	PLOS ONE			English	Article							HEART-RATE RESPONSES; GLOBAL POSITIONING SYSTEM; METABOLIC POWER; ENERGY-COST; PHYSICAL DEMANDS; INJURY RISK; FOOTBALL; PERFORMANCE; INTENSITY; NUMBER	The current study determined the area-per-player during small- or large-sided games with or without goalkeeper that replicates the relative (m center dot min(-1)) total distance, high-intensity running distance, sprint distance and metabolic power covered during official matches. Time-motion analysis was performed on twenty-five elite soccer-players during 26 home-matches. A total of 2565 individual samples for SSGs using different pitch sizes and different number of players were collected and classified as SSGs with (SSG-G) or without goalkeeper (SSG-P). A between-position comparison was also performed. The area-per-player needed to replicate the official match demands waslargelyhigher in SSG-GvsSSG-P for total distance [187 +/- 53 vs 115 +/- 35 m(2), effect size (ES): 1.60 95%CI 0.94/2.21], high-intensity running distance [262 +/- 72 vs 166 +/- 39 m(2), ES: 1.66(0.99/2.27)] and metabolic power [177 +/- 42 vs 94 +/- 40, ES: 1.99(1.31/2.67)], but similar for sprint distance [(316 +/- 75 vs 295 +/- 99 m(2), ES: 0.24(-0.32/0.79)] with direction of larger area-per-player for sprint distance > high-intensity running > total distance x224c; metabolic power for both SSG-G and SSG-P. In SSG-G, forwards required higher area-per-player than central-defenders [ES: 2.96(1.07/4.35)], wide-midfielders [ES: 2.45(0.64/3.78)] and wide-defenders [ES: 3.45(1.13/4.99)]. Central-midfielders required higher area-per-player than central-defenders [ES: 1.69(0.20/2.90)] and wide-midfielders [ES: 1.35(-0.13/2.57)]. In SSG-P, central defenders need lower area-per-player (ES: -6.01/-0.92) to overall replicate the match demands compared to all other positions. The current results may be used to gain knowledge of the SSGs relative to the match demands. This imply manipulating SSGs using higher or lower ApP, the presence of the goalkeeper or design specific rules to increase or decrease the position-specific demands with respect to the desired external load outcomes.	[Riboli, Andrea] Atalanta BC, Performance Dept, Bergamo, Italy; [Riboli, Andrea; Coratella, Giuseppe; Rampichini, Susanna; Ce, Emiliano; Esposito, Fabio] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	University of Milan	Riboli, A (corresponding author), Atalanta BC, Performance Dept, Bergamo, Italy.; Riboli, A (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	riboliandrea@outlook.com	Riboli, Andrea/AAI-3232-2020; Riboli, Andrea/AAC-1340-2021; Esposito, Fabio/E-9340-2011	Riboli, Andrea/0000-0003-3088-0224; Esposito, Fabio/0000-0002-4420-2611; CORATELLA, GIUSEPPE/0000-0001-7523-9102				Aguiar M, 2012, J HUM KINET, V33, P103, DOI 10.2478/v10078-012-0049-x; [Anonymous], 2010, OFFICIAL J L, V27, P1; [Anonymous], 2009, WORLD ARCHAEOL, V41; Bowen L, 2019, BRIT J SPORT MED, DOI [10.1136/bjsports-2018-099422, DOI 10.1136/BJSP0RTS-2018-099422]; Bowen L, 2017, BRIT J SPORT MED, V51, P452, DOI 10.1136/bjsports-2015-095820; Brown DM, 2016, INT J SPORT PHYSIOL, V11, P1067, DOI 10.1123/ijspp.2016-0021; Buchheit M, 2015, INT J SPORTS MED, V36, P1149, DOI 10.1055/s-0035-1555927; Buchheit M, 2014, J SPORT SCI, V32, P1271, DOI 10.1080/02640414.2014.884721; Buchheit M, 2014, INT J SPORT PHYSIOL, V9, P442, DOI [10.1123/ijspp.2013-0187, 10.1123/IJSPP.2013-0187]; Castagna C, 2019, INT J SPORT PHYSIOL, V14, P1265, DOI 10.1123/ijspp.2018-0645; Castagna C, 2017, INT J SPORT PHYSIOL, V12, P490, DOI 10.1123/ijspp.2016-0160; Castellano J, 2013, J STRENGTH COND RES, V27, P1295, DOI 10.1519/JSC.0b013e318267a5d1; Castellano J, 2013, J SPORT SCI MED, V12, P209; Castellano J, 2012, J HUM KINET, V31, P139, DOI 10.2478/v10078-012-0015-7; Coutts AJ, 2015, J SCI MED SPORT, V18, P219, DOI 10.1016/j.jsams.2014.02.003; da Silva CD, 2011, J STRENGTH COND RES, V25, P2746, DOI 10.1519/JSC.0b013e31820da061; Dellal A, 2008, J STRENGTH COND RES, V22, P1449, DOI 10.1519/JSC.0b013e31817398c6; di Prampero PE, 2015, EUR J APPL PHYSIOL, V115, P451, DOI 10.1007/s00421-014-3086-4; di Prampero PE, 2018, INT J SPORTS MED, V39, P581, DOI 10.1055/a-0592-7660; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Gaudino P, 2014, INT J SPORTS MED, V35, P489, DOI 10.1055/s-0033-1355418; Gaudino P, 2014, HUM MOVEMENT SCI, V36, P123, DOI 10.1016/j.humov.2014.05.006; Gregson W, 2010, INT J SPORTS MED, V31, P237, DOI 10.1055/s-0030-1247546; Harley JA, 2011, J STRENGTH COND RES, V25, P2334, DOI 10.1519/JSC.0b013e3181f0a88f; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hoppe MW, 2015, INT J SPORTS MED, V36, P563, DOI 10.1055/s-0034-1398578; Kempton T, 2015, J SPORT SCI, V33, P39, DOI 10.1080/02640414.2014.921832; Koklu Y, 2015, J STRENGTH COND RES, V29, P964, DOI 10.1519/JSC.0b013e3182a744a1; Krustrup P, 2005, MED SCI SPORT EXER, V37, P1242, DOI 10.1249/01.mss.0000170062.73981.94; Kunz P, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0180-5; Lacome M, 2018, INT J SPORT PHYSIOL, V13, P668, DOI 10.1123/ijspp.2017-0340; Lacome M, 2018, INT J SPORT PHYSIOL, V13, P568, DOI 10.1123/ijspp.2017-0214; Mallo J, 2008, J SPORT MED PHYS FIT, V48, P166; Malone S, 2017, J SPORT MED PHYS FIT, V57, P543, DOI 10.23736/S0022-4707.16.06233-2; Malone S, 2017, J SCI MED SPORT, V20, P250, DOI 10.1016/j.jsams.2016.08.005; Manzi V, 2014, J STRENGTH COND RES, V28, P914, DOI 10.1519/JSC.0000000000000239; Martin-Garcia A, 2018, J STRENGTH COND RES, V32, P3511, DOI 10.1519/JSC.0000000000002816; Minetti AE, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.182303; Moniz F, 2020, J HUM KINET, V71, P167, DOI 10.2478/hukin-2019-0080; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Planells-Palop V, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0653-4; Polglaze T, 2019, INT J SPORT PHYSIOL, V14, P407, DOI 10.1123/ijspp.2018-0661; Polglaze T, 2018, MED SCI SPORT EXER, V50, P1487, DOI 10.1249/MSS.0000000000001575; Polglaze T, 2018, J SPORT SCI, V36, P140, DOI 10.1080/02640414.2017.1287933; Rampinini E, 2007, INT J SPORTS MED, V28, P1018, DOI 10.1055/s-2007-965158; Rampinini E, 2015, INT J SPORTS MED, V36, P49, DOI 10.1055/s-0034-1385866; Randers MB, 2010, J SPORT SCI, V28, P171, DOI 10.1080/02640410903428525; Stevens TGA, 2015, MED SCI SPORT EXER, V47, P1219, DOI 10.1249/MSS.0000000000000515; Young D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225947	49	19	19	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0229194	10.1371/journal.pone.0229194	http://dx.doi.org/10.1371/journal.pone.0229194			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966305	gold, Green Published, Green Submitted			2022-12-26	WOS:000575688700008
J	Cappellini, A; Mongiorgi, S; Finelli, C; Fazio, A; Ratti, S; Marvi, MV; Curti, A; Salvestrini, V; Pellagatti, A; Billi, AM; Suh, PG; McCubrey, JA; Boultwood, J; Manzoli, L; Cocco, L; Follo, MY				Cappellini, Alessandra; Mongiorgi, Sara; Finelli, Carlo; Fazio, Antonietta; Ratti, Stefano; Marvi, Maria Vittoria; Curti, Antonio; Salvestrini, Valentina; Pellagatti, Andrea; Billi, Anna Maria; Suh, Pann-Ghill; McCubrey, James A.; Boultwood, Jacqueline; Manzoli, Lucia; Cocco, Lucio; Follo, Matilde Y.			Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS)	FASEB JOURNAL			English	Article						deferasirox; inositides; reactive oxygen species	NUCLEAR PI-PLCBETA1; BONE-MARROW; DEFERASIROX; CELLS; ACTIVATION; OVERLOAD; DIFFERENTIATION; AZACITIDINE; INVOLVEMENT; EXPRESSION	MDS are characterized by anemia and transfusion requirements. Transfused patients frequently show iron overload that negatively affects hematopoiesis. Iron chelation therapy can be effective in these MDS cases, but the molecular consequences of this treatment need to be further investigated. That is why we studied the molecular features of iron effect and Deferasirox therapy on PI-PLCbeta1 inositide signaling, using hematopoietic cells and MDS samples. At baseline, MDS patients showing a positive response after iron chelation therapy displayed higher levels of PI-PLCbeta1/Cyclin D3/PKCalpha expression. During treatment, these responder patients, as well as hematopoietic cells treated with FeCl(3)and Deferasirox, showed a specific reduction of PI-PLCbeta1/Cyclin D3/PKCalpha expression, indicating that this signaling pathway is targeted by Deferasirox. The treatment was also able to specifically decrease the production of ROS. This effect correlated with a reduction of IL-1A and IL-2, as well as Akt/mTOR phosphorylation. In contrast, cells exposed only to FeCl(3)and cells from MDS patients refractory to Deferasirox showed a specific increase of ROS and PI-PLCbeta1/Cyclin D3/PKCalpha expression. All in all, our data show that PI-PLCbeta1 signaling is a target for iron-induced oxidative stress and suggest that baseline PI-PLCbeta1 quantification could predict iron chelation therapy response in MDS.	[Cappellini, Alessandra; Mongiorgi, Sara; Fazio, Antonietta; Ratti, Stefano; Marvi, Maria Vittoria; Billi, Anna Maria; Manzoli, Lucia; Cocco, Lucio; Follo, Matilde Y.] Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Via Irnerio 48, I-40126 Bologna, Italy; [Finelli, Carlo; Curti, Antonio; Salvestrini, Valentina] Univ Hosp S Orsola Malpighi, Inst Hematol L & A Seragnoli, Dept Hematol & Oncol, Bologna, Italy; [Pellagatti, Andrea; Boultwood, Jacqueline] Univ Oxford, Nuffield Div Clin Lab Sci, Radcliffe Dept Med, Blood Canc UK Mol Haematol Unit, Oxford, England; [Pellagatti, Andrea; Boultwood, Jacqueline] Oxford BRC Haematol Theme, Oxford, England; [Suh, Pann-Ghill] Korea Brain Res Inst, Daegu, South Korea; [Suh, Pann-Ghill] UNIST, Sch Life Sci, Ulsan, South Korea; [McCubrey, James A.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Oxford; Korea Brain Research Institute (KBRI); Ulsan National Institute of Science & Technology (UNIST); University of North Carolina; East Carolina University	Cocco, L; Follo, MY (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Via Irnerio 48, I-40126 Bologna, Italy.	lucio.cocco@unibo.it; matilde.follo@unibo.it	ratti, stefano/AAC-8714-2022	RATTI, STEFANO/0000-0002-6258-5345; Curti, Antonio/0000-0002-7752-6049; Pellagatti, Andrea/0000-0002-6122-0221	Italian Ministry of Education, University and Research-Research Projects of National Interest; Intesa San Paolo Foundation; Blood Cancer UK [13042]	Italian Ministry of Education, University and Research-Research Projects of National Interest; Intesa San Paolo Foundation; Blood Cancer UK	Italian Ministry of Education, University and Research-Research Projects of National Interest; Intesa San Paolo Foundation; Blood Cancer UK, Grant/Award Number: 13042	Angelucci E, 2014, EUR J HAEMATOL, V92, P527, DOI 10.1111/ejh.12300; Bae J, 2008, J MICROBIOL BIOTECHN, V18, P377; Bowen D, 2003, HAEMATOLOGICA, V88, P1070; Cappellini Maria Domenica, 2007, Ther Clin Risk Manag, V3, P291, DOI 10.2147/tcrm.2007.3.2.291; Casciaro F, 2018, AGING-US, V10, P2911, DOI 10.18632/aging.101599; Cermak J, 2013, LEUKEMIA RES, V37, P1612, DOI 10.1016/j.leukres.2013.07.021; Chan S, 2015, CELL PHYSIOL BIOCHEM, V36, P2063, DOI 10.1159/000430173; Chen YL, 2015, BBA-MOL CELL RES, V1853, P2662, DOI 10.1016/j.bbamcr.2015.07.025; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; Cocco L, 2015, J LEUKOCYTE BIOL, V98, P769, DOI 10.1189/jlb.2MA1114-541R; Fabiani E, 2019, BRIT J HAEMATOL, V185, P954, DOI 10.1111/bjh.15655; Faenza I, 2005, ANTICANCER RES, V25, P2039; Faenza I, 2003, J CELL PHYSIOL, V195, P446, DOI 10.1002/jcp.10264; Follo MY, 2012, LEUKEMIA, V26, P2474, DOI 10.1038/leu.2012.133; Follo MY, 2012, LEUKEMIA, V26, P943, DOI 10.1038/leu.2011.300; Follo MY, 2011, LEUKEMIA, V25, P271, DOI 10.1038/leu.2010.266; Follo MY, 2019, LEUKEMIA, V33, P2276, DOI 10.1038/s41375-019-0416-x; Follo Matilde Y., 2013, Advances in Biological Regulation, V53, P2, DOI 10.1016/j.jbior.2012.09.009; Follo MY, 2010, J CELL BIOCHEM, V109, P1065, DOI 10.1002/jcb.22483; Forciniti S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062257; Garlanda C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00396; Gattermann N, 2012, HAEMATOL-HEMATOL J, V97, P1364, DOI 10.3324/haematol.2011.048546; Ghoti H, 2010, HAEMATOL-HEMATOL J, V95, P1433, DOI 10.3324/haematol.2010.024992; Gozali MV, 2016, SCI REP-UK, V6, DOI 10.1038/srep27402; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Guida M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/456937; Harmening D, 1983, MODERN BLOOD BANKING; Hartmann J, 2013, LEUKEMIA RES, V37, P327, DOI 10.1016/j.leukres.2012.11.005; Jayavelu AK, 2016, EXP HEMATOL, V44, P1113, DOI 10.1016/j.exphem.2016.08.008; Jimenez-Solas T, 2019, BRIT J HAEMATOL, V187, P93, DOI 10.1111/bjh.16013; Kelly E, 2002, J IMMUNOL, V168, P597, DOI 10.4049/jimmunol.168.2.597; Keune Willem-Jan, 2013, Adv Biol Regul, V53, P179, DOI 10.1016/j.jbior.2013.02.001; Leitch HA, 2019, CRIT REV ONCOL HEMAT, V141, P54, DOI 10.1016/j.critrevonc.2019.06.002; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Lo Vasco VR, 2004, LEUKEMIA, V18, P1122, DOI 10.1038/sj.leu.2403368; MANZOLI L, 1995, CANCER RES, V55, P2978; Manzoli L, 2014, MINI-REV MED CHEM, V14, P873, DOI 10.2174/1389557514666141013125936; Messa E, 2010, HAEMATOL-HEMATOL J, V95, P1308, DOI 10.3324/haematol.2009.016824; Mongiorgi S, 2016, EXPERT OPIN THER TAR, V20, P677, DOI 10.1517/14728222.2016.1125885; Mongiorgi S, 2016, CURR PHARM DESIGN, V22, P2345, DOI 10.2174/1381612822666160226132338; NOCKA KH, 1988, CANCER RES, V48, P3571; Nolte F, 2013, ANN HEMATOL, V92, P191, DOI 10.1007/s00277-012-1594-z; Novotna B, 2009, LEUKEMIA RES, V33, P340, DOI 10.1016/j.leukres.2008.07.005; Pellagatti A, 2016, LEUKEMIA, V30, P247, DOI 10.1038/leu.2015.129; Poli A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092080; Poli A, 2018, FASEB J, V32, P681, DOI 10.1096/fj.201700690R; Poli A, 2017, J CELL PHYSIOL, V232, P2550, DOI 10.1002/jcp.25642; Poli A, 2014, BIOCHEM SOC T, V42, P1471, DOI 10.1042/BST20140128; Ramazzotti G, 2011, J CELL PHYSIOL, V226, P14, DOI 10.1002/jcp.22334; Ratti S, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118649; Ratti S, 2019, J LIPID RES, V60, P312, DOI 10.1194/jlr.R089763; Ratti Stefano, 2018, Advances in Biological Regulation, V67, P1, DOI 10.1016/j.jbior.2017.10.008; Ratti S, 2017, J CELL BIOCHEM, V118, P1969, DOI 10.1002/jcb.25894; Saigo Katsuyasu, 2013, J Clin Med Res, V5, P57, DOI 10.4021/jocmr1180w; Silva A, 2011, LEUKEMIA, V25, P960, DOI 10.1038/leu.2011.56; Song MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134235; Suire S, 2019, J LEUKOCYTE BIOL, V106, P815, DOI 10.1002/JLB.2HI0918-359RR; Tataranni T, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1293-y; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Xian J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030697; Zeitz MJ, 2009, J CELL BIOCHEM, V108, P125, DOI 10.1002/jcb.22234; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhu GZ, 2018, CELL IMMUNOL, V328, P9, DOI 10.1016/j.cellimm.2018.02.015; Zuo Y, 2009, CELL RES, V19, P449, DOI 10.1038/cr.2009.19	64	2	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15400	15416		10.1096/fj.202000933RR	http://dx.doi.org/10.1096/fj.202000933RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959428	Green Published, hybrid			2022-12-26	WOS:000573858100001
J	Gowen, KM; de Smet, TS				Gowen, Kyle M.; de Smet, Timothy S.			Testing least cost path (LCP) models for travel time and kilocalorie expenditure: Implications for landscape genomics	PLOS ONE			English	Article							GENETICS	Least Cost Path (LCP) analysis allows a user to define a cost parameter through which cost of movement can be assessed using Geographical Information Systems (GIS). These analyses are commonly used to construct theoretical movement through a landscape, which has been useful for creating hypotheses concerning prehistoric archaeology and landscape genomics. However, LCP analysis is commonly employed without testing the generated LCP(s), complicating its usefulness as a methodological tool. This paper proposes a model for analyzing movement in ArcGIS by using topography data to calculate slope. This slope data is then then used to calculate LCPs based on travel time and kilocalorie expenditure. LCPs were constructed in the Nature Preserve at Binghamton University, a 182-acre area that consists of wetland and mountainous terrain, and a Fitbit (R) Surge activity monitor was used to test the accuracy of the model's predictions. Paired sample t-tests show a lack of significant difference between calculated and walked time in our analysis (p = .953), suggesting that our model can estimate travel time between two points based solely on slope of the region. Paired sample t-tests also show a lack of significant difference between calculated and observed kilocalorie expenditure (p = .930), suggesting that our model is also capable of estimating kilocalorie expenditure associated with movement between two points. Finally, paired sample t-tests confirm that straight line distances do not reflect real movement through a terrain (p = .009), highlighting the need for alternate measures of movement when analyzing the effects of local landscape on movement. Our current model shows strength in its estimations of travel time and kilocalorie expenditure based on topography of a region-future iterations of the model need to establish the statistical similarity between our model's estimations and recorded values for walking time and kilocalorie expenditure.	[Gowen, Kyle M.; de Smet, Timothy S.] Binghamton Univ, Dept Anthropol, Binghamton, NY USA; [Gowen, Kyle M.] Binghamton Univ, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA; [de Smet, Timothy S.] Binghamton Univ, Geophys & Remote Sensing Lab, Binghamton, NY USA; [de Smet, Timothy S.] Binghamton Univ, Dept Geol Sci & Environm Studies, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Gowen, KM (corresponding author), Binghamton Univ, Dept Anthropol, Binghamton, NY USA.; Gowen, KM (corresponding author), Binghamton Univ, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA.	kgowen1@binghamton.edu		Gowen, Kyle/0000-0002-6264-9820				Cushman SA, 2002, AM NATURALIST, V168, P486; Field Sean., 2019, J COMPUTER APPL ARCH, V2, P136; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; GAJDUSEK DC, 1972, AM J HUM GENET, V24, pS1; GAJDUSEK DC, 1977, SCIENCE, V197, P943, DOI 10.1126/science.142303; Gustas R, 2017, J ARCHAEOL SCI, V78, P40, DOI 10.1016/j.jas.2016.11.006; Kantner J., 2012, LEAST COST ANAL SOCI, P225, DOI DOI 10.13140/2.1.1765.4725; Leidwanger J, 2013, J ARCHAEOL SCI, V40, P3302, DOI 10.1016/j.jas.2013.03.016; Li MA, 2020, AM J PHYS ANTHROPOL, V172, P87, DOI 10.1002/ajpa.24047; Lindenbaum S., 1979, KURU SORCERY DISEASE; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; Mccoy MD, 2011, J ARCHAEOL SCI, V38, P2547, DOI 10.1016/j.jas.2011.04.017; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; PANDOLF KB, 1977, ERGONOMICS, V20, P399, DOI 10.1080/00140137708931642; Santee WR, 2001, AVIAT SPACE ENVIR MD, V72, P562; Spark C., 2005, HLTH HIST, V7, P80; Taliaferro MS, 2010, J ARCHAEOL SCI, V37, P536, DOI 10.1016/j.jas.2009.10.018; Tobler W., 1993, 931 U CAL NAT GEOGR; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; White DA, 2012, J ARCHAEOL SCI, V39, P2684, DOI 10.1016/j.jas.2012.04.017	21	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239387	10.1371/journal.pone.0239387	http://dx.doi.org/10.1371/journal.pone.0239387			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960937	gold, Green Published			2022-12-26	WOS:000575109500017
J	Pearse, AR; McGree, JM; Som, NA; Leigh, C; Maxwell, P; Ver Hoef, JM; Peterson, EE				Pearse, Alan R.; McGree, James M.; Som, Nicholas A.; Leigh, Catherine; Maxwell, Paul; Ver Hoef, Jay M.; Peterson, Erin E.			SSNdesign-An R package for pseudo-Bayesian optimal and adaptive sampling designs on stream networks	PLOS ONE			English	Article							SPATIAL STATISTICAL-MODELS; THREATS; RIVER	Streams and rivers are biodiverse and provide valuable ecosystem services. Maintaining these ecosystems is an important task, so organisations often monitor the status and trends in stream condition and biodiversity using field sampling and, more recently, autonomousin-situsensors. However, data collection is often costly, so effective and efficient survey designs are crucial to maximise information while minimising costs. Geostatistics and optimal and adaptive design theory can be used to optimise the placement of sampling sites in freshwater studies and aquatic monitoring programs. Geostatistical modelling and experimental design on stream networks pose statistical challenges due to the branching structure of the network, flow connectivity and directionality, and differences in flow volume. Geostatistical models for stream network data and their unique features already exist. Some basic theory for experimental design in stream environments has also previously been described. However, open source software that makes these design methods available for aquatic scientists does not yet exist. To address this need, we presentSSNdesign, an R package for solving optimal and adaptive design problems on stream networks that integrates with existing open-source software. We demonstrate the mathematical foundations of our approach, and illustrate the functionality ofSSNdesignusing two case studies involving real data from Queensland, Australia. In both case studies we demonstrate that the optimal or adaptive designs outperform random and spatially balanced survey designs implemented in existing open-source software packages. TheSSNdesignpackage has the potential to boost the efficiency of freshwater monitoring efforts and provide much-needed information for freshwater conservation and management.	[Pearse, Alan R.; Leigh, Catherine; Peterson, Erin E.] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld, Australia; [Pearse, Alan R.; McGree, James M.; Leigh, Catherine; Peterson, Erin E.] Queensland Univ Technol, Australian Res Council, Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia; [McGree, James M.; Leigh, Catherine; Peterson, Erin E.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia; [Som, Nicholas A.] US Fish & Wildlife Serv, Arcata, CA USA; [Som, Nicholas A.] Humboldt State Univ, Arcata, CA 95521 USA; [Maxwell, Paul] Hlthy Land & Water, Brisbane, Qld, Australia; [Ver Hoef, Jay M.] NOAA Fisheries, Alaska Fisheries Sci Ctr, Seattle, WA, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); Queensland University of Technology (QUT); United States Department of the Interior; US Fish & Wildlife Service; California State University System; California State Polytechnic University, Humboldt	Pearse, AR (corresponding author), Queensland Univ Technol, Inst Future Environm, Brisbane, Qld, Australia.; Pearse, AR (corresponding author), Queensland Univ Technol, Australian Res Council, Ctr Excellence Math & Stat Frontiers, Brisbane, Qld, Australia.	arp320@uowmail.edu.au		Pearse, Alan/0000-0002-4133-8548; Leigh, Catherine/0000-0003-4186-1678	Healthy Land and Water; Australian Research Council [DP200101263]	Healthy Land and Water; Australian Research Council(Australian Research Council)	This study received funding and support from Healthy Land and Water (https://hlw.org.au/) and was motivated by their monitoring needs and desire to transition their freshwater monitoring program to the use of in-situ sensors at broad spatial scales. E.E.P and J.M.M received the award from Healthy Land and Water. P.M. works for Healthy Land and Water and P.M. assisted in identifying the two motivating examples/case studies for the study and provided the data used in the second case study. P.M. also contributed to the preparation of the manuscript. In addition, JMM was supported by an Australian Research Council Discovery Project (DP200101263).	Atkinson AC., 2007, OPTIMUM EXPT DESIGNS; Clyde MA, 1999, BAYESIAN STATISTICS 6, P157; Cressie N., 2011, STAT SPATIO TEMPORAL; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Evangelou E, 2012, J STAT PLAN INFER, V142, P3242, DOI 10.1016/j.jspi.2012.05.008; Falk MG, 2014, ENVIRON ECOL STAT, V21, P751, DOI 10.1007/s10651-014-0279-2; Hoef JMV, 2001, SPATIAL UNCERTAINTY IN ECOLOGY, P214; Isaak DJ, 2017, WATER RESOUR RES, V53, P9181, DOI 10.1002/2017WR020969; Kang SY, 2016, ECOL APPL, V26, P2635, DOI 10.1002/eap.1409; Kincaid T., 2018, SPSURVEY SPATIAL SUR; Larsen DP, 2008, J AGR BIOL ENVIR ST, V13, P243, DOI 10.1198/108571108X336593; Lu BB, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7080293; Marsha A, 2018, ECOL INDIC, V84, P11, DOI 10.1016/j.ecolind.2017.08.028; McGree JM, 2012, J STAT PLAN INFER, V142, P1480, DOI 10.1016/j.jspi.2011.12.029; Melo O., 2012, GEOSPT R PACKAGE SPA; MORRIS MD, 1995, J STAT PLAN INFER, V43, P381, DOI 10.1016/0378-3758(94)00035-T; Muller P, 1999, BAYESIAN STATISTICS 6, P459; Muller P, 2007, J STAT PLAN INFER, V137, P3140, DOI 10.1016/j.jspi.2006.05.021; Peterson EE, 2011, STARS SPATIAL TOOLS; Peterson EE, 2014, J STAT SOFTW, V56, P1; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Poff N. LeRoy, 2012, P309; Pronzato L, 2012, STAT COMPUT, V22, P681, DOI 10.1007/s11222-011-9242-3; R Core Team, 2018, R LANG ENV STAT COMP; Royle JA, 2002, J STAT PLAN INFER, V100, P121, DOI 10.1016/S0378-3758(01)00127-6; Som NA, 2014, ENVIRONMETRICS, V25, P306, DOI 10.1002/env.2284; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; United Nations Water, 2016, RIGHT PRIV DIG AG; Ver Hoef J. M., 2014, J STAT SOFTW, V56, P3; Ver Hoef JM, 2006, ENVIRON ECOL STAT, V13, P449, DOI 10.1007/s10651-006-0022-8; Ver Hoef JM, 2018, METHODS ECOL EVOL, V9, P1600, DOI 10.1111/2041-210X.12979; Ver Hoef JM, 2010, J AM STAT ASSOC, V105, P6, DOI 10.1198/jasa.2009.ap08248; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440	33	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0238422	10.1371/journal.pone.0238422	http://dx.doi.org/10.1371/journal.pone.0238422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960894	Green Published, gold, Green Submitted			2022-12-26	WOS:000575109500048
J	Frett, T; Green, DA; Mulder, E; Noppe, A; Arz, M; Pustowalow, W; Petrat, G; Tegtbur, U; Jordan, J				Frett, Timo; Green, David Andrew; Mulder, Edwin; Noppe, Alexandra; Arz, Michael; Pustowalow, Willi; Petrat, Guido; Tegtbur, Uwe; Jordan, Jens			Tolerability of daily intermittent or continuous short-arm centrifugation during 60-day 6(o) head down bed rest (AGBRESA study)	PLOS ONE			English	Article							MOTION SICKNESS ADAPTATION; SOPITE SYNDROME; ORTHOSTATIC INTOLERANCE; ARTIFICIAL GRAVITY; GENDER-DIFFERENCES; FLIGHT; MOVEMENTS; SPACE; SPACEFLIGHT; ASTRONAUTS	Artificial gravity through short-arm centrifugation has potential as a multi-system countermeasure for deconditioning and cranial fluid shifts that may underlie ocular issues in microgravity. However, the optimal short-arm centrifugation protocol that is effective whilst remaining tolerable has yet to be determined. Given that exposure to centrifugation is associated with presyncope and syncope and in addition motion sickness an intermittent protocol has been suggested to be more tolerable. Therefore, we assessed cardiovascular loading and subjective tolerability of daily short arm centrifugation with either an intermittent or a continuous protocol during long-term head-down bed rest as model for microgravity exposure in a mixed sex cohort. During the Artificial Gravity Bed Rest with European Space Agency (AGBRESA) 60 day 6 degrees head down tilt bed rest study we compared the tolerability of daily +1Gzexposure at the center of mass centrifugation, either performed continuously for 30 minutes, or intermittedly (6 x 5 minutes). Heart rate and blood pressure were assessed daily during centrifugation along with post motion sickness scoring and rate of perceived exertion. During bed rest, 16 subjects (6 women, 10 men), underwent 960 centrifuge runs in total. Ten centrifuge runs had to be terminated prematurely, 8 continuous runs and 2 intermittent runs, mostly due to pre-syncopal symptoms and not motion sickness. All subjects were, however, able to resume centrifuge training on subsequent days. We conclude that both continuous and intermittent short-arm centrifugation protocols providing artificial gravity equivalent to +1Gzat the center of mass is tolerable in terms of cardiovascular loading and motion sickness during long-term head down tilt bed rest. However, intermittent centrifugation appears marginally better tolerated, albeit differences appear minor.	[Frett, Timo; Mulder, Edwin; Noppe, Alexandra; Arz, Michael; Pustowalow, Willi; Petrat, Guido; Jordan, Jens] German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany; [Green, David Andrew] European Space Agcy, European Astronaut Ctr, Space Med Team, Cologne, Germany; [Green, David Andrew] KBRwyle GmbH, Cologne, Germany; [Green, David Andrew] Kings Coll London, London, England; [Tegtbur, Uwe] Hannover Med Sch, Inst Sports Med, Hannover, Germany; [Jordan, Jens] Univ Cologne, Chair Aerosp Med, Cologne, Germany	Helmholtz Association; German Aerospace Centre (DLR); European Space Agency; University of London; King's College London; Hannover Medical School; University of Cologne	Frett, T (corresponding author), German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany.	Timo.frett@dlr.de		Frett, Timo/0000-0002-5572-1177	NASA; ESA; DLR Institute of Aerospace Medicine	NASA(National Aeronautics & Space Administration (NASA)); ESA(European Space Agency); DLR Institute of Aerospace Medicine(Helmholtz AssociationGerman Aerospace Centre (DLR))	The "Artificial Bed Rest study with European Space Agency" (ABRESA) study was financed by NASA and ESA. Our experiments were included into the study conduction and financed by the DLR Institute of Aerospace Medicine. KBRwyle GmbH provided support in the form of salaries only for author D.G, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2019, CANC DISCOV, V10, pOF5; Arnauld E, 2016, SPACE PHYSL MED EVID; Barbic F, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01061; Bertolini G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00014; Blaber AP, 2011, STROKE, V42, P1844, DOI 10.1161/STROKEAHA.110.610576; Bles W, 1998, BRAIN RES BULL, V47, P481, DOI 10.1016/S0361-9230(98)00115-4; Borg Gunnar, 1998, BORGS PERCEIVED EXER, P104; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; Chang DG, 2016, SPINE, V41, P1917, DOI 10.1097/BRS.0000000000001873; Clement G, 2016, J MUSCULOSKEL NEURON, V16, P84; Clement G, 2015, J MUSCULOSKEL NEURON, V15, P60; Clement G., 2007, ARTIFICIAL GRAVITY, V20; Convertino VA, 1998, AM J PHYSIOL-REG I, V275, pR1909, DOI 10.1152/ajpregu.1998.275.6.R1909; Evans CR, 2018, UPDATES SURG, V70, P357, DOI 10.1007/s13304-018-0574-9; Evans JM, 2004, AVIAT SPACE ENVIR MD, V75, P850; Evans JM, 2001, J APPL PHYSIOL, V91, P2611, DOI 10.1152/jappl.2001.91.6.2611; Gianaros PJ, 2001, AVIAT SPACE ENVIR MD, V72, P115; Golding JF, 2006, PERS INDIV DIFFER, V41, P237, DOI 10.1016/j.paid.2006.01.012; Goswami N, 2019, PHYSIOL REV, V99, P807, DOI 10.1152/physrev.00006.2018; Goswami N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125780; GRAYBIEL A, 1976, AVIAT SPACE ENVIR MD, V47, P873; Hackney KJ, 2015, J STRENGTH COND RES, V29, P3531, DOI 10.1519/JSC.0000000000001191; Hargens AR, 2016, J APPL PHYSIOL, V120, P891, DOI 10.1152/japplphysiol.00935.2015; Iwase Satoshi, 2002, Environmental Medicine (Nagoya), V46, P29; Kaderka J, 2010, ACTA ASTRONAUT, V67, P1090, DOI 10.1016/j.actaastro.2010.06.032; Lang T, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0013-0; Lawson BD, 1998, ACTA ASTRONAUT, V43, P181, DOI 10.1016/S0094-5765(98)00153-2; Lee AG, 2018, EYE, V32, P1164, DOI 10.1038/s41433-018-0070-y; Lee SMC, 2015, AEROSP MED HUM PERF, V86, pA54, DOI 10.3357/AMHP.EC08.2015; Moore AD, 2014, J APPL PHYSIOL, V117, P231, DOI 10.1152/japplphysiol.01251.2013; Newman MC, 2013, AVIAT SPACE ENVIR MD, V84, P104, DOI 10.3357/ASEM.3170.2013; Petersen N, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0050-4; Reason J.T., 1975, MOTION SICKNESS, P310; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Roberts DR, 2017, NEW ENGL J MED, V377, P1746, DOI 10.1056/NEJMoa1705129; STYF J, 1990, CLIN PHYSIOL, V10, P77, DOI 10.1111/j.1475-097X.1990.tb00085.x; Suresh R, 2017, AEROSP MED HUM PERF, V88, P1008, DOI 10.3357/AMHP.4910.2017; Van Ombergen A, 2016, INT J AUDIOL, V55, P189, DOI 10.3109/14992027.2015.1111526; Verma AK, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00712; Young LR, 2003, J VESTIBUL RES-EQUIL, V13, P65; Young LR, 2001, ACTA ASTRONAUT, V49, P215, DOI 10.1016/S0094-5765(01)00100-X; Zawadzka-Bartczak EK, 2011, AVIAT SPACE ENVIR MD, V82, P599, DOI 10.3357/ASEM.2558.2011	42	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239228	10.1371/journal.pone.0239228	http://dx.doi.org/10.1371/journal.pone.0239228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946482	Green Published, gold, Green Accepted			2022-12-26	WOS:000573851100064
J	Gotham, D; McKenna, L; Frick, M; Lessem, E				Gotham, Dzintars; McKenna, Lindsay; Frick, Mike; Lessem, Erica			Public investments in the clinical development of bedaquiline	PLOS ONE			English	Article								Introduction In 2012, bedaquiline became the first new treatment from a novel class to be approved for tuberculosis in nearly five decades and is now a core component of the standard of care for multidrug-resistant tuberculosis. In addition to the originator pharmaceutical company, Janssen, a range of governmental and non-profit entities have contributed to the development of bedaquiline. Materials and methods We identified various avenues of public investments in the development of bedaquiline: direct funding of clinical trials and a donation programme, tax credits and deductions, and revenues resulting from the priority review voucher (PRV) awarded to the originator. Data on investments were gathered through contact with study leads and/or funders; for non-responses, published average costs were substituted. The originator company's expenses were estimated by similar methods. Tax credits and deductions were calculated based on estimated originator trial costs and donation expenses. The value of the PRV was estimated by application of a published model. Results Public contributions through clinical trials funding were estimated at US$109-252 million, tax credits at US$22-36 million, tax deductions at US$8-27 million, administration of a donation programme at US$5 million, PRV revenues at US$300-400 million. Total public investments were US$455-747 million and originator investments were US$90-240 million (if capitalized and risk-adjusted, US$647-1,201 million and US$292-772 million, respectively). Conclusions Estimating the investments in the development of a medicine can inform discussions regarding fair pricing and future drug development. We estimated that total public investments exceeded the originator's by a factor of 1.6-5.1.	[McKenna, Lindsay; Frick, Mike; Lessem, Erica] Treatment Act Grp, New York, NY USA			dzintarsgotham@gmail.com			Treatment Action Group (TAG), New York	Treatment Action Group (TAG), New York	This analysis was funded by Treatment Action Group (TAG), New York (http://www.treatmentactiongroup.org/).There are no associated grant numbers. The funder provided support in the form of salaries for authors LM, MF, EL, and a grant to DG working as an independent researcher, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; [Anonymous], 2018, COMMUNICATION   0924; Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Brigden G, 2015, INFECT DRUG RESIST, V8, P367, DOI 10.2147/IDR.S68351; DR-TB STAT, COUNTR UPD; Drugs for Neglected Diseases Initiative, 2019, 15 YEARS NEEDS DRIV; Ellis WY, METHODS TREATING ANT; Frost & Sullivan, 2016, AS PREF DEST CLIN TR; Gotham D, 2017, J ANTIMICROB CHEMOTH, V72, P1243, DOI 10.1093/jac/dkw522; Light DW, 2011, BIOSOCIETIES, V6, P34, DOI 10.1057/biosoc.2010.40; Medecins Sans Frontieres, 2018, OP LETT J J CALL AFF; MSF Access Campaign, 2016, DR TB DRUGS MICR SOU; Reuter A, 2017, INT J TUBERC LUNG D, V21, P1114, DOI 10.5588/ijtld.17.0468; Ridley DB, 2016, HEALTH AFFAIR, V35, P776, DOI 10.1377/hlthaff.2015.1314; Scaliti Matthew, 2018, TAX DEDUCTION PHARM; Schnippel K, 2018, LANCET RESP MED, V6, P699, DOI 10.1016/S2213-2600(18)30235-2; Sertkaya A, 2016, CLIN TRIALS, V13, P117, DOI 10.1177/1740774515625964; Stop TB Partnership, 2018, S AFR ENS RED PRIC B; USAID, BED DON PROGR; World Bank, INFL DEFL ANN; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2018, RAP COMM KEY CHANG T	23	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239118	10.1371/journal.pone.0239118	http://dx.doi.org/10.1371/journal.pone.0239118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946474	Green Published, gold			2022-12-26	WOS:000573851100090
J	Morris, JT; Renken, KA				Morris, James T.; Renken, Katherine A.			Past, present, and future nuisance flooding on the Charleston peninsula	PLOS ONE			English	Article							SEA-LEVEL DATA; ACCELERATION; SUBSIDENCE; EXTREME; COAST	A forecast of nuisance flooding of Charleston peninsula is presented, based on an analysis of tide records from Charleston Harbor, SC. The forecast was based on past trends in local sea level and tidal harmonics, including the 18.6-yr lunar nodal and annual cycles. The data document an exponential rise in mean sea level. Extrapolating to year 2060 shows that the sea-level trend already is equivalent to the RCP4.5 scenario and on track to exceed NOAA's intermediate low sea-level rise scenario of 0.5 m this century. If the trend continues, MSL will have risen by 0.22 m in 50 yr at an annual rate of 0.5 cm/yr in 2069. Simulations to 2064-2068, based on an empirical relationship between the annual number of flood events, defined as a water level exceeding 1.17 m NAVD (North American Vertical Datum of 1988), and the annual sum of monthly mean high water (r(2)= 0.84), predict annual flood events will rise to the 60 to 75 range. Application of the hourly tidal harmonics to the long-term sea-level trend provided estimates of total land area flooded and duration of flooding. Flood duration is expected to rise to 6.5% by 2046-2050 and 8.2% of time by 2064-2068. The area exposed to flooding will be 4.23 km(2)in 2046-2050 and 4.46 km(2)in 2064-2068, corresponding to about 20-21% of peninsular area on what was formerly marshland and creeks, filled in earlier centuries. Finally, the estimated cost of defending the city and a proposal for a climate tax are discussed.	[Morris, James T.; Renken, Katherine A.] Univ South Carolina, Belle Baruch Inst Coastal & Marine Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Morris, JT (corresponding author), Univ South Carolina, Belle Baruch Inst Coastal & Marine Sci, Columbia, SC 29208 USA.	morris@inlet.geol.sc.edu	morris, james/ABC-8111-2020		National Park Service Northeastern Coastal and Barrier Network [P15AC00006]; National Science Foundation LTREB grant [1654853]; National Oceanic and Atmospheric Administration (NOAA) [NA16NOS4780208]	National Park Service Northeastern Coastal and Barrier Network; National Science Foundation LTREB grant; National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	National Park Service Northeastern Coastal and Barrier Network Grant Number P15AC00006 and National Science Foundation LTREB grant 1654853 to JTM, and NA16NOS4780208 from the National Oceanic and Atmospheric Administration (NOAA). No author received salary or other funding from commercial companies URLs to sponsors' websites. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FT920 US CENS BUR; Boon JD, 2012, J COASTAL RES, V28, P1437, DOI 10.2112/JCOASTRES-D-12-00102.1; Calafat FM, 2013, GEOPHYS RES LETT, V40, P3661, DOI 10.1002/grl.50731; Calafat FM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04898-y; Crossett K, 2013, NOAA STATE COAST REP; Ezer T, 2015, GLOBAL PLANET CHANGE, V129, P23, DOI 10.1016/j.gloplacha.2015.03.002; Foster G, 2015, CLIM DYNAM, V45, P291, DOI 10.1007/s00382-014-2224-3; Goddard PB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7346; Haigh ID, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4635; Haigh ID, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006645; Hong BG, 2000, J PHYS OCEANOGR, V30, P2088, DOI 10.1175/1520-0485(2000)030<2088:SLOTUS>2.0.CO;2; Karegar MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11544-y; Karegar MA, 2016, GEOPHYS RES LETT, V43, P3126, DOI 10.1002/2016GL068015; LeRoy S., 2019, HIGH TIDE TAX PRICE; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Miller MM, 2019, REMOTE SENS ENVIRON, V225, P368, DOI 10.1016/j.rse.2019.03.022; Moftakhari HR, 2015, GEOPHYS RES LETT, V42, P9846, DOI 10.1002/2015GL066072; National Research Council, 1987, RESP CHANG SEA LEV E; Nerem RS, 2018, P NATL ACAD SCI USA, V115, P2022, DOI 10.1073/pnas.1717312115; Page & Turnbull Inc, 2008, VIS COMM HER PRES PL; PATTULLO J, 1955, J MAR RES, V14, P88; Pugh DT, 1996, TIDES SURGES MEAN SE; Rahmstorf S, 2011, J COASTAL RES, V27, P784, DOI 10.2112/JCOASTRES-D-11-00082.1; Ray RD, 2016, EARTHS FUTURE, V4, P578, DOI 10.1002/2016EF000423; Sturges W, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006492; Sweet WV, 2014, EARTHS FUTURE, V2, P579, DOI 10.1002/2014EF000272; Sweet WV, 2018, 083 NOAA NOS COOPS; Sweet WV, 2017, 086 NOAA NOS COOPS; Torres RR, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008159; U.S. Army Corps of Engineers, 2013, 11652212 US ARM CORP; US Census Bureau ACS demographic and housing estimates, 2022, ACS DEM HOUS EST 201; Wilbert M, 2019, COMMUNICATION; Woodworth PL, 1999, GEOPHYS J INT, V136, P651, DOI 10.1046/j.1365-246x.1999.00751.x	33	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238770	10.1371/journal.pone.0238770	http://dx.doi.org/10.1371/journal.pone.0238770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946476	gold, Green Published			2022-12-26	WOS:000573851100049
J	Aladwani, M; Lophatananon, A; Robinson, F; Rahman, A; Ollier, W; Kote-Jarai, Z; Dearnaley, D; Koveela, G; Hussain, N; Rageevakumar, R; Keating, D; Osborne, A; Dadaev, T; Brook, M; Eeles, R; Muir, KR				Aladwani, Mohammad; Lophatananon, Artitaya; Robinson, Fredie; Rahman, Aneela; Ollier, William; Kote-Jarai, Zsofia; Dearnaley, David; Koveela, Govindasami; Hussain, Nafisa; Rageevakumar, Reshma; Keating, Diana; Osborne, Andrea; Dadaev, Tokhir; Brook, Mark; Eeles, Rosalind; Muir, Kenneth R.		British Assoc Urological Surg Sect	Relationship of self-reported body size and shape with risk for prostate cancer: A UK case-control study	PLOS ONE			English	Article							DOSE-RESPONSE METAANALYSIS; MASS INDEX; WEIGHT CHANGE; ABDOMINAL OBESITY; LIFE-STYLE; ASSOCIATION; PREVENTION; HEIGHT; SWEDISH; GAIN	Introduction Previous evidence has suggested a relationship between male self-reported body size and the risk of developing prostate cancer. In this UK-wide case-control study, we have explored the possible association of prostate cancer risk with male self-reported body size. We also investigated body shape as a surrogate marker for fat deposition around the body. As obesity and excessive adiposity have been linked with increased risk for developing a number of different cancers, further investigation of self-reported body size and shape and their potential relationship with prostate cancer was considered to be appropriate. Objective The study objective was to investigate whether underlying associations exist between prostate cancer risk and male self-reported body size and shape. Methods Data were collected from a large case-control study of men (1928 cases and 2043 controls) using self-administered questionnaires. Data from self-reported pictograms of perceived body size relating to three decades of life (20's, 30's and 40's) were recorded and analysed, including the pattern of change. The associations of self-identified body shape with prostate cancer risk were also explored. Results Self-reported body size for men in their 20's, 30's and 40's did not appear to be associated with prostate cancer risk. More than half of the subjects reported an increase in self-reported body size throughout these three decades of life. Furthermore, no association was observed between self-reported body size changes and prostate cancer risk. Using 'symmetrical' body shape as a reference group, subjects with an 'apple' shape showed a significant 27% reduction in risk (Odds ratio = 0.73, 95% C.I. 0.57-0.92). Conclusions Change in self-reported body size throughout early to mid-adulthood in males is not a significant risk factor for the development of prostate cancer. Body shape indicative of body fat distribution suggested that an 'apple' body shape was protective and inversely associated with prostate cancer risk when compared with 'symmetrical' shape. Further studies which investigate prostate cancer risk and possible relationships with genetic factors known to influence body shape may shed further light on any underlying associations.	[Aladwani, Mohammad; Lophatananon, Artitaya; Ollier, William; Muir, Kenneth R.] Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England; [Robinson, Fredie] Univ Malaysia Sabah, Sch Med, Kota Kinabalu, Sabah, Malaysia; [Rahman, Aneela] Shaheed Mohtarma Benazir Bhutto Med Univ, Bakrani, Pakistan; [Ollier, William] Manchester Metropolitan Univ, Fac Sci & Engn, Sch Healthcare Sci, Manchester, Lancs, England; [Kote-Jarai, Zsofia; Dearnaley, David; Koveela, Govindasami; Hussain, Nafisa; Rageevakumar, Reshma; Keating, Diana; Osborne, Andrea; Dadaev, Tokhir; Brook, Mark; Eeles, Rosalind] Inst Canc Res, London, England; [British Assoc Urological Surg Sect] British Assoc Urol Surg Ltd, London, England; [Eeles, Rosalind] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England	University of Manchester; Universiti Malaysia Sabah; Manchester Metropolitan University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Muir, KR (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Hlth Sci, Div Populat Hlth Hlth Serv Res & Primary Care, Manchester, Lancs, England.	kenneth.muir@manchester.ac.uk		Eeles, Rosalind/0000-0002-3698-6241; Aladwani, Mohammad/0000-0003-0785-460X; Brook, Mark/0000-0002-8969-2378	Prostate Cancer Research Foundation; Cancer Research UK Grant [C5047/A8385]; NIHR; NIHR Manchester Biomedical Research Centre; ICEP (CRUK) [C18281/A19169]; Kuwait's Ministry of Health; National Institute for Health Research [NF-SI-0611-10106] Funding Source: researchfish	Prostate Cancer Research Foundation; Cancer Research UK Grant(Cancer Research UK); NIHR(National Institute for Health Research (NIHR)); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); ICEP (CRUK); Kuwait's Ministry of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This research was supported by the Prostate Cancer Research Foundation (currently Prostate Action) and Cancer Research UK Grant C5047/A8385. We acknowledge support from the NIHR to the Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust. KM and AL are supported by the NIHR Manchester Biomedical Research Centre and by the ICEP ("This work was also supported by CRUK [grant number C18281/A19169]). MA is supported by Kuwait's Ministry of Health. The funder provided support in the form of salaries for authors [RE, KM, AL, MA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section." The British Association of Urological Surgeons' Section of Oncology only played a role in notification of prostate cancer cases and there is no other additional roles.	Allott EH, 2013, EUR UROL, V63, P800, DOI 10.1016/j.eururo.2012.11.013; Andy K, 2018, CANC REGISTRATION ST; [Anonymous], 2012, REGEN MED S3, V7, pS14; BALLARDBARBASH R, 1990, CANCER RES, V50, P2152; Barberio AM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08159-w; Bassett JK, 2012, INT J CANCER, V131, P1711, DOI 10.1002/ijc.27414; Bayomi DJ, 2008, ANN EPIDEMIOL, V18, P36, DOI 10.1016/j.annepidem.2007.06.009; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Boehm K, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2015.07.006; Bonovas S, 2004, DIABETOLOGIA, V47, P1071, DOI 10.1007/s00125-004-1415-6; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bulik CM, 2001, INT J OBESITY, V25, P1517, DOI 10.1038/sj.ijo.0801742; Cao Y, 2011, CANCER PREV RES, V4, P486, DOI 10.1158/1940-6207.CAPR-10-0229; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Chamberlain C, 2011, INT J CANCER, V129, P1199, DOI 10.1002/ijc.25739; Chan JM, 1998, SEMIN CANCER BIOL, V8, P263, DOI 10.1006/scbi.1998.0075; Chen Q, 2016, INT J CANCER, V138, P866, DOI 10.1002/ijc.29846; Dal Maso L, 2004, BRIT J CANCER, V90, P2176, DOI 10.1038/sj.bjc.6601859; Davies NM, 2015, CANCER CAUSE CONTROL, V26, P1603, DOI 10.1007/s10552-015-0654-9; De Nunzio C, 2013, UROL ONCOL-SEMIN ORI, V31, P997, DOI 10.1016/j.urolonc.2011.08.007; De Nunzio C, 2011, EUR UROL, V60, P106, DOI 10.1016/j.eururo.2011.03.055; Di Sebastiano KM, 2017, PROSTATE, V77, P211, DOI 10.1002/pros.23262; Dimitropoulou P, 2011, BRIT J CANCER, V104, P875, DOI 10.1038/sj.bjc.6606066; Discacciati A, 2012, ANN ONCOL, V23, P1665, DOI 10.1093/annonc/mdr603; Discacciati A, 2011, BRIT J CANCER, V105, P1061, DOI 10.1038/bjc.2011.319; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Freedland SJ, 2006, CANCER CAUSE CONTROL, V17, P5, DOI 10.1007/s10552-005-0378-3; Freedland SJ, 2005, J UROLOGY, V174, P1266, DOI 10.1097/01.ju.0000173093.89897.97; Friedenreich CM, 2004, INT J CANCER, V110, P278, DOI 10.1002/ijc.20110; Gade-Andavolu R, 2006, CANC J; Gallina A, 2007, INT J CANCER, V121, P791, DOI 10.1002/ijc.22730; Gilbert J, 2017, MEDICINE, V45, P506, DOI [10.1016/j.mpmed.2017.05.009, DOI 10.1016/J.MPMED.2017.05.009]; Giles GG, 2003, INT J CANCER, V103, P241, DOI 10.1002/ijc.10810; Giovannucci E, 1997, CANCER EPIDEM BIOMAR, V6, P557; Goktas S, 2005, UROLOGY, V65, P1168, DOI 10.1016/j.urology.2004.12.053; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Hack EE, 2010, PROSTATE, V70, P1683, DOI 10.1002/pros.21203; Hernandez BY, 2009, CANCER EPIDEM BIOMAR, V18, P2413, DOI 10.1158/1055-9965.EPI-09-0293; Hsing AW, 2007, AM J CLIN NUTR, V86, p843S, DOI 10.1093/ajcn/86.3.843S; Jackson MD, 2010, CANCER CAUSE CONTROL, V21, P909, DOI 10.1007/s10552-010-9520-y; Jonsson F, 2003, INT J CANCER, V106, P594, DOI 10.1002/ijc.11266; Keum N, 2015, JNCI-J NATL CANCER I, V107, DOI [10.1093/jnci/dju428, 10.1093/jnci/djv088]; Littman AJ, 2007, AM J EPIDEMIOL, V165, P1271, DOI 10.1093/aje/kwm013; Lonnebotn M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195697; MacInnis RJ, 2003, CANCER EPIDEM BIOMAR, V12, P1417; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z; Markozannes G, 2016, EUR J CANCER, V69, P61, DOI 10.1016/j.ejca.2016.09.026; Moller E, 2016, INT J CANCER, V138, P853, DOI 10.1002/ijc.29842; Moller E, 2013, CANCER CAUSE CONTROL, V24, P2143, DOI 10.1007/s10552-013-0291-0; Mori M, 2011, ASIAN PAC J CANCER P, V12, P743; MUST A, 1993, AM J EPIDEMIOL, V138, P56, DOI 10.1093/oxfordjournals.aje.a116777; Nomura AM, 2001, EPIDEMIOL REV, V23, P126, DOI 10.1093/oxfordjournals.epirev.a000777; Perez-Cornago A, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0876-7; Pischon T, 2008, CANCER EPIDEM BIOMAR, V17, P3252, DOI 10.1158/1055-9965.EPI-08-0609; Platz EA, 2005, CANCER EPIDEM BIOMAR, V14, P1262, DOI 10.1158/1055-9965.EPI-04-0371; Putnam SD, 2000, ANN EPIDEMIOL, V10, P361, DOI 10.1016/S1047-2797(00)00057-0; Rapp K, 2008, ANN ONCOL, V19, P641, DOI 10.1093/annonc/mdm549; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Robinson WR, 2008, CANCER CAUSE CONTROL, V19, P793, DOI 10.1007/s10552-008-9142-9; Robinson WR, 2005, AM J EPIDEMIOL, V161, P1107, DOI 10.1093/aje/kwi150; Rodriguez C, 2007, CANCER EPIDEM BIOMAR, V16, P63, DOI 10.1158/1055-9965.EPI-06-0754; SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3; Schuurman AG, 2000, AM J EPIDEMIOL, V151, P541, DOI 10.1093/oxfordjournals.aje.a010241; StataCorp, 2017, STATA STAT SOFTWARE; Stattin P, 2001, J CLIN ENDOCR METAB, V86, P1341, DOI 10.1210/jc.86.3.1341; Stevens VL, 2017, CANCER EPIDEM BIOMAR, V26, P1812, DOI 10.1158/1055-9965.EPI-17-0802; Stocks T, 2010, INT J CANCER, V127, P1660, DOI 10.1002/ijc.25171; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Sutcliffe S, 2013, NAT REV CANCER, V13, P208, DOI 10.1038/nrc3434; Turner EL, 2011, INT J CANCER, V128, P440, DOI 10.1002/ijc.25360; Wallstrom P, 2009, BRIT J CANCER, V100, P1799, DOI 10.1038/sj.bjc.6605077; Wellman NS, 2002, ASIA PAC J CLIN NUTR, V11, pS705, DOI 10.1046/j.1440-6047.11.s8.6.x; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; Wilson KM, 2012, ASIAN J ANDROL, V14, P365, DOI 10.1038/aja.2011.142; Wright ME, 2007, CANCER-AM CANCER SOC, V109, P675, DOI 10.1002/cncr.22443; Zhong S, 2016, PROSTATE CANCER P D, V19, P122, DOI 10.1038/pcan.2015.64	79	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238928	10.1371/journal.pone.0238928	http://dx.doi.org/10.1371/journal.pone.0238928			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941451	gold, Green Published			2022-12-26	WOS:000573848800023
J	Broder, GB; Lucas, JP; Davis, J; Wallace, SE; Luthuli, N; Baepanye, K; White, RR; Bolton, M; Blanchette, C; Andrasik, MP				Broder, Gail B.; Lucas, Jonathan P.; Davis, Jontraye; Wallace, Stephaun E.; Luthuli, Nandisile; Baepanye, Kagisho; White, Rhonda R.; Bolton, Marcus; Blanchette, Cheryl; Andrasik, Michele P.			Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials	PLOS ONE			English	Article							BLACK-MEN; SEX; EPIDEMIC; NEED	Good Participatory Practice (GPP) guidelines support and direct community engagement practices in biomedical HIV prevention trials, however no standardized metrics define the implementation and evaluation of these practices. Collaboratively, the Community Program staff of the HIV Vaccine Trials Network (HVTN) and the HIV Prevention Trials Network (HPTN) created a metric to describe, monitor, and evaluate one component of GPP, recruitment practices, in two HIV monoclonal Antibody Mediated Prevention (AMP) clinical trials, HVTN 703/HPTN 081 and HVTN 704/HPTN 085. Through consultation with community representatives from each clinical research site (hereafter "site(s)"), who made up the study Community Working Groups, recruitment strategy descriptors were developed for both trials to characterize responses to "How did you hear about the AMP study?" The Community Working Groups also helped to define and establish time points that were selected to allow comparisons across sites. Data were collected by 43 of 46 clinical research sites from January 1, 2017 to February 28, 2018. All 43 sites used multiple recruitment strategies successfully, but strategies varied by region. Globally, referrals was the most efficient and effective recruitment strategy as evidenced by the screening: enrollment ratio of 2.2:1 in Africa, and 2.1:1 in the Americas/Switzerland. Print materials were also valuable globally (3:1 Africa, 4.2:1 Americas/Switzerland). In Africa, in-person outreach was also quite effective (2.3:1) and led to the most enrollments (748 of 1186, 63%). In the Americas/Switzerland, outreach was also effective (2.6:1), but internet use resulted in the most screens (1893 of 4275, 44%) and enrollments (677 of 1531, 44%), compared to 12 of 2887 (0.4%) and 2 of 1204 (0.1%) in Africa, respectively. Standardized metrics and data collection aid meaningful comparisons of optimal community engagement methods for trial enrollment. Internet strategies had better success in the Americas/Switzerland than in sub-Saharan African countries. Data are essential in outreach staff efforts to improve screening-to-enrollment ratios. Because the effectiveness of recruitment strategies varies by region, it is critical that clinical research sites tailor community engagement and recruitment strategies to their local environment, and that they are supported with resources enabling use of a range of approaches.	[Broder, Gail B.; Wallace, Stephaun E.; Luthuli, Nandisile; Baepanye, Kagisho; Andrasik, Michele P.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Lucas, Jonathan P.; Davis, Jontraye; White, Rhonda R.; Bolton, Marcus; Blanchette, Cheryl] FHI 360, Sci Facilitat Dept, Durham, NC USA	Fred Hutchinson Cancer Center; FHI 360	Broder, GB (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	gbroder@fredhutch.org	Broder, Gail Beth/GOH-1843-2022	Broder, Gail/0000-0002-5352-3097				Alvarez RA, 2006, WESTERN J NURS RES, V28, P541, DOI 10.1177/0193945906287215; [Anonymous], 2019, WE T MAGAZINE, V31, P1, DOI DOI 10.1007/s42241-019-0020-6; Barresi P, 2010, AIDS EDUC PREV, V22, P28, DOI 10.1521/aeap.2010.22.1.28; BORNSTEIN RF, 1989, PSYCHOL BULL, V106, P265, DOI 10.1037/0033-2909.106.2.265; Edupuganti S, 2018, ANTIBODY MEDIATED PR; Fisher HH, 2006, AIDS BEHAV, V10, P553, DOI 10.1007/s10461-006-9109-3; Fregonese F, 2018, BMC MED ETHICS, V19, DOI 10.1186/s12910-018-0283-4; Harro CD, 2004, JAIDS-J ACQ IMM DEF, V37, P1385, DOI 10.1097/01.qai.0000122983.87519.b5; Holzer JK, 2014, J INVEST MED, V62, P851, DOI 10.1097/JIM.0000000000000097; King KF, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-84; MacQueen KM, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0033-9; Magnus M, 2014, J PUBLIC HEALTH MAN, V20, pE1, DOI 10.1097/PHH.0000000000000025; Malebranche DJ, 2003, AM J PUBLIC HEALTH, V93, P862, DOI 10.2105/AJPH.93.6.862; Morin SF, 2003, JAIDS-J ACQ IMM DEF, V33, P513, DOI 10.1097/00126334-200308010-00013; Newman PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135937; Singh JA, 2005, PLOS MED, V2, P824, DOI 10.1371/journal.pmed.0020234; Ssetaala A, 2015, PAN AFR MED J, V21, DOI 10.11604/pamj.2015.21.104.4962; Thomas R, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3791-8; UNAIDS, 2011, GOOD PART PRACT GUID; Wilson PA, 2009, AM J PUBLIC HEALTH, V99, P1013, DOI 10.2105/AJPH.2008.140681; Witte SS, 2004, J WOMENS HEALTH, V13, P1137, DOI 10.1089/jwh.2004.13.1137; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239276	10.1371/journal.pone.0239276	http://dx.doi.org/10.1371/journal.pone.0239276			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941520	gold, Green Published			2022-12-26	WOS:000573848800050
J	Peh, E; Kittler, S; Reich, F; Kehrenberg, C				Peh, Elisa; Kittler, Sophie; Reich, Felix; Kehrenberg, Corinna			Antimicrobial activity of organic acids againstCampylobacterspp. and development of combinations-A synergistic effect?	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI COLONIZATION; CHAIN FATTY-ACIDS; DRINKING-WATER; IN-VITRO; BROILERS; PERFORMANCE; EFFICACY	Contaminated poultry meat is considered to be the main source of human infection withCampylobacterspp., a pathogen that asymptomatically colonizes broiler chickens during fattening and contaminates carcasses during slaughter. To prevent or reduce the colonization of broiler flocks withCampylobacterspp., applying different organic acids, especially in combinations, via feed or drinking water seems to be a promising approach. However, only very few combinations of organic acids have been tested for their antibacterial efficacy againstCampylobacterspp. Therefore, thein vitrosusceptibility of 30Campylobacterspp. isolates (20C.jejuniand tenC.coli) to ten organic acids and ten combinations was determined. The testing of minimum inhibitory concentration (MIC) values was performed at pH 6.0 and 7.3 by using the broth microdilution method and included the following organic acids: Caprylic acid, sorbic acid, caproic acid, benzoic acid, ascorbic acid, propionic acid, acetic acid, formic acid, fumaric acid and tartaric acid and combinations thereof. The lowest MIC values were seen for caprylic acid (MIC range at pH 7.3: 0.5-2 mmol/L) and sorbic acid (MIC range at pH 7.3: 1-4 mmol/L). One to two dilution steps lower MIC values were determined at the lower pH value of 6.0. Furthermore, ten combinations consisting of three to five organic acids were developed. In addition to the tested antibacterial activity, other criteria were included such as approval as feed additives, reported synergistic effects and chemical properties. For nine of ten combinations, the MIC(90)values of the organic acids decreased 1.25- to 241.5-fold compared to the MIC(90)values for the individual substances. Furthermore, nine of ten combinations exhibited synergistic activities against two or more of the testedC.jejuniandC.coliisolates. A combination of caprylic acid, sorbic acid and caproic acid exhibited synergistic activities against the largest number ofCampylobacterspp. isolates (sixC.jejuniand fourC.coli) with fractional inhibitory concentration (FIC) indices ( n-ary sumation FIC) ranging from 0.33 to 1.42. This study showsin vitrosynergistic activities of different organic acids in combinations against the majorCampylobacterspecies and could therefore be a promising basis for reducingCampylobacterspp.in vivo.	[Peh, Elisa; Kittler, Sophie; Reich, Felix] Univ Vet Med Hannover, Food Qual & Food Safety, Hannover, Germany; [Reich, Felix] German Fed Inst Risk Assessment BfR, Berlin, Germany; [Kehrenberg, Corinna] Justus Liebig Univ Giessen, Inst Vet Food Sci, Giessen, Germany	University of Veterinary Medicine Hannover, Foundation; Federal Institute for Risk Assessment; Justus Liebig University Giessen	Kehrenberg, C (corresponding author), Justus Liebig Univ Giessen, Inst Vet Food Sci, Giessen, Germany.	Corinna.Kehrenberg@vetmed.uni-giessen.de	Kehrenberg, Corinna/GSI-9835-2022; Reich, Felix/C-5636-2015; Peh, Elisa/AHC-4493-2022	Reich, Felix/0000-0001-7835-5328; 	German Federal Ministry of Education and Research (BMBF) [IP5/01Kl1725C]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was financially supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the consortium "PAC-Campy" (IP5/01Kl1725C). (SK, FR, CK) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adil S, 2011, LIVESTOCK RES RURAL, V23, DOI [10.4061/2010/479485, DOI 10.4061/2010/479485]; Andreoletti O, 2011, EFSA J, V9, DOI [10.2903/j.efsa.2011.2105, 10.2903/j.efsa.2011.2490]; Beier RC, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7080223; BERENBAUM MC, 1978, J INFECT DIS, V137, P122, DOI 10.1093/infdis/137.2.122; Bergsson G, 2001, APMIS, V109, P670, DOI 10.1034/j.1600-0463.2001.d01-131.x; Byrd JA, 2001, POULTRY SCI, V80, P278, DOI 10.1093/ps/80.3.278; Campos FM, 2009, INT J FOOD MICROBIOL, V135, P144, DOI 10.1016/j.ijfoodmicro.2009.07.031; CAVE NAG, 1984, POULTRY SCI, V63, P131, DOI 10.3382/ps.0630131; Cengiz O, 2012, VET MED-CZECH, V57, P515, DOI 10.17221/6363-VETMED; Chaveerach P, 2002, POULTRY SCI, V81, P621, DOI 10.1093/ps/81.5.621; Clinical and Laboratory Standards Institute (CLSI), 2013, VET01 A4, V4; de los Santos FS, 2008, POULTRY SCI, V87, P800, DOI 10.3382/ps.2007-00280; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Dibner JJ, 2002, J APPL POULTRY RES, V11, P453, DOI 10.1093/japr/11.4.453; EFSA, 2019, EFSA J, P17; Epps SVR, 2013, INT J ENV RES PUB HE, V10, P6292, DOI 10.3390/ijerph10126292; Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149; Grilli E, 2013, J APPL MICROBIOL, V114, P308, DOI 10.1111/jam.12053; Guyard-Nicodeme M, 2016, POULTRY SCI, V95, P298, DOI 10.3382/ps/pev303; Hermans D, 2012, POULTRY SCI, V91, P1733, DOI 10.3382/ps.2011-02106; Hermans D, 2010, POULTRY SCI, V89, P1144, DOI 10.3382/ps.2010-00717; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Kim SA, 2013, APPL ENVIRON MICROB, V79, P6552, DOI 10.1128/AEM.02164-13; Leeson S, 2005, POULTRY SCI, V84, P1418, DOI 10.1093/ps/84.9.1418; Metcalf JH, 2011, POULTRY SCI, V90, P494, DOI 10.3382/ps.2010-00891; Molatova Z, 2011, J ANIM PHYSIOL AN N, V95, P701, DOI 10.1111/j.1439-0396.2010.01100.x; Molatova Z, 2010, FOLIA MICROBIOL, V55, P215, DOI 10.1007/s12223-010-0031-8; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Ricke SC, 2003, POULTRY SCI, V82, P632, DOI 10.1093/ps/82.4.632; RUSSELL JB, 1992, J APPL BACTERIOL, V73, P363, DOI 10.1111/j.1365-2672.1992.tb04990.x; Skanseng B, 2010, J APPL MICROBIOL, V109, P1265, DOI 10.1111/j.1365-2672.2010.04766.x; Thompson JL, 1997, BRIT POULTRY SCI, V38, P59, DOI 10.1080/00071669708417941; Vale M, 2004, SCI AGR SCI AGR, V61; van Gerwe T, 2010, VET MICROBIOL, V143, P314, DOI 10.1016/j.vetmic.2009.11.029; de Oliveira CEV, 2010, INT J FOOD MICROBIOL, V137, P312, DOI 10.1016/j.ijfoodmicro.2009.11.019	36	14	14	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239312	10.1371/journal.pone.0239312	http://dx.doi.org/10.1371/journal.pone.0239312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941534	Green Published, gold			2022-12-26	WOS:000573848800060
J	Will, M; Conard, NJ				Will, Manuel; Conard, Nicholas J.			Regional patterns of diachronic technological change in the Howiesons Poort of southern Africa	PLOS ONE			English	Article							MIDDLE STONE-AGE; DIEPKLOOF ROCK SHELTER; WESTERN CAPE; STILL BAY; HUMAN-BEHAVIOR; KLIPDRIFT SHELTER; KLASIES RIVER; SIBUDU CAVE; VARIABILITY; EVOLUTION	The Howiesons Poort (HP) of southern Africa plays an important role in models on the early behavioral evolution ofHomo sapiens. The HP is often portrayed as a coherent MSA industry characterized by early complex material culture. Recent work has emphasized parallel technological change through time across southern Africa potentially driven by ecological adaptations or demographic change. Here we examine patterns of diachronic variation within the HP and evaluate potential causal factors behind these changes. We test previous temporal assessments of the technocomplex at the local and regional level based on high-resolution quantitative data on HP lithic assemblages from Sibudu (KwaZulu-Natal) and comparisons with other southern African sites. At Sibudu, consistent unidirectional change in lithic technology characterizes the HP sequence. The results show a gradual reduction in typical HP markers such as the proportion of blades, backed pieces, and HP cores, as well as declining size of blades and backed artifacts. Quantitative comparisons with seven HP sites in South Africa suggest that lithic technology varies between regions over time instead of following similar changes. Concerning hypotheses of causal drivers, directional changes in lithic technology at Sibudu covary with shifting hunting patterns towards larger-sized bovids and a gradual opening of the vegetation. In contrast, variation in lithic technology shows little association with site use, mobility patterns or demographic expansions. Unlike at Sibudu, diachronic changes at other HP sites such as Diepkloof, Klasies River and Klipdrift appear to be associated with aspects of mobility, technological organization and site use. The regional diachronic patterns in the HP partly follow paleoclimatic zones, which could imply different ecological adaptations and distinct connection networks over time. Divergent and at times decoupled changes in lithic traits across sites precludes monocausal explanations for the entire HP, supporting more complex models for the observed technological trajectories.	[Will, Manuel; Conard, Nicholas J.] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [Conard, Nicholas J.] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoecol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Will, M (corresponding author), Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany.	manuel.will@uni-tuebingen.de		Will, Manuel/0000-0001-8116-2543; Conard, Nicholas/0000-0002-4633-0385	Deutsche Forschungsgemeinschaft [WI 4978/1-1, CO 226/28-1, CO 226/34-1]; Heidelberger Akademie der Wissenschaften; University of Tubingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberger Akademie der Wissenschaften; University of Tubingen	MW has been funded by the Deutsche Forschungsgemeinschaft (WI 4978/1-1; www.dfg.de).NJC has been funded by the Deutsche Forschungsgemeinschaft (CO 226/28-1; CO 226/34-1; www.dfg.de).NJC was also funded by the Heidelberger Akademie der Wissenschaften in the context of the long-term research project "The Role of Culture in Early Expansions of Humans" (www.roceeh.net).We acknowledge support by Open Access Publishing Fund of University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Allott L.F., 2006, S AFR HUMANIT, V18, P173; Ambrose SH., 2022, SOCIAL ECOLOGICAL MO, P3, DOI [DOI 10.1515/9781474470957-003, 10.1515/9781474470957-003]; Andrefsky W, 2009, J ARCHAEOL RES, V17, P65, DOI 10.1007/s10814-008-9026-2; Bader GD, 2015, S AFR ARCHAEOL BULL, V70, P149; BAMFORTH DB, 1986, AM ANTIQUITY, V51, P38, DOI 10.2307/280392; Bentley AR, 2003, COMPLEX SYSTEMS ARCH; Bentley RA., 2003, COMPLEX SYSTEMS ARCH, P9; BINFORD LR, 1979, J ANTHROPOL RES, V35, P255, DOI 10.1086/jar.35.3.3629902; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Blome MW, 2012, J HUM EVOL, V62, P563, DOI 10.1016/j.jhevol.2012.01.011; Brenner MJ, 2019, J ARCHAEOL SCI-REP, V26, DOI 10.1016/j.jasrep.2019.101891; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Bruch AA, 2012, QUATERNARY SCI REV, V45, P7, DOI 10.1016/j.quascirev.2012.04.005; Chamberlin T. C., 1890, SCIENCE, V15, P92, DOI DOI 10.1126/SCIENCE.NS-15.366.92; Clark JL, 2008, J HUM EVOL, V54, P886, DOI 10.1016/j.jhevol.2007.12.004; Clark JL, 2017, J HUM EVOL, V107, P49, DOI 10.1016/j.jhevol.2017.03.002; Clark Jamie L., 2013, P9; Clark JL, 2013, CURR ANTHROPOL, V54, pS269, DOI 10.1086/673386; Clark JL, 2011, J ANTHROPOL ARCHAEOL, V30, P273, DOI 10.1016/j.jaa.2011.04.002; Clarkson C, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P43, DOI 10.1007/978-1-4419-6861-6_3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conard N.J., 2014, MITTEILUNGEN GESELLS, V23, P121; Conard NJ, 2015, S AFR ARCHAEOL BULL, V70, P127; Conard NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130001; Conard NJ, 2012, S AFR ARCHAEOL BULL, V67, P180; Conard NJ, 2004, S AFR ARCHAEOL BULL, V59, P12, DOI 10.2307/3889318; Conard NJ, 2008, S AFR ARCHAEOL SOC G, V10, P175; Conard NJ, 2005, TOOLS SYMBOLS EARLY, P294; Conard NJ, 2015, HDB PALEOANTHROPOLOG, P2465; Croux C, 2010, STAT METHOD APPL-GER, V19, P497, DOI 10.1007/s10260-010-0142-z; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; de la Pena P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185845; de la Pena P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143451; de la Pena P, 2014, QUATERN INT, V350, P26, DOI 10.1016/j.quaint.2014.03.043; de la Pena P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101534; Deacon H.J., 1995, S AFR ARCHAEOL B, V50, P121, DOI [10.2307/3889061, DOI 10.2307/3889061]; DEACON HJ, 1989, HUMAN REVOLUTION, P547; Deacon HJ, 2005, AFRICAN ARCHAEOLOGY, P130; Delagnes A., 2006, SO AFRICAN HUMANITIE, V18, P43; Douze K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206238; Dusseldorp GL, 2012, QUATERN INT, V270, P70, DOI 10.1016/j.quaint.2011.02.011; Feathers J, 2015, J ARCHAEOL SCI, V63, P164, DOI 10.1016/j.jas.2015.02.012; French JC, 2016, J ARCHAEOL METHOD TH, V23, P150, DOI 10.1007/s10816-014-9237-4; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Guerin G, 2013, J HUM EVOL, V64, P314, DOI 10.1016/j.jhevol.2013.01.006; Hahn J., 1991, ERKENNEN BESTIMMEN S, V10; Hall G, 2014, J AFR ARCHAEOL, V12, P7, DOI 10.3213/2191-5784-10246; Henrich J, 2001, AM ANTHROPOL, V103, P992, DOI 10.1525/aa.2001.103.4.992; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Henshilwood CS, 2011, CURR ANTHROPOL, V52, P361, DOI 10.1086/660022; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Hogberg A, 2020, J PALEOLITH ARCHAEOL, V3, P633, DOI 10.1007/s41982-019-00042-4; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Igreja M, 2013, J ARCHAEOL SCI, V40, P3475, DOI 10.1016/j.jas.2013.02.026; Isaac GL, 1989, ARCHAEOLOGY HUMAN OR; Jacobs Z, 2008, S AFRICAN ARCHAEOLOG, V10, P9; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1790, DOI 10.1016/j.jas.2007.11.028; Jacobs Z, 2017, J HUM EVOL, V107, P1, DOI 10.1016/j.jhevol.2017.02.004; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Jacobs Zenobia, 2009, Commun Integr Biol, V2, P191; Kandel AW, 2016, J ARCHAEOL METHOD TH, V23, P623, DOI 10.1007/s10816-015-9254-y; Kaplan J, 1990, SOUTH AFR HUMANIT, P94; Karkanas P, 2015, J HUM EVOL, V85, P1, DOI 10.1016/j.jhevol.2015.04.006; Kauffman S., 1995, HOME UNIVERSE SEARCH; Kauffman S.A., 2000, INVESTIGATIONS; KELLY RL, 1983, J ANTHROPOL RES, V39, P277, DOI 10.1086/jar.39.3.3629672; Klein R., 2002, DAWN HUMAN CULTURE; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; KLEIN RG, 1994, INTERD CONT, P3; Klein RG, 2019, EVOL ANTHROPOL, V28, P179, DOI 10.1002/evan.21788; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; KUHN SL, 1992, J ANTHROPOL RES, V48, P185, DOI 10.1086/jar.48.3.3630634; Kuhn SL, 1995, LIFEWAYS HUNTER GATH; Kuhn SL, 2006, INTERD CONTRIB ARCH, P109, DOI 10.1007/0-387-24661-4_6; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2019, AZANIA, V54, P141, DOI 10.1080/0067270X.2019.1619280; Lombard M, 2016, VERTEBR PALEOBIOL PA, P135, DOI 10.1007/978-94-017-7426-0_12; Lombard M, 2012, S AFR ARCHAEOL BULL, V67, P123; Lombard M, 2012, QUATERN INT, V270, P140, DOI 10.1016/j.quaint.2012.02.033; Lombard M, 2011, ANTIQUITY, V85, P1433, DOI 10.1017/S0003598X00062153; Lombard M, 2011, J ARCHAEOL SCI, V38, P1918, DOI 10.1016/j.jas.2011.04.001; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lombard M, 2010, J ARCHAEOL SCI, V37, P1773, DOI 10.1016/j.jas.2010.02.015; Lombard M, 2009, S AFR ARCHAEOL BULL, V64, P4; Lukich V, 2019, J PALEOLITH ARCHAEOL, V2, P235, DOI 10.1007/s41982-019-00031-7; Mackay A, 2010, S AFR ARCHAEOL B, V65, P192; Mackay A, 2016, VERTEBR PALEOBIOL PA, P49, DOI 10.1007/978-94-017-7520-5_3; Mackay A, 2014, J HUM EVOL, V72, P26, DOI 10.1016/j.jhevol.2014.03.003; Mackay A, 2011, J ARCHAEOL SCI, V38, P1430, DOI 10.1016/j.jas.2011.02.006; Manly B.F.J., 2004, MULTIVARIATE STAT ME; Marean CW, 2015, EVOL ANTHROPOL, V24, P62, DOI 10.1002/evan.21443; Marean CW, 2011, INTERD CONTRIB ARCH, P421, DOI 10.1007/978-1-4419-8219-3_18; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCall GS, 2007, J ARCHAEOL SCI, V34, P1738, DOI 10.1016/j.jas.2006.12.015; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Mesoudi A., 2011, CULTURAL EVOLUTION D; Miller CEM., 2015, SETTLEMENT DYNAMICS, P27; Miller CE, 2013, J ARCHAEOL SCI, V40, P3432, DOI 10.1016/j.jas.2013.02.014; Odell GH, 2004, LITHIC ANAL; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Plavcan JM, 2001, EVOL ANTHROPOL, V10, P204, DOI 10.1002/evan.20001; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Reynard JP, 2016, PALAEOGEOGR PALAEOCL, V449, P349, DOI 10.1016/j.palaeo.2016.02.035; Richerson PJ., 2005, NOT GENES ALONE CULT; Riel-Salvatore J, 2004, AM ANTIQUITY, V69, P257, DOI 10.2307/4128419; Rito T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41176-3; Robinson JR, 2018, J ARCHAEOL SCI, V100, P32, DOI 10.1016/j.jas.2018.10.002; Roth BJ, 1998, AM ANTIQUITY, V63, P47, DOI 10.2307/2694775; Roussel M, 2009, BULL SOC PREHIST FR, V106, P219, DOI 10.3406/bspf.2009.13846; Scerri EML, 2018, TRENDS ECOL EVOL, V33, P582, DOI 10.1016/j.tree.2018.05.005; Scerri EML, 2016, J ARCHAEOL METHOD TH, V23, P669, DOI 10.1007/s10816-015-9255-x; Schlebusch CM, 2020, MOL BIOL EVOL, V37, P2944, DOI 10.1093/molbev/msaa140; Sehlebusch CM, 2017, SCIENCE, V358, P652, DOI 10.1126/science.aao6266; Shennan S, 2000, CURR ANTHROPOL, V41, P811, DOI 10.1086/317403; Sievers C., 2006, SOUTH AFR HUMANIT, V18, P203; Singer R., 1982, MIDDLE STONE AGE KLA; Soares P, 2016, VERTEBR PALEOBIOL PA, P383, DOI 10.1007/978-94-017-7520-5_18; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Soriano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131127; Steele Teresa E., 2016, Paleoanthropology, P100; SULLIVAN AP, 1985, AM ANTIQUITY, V50, P755, DOI 10.2307/280165; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Tostevin GB, 2003, STRANSKA SKALA ORIGI, P69; Tostevin GB, 2012, MIDDLE RANGE THEORY; Tribolo C, 2013, J ARCHAEOL SCI, V40, P3401, DOI 10.1016/j.jas.2012.12.001; Tryon CA, 2013, CURR ANTHROPOL, V54, pS234, DOI 10.1086/673752; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Volman T.P., 1984, P169; Wadley L., 2006, SN HUMANITIES, V18, P315; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L., 1989, S AFR ARCHAEOL BULL, V44, P23, DOI DOI 10.2307/3888316; Wadley L, 2008, S AFRICAN ARCHAEOLOG, V1, P122; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2015, AZANIA, V50, P155, DOI 10.1080/0067270X.2015.1039236; Wadley L, 2013, S AFR ARCHAEOL BULL, V68, P41; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wilkins J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174051; Will M., 2019, MODERN HUMAN ORIGINS, P25; Will M, 2018, ARCHAEOL ANTHROP SCI, V10, P389, DOI 10.1007/s12520-016-0361-9; Will M, 2017, J ARCHAEOL SCI-REP, V15, P630, DOI 10.1016/j.jasrep.2016.11.046; Will M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098359; Wright S, P 6 ANN C GEN, V1, P356; Wurz S, 1999, S AFR ARCHAEOL BULL, V54, P38, DOI 10.2307/3889138; Wurz S., 2000, MIDDLE STONE AGE KLA; Wurz S., 2005, AFR ARCHAEOL REV, V22, P1; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283; ZAR JH, 1996, BIOSTATISTICAL ANAL; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897	160	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239195	10.1371/journal.pone.0239195	http://dx.doi.org/10.1371/journal.pone.0239195			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941544	gold, Green Published			2022-12-26	WOS:000573848800107
J	Stieg, DC; Cooper, KF; Strich, R				Stieg, David C.; Cooper, Katrina F.; Strich, Randy			The extent of cyclin C promoter occupancy directs changes in stress-dependent transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription; chromatin immunoprecipitation (ChIP); transcription promoter; oxidative stress; mammalian target of rapamycin (mTOR); cyclin-dependent kinase (CDK); cell death; transcription regulation	MITOCHONDRIAL FISSION; OXIDATIVE STRESS; MODULE ASSOCIATION; MEDIATOR COMPLEX; KINASE MODULE; CDK8; DEGRADATION; AUTOPHAGY; CANCER; MED13	The Cdk8 kinase module (CKM) is a detachable Mediator subunit composed of cyclin C and one each of paralogs Cdk8/Cdk19, Med12/Med12L, and Med13/Med13L. Our previous RNA-Seq studies demonstrated that cyclin C represses a subset of hydrogen peroxide-induced genes under normal conditions but is involved in activating other loci following stress. Here, we show that cyclin C directs this transcriptional reprograming through changes in its promoter occupancy. Following peroxide stress, cyclin C promoter occupancy increased for genes it activates while decreasing at loci it represses under normal conditions. Promoter occupancy of other CKM components generally mirrored cyclin C, indicating that the CKM moves as a single unit. It has previously been shown that some cyclin C leaves the nucleus following cytotoxic stress to induce mitochondrial fragmentation and apoptosis. We observed that CKM integrity appeared compromised at a subset of repressed promoters, suggesting a source of cyclin C that is targeted for nuclear release. Interestingly, mTOR inhibition induced a new pattern of cyclin C promoter occupancy indicating that this control is fine-tuned to the individual stress. Using inhibitors, we found that Cdk8 kinase activity is not required for CKM movement or repression but was necessary for full gene activation. In conclusion, this study revealed that different stress stimuli elicit specific changes in CKM promoter occupancy correlating to altered transcriptional outputs. Finally, although CKM components were recruited or expelled from promoters as a unit, heterogeneity was observed at individual promoters, suggesting a mechanism to generate gene- and stress-specific responses.	[Stieg, David C.; Cooper, Katrina F.; Strich, Randy] Rowan Univ, Grad Sch Biomed Sci, Dept Mol Biol, Stratford, NJ 08084 USA	Rowan University	Strich, R (corresponding author), Rowan Univ, Grad Sch Biomed Sci, Dept Mol Biol, Stratford, NJ 08084 USA.	strichra@rowan.edu		Stieg, David/0000-0003-2746-3315	National Institutes of Health [GM113196, GM113052]; W. W. Smith Foundation; New Jersey Camden Health Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Foundation; New Jersey Camden Health Initiative	This work was supported by National Institutes of Health Grants GM113196 (to K. F. C.) and GM113052 (to R. S.). This work was also supported by funds from the W. W. Smith Foundation (to K. F. C.) and the New Jersey Camden Health Initiative (to R. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adegbola A, 2015, EUR J HUM GENET, V23, P1308, DOI 10.1038/ejhg.2015.26; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avery SV, 2011, BIOCHEM J, V434, P201, DOI 10.1042/BJ20101695; Blok LS, 2018, HUM GENET, V137, P375, DOI 10.1007/s00439-018-1887-y; Borggrefe T, 2002, J BIOL CHEM, V277, P44202, DOI 10.1074/jbc.M207195200; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Calpena E, 2019, AM J HUM GENET, V104, P709, DOI 10.1016/j.ajhg.2019.02.006; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Clark AD, 2015, CRIT REV BIOCHEM MOL, V50, P393, DOI 10.3109/10409238.2015.1064854; Cooper KF, 2014, DEV CELL, V28, P161, DOI 10.1016/j.devcel.2013.12.009; Cooper KF, 1997, EMBO J, V16, P4665, DOI 10.1093/emboj/16.15.4665; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Di Giovanni C, 2016, EXPERT OPIN INV DRUG, V25, P1215, DOI 10.1080/13543784.2016.1234603; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Filomeni G, 2010, AUTOPHAGY, V6, P999, DOI 10.4161/auto.6.7.12754; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fulda Simone, 2010, Int J Cell Biol, V2010, P214074, DOI 10.1155/2010/214074; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Ganesan V, 2019, MOL BIOL CELL, V30, P302, DOI 10.1091/mbc.E18-07-0463; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hua H, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0754-1; Jezek J, 2019, EMBO REP, V20, DOI 10.15252/embr.201847425; Jezek J, 2019, J CELL SCI, V132, DOI 10.1242/jcs.230029; Khakhina S, 2014, MOL BIOL CELL, V25, P2807, DOI 10.1091/mbc.E14-05-0953; Knuesel MT, 2009, MOL CELL BIOL, V29, P650, DOI 10.1128/MCB.00993-08; Li N, 2014, NAT CELL BIOL, V16, P1080, DOI 10.1038/ncb3046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; Menzl I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12656-x; Miao YL, 2018, BIOL REPROD, V98, P449, DOI 10.1093/biolre/ioy004; Nizon M, 2019, GENET MED, V21, P2713, DOI 10.1038/s41436-019-0557-3; Porter DC, 2012, P NATL ACAD SCI USA, V109, P13799, DOI 10.1073/pnas.1206906109; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; Siauciunaite R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123040; Stieg DC, 2019, G3-GENES GENOM GENET, V9, P1901, DOI 10.1534/g3.119.400077; Stieg DC, 2018, MOL BIOL CELL, V29, P363, DOI 10.1091/mbc.E17-08-0493; STRICH R, 1989, P NATL ACAD SCI USA, V86, P10018, DOI 10.1073/pnas.86.24.10018; SUROSKY RT, 1994, MOL CELL BIOL, V14, P3446, DOI 10.1128/MCB.14.5.3446; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; van Haelst MM, 2015, EUR J HUM GENET, V23, P135, DOI 10.1038/ejhg.2014.69; Wang K, 2015, MOL BIOL CELL, V26, P1030, DOI 10.1091/mbc.E14-08-1315; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; Willis SD, 2020, MOL BIOL CELL, V31, P1015, DOI 10.1091/mbc.E19-11-0622; Willis SD, 2018, MICROB CELL, V5, P357, DOI 10.15698/mic2018.08.641; Yamamoto Toshiyuki, 2015, Hum Genome Var, V2, P15018, DOI 10.1038/hgv.2015.18	51	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16280	16291		10.1074/jbc.RA120.015215	http://dx.doi.org/10.1074/jbc.RA120.015215			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32934007	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000598519500009
J	Collura, KM; Niu, JW; Sanders, SS; Montersino, A; Holland, SM; Thomas, GM				Collura, Kaitlin M.; Niu, Jingwen; Sanders, Shaun S.; Montersino, Audrey; Holland, Sabrina M.; Thomas, Gareth M.			The palmitoyl acyltransferases ZDHHC5 and ZDHHC8 are uniquely present in DRG axons and control retrograde signaling via the Gp130/JAK/STAT3 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein acylation; axon; neuron; protein kinase; protein palmitoylation; intracellular trafficking; DLK; DRG	MICROFLUIDIC CULTURE PLATFORM; CILIARY NEUROTROPHIC FACTOR; LIPID RAFTS; PROTEIN PALMITOYLATION; RECEPTOR; INJURY; LOCALIZATION; TRANSPORT; GENE; DEGENERATION	Palmitoylation, the modification of proteins with the lipid palmitate, is a key regulator of protein targeting and trafficking. However, knowledge of the roles of specific palmitoyl acyltransferases (PATs), which catalyze palmitoylation, is incomplete. For example, little is known about which PATs are present in neuronal axons, although long-distance trafficking of palmitoyl-proteins is important for axon integrity and for axon-to-soma retrograde signaling, a process critical for axon development and for responses to injury. Identifying axonally targeted PATs might thus provide insights into multiple aspects of axonal biology. We therefore comprehensively determined the subcellular distribution of mammalian PATs in dorsal root ganglion (DRG) neurons and, strikingly, found that only two PATs, ZDHHC5 and ZDHHC8, were enriched in DRG axons. Signals via the Gp130/JAK/STAT3 and DLK/JNK pathways are important for axonal injury responses, and we found that ZDHHC5 and ZDHHC8 were required for Gp130/JAK/STAT3, but not DLK/JNK, axon-to-soma signaling. ZDHHC5 and ZDHHC8 robustly palmitoylated Gp130 in cotransfected nonneuronal cells, supporting the possibility that Gp130 is a direct ZDHHC5/8 substrate. In DRG neurons, Zdhhc5/8 shRNA knockdown reduced Gp130 palmitoylation and even more markedly reduced Gp130 surface expression, potentially explaining the importance of these PATs for Gp130-dependent signaling. Together, these findings provide new insights into the subcellular distribution and roles of specific PATs and reveal a novel mechanism by which palmitoylation controls axonal retrograde signaling.	[Collura, Kaitlin M.; Niu, Jingwen; Sanders, Shaun S.; Montersino, Audrey; Holland, Sabrina M.; Thomas, Gareth M.] Temple Univ, Shriners Hosp, Ctr Neurorehabil & Neural Repair, Pediat Res Ctr, Philadelphia, PA 19122 USA; [Thomas, Gareth M.] Temple Univ, Dept Anat & Cell Biol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Thomas, GM (corresponding author), Temple Univ, Shriners Hosp, Ctr Neurorehabil & Neural Repair, Pediat Res Ctr, Philadelphia, PA 19122 USA.; Thomas, GM (corresponding author), Temple Univ, Dept Anat & Cell Biol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.	gareth.thomas@temple.edu		Holland, Sabrina M/0000-0003-4805-1803; Niu, Jingwen/0000-0001-5456-1485; Thomas, Gareth/0000-0003-3183-8431	National Institutes of Health [R01 NS094402]; Shriners Hospitals for Children Grant [86610 PHI]; Brody Family Medical Trust Fund Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children Grant; Brody Family Medical Trust Fund Fellowship	This work was supported by National Institutes of Health Grant R01 NS094402 and Shriners Hospitals for Children Grant 86610 PHI (to G. M. T.). S. S. received a Brody Family Medical Trust Fund Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; Allen MJ, 2014, J NUTR, V144, P1306, DOI 10.3945/jn.114.194407; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1; Brigidi GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9200; Brigidi GS, 2014, NAT NEUROSCI, V17, P522, DOI 10.1038/nn.3657; Buk DM, 2004, J CELL SCI, V117, P2063, DOI 10.1242/jcs.01049; Carbia-Nagashima A, 2004, IUBMB LIFE, V56, P83, DOI 10.1080/15216540410001668064; Chen BE, 2018, CELL CHEM BIOL, V25, P817, DOI 10.1016/j.chembiol.2018.05.003; Chen ML, 2008, J MOL HISTOL, V39, P125, DOI 10.1007/s10735-007-9144-z; Chesarino NM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0091-3; CURTIS R, 1993, NATURE, V365, P253, DOI 10.1038/365253a0; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; De I, 2018, EUR J CELL BIOL, V97, P319, DOI 10.1016/j.ejcb.2018.03.005; DeSouza S, 2002, J NEUROSCI, V22, P3493; Ernst AM, 2018, DEV CELL, V47, P479, DOI 10.1016/j.devcel.2018.10.024; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Ghosh AS, 2011, J CELL BIOL, V194, P751, DOI 10.1083/jcb.201103153; Gorleku OA, 2011, J BIOL CHEM, V286, P39573, DOI 10.1074/jbc.M111.272369; Guedes-Dias P, 2019, SCIENCE, V366, P199, DOI 10.1126/science.aaw9997; Harrington AW, 2013, NAT REV NEUROSCI, V14, P177, DOI 10.1038/nrn3253; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; He M, 2014, J CELL BIOL, V206, P273, DOI 10.1083/jcb.201401016; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herincs Z, 2005, J CELL SCI, V118, P1687, DOI 10.1242/jcs.02296; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Holland SM, 2017, J NEUROSCI RES, V95, P1528, DOI 10.1002/jnr.24003; Holland SM, 2016, P NATL ACAD SCI USA, V113, P763, DOI 10.1073/pnas.1514123113; Houck KL, 2019, J THROMB HAEMOST, V17, P1500, DOI 10.1111/jth.14525; Howie J, 2014, P NATL ACAD SCI USA, V111, P17534, DOI 10.1073/pnas.1413627111; Janoschek R, 2006, P NATL ACAD SCI USA, V103, P10707, DOI 10.1073/pnas.0600425103; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Keith DJ, 2012, J NEUROSCI, V32, P7119, DOI 10.1523/JNEUROSCI.0784-12.2012; Kilpatrick CL, 2016, J BIOL CHEM, V291, P27371, DOI 10.1074/jbc.M116.732768; Kroy DC, 2010, HEPATOLOGY, V51, P463, DOI 10.1002/hep.23322; Lee MY, 2010, J LIPID RES, V51, P2082, DOI 10.1194/jlr.M001545; Lerch JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030417; Li Y, 2012, J BIOL CHEM, V287, P523, DOI 10.1074/jbc.M111.306183; Lorent JH, 2015, CHEM PHYS LIPIDS, V192, P23, DOI 10.1016/j.chemphyslip.2015.07.022; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Mahar M, 2018, NAT REV NEUROSCI, V19, P323, DOI 10.1038/s41583-018-0001-8; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Milde S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001539; Mok SA, 2009, CELL RES, V19, P546, DOI 10.1038/cr.2009.11; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2015, NEURON, V86, P680, DOI 10.1016/j.neuron.2015.04.003; Niethammer P, 2002, J CELL BIOL, V157, P521, DOI 10.1083/jcb.200109059; Niu J., 2020, BIORXIV, DOI [10.1101/2020.09.01.276287, DOI 10.1101/2020.09.01.276287]; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Oku S, 2013, J BIOL CHEM, V288, P19816, DOI 10.1074/jbc.M112.431676; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Plum W, 2010, AM J PATHOL, V176, P2236, DOI 10.2353/ajpath.2010.090469; Port MD, 2007, J NEUROCHEM, V101, P782, DOI 10.1111/j.1471-4159.2007.04471.x; Prescott GR, 2009, J NEUROCHEM, V110, P1135, DOI 10.1111/j.1471-4159.2009.06205.x; Quarta S, 2014, J NEUROSCI, V34, P13222, DOI 10.1523/JNEUROSCI.1209-13.2014; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Sanders SS, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0333-7; Sanders SS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004405; Scheib J, 2013, NAT REV NEUROL, V9, P668, DOI 10.1038/nrneurol.2013.227; Serwa RA, 2015, CHEM BIOL, V22, P1008, DOI 10.1016/j.chembiol.2015.06.024; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Simon DJ, 2016, CELL, V164, P1031, DOI 10.1016/j.cell.2016.01.032; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Sleigh JN, 2019, NAT REV NEUROL, V15, P691, DOI 10.1038/s41582-019-0257-2; Sobocinska J, 2018, MOL CELL PROTEOMICS, V17, P233, DOI 10.1074/mcp.RA117.000050; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Summers DW, 2018, P NATL ACAD SCI USA, V115, pE8746, DOI 10.1073/pnas.1806933115; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Thomas GM, 2013, J NEUROSCI, V33, P15401, DOI 10.1523/JNEUROSCI.1283-13.2013; Thomas GM, 2012, NEURON, V73, P482, DOI 10.1016/j.neuron.2011.11.021; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Woolfrey KM, 2015, J NEUROSCI, V35, P442, DOI 10.1523/JNEUROSCI.2243-14.2015; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	82	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 13	2020	295	46					15427	15437		10.1074/jbc.RA120.013815	http://dx.doi.org/10.1074/jbc.RA120.013815			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OY6NO	32958558	Green Published, hybrid			2022-12-26	WOS:000594361600001
J	Xin, GW; Fu, JY; Luo, J; Deng, ZX; Jiang, Q; Zhang, CM				Xin, Guangwei; Fu, Jingyan; Luo, Jia; Deng, Zhaoxuan; Jiang, Qing; Zhang, Chuanmao			Aurora B regulates PP1 gamma-Repo-Man interactions to maintain the chromosome condensation state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromosome condensation; Aurora B; PP1&#947; Repo-Man; cell cycle; chromatin; phosphoprotein phosphatase 1 (PP1); mitosis; chromatin modification; chromosome condensation; PP1&#947	PROTEIN PHOSPHATASE 1; HISTONE H3; KINASE INHIBITOR; PHOSPHORYLATION; RECRUITMENT; CENTROMERES; CHROMATIN; SPINDLE; MITOSIS; HASPIN	The mitotic kinase Aurora B regulates the condensation of chromatin into chromosomes by phosphorylating chromatin proteins during early mitosis, whereas the phosphatase PP1 gamma performs the opposite function. The roles of Aurora B and PP1 gamma must be tightly coordinated to maintain chromosomes at a high phosphorylation state, but the precise mechanisms regulating their function remain largely unclear. Here, mainly through immunofluorescence microscopy and co-immunoprecipitation assays, we find that dissociation of PP1 gamma from chromosomes is essential for maintaining chromosome phosphorylation. We uncover that PP1 gamma is recruited to mitotic chromosomes by its regulatory subunit Repo-Man in the absence of Aurora B activity and that Aurora B regulates dissociation of PP1 gamma by phosphorylating and disrupting PP1 gamma-Repo-Man interactions on chromatin. Overexpression of Repo-Man mutants that cannot be phosphorylated or inhibition of Aurora B kinase activity resulted in the retention of PP1 gamma on chromatin and prolonged the chromatin condensation process; a similar outcome was caused by the ectopic targeting of PP1 gamma to chromatin. Together, our findings reveal a novel regulation mechanism of chromatin condensation in which Aurora B counteracts PP1 gamma activity by releasing PP1 gamma from Repo-Man and may have important implications for understanding the regulations of dynamic structural changes of the chromosomes in mitosis.	[Xin, Guangwei; Fu, Jingyan; Luo, Jia; Deng, Zhaoxuan; Jiang, Qing; Zhang, Chuanmao] Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China	Peking University	Zhang, CM (corresponding author), Peking Univ, Coll Life Sci, Minist Educ, Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China.	zhangcm@pku.edu.cn		Zhang, Chuanmao/0000-0003-1359-6475	Ministry of Science and Technology of China; National Natural Science Foundation of China [2016YFA0500201, 2016YFA0100501, 31520103906, 91854204, 31430051]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology of China and the National Natural Science Foundation of China (Grants 2016YFA0500201, 2016YFA0100501, 31520103906, 91854204, and 31430051).	Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; BRADBURY EM, 1992, BIOESSAYS, V14, P9; de Castro IJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14048; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Fu JY, 2009, P NATL ACAD SCI USA, V106, P6939, DOI 10.1073/pnas.0900833106; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Gorbsky GJ, 2004, CURR BIOL, V14, pR346, DOI 10.1016/j.cub.2004.04.022; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Hirano T, 2000, ANNU REV BIOCHEM, V69, P115, DOI 10.1146/annurev.biochem.69.1.115; Hirota T, 2005, NATURE, V438, P1176, DOI 10.1038/nature04254; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kim Y, 2010, CELL, V142, P444, DOI 10.1016/j.cell.2010.06.039; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lesage B, 2011, CURR BIOL, V21, pR898, DOI 10.1016/j.cub.2011.08.063; Li S, 2015, J BIOL CHEM, V290, P17546, DOI 10.1074/jbc.M115.652453; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Murnion ME, 2001, J BIOL CHEM, V276, P26656, DOI 10.1074/jbc.M102288200; Nasa I, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aai8669; Peng AM, 2010, CURR BIOL, V20, P387, DOI 10.1016/j.cub.2010.01.020; Qian JB, 2013, CURR BIOL, V23, P1136, DOI 10.1016/j.cub.2013.05.017; Qian JB, 2011, CURR BIOL, V21, P766, DOI 10.1016/j.cub.2011.03.047; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vagnarelli P, 2011, DEV CELL, V21, P328, DOI 10.1016/j.devcel.2011.06.020; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yang J, 2007, BLOOD, V110, P2034, DOI 10.1182/blood-2007-02-073700; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200	41	1	1	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 23	2020	295	43					14780	14788		10.1074/jbc.AC120.012772	http://dx.doi.org/10.1074/jbc.AC120.012772			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	OP9LU	32938714	hybrid, Green Published			2022-12-26	WOS:000588412800022
J	Feng, YP; Yang, TS; Chung, CH; Chien, WC; Wong, CS				Feng, Yu-Pin; Yang, Tsorng-Shyang; Chung, Chi-Hsiang; Chien, Wu-Chien; Wong, Chih-Shung			Early childhood general anesthesia exposure associated with later developmental delay: A national population-based cohort study	PLOS ONE			English	Article							CHILDREN; AGE; LANGUAGE; SURGERY; DISORDER; OUTCOMES; SINGLE; BRAIN; RISK	Exposure to general anesthesia has been reported to induce neurotoxicity, impair learning, memory, attention, motor functions, as well as affect behavior in adult rodents and nonhuman primates. Though many have speculated similar effects in humans, previous literature has shown conflicting findings. To investigate the differences in risk of developmental delay among young children exposed to general anesthesia compared to matched unexposed individuals, a population-based cohort study was conducted with a longitudinal dataset spanning 2000 to 2013 from the Taiwan National Health Insurance Research Database (NHIRD). Procedure codes were used to identify children who received anesthesia. For each exposed child, two unexposed children matched by gender and age were enrolled into the comparison cohort. Neurocognitive outcome was measured by the presence of ICD-9-CM codes related to developmental delay (DD). Cox regression models were used to obtain hazard ratios of developing DD after varying levels of anesthesia exposure. After excluding 4,802 individuals who met the exclusion criteria, a total of 11,457 children who received general anesthesia before two years of age was compared to 22,914 children (matched by gender and age) unexposed to anesthesia. Increased risk of DD was observed in the exposure group with a hazard ratio (HR) of 1.320 (95% CI 1.143-1.522, P < 0.001). Subgroup analysis demonstrated further elevated risks of DD with multiple anesthesia exposures (1 anesthesia event: HR 1.145, 95% CI 1.010-1.246, P = 0.04; 2 anesthesia events: HR 1.476, 95% CI 1.155-1.887, P = 0.005; >= 3 anesthesia events: HR 2.222, 95% CI 1.810-2.621, P < 0.001) and longer total anesthesia durations (Total anesthesia <2 hours: HR 1.124, 95% CI 1.003-1.499, P = 0.047; Total anesthesia 2-4 hours: HR 1.450, 95% CI 1.157-1.800, P = 0.004; Total anesthesia > 4 hours: HR 1.598, 95% CI 1.343-1.982, P < 0.001) compared with children unexposed to anesthesia. These results suggest that children exposed to general anesthesia before two years of age have an increased risk of DD. This risk is further elevated with increased frequency of anesthesia, and longer total anesthesia duration. The findings of this study should prompt clinical practitioners to proceed with caution when assessing young patients and planning managements involving procedures requiring general anesthesia.	[Feng, Yu-Pin] Cathay Gen Hosp Xizhi, Dept Anesthesiol, New Taipei, Taiwan; [Yang, Tsorng-Shyang; Wong, Chih-Shung] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc TI, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan	Cathay General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Wong, CS (corresponding author), Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Med Res, Taipei, Taiwan.; Chien, WC (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	chienwu@ndmctsgh.edu.tw; w82556@gmail.com	Chung, Chi-Hsiang/AAY-3386-2021		Tri-Service General Hospital Research Foundation [TSGH C108-003]	Tri-Service General Hospital Research Foundation	Initials of the authors who received each award: WCC. Grant numbers awarded to each author: TSGH C108-003. The full name of each funder: Tri-Service General Hospital Research Foundation. URL of each funder website: https://www.google.com/url?sa=t&rct=j&q=&esrc= s&source=web&cd=4&cad=rja&uact=8&ved= 2ahUKEwiU1oLOiqnfAhUKE7wKHWloAvwQFjADegQICRAB&url=https%3A%2F%2Fwww.tsgh.ndmctsgh.edu.tw%2F&usg= AOvVaw16mt5MD9ugrukObCZqDCdC The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2010, J CHILD PSYCHOL PSYC, V51, P652, DOI 10.1111/j.1469-7610.2009.02193.x; Amrock LG, 2015, ANESTHESIOLOGY, V122, P87, DOI 10.1097/ALN.0000000000000477; [Anonymous], 2015, MEDICINE, V94, pe1435; Baumer FM, 2018, J PEDIATR-US, V194, P13, DOI 10.1016/j.jpeds.2017.10.031; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; Caplan R, 2009, EPILEPSIA, V50, P2397, DOI 10.1111/j.1528-1167.2009.02199.x; Davidson AJ, 2015, PEDIATR ANESTH, V25, P447, DOI 10.1111/pan.12652; Deng M, 2014, BRIT J ANAESTH, V113, P443, DOI 10.1093/bja/aet469; [鄂亚佳 E Yajia], 2011, [内燃机工程, Chinese Internal Combustion Engine Engineering], V32, P63; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Glatz P, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.3470; Graham MR, 2016, ANESTHESIOLOGY, V125, P667, DOI 10.1097/ALN.0000000000001245; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Ing C, 2017, BRIT J ANAESTH, V119, P532, DOI 10.1093/bja/aew413; Ing C, 2017, ANESTH ANALG, V125, P1988, DOI 10.1213/ANE.0000000000002423; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jevtovic-Todorovic V, 2018, ANESTHESIOLOGY, V128, P832, DOI 10.1097/ALN.0000000000002047; Ko WR, 2015, EUR J ANAESTH, V32, P303, DOI 10.1097/EJA.0000000000000130; Kuo HT, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S84088; Lee JR, 2017, BRIT J ANAESTH, V119, P492, DOI 10.1093/bja/aex219; Luna Ruth Ann, 2016, Curr Dev Disord Rep, V3, P75; Nithianantharajah Jess, 2017, Curr Dev Disord Rep, V4, P28, DOI 10.1007/s40474-017-0111-4; Noguchi KK, 2017, BRIT J ANAESTH, V119, P524, DOI 10.1093/bja/aex123; Noguchi KK, 2016, SCI REP-UK, V6, DOI 10.1038/srep22427; O'Leary JD, 2016, ANESTHESIOLOGY, V125, P272, DOI 10.1097/ALN.0000000000001200; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Rothman KJ, 2012, MODERN EPIDEMIOLOGY; Startin CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131604; Sun LS, 2016, JAMA-J AM MED ASSOC, V315, P2312, DOI 10.1001/jama.2016.6967; Tai D, 2006, ARCH PEDIAT ADOL MED, V160, P293, DOI 10.1001/archpedi.160.3.293; Tai YM, 2009, INT J MED INFORM, V78, pE75, DOI 10.1016/j.ijmedinf.2009.09.005; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Woodward M., EPIDEMIOLOGY STUDY D, VSecond ed.	34	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238289	10.1371/journal.pone.0238289	http://dx.doi.org/10.1371/journal.pone.0238289			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970686	gold, Green Published			2022-12-26	WOS:000576265600074
J	Hammock, BG; Ramirez-Duarte, WF; Garcia, PAT; Schultz, AA; Avendano, LI; Hung, TC; White, JR; Bong, YT; Teh, SJ				Hammock, Bruce G.; Ramirez-Duarte, Wilson F.; Triana Garcia, Pedro Alejandro; Schultz, Andrew A.; Avendano, Leonie, I; Hung, Tien-Chieh; White, James R.; Bong, Yih-Tyng; Teh, Swee J.			The health and condition responses of Delta Smelt to fasting: A time series experiment	PLOS ONE			English	Article							LONG-TERM STARVATION; RNA-DNA RATIO; CLIMATE-CHANGE; ATLANTIC COD; FISH; AUTOPHAGY; LIVER; STRESS; GROWTH; CONTAMINANT	There is an extensive literature establishing, validating, and quantifying a wide range of responses of fishes to fasting. Our study complements this work by comparing fed and unfed treatments of hatchery-raised Delta Smelt (Hypomesus transpacificus)-an imperiled fish that is endemic to the San Francisco Estuary and its tributaries in California, USA-across a diverse suite of endpoints over a two-month time series. The experiment was conducted at 15.9 degrees C, and individuals were sampled at 12 time points as starvation became increasingly severe. We found that hepatosomatic index and condition factor were relatively sensitive to starvation, becoming significantly depressed at Day 4 and 7, respectively. Histological analysis of liver showed elevated cytoplasmic inclusion bodies at Day 7, followed by increased glycogen depletion, single cell necrosis, and hydropic vacuolar degeneration at Day 14, 21, and 28, respectively. Of four antioxidants measured, glutathione decreased at Day 4, superoxide dismutase increased at Day 14, catalase increased at Day 56, and glutathione peroxidase was not affected by starvation. The net result was a similar to 2-fold increase in lipid peroxidation (malondialdehyde) in fasted fish that was highly inconsistent through time. RNA to DNA ratio and triglycerides in muscle were relatively insensitive to starvation, only consistently decreasing with fasting after mortality began increasing in the 'No Feeding' treatment, at Day 21. Together, these results suggest that Delta Smelt mobilize hepatic energy stores far more rapidly than lipids in muscle when subjected to fasting, leading to rapid atrophy of liver and the development of cytoplasmic inclusion bodies-possibly autophagosomes-in hepatocytes.	[Hammock, Bruce G.; Ramirez-Duarte, Wilson F.; Triana Garcia, Pedro Alejandro; Avendano, Leonie, I; Bong, Yih-Tyng; Teh, Swee J.] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Aquat Hlth Program, Davis, CA 95616 USA; [Ramirez-Duarte, Wilson F.; Triana Garcia, Pedro Alejandro] Univ Llanos, Inst Acuicultura Llanos, Grp Invest Sanidad Organismos Acuat, Villavicencio, Meta, Colombia; [Schultz, Andrew A.] US Bur Reclamat Bay Delta Off, Sci Div, Sacramento, CA USA; [Hung, Tien-Chieh] Univ Calif Davis, Biol & Agr Engn Dept, Fish Conservat & Culture Lab, Davis, CA 95616 USA; [White, James R.] Calif Dept Fish & Wildlife, Stockton, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Hammock, BG (corresponding author), Univ Calif Davis, Dept Anat Physiol & Cell Biol, Sch Vet Med, Aquat Hlth Program, Davis, CA 95616 USA.	brucehammock@gmail.com	Hung, Tien-Chieh/C-1047-2008	Hung, Tien-Chieh/0000-0001-9618-5887; White, James/0000-0001-7977-1956; Ramirez Duarte, Wilson Ferney/0000-0002-9943-9106	U.S. Bureau of Reclamation [R17AC00129]	U.S. Bureau of Reclamation	This work was supported by a grant (U.S. Bureau of Reclamation R17AC00129) to SJT and BGH. The funder (AAS) assisted with study design and preparation of the manuscript. Funder's website: https://www.usbr.gov.	Agamy E, 2012, ECOTOX ENVIRON SAFE, V75, P171, DOI 10.1016/j.ecoenv.2011.09.010; ALPINE AE, 1992, LIMNOL OCEANOGR, V37, P946, DOI 10.4319/lo.1992.37.5.0946; [Anonymous], 2019, SAN FRANC ESTUARY WA, DOI DOI 10.15447/sfews.2019v17iss3art3; [Anonymous], 2009, HOME TEXTILES TODAY, V30, P1; BAGDADE JD, 1970, NEW ENGL J MED, V282, P166; Baumgarner BL, 2012, FISH PHYSIOL BIOCHEM, V38, P319, DOI 10.1007/s10695-011-9509-9; Bennett W., 2005, SAN FRANCISCO ESTUAR, V3, DOI DOI 10.15447/SFEWS.2005V3ISS2ART1; Birnie-Gauvin K, 2017, FISH FISH, V18, P928, DOI 10.1111/faf.12215; BLACK D, 1986, J COMP PHYSIOL B, V156, P469, DOI 10.1007/BF00691032; BOUJARD T, 1992, FISH PHYSIOL BIOCHEM, V10, P111, DOI 10.1007/BF00004522; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buckley L, 1999, HYDROBIOLOGIA, V401, P265, DOI 10.1023/A:1003798613241; BUCKLEY LJ, 1984, MAR BIOL, V80, P291, DOI 10.1007/BF00392824; Caldarone EM, 2001, NE FISH SCI CTR REF; Cazenave J, 2005, AQUAT TOXICOL, V75, P178, DOI 10.1016/j.aquatox.2005.08.002; Chiarelli R, 2016, CELL STRESS CHAPERON, V21, P19, DOI 10.1007/s12192-015-0639-3; Davis TW, 2009, HARMFUL ALGAE, V8, P715, DOI 10.1016/j.hal.2009.02.004; De Pedro N, 2003, J COMP PHYSIOL B, V173, P475, DOI 10.1007/s00360-003-0355-7; Deng SX, 2010, AQUACULTURE, V307, P233, DOI 10.1016/j.aquaculture.2010.07.029; Deutsch C, 2015, SCIENCE, V348, P1132, DOI 10.1126/science.aaa1605; Duguid WDP, 2018, MAR COAST FISH, V10, P204, DOI 10.1002/mcf2.10020; Eskelinen EL, 2011, AUTOPHAGY, V7, P935, DOI 10.4161/auto.7.9.15760; Fernandez-Diaz C, 2006, AQUACULTURE, V251, P573, DOI 10.1016/j.aquaculture.2005.06.014; Feyrer F, 2003, ENVIRON BIOL FISH, V67, P277, DOI 10.1023/A:1025839132274; Feyrer F, 2011, ESTUAR COAST, V34, P120, DOI 10.1007/s12237-010-9343-9; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Foott JS, 2010, CALIF FISH GAME, V96, P223; FRENCH CJ, 1983, AM J PHYSIOL, V245, pR827, DOI 10.1152/ajpregu.1983.245.6.R827; Furne M, 2009, AQUACULT NUTR, V15, P587, DOI 10.1111/j.1365-2095.2008.00626.x; Garcia-Esquivel Z, 2002, COMP BIOCHEM PHYS A, V133, P63, DOI 10.1016/S1095-6433(02)00112-5; Greenfield BK, 2008, ARCH ENVIRON CON TOX, V55, P270, DOI 10.1007/s00244-007-9112-3; HAKANSON JL, 1994, ICES J MAR SCI, V51, P147, DOI 10.1006/jmsc.1994.1016; Hamilton SA, 2018, ENVIRON MANAGE, V62, P365, DOI 10.1007/s00267-018-1014-9; Hammock BG, 2019, ESTUAR COAST, V42, P857, DOI 10.1007/s12237-019-00521-5; Hammock BG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173497; Hammock BG, 2015, SCI TOTAL ENVIRON, V532, P316, DOI 10.1016/j.scitotenv.2015.06.018; Hards AR, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11050071; Hobbs JA, 2006, J FISH BIOL, V69, P907, DOI 10.1111/j.1095-8649.2006.01176.x; Houlihan D, 2008, FOOD INTAKE FISH; Hur JW, 2006, ICHTHYOL RES, V53, P306, DOI 10.1007/s10228-006-0348-0; Isaak DJ, 2013, GLOBAL CHANGE BIOL, V19, P742, DOI 10.1111/gcb.12073; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KIMMERER WJ, 1994, MAR ECOL PROG SER, V113, P81, DOI 10.3354/meps113081; Komoroske LM, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou008; Kuivila KM, 2004, AM FISH S S, V39, P229; Kumar V, 2014, ROBBINS COTRAN PATHO; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lehman PW, 2017, HARMFUL ALGAE, V63, P94, DOI 10.1016/j.hal.2017.01.011; Lehman PW, 2010, HYDROBIOLOGIA, V637, P229, DOI 10.1007/s10750-009-9999-y; Lesser MP, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P9; Li HY, 2018, AQUACULTURE, V496, P166, DOI 10.1016/j.aquaculture.2018.07.015; Li S, 2017, FISH SHELLFISH IMMUN, V71, P50, DOI 10.1016/j.fsi.2017.09.050; Lindberg JC, 2013, N AM J AQUACULT, V75, P186, DOI 10.1080/15222055.2012.751942; LOCHMANN SE, 1995, CAN J FISH AQUAT SCI, V52, P1294, DOI 10.1139/f95-126; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu DL, 2019, J PHYSIOL-LONDON, V597, P1585, DOI [10.1113/JP277091, 10.1113/jp277091]; Marino G, 2014, NAT REV MOL CELL BIO, V15, P81, DOI 10.1038/nrm3735; MEHNER T, 1994, J FISH BIOL, V45, P325, DOI 10.1111/j.1095-8649.1994.tb01311.x; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Monserrat JM, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P317; Moore MN, 2008, METHOD ENZYMOL, V451, P581, DOI 10.1016/S0076-6879(08)03233-3; Morales AE, 2004, COMP BIOCHEM PHYS C, V139, P153, DOI 10.1016/j.cca.2004.10.008; Morales AE, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P281; MOYLE PB, 1992, T AM FISH SOC, V121, P67, DOI 10.1577/1548-8659(1992)121<0067:LHASOD>2.3.CO;2; Moyle Peter B., 2016, San Francisco Estuary & Watershed Science, V14, P6; NAGAI M, 1971, B JPN SOC SCI FISH, V37, P404; Navarro Isabel, 1995, Biochemistry and Molecular Biology of Fishes, V4, P393; Nicolas JM, 1999, AQUAT TOXICOL, V45, P77, DOI 10.1016/S0166-445X(98)00095-2; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAOLETTI F, 1990, CHEM-BIOL INTERACT, V76, P3, DOI 10.1016/0009-2797(90)90030-Q; Peragon J, 1999, MOL CELL BIOCHEM, V201, P1, DOI 10.1023/A:1006953917697; PEREIRA JJ, 1993, ARCH ENVIRON CON TOX, V24, P427, DOI 10.1007/BF01146157; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rabalais NN, 2002, AMBIO, V31, P102, DOI 10.1579/0044-7447-31.2.102; Ramirez-Duarte WF, 2016, SCI TOTAL ENVIRON, V568, P26, DOI 10.1016/j.scitotenv.2016.05.179; Ricciardi A, 1998, J ANIM ECOL, V67, P613, DOI 10.1046/j.1365-2656.1998.00220.x; RICKER W E, 1975, P382; Rossi A, 2015, ECOL INDIC, V56, P161, DOI 10.1016/j.ecolind.2015.04.001; Sall J, 2007, JMP START STAT GUIDE; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seiliez I, 2010, COMP BIOCHEM PHYS B, V157, P258, DOI 10.1016/j.cbpb.2010.06.011; Sobczak WV, 2002, P NATL ACAD SCI USA, V99, P8101, DOI 10.1073/pnas.122614399; Sommer T, 2007, FISHERIES, V32, P270, DOI 10.1577/1548-8446(2007)32[270:TCOPFI]2.0.CO;2; Stehr CM, 1998, DIS AQUAT ORGAN, V32, P119, DOI 10.3354/dao032119; Teh SJ, 1997, AQUAT TOXICOL, V37, P51, DOI 10.1016/S0166-445X(96)00808-9; Teh SJ, 2020, SCI TOTAL ENVIRON, V726, DOI 10.1016/j.scitotenv.2020.138333; Teh SJ, 2016, AQUAT TOXICOL, V170, P152, DOI 10.1016/j.aquatox.2015.11.009; Werner I, 2000, ENVIRON TOXICOL CHEM, V19, P215, DOI [10.1897/1551-5028(2000)019&lt;0215:ICTTCD&gt;2.3.CO;2, 10.1002/etc.5620190126]; Weston DP, 2014, ENVIRON TOXICOL CHEM, V33, P920, DOI 10.1002/etc.2512; Williams DE, 1997, CHEM RES TOXICOL, V10, P463, DOI 10.1021/tx9601519; Wolf JC, 2005, TOXICOL PATHOL, V33, P75, DOI 10.1080/01926230590890187; Xia XJ, 2019, AQUACULTURE, V511, DOI 10.1016/j.aquaculture.2019.734212; Yabu T, 2012, MAR BIOTECHNOL, V14, P491, DOI 10.1007/s10126-012-9432-9; Zeng LQ, 2012, COMP BIOCHEM PHYS A, V162, P200, DOI 10.1016/j.cbpa.2012.02.022	95	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239358	10.1371/journal.pone.0239358	http://dx.doi.org/10.1371/journal.pone.0239358			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970715	Green Published, gold			2022-12-26	WOS:000576265600096
J	Ribeiro, ESS; Damasceno, KSFSC; Dantas, LMD; de Azevedo, WM; Leite, PIP; de Assis, CF; de Sousa, FC				Sena Ribeiro, Ellane Sabryna; Silva Chaves Damasceno, Karla Suzanne Florentino; da Costa Dantas, Livia Maria; de Azevedo, Wendell Medeiros; Palacio Leite, Pedro Ivo; de Assis, Cristiane Fernandes; de Sousa Junior, Francisco Caninde			Fermented yellow mombin juice usingLactobacillus acidophilusNRRL B-4495: Chemical composition, bioactive properties and survival in simulated gastrointestinal conditions	PLOS ONE			English	Article							LACTOBACILLUS-PLANTARUM; ANTIOXIDANT; VIABILITY; QUALITY; APPLE; ACID; ACCEPTANCE; PROBIOTICS; BACTERIA; IMPACT	The purpose of the present study was to evaluate yellow mombin (Spondias mombinL.) juice as a vehicle for theLactobacillus acidophilusNRRL B-4495 probiotic. The initial pH and fermentation temperature conditions were optimized by central composite rotational design. The beverage was evaluated for its chemical composition, bioactive properties, microbiological stability, survival in simulated gastrointestinal conditions and sensory analysis. The ideal conditions for probiotic juice production were an initial pH of 6.4 and 16 h of fermentation, with maximum viability of 12.9 +/- 0.4 Log CFU/mL. The fermented juice showed a total phenolic concentration of 94.90 +/- 7.12 GAE/mL and antioxidant activity, as measured by DPPH (0.31 +/- 0.00 mu mol TE/mL) and ABTS sequestration (2.59 +/- 0.30 mu mol TE/mL). Antibacterial activity could also be observed againstS.aureus,E.coliandK.pneumoniae. The obtained formulation showed good microbiological stability when stored at 4oC for 28 days. In addition, there was no significant change in viability after exposure to simulated gastrointestinal conditions. The sensory analysis showed that the probiotic beverage was not well accepted. However, the Just-About-Right (JAR) ideal scale test enabled identifying the specific attributes which need to be improved from the tasters' point of view so that it is possible to improve product acceptance.	[Sena Ribeiro, Ellane Sabryna; Silva Chaves Damasceno, Karla Suzanne Florentino; de Assis, Cristiane Fernandes; de Sousa Junior, Francisco Caninde] Univ Fed Rio Grande do Norte, Nutr Grad Program, Natal, RN, Brazil; [Silva Chaves Damasceno, Karla Suzanne Florentino] Univ Fed Rio Grande do Norte, Dept Nutr, Natal, RN, Brazil; [da Costa Dantas, Livia Maria; de Azevedo, Wendell Medeiros; Palacio Leite, Pedro Ivo; de Assis, Cristiane Fernandes; de Sousa Junior, Francisco Caninde] Univ Fed Rio Grande do Norte, Dept Pharm, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	de Sousa, FC (corresponding author), Univ Fed Rio Grande do Norte, Nutr Grad Program, Natal, RN, Brazil.; de Sousa, FC (corresponding author), Univ Fed Rio Grande do Norte, Dept Pharm, Natal, RN, Brazil.	fcfarma@yahoo.com.br	Assis, Cristiane Fernandes de/AAY-9213-2021; PALACIO LEITE, PEDRO IVO/AAJ-2891-2021	Assis, Cristiane Fernandes de/0000-0001-7595-5395; Azevedo, Wendell/0000-0001-8707-2493	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partly financed by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 (ESSR).	Andrade R, 2019, FOOD BIOSCI, V32, DOI 10.1016/j.fbio.2019.100470; [Anonymous], 2017, BAG B, V50, P28; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinques GB, 2011, J FOOD ENG, V103, P123, DOI 10.1016/j.jfoodeng.2010.10.006; Brito SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201561; Pereira BLB, 2020, J CELL MOL MED, V24, P7862, DOI 10.1111/jcmm.15419; Chen C, 2019, FOOD BIOSCI, V27, P30, DOI 10.1016/j.fbio.2018.11.006; Clinical Laboratory Standards Institute (CLSI), 2018, METHODS DILUTION ANT; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105; da Costa GM, 2017, LWT-FOOD SCI TECHNOL, V75, P195, DOI 10.1016/j.lwt.2016.08.051; Padilha CED, 2018, SEP SCI TECHNOL, V53, P2126, DOI 10.1080/01496395.2018.1442865; de Azevedo WM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232224; de Carvalho JM, 2015, J FOOD SCI TECH MYS, V52, P1182, DOI 10.1007/s13197-013-1100-1; de Souza VR, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110707; dos Santos AL, 2019, LWT-FOOD SCI TECHNOL, V99, P371, DOI 10.1016/j.lwt.2018.10.007; Espirito-Santo AP, 2015, FOOD RES INT, V78, P352, DOI 10.1016/j.foodres.2015.09.014; Farias N, 2016, LWT-FOOD SCI TECHNOL, V71, P149, DOI 10.1016/j.lwt.2016.03.014; Favaro-Trindade CS, 2007, FOOD SCI TECHNOL INT, V13, P285, DOI 10.1177/1082013207082387; Pereira ALF, 2017, FOOD RES INT, V100, P603, DOI 10.1016/j.foodres.2017.07.055; Pereira ALF, 2013, FOOD BIOPROCESS TECH, V6, P3155, DOI 10.1007/s11947-012-1032-1; Fonteles TV, 2012, FOOD BIOPROCESS TECH, V5, P2819, DOI 10.1007/s11947-011-0600-0; Fujita A, 2013, FOOD RES INT, V54, P495, DOI 10.1016/j.foodres.2013.07.025; Gudina EJ, 2010, LETT APPL MICROBIOL, V50, P419, DOI 10.1111/j.1472-765X.2010.02818.x; Hashemi SMB, 2017, J FUNCT FOODS, V38, P409, DOI 10.1016/j.jff.2017.09.040; Ismail M, 2018, BRIT FOOD J, V120, P499, DOI [10.1108/BFJ-04-2017-0259, 10.1108/bfj-04-2017-0259]; Kandylis P, 2016, CURR OPIN FOOD SCI, V7, P58, DOI 10.1016/j.cofs.2015.11.012; Lievin-Le Moal V, 2014, CLIN MICROBIOL REV, V27, P167, DOI 10.1128/CMR.00080-13; Moreira RM, 2017, LWT-FOOD SCI TECHNOL, V77, P259, DOI 10.1016/j.lwt.2016.11.049; Panghal A, 2018, FOOD BIOSCI, V21, P80, DOI 10.1016/j.fbio.2017.12.003; Pereira A.L.F., 2018, FRUIT JUICES, P279, DOI DOI 10.1016/B978-0-12-802230-6.00015-1; Pereira ALF, 2011, FOOD RES INT, V44, P1276, DOI 10.1016/j.foodres.2010.11.035; Ribeiro VT, 2019, APPL MICROBIOL BIOT, V103, P6495, DOI 10.1007/s00253-019-09948-z; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Sameh S, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/5382904; Sanders ME, 2019, NAT REV GASTRO HEPAT, V16, P605, DOI 10.1038/s41575-019-0173-3; de Farias TGS, 2019, LWT-FOOD SCI TECHNOL, V100, P391, DOI 10.1016/j.lwt.2018.10.084; Tejero-Sarinena S, 2012, ANAEROBE, V18, P530, DOI 10.1016/j.anaerobe.2012.08.004; Tiburski JH, 2011, FOOD RES INT, V44, P2326, DOI 10.1016/j.foodres.2011.03.037; Vivek K, 2019, LWT-FOOD SCI TECHNOL, V108, P55, DOI 10.1016/j.lwt.2019.03.046; Yoon KY, 2006, BIORESOURCE TECHNOL, V97, P1427, DOI 10.1016/j.biortech.2005.06.018	40	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239392	10.1371/journal.pone.0239392	http://dx.doi.org/10.1371/journal.pone.0239392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970721	Green Published, gold			2022-12-26	WOS:000576265600031
J	Jibril, AH; Okeke, IN; Dalsgaard, A; Kudirkiene, E; Akinlabi, OC; Bello, MB; Olsen, JE				Jibril, Abdurrahman Hassan; Okeke, Iruka N.; Dalsgaard, Anders; Kudirkiene, Egle; Akinlabi, Olabisi Comfort; Bello, Muhammad Bashir; Olsen, John Elmerdahl			Prevalence and risk factors of Salmonella in commercial poultry farms in Nigeria	PLOS ONE			English	Article							CONTAMINATION	Salmonellais an important human pathogen and poultry products constitute an important source of human infections. This study investigated prevalence; identified serotypes based on whole genome sequence, described spatial distribution ofSalmonellaserotypes and predicted risk factors that could influence the prevalence ofSalmonellainfection in commercial poultry farms in Nigeria. A cross sectional approach was employed to collect 558 pooled shoe socks and dust samples from 165 commercial poultry farms in North West Nigeria. On-farm visitation questionnaires were administered to obtain information on farm management practices in order to assess risk factors forSalmonellaprevalence.Salmonellawas identified by culture, biotyping, serology and polymerase chain reaction (PCR). PCR confirmed isolates were paired-end Illumina- sequenced. Followingde novogenome assembly, draft genomes were used to obtain serotypes by SeqSero2 and SISTR pipeline and sequence types by SISTR and Enterobase. Risk factor analysis was performed using the logit model. A farm prevalence of 47.9% (CI95[40.3-55.5]) forSalmonellawas observed, with a sample level prevalence of 15.9% (CI95[12.9-18.9]). Twenty-three different serotypes were identified, withS. Kentucky andS. Isangi as the most prevalent (32.9% and 11%). Serotypes showed some geographic variation.Salmonelladetection was strongly associated with disposal of poultry waste and with presence of other livestock on the farm.Salmonellawas commonly detected on commercial poultry farms in North West Nigeria andS. Kentucky was found to be ubiquitous in the farms.	[Jibril, Abdurrahman Hassan; Dalsgaard, Anders; Kudirkiene, Egle; Olsen, John Elmerdahl] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark; [Jibril, Abdurrahman Hassan] Usmanu Danfodiyo Univ Sokoto, Fac Vet Med, Dept Vet Publ Hlth & Prevent Med, Sokoto, Nigeria; [Okeke, Iruka N.; Akinlabi, Olabisi Comfort] Univ Ibadan, Fac Pharm, Dept Pharmaceut Microbiol, Ibadan, Nigeria; [Bello, Muhammad Bashir] Usmanu Danfodiyo Univ Sokoto, Fac Vet Med, Dept Vet Microbiol, Sokoto, Nigeria; [Bello, Muhammad Bashir] Usmanu Danfodiyo Univ Sokoto, Ctr Adv Med Res & Training, Sokoto, Nigeria	University of Copenhagen; University of Ibadan	Olsen, JE (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark.	jeo@sund.ku.dk	Kudirkiene, Egle/ABG-5736-2021; Jibril, Abdurrahman Hassan/HHS-9424-2022	Jibril, Abdurrahman/0000-0003-4721-5642; Olsen, John Elmerdahl/0000-0001-6225-6587	UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement is also part of the EDCTP2 programme - European Union; MRC [MR/L00464X/1] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement is also part of the EDCTP2 programme - European Union; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was part-supported by an African Research Leader Award to INO from the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement that is also part of the EDCTP2 programme supported by the European Union.	Aarestrup FM, 2007, EMERG INFECT DIS; Adell E, 2014, ANN AGR ENV MED; Adesiyun A, 2014, J FOOD PROTECT, V77, P1471, DOI 10.4315/0362-028X.JFP-14-021; Agency A and P health, 2019, SALM LIV PROD GB; Agron PG, 2001, APPL ENV MICROBIOL; Ahmed AO, 2019, ONDERSTEPOORT J VET, V86, DOI 10.4102/ojvr.v86i1.1667; Andoh LA, 2016, EPIDEMIOL INFECT, V144, P3288, DOI 10.1017/S0950268816001126; [Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; [Anonymous], 2017, Future Oncol, V13, P1, DOI 10.2217/fon-2017-0071; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2008, IARC PUBL, VIX, P1; [Anonymous], 2018, FRONT MICROBIOL, V9, P1; [Anonymous], 2017, INT J RES HUMANITIES, V46, P1; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2018, STAT NB 1 1 0 POPULA, P7; [Anonymous], 2017, INT STANDARD HORIZON; [Anonymous], 2018, BMC VET RES, V14, P1, DOI [10.1186/s12917-018-1408-1LK, 10.1186./02Fs12917-018-1408-1&atitle, DOI 10.1186/S12917-018-1408-1LK]; Bai J, 2016, CIPROFLOXACIN RESIST, P2010; Barua H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035914; Bettridge JM, 2014, PREV VET MED; Bonalli M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-49; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Davis M, 2005, AVIAN DIS; Deng X, 2016, ANN REV FOOD SCI TEC; Diep B, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02554; Djeffal S, 2018, VET WORLD, V11, P1102, DOI 10.14202/vetworld.2018.1102-1108; DTU F, 2018, ANN REP ZOON DENM 20, P1; Du XF, 2018, INT J BIOL MACROMOL, V107, P393, DOI 10.1016/j.ijbiomac.2017.09.005; Eckerle I, 2010, J CLIN MICROBIOL; European Food Safety Authority (EFSA), 2015, EFSA J, V13, pe4138, DOI 10.2903/j.efsa.2015.4138; Fagbamila IO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173097; Foley SL, 2011, APPL ENV MICROBIOLOG; Fonteneau L, 2017, EUROSURVEILLANCE; Food and Agriculture Organization, 2018, LIV LIV SPOTL NIGERI LIV LIV SPOTL NIGERI; Galanis E, 2006, EMERG INFECT DIS; Gast RK, 2007, AVIAN DIS; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Gurevich A, 2013, BIOINFORMATICS; Gymoese P, 2017, EMERG INFECT DIS, V23, P1631, DOI 10.3201/eid2310.161248; Herrera-Leon S, 2007, RES MICROBIOL; Kagambega A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-253; Koutsoumanis K., 2019, EFSA J, V17; Langridge GC, 2015, P NATL ACAD SCI US; Laughlin M, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268819001596; Le Hello S, 2013, LANCET INFECT DIS; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; Lettini AA, 2016, ZOONOSES PUBLIC HLTH; Li X, 2007, POULT SCI; M M., 2010, VET MICROBIOL; Majowicz SE, 2010, CLIN INFECT DIS; Mohammed S, 2018, VEGETATION DENSITY D, V4, P195; Mollenhorst H, 2005, POULTRY SCI, V84, P1308, DOI 10.1093/ps/84.8.1308; Namata H, 2009, PREV VET MED, V90, P211, DOI 10.1016/j.prevetmed.2009.03.006; Pointon A, 2008, J FOOD PROT; R Core Team, 2019, R LANG ENV STAT COMP; Radke BR, 2002, CAN VET J; Rauch HE, 2018, ZOONOSES PUBLIC HLTH; Raufu I, 2013, J APPL MICROBIOL; Raufu IA, 2014, J INFECT DEV CTRIES; Suleyman G, 2016, INFECT CONTROL HOSP; Tay MYF, 2019, FOODBORNE PATHOG DIS, V16, P531, DOI 10.1089/fpd.2018.2604; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; Uelze L, 2019, APPL ENV MICROBIOL; Useh NM, 2016, DRAFT GENOME SEQUENC, V4, P15; van Cauteren D, 2009, EURO SURVEILL; Vanegas RA, 1995, J BACTERIOL; Vinueza-Burgos C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159567; Vosik D, 2018, FOODBORNE PATHOG DIS, V15, P101, DOI 10.1089/fpd.2017.2298; Waghamare RN, 2018, VET WORLD; Wattiau P, 2011, APPL ENV MICROBIOL; Wierup M, 2017, ACTA VET SCAND, V59, P1, DOI 10.1186/s13028-017-0281-4; Wilkinson KG, 2011, POULT SCI; Williams JE, 1978, AVIAN DIS; Yachison CA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01044; Yoshida CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147101; Zhang SK, 2015, J CLIN MICROBIOL, V53, P1685, DOI 10.1128/JCM.00323-15; Zhou Z, 2020, GENOME RES; 2012, SURG OBES RELAT DIS, V8	79	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238190	10.1371/journal.pone.0238190	http://dx.doi.org/10.1371/journal.pone.0238190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966297	Green Published, gold			2022-12-26	WOS:000575688700003
J	Jones, T; Naslavsky, N; Caplan, S				Jones, Tyler; Naslavsky, Naava; Caplan, Steve			Eps15 Homology Domain Protein 4 (EHD4) is required for Eps15 Homology Domain Protein 1 (EHD1)-mediated endosomal recruitment and fission	PLOS ONE			English	Article							PLASMA-MEMBRANE; ENDOCYTIC TRAFFICKING; WASH COMPLEX; RETROMER; INTERACT; BINDING; ACTIN; NPF; DEGRADATION; RABENOSYN-5	Upon internalization, receptors are trafficked to sorting endosomes (SE) where they undergo sorting and are then packaged into budding vesicles that undergo fission and transport within the cell. Eps15 Homology Domain Protein 1 (EHD1), the best-characterized member of the Eps15 Homology Domain Protein (EHD) family, has been implicated in catalyzing the fission process that releases endosome-derived vesicles for recycling to the plasma membrane. Indeed, recent studies suggest that upon receptor-mediated internalization, EHD1 is recruited from the cytoplasm to endosomal membranes where it catalyzes vesicular fission. However, the mechanism by which this recruitment occurs remains unknown. Herein, we demonstrate that the EHD1 paralog, EHD4, is required for the recruitment of EHD1 to SE. We show that EHD4 preferentially dimerizes with EHD1, and knock-down of EHD4 expression by siRNA, shRNA or by CRISPR/Cas9 gene-editing leads to impaired EHD1 SE-recruitment and enlarged SE. Moreover, we demonstrate that at least 3 different asparagine-proline-phenylalanine (NPF) motif-containing EHD binding partners, Rabenosyn-5, Syndapin2 and MICAL-L1, are required for the recruitment of EHD1 to SE. Indeed, knock-down of any of these SE-localized EHD interaction partners leads to enlarged SE, presumably due to impaired endosomal fission. Overall, we identify a novel mechanistic role for EHD4 in recruitment of EHD1 to SE, thus positioning EHD4 as an essential component of the EHD1-fission machinery at SE.	[Jones, Tyler; Naslavsky, Naava; Caplan, Steve] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Caplan, Steve] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.; Caplan, S (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	scaplan@unmc.edu			National Institutes of General Medical Sciences at the National Institutes of Health [R01 GM123557]; NIGMS: INBRE grant [P20 GM103427]; National Cancer Institute for The Fred & Pamela Buffett Cancer Center Support Grant [P30 CA036727]; Nebraska Research Initiative; NIGMS: COBRE grant [P30 GM106397]	National Institutes of General Medical Sciences at the National Institutes of Health; NIGMS: INBRE grant; National Cancer Institute for The Fred & Pamela Buffett Cancer Center Support Grant; Nebraska Research Initiative; NIGMS: COBRE grant	S.C. was supported by R01 GM123557 from the National Institutes of General Medical Sciences at the National Institutes of Health. The authors thank the University of Nebraska Medical Center Advanced Microscopy Core Facility, which receives partial support from NIGMS: INBRE P20 GM103427 and COBRE P30 GM106397 grants, as well as support from the National Cancer Institute for The Fred & Pamela Buffett Cancer Center Support Grant P30 CA036727, and the Nebraska Research Initiative. The funders had no role in study design, data collection, analysis, decision to publish or manuscript preparation.	[Anonymous], 2018, OBSTET GYNECOL, V131, P49, DOI DOI 10.1097/AOG.0000000000002501; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Bahl K, 2016, J BIOL CHEM, V291, P13465, DOI 10.1074/jbc.M116.716407; Bahl K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123710; Bartuzi P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10961; Benjamin S, 2011, BIOCHEM J, V439, P433, DOI 10.1042/BJ20111010; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Bregnard C, 2013, J VIROL, V87, P3729, DOI 10.1128/JVI.02477-12; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Cai BS, 2012, MOL BIOL CELL, V23, P1874, DOI 10.1091/mbc.E11-10-0881; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142; Clairfeuille T, 2016, NAT STRUCT MOL BIOL, V23, P921, DOI 10.1038/nsmb.3290; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Deo R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07586-z; Dhawan K, 2020, J BIOL CHEM; Doherty KR, 2008, J BIOL CHEM; Dun W, 2018, LIFE SCI, V201, P72, DOI 10.1016/j.lfs.2018.03.024; Farfan P, 2013, TRAFFIC, V14, P823, DOI 10.1111/tra.12076; FOLKS JL, 1984, HDB STATISTICS, V4, P113, DOI DOI 10.1016/S0169-7161(84)04008-6; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; George M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017838; George M, 2010, GENESIS, V48, P328, DOI 10.1002/dvg.20620; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Huang Y.W., 2014, J DONGBEI U FINANCE, V2, P22; Jakobsson J, 2011, J NEUROSCI, V31, P13972, DOI 10.1523/JNEUROSCI.1289-11.2011; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Kamerkar SC, 2019, BIOCHEMISTRY-US, V58, P65, DOI 10.1021/acs.biochem.8b00925; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Kuo HJ, 2001, J BIOL CHEM, V276, P43103, DOI 10.1074/jbc.M106128200; Maeda M, 2006, ONCOGENE, V25, P4595, DOI 10.1038/sj.onc.1209396; McNally KE, 2017, NAT CELL BIOL, V19, P1214, DOI 10.1038/ncb3610; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Pekar O, 2012, BIOCHEM J, V444, P383, DOI 10.1042/BJ20111268; Rahajeng J, 2009, EXP CELL RES; Rahman SS, 2017, FASEB J, V31, P5217, DOI 10.1096/fj.201601182RR; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; RICE WR, 1990, BIOMETRICS, V46, P303, DOI 10.2307/2531435; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Sengupta S, 2009, J BIOL CHEM, V284, P20121, DOI 10.1074/jbc.M109.025668; Shah C, 2014, STRUCTURE, V22, P409, DOI 10.1016/j.str.2013.12.015; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Sharma Mahak, 2010, Commun Integr Biol, V3, P181; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Simone LC, 2014, HISTOL HISTOPATHOL, V29, P285, DOI 10.14670/HH-29.285; Simone LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074519; Solinger JA, 2020, NAT CELL BIOL, V22, P213, DOI 10.1038/s41556-019-0456-5; Steinberg F, 2012, J CELL BIOL, V197, P219, DOI 10.1083/jcb.201111121; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; van Kerkhof P, 2005, EMBO J, V24, P2851, DOI 10.1038/sj.emboj.7600756; Wang J, 2018, TRAFFIC; Xie S, 2018, MOL BIOL CELL, pmbcE18040241; Xie SW, 2019, J CELL SCI, V132, DOI 10.1242/jcs.233973; Yap CCC, 2010, J NEUROSCI, V30, P6646, DOI 10.1523/JNEUROSCI.5428-09.2010; Yeow I, 2017, CURR BIOL; Zhang J, 2012, TRAFFIC, V13, P745, DOI 10.1111/j.1600-0854.2012.01334.x	75	6	6	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239657	10.1371/journal.pone.0239657	http://dx.doi.org/10.1371/journal.pone.0239657			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966336	gold, Green Published			2022-12-26	WOS:000575688700030
J	Yessoufou, K; Sithole, M; Elansary, HO				Yessoufou, Kowiyou; Sithole, Mercy; Elansary, Hosam O.			Effects of urban green spaces on human perceived health improvements: Provision of green spaces is not enough but how people use them matters	PLOS ONE			English	Article							MENTAL-HEALTH; PHYSICAL-ACTIVITY; ENVIRONMENTS; ASSOCIATION; QUALITY; AREA	How could we explain the mechanism driving the effects of Urban Green Space (UGS) on human health? This mechanism is a complex one suggesting, on one hand, an indirect effect of UGS Provision (measured as quantity, quality or accessibility of UGS) on health through UGS Exposure (measured as visit frequency to UGS, duration of visit or intensity of activities taking place during the visit). On the other hand, UGS Provision may have an indirect effect on Exposure, mediated by people's perception of UGS. The mechanism further suggests that UGS Exposure may influence indirectly human Health but mediated by human motivation to use UGS. We tested these different expectations by fitting 12 alternative structural equation models (SEMs) corresponding to four different scenarios, depending on how UGS Provision was approximated. We show that SEMs where i) Provision is approximated as UGS quantity, and Exposure as duration (SEMi), ii) Provision is approximated as quantity, and Exposure as intensity (SEMii) and iii) Provision is approximated as distance of the closest UGS from people's house, and Exposure as intensity (SEMiii) are equally the best of all 12 SEMs tested. However, apart from the SEM(i)that has no significant path, SEM(ii)and SEM(iii)have the same significant path (motivation similar to intensity; beta = 7.86 +/- 2.03, p = 0.0002), suggesting that visits to UGS may be motivated by opportunities of physical activities offered by UGS. In all our scenarios, the best SEM is always the one where Exposure is measured as intensity, irrespective of how Provision is approximated. This suggests that it is not only UGS provision that matters the most in the mechanism linking UGS to human health improvement, but rather intensity, i.e. the type of activities people engage in when they visit UGSs. Overall, our findings support the theoretical model tested in this study.	[Yessoufou, Kowiyou; Sithole, Mercy; Elansary, Hosam O.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, Johannesburg, South Africa; [Elansary, Hosam O.] King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, Riyadh, Saudi Arabia; [Elansary, Hosam O.] Alexandria Univ, Fac Agr El Shatby, Floriculture Ornamental Hort & Garden Design Dept, Alexandria, Egypt	University of Johannesburg; King Saud University; Egyptian Knowledge Bank (EKB); Alexandria University	Yessoufou, K (corresponding author), Univ Johannesburg, Dept Geog Environm Management & Energy Studies, Johannesburg, South Africa.	kowiyouy@uj.ac.za	Elansary, Hosam O./E-3684-2019	Elansary, Hosam O./0000-0002-4476-2408; Yessoufou, Prof. Kowiyou/0000-0002-4789-1723	King Saud University, Research Support Project [RSP-2020/118]; National Research Foundation South Africa [RSP-2020/118, 112113]	King Saud University, Research Support Project; National Research Foundation South Africa(National Research Foundation - South AfricaSouth African Medical Research Council)	This research was funded by King Saud University, Research Support Project, grant number RSP-2020/118 to HOE and National Research Foundation South Africa, grant number 112113 to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors extent their appreciation to King Saud University for assistance (RSP-2020/118) as well as all the respondents to our questions during data collection.	Alcock I, 2014, ENVIRON SCI TECHNOL, V48, P1247, DOI 10.1021/es403688w; Astell-Burt T, 2014, J EPIDEMIOL COMMUN H, V68, P578, DOI 10.1136/jech-2013-203767; Barton J, 2010, ENVIRON SCI TECHNOL, V44, P3947, DOI 10.1021/es903183r; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Chaguta T., 2013, PREVENTING RESOLVING; Cohen-Cline Hannah, 2015, J Epidemiol Community Health, V69, P523, DOI 10.1136/jech-2014-204667; Cox DTC, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020172; Dadvand P, 2012, ENVIRON HEALTH PERSP, V120, P1481, DOI 10.1289/ehp.1205244; Dadvand P, 2012, ENVIRON INT, V40, P110, DOI 10.1016/j.envint.2011.07.004; de Vries S, 2003, ENVIRON PLANN A, V35, P1717, DOI 10.1068/a35111; Donovan GH, 2018, NAT PLANTS, V4, P358, DOI 10.1038/s41477-018-0151-8; Enger S.C., 2005, PLANNING PARKS RECRE; Francis J, 2012, SOC SCI MED, V74, P1570, DOI 10.1016/j.socscimed.2012.01.032; Grinde B, 2009, INT J ENV RES PUB HE, V6, P2332, DOI 10.3390/ijerph6092332; Haq S. M. A., 2011, Journal of Environmental Protection, V2, P601, DOI 10.4236/jep.2011.25069; James Peter, 2015, Curr Epidemiol Rep, V2, P131; Jennings V, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020196; Jonker MF, 2014, J EPIDEMIOL COMMUN H, V68, P999, DOI 10.1136/jech-2014-203847; Kondo MC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030445; Lee ACK, 2015, RISK MANAG HEALTHC P, V8, P131, DOI 10.2147/RMHP.S61654; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lindholst AC, 2015, PLAN PRACT RES, V30, P376, DOI 10.1080/02697459.2015.1057943; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; Martens D, 2011, J ENVIRON PSYCHOL, V31, P36, DOI 10.1016/j.jenvp.2010.11.001; Mubvami T., 2012, J URBAN AGR MAGAZINE, V20, P31; Paquet C, 2013, LANDSCAPE URBAN PLAN, V118, P70, DOI 10.1016/j.landurbplan.2012.11.011; Pretty J, 2007, J ENVIRON PLANN MAN, V50, P211, DOI 10.1080/09640560601156466; R Core Team, 2018, R LANG ENV STAT COMP; Roe JJ, 2013, INT J ENV RES PUB HE, V10, P4086, DOI 10.3390/ijerph10094086; Song C, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-8; Takano T, 2002, HEALTH POLICY, V61, P239, DOI 10.1016/S0168-8510(01)00234-2; Tan PY, 2013, CITIES, V32, P24, DOI 10.1016/j.cities.2013.02.001; Triguero-Mas M, 2015, ENVIRON INT, V77, P35, DOI 10.1016/j.envint.2015.01.012; Tsunetsugu Y, 2013, LANDSCAPE URBAN PLAN, V113, P90, DOI 10.1016/j.landurbplan.2013.01.014; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; van Dillen SME, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2009.104695; White MP, 2013, PSYCHOL SCI, V24, P920, DOI 10.1177/0956797612464659; Witten K, 2008, PREV MED, V47, P299, DOI 10.1016/j.ypmed.2008.04.010; Woolley, 2002, IMPROVING URBAN PARK; Yang J, 2018, SCI TOTAL ENVIRON, V639, P1453, DOI 10.1016/j.scitotenv.2018.05.253; Yang J, 2017, URBAN FOR URBAN GREE, V22, P1, DOI 10.1016/j.ufug.2017.01.002; Zhang GC, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102314; ZHANG L, 2017, J URBAN ECON, V3, P1	43	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239314	10.1371/journal.pone.0239314	http://dx.doi.org/10.1371/journal.pone.0239314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966324	gold, Green Published			2022-12-26	WOS:000575688700061
J	Makhatova, A; Mazhit, B; Sarbassov, Y; Meiramkulova, K; Inglezakis, VJ; Poulopoulos, SG				Makhatova, Ardak; Mazhit, Birzhan; Sarbassov, Yerbol; Meiramkulova, Kulyash; Inglezakis, Vassilis J.; Poulopoulos, Stavros G.			Effective photochemical treatment of a municipal solid waste landfill leachate	PLOS ONE			English	Article							ADVANCED OXIDATION PROCESSES; FENTON-LIKE OXIDATION; PHOTO-FENTON; WATER TREATMENT; HYDROGEN-PEROXIDE; ORGANIC-COMPOUNDS; PROCESSES AOPS; DEGRADATION; KINETICS; ANIONS	This work aimed at studying the photochemical treatment of a landfill leachate using ultraviolet light, hydrogen peroxide, and ferrous or ferric ions, in a batch recycle photoreactor. The effect of inorganic carbon presence, pH, initial H(2)O(2)amount (0-9990 mg L-1) as well as Fe(II) (200-600 ppm) and Fe(III) (300-700 ppm) concentrations on the total carbon removal and color change was studied. Prior to the photochemical treatment, a pretreatment process was applied; inorganic nitrogen and inorganic carbon were removed by means of air stripping and initial pH regulation, respectively. The leachate sent subsequently for photochemical treatment was free of inorganic carbon and contained only organic carbon with concentration 1200 +/- 100 mg L(-1)at pH 5.1-5.3. The most favorable concentrations of H(2)O(2)and ferric ions for carbon removal were 6660 mg L(-1)and 400 ppm, respectively. Adjusting the initial pH value in the range of 2.2-5.3 had a significant effect on the organic carbon removal. The photo-Fenton-like process was more advantageous than the photo-Fenton one for leachate treatment. By applying the most favorable operating conditions, 88.7% removal of total organic carbon, 100% removal of total inorganic carbon, 96.5% removal of total nitrogen, and 98.2% color removal were achieved.	[Makhatova, Ardak; Mazhit, Birzhan; Sarbassov, Yerbol; Inglezakis, Vassilis J.; Poulopoulos, Stavros G.] Nazarbayev Univ, Environm & Resource Efficiency Cluster EREC, Environm Sci & Technol Grp ESTg, Dept Chem & Mat Engn,Sch Engn & Digital Sci, Nur Sultan, Kazakhstan; [Meiramkulova, Kulyash] LN Gumilyov Eurasian Natl Univ, Fac Nat Sci, Dept Environm Engn & Management, Nur Sultan, Kazakhstan; [Inglezakis, Vassilis J.] Univ Strathclyde, Dept Chem & Proc Engn, Glasgow, Lanark, Scotland	Nazarbayev University; L.N. Gumilyov Eurasian National University; University of Strathclyde	Poulopoulos, SG (corresponding author), Nazarbayev Univ, Environm & Resource Efficiency Cluster EREC, Environm Sci & Technol Grp ESTg, Dept Chem & Mat Engn,Sch Engn & Digital Sci, Nur Sultan, Kazakhstan.	stavros.poulopoulos@nu.edu.kz	Inglezakis, Vassilis J./F-8554-2013	Inglezakis, Vassilis J./0000-0002-0195-0417; Makhatova, Ardak/0000-0003-1980-3308; Poulopoulos, Stavros/0000-0001-7010-855X	Nazarbayev University project "Cost-Effective Photocatalysts for the Treatment of Wastewaters containing Emerging Pollutants", Facultydevelopment competitive research grants program for 2020-2022 [240919FD3932]; Ministry of Education and Science, Republic of Kazakhstan [BR05236844/215]	Nazarbayev University project "Cost-Effective Photocatalysts for the Treatment of Wastewaters containing Emerging Pollutants", Facultydevelopment competitive research grants program for 2020-2022; Ministry of Education and Science, Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	This research was funded by the Nazarbayev University project "Cost-Effective Photocatalysts for the Treatment of Wastewaters containing Emerging Pollutants", Facultydevelopment competitive research grants program for 2020-2022, Grant Number 240919FD3932 awarded to Dr. S.G. Poulopoulos. Dr. K. Meiramkulova acknowledges the financial support by the grant "Reducing the technogenic impact on water resources with using water recycling technology". BR05236844/215 for 2018-2020, from the Ministry of Education and Science, Republic of Kazakhstan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari B., 2015, IOSR J ENV SCI TOXIC, V9, P23, DOI DOI 10.9790/2402-09132336; Akpor O.B., 2014, INT J ENV RES EARTH, V3, P50; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; ARNOLD SM, 1995, ENVIRON SCI TECHNOL, V29, P2083, DOI 10.1021/es00008a030; Ban XJ, 2006, ADV SOFT COMP, P47; Bautista P, 2014, WATER SCI TECHNOL, V70, P472, DOI 10.2166/wst.2014.246; Bouasla C, 2012, INT J IND CHEM, V3, DOI 10.1186/2228-5547-3-15; Carre E, 2018, J WATER PROCESS ENG, V22, P87, DOI 10.1016/j.jwpe.2018.01.016; CHIAN ESK, 1976, J ENV ENG DIV-ASCE, V102, P411; Coates J., 2006, ENCY ANAL CHEM, P1, DOI 10.1002/9780470027318.a5606; Coelho A, 2006, J HAZARD MATER, V137, P178, DOI 10.1016/j.jhazmat.2006.01.051; da Costa FM, 2018, WASTE MANAGE, V76, P606, DOI 10.1016/j.wasman.2018.02.030; De Laat J, 1999, ENVIRON SCI TECHNOL, V33, P2726, DOI 10.1021/es981171v; Deng Y., 2009, International Journal of Environment and Waste Management, V4, P366, DOI 10.1504/IJEWM.2009.027402; Deng Y, 2006, WATER RES, V40, P3683, DOI 10.1016/j.watres.2006.08.009; Deng Y, 2012, WASTE MANAGE RES, V30, P12, DOI 10.1177/0734242X10378185; Devi LG, 2010, CHEM PAP, V64, P378, DOI 10.2478/s11696-010-0011-0; Ding WC, 2018, J ENVIRON ENG, V144, DOI [10.1061/(ASCE)EE.1943-7870.0001291, 10.1061/(asce)ee.1943-7870.0001291]; Ebrahiem EE, 2017, ARAB J CHEM, V10, pS1674, DOI 10.1016/j.arabjc.2013.06.012; Ferraz FM, 2014, J ENVIRON MANAGE, V141, P9, DOI 10.1016/j.jenvman.2014.03.022; Gallard H, 1998, NEW J CHEM, V22, P263, DOI 10.1039/a708335a; Gogate PR, 2004, ADV ENVIRON RES, V8, P501, DOI 10.1016/S1093-0191(03)00032-7; Goi A, 2010, J ENVIRON ENG-ASCE, V136, P46, DOI 10.1061/(ASCE)EE.1943-7870.0000132; Gottschalk C., 2009, OZONATION WATER WAST; HARMSEN J, 1983, WATER RES, V17, P699, DOI 10.1016/0043-1354(83)90239-7; Hasar H, 2009, J HAZARD MATER, V171, P309, DOI 10.1016/j.jhazmat.2009.06.003; Hermosilla D, 2009, SCI TOTAL ENVIRON, V407, P3473, DOI 10.1016/j.scitotenv.2009.02.009; Huo SL, 2009, WATER ENVIRON J, V23, P15, DOI 10.1111/j.1747-6593.2007.00104.x; Inglezakis VJ, 2018, DESALIN WATER TREAT, V112, P218, DOI 10.5004/dwt.2018.22252; Jamil TS, 2011, J HAZARD MATER, V185, P353, DOI 10.1016/j.jhazmat.2010.09.041; Kang KH, 2002, WATER RES, V36, P4023, DOI 10.1016/S0043-1354(02)00114-8; Kim DH, 2019, J HAZARD MATER, V372, P121, DOI 10.1016/j.jhazmat.2018.03.055; Kim JS, 2001, J CHIN INST CHEM ENG, V32, P425; Kim YK, 1997, ENVIRON ENG SCI, V14, P73, DOI 10.1089/ees.1997.14.73; Kondo MM, 2010, SEP SCI TECHNOL, V45, P1506, DOI 10.1080/01496395.2010.487451; Krishnan S, 2017, IOP CONF SER-MAT SCI, V206, DOI 10.1088/1757-899X/206/1/012089; KUO WG, 1992, WATER RES, V26, P881, DOI 10.1016/0043-1354(92)90192-7; Kurniawan TA, 2006, CHEM ENG J, V125, P35, DOI 10.1016/j.cej.2006.07.006; Kurniawan TA, 2010, J ENVIRON MONITOR, V12, P2032, DOI 10.1039/c0em00076k; Lin HJ, 2013, DESALINATION, V314, P169, DOI 10.1016/j.desal.2013.01.019; Litter M. I., 2014, ADV OXIDATION TECHNO; Liu SQ, 2010, J HAZARD MATER, V182, P665, DOI 10.1016/j.jhazmat.2010.06.083; Machulek A, 2007, ENVIRON SCI TECHNOL, V41, P8459, DOI 10.1021/es071884q; Cuerda-Correa EM, 2020, WATER-SUI, V12, DOI 10.3390/w12010102; Neyens E, 2003, J HAZARD MATER, V98, P33, DOI 10.1016/S0304-3894(02)00282-0; Niaounakis M, 2006, WASTE MANAG SER, V5, P23; Oturan MA, 2014, CRIT REV ENV SCI TEC, V44, P2577, DOI 10.1080/10643389.2013.829765; Parkes SD, 2007, ENVIRON MONIT ASSESS, V124, P51, DOI 10.1007/s10661-006-9208-7; Pignatello JJ, 2006, CRIT REV ENV SCI TEC, V36, P1, DOI 10.1080/10643380500326564; PIGNATELLO JJ, 1992, ENVIRON SCI TECHNOL, V26, P944, DOI 10.1021/es00029a012; Poulopoulos SG, 2008, J HAZARD MATER, V153, P582, DOI 10.1016/j.jhazmat.2007.09.002; Primo O, 2008, J HAZARD MATER, V153, P834, DOI 10.1016/j.jhazmat.2007.09.053; Renou S, 2008, J HAZARD MATER, V150, P468, DOI 10.1016/j.jhazmat.2007.09.077; Rivas FJ, 2003, J ENVIRON SCI HEAL A, V38, P371, DOI 10.1081/ESE-120016901; Rodriguez-Narvaez OM, 2019, INT J ENVIRON SCI TE, V16, P1515, DOI 10.1007/s13762-018-1764-1; Saeed S. M., 2008, From the pharaohs to the future. Eighth International Symposium on Tilapia in Aquaculture. Proceedings. Cairo, Egypt, 12-14 October, 2008, P475; Sharma S., 2011, P I TECHN NIRM U INT; Singh H, 2020, TOP CATAL, V63, P1097, DOI 10.1007/s11244-020-01278-z; Stasinakis AS, 2008, GLOBAL NEST J, V10, P376; Stripping Air, 1993, STUDIES ENV SCI, P261; Tai C, 2002, TALANTA, V58, P661, DOI 10.1016/S0039-9140(02)00370-3; Talalaj IA, 2019, ENVIRON CHEM LETT, V17, P1177, DOI 10.1007/s10311-019-00860-6; Tang WZ, 1996, ENVIRON TECHNOL, V17, P1371, DOI 10.1080/09593331708616506; Tarr M.A., 2003, CHEM DEGRADATION MET; Tesar M, 2007, J ENVIRON MONITOR, V9, P110, DOI [10.1039/b614002e, 10.1039/B614002E]; Trovo AG, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/340347; Vilar VJP, 2012, SOL ENERGY, V86, P3301, DOI 10.1016/j.solener.2012.08.014; Vilar VJP, 2011, WATER RES, V45, P2647, DOI 10.1016/j.watres.2011.02.019; Vogelpohl A, 2004, J IND ENG CHEM, V10, P33; Wang JL, 2012, CRIT REV ENV SCI TEC, V42, P251, DOI 10.1080/10643389.2010.507698; Wang S, 2008, DYES PIGMENTS, V76, P714, DOI 10.1016/j.dyepig.2007.01.012; Zhao L, 2013, TREATMENT TECHNOLOGI, DOI [10.5772/52665, DOI 10.5772/52665]	72	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239433	10.1371/journal.pone.0239433	http://dx.doi.org/10.1371/journal.pone.0239433			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960913	Green Accepted, gold, Green Published			2022-12-26	WOS:000575109500045
J	Mancilla, TR; Davis, LR; Aune, GJ				Mancilla, T. R.; Davis, L. R.; Aune, G. J.			Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts	PLOS ONE			English	Article							MITOCHONDRIAL DYSFUNCTION; MYOCYTE HYPERTROPHY; CHILDHOOD-CANCER; HEART; INTERLEUKIN-1-BETA; CARDIOTOXICITY; CARDIOMYOPATHY; MECHANISMS; TOXICITY; PROTEINS	Anthracyclines are the critical component in a majority of pediatric chemotherapy regimens due to their broad anticancer efficacy. Unfortunately, the vast majority of long-term childhood cancer survivors will develop a chronic health condition caused by their successful treatments and severe cardiac disease is a common life-threatening outcome that is unequivocally linked to previous anthracycline exposure. The intricacies of how anthracyclines such as doxorubicin, damage the heart and initiate a disease process that progresses over multiple decades is not fully understood. One area left largely unstudied is the role of the cardiac fibroblast, a key cell type in cardiac maturation and injury response. In this study, we demonstrate the effect of doxorubicin on cardiac fibroblast function in the presence and absence of the critical DNA damage response protein p53. In wildtype cardiac fibroblasts, doxorubicin-induced damage correlated with decreased proliferation and migration, cell cycle arrest, and a dilated cardiomyopathy gene expression profile. Interestingly, these doxorubicin-induced changes were completely or partially restored in p53(-/-)cardiac fibroblasts. Moreover, in wildtype cardiac fibroblasts, doxorubicin produced DNA damage and mitochondrial dysfunction, both of which are well-characterized cell stress responses induced by cytotoxic chemotherapy and varied forms of heart injury. A 3-fold increase in p53 (p = 0.004) prevented the completion of mitophagy (p = 0.032) through sequestration of Parkin. Interactions between p53 and Parkin increased in doxorubicin-treated cardiac fibroblasts (p = 0.0003). Finally, Parkin was unable to localize to the mitochondria in wildtype cardiac fibroblasts, but mitochondrial localization was restored in p53(-/-)cardiac fibroblasts. These findings strongly suggest that cardiac fibroblasts are an important myocardial cell type that merits further study in the context of doxorubicin treatment. A more robust knowledge of the role cardiac fibroblasts play in the development of doxorubicin-induced cardiotoxicity will lead to novel clinical strategies that will improve the quality of life of cancer survivors.	[Mancilla, T. R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Mancilla, T. R.; Davis, L. R.; Aune, G. J.] Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA; [Aune, G. J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol Oncol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Aune, GJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Greehey Childrens Canc Res Inst, San Antonio, TX 78229 USA.; Aune, GJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, Div Hematol Oncol, San Antonio, TX 78229 USA.	Aune@uthscsa.edu	Aune, Gregory/I-5895-2015	Aune, Gregory/0000-0002-2750-6461; Ramirez Mancilla, Trevi/0000-0003-3722-4879	St. Baldrick's Foundation Scholar (Career Development Award); Turn it Gold Foundation; NIH [T32GM113896/STXMSTP]	St. Baldrick's Foundation Scholar (Career Development Award); Turn it Gold Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	GJA was supported by the following: St. Baldrick's Foundation Scholar (Career Development Award) https://www.stbaldricks.org Turn it Gold Foundation https://turnitgold.org TRM was supported by the following: NIH T32GM113896/STXMSTP https://www.nigms.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo D, 2014, INT J BIOL MACROMOL, V66, P144, DOI 10.1016/j.ijbiomac.2014.02.028; Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Altara R, 2016, CLIN SCI, V130, P463, DOI 10.1042/CS20150666; Ancey C, 2003, CARDIOVASC RES, V59, P78, DOI 10.1016/S0008-6363(03)00346-8; Andrews TG, 2014, ECHOCARDIOGR-J CARD, V31, P375, DOI 10.1111/echo.12351; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 2001, AM J PHYSIOL-HEART C, V280, pH2674; [Anonymous], 1998, CIENCIA INFORM, V27, P53, DOI DOI 10.1017/S0047404500019722; [Anonymous], 2016, THE TOTAL AUDIENCE R; Armenian SH, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.3920; Armenian SH, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/713294; Armstrong GT, 2014, J CLIN ONCOL, V32, P1218, DOI 10.1200/JCO.2013.51.1055; Bhakta N, 2017, LANCET, V390, P2569, DOI 10.1016/S0140-6736(17)31610-0; Boyle KA, 2018, J BIOL CHEM, V293, P14891, DOI 10.1074/jbc.RA117.001469; Cordani M, 2016, MOL ONCOL, V10, P1008, DOI 10.1016/j.molonc.2016.04.001; DACOSTA CA, 2019, FRONT NEUROSCI-SWITZ, V12, DOI DOI 10.3389/FNINS.2018.00965; Darcansoy iseri O., 2009, INVESTIGATION DOCETA; Dhingra R, 2014, P NATL ACAD SCI USA, V111, pE5537, DOI 10.1073/pnas.1414665111; Distelmaier F, 2015, BBA-MOL BASIS DIS, V1852, P529, DOI 10.1016/j.bbadis.2014.12.012; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Feridooni T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022801; Ferreira-Cornwell MC, 2002, J CELL SCI, V115, P1623; Fredj S, 2005, J CELL PHYSIOL, V204, P428, DOI 10.1002/jcp.20307; Fu HY, 2016, CIRC RES, V118, P798, DOI 10.1161/CIRCRESAHA.115.307604; Fu Z, 2010, TOXICOL IN VITRO, V24, P1584, DOI 10.1016/j.tiv.2010.06.009; Ghigo A, 2016, BBA-MOL CELL RES, V1863, P1916, DOI 10.1016/j.bbamcr.2016.01.021; Gray MO, 1998, CARDIOVASC RES, V40, P352, DOI 10.1016/S0008-6363(98)00121-7; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; Harkey Shirley S, 2009, TRANSCRIPTIONAL REGU; Hoshino A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3308; Howlader N NA, 2015, SEER CANC STAT REV 1; Hu JX, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109475; Jedrak P, 2018, METAB BRAIN DIS, V33, P2005, DOI 10.1007/s11011-018-0308-1; Kang X, 2019, ARTIF CELL NANOMED B, V47, P1961, DOI 10.1080/21691401.2019.1593854; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Liau B, 2017, SCI REP-UK, V7, DOI 10.1038/srep42290; Lindsey ML, 2014, AM J PHYSIOL-HEART C, V307, pH1379, DOI 10.1152/ajpheart.00099.2014; Lu Min, 2011, Genes Cancer, V2, P985, DOI 10.1177/1947601911436199; Ma YG, 2014, PFLUG ARCH EUR J PHY, V466, P1113, DOI 10.1007/s00424-014-1463-9; Mackenzie S. G., 2013, British Poultry Abstracts, V9, P10; Mak SK, 2011, J PARKINSON DIS, V1, P175, DOI 10.3233/JPD-2011-11025; Mancilla TR, 2019, COMPR PHYSIOL, V9, P905, DOI 10.1002/cphy.c180017; Nanasi P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231223; Nitiss KC, 2014, CLIN CANCER RES, V20, P4737, DOI 10.1158/1078-0432.CCR-14-0821; Niu ZD, 2016, ENVIRON TOXICOL PHAR, V45, P212, DOI 10.1016/j.etap.2016.06.006; Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Pecoraro M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102121; Pellman J, 2016, J MOL CELL CARDIOL, V94, P22, DOI 10.1016/j.yjmcc.2016.03.005; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Qiao XH, 2020, P NATL ACAD SCI USA, V117, P15182, DOI 10.1073/pnas.1922072117; Rog-Zielinska EA, 2016, TRENDS MOL MED, V22, P99, DOI 10.1016/j.molmed.2015.12.006; Sauter KAD, 2011, CANCER BIOL THER, V11, P1008, DOI 10.4161/cbt.11.12.15540; Scuderi GJ, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00050; Shizukuda Y, 2005, MOL CELL BIOCHEM, V273, P25, DOI 10.1007/s11010-005-5905-8; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Sullivan KE, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024349; Taymaz-Nikerel H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31939-9; Tian Y, 2012, CIRC RES, V110, P1023, DOI 10.1161/CIRCRESAHA.111.243899; Tsipis A, 2010, PATHOL RES PRACT, V206, P625, DOI 10.1016/j.prp.2010.05.007; Vahebi S, 2007, CIRC RES, V100, P408, DOI 10.1161/01.RES.0000258116.60404.ad; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Burgh R, 2014, J BIOL CHEM, V289, P5000, DOI 10.1074/jbc.M113.536920; Wang F, 2018, J PEDIAT HEMATOL ONC, V40, P208, DOI 10.1097/MPH.0000000000001112; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Wei RJ, 2018, CELL STRESS CHAPERON, V23, P1295, DOI 10.1007/s12192-018-0937-7; Yan C, 2018, ANTICANCER RES, V38, P617, DOI 10.21873/anticanres.12266; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Yu LR, 2018, EXP BIOL MED, V243, P248, DOI 10.1177/1535370217746383; Zhan H, 2016, CARDIOVASC RES, V110, P85, DOI 10.1093/cvr/cvw032; Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; 2013, SURG OBES RELAT DIS, V9	79	15	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0238856	10.1371/journal.pone.0238856	http://dx.doi.org/10.1371/journal.pone.0238856			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960902	Green Submitted, Green Published, gold			2022-12-26	WOS:000575109500009
J	Sareen, N; Abu-El-Rub, E; Ammar, HI; Yan, WA; Sequiera, GL; ShamsEldeen, AM; Moudgil, M; Dhingra, R; Shokry, HS; Rashed, LA; Kirshenbaum, LA; Dhingra, S				Sareen, Niketa; Abu-El-Rub, Ejlal; Ammar, Hania I.; Yan, Weiang; Sequiera, Glen Lester; ShamsEldeen, Asmaa M.; Moudgil, Meenal; Dhingra, Rimpy; Shokry, Heba S.; Rashed, Laila A.; Kirshenbaum, Lorrie A.; Dhingra, Sanjiv			Hypoxia-induced downregulation of cyclooxygenase 2 leads to the loss of immunoprivilege of allogeneic mesenchymal stem cells	FASEB JOURNAL			English	Article						COP9 signalosome; COX2; CSN5; mesenchymal stem cells; PGE2	T-CELLS; MYOCARDIAL-INFARCTION; DEPENDENT DEGRADATION; CARDIAC REPAIR; INFLAMMATION; DIFFERENTIATION; PROLIFERATION; MECHANISMS; RESOLUTION; EXPRESSION	Allogeneic mesenchymal stem cells (MSCs) from young and healthy donors are reported to hold the potential to treat several immunological and degenerative disorders. However, recent data from animal studies and clinical trials demonstrate that immunogenicity and poor survival of transplanted MSCs impaired the efficacy of cells for regenerative applications. It is reported that initially immunoprivileged under in vitro conditions, MSCs are targeted by the host immune system after transplantation in the ischemic tissues in vivo. We performed in vitro (in MSCs) and in vivo (in the rat model of myocardial infarction [MI]) studies to elucidate the mechanisms responsible for the change in the immunophenotype of MSCs from immunoprivileged to immunogenic under ischemic conditions. We have recently reported that a soluble factor prostaglandin E2 (PGE2) preserves the immunoprivilege of allogeneic MSCs. In the current study, we found that PGE2 levels, which were elevated during normoxia, decreased in MSCs following exposure to hypoxia. Further, we found that proteasome-mediated degradation of cyclooxygenase-2 (COX2, rate-limiting enzyme in PGE2 biosynthesis) in hypoxic MSCs is responsible for PGE2 decrease and loss of immunoprivilege of MSCs. While investigating the mechanisms of COX2 degradation in hypoxic MSCs, we found that in normoxic MSCs, COP9 signalosome subunit 5 (CSN5) binds to COX2 and prevents its degradation by the proteasome. However, exposure to hypoxia leads to a decrease in CSN5 levels and its binding to COX2, rendering COX2 protein susceptible to proteasome-mediated degradation. This subsequently causes PGE2 downregulation and loss of immunoprivilege of MSCs. Maintaining COX2 levels in MSCs preserves immunoprivilege in vitro and improves the survival of transplanted MSCs in a rat model of MI. These data provide novel mechanistic evidence that PGE2 is downregulated in hypoxic MSCs which is responsible for the post-transplantation rejection of allogeneic MSCs. Therefore, our data suggest that the new strategies that target CSN5-COX2 signaling may improve survival and utility of transplanted allogeneic MSCs in the ischemic heart.	[Sareen, Niketa; Abu-El-Rub, Ejlal; Yan, Weiang; Sequiera, Glen Lester; Moudgil, Meenal; Dhingra, Rimpy; Kirshenbaum, Lorrie A.; Dhingra, Sanjiv] Univ Manitoba, Inst Cardiovasc Sci, St Boniface Hosp,Rady Fac Hlth Sci, Max Rady Coll Med,Albrechtsen Res Ctr, Winnipeg, MB, Canada; [Sareen, Niketa; Abu-El-Rub, Ejlal; Yan, Weiang; Sequiera, Glen Lester; Moudgil, Meenal; Dhingra, Rimpy; Kirshenbaum, Lorrie A.; Dhingra, Sanjiv] Univ Manitoba, Dept Physiol & Pathophysiol, Winnipeg, MB, Canada; [Ammar, Hania I.; ShamsEldeen, Asmaa M.; Shokry, Heba S.; Rashed, Laila A.] Cairo Univ, Dept Physiol & Biochem, Fac Med, Cairo, Egypt	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Egyptian Knowledge Bank (EKB); Cairo University	Dhingra, S (corresponding author), St Boniface Gen Hosp, Inst Cardiovasc Sci, Regenerat Med Program, Res Ctr, R-3028-2,351 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	sdhingra@sbrc.ca	Shamseldeen, Asmaa/AAR-2357-2020; Shams, A/HHZ-1192-2022; Dhingra, Sanjiv/D-8766-2014	Shamseldeen, Asmaa/0000-0002-4250-0818; Yan, Weiang/0000-0002-1065-4847; Dhingra, Sanjiv/0000-0002-2664-7633	Gouvernement du Canada; Canadian Institutes of Health Research (CIHR) [MOP142265]	Gouvernement du Canada; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP142265	Abu-El-Rub E, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1359-x; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Ammar HI, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0142-x; Badillo AT, 2007, BIOL BLOOD MARROW TR, V13, P412, DOI 10.1016/j.bbmt.2006.12.447; Bagno L, 2018, MOL THER, V26, P1610, DOI 10.1016/j.ymthe.2018.05.009; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Berglund AK, 2017, STEM CELL RES THER, V8, P1; CAI M, 2016, SCI REPORTS, V6, P1, DOI DOI 10.1038/SREP31528; Callige M, 2005, MOL CELL BIOL, V25, P4349, DOI 10.1128/MCB.25.11.4349-4358.2005; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Chen C, 2010, NAT CHEM BIOL, V6, P401, DOI 10.1038/nchembio.375; Collins GA, 2017, CELL, V169, P792, DOI 10.1016/j.cell.2017.04.023; Dhingra S, 2013, CIRCULATION, V128, pS69, DOI 10.1161/CIRCULATIONAHA.112.000324; Dhingra S, 2010, TRENDS CARDIOVAS MED, V20, P263, DOI 10.1016/j.tcm.2011.12.002; Ejtehadifar M, 2015, ADV PHARM BULL, V5, P141, DOI 10.15171/apb.2015.021; Gandhi J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00538; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Huang J., 2007, 2007 INT C COMM CIRC, V1, P67; Huang XP, 2016, FASEB J, V30, P3069, DOI 10.1096/fj.201600331R; Isakova IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087238; Kabat M, 2020, STEM CELL TRANSL MED, V9, P17, DOI 10.1002/sctm.19-0202; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; Li J, 2018, BIOCHEM BIOPH RES CO, V500, P132, DOI 10.1016/j.bbrc.2018.03.183; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2357, DOI 10.1016/j.jacc.2011.08.034; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lukomska B, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/9628536; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Murn J, 2008, J EXP MED, V205, P3091, DOI 10.1084/jem.20081163; Natsumeda M, 2017, J AM COLL CARDIOL, V70, P2504, DOI 10.1016/j.jacc.2017.09.036; Neuss H, 2007, J MOL MED-JMM, V85, P961, DOI 10.1007/s00109-007-0197-y; Pacini S, 2017, SEARCH VIVO MSC; Padda J, 2015, CAN J PHYSIOL PHARM, V93, P835, DOI 10.1139/cjpp-2014-0468; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Pezzanite LM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0053-x; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Saravanan S., 2018, SCI REPORTS, V8, P1; Sareen N, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0867-4; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Sequiera GL, 2019, CAN J PHYSIOL PHARM, V97, P536, DOI 10.1139/cjpp-2018-0553; Singh B, 2005, INT J ONCOL, V26, P1393; Sun YQ, 2015, STEM CELLS, V33, P3452, DOI 10.1002/stem.2094; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Uccelli A, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3346-z; Volarevic V, 2018, INT J MED SCI, V15, P36, DOI 10.7150/ijms.21666; Walter J, 2014, LANCET RESP MED, V2, P1016, DOI 10.1016/S2213-2600(14)70217-6; Wei X, 2013, ACTA PHARMACOL SIN, V34, P747, DOI 10.1038/aps.2013.50; Yan W, 2019, AM J PHYSIOL-HEART C, V317, pH213, DOI 10.1152/ajpheart.00065.2019; Zhang J, 2012, AM J PHYSIOL-CELL PH, V303, pC115, DOI 10.1152/ajpcell.00326.2011; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	62	6	6	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15236	15251		10.1096/fj.202001478R	http://dx.doi.org/10.1096/fj.202001478R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959405				2022-12-26	WOS:000573858900001
J	Spahr, E; Kasson, MT; Kijimoto, T				Spahr, Ellie; Kasson, Matt T.; Kijimoto, Teiya			Micro-computed tomography permits enhanced visualization of mycangia across development and between sexes inEuwallaceaambrosia beetles	PLOS ONE			English	Article							COLEOPTERA-CURCULIONIDAE SCOLYTINAE; AMBROSIA BEETLE; EUWALLACEA-FORNICATUS; FUNGAL SYMBIONT; SERIOUS THREAT; SP-NOV; FUSARIUM; EVOLUTION; AVOCADO; INVASION	Symbiosis can facilitate the development of specialized organs in the host body to maintain relationships with beneficial microorganisms. To understand the developmental and genetic mechanisms by which such organs develop, it is critical to first investigate the morphology and developmental timing of these structures during the onset of host development. We utilized micro-computed tomography (mu CT) to describe the morphology and development of mycangia, a specialized organ, in the Asian ambrosia beetle speciesEuwallacea validuswhich maintains a mutualistic relationship with the Ascomycete fungus,Fusarium oligoseptatum. We scanned animals in larval, pupal and adult life stages and identified that mycangia develop during the late pupal stage. Here we reconcile preliminary evidence and provide additional morphological data for a second paired set of structures, including the superior, medial mycangia and an inferior, lateral pair of pouch-like structures, in both late-stage pupae and adult female beetles. Furthermore, we report the possible development of rudimentary, or partially developed pairs of medial mycangia in adult male beetles which has never been reported for any male Xyleborini. Our results illustrate the validity of mu CT in observing soft tissues and the complex nature of mycangia morphology and development.	[Spahr, Ellie; Kasson, Matt T.; Kijimoto, Teiya] West Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA	West Virginia University	Kijimoto, T (corresponding author), West Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA.	tekijimoto@mail.wvu.edu		Kijimoto, Teiya/0000-0002-0877-7223	USDA National Institute of Food and Agriculture [WVA00712]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This work is supported by Hatch [WVA00712] from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aoki T., 2018, Fungal Systematics and Evolution, V1, P23, DOI 10.3114/fuse.2018.01.03; Bateman C, 2017, FUNGAL ECOL, V25, P41, DOI 10.1016/j.funeco.2016.10.008; Cassier P, 1996, J INSECT PHYSIOL, V42, P171, DOI 10.1016/0022-1910(95)00056-9; Cooperband MF, 2016, AGR FOREST ENTOMOL, V18, P223, DOI 10.1111/afe.12155; Garcia-Avila CD, 2016, FLA ENTOMOL, V99, P555, DOI 10.1653/024.099.0335; DENARIE J, 1992, ANNU REV MICROBIOL, V46, P497, DOI 10.1146/annurev.mi.46.100192.002433; Fernando EFW, 1959, TEA Q, V30, P50; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Francke-Grosmann H., 1967, P141; Freeman S, 2016, SYMBIOSIS, V68, P115, DOI 10.1007/s13199-015-0356-9; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Goto H, 1998, P 6 EUR C ENT AUG, V23, P23; Hulcr J, 2017, ANN REV ENTOMOLOGY, V62; Hulcr J, 2010, EVOLUTION, V64, P3205, DOI 10.1111/j.1558-5646.2010.01055.x; Jiang ZR, 2019, ENTOMOL SCI, V22, P173, DOI 10.1111/ens.12353; Jordal BH, 2000, BIOL J LINN SOC, V71, P483, DOI 10.1111/j.1095-8312.2000.tb01270.x; Jordal BH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-133; Kasson MT, 2016, FUNGAL ECOL, V23, P86, DOI 10.1016/j.funeco.2016.07.002; Kasson MT, 2013, FUNGAL GENET BIOL, V56, P147, DOI 10.1016/j.fgb.2013.04.004; Kent DS, 2008, AUST J ENTOMOL, V47, P9, DOI 10.1111/j.1440-6055.2007.00612.x; KIRKENDALL LR, 1983, ZOOL J LINN SOC-LOND, V77, P293, DOI 10.1111/j.1096-3642.1983.tb00858.x; Kremer N, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00165-18; Li Y, 2018, J INSECT SCI, V18, DOI 10.1093/jisesa/iey096; Li Y, 2019, INSECT SCI, V26, P732, DOI 10.1111/1744-7917.12590; Lynch SC, 2016, MYCOLOGIA, V108, P313, DOI 10.3852/15-063; Mayers CG, 2020, MYCOLOGIA, V112, P1104, DOI 10.1080/00275514.2020.1755209; McNamara Kenneth J., 1995, P65; Mendel Z, 2012, PHYTOPARASITICA, V40, P235, DOI 10.1007/s12600-012-0223-7; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mueller UG, 2002, P NATL ACAD SCI USA, V99, P15247, DOI 10.1073/pnas.242594799; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; NAKASHIMA T, 1971, Applied Entomology and Zoology, V6, P131; Nakashima T., 1982, P87; O'Donnell K, 2016, PHYTOPARASITICA, V44, P435, DOI 10.1007/s12600-016-0543-0; Paap T, 2018, AUSTRALAS PLANT PATH, V47, P231, DOI 10.1007/s13313-018-0545-0; WOOD S L, 1977, Great Basin Naturalist, V37, P67	38	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0236653	10.1371/journal.pone.0236653	http://dx.doi.org/10.1371/journal.pone.0236653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956411	gold, Green Published			2022-12-26	WOS:000574571500014
J	Wang, XP; Xing, CY; Zhang, JX; Zhou, JH; Li, YC; Yang, HY; Zhang, PF; Zhang, W; Huang, Y; Long, JG; Gao, F; Zhang, X; Li, J				Wang, Xin-Pei; Xing, Chang-Yang; Zhang, Jia-Xin; Zhou, Jia-Heng; Li, Yun-Chu; Yang, Hong-Yan; Zhang, Peng-Fei; Zhang, Wei; Huang, Yin; Long, Jian-Gang; Gao, Feng; Zhang, Xing; Li, Jia			Time-restricted feeding alleviates cardiac dysfunction induced by simulated microgravity via restoring cardiac FGF21 signaling	FASEB JOURNAL			English	Article						cardiac function; FGF21; glucose utilization; microgravity; diet	GLUCOSE-METABOLISM; MOUSE MODEL; BED REST; SPACE; HEART; EXERCISE; ATROPHY; LIVER; RESYNCHRONIZATION; COUNTERMEASURE	Dietary restriction has been well-described to improve health metrics, but whether it could benefit pathophysiological adaptation to extreme environment, for example, microgravity, remains unknown. Here, we investigated the effects of a daily rhythm of fasting and feeding without reducing caloric intake on cardiac function and metabolism against simulated microgravity. Male rats under ad libitum feeding or time-restricted feeding (TRF; food access limited to 8 hours every day) were subjected to hindlimb unloading (HU) to simulate microgravity. HU for 6 weeks led to left ventricular dyssynchrony and declined cardiac function. HU also lowered pyruvate dehydrogenase (PDH) activity and impaired glucose utilization in the heart. All these were largely preserved by TRF. TRF showed no effects on HU-induced loss of cardiac mass, but significantly improved contractile function of cardiomyocytes. Interestingly, TRF raised liver-derived fibroblast growth factor 21 (FGF21) level and enhanced cardiac FGF21 signaling as manifested by upregulation of FGF receptor-1 (FGFR1) expression and its downstream markers in HU rats. In isolated cardiomyocytes, FGF21 treatment improved PDH activity and glucose utilization, consequently enhancing cell contractile function. Finally, both liver-specific knockdown (KD) of FGF21 and cardiac-specific FGFR1 KD abrogated the cardioprotective effects of TRF in HU rats. These data demonstrate that TRF improves cardiac glucose utilization and ameliorates cardiac dysfunction induced by simulated microgravity, at least partially, through restoring cardiac FGF21 signaling, suggesting TRF as a potential countermeasure for cardioprotection in long-term spaceflight.	[Wang, Xin-Pei; Xing, Chang-Yang; Zhang, Jia-Xin; Zhou, Jia-Heng; Li, Yun-Chu; Yang, Hong-Yan; Zhang, Peng-Fei; Gao, Feng; Zhang, Xing; Li, Jia] Fourth Mil Med Univ, Sch Aerosp Med, Xian, Peoples R China; [Xing, Chang-Yang] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Med, Xian, Peoples R China; [Zhang, Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Cardiol, Xian, Peoples R China; [Huang, Yin] China Pharmaceut Univ, Key Lab Drug Qual Control & Pharmacovigilance, Nanjing, Peoples R China; [Long, Jian-Gang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Ctr Mitochondrial Biol & Med, Ctr Translat Med, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; China Pharmaceutical University; Xi'an Jiaotong University	Zhang, X (corresponding author), Fourth Mil Med Univ, 169 Changlexi Rd, Xian 710032, Peoples R China.	lbmed@163.com; jiali816@fmmu.edu.cn	Zhang, Xing/ACQ-5035-2022; Xing, Changyang/AAE-2899-2019	Xing, Changyang/0000-0003-1605-8285	National Natural Science Foundation of China (NSFC) [31771265, 81470537, 31871146]; National High Technology Research and Development Program of China [2014AA020542]; Foundation Grants of Fourth Military Medical University [2019RCFCLJ, HYZHXM01001, 2018JSTS15]; National Postdoctoral Program for Innovative Talents [BX20180377]; National Postdoctoral Science Foundation [2019M653965]; Youth Innovation Team of Shaanxi Universities	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Foundation Grants of Fourth Military Medical University; National Postdoctoral Program for Innovative Talents; National Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Team of Shaanxi Universities	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31771265, 81470537 and 31871146; National High Technology Research and Development Program of China, Grant/Award Number: 2014AA020542; Foundation Grants of Fourth Military Medical University, Grant/Award Number: 2019RCFCLJ, HYZHXM01001 and 2018JSTS15; National Postdoctoral Program for Innovative Talents, Grant/Award Number: BX20180377; National Postdoctoral Science Foundation Grant, Grant/Award Number: 2019M653965; Youth Innovation Team of Shaanxi Universities	Arbeille P, 2016, AEROSP MED HUM PERF, V87, P449, DOI 10.3357/AMHP.4493.2016; Baskin KK, 2014, EMBO MOL MED, V6, P436, DOI 10.1002/emmm.201303800; Biering-Sorensen T, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005521; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Boucsein A, 2019, FASEB J, V33, P12175, DOI 10.1096/fj.201901004R; BUNGO MW, 1987, J APPL PHYSIOL, V62, P278, DOI 10.1152/jappl.1987.62.1.278; Chaix A, 2019, CELL METAB, V29, P303, DOI 10.1016/j.cmet.2018.08.004; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chung H, 2016, METABOLISM, V65, P1743, DOI 10.1016/j.metabol.2016.09.006; Coupe M, 2011, AM J PHYSIOL-REG I, V301, pR1748, DOI 10.1152/ajpregu.00234.2011; Crewe C, 2017, J BIOL CHEM, V292, P305, DOI 10.1074/jbc.M116.754127; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; de Lucia C, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004153; Dong TA, 2020, AM J MED, V133, P901, DOI 10.1016/j.amjmed.2020.03.030; Dorfman TA, 2007, J APPL PHYSIOL, V103, P8, DOI 10.1152/japplphysiol.01162.2006; Feng YF, 2013, CRIT CARE MED, V41, pE74, DOI 10.1097/CCM.0b013e318278b6e7; Fu Q, 2019, CIRCULATION, V140, P729, DOI 10.1161/CIRCULATIONAHA.119.041050; Gabel Kelsey, 2018, Nutr Healthy Aging, V4, P345, DOI 10.3233/NHA-170036; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Geng LL, 2019, CELL REP, V26, P2738, DOI 10.1016/j.celrep.2019.02.014; Gill S, 2015, SCIENCE, V347, P1265, DOI 10.1126/science.1256682; Griffin TM, 2016, BIOCHIMIE, V124, P74, DOI 10.1016/j.biochi.2015.10.013; Guo YZ, 2018, CARDIOVASC RES, V114, P979, DOI 10.1093/cvr/cvy052; Hamilton DR, 2011, ECHOCARDIOGR-J CARD, V28, P491, DOI 10.1111/j.1540-8175.2011.01385.x; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Hua YF, 2019, ANAL BIOANAL CHEM, V411, P2045, DOI 10.1007/s00216-019-01626-3; Hughson RL, 2012, J APPL PHYSIOL, V112, P719, DOI 10.1152/japplphysiol.01196.2011; Hughson RL, 2018, NAT REV CARDIOL, V15, P167, DOI 10.1038/nrcardio.2017.157; Kirk JA, 2013, CIRC RES, V113, P765, DOI 10.1161/CIRCRESAHA.113.300270; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; LANE HW, 1992, J NUTR, V122, P13, DOI 10.1093/jn/122.1.13; Levine BD, 1996, J APPL PHYSIOL, V81, P686, DOI 10.1152/jappl.1996.81.2.686; Li T, 2017, CELL METAB, V25, P374, DOI 10.1016/j.cmet.2016.11.005; Li TT, 2017, AM J PHYSIOL-ENDOC M, V313, pE577, DOI 10.1152/ajpendo.00014.2017; Liang QN, 2014, DIABETES, V63, P4064, DOI 10.2337/db14-0541; Liu H, 2015, LIFE SCI, V121, P1, DOI 10.1016/j.lfs.2014.10.023; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; MANCHESTER JK, 1990, FASEB J, V4, P55, DOI 10.1096/fasebj.4.1.1967237; Marcus KA, 2012, AM J PHYSIOL-HEART C, V302, pH196, DOI 10.1152/ajpheart.00740.2011; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Melkani GC, 2017, J PHYSIOL-LONDON, V595, P3691, DOI 10.1113/JP273094; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125; Perhonen MA, 2001, J APPL PHYSIOL, V91, P645, DOI 10.1152/jappl.2001.91.2.645; Petersen N, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0050-4; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Redondo-Angulo I, 2017, CARDIOVASC RES, V113, P1574, DOI 10.1093/cvr/cvx088; Rohm M, 2018, DIABETES, V67, P1057, DOI 10.2337/db17-1195; Schlein C, 2016, CELL METAB, V23, P441, DOI 10.1016/j.cmet.2016.01.006; Shi L, 2021, CELL MOL IMMUNOL, V18, P1489, DOI 10.1038/s41423-019-0346-6; Sun J, 2015, ACUPUNCT MED, V33, P381, DOI 10.1136/acupmed-2014-010730; Sutton EF, 2018, CELL METAB, V27, P1212, DOI 10.1016/j.cmet.2018.04.010; Tobin BW, 2002, NUTRITION, V18, P842, DOI 10.1016/S0899-9007(02)00940-1; Wakabayashi H, 2019, MOL IMAGING BIOL, V21, P654, DOI 10.1007/s11307-018-1279-7; Wang Y, 2016, J PROTEOME RES, V15, P29, DOI 10.1021/acs.jproteome.5b00777; Wolff SM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0274-6; Yousefzadeh MJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12706; Yu CM, 2005, J AM COLL CARDIOL, V45, P677, DOI 10.1016/j.jacc.2004.12.003; Zhong GH, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00274	62	9	10	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15180	15196		10.1096/fj.202001246RR	http://dx.doi.org/10.1096/fj.202001246RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32954538				2022-12-26	WOS:000573726900001
J	Maggini, I; Cardinale, M; Sundberg, JH; Spina, F; Fusani, L				Maggini, Ivan; Cardinale, Massimiliano; Sundberg, Jonas Hentati; Spina, Fernando; Fusani, Leonida			Recent phenological shifts of migratory birds at a Mediterranean spring stopover site: Species wintering in the Sahel advance passage more than tropical winterers	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; LONG-DISTANCE MIGRATION; CLIMATE-CHANGE; AVIAN MIGRATION; AUTUMN MIGRATION; ARRIVAL DATES; TEMPERATURE SENSITIVITY; INDIVIDUAL CONSISTENCY; ECOLOGICAL CONDITIONS; HABITAT USE	Spring migration phenology is shifting towards earlier dates as a response to climate change in many bird species. However, the patterns of change might not be the same for all species, populations, sex and age classes. In particular, patterns of change could differ between species with different ecology. We analyzed 18 years of standardized bird capture data at a spring stopover site on the island of Ponza, Italy, to determine species-specific rates of phenological change for 30 species following the crossing of the Mediterranean Sea. The advancement of spring passage was more pronounced in species wintering in Northern Africa (i.e. short-distance migrants) and in the Sahel zone. Only males from species wintering further South in the forests of central Africa advanced their passage, with no effect on the overall peak date of passage of the species. The migration window on Ponza broadened in many species, suggesting that early migrants within a species are advancing their migration more than late migrants. These data suggest that the cues available to the birds to adjust departure might be changing at different rates depending on wintering location and habitat, or that early migrants of different species might be responding differently to changing conditions along the route. However, more data on departure time from the wintering areas are required to understand the mechanisms underlying such phenological changes.	[Maggini, Ivan; Fusani, Leonida] Univ Vet Med Vienna, Austrian Ornithol Ctr, Konrad Lorenz Inst Ethol, Vienna, Austria; [Cardinale, Massimiliano; Sundberg, Jonas Hentati] Swedish Univ Agr Sci, Inst Marine Res, Dept Aquat Resources, Lysekil, Sweden; [Spina, Fernando] Inst Environm Protect & Res ISPRA, Ozzano Dellemilia, BO, Italy; [Fusani, Leonida] Univ Vienna, Dept Behav & Cognit Biol, Vienna, Austria	University of Veterinary Medicine Vienna; Swedish University of Agricultural Sciences; Italian Institute for Environmental Protection & Research (ISPRA); University of Vienna	Maggini, I (corresponding author), Univ Vet Med Vienna, Austrian Ornithol Ctr, Konrad Lorenz Inst Ethol, Vienna, Austria.	ivan.maggini@vetmeduni.ac.at	Hentati-Sundberg, Jonas/N-6535-2017	Hentati-Sundberg, Jonas/0000-0002-3201-9262; Maggini, Ivan/0000-0002-1528-2288	Research Council of Norway [196451/V40]; University of Ferrara; Max Planck Society; University of Veterinary Medicine, Vienna	Research Council of Norway(Research Council of Norway); University of Ferrara; Max Planck Society(Max Planck SocietyFoundation CELLEX); University of Veterinary Medicine, Vienna	Funding across the study period was provided to LF by The Research Council of Norway grant N. 196451/V40 (https://www.forskningsradet.no/en/); the University of Ferrara, FAR 2008-2013 (http://www.unife.it/international); the Max Planck Society (https://www.mpg.de/en); and start-up funds of the University of Veterinary Medicine, Vienna (https://www.vetmeduni.ac.at/en/), and the University of Vienna (https://www.univie.ac.at/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all ringers and volunteers helping through the years at the station in Ponza. We are also grateful to the Italian Presidenza della Repubblica for providing qualified personnel from the Castelporziano estate. We also thank Alessandro Orio and Valerio Bartolino for their precious help with the analyses. Two anonymous reviewers greatly contributed to improve the manuscript. This is paper no. 70 from the Piccole Isole Project of the Italian National Institute for Environmental Protection and Research (ISPRA).	Altwegg R, 2012, P ROY SOC B-BIOL SCI, V279, P1485, DOI 10.1098/rspb.2011.1897; Askeyev OV, 2009, CENT EUR J BIOL, V4, P595, DOI 10.2478/s11535-009-0046-9; Bairlein F, 2016, SCIENCE, V354, P547, DOI 10.1126/science.aah6647; Barlein F., 2001, CLIMATE 21 CENTURY C, P278; Battley PF, 2006, BIOL LETTERS, V2, P517, DOI 10.1098/rsbl.2006.0535; Beaumont LJ, 2006, GLOBAL CHANGE BIOL, V12, P1339, DOI 10.1111/j.1365-2486.2006.01171.x; Bitterlin LR, 2014, CLIM RES, V61, P109, DOI 10.3354/cr01238; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2007, SCIENCE, V315, DOI 10.1126/science.1136148; Both C, 2010, CURR BIOL, V20, P243, DOI 10.1016/j.cub.2009.11.074; Briedis M, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2509-3; Bussiere EMS, 2015, GLOBAL CHANGE BIOL, V21, P2179, DOI 10.1111/gcb.12857; Butler CJ, 2003, IBIS, V145, P484, DOI 10.1046/j.1474-919X.2003.00193.x; Conklin JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054535; Coppack T, 2009, INTEGR COMP BIOL, V49, P493, DOI 10.1093/icb/icp029; Cotton PA, 2003, P NATL ACAD SCI USA, V100, P12219, DOI 10.1073/pnas.1930548100; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Dardel C, 2014, REMOTE SENS ENVIRON, V140, P350, DOI 10.1016/j.rse.2013.09.011; Dong BW, 2015, NAT CLIM CHANGE, V5, P757, DOI [10.1038/nclimate2664, 10.1038/NCLIMATE2664]; Dunn PO, 2014, J ANIM ECOL, V83, P729, DOI 10.1111/1365-2656.12162; Emmenegger T, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1385; Forchhammer MC, 2002, J ANIM ECOL, V71, P1002, DOI 10.1046/j.1365-2656.2002.00664.x; Gienapp P, 2007, CLIM RES, V35, P25, DOI 10.3354/cr00712; Gill JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2161; Goodenough AE, 2015, IBIS, V157, P384, DOI 10.1111/ibi.12227; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; Gordo O, 2011, ADV GLOB CHANGE RES, V46, P153, DOI 10.1007/978-94-007-1372-7_11; Hahn S, 2014, ECOL EVOL, V4, P4150, DOI 10.1002/ece3.1279; Hasselquist D, 2017, J AVIAN BIOL, V48, P91, DOI 10.1111/jav.01292; Hedlund JSU, 2015, J AVIAN BIOL, V46, P97, DOI 10.1111/jav.00484; Horton KG, 2020, NAT CLIM CHANGE, V10, P63, DOI 10.1038/s41558-019-0648-9; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hotker H, 2002, ARDEA, V90, P379; Hubalek Z, 2008, FOLIA ZOOL, V57, P212; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Huppop O, 2006, J ORNITHOL, V147, P344, DOI 10.1007/s10336-005-0049-x; Huppop O, 2003, P ROY SOC B-BIOL SCI, V270, P233, DOI 10.1098/rspb.2002.2236; Jenni L, 2020, MOULT AND AGEING OF EUROPEAN PASSERINES, 2 EDITION, P1; Jenni L, 2003, P ROY SOC B-BIOL SCI, V270, P1467, DOI 10.1098/rspb.2003.2394; Jin FJ, 2010, PHILOS T R SOC A, V368, P5137, DOI 10.1098/rsta.2010.0204; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Kluen E, 2017, J AVIAN BIOL, V48, P611, DOI 10.1111/jav.01110; Knudsen E, 2007, CLIM RES, V35, P59, DOI 10.3354/cr00714; Kolarova E, 2017, INT J BIOMETEOROL, V61, P1279, DOI 10.1007/s00484-017-1305-5; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Maggini I, 2020, J ORNITHOL, V161, P793, DOI 10.1007/s10336-020-01768-7; Maggini I, 2013, J ORNITHOL, V154, P321, DOI 10.1007/s10336-012-0896-1; Maggini I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031271; Markets I.S.I.E. and Prohibited U.D., 2012, INT, V2016, P12, DOI [DOI 10.1155/2016/7230450, 10.1002/9781119971641.ch8]; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; Mills AM, 2005, IBIS, V147, P259, DOI 10.1111/j.1474-919X.2005.00380.x; Moreau R., 1972, PALAEARCTIC AFRICAN; MOREL GJ, 1992, IBIS, V134, P83; Newson SE, 2016, IBIS, V158, P481, DOI 10.1111/ibi.12367; Nicholson SE, 2018, GLOBAL PLANET CHANGE, V165, P114, DOI 10.1016/j.gloplacha.2017.12.014; PEARSON DJ, 1992, IBIS, V134, P89; Pedersen L, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2553-z; Radchuk V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10924-4; Raible CC, 2010, CLIM DYNAM, V35, P473, DOI 10.1007/s00382-009-0678-5; Rainio K, 2007, CLIM RES, V35, P107, DOI 10.3354/cr00717; Rainio K, 2006, J AVIAN BIOL, V37, P507, DOI 10.1111/j.0908-8857.2006.03740.x; Robson D, 2011, J ANIM ECOL, V80, P320, DOI 10.1111/j.1365-2656.2010.01772.x; Rubolini D, 2005, BIOL J LINN SOC, V85, P199, DOI 10.1111/j.1095-8312.2005.00484.x; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Ruthrauff DR, 2019, AUK, V136, DOI 10.1093/auk/uky007; Saino N, 2004, ECOL LETT, V7, P21, DOI 10.1046/j.1461-0248.2003.00553.x; Saino N, 2007, CLIM RES, V35, P123, DOI 10.3354/cr00719; Samplonius JM, 2018, GLOBAL CHANGE BIOL, V24, P3780, DOI [10.1111/gcb.14160, 10.1111/gcb.141]; Schaub M, 2008, BEHAV ECOL, V19, P657, DOI 10.1093/beheco/arn023; Schewe J, 2012, CLIM PAST, V8, P535, DOI 10.5194/cp-8-535-2012; Sokolov Leonid V., 2003, Trudy Zoologicheskogo Instituta, V299, P141; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P22, DOI 10.1111/j.1365-2486.2004.00887.x; Spina F., 1993, VOGELWARTE, V37, P1, DOI DOI 10.1111/J.2041-210X.2011.00123.X; Spottiswoode CN, 2006, P ROY SOC B-BIOL SCI, V273, P3023, DOI 10.1098/rspb.2006.3688; Stanley CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040688; Stervander M, 2005, J AVIAN BIOL, V36, P210, DOI 10.1111/j.0908-8857.2005.03360.x; Svensson L., 1992, IDENTIFICATION GUIDE; Thorup K, 2007, OECOLOGIA, V151, P697, DOI 10.1007/s00442-006-0608-8; Thorup K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601360; Tottrup AP, 2012, SCIENCE, V338, P1307, DOI 10.1126/science.1227548; Tottrup AP, 2006, ARDEA, V94, P527; Tottrup AP, 2006, J AVIAN BIOL, V37, P84, DOI 10.1111/j.2006.0908-8857.03391.x; Usui T, 2017, J ANIM ECOL, V86, P250, DOI 10.1111/1365-2656.12612; Vahatalo AV, 2004, J AVIAN BIOL, V35, P210; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; van Noordwijk AJ, 2003, NATURE, V422, P29, DOI 10.1038/422029a; van Wijk RE, 2016, ECOL EVOL, V6, P8679, DOI 10.1002/ece3.2578; Vardanis Y, 2011, BIOL LETTERS, V7, P502, DOI 10.1098/rsbl.2010.1180; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Visser ME, 2012, J ORNITHOL, V153, pS75, DOI 10.1007/s10336-011-0770-6; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weber TP, 1999, BEHAV ECOL SOCIOBIOL, V46, P280, DOI 10.1007/s002650050621; Wellbrock AHJ, 2017, J AVIAN BIOL, V48, P897, DOI 10.1111/jav.01251	94	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239489	10.1371/journal.pone.0239489	http://dx.doi.org/10.1371/journal.pone.0239489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946519	gold, Green Published			2022-12-26	WOS:000573851100023
J	Stubbe, HC; Dahlke, C; Rotheneder, K; Stirner, R; Roider, J; Conca, R; Seybold, U; Bogner, J; Addo, MM; Draenert, R				Stubbe, Hans Christian; Dahlke, Christine; Rotheneder, Katharina; Stirner, Renate; Roider, Julia; Conca, Raffaele; Seybold, Ulrich; Bogner, Johannes; Addo, Marylyn Martina; Draenert, Rika			Integration of microarray data and literature mining identifies a sex bias in DPP4+CD4+T cells in HIV-1 infection	PLOS ONE			English	Article							BLOOD GENE-EXPRESSION; T-CELLS; CD26; PROGRESSION; THERAPY	HIV-1 infection exhibits a significant sex bias. This study aimed at identifying and examining lymphocyte associated sex differences in HIV-1 pathogenesis using a data-driven approach. To select targets for investigating sex differences in lymphocytes, data of microarray experiments and literature mining were integrated. Data from three large-scale microarray experiments were obtained from NCBI/GEO and screened for sex differences in gene expression. Literature mining was employed to identify sex biased genes in the microarray data, which were relevant to HIV-1 pathogenesis and lymphocyte biology. Sex differences in gene expression of selected genes were investigated by RT-qPCR and flowcytometry in healthy individuals and persons living with HIV-1. A significant and consistent sex bias was identified in 31 genes, the majority of which were related to immunity and expressed at higher levels in women. Using literature mining, three genes (DPP4, FCGR1A and SOCS3) were selected for analysis by qPCR because of their relevance to HIV, as well as, B and T cell biology. DPP4 exhibited the most significant sex bias in mRNA expression (p = 0.00029). Therefore, its expression was further analyzed on B and T cells using flowcytometry. In HIV-1 infected controllers and healthy individuals, frequencies of CD4+DPP4+ T cells were higher in women compared to men (p = 0.037 and p = 0.027). In women, CD4 T cell counts correlated with a predominant decreased in DPP4+CD4+ T cells (p = 0.0032). Sex differences in DPP4 expression abrogated in progressive HIV-1 infection. In conclusion, we found sex differences in the pathobiology of T cells in HIV-1 infection using a data-driven approach. Our results indicate that DPP4 expression on CD4+ T cells might contribute to the immunological sex differences observed in chronic HIV-1 infection.	[Stubbe, Hans Christian; Rotheneder, Katharina; Stirner, Renate; Roider, Julia; Seybold, Ulrich; Bogner, Johannes; Draenert, Rika] Hosp LMU Munich, Dept Med 4, Div Infect Dis, Munich, Germany; [Stubbe, Hans Christian; Rotheneder, Katharina; Stirner, Renate; Roider, Julia; Seybold, Ulrich; Bogner, Johannes; Draenert, Rika] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Stubbe, Hans Christian] Hosp LMU Munich, Dept Med 2, Munich, Germany; [Stubbe, Hans Christian; Dahlke, Christine; Addo, Marylyn Martina] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Div Infect Dis, Hamburg, Germany; [Dahlke, Christine; Addo, Marylyn Martina] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Heidelberg, Germany; [Dahlke, Christine; Addo, Marylyn Martina] Bernhard Nocht Inst Trop Med, Dept Clin Immunol Infect Dis, Hamburg, Germany; [Conca, Raffaele] Hosp LMU Munich, Dr Von Hauner Childrens Hosp, Dept Pediat, Munich, Germany; [Draenert, Rika] Hosp LMU Munich, Antibiot Stewardship Team, Munich, Germany	University of Munich; German Center for Infection Research; University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; German Center for Infection Research; Bernhard Nocht Institut fur Tropenmedizin; University of Munich; University of Munich	Draenert, R (corresponding author), Hosp LMU Munich, Dept Med 4, Div Infect Dis, Munich, Germany.; Draenert, R (corresponding author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.; Draenert, R (corresponding author), Hosp LMU Munich, Antibiot Stewardship Team, Munich, Germany.	rika.draenert@med.uni-muenchen.de	Roider, Julia/ADV-9989-2022; Addo, Marylyn M./GNP-2548-2022	Stubbe, Hans Christian/0000-0002-7873-996X; Dahlke, Christine/0000-0002-2056-9195; Roider, Julia/0000-0002-1347-2838; Addo, Marylyn/0000-0003-2836-9224	German Center of Infections Research (DZIF)	German Center of Infections Research (DZIF)	HCS received a MD scholarship by the German Center of Infections Research (DZIF). Website: https://www.dzif.de/en The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT CA, 1994, IMMUNOGENETICS, V40, P331, DOI 10.1007/BF01246674; Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bengsch B, 2012, J IMMUNOL, V188, P5438, DOI 10.4049/jimmunol.1103801; BLAZQUEZ MV, 1992, J IMMUNOL, V149, P3073; Broad Institute, 2018, GSEA; Callebaut C, 1998, EXP CELL RES, V241, P352, DOI 10.1006/excr.1998.4063; Chang JJ, 2013, J INFECT DIS, V208, P830, DOI 10.1093/infdis/jit262; Dahlke C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049435; Deeks SG, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.35; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Gerring Z, 2016, CEPHALALGIA, V36, P669, DOI 10.1177/0333102416628463; Grinsztejn B, 2011, ANTIVIR THER, V16, P1057, DOI 10.3851/IMP1872; Hemani G, 2014, NATURE, V508, P249, DOI 10.1038/nature13005; HGNC, 2019, SYMB REP DDP4; Karlovich C, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-33; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Klemann C, 2016, CLIN EXP IMMUNOL, V185, P1, DOI 10.1111/cei.12781; Lewis DA, 2011, THROMB RES, V128, P536, DOI 10.1016/j.thromres.2011.06.003; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; McRae AF, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r73; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; NCBI, 2015, GEO2R; O'Neill K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003365; Ohtsuki T, 2000, J DERMATOL SCI, V22, P152, DOI 10.1016/S0923-1811(99)00081-X; Ploquin MJ, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25144; Prabhu SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162242; R Core Team, 2014, LANG ENV STAT COMP; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Smith RE, 1998, AIDS RES HUM RETROV, V14, P851, DOI 10.1089/aid.1998.14.851; Songok EM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-343; Perez-Durillo FT, 2018, MOLECULES, V23, DOI 10.3390/molecules23071564; UNAIDS, 2019, UNAIDS DAT 2019; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagner L, 2016, CLIN EXP IMMUNOL, V184, P265, DOI 10.1111/cei.12757	36	3	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239399	10.1371/journal.pone.0239399	http://dx.doi.org/10.1371/journal.pone.0239399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946499	Green Published, gold			2022-12-26	WOS:000573851100092
J	Liu, S; Zhao, WJ; Liu, XY; Cheng, LX				Liu, Sheng; Zhao, Wenjing; Liu, Xueyan; Cheng, Lixin			Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target	FASEB JOURNAL			English	Article						atherosclerosis; cardiovascular diseases; gut microbiota; metabolites; metagenome	C-REACTIVE PROTEIN; VASCULAR-DISEASE; NICOTINIC-ACID; FOLIC-ACID; METHANOBREVIBACTER-SMITHII; CARDIOVASCULAR-DISEASE; INTESTINAL MICROBIOTA; WIDE ASSOCIATION; OXIDATIVE STRESS; SERUM METABOLOME	The gut microbiota is associated with cardiovascular diseases, including atherosclerosis. However, the composition, functional capacity, and metabolites of the gut microbiome about atherosclerosis have not been comprehensively studied. Here, we reanalyzed 25 metagenomic stool samples from Sweden and 385 metagenomic stool samples from China using HUMAnN2, PanPhlAn, and MelonnPan to obtain more sufficient information. We found that the samples from atherosclerotic patients in both cohorts were depleted inBacteroides xylanisolvens,Odoribacter splanchnicus,Eubacterium eligens,Roseburia inulinivorans,andRoseburia intestinalis. At the functional level, healthy metagenomes were both enriched in pathways of starch degradation V, glycolysis III (from glucose), CDP-diacylglycerol biosynthesis, and folate transformations.R inulinivoransandR intestinalisare major contributors to starch degradation V, whileE eligensgreatly contribute to the pathway CDP-diacylglycerol biosynthesis, andB xylanisolvensandB uniformiscontribute to folate transformations II. The 11 marker species selected from the Chinese cohort distinguish patients from controls with an area under the receiver operating characteristics curve (AUC) of 0.86. Strain-level microbial analysis revealed a geographically associated adaptation of the strains fromE eligens,B uniformis, andE coli. Two gut microbial metabolites, nicotinic acid and hydrocinnamic acid, had significantly higher predicted abundance in the control samples compared to the patients in the Chinese cohort, and interestinglynicotinic acid is already an effective lipid-lowering drug to reducing cardiovascular risk. Our results indicate intestinal bacteria such asB xylanisolvens,E eligens,andR inulinivoranscould be promising probiotics and potential therapeutic target for atherosclerosis.	[Liu, Sheng; Zhao, Wenjing] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Sch Med, Guangzhou, Peoples R China; [Liu, Sheng; Liu, Xueyan; Cheng, Lixin] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Crit Care Med, Shenzhen, Peoples R China	Sun Yat Sen University; Jinan University	Liu, XY; Cheng, LX (corresponding author), Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Crit Care Med, Shenzhen, Peoples R China.	XYLiu@qq.com; easonlcheng@gmail.com	Cheng, Lixin/I-6191-2019	Cheng, Lixin/0000-0002-9427-383X; Liu, Sheng/0000-0001-5119-0324; Zhao, Wenjing/0000-0003-1706-6324	National Natural Science Foundation of China (NSFC) [31900056]; Health and Family Planning Commission of Shenzhen Municipality [SZXJ2017027]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Shenzhen Municipality	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31900056; Health and Family Planning Commission of Shenzhen Municipality, Grant/Award Number: SZXJ2017027	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Bartolomaeus H, 2019, CIRCULATION, V139, P1407, DOI 10.1161/CIRCULATIONAHA.118.036652; Bennett J.E., 2015, MANDELL DOUGLAS BENN; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Bouter KE, 2017, GASTROENTEROLOGY, V152, P1671, DOI 10.1053/j.gastro.2016.12.048; Brown BG, 2008, AM J CARDIOL, V101, p58B, DOI 10.1016/j.amjcard.2008.02.039; Brown JM, 2018, NAT REV MICROBIOL, V16, P171, DOI 10.1038/nrmicro.2017.149; Cerqueira FM, 2020, TRENDS MICROBIOL, V28, P95, DOI 10.1016/j.tim.2019.09.004; Chassard C, 2008, INT J SYST EVOL MICR, V58, P1008, DOI 10.1099/ijs.0.65504-0; Chung WSF, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix127; Coker OO, 2018, GUT, V67, P1024, DOI 10.1136/gutjnl-2017-314281; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Duncan SH, 2006, INT J SYST EVOL MICR, V56, P2437, DOI 10.1099/ijs.0.64098-0; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Etxeberria U, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500906; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Forstermann U, 2017, CIRC RES, V120, P713, DOI 10.1161/CIRCRESAHA.116.309326; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Grine G, 2017, EUR J CLIN MICROBIOL, V36, P2449, DOI 10.1007/s10096-017-3084-7; Guenther BD, 1999, NAT STRUCT BIOL, V6, P359, DOI 10.1038/7594; He Y, 2018, NAT MED, V24, P1532, DOI 10.1038/s41591-018-0164-x; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Jonsson AL, 2017, NAT REV CARDIOL, V14, P79, DOI 10.1038/nrcardio.2016.183; Julius U, 2013, ATHEROSCLEROSIS SUPP, V14, P7, DOI 10.1016/j.atherosclerosissup.2012.10.036; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Kasahara K, 2018, NAT MICROBIOL, V3, P1461, DOI 10.1038/s41564-018-0272-x; Kasselman LJ, 2018, ATHEROSCLEROSIS, V271, P203, DOI 10.1016/j.atherosclerosis.2018.02.036; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Knopp RH, 1999, NEW ENGL J MED, V341, P498, DOI 10.1056/NEJM199908123410707; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li J, 2016, CIRCULATION, V133, P2434, DOI 10.1161/CIRCULATIONAHA.115.019645; Li YP, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003768; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Mallick H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10927-1; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; McOrist AL, 2011, J NUTR, V141, P883, DOI 10.3945/jn.110.128504; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mischke M, 2016, ADV EXP MED BIOL, V902, P33, DOI 10.1007/978-3-319-31248-4_3; Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Park J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04632-6; Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Santoru ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10034-5; Scholz M, 2016, NAT METHODS, V13, P435, DOI [10.1038/NMETH.3802, 10.1038/nmeth.3802]; Scott KP, 2011, P NATL ACAD SCI USA, V108, P4672, DOI 10.1073/pnas.1000091107; Skagen K, 2016, ATHEROSCLEROSIS, V247, P64, DOI 10.1016/j.atherosclerosis.2016.01.033; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Title LM, 2000, J AM COLL CARDIOL, V36, P758, DOI 10.1016/S0735-1097(00)00809-3; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Tso SC, 2013, P NATL ACAD SCI USA, V110, P9728, DOI 10.1073/pnas.1303220110; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Ulsemer P, 2012, APPL ENVIRON MICROB, V78, P528, DOI 10.1128/AEM.06641-11; Visconti A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12476-z; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wald DS, 2006, BMJ-BRIT MED J, V333, P1114, DOI 10.1136/bmj.39000.486701.68; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang CCL, 2016, CIRCULATION, V133, P2459, DOI 10.1161/CIRCULATIONAHA.116.022194; Wang J, 2016, NAT REV MICROBIOL, V14, P508, DOI 10.1038/nrmicro.2016.83; Wang Y, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00450-19; Wang ZN, 2018, PROTEIN CELL, V9, P416, DOI 10.1007/s13238-018-0549-0; Xu YQ, 2019, J BIOL CHEM, V294, P16740, DOI 10.1074/jbc.RA119.009992; Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7; Zhang L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38216-9; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	87	21	24	5	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14166	14181		10.1096/fj.202000622R	http://dx.doi.org/10.1096/fj.202000622R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939880				2022-12-26	WOS:000570971000001
J	Lundahl, G; Gransberg, L; Bergqvist, G; Bergstrom, G; Bergfeldt, L				Lundahl, Gunilla; Gransberg, Lennart; Bergqvist, Gabriel; Bergstrom, Goran; Bergfeldt, Lennart			Automatic identification of a stable QRST complex for non-invasive evaluation of human cardiac electrophysiology	PLOS ONE			English	Article							T ANGLE; INTERVAL; REPOLARIZATION; SYSTEM; DEATH; LONG; VECTORCARDIOGRAPHY; DURATION; RISK; AREA	Background A vectorcardiography approach to electrocardiology contributes to the non-invasive assessment of electrical heterogeneity in the ventricles of the heart and to risk stratification for cardiac events including sudden cardiac death. The aim of this study was to develop an automatic method that identifies a representative QRST complex (QRSonset to Tend) from a Frank vectorcardiogram (VCG). This method should provide reliable measurements of morphological VCG parameters and signal when such measurements required manual scrutiny. Methods Frank VCG was recorded in a population-based sample of 1094 participants (550 women) 50-65 years old as part of the Swedish CArdioPulmonary bioImage Study (SCAPIS) pilot. Standardized supine rest allowing heart rate stabilization and adaptation of ventricular repolarization preceded a recording period lasting >= 5 minutes. In the Frank VCG a recording segment during steady-state conditions and with good signal quality was selected based on QRST variability. In this segment a representative signal-averaged QRST complex from cardiac cycles during 10s was selected. Twenty-eight morphological parameters were calculated including both conventional conduction intervals and VCG-derived parameters. The reliability and reproducibility of these parameters were evaluated when using completely automatic and automatic but manually edited annotation points. Results In 1080 participants (98.7%) our automatic method reliably selected a representative QRST complex where its instability measure effectively identified signal variability due to both external disturbances ("noise") and physiologic and pathophysiologic variability, such as e.g. sinus arrhythmia and atrial fibrillation. There were significant sex-related differences in 24 of 28 VCG parameters. Some VCG parameters were insensitive to the instability value, while others were moderately sensitive. Conclusion We developed an automatic process for identification of a signal-averaged QRST complex suitable for morphologic measurements which worked reliably in 99% of participants. This process is applicable for all non-invasive analyses of cardiac electrophysiology including risk stratification for cardiac death based on such measurements.	[Lundahl, Gunilla; Gransberg, Lennart; Bergqvist, Gabriel; Bergstrom, Goran; Bergfeldt, Lennart] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Bergstrom, Goran] Sahlgrens Univ Hosp, Reg Vastra Gotaland, Dept Clin Physiol, Gothenburg, Sweden; [Bergfeldt, Lennart] Sahlgrens Univ Hosp, Reg Vastra Gotaland, Dept Cardiol, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; Sahlgrenska University Hospital	Bergfeldt, L (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.; Bergfeldt, L (corresponding author), Sahlgrens Univ Hosp, Reg Vastra Gotaland, Dept Cardiol, Gothenburg, Sweden.	lennart.bergfeldt@hjl.gu.se		Bergfeldt, Lennart/0000-0002-0161-9388	Swedish Heart and Lung Foundation [20190652]; Swedish government [ALFGBG-722431]; Swedish county councils, the ALF-agreement [ALFGBG-722431]; Knut and Alice Wallenberg Foundation; Swedish Research Council; VINNOVA; Sahlgrenska Academy at Gothenburg University; ALF/LUA in Western Sweden	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish government; Swedish county councils, the ALF-agreement; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Sahlgrenska Academy at Gothenburg University; ALF/LUA in Western Sweden	This study was supported by the Swedish Heart and Lung Foundation (to LB #20190652) and by grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement to LB (ALFGBG-722431). SCAPIS is supported by the Swedish Heart and Lung Foundation, the Knut and Alice Wallenberg Foundation, the Swedish Research Council and VINNOVA. The SCAPIS pilot study also received funding from the Sahlgrenska Academy at Gothenburg University and strategic grants from ALF/LUA in Western Sweden. The sponsors did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib Sana M, 2018, Circulation, V138, pe272, DOI 10.1161/CIR.0000000000000549; Axelsson KJ, 2020, ANN NONINVAS ELECTRO, V25, P141, DOI 10.1111/anec.12713; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Bergfeldt L, 2003, J APPL PHYSIOL, V94, P2217, DOI 10.1152/japplphysiol.01037.2002; BERGFELDT L, 1991, J AM COLL CARDIOL, V18, P792, DOI 10.1016/0735-1097(91)90804-I; Bergfeldt L, 2020, J ELECTROCARDIOL, V61, P112, DOI 10.1016/j.jelectrocard.2020.05.013; Bergfeldt L, 2017, J ELECTROCARDIOL, V50, P424, DOI 10.1016/j.jelectrocard.2017.03.014; Bergstrom G, 2015, J INTERN MED, V278, P645, DOI 10.1111/joim.12384; Bjork J, 2017, SCAND J PUBLIC HEALT, V45, P45, DOI 10.1177/1403494817702326; Chouvardas V. G., 2008, DISPLAYS, V29, P185; Diamant UB, 2013, J APPL PHYSIOL, V115, P1423, DOI 10.1152/japplphysiol.00665.2013; Diamant UB, 2010, J ELECTROCARDIOL, V43, P25, DOI 10.1016/j.jelectrocard.2009.09.008; DRAPER HW, 1964, CIRCULATION, V30, P853, DOI 10.1161/01.CIR.30.6.853; FRANK E, 1956, CIRCULATION, V13, P737, DOI 10.1161/01.CIR.13.5.737; Johnson JN, 2009, BRIT J SPORT MED, V43, P657, DOI 10.1136/bjsm.2008.054734; Kardys I, 2003, EUR HEART J, V24, P1357, DOI 10.1016/S0195-668X(03)00203-3; Kligfield P, 2007, ANN NONINVAS ELECTRO, V12, P145, DOI 10.1111/j.1542-474X.2007.00153.x; LEPESCHKIN E, 1952, CIRCULATION, V6, P378, DOI 10.1161/01.CIR.6.3.378; Lingman M, 2016, INT J CARDIOL, V218, P1, DOI 10.1016/j.ijcard.2016.05.005; Man S, 2015, J ELECTROCARDIOL, V48, P463, DOI 10.1016/j.jelectrocard.2015.05.002; Oehler A, 2014, ANN NONINVAS ELECTRO, V19, P534, DOI 10.1111/anec.12206; Schreurs CA, 2010, J ELECTROCARDIOL, V43, P294, DOI 10.1016/j.jelectrocard.2010.03.009; SEED WA, 1987, BRIT HEART J, V57, P32; Vahedi F, 2013, HEART RHYTHM, V10, P1169, DOI 10.1016/j.hrthm.2013.05.001; Vahedi F, 2012, J APPL PHYSIOL, V113, P368, DOI 10.1152/japplphysiol.01190.2011; van Deursen CJM, 2015, J CARDIOVASC TRANSL, V8, P128, DOI 10.1007/s12265-015-9615-7; van Deursen CJM, 2015, J ELECTROCARDIOL, V48, P45, DOI 10.1016/j.jelectrocard.2014.10.003; Vink AS, 2018, CIRCULATION, V138, P2345, DOI 10.1161/CIRCULATIONAHA.118.033943; Voulgari C, 2013, CURR CARDIOL REV, V9, P197, DOI 10.2174/1573403X113099990031; Waks JW, 2016, CIRCULATION, V133, P2222, DOI 10.1161/CIRCULATIONAHA.116.021306; WILLEMS JL, 1985, CIRCULATION, V71, P523, DOI 10.1161/01.CIR.71.3.523; Yamazaki T, 2005, HEART RHYTHM, V2, P73, DOI 10.1016/j.hrthm.2004.10.040; Zhang XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136174; Zhang ZM, 2017, J ELECTROCARDIOL, V50, P661, DOI 10.1016/j.jelectrocard.2017.05.001	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239074	10.1371/journal.pone.0239074	http://dx.doi.org/10.1371/journal.pone.0239074			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941513	Green Published, gold			2022-12-26	WOS:000573848800106
J	Gavigan, J; Kefela, T; Macadam-Somer, I; Suh, S; Geyer, R				Gavigan, Jenna; Kefela, Timnit; Macadam-Somer, Ilan; Suh, Sangwon; Geyer, Roland			Synthetic microfiber emissions to land rival those to waterbodies and are growing	PLOS ONE			English	Article							WASTE-WATER TREATMENT; MICROPLASTIC PARTICLES; WASHING MACHINES; TREATMENT PLANTS; SEWAGE-SLUDGE; FIBERS; SEA; TRANSPORT; RELEASE; RIVER	Synthetic microfibers are found virtually everywhere in the environment, but emission pathways and quantities are poorly understood. By connecting regionalized global datasets on apparel production, use, and washing with emission and retention rates during washing, wastewater treatment, and sludge management, we estimate that 5.6 Mt of synthetic microfibers were emitted from apparel washing between 1950 and 2016. Half of this amount was emitted during the last decade, with a compound annual growth rate of 12.9%. Waterbodies received 2.9 Mt, while combined emissions to terrestrial environments (1.9 Mt) and landfill (0.6 Mt) were almost as large and are growing. Annual emissions to terrestrial environments (141.9 kt yr(-1)) and landfill (34.6 kt yr(-1)) combined are now exceeding those to waterbodies (167.2 kt yr(-1)). Improving access to wastewater treatment is expected to further shift synthetic microfiber emissions from waterbodies to terrestrial environments. Preventing emissions at the source would therefore be a more effective mitigation measure.	[Gavigan, Jenna; Kefela, Timnit; Macadam-Somer, Ilan; Suh, Sangwon; Geyer, Roland] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Gavigan, J (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	jngavigan@gmail.com	Suh, Sangwon/E-2019-2011	Suh, Sangwon/0000-0001-8290-6276	Ocean Conservancy, Purnell; Outdoor Industry Association Microfiber Research Cohort; US Environmental Protection Agency's Science to Achieve Results Program [83557907]; H. William Kuni Interdisciplinary Fellowship	Ocean Conservancy, Purnell; Outdoor Industry Association Microfiber Research Cohort; US Environmental Protection Agency's Science to Achieve Results Program(United States Environmental Protection Agency); H. William Kuni Interdisciplinary Fellowship	This work was supported by Ocean Conservancy, Purnell, and the Outdoor Industry Association Microfiber Research Cohort; S.S. acknowledges the financial support of the US Environmental Protection Agency's Science to Achieve Results Program under Grant No. 83557907; and the authors thank H. William Kuni for his generous support for TK's and RG's involvement through the H. William Kuni Interdisciplinary Fellowship.	Abernathy F.H., 1999, STITCH TIME LEAN RET; Allen S, 2019, NAT GEOSCI, V12, P339, DOI 10.1038/s41561-019-0335-5; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Andreoli C. V., GLOBAL ATLAS EXCRETA, P117; [Anonymous], 2017, FIB YEAR 2017 WORLD; Australian Bureau of Statistics, 2014, 46020 55001 ENV ISS; Botterell ZLR, 2019, ENVIRON POLLUT, V245, P98, DOI 10.1016/j.envpol.2018.10.065; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Cabeza LF, 2018, RENEW SUST ENERG REV, V98, P1, DOI 10.1016/j.rser.2018.09.006; Carr SA, 2016, WATER RES, V91, P174, DOI 10.1016/j.watres.2016.01.002; Catarino AI, 2018, ENVIRON POLLUT, V237, P675, DOI 10.1016/j.envpol.2018.02.069; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Cooklin G., 1997, GARMENT TECHNOLOGY F; Corradini F, 2019, SCI TOTAL ENVIRON, V671, P411, DOI 10.1016/j.scitotenv.2019.03.368; Cox KD, 2019, ENVIRON SCI TECHNOL, V53, P7068, DOI 10.1021/acs.est.9b01517; Davis J, 2007, RESOUR CONSERV RECY, V51, P118, DOI 10.1016/j.resconrec.2006.08.007; De Falco F, 2018, ENVIRON POLLUT, V236, P916, DOI 10.1016/j.envpol.2017.10.057; Dris R, 2016, MAR POLLUT BULL, V104, P290, DOI 10.1016/j.marpolbul.2016.01.006; Dris R, 2015, ENVIRON CHEM, V12, P539, DOI 10.1071/EN14172; Drycleaning Institute of Australia, 2015, INT FAIR CLAIMS GUID; Eurostat, SEW SLUD PROD DISP U; Geyer R., 2019, PLASTIC WASTE RECYCL; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Gies EA, 2018, MAR POLLUT BULL, V133, P553, DOI 10.1016/j.marpolbul.2018.06.006; Habib D, 1998, WATER AIR SOIL POLL, V103, P1, DOI 10.1023/A:1004908110793; Hartline NL, 2016, ENVIRON SCI TECHNOL, V50, P11532, DOI 10.1021/acs.est.6b03045; Hernandez E, 2017, ENVIRON SCI TECHNOL, V51, P7036, DOI 10.1021/acs.est.7b01750; Jemec A, 2016, ENVIRON POLLUT, V219, P201, DOI 10.1016/j.envpol.2016.10.037; Laitala K, 2018, USE PHASE APPAREL LI; Lares M, 2018, WATER RES, V133, P236, DOI 10.1016/j.watres.2018.01.049; Lautze J, 2014, GLOBAL EXPERIENCES W; Leslie HA, 2017, ENVIRON INT, V101, P133, DOI 10.1016/j.envint.2017.01.018; Machado AAD, 2019, ENVIRON SCI TECHNOL, V53, P6044, DOI 10.1021/acs.est.9b01339; Machado AAD, 2018, ENVIRON SCI TECHNOL, V52, P9656, DOI 10.1021/acs.est.8b02212; Magnusson K, 2016, MICROLITTER SEWAGE T; Mahon AM, 2017, ENVIRON SCI TECHNOL, V51, P810, DOI 10.1021/acs.est.6b04048; Malik OA, 2015, ENVIRON SCI POLICY, V48, P172, DOI 10.1016/j.envsci.2015.01.005; Mateo-Sagasta J., 2015, WASTEWATER, P15, DOI DOI 10.1007/978-94-017-9545-6_2; McNeil MA, 2010, ENERG BUILDINGS, V42, P783, DOI 10.1016/j.enbuild.2009.11.015; Michielssen MR, 2016, ENVIRON SCI-WAT RES, V2, P1064, DOI [10.1039/c6ew00207b, 10.1039/C6EW00207B]; Miller RZ, 2017, MAR POLLUT BULL, V124, P245, DOI 10.1016/j.marpolbul.2017.07.028; Mills J., 2011, COMMUNICATION 1006; Ministry of Land Infrastructure Transport and Tourism, SEW FORM RES EN CIRC; Murphy F, 2016, ENVIRON SCI TECHNOL, V50, P5800, DOI 10.1021/acs.est.5b05416; Napper IE, 2016, MAR POLLUT BULL, V112, P39, DOI 10.1016/j.marpolbul.2016.09.025; National Bureau of Statistics of China, 2013, CHIN STAT YB 2013; Nizzetto L, 2016, ENVIRON SCI TECHNOL, V50, P10777, DOI 10.1021/acs.est.6b04140; Nizzetto L, 2016, ENVIRON SCI-PROC IMP, V18, P1050, DOI [10.1039/c6em00206d, 10.1039/C6EM00206D]; Obbard RW, 2014, EARTHS FUTURE, V2, P315, DOI 10.1002/2014EF000240; OECD, SEW SLUDG PROD DISP; OECD, 2020, WAST TREATM POP CONN; Pakula C, 2010, ENERG EFFIC, V3, P365, DOI 10.1007/s12053-009-9072-8; PCI Wood Mackenzie, 2017, FIB GLOB SUPPL DEM R; Pirc U, 2016, ENVIRON SCI POLLUT R, V23, P22206, DOI 10.1007/s11356-016-7703-0; Rao ND, 2017, ENERGY RES SOC SCI, V27, P106, DOI 10.1016/j.erss.2017.03.005; Rezaei M, 2019, SCI TOTAL ENVIRON, V669, P273, DOI 10.1016/j.scitotenv.2019.02.382; Richard RP, GLOBAL ATLAS EXCRETA; Rissanen T, 2007, TYPES FASHION DESIGN; Sato T, 2013, AGR WATER MANAGE, V130, P1, DOI 10.1016/j.agwat.2013.08.007; Schmutz, 2008, REV THOMISTE, V108, P131; Siebens J, 2013, EXTENDED MEASURES WE, P13; Simon M, 2018, WATER RES, V142, P1, DOI 10.1016/j.watres.2018.05.019; Talvitie J, 2017, WATER RES, V109, P164, DOI 10.1016/j.watres.2016.11.046; The World Bank, GDP PER CAP PPP CURR; The World Bank, ACC EL POP; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; UN Habitat, 2002, HOUS PROJ PROJ; WaterAid, ASS FAEC SLUDG MAN P; Watts AJR, 2015, ENVIRON SCI TECHNOL, V49, P14597, DOI 10.1021/acs.est.5b04026; Woodall LC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140317; Wright SL, 2017, ENVIRON SCI TECHNOL, V51, P6634, DOI 10.1021/acs.est.7b00423; Yang G, 2015, WATER RES, V78, P60, DOI 10.1016/j.watres.2015.04.002; Yang LB, 2019, ENVIRON POLLUT, V249, P136, DOI 10.1016/j.envpol.2019.03.011; Yuan ZW, 2016, INT J LIFE CYCLE ASS, V21, P15, DOI 10.1007/s11367-015-0993-5; Zhang GS, 2019, SCI TOTAL ENVIRON, V670, P1, DOI 10.1016/j.scitotenv.2019.03.149; Ziajahromi S, 2017, ENVIRON SCI TECHNOL, V51, P13397, DOI 10.1021/acs.est.7b03574; Zubris KAV, 2005, ENVIRON POLLUT, V138, P201, DOI 10.1016/j.envpol.2005.04.013	77	32	32	8	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0237839	10.1371/journal.pone.0237839	http://dx.doi.org/10.1371/journal.pone.0237839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936800	Green Published, gold			2022-12-26	WOS:000573658000026
J	McMullan, BJ; Haeusler, GM; Hall, L; Cooley, L; Stewardson, AJ; Blyth, CC; Jones, CA; Konecny, P; Babl, FE; Mechinaud, F; Thursky, K				McMullan, Brendan J.; Haeusler, Gabrielle M.; Hall, Lisa; Cooley, Louise; Stewardson, Andrew J.; Blyth, Christopher C.; Jones, Cheryl A.; Konecny, Pamela; Babl, Franz E.; Mechinaud, Francoise; Thursky, Karin		Australian PICNICC Study Grp; PREDICT Network	Aminoglycoside use in paediatric febrile neutropenia - Outcomes from a nationwide prospective cohort study	PLOS ONE			English	Article							CELL TRANSPLANTATION RECIPIENTS; EXTERNAL VALIDATION; FEVER; CANCER; MANAGEMENT; CHILDREN; GUIDELINE; THERAPY	Aminoglycosides are commonly prescribed to children with febrile neutropenia (FN) but their impact on clinical outcomes is uncertain and extent of guideline compliance is unknown. We aimed to review aminoglycoside prescription and additional antibiotic prescribing, guideline compliance and outcomes for children with FN. We analysed data from the Australian Predicting Infectious ComplicatioNs in Children with Cancer (PICNICC) prospective multicentre cohort study, in children <18 years with FN between November 2016 and January 2018. Impact of aminoglycoside use in the first 12 hours of FN on composite unfavourable outcome of death, ICU admission, relapse of infection or late-onset sepsis was assessed using multivariable Cox regression. The study was conducted in Australia where antimicrobial resistance among gram negative organisms is relatively low. Data from 858 episodes of FN in 462 children from 8 centres were assessed, median age 5.8 years (IQR 3.5-10.8 years). Early empiric aminoglycosides were prescribed in 255 episodes (29.7%). Guideline non-compliance was common: in 46% (184/400) of eligible episodes, patients did not receive aminoglycosides, while aminoglycosides were prescribed in 9% (39/458) of guideline-ineligible episodes. Adjusted hazard of the composite unfavourable outcome was 3.81 times higher among patients prescribed empiric aminoglycosides than among those who weren't (95% confidence interval, 1.89-7.67), with no increased risk of unfavourable outcome in eligible patients who did not receive aminoglycosides. In a large paediatric FN cohort, aminoglycoside prescription was common and was often non-compliant with guidelines. There was no evidence for improved outcome with aminoglycosides, even in those who met guideline criteria, within a low-resistance setting. Empiric aminoglycoside prescription for children with FN requires urgent review in guidelines and in national practice.	[McMullan, Brendan J.; Haeusler, Gabrielle M.; Thursky, Karin] Univ Melbourne, NHMRC Natl Ctr Infect Canc, Melbourne, Vic, Australia; [McMullan, Brendan J.] Sydney Childrens Hosp, Dept Immunol & Infect Dis, Sydney, NSW, Australia; [McMullan, Brendan J.] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Haeusler, Gabrielle M.] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia; [Haeusler, Gabrielle M.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia; [Haeusler, Gabrielle M.] Paediat Integrated Canc Serv, Parkville, Vic, Australia; [Haeusler, Gabrielle M.] Royal Childrens Hosp, Dept Gen Med, Infect Dis Unit, Parkville, Vic, Australia; [Haeusler, Gabrielle M.] Murdoch Childrens Res Inst, Infect & Immun Theme, Parkville, Vic, Australia; [Hall, Lisa] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Cooley, Louise] Univ Tasmania, Dept Microbiol & Infect Dis, Dept Med, Hobart, Tas, Australia; [Stewardson, Andrew J.] Monash Univ, Alfred & Cent Clin Sch, Dept Infect Dis, Melbourne, Vic, Australia; [Blyth, Christopher C.] Univ Western Australia, Sch Med, Perth, WA, Australia; [Blyth, Christopher C.] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Perth, WA, Australia; [Blyth, Christopher C.] Perth Childrens Hosp, Dept Paediat Infect Dis, Perth, WA, Australia; [Blyth, Christopher C.] QEII Med Ctr, Dept Microbiol, PathWest Lab Med, Perth, WA, Australia; [Jones, Cheryl A.] Univ Sydney, Fac Med & Hlth, Sydney Med Sch, Sydney, NSW, Australia; [Jones, Cheryl A.] Sydney Childrens Hosp Network Childrens Westmead, Westmead, NSW, Australia; [Jones, Cheryl A.; Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Jones, Cheryl A.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Konecny, Pamela] St George Hosp, Dept Infect Dis Immunol & Sexual Hlth, Sydney, NSW, Australia; [Konecny, Pamela] Univ New South Wales, St George & Sutherland Clin Sch, Sydney, NSW, Australia; [Babl, Franz E.] Murdoch Childrens Res Inst, Dept Clin Sci, Parkville, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Parkville, Vic, Australia; [Babl, Franz E.] Paediat Res Emergency Dept Int Collaborat PREDICT, Parkville, Vic, Australia; [Mechinaud, Francoise] Royal Childrens Hosp, Parkville, Vic, Australia; [Mechinaud, Francoise] Nord Univ Paris, Hop Robert Debre, AP HP, Paris, France; [Thursky, Karin] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Thursky, Karin] Peter Doherty Inst Infect & Immun, NHMRC Natl Ctr Antimicrobial Stewardship, Melbourne, Vic, Australia	University of Melbourne; University of Sydney; University of New South Wales Sydney; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Queensland; University of Tasmania; Monash University; University of Western Australia; Telethon Kids Institute; Wesfarmers Limited; University of Sydney; University of Melbourne; Murdoch Children's Research Institute; St George Hospital; University of New South Wales Sydney; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Melbourne	McMullan, BJ (corresponding author), Univ Melbourne, NHMRC Natl Ctr Infect Canc, Melbourne, Vic, Australia.; McMullan, BJ (corresponding author), Sydney Childrens Hosp, Dept Immunol & Infect Dis, Sydney, NSW, Australia.; McMullan, BJ (corresponding author), Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.	brendanoch@yahoo.co.uk	Blyth, Christopher/ABG-8231-2020; Cooley, Louise/ABE-9706-2020; thursky, karin/AAV-4524-2021; Stewardson, Andrew/ABC-5208-2020	Blyth, Christopher/0000-0003-2017-0683; Stewardson, Andrew/0000-0001-6805-1224; thursky, karin/0000-0002-7400-232X	National Health and Medical Research Council [APP1104527]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council (APP1104527) to Professor Karin Thursky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann RA, 2010, J CLIN ONCOL, V28, P2008, DOI 10.1200/JCO.2009.25.8988; Australian Commission on Safety and Quality in Health Care (ACSQHC), 2019, 3 AUSTR REP ANT US R; Deelen JT, 2020, CLIN MICROBIOLOGY IN; EUCAST, 2020, GUID IMPL US 2020 RE; Freifeld AG, 2011, CLIN INFECT DIS, V52, P427, DOI 10.1093/cid/ciq147; Furno P, 2002, LANCET INFECT DIS, V2, P231, DOI 10.1016/S1473-3099(02)00241-4; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Haeusler GM, 2018, J PAEDIATR CHILD H, V54, P761, DOI 10.1111/jpc.13899; Haeusler GM, 2018, PEDIATR INFECT DIS J, V37, P329, DOI 10.1097/INF.0000000000001777; Haeusler GM, 2017, BRIT J CANCER, V117, P171, DOI 10.1038/bjc.2017.154; Haeusler GM, 2015, PEDIATR BLOOD CANCER, V62, P483, DOI 10.1002/pbc.25335; Haeusler GM, 2020, J PEDIAT INFECT DIS; Haeusler GMT K.A., 2019, ECLINICALMEDICINE; Hann I, 1997, BRIT J HAEMATOL, V99, P580, DOI 10.1046/j.1365-2141.1997.4453255.x; Innes H, 2005, BRIT J CANCER, V93, P1324, DOI 10.1038/sj.bjc.6602872; Lee NH, 2020, PEDIAT INFECT DIS J; Lehrnbecher T, 2017, J CLIN ONCOL, V35, P2082, DOI 10.1200/JCO.2016.71.7017; Mueller EL, 2015, PEDIATR HEMAT ONCOL, V32, P331, DOI 10.3109/08880018.2015.1036331; O'Horo JC, 2019, J ONCOL PRACT, V15, pE843, DOI 10.1200/JOP.18.00775; Paul M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003038.pub2; Rhee C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20498; Robinson PD, 2016, J CLIN ONCOL, V34, P2054, DOI 10.1200/JCO.2015.65.8591; Tam CS, 2011, INTERN MED J, V41, P90, DOI 10.1111/j.1445-5994.2010.02340.x; Tamma PD, 2013, JAMA PEDIATR, V167, P903, DOI 10.1001/jamapediatrics.2013.196	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238787	10.1371/journal.pone.0238787	http://dx.doi.org/10.1371/journal.pone.0238787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936822	Green Published, gold			2022-12-26	WOS:000573658000033
J	Lotsch, J; Ultsch, A				Loetsch, Joern; Ultsch, Alfred			A non-parametric effect-size measure capturing changes in central tendency and data distribution shape	PLOS ONE			English	Article								Motivation Calculating the magnitude of treatment effects or of differences between two groups is a common task in quantitative science. Standard effect size measures based on differences, such as the commonly used Cohen's, fail to capture the treatment-related effects on the data if the effects were not reflected by the central tendency. The present work aims at (i) developing a non-parametric alternative to Cohen's d, which (ii) circumvents some of its numerical limitations and (iii) involves obvious changes in the data that do not affect the group means and are therefore not captured by Cohen's d. Results We propose "Impact" as a novel non-parametric measure of effect size obtained as the sum of two separate components and includes (i) a difference-based effect size measure implemented as the change in the central tendency of the group-specific data normalized to pooled variability and (ii) a data distribution shape-based effect size measure implemented as the difference in probability density of the group-specific data. Results obtained on artificial and empirical data showed that "Impact"is superior to Cohen's d by its additional second component in detecting clearly visible effects not reflected in central tendencies. The proposed effect size measure is invariant to the scaling of the data, reflects changes in the central tendency in cases where differences in the shape of probability distributions between subgroups are negligible, but captures changes in probability distributions as effects and is numerically stable even if the variances of the data set or its subgroups disappear. Conclusions The proposed effect size measure shares the ability to observe such an effect with machine learning algorithms. Therefore, the proposed effect size measure is particularly well suited for data science and artificial intelligence-based knowledge discovery from big and heterogeneous data.	[Loetsch, Joern] Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany; [Loetsch, Joern] Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol IME TMP, Frankfurt, Germany; [Ultsch, Alfred] Univ Marburg, DataBion Res Grp, Marburg, Germany	Goethe University Frankfurt; Fraunhofer Gesellschaft; Philipps University Marburg	Lotsch, J (corresponding author), Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany.; Lotsch, J (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol, Project Grp Translat Med & Pharmacol IME TMP, Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	Landesoffensive zur Entwicklung wissenschaftlichokonomischer Exzellenz (LOEWE)	Landesoffensive zur Entwicklung wissenschaftlichokonomischer Exzellenz (LOEWE)	This work has been funded by the Landesoffensive zur Entwicklung wissenschaftlichokonomischer Exzellenz (LOEWE), LOEWE-Zentrum fur Translationale Medizin und Pharmakologie (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; [Anonymous], 2019, CATOOLS TOOLS MOVING; [Anonymous], 2018, R LANG ENV STAT COMP, DOI DOI 10.18637/JSS.V028.I05; Bengtsson H., 2021, MATRIXSTATS FUNCTION; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Burke D, 2019, EUR J PAIN, V23, P1264, DOI 10.1002/ejp.1402; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J., 1998, STAT POWER ANAL BEHA, V1998; Cohen J.E., 1988, STAT POWER ANAL BEHA; Doehring A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017724; Eckert A., 2018, PARALLELDIST PARALLE; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Good PI, 2006, RESAMPLING METHODS P, P5, DOI 10.1007/0-8176-4444-X_2; Hartung J, 2008, STAT METAANALYSIS AP, V2008; JARDINE N, 1971, INFORM STORAGE RET, V7, P217, DOI 10.1016/0020-0271(71)90051-9; John J. A., 1980, Applied Statistics, V29, P190, DOI 10.2307/2986305; Gomez-Torres MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210605; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kuhn Max, 2020, CRAN; Maher JM, 2013, CBE-LIFE SCI EDUC, V12, P345, DOI 10.1187/cbe.13-04-0082; Meyerson A, 2004, MACH LEARN, V56, P61, DOI 10.1023/B:MACH.0000033115.78247.f0; Minuzzo S, 2005, BRIT J HAEMATOL, V130, P878, DOI 10.1111/j.1365-2141.2005.05699.x; Morgan AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197102; Pampalk E, 2002, LECT NOTES COMPUT SC, V2415, P871; Pearson K, 1900, PHILOS MAG, V50, P157, DOI 10.1080/14786440009463897; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Revelle William, 2020, CRAN; Rosenthal JA, 1996, J SOC SERV RES, V21, P37, DOI 10.1300/J079v21n04_02; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; Tatti N, 2007, J MACH LEARN RES, V8, P131; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Ultsch A, 2005, ST CLASS DAT ANAL, P91, DOI 10.1007/3-540-26981-9_12; Ultsch A, 2015, INT J MOL SCI, V16, P25897, DOI 10.3390/ijms161025897; Ultsch A, 2010, STUD CLASS DATA ANAL, P505, DOI 10.1007/978-3-642-01044-6_46; Verjans-Janssen SRB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204560; Weston Steve, 2019, DOPARALLEL FOREACH P; Yu JH, 2013, CHIN J CANCER, V32, P213, DOI 10.5732/cjc.012.10041	42	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239623	10.1371/journal.pone.0239623	http://dx.doi.org/10.1371/journal.pone.0239623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970758	Green Published, gold			2022-12-26	WOS:000576265600080
J	Moore, J; Shu, XH; Lopes, BT; Wu, R; Abass, A				Moore, Joshua; Shu, Xuhan; Lopes, Bernardo T.; Wu, Richard; Abass, Ahmed			Limbus misrepresentation in parametric eye models	PLOS ONE			English	Article							POSTERIOR CORNEAL SURFACE; STRESS-FREE CONFIGURATION; IN-SITU KERATOMILEUSIS; SPHERICAL-ABERRATION; PHOTOREFRACTIVE KERATECTOMY; BIOMECHANICAL PROPERTIES; MEAN SHAPE; ASPHERICITY; ANTERIOR; ASTIGMATISM	Purpose To assess the axial, radial and tangential limbus position misrepresentation when parametric models are used to represent the cornea and the sclera. Methods This retrospective study included 135 subjects aged 22 to 65 years (36.5 mean +/- 9.8 STD), 71 females and 64 males. Topography measurements were taken using an Eye Surface Profiler topographer and processed by a custom-built MATLAB code. Eye surfaces were freed from edge-effect artefacts and fitted to spherical, conic and biconic models. Results When comparing the radial position of the limbus, average errors of -0.83 +/- 0.19mm, -0.76 +/- 0.20mm and -0.69 +/- 0.20mm were observed within the right eye population for the spherical, conic and biconic models fitted up to 5mm. For the same fitting radius, the average fitting errors were -0.86 +/- 0.23mm, -0.78 +/- 0.23mm and -0.73 +/- 0.23mm for the spherical, conic and biconic models respectively within the left eye population. For the whole cornea fit, the average errors were -0.27 +/- 0.12mm and -0.28 +/- 0.13mm for the spherical models, -0.02 +/- 0.29mm and -0.05 +/- 0.27mm for the conic models, and -0.22 +/- 0.16mm and 0.24 +/- 0.17mm for the biconic models in the right and left eye populations respectively. Conclusions Through the use of spherical, conic and biconic parametric modelling methods, the eye's limbus is being mislocated. Additionally, it is evident that the magnitude of fitting error associated with the sclera may be propagating through the other components of the eye. This suggests that a corneal nonparametric model may be necessary to improve the representation of the limbus.	[Moore, Joshua] Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England; [Moore, Joshua; Lopes, Bernardo T.; Abass, Ahmed] Univ Liverpool, Sch Engn, Liverpool, Merseyside, England; [Shu, Xuhan] Univ Guelph, Coll Phys Sci, Guelph, ON, Canada; [Lopes, Bernardo T.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Wu, Richard] Cent Taiwan Univ Sci & Technol, Dept Optometry, Taichung, Taiwan; [Wu, Richard] Pacific Univ, Coll Optometry, Forest Grove, OR USA	University of Liverpool; University of Liverpool; University of Guelph; Universidade Federal de Sao Paulo (UNIFESP); Central Taiwan University Science & Technology	Abass, A (corresponding author), Univ Liverpool, Sch Engn, Liverpool, Merseyside, England.	A.Abass@liverpool.ac.uk	Abass, Ahmed/S-3107-2019	Abass, Ahmed/0000-0002-8622-4632; Moore, Jessica/0000-0003-2233-2527				Abass A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219789; Abass A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207710; Abass A, 2018, CURR EYE RES, V43, P1404, DOI 10.1080/02713683.2018.1500609; Al-Ageel S, 2009, SAUDI J OPHTHALMOL, V23, P181, DOI 10.1016/j.sjopt.2009.10.002; [Anonymous], 2004, BIOINFORMATICS, V20, pi248; Aramberri J, 2012, J CATARACT REFR SURG, V38, P1934, DOI 10.1016/j.jcrs.2012.06.049; Arvo J., 1992, GRAPHICS GEMS, P117; Bao FJ, 2018, J MECH BEHAV BIOMED, V83, P126, DOI 10.1016/j.jmbbm.2018.04.016; Bao FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073412; Bjrck A., 1996, NUMERICAL METHODS LE; Bottos KM, 2011, J CATARACT REFR SURG, V37, P1109, DOI 10.1016/j.jcrs.2010.12.058; Bower A.F., 2009, APPL MECH SOLIDS; Budak K, 1999, J CATARACT REFR SURG, V25, P814, DOI 10.1016/S0886-3350(99)00036-X; BUREK H, 1993, OPHTHAL PHYSL OPT, V13, P68, DOI 10.1111/j.1475-1313.1993.tb00428.x; Businaro E, 2016, MED ENG PHYS, V38, P339, DOI 10.1016/j.medengphy.2016.01.012; Chen KJ, 2019, J CATARACT REFR SURG, V45, P1316, DOI 10.1016/j.jcrs.2019.04.004; Consejo A, 2018, OPHTHAL PHYSL OPT, V38, P609, DOI 10.1111/opo.12587; Consejo A, 2017, J CATARACT REFR SURG, V43, P667, DOI 10.1016/j.jcrs.2017.02.027; Davis WR, 2005, INVEST OPHTH VIS SCI, V46, P1899, DOI 10.1167/iovs.04-0558; Douthwaite WA, 1999, OPHTHAL PHYSL OPT, V19, P467, DOI 10.1046/j.1475-1313.1999.00462.x; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Dubbelman M, 2002, ACTA OPHTHALMOL SCAN, V80, P379, DOI 10.1034/j.1600-0420.2002.800406.x; Elsheikh A, 2013, MED ENG PHYS, V35, P211, DOI 10.1016/j.medengphy.2012.09.006; Elsheikh A, 2010, J R SOC INTERFACE, V7, P1475, DOI 10.1098/rsif.2010.0108; Elsheikh A, 2010, EXP EYE RES, V90, P624, DOI 10.1016/j.exer.2010.02.010; EM Arvacheh, 2006, 2006 INT C IM PROC 8; Fares U, 2012, CONTACT LENS ANTERIO, V35, P39, DOI 10.1016/j.clae.2011.07.004; Gatinel D, 2011, CORNEA, V30, P508, DOI 10.1097/ICO.0b013e3181fb4fa7; Geraghty B, 2020, J BIOMECH, V98, DOI 10.1016/j.jbiomech.2019.109438; Geraghty B, 2012, J MECH BEHAV BIOMED, V16, P181, DOI 10.1016/j.jmbbm.2012.10.011; Gonzalez-Meijome JM, 2007, J CATARACT REFR SURG, V33, P465, DOI 10.1016/j.jcrs.2006.11.004; GUILLON M, 1986, OPHTHAL PHYSL OPT, V6, P47, DOI 10.1111/j.1475-1313.1986.tb00699.x; Harthan JS, 2018, CLIN OPTOM, V10, P65, DOI 10.2147/OPTO.S144357; Hersh PS, 2003, J CATARACT REFR SURG, V29, P2096, DOI 10.1016/j.jcrs.2003.09.008; Hoffmann PC, 2014, CURR EYE RES, V39, P1178, DOI 10.3109/02713683.2014.898376; Holladay JT, 1999, J CATARACT REFR SURG, V25, P663, DOI 10.1016/S0886-3350(99)00011-5; Holmes-Higgin DK, 1999, CHARACTERIZATION ASP, P520; Iskander DR, 2016, OPHTHAL PHYSL OPT, V36, P266, DOI 10.1111/opo.12292; Jesus DA, 2014, 7 EUR WORLD M VIS PH; Jimenez JR, 2003, AM J OPHTHALMOL, V135, P279, DOI 10.1016/S0002-9394(02)01968-2; Jogi R., 2008, BASIC OPHTHALMOLOGY, DOI [10.1016/j.ophtha.2008.07.018, DOI 10.1016/J.OPHTHA.2008.07.018]; KIELY PM, 1982, OPT ACTA, V29, P1027, DOI 10.1080/713820960; Koch DD, 2013, J CATARACT REFR SURG, V39, P1803, DOI 10.1016/j.jcrs.2013.06.027; Lam AKC, 1997, OPHTHAL PHYSL OPT, V17, P348, DOI 10.1111/j.1475-1313.1997.tb00066.x; Langenbucher A, 2002, CONOIDAL FITTING COR, P63; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Llorente L, 2004, J VISION, V4, P288, DOI 10.1167/4.4.5; LOTMAR W, 1974, J OPT SOC AM, V64, P510, DOI 10.1364/JOSA.64.000510; MAHROO OAR, 2014, INVEST OPHTH VIS SCI, V55; Mainstone Julia C, 1998, Clin Exp Optom, V81, P131; Manns F, 2004, EXP EYE RES, V78, P39, DOI 10.1016/j.exer.2003.09.025; Marcus David, 2013, WASH U L REV, V90, P587; Mashige KP, 2013, AFR VIS EYE HEALTH J, V72, P11; Mastropasqua L, 2006, J CATARACT REFR SURG, V32, P109, DOI 10.1016/j.jcrs.2005.11.026; Maurice DM, 1962, VEGETATIVE PHYSL BIO, P289, DOI DOI 10.1016/B978-1-4832-3090-0.50013-7; McKendrick AM, 1996, J OPT SOC AM A, V13, P206, DOI 10.1364/JOSAA.13.000206; Meek K. M., 2008, P359, DOI 10.1007/978-0-387-73906-9_13; Mejia-Barbosa Y, 2001, OPTOMETRY VISION SCI, V78, P240, DOI 10.1097/00006324-200104000-00013; MILLODOT M, 1979, VISION RES, V19, P685, DOI 10.1016/0042-6989(79)90244-X; MLA Lourakis, 2005, 10 IEEE INT C COMP V, V1; Mutti DO, 2004, OPTOMETRY VISION SCI, V81, P753, DOI 10.1097/00006324-200410000-00007; Nadarasa J, 2018, BIOMECH MODEL MECHAN, V17, P517, DOI 10.1007/s10237-017-0975-6; Navarro R, 2006, J OPT SOC AM A, V23, P219, DOI 10.1364/JOSAA.23.000219; Navarro R, 2009, J OPTOM, V2, P3, DOI DOI 10.3921/JOPTOM.2009.3; Nieto-Bona A, 2009, GRAEF ARCH CLIN EXP, V247, P815, DOI 10.1007/s00417-008-1013-2; OGDEN RW, 1972, PROC R SOC LON SER-A, V326, P565, DOI 10.1098/rspa.1972.0026; Ortiz S, 2012, BIOMED OPT EXPRESS, V3, P2471, DOI 10.1364/BOE.3.002471; Patel DV, 2006, INVEST OPHTH VIS SCI, V47, P2823, DOI 10.1167/iovs.05-1492; Pijanka JK, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15047; Pinero DP, 2010, J CATARACT REFR SURG, V36, P814, DOI 10.1016/j.jcrs.2009.11.012; Preussner PR, 2015, CURR EYE RES, V40, P809, DOI 10.3109/02713683.2014.959708; Priest AD, 2005, DEV AVERAGE ANATOMIC; Shih PJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14293-0; Smit G., 1970, EYE VISUAL OPTICAL I; Smith D.A.G., 2000, OPTICS HUMAN EYE; Surhone LM, 2010, MISES YIELD CRITERIO; Tan B, 2014, OPTOMETRY VISION SCI, V91, P650, DOI 10.1097/OPX.0000000000000267; The Society Of Thoracic Surgeons Endovascular Surgery Task Force, 2008, ANN THORAC SURG, V85, pS1; Upton G., 2001, INTRO STAT; Vojnikovic B, 2013, COLLEGIUM ANTROPOL, V37, P41; Vroon J, 2018, BIOMECH MODEL MECHAN, V17, P975, DOI 10.1007/s10237-018-1006-y; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Ying JL, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.075005; Zhang ZW, 2011, OPTOMETRY VISION SCI, V88, P1232, DOI 10.1097/OPX.0b013e31822717ca	84	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0236096	10.1371/journal.pone.0236096	http://dx.doi.org/10.1371/journal.pone.0236096			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970690	gold, Green Published			2022-12-26	WOS:000576265600048
J	Nori, VS; Hane, CA; Sun, YZ; Crown, WH; Bleicher, PA				Nori, Vijay S.; Hane, Christopher A.; Sun, Yezhou; Crown, William H.; Bleicher, Paul A.			Deep neural network models for identifying incident dementia using claims and EHR datasets	PLOS ONE			English	Article							RISK SCORE; PREDICTION MODEL; VALIDATION; DISEASE	This study investigates the use of deep learning methods to improve the accuracy of a predictive model for dementia, and compares the performance to a traditional machine learning model. With sufficient accuracy the model can be deployed as a first round screening tool for clinical follow-up including neurological examination, neuropsychological testing, imaging and recruitment to clinical trials. Seven cohorts with two years of data, three to eight years prior to index date, and an incident cohort were created. Four trained models for each cohort, boosted trees, feed forward network, recurrent neural network and recurrent neural network with pre-trained weights, were constructed and their performance compared using validation and test data. The incident model had an AUC of 94.4% and F1 score of 54.1%. Eight years removed from index date the AUC and F1 scores were 80.7% and 25.6%, respectively. The results for the remaining cohorts were between these ranges. Deep learning models can result in significant improvement in performance but come at a cost in terms of run times and hardware requirements. The results of the model at index date indicate that this modeling can be effective at stratifying patients at risk of dementia. At this time, the inability to sustain this quality at longer lead times is more an issue of data availability and quality rather than one of algorithm choices.	[Nori, Vijay S.; Hane, Christopher A.; Sun, Yezhou; Crown, William H.; Bleicher, Paul A.] OptumLabs, Boston, MA 02108 USA	Optum	Nori, VS (corresponding author), OptumLabs, Boston, MA 02108 USA.	vijay.nori@optum.com			OptumLabs; Global CEO Initiative; Biogen; Janssen Pharmaceutical; Merck	OptumLabs; Global CEO Initiative; Biogen(Biogen); Janssen Pharmaceutical; Merck(Merck & Company)	The project was sponsored by OptumLabs, Global CEO Initiative, Biogen, Janssen Pharmaceutical, and Merck. A donation of computer hardware by Dell was graciously received, which allowed the project to fit large models efficiently. OptumLabs provided support in the form of salaries for authors [VSN, CAH, YS, WHC, PAB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alaa AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213653; Albrecht JS, 2018, J MANAG CARE SPEC PH, V24, P1138, DOI 10.18553/jmcp.2018.24.11.1138; [Anonymous], 2019, WORLD ALZH REP 2019; Bahdanau D, 2014, ARXIV14090473CSSTAT; Barnes DE, 2009, NEUROLOGY, V73, P173, DOI 10.1212/WNL.0b013e3181a81636; Barnes DE, 2014, ALZHEIMERS DEMENT, V10, P656, DOI 10.1016/j.jalz.2013.11.006; Ben Miled Z, 2020, ARTIF INTELL MED, V102, DOI 10.1016/j.artmed.2019.101771; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Byeon H, 2015, INT J ADV COMPUT SC, V6, P8; Chaudhari S, 2019, ARXIV190402874V1CSLG; Cho K., 2014, EMNLP 2014 2014 C EM, DOI DOI 10.3115/V1/D14-1179; Choi E, 2015, ARXIV151105942CS; Choi E, 2016, ARXIV160805745CS; Claesen M, 2015, ARXIV150202127CSSTAT; Exalto LG, 2014, ALZHEIMERS DEMENT, V10, P562, DOI 10.1016/j.jalz.2013.05.1772; Exalto LG, 2013, LANCET DIABETES ENDO, V1, P183, DOI 10.1016/S2213-8587(13)70048-2; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Kasper JD, 2015, HEALTH AFFAIR, V34, P1642, DOI 10.1377/hlthaff.2015.0536; Ke GL, 2017, ADV NEUR IN, V30; Kim WJ, 2019, JMIR MED INF, V7, DOI 10.2196/13139; Kingma DP., 2014, ADAM METHOD STOCHAST; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; McCoy RG, 2016, HEALTH SERV RES, V51, P1896, DOI 10.1111/1475-6773.12461; Nori VS, 2019, ALZH DEMENT-TRCI, V5, P918, DOI 10.1016/j.trci.2019.10.006; Nori VS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0203246; OptumLabs, 2019, OPTUMLABS OPTUMLABS; Paszke A, 2019, ADV NEUR IN, V32; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Reitz C, 2010, ARCH NEUROL-CHICAGO, V67, P835, DOI 10.1001/archneurol.2010.136; Segar MW, 2019, DIABETES CARE, V42, P2298, DOI 10.2337/dc19-0587; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Wallace PJ, 2014, HEALTH AFFAIR, V33, P1187, DOI 10.1377/hlthaff.2014.0038; Xiao J, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1860-0; Yang S, 2020, ARXIV200207526CSCL	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0236400	10.1371/journal.pone.0236400	http://dx.doi.org/10.1371/journal.pone.0236400			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970677	Green Published, gold			2022-12-26	WOS:000576265600104
J	Zhang, S; Yan, L; Kim, SM				Zhang, Shuang; Yan, Lei; Kim, Sang Moo			Vanadium-protein complex inhibits human adipocyte differentiation through the activation of beta-catenin and LKB1/AMPK signaling pathway	PLOS ONE			English	Article							3T3-L1; ADIPOGENESIS; DERIVATIVES; GLUCOSE; AMPK; TRANSLOCATION; KINASE	Obesity is a common disease over the world and is tightly associated with diabetes mellitus, cardiovascular and cancer disease. Although our previous study showed that the synthetic vanadium-protein (V-P) complex had a better effect on antioxidant and antidiabetic, the relative molecular mechanisms are still entirely unknown. Hence, we investigated the effect of the synthetic V-P complex on adipocyte differentiation (adipogenesis) using human preadipocytes to clarify its molecular mechanisms of action. The primary human preadipocytes were cultured with and without V-P complex during adipocyte differentiation. The cell proliferation, lipid accumulation, and the protein expression of transcription factors and related enzymes were determined for the differentiated human preadipocytes. In this study, the 20 mu g/mL of V-P complex reduced the lipid and triglyceride (TG) content by 74.47 and 57.39% (p < 0.05), respectively, and down-regulated the protein expressions of peroxisome proliferator-activated receptor-gamma (PPAR gamma), CCAAT/enhancer-binding protein alpha (C/EBP alpha), sterol regulatory element-binding protein 1 (SREBP-1) and fatty acid synthase (FAS). Additionally, the V-P complex significantly up-regulated the protein levels of total beta-catenin (t-beta-catenin), nuclear beta-catenin (n-beta-catenin), phosphorylated adenosine monophosphate-activated protein kinase alpha (p-AMPK alpha) and liver kinase B1 (p-LKB1). These showed that the inhibitory effect of V-P complex on human adipogenesis was mediated by activating Wnt/beta-catenin and LKB1/AMPK-dependent signaling pathway. Therefore, the synthetic V-P complex could be considered as a candidate for prevention and treatment of obesity.	[Zhang, Shuang; Yan, Lei] Heilongjiang Bayi Agr Univ, Coll Life Sci & Biotechnol, Heilongjiang Prov Key Lab Environm Microbiol & Re, Daqing, Heilongjiang, Peoples R China; [Zhang, Shuang; Kim, Sang Moo] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung, Gangwon Do, South Korea	Heilongjiang Bayi Agricultural University; Kangnung Wonju National University	Kim, SM (corresponding author), Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Kangnung, Gangwon Do, South Korea.	smkim@gwnu.ac.kr		Yan, Lei/0000-0003-2596-6840	Ministry of Oceans and Fisheries, Republic of Korea; Open Foundation of the Heilongjiang Provincial Key Laboratory of Environmental Microbiology and Recycling of Argo-Waste in Cold Region [201707]; Scientific Research Staring Foundation in HBAU [XZR2014-15]	Ministry of Oceans and Fisheries, Republic of Korea; Open Foundation of the Heilongjiang Provincial Key Laboratory of Environmental Microbiology and Recycling of Argo-Waste in Cold Region; Scientific Research Staring Foundation in HBAU	Haizhibao company supported travel expenses and incentives for consulting. Haizhibao company provided support in the form of consulting incentive for author S.M. Kim but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Additionally, this research was a part of the project (20170071) entitled "Future Marine Technology Development", funded by the Ministry of Oceans and Fisheries, Republic of Korea; Open Foundation of the Heilongjiang Provincial Key Laboratory of Environmental Microbiology and Recycling of Argo-Waste in Cold Region (201707), and Scientific Research Staring Foundation in HBAU (XZR2014-15). No additional external funding was received for this study.	Ahn JH, 2004, BIOORG MED CHEM LETT, V14, P4461, DOI 10.1016/j.bmcl.2004.06.046; Ahn JH, 2002, BIOORG MED CHEM LETT, V12, P1941, DOI 10.1016/S0960-894X(02)00331-1; Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; del Rio D, 2003, DALTON T, P1813, DOI 10.1039/b300914a; Du JJ, 2020, NANOSCALE, V12, P9219, DOI 10.1039/d0nr00810a; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Gunasinghe MA, 2018, J FOOD ENCE TECHNOLO; Gunasinghe MA, 2019, APPL BIOCHEM BIOTECH, V189, P49, DOI 10.1007/s12010-019-02982-7; Han G, 2010, ASS VITAMIN D DEFICI; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; He YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070135; HEYLIGER CE, 1985, SCIENCE, V227, P1474, DOI 10.1126/science.3156405; Hirota K, 2010, J AGR FOOD CHEM, V58, P5821, DOI 10.1021/jf903911e; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hu YS, 2010, FITOTERAPIA, V81, P259, DOI 10.1016/j.fitote.2009.09.012; Jeon T, 2004, LIFE SCI, V75, P3195, DOI 10.1016/j.lfs.2004.06.012; Kachur S, 2017, MINERVA MED, V108, P212, DOI 10.23736/S0026-4806.17.05022-4; Kim GS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-31; Kim KJ, 2010, LIFE SCI, V86, P791, DOI 10.1016/j.lfs.2010.03.010; Kim SH, 2008, BIOCHEM BIOPH RES CO, V372, P108, DOI 10.1016/j.bbrc.2008.04.188; Kong CS, 2009, FOOD CHEM TOXICOL, V47, P2401, DOI 10.1016/j.fct.2009.06.010; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737; Levina A, 2011, DALTON T, V40, P11675, DOI 10.1039/c1dt10380f; Liu HL, 2018, 2018 INTERNATIONAL CONFERENCE ON BIG DATA AND ARTIFICIAL INTELLIGENCE (BDAI 2018), P10, DOI 10.1109/BDAI.2018.8546662; Liu YJ, 2015, J FUNCT FOODS, V17, P504, DOI 10.1016/j.jff.2015.06.009; Lu LP, 2011, J INORG BIOCHEM, V105, P1323, DOI 10.1016/j.jinorgbio.2011.07.008; MEEKS MJ, 1971, J PHARM SCI, V60, P482, DOI 10.1002/jps.2600600336; Mitsuhashi K, 2016, ENDOCRINE, V51, P174, DOI 10.1007/s12020-015-0666-y; Nerurkar PV, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-34; Niu X, 2017, J INORG BIOCHEM; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Park YK, 2016, INT J MOL MED, V37, P157, DOI 10.3892/ijmm.2015.2415; Pillai SI, 2013, EUR J MED CHEM, V63, P109, DOI 10.1016/j.ejmech.2013.02.002; Pranczk J, 2015, EUR J INORG CHEM, P3343, DOI 10.1002/ejic.201500272; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sakurai H, 2005, EXPERT OPINION INVES, V12, P1189; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Srivastava AK, 2000, MOL CELL BIOCHEM, V206, P177, DOI 10.1023/A:1007075204494; Ueki T, 2003, BBA-GENE STRUCT EXPR, V1626, P43, DOI 10.1016/S0167-4781(03)00036-8; Wang N, 2015, J INORG BIOCHEM, V152, P104, DOI 10.1016/j.jinorgbio.2015.07.012; Zhang L, 2016, U CHINESE ACAD SCI; Zhang L, 2016, J INORG BIOCHEM, V162, P1, DOI 10.1016/j.jinorgbio.2016.06.013; Zhang SB, 2020, J AM OIL CHEM SOC, V97, P93, DOI 10.1002/aocs.12309	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239547	10.1371/journal.pone.0239547	http://dx.doi.org/10.1371/journal.pone.0239547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970728	Green Published, gold			2022-12-26	WOS:000576265600026
J	Berner-Rodoreda, A; Geldsetzer, P; Barnighausen, K; Hettema, A; Barnighausen, T; Matse, S; McMahon, SA				Berner-Rodoreda, Astrid; Geldsetzer, Pascal; Baernighausen, Kate; Hettema, Anita; Baernighausen, Till; Matse, Sindy; McMahon, Shannon A.			"It's hard for us men to go to the clinic. We naturally have a fear of hospitals." Men's risk perceptions, experiences and program preferences for PrEP: A mixed methods study in Eswatini	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS PREP; HIV PREVENTION; ANTIRETROVIRAL THERAPY; HETEROSEXUAL MEN; SEXUAL-BEHAVIOR; SOUTH-AFRICA; COMPENSATION; PARTICIPANTS; STRATEGIES; ADHERENCE	Few studies on HIV Pre-Exposure Prophylaxis (PrEP) have focused on men who have sex with women. We present findings from a mixed-methods study in Eswatini, the country with the highest HIV prevalence in the world (27%). Our findings are based on risk assessments, in-depth interviews and focus-group discussions which describe men's motivations for taking up or declining PrEP. Quantitatively, men self-reported starting PrEP because they had multiple or sero-discordant partners or did not know the partner's HIV-status. Men's self-perception of risk was echoed in the qualitative data, which revealed that the hope of facilitated sexual performance or relations, a preference for pills over condoms and the desire to protect themselves and others also played a role for men to initiate PrEP. Trust and mistrust and being able or unable to speak about PrEP with partner(s) were further considerations for initiating or declining PrEP. Once on PrEP, men's sexual behavior varied in terms of number of partners and condom use. Men viewed daily pill-taking as an obstacle to starting PrEP. Side-effects were a major reason for men to discontinue PrEP. Men also worried that taking anti-retroviral drugs daily might leave them mistaken for a person living with HIV, and viewed clinic-based PrEP education and initiation processes as a further obstacle. Given that men comprise only 29% of all PrEP users in Eswatini, barriers to men's uptake of PrEP will need to be addressed, in terms of more male-friendly services as well as trialing community-based PrEP education and service delivery.	[Berner-Rodoreda, Astrid; Geldsetzer, Pascal; Baernighausen, Kate; Baernighausen, Till; McMahon, Shannon A.] Ruprecht Karls Univ Heidelberg, Inst Global Hlth, Heidelberg, Germany; [Geldsetzer, Pascal] Stanford Univ, Dept Med, Div Primary Care & Populat Hlth, Stanford, CA 94305 USA; [Baernighausen, Kate] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Hettema, Anita] Clinton Hlth Access Initiat Swaziland, Mbabane, Eswatini; [Baernighausen, Till] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Matse, Sindy] Eswatini Minist Hlth, Mbabane, Eswatini; [McMahon, Shannon A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Hettema, Anita] Clinton Hlth Access Initiat, Corner Mbilibhi & Tsekwane St, Mbabane, Eswatini	Ruprecht Karls University Heidelberg; Stanford University; University of Witwatersrand; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Berner-Rodoreda, A (corresponding author), Ruprecht Karls Univ Heidelberg, Inst Global Hlth, Heidelberg, Germany.	astrid.berner-rodoreda@uni-heidelberg.de	Bärnighausen, Till/Y-2388-2019	Geldsetzer, Pascal/0000-0002-8878-5505; McMahon, Shannon/0000-0002-8634-9283; Berner-Rodoreda, Astrid/0000-0002-5484-890X	Bob L. Herd Foundation; Alexander von Humboldt Foundation; Alexander von Humboldt Professor Award - Federal Ministry of Education and Research; Olympia-Morata-Program; National Center for Advancing Translational Sciences of the National Institutes of Health	Bob L. Herd Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Alexander von Humboldt Professor Award - Federal Ministry of Education and Research; Olympia-Morata-Program; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was funded through the Bob L. Herd Foundation and the Alexander von Humboldt Foundation. Till Barnighausen was supported through the Alexander von Humboldt Professor Award, funded by the Federal Ministry of Education and Research. Shannon A. McMahon was supported by the Olympia-Morata-Program and Pascal Geldsetzer was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health. We would also like to acknowledge Mylan Pharmaceuticals for donating TDF/3TC to the Eswatini PrEP demonstration project. The funders had no role in the preparation of this manuscript. The content is the sole responsibility of the authors and does not necessarily represent the views of any funder.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Atujuna M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191251; Barnighausen K, 2020, AIDS CARE, V32, P267, DOI 10.1080/09540121.2019.1653437; Barnighausen KE, 2019, AIDS, V33, pS45, DOI [10.1097/QAD.0000000000002178, 10.1097/qad.0000000000002178]; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002099; Baker P, 2016, TREND UROL MENS HEAL, V7, P11, DOI 10.1002/tre.519; Berner-Rodoreda A, 2018, INTEREST C KIG RWAND; Bor J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002463; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bowleg L, 2011, CULT HEALTH SEX, V13, P545, DOI 10.1080/13691058.2011.556201; Buetikofer S, 2014, Swiss Med Wkly, V144, pw13961, DOI 10.4414/smw.2014.13961; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Charmaz K, 2017, QUAL INQ, V23, P34, DOI 10.1177/1077800416657105; Cheng CY, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7276-1; Cornell M, 2015, TROP MED INT HEALTH, V20, P1634, DOI 10.1111/tmi.12593; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; Courtenay W. H., 2000, SOCIAL SCI, P17; Creswell J. W., 2013, QUALITATIVE INQUIRY; Creswell J.W., 2003, RES DESIGN QUALQUAN, DOI DOI 10.2307/1523157; Dovel K, 2015, AIDS, V29, P1123, DOI 10.1097/QAD.0000000000000655; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Eaton LA, 2017, AIDS BEHAV, V21, P1236, DOI 10.1007/s10461-017-1690-0; Eaton LA, 2015, AIDS PATIENT CARE ST, V29, P423, DOI 10.1089/apc.2014.0303; Falcao JRSP, 2016, SEX HEALTH, V13, P345, DOI 10.1071/SH15143; Feldacker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050871; Fitch L, 2018, AIDS RES HUM RETROV, V34, P22; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Gafos M, 2019, AIDS BEHAV, V23, P1708, DOI 10.1007/s10461-018-2300-5; Glanz K., 2005, PUBLIC HLTH SERVICE; Golub SA, 2018, CURR HIV-AIDS REP, V15, P190, DOI 10.1007/s11904-018-0385-0; Govender E, 2018, AIDS CARE, V30, P1311, DOI 10.1080/09540121.2018.1488027; Grov C, 2015, AIDS BEHAV, V19, P2234, DOI 10.1007/s10461-015-1030-1; Guest G, 2008, SEX TRANSM DIS, V35, P1002, DOI 10.1097/OLQ.0b013e3181812939; Haberer JE, 2015, AIDS, V29, P1277, DOI 10.1097/QAD.0000000000000647; Hannaford A, 2020, GLOB PUBLIC HEALTH, V15, P1337, DOI 10.1080/17441692.2020.1744680; Hensen B, 2014, AIDS, V28, P2133, DOI 10.1097/QAD.0000000000000395; Higgins JA, 2010, AM J PUBLIC HEALTH, V100, P435, DOI 10.2105/AJPH.2009.159723; Hojilla JC, 2018, AIDS BEHAV, V22, P1096, DOI 10.1007/s10461-017-2009-x; Hojilla JC, 2016, AIDS BEHAV, V20, P1461, DOI 10.1007/s10461-015-1055-5; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johnson L. F., 2015, RATES HIV TESTING DI; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Koechlin FM, 2017, AIDS BEHAV, V21, P1325, DOI 10.1007/s10461-016-1627-z; Kumar SGP, 2013, INDIAN J MED RES, V137, P1061; Liu AY, 2013, JAIDS-J ACQ IMM DEF, V64, P87, DOI 10.1097/QAI.0b013e31828f097a; Mabire X, 2019, AM J MENS HEALTH, V13, DOI 10.1177/1557988319827396; Marcus JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081997; McMahon SA, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000837; Molina JM, 2017, LANCET HIV, V4, pE402, DOI 10.1016/S2352-3018(17)30089-9; NERCHA, 2017, EXT NAT MULT HIV AID; Nyanzi S, 2009, MEN MASC, V12, P73, DOI 10.1177/1097184X07309503; O'Connell S, 2017, INT J STD AIDS, V28, P814, DOI 10.1177/0956462416674093; O'Malley G, 2019, CURR HIV-AIDS REP, V16, P141, DOI 10.1007/s11904-019-00437-6; Parsons JT, 2017, JAIDS-J ACQ IMM DEF, V74, P285, DOI 10.1097/QAI.0000000000001251; Pelto PJ, 1997, MED ANTHROPOL Q, V11, P147, DOI 10.1525/maq.1997.11.2.147; Reniers G, 2017, LANCET HIV, V4, pE113, DOI 10.1016/S2352-3018(16)30225-9; Seymour-Smith S, 2002, J HEALTH PSYCHOL, V7, P253, DOI 10.1177/1359105302007003220; Siedner MJ, 2018, AIDS, V32, P1541, DOI [10.1097/QAD.0000000000001859, 10.1097/qad.0000000000001859]; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Smith J. A., 2006, MJA, V184, P3; Sorrell JBJ, 2005, CULT HEALTH SEX, V7, P585, DOI [10.1080/136910500250198, 10.1080/13691050500250198]; Spinner CD, 2016, INFECTION, V44, P151, DOI 10.1007/s15010-015-0850-2; Swaziland National Aids Programme (SNAP), 2016, PREEXP PROPH PREP PR; Tabatabai J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24795; Toledo Lauren, 2015, World J AIDS, V5, P10; Tolley EE, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25408; Traeger MW, 2018, CLIN INFECT DIS, V67, P676, DOI 10.1093/cid/ciy182; UNAIDS, 2017, BLIND SPOT REACH MEN; Varga C A, 2001, Afr J Reprod Health, V5, P175, DOI 10.2307/3583334; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; World Health Organization, 2012, GUID PREEX OR PROPH; Young I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005717; 2010, SLUZBENI GLASNIK RS, V5, P1	75	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0237427	10.1371/journal.pone.0237427	http://dx.doi.org/10.1371/journal.pone.0237427			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966307	Green Published, gold			2022-12-26	WOS:000575688700005
J	Lightfoot, KL; Telfair, J; Burford, JH; England, GCW; Bowen, IM; Freeman, SL				Lightfoot, Katie L.; Telfair, Joseph; Burford, John H.; England, Gary C. W.; Bowen, I. Mark; Freeman, Sarah L.			Mixed methods investigation of the use of telephone triage within UK veterinary practices for horses with abdominal pain: A Participatory action research study	PLOS ONE			English	Article							RESPONSE RATES; HEALTH-CARE; DOGS; PREVENTION; DECISION; PATIENT; SYSTEM; RISK	Background Telephone triage is an integral part of modern patient care systems in human medicine, and a key component of veterinary practice care systems. There is currently no published research on telephone triage within the veterinary profession. Objective To investigate current approaches to telephone triage of horses with abdominal pain (colic) in veterinary practice and develop new resources to support decision-making. Study design Participatory action research using mixed-methods approach. Methods An online survey assessed current approaches to telephone triage of horses with colic in UK veterinary practices. Structured group and individual interviews were conducted with four equine client care (reception) teams on their experiences around telephone triage of colic. Evidence-based resources, including an information pack, decision flow chart and recording form, were developed and implemented within the practices. Participant feedback was obtained through interviews six months after implementation of the resources. Results There were 116 participants in the online survey. Management and client care staff (53/116) felt less confident giving owner advice (p<0.01) and recognising critical indicators (p = 0.03) compared to veterinary surgeons and nurses (63/116). Thirteen themes were identified in the survey relating to owner advice; exercise and owner safety were most frequently mentioned, but conflicting guidance was often given. Fourteen client care staff were interviewed. They were confident recognising colic during a telephone conversation with an owner and identified the most common signs of critical cases as sweating and recumbency. The new resources received positive feedback; the decision flow chart and information on critical indicators were identified as most useful. After resource implementation, there was an increase in confidence in recognising critical cases and giving owners advice. Main limitations Limited sample population. Conclusions This study described existing approaches to telephone triage, identified variations in advice given, and worked with client care teams to develop new resources to aid decision-making.	[Lightfoot, Katie L.; Telfair, Joseph; Burford, John H.; England, Gary C. W.; Bowen, I. Mark; Freeman, Sarah L.] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England	University of Nottingham	Lightfoot, KL (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England.	svxkl@exmail.nottingham.ac.uk	Freeman, Sarah/H-1228-2011	Freeman, Sarah/0000-0002-3119-2207; Burford, John/0000-0003-0505-1520; England, Gary/0000-0001-5800-3106	World Horse Welfare; School of Veterinary Medicine and Science	World Horse Welfare; School of Veterinary Medicine and Science	KL, JHB, GCWE, IMB and SLF received joint funding for 50% of KL PhD studentship from World Horse Welfare (www.worldhorsewelfare.org) and the School of Veterinary Medicine and Science (www.nottingham.ac.uk/vet).The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abutarbush SM, 2005, CAN VET J, V46, P800; Aitken C, 2008, AUST NZ J PUBL HEAL, V32, P288, DOI 10.1111/j.1753-6405.2008.00232.x; [Anonymous], 2013, Cancer Discov, V3, pOF14, DOI 10.1158/2159-8290.CD-NB2013-074; [Anonymous], 2017, EQUINE VET J S51, DOI DOI 10.1111/EVJ.12640; [Anonymous], 2017, CASE W RESERVE JIL, V49, P14; Barber JW, 2000, PEDIATRICS, V105, P819, DOI 10.1542/peds.105.4.819; Belshaw Z, 2018, VET REC, V183, P1, DOI 10.1136/vr.104773; Bowden A, 2020, EQUINE VET J, V52, P262, DOI 10.1111/evj.13173; Bowling A., 2014, RES METHODS HLTH INV, Vfourth; Braun V., 2022, THEMATIC ANAL PRACTI; BUNN F., 2004, COCHRANE DATABASE SY; Campbell JL, 2014, LANCET, V384, P1859, DOI 10.1016/S0140-6736(14)61058-8; Cary JA, 2010, J VET MED EDUC, V37, P130, DOI 10.3138/jvme.37.2.130; Christensen MB, 1998, BMJ-BRIT MED J, V316, P1502, DOI 10.1136/bmj.316.7143.1502; Cook VL, 2014, VET CLIN N AM-EQUINE, V30, P383, DOI 10.1016/j.cveq.2014.04.001; Crouch S, 2011, AUST NZ J PUBL HEAL, V35, P187, DOI 10.1111/j.1753-6405.2011.00687.x; Curtis L, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0160-9; Donnelly E, 2016, IN PRACTICE, V38, P6, DOI 10.1136/inp.i5803; EVANS R., 2003, FUTURE PRIMARY CARE; FREY JH, 1991, SOC SCI J, V28, P175, DOI 10.1016/0362-3319(91)90003-M; Fultz LE, 2013, JAVMA-J AM VET MED A, V242, P1146, DOI 10.2460/javma.242.8.1146; Gawande Atul, 2010, CHECKLIST MANIFESTO; Hammersley M., 2008, QUESTIONING QUALITAT; Harding KE, 2011, AUST HEALTH REV, V35, P371, DOI 10.1071/AH10927; Hardy J, 2000, Equine Vet J Suppl, P95; Hillyer MH, 2002, EQUINE VET J, V34, P455, DOI 10.2746/042516402776117746; Ireland JL, 2013, RES VET SCI, V95, P418, DOI 10.1016/j.rvsc.2013.05.007; Ireland JL, 2012, EQUINE VET J, V44, P94, DOI 10.1111/j.2042-3306.2011.00394.x; JOHNSON R. B., 2004, EDUC RESEARCHER, V33, P14, DOI 10.3102/0013189X033007014; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Kinnison T, 2015, VET REC, V177, DOI 10.1136/vr.103312; LAMBERT A., 2012, CUSTOMER EXPERIENCE; Leblond A, 2000, VET RES COMMUN, V24, P85, DOI 10.1023/A:1006408522233; Leece P, 2004, J MED INTERNET RES, V6, P26, DOI 10.2196/jmir.6.3.e30; Leibowitz R, 2003, FAM PRACT, V20, P311, DOI 10.1093/fampra/cmg313; Lisciandro GR, 2016, J VET EMERG CRIT CAR, V26, P125, DOI 10.1111/vec.12374; MACKWAY-JONES K., 2014, EMERGENCY TRIAGE; MATHEWS K.A, 2006, VET EMERGENCY CRITIC; Murray Michael, 2004, CJEM, V6, P421; National Research Council, 2013, NONRESPONSE SOCIAL S; Olsen LE, 2014, JAVMA-J AM VET MED A, V245, P923, DOI 10.2460/javma.245.8.923; Parkinson A, 2015, AUST J PRIM HEALTH, V21, P254, DOI 10.1071/PY13129; Pope C, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014815; Pope C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-111; Proudman CJ, 2002, EQUINE VET J, V34, P432, DOI 10.2746/042516402776117845; Rahm E., 2000, IEEE DATA ENG B, V23, P3; Ravetz G., 2017, VET BUS J, V170, P16; Reeves MJ, 1997, EQUINE VET J, V29, P413, DOI 10.1111/j.2042-3306.1997.tb03150.x; Rockar R. A., 1994, Journal of Veterinary Emergency & Critical Care, V4, P77, DOI 10.1111/j.1476-4431.1994.tb00118.x; Roshier AL, 2013, VET REC, V172, DOI 10.1136/vr.101124; ROYAL COLLEGE OF VETERINARY SURGEONS, 2019, PRACT STAND SCHEM EQ; Ruys LJ, 2012, J VET EMERG CRIT CAR, V22, P303, DOI 10.1111/j.1476-4431.2012.00736.x; Salem SE, 2016, EQUINE VET J, V48, P143, DOI 10.1111/evj.12517; Scantlebury CE, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-S1-S1; SCHMITT, 2019, TELEPHONE TRIAGE PRO; Southwood LL, 2013, PRACTICAL GUIDE TO EQUINE COLIC, P1; Tinker MK, 1997, EQUINE VET J, V29, P448, DOI 10.1111/j.2042-3306.1997.tb03157.x; Traub-Dargatz JL, 2001, J AM VET MED ASSOC, V219, P67, DOI 10.2460/javma.2001.219.67; Turnbull J, 2017, HEALTH RISK SOC, V19, P189, DOI 10.1080/13698575.2017.1324946; VanGeest JB, 2007, EVAL HEALTH PROF, V30, P303, DOI 10.1177/0163278707307899; WILLIAMS J. M., 2017, VET REC; YEOMAN S., 2017, EQUINE VET ED, V29, P33	62	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238874	10.1371/journal.pone.0238874	http://dx.doi.org/10.1371/journal.pone.0238874			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966300	gold, Green Published			2022-12-26	WOS:000575688700010
J	Goodman-Meza, D; Rudas, A; Chiang, JN; Adamson, PC; Ebinger, J; Sun, N; Botting, P; Fulcher, JA; Saab, FG; Brook, R; Eskin, E; An, U; Kordi, M; Jew, B; Balliu, B; Chen, ZY; Hill, BL; Rahmani, E; Halperin, E; Manuel, V				Goodman-Meza, David; Rudas, Akos; Chiang, Jeffrey N.; Adamson, Paul C.; Ebinger, Joseph; Sun, Nancy; Botting, Patrick; Fulcher, Jennifer A.; Saab, Faysal G.; Brook, Rachel; Eskin, Eleazar; An, Ulzee; Kordi, Misagh; Jew, Brandon; Balliu, Brunilda; Chen, Zeyuan; Hill, Brian L.; Rahmani, Elior; Halperin, Eran; Manuel, Vladimir			A machine learning algorithm to increase COVID-19 inpatient diagnostic capacity	PLOS ONE			English	Article								Worldwide, testing capacity for SARS-CoV-2 is limited and bottlenecks in the scale up of polymerase chain reaction (PCR-based testing exist. Our aim was to develop and evaluate a machine learning algorithm to diagnose COVID-19 in the inpatient setting. The algorithm was based on basic demographic and laboratory features to serve as a screening tool at hospitals where testing is scarce or unavailable. We used retrospectively collected data from the UCLA Health System in Los Angeles, California. We included all emergency room or inpatient cases receiving SARS-CoV-2 PCR testing who also had a set of ancillary laboratory features (n = 1,455) between 1 March 2020 and 24 May 2020. We tested seven machine learning models and used a combination of those models for the final diagnostic classification. In the test set (n = 392), our combined model had an area under the receiver operator curve of 0.91 (95% confidence interval 0.87-0.96). The model achieved a sensitivity of 0.93 (95% CI 0.85-0.98), specificity of 0.64 (95% CI 0.58-0.69). We found that our machine learning algorithm had excellent diagnostic metrics compared to SARS-CoV-2 PCR. This ensemble machine learning algorithm to diagnose COVID-19 has the potential to be used as a screening tool in hospital settings where PCR testing is scarce or unavailable.	[Goodman-Meza, David; Adamson, Paul C.; Fulcher, Jennifer A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA; [Rudas, Akos; Chiang, Jeffrey N.; Eskin, Eleazar; Kordi, Misagh; Jew, Brandon; Balliu, Brunilda; Halperin, Eran] Univ Calif Los Angeles, Dept Computat Med, Los Angeles, CA USA; [Rudas, Akos] Eotvos Lorand Univ, Fac Informat, Budapest, Hungary; [Ebinger, Joseph; Sun, Nancy; Botting, Patrick] Cedars Sinai Med Ctr, Dept Cardiol, Los Angeles, CA 90048 USA; [Saab, Faysal G.; Brook, Rachel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Eskin, Eleazar; An, Ulzee; Chen, Zeyuan; Hill, Brian L.; Rahmani, Elior; Halperin, Eran] Univ Calif Los Angeles, Dept Comp Sci, Los Angeles, CA 90024 USA; [Eskin, Eleazar; Halperin, Eran] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Halperin, Eran] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Manuel, Vladimir] Univ Calif Los Angeles, David Geffen Sch Med, Fac Practice Grp, Los Angeles, CA 90095 USA; [Manuel, Vladimir] Univ Calif Los Angeles, Clin & Translat Sci Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Eotvos Lorand University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Goodman-Meza, D (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA.	dgoodman@mednet.ucla.edu	Adamson, Paul/AAR-1405-2020; Fulcher, Jennifer A./AAG-1495-2020	Adamson, Paul/0000-0002-2776-6458; Fulcher, Jennifer A./0000-0001-9895-8636; Goodman, David/0000-0001-9382-3564; Rudas, Akos/0000-0003-4346-8239; Saab, Faysal/0000-0002-4568-3613; Reis, AlessanRSS/0000-0001-8486-7469; Hill, Brian/0000-0002-6881-5770; Chiang, Jeffrey/0000-0002-6843-1355	U.S. National Institute on Drug Abuse [K08DA048163]; U.S. National Institute of Mental Health [T32MH080634]; U.S. National Institute of Allergy and Infectious Disease [K08AI124979]; Doris Duke Charitable Foundation [2019086]; National Science Foundation [1705197]; National Institute of Health (NIH/NHGRI) [HG010505-02]; National Institute of Health (NIH) [5UL1TR001881, 1R01MH115979, 5R25GM112625]	U.S. National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); U.S. National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); U.S. National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health (NIH/NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	DGM was supported by the U.S. National Institute on Drug Abuse (K08DA048163, PI Goodman-Meza). PCA was supported by the U.S. National Institute of Mental Health (T32MH080634, PI Currier). JAF was supported by the U.S. National Institute of Allergy and Infectious Disease (K08AI124979, PI Fulcher) and by the Doris Duke Charitable Foundation (Grant 2019086). This project was partially supported by the National Science Foundation (Grant No. 1705197, PI Halperin), and the National Institute of Health (NIH/NHGRI HG010505-02 [PI Halperin], NIH 1R01MH115979 [PI Flint], NIH 5R25GM112625 [PI Eskin], and NIH 5UL1TR001881 [PI Dubinett]). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or their employing institutions.	Batista AF., 2020, COVID 19 DIAGNOSIS P, DOI [10.1101/2020.04.04.20052092, DOI 10.1101/2020.04.04.20052092]; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Feng C, 2020, SSRN ELECT J, pSSRN, DOI [DOI 10.2139/SSRN.3551355, 10.1101/2020.03.19.20039099, DOI 10.1101/2020.03.19.20039099]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Meng Z., 2020, DEVELOPMENT UTILIZAT, DOI [10.1101/2020.03.18.20035816, DOI 10.1101/2020.03.18.20035816, 10.1101/2020.03.18.20035816.]; Petrilli CM, 2020, FACTORS ASS HOSPITAL, V2020, P4, DOI [DOI 10.1101/2020.04.08.20057794, 10.1101/2020.04.08.20057794]; Service RF, 2020, SCIENCE, DOI [10.1126/science.abb8400, DOI 10.1126/SCIENCE.ABB8400]; Sheridan Cormac, 2020, Nat Biotechnol, V38, P382, DOI 10.1038/d41587-020-00002-2; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Ward S, 2020, J ALLERGY CLIN IMMUN, V146, P23, DOI 10.1016/j.jaci.2020.05.012; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	16	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239474	10.1371/journal.pone.0239474	http://dx.doi.org/10.1371/journal.pone.0239474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960917	Green Published, gold			2022-12-26	WOS:000575109500025
J	Aiyama, T; Orimo, T; Yokoo, H; Ohata, T; Hatanaka, KC; Hatanaka, Y; Fukai, M; Kamiyama, T; Taketomi, A				Aiyama, Takeshi; Orimo, Tatsuya; Yokoo, Hideki; Ohata, Takanori; Hatanaka, Kanako C.; Hatanaka, Yutaka; Fukai, Moto; Kamiyama, Toshiya; Taketomi, Akinobu			Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis	PLOS ONE			English	Article							STEM/PROGENITOR CELLS; EB1; CANCER; EXPRESSION; HEPCIDIN; TISSUE; ACTIN; DLK1; OVEREXPRESSION; IDENTIFICATION	This study was performed to determine the clinical significance of adenomatous polyposis coli (APC)-binding protein end-binding 1 (EB1) in hepatocellular carcinoma (HCC) and to characterize its biochemical role in comparison with previous reports. We performed immunohistochemical staining to detect EB1 expression in tissues from 235 patients with HCC and investigated its correlations with clinicopathological features and prognosis. We also investigated the roles of EB1 in cell proliferation, migration, and tumorigenesisin vitroandin vivoby siRNA- and CRISPR/Cas9-mediated modulation of EB1 expression in human HCC cell lines. The results showed that EB1 expression was significantly correlated with several important factors associated with tumor malignancy, including histological differentiation, portal vein invasion status, and intrahepatic metastasis. Patients with high EB1 expression in HCC tissue had poorer overall survival and higher recurrence rates than patients with low EB1 expression. EB1 knockdown and knockout in HCC cells reduced cell proliferation, migration, and invasionin vitroand inhibited tumor growthin vivo. Further, genes encoding Dlk1, HAMP, and SLCO1B3 that were differentially expressed in association with EB1 were identified using RNA microarray analysis. In conclusion, elevated expression of EB1 promotes tumor growth and metastasis of HCC. EB1 may serve as a new biomarker for HCC, and genes coexpressed with EB1 may represent potential targets for therapy.	[Aiyama, Takeshi; Orimo, Tatsuya; Yokoo, Hideki; Ohata, Takanori; Fukai, Moto; Kamiyama, Toshiya; Taketomi, Akinobu] Hokkaido Univ, Dept Gastroenterol Surg 1, Grad Sch Med, Sapporo, Hokkaido, Japan; [Hatanaka, Kanako C.; Hatanaka, Yutaka] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Yokoo, H (corresponding author), Hokkaido Univ, Dept Gastroenterol Surg 1, Grad Sch Med, Sapporo, Hokkaido, Japan.	hi-yokoo@mua.biglobe.ne.jp		Yokoo, Hideki/0000-0002-6203-8528; aiyama, takeshi/0000-0001-5658-2730	JSPS KAKENHI [JP25430134, JP16k10561, JP17k10683]; AMED [JP18fk0210041, JP18fk0310111]; Mitsui Life Social Welfare Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Mitsui Life Social Welfare Foundation	This study was supported in part by JSPS KAKENHI Grant Number JP25430134 and JP16k10561, JP17k10683, and by AMED under Grant Numbers JP18fk0210041 and JP18fk0310111, and by Grant from Mitsui Life Social Welfare Foundation (2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the munuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Alsinnawi M, 2019, PROSTATE CANCER P D, V22, P560, DOI 10.1038/s41391-019-0141-6; Berges R, 2014, ONCOTARGET, V5, P12769, DOI 10.18632/oncotarget.2646; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen Q, 2014, THORAC CANCER, V5, P14, DOI 10.1111/1759-7714.12046; Ciniselli CM, 2015, EXPERT REV PROTEOMIC, V12, DOI 10.1586/14789450.2015.1099436; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dong X, 2010, J PATHOL, V220, P361, DOI 10.1002/path.2662; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Fujii K, 2005, PROTEOMICS, V5, P1411, DOI 10.1002/pmic.200401004; Fukuhara T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004534; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Huang J, 2007, CARCINOGENESIS, V28, P1094, DOI 10.1093/carcin/bgl215; Kudo M, 2016, HEPATOL RES, V46, P372, DOI 10.1111/hepr.12697; Mizukami Tatsuzo, 2018, Oncotarget, V9, P33844, DOI 10.18632/oncotarget.26117; Morio H, 2018, BIOL PHARM BULL, V41, P445, DOI 10.1248/bpb.b17-00743; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Nishigaki R, 2005, PROTEOMICS, V5, P3205, DOI 10.1002/pmic.200401307; Orimo T, 2008, HEPATOLOGY, V48, P1851, DOI 10.1002/hep.22552; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Schliwa M, 2002, NAT REV MOL CELL BIO, V3, P291, DOI 10.1038/nrm781; Schmidt JV, 2000, GENE DEV, V14, P1997; Schober JM, 2009, CANCER LETT, V284, P30, DOI 10.1016/j.canlet.2009.04.007; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Shimada S, 2017, WORLD J SURG, V41, P2087, DOI 10.1007/s00268-017-3964-0; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; Sugihara Y, 2012, J PROTEOMICS, V75, P5342, DOI 10.1016/j.jprot.2012.06.013; Sun L, 2008, P NATL ACAD SCI USA, V105, P7153, DOI 10.1073/pnas.0710018105; Tanaka M, 2009, MECH DEVELOP, V126, P665, DOI 10.1016/j.mod.2009.06.939; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Toshiyama R, 2018, ONCOL LETT, V15, P8125, DOI 10.3892/ol.2018.8357; Tsukiyama T, 2015, MOL CELL BIOL, V35, P2007, DOI 10.1128/MCB.00159-15; van de Steeg E, 2012, J CLIN INVEST, V122, P519, DOI 10.1172/JCI59526; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Wang YH, 2005, ONCOGENE, V24, P6637, DOI 10.1038/sj.onc.1208819; Xu X, 2012, MOL CANCER THER, V11, P629, DOI 10.1158/1535-7163.MCT-11-0531; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yu F, 2010, LIVER INT, V30, P703, DOI 10.1111/j.1478-3231.2010.02214.x	44	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239462	10.1371/journal.pone.0239462	http://dx.doi.org/10.1371/journal.pone.0239462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956413	Green Published, gold			2022-12-26	WOS:000574571500028
J	Li, LY; Chen, XS; Wang, KS; Guan, YD; Ren, XC; Cao, DS; Sun, XY; Li, AX; Tao, YG; Zhang, Y; Yin, MZ; Wang, XL; Wu, MH; Yang, JM; Cheng, Y				Li, Lan-Ya; Chen, Xi-Sha; Wang, Kuan-Song; Guan, Yi-Di; Ren, Xing-Cong; Cao, Dong-Sheng; Sun, Xin-Yuan; Li, Ao-Xue; Tao, Yong-Guang; Zhang, Yi; Yin, Ming-Zhu; Wang, Xin-Luan; Wu, Ming-Hua; Yang, Jin-Ming; Cheng, Yan			RSK2 protects human breast cancer cells under endoplasmic reticulum stress through activating AMPK alpha 2-mediated autophagy	ONCOGENE			English	Article							ER STRESS; SIGNALING PATHWAY; INDUCED APOPTOSIS; CARCINOMA-CELLS; INHIBITION; SURVIVAL; KINASE; PROTEINS; PHOSPHORYLATION; SENSITIVITY	Autophagy can protect stressed cancer cell by degradation of damaged proteins and organelles. However, the regulatory mechanisms behind this cellular process remain incompletely understood. Here, we demonstrate that RSK2 (p90 ribosomal S6 kinase 2) plays a critical role in ER stress-induced autophagy in breast cancer cells. We demonstrated that the promotive effect of RSK2 on autophagy resulted from directly binding of AMPK alpha 2 in nucleus and phosphorylating it at Thr172 residue. IRE1 alpha, an ER membrane-associated protein mediating unfolded protein response (UPR), is required for transducing the signal for activation of ERK1/2-RSK2 under ER stress. Suppression of autophagy by knockdown of RSK2 enhanced the sensitivity of breast cancer cells to ER stress both in vitro and in vivo. Furthermore, we demonstrated that inhibition of RSK2-mediated autophagy rendered breast cancer cells more sensitive to paclitaxel, a chemotherapeutic agent that induces ER stress-mediated cell death. This study identifies RSK2 as a novel controller of autophagy in tumor cells and suggests that targeting RSK2 can be exploited as an approach to reinforce the efficacy of ER stress-inducing agents against cancer.	[Li, Lan-Ya; Chen, Xi-Sha; Guan, Yi-Di; Sun, Xin-Yuan; Cheng, Yan] Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha 410011, Peoples R China; [Li, Lan-Ya; Cao, Dong-Sheng; Sun, Xin-Yuan; Li, Ao-Xue] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha 410008, Peoples R China; [Wang, Kuan-Song] Cent South Univ, Sch Basic Med, Xiangya Hosp, Dept Pathol, Changsha 410078, Peoples R China; [Wang, Kuan-Song] Cent South Univ, Sch Basic Med, Dept Pathol, Changsha 410078, Peoples R China; [Ren, Xing-Cong; Yang, Jin-Ming] Univ Kentucky, Coll Med, Markey Canc Ctr, Dept Pharmacol,Dept Canc Biol & Toxicol, Lexington, KY 40536 USA; [Tao, Yong-Guang; Wu, Ming-Hua] Cent South Univ, Sch Basic Med, Canc Res Inst, Changsha 410078, Peoples R China; [Tao, Yong-Guang; Wu, Ming-Hua] Cent South Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha 410078, Peoples R China; [Zhang, Yi] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou 410008, Peoples R China; [Yin, Ming-Zhu] Cent South Univ, Xiangya Hosp, Hunan Engn Res Ctr Skin Hlth & Dis, Dept Dermatol,Hunan Key Lab Skin Canc & Psoriasis, Changsha 410008, Hunan, Peoples R China; [Wang, Xin-Luan] Chinese Acad Sci, Shenzhen Inst Adv Technol, Translat Med R&D Ctr, Inst Biomed & Hlth Engn, Shenzhen 518057, Peoples R China	Central South University; Central South University; Central South University; Central South University; University of Kentucky; Central South University; Central South University; Soochow University - China; Central South University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Cheng, Y (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Pharm, Changsha 410011, Peoples R China.	yancheng@csu.edu.cn		tao, yongguang/0000-0003-2354-5321; Chen, Xisha/0000-0003-3091-2919	National Natural Science Foundation of China [81472593, 81972480]; Postgraduate Research and Innovation Project of Central South University [1053320183910]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research and Innovation Project of Central South University	This work was supported by the National Natural Science Foundation of China under Grant Nos. 81472593 and 81972480; the Postgraduate Research and Innovation Project of Central South University under Grant No. 1053320183910.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bhardwaj M, 2020, SEMIN CANCER BIOL, V66, P116, DOI 10.1016/j.semcancer.2019.11.007; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cheng Y, 2013, PHARMACOL REV, V65, P1162, DOI 10.1124/pr.112.007120; Cheng Y, 2013, AUTOPHAGY, V9, P208, DOI 10.4161/auto.22801; Cho YY, 2012, CARCINOGENESIS, V33, P2529, DOI 10.1093/carcin/bgs271; Cho YY, 2009, CANCER RES, V69, P4398, DOI 10.1158/0008-5472.CAN-08-4959; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; Cubillos-Ruiz JR, 2017, CELL, V168, P692, DOI 10.1016/j.cell.2016.12.004; Dey S, 2013, AUTOPHAGY, V9, P612, DOI 10.4161/auto.23486; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Fujiki K, 2014, ARCH TOXICOL, V88, P403, DOI 10.1007/s00204-013-1129-y; Gao J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.444; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gawecka JE, 2012, J BIOL CHEM, V287, P43424, DOI 10.1074/jbc.M112.423046; Goncalves RLS, 2019, CELL METAB, V30, P999, DOI 10.1016/j.cmet.2019.11.008; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; He J, 2015, AUTOPHAGY, V11, P373, DOI 10.1080/15548627.2015.1009781; Hong-Brown LQ, 2017, ALCOHOL CLIN EXP RES, V41, P895, DOI 10.1111/acer.13377; Hospital MA, 2018, LEUKEMIA, V32, P597, DOI 10.1038/leu.2017.284; Houles T, 2018, SEMIN CANCER BIOL, V48, P53, DOI 10.1016/j.semcancer.2017.04.016; Im JY, 2018, ONCOGENE, V37, P1251, DOI 10.1038/s41388-017-0025-y; Janczar S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.346; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Kang SM, 2011, EXPERT OPIN THER TAR, V15, P11, DOI 10.1517/14728222.2010.531013; Lara R, 2013, CANCER RES, V73, P5301, DOI 10.1158/0008-5472.CAN-12-4448; Lei Y, 2015, ONCOGENE, V34, P485, DOI 10.1038/onc.2013.566; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; Li X, 2016, AUTOPHAGY, V12, P1521, DOI 10.1080/15548627.2016.1191722; Lim HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074334; Liu KD, 2011, J BIOL CHEM, V286, P2057, DOI 10.1074/jbc.M110.147306; Liu SL, 2015, INT J ONCOL, V46, P2399, DOI 10.3892/ijo.2015.2937; Lozy F, 2014, AUTOPHAGY, V10, P662, DOI 10.4161/auto.27867; Luan Q, 2015, AUTOPHAGY, V11, P975, DOI 10.1080/15548627.2015.1049800; Maddalena F, 2013, MOL ONCOL, V7, P895, DOI 10.1016/j.molonc.2013.04.009; Nam HY, 2013, AUTOPHAGY, V9, P1631, DOI 10.4161/auto.25879; Nawrocki ST, 2005, CANCER RES, V65, P11510, DOI 10.1158/0008-5472.CAN-05-2394; Piasecka D, 2016, ONCOTARGET, V7, P86011, DOI 10.18632/oncotarget.13322; Qiang L, 2017, AUTOPHAGY, V13, P2086, DOI 10.1080/15548627.2017.1380757; Rao SV, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3055-5; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Salt IP, 2017, CIRC RES, V120, P1825, DOI 10.1161/CIRCRESAHA.117.309633; Schaffer BE, 2015, CELL METAB, V22, P907, DOI 10.1016/j.cmet.2015.09.009; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; She QB, 2002, J BIOL CHEM, V277, P24039, DOI 10.1074/jbc.M109907200; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Shin HJR, 2016, NATURE, V534, P553, DOI 10.1038/nature18014; Smith MD, 2018, DEV CELL, V44, P217, DOI 10.1016/j.devcel.2017.11.024; Spaan CN, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1729-4; Stratford AL, 2012, STEM CELLS, V30, P1338, DOI 10.1002/stem.1128; Sulzmaier FJ, 2016, ONCOTARGET, V7, P79855, DOI 10.18632/oncotarget.13084; Tameire F, 2019, NAT CELL BIOL, V21, P889, DOI 10.1038/s41556-019-0347-9; van Jaarsveld MTM, 2013, EUR J CANCER, V49, P345, DOI 10.1016/j.ejca.2012.08.024; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang QL, 2017, AUTOPHAGY, V13, P404, DOI 10.1080/15548627.2016.1263776; Wen J, 2015, BREAST CANCER RES TR, V149, P619, DOI 10.1007/s10549-015-3283-9; Xiang XY, 2016, ONCOL REP, V35, P3471, DOI 10.3892/or.2016.4725; Xu L, 2015, CANCER RES TREAT, V47, P313, DOI 10.4143/crt.2013.222; Xu LY, 2012, MOL CANCER THER, V11, P2174, DOI 10.1158/1535-7163.MCT-12-0602; Zaouali MA, 2013, J PINEAL RES, V55, P65, DOI 10.1111/jpi.12051; Zhang DY, 2016, AUTOPHAGY, V12, P1447, DOI 10.1080/15548627.2016.1185576; Zhang SF, 2015, AUTOPHAGY, V11, P225, DOI 10.1080/15548627.2014.998931; Zhao C, 2013, AUTOPHAGY, V9, P196, DOI 10.4161/auto.22805; Zhu YX, 2015, BLOOD, V125, P483, DOI 10.1182/blood-2014-05-577130	66	7	9	0	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2020	39	43					6704	6718		10.1038/s41388-020-01447-0	http://dx.doi.org/10.1038/s41388-020-01447-0		SEP 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OF2UT	32958832				2022-12-26	WOS:000571674200001
J	Shen, Y; Cong, W; Zhang, AH; Meng, XC				Shen, Ying; Cong, Wei; Zhang, Ai-hua; Meng, Xiangcai			Complexity of active medicinal ingredients in radix scutellariae with sodium hydrosulfite exposure	PLOS ONE			English	Article							FLAVONOIDS; QUALITY; ROOT	Both plants and animals are living things made up of similar cells as well as organelles, and their essence of life is the same. However, plants face more environmental stress than animals and generate excessive reactive oxygen species (ROS), a group of small molecules that can harm proteins, necessitating distinctive metabolic processes. Secondary metabolites in plants are a group of chemical components that can eliminate ROS and can also exhibit medicinal properties; therefore, herbal medicines are often closely linked to the ecological significance of secondary metabolites. Why plants contain so many, not few, active medicinal ingredients is unknown. The root ofScutellaria baicalensis, a popular herbal medicine, is rich in various flavonoids with diverse structural features. Sodium hydrosulfite (Na2S2O4) can produce O(2)(-)radicals and induce physical conditions under environmental stress. Using UHPLC-ESI-Q-TOF-MS/MS analysis, a total of 25 different compounds were identified in the roots ofS.baicalensisbetween the Na(2)S(2)O(4)groups and suitable conditions. Based on the results of the t-test (P<0.05) performed for the groups and ions with values of VIP >= 2, the most significantly different chemical markers with Na(2)S(2)O(4)treatment were shikimic acid, citric acid, baicalin, wogonoside, baicalein, wogonin, 3,5,7,2',6'-pentahydroxyflavanone, 5,2',6'-trihydroxy-7,8-dimethoxy flavone, chrysin, eriodictyol, 5,8-dihydroxy-6,7 -dimethoxy flavone, skullcapflavone II, and 5,7-dihydroxy-6,8,2',3'-tetrame thoxyflavone, and most of them were free flavonoids with many phenolic hydroxyl or methoxyl groups and characteristically high antioxidant activities.S.baicalensisroots modified their ability to eliminate ROS and maintained the equilibrium of ROS through the multitudinous biosynthesis and conversion of flavonoids, which is similar to the equilibrium established by an intricate buffer solution and perfectly explains the diversity and complexity of medicinal plant ingredients.	[Shen, Ying; Cong, Wei; Zhang, Ai-hua; Meng, Xiangcai] Heilongjiang Univ Chinese Med, Dept Pharmacognosy, Harbin, Peoples R China; [Cong, Wei] Heilongjiang Univ Chinese Med, GAP Res Ctr, Harbin, Peoples R China	Heilongjiang University of Chinese Medicine; Heilongjiang University of Chinese Medicine	Meng, XC (corresponding author), Heilongjiang Univ Chinese Med, Dept Pharmacognosy, Harbin, Peoples R China.	13845044491@163.com			National Science Foundation [81573523]	National Science Foundation(National Science Foundation (NSF))	The authors wish to thank for providing financial supports from the National Science Foundation (81573523).	Blach-Olszewska Z, 2008, J INTERF CYTOK RES, V28, P571, DOI 10.1089/jir.2008.0125; Bueno PCP, 2020, ACS OMEGA, V5, P1752, DOI 10.1021/acsomega.9b03668; Cao YW, 2019, PHYTOCHEMISTRY, V166, DOI 10.1016/j.phytochem.2019.112058; Cheng YL, 2006, SCI CHINA SER C, V49, P1, DOI 10.1007/s11427-005-0066-2; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Elstner EF., 1991, ACTIVE OXYGEN OXIDAT, V6, P13, DOI [10.1017/S0269727000014068, DOI 10.1016/J.PBI.2005.05.014]; Foyer CH., 1997, OXIDATIVE STRESS MOL, P587; Guo HM, 2016, INT J PHARM INVESTIG, V6, P225, DOI 10.4103/2230-973X.195932; Hirotani M, 2000, PLANTA, V210, P1006, DOI 10.1007/PL00008158; Janas KM, 2002, PLANT SCI, V163, P369, DOI 10.1016/S0168-9452(02)00136-X; Jiang H, 2018, RUSS J PLANT PHYSL+, V65, P680, DOI 10.1134/S1021443718050084; Jorge TF, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0370; Lin HQ, 2019, J AGR FOOD CHEM, V67, P5801, DOI 10.1021/acs.jafc.9b01581; Lin HQ, 2019, MOLECULES, V24, DOI 10.3390/molecules24050942; Liu Tai-ming, 2006, Zhongguo Zhong Yao Za Zhi, V31, P999; Noshita T, 2018, J NAT MED-TOKYO, V72, P551, DOI 10.1007/s11418-017-1169-3; Posmyk MM, 2005, J PLANT PHYSIOL, V162, P403, DOI 10.1016/j.jplph.2004.08.004; Qi S, 2016, PHARMACOGN MAG, V12, P84, DOI 10.4103/0973-1296.176063; Qin S.S., 2010, CHIN J EXP TRADIT ME, V16, P99; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Song Q, 2019, PHARMACOGN MAG, V15, P107, DOI 10.4103/pm.pm_598_17; Wang HL, 2013, J CHROMATOGR A, V1315, P107, DOI 10.1016/j.chroma.2013.09.052; Wang L, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-2871-3; Wang XY, 2020, MOLECULES, V25, DOI 10.3390/molecules25020422; Wang ZL, 2018, PHARM BIOL, V56, P465, DOI 10.1080/13880209.2018.1492620; Wen YK, 1989, PROG BIOCHEM BIOPHYS, V16, P209; Woznicka E, 2013, ACTA POL PHARM, V70, P567; Wu T, 2013, BBA-BIOMEMBRANES, V1828, P2751, DOI 10.1016/j.bbamem.2013.07.029; Yang L, 2018, MOLECULES, V23, DOI 10.3390/molecules23040762; Yang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084580; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946; [张榕 Zhang Rong], 2010, [复旦学报. 自然科学版, Journal of Fudan University. Natural Sciences], V49, P575; Zhao Q, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501780	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238927	10.1371/journal.pone.0238927	http://dx.doi.org/10.1371/journal.pone.0238927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956425	Green Published, gold			2022-12-26	WOS:000574571500020
J	Aslam, MM; Jalil, F; John, P; Fan, KH; Bhatti, A; Feingold, E; Demirci, FY; Kamboh, MI				Aslam, Muhammad Muaaz; Jalil, Fazal; John, Peter; Fan, Kang-Hsien; Bhatti, Attya; Feingold, Eleanor; Demirci, F. Yesim; Kamboh, M. Ilyas			A sequencing study ofCTLA4in Pakistani rheumatoid arthritis cases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CTLA-4; RISK; POLYMORPHISM; HAPLOTYPE; INSIGHTS; STAT4	Rheumatoid arthritis (RA) is a multifactorial autoimmune disease. The interaction of genetic and environmental factors is likely necessary for RA. Among potential genetic factors, many major histocompatibility complex (MHC) and non-MHC variants may be involved in RA susceptibility.CTLA4is involved in the regulation of T-cell response during an immune reaction, and multipleCTLA4single nucleotide polymorphisms (SNPs) have been associated with numerous autoimmune diseases, including RA. To our knowledge, the genetic association ofCTLA4with RA risk has not been examined previously in the Pakistani population. In this study, we sequenced the entireCTLA4gene and flanking regions in 95 Pakistani RA cases followed the screening of identified variants in Study 1 sample consisting of 350 RA cases and controls. Four common significant variants identified in Study 1 sample were further examined in a larger Study 2 replication sample comprising 1,678 independent RA cases and controls. We report significant associations of three variants from the combined analysis: rs3087243 (OR = 1.26, p = 4.47E-03), rs5742909 (OR = 1.78, p = 4.60E-03), and rs11571319 (OR = 1.48, p = 6.64E-03); the latter is a novel association in the Pakistani sample.	[Aslam, Muhammad Muaaz; John, Peter; Bhatti, Attya] Natl Univ Sci & Technol, Atta ur Rahman Sch Appl Biosci, Islamabad, Pakistan; [Aslam, Muhammad Muaaz; Fan, Kang-Hsien; Feingold, Eleanor; Demirci, F. Yesim; Kamboh, M. Ilyas] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Jalil, Fazal] Abdul Wali Khan Univ, Dept Biotechnol, Mardan, Pakistan	National University of Sciences & Technology - Pakistan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Abdul Wali Khan University	Kamboh, MI (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	kamboh@pitt.edu	aslam, muhammad muaaz/V-9990-2019; Jalil, Fazal/HDN-4658-2022	aslam, muhammad muaaz/0000-0003-1817-7894; Fan, Kang-hsien/0000-0003-0121-3959; Jalil, Fazal/0000-0002-3372-4457				Akhter E, 2011, RHEUMATOL INT, V31, P849, DOI 10.1007/s00296-011-1820-3; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2019, BRAIN STIMUL MAR; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Aslam MM, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3494937; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Choi H, 2017, ENVIRON POLLUT, V231, P1134, DOI 10.1016/j.envpol.2017.07.057; Diaz-Gallo LM, 2018, ANN RHEUM DIS, V77, P1454, DOI 10.1136/annrheumdis-2018-213412; Elshazli R, 2015, IMMUNOBIOLOGY, V220, P1012, DOI 10.1016/j.imbio.2015.04.003; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Fan QE, 2018, J HUM GENET, V63, P579, DOI 10.1038/s10038-018-0414-2; Fattah SA, 2017, ARCH PHYSIOL BIOCHEM, V123, P50, DOI 10.1080/13813455.2016.1230135; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Jalil F, 2017, PAK J PHARM SCI, V30, P1219; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kristiansen OP, 2000, GENES IMMUN, V1, P170, DOI 10.1038/sj.gene.6363655; Li F, 2018, ANN HUM GENET, V82, P358, DOI 10.1111/ahg.12262; Luterek-Puszynska K, 2017, CLIN RHEUMATOL, V36, P1129, DOI 10.1007/s10067-016-3496-2; McInnes IB, 2017, LANCET, V389, P2328, DOI 10.1016/S0140-6736(17)31472-1; Mechanisms Clinical Strategies., 2015, 12 INT C AD PD NIC F, V15, P1, DOI DOI 10.1520/D6415; Migita K, 2012, MODERN RHEUMATOLOGY; Mirkov MU, 2013, ANN RHEUM DIS, V72, P1375, DOI 10.1136/annrheumdis-2012-202405; Munoz-Valle JF, 2010, CLIN CHIM ACTA, V411, P725, DOI 10.1016/j.cca.2010.02.001; Naser SA, 2012, WORLD J GASTROENTERO, V18, P412, DOI 10.3748/wjg.v18.i5.412; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ortona Elena, 2016, Ann Ist Super Sanita, V52, P205, DOI 10.4415/ANN_16_02_12; Plant D, 2010, ANN RHEUM DIS, V69, P1548, DOI 10.1136/ard.2009.121020; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Scalapino KJ, 2008, IMMUNOL REV, V223, P143, DOI 10.1111/j.1600-065X.2008.00639.x; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Sulaiman FN, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014945; Taylor PC, 2017, NEW ENGL J MED, V376, P652, DOI 10.1056/NEJMoa1608345; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Torres-Carrillo N, 2013, CELL BIOCHEM BIOPHYS, V67, P1217, DOI 10.1007/s12013-013-9640-6; Tsukahara S, 2008, ANN RHEUM DIS, V67, P428, DOI 10.1136/ard.2007.079186; Walker EJ, 2009, ARTHRITIS RHEUM-US, V60, P931, DOI 10.1002/art.24412; Wang K, 2017, GENET TEST MOL BIOMA, V21, P222, DOI 10.1089/gtmb.2016.0335; 2013, SURG OBES RELAT DIS, V9	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239426	10.1371/journal.pone.0239426	http://dx.doi.org/10.1371/journal.pone.0239426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946523	gold, Green Published			2022-12-26	WOS:000573851100067
J	Benedito-Silva, AA; Evans, S; Mendes, JV; Castro, J; Goncalves, BDB; Ruiz, FS; Beijamini, F; Evangelista, FS; Vallada, H; Krieger, JE; von Schantz, M; Pereira, AC; Pedrazzoli, M				Benedito-Silva, Ana Amelia; Evans, Simon; Mendes, Juliana Viana; Castro, Juliana; Goncalves, Bruno da Silva B.; Ruiz, Francieli S.; Beijamini, Felipe; Evangelista, Fabiana S.; Vallada, Homero; Krieger, Jose Eduardo; von Schantz, Malcolm; Pereira, Alexandre C.; Pedrazzoli, Mario			Association between light exposure and metabolic syndrome in a rural Brazilian town	PLOS ONE			English	Article							VITAMIN-D; SHIFT WORK; ARTIFICIAL-LIGHT; 25-HYDROXYVITAMIN D; BODY-MASS; MELATONIN; NIGHT; OBESITY; HEALTH; RISK	Context Metabolic syndrome (MetS) is a complex condition comprising a 'clustering' of components representing cardiometabolic risk factors for heart disease and diabetes; its prevalence rate is high and consequences serious. Evidence suggests that light exposure patterns and misalignment of circadian rhythms might contribute to MetS etiology by impacting energy metabolism and glucose regulation. Objective We hypothesised that individuals with MetS would show disrupted circadian and sleep parameters alongside differences in light exposure profiles. We investigated this using data from a cohort study in Brazil. Methods Data from 103 individuals from the Baependi Heart Cohort Study aged between 50 and 70 were analysed. Motor activity and light exposure were measured using wrist-worn actigraphy devices. Cardiometabolic data were used to calculate the number of MetS components present in each participant, and participants grouped as MetS/non-MetS according to standard guidelines. Between-group comparisons were made for the actigraphy measures; additionally, correlation analyses were conducted. Results Motor activity and circadian profiles showed no differences between groups. However, the MetS group presented lower light exposure during the day and higher light exposure at night. Correlation analyses, including all participants, showed that greater daytime light exposure and greater light exposure difference between day and night were associated with reduced MetS risk (a lower number of MetS components). Also, the light exposure difference between day and night correlated with body mass index across all participants. Conclusions The observed results suggest a direct association between light exposure and MetS which appears to not be attributable to disruptions in circadian activity rhythm nor to sleep parameters. This link between light exposure patterns and MetS risk could inform possible prevention strategies.	[Benedito-Silva, Ana Amelia; Mendes, Juliana Viana; Castro, Juliana; Goncalves, Bruno da Silva B.; Evangelista, Fabiana S.; Pedrazzoli, Mario] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil; [Evans, Simon; Ruiz, Francieli S.; von Schantz, Malcolm] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Ruiz, Francieli S.; Beijamini, Felipe; Vallada, Homero] Univ Sao Paulo, Inst Psychiat, Med Sch, Sao Paulo, Brazil; [Beijamini, Felipe; Krieger, Jose Eduardo] Fed Univ Fronteira Sul UFFS, Realeza, Brazil; [Pereira, Alexandre C.] Univ Sao Paulo, Heart Inst InCor, Lab Genet & Mol Cardiol, Med Sch, Sao Paulo, Brazil	Universidade de Sao Paulo; University of Surrey; Universidade de Sao Paulo; Universidade de Sao Paulo	Benedito-Silva, AA (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, Brazil.	aamelia@usp.br	Evangelista, Fabiana/AAC-2960-2021; Pereira, Alexandre/HHN-1038-2022; Beijamini, Felipe/B-5670-2015; von Schantz, Malcolm/C-5962-2014	Evangelista, Fabiana/0000-0002-8103-6923; Beijamini, Felipe/0000-0002-8632-2101; Ruiz, Francieli S/0000-0002-9675-4063; von Schantz, Malcolm/0000-0002-9911-9436	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2013/17368-0, 2007/581507, 2010/51010-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [400791/2015-5]; Research Collaboration Fund of the Universities Global Partnership Network: RFC 2017; Academy of Medical Sciences/Newton International Fellowship [NIF004\1030]; Hospital Samaritano [25.000.180.664/2011-35]; Institute of Advanced Studies of University of Surrey: 2018/19	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Research Collaboration Fund of the Universities Global Partnership Network: RFC 2017; Academy of Medical Sciences/Newton International Fellowship; Hospital Samaritano; Institute of Advanced Studies of University of Surrey: 2018/19	This study was supported by awards from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: 2013/17368-0 to ACP, 2007/581507 to JEK, 2010/51010-8 to MP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico: 400791/2015-5 to HPVF and MvS; Research Collaboration Fund of the Universities Global Partnership Network: RFC 2017 to SE and MP; Academy of Medical Sciences/Newton International Fellowship: NIF004\1030 to FRdS; Hospital Samaritano: 25.000.180.664/2011-35; and Institute of Advanced Studies of University of Surrey: 2018/19 to FB.	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amaral FG, 2014, J NEUROENDOCRINOL, V26, P603, DOI 10.1111/jne.12144; Amstrup AK, 2016, CLIN ENDOCRINOL, V84, P342, DOI 10.1111/cen.12942; [Anonymous], 2005, ARQ BRAS CARDIOL, V84, P1; [Anonymous], 2012, CIT PLUS, V7-8, P11; Arendt J, 2005, SLEEP MED REV, V9, P25, DOI 10.1016/j.smrv.2004.05.002; Baron KG, 2014, INT REV PSYCHIATR, V26, P139, DOI 10.3109/09540261.2014.911149; Bedrosian TA, 2016, ANNU REV PHYSIOL, V78, P109, DOI 10.1146/annurev-physiol-021115-105102; Boggild H, 1999, SCAND J WORK ENV HEA, V25, P85, DOI 10.5271/sjweh.410; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Chan JL, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.04.007; Cho Y, 2015, CHRONOBIOL INT, V32, P1294, DOI 10.3109/07420528.2015.1073158; Cipolla-Neto J, 2014, J PINEAL RES, V56, P371, DOI 10.1111/jpi.12137; Cipolla-Neto J, 1999, NEUROENDOCRINOLOGY, V69, P97, DOI 10.1159/000054407; Cipolla-Neto J, 2018, ENDOCR REV, V39, P990, DOI 10.1210/er.2018-00084; de Oliveira CM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-32; Egan KJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011598; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Ford ES, 2009, J DIABETES, V1, P296, DOI 10.1111/j.1753-0407.2009.00046.x; Fukuda Y, 2017, CHRONOBIOL INT, V34, P1465, DOI 10.1080/07420528.2017.1362422; Gagnon C, 2011, DIABETES CARE, V34, P1133, DOI 10.2337/dc10-2167; Gallagher EJ, 2011, MED CLIN N AM, V95, P855, DOI 10.1016/j.mcna.2011.06.001; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Goncalves BSB, 2015, SLEEP MED REV, V20, P84, DOI 10.1016/j.smrv.2014.06.002; Goncalves BSB, 2014, SLEEP SCI, V7, P158, DOI 10.1016/j.slsci.2014.09.013; Grimaldi S, 2009, J ENVIRON PUBLIC HEA, V2009, DOI 10.1155/2009/165013; Gupte AA, 2009, DIABETES, V58, P567, DOI 10.2337/db08-1070; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; Hildrum B, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-220; Iftikhar IH, 2015, ANN AM THORAC SOC, V12, P1364, DOI 10.1513/AnnalsATS.201504-190OC; Kawabe Y, 2014, J ATHEROSCLER THROMB, V21, P703, DOI 10.5551/jat.19380; Kim CE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5557-8; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; Knutsson A, 2014, CHRONOBIOL INT, V31, P1146, DOI 10.3109/07420528.2014.957308; Koo YS, 2016, CHRONOBIOL INT, V33, P301, DOI 10.3109/07420528.2016.1143480; Lian Y, 2019, PSYCHIAT RES, V274, P66, DOI 10.1016/j.psychres.2019.01.096; Lin YC, 2015, INT J OCCUP MED ENV, V28, P675, DOI 10.13075/ijomeh.1896.00335; Lunn RM, 2017, SCI TOTAL ENVIRON, V607, P1073, DOI 10.1016/j.scitotenv.2017.07.056; Maki KC, 2012, METAB SYNDR RELAT D, V10, P363, DOI 10.1089/met.2012.0020; Marshall J, 2016, EYE, V30, P211, DOI 10.1038/eye.2015.265; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; McFadden E, 2014, AM J EPIDEMIOL, V180, P245, DOI 10.1093/aje/kwu117; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Park YMM, 2019, JAMA INTERN MED, V179, P1061, DOI 10.1001/jamainternmed.2019.0571; Parker J, 2010, MATURITAS, V65, P225, DOI 10.1016/j.maturitas.2009.12.013; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Peschke E, 2015, J PINEAL RES, V59, P1, DOI 10.1111/jpi.12240; Plano SA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00558; Reid KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092251; Rios-Lugo MJ, 2010, J PINEAL RES, V49, P342, DOI 10.1111/j.1600-079X.2010.00798.x; Rybnikova NA, 2016, INT J OBESITY, V40, P815, DOI 10.1038/ijo.2015.255; SAARELA S, 1994, LIFE SCI, V54, P295, DOI 10.1016/0024-3205(94)00786-1; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schmitt EB, 2018, MATURITAS, V107, P97, DOI 10.1016/j.maturitas.2017.10.011; Sinha MK, 1996, J CLIN INVEST, V97, P1344, DOI 10.1172/JCI118551; Sohail S, 2015, CHRONOBIOL INT, V32, P802, DOI 10.3109/07420528.2015.1041597; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Strange RC, 2015, WORLD J DIABETES, V6, P896, DOI 10.4239/wjd.v6.i7.896; Sun H, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/2304746; Turi BC, 2016, CIENC SAUDE COLETIVA, V21, P1043, DOI 10.1590/1413-81232015214.23042015; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; vanSomeren EJW, 1996, BIOL PSYCHIAT, V40, P259, DOI 10.1016/0006-3223(95)00370-3; Villamor E, 2017, PUBLIC HEALTH NUTR, V20, P255, DOI [10.1017/S1368980016002342, 10.1017/s1368980016002342]; Vitezova A, 2015, EUR J ENDOCRINOL, V172, P327, DOI 10.1530/EJE-14-0580; von Schantz M, 2015, SCI REP-UK, V5, DOI [10.1038/srep09214, 10.1016/j.sleep.2015.02.105]; Zephy D, 2015, DIABETES METAB SYND, V9, P127, DOI 10.1016/j.dsx.2014.09.018; Zimmet P, 2019, J INTERN MED, V286, P181, DOI 10.1111/joim.12924	72	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238772	10.1371/journal.pone.0238772	http://dx.doi.org/10.1371/journal.pone.0238772			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946454	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000573851100073
J	Parikh, TJ; Stryczek, KC; Gillespie, C; Sayre, GG; Feemster, L; Udris, E; Majerczyk, B; Rinne, ST; Wiener, RS; Au, DH; Helfrich, CD				Parikh, Toral J.; Stryczek, Krysttel C.; Gillespie, Chris; Sayre, George G.; Feemster, Laura; Udris, Edmunds; Majerczyk, Barbara; Rinne, Seppo T.; Wiener, Renda Soylemez; Au, David H.; Helfrich, Christian D.			Provider anticipation and experience of patient reaction when deprescribing guideline discordant inhaled corticosteroids	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OLDER-ADULTS; CLINICAL CONSEQUENCES; SAMPLE-SIZE; POLYPHARMACY; BELIEFS; MEDICATION	Introduction Despite evidence of possible patient harm and substantial costs, medication overuse is persistent. Patient reaction is one potential barrier to deprescribing, but little research has assessed this in specific instances of medication discontinuation. We sought to understand Veteran and provider experience when de-implementing guideline-discordant use of inhaled corticosteroids (ICS) in those with mild-to-moderate chronic obstructive pulmonary disease (COPD). Methods We conducted a mixed-methods analysis in a provider-randomized quality improvement project testing a proactive electronic-consultation from pulmonologists recommending ICS discontinuation when appropriate. PCPs at two Veterans Health Administration healthcare systems were included. We completed interviews with 16 unexposed providers and 6 intervention-exposed providers. We interviewed 9 patients within 3 months after their PCP proposed ICS discontinuation. We conducted inductive and deductive content analysis of qualitative data to explore an emergent theme of patient reaction. Forty-eight PCPs returned surveys (24 exposed and 24 unexposed, response rate: 35%). Results The unexposed providers anticipated their patients might resist ICS discontinuation because it seems counterintuitive to stop something that is working, patient's fear of worsening symptoms, or if the prescription was initiated by another provider. Intervention-exposed providers reported similar experiences in post-intervention interviews. Unexposed providers anticipated that patients may accept ICS discontinuation, citing tactical use of patient-centered care strategies. This was echoed by intervention-exposed providers who had successfully discontinued an ICS. Veterans reported acceding to their providers out of trust or deference to their advanced training, even after describing an ICS as a 'security blanket'. Our survey findings supported the subthemes from our interviews. Among providers who proposed discontinuation of an ICS, 76% reported that they were able to discontinue it or switch to another more appropriate medication. Conclusions While PCPs anticipated that patients would resist discontinuing an ICS, interviews with patient and intervention-exposed PCPs along with surveys suggest that patients were receptive to this change.	[Parikh, Toral J.; Sayre, George G.; Feemster, Laura; Udris, Edmunds; Majerczyk, Barbara; Au, David H.; Helfrich, Christian D.] VA Puget Sound Healthcare Syst, Seattle Denver Ctr Innovat Vet Ctr & Value Driven, Seattle, WA 98108 USA; [Parikh, Toral J.] Univ Washington, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Stryczek, Krysttel C.] VA Northeast Ohio Healthcare Syst, Cleveland, OH USA; [Gillespie, Chris; Rinne, Seppo T.; Wiener, Renda Soylemez] Edith Nourse Rogers Mem Vet Hosp, Ctr Healthcare Org & Implementat Res, Bedford, MA USA; [Sayre, George G.; Helfrich, Christian D.] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA; [Feemster, Laura; Au, David H.] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [Rinne, Seppo T.; Wiener, Renda Soylemez] Boston Univ, Sch Med, Pulm Ctr, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Boston University	Parikh, TJ (corresponding author), VA Puget Sound Healthcare Syst, Seattle Denver Ctr Innovat Vet Ctr & Value Driven, Seattle, WA 98108 USA.; Parikh, TJ (corresponding author), Univ Washington, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.	parikht@uw.edu	Wiener, Renda/AAO-1557-2020; Helfrich, Christian/D-2382-2016	Helfrich, Christian/0000-0002-9827-4768	United States (U.S.) Department of Veterans Affairs Quality Enhancement Research Initiative [QUE 15-271]; VA Office of Academic Affiliations' Advanced Fellowship in Health Services Research and Development [TPH 61-001]	United States (U.S.) Department of Veterans Affairs Quality Enhancement Research Initiative; VA Office of Academic Affiliations' Advanced Fellowship in Health Services Research and Development	This work was supported by grant #QUE 15-271 from the United States (U.S.) Department of Veterans Affairs Quality Enhancement Research Initiative awarded to CDH and DHA. In addition, this material is based on work supported by a VA Office of Academic Affiliations' Advanced Fellowship in Health Services Research and Development to Dr. Parikh (TJP) (#TPH 61-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006544; [Anonymous], 2004, J CIRC RYTHMS, V2, P7; Bokhof B, 2016, DRUG AGING, V33, P249, DOI 10.1007/s40266-016-0354-5; Cataldo D, 2018, INT J CHRONIC OBSTR, V13, P2089, DOI 10.2147/COPD.S164259; Charlesworth CJ, 2015, J GERONTOL A-BIOL, V70, P989, DOI 10.1093/gerona/glv013; CLEE MA, 1980, J CONSUM RES, V6, P389, DOI 10.1086/208782; Clyne B, 2017, BRIT J GEN PRACT, V67, pE507, DOI 10.3399/bjgp17X691073; Creswell JW., 2017, DESIGNING CONDUCTING; Department of Veterans Affairs, IMPR SAF QUAL EV BAS; Edelman M, 2019, DRUG AGING, V36, P1133, DOI 10.1007/s40266-019-00712-6; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Field TS, 2005, MED CARE, V43, P1171, DOI 10.1097/01.mlr.0000185690.10336.70; Gibbs L, 2007, AUST NZ J PUBL HEAL, V31, P540, DOI 10.1111/j.1753-6405.2007.00140.x; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Helfrich CD, 2018, J EVAL CLIN PRACT, V24, P198, DOI 10.1111/jep.12855; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Kitson AL, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-1; Linsky A, 2015, PATIENT EDUC COUNS, V98, P220, DOI 10.1016/j.pec.2014.11.010; Maher RL, 2014, EXPERT OPIN DRUG SAF, V13, P57, DOI 10.1517/14740338.2013.827660; Malerba M, 2019, FRONT PHARMACOL, P10, DOI DOI 10.3389/FPHAR.2019.00390/FULL; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Mannino DM, 2015, CHRON OBSTR PULM DIS, V2, P223, DOI 10.15326/jcopdf.2.3.2014.0151; Martin P, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015959; McCormack B, 2002, J ADV NURS, V38, P94, DOI 10.1046/j.1365-2648.2002.02150.x; Morgan DJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4534; Quick BL, 2007, COMMUN RES, V34, P255, DOI 10.1177/0093650207300427; Reeve E, 2018, JAMA INTERN MED, V178, P1673, DOI 10.1001/jamainternmed.2018.4720; Reeve E, 2016, BRIT J GEN PRACT, V66, pE552, DOI 10.3399/bjgp16X685669; Reeve E, 2015, BRIT J CLIN PHARMACO, V80, P1254, DOI 10.1111/bcp.12732; Reeve E, 2013, DRUG AGING, V30, P793, DOI 10.1007/s40266-013-0106-8; Rossi Michelle I, 2007, Am J Geriatr Pharmacother, V5, P317, DOI 10.1016/j.amjopharm.2007.12.001; Rycroft-Malone J, 2004, J ADV NURS, V47, P81, DOI 10.1111/j.1365-2648.2004.03068.x; Salazar JA, 2007, EXPERT OPIN DRUG SAF, V6, P695, DOI 10.1517/14740338.6.6.695; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Simeone JC, 2017, INT J CHRONIC OBSTR, V12, P73, DOI 10.2147/COPD.S122013; Sobieraj DM, 2008, CLIN THER, V30, P1416, DOI 10.1016/j.clinthera.2008.08.004; Stryczek K, 2019, J GEN INTERN MED, DOI DOI 10.1007/S11606-019-05193-231396814; Tannenbaum C, 2014, JAMA INTERN MED, V174, P890, DOI 10.1001/jamainternmed.2014.949; Tashkin DP, 2018, INT J CHRONIC OBSTR, V13, P2587, DOI 10.2147/COPD.S172240; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Weir K, 2017, J GERONTOL B    1128, DOI [10.1093/geronb/gbx138/4668532, DOI 10.1093/GER0NB/GBX138/4668532]; Yawn BP, 2013, INT J CHRONIC OBSTR, V8, P295, DOI 10.2147/COPD.S42366	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238511	10.1371/journal.pone.0238511	http://dx.doi.org/10.1371/journal.pone.0238511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941462	Green Published, gold			2022-12-26	WOS:000573848800009
J	Wagner, WL; Zheng, YF; Pierce, A; Ackermann, M; Horstmann, H; Kuner, T; Ronchi, P; Schwab, Y; Konietzke, P; Wunnemann, F; Wielputz, MO; Kauczor, HU; Mentzer, SJ				Wagner, Willi L.; Zheng, Yifan; Pierce, Aidan; Ackermann, Maximilian; Horstmann, Heinz; Kuner, Thomas; Ronchi, Paolo; Schwab, Yannick; Konietzke, Philip; Wuennemann, Felix; Wielpuetz, Mark O.; Kauczor, Hans-Ulrich; Mentzer, Steven J.			Mesopolysaccharides: The extracellular surface layer of visceral organs	PLOS ONE			English	Article							PLEURAL MESOTHELIAL CELLS; PERITONEAL MESOTHELIUM; ENDOTHELIAL GLYCOCALYX; RUTHENIUM RED; LECTIN; IDENTIFICATION; GLYCOPROTEINS; MICROVILLI; EXPRESSION; MEMBRANE	The mesothelium is a dynamic and specialized tissue layer that covers the somatic cavities (pleural, peritoneal, and pericardial) as well as the surface of the visceral organs such as the lung, heart, liver, bowel and tunica vaginalis testis. The potential therapeutic manipulation of visceral organs has been complicated by the carbohydrate surface layer-here, called the mesopolysaccharide (MPS)-that coats the outer layer of the mesothelium. The traditional understanding of MPS structure has relied upon fixation techniques known to degrade carbohydrates. The recent development of carbohydrate-preserving fixation for high resolution imaging techniques has provided an opportunity to re-examine the structure of both the MPS and the visceral mesothelium. In this report, we used high pressure freezing (HPF) as well as serial section transmission electron microscopy to redefine the structure of the MPS expressed on the murine lung, heart and liver surface. Tissue preserved by HPF and examined by transmission electron microscopy demonstrated a pleural MPS layer 13.01 +/- 1.1 um deep-a 100-fold increase in depth compared to previously reported data obtained with conventional fixation techniques. At the base of the MPS were microvilli 1.1 +/- 0.35 um long and 42 +/- 5 nm in diameter. Morphological evidence suggested that the MPS was anchored to the mesothelium by microvilli. In addition, membrane pits 97 +/- 17 nm in diameter were observed in the apical mesothelial membrane. The spatial proximity and surface density (29 +/- 4.5%) of the pits suggested an active process linked to the structural maintenance of the MPS. The striking magnitude and complex structure of the MPS indicates that it is an important consideration in studies of the visceral mesothelium.	[Wagner, Willi L.; Konietzke, Philip; Wuennemann, Felix; Wielpuetz, Mark O.; Kauczor, Hans-Ulrich] Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Wagner, Willi L.; Horstmann, Heinz; Kuner, Thomas; Ronchi, Paolo; Schwab, Yannick; Konietzke, Philip; Wuennemann, Felix; Wielpuetz, Mark O.; Kauczor, Hans-Ulrich] Heidelberg Univ, German Ctr Lung Res, Translat Lung Res Ctr, Heidelberg, Germany; [Wagner, Willi L.; Zheng, Yifan; Pierce, Aidan; Mentzer, Steven J.] Harvard Med Sch, Brigham & Womens Hosp, Lab Adapt & Regenerat Biol, Boston, MA 02115 USA; [Ackermann, Maximilian] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany; [Horstmann, Heinz; Kuner, Thomas] Heidelberg Univ, Inst Anat & Cell Biol, Dept Funct Neuroanat, Heidelberg, Germany; [Ronchi, Paolo; Schwab, Yannick] European Mol Biol Lab, Electron Microscopy Core Facil, Heidelberg, Germany; [Schwab, Yannick] European Mol Biol Lab, Cell Biol & Biophys Unit, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Mentzer, SJ (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Lab Adapt & Regenerat Biol, Boston, MA 02115 USA.	smentzer@bwh.harvard.edu	Wielpütz, Mark Oliver/ADP-0499-2022; Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021; Wielpuetz, Mark/ABE-1790-2020	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; Ronchi, Paolo/0000-0001-9010-533X	NIH [HL94567, HL134229, HL007734, ES000002]; German Center for Lung Research (DZL); German Research Foundation [SFB1066]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Center for Lung Research (DZL); German Research Foundation(German Research Foundation (DFG))	This study was supported in part by NIH Grant HL94567, HL134229, HL007734, ES000002, the German Center for Lung Research (DZL) and the German Research Foundation (SFB1066).	ANDREWS PM, 1973, ANAT RECORD, V177, P409, DOI 10.1002/ar.1091770307; [Anonymous], 2017, INT J MOL SCI, V18, pE961; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; BARADI AF, 1976, TISSUE CELL, V8, P159, DOI 10.1016/0040-8166(76)90027-6; BENNETT HS, 1963, J HISTOCHEM CYTOCHEM, V11, P14, DOI 10.1177/11.1.14; BROEKAERT WF, 1984, BIOCHEM J, V221, P163, DOI 10.1042/bj2210163; Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Choi SY, 2017, INT UROL NEPHROL, V49, P171, DOI 10.1007/s11255-016-1430-9; DUBOCHET J, 1981, J MICROSC-OXFORD, V124, pRP3; Fassel TA, 1999, BIOTECH HISTOCHEM, V74, P194, DOI 10.3109/10520299909047974; Giddings TH, 1927, METHOD CELL BIOL, V67, P27; GILKEY JC, 1986, J ELECTRON MICR TECH, V3, P177, DOI 10.1002/jemt.1060030206; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Henderson DW, 1998, AM J CLIN PATHOL, V110, P397, DOI 10.1093/ajcp/110.3.397; JONJIC N, 1992, J EXP MED, V176, P1165, DOI 10.1084/jem.176.4.1165; Li Y, 2015, ANAL CHEM, V87, P4683, DOI 10.1021/ac504304v; Lucas PA, 2007, INT J ARTIF ORGANS, V30, P550, DOI 10.1177/039139880703000613; LUFT JH, 1964, J CELL BIOL, V23, pA54; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; MADISON LD, 1979, J CELL BIOL, V82, P783, DOI 10.1083/jcb.82.3.783; MATSUMOTO I, 1983, J BIOL CHEM, V258, P2886; Michailova K, 1999, ANN ANAT, V181, P253, DOI 10.1016/S0940-9602(99)80040-5; MICHAILOVA KN, 1995, EUR J MORPHOL, V33, P265; Michailova TN, SEROSAL MEMBRANES AD, P1; MIRONOV VA, 1979, CELL TISSUE RES, V201, P327; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Mutsaers SE, 1996, J PATHOL, V180, P333; Mutsaers SE, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00113; Mutsaers SE, 2016, FERTIL STERIL, V106, P1018, DOI 10.1016/j.fertnstert.2016.09.005; NACHBAR MS, 1980, J BIOL CHEM, V255, P2056; NAGATA Y, 1974, J BIOL CHEM, V249, P3116; Nguyen MN, 2010, PLOS ONE, V5, pe9907; ODOR DL, 1954, AM J ANAT, V95, P433; OHTSUKA A, 1994, ARCH HISTOL CYTOL, V57, P307, DOI 10.1679/aohc.57.307; Price RD, 2007, J PLAST RECONSTR AES, V60, P1110, DOI 10.1016/j.bjps.2007.03.005; REEKE GN, 1974, ANN NY ACAD SCI, V234, P369, DOI 10.1111/j.1749-6632.1974.tb53049.x; RENNARD SI, 1984, AM REV RESPIR DIS, V130, P267; Shaw TJ, 2016, INT J GYNECOL CANCER, V26, P833, DOI 10.1097/IGC.0000000000000697; Sironi C, 2013, RESP PHYSIOL NEUROBI, V188, P60, DOI 10.1016/j.resp.2013.05.003; SMITH U, 1971, SCIENCE, V173, P925, DOI 10.1126/science.173.4000.925; SUGANUMA A, 1961, J BIOPHYS BIOCHEM CY, V10, P292, DOI 10.1083/jcb.10.2.292; Tarbell JM, 2010, CARDIOVASC RES, V87, P320, DOI 10.1093/cvr/cvq146; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Tian Y, 2011, PROTEOMICS, V11, P4677, DOI 10.1002/pmic.201000811; WANG NS, 1985, CLIN CHEST MED, V6, P3; WANG NS, 1974, AM REV RESPIR DIS, V110, P623; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Wornle M, 2010, APPL BIOCHEM BIOTECH, V160, P1179, DOI 10.1007/s12010-009-8643-7; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238798	10.1371/journal.pone.0238798	http://dx.doi.org/10.1371/journal.pone.0238798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941441	gold, Green Published			2022-12-26	WOS:000573848800063
J	Baio, G; Fabbi, M; Cilli, M; Rosa, F; Boccardo, S; Valdora, F; Salvi, S; Basso, L; Emionite, L; Gianolio, E; Aime, S; Neumaier, CE				Baio, Gabriella; Fabbi, Marina; Cilli, Michele; Rosa, Francesca; Boccardo, Simona; Valdora, Francesca; Salvi, Sandra; Basso, Luca; Emionite, Laura; Gianolio, Eliana; Aime, Silvio; Neumaier, Carlo Emanuele			Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors	PLOS ONE			English	Article							SENSING RECEPTOR; CA2+; CHANNEL; EXPRESSION; TRPV6; CALBINDIN-D-28K; HOMEOSTASIS; ACTIVATION; TARGET; CAT1	Procedures To preliminary assess the relationship between Manganese Enhanced Magnetic Resonance Imaging (MEMRI) and the expression of calcium receptors in human prostate and breast cancer animal models. Methods NOD/SCID mice were inoculated with MDA-MB-231 breast cancer cells and prostate PC3 cancer cells to develop orthotopic or pseudometastatic cancer animal models. Mice were studied on a clinical 3T scanner by using a prototype birdcage coil before and after intravenous injection of MnCl2. Assessment of receptor's status was carried out after the MR images acquisition by immunohistochemistry on excised tumours. Results Manganese contrast enhancement in breast or prostate cancer animal models well correlated with CaSR expression (p<0.01), whereas TRPV6 expression levels appeared not relevant to the Mn uptake. Conclusion Our preliminary results suggest that MEMRI appears an efficient tool to characterize human breast and prostate cancer animal models in the presence of different expression level of calcium receptors.	[Baio, Gabriella] Univ East Anglia, NNUH Norfolk, Norwich, Norfolk, England; [Baio, Gabriella] Univ East Anglia, Norwich Univ Hosp, Norwich, Norfolk, England; [Baio, Gabriella] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Baio, Gabriella; Rosa, Francesca; Valdora, Francesca; Basso, Luca; Neumaier, Carlo Emanuele] IRCCS Osped Policlin San Martino, Diagnost Imaging & Senol Unit, Genoa, Italy; [Fabbi, Marina] IRCCS Osped Policlin San Martino, Biotherapies Unit, Genoa, Italy; [Cilli, Michele; Emionite, Laura] IRCCS Osped Policlin San Martino, Anim Facil, Genoa, Italy; [Boccardo, Simona] IRCCS Osped Policlin San Martino, Lung Canc Unit, Genoa, Italy; [Valdora, Francesca] Univ Genoa, Dept Hlth Sci, Genoa, Italy; [Salvi, Sandra] IRCCS Osped Policlin San Martino, Dept Pathol, Genoa, Italy; [Gianolio, Eliana; Aime, Silvio] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Gianolio, Eliana; Aime, Silvio] Univ Torino, Mol Imaging Ctr, Turin, Italy	University of East Anglia; University of East Anglia; University of East Anglia; University of Genoa; University of Genoa; University of Turin; University of Turin	Baio, G (corresponding author), Univ East Anglia, NNUH Norfolk, Norwich, Norfolk, England.; Baio, G (corresponding author), Univ East Anglia, Norwich Univ Hosp, Norwich, Norfolk, England.; Baio, G (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England.; Baio, G (corresponding author), IRCCS Osped Policlin San Martino, Diagnost Imaging & Senol Unit, Genoa, Italy.	g.baio@uea.ac.uk	Rosa, Francesca/AAJ-6383-2021; gianolio, eliana/AAC-2521-2021	Rosa, Francesca/0000-0002-7744-4385; Cilli, Michele/0000-0003-4083-8986				Aggarwal A, 2015, BBA-MOL CELL RES, V1853, P2158, DOI 10.1016/j.bbamcr.2015.02.011; Ahearn TU, 2016, J CLIN ENDOCR METAB, V101, P2520, DOI 10.1210/jc.2016-1082; Baio G, 2015, MOL IMAGING BIOL, V17, P548, DOI 10.1007/s11307-015-0823-y; Baio G, 2012, EUR RADIOL, V22, P551, DOI 10.1007/s00330-011-2285-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bianchi A, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3790; Bodding M, 2004, J BIOL CHEM, V279, P36546, DOI 10.1074/jbc.M404679200; Bodding M, 2002, J BIOL CHEM, V277, P36656, DOI 10.1074/jbc.M202822200; Bodding M, 2007, CELL SIGNAL, V19, P617, DOI 10.1016/j.cellsig.2006.08.012; Bolanz KA, 2008, MOL CANCER THER, V7, P271, DOI 10.1158/1535-7163.MCT-07-0478; Brennan SC, 2013, BBA-MOL CELL RES, V1833, P1732, DOI 10.1016/j.bbamcr.2012.12.011; Castets CR, 2016, SCI REP-UK, V6, DOI 10.1038/srep39449; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Corey E, 2002, PROSTATE, V52, P20, DOI 10.1002/pros.10091; Crossgrove J, 2004, NMR BIOMED, V17, P544, DOI 10.1002/nbm.931; Fecher-Trost C, 2014, HANDB EXP PHARMACOL, V222, P359, DOI 10.1007/978-3-642-54215-2_14; Gianolio E, 2015, NMR BIOMED, V28, P1104, DOI 10.1002/nbm.3349; Grunecker B, 2010, NMR BIOMED, V23, P913, DOI 10.1002/nbm.1508; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Joeckel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-42; Li XY, 2014, TUMOR BIOL, V35, P5709, DOI 10.1007/s13277-014-1756-9; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Machaca K, 2011, CELL CALCIUM, V49, P323, DOI 10.1016/j.ceca.2011.05.004; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; Mihai R, 2006, EJSO, V32, P511, DOI 10.1016/j.ejso.2006.02.009; Missiaen L, 2000, CELL CALCIUM, V28, P1, DOI 10.1054/ceca.2000.0131; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nofiele JT, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2013.00071; Parkash J, 2004, INT J ONCOL, V24, P1111; Parkash J, 2004, INT J MOL MED, V13, P3; Parkash J, 2010, LIFE SCI, V87, P587, DOI 10.1016/j.lfs.2010.09.013; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Pautler Robia G, 2006, Methods Mol Med, V124, P365; Peng JB, 2001, BIOCHEM BIOPH RES CO, V282, P729, DOI 10.1006/bbrc.2001.4638; Peters AA, 2012, MOL CANCER THER, V11, P2158, DOI 10.1158/1535-7163.MCT-11-0965; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Shapovalov G, 2016, SEMIN IMMUNOPATHOL, V38, P357, DOI 10.1007/s00281-015-0525-1; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Stoerger C, 2014, BIOCHEM CELL BIOL, V92, P441, DOI 10.1139/bcb-2014-0063; Wen L, 2018, TOMOGRAPHY, V4, P78, DOI 10.18383/j.tom.2018.00008; Wissenbach U, 2001, J BIOL CHEM, V276, P19461, DOI 10.1074/jbc.M009895200; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	46	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0224414	10.1371/journal.pone.0224414	http://dx.doi.org/10.1371/journal.pone.0224414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931488	Green Published, gold, Green Submitted			2022-12-26	WOS:000573375500015
J	Moran, MM; Wilson, BM; Li, J; Engen, PA; Naqib, A; Green, SJ; Virdi, AS; Plaas, A; Forsyth, CB; Keshavarzian, A; Sumner, DR				Moran, Meghan M.; Wilson, Brittany M.; Li, Jun; Engen, Phillip A.; Naqib, Ankur; Green, Stefan J.; Virdi, Amarjit S.; Plaas, Anna; Forsyth, Christopher B.; Keshavarzian, Ali; Sumner, Dale R.			The gut microbiota may be a novel pathogenic mechanism in loosening of orthopedic implants in rats	FASEB JOURNAL			English	Article						bone volume; gut microbiome; implant; implant fixation; orthopedics	PARTICLE-INDUCED OSTEOLYSIS; BONE TURNOVER MARKERS; TOTAL HIP; KNEE ARTHROPLASTY; INFLAMMATORY RESPONSE; COMMENSAL MICROBIOTA; PROBIOTIC REGULATION; UNITED-STATES; MODEL; LIVER	Particles released from implants cause inflammatory bone loss, which is a key factor in aseptic loosening, the most common reason for joint replacement failure. With the anticipated increased incidence of total joint replacement in the next decade, implant failure will continue to burden patients. The gut microbiome is increasingly recognized as an important factor in bone physiology, however, its role in implant loosening is currently unknown. We tested the hypothesis that implant loosening is associated with changes in the gut microbiota in a preclinical model. When the particle challenge caused local joint inflammation, decreased peri-implant bone volume, and decreased implant fixation, the gut microbiota was affected. When the particle challenge did not cause this triad of local effects, the gut microbiota was not affected. Our results suggest that cross-talk between these compartments is a previously unrecognized mechanism of failure following total joint replacement.	[Moran, Meghan M.; Wilson, Brittany M.; Naqib, Ankur; Virdi, Amarjit S.; Sumner, Dale R.] Rush Univ, Med Ctr, Dept Cell & Mol Med, 600 S Paulina St,Suite 507 AAC, Chicago, IL 60612 USA; [Li, Jun; Plaas, Anna] Rush Univ, Rush Med Coll, Dept Internal Med, Div Rheumatol,Med Ctr, Chicago, IL 60612 USA; [Engen, Phillip A.; Naqib, Ankur; Forsyth, Christopher B.; Keshavarzian, Ali] Rush Med Coll, Div Digest Dis & Nutr, Dept Internal Med, Chicago, IL 60612 USA; [Green, Stefan J.] Univ Illinois, Res Resources Ctr, Genome Res Core, Chicago, IL USA	Rush University; Rush University; Rush University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Moran, MM (corresponding author), Rush Univ, Med Ctr, Dept Cell & Mol Med, 600 S Paulina St,Suite 507 AAC, Chicago, IL 60612 USA.	meghan_moran@rush.edu		Sumner, Dale/0000-0001-9575-3862	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR066562, R21AR075130-01]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR066562 and R21AR075130-01	Akbar M, 2012, J R SOC INTERFACE, V9, P2109, DOI 10.1098/rsif.2012.0006; Anand S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02147; Anrather J, 2016, NEUROTHERAPEUTICS, V13, P661, DOI 10.1007/s13311-016-0483-x; Beckmann N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205307; Bellocchi C, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0758-9; Bosch U, 2001, KNEE SURG SPORT TR A, V9, P282, DOI 10.1007/s001670100218; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Britton RA, 2014, J CELL PHYSIOL, V229, P1822, DOI 10.1002/jcp.24636; Burke DG, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0968-8; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Catrina AI, 2016, RHEUMATOLOGY, V55, P391, DOI 10.1093/rheumatology/keu469; Chamaon K, 2019, J BIOMED MATER RES B, V107, P1246, DOI 10.1002/jbm.b.34217; Chan DD, 2015, OSTEOARTHR CARTILAGE, V23, P1879, DOI 10.1016/j.joca.2015.06.021; Cheung AC, 2016, BONE JOINT J, V98B, P6, DOI 10.1302/0301-620X.98B1.36374; Cheuy VA, 2017, J ARTHROPLASTY, V32, P2604, DOI 10.1016/j.arth.2017.02.005; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cobelli N, 2011, NAT REV RHEUMATOL, V7, P600, DOI 10.1038/nrrheum.2011.128; Collins S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090523; Culliford D, 2015, OSTEOARTHR CARTILAGE, V23, P594, DOI 10.1016/j.joca.2014.12.022; Czarnek K, 2015, CENT EUR J IMMUNOL, V40, P236, DOI 10.5114/ceji.2015.52837; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Earley ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129996; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; GLANT TT, 1993, J BONE MINER RES, V8, P1071; GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001; Gur TL, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00005; Guss JD, 2019, OSTEOARTHR CARTILAGE, V27, P129, DOI 10.1016/j.joca.2018.07.020; Guss JD, 2017, J BONE MINER RES, V32, P1343, DOI 10.1002/jbmr.3114; Hallab NJ, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00005; Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182; He ZH, 2010, RESPIROLOGY, V15, P478, DOI 10.1111/j.1440-1843.2010.01709.x; Hernandez CJ, 2017, ADV EXP MED BIOL, V1033, P249, DOI 10.1007/978-3-319-66653-2_12; Hernandez CJ, 2016, J BONE MINER RES, V31, P1638, DOI 10.1002/jbmr.2887; Holloway L, 2007, BRIT J NUTR, V97, P365, DOI 10.1017/S000711450733674X; HUANG GT, 2017, FRONT MICROBIOL, V8; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Inacio MCS, 2017, OSTEOARTHR CARTILAGE, V25, P1797, DOI 10.1016/j.joca.2017.07.022; Inacio MCS, 2017, CLIN ORTHOP RELAT R, V475, P2130, DOI 10.1007/s11999-017-5377-7; Kandahari AM, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.14; Koh A, 2020, MOL CELL, V78, P584, DOI 10.1016/j.molcel.2020.03.005; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Liu S, 2012, ARTHRITIS RHEUM-US, V64, P4012, DOI 10.1002/art.37697; Liu SO, 2012, J BIOMED MATER RES A, V100A, P918, DOI 10.1002/jbm.a.34029; Mackos AR, 2017, HORM BEHAV, V88, P70, DOI 10.1016/j.yhbeh.2016.10.006; Matharu D, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9940-0; McCabe L, 2015, CURR OSTEOPOROS REP, V13, P363, DOI 10.1007/s11914-015-0292-x; McCabe LR, 2018, CALCIFIED TISSUE INT, V102, P480, DOI 10.1007/s00223-018-0403-7; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McGinty T, 2018, CURR OPIN HIV AIDS, V13, P28, DOI 10.1097/COH.0000000000000425; Moran MM, 2017, J ORTHOP RES, V35, P2595, DOI 10.1002/jor.23619; Moran MM, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.61; Moucha CS, 2006, JOINT REPLACEMENTS B, P13; Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030; Naqib A, 2018, METHODS MOL BIOL, V1783, P149, DOI 10.1007/978-1-4939-7834-2_7; Nemes S, 2015, ACTA ORTHOP, V86, P426, DOI 10.3109/17453674.2015.1034608; Nemes S, 2014, ACTA ORTHOP, V85, P238, DOI 10.3109/17453674.2014.913224; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pan HD, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0719-1; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson JB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24931-w; Rios-Arce ND, 2020, BONE, V134, DOI 10.1016/j.bone.2020.115269; Roberfroid MB, 2002, J NUTR, V132, P3599, DOI 10.1093/jn/132.12.3599; Ross RD, 2014, J ORTHOP RES, V32, P967, DOI 10.1002/jor.22607; Rutherford RW, 2018, J ARTHROPLASTY, V33, pS177, DOI 10.1016/j.arth.2018.03.037; Samelko L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160141; Sansone V, 2013, CLIN CASES MINER BON, V10, P34, DOI 10.11138/ccmbm/2013.10.1.034; Schepper JD, 2020, J BONE MINER RES, V35, P801, DOI 10.1002/jbmr.3947; Schepper JD, 2019, J BONE MINER RES, V34, P681, DOI 10.1002/jbmr.3635; Scher JU, 2016, ARTHRITIS RHEUMATOL, V68, P35, DOI 10.1002/art.39259; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Scholz-Ahrens KE, 2007, J NUTR, V137, p838S, DOI 10.1093/jn/137.3.838S; Scholz-Ahrens KE, 2001, AM J CLIN NUTR, V73, p459S, DOI 10.1093/ajcn/73.2.459s; Schott EM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.95997; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Servick K, 2016, SCIENCE, V353, P741, DOI 10.1126/science.353.6301.741; Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y; Smith RA, 2010, J BIOMED MATER RES A, V93A, P227, DOI 10.1002/jbm.a.32531; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Stephens M, 2018, CELL TISSUE RES, V371, P599, DOI 10.1007/s00441-017-2779-5; Takahara S, 2000, J NUTR, V130, P1792, DOI 10.1093/jn/130.7.1792; Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z; Urban RM, 2004, J ARTHROPLASTY, V19, P94, DOI 10.1016/j.arth.2004.09.013; Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002; Ursell LK, 2012, NUTR REV, V70, pS38, DOI 10.1111/j.1753-4887.2012.00493.x; Voigt RM, 2016, ALCOHOL CLIN EXP RES, V40, P335, DOI 10.1111/acer.12943; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wan SZ, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00018; Wang ZH, 2017, INT J NANOMED, V12, DOI 10.2147/IJN.S130485; WILLERT HG, 1974, J BONE JOINT SURG AM, VA 56, P1368, DOI 10.2106/00004623-197456070-00005; WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95; WILLERT HG, 1977, J BIOMED MATER RES, V11, P157, DOI 10.1002/jbm.820110202; Willert HG, 1996, CLIN ORTHOP RELAT R, P4; Wilson BM, 2020, J ORTHOP RES, V38, P1216, DOI 10.1002/jor.24563; Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202; Xiao L, 2019, J NUTR, V149, P856, DOI 10.1093/jn/nxz006; Yadav Jessica, 2013, Open Orthop J, V7, P605, DOI 10.2174/1874325001307010605; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang WY, 2016, TOXICOL LETT, V258, P192, DOI 10.1016/j.toxlet.2016.07.003; Zhu CS, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060113	106	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14302	14317		10.1096/fj.202001364R	http://dx.doi.org/10.1096/fj.202001364R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931052	Green Accepted, Bronze			2022-12-26	WOS:000570776000001
J	Hossain, MA; Jahid, MIK; Hossain, KMA; Walton, LM; Uddin, Z; Haque, MO; Kabir, MF; Arafat, SMY; Sakel, M; Faruqui, R; Hossain, Z				Hossain, Mohammad Anwar; Jahid, Md Iqbal Kabir; Hossain, K. M. Amran; Walton, Lori Maria; Uddin, Zakir; Haque, Md Obaidul; Kabir, Md Feroz; Arafat, S. M. Yasir; Sakel, Mohamed; Faruqui, Rafey; Hossain, Zahid			Knowledge, attitudes, and fear of COVID-19 during the Rapid Rise Period in Bangladesh	PLOS ONE			English	Article								The study aims to determine the level of Knowledge, Attitude, and Practice (KAP) related to COVID-19 preventive health habits and perception of fear towards COVID-19 in subjects living in Bangladesh. Design: Prospective, cross-sectional survey of (n = 2157) male and female subjects, 13-88 years of age, living in Bangladesh. Methods: Ethical approval and trial registration were obtained before the commencement of the study. Subjects who volunteered to participate and signed the informed consent were enrolled in the study and completed the structured questionnaire on KAP and Fear of COVID-19 scale (FCV-19S). Results: Twenty-eight percent (28.69%) of subjects reported one or more COVID-19 symptoms, and 21.4% of subjects reported one or more co-morbidities. Knowledge scores were slightly higher in males (8.75 +/- 1.58) than females (8.66 +/- 1.70). Knowledge was significantly correlated with age (p < .005), an education level (p < .001), attitude (p < .001), and urban location (p < .001). Knowledge scores showed an inverse correlation with fear scores (p < .001). Eighty-three percent (83.7%) of subjects with COVID-19 symptoms reported wearing a mask in public, and 75.4% of subjects reported staying away from crowded places. Subjects with one or more symptoms reported higher fear compared to subjects without (18.73 +/- 4.6; 18.45 +/- 5.1). Conclusion: Bangladeshis reported a high prevalence of self-isolation, positive preventive health behaviors related to COVID-19, and moderate to high fear levels. Higher knowledge and Practice were found in males, higher education levels, older age, and urban location. Fear of COVID-19 was more prevalent in female and elderly subjects. A positive attitude was reported for the majority of subjects, reflecting the belief that COVID-19 was controllable and containable.	[Hossain, Mohammad Anwar; Jahid, Md Iqbal Kabir] Jashore Univ Sci & Technol JUST, Dept Microbiol, Jashore, Bangladesh; [Hossain, K. M. Amran; Haque, Md Obaidul; Hossain, Zahid] Bangladesh Hlth Profess Inst BHPI, Dept Physiotherapy, Dhaka, Bangladesh; [Walton, Lori Maria] Univ Scranton, Sch Hlth Sci, Dept Phys Therapy, Scranton, PA 18510 USA; [Uddin, Zakir] McGill Univ, Fac Med, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Kabir, Md Feroz] Jashore Univ Sci & Technol JUST, Dept Physiotherapy & Rehabil, Jashore, Bangladesh; [Arafat, S. M. Yasir] Enam Med Coll Hosp, Dept Psychiat, Dhaka, Bangladesh; [Sakel, Mohamed] East Kent Univ NHS FT Hosp, Canterbury, Kent, England; [Faruqui, Rafey] Kent & Medway NHS & Social Care Partnership Trust, Canterbury, Kent, England; [Faruqui, Rafey] Univ Kent, Canterbury, Kent, England	University of Scranton; McGill University; University of Kent	Hossain, KMA (corresponding author), Bangladesh Hlth Profess Inst BHPI, Dept Physiotherapy, Dhaka, Bangladesh.	amranphysio@gmail.com	Arafat, S M Yasir/P-9260-2015; Hossain, Md. Zahid/AFC-5937-2022	Arafat, S M Yasir/0000-0003-0521-5708; Hossain, Md. Zahid/0000-0003-2512-8329; Hossain, Kazi Md Amran/0000-0003-2124-2087; Uddin, Zakir/0000-0002-3018-0327; Hossain, Mohammad Anwar/0000-0002-1952-9436; Jahid, Iqbal Kabir/0000-0003-0717-0806; Hossain, M Anwar/0000-0001-9777-0332; Physiotherapist, Dr. Md. Feroz Kabir/0000-0002-5885-4514; Walton, Lori Maria/0000-0002-3221-7365				Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7; Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; [Anonymous], 2020, CORONAVIRUS DIS 2019; [Anonymous], 2020, THE ECONOMIST; [Anonymous], 2020, COVID 19; [Anonymous], 2020, DAILY STAR; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; [Anonymous], 2020, COVID 19 TRACK; Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154; Banerjee D, 2020, ASIAN J PSYCHIATR, V50, DOI 10.1016/j.ajp.2020.102014; Centers for Disease Control and Prevention, 2021, INT INF PREV CONTR G; Chowdhury T, 2020, ALJAZEERA; Ferdous MZ, 2020, KNOWLEDGE ATTITUDE P, DOI [10.1101/2020.05.26.20105700, DOI 10.1101/2020.05.26.20105700]; Haque T., 2020, KNOWLEDGE ATTITUDE P, DOI [10.21203/rs.3.rs-24562/v1, DOI 10.21203/RS.3.RS-24562/V1, 10.21203/rs.3.rs-24562/v1.]; Hasina S, 2020, GUARDIAN; Karim A, 2020, KNOWLEDGE ATTITUDE C, DOI [10.1101/2020.05.26.20104497, DOI 10.1101/2020.05.26.20104497]; Mamun MA, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102073; Mamun S, 2020, DHAKA TRIBUNE   0703; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Mustazir H, 2020, COVID 19 BANGLADESH; Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Watkins J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m810; WHO, 2020, WHO PROC TRANSL AD I; World Health Organization, 2020, COVID 19 STRAT UPD 1; World Health Organization. Regional Office for the Western Pacific, 2020, DENG SIT UPD 2020; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	28	92	94	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239646	10.1371/journal.pone.0239646	http://dx.doi.org/10.1371/journal.pone.0239646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970769	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000576265600060
J	Lyu, P; Yoo, KW; Yadav, MK; Atala, A; Aartsma-Rus, A; van Putten, M; Duan, DS; Lu, BS				Lyu, Pin; Yoo, Kyung Whan; Yadav, Manish Kumar; Atala, Anthony; Aartsma-Rus, Annemieke; van Putten, Maaike; Duan, Dongsheng; Lu, Baisong			Sensitive and reliable evaluation of single-cut sgRNAs to restore dystrophin by a GFP-reporter assay	PLOS ONE			English	Article							MOUSE MODEL; MUSCLE; GENE; INTERROGATION; DELETIONS	Most Duchenne muscular dystrophy (DMD) cases are caused by deletions or duplications of one or more exons that disrupt the reading frame ofDMDmRNA. Restoring the reading frame allows the production of partially functional dystrophin proteins, and result in less severe symptoms. Antisense oligonucleotide mediated exon skipping has been approved for DMD, but this strategy needs repeated treatment. CRISPR/Cas9 can also restore dystrophin reading frame. Although recentin vivostudies showed the efficacy of the single-cut reframing/exon skipping strategy, methods to find the most efficient single-cut sgRNAs for a specific mutation are lacking. Here we show that the insertion/deletion (INDEL) generating efficiency and the INDEL profiles both contribute to the reading frame restoring efficiency of a single-cut sgRNA, thus assays only examining INDEL frequency are not able to find the best sgRNAs. We therefore developed a GFP-reporter assay to evaluate single-cut reframing efficiency, reporting the combined effects of both aspects. We show that the GFP-reporter assay can reliably predict the performance of sgRNAs in myoblasts. This GFP-reporter assay makes it possible to efficiently and reliably find the most efficient single-cut sgRNA for restoring dystrophin expression.	[Lyu, Pin; Yoo, Kyung Whan; Yadav, Manish Kumar; Atala, Anthony; Lu, Baisong] Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA; [Aartsma-Rus, Annemieke; van Putten, Maaike] Leiden Univ, Med Ctr, Leiden, Netherlands; [Duan, Dongsheng] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65212 USA	Wake Forest University; Wake Forest University School of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Missouri System; University of Missouri Columbia	Lu, BS (corresponding author), Wake Forest Univ Hlth Sci, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.	blu@wakehealth.edu	; Lu, Baisong/B-5837-2013; Yadav, Manish Kumar/J-2250-2016	lyu, pin/0000-0001-6841-1373; Aartsma-Rus, Annemieke/0000-0003-1565-654X; van Putten, Maaike/0000-0002-0683-8897; Lu, Baisong/0000-0001-9240-558X; Yadav, Manish Kumar/0000-0001-8218-4859	Lu North Carolina State Grant [330054]; NIH [AR-60985]; Jackson Freel DMD Research Fund	Lu North Carolina State Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jackson Freel DMD Research Fund	Lu North Carolina State Grant 330054 (to A.A.), NIH AR-60985 and Jackson Freel DMD Research Fund (to D.D.).	Allen F, 2019, NAT BIOTECHNOL, V37, P64, DOI 10.1038/nbt.4317; Allen RE, 1997, METHOD CELL BIOL, V52, P155, DOI 10.1016/S0091-679X(08)60378-7; Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549; Amoasii L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8081; Anthony K, 2014, JAMA NEUROL, V71, P32, DOI 10.1001/jamaneurol.2013.4908; Bengtsson NE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14454; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chakrabarti AM, 2019, MOL CELL, V73, P699, DOI 10.1016/j.molcel.2018.11.031; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Conboy MJ, 2010, METHODS MOL BIOL, V621, P149, DOI 10.1007/978-1-60761-063-2_10; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Duchene BL, 2018, MOL THER, V26, P2604, DOI 10.1016/j.ymthe.2018.08.010; Gong SZ, 2018, CELL REP, V22, P359, DOI 10.1016/j.celrep.2017.12.041; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Helderman-van den Enden ATJM, 2010, NEUROMUSCULAR DISORD, V20, P251, DOI 10.1016/j.nmd.2010.01.013; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Isaac RS, 2016, ELIFE, V5, DOI 10.7554/eLife.13450; Javidi-Parsijani P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177444; Koo T, 2018, MOL THER, V26, P1529, DOI 10.1016/j.ymthe.2018.03.018; Li HL, 2015, STEM CELL REP, V4, P143, DOI 10.1016/j.stemcr.2014.10.013; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lu BS, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz093; Lyu P, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz605; Min YL, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4324; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ousterout DG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7244; Park J, 2017, BIOINFORMATICS, V33, P286, DOI 10.1093/bioinformatics/btw561; Raper AT, 2018, J AM CHEM SOC, V140, P2971, DOI 10.1021/jacs.7b13047; Singh D, 2018, P NATL ACAD SCI USA, V115, P5444, DOI 10.1073/pnas.1718686115; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Vakulskas CA, 2018, NAT MED, V24, P1216, DOI 10.1038/s41591-018-0137-0; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; van Overbeek M, 2016, MOL CELL, V63, P633, DOI 10.1016/j.molcel.2016.06.037; Veltrop M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193289; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Watanabe N, 2018, MOL THER-NUCL ACIDS, V13, P442, DOI 10.1016/j.omtn.2018.09.017; Xu L, 2016, MOL THER, V24, P564, DOI 10.1038/mt.2015.192; Zhang YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05405; Zhang Y, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602814	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239468	10.1371/journal.pone.0239468	http://dx.doi.org/10.1371/journal.pone.0239468			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970732	Green Published, gold			2022-12-26	WOS:000576265600082
J	Nabunya, P; Mubeezi, R; Awor, P				Nabunya, Phoebe; Mubeezi, Ruth; Awor, Phyllis			Prevalence of exclusive breastfeeding among mothers in the informal sector, Kampala Uganda	PLOS ONE			English	Article							BARRIERS; INFANT	Exclusive breastfeeding (EBF) for the first six months of life is effective in preventing infant morbidity and mortality. However, 36% of Ugandan children below 6 months are not breastfed exclusively despite its active promotion. This study determined the prevalence and factors associated with exclusive breastfeeding among mothers working in the informal sector in Kampala district. A community based cross-sectional study targeting 428 interviews with mothers with children aged 0-5 months was conducted. Analysis was done using modified Poisson regression in Stata version 14. The prevalence of exclusive breastfeeding was 42.8%. The factors associated with exclusive breastfeeding included: attending antenatal care at least 4 times (APR = 1.24; 95% CI: 1.01-1.51), intention to exclusively breastfeed for 6 months (APR = 1.26; 95% CI: 1.01-1.57) or longer (APR = 1.38; 95% CI: 1.06-1.76), proper breastfeeding practices (APR = 4.12; 95% CI: 2.88-5.90), age of the infant (APR = 0.78; 95% CI: 0.65-0.94) and (APR = 0.48; 95% CI: 0.39-0.60) for children aged 2-3 and 4-5 months respectively and working in a lower position (APR = 0.68; 95% CI: 0.55-0.83). Mothers should be encouraged to attend antenatal care where they learn about the benefits of exclusive breastfeeding to children below 6 months hence enabling them to make informed decisions about exclusive breastfeeding. The government of Uganda should ensure maternity leave benefits of the employment act are enforced in the informal sector to allow women to practice EBF.	[Nabunya, Phoebe] Makerere Sch Publ Hlth, Dept Biostat & Epidemiol, Kampala, Uganda; [Mubeezi, Ruth] Makerere Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Awor, Phyllis] Makerere Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Nabunya, Phoebe] Uganda Publ Hlth Fellowship, Nakasero Hill, Kampala, Uganda		Nabunya, P (corresponding author), Makerere Sch Publ Hlth, Dept Biostat & Epidemiol, Kampala, Uganda.; Nabunya, P (corresponding author), Uganda Publ Hlth Fellowship, Nakasero Hill, Kampala, Uganda.	nabunyaphoebe@gmail.com		Nabunya, phoebe/0000-0001-5181-6622				[Anonymous], 2011, REP CENS BUS EST 201; [Anonymous], 2012, UG DEM HLTH SURV 201; [Anonymous], 2018, FUEL CELLS B, V2018, P4; [Anonymous], 2016, MANAG CARE S, V11, P12; Asemahagn MA, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0081-x; Bennett S, 1991, SIMPLIFIED GEN METHO; Besore CT, 2014, BREASTFEED MED, V9, P352, DOI 10.1089/bfm.2014.0090; Bhutta ZA, 2011, LANCET, V378, P378, DOI 10.1016/S0140-6736(11)60897-0; Colaizy TT, 2012, PUBLIC HEALTH NUTR, V15, P702, DOI 10.1017/S1368980011002229; Dally EI, 2012, INT BREASTFEEDING J; Egata G, 2015, EXCLUSIVE BREASTFEED; Eide KT, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30578; FANTA, 1999, INF CHILD FEED IND M; Fishbein M., 1977, BELIEF ATTITUDE INTE; ILO, 2011, STAT UPD EMPL INF EC, P3; Janmohamed A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020440; Johnson AM, 2015, J HUM LACT, V31, P425, DOI 10.1177/0890334415573001; KCCA, 2017, REG EN ROL CIT GOV E; Khamis AG, 2017, CLIN MOTHER CHILD HL, V14, P2, DOI DOI 10.4172/2090-7214.1000259; Kimani-Murage EW, 2015, MATERN CHILD NUTR, V11, P314, DOI 10.1111/mcn.12161; Lau CYK, 2018, MATERN CHILD HLTH J, V22, P327, DOI 10.1007/s10995-018-2453-x; Malhotra N, 2013, PUBLIC HEALTH NUTR, V16, P1723, DOI 10.1017/S1368980012004065; Marias YF., 2014, GUIDELINES ASSESSING; McAndrew F, 2012, INFANT FEEDING SURVE; Meedya Shahla, 2010, Women Birth, V23, P135, DOI 10.1016/j.wombi.2010.02.002; Mills SP, 2009, AAOHN J, V57, P227, DOI 10.3928/08910162-20090518-02; [MOH Health Mo], 2006, POL GUID INF YOUNG C, P5; Musoke D, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.36; Nair M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004434; Nkrumah J, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0100-6; Oddo VM, 2018, AM J CLIN NUTR, V107, P335, DOI 10.1093/ajcn/nqy001; oun I, 2005, MATERNITY WORK REV N; Oyang W, 2007, PREVALENCE FACTORS A; Pullum TW, 2014, GLOB HEALTH-SCI PRAC, V2, P355, DOI 10.9745/GHSP-D-14-00061; Saad-Haddad G, 2016, J GLOB HEALTH, V6, DOI [10.7189/jogh.06.010404, 10.7189/Jogh.06.010404]; Scheers I, 2018, J PEDIAT GASTROENTER; Statistics KNBo, 2015, KEN DEM HLTH SURV 20, P8; Stewart-Glenn J, 2008, AAOHN J, V56, P423, DOI 10.3928/08910162-20081001-02; Subramanyam MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011392; UBOS, 2016, UG NAT HOUS SURV UBO; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; Uganda Bureau of Statistics (UBOS), 2017, UG DEM HLTH SURV 201; Uganda_parliament, 2018, FAC BREAST FEED MOTH; UNICEF, BREASTF NUTR; UNICEF WHO, 2015, ADVOCACY STRATEGY BR; Victor R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001529; Wilber ST, 2010, ACAD EMERG MED, V17, P649, DOI 10.1111/j.1553-2712.2010.00773.x; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6	48	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239062	10.1371/journal.pone.0239062	http://dx.doi.org/10.1371/journal.pone.0239062			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970700	gold, Green Published			2022-12-26	WOS:000576265600078
J	Nestegard, O; Johnsen, KM; Sorbye, SW; Halvorsen, FA; Tonnessen, T; Paulssen, EJ; Melby, KK; Goll, R; Florholmen, J				Nestegard, Oddmund; Johnsen, Kay-Martin; Sorbye, Sveinung W.; Halvorsen, Fred-Arne; Tonnessen, Tor; Paulssen, Eyvind J.; Melby, Kjetil K.; Goll, Rasmus; Florholmen, Jon			Clinical characterization ofHelicobacter pyloriinfected patients 15 years after unsuccessful eradication	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; IRRITABLE-BOWEL-SYNDROME; GASTROINTESTINAL SYMPTOMS; ANTIBIOTIC-RESISTANCE; NATURAL-HISTORY; TRIPLE THERAPY; RATING-SCALE; PREVALENCE; RISK; LEVOFLOXACIN	Background and aims Patients that have failed therapy forHelicobacter pylori(H.pylori) infection are incompletely characterized. The aim of this study was to characterize aH.pyloritreatment resistant cohort compared to the cohorts of newly diagnosed, earlier eradicated and non-infected. Material and methods Patients were selected from routine referrals to the Endoscopy units at three different Norwegian hospitals. In all four cohorts, gastric biopsies were scored according to the Sydney classification, and symptoms according to the Gastrointestinal Symptom Rating Scale score, including sub-scores for upper gastrointestinal symptoms and functional bowel symptoms. Patients in theH.pyloriresistant group were treated with a triple therapy regimen that consisted of levofloxacin, amoxicillin and a proton pump inhibitor. Results We included 185 patients, 42H.pyloritreatment resistant, 50 newly diagnosed, 61 previouslyH.pylorieradicated and 32 never infected. The treatment-resistant cohort had higher scores for upper gastrointestinal symptoms and functional bowel symptoms compared to the other groups except for the group being neverH.pyloriinfected. TheH.pyloriresistant patients had lower Sydney scores than patients with newly diagnosedH.pyloriinfection. The triple combination showed a high efficacy of 91% to eradicateH.pylori. Conclusions Patients with treatment-resistantH.pyloriinfection had more gastrointestinal symptoms, but a lower Sydney score than patients with newly diagnosed infection. A treatment regimen including levofloxacin showed a high efficacy in eradicatingH.pyloriin patients that previously had failed eradication treatment.	[Nestegard, Oddmund] Vestre Viken Hosp, Dept Gastroenterol, Honefoss, Norway; [Nestegard, Oddmund; Johnsen, Kay-Martin; Paulssen, Eyvind J.; Goll, Rasmus; Florholmen, Jon] UiT Arctic Univ Norway, Dept Clin Med, Res Grp Gastroenterol & Nutr, Tromso, Norway; [Sorbye, Sveinung W.] Univ Hosp North Norway, Dept Pathol, Tromso, Norway; [Halvorsen, Fred-Arne; Tonnessen, Tor] Vestre Viken Hosp, Dept Gastroenterol, Drammen, Norway; [Melby, Kjetil K.] Univ Hosp Oslo, Dept Microbiol, Oslo, Norway; [Melby, Kjetil K.] Univ Oslo, Oslo, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; University of Oslo	Nestegard, O (corresponding author), Vestre Viken Hosp, Dept Gastroenterol, Honefoss, Norway.; Nestegard, O (corresponding author), UiT Arctic Univ Norway, Dept Clin Med, Res Grp Gastroenterol & Nutr, Tromso, Norway.	Oddmund.nestegard@vestreviken.no	Sorbye, Sveinung Wergeland/AAE-7208-2020	Sorbye, Sveinung Wergeland/0000-0002-8250-3992	Gastroenterological section, University hospital of Northern Norway, Tromso	Gastroenterological section, University hospital of Northern Norway, Tromso	The project is funded by Gastroenterological section, University hospital of Northern Norway, 9038 Tromso, ref. prof. Jon Florholmen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu MA, 2010, EUR J EPIDEMIOL, V25, P439, DOI 10.1007/s10654-010-9482-0; AGREUS L, 1995, SCAND J GASTROENTERO, V30, P752, DOI 10.3109/00365529509096323; Asfeldt AM, 2008, EUR J EPIDEMIOL, V23, P625, DOI 10.1007/s10654-008-9275-x; Breckan RK, 2016, HELICOBACTER, V21, P586, DOI 10.1111/hel.12316; Breckan RK, 2012, SCAND J GASTROENTERO, V47, P1274, DOI 10.3109/00365521.2012.688215; Breckan RK, 2009, SCAND J GASTROENTERO, V44, P1060, DOI 10.1080/00365520903093728; de Vries AC, 2008, GASTROENTEROLOGY, V134, P945, DOI 10.1053/j.gastro.2008.01.071; Di Caro S, 2012, WORLD J GASTROENTERO, V18, P5669, DOI 10.3748/wjg.v18.i40.5669; DIMENAS E, 1993, SCAND J GASTROENTERO, V28, P681, DOI 10.3109/00365529309098272; Fischbach L, 2007, ALIMENT PHARM THER, V26, P343, DOI 10.1111/j.1365-2036.2007.03386.x; Ford AC, 2008, AM J GASTROENTEROL, V103, P1229, DOI 10.1111/j.1572-0241.2007.01740.x; Fox M, 2006, BMJ-BRIT MED J, V332, P88, DOI 10.1136/bmj.332.7533.88; Gisbert JP, 2013, SCAND J GASTROENTERO, V48, P652, DOI 10.3109/00365521.2013.786132; Go MF, 2002, ALIMENT PHARM THER, V16, P3, DOI 10.1046/j.1365-2036.2002.0160s1003.x; Katelaris PH, 2017, INTERN MED J, V47, P761, DOI 10.1111/imj.13432; Kawamura A, 2001, AM J GASTROENTEROL, V96, P1946, DOI 10.1111/j.1572-0241.2001.03910.x; Larsen AL, 2013, APMIS, V121, P353, DOI 10.1111/apm.12009; Lind T, 1996, Helicobacter, V1, P138, DOI 10.1111/j.1523-5378.1996.tb00027.x; Locke GR, 2000, AM J GASTROENTEROL, V95, P1906, DOI 10.1111/j.1572-0241.2000.02251.x; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2017, GUT, V66, P6, DOI 10.1136/gutjnl-2016-312288; Megraud F, 2007, CLIN MICROBIOL REV, V20, P280, DOI 10.1128/CMR.00033-06; Moayyedi P, 2006, LANCET, V367, P2086, DOI 10.1016/S0140-6736(06)68932-0; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Revicki DA, 1998, QUAL LIFE RES, V7, P75; Rokkas T, 2007, HELICOBACTER, V12, P32, DOI 10.1111/j.1523-5378.2007.00563.x; Saracino IM, 2012, J GASTROINTEST LIVER, V21, P363; Sharma P, 2003, ALIMENT PHARM THER, V17, P297, DOI 10.1046/j.1365-2036.2003.01428.x; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; WARREN JR, 1983, LANCET, V1, P1273; Wiklund IK, 2003, SCAND J GASTROENTERO, V38, P947, DOI 10.1080/00365520310004209	32	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238944	10.1371/journal.pone.0238944	http://dx.doi.org/10.1371/journal.pone.0238944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966303	gold, Green Published			2022-12-26	WOS:000575688700054
J	Sun, X; Zhang, HB; Xie, LH; Qian, C; Ye, YY; Mao, HX; Wang, BY; Zhang, H; Zhang, YZ; He, XZ; Zhang, SZ				Sun, Xiang; Zhang, Hongbo; Xie, Linghai; Qian, Chen; Ye, Yongyi; Mao, Hengxu; Wang, Baoyan; Zhang, Huan; Zhang, Yizhou; He, Xiaozheng; Zhang, Shizhong			Tristetraprolin destabilizes NOX2 mRNA and protects dopaminergic neurons from oxidative damage in Parkinson's disease	FASEB JOURNAL			English	Article						apoptosis; mRNA stability; ROS	UP-REGULATION; EXPRESSION; STRESS; PROTEINS; GLIOMA; MODEL; ACTIVATION; MECHANISMS; REGULATOR; APOPTOSIS	Tristetraprolin (TTP), an RNA-binding protein encoded by the ZFP36 gene, is vital for neural differentiation; however, its involvement in neurodegenerative diseases such as Parkinson's disease (PD) remains unclear. To explore the role of TTP in PD, an in vitro 1-methyl-4-phenylpyridinium (MPP+) cell model and an in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) of PD were used. Transfection of small interfering (si)-TTP RNA upregulated pro-oxidative NOX2 expression and ROS formation, downregulated anti-oxidative GSH and SOD activity(sic)si-TTP upregulated pro-apoptotic cleaved-caspase-3 expression, and downregulated antiapoptotic Bcl-2 expression; while overexpression (OE)-TTP lentivirus caused opposite effects. Through database prediction, luciferase experiment, RNA immunoprecipitation (RIP), and mRNA stability analysis, we evaluated the potential binding sites of TTP to 3 '-untranslated regions (3 '-UTR) of NOX2 mRNA. TTP affected the NOX2 luciferase activity by binding to two sites in the NOX2 3 '-UTR. RIP-qPCR confirmed TTP binding to both sites, with a higher affinity for site-2. In addition, TTP reduced the NOX2 mRNA stability. si-NOX2 and antioxidant N-acetyl cysteine (NAC) reversed si-TTP-induced cell apoptosis. In MPTP-treated mice, TTP expression increased and was co-located with dopaminergic neurons. TTP also inhibited NOX2 and decreased the oxidative stress in vivo. In conclusion, TTP protects against dopaminergic oxidative injury by promoting NOX2 mRNA degradation in the MPP+/MPTP model of PD, suggesting that TTP could be a potential therapeutic target for regulating the oxidative stress in PD.	[Sun, Xiang; Zhang, Hongbo; Xie, Linghai; Qian, Chen; Mao, Hengxu; Wang, Baoyan; Zhang, Huan; He, Xiaozheng; Zhang, Shizhong] Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Natl Key Clin Specialty,Engn Technol Res Ctr, Educ Minist China,Dept Neurosurg,Zhujiang Hosp, 253 Ind Rd, Guangzhou 510282, Peoples R China; [Ye, Yongyi] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Guangzhou, Peoples R China; [Zhang, Yizhou] Tarbut VTorah Community Day Sch, Irvine, CA USA	Southern Medical University - China; Guangzhou Medical University	He, XZ; Zhang, SZ (corresponding author), Southern Med Univ, Guangdong Prov Key Lab Brain Funct Repair & Regen, Natl Key Clin Specialty,Engn Technol Res Ctr, Educ Minist China,Dept Neurosurg,Zhujiang Hosp, 253 Ind Rd, Guangzhou 510282, Peoples R China.	hxz_smu@163.com; zhangshizhong@smu.edu.cn	毛, 珩旭/GLR-3328-2022		National Natural Science Foundation of China (NSFC) [81671240]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2016A030310384]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671240; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2016A030310384	Abdelmohsen K, 2008, BIOL CHEM, V389, P243, DOI 10.1515/BC.2008.022; Alkallas R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00867-z; Ash PEA, 2014, BRAIN RES, V1584, P52, DOI 10.1016/j.brainres.2014.05.052; Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001; Belarbi K, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0225-5; Bollmann F, 2014, J BIOL CHEM, V289, P15653, DOI 10.1074/jbc.M114.566984; Brooks SA, 2013, BBA-GENE REGUL MECH, V1829, P666, DOI 10.1016/j.bbagrm.2013.02.003; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Cao HP, 2003, ARCH BIOCHEM BIOPHYS, V412, P106, DOI 10.1016/S0003-9861(03)00012-2; Cargnin F, 2014, J NEUROSCI, V34, P16650, DOI 10.1523/JNEUROSCI.1650-14.2014; Castells-Roca L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148204; Cheng L, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1289-z; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Dai WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8576; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Ding XM, 2019, CHEM-BIOL INTERACT, V307, P73, DOI 10.1016/j.cbi.2019.04.017; Eshelman MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50957-9; Frasca D, 2007, J IMMUNOL, V179, P918, DOI 10.4049/jimmunol.179.2.918; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Gordon R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12932; Guhathakurta S, 2017, PROG NEUROBIOL, V154, P21, DOI 10.1016/j.pneurobio.2017.04.004; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jiang LL, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0573-z; Joe Y, 2015, AM J PATHOL, V185, P2867, DOI 10.1016/j.ajpath.2015.07.002; Kim YC, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00013; Kuchler L, 2014, ANTIOXID REDOX SIGN, V21, P2483, DOI 10.1089/ars.2013.5760; Kuzniewska B, 2016, MOL NEUROBIOL, V53, P1478, DOI 10.1007/s12035-014-9089-7; Vo MT, 2017, ONCOTARGET, V8, P41903, DOI 10.18632/oncotarget.16706; Marchese Domenica, 2017, Nucleic Acids Res, V45, P12888, DOI 10.1093/nar/gkx1048; Matsuo R, 2017, CURR GENET, V63, P895, DOI 10.1007/s00294-017-0689-4; Park A, 2019, ARCH TOXICOL, V93, P1239, DOI 10.1007/s00204-019-02424-7; Perier C, 2007, P NATL ACAD SCI USA, V104, P8161, DOI 10.1073/pnas.0609874104; Puspita L, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0340-9; Qian C, 2019, EXP CELL RES, V384, DOI 10.1016/j.yexcr.2019.111614; Raut GK, 2019, FREE RADICAL BIO MED, V145, P428, DOI 10.1016/j.freeradbiomed.2019.09.020; Ross EA, 2017, ANN RHEUM DIS, V76, P612, DOI 10.1136/annrheumdis-2016-209424; Ryu J, 2015, MOL CELLS, V38, P991, DOI 10.14348/molcells.2015.0197; Sanduja S, 2012, FRONT BIOSCI-LANDMRK, V17, P174, DOI 10.2741/3920; Sanduja S, 2011, WIRES RNA, V2, P42, DOI 10.1002/wrna.28; Sathe K, 2012, BRAIN, V135, P3336, DOI 10.1093/brain/aws250; Savelieff MG, 2019, CHEM REV, V119, P1221, DOI 10.1021/acs.chemrev.8b00138; Saxena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12398-w; Selmi T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1388-5; Selmi T, 2012, CELL CYCLE, V11, P1977, DOI 10.4161/cc.20309; Suswam E, 2008, CANCER RES, V68, P674, DOI 10.1158/0008-5472.CAN-07-2751; Thalmeier A, 2008, INT J NEUROPSYCHOPH, V11, P217, DOI 10.1017/S1461145707007894; Tian FJ, 2018, MOL THER-NUCL ACIDS, V12, P600, DOI 10.1016/j.omtn.2018.07.001; Tseng YT, 2014, PHYTOMEDICINE, V21, P724, DOI 10.1016/j.phymed.2013.11.001; Wang HQ, 2016, BRAIN PATHOL, V26, P167, DOI 10.1111/bpa.12267; Wang QH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00892-y; Wang XL, 2011, AGING CELL, V10, P807, DOI 10.1111/j.1474-9726.2011.00721.x; Yan JQ, 2018, CELL PHYSIOL BIOCHEM, V51, P1957, DOI 10.1159/000495720; Yao LP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1053-4; Ye YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0821-5; Yin J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00096; Zawada WM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-129; Zeng B, 2016, INT IMMUNOPHARMACOL, V39, P63, DOI 10.1016/j.intimp.2016.07.001; Zhang DS, 2015, J PHARMACOL SCI, V127, P135, DOI 10.1016/j.jphs.2014.11.012; Zhang H, 2014, J EXP BOT, V65, P5795, DOI 10.1093/jxb/eru313; Zhong JH, 2019, FREE RADICAL BIO MED, V135, P87, DOI 10.1016/j.freeradbiomed.2019.02.027; Zhong JH, 2018, REDOX BIOL, V16, P47, DOI 10.1016/j.redox.2018.02.008	62	6	6	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15047	15061		10.1096/fj.201902967R	http://dx.doi.org/10.1096/fj.201902967R		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32954540				2022-12-26	WOS:000573727300001
J	Wang, S; Toy, M; Pham, TTH; So, S				Wang, Sonia; Toy, Mehlika; Hang Pham, Thi T.; So, Samuel			Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the US, 2010-2019	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; UNITED-STATES; VIRUS-INFECTION; HEPATITIS-B; ALCOHOL-USE; PREVALENCE; CIRRHOSIS; OUTCOMES; OBESITY	Background and aims The national Organ Procurement and Transplant Network (OPTN) reported the major indication for liver transplants in 2018 was for other/unknown causes. This study was undertaken to examine all causes and trends in liver disease and hepatocellular carcinoma (HCC) among adults who received liver transplants in the past 10 years. Methods A national cohort study of all adults who received liver transplants from Jan 1, 2010 to Dec 31, 2019 recorded in the OPTN STAR database analyzed by etiology of liver disease and HCC, and gender. Results Adult liver transplants increased from 5,731 in 2010 to 8,345 in 2019 (45.6% increase). Between 2010 and 2014, liver disease and HCC associated with hepatitis C (HCV) was the major cause for liver transplantation. Proportion of liver transplants for HCV associated liver disease and HCC has since decreased to 18.7% in 2019 compared with 44.5% in 2010 [25.8%, (95% CI 24.3% to 27.3%), p<0.001], while liver transplants for liver disease and HCC associated with alcohol-associated liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD) increased from 12.7% to 28.8% [16.1%, (95% CI 14.8% to 17.4%), p<0.001], and from 9.1% to 21.5% [12.4%, (95% CI 11.2% to 13.5%), p<0.001], respectively. When all causes of liver disease were examined, only 1.7% of liver transplants had unspecified causes. The five major causes of liver disease and HCC among men receiving liver transplants in 2019 were ALD (33.1%), HCV (21.9%), NAFLD (18.5%), cholestatic liver disease (5.7%) and hepatitis B (4.9%), while the major causes among women were NAFLD (26.8%), ALD (21.1%), HCV (13.1%), cholestatic liver disease (11.1%), and autoimmune liver disease (5.6%). Conclusions Our study found NAFLD in 2017 in women and ALD in 2019 in men have surpassed HCV as the leading causes of liver disease and HCC among adults receiving liver transplants.	[Wang, Sonia; Toy, Mehlika; Hang Pham, Thi T.; So, Samuel] Stanford Univ, Sch Med, Asian Liver Ctr, Dept Surg, Stanford, CA 94305 USA	Stanford University	So, S (corresponding author), Stanford Univ, Sch Med, Asian Liver Ctr, Dept Surg, Stanford, CA 94305 USA.	samso@stanford.edu		Pham, Thi Thanh Hang/0000-0002-2480-4586; Toy, Mehlika/0000-0001-7848-4816	Asian Liver Center, Department of Surgery, Stanford University School of Medicine; Health Resources and Services Administration [234-2005-370011C]	Asian Liver Center, Department of Surgery, Stanford University School of Medicine; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	All the funding and support for this study is provided by the Asian Liver Center, Department of Surgery, Stanford University School of Medicine. There was no additional external funding received for this study.; This work was based on data collected and provided by the Organ Procurement and Transplant Network which is supported in part by Health Resources and Services Administration contract 234-2005-370011C. The content is the responsibility of the authors alone and does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.	[Anonymous], 2019, LANCET GASTROENTEROL, DOI DOI 10.1001/JAMA.2020.1123; Bailey MB, 2011, J COMMUN HEALTH, V36, P538, DOI 10.1007/s10900-010-9339-1; Centers for Disease Control and Prevention, STRAT PREV MAN OB; Centers for Disease Control and Prevention (USA), 2012, MMWR RECOMM REP, V61, P886; Chao SD, 2009, J IMMIGR MINOR HEALT, V11, P281, DOI 10.1007/s10903-007-9094-2; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Fayek SA, 2016, AM J TRANSPLANT, V16, P3093, DOI 10.1111/ajt.14017; Goldberg D, 2017, GASTROENTEROLOGY, V152, P1090, DOI 10.1053/j.gastro.2017.01.003; Grant BF, 2017, JAMA PSYCHIAT, V74, P911, DOI 10.1001/jamapsychiatry.2017.2161; Grucza RA, 2018, ALCOHOL CLIN EXP RES, V42, P1939, DOI 10.1111/acer.13859; Guirguis J, 2015, ALCOHOL CLIN EXP RES, V39, P2085, DOI 10.1111/acer.12887; Hydes T, 2019, J HEPATOL, V70, P223, DOI 10.1016/j.jhep.2018.10.036; Kim WR, 2018, AM J TRANSPLANT, V18, P172, DOI 10.1111/ajt.14559; Kwong A, 2020, AM J TRANSPLANT, V20, DOI 10.1111/ajt.15674; Lee BP, 2019, JAMA INTERN MED, V179, P340, DOI 10.1001/jamainternmed.2018.6536; LeFevre ML, 2014, ANN INTERN MED, V161, P58, DOI 10.7326/M14-1018; Marrero JA, 2019, HEPATOLOGY, V70, P459, DOI 10.1002/hep.30854; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Nat Acad Sci Engn Med, 2016, ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES: PHASE ONE REPORT, P1, DOI 10.17226/23407; Noureddin M, 2018, AM J GASTROENTEROL, V113, P1649, DOI 10.1038/s41395-018-0088-6; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Sumida Y, 2018, J GASTROENTEROL, V53, P362, DOI 10.1007/s00535-017-1415-1; Wadden TA, 2014, JAMA-J AM MED ASSOC, V312, P1779, DOI 10.1001/jama.2014.14173; White A, 2015, ALCOHOL CLIN EXP RES, V39, P1712, DOI 10.1111/acer.12815; Wong RJ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.20294; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986	27	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239393	10.1371/journal.pone.0239393	http://dx.doi.org/10.1371/journal.pone.0239393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946502	gold, Green Published			2022-12-26	WOS:000573851100081
J	Gaukler, SM; Murphy, SM; Berryhill, JT; Thompson, BE; Sutter, BJ; Hathcock, CD				Gaukler, Shannon M.; Murphy, Sean M.; Berryhill, Jesse T.; Thompson, Brent E.; Sutter, Benjamin J.; Hathcock, Charles D.			Investigating effects of soil chemicals on density of small mammal bioindicators using spatial capture-recapture models	PLOS ONE			English	Article							WHITE-FOOTED MICE; ESTIMATING POPULATION-SIZE; POLYCHLORINATED BIPHENYL; BEAR POPULATION; HOME RANGES; POLLUTANTS; SELECTION; RECOLONIZATION; PARAMETERS; ESTIMATORS	Monitoring the ecological impacts of environmental pollution and the effectiveness of remediation efforts requires identifying relationships between contaminants and the disruption of biological processes in populations, communities, or ecosystems. Wildlife are useful bioindicators, but traditional comparative experimental approaches rely on a staunch and typically unverifiable assumption that, in the absence of contaminants, reference and contaminated sites would support the same densities of bioindicators, thereby inferring direct causation from indirect data. We demonstrate the utility of spatial capture-recapture (SCR) models for overcoming these issues, testing if community density of common small mammal bioindicators was directly influenced by soil chemical concentrations. By modeling density as an inhomogeneous Poisson point process, we found evidence for an inverse spatial relationship betweenPeromyscusdensity and soil mercury concentrations, but not other chemicals, such as polychlorinated biphenyls, at a site formerly occupied by a nuclear reactor. Although the coefficient point estimate supportedPeromyscusdensity being lower where mercury concentrations were higher (beta = -0.44), the 95% confidence interval overlapped zero, suggesting no effect was also compatible with our data. Estimated density from the most parsimonious model (2.88 mice/ha; 95% CI = 1.63-5.08), which did not support a density-chemical relationship, was within the range of reported densities forPeromyscusthat did not inhabit contaminated sites elsewhere. Environmental pollution remains a global threat to biodiversity and ecosystem and human health, and our study provides an illustrative example of the utility of SCR models for investigating the effects that chemicals may have on wildlife bioindicator populations and communities.	[Gaukler, Shannon M.; Berryhill, Jesse T.; Thompson, Brent E.; Hathcock, Charles D.] Los Alamos Natl Lab, Environm Stewardship Grp, Los Alamos, NM 87545 USA; [Murphy, Sean M.] Univ Kentucky, Dept Forestry & Nat Resources, Lexington, KY USA; [Sutter, Benjamin J.] Los Alamos Natl Lab, Infrastruct Program Off, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Kentucky; United States Department of Energy (DOE); Los Alamos National Laboratory	Gaukler, SM; Hathcock, CD (corresponding author), Los Alamos Natl Lab, Environm Stewardship Grp, Los Alamos, NM 87545 USA.	sgaukler@lanl.gov; hathcock@lanl.gov	Murphy, Sean/AAM-4692-2021	Murphy, Sean/0000-0002-9404-8878	Los Alamos National Laboratory; U.S. Department of Energy's National Nuclear Security Administration	Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	All authors and this work were supported by Los Alamos National Laboratory, managed by Triad National Security, LLC, which receives its core funding from the U.S. Department of Energy's National Nuclear Security Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2005, WORLD EC INT RELATIO, V11, P3; Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Augustine BC, 2014, METHODS ECOL EVOL, V5, P1154, DOI 10.1111/2041-210X.12289; Banks JE, 2010, RISK ANAL, V30, P175, DOI 10.1111/j.1539-6924.2009.01349.x; BATTY J, 1990, ARCH ENVIRON CON TOX, V19, P283, DOI 10.1007/BF01056098; Bernanke J, 2008, REV ENV CONTAMINATIO, V198; BJORNSTAD ON, 1994, OIKOS, V69, P167, DOI 10.2307/3545298; Boonstra R, 2003, ENVIRON TOXICOL CHEM, V22, P1394, DOI [10.1897/1551-5028(2003)022&lt;1394:DOSTSP&gt;2.0.CO;2, 10.1002/etc.5620220628]; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; BURTON GV, 1977, ENVIRON RES, V14, P30, DOI 10.1016/0013-9351(77)90063-9; Carignan V, 2002, ENVIRON MONIT ASSESS, V78, P45, DOI 10.1023/A:1016136723584; Casula P, 2019, BASIC APPL ECOL, V34, P46, DOI 10.1016/j.baae.2018.11.002; Caswell H, 2009, OIKOS, V118, P1763, DOI 10.1111/j.1600-0706.2009.17620.x; Dawson DK, 2009, J APPL ECOL, V46, P1201, DOI 10.1111/j.1365-2664.2009.01731.x; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Distiller G, 2015, ECOL EVOL, V5, P5075, DOI 10.1002/ece3.1748; Dupont P, 2019, METHODS ECOL EVOL, V10, P661, DOI 10.1111/2041-210X.13158; Eckrich CA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189471; Efford M, 2018, HABITAT MASKS PACKAG; Efford M. G., 2004, Animal Biodiversity and Conservation, V27, P217; Efford MG, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2580; Efford MG, 2013, OIKOS, V122, P918, DOI 10.1111/j.1600-0706.2012.20440.x; Efford MG, 2009, ECOLOGY, V90, P2676, DOI 10.1890/08-1735.1; ESRI, 2019, COMPARING MODELS; ESRI, 2019, WHAT IS EMPIRICAL BA; Evans MJ, 2017, LANDSCAPE URBAN PLAN, V162, P13, DOI 10.1016/j.landurbplan.2017.01.009; Evers D., 2018, ENCY ANTHROPOCENE, V5, P181, DOI DOI 10.1016/B978-0-12-809665-9.09985-7; Gamelon M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602298; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Gerber BD, 2015, ECOL APPL, V25, P695, DOI 10.1890/14-0960.1; Goutte A, 2015, ENVIRON POLLUT, V200, P1, DOI 10.1016/j.envpol.2015.01.033; Goutte A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3313; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Gupta A, 2017, ENVIRON EARTH SCI, V76, DOI 10.1007/s12665-017-6814-3; Hansen L, 2019, ALAMOS NATL LAB REPO; Harvey D, 2004, ALAMOS NATL LAB REPO; Helsel DR, 2012, STAT CENSORED ENV DA, P194; Helsel DR, 2012, STAT CENSORED ENV DA, P1; Hilty J, 2000, BIOL CONSERV, V92, P185, DOI 10.1016/S0006-3207(99)00052-X; Holt E. A., 2011, NATURE ED KNOWLEDGE, V3, P8; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; Humm JM, 2017, J WILDLIFE MANAGE, V81, P1187, DOI 10.1002/jwmg.21294; Jepson PD, 2016, SCIENCE, V352, P1388, DOI 10.1126/science.aaf9075; Johnson DH, 2002, J WILDLIFE MANAGE, V66, P919, DOI 10.2307/3802926; Jorgensen EE, 2004, J MAMMAL, V85, P531, DOI 10.1644/BER-019; Kelly BC, 2007, SCIENCE, V317, P236, DOI 10.1126/science.1138275; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Krause E., 2012, DEALING EXTREME VALU; Krebs C.J., 2013, POPULATION FLUCTUATI; LANDRES PB, 1988, CONSERV BIOL, V2, P316, DOI 10.1111/j.1523-1739.1988.tb00195.x; LANL, 2008, ALAMOS NATL LAB REPO; LANL, 2011, ALAMOS NATAIONAL LAB; LANL, 2006, ALAMOS NATL LAB REPO; Laufenberg JS, 2018, BIOL CONSERV, V224, P188, DOI 10.1016/j.biocon.2018.05.004; Levengood JM, 2008, SCI TOTAL ENVIRON, V389, P320, DOI 10.1016/j.scitotenv.2007.08.050; LINZEY AV, 1987, ARCH ENVIRON CON TOX, V16, P455, DOI 10.1007/BF01055267; LINZEY AV, 1994, ARCH ENVIRON CON TOX, V27, P521; MAC ARTHUR ROBERT H., 1967; Markert B, 1999, J RADIOANAL NUCL CH, V240, P425, DOI 10.1007/BF02349387; Mills L. S., 2013, CONSERVATION WILDLIF; Murphy SM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40926-7; Murphy SM, 2016, J WILDLIFE MANAGE, V80, P1390, DOI 10.1002/jwmg.21144; Obbard ME, 2010, J APPL ECOL, V47, P76, DOI 10.1111/j.1365-2664.2009.01758.x; OTIS DL, 1978, WILDLIFE MONOGR, P1; Phelps KL, 2010, SOUTHWEST NAT, V55, P363, DOI 10.1894/MLK-08.1; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; R Core Team, 2018, R LANG ENV STAT COMP; Reza SK, 2015, ENVIRON EARTH SCI, V73, P5425, DOI 10.1007/s12665-014-3797-1; Rhind SM, 2009, PHILOS T R SOC B, V364, P3391, DOI 10.1098/rstb.2009.0122; Ribble DO, 2002, J MAMMAL, V83, P260, DOI 10.1644/1545-1542(2002)083<0260:ACOHRO>2.0.CO;2; Ribeiro J. R., 2001, R NEWS, V1, P1609; RICKLEFS RE, 2000, ECOLOGY; Romairone J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198766; Roos A, 2001, ENVIRON POLLUT, V111, P457, DOI 10.1016/S0269-7491(00)00085-3; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2013, ECOLOGY, V94, P287, DOI 10.1890/12-0413.1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Samsonova VP, 2017, EURASIAN SOIL SCI+, V50, P305, DOI 10.1134/S1064229317030103; Schwemm CA, 2018, WEST N AM NATURALIST, V78, P496; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Smith PN, 2002, ENVIRON POLLUT, V119, P261, DOI 10.1016/S0269-7491(01)00306-2; Sollmann R, 2015, MAMM BIOL, V80, P247, DOI 10.1016/j.mambio.2015.03.002; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Spiegel SJ, 2017, LANCET, V390, P226, DOI 10.1016/S0140-6736(17)31810-X; Storelli MM, 2008, FOOD CHEM TOXICOL, V46, P2782, DOI 10.1016/j.fct.2008.05.011; Sun CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088025; Sutherland C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26847-x; Sutherland C, 2016, HERPETOLOGICA, V72, P6, DOI 10.1655/HERPETOLOGICA-D-15-00027; Talmage SS, 1991, REV ENVIRON CONTAM T, P47, DOI 10.1007/978-1-4612-3078-6_2; Tovar-Sanchez E., 2018, HEAVY METALS, V383, DOI [10.5772/intechopen.74052, DOI 10.5772/INTECHOPEN.74052]; US Climate Data, 2019, CLIMATE ALAMOS NEW M; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Villette P, 2016, J MAMMAL, V97, P32, DOI 10.1093/jmammal/gyv150; Wasserstein RL, 2019, AM STAT, V73, P1, DOI 10.1080/00031305.2019.1583913; WREN CD, 1986, ENVIRON MONIT ASSESS, V6, P127, DOI 10.1007/BF00395625; WREN CD, 1991, J TOXICOL ENV HEALTH, V33, P549, DOI 10.1080/15287399109531540	102	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238870	10.1371/journal.pone.0238870	http://dx.doi.org/10.1371/journal.pone.0238870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941472	gold, Green Published			2022-12-26	WOS:000573848800011
J	Marois, G; Muttarak, R; Scherbov, S				Marois, Guillaume; Muttarak, Raya; Scherbov, Sergei			Assessing the potential impact of COVID-19 on life expectancy	PLOS ONE			English	Article								Background The COVID-19 virus pandemic has caused a significant number of deaths worldwide. If the prevalence of the infection continues to grow, this could impact life expectancy. This paper provides first estimates of the potential direct impact of the COVID-19 pandemic on period life expectancy. Methods From the estimates of bias-adjusted age-specific infection fatality rates in Hubei (China) and a range of six prevalence rate assumptions ranging from 1% to 70%, we built a discrete-time microsimulation model that simulates the number of people infected by COVID-19, the number dying from it, and the number of deaths from all causes week by week for a period of one year. We applied our simulation to four broad regions: North America and Europe; Latin America and the Caribbean; Southeastern Asia; and sub-Saharan African. For each region, 100,000 individuals per each 5-year age group are simulated. Results At a 10% COVID-19 prevalence rate, the loss in life expectancy at birth is likely above 1 year in North America and Europe and in Latin America and the Caribbean. In Southeastern Asia and sub-Saharan Africa, one year lost in life expectancy corresponds to an infection prevalence of about 15% and 25%, respectively. Given the uncertainty in fatality rates, with a 50% prevalence of COVID-19 infections under 95% prediction intervals, life expectancy would drop by 3 to 9 years in North America and Europe, by 3 to 8 years in Latin America and the Caribbean, by 2 to 7 years in Southeastern Asia, and by 1 to 4 years in sub-Saharan Africa. In all prevalence scenarios, as long as the COVID-19 infection prevalence rate remains below 1 or 2%, COVID-19 would not affect life expectancy in a substantial manner. Interpretation In regions with relatively high life expectancy, if the infection prevalence threshold exceeds 1 or 2%, the COVID-19 pandemic will break the secular trend of increasing life expectancy, resulting in a decline in period life expectancy. With life expectancy being a key indicator of human development, mortality increase, especially among the vulnerable subgroups of populations, would set a country back on its path of human development.	[Marois, Guillaume] Shanghai Univ, Asian Demog Res Inst, Shanghai, Peoples R China; [Marois, Guillaume; Muttarak, Raya; Scherbov, Sergei] Univ Vienna, Wittgenstein Ctr Demog & Global Human Capital, IIASA, VID OAW,Int Inst Appl Syst Anal IIASA, Laxenburg, Austria; [Muttarak, Raya] Univ East Anglia, Sch Int Dev, Norwich, Norfolk, England	Shanghai University; International Institute for Applied Systems Analysis (IIASA); University of Vienna; University of East Anglia	Marois, G (corresponding author), Shanghai Univ, Asian Demog Res Inst, Shanghai, Peoples R China.; Marois, G (corresponding author), Univ Vienna, Wittgenstein Ctr Demog & Global Human Capital, IIASA, VID OAW,Int Inst Appl Syst Anal IIASA, Laxenburg, Austria.	marois@iiasa.ac.at	Marois, Guillaume/AAC-2507-2019	Marois, Guillaume/0000-0002-2701-6286; Scherbov, Sergei/0000-0002-0881-1073				Alimohamadi Yousef, 2020, J Prev Med Public Health, V53, P151, DOI 10.3961/jpmph.20.076; [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961; [Anonymous], 2020, REUTERS; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Day M, 2020, BMJ-BRIT MED J, P369; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; EuroMOMO, 2020, EUROMOMO B; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Ghislandi S., 2020, NEWS FRONT ESTIMATIO; Goujon A, 2020, AGE GENDER TERRITORY, P26; Helleringer Stephane, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.01a99f8342b42a58d806d7d1749574ea; Heuveline P, 2020, DEATHS CAPITA COMP C; IHME, 2020, UPD IHME COVID 19 PR; Istituto Superiore di Sanita, 2020, CHAR COVID 19 PAT DY; Jia Y, 2020, SPR OCEANOGR, P1, DOI 10.1007/978-981-13-7032-8; Lake MA, 2020, CLIN MED, V20, P124, DOI 10.7861/clinmed.2019-coron; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lazzerini M, 2020, LANCET GLOBAL HLTH, V0; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Odone A, 2020, LANCET PUBLIC HEALTH, V5, pE310, DOI 10.1016/S2468-2667(20)30099-2; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pan ZH, 2020, ENERGY STORAGE MATER, V25, P124, DOI 10.1016/j.ensm.2019.10.023; Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967; Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033; Shahid Z, 2020, J AM GERIATR SOC, V68, P926, DOI 10.1111/jgs.16472; Shuchman M, 2020, NATURE MED; Signorelli Carlo, 2020, Acta Biomed, V91, P175, DOI 10.23750/abm.v91i3-S.9511; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HEALTH, V8, pe545, DOI DOI 10.1016/S2214-109X(20)30068-1; Trias-Llimos S, 2020, MONITORING LIFE EXPE; United Nations (UN) Department of Economic and Social Affairs Population Division, 2019, WORLD POP PROSP 2019; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	34	40	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238678	10.1371/journal.pone.0238678	http://dx.doi.org/10.1371/journal.pone.0238678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941467	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000573848800065
J	Maunders, EA; Triniman, RC; Western, J; Rahman, T; Welch, M				Maunders, Eve A.; Triniman, Rory C.; Western, Joshua; Rahman, Taufiq; Welch, Martin			Global reprogramming of virulence and antibiotic resistance in Pseudomonas aeruginosa by a single nucleotide polymorphism in elongation factor, fusA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pseudomonas aeruginosa; translation; FusA1; transcriptomics; proteomics; Type III secretion; Type VI secretion; exopolysaccharide; antibiotic resistance; aminoglycoside; Pseudomonas aeruginosa (P; aeruginosa); Type III secretion system (T3SS); aminoglycoside; Type VI secretion system	III SECRETION SYSTEM; VI SECRETION; EFFLUX PUMP; REGULATORY SYSTEM; GENE-EXPRESSION; RIBOSOME; IRON; CLONING; IDENTIFICATION; PROTEINS	Clinical isolates of the opportunistic pathogen Pseudomonas aeruginosa from patients with cystic fibrosis (CF) frequently contain mutations in the gene encoding an elongation factor, FusA1. Recent work has shown that fusA1 mutants often display elevated aminoglycoside resistance due to increased expression of the efflux pump, MexXY. However, we wondered whether these mutants might also be affected in other virulence-associated phenotypes. Here, we isolated a spontaneous gentamicin-resistant fusA1 mutant (FusA1(P443L)) in which mexXY expression was increased. Proteomic and transcriptomic analyses revealed that the fusA1 mutant also exhibited discrete changes in the expression of key pathogenicity-associated genes. Most notably, the fusA1 mutant displayed greatly increased expression of the Type III secretion system (T3SS), widely considered to be the most potent virulence factor in the P. aeruginosa arsenal, and also elevated expression of the Type VI (T6) secretion machinery. This was unexpected because expression of the T3SS is usually reciprocally coordinated with T6 secretion system expression. The fusA1 mutant also displayed elevated exopolysaccharide production, dysregulated siderophore production, elevated ribosome synthesis, and transcriptomic signatures indicative of translational stress. Each of these phenotypes (and almost all of the transcriptomic and proteomic changes associated with the fusA1 mutation) were restored to levels comparable with that in the progenitor strain by expression of the WT fusA1 gene in trans, indicating that the mutant gene is recessive. Our data show that in addition to elevating antibiotic resistance through mexXY expression (and also additional contributory resistance mechanisms), mutations in fusA1 can lead to highly selective dysregulation of virulence gene expression.	[Maunders, Eve A.; Triniman, Rory C.; Western, Joshua; Welch, Martin] Univ Cambridge, Dept Biochem, Cambridge, England; [Triniman, Rory C.; Rahman, Taufiq] Univ Cambridge, Dept Pharmacol, Cambridge, England	University of Cambridge; University of Cambridge	Welch, M (corresponding author), Univ Cambridge, Dept Biochem, Cambridge, England.	mw240@cam.ac.uk	Maunders, Eve/GVU-3355-2022; rahman, taufiq/GON-8210-2022; Welch, Martin/A-6186-2016	rahman, taufiq/0000-0003-3830-5160; Maunders, Eve/0000-0003-2812-6943; Welch, Martin/0000-0003-3646-1733	Medical Research Council (MRC) DTP Programme Studentship [MR/K50127X/1]; MRC; Hughes Hall Cambridge; Evelyn Trust; BBSRC [BB/M019411/1] Funding Source: UKRI	Medical Research Council (MRC) DTP Programme Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hughes Hall Cambridge; Evelyn Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Medical Research Council (MRC) DTP Programme Studentship MR/K50127X/1 (to E. A. M.) and by two flexible supplement awards (also from the MRC) for training in proteomic and transcriptomic analysis. R. C. T. was supported by a Ph.D. studentship from Hughes Hall Cambridge. Elements of the biochemical and genetic characterization were supported by a grant from the Evelyn Trust.	Alhede M, 2014, ADV APPL MICROBIOL, V86, P1, DOI 10.1016/B978-0-12-800262-9.00001-9; Athar A, 2019, NUCLEIC ACIDS RES, V47, pD711, DOI 10.1093/nar/gky964; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Belardinelli R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10916-8; Berube BJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01202-17; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Bolard A, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01835-17; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Bronstein PA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-209; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chou HT, 2013, J BACTERIOL, V195, P3906, DOI 10.1128/JB.00275-13; Chung JCS, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120131; Cutruzzola F, 2002, J INORG BIOCHEM, V88, P353, DOI 10.1016/S0162-0134(01)00390-7; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Diaz MR, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00089; Diraviam Sriramulu D., 2009, J PROTEOMICS BIOINFO, V2, P131, DOI 10.4172/jpb.1000070; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Galle M, 2012, CURR PROTEIN PEPT SC, V13, P831, DOI 10.2174/138920312804871210; Gicquel G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080407; Gillis RJ, 2005, ANTIMICROB AGENTS CH, V49, P3858, DOI 10.1128/AAC.49.9.3858-3867.2005; Gode-Potratz CJ, 2010, J BACTERIOL, V192, P6025, DOI 10.1128/JB.00654-10; Hay T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056858; Hodgkinson JT, 2016, CHEM SCI, V7, P2553, DOI 10.1039/c5sc04197j; Holtkamp W, 2014, BIOESSAYS, V36, P908, DOI 10.1002/bies.201400076; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Jeannot K, 2005, J BACTERIOL, V187, P5341, DOI 10.1128/JB.187.15.5341-5346.2005; Jones C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081132; Kurushima J, 2012, MICROBIOL IMMUNOL, V56, P356, DOI 10.1111/j.1348-0421.2012.00442.x; Li W, 2011, PROTEINS, V79, P1478, DOI 10.1002/prot.22976; Lin JZ, 2015, CELL, V160, P219, DOI 10.1016/j.cell.2014.11.049; Llamas MA, 2008, MOL MICROBIOL, V67, P458; Mace K, 2018, NUCLEIC ACIDS RES, V46, P3211, DOI 10.1093/nar/gky081; Margus T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022789; Maunders E, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx120; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McCarthy RR, 2014, MICROBIOL-SGM, V160, P1488, DOI 10.1099/mic.0.075291-0; Mikkelsen H, 2007, J BACTERIOL, V189, P2411, DOI 10.1128/JB.01687-06; Miller HK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004194; Mogre A, 2014, DNA RES, V21, P711, DOI 10.1093/dnares/dsu032; Morita Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00408; Morita Y, 2009, J BACTERIOL, V191, P4966, DOI 10.1128/JB.00073-09; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Trinh NTN, 2015, EUR RESPIR J, V45, P1590, DOI 10.1183/09031936.00076214; Palmer SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080252; Pang Z, 2019, BIOTECHNOL ADV, V37, P177, DOI 10.1016/j.biotechadv.2018.11.013; Pereira SG, 2014, J APPL MICROBIOL, V116, P1359, DOI 10.1111/jam.12463; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakhtah H, 2016, P NATL ACAD SCI USA, V113, pE3538, DOI 10.1073/pnas.1600424113; Salsi E, 2015, J MOL BIOL, V427, P454, DOI 10.1016/j.jmb.2014.11.010; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Schobert M, 1999, MICROBIOL-SGM, V145, P471, DOI 10.1099/13500872-145-2-471; Sekiya H, 2003, ANTIMICROB AGENTS CH, V47, P2990, DOI 10.1128/AAC.47.9.2990-2992.2003; Shen DK, 2006, INFECT IMMUN, V74, P1121, DOI 10.1128/IAI.74.2.1121-1129.2006; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Vetter IR, 2014, RAS SUPERFAMILY SMAL, V1, P25; Wang YP, 2003, ANTIMICROB AGENTS CH, V47, P95, DOI 10.1128/AAC.47.1.95-101.2003; Wilderman PJ, 2004, P NATL ACAD SCI USA, V101, P9792, DOI 10.1073/pnas.0403423101; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Zhou L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001291	64	7	8	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16411	16426		10.1074/jbc.RA119.012102	http://dx.doi.org/10.1074/jbc.RA119.012102			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32943550	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000598519500019
J	Kim, S; Ko, Y; Kim, YJ; Jung, E				Kim, Soyoung; Ko, Youngsuk; Kim, Yae-Jean; Jung, Eunok			The impact of social distancing and public behavior changes on COVID-19 transmission dynamics in the Republic of Korea	PLOS ONE			English	Article								Background In the Republic of Korea (ROK), social distancing and public behavior changes mitigated COVID-19 spread. However, a second wave of the epidemic is expected in the fall if neither vaccine nor antiviral drugs become available. This study investigated the impact of non-pharmaceutical measures on short- and long-term outbreak dynamics. Methods A mathematical model based on Susceptible-Exposed-Infectious-Recovered model is developed considering isolated and behavior-changed groups. Using the least-squares fitting method, transmission and behavior change rates were estimated using cases reported from February 16 to April 20, 2020. Findings The estimated transmission rate of COVID-19 was 4 center dot 6180 and behavior change rate was 2 center dot 6044. The model predicted the number of new cases to continuously decrease, with less than one case expected after May 6, 2020. Concurrently, a 25% reduction in behavioral changes during the outbreak would increase the case count by 60,000, resulting in 4,000 cases at maximum, exceeding the medical system's capacity. As behavioral restrictions are eased, local transmission will likely increase, with forecasted second wave peak in October 2020. Interpretation Social distancing and public behavior changes have curbed the spread of COVID-19 in the ROK. Mathematical modeling demonstrates the importance of these measures in reducing and delaying outbreaks. Nevertheless, non-pharmaceutical interventions cannot eliminate the disease. In the future, vaccines and antiviral treatments combined with social distancing and public behavior changes will be paramount to ending COVID-19 epidemic.	[Kim, Soyoung; Ko, Youngsuk; Jung, Eunok] Konkuk Univ, Dept Math, Seoul, South Korea; [Kim, Yae-Jean] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pediat, Sch Med, Seoul, South Korea	Konkuk University; Sungkyunkwan University (SKKU); Samsung Medical Center	Jung, E (corresponding author), Konkuk Univ, Dept Math, Seoul, South Korea.	junge@konkuk.ac.kr		Kim, Soyoung/0000-0003-4918-1087; Ko, Youngsuk/0000-0001-9063-176X	Korea National Research Foundation (NRF) - Korean government (MEST) [NRF-2019R1A6A3A01091838, NRF-2017R1A2B2004651]	Korea National Research Foundation (NRF) - Korean government (MEST)	S. Kim's work is supported by the Korea National Research Foundation (NRF) grant funded by the Korean government (MEST; grant No. NRF-2019R1A6A3A01091838). E. Jung's work is supported by the Korea National Research Foundation (NRF) grant conferred by the Korean government (MEST; grant No. NRF-2017R1A2B2004651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, KOR SIT REP COVID 19; [Anonymous], 2005, STAT 2 M INT HLTH RE; [Anonymous], 2020, J KOREAN MED SCI, V35, pe112; [Anonymous], 2020, CORONAVIRUS DIS COVI; Coyne M, 2020, FORBES; Ki M, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020007; Kissler SM, 2020, SOCIAL DISTANCING ST; Korean Statistical Information Service (KOSIS), RES REG POP ADM DIST; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Perra N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023084; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6	11	24	24	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238684	10.1371/journal.pone.0238684	http://dx.doi.org/10.1371/journal.pone.0238684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970716	gold, Green Published			2022-12-26	WOS:000576265600073
J	Jang, AY; Kim, BG; Kwon, S; Seo, J; Kim, HK; Chang, HJ; Chang, SA; Cho, GY; Rhee, SJ; Jung, HO; Kim, KH; Seo, HS; Kim, KH; Shin, J; Lee, JS; Kim, M; Lee, YJ; Chung, WJ				Jang, Albert Youngwoo; Kim, Bo-Gyeong; Kwon, Sunkoo; Seo, Jiyoung; Kim, Hyung Kwan; Chang, Hyuk-Jae; Chang, Sung-A; Cho, Goo-Yeong; Rhee, Sang Jae; Jung, Hae Ok; Kim, Kyung-Hee; Seo, Hye Sun; Kim, Kye Hun; Shin, Jinho; Lee, Jun Soo; Kim, Minsu; Lee, Young Jae; Chung, Wook-Jin			Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort	PLOS ONE			English	Article							BMPR2 MUTATIONS; SURVIVAL; OUTCOMES	Background Pulmonary arterial hypertension (PAH) is a progressive chronic disease with poor outcomes. One reason for poor prognosis is the lack of understanding regarding individual variability in response to treatment. Idiopathic PAH (IPAH) patients with bone morphogenetic protein receptor type 2(BMPR2) mutations have distinct phenotypes that are crucial for individualized therapy but evidence regarding their prevalence and clinical features in the Korean population is lacking. Therefore, the present study aimed to screen Korean IPAH patients forBMPR2mutations and analyze their clinical phenotypes. Methods We enrolled 73 unrelated IPAH patients forBMPR2mutation screening between March 2010 to November 2015 from 11 hospitals in Korea. Thirty-three lineal family members from 6 families ofBMPR2mutation carriers were also screened. Results Among 73 patients, 16 (22%) hadBMPR2mutations. Mutation carriers were younger (27 vs. 47 years; p = 0.02) and had a higher mean pulmonary arterial pressure (mPAP) than non-carriers (64 vs. 51 mmHg; p<0.05). Of the 16 individuals with mutations, 5 deletion, 2 splice-site, 6 nonsense, and 3 missense mutations were found, among which, 9 were newly identified mutation types. Patients less than 30 years old had moreBMPR2mutations (44 vs. 14%; p = 0.04) and a higher mPAP (64 vs. 50 mmHg; p = 0.04) compared with those equaled to or over 30 years old. There were no differences in hemodynamic profiles or the proportion ofBMPR2mutation carriers between groups according to sex. Conclusion The prevalence ofBMPR2mutations in Korean IPAH patients was 22%. Mutation carriers were younger and had a poorer hemodynamic profile compared with the non-carriers.	[Jang, Albert Youngwoo; Kwon, Sunkoo; Lee, Jun Soo; Kim, Minsu; Chung, Wook-Jin] Gachon Univ, Dept Cardiovasc Med, Gil Med Ctr, Incheon, South Korea; [Jang, Albert Youngwoo; Kim, Minsu; Chung, Wook-Jin] Gachon Univ, Gachon Cardiovasc Res Inst, Incheon, South Korea; [Kim, Bo-Gyeong; Seo, Jiyoung; Lee, Young Jae] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon, South Korea; [Kim, Hyung Kwan] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Sect Cardiovasc Imaging, Seoul, South Korea; [Kim, Hyung Kwan] Seoul Natl Univ Hosp, Cardiovasc Ctr, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol,Coll Med, Seoul, South Korea; [Chang, Sung-A] Sungkyunkwan Univ, Samsung Med Ctr, Heart Vasc Stroke Inst, Div Cardiol,Dept Med,Sch Med, Seoul, South Korea; [Cho, Goo-Yeong] Seoul Natl Univ, Cardiovasc Ctr, Bundang Hosp, Seongnam, Gyeonggi, South Korea; [Rhee, Sang Jae] Wonkwang Univ Hosp, Dept Cardiovasc Med, Iksan, South Korea; [Jung, Hae Ok] Catholic Univ Korea, Dept Internal Med, Div Cardiol, Seoul St Marys Hosp, Seoul, South Korea; [Kim, Kyung-Hee] Sejong Gen Hosp, Dept Internal Med, Div Cardiol, Bucheon, South Korea; [Seo, Hye Sun] Soonchunhyang Univ Hosp, Dept Cardiol, Bucheon, South Korea; [Kim, Kye Hun] Chonnam Natl Univ Hosp, Heart Ctr, Gwangju, South Korea; [Shin, Jinho] Hanyang Univ, Dept Internal Med, Div Cardiol, Med Ctr, Seoul, South Korea	Gachon University; Gachon University; Gachon University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Wonkwang University; Catholic University of Korea; Seoul St. Mary's Hospital; Sejong General Hospital; Soonchunhyang University; Soonchunhyang University Hospital; Chonnam National University; Chonnam National University Hospital; Hanyang University	Chung, WJ (corresponding author), Gachon Univ, Dept Cardiovasc Med, Gil Med Ctr, Incheon, South Korea.; Chung, WJ (corresponding author), Gachon Univ, Gachon Cardiovasc Res Inst, Incheon, South Korea.; Lee, YJ (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Incheon, South Korea.	leeyj@gachon.ac.kr; heart@gachon.ac.kr	Chung, Wook-Jin/AAJ-5613-2021	Chung, Wook-Jin/0000-0002-9767-7098; Chang, Hyuk-Jae/0000-0002-6139-7545; Shin, Jinho/0000-0001-6706-6504; Kim, Hyung-Kwan/0000-0001-7950-2131; Lee, Young Jae/0000-0002-3841-1994	Bayer Co [GCU-2010-2278]; Research of Korea Centers for Disease Control and Prevention [2018-ER6304-00, 2018ER6304-01]; Korean Society of Cardiology [KSC 200403-17]	Bayer Co; Research of Korea Centers for Disease Control and Prevention; Korean Society of Cardiology	This research was supported by grants by Bayer & Co (https://www.bayer.co.kr/, Grant number: GCU-2010-2278) and partially supported by the Research of Korea Centers for Disease Control and Prevention (http://www.cdc.go.kr/, Grant number: 2018-ER6304-00 and 2018ER6304-01) and the Korean Society of Cardiology https://www.circulation.or.kr:4443/eng/, Grant number: KSC 200403-17). Role of sponsors: The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript.	Ahn KJ, 2019, CLIN HYPERTENS, V25, DOI 10.1186/s40885-019-0127-7; [Anonymous], 2013, NEW ENGL J MED, V369, P351; [Anonymous], 2019, EARTH NEGOTIATIONS B, V25; [Anonymous], 2016, FED REGISTER, V81, P31143; Austin ED, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-87; Cai Z, 2011, EUR J HUM GENET, V19, P667, DOI 10.1038/ejhg.2010.257; Chung WJ, 2015, J KOREAN MED SCI, V30, P1429, DOI 10.3346/jkms.2015.30.10.1429; Elliott CG, 2006, CIRCULATION, V113, P2509, DOI 10.1161/CIRCULATIONAHA.105.601930; Evans JDW, 2016, LANCET RESP MED, V4, P129, DOI 10.1016/S2213-2600(15)00544-5; Gaine SP, 1998, LANCET, V352, P719, DOI 10.1016/S0140-6736(98)02111-4; Ge XY, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1309-2; Girerd B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-73; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Isobe S, 2016, AM J RESP CRIT CARE, V193, P1310, DOI 10.1164/rccm.201601-0158LE; Jang AY, 2019, KOREAN J INTERN MED, V34, P696, DOI 10.3904/kjim.2019.185; Kabata H, 2013, RESPIROLOGY, V18, P1076, DOI 10.1111/resp.12117; Liu D, 2012, CIRC-CARDIOVASC GENE, V5, P511, DOI 10.1161/CIRCGENETICS.111.962209; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Morisaki H, 2004, HUM MUTAT, V23, P632, DOI 10.1002/humu.9251; Morrell Nicholas W, 2006, Proc Am Thorac Soc, V3, P680, DOI 10.1513/pats.200605-118SF; Morrell NW, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01899-2018; Pfarr N, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-3; Pfarr N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-99; Rabinovitch M, 2014, CIRC RES, V115, P165, DOI 10.1161/CIRCRESAHA.113.301141; Rosenzweig EB, 2008, J HEART LUNG TRANSPL, V27, P668, DOI 10.1016/j.healun.2008.02.009; Savale L, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0004-2018; Simonneau G, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01913-2018; Sztrymf B, 2004, REV MAL RESPIR, V21, P909; Sztrymf B, 2008, AM J RESP CRIT CARE, V177, P1377, DOI 10.1164/rccm.200712-1807OC; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Tokunaga N, 2016, J CARDIOL, V68, P542, DOI 10.1016/j.jjcc.2015.11.012; Yang H, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0789-9	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238698	10.1371/journal.pone.0238698	http://dx.doi.org/10.1371/journal.pone.0238698			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966279	Green Published, gold			2022-12-26	WOS:000575688700043
J	Nikolaev, YA; Tutel'yan, AV; Loiko, NG; Buck, J; Sidorenko, SV; Lazareva, I; Gostev, V; Manzen'yuk, OY; Shemyakin, IG; Abramovich, RA; Huwyler, J; El'-Registan, GI				Nikolaev, Y. A.; Tutel'yan, A. V.; Loiko, N. G.; Buck, J.; Sidorenko, S. V.; Lazareva, I.; Gostev, V.; Manzen'yuk, O. Y.; Shemyakin, I. G.; Abramovich, R. A.; Huwyler, J.; El'-Registan, G. I.			The use of 4-Hexylresorcinol as antibiotic adjuvant	PLOS ONE			English	Article							RESISTANT ACINETOBACTER-BAUMANNII; PERSISTENT BACTERIAL-INFECTIONS; ALKYL PHENYL ALCOHOL; CHEMICAL ANALOGS; TOLERANCE; ALKYLRESORCINOLS; COMBINATION; AUTOREGULATORS; STRATEGIES; COLISTIN	Ever decreasing efficiency of antibiotic treatment due to growing antibiotic resistance of pathogenic bacteria is a critical issue in clinical practice. The two generally accepted major approaches to this problem are the search for new antibiotics and the development of antibiotic adjuvants to enhance the antimicrobial activity of known compounds. It was therefore the aim of the present study to test whether alkylresorcinols, a class of phenolic lipids, can be used as adjuvants to potentiate the effect of various classes of antibiotics. Alkylresorcinols were combined with 12 clinically used antibiotics. Growth-inhibiting activity against a broad range of pro- and eukaryotic microorganisms was determined. Test organisms did comprise 10 bacterial and 2 fungal collection strains, includingE. coliandS. aureus, and clinical isolates ofK. pneumoniae. The highest adjuvant activity was observed in the case of 4-hexylresorcinol (4-HR), a natural compound found in plants with antimicrobial activity. 50% of the minimal inhibitory concentration (MIC) of 4-HR caused an up to 50-fold decrease in the MIC of antibiotics of various classes. Application of 4-HR as an adjuvant revealed its efficiency against germination of bacterial dormant forms (spores) and prevented formation of antibiotic-tolerant persister cells. Using anin vivomouse model ofK. pneumoniae-induced sepsis, we could demonstrate that the combination of 4-HR and polymyxin was highly effective. 75% of animals were free of infection after treatment as compared to none of the animals receiving the antibiotic alone. We conclude that alkylresorcinols such as 4-HR can be used as an adjuvant to increase the efficiency of several known antibiotics. We suggest that by this approach the risk for development of genetically determined antibiotic resistance can be minimized due to the multimodal mode of action of 4-HR.	[Nikolaev, Y. A.; Loiko, N. G.; El'-Registan, G. I.] Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, Moscow, Russia; [Tutel'yan, A. V.] Sechenov Univ, Cent Res Inst Epidemiol Russian Fed Serv Surveill, Moscow, Russia; [Tutel'yan, A. V.] Sechenov Univ, IM Sechenov First Moscow State Med Univ, Minist Hlth Russian Federat, Moscow, Russia; [Buck, J.; Huwyler, J.] Univ Basel, Dept Pharmaceut Sci, Basel, Switzerland; [Abramovich, R. A.] RUDN Univ, Peoples Friendship Univ Russia, Moscow, Russia; [Sidorenko, S. V.; Lazareva, I.; Gostev, V.] Pediat Res & Clin Ctr Infect Dis, St Petersburg, Russia; [Sidorenko, S. V.; Lazareva, I.; Gostev, V.] II Mechnikov North Western State Med Univ, St Petersburg, Russia; [Manzen'yuk, O. Y.; Shemyakin, I. G.] Russian Fed Serv Surveillance Consumer Rights Pro, State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Sechenov First Moscow State Medical University; Ministry of Health of the Russian Federation; Sechenov First Moscow State Medical University; University of Basel; Peoples Friendship University of Russia; North-Western State Medical University named after I.I. Mechnikov	Nikolaev, YA (corresponding author), Russian Acad Sci, Fed Res Ctr Fundamentals Biotechnol, Moscow, Russia.	nikolaevya@mail.ru	LAZAREVA, IRINA/GZM-6019-2022; Gostev, Vladimir V/P-1949-2016; Sidorenko, Sergey/E-5870-2011; Manzenyuk, Oksana/AAZ-7596-2021; Loiko, Natalia/AAZ-2904-2020; Tutel'an, Aleksei/A-4895-2017	Gostev, Vladimir V/0000-0002-3480-8089; Sidorenko, Sergey/0000-0003-3550-7875; Loiko, Natalia/0000-0001-5204-007X; Buck, Jonas/0000-0002-4676-3113; Tutel'an, Aleksei/0000-0002-2706-6689	Russian Academy of Sciences; University of Basel; Swiss National Science Foundation (SNF) [173057]; RUDN University Program 5-100; Sectoral Scientific Program of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing	Russian Academy of Sciences(Russian Academy of Sciences); University of Basel; Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); RUDN University Program 5-100; Sectoral Scientific Program of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing	This work was supported by internal funding from the Russian Academy of Sciences and the University of Basel. JB and JH were supported by the Swiss National Science Foundation (SNF grant No. 173057).; The publication has been prepared with the support of the "RUDN University Program 5-100". Animal Research was supported by the Sectoral Scientific Program of the Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. We thank Viktoria Schreiner for editorial support. The authors declare that they have no conflict of interest.	Amoh T, 2017, J ANTIMICROB CHEMOTH, V72, P2230, DOI 10.1093/jac/dkx132; [Anonymous], 2016, CIRE ANTILLES GUYANE; [Anonymous], 1999, NEW AGR, V99, P1; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Brameyer S, 2015, P NATL ACAD SCI USA, V112, P572, DOI 10.1073/pnas.1417685112; Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34; Brooks BD, 2014, ADV DRUG DELIVER REV, V78, P14, DOI 10.1016/j.addr.2014.10.027; Brown D, 2015, NAT REV DRUG DISCOV, V14, P821, DOI 10.1038/nrd4675; Buta JG, 1999, J AGR FOOD CHEM, V47, P1, DOI 10.1021/jf980712x; Butler MS, 2013, J ANTIBIOT, V66, P571, DOI 10.1038/ja.2013.86; Cabral DJ, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010014; Cai BX, 2016, ANTIMICROB AGENTS CH, V60, P4013, DOI 10.1128/AAC.03064-15; Chen X, 2011, APPL ENVIRON MICROB, V77, P4878, DOI 10.1128/AEM.02440-10; Chhabra RS, 1988, NATL TOXICOL PROGRAM, V330, P1; Chung JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28168; Cohen NR, 2013, CELL HOST MICROBE, V13, P632, DOI 10.1016/j.chom.2013.05.009; Davydova OK, 2007, MICROBIOLOGY+, V76, P266, DOI 10.1134/S0026261707030022; Deryabin D. G., 2013, Immunologiya, V34, P27; Domalaon R, 2018, CLIN MICROBIOL REV, V31, DOI [10.1128/CMR.00077-17, 10.1128/cmr.00077-17]; Douafer H, 2019, J MED CHEM, V62, P8665, DOI 10.1021/acs.jmedchem.8b01781; El-Registan GI, 2006, MICROBIOLOGY+, V75, P380, DOI 10.1134/S0026261706040035; ELIOPOULOS G M, 1988, Clinical Microbiology Reviews, V1, P139; Finlay J, 2003, J ANTIMICROB CHEMOTH, V52, P18, DOI 10.1093/jac/dkg286; Fisher RA, 2017, NAT REV MICROBIOL, V15, P453, DOI 10.1038/nrmicro.2017.42; Franco NH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002399; Gill EE, 2015, CHEM BIOL DRUG DES, V85, P56, DOI 10.1111/cbdd.12478; Golod NA, 2009, MICROBIOLOGY+, V78, P678, DOI 10.1134/S0026261709060034; Gomez-Simmonds A, 2015, J CLIN MICROBIOL, V53, P2060, DOI 10.1128/JCM.03455-14; Goneau LW, 2014, ANTIMICROB AGENTS CH, V58, P2089, DOI 10.1128/AAC.02552-13; Gonzalez-Aguilar GA, 2000, J AGR FOOD CHEM, V48, P4204, DOI 10.1021/jf991384j; Gonzalez-Bello C, 2017, BIOORG MED CHEM LETT, V27, P4221, DOI 10.1016/j.bmcl.2017.08.027; Gordon D, 2010, KUCERS USE ANTIBIOTI, P187; Grant SS, 2013, VIRULENCE, V4, P273, DOI 10.4161/viru.23987; Hao YB, 2018, MOLECULES, V23, DOI 10.3390/molecules23092173; Helaine S, 2014, TRENDS MICROBIOL, V22, P417, DOI 10.1016/j.tim.2014.03.008; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; KAPRELYANTS AS, 1987, BIOL MEMBRANY, V4, P254; Kawai Y, 2018, CELL, V172, P1038, DOI 10.1016/j.cell.2018.01.021; Kemme M, 2018, J FUNCT BIOMATER, V9, DOI 10.3390/jfb9010004; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kim SG, 2011, ONCOL REP, V26, P1527, DOI 10.3892/or.2011.1436; Krupyanskii YF, 2012, RUSS J PHYS CHEM B+, V6, P301, DOI 10.1134/S1990793112020078; Lee HJ, 2013, ANTIMICROB AGENTS CH, V57, P3738, DOI 10.1128/AAC.00703-13; Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Linko AM, 2005, BRIT J NUTR, V93, P10, DOI 10.1079/BJN20041281; Liukkonen KH, 2003, P NUTR SOC, V62, P117, DOI 10.1079/PNS2002218; Luis A, 2016, MINI-REV MED CHEM, V16, P851, DOI 10.2174/1389557516666160211121437; Mart'ianov S V, 2015, Mikrobiologiia, V84, P27; Martirosova EI, 2004, MICROBIOLOGY+, V73, P609, DOI 10.1023/B:MICI.0000044252.10568.08; Mehta KC, 2014, J CLIN DIAGN RES, V8, pME5, DOI 10.7860/JCDR/2014/8778.4489; Michiels J, 2016, BACTERIAL PERSISTENC; MORRIS TH, 1995, LAB ANIM, V29, P16, DOI 10.1258/002367795780740393; Nikolaev YA, 2006, MICROBIOLOGY+, V75, P420, DOI 10.1134/S0026261706040096; O'Hara JA, 2013, ANTIMICROB AGENTS CH, V57, P2103, DOI 10.1128/AAC.02501-12; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Omardien S, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00111; Ren H, 2015, J ANTIMICROB CHEMOTH, V70, P3267, DOI 10.1093/jac/dkv251; Ross AB, 2004, NUTR REV, V62, P81, DOI [10.1111/j.1753-4887.2004.tb00029.x, 10.1301/nr.2004.mar.81-95]; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Stasiuk M, 2010, CELL MOL LIFE SCI, V67, P841, DOI 10.1007/s00018-009-0193-1; Sumino M, 2002, CHEM PHARM BULL, V50, P1484, DOI 10.1248/cpb.50.1484; Sviridova T. G., 2013, Immunologiya, V34, P84; Vorobyev A.A., 1962, STAT METHODS MICROBI; Windels EM, 2019, ISME J, V13, P1239, DOI 10.1038/s41396-019-0344-9; Wright GD, 2016, TRENDS MICROBIOL, V24, P928, DOI 10.1016/j.tim.2016.07.008; Yen GC, 2003, FREE RADICAL RES, V37, P509, DOI 10.1080/1071576031000083099	69	7	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239147	10.1371/journal.pone.0239147	http://dx.doi.org/10.1371/journal.pone.0239147			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960928	gold, Green Published			2022-12-26	WOS:000575109500020
J	Shapira, G; Shomron, N; Gurwitz, D				Shapira, Guy; Shomron, Noam; Gurwitz, David			Ethnic differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in COVID-19 fatality rates	FASEB JOURNAL			English	Article						alpha-1 antitrypsin; COVID-19; rs17580; rs28929474; SERPINA1		Infection rates, severity, and fatalities due to COVID-19, the pandemic mediated by SARS-CoV-2, vary greatly between countries. With few exceptions, these are lower in East and Southeast Asian and Sub-Saharan African countries compared with other regions. Epidemiological differences may reflect differences in border closures, lockdowns, and social distancing measures taken by each county, and by cultural differences, such as common use of face masks in East and Southeast Asian countries. The plasma serine protease inhibitor alpha-1 antitrypsin was suggested to protect from COVID-19 by inhibiting TMPRSS2, a cell surface serine protease essential for the SARS-CoV-2 cell entry. Here, we present evidence that population differences in alpha-1 antitrypsin deficiency allele frequencies may partially explain national differences in the COVID-19 epidemiology. Our study compared reported national estimates for the major alpha-1 antitrypsin deficiency alleles PiZ and PiS (SERPINA1rs28929474 and rs17580, respectively) with the Johns Hopkins University Coronavirus Resource Center dataset. We found a significant positive correlation (R = .54,P = 1.98e-6) between the combined frequencies of the alpha-1 antitrypsin PiZ and PiS deficiency alleles in 67 countries and their reported COVID-19 mortality rates. Our observations suggest that alpha-1 antitrypsin deficiency alleles may contribute to national differences in COVID-19 infection, severity, and mortality rates. Population-wide screening for carriers of alpha-1 antitrypsin deficiency alleles should be considered for prioritizing individuals for stricter social distancing measures and for receiving a SARS-CoV-2 vaccine once it becomes available.	[Shapira, Guy; Shomron, Noam; Gurwitz, David] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Shomron, Noam; Gurwitz, David] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Shomron, Noam] Tel Aviv Univ, Edmond J Safra Ctr Bioinformat, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University	Shomron, N; Gurwitz, D (corresponding author), Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.	nshomron@tauex.tau.ac.il; gurwitz@tauex.tau.ac.il	; Gurwitz, David/E-7642-2013	Shapira, Guy/0000-0001-9376-4955; Gurwitz, David/0000-0002-9363-1869; Reis, AlessanRSS/0000-0001-8486-7469	Yoran Institute for Human Genome Research at Tel Aviv University; Adelis Foundation	Yoran Institute for Human Genome Research at Tel Aviv University; Adelis Foundation	D. Gurwitz is supported by the Yoran Institute for Human Genome Research at Tel Aviv University. The N. Shomron lab is partially supported by the Adelis Foundation. The authors thank Cindy Cohen for professional editorial assistance.	Azouz Nurit P, 2020, bioRxiv, DOI 10.1101/2020.05.04.077826; Blanco I, 2017, INT J CHRONIC OBSTR, V12, P1683, DOI 10.2147/COPD.S137852; Cirovic B, 2020, CELL HOST MICROBE, V28, P322, DOI 10.1016/j.chom.2020.05.014; de Loyola MB, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2157; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Gaye B, 2020, NAT MED, V26, P996, DOI 10.1038/s41591-020-0960-y; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Iwasaki A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012481; Lindley VM, 2021, J AM COLL NUTR, V40, P98, DOI 10.1080/07315724.2020.1740629; McElvaney OJ, 2020, AM J RESP CRIT CARE, V202, P812, DOI 10.1164/rccm.202005-1583OC; Meltzer DO, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19722; Mitchell EL, 2018, CURR PATHOBIOL REP, V6, P97, DOI 10.1007/s40139-018-0164-z; Pacha O, 2020, NAT REV IMMUNOL, V20, P345, DOI 10.1038/s41577-020-0328-z; Pervakova MY, 2020, PULM MED, V2020, DOI 10.1155/2020/9738032; Schuster R, 2020, CELL IMMUNOL, V356, DOI 10.1016/j.cellimm.2020.104177; Vaidyanathan G, 2020, NATURE, V585, P167, DOI 10.1038/d41586-020-02507-x; Vianello A, 2020, ARCH BRONCONEUMOL, V56, P609, DOI [10.1016/j.arbres.2020.05.015, 10.1016/j.arbr.2020.05.011]; Wettstein L, 2020, BIORXIV, P1, DOI [10.1101/2020.07.02.183764, DOI 10.1101/2020.07.02.183764]; Yamamoto M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060629; Yi R, 2004, PROTEOMICS, V4, P3477, DOI 10.1002/pmic.200400897; Yitbarek K, 2020, VACCINE, V38, P6374, DOI 10.1016/j.vaccine.2020.08.018	21	26	26	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14160	14165		10.1096/fj.202002097	http://dx.doi.org/10.1096/fj.202002097		SEP 2020	6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32960480	Green Published, Green Submitted			2022-12-26	WOS:000573862800001
J	Yang, T; Wang, LJ; Wang, ZH; Kutel, ZS				Yang, Ting; Wang, Lejun; Wang, Zihao; Kutel, Zeynep Safak			Chinese residents' environmental concern and expectation of sending children to study abroad	PLOS ONE			English	Article							AIR-POLLUTION; STUDENTS; PROTECTION; QUALITY	The majority of existing studies find that Chinese residents would like to send children to study abroad for higher education quality and multiple opportunities. Previous studies have paid little attention to the association of this issue with environmental degradation in recent years. Merging data on adults from the China Family Panel Studies (CFPS) in 2016 with data on children, this paper investigates the effect of environmental concern on the educational level at which Chinese residents are willing to send children to study abroad based on the ordered logit model and Heckman Probit Model (HPM). The results show that environmental concern predicted a positive attitude toward a willingness to send children to study abroad at a decreased schooling level after concerns about the Chinese education system and educational expectations for children and other sociodemographic factors were controlled for. The marginal effects of environmental concern on expectations of sending children to study abroad at different educational levels showed that increasing environmental concern leads to the probability of residents considering sending children to study abroad during junior college or below increasing, while it leads to the probability of residents considering sending their children to study abroad during undergraduate or higher education decreasing. The HPM further verified that environmental concern had a positive effect on residents' willingness of sending their children to study during junior college or below. The study offers an important early step in the empirical testing of the relationship between Chinese residents' environmental concern and the educational level at which they would consider sending children to study abroad.	[Yang, Ting; Wang, Lejun; Wang, Zihao; Kutel, Zeynep Safak] Huazhong Univ Sci & Technol, Sch Sociol, Wuhan, Peoples R China	Huazhong University of Science & Technology	Yang, T (corresponding author), Huazhong Univ Sci & Technol, Sch Sociol, Wuhan, Peoples R China.	yangting.511@163.com						[Anonymous], 2017, NEW ORIENTAL, P2018; Arnocky S, 2012, POPUL ENVIRON, V34, P279, DOI 10.1007/s11111-011-0164-y; Cebolla-Boado H, 2018, BRIT J SOCIOL EDUC, V39, P365, DOI 10.1080/01425692.2017.1349649; Center for China and Globalization, 2013, REP CHIN STUD STUD A; Chan SJ, 2012, HIGH EDUC POLICY, V25, P207, DOI 10.1057/hep.2012.3; China Education Online, 2016, CHINA ED ONLINE REPO; Education C.M.o, 2019, STAT CHIN STUD STUD; Farrugia C, 2017, TRENDS INT SECONDARY; Ghazarian PG, 2016, J INT STUDENTS, V6, P700; Givens JE, 2011, ORGAN ENVIRON, V24, P74, DOI 10.1177/1086026611406030; INGLEHART R, 1995, PS, V28, P57, DOI 10.2307/420583; James-MacEachern M, 2017, INT J EDUC MANAG, V31, P343, DOI 10.1108/IJEM-11-2015-0158; Landry N, 2018, J ENVIRON PSYCHOL, V55, P18, DOI 10.1016/j.jenvp.2017.12.003; Li XY, 2018, CHINA QUART, V234, P340, DOI 10.1017/S0305741017001382; Long WF, 2016, WATER SCI TECH-W SUP, V16, P1514, DOI 10.2166/ws.2016.079; Neidell MJ, 2004, J HEALTH ECON, V23, P1209, DOI 10.1016/j.jhealeco.2004.05.002; Petzold K, 2018, HIGH EDUC, V75, P35, DOI 10.1007/s10734-017-0119-z; Rohde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135749; Shao S, 2018, WORLD DEV, V105, P83, DOI 10.1016/j.worlddev.2017.12.033; Yu L, 2008, J CAN HIST ASSOC, V19, P180, DOI [10.7202/037753ar, DOI 10.7202/037753AR]; Zeng XW, 2016, ATMOS ENVIRON, V138, P144, DOI 10.1016/j.atmosenv.2016.05.003; Zhang HF, 2016, J CLEAN PROD, V112, P1519, DOI 10.1016/j.jclepro.2015.04.092; Zhu L, 2019, INT J EDUC MANAG, V33, P999, DOI 10.1108/IJEM-11-2017-0339	23	1	1	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0238180	10.1371/journal.pone.0238180	http://dx.doi.org/10.1371/journal.pone.0238180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NW6FH	32960893	Green Published, gold			2022-12-26	WOS:000575109500028
J	Boas, FE; Nurili, F; Bendet, A; Cheleuitte-Nieves, C; Basturk, O; Askan, G; Michel, AO; Monette, S; Ziv, E; Sofocleous, CT; Maxwell, AWP; Schook, LB; Solomon, SB; Kelsen, DP; Scherz, A; Yarmohammadi, H				Boas, F. Edward; Nurili, Fuad; Bendet, Achiude; Cheleuitte-Nieves, Christopher; Basturk, Olca; Askan, Gokce; Michel, Adam O.; Monette, Sebastien; Ziv, Etay; Sofocleous, Constantinos T.; Maxwell, Aaron W. P.; Schook, Lawrence B.; Solomon, Stephen B.; Kelsen, David P.; Scherz, Avigdor; Yarmohammadi, Hooman			Induction and characterization of pancreatic cancer in a transgenic pig model	PLOS ONE			English	Article							CHEMOTHERAPY; GEMCITABINE; ULTRASOUND; INFUSION	Background Preclinical testing of new locoregional therapies for pancreatic cancer has been challenging, due to the lack of a suitable large animal model. Purpose To develop and characterize a porcine model of pancreatic cancer. Unlike small animals, pigs have similar physiology, drug dosing, and immune response to humans. Locoregional therapy in pigs can be performed using the same size catheters and devices as in humans. Methods The Oncopig is a transgenic pig with Cre-inducibleTP53(R167H)andKRAS(G12D)mutations. In 12 Oncopigs, CT-guided core biopsy of the pancreas was performed. The core biopsy was incubated with an adenoviral vector carrying the Cre recombinase gene. The transformed core biopsy was injected back into the pancreas (head, tail, or both). The resulting tumors (n= 19) were characterized on multi-phase contrast-enhanced CT, and on pathology, including immunohistochemistry. Angiographic characterization of the tumors was performed in 3 pigs. Results Pancreatic tumors developed at 19 out of 22 sites (86%) that were inoculated. Average tumor size was 3.0 cm at 1 week (range: 0.5-5.1 cm). H&E and immunohistochemical stains revealed undifferentiated carcinomas, similar to those of the pancreatobiliary system in humans. Neoplastic cells were accompanied by a major inflammatory component. 1 of 12 pigs only had inflammatory nodules without evidence of neoplasia. On multiphase CT, tumors were hypovascular compared to the normal pancreas. There was no pancreatic duct dilation. In 3 pigs, angiography was performed, and in all 3 cases, the artery supplying the pancreatic tumor could be catheterized using a 2.4 F microcatheter. Selective angiography showed the pancreatic tumor, without extra-pancreatic perfusion. Conclusion Pancreatic cancer can be induced in a transgenic pig. Intra-arterial procedures using catheters designed for human interventions were technically feasible in this large animal model.	[Boas, F. Edward; Nurili, Fuad; Bendet, Achiude; Ziv, Etay; Sofocleous, Constantinos T.; Maxwell, Aaron W. P.; Solomon, Stephen B.; Yarmohammadi, Hooman] Mem Sloan Kettering Canc Ctr, Dept Radiol, Intervent Radiol Serv, 1275 York Ave, New York, NY 10021 USA; [Cheleuitte-Nieves, Christopher] Sloan Kettering Inst, Res Anim Resource Ctr, New York, NY USA; [Basturk, Olca; Askan, Gokce] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Michel, Adam O.; Monette, Sebastien] Rockefeller Univ, Mem Sloan Kettering Canc Ctr, Lab Comparat Pathol, Weill Cornell Med, 1230 York Ave, New York, NY 10021 USA; [Schook, Lawrence B.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Kelsen, David P.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Scherz, Avigdor] Weizmann Inst Sci, Dept Plant & Environm Sci, Rehovot, Israel	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University; University of Illinois System; University of Illinois Urbana-Champaign; Memorial Sloan Kettering Cancer Center; Weizmann Institute of Science	Boas, FE (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiol, Intervent Radiol Serv, 1275 York Ave, New York, NY 10021 USA.	boasf@mskcc.org	Maxwell, Aaron/AAN-8401-2021	Boas, Franz/0000-0002-1382-5365; Askan, Gokce/0000-0002-9255-649X; Nurili, Fuad/0000-0002-0413-9363; Cheleuitte-Nieves, Christopher/0000-0002-3881-1496	Thompson Family Foundation; John and Elizabeth Montgomery; Patrice Tarsey; Society of Interventional Radiology (Ernest Ring Academic Development Grant); NIH [U42 OD011140]; GE; NIH/NCI Cancer Center Support Grant [P30 CA008748]	Thompson Family Foundation; John and Elizabeth Montgomery; Patrice Tarsey; Society of Interventional Radiology (Ernest Ring Academic Development Grant); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE; NIH/NCI Cancer Center Support Grant	This work was supported by the Thompson Family Foundation (to FEB, DPK, AS, and HY), John and Elizabeth Montgomery (to HY), Patrice Tarsey (to HY), and the Society of Interventional Radiology (Ernest Ring Academic Development Grant to HY). Some pigs were supplied by the National Swine Resource and Research Center, which was supported by NIH grant U42 OD011140. Our animal facility was supported in part by GE, and core facilities were funded in part through an NIH/NCI Cancer Center Support Grant (P30 CA008748). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chick JFB, 2016, J VASC INTERV RADIOL, V27, P922, DOI 10.1016/j.jvir.2015.12.758; Committee for the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016, 2017, JJAAM, V28, ps1; Committee for the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016, 2017, JJAAM, V28, ps1; Dawson HD, 2017, VET MICROBIOL, V202, P2, DOI 10.1016/j.vetmic.2016.05.013; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; Dimcevski G, 2016, J CONTROL RELEASE, V243, P172, DOI 10.1016/j.jconrel.2016.10.007; Eifler AC, 2009, J VASC INTERV RADIOL, V20, P1075, DOI 10.1016/j.jvir.2009.04.051; ESGCT, 2019, HUM GENE THER, V30, pA1; ESGCT, 2019, HUM GENE THER, V30, pA1; Gao F, 2019, THERANOSTICS, V9, P6002, DOI 10.7150/thno.36135; Hirooka Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4453-z; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Kalla D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020488; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Lee Jae W, 2016, Curr Protoc Pharmacol, V73, DOI 10.1002/cpph.2; Lei YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15130; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Muraki T, 2016, AM J SURG PATHOL, V40, P1203, DOI 10.1097/PAS.0000000000000689; Murata S, 2018, CARDIOVASC INTER RAD, V41, P1081, DOI 10.1007/s00270-018-1943-y; Murata S, 2015, RADIOLOGY, V276, P102, DOI 10.1148/radiol.15141596; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; National Research Council, 2011, GUIDE CARE USE LAB A; Nurili F, 2020, J VASCULAR INT UNPUB; Overgaard NH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01301; Overgaard NH, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00286; Principe DR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30916-6; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Reid MD, 2011, MODERN PATHOL, V24, P1612, DOI 10.1038/modpathol.2011.113; Rosemurgy AS, 2017, J PANCREATIC CANCER, V3, P58, DOI 10.1089/pancan.2017.0011; Scheffer HJ, 2017, RADIOLOGY, V282, P585, DOI 10.1148/radiol.2016152835; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schook LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128864; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Tanaka T, 2009, AM J ROENTGENOL, V192, pW168, DOI 10.2214/AJR.08.1392; Wang MN, 2017, J CANCER, V8, P761, DOI 10.7150/jca.17648; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Yoon H, 2018, OUTCOMES LOCOREGIONA; Yoshida H, 1999, HEPATO-GASTROENTEROL, V46, P2612	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239391	10.1371/journal.pone.0239391	http://dx.doi.org/10.1371/journal.pone.0239391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956389	Green Published, gold			2022-12-26	WOS:000574571500044
J	Ronda, OAHO; van de Heijning, BJM; de Bruin, A; Thomas, RE; Martini, I; Koehorst, M; Gerding, A; Koster, MH; Bloks, VW; Jurdzinski, A; Mulder, NL; Havinga, R; van der Beek, EM; Reijngoud, DJ; Kuipers, F; Verkade, HJ				Ronda, Onne A. H. O.; van de Heijning, Bert J. M.; de Bruin, Alain; Thomas, Rachel E.; Martini, Ingrid; Koehorst, Martijn; Gerding, Albert; Koster, Mirjam H.; Bloks, Vincent W.; Jurdzinski, Angelika; Mulder, Niels L.; Havinga, Rick; van der Beek, Eline M.; Reijngoud, Dirk-Jan; Kuipers, Folkert; Verkade, Henkjan J.			Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet	PLOS ONE			English	Article							BILE-ACID; NONALCOHOLIC STEATOHEPATITIS; METABOLIC ADAPTATION; FATTY-ACIDS; EXPRESSION; CHOLESTEROL; TRANSPORTER; DEFICIENCY; ABSORPTION; HEPATITIS	Mouse models are frequently used to study mechanisms of human diseases. Recently, we observed a spontaneous bimodal variation in liver weight in C57BL/6JOlaHsd mice fed a semisynthetic diet. We now characterized the spontaneous variation in liver weight and its relationship with parameters of hepatic lipid and bile acid (BA) metabolism. In male C57BL/6JOlaHsd mice fed AIN-93G from birth to postnatal day (PN)70, we measured plasma BA, lipids, Very low-density lipoprotein (VLDL)-triglyceride (TG) secretion, and hepatic mRNA expression patterns. Mice were sacrificed at PN21, PN42, PN63 and PN70. Liver weight distribution was bimodal at PN70. Mice could be subdivided into two nonoverlapping groups based on liver weight: 0.6 SD 0.1 g (approximately one-third of mice, small liver; SL), and 1.0 SD 0.1 g (normal liver; NL; p<0.05). Liver histology showed a higher steatosis grade, inflammation score, more mitotic figures and more fibrosis in the SLversusthe NL group. Plasma BA concentration was 14-fold higher in SL (p<0.001). VLDL-TG secretion rate was lower in SL mice, both absolutely (-66%, p<0.001) and upon correction for liver weight (-44%, p<0.001). Mice that would later have the SL-phenotype showed lower food efficiency ratios during PN21-28, suggesting the cause of the SL phenotype is present at weaning (PN21). Our data show that approximately one-third of C57BL/6JOlaHsd mice fed semisynthetic diet develop spontaneous liver disease with aberrant histology and parameters of hepatic lipid, bile acid and lipoprotein metabolism. Study designs involving this mouse strain on semisynthetic diets need to take the SL phenotype into account. Plasma lipids may serve as markers for the identification of the SL phenotype.	[Ronda, Onne A. H. O.; de Bruin, Alain; Koster, Mirjam H.; Bloks, Vincent W.; Jurdzinski, Angelika; Mulder, Niels L.; Havinga, Rick; van der Beek, Eline M.; Reijngoud, Dirk-Jan; Kuipers, Folkert; Verkade, Henkjan J.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [van de Heijning, Bert J. M.; van der Beek, Eline M.] Danone Nutricia Res, Uppsalalaan, Utrecht, Netherlands; [de Bruin, Alain; Thomas, Rachel E.] Univ Utrecht, Fac Vet Med, Dutch Mol Pathol Ctr, Utrecht, Netherlands; [Martini, Ingrid; Koehorst, Martijn; Gerding, Albert; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; Danone Nutricia; Utrecht University; University of Groningen	Verkade, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands.	h.j.verkade@umcg.nl	; Bloks, Vincent Walter/A-7609-2012	de Bruin, Alain/0000-0001-8579-2649; Bloks, Vincent Walter/0000-0001-6493-7482; Koehorst, Martijn/0000-0001-6219-0901; Reijngoud, Dirk-Jan/0000-0003-1157-4491; Verkade, Henkjan J/0000-0002-7034-2861; Ronda, Onne/0000-0002-7148-8635; Kuipers, Folkert/0000-0003-2518-737X	Danone Nutricia Research	Danone Nutricia Research(Danone Nutricia)	Danone Nutricia Research provided funding for this study in the form of a grant used to cover bench fees and salary support for OR, as well as in the form of salaries for BvdH and EMvdB. The specific roles of these authors are articulated in the `author contributions' section. The funder had no role in study design, data collection and analysis, or decision to publish.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bouchard G, 2002, J LIPID RES, V43, P1105, DOI 10.1194/jlr.M200102-JLR200; Boulange CL, 2013, J PROTEOME RES, V12, P1956, DOI 10.1021/pr400051s; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Buttet M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145626; Charrez B, 2016, WORLD J GASTROENTERO, V22, P2494, DOI 10.3748/wjg.v22.i8.2494; Chung KC, 2010, PLAST RECONSTR SURG, V126, P515, DOI 10.1097/PRS.0b013e3181df64fa; Cudalbu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069782; Derks TGJ, 2008, J INHERIT METAB DIS, V31, P88, DOI 10.1007/s10545-007-0492-3; Dimova LG, 2017, GASTROENTEROLOGY, V153, P382, DOI 10.1053/j.gastro.2017.04.019; Elizondo A, 2007, OBESITY, V15, P24, DOI 10.1038/oby.2007.518; Enguita M, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1243-0; Festing MFW, 2014, ILAR J, V55, P399, DOI 10.1093/ilar/ilu036; Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002; George ED, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-123; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Ji SY, 2019, DEV CELL, V48, P460, DOI 10.1016/j.devcel.2018.12.021; Kang SK, 2019, EPILEPSIA OPEN, V4, P164, DOI 10.1002/epi4.12287; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Lackner C, 2011, EXPERT REV GASTROENT, V5, P223, DOI [10.1586/EGH.11.8, 10.1586/egh.11.8]; Lee J, 2014, EXP MOL PATHOL, V96, P118, DOI 10.1016/j.yexmp.2013.09.004; Lee JM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010023; Lemoy MJMF, 2013, J AM ASSOC LAB ANIM, V52, P444; Lionarons DA, 2012, J LIPID RES, V53, P1535, DOI 10.1194/jlr.M025726; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Muoio Deborah M, 2007, Novartis Found Symp, V286, P24; Nagy TR, 2002, OBES RES, V10, P412, DOI 10.1038/oby.2002.57; Nguyen KD, 2014, WORLD J GASTROENTERO, V20, P9418, DOI 10.3748/wjg.v20.i28.9418; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Oosting A, 2012, PEDIATR RES, V72, P362, DOI 10.1038/pr.2012.101; Paalvast Y, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13376; Peng KY, 2018, J LIPID RES, V59, P1977, DOI 10.1194/jlr.M085613; Rattay S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199863; RCore Team, 2020, R LANG ENV STAT COMP; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Ronda OAHO, 2018, J PEDIAT GASTROENTER, P1095; Ronda OAHO, 2019, J PEDIAT GASTROENTER, V68, P750; Ronda OAHO, 2019, BRIT J NUTR, V122, P1321, DOI 10.1017/S0007114519002083; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Sinha J, 2008, AM J PHYSIOL-GASTR L, V295, pG996, DOI 10.1152/ajpgi.90343.2008; Skoko JJ, 2014, TOXICOL SCI, V141, P112, DOI 10.1093/toxsci/kfu109; Tarasco E, 2018, AM J PHYSIOL-GASTR L, V315, pG602, DOI 10.1152/ajpgi.00081.2018; Thomas BA, 2005, PROSTAG LEUKOTR ESS, V72, P335, DOI 10.1016/j.plefa.2005.01.001; Toyoda A, 2018, NEUROSCI LETT, V670, P36, DOI 10.1016/j.neulet.2018.01.025; Tuchweber B, 1996, LAB INVEST, V74, P265; VACHA J, 1975, PHYSIOL BOHEMOSLOV, V24, P413; Vaz FM, 2015, HEPATOLOGY, V61, P260, DOI 10.1002/hep.27240; VERKADE HJ, 1991, AM J CLIN NUTR, V53, P643, DOI 10.1093/ajcn/53.3.643; Violante S, 2013, BBA-MOL CELL BIOL L, V1831, P1467, DOI 10.1016/j.bbalip.2013.06.007; Wieczorek A, 2017, CLIN EXP HEPATOL, V3, P169, DOI 10.5114/ceh.2017.68287; Wolters H, 2002, J HEPATOL, V37, P556, DOI 10.1016/S0168-8278(02)00247-7; Xiao YT, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0181-3; Zurita E, 2011, TRANSGENIC RES, V20, P481, DOI 10.1007/s11248-010-9403-8; 2018, INT J COMMUN SYST, V31, pE3873	59	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0232069	10.1371/journal.pone.0232069	http://dx.doi.org/10.1371/journal.pone.0232069			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956351	gold, Green Published, Green Submitted			2022-12-26	WOS:000574571500021
J	Cartee, NMP; Wang, MM				Cartee, Naw May Pearl; Wang, Michael M.			Binding of omeprazole to protein targets identified by monoclonal antibodies	PLOS ONE			English	Article							PROTON-PUMP INHIBITORS; ANTIBACTERIAL ACTIVITY; IN-VITRO; RISK; PHARMACOKINETICS; LANSOPRAZOLE; PANTOPRAZOLE; TRENDS; SITE	Omeprazole is the most commonly used proton pump inhibitor (PPI), a class of medications whose therapeutic mechanism of action involves formation of a disulfide linkage to cysteine residues in the H+/K+ ATPase pump on gastric secretory cells. Covalent linkage between the sole sulfur group of omeprazole and selected cysteine residues of the pump protein results in inhibition of acid secretion in the stomach, an effect that ameliorates gastroesophageal reflux and peptic ulcer disease. PPIs, though useful for specific conditions when used transiently, are associated with diverse untoward effects when used long term. The mechanisms underlying these potential off-target effects remain unclear. PPIs may, in fact, interact with non-canonical target proteins (non-pump molecules) resulting in unexpected pathophysiological effects, but few studies describe off-target PPI binding. Here, we describe successful cloning of monoclonal antibodies against protein-bound omeprazole. We developed and used monoclonal antibodies to characterize the protein target range of omeprazole, stability of omeprazole-bound proteins, and the involvement of cysteines in binding of omeprazole to targets. We demonstrate that a wide range of diverse proteins are targeted by omeprazole. Protein complexes, detected by Western blotting, are resistant to heat, detergents, and reducing agents. Reaction of omeprazole occurs with cysteine-free proteins, is not fully inhibited by cysteine alkylation, occurs at neutral pH, and induces protein multimerization. At least two other clinically used PPIs, rabeprazole and tenatoprazole, are capable of binding to proteins in a similar fashion. We conclude that omeprazole binds to multiple proteins and is capable of forming highly stable complexes that are not dependent on disulfide linkages between the drug and protein targets. Further studies made possible by these antibodies may shed light on whether PPI-protein complexes underlie off-target untoward effects of chronic PPI use.	[Cartee, Naw May Pearl; Wang, Michael M.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Cartee, Naw May Pearl; Wang, Michael M.] VA Ann Arbor Healthcare Syst, Dept Vet Affairs, Neurol Serv, Ann Arbor, MI 48105 USA; [Wang, Michael M.] Univ Michigan, Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Wang, MM (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.; Wang, MM (corresponding author), VA Ann Arbor Healthcare Syst, Dept Vet Affairs, Neurol Serv, Ann Arbor, MI 48105 USA.; Wang, MM (corresponding author), Univ Michigan, Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	micwang@umich.edu			Department of Veterans Affairs Merit [BX0003824, BX003855]; National Institutes of Health [NS099783, NS099160]	Department of Veterans Affairs Merit(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The following funding sources are gratefully acknowledged: Department of Veterans Affairs Merit Awards to MW(BX0003824 and BX003855) and National Institutes of Health grants NS099783 and NS099160 to MW. Further information is found at VA.gov and NIH.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cronican AA, 2010, BIOCHEM PHARMACOL, V79, P1310, DOI 10.1016/j.bcp.2009.12.018; DIAZ D, 1990, GASTROENTEROLOGY, V99, P737, DOI 10.1016/0016-5085(90)90963-2; Fawaz MV, 2014, ACS CHEM NEUROSCI, V5, P718, DOI 10.1021/cn500103u; Gawron AJ, 2013, J GEN INTERN MED, V28, P930, DOI 10.1007/s11606-013-2345-0; Glew CM, 2007, J AM MED DIR ASSOC, V8, P607, DOI 10.1016/j.jamda.2007.07.001; Gomm W, 2016, JAMA NEUROL, V73, P410, DOI 10.1001/jamaneurol.2015.4791; Haenisch B, 2015, EUR ARCH PSY CLIN N, V265, P419, DOI 10.1007/s00406-014-0554-0; Holbrook LM, 2016, MABS-AUSTIN, V8, P672, DOI 10.1080/19420862.2016.1152443; Horn J, 2000, CLIN THER, V22, P266, DOI 10.1016/S0149-2918(00)80032-6; Huber R, 1996, INT J CLIN PHARM TH, V34, P185; Hussain S, 2020, J GASTROEN HEPATOL, V35, P19, DOI 10.1111/jgh.14789; Janarthanan S, 2012, AM J GASTROENTEROL, V107, P1001, DOI 10.1038/ajg.2012.179; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Lanas-Gimeno A, 2019, EXPERT OPIN DRUG SAF, V18, P1043, DOI 10.1080/14740338.2019.1664470; Lin MZ, 2018, INT J BIOL MACROMOL, V117, P538, DOI 10.1016/j.ijbiomac.2018.05.172; Mafi JN, 2019, J AM GERIATR SOC, V67, P2600, DOI 10.1111/jgs.16117; Moayyedi P, 2019, GASTROENTEROLOGY, V157, P682, DOI 10.1053/j.gastro.2019.05.056; MORII M, 1990, BIOCHEM BIOPH RES CO, V167, P754, DOI 10.1016/0006-291X(90)92089-I; Olbe L, 2003, NAT REV DRUG DISCOV, V2, P132, DOI 10.1038/nrd1010; Pang J, 2019, IJC HEART VASC, V23, DOI 10.1016/j.ijcha.2018.12.016; Pawar SK, 2017, J BIOMOL STRUCT DYN, V35, P3205, DOI 10.1080/07391102.2016.1251337; REGARDH CG, 1985, SCAND J GASTROENTERO, V20, P79, DOI 10.3109/00365528509095821; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Schumock GT, 2016, AM J HEALTH-SYST PH, V73, P1058, DOI 10.2146/ajhp160205; Seo YH, 2009, P NATL ACAD SCI USA, V106, P16163, DOI 10.1073/pnas.0903015106; SHIN JM, 1993, BIOCHIM BIOPHYS ACTA, V1148, P223, DOI 10.1016/0005-2736(93)90133-K; Sjostrom JE, 1996, ANTIMICROB AGENTS CH, V40, P621, DOI 10.1128/AAC.40.3.621; Sjostrom JE, 1997, ANTIMICROB AGENTS CH, V41, P1797; Song YQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219213; Tonazzi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082286; Young KZ, 2020, EXP NEUROL, V328, DOI 10.1016/j.expneurol.2020.113261; Zhang Y, 2020, EUR J CLIN PHARMACOL, V76, P139, DOI 10.1007/s00228-019-02753-7; Zhou B, 2016, OSTEOPOROSIS INT, V27, P339, DOI 10.1007/s00198-015-3365-x; 2010, J ROYAL ANTHR I, V16, pE228	34	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239464	10.1371/journal.pone.0239464	http://dx.doi.org/10.1371/journal.pone.0239464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946534	gold, Green Published			2022-12-26	WOS:000573851100070
J	Huot, S; Laflamme, C; Fortin, PR; Boilard, E; Pouliot, M				Huot, Sandrine; Laflamme, Cynthia; Fortin, Paul R.; Boilard, Eric; Pouliot, Marc			IgG-aggregates rapidly upregulate FcgRI expression at the surface of human neutrophils in a FcgRII-dependent fashion: A crucial role for FcgRI in the generation of reactive oxygen species	FASEB JOURNAL			English	Article						auto-immune diseases; Fc gamma receptors; human; immunecomplexesimmunology; lupusneutrophils; reactive oxygen species; signalling	FC-GAMMA-RIIA; HIGH-AFFINITY RECEPTOR; IMMUNE-COMPLEXES; DIAGNOSTIC MARKER; CD64 EXPRESSION; CROSS-LINKING; ACTIVATION; ADENOSINE; IMPACT; CYCLOOXYGENASE-2	Autoimmune complexes are an important feature of several autoimmune diseases such as lupus, as they contribute to tissue damage through the activation of immune cells. Neutrophils, key players in lupus, interact with immune complexes through Fc gamma receptors (FcgR). Incubation of neutrophils with aggregated-IgGs caused degranulation and increased the surface expression of FcgRI within minutes in a concentration-dependent fashion. After 30 minutes, IgG aggregates (1 mg/mL) upregulated FcgRI by 4.95 +/- 0.45-fold. FcgRI-positive neutrophils reached 67.24% +/- 6.88% on HA-IgGs stimulated neutrophils, from 3.12% +/- 1.62% in non-stimulated cells, ranking IgG-aggregates among the most potent known agonists. FcgRIIa, and possibly FcgRIIIa, appeared to mediate this upregulation. Also, FcgRI-dependent signaling proved necessary for reactive oxygen species (ROS) production in response to IgG-aggregates. Finally, combinations of bacterial materials with aggregates dramatically boosted ROS production. This work suggests FcgRI as an essential component in the response of human neutrophils to immune complexes leading to the production of ROS, which may help explain how neutrophils contribute to tissue damage associated with immune complex-associated diseases, such as lupus.	[Huot, Sandrine; Laflamme, Cynthia; Boilard, Eric; Pouliot, Marc] Univ Laval, CHU Quebec, Fac Med, Ctr Rech,Dept Microbiol & Immunol, 2705 Laurier Blvd,Off T1-49, Quebec City, PQ G1V 4G2, Canada; [Huot, Sandrine; Laflamme, Cynthia; Fortin, Paul R.; Boilard, Eric; Pouliot, Marc] Univ Laval, CHU Quebec, Ctr Rech, Axe Malad Infect & Immunitaires, Quebec City, PQ, Canada; [Fortin, Paul R.] Univ Laval, CHU Quebec, Dept Med, Div Rhumatol, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Pouliot, M (corresponding author), Univ Laval, CHU Quebec, Fac Med, Ctr Rech,Dept Microbiol & Immunol, 2705 Laurier Blvd,Off T1-49, Quebec City, PQ G1V 4G2, Canada.	Marc.Pouliot@crchul.ulaval.ca		Fortin, Paul R./0000-0002-7278-2596; Pouliot, Marc/0000-0002-2466-5424	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR) [MOP220733]	Gouvernement du Canada \ Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Gouvernement du Canada vertical bar Canadian Institutes of Health Research (CIHR), Grant/Award Number: MOP220733	Abd-Elhamid Yasser A, 2017, Egypt J Immunol, V24, P67; Ajmani S, 2019, CLIN RHEUMATOL, V38, P997, DOI 10.1007/s10067-018-4334-5; Albanesi M, 2013, BLOOD, V122, P3160, DOI 10.1182/blood-2013-04-497446; Babior B M, 1988, Basic Life Sci, V49, P815; Bengtsson AA, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02221-z; Bonegio RG, 2019, J IMMUNOL, V202, P675, DOI 10.4049/jimmunol.1800300; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; BUCKLE AM, 1989, J IMMUNOL, V143, P2295; Bzowska M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/284759; Cadieux JS, 2005, J CELL SCI, V118, P1437, DOI 10.1242/jcs.01737; Chen K, 2012, BLOOD, V120, P4421, DOI 10.1182/blood-2011-12-401133; Cloutier N, 2018, P NATL ACAD SCI USA, V115, pE1550, DOI 10.1073/pnas.1720553115; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Eighetany MT, 2004, J CLIN LAB ANAL, V18, P36, DOI 10.1002/jcla.20001; Fiset MT, 2003, BIOCHEMISTRY-US, V42, P10498, DOI 10.1021/bi0300635; Fjaertoft G, 2007, SCAND J INFECT DIS, V39, P525, DOI 10.1080/00365540601113693; Fossati G, 2002, ANN RHEUM DIS, V61, P13, DOI 10.1136/ard.61.1.13; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P1185, DOI 10.1016/j.intimp.2013.11.010; GALE R, 1984, ANN RHEUM DIS, V43, P34, DOI 10.1136/ard.43.1.34; Garcia-Garcia E, 2009, J IMMUNOL, V182, P4547, DOI 10.4049/jimmunol.0801468; Giambelluca MS, 2014, FASEB J, V28, P3679, DOI 10.1096/fj.14-251900; Golay J, 2019, BLOOD, V133, P1395, DOI 10.1182/blood-2018-07-864538; Gray RD, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-12; Hoffmann JJML, 2009, CLIN CHEM LAB MED, V47, P903, DOI 10.1515/CCLM.2009.224; Jonsson F, 2013, J LEUKOCYTE BIOL, V94, P643, DOI 10.1189/jlb.1212623; Johnson JL, 2016, J BIOL CHEM, V291, P25965, DOI 10.1074/jbc.M116.741884; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Khan SQ, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00052; Kikuchi-Taura A, 2015, LUPUS, V24, P1076, DOI 10.1177/0961203315579093; KIMBERLY RP, 1990, J EXP MED, V171, P1239, DOI 10.1084/jem.171.4.1239; Lood C, 2017, J EXP MED, V214, P2103, DOI 10.1084/jem.20161512; Lorenz G, 2015, SEMIN NEPHROL, V35, P410, DOI 10.1016/j.semnephrol.2015.08.003; Marois L, 2011, J BIOL CHEM, V286, P15073, DOI 10.1074/jbc.M110.213660; McColl SR, 2005, FASEB J, V19, P187, DOI 10.1096/fj.05-4804fje; Michon JM, 1998, BRIT J HAEMATOL, V100, P550, DOI 10.1046/j.1365-2141.1998.00597.x; Ng PC, 2004, PEDIATR RES, V56, P796, DOI 10.1203/01.PDR.0000142586.47798.5E; Nguyen GT, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00373; Nishi H, 2019, CURR OPIN RHEUMATOL, V31, P193, DOI 10.1097/BOR.0000000000000577; Nishi H, 2017, J CLIN INVEST, V127, P3810, DOI 10.1172/JCI94039; Patel KR, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00223; PERUSSIA B, 1983, J EXP MED, V158, P1092, DOI 10.1084/jem.158.4.1092; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Pricop L, 2002, ANTIOXID REDOX SIGN, V4, P85, DOI 10.1089/152308602753625889; Aleman OR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/2908034; Ramsland PA, 2011, J IMMUNOL, V187, P3208, DOI 10.4049/jimmunol.1101467; REPP R, 1991, BLOOD, V78, P885, DOI 10.1182/blood.V78.4.885.bloodjournal784885; Rosales C., 2017, FRONT IMMUNOL, V8, P1; Sack U, 2017, CYTOM PART B-CLIN CY, V92, P189, DOI 10.1002/cyto.b.21216; Sandilands GP, 2005, IMMUNOLOGY, V114, P354, DOI 10.1111/j.1365-2567.2004.02114.x; St-Onge M, 2007, BBA-MOL CELL BIOL L, V1771, P1235, DOI 10.1016/j.bbalip.2007.06.002; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Takano K, 2000, INT J HEMATOL, V72, P48; Takei H, 1996, J LEUKOCYTE BIOL, V59, P229, DOI 10.1002/jlb.59.2.229; Tamm A, 1996, J IMMUNOL, V157, P1576; Treffers LW, 2018, FRONT IMMUNOL, V9, P1; Tsuboi N, 2008, IMMUNITY, V28, P833, DOI 10.1016/j.immuni.2008.04.013; Turina M, 2005, INFLAMMATION, V29, P55, DOI 10.1007/s10753-006-8970-6; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Wang XL, 2016, J IMMUNOL, V197, P4090, DOI 10.4049/jimmunol.1600051; Wang YJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00829; Warren JS., 2017, ELS, P1, DOI DOI 10.1002/9780470015902.A0002164.PUB3; Yin C, 2018, CELL TISSUE RES, V371, P455, DOI 10.1007/s00441-017-2731-8; Zen K, 2004, J BIOL CHEM, V279, P44924, DOI 10.1074/jbc.M402115200; Zhang HF, 2018, LIFE SCI, V207, P296, DOI 10.1016/j.lfs.2018.06.015; Zhang YH, 2000, IMMUNITY, V13, P387, DOI 10.1016/S1074-7613(00)00038-8; Zhang YX, 2010, P NATL ACAD SCI USA, V107, P19332, DOI 10.1073/pnas.1008248107; Zivkovic V, 2018, RHEUMATOL INT, V38, P1003, DOI 10.1007/s00296-017-3888-x	69	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15208	15221		10.1096/fj.202001085R	http://dx.doi.org/10.1096/fj.202001085R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32946139	Green Submitted			2022-12-26	WOS:000572282200001
J	Koren, M; Peto, R				Koren, Miklos; Peto, Rita			Business disruptions from social distancing	PLOS ONE			English	Article							DIVISION-OF-LABOR; CITIES; INTERVENTIONS; GROWTH	Social distancing interventions can be effective against epidemics but are potentially detrimental for the economy. Businesses that rely heavily on face-to-face communication or close physical proximity when producing a product or providing a service are particularly vulnerable. There is, however, no systematic evidence about the role of human interactions across different lines of business and about which will be the most limited by social distancing. Here we provide theory-based measures of the reliance of U.S. businesses on human interaction, detailed by industry and geographic location. We find that, before the pandemic hit, 43 million workers worked in occupations that rely heavily on face-to-face communication or require close physical proximity to other workers. Many of these workers lost their jobs since. Consistently with our model, employment losses have been largest in sectors that rely heavily on customer contact and where these contacts dropped the most: retail, hotels and restaurants, arts and entertainment and schools. Our results can help quantify the economic costs of social distancing.	[Koren, Miklos] Cent European Univ, Budapest, Hungary; [Koren, Miklos; Peto, Rita] Ctr Econ & Reg Studies, Budapest, Hungary; [Koren, Miklos] CEPR, London, England	Central European University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies; Centre for Economic Policy Research - UK	Koren, M (corresponding author), Cent European Univ, Budapest, Hungary.; Koren, M (corresponding author), Ctr Econ & Reg Studies, Budapest, Hungary.; Koren, M (corresponding author), CEPR, London, England.	korenm@ceu.edu		Peto, Rita/0000-0002-3567-3630				Adda J, 2016, Q J ECON, V131, P891, DOI 10.1093/qje/qjw005; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2002, TRENDS MOL MED S, V8, pS14; [Anonymous], 2020, NY TIMES; [Anonymous], 2020, MAYOR BLASIO ISSUES; Autor DH, 2013, AM ECON REV, V103, P1553, DOI 10.1257/aer.103.5.1553; Baldwin R.E., 2020, EC TIME COVID 19; Barrot JN, 2020, SECTORAL EFFECTS SOC; BECKER GS, 1992, Q J ECON, V107, P1137, DOI 10.2307/2118383; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Caliendo L., 2014, IMPACT REGIONAL SECT, P20168; Caselli F, 2020, Q J ECON, V135, P449, DOI 10.1093/qje/qjz028; Charlot S, 2004, J URBAN ECON, V56, P581, DOI 10.1016/j.jue.2004.08.001; Cohen J., 2020, SCIENCE, V2020; Cuberes D, 2013, ARE INTERNET FACE FA; Duarte Margarida, 2019, J EUR EC ASS; Firpo S., 2011, IZA DISCUSSION PAPER, P5542; Garicano L, 2009, J LAW ECON ORGAN, V25, P339, DOI 10.1093/jleo/ewn003; Gaspar J, 1998, J URBAN ECON, V43, P136, DOI 10.1006/juec.1996.2031; Glaeser EL, 2002, J URBAN ECON, V51, P205, DOI 10.1006/juec.2001.2262; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Henderson JV, 2010, J REGIONAL SCI, V50, P515, DOI 10.1111/j.1467-9787.2009.00636.x; Henderson V, 2002, WORLD BANK RES OBSER, V17, P89, DOI 10.1093/wbro/17.1.89; Herrendorf B, 2014, HBK ECON, P855, DOI 10.1016/B978-0-444-53540-5.00006-9; Krugman P., 1991, GEOGRAPHY TRADE; Leibovici F., 2020, SOCIAL DISTANCING CO; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Marshall A., 1890, PRINCIPLES EC; McGill A., 2020, WHO IS MOST RISK COR; Mongey S, 2020, CHARACTERISTICS WORK; National Center for O*NET Development, 2020, O NET ONLINE; Neiman B, 2020, MANY JOBS; SafeGraph, 2020, PATT DAT; Smith, 1778, INQUIRY NATURE CAUSE, Vi; Storper M, 2004, J ECON GEOGR, V4, P351, DOI 10.1093/jnlecg/lbh027; Tian Lin, 2021, DIVISION LABOR UNPUB; U S Bureau of Labor Statistics, 2020, NAT EMPL MATR DAT; U S Bureau of Labor Statistics, 2018, AM TIM US SURV DAT; U S Bureau of Labor Statistics, 2020, CURR EMPL STAT DAT; U S Bureau of the Census, 2017, COUNT BUS PATT DAT; Von Gaudecker H. M., 2020, LABOUR SUPPLY EARLY; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Wren-Lewis S., 2020, EC TIME COVID 19, P109, DOI [10.1126/sciadv.abb6914, DOI 10.1126/SCIADV.ABB6914]	43	50	51	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239113	10.1371/journal.pone.0239113	http://dx.doi.org/10.1371/journal.pone.0239113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946463	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000573851100094
J	Lopez, I; Chalatsi, E; Ellenbroek, SIJ; Andrieux, A; Roux, PF; Cerapio, JP; Jouvion, G; van Rheenen, J; Seeler, JS; Dejean, A				Lopez, Ignacio; Chalatsi, Eleftheria; Ellenbroek, Saskia I. J.; Andrieux, Alexandra; Roux, Pierre-Francois; Cerapio, Juan P.; Jouvion, Gregory; van Rheenen, Jacco; Seeler, Jacob-S.; Dejean, Anne			An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency	ONCOGENE			English	Article							CRYPT STEM-CELLS; ENRICHMENT ANALYSIS; CONJUGATING ENZYME; DNA-DAMAGE; SUMOYLATION; EXPRESSION; INFLAMMATION; CANCER; UBIQUITIN; COLON	Sumoylation is an essential posttranslational modification in eukaryotes that has emerged as an important pathway in oncogenic processes. Most human cancers display hyperactivated sumoylation and many cancer cells are remarkably sensitive to its inhibition, thus supporting application of chemical sumoylation inhibitors in cancer treatment. Here we show, first, that transformed embryonic fibroblasts derived from mice haploinsufficient for Ubc9, the essential and unique gene encoding the SUMO E2 conjugating enzyme, exhibit enhanced proliferation and transformed phenotypes in vitro and as xenografts ex vivo. To then evaluate the possible impact of loss of oneUbc9allele in vivo, we used a mouse model of intestinal tumorigenesis. We crossedUbc9(+/-)mice with mice harboring a conditional ablation of Apc either all along the crypt-villus axis or only in Lgr5(+)crypt-based columnar (CBC) cells, the cell compartment that includes the intestinal stem cells proposed as cells-of-origin of intestinal cancer. WhileUbc9(+/-)mice display no overt phenotypes and no globally visible hyposumoylation in cells of the small intestine, we found, strikingly, that, upon loss of Apc in both models,Ubc9(+/-)mice develop more (>2-fold) intestinal adenomas and show significantly shortened survival. This is accompanied by reduced global sumoylation levels in the polyps, indicating that Ubc9 levels become critical upon oncogenic stress. Moreover, we found that, in normal conditions,Ubc9(+/-)mice show a moderate but robust (15%) increase in the number of Lgr5(+)CBC cells when compared to their wild-type littermates, and further, that these cells display higher degree of stemness and cancer-related and inflammatory gene expression signatures that, altogether, may contribute to enhanced intestinal tumorigenesis. The phenotypes of Ubc9 haploinsufficiency discovered here indicate an unanticipated tumor-suppressive role of sumoylation, one that may have important implications for optimal use of sumoylation inhibitors in the clinic.	[Lopez, Ignacio; Chalatsi, Eleftheria; Andrieux, Alexandra; Roux, Pierre-Francois; Cerapio, Juan P.; Seeler, Jacob-S.; Dejean, Anne] Inst Pasteur, Equipe Labellisee Ligue Natl Canc, INSERM, Nucl Org & Oncogenesis Unit,U993, F-75015 Paris, France; [Chalatsi, Eleftheria] Sorbonne Univ, Coll Doctoral, F-75005 Paris, France; [Ellenbroek, Saskia I. J.; van Rheenen, Jacco] Netherlands Canc Inst, Oncode Inst, Div Mol Pathol, Amsterdam, Netherlands; [Jouvion, Gregory] Inst Pasteur, Expt Neuropathol Unit, F-75015 Paris, France; [Chalatsi, Eleftheria] Biorad Labs, Marnes La Coquette, France; [Cerapio, Juan P.] Univ Toulouse, Ctr Rech Cancerol Toulouse, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Netherlands Cancer Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Seeler, JS; Dejean, A (corresponding author), Inst Pasteur, Equipe Labellisee Ligue Natl Canc, INSERM, Nucl Org & Oncogenesis Unit,U993, F-75015 Paris, France.	jacob.seeler@pasteur.fr; anne.dejean@pasteur.fr	Dejean, Anne/L-5145-2018; Roux, Pierre-François/J-8875-2019; Jouvion, Grégory/AAL-2620-2021	Roux, Pierre-François/0000-0002-0695-4206; Lopez, Ignacio/0000-0001-9669-8906; Cerapio Arroyo, Juan Pablo/0000-0002-3032-3180; Ellenbroek, Saskia/0000-0001-8007-2634; Chalatsi, Eleftheria/0000-0003-2447-5572	INCa; ANR; ERC-AdG "SUMOSTRESS"; Josef Steiner Cancer Foundation; ERC-CoG "Cancer Recurrence"; Fondation ARC [PDF20170505624]; LNCC (Equipe labellisee); Odyssey; ERC-AdG "SUMiDENTITY"	INCa(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); ERC-AdG "SUMOSTRESS"; Josef Steiner Cancer Foundation; ERC-CoG "Cancer Recurrence"; Fondation ARC; LNCC (Equipe labellisee); Odyssey; ERC-AdG "SUMiDENTITY"	This work was supported by grants from INCa, LNCC (Equipe labellisee), Odyssey, ANR and ERC-AdG "SUMOSTRESS" and "SUMiDENTITY" to AD, and by the Josef Steiner Cancer Foundation and ERC-CoG "Cancer Recurrence" to JvR. IL was supported by Fondation ARC (PDF20170505624). We thank Dr. Giulia Nigro and the Institut Pasteur UTechS facility for technical input and Drs. Bob Weinberg, Maria Jasin, and Sergio F. de Almeida for providing reagents.	Alvarez A, 2014, JOVE-J VIS EXP, DOI 10.3791/51742; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Basak O, 2014, EMBO J, V33, P2057, DOI 10.15252/embj.201488017; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Bu PC, 2016, CELL STEM CELL, V18, P189, DOI 10.1016/j.stem.2016.01.006; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cheloufi S, 2015, NATURE, V528, P218, DOI 10.1038/nature15749; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Cossec JC, 2018, CELL STEM CELL, V23, P742, DOI 10.1016/j.stem.2018.10.001; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Decque A, 2016, NAT IMMUNOL, V17, P140, DOI 10.1038/ni.3342; Demarque MD, 2011, GASTROENTEROLOGY, V140, P286, DOI 10.1053/j.gastro.2010.10.002; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hayashi T, 2002, EXP CELL RES, V280, P212, DOI 10.1006/excr.2002.5634; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He XY, 2017, NAT CHEM BIOL, V13, P1164, DOI [10.1038/nchembio.2463, 10.1038/NCHEMBIO.2463]; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jackstadt R, 2016, J PATHOL, V238, P141, DOI 10.1002/path.4645; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; MOLL R, 1993, DIFFERENTIATION, V53, P75, DOI 10.1111/j.1432-0436.1993.tb00648.x; Moschos SJ, 2010, HUM PATHOL, V41, P1286, DOI 10.1016/j.humpath.2010.02.007; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Mustfa SA, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170024; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nagel R, 2016, EMBO REP, V17, P1516, DOI 10.15252/embr.201643030; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ordonez-Moran P, 2015, CANCER CELL, V28, P815, DOI 10.1016/j.ccell.2015.11.001; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Rafehi H, 2011, JOVE-J VIS EXP, DOI 10.3791/2573; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Seeler JS, 2017, NAT REV CANCER, V17, P184, DOI 10.1038/nrc.2016.143; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Stankovic-Valentin N, 2018, MOL ASPECTS MED, V63, P3, DOI 10.1016/j.mam.2018.07.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suhail A, 2019, CELL REP, V29, P3522, DOI 10.1016/j.celrep.2019.11.028; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tetteh PW, 2016, CELL STEM CELL, V18, P203, DOI 10.1016/j.stem.2016.01.001; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Yu B, 2015, P NATL ACAD SCI USA, V112, pE1724, DOI 10.1073/pnas.1415569112	61	4	4	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 22	2020	39	43					6692	6703		10.1038/s41388-020-01457-y	http://dx.doi.org/10.1038/s41388-020-01457-y		SEP 2020	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	OF2UT	32948837	Green Published, hybrid			2022-12-26	WOS:000570855500001
J	Padmanabha, M; Kobelski, A; Hempel, AJ; Streif, S				Padmanabha, Murali; Kobelski, Alexander; Hempel, Arne-Jens; Streif, Stefan			A comprehensive dynamic growth and development model ofHermetia illucenslarvae	PLOS ONE			English	Article							BLACK SOLDIER FLY; LARVAE HERMETIA-ILLUCENS; DIPTERA STRATIOMYIDAE; LIFE-HISTORY; FOOD WASTE; FEED; BIOCONVERSION; TEMPERATURE; PERFORMANCE; L.	Larvae ofHermetia illucens, also commonly known as black soldier fly (BSF) have gained significant importance in the feed industry, primarily used as feed for aquaculture and other livestock farming. Mathematical models such as the Von Bertalanffy growth model and dynamic energy budget models are available for modelling the growth of various organisms but have their demerits for their application to the growth and development of BSF. Also, such dynamic models were not yet applied to the growth of the BSF larvae despite models proven to be useful for automation of industrial production process (e.g. feeding, heating/cooling, ventilation, harvesting, etc.). This work primarily focuses on developing a model based on the principles of the afore mentioned models from literature that can provide accurate mathematical description of the dry mass changes throughout the life cycle and the transition of development phases of the larvae. To further improve the accuracy of these models, various factors affecting the growth and development such as temperature, feed quality, feeding rate, moisture content in feed, and airflow rate are developed and integrated into the dynamic growth model. An extensive set of data was aggregated from various literature and used for the model development, parameter estimation and validation. Models describing the environmental factors were individually validated based on the data sets collected. In addition, the dynamic growth model was also validated for dry mass evolution and development stage transition of larvae reared on different substrate feeding rates. The developed models with the estimated parameters performed well, highlighting their potential application in decision-support systems and automation for large scale production.	[Padmanabha, Murali; Kobelski, Alexander; Hempel, Arne-Jens; Streif, Stefan] Tech Univ Chemnitz, Automat Control & Syst Dynam Lab, Chemnitz, Germany	Technische Universitat Chemnitz	Streif, S (corresponding author), Tech Univ Chemnitz, Automat Control & Syst Dynam Lab, Chemnitz, Germany.	stefan.streif@etit.tu-chemnitz.de		Streif, Stefan/0000-0002-3398-1226	European Social Funds (ESF) [100316180]	European Social Funds (ESF)(European Social Fund (ESF))	Murali Padmanabha received funds from European Social Funds (ESF) grant number 100316180. URL: https://www.sab.sachsen.de/f% C3%B6rderprogramme/sie-planen-ihremitarbeiter-oder-sich-selbst-weiterzubilden/promotionen.jsp#program_intro The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERS RC, 1984, J ECON ENTOMOL, V77, P1459, DOI 10.1093/jee/77.6.1459; Banavar JR, 2002, NATURE, V420, P626, DOI 10.1038/420626a; Barragan-Fonseca KB, 2017, J INSECTS FOOD FEED, V3, P105, DOI 10.3920/JIFF2016.0055; Barragan-Fonseca KB, 2018, ENTOMOL EXP APPL, V166, P761, DOI 10.1111/eea.12716; Bava L, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060289; BONDARI K, 1981, AQUACULTURE, V24, P103, DOI 10.1016/0044-8486(81)90047-8; Cheng JYK, 2017, WASTE MANAGE, V67, P315, DOI 10.1016/j.wasman.2017.05.046; Chia SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206097; Diener S, 2011, 2 INT C SOL WAST MAN; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; FATCHUROCHIM S, 1989, J ENTOMOL SCI, V24, P224, DOI 10.18474/0749-8004-24.2.224; Ferrarezi R, 2016, UVI AES ANN REPORT 2; Gao ZH, 2019, J CLEAN PROD, V230, P974, DOI 10.1016/j.jclepro.2019.05.074; GLASSTONE S, 1941, THEORY RATE PROCESSE; Gligorescu A, 2018, J INSECTS FOOD FEED, V4, P123, DOI 10.3920/JIFF2017.0080; Gligorescu A, 2019, J APPL ENTOMOL, V143, P875, DOI 10.1111/jen.12653; Harnden LM, 2016, FORENSIC SCI INT, V266, P109, DOI 10.1016/j.forsciint.2016.05.007; Holmes LA, 2016, J INSECTS FOOD FEED, V2, P255, DOI 10.3920/JIFF2016.0008; Holmes LA, 2012, ENVIRON ENTOMOL, V41, P971, DOI 10.1603/EN12054; Jucker C, 2017, ENVIRON ENTOMOL, V46, P1415, DOI 10.1093/ee/nvx154; Kim Wontae, 2010, International Journal of Industrial Entomology, V21, P185; Kooijman B., 2010, DYNAMIC ENERGY BUDGE; Kooijman SALM, 2008, BIOL REV, V83, P533, DOI 10.1111/j.1469-185X.2008.00053.x; Kroeckel S, 2012, AQUACULTURE, V364, P345, DOI 10.1016/j.aquaculture.2012.08.041; Lalander C, 2019, J CLEAN PROD, V208, P211, DOI 10.1016/j.jclepro.2018.10.017; LARDE G, 1990, BIOL WASTE, V33, P307, DOI 10.1016/0269-7483(90)90134-E; Liu XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182572; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Manurung Robert, 2016, Journal of Entomology and Zoology Studies, V4, P1036; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Meneguz M, 2018, J SCI FOOD AGR, V98, P5776, DOI 10.1002/jsfa.9127; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; Newton L, 2005, S STAT SCI AN MAN WA; Nguyen TTX, 2015, ENVIRON ENTOMOL, V44, P406, DOI 10.1093/ee/nvv002; Nguyen TTX, 2013, J MED ENTOMOL, V50, P898, DOI 10.1603/ME12260; Padmanabha M, 2020, 21 IFAC WORLD C 2020; Padmanabha M, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9235166; Palma L, 2018, J SCI FOOD AGR, V98, P5893, DOI 10.1002/jsfa.9252; Paz ASP, 2015, WASTE BIOMASS VALORI, V6, P1059, DOI 10.1007/s12649-015-9418-8; Permana, 2018, IOP C SERIES EARTH E, V187, DOI [10.1088/1755-1315/187/1/012070, DOI 10.1088/1755-1315/187/1/012070]; PRUESS KP, 1983, ENVIRON ENTOMOL, V12, P613, DOI 10.1093/ee/12.3.613; Richard TL, 2006, BIOTECHNOL PROGR, V22, P60, DOI 10.1021/bp050171d; RUSSELLE MP, 1984, CROP SCI, V24, P28, DOI 10.2135/cropsci1984.0011183X002400010007x; Salomone R, 2017, J CLEAN PROD, V140, P890, DOI 10.1016/j.jclepro.2016.06.154; SCHREMMER F, 1984, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V88-89, P405; Shi PJ, 2014, ECOL MODEL, V276, P23, DOI 10.1016/j.ecolmodel.2013.12.020; Shumo M, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9030079; Smetana S, 2019, RESOUR CONSERV RECY, V144, P285, DOI 10.1016/j.resconrec.2019.01.042; Spranghers T, 2017, J SCI FOOD AGR, V97, P2594, DOI 10.1002/jsfa.8081; Sripontan Y, 2020, J ECON ENTOMOL, V113, P742, DOI 10.1093/jee/toz337; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Wang YS, 2017, FOODS, V6, DOI 10.3390/foods6100091; Yu Guo-Hui, 2014, Acta Entomologica Sinica, V57, P943	58	6	6	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239084	10.1371/journal.pone.0239084	http://dx.doi.org/10.1371/journal.pone.0239084			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946462	Green Published, gold, Green Submitted			2022-12-26	WOS:000573851100006
J	Palmas, S; Chamberlin, J				Palmas, Sebastian; Chamberlin, Jordan			Fertilizer profitability for smallholder maize farmers in Tanzania: A spatially-explicit ex ante analysis	PLOS ONE			English	Article							TECHNOLOGY ADOPTION; YIELD RESPONSE; RISK; INTENSIFICATION	We present an easily calibrated spatial modeling framework for estimating location-specific fertilizer responses, using smallholder maize farming in Tanzania as a case study. By incorporating spatially varying input and output prices, we predict the expected profitability for a location-specific smallholder farmer. A stochastic rainfall component of the model allows us to quantify the uncertainty around expected economic returns. The resulting mapped estimates of expected profitability and uncertainty are good predictors of actual smallholder fertilizer usage in nationally representative household survey data. The integration of agronomic and economic information in our framework makes it a powerful tool for spatially explicit targeting of agricultural technologies and complementary investments, as well as estimating returns to investments at multiple scales.	[Palmas, Sebastian; Chamberlin, Jordan] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya	CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Palmas, S (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya.	palmasforest@gmail.com	Palmas, Sebastian/L-5456-2018; Chamberlin, Jordan/W-7127-2018	Palmas, Sebastian/0000-0001-9474-5406; Chamberlin, Jordan/0000-0001-9522-3001	Bill & Melinda Gates Foundation, through the Taking Maize Agronomy to Scale in Africa (TAMASA) project [OPP1113374]; U.S. Agency for International Development (USAID) via the Geospatial and Farming Systems Consortium; CGIAR Research Program MAIZE	Bill & Melinda Gates Foundation, through the Taking Maize Agronomy to Scale in Africa (TAMASA) project(CGIAR); U.S. Agency for International Development (USAID) via the Geospatial and Farming Systems Consortium(United States Agency for International Development (USAID)); CGIAR Research Program MAIZE(CGIAR)	Support for this study was provided by the Bill & Melinda Gates Foundation, through the Taking Maize Agronomy to Scale in Africa (TAMASA) project (grant no: OPP1113374); from a grant from the U.S. Agency for International Development (USAID) via the Geospatial and Farming Systems Consortium led by the University of California at Davis; and from the CGIAR Research Program MAIZE, led by the International Maize and Wheat Improvement Centre (CIMMYT).	Barrett CB, 2013, J DEV STUD, V49, P976, DOI 10.1080/00220388.2013.785527; Benson T, 2018, FOOD SECUR, V10, P1479, DOI 10.1007/s12571-018-0863-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burke WJ, 2017, AGR ECON-BLACKWELL, V48, P115, DOI 10.1111/agec.12299; Cedrez CB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227764; Center for International Earth Science Information Network Columbia University CUNY Institute for Demographic Research International Food Policy Research Institute The World Bank Centro Internacional de Agricultura Tropical, 2017, GLOB RUR URB MAPP PR; Chamberlain G., 1984, HDB ECONOMETRICS, V2, P1247; Chamberlin J, 2018, HOUSEHOLD DATA; Chamberlin J, 2013, WORLD DEV, V41, P245, DOI 10.1016/j.worlddev.2012.06.004; Dercon S, 2008, J AFR ECON, V17, P97, DOI 10.1093/jae/ejn019; Emerick K, 2016, AM ECON REV, V106, P1537, DOI 10.1257/aer.20150474; ESA-UCLouvain, 2010, GLOBCOVER 2009 GLOB; Harou AP, 2017, J AFR ECON, V26, P342, DOI 10.1093/jae/ejx002; Hengl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125814; Holden ST, 2018, GLOB FOOD SECUR-AGR, V18, P20, DOI 10.1016/j.gfs.2018.07.001; Holden ST, 2017, EUR REV AGRIC ECON, V44, P285, DOI 10.1093/erae/jbw016; Ichami SM, 2019, NUTR CYCL AGROECOSYS, V113, P1, DOI 10.1007/s10705-018-9958-y; JANSSEN BH, 1990, GEODERMA, V46, P299, DOI 10.1016/0016-7061(90)90021-Z; Jarvis A, 2008, HOLE FILLED SEAMLESS; Jayne TS, 2013, AGR ECON-BLACKWELL, V44, P547, DOI 10.1111/agec.12073; Jayne TS, 2018, FOOD POLICY, V75, P1, DOI 10.1016/j.foodpol.2018.01.003; Kaizzi KC, 2012, AGRON J, V104, P73, DOI 10.2134/agronj2011.0181; Kanyeka E, 2007, IMPROVED AGR TECHNOL, P6; Kihara J, 2016, NUTR CYCL AGROECOSYS, V105, P171, DOI 10.1007/s10705-015-9717-2; Koussoube E, 2017, EUR REV AGRIC ECON, V44, P183, DOI 10.1093/erae/jbw018; Liverpool-Tasie LSO, 2017, FOOD POLICY, V67, P41, DOI 10.1016/j.foodpol.2016.09.011; Magruder JR, 2018, ANNU REV RESOUR ECON, V10, P299, DOI 10.1146/annurev-resource-100517-023202; Maidment RI, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.63; Marenya PP, 2009, AM J AGR ECON, V91, P991, DOI 10.1111/j.1467-8276.2009.01313.x; Mather D, 2016, FOOD SECURITY COLLAB, V245891; Minten B, 2013, AGR ECON-BLACKWELL, V44, P629, DOI 10.1111/agec.12078; Mukasa AN, 2018, WORLD DEV, V105, P299, DOI 10.1016/j.worlddev.2017.12.006; MUNDLAK Y, 1978, ECONOMETRICA, V46, P69, DOI 10.2307/1913646; Ndiaye M, 2015, WORLD BANK POLICY RE; Njoroge R, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8040049; Njoroge S, 2017, FIELD CROP RES, V214, P321, DOI 10.1016/j.fcr.2017.09.026; R Core Team, 2021, R LANGUAGE ENV STAT; Rurinda J, 2020, AGR SYST, V180, DOI 10.1016/j.agsy.2020.102790; Sheahan M, 2017, FOOD POLICY, V67, P12, DOI 10.1016/j.foodpol.2016.09.010; Sheahan M, 2013, FOOD POLICY, V41, P39, DOI 10.1016/j.foodpol.2013.04.008; Snapp SS, 2003, FOOD POLICY, V28, P349, DOI 10.1016/j.foodpol.2003.08.002; Stifel D, 2008, AGR ECON-BLACKWELL, V39, P1, DOI 10.1111/j.1574-0862.2008.00310.x; van Ittersum MK, 2016, P NATL ACAD SCI USA, V113, P14964, DOI 10.1073/pnas.1610359113; Vanlauwe B, 2011, PLANT SOIL, V339, P35, DOI 10.1007/s11104-010-0462-7; World Bank, NAT PAN SURV 2014 20; Xu ZY, 2009, AGR ECON-BLACKWELL, V40, P437, DOI 10.1111/j.1574-0862.2009.00384.x	46	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239149	10.1371/journal.pone.0239149	http://dx.doi.org/10.1371/journal.pone.0239149			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946511	Green Published, gold			2022-12-26	WOS:000573851100061
J	Tominack, SA; Coffey, KZ; Yoskowitz, D; Sutton, G; Wetz, MS				Tominack, Sarah A.; Coffey, Kara Z.; Yoskowitz, David; Sutton, Gail; Wetz, Michael S.			An assessment of trends in the frequency and duration ofKarenia brevisred tide blooms on the South Texas coast (western Gulf of Mexico)	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; KARENIA-BREVIS; RED-TIDE; FLORIDA SHELF; TOXIC DINOFLAGELLATE; NUTRIENT SOURCES; TAMPA BAY; ABUNDANCE; SALINITY; PATTERNS	Limited data coverage on harmful algal blooms (HABs) in some regions makes assessment of long-term trends difficult, and also impedes understanding of bloom ecology. Here, observations reported in a local newspaper were combined with cell count and environmental data from resource management agencies to assess trends inKarenia brevis"red tide" frequency and duration in the Nueces Estuary (Texas) and adjacent coastal waters, and to determine relationships with environmental factors. Based on these analyses, the Coastal Bend region of the Texas coast has experienced a significant increase in the frequency of red tide blooms since the mid-1990s. Salinity was positively correlated with red tide occurrence in the Nueces Estuary, and a documented long-term increase in salinity of the Nueces Estuary may be a major factor in the long-term increase in bloom frequency. This suggests that freshwater inflow management efforts in Texas should consider impacts on red tide habitat suitability (i.e., salinity regime) in downstream estuaries. Natural climate variability such as the El Nino-Southern Oscillation, which is strongly related to rainfall and salinity in Central and South Texas, was also an influential predictor of red tide presence/absence. Though no significant change in the duration of blooms was detected, there was a negative correlation between duration and temperature. Specifically, summer-like temperatures were not favorable toK.brevisbloom development. The relationships found here between red tide frequency/duration and environmental drivers present a new avenue of research that will aid in refining monitoring and forecasting efforts for red tides on the Texas coast and elsewhere. Findings also highlight the importance of factors (i.e., salinity, temperature) that are likely to be altered in the future due to both population growth in coastal watersheds and anthropogenic climate change.	[Tominack, Sarah A.; Coffey, Kara Z.; Yoskowitz, David; Sutton, Gail; Wetz, Michael S.] Texas A&M Univ Corpus Christi, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA	Texas A&M University System; Texas A&M University Corpus Christi	Tominack, SA (corresponding author), Texas A&M Univ Corpus Christi, Harte Res Inst Gulf Mexico Studies, Corpus Christi, TX 78412 USA.	sarah.tominack@tamucc.edu		Tominack, Sarah/0000-0001-6464-3070	Texas OneGulf Center of Excellence through COE Grant from the Texas Office of the Governor [1-2016]	Texas OneGulf Center of Excellence through COE Grant from the Texas Office of the Governor	Funding for this project was provided by the Texas OneGulf Center of Excellence through COE Grant Agreement 1-2016 from the Texas Office of the Governor and received by G.S. and D. Y. URL of the funder website: https://www.texasonegulf.org/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH DV, 1960, BIOL BULL, V119, P57, DOI 10.2307/1538932; Alheit J, 2019, DEEP-SEA RES PT II, V159, P130, DOI 10.1016/j.dsr2.2018.11.011; Anderson D.M., 1989, P11; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; [Anonymous], 2014, DIABETES CARE SUPPL, V37, pS5; [Anonymous], 2012, EUROPEAN J NUCL MED, V39, pS493; BADEN DG, 1979, PHYTOCHEMISTRY, V18, P247, DOI 10.1016/0031-9422(79)80063-1; Barnston AG, 2019, CLIM DYNAM, V53, P7215, DOI 10.1007/s00382-017-3603-3; Barton K, 2019, R PACKAGE VERSION, V1, P6, DOI DOI 10.1016/J.AGEE.2019.04.009; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brand LE, 2007, HARMFUL ALGAE, V6, P232, DOI 10.1016/j.hal.2006.08.005; Brand LE, 2012, HARMFUL ALGAE, V14, P156, DOI 10.1016/j.hal.2011.10.020; Bricker SB, 2008, HARMFUL ALGAE, V8, P21, DOI 10.1016/j.hal.2008.08.028; Bugica K, 2020, MAR POLLUT BULL, V152, DOI 10.1016/j.marpolbul.2020.110903; Buskey EJ, 1996, CCBNEP07174 TEX NAT; Campbell L, 2013, ENVIRON SCI POLLUT R, V20, P6896, DOI 10.1007/s11356-012-1437-4; Cheng YS, 2005, HARMFUL ALGAE, V4, P87, DOI 10.1016/j.hal.2003.12.002; Dardis C., 2015, **DATA OBJECT**; Davidson K, 2016, HARMFUL ALGAE, V53, P1, DOI 10.1016/j.hal.2015.11.005; Davidson K, 2014, J ENVIRON MANAGE, V146, P206, DOI 10.1016/j.jenvman.2014.07.002; Dixon LK, 2014, HARMFUL ALGAE, V38, P8, DOI 10.1016/j.hal.2014.07.001; Engelhard GH, 2016, ICES J MAR SCI, V73, P1386, DOI 10.1093/icesjms/fsv219; Flaherty KE, 2011, ESTUAR COAST, V34, P417, DOI 10.1007/s12237-010-9350-x; Harris RJ, 2020, HARMFUL ALGAE, V97, DOI 10.1016/j.hal.2020.101851; Hart JA, 2015, MAR ENVIRON RES, V112, P9, DOI 10.1016/j.marenvres.2015.08.010; Heil CA, 2014, HARMFUL ALGAE, V38, P127, DOI 10.1016/j.hal.2014.07.016; Henrichs DW, 2015, ECOL MODEL, V313, P251, DOI 10.1016/j.ecolmodel.2015.06.038; Hetland RD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030474; Jackman S., 2017, PSCL CLASSES METHODS; Kirkpatrick B, 2004, HARMFUL ALGAE, V3, P99, DOI 10.1016/j.hal.2003.08.005; Kittinger JN, 2015, MARINE HIST ECOLOGY; Landsberg J.H., 1998, HARMFUL ALGAE, P97; Magana HA, 2006, HARMFUL ALGAE, V5, P192, DOI 10.1016/j.hal.2005.07.003; Magana HA, 2003, HARMFUL ALGAE, V2, P163, DOI 10.1016/S1568-9883(03)00026-X; McHugh KA, 2011, MAR MAMMAL SCI, V27, P622, DOI 10.1111/j.1748-7692.2010.00428.x; Montagna PA, 2002, ESTUARIES, V25, P1243, DOI 10.1007/BF02692221; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Parazoo NC, 2015, GLOBAL BIOGEOCHEM CY, V29, P1247, DOI 10.1002/2015GB005125; Paul JH, 2002, AQUAT MICROB ECOL, V27, P21, DOI 10.3354/ame027021; Pennock J, 2004, MX974413010 USEPA GU; Pettitt A. N., 1979, Applied Statistics, V28, P126, DOI 10.2307/2346729; Pohlert T., 2020, TREND NONPARAMETRIC; Rounsefell GA, 1966, 535 US FISH WILDL SE; Schrope M, 2008, NATURE, V452, P24, DOI 10.1038/452024a; Smith T.J., 2013, MULTIPLE LINEAR REGR, V39, P17, DOI DOI 10.1201/9780429066665-6; STEIDINGER KA, 1972, ENVIRON LETT, V3, P271, DOI 10.1080/00139307209435473; Steidinger KA, 2009, HARMFUL ALGAE, V8, P549, DOI 10.1016/j.hal.2008.11.009; Stumpf RP, 2008, CONT SHELF RES, V28, P189, DOI 10.1016/j.csr.2007.04.017; Tester PA, 1997, LIMNOL OCEANOGR, V42, P1039, DOI 10.4319/lo.1997.42.5_part_2.1039; Tester PA, 2004, HARMFUL ALGAE 2002, P41; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Thyng KM., 2013, LIMNOL OCEANOGR FLUI, V3, P269, DOI DOI 10.1215/21573689-2417719; Tolan JM, 2007, ESTUAR COAST SHELF S, V72, P247, DOI 10.1016/j.ecss.2006.10.018; Tomlinson MC, 2009, REMOTE SENS ENVIRON, V113, P598, DOI 10.1016/j.rse.2008.11.003; Trebatoski B, 1988, 802 TEX WAT COMM; Vargo GA, 2009, HARMFUL ALGAE, V8, P573, DOI 10.1016/j.hal.2008.11.002; Walker DA, 2016, J MOD APPL STAT METH; Walters S, 2013, MAR ECOL PROG SER, V479, P191, DOI 10.3354/meps10219; Weisberg RH, 2019, J GEOPHYS RES-OCEANS, V124, P2501, DOI 10.1029/2018JC014887; Weisberg RH, 2016, CONT SHELF RES, V120, P106, DOI 10.1016/j.csr.2016.03.011; WILSON WB, 1956, ECOLOGY, V37, P388, DOI 10.2307/1933156; Wynne TT, 2005, HARMFUL ALGAE, V4, P992, DOI 10.1016/j.hal.2005.02.004	62	9	9	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239309	10.1371/journal.pone.0239309	http://dx.doi.org/10.1371/journal.pone.0239309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946494	gold, Green Published			2022-12-26	WOS:000573851100060
J	Trindade, F; Saraiva, F; Keane, S; Leite-Moreira, A; Vitorino, R; Tajsharghi, H; Falcao-Pires, I				Trindade, Fabio; Saraiva, Francisca; Keane, Simon; Leite-Moreira, Adelino; Vitorino, Rui; Tajsharghi, Homa; Falcao-Pires, Ines			Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; CARDIAC-HYPERTROPHY; MASS REGRESSION; MDM2; IMPACT; DYSFUNCTION; PROTEINS; FIBROSIS; SURVIVAL; HEART	Currently, aortic valve replacement is the only treatment capable of relieving left ventricle pressure overload in patients with severe aortic stenosis. It aims to improve cardiac function and revert hypertrophy, by triggering myocardial reverse remodeling. Despite immediately relieving afterload, reverse remodeling turns out to be extremely variable. Among other factors, the extent of reverse remodeling may depend on how well ubiquitin-proteasome system tackle hypertrophy. Therefore, we assessed tagged ubiquitin and ubiquitin ligases in the left ventricle collected from patients undergoing valve replacement and tested their association to the degree of reverse remodeling. Patients were classified according to the regression of left ventricle mass (Delta LVM) and assigned to complete (Delta LVM >= 15%) or incomplete (Delta LVM <= 5%) reverse remodeling groups. No direct inter-group differences were observed. Nevertheless, correlation analysis supports a fundamental role of the ubiquitin-proteasome system during reverse remodeling. Indeed, total protein ubiquitination was associated to hypertrophic indexes such as interventricular septal thickness (r = 0.55,p= 0.03) and posterior wall thickness (r = 0.65,p= 0.009). No significant correlations were observed for Muscle Ring Finger 3. Surprisingly, though, higher levels of atrogin-1 were associated to postoperative interventricular septal thickness (r = 0.71,p= 0.005). In turn, Muscle Ring Finger 1 correlated negatively with this postoperative hypertrophy marker (r = -0.68,p= 0.005), suggesting a cardioprotective role during reverse remodeling. No significant correlations were found with left ventricle mass regression, although a trend for a negative association between the ligase Murine Double Minute 2 and mass regression (r = -0.44,p= 0.10) was found. Animal studies will be necessary to understand whether this ligase is protective or detrimental. Herein, we show, for the first time, an association between the preoperative myocardial levels of ubiquitin ligases and postoperative hypertrophy, highlighting the therapeutic potential of targeting ubiquitin ligases in incomplete reverse remodeling.	[Trindade, Fabio; Vitorino, Rui] Univ Aveiro, iBiMED Inst Biomed, Dept Med Sci, Aveiro, Portugal; [Trindade, Fabio; Saraiva, Francisca; Leite-Moreira, Adelino; Vitorino, Rui; Falcao-Pires, Ines] Univ Porto, Fac Med, UnIC Cardiovasc Res & Dev Ctr, Dept Surg & Physiol, Porto, Portugal; [Keane, Simon; Tajsharghi, Homa] Univ Skovde, Sch Hlth Sci, Div Biomed, Skovde, Sweden	Universidade de Aveiro; Universidade do Porto; University of Skovde	Falcao-Pires, I (corresponding author), Univ Porto, Fac Med, UnIC Cardiovasc Res & Dev Ctr, Dept Surg & Physiol, Porto, Portugal.	ipires@med.up.pt	Saraiva, Francisca/AAL-8911-2020; Trindade, Fábio/M-8330-2018; Leite-Moreira, Adelino F./A-1463-2018; Vitorino, Rui/AAJ-3621-2021	Saraiva, Francisca/0000-0001-7961-9962; Trindade, Fábio/0000-0002-3415-2040; Leite-Moreira, Adelino F./0000-0001-7808-3596; Vitorino, Rui/0000-0003-3636-5805; Falcao-Pires, Ines/0000-0003-1937-3782; Keane, Simon/0000-0002-0471-6896	Portuguese Foundation for Science and Technology (FCT) [UID/BIM/04501/2020, POCI-01-0145-FEDER-007628, UIDB/00051/2020, UIDP/00051/2020]; European Union [UID/BIM/04501/2020, POCI-01-0145-FEDER-007628, UIDB/00051/2020, UIDP/00051/2020]; Quadro de Referencia Estrategico Nacional (QREN) [UID/BIM/04501/2020, POCI-01-0145-FEDER-007628, UIDB/00051/2020, UIDP/00051/2020]; Fundo Europeu de Desenvolvimento Regional (FEDER) [UID/BIM/04501/2020, POCI-01-0145-FEDER-007628, UIDB/00051/2020, UIDP/00051/2020]; Programa Operacional de Competitividade (COMPETE) [UID/BIM/04501/2020, POCI-01-0145-FEDER-007628, UIDB/00051/2020, UIDP/00051/2020]; FEDER through COMPETE 2020 -Programa Operacional Competitividade E Internacionalizacao (POCI); project DOCNET - Norte Portugal regional operational programme (NORTE 2020), under the Portugal 2020 partnership agreement, through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000003]; project NETDIAMOND - European Structural And Investment Funds, Lisbon's regional operational program 2020 [POCI-01-0145-FEDER-016385, SAICTPAC/0047/2015]; European Union's Seventh Framework Programme for research, technological development and demonstration [608473]; Swedish Research Council; Universidade do Porto/FMUP; FSE-Fundo Social Europeu, NORTE 2020Programa Operacional Regional do Norte [NORTE-08-5369-FSE-000024]; COST Action [BM1307/PROTEOSTASIS];  [IF/00286/2015];  [SFRH/BD/111633/2015]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); European Union(European Commission); Quadro de Referencia Estrategico Nacional (QREN); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional de Competitividade (COMPETE); FEDER through COMPETE 2020 -Programa Operacional Competitividade E Internacionalizacao (POCI); project DOCNET - Norte Portugal regional operational programme (NORTE 2020), under the Portugal 2020 partnership agreement, through the European Regional Development Fund (ERDF); project NETDIAMOND - European Structural And Investment Funds, Lisbon's regional operational program 2020; European Union's Seventh Framework Programme for research, technological development and demonstration; Swedish Research Council(Swedish Research CouncilEuropean Commission); Universidade do Porto/FMUP; FSE-Fundo Social Europeu, NORTE 2020Programa Operacional Regional do Norte; COST Action(European Cooperation in Science and Technology (COST)); ; 	The authors thank Portuguese Foundation for Science and Technology (FCT), European Union, Quadro de Referencia Estrategico Nacional (QREN), Fundo Europeu de Desenvolvimento Regional (FEDER) and Programa Operacional de Competitividade (COMPETE) for funding iBiMED (UID/BIM/04501/2020 and POCI-01-0145-FEDER-007628) and UnIC (UIDB/00051/2020 and UIDP/00051/2020) research units. This project is supported by FEDER through COMPETE 2020 -Programa Operacional Competitividade E Internacionalizacao (POCI), the project DOCNET (NORTE-01-0145-FEDER-000003), supported by Norte Portugal regional operational programme (NORTE 2020), under the Portugal 2020 partnership agreement, through the European Regional Development Fund (ERDF), the project NETDIAMOND (POCI-01-0145-FEDER-016385, SAICTPAC/0047/2015), supported by European Structural And Investment Funds, Lisbon's regional operational program 2020. HT is supported by the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 608473 and the Swedish Research Council. RV and FT are supported by IF/00286/2015 and SFRH/BD/111633/2015 fellowship grants, respectively. FS is supported by Universidade do Porto/FMUP and FSE-Fundo Social Europeu, NORTE 2020Programa Operacional Regional do Norte, NORTE-08-5369-FSE-000024-Programas Doutorais. The authors would like also to address a special thanks to COST Action BM1307/PROTEOSTASIS for funding this work and granting FT with a shortterm scientific mission stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, LANCET ONCOL, V16, P233, DOI 10.1016/S1470-2045(15)70089-6; [Anonymous], 2010, CIRCULATION, V122, pS639; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; Brown DI, 2017, COMPR PHYSIOL, V7, P841, DOI 10.1002/cphy.c160024; Coffey S, 2014, J AM COLL CARDIOL, V63, P2852, DOI 10.1016/j.jacc.2014.04.018; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Gaspar-Pereira S, 2012, AM J PATHOL, V180, P929, DOI 10.1016/j.ajpath.2011.11.007; Gaudino M, 2005, EUR HEART J, V26, P51, DOI 10.1093/eurheartj/ehi012; Gavina C, 2014, INT J CARDIOL, V170, P324, DOI 10.1016/j.ijcard.2013.11.006; Gavina C, 2012, CURR PHARM BIOTECHNO, V13, P2503; Hanayama N, 2005, J CARDIAC SURG, V20, P307, DOI 10.1111/j.1540-8191.2005.200485.x; Hauck L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189861; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hellawell JL, 2012, CARDIOVASC THER, V30, P172, DOI 10.1111/j.1755-5922.2010.00247.x; Hou YC1, 2009, AM J PHYSIOL-LUNG C, V296, pL288; Kamalov G, 2013, J CARDIOVASC PHARM, V62, P497, DOI 10.1097/FJC.0000000000000011; Kim GH, 2018, NAT REV CARDIOL, V15, P83, DOI 10.1038/nrcardio.2017.139; Kulik A, 2006, CIRCULATION, V114, pI553, DOI 10.1161/CIRCULATIONAHA.105.001180; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leri A, 1999, AM J PATHOL, V154, P567, DOI 10.1016/S0002-9440(10)65302-3; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Lund O, 2003, EUR HEART J, V24, P1437, DOI 10.1016/S0195-668X(03)00316-6; Maejima Y, 2014, CIRC-HEART FAIL, V7, P479, DOI 10.1161/CIRCHEARTFAILURE.113.000713; Olive M, 2015, HUM MOL GENET, V24, P6264, DOI 10.1093/hmg/ddv311; Fortes MAS, 2016, ANAL BIOCHEM, V504, P38, DOI 10.1016/j.ab.2016.03.023; Shimizu I, 2016, J MOL CELL CARDIOL, V97, P245, DOI 10.1016/j.yjmcc.2016.06.001; Tian LF, 2006, BIOCHEM BIOPH RES CO, V345, P355, DOI 10.1016/j.bbrc.2006.04.108; Toth A, 2006, J BIOL CHEM, V281, P3679, DOI 10.1074/jbc.M509630200; Usui S, 2011, CIRC RES, V109, P161, DOI 10.1161/CIRCRESAHA.110.238717; Weidemann F, 2009, CIRCULATION, V120, P577, DOI 10.1161/CIRCULATIONAHA.108.847772; Willis MS, 2014, J MOL CELL CARDIOL, V71, P43, DOI 10.1016/j.yjmcc.2013.11.008; Willis MS, 2013, NEW ENGL J MED, V368, P455, DOI 10.1056/NEJMra1106180; Zeng Y, 2016, EXP THER MED, V11, P1184, DOI 10.3892/etm.2016.3048; Zhao H, 2017, INFLAMMATION, V40, P232, DOI 10.1007/s10753-016-0473-5; Zybach-Benz RE, 2006, INT J CARDIOL, V109, P41, DOI 10.1016/j.ijcard.2005.05.050; 2016, AM J PHYSL RENAL PHY, V310, pH1402	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0237000	10.1371/journal.pone.0237000	http://dx.doi.org/10.1371/journal.pone.0237000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946439	Green Published, gold			2022-12-26	WOS:000573851100068
J	Li, JJ; Abosmaha, E; Coffin, CS; Labonte, P; Bukong, TN				Li, Jingjing; Abosmaha, Ebtisam; Coffin, Carla S.; Labonte, Patrick; Bukong, Terence Ndonyi			Reticulon-3 modulates the incorporation of replication competent hepatitis C virus molecules for release inside infectious exosomes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; HCV INFECTION; PROTEIN; RNA	Background Cell released microvesicles specifically, exosomes, play an important role in mediating immunologic escape, treatment resistance, and disease persistence of Hepatitis C virus (HCV) infection. Reports on the molecular compositions of exosomes released by cells under diverse conditions, especially during viral infections, suggest that their cargo contents are not randomly loaded. However, the precise molecular mechanisms directing the selective cargo sorting and loading inside infectious viral exosomes remains elusive. Aim To decipher the role of Reticulon 3 (RTN3) in the selective molecular cargo sorting and loading inside infectious viral exosomes during HCV infection. Methods We used Huh7 cells-JFH1 HCV infection and HCV Full-Length (FL) replicon systems. Additionally, we analyzed human liver and serum exosome samples from healthy and treatment naive HCV infected individuals. Our experiments made use of molecular biology and immunology techniques. Results HCV infection (JFH1-Huh7 or HCV-FL replicon cells) was associated with increased RTN3L&S isoforms expression in cells and cell released exosomes. Accordingly, increased expression of RTN3L&S was observed in liver and serum exosome samples of HCV infected individuals compared to healthy controls. RNA-ChIP analysis revealed that RTN3L&S interacted with dsHCV RNA. Lentiviral CRISPR/Cas9 mediated knockdown (KD) of RTN3 and plasmid overexpression (OE) of wild type, C- and N-terminal deletion mutants of RTN3L&S in HCV- infected Huh7 cells differentially impacted the cellular release of infectious viral exosomes. RTN3L&S KD significantly decreased, while RTN3S OE significantly increased the number of Huh7 cell-released infectious exosomes. The C-terminal domain of RTN3 interacted with and modulated the loading of dsHCV RNA inside infectious exosomes. Antiviral treatment of HCV infected Huh7 cells reduced virus-induced RTN3L&S expression and attenuated the release of infectious exosomes. Conclusion RTN3 constitutes a novel regulator and a potential therapeutic target that mediates the specific loading of infectious viral exosomes.	[Li, Jingjing; Abosmaha, Ebtisam; Labonte, Patrick; Bukong, Terence Ndonyi] Inst Natl Rech Sci, INRS Inst Arm & Frappier, Laval, PQ, Canada; [Coffin, Carla S.] Univ Calgary, Dept Med, Calgary, AB, Canada	University of Quebec; Institut national de la recherche scientifique (INRS); University of Calgary	Bukong, TN (corresponding author), Inst Natl Rech Sci, INRS Inst Arm & Frappier, Laval, PQ, Canada.	terencendonyi.bukong@iaf.inrs.ca		Coffin, Carla/0000-0002-1472-0901	INRS-IAF; NSERC of Canada; CIHR; Alberta Innovates; Fondation ArmandFrappier	INRS-IAF; NSERC of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); Alberta Innovates; Fondation ArmandFrappier	This work was funded by a grant from the INRS-IAF to TNB. Patrick Labonte is supported by NSERC of Canada. Carla S. Coffin is supported by CIHR and Alberta Innovates. JingJing Li received scholarship support from the Fondation ArmandFrappier.	Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055; Anderson MR, 2016, NEUROTHERAPEUTICS, V13, P535, DOI 10.1007/s13311-016-0450-6; [Anonymous], 2017, PRIMARY MED FORUM, V21, P986; Arenaccio C, 2014, J VIROL, V88, P11529, DOI 10.1128/JVI.01712-14; Babst M, 2011, CURR OPIN CELL BIOL, V23, P452, DOI 10.1016/j.ceb.2011.04.008; Bagaglio S, 2017, DRUGS, V77, P1043, DOI 10.1007/s40265-017-0753-x; Barajas D, 2014, VIROLOGY, V471, P72, DOI 10.1016/j.virol.2014.10.005; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424; Chino H, 2019, MOL CELL, V74, P909, DOI 10.1016/j.molcel.2019.03.033; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; Grumati P, 2017, ELIFE, V6, DOI 10.7554/eLife.25555; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659; Klepper A, 2017, HEPATOLOGY, V66, P357, DOI 10.1002/hep.28846; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; Li DK, 2019, METHODS MOL BIOL, V1911, P3, DOI 10.1007/978-1-4939-8976-8_1; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lin CL, 2017, ANTICANCER RES, V37, P2885, DOI 10.21873/anticanres.11641; Martins TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198820; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Pawelczyk A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-346; Pleet ML, 2017, DNA CELL BIOL, V36, P243, DOI 10.1089/dna.2017.3639; Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Siddiqi S, 2018, CAN J PHYSIOL PHARM, V96, P668, DOI 10.1139/cjpp-2018-0077; Stedman C, 2014, THER ADV GASTROENTER, V7, P131, DOI 10.1177/1756283X13515825; Suguitan Jr AL, 2011, PLOS ONE, V6; Tripathi LP, 2013, J PROTEOME RES, V12, P2537, DOI 10.1021/pr3011217; Villarroya-Beltri C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13588; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wakita Takaji, 2009, V510, P305, DOI 10.1007/978-1-59745-394-3_23; Wu MJ, 2014, CELL MICROBIOL, V16, P1603, DOI 10.1111/cmi.12318; Wyles David L, 2017, Top Antivir Med, V25, P103; Yang YL, 2017, CELL MOL IMMUNOL, V14, P465, DOI 10.1038/cmi.2016.24; Yang YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-234; Yek C, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0969-3; Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206; 2013, Q J RES SCI TECHNOLO, V57, P70	46	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239153	10.1371/journal.pone.0239153	http://dx.doi.org/10.1371/journal.pone.0239153			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941510	Green Published, gold			2022-12-26	WOS:000573848800049
J	Long, WJ; Li, Q; Wan, NX; Feng, DJ; Kong, FL; Zhou, Y; Yuan, JC				Long, Wengjing; Li, Qiang; Wan, Nianxin; Feng, Dongju; Kong, Fanlei; Zhou, Yong; Yuan, Jichao			Root morphological and physiological characteristics in maize seedlings adapted to low iron stress	PLOS ONE			English	Article							MOBILIZATION; DEFICIENCY; TOLERANCE	Iron (Fe) deficiency is a common challenge in crop production. Screening and research of Fe-efficient cultivars could alleviate plant stress and increase crop yields in Fe-deficient soils. In the present study, we conducted two hydroponic culture experiments with a control (100 mu mol/L Fe3+-EDTA) and low Fe treatment (10 mu mol/L Fe3+-EDTA) to study the morphological and physiological mechanisms of response to low Fe stress in maize hybrids seedlings. In the first experiment, we investigated 32 major maize hybrids in Southwest China. We found that six of them, including Zhenghong 2 (ZH 2), were Fe-efficient. Fifteen other cultivars, such as Chuandan 418 (CD 418), were Fe-inefficient. In the second experiment, we investigated the Fe-efficient ZH 2 and Fe-inefficient CD 418 cultivars and found that low Fe stress resulted in significant decreases in root volume, root length, number of root tips, root surface area, and root dry weight, and increased root to shoot ratio, average root diameter, and Fe-dissolution ability per mass of roots in both maize cultivars. However, the increase in Fe-dissolution ability per mass of roots in ZH 2 was higher than that in CD 418, whereas for the other measurements, the low Fe stress-induced changes in ZH 2 were less pronounced than in CD 418. Therefore, under low Fe stress, the above-mentioned growth factors in ZH 2 were higher by 54.84%, 121.46%, 107.67%, 83.96%, 140.00%, and 18.16%, respectively, than those in CD 418. In addition, leaf area, chlorophyll content, net photosynthetic rate, soluble protein content, and Catalase (CAT) and Peroxidase (POD) activities in ZH 2 were higher by 274.95%, 113.95%, 223.60%, 56.04%, 17.01% and 21.13% than those in CD 418. Therefore, compared with the Fe-inefficient cultivar (CD 418), the Fe-efficient cultivar (ZH 2) had a more developed root system and greater Fe absorption capacity per mass of roots under low iron stress, promoted the efficient absorption of Fe, maintained a higher photosynthetic area and photosynthetic rate, thereby facilitating the accumulation of photosynthetic products. Moreover, higher soluble protein content and activities of CAT and POD permitted high osmotic regulation and scavenging ability, which is an important physiological mechanism for ZH 2 adaptation to low Fe stress.	[Long, Wengjing] Sichuan Acad Agr Sci, Natl Sorghum Improvement Ctr, Rice & Sorghum Inst, Sichuan Branch, Deyang, Peoples R China; [Li, Qiang; Zhou, Yong] Chongqing Univ Arts & Sci, Collaborat Innovat Ctr Special Plant Ind Chongqin, Inst Special Plants, Chongqing Key Lab Econ Plant Biotechnol, Yongchuan, Peoples R China; [Wan, Nianxin] Luxian Management Comm Modern Agr Pk, Luzhou, Peoples R China; [Feng, Dongju; Kong, Fanlei; Yuan, Jichao] Sichuan Agr Univ, Key Lab Crop Ecophysiol & Farming Syst Southwest, Minist Agr, Chengdu, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS); Chongqing University of Arts & Sciences; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University	Yuan, JC (corresponding author), Sichuan Agr Univ, Key Lab Crop Ecophysiol & Farming Syst Southwest, Minist Agr, Chengdu, Peoples R China.	yuanjichao5@163.com		LONG, Wenjing/0000-0002-9637-6007	National Key Research and Development Program for Grain High-yield Science and Technology Innovation Project of China [2016YFD0300307, 2017YFD0301704, 2018YFD0301206]; Special Fund for Agroscientific Research in the Public Interest of China [20150312705]	National Key Research and Development Program for Grain High-yield Science and Technology Innovation Project of China; Special Fund for Agroscientific Research in the Public Interest of China	This study was financially supported by the National Key Research and Development Program for Grain High-yield Science and Technology Innovation Project of China (Grant No. 2016YFD0300307, 2017YFD0301704, 2018YFD0301206), and the Special Fund for Agroscientific Research in the Public Interest of China (Grant No. 20150312705) to JY.	[Anonymous], 2014, Duke Med Health News, V20, P8; [Anonymous], 2002, BAUDOUIN, V27, P19; [Anonymous], 2019, CRIT INQUIRY, V45, P601; Barberon M, 2016, CELL, V164, P447, DOI 10.1016/j.cell.2015.12.021; Briat JF, 2015, TRENDS PLANT SCI, V20, P33, DOI 10.1016/j.tplants.2014.07.005; Brumbarova T, 2015, TRENDS PLANT SCI, V20, P124, DOI 10.1016/j.tplants.2014.11.004; [陈旭蕾 Chen Xulei], 2017, [中国农业大学学报, Journal of China Agricultural University], V22, P49; Dasgan HY, 2004, EUPHYTICA, V139, P51, DOI 10.1007/s10681-004-2033-6; Galindo-Castaneda T, 2018, PLANT CELL ENVIRON, V41, P1579, DOI 10.1111/pce.13197; Gao F, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00006; [高丽 GAO Li], 2008, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V30, P168; Gattullo CE, 2018, PEDOSPHERE, V28, P59, DOI 10.1016/S1002-0160(15)60104-7; Grillet L, 2018, NAT PLANTS, V4, P953, DOI 10.1038/s41477-018-0266-y; Hamzeh R, 2015, INT J AGR POL RES, V3, P368, DOI [10.15739/IJAPR.062, DOI 10.15739/IJAPR.062]; [敬岩 JING Yan], 2007, [植物营养与肥料学报, Plant nutrition and fertitizer science], V13, P809; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Long WJ, 2015, J MAIZE SCI, V25, P1163; Lupini A, 2016, PLANT GROWTH REGUL, V78, P263, DOI 10.1007/s10725-015-0091-5; Niu L, 2019, J ANHUI AGR SCI, V47, P128; Rajniak J, 2018, NAT CHEM BIOL, V14, P442, DOI 10.1038/s41589-018-0019-2; Ren BZ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01216; [邵国庆 SHAO Guo-qing], 2009, [中国农业科学, Scientia Agricultura Sinica], V42, P3459; Shi RongLi, 2010, Plant Nutrition and Fertilizer Science, V16, P1306; Tian JG, 2019, SCIENCE, V365, P658, DOI 10.1126/science.aax5482; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tripathi DK, 2018, FRONT ENV SCI-SWITZ, V5, DOI 10.3389/fenvs.2017.00086; Tsai HH, 2017, TRENDS PLANT SCI, V22, P538, DOI 10.1016/j.tplants.2017.03.008; Wang WT, 2008, CHINESE J ANAL CHEM, V36, P66; Wu ZiRan, 2016, Journal of Yangzhou University, Agricultural and Life Sciences Edition, V37, P106; Xu JianQin, 2017, Scientia Agricultura Sinica, V50, P1223; Yue LJ, 2009, EFFECT IRON STRESS I; Zhang Z, 2015, VIRUS GENES, V51, P69, DOI 10.1007/s11262-015-1218-5	32	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239075	10.1371/journal.pone.0239075	http://dx.doi.org/10.1371/journal.pone.0239075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941470	Green Published, gold			2022-12-26	WOS:000573848800101
J	Pitol, AK; Kohn, T; Julian, TR				Pitol, Ana K.; Kohn, Tamar; Julian, Timothy R.			Retention ofE.coliand water on the skin after liquid contact	PLOS ONE			English	Article							TRANSFER EFFICIENCY; RISK-ASSESSMENT; VIRUS TRANSFER; HANDS; BACTERIA; QMRA	The frequent contact people have with liquids containing pathogenic microorganisms provides opportunities for disease transmission. In this work, we quantified the transfer of bacteria-usingE.colias a model- from liquid to skin, estimated liquid retention on the skin after different contact activities (hand immersion, wet-cloth and wet-surface contact), and estimated liquid transfer following hand-to-mouth contacts. The results of our study show that the number ofE.colitransferred to the skin per surface area (n [E.coli/cm(2)]) can be modeled usingn=C(10(-3.38)+h), whereC[E.coli/cm(3)] is the concentration ofE.coliin the liquid, andh[cm] is the film thickness of the liquid retained on the skin. Findings from theE.colitransfer experiments reveal a significant difference between the transfer ofE.colifrom liquid to the skin and the previously reported transfer of viruses to the skin. Additionally, our results demonstrate that the time elapsed since the interaction significantly influences liquid retention, therefore modulating the risks associated with human interaction with contaminated liquids. The findings enhance our understanding of liquid-mediated disease transmission processes and provide quantitative estimates as inputs for microbial risk assessments.	[Pitol, Ana K.; Julian, Timothy R.] Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland; [Pitol, Ana K.; Kohn, Tamar] Ecole Polytech Fed Lausanne EPFL, Lab Environm Chem, Sch Architecture Civil & Environm Engn ENAC, Lausanne, Switzerland; [Julian, Timothy R.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Julian, Timothy R.] Univ Basel, Basel, Switzerland; [Pitol, Ana K.] Imperial Coll London, Dept Civil & Environm Engn, South Kensington Campus, London, England	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Imperial College London	Pitol, AK; Julian, TR (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Eawag, Dubendorf, Switzerland.; Pitol, AK (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Environm Chem, Sch Architecture Civil & Environm Engn ENAC, Lausanne, Switzerland.; Julian, TR (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Julian, TR (corresponding author), Univ Basel, Basel, Switzerland.; Pitol, AK (corresponding author), Imperial Coll London, Dept Civil & Environm Engn, South Kensington Campus, London, England.	a.pitol-garcia@imperial.ac.uk; tim.julian@eawag.ch	Kohn, Tamar/H-1430-2011	Kohn, Tamar/0000-0003-0395-6561	Eawag Discretionary Funds for Research; EPFL	Eawag Discretionary Funds for Research; EPFL	This study was funded by Eawag Discretionary Funds for Research and EPFL internal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, GRIFFITH LAW REV, V1, pviii; ANSARI SA, 1988, J CLIN MICROBIOL, V26, P1513, DOI 10.1128/JCM.26.8.1513-1518.1988; AuYeung W, 2008, ENVIRON RES, V108, P294, DOI 10.1016/j.envres.2008.07.010; Bischel HN, 2019, ENVIRON SCI TECHNOL, V53, P7055, DOI 10.1021/acs.est.9b01092; de Man H, 2014, WATER RES, V54, P254, DOI 10.1016/j.watres.2014.02.010; de Man H, 2014, WATER RES, V48, P90, DOI 10.1016/j.watres.2013.09.022; Flores AP, 2011, J HAZARD MATER, V189, P222, DOI 10.1016/j.jhazmat.2011.02.028; Haas CN, 2014, QUANTITATIVE MICROBIAL RISK ASSESSMENT, 2ND EDITION, P1, DOI 10.1002/9781118910030; Julian TR, 2010, J APPL MICROBIOL, V109, P1868, DOI 10.1111/j.1365-2672.2010.04814.x; Julian TR, 2018, SCI TOTAL ENVIRON, V635, P120, DOI 10.1016/j.scitotenv.2018.04.100; Lopez GU, 2013, APPL ENVIRON MICROB, V79, P5728, DOI 10.1128/AEM.01030-13; MACKINTOSH CA, 1984, J HYG-CAMBRIDGE, V92, P345, DOI 10.1017/S0022172400064561; Ng MG, 2014, J OCCUP ENVIRON HYG, V11, P633, DOI 10.1080/15459624.2014.895373; O'Mara M, 2017, PREDICTING HAND SURF; Pecson BM, 2017, WATER RES, V122, P258, DOI 10.1016/j.watres.2017.06.014; Pitol AK, 2017, ENVIRON SCI TECHNOL, V51, P14417, DOI 10.1021/acs.est.7b04949; Pitol AK, 2018, APPL ENV MCROBIOLOGY, V84, P1; Romero-Barrios P, 2013, FOOD CONTROL, V29, P343, DOI 10.1016/j.foodcont.2012.05.043; Rusin P, 2002, J APPL MICROBIOL, V93, P585, DOI 10.1046/j.1365-2672.2002.01734.x; Schoen ME, 2017, MICROB RISK ANAL, V5, P32, DOI 10.1016/j.mran.2017.01.002; US Environmental Protection Agency, 2011, EXP FACT HDB 2011 ED, V1, P1; Verbyla ME, 2019, ENVIRON SCI TECHNOL, V53, P2852, DOI 10.1021/acs.est.8b06156; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; World Health Organization, 2016, QUANT MICR RISK ASS; World Health Organization (WHO), 2010, HUM HLTH RISK ASS TO	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238998	10.1371/journal.pone.0238998	http://dx.doi.org/10.1371/journal.pone.0238998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941473	Green Published, gold			2022-12-26	WOS:000573848800010
J	Suzuki, M; Kawata, N; Abe, M; Yokota, H; Anazawa, R; Matsumura, Y; Ikari, J; Matsuoka, S; Tsushima, K; Tatsumi, K				Suzuki, Masaki; Kawata, Naoko; Abe, Mitsuhiro; Yokota, Hajime; Anazawa, Rie; Matsumura, Yukiko; Ikari, Jun; Matsuoka, Shin; Tsushima, Kenji; Tatsumi, Koichiro			Objective quantitative multidetector computed tomography assessments in patients with combined pulmonary fibrosis with emphysema: Relationship with pulmonary function and clinical events	PLOS ONE			English	Article							VITAL CAPACITY; LUNG-FUNCTION; MORTALITY; DISEASE; PROGRESSION; DIAGNOSIS; COPD; EXACERBATIONS; COMORBIDITIES; HYPERTENSION	Background Combined pulmonary fibrosis with emphysema (CPFE) is a clinically meaningful syndrome characterized by coexisting upper-lobe emphysema and lower-lobe interstitial fibrosis. However, ambiguous diagnostic criteria and, particularly, the absence of objective methods to quantify emphysematous/fibrotic lesions in patients with CPFE confound the interpretation of the pathophysiology of this syndrome. We analyzed the relationship between objectively quantified computed tomography (CT) measurements and the results of pulmonary function testing (PFT) and clinical events in CPFE patients. Materials and methods We enrolled 46 CPFE patients who underwent CT and PFT. The extent of emphysematous lesions was obtained by calculating the percent of low attenuation area (%LAA). The extent of fibrotic lesions was calculated as the percent of high attenuation area (%HAA). %LAA and %HAA values were combined to yield the percent of abnormal area (%AA). We assessed the relationships between CT parameters and other clinical indices, including PFT results. Multivariate analysis was performed to examine the association between the CT parameters and clinical events. Results A greater negative correlation with percent predicted diffusing capacity of the lung for carbon monoxide (DLCO%predicted) existed for %AA (r = -0.73, p < 0.001) than for %LAA or %HAA alone. The %HAA value was inversely correlated with percent predicted forced vital capacity (r = -0.48, p < 0.001), percent predicted total lung capacity (r = -0.48, p < 0.01), and DLCO%predicted (r = -0.47, p < 0.01). Multivariate logistic regression analysis found that %AA showed the strongest association with hospitalization events (odds ratio = 1.20, 95% confidence interval = 1.01-1.54, p = 0.029). Conclusion Quantitative CT measurements reflected deterioration in pulmonary function and were associated with hospitalization in patients with CPFE. This approach could serve as a useful method to determine the extent of lung morphology, pathophysiology, and the clinical course of patients with CPFE.	[Suzuki, Masaki; Kawata, Naoko; Abe, Mitsuhiro; Anazawa, Rie; Matsumura, Yukiko; Ikari, Jun; Tatsumi, Koichiro] Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Chiba, Japan; [Yokota, Hajime] Chiba Univ, Grad Sch Med, Dept Diagnost Radiol & Radiat Oncol, Chiba, Chiba, Japan; [Matsuoka, Shin] St Marianna Univ, Dept Radiol, Sch Med, Kawasaki, Kanagawa, Japan; [Tsushima, Kenji] Int Univ Hlth & Welf, Sch Med, Dept Pulm Med, Narita City, Chiba, Japan	Chiba University; Chiba University; Saint Marianna University; International University of Health & Welfare	Suzuki, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Respirol, Chiba, Chiba, Japan.	suzuki-m.7447@chiba-u.jp	Yokota, Hajime/ABI-7913-2020	Suzuki, Masaki/0000-0003-3773-4860; Kawata, Naoko/0000-0002-4083-4531	Ministry of Education, Science, Sports and Culture [16K01407, 19K12816]; Chiba Foundation for Health Promotion & Disease Prevention [1272]; Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan [H26-Intractable diseases-General-076]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chiba Foundation for Health Promotion & Disease Prevention; Respiratory Failure Research Group from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	NK recieved the grants from the Ministry of Education, Science, Sports and Culture, Grantin-Aid for Scientific Research (C) (16K01407,19K12816), the Chiba Foundation for Health Promotion & Disease Prevention(No.1272). Koichiro T recieved the grants from the Respiratory Failure Research Group (H26-Intractable diseases-General-076) from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2009, RESP MED, V103, P1209, DOI 10.1016/j.rmed.2009.02.001; Ando K, 2013, LUNG, V191, P585, DOI 10.1007/s00408-013-9513-1; [Anonymous], 2004, Nihon Kokyuki Gakkai Zasshi, VSuppl, P1; [Anonymous], 2011, MED PR, V63, P295; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Antoniou KM, 2008, AM J RESP CRIT CARE, V177, P190, DOI 10.1164/rccm.200612-1759OC; Behr J, 2015, EUR RESPIR J, V46, P186, DOI 10.1183/09031936.00217614; Camiciottoli G, 2006, CHEST, V129, P558, DOI 10.1378/chest.129.3.558; Caminati A, 2009, RESP MED, V103, P117, DOI 10.1016/j.rmed.2008.07.022; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chae KJ, 2015, EUR RADIOL, V25, P2326, DOI 10.1007/s00330-015-3617-3; Champtiaux N, 2019, SEMIN ARTHRITIS RHEU, V49, P98, DOI 10.1016/j.semarthrit.2018.10.011; Chilosi M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-3; Choi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107476; Ciccarese F, 2016, RADIOL MED, V121, P564, DOI 10.1007/s11547-016-0627-4; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Cottin V, 2010, EUR RESPIR J, V35, P105, DOI 10.1183/09031936.00038709; Diaz AA, 2015, RESP MED, V109, P882, DOI 10.1016/j.rmed.2015.04.009; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P459, DOI 10.1164/rccm.201011-1790OC; Durheim MT, 2015, LANCET RESP MED, V3, P388, DOI 10.1016/S2213-2600(15)00093-4; Farkhooy A, 2013, COPD, V10, P180, DOI 10.3109/15412555.2012.734873; Fujimoto K, 2012, EUR RADIOL, V22, P83, DOI 10.1007/s00330-011-2211-6; Graham BL, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00016-2016; Haruna A, 2010, CHEST, V138, P635, DOI 10.1378/chest.09-2836; Hillas G, 2015, INT J CHRONIC OBSTR, V10, P95, DOI 10.2147/COPD.S54473; Hubbard RB, 2008, AM J RESP CRIT CARE, V178, P1257, DOI 10.1164/rccm.200805-725OC; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Jo HE, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0575-y; Kishaba T, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000988; Kitaguchi Y, 2014, INT J CHRONIC OBSTR, V9, P805, DOI 10.2147/COPD.S65621; Kitaguchi Y, 2013, RESP MED, V107, P1986, DOI 10.1016/j.rmed.2013.06.015; Kitaguchi Y, 2010, RESPIROLOGY, V15, P265, DOI 10.1111/j.1440-1843.2009.01676.x; Loeh B, 2019, CHEST, V155, P972, DOI 10.1016/j.chest.2019.01.019; Lynch DA, 2005, AM J RESP CRIT CARE, V172, P488, DOI 10.1164/rccm.200412-1756OC; Lynch DA, 2015, RADIOLOGY, V277, P192, DOI 10.1148/radiol.2015141579; Mascalchi M, 2017, J THORAC DIS, V9, P3319, DOI 10.21037/jtd.2017.08.17; Matsuoka S, 2015, ACAD RADIOL, V22, P626, DOI 10.1016/j.acra.2015.01.008; Matsuoka S, 2015, J COMPUT ASSIST TOMO, V39, P153, DOI 10.1097/RCT.0000000000000184; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Mouronte-Roibas C, 2018, INT J CHRONIC OBSTR, V13, P3563, DOI 10.2147/COPD.S178109; Natsuizaka M, 2014, AM J RESP CRIT CARE, V190, P773, DOI 10.1164/rccm.201403-0566OC; Ohkubo H, 2018, RESPIR INVESTIG, V56, P5, DOI 10.1016/j.resinv.2017.10.003; Ostridge K, 2016, EUR RESPIR J, V48, P216, DOI 10.1183/13993003.00041-2016; Papaioannou AI, 2016, RESP MED, V117, P14, DOI 10.1016/j.rmed.2016.05.005; Papiris SA, 2013, EXPERT REV RESP MED, V7, P19, DOI [10.1586/ERS.12.80, 10.1586/ers.12.80]; Park J, 2020, CHEST, V157, P47, DOI 10.1016/j.chest.2019.06.015; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Shin KE, 2011, J COMPUT ASSIST TOMO, V35, P266, DOI 10.1097/RCT.0b013e31820ccf18; Smith BM, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2013.09.020; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Takayanagi S, 2017, INT J CHRONIC OBSTR, V12, DOI 10.2147/COPD.S121405; Tanabe N, 2011, AM J RESP CRIT CARE, V183, P1653, DOI 10.1164/rccm.201009-1535OC; Todd NW, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-6; Washko GR, 2011, NEW ENGL J MED, V364, P897, DOI 10.1056/NEJMoa1007285; Wrobel JP, 2012, J HEART LUNG TRANSPL, V31, P557, DOI 10.1016/j.healun.2012.02.029; Wu XP, 2019, AM J RESP CRIT CARE, V199, P12, DOI 10.1164/rccm.201803-0444PP	59	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239066	10.1371/journal.pone.0239066	http://dx.doi.org/10.1371/journal.pone.0239066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941486	Green Published, gold			2022-12-26	WOS:000573848800087
J	Danielsson, O; Haggqvist, B; Grontoft, L; Ollinger, K; Ernerudh, J				Danielsson, Olof; Haggqvist, Bo; Grontoft, Liv; Ollinger, Karin; Ernerudh, Jan			Apoptosis in idiopathic inflammatory myopathies with partial invasion; a role for CD8(+)cytotoxic T cells?	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY ANALYSIS; INCLUSION-BODY MYOSITIS; WORKSHOP PATHOLOGY DIAGNOSIS; DUCHENNE MUSCULAR-DYSTROPHY; MUSCLE-FIBERS; MONONUCLEAR-CELLS; GRANZYME-B; MEDIATED CYTOTOXICITY; DNA FRAGMENTATION; FAS LIGAND	Polymyositis and inclusion body myositis are idiopathic inflammatory myopathies, with a pathology characterized by partial invasion of non-necrotic muscle fibres by CD8(+)cytotoxic T-cells, leading to fibre degeneration. Although the main effector pathway of CD8(+)T-cells is to induce apoptosis of target cells, it has remained unclear if apoptosis occurs in these diseases, and if so, if it is mediated by CD8(+)T-cells. In consecutive biopsy sections from 10 patients with partial invasion, muscle fibres and inflammatory cells were assessed by immunohistochemistry and apoptotic nuclei by the TUNEL assay. Analysis of muscle fibre morphology, staining pattern and quantification were performed on digital images, and they were compared with biopsies from 10 dermatomyositis patients and 10 controls without muscle disease. Apoptotic myonuclei were found in muscle with partial invasion, but not in the invaded fibres. Fibres with TUNEL positive nuclei were surrounded by CD8(+)T-cells, granzyme B(+)cells and macrophages, but lacked FAS receptor expression. In contrast, apoptotic myonuclei were rare in dermatomyositis and absent in controls. The findings confirm that apoptosis occurs in idiopathic inflammatory myopathies and support that it is mediated by CD8(+)cytotoxic T- cells, acting in parallel to the process of partial invasion.	[Danielsson, Olof; Haggqvist, Bo; Grontoft, Liv] Linkoping Univ, Fac Med & Hlth Sci, Dept Biomed & Clin Sci, Div Neurol, Linkoping, Sweden; [Ollinger, Karin] Linkoping Univ, Dept Biomed & Clin Sci, Div Expt Pathol, Linkoping, Sweden; [Ernerudh, Jan] Linkoping Univ, Dept Biomed & Clin Sci, Div Clin Immunol & Transfus Med, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Danielsson, O (corresponding author), Linkoping Univ, Fac Med & Hlth Sci, Dept Biomed & Clin Sci, Div Neurol, Linkoping, Sweden.	olof.danielsson@regionostergotland.se			Region Ostergotland [LIO-535621]	Region Ostergotland	OD received a finacial grant from Region Ostergotland. Grant no: LIO-535621. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	APPLEYARD ST, 1985, LANCET, V1, P361; ARAHATA K, 1988, ANN NEUROL, V23, P493, DOI 10.1002/ana.410230511; ARAHATA K, 1986, ANN NEUROL, V19, P112, DOI 10.1002/ana.410190203; ARAHATA K, 1988, ANN NEUROL, V23, P168, DOI 10.1002/ana.410230210; ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; Ashton-Rickardt PG, 2005, CRIT REV IMMUNOL, V25, P161, DOI 10.1615/CritRevImmunol.v25.i3.10; Behrens L, 1997, BRAIN, V120, P929, DOI 10.1093/brain/120.6.929; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Chahin N, 2008, NEUROLOGY, V70, P418, DOI 10.1212/01.wnl.0000277527.69388.fe; Cherin P, 1996, J RHEUMATOL, V23, P1135; Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225; Dalakas MC, 2003, LANCET, V362, P971, DOI 10.1016/S0140-6736(03)14368-1; Danielsson O, 2013, J RHEUMATOL, V40, P1173, DOI 10.3899/jrheum.120804; Danielsson O, 2009, NEUROMUSCULAR DISORD, V19, P412, DOI 10.1016/j.nmd.2009.03.008; De Bleecker JL, 2015, NEUROMUSCULAR DISORD, V25, P268, DOI 10.1016/j.nmd.2014.12.001; De Bleecker JL, 2013, NEUROMUSCULAR DISORD, V23, P945, DOI 10.1016/j.nmd.2013.07.007; De Bleecker JL, 2001, ACTA NEUROPATHOL, V101, P572; De Paepe B, 2012, NEUROMUSCULAR DISORD, V22, P26, DOI 10.1016/j.nmd.2011.07.007; De Paepe B, 2009, ANN NY ACAD SCI, V1173, P463, DOI 10.1111/j.1749-6632.2009.04812.x; Dorph C, 2006, ANN RHEUM DIS, V65, P1565, DOI 10.1136/ard.2005.051086; Dubowitz VS C., 2013, MUSCLE BIOPSY; Edston E, 2002, INT J LEGAL MED, V116, P22, DOI 10.1007/s004140100254; ENGEL AG, 1982, ANN NEUROL, V12, P289, DOI 10.1002/ana.410120314; Fyhr IM, 1998, ANN NEUROL, V43, P127, DOI 10.1002/ana.410430123; Gao XJ, 2015, CELL STRESS CHAPERON, V20, P653, DOI 10.1007/s12192-015-0589-9; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Greenberg SA, 2007, MUSCLE NERVE, V35, P17, DOI 10.1002/mus.20649; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hutchinson DO, 1998, NEUROLOGY, V51, P1742, DOI 10.1212/WNL.51.6.1742; Ibi T, 1995, Rinsho Shinkeigaku, V35, P1163; Ibi T, 1996, Rinsho Shinkeigaku, V36, P735; Inukai A, 1997, MUSCLE NERVE, V20, P702; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Massimino ML, 1997, BIOCHEM BIOPH RES CO, V235, P754, DOI 10.1006/bbrc.1997.6823; Nagaraju K, 2000, J IMMUNOL, V164, P5459, DOI 10.4049/jimmunol.164.10.5459; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Olive M, 1997, MUSCLE NERVE, V20, P1328, DOI 10.1002/(SICI)1097-4598(199710)20:10<1328::AID-MUS20>3.0.CO;2-Y; ORIMO S, 1994, NEUROMUSCULAR DISORD, V4, P219, DOI 10.1016/0960-8966(94)90022-1; Park SY, 2014, INT J MOL MED, V33, P1110, DOI 10.3892/ijmm.2014.1675; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Peng QL, 2015, J RHEUMATOL, V42, P979, DOI 10.3899/jrheum.141307; Philippidis P, 2004, CIRC RES, V94, P119, DOI 10.1161/01.RES.0000109414.78907.F9; Rayavarapu S, 2012, CURR RHEUMATOL REP, V14, P238, DOI 10.1007/s11926-012-0247-5; Rostasy K M, 2008, Acta Myol, V27, P49; Schmidt J, 2004, BRAIN, V127, P1182, DOI 10.1093/brain/awh148; Schneider C, 1996, J NEUROPATH EXP NEUR, V55, P1205, DOI 10.1097/00005072-199612000-00003; SHI LF, 1992, J EXP MED, V175, P553, DOI 10.1084/jem.175.2.553; Sugiura T, 1999, ARTHRITIS RHEUM, V42, P291, DOI 10.1002/1529-0131(199902)42:2<291::AID-ANR11>3.0.CO;2-1; Sutton VR, 1997, J IMMUNOL, V158, P5783; Tews DS, 1998, CLIN IMMUNOL IMMUNOP, V87, P240, DOI 10.1006/clin.1998.4527; Tews DS, 2005, MUSCLE NERVE, V32, P443, DOI 10.1002/mus.20348; TIAN QS, 1991, CELL, V67, P629, DOI 10.1016/0092-8674(91)90536-8; Uruha A, 2019, NEUROPATH APPL NEURO, V45, P513, DOI 10.1111/nan.12519; Vattemi G, 2000, J NEUROIMMUNOL, V111, P146, DOI 10.1016/S0165-5728(00)00381-7; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Wensink AC, 2015, J IMMUNOL, V194, P491, DOI 10.4049/jimmunol.1401214; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	64	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0239176	10.1371/journal.pone.0239176	http://dx.doi.org/10.1371/journal.pone.0239176			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936839	Green Published, gold			2022-12-26	WOS:000573658000023
J	Larkin, AA; Moreno, AR; Fagan, AJ; Fowlds, A; Ruiz, A; Martiny, AC				Larkin, Alyse A.; Moreno, Allison R.; Fagan, Adam J.; Fowlds, Alyssa; Ruiz, Alani; Martiny, Adam C.			Persistent El Nino driven shifts in marine cyanobacteria populations	PLOS ONE			English	Article							ALTERNATIVE STABLE STATES; PROCHLOROCOCCUS ECOTYPES; WATER COLUMN; INTERANNUAL VARIABILITY; BIOLOGICAL PUMP; BACTERIAL; COMMUNITY; ATLANTIC; SYNECHOCOCCUS; DISTRIBUTIONS	In the California Current Ecosystem, El Nino acts as a natural phenomenon that is partially representative of climate change impacts on marine bacteria at timescales relevant to microbial communities. Between 2014-2016, the North Pacific warm anomaly (a.k.a., the "blob") and an El Nino event resulted in prolonged ocean warming in the Southern California Bight (SCB). To determine whether this "marine heatwave" resulted in shifts in microbial populations, we sequenced therpoC1 gene from the biogeochemically important picocyanobacteriaProchlorococcusandSynechococcusat 434 time points from 2009-2018 in the MICRO time series at Newport Beach, CA. Across the time series, we observed an increase in the abundance ofProchlorococcusrelative toSynechococcusas well as elevated frequencies of ecotypes commonly associated with low-nutrient and high-temperature conditions. The relationships between environmental and ecotype trends appeared to operate on differing temporal scales. In contrast to ecotype trends, most microdiverse populations were static and possibly reflect local habitat conditions. The only exceptions were microdiversity fromProchlorococcousHLI andSynechococcusClade II that shifted in response to the 2015 El Nino event. Overall,ProchlorococcusandSynechococcuspopulations did not return to their pre-heatwave composition by the end of this study. This research demonstrates that extended warming in the SCB can result in persistent changes in key microbial populations.	[Larkin, Alyse A.; Fagan, Adam J.; Fowlds, Alyssa; Ruiz, Alani; Martiny, Adam C.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; [Moreno, Allison R.; Martiny, Adam C.] Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Martiny, AC (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.; Martiny, AC (corresponding author), Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92697 USA.	amartiny@uci.edu		Larkin, Alyse/0000-0003-4466-0791	UCI Undergraduate Research Opportunities Program; NSF Graduate Research Fellowship Program; UCI Chancellor's Club Fellowship; NSF Biological Oceanography [OCE-1848576, OCE-1948842]	UCI Undergraduate Research Opportunities Program; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); UCI Chancellor's Club Fellowship; NSF Biological Oceanography(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support for this work was provided by the UCI Undergraduate Research Opportunities Program (to AJF and AF), NSF Graduate Research Fellowship Program and UCI Chancellor's Club Fellowship (to ARM), and NSF Biological Oceanography (OCE-1848576 and OCE-1948842 to ACM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren NA, 2019, ENVIRON MICROBIOL, V21, P2948, DOI 10.1111/1462-2920.14687; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Amend AS, 2016, ISME J, V10, P109, DOI 10.1038/ismej.2015.96; [Anonymous], 2019, FRONTIERS PLANT SCI; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Blodau C, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000165; Bograd SJ, 2015, DEEP-SEA RES PT II, V112, P42, DOI 10.1016/j.dsr2.2014.04.009; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; BUSH T, 2017, NATURE COMMUNICATION, V8, P1; Cavicchioli R, 2019, NAT REV MICROBIOL, V17, P569, DOI 10.1038/s41579-019-0222-5; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Cram JA, 2015, ISME J, V9, P2573, DOI 10.1038/ismej.2015.76; Cram JA, 2015, ISME J, V9, P563, DOI 10.1038/ismej.2014.153; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Edwards M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057212; El-Swais H, 2015, ENVIRON MICROBIOL, V17, P3642, DOI 10.1111/1462-2920.12629; Fagan AJ, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00386; Ferris MJ, 1998, NATURE, V396, P226, DOI 10.1038/24297; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Fox J., 2018, R COMPANION APPL REG, VThird; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Hatosy SM, 2013, ECOLOGY, V94, P1898, DOI 10.1890/12-2125.1; Hennig C., 2018, FPC FLEXIBLE PROCEDU; Hewson I, 2007, DEEP-SEA RES PT I, V54, P811, DOI 10.1016/j.dsr.2007.02.003; Jacox MG, 2016, GEOPHYS RES LETT, V43, P7072, DOI 10.1002/2016GL069716; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Jones SE, 2008, LIMNOL OCEANOGR, V53, P1319, DOI 10.4319/lo.2008.53.4.1319; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Kelly TB, 2018, DEEP-SEA RES PT I, V140, P14, DOI 10.1016/j.dsr.2018.08.007; Kent AG, 2019, ISME J, V13, P430, DOI 10.1038/s41396-018-0287-6; Larkin AA, 2020, LIMNOL OCEANOGR, V65, pS220, DOI 10.1002/lno.11251; Larkin AA, 2016, ISME J, V10, P1555, DOI 10.1038/ismej.2015.244; Lilly LE, 2018, DEEP-SEA RES PT I, V140, P36, DOI 10.1016/j.dsr.2018.07.015; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Martiny AC, 2016, LIMNOL OCEANOGR, V61, P531, DOI 10.1002/lno.10233; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; McMahon KW, 2015, SCIENCE, V350, P1530, DOI 10.1126/science.aaa9942; Meinvielle M, 2013, J GEOPHYS RES-OCEANS, V118, P6687, DOI 10.1002/2013JC009299; Moore JK, 2013, J CLIMATE, V26, P9291, DOI 10.1175/JCLI-D-12-00566.1; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Morrow RM, 2018, DEEP-SEA RES PT I, V140, P52, DOI 10.1016/j.dsr.2018.07.012; Nagarkar M, 2018, ISME J, V12, P2278, DOI 10.1038/s41396-018-0172-3; Needham DM, 2013, ISME J, V7, P1274, DOI 10.1038/ismej.2013.19; Ohman MD, 2018, DEEP-SEA RES PT I, V140, P1, DOI 10.1016/j.dsr.2018.08.011; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; R Core TeamTeam, 2019, R LANG ENV STAT COMP; Rusch Douglas B, 2010, Proc Natl Acad Sci U S A, V107, P16184, DOI 10.1073/pnas.1009513107; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Shade A, 2012, ISME J, V6, P2153, DOI 10.1038/ismej.2012.56; Stark C, 2007, APPL SOIL ECOL, V35, P79, DOI 10.1016/j.apsoil.2006.05.001; Tai V, 2011, MAR ECOL PROG SER, V426, P133, DOI 10.3354/meps09030; Tai V, 2009, ISME J, V3, P903, DOI 10.1038/ismej.2009.35; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; von Scheibner M, 2014, ENVIRON MICROBIOL, V16, P718, DOI 10.1111/1462-2920.12195; Wang X, 2014, GLOBAL CHANGE BIOL, V20, P3229, DOI 10.1111/gcb.12620; Ward CS, 2017, ISME J, V11, P1412, DOI 10.1038/ismej.2017.4; West NJ, 1999, APPL ENVIRON MICROB, V65, P2585; Zinser ER, 2007, LIMNOL OCEANOGR, V52, P2205, DOI 10.4319/lo.2007.52.5.2205; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	71	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238405	10.1371/journal.pone.0238405	http://dx.doi.org/10.1371/journal.pone.0238405			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936809	gold, Green Published			2022-12-26	WOS:000573658000028
J	Vaporova, E; Zmyj, N				Vaporova, Elena; Zmyj, Norbert			Social evaluation and imitation of prosocial and antisocial agents in infants, children, and adults	PLOS ONE			English	Article							DEVELOPMENTAL-CHANGES; DEFERRED IMITATION; PREVERBAL INFANTS; TELEVISION; PREFERENCES; INTENTIONS; EXCLUSION; FAIL	The question of whether infants prefer prosocial agents over antisocial agents is contentious. Therefore, the first goal of the present study was to replicate previous findings regarding infants' preference. The second goal was to assess whether infants are more likely to imitate a prosocial agent than an antisocial agent. We tested 9-month-old, 14-month-old, and 4-year-old children. The study used the "opening a box to get a toy" paradigm in which an animal puppet is trying unsuccessfully to open a box and is either helped by a prosocial puppet or hindered by an antisocial puppet. We presented these social events via video, and subsequently administered an imitation task. As an additional control, adults were asked to describe the videos showing the prosocial and antisocial agent. Although most adults were able to identify both agents, the three age groups of children did not prefer the prosocial agent over the antisocial agent, and were not more likely to imitate the prosocial agent. The lack of differences might be explained by methodological issues or by a lack of robustness of the effect.	[Vaporova, Elena; Zmyj, Norbert] TU Dortmund Univ, Inst Psychol, Dortmund, Germany	Dortmund University of Technology	Zmyj, N (corresponding author), TU Dortmund Univ, Inst Psychol, Dortmund, Germany.	norbert.zmyj@tu-dortmund.de		Vaporova, Elena/0000-0002-4441-4825	Deutsche Forschungsgemeinschaft; TU Dortmund University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TU Dortmund University	We acknowledge financial support from the Deutsche Forschungsgemeinschaft and TU Dortmund University within the funding programme Open Access Publishing (https://www.ub.tu-dortmund.de/open-access/index.html.en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks to Raphaela Wehlig for preparing the stimuli and her help in the data acquisition and the coding of Experiment 1. Thanks to Johanna Schweer for her help in the data acquisition and the coding of Experiment 2 and 3.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Anderson DR, 2005, AM BEHAV SCI, V48, P505, DOI 10.1177/0002764204271506; Bandura A., 1971, SOCIAL LEARNING THEO; Barr R, 1996, INFANT BEHAV DEV, V19, P159, DOI 10.1016/S0163-6383(96)90015-6; Barr R, 2007, DEVELOPMENTAL SCI, V10, P910, DOI 10.1111/j.1467-7687.2007.00641.x; Barr R, 2007, DEV PSYCHOBIOL, V49, P196, DOI 10.1002/dev.20208; Behne T, 2005, DEV PSYCHOL, V41, P328, DOI 10.1037/0012-1649.41.2.328; BISCHOFKOHLER D, 1988, SCHWEIZ Z PSYCHOL, V47, P147; Brugger A, 2007, CHILD DEV, V78, P806, DOI 10.1111/j.1467-8624.2007.01034.x; Buon M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088612; Chae JJK, 2018, BRIT J DEV PSYCHOL, V36, P620, DOI 10.1111/bjdp.12246; Chen ML, 2013, DEV PSYCHOL, V49, P426, DOI 10.1037/a0029486; Cowell JM, 2015, P NATL ACAD SCI USA, V112, P12657, DOI 10.1073/pnas.1508832112; Fawcett C, 2012, INFANT CHILD DEV, V21, P239, DOI 10.1002/icd.739; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; Hamlin JK, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01563; Hamlin JK, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00614; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2013, COGNITION, V128, P451, DOI 10.1016/j.cognition.2013.04.004; Hamlin JK, 2013, CURR DIR PSYCHOL SCI, V22, P186, DOI 10.1177/0963721412470687; Hamlin JK, 2013, PSYCHOL SCI, V24, P589, DOI 10.1177/0956797612457785; Hamlin JK, 2012, COGNITIVE DEV, V27, P227, DOI 10.1016/j.cogdev.2012.05.005; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Hayne H, 2003, DEVELOPMENTAL SCI, V6, P254, DOI 10.1111/1467-7687.00281; Hinojosa T, 2003, DEV PSYCHOBIOL, V43, P328, DOI 10.1002/dev.10142; Hinten AE, 2018, INFANT CHILD DEV, V27, DOI 10.1002/icd.2093; Holvoet C, 2019, EARLY CHILD DEV CARE, V189, P1018, DOI 10.1080/03004430.2017.1361415; Holvoet C, 2018, SAGE OPEN, V8, DOI 10.1177/2158244018784993; Kanakogi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065292; Killen M, 2001, DEV PSYCHOL, V37, P587, DOI 10.1037/0012-1649.37.5.587; Lucca K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192848; Margoni F, 2018, DEV PSYCHOL, V54, P1445, DOI 10.1037/dev0000538; Maxwell L., P BCCD15 BUD CEU C C, P143; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Ml A, 2010, CURR GENOM, V11, P7; Nam KW, 2005, ARCH PHARM RES, V28, P675, DOI 10.1007/BF02969357; NUNNERWINKLER G, 1988, CHILD DEV, V59, P1323, DOI 10.2307/1130495; Over H, 2013, CHILD DEV PERSPECT, V7, P6, DOI 10.1111/cdep.12006; Paulus M, 2014, DEV PSYCHOL, V50, P914, DOI 10.1037/a0034169; RAMSAY DS, 1980, INFANT BEHAV DEV, V3, P377, DOI 10.1016/S0163-6383(80)80045-2; Sakkalou E, 2012, COGNITIVE DEV, V27, P1, DOI 10.1016/j.cogdev.2011.08.003; Salvadori E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140570; Scarf D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042698; Scola C, 2015, INFANCY, V20, P684, DOI 10.1111/infa.12095; Shimizu Y, 2018, INFANCY, V23, P748, DOI 10.1111/infa.12240; SMETANA JG, 1990, MERRILL PALMER QUART, V36, P329; SMETANA JG, 1993, CHILD DEV, V64, P202, DOI 10.2307/1131446; Smetana JG, 2012, CHILD DEV, V83, P683, DOI 10.1111/j.1467-8624.2011.01714.x; Steckler CM, 2017, COGNITION, V167, P255, DOI 10.1016/j.cognition.2017.03.018; Tasimi A, 2016, COGNITION, V151, P76, DOI 10.1016/j.cognition.2016.03.004; Theimer CE, 2001, DEV PSYCHOL, V37, P18, DOI 10.1037/0012-1649.37.1.18; Van de Vondervoort JW, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01851; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Wilks M, 2019, J EXP CHILD PSYCHOL, V185, P164, DOI 10.1016/j.jecp.2019.04.018; Woo BM, 2017, COGNITION, V168, P154, DOI 10.1016/j.cognition.2017.06.029; Wood LA, 2013, DEV REV, V33, P341, DOI 10.1016/j.dr.2013.08.002; Zmyj N, 2013, INFANT CHILD DEV, V22, P622, DOI 10.1002/icd.1811; Zmyj N, 2010, J EXP CHILD PSYCHOL, V106, P208, DOI 10.1016/j.jecp.2010.03.002	61	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0235595	10.1371/journal.pone.0235595	http://dx.doi.org/10.1371/journal.pone.0235595			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936791	gold, Green Published			2022-12-26	WOS:000573658000032
J	Hildyard, JCW; Rawson, F; Wells, DJ; Piercy, RJ				Hildyard, John C. W.; Rawson, Faye; Wells, Dominic J.; Piercy, Richard J.			Multiplex in situ hybridization within a single transcript: RNAscope reveals dystrophin mRNA dynamics	PLOS ONE			English	Article							MUSCULAR-DYSTROPHY; POSITIVE FIBERS; MOUSE MUSCLE; MDX MOUSE; DUCHENNE; GENE; EXPRESSION; ASSOCIATION; PRODUCT; MODEL	Dystrophin plays a vital role in maintaining muscle health, yet low mRNA expression, lengthy transcription time and the limitations of traditionalin-situhybridization (ISH) methodologies mean that the dynamics of dystrophin transcription remain poorly understood. RNAscope is highly sensitive ISH method that can be multiplexed, allowing detection of individual transcript molecules at sub-cellular resolution, with different target mRNAs assigned to distinct fluorophores. We instead multiplex within a single transcript, using probes targeted to the 5' and 3' regions of muscle dystrophin mRNA. Our approach shows this method can reveal transcriptional dynamics in health and disease, resolving both nascent myonuclear transcripts and exported mature mRNAs in quantitative fashion (with the latter absent in dystrophic muscle, yet restored following therapeutic intervention). We show that even in healthy muscle, immature dystrophin mRNA predominates (60-80% of total), with the surprising implication that the half-life of a mature transcript is markedly shorter than the time invested in transcription: at the transcript level, supply may exceed demand. Our findings provide unique spatiotemporal insight into the behaviour of this long transcript (with implications for therapeutic approaches), and further suggest this modified multiplex ISH approach is well-suited to long genes, offering a highly tractable means to reveal complex transcriptional dynamics.	[Hildyard, John C. W.; Rawson, Faye; Piercy, Richard J.] Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, London, England; [Wells, Dominic J.] Royal Vet Coll, Dept Comparat Biomed Sci, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Hildyard, JCW (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, Comparat Neuromuscular Dis Lab, London, England.	jhildyard@rvc.ac.uk	Hildyard, John/AAB-2260-2021	Hildyard, John/0000-0003-2283-2118	Wellcome Trust [101550]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust [Grant number 101550], awarded to RJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACDbio, RNASCOPE REF GUIDE20; Amoasii L, 2018, SCIENCE, V362, P86, DOI 10.1126/science.aau1549; Amoasii L, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8081; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2013, ENCY BIOPHYSICS; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; Bevilacqua PC, 2016, ANNU REV GENET, V50, P235, DOI 10.1146/annurev-genet-120215-035034; BRENMAN JE, 1995, CELL, V82, P743, DOI 10.1016/0092-8674(95)90471-9; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CHAMBERLAIN JS, 1988, SCIENCE, V239, P1416, DOI 10.1126/science.3347839; Chen H, 2012, P NATL ACAD SCI USA, V109, P799, DOI 10.1073/pnas.1119057109; Chi QJ, 2013, PHYSICA A, V392, P1072, DOI 10.1016/j.physa.2012.09.022; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; de Leon MB, 2005, J BIOL CHEM, V280, P5290, DOI 10.1074/jbc.M411571200; DSOUZA VN, 1995, HUM MOL GENET, V4, P837, DOI 10.1093/hmg/4.5.837; FANIN M, 1995, MUSCLE NERVE, V18, P1115, DOI 10.1002/mus.880181007; FANIN M, 1992, NEUROMUSCULAR DISORD, V2, P41, DOI 10.1016/0960-8966(92)90025-2; Garcia HG, 2013, CURR BIOL, V23, P2140, DOI 10.1016/j.cub.2013.08.054; Gazzoli I, 2016, RNA BIOL, V13, P290, DOI 10.1080/15476286.2015.1125074; Godfrey C, 2015, HUM MOL GENET, V24, P4225, DOI 10.1093/hmg/ddv155; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; Heintzmann Rainer, 2006, Briefings in Functional Genomics & Proteomics, V5, P289, DOI 10.1093/bfgp/ell036; Hildyard JCW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211384; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86; Ingham Patricia Clare, 1996, ARTHURIANA, V6, P25; JEDWAB MR, 1993, J APPL BIOMATER, V4, P77, DOI 10.1002/jab.770040111; Kawaguchi T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061546; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; Lai WJC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06792-z; Li W, 2018, MOV DISORD CLIN PRAC, V5, P177, DOI 10.1002/mdc3.12599; LIDOV HGW, 1995, HUM MOL GENET, V4, P329, DOI 10.1093/hmg/4.3.329; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; MANDEL JL, 1989, NATURE, V339, P584, DOI 10.1038/339584a0; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mashhadi S., 2012, INT J NETWORK SECURI, V14, P22; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Mitsui T, 1997, J NEUROPATH EXP NEUR, V56, P94, DOI 10.1097/00005072-199701000-00010; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; MUNTONI F, 1989, FEBS LETT, V252, P95, DOI 10.1016/0014-5793(89)80896-8; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Newlands S, 1998, GENE DEV, V12, P2748, DOI 10.1101/gad.12.17.2748; Nicolas D, 2017, MOL BIOSYST, V13, P1280, DOI 10.1039/c7mb00154a; PEARSON J, 1974, STAIN TECHNOL, V49, P143, DOI 10.3109/10520297409116965; Petkova MV, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0095-5; Pigozzo SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072147; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; SCOTT MO, 1988, SCIENCE, V239, P1418, DOI 10.1126/science.2450401; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Siebrasse JP, 2012, P NATL ACAD SCI USA, V109, P9426, DOI 10.1073/pnas.1201781109; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Smith KP, 1999, J CELL BIOL, V144, P617, DOI 10.1083/jcb.144.4.617; Snedecor G W, 1989, STAT METHODS; SPENCER CA, 1990, ONCOGENE, V5, P777; Stark AE, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.10.45; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; Tennyson CN, 1996, NUCLEIC ACIDS RES, V24, P3059, DOI 10.1093/nar/24.15.3059; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; Verhaart IEC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.1; Wilton SD, 1997, MUSCLE NERVE, V20, P728; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; Yiu EM, 2015, J PAEDIATR CHILD H, V51, P759, DOI 10.1111/jpc.12868; Yoffe AM, 2008, P NATL ACAD SCI USA, V105, P16153, DOI 10.1073/pnas.0808089105	70	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239467	10.1371/journal.pone.0239467	http://dx.doi.org/10.1371/journal.pone.0239467			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970731	gold, Green Submitted, Green Published			2022-12-26	WOS:000576265600084
J	Vendramini, THA; Macedo, HT; Amaral, AR; Rentas, MF; Macegoza, MV; Zafalon, RVA; Pedrinelli, V; Mesquita, LG; Balieiro, JCD; Pfrimer, K; Pedreira, RS; Nowosh, V; Pontieri, CFF; Massoco, CD; Brunetto, MA				Annibale Vendramini, Thiago Henrique; Macedo, Henrique Tobaro; Amaral, Andressa Rodrigues; Rentas, Mariana Fragoso; Macegoza, Matheus Vinicius; Amorim Zafalon, Rafael Vessecchi; Pedrinelli, Vivian; Mesquita, Ligia Garcia; de Carvalho Balieiro, Julio Cesar; Pfrimer, Karina; Pedreira, Raquel Silveira; Nowosh, Victor; Ferreira Pontieri, Cristiana Fonseca; Massoco, Cristina de Oliveira; Brunetto, Marcio Antonio			Gene expression of the immunoinflammatory and immunological status of obese dogs before and after weight loss	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; LIMITED FOOD-CONSUMPTION; BODY CONDITION SCORE; C-REACTIVE PROTEIN; ADIPOSE-TISSUE; METABOLICALLY HEALTHY; VETERINARY PRACTICES; INSULIN-RESISTANCE; CANINE OBESITY; ADIPONECTIN CONCENTRATIONS	Obesity is characterized by a low degree of chronic inflammation state that, along with metabolic modifications, promotes important changes in the animal's organism. Adipose tissue actively participates in inflammation and immunity, and several defense cells of the organism may, therefore, be involved in the diversity found between obese and ideal weight individuals. Studies regarding this subject have shown immune cell changes in humans and rats, however, the literature is scarce in relation to dogs. Thus, the present study aimed to evaluate the gene expression profile of immunoinflammatory response and the lymphoproliferation of obese dogs before and after weight loss. Eight female dogs, neutered, of different breeds, aged between 1 and 8 years (4.74 +/- 3.19), obese, with body condition score (BCS) of 9 out of a 9-point scale and body composition determined by the deuterium isotope dilution method were included. The obese dogs were enrolled in a weight loss program and after losing 20% of their initial weight became a second experimental group. A third experimental group consisted of eight female dogs, neutered, aged between 1 and 8 years (3.11 +/- 0.78) and with ideal BCS (5 out of a 9-point scale). Gene expression of immunoinflammatory cytokines (resistin, leptin, adiponectin, TNF-alpha, IL-6, IL-8, and IL-10) was assessed by qRT-PCR and immunity was assessed by lymphoproliferative response using the flow cytometry technique. The data that presented normal distribution was evaluated by analysis of variance by the PROC MIXED of the SAS and when differences were detected, these were compared by the Tukey test. Regarding the gene expression data, the procedure PROC GLIMMIX was adopted and the methodology of generalized linear model was used, in which the Gama distribution proved to be adequate. Values of p<0.05 were considered significant. The mean weight loss period of the animals included in the study was 194.25 +/- 28.31 days and the mean weekly weight loss rate was 1.02 +/- 0.82%. The average fat mass, both in percentage (P<0.001) and in kilograms (P = 0.012), was higher in the obese group (40.88%; 8.91kg), returning to normal and without difference between the control group (19.16%; 3.01kg) and after weight loss (22.10%; 4.11kg). The weight loss program resulted in an increase in percentage of lean body mass (P = 0.001), 55.50% in obese animals vs 77.90% in obese dogs after weight loss, the latter with no difference when compared to the control group (80.84%). The obese group presented increased gene expression of resistin and IL-8 in relation to the weight loss group (P = 0.002). In adiponectin, the obese group presented increased mRNA gene expression when compared to the weight loss group (P = 0.003). The evaluation of lymphocyte proliferation showed differences between the group of obese animals before and after weight loss (P = 0.004). Weight loss resulted in an increase in the lymphoproliferation rate (18.48%) compared to obese dogs at the beginning of the study (10.71%). These results indicate that weight loss modulates the immunoinflammatory response of obese dogs and may present important benefits to health and longevity of dogs.	[Annibale Vendramini, Thiago Henrique; Macedo, Henrique Tobaro; Rentas, Mariana Fragoso; Macegoza, Matheus Vinicius; Amorim Zafalon, Rafael Vessecchi; Mesquita, Ligia Garcia; de Carvalho Balieiro, Julio Cesar; Brunetto, Marcio Antonio] Univ Sao Paulo, Pet Nutrol Res Ctr, Sch Vet Med & Anim Sci, Nutr & Prod Dept, Pirassununga, SP, Brazil; [Amaral, Andressa Rodrigues; Pedrinelli, Vivian; Brunetto, Marcio Antonio] Univ Sao Paulo, Teaching Vet Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, SP, Brazil; [Pfrimer, Karina] Univ Sao Paulo, Med Sch Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Pedreira, Raquel Silveira; Ferreira Pontieri, Cristiana Fonseca] Grandfood Ind & Comercio, Dourado, SP, Brazil; [Nowosh, Victor; Massoco, Cristina de Oliveira] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Brunetto, MA (corresponding author), Univ Sao Paulo, Pet Nutrol Res Ctr, Sch Vet Med & Anim Sci, Nutr & Prod Dept, Pirassununga, SP, Brazil.; Brunetto, MA (corresponding author), Univ Sao Paulo, Teaching Vet Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, SP, Brazil.	mabrunetto@usp.br	Balieiro, Julio/D-8647-2012; Pedrinelli, Vivian/AFG-3190-2022; Brunetto, Marcio/AAQ-9767-2021; Pedrinelli, Vivian/AAF-1350-2022; Pedrinelli, Vivian/AAH-4103-2019	Balieiro, Julio/0000-0003-0540-1850; Pedrinelli, Vivian/0000-0001-5954-4086; Pedrinelli, Vivian/0000-0001-5954-4086; Rodrigues Amaral, Andressa/0000-0002-3852-0525; Vendramini, Thiago/0000-0003-4457-8392				Aguilar-Salinas CA, 2008, J CLIN ENDOCR METAB, V93, P4075, DOI 10.1210/jc.2007-2724; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Montoya-Alonso JA, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00059; [Anonymous], 1985, ANN INTERN MED, V103, P1073, DOI 10.7326/0003-4819-103-6-1073; [Anonymous], 2008, IEEE CONTROL SYSTEMS, V28, P26; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Balistreri CR, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/802078; Barreto Villela N., 2004, Nutr. Hosp., V19, P367; Bastien BC, 2015, VET IMMUNOL IMMUNOP, V163, P174, DOI 10.1016/j.vetimm.2014.12.003; Beavers KM, 2010, CLIN CHIM ACTA, V411, P785, DOI 10.1016/j.cca.2010.02.069; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bergman RN, 2006, OBESITY, V14, p16S, DOI 10.1038/oby.2006.277; Bjornvad CR, 2014, DOMEST ANIM ENDOCRIN, V47, P55, DOI 10.1016/j.domaniend.2013.11.006; Brown DC, 1996, VET COMP ORTHOPAED, V9, P75; Brunetto MA., 2010, THESIS; Brunetto MA, 2011, BRIT J NUTR, V106, pS194, DOI 10.1017/S0007114511000870; Brunetto MA, 2011, CIENC RURAL, V41, P266, DOI 10.1590/S0103-84782011005000004; Carciofi AC, 2008, J ANIM PHYSIOL AN N, V92, P326, DOI 10.1111/j.1439-0396.2007.00794.x; Carciofi Aulus Cavalieri, 2005, Cienc. Rural, V35, P1331, DOI 10.1590/S0103-84782005000600016; Carpagnano GE, 2010, TRANSL RES, V155, P35, DOI 10.1016/j.trsl.2009.09.004; CHIKAMUNE T, 1995, J VET MED SCI, V57, P595, DOI 10.1292/jvms.57.595; Christiansen T, 2005, INT J OBESITY, V29, P146, DOI 10.1038/sj.ijo.0802839; Ciortea R, 2014, ANTICANCER RES, V34, P379; Coradini M, 2013, DOMEST ANIM ENDOCRIN, V45, P79, DOI 10.1016/j.domaniend.2013.06.001; Costa Joana V, 2006, Acta Med Port, V19, P251; CRANE SW, 1991, J SMALL ANIM PRACT, V32, P275, DOI 10.1111/j.1748-5827.1991.tb00930.x; Dalmas E, 2014, DIABETES, V63, P1966, DOI 10.2337/db13-1511; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; De Rosa V, 2015, SEMIN IMMUNOL, V27, P300, DOI 10.1016/j.smim.2015.10.001; Devito F. C., 2015, Clinica Veterinaria, V20, P42; Doumatey AP, 2012, J ENDOCRINOL METAB, V2, P51, DOI 10.4021/jem95w; EDNEY ATB, 1986, VET REC, V118, P391, DOI 10.1136/vr.118.14.391; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; FEDIAF, 2019, NUTR GUID COMPL COMP; Ferrier L, 2002, J NUTR, V132, p1725S, DOI 10.1093/jn/132.6.1725S; Fonseca-Alaniz Miriam H., 2006, Arq Bras Endocrinol Metab, V50, P216, DOI 10.1590/S0004-27302006000200008; Frank L, 2015, VET IMMUNOL IMMUNOP, V167, P104, DOI 10.1016/j.vetimm.2015.07.010; Gayet C, 2004, J ANIM PHYSIOL AN N, V88, P157, DOI 10.1111/j.1439-0396.2003.00473.x; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; German AJ, 2010, VET J, V185, P4, DOI 10.1016/j.tvjl.2010.04.004; Gossellin J, 2007, J VET PHARMACOL THER, V30, P1, DOI 10.1111/j.1365-2885.2007.00863.x; Greeley EH, 2006, VET IMMUNOL IMMUNOP, V111, P287, DOI 10.1016/j.vetimm.2006.02.002; HENDRICKS JC, 1992, VET CLIN N AM-SMALL, V22, P1145, DOI 10.1016/S0195-5616(92)50306-0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ishioka K, 2009, J VET MED SCI, V71, P189, DOI 10.1292/jvms.71.189; Jagannathan-Bogdan M, 2011, J IMMUNOL, V186, P1162, DOI 10.4049/jimmunol.1002615; Jeusette IC, 2005, RES VET SCI, V79, P169, DOI 10.1016/j.rvsc.2004.11.012; Jonke J, 2002, OBES RES, V10, P1; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1; Karelis AD, 2008, DIABETES METAB, V34, P183, DOI 10.1016/j.diabet.2007.11.004; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Kealy RD, 2000, J AM VET MED ASSOC, V217, P1678, DOI 10.2460/javma.2000.217.1678; Kealy RD, 1997, J AM VET MED ASSOC, V210, P222; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Laflamme D, 1997, CANINE PRACT, V22, P10; Laflamme DP, 2012, J ANIM SCI, V90, P1653, DOI 10.2527/jas.2011-4571; Laflamme DP, 1997, J AM ANIM HOSP ASSOC, V33, P253, DOI 10.5326/15473317-33-3-253; Lazar MA, 2006, NAT MED, V12, P43, DOI 10.1038/nm0106-43; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Mao JF, 2013, PREV VET MED, V112, P438, DOI 10.1016/j.prevetmed.2013.08.012; Matarese G, 2004, TRENDS IMMUNOL, V25, P193, DOI 10.1016/j.it.2004.02.009; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; McGreevy PD, 2005, VET REC, V156, P695, DOI 10.1136/vr.156.22.695; Michel KE, 2011, BRIT J NUTR, V106, pS57, DOI 10.1017/S000711451100050X; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Morrison JA, 2010, TRANSL RES, V156, P302, DOI 10.1016/j.trsl.2010.08.003; Muranaka S, 2011, RES VET SCI, V91, P358, DOI 10.1016/j.rvsc.2010.09.012; Nakamura K, 2014, J CARDIOL, V63, P250, DOI 10.1016/j.jjcc.2013.11.006; NATIONAL RESEARCH COUNCIL-NRC, 2006, NUTR REQUIREMENTS DO; Neto GBP, 2010, PESQUI VET BRASIL, V30, P167, DOI 10.1590/S0100-736X2010000200012; Nieman DC, 1999, J AM DIET ASSOC, V99, P294, DOI 10.1016/S0002-8223(99)00077-2; Nikolajczyk BS, 2012, IMMUNOL REV, V249, P253, DOI 10.1111/j.1600-065X.2012.01142.x; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; OMS, OB OV; Park HJ, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-113; Pereira-Neto GB, 2018, J ANIM PHYSIOL AN N, V102, P1743, DOI 10.1111/jpn.12963; Pereira-Neto GB, 2014, PESQUI VET BRASIL, V34, P87, DOI 10.1590/S0100-736X2014001300016; Piantedosi D, 2016, VET J, V216, P72, DOI 10.1016/j.tvjl.2016.07.002; Porsani MYH., 2019, THESIS; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Procaccini C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00332; Radin MJ, 2009, VET CLIN PATH, V38, P136, DOI 10.1111/j.1939-165X.2009.00133.x; Samartin S, 2001, NUTR RES, V21, P243, DOI 10.1016/S0271-5317(00)00255-4; Sathiyaseelan T, 2000, RES VET SCI, V69, P275, DOI 10.1053/rvsc.2000.0429; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tamura Y, 2014, J VET MED SCI, V76, P1407, DOI 10.1292/jvms.13-0635; Tizard I.R., 2013, VET IMMUNOLOGY INTRO; Trayhurn P, 2005, ENDOCRINOLOGY, V146, P1003, DOI 10.1210/en.2004-1597; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Tropf M, 2017, J VET INTERN MED, V31, P1000, DOI 10.1111/jvim.14775; Troseid M, 2004, EUR HEART J, V25, P349, DOI 10.1016/j.ehj.2003.12.006; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Tvarijonaviciute A, 2012, DOMEST ANIM ENDOCRIN, V42, P129, DOI 10.1016/j.domaniend.2011.10.003; Tvarijonaviciute A, 2012, VET J, V193, P570, DOI 10.1016/j.tvjl.2012.02.015; Usui S, 2016, ASIAN PAC J TROP BIO, V6, P338, DOI 10.1016/j.apjtb.2016.01.011; van Beek L, 2014, METABOLISM, V63, P492, DOI 10.1016/j.metabol.2013.12.002; Van de Velde H, 2013, VET IMMUNOL IMMUNOP, V152, P237, DOI [10.1016/j.vetimm.2012.12.01.1, 10.1016/j.vetimm.2012.12.011]; Van de Velde H, 2012, VET IMMUNOL IMMUNOP, V145, P431, DOI 10.1016/j.vetimm.2011.12.021; Vitger AD, 2017, DOMEST ANIM ENDOCRIN, V59, P58, DOI 10.1016/j.domaniend.2016.10.007; Wagner NM, 2013, OBESITY, V21, P461, DOI 10.1002/oby.20087; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Witzel AL, 2015, DOMEST ANIM ENDOCRIN, V53, P70, DOI 10.1016/j.domaniend.2015.05.001; Wood IS, 2005, HORM METAB RES, V37, P474, DOI [10.1055/s-870325, 10.1055/s-2005-870325]	107	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238638	10.1371/journal.pone.0238638	http://dx.doi.org/10.1371/journal.pone.0238638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966299	Green Published, gold			2022-12-26	WOS:000575688700007
J	Srivastava, U; Singh, KK; Yadav, PK				Srivastava, Ujjaval; Singh, Kaushalendra Kumar; Yadav, Pawan Kumar			Disaggregated analysis of birth averted due to family planning use in India: An evidence from NFHS-4 (2015-16)	PLOS ONE			English	Article								Background and objective India contributes a major share of global unintended births. It is established that contraception plays a significant role in preventing unintended pregnancies, maternal mortality and induced abortion. In this study, to analyze the effectiveness of our family welfare program, we tried to give district-level estimates of number of births averted due to contraception. Data and methods Data for this study came from the cross-sectional, population-based data from the fourth round of National Family Health Survey (NFHS-4) conducted in 2015-16. Here, we discussed two methods based on robust regression for computing number of births averted at district level. Further, we analyzed the percentage increase in births (PIB) that would be experienced by each district in the absence of contraception. Results Findings of this study clearly showed that there was a huge variation in the estimates of number of births averted among different districts as well as states of India. Out of 640 districts, 315 districts achieved below-replacement fertility and 365 districts have contraceptive prevalence rate (CPR) more than 50 percent. Method 1 found around 22 percent districts showed less than 15 percent reduction in births while Method 2 suggested nearly 14 percent districts predominantly located in Uttar Pradesh, Bihar, Jharkhand, Arunachal Pradesh, Meghalaya and Manipur exhibited less than 30 percent reduction of births due to use of all forms of contraception. At all India level, an average estimate obtained by two methods, nearly 63 million births would have been averted by the use of contraception or 40 percent more than the number of births occurred during that period. Conclusion The study successfully identified the districts that were not performing well at the front of utilization of various family planning methods for birth control. To achieve objectives of National Population Policy (2000), poor-performing districts must be monitored like the government keeps monitoring ofAspirational districts.	[Srivastava, Ujjaval; Singh, Kaushalendra Kumar] Banaras Hindu Univ, Dept Stat, Varanasi, Uttar Pradesh, India; [Srivastava, Ujjaval] Govt India, Natl Stat Syst Training Acad, Minist Stat & Programme Implementat, Pondicherry, India; [Yadav, Pawan Kumar] Int Inst Populat Sci, Mumbai, Maharashtra, India	Banaras Hindu University (BHU); International Institute for Population Sciences	Srivastava, U (corresponding author), Banaras Hindu Univ, Dept Stat, Varanasi, Uttar Pradesh, India.; Srivastava, U (corresponding author), Govt India, Natl Stat Syst Training Acad, Minist Stat & Programme Implementat, Pondicherry, India.	ujjavalsri777@gmail.com		Srivastava, Ujjaval/0000-0002-2541-4504; YADAV, PAWAN KUMAR/0000-0002-3567-8570				Addendum Manual UN, 1986, 9 METH MEA IMP FAM P; AGARWALA SN, 1960, LAW CONTEMP PROBL, V25, P577, DOI 10.2307/1190756; [Anonymous], **NON-TRADITIONAL**; [Anonymous], 2007, AGILENT TECHNOLOGIES, V1; [Anonymous], 2012, LD3320 NEW TECHNOLOG, V2, P47; Bhattacharya B N, 1984, Sankhya, V46, P320; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Collins John J., 2000, ENCY APOCALYPTICISM, V1, pvii; International Institute for Population Sciences, 2017, NAT FAM HLTH SURV NF; International Institute for Population Sciences, 1995, NAT FAM HLTH SURV NF; KEENY SM, 1968, STUD FAMILY PLANN, P1; KELLY WJ, 1971, STUD FAMILY PLANN, V2, P197, DOI 10.2307/1964905; Liu L, 2008, POP STUD-J DEMOG, V62, P191, DOI 10.1080/00324720801897796; Manual UN, 1979, 9 METH MES IMP FAM P; MAULDIN WP, 1968, STUD FAMILY PLANN, P1; NITI Aayog, 2018, ASP DISTR UNL POT; POTTER R G, 1970, Theoretical Population Biology, V1, P251, DOI 10.1016/0040-5809(70)90046-8; Potter RG, 1969, FERTILITY FAMILY PLA, P413; Rai PK, 2018, J DATA SCI, V647, P676; Schoumaker B, 2013, DEMOGR RES, V28, P1093, DOI 10.4054/DemRes.2013.28.38; United Nations Department of Economic and Social Affairs Population Division, 2019, POPDBCPREV2019; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248; VENKATACHARYA K, 1971, DEMOGRAPHY, V8, P491, DOI 10.2307/2060685; Venkatacharya K, 1972, SANKHYA INDIAN J S B, P297; WOLFERS D, 1969, POP STUD-J DEMOG, V23, P111, DOI 10.1080/00324728.1969.10406033	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239376	10.1371/journal.pone.0239376	http://dx.doi.org/10.1371/journal.pone.0239376			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NX4NF	32966322	Green Published, gold			2022-12-26	WOS:000575688700033
J	Kawano, S; Fujimoto, K; Yasuda, K; Ikeda, S				Kawano, Shinji; Fujimoto, Kunpei; Yasuda, Kazushi; Ikeda, Shogo			DNA binding activity of the proximal C-terminal domain of rat DNA topoisomerase II beta is involved in ICRF-193-induced closed-clamp formation	PLOS ONE			English	Article							STRUCTURAL BASIS; ALPHA; MECHANISM; EXPRESSION; DYNAMICS; ISOFORMS; LOCALIZATION; RECOGNITION; RELAXATION; CLEAVAGE	DNA topoisomerase II (topo II) is an essential enzyme that regulates DNA topology by DNA cleavage and re-ligation. In vertebrates, there are two isozymes, alpha and beta. The C-terminal domain (CTD) of the isozymes, which shows a low degree of sequence homology between alpha and beta, is involved in each isozyme-specific intracellular behavior. The CTD of topo II beta is supposedly involved in topo II regulation. Topo II beta is maintained in an inactive state in the nucleoli by the binding of RNA to the 50-residue region termed C-terminal regulatory domain (CRD) present in the CTD. Althoughin vitrobiochemical analysis indicates that the CTD of topo II beta has DNA binding activity, it is unclear whether CTD influences catalytic reaction in the nucleoplasm. Here, we show that the proximal CTD (hereafter referred to as pCTD) of rat topo II beta, including the CRD, is involved in the catalytic reaction in the nucleoplasm. We identified the pCTD as a domain with DNA binding activity byin vitrocatenation assay and electrophoretic mobility shift assay. Fluorescence recovery after photo-bleaching (FRAP) analysis of pCTD-lacking mutant (Delta pCTD) showed higher mobility in nucleoplasm than that of the wild-type enzyme, indicating that the pCTD also affected the nuclear dynamics of topo II beta. ICRF-193, one of the topo II catalytic inhibitors, induces the formation of closed-clamp intermediates of topo II. Treatment of Delta pCTD with ICRF-193 significantly decreased the efficiency of closed-clamp formation. Altogether, our data indicate that the binding of topo II beta to DNA through the pCTD is required for the catalytic reaction in the nucleoplasm.	[Kawano, Shinji; Fujimoto, Kunpei; Yasuda, Kazushi; Ikeda, Shogo] Okayama Univ Sci, Fac Sci, Dept Biochem, Okayama, Japan	Okayama University of Science	Kawano, S (corresponding author), Okayama Univ Sci, Fac Sci, Dept Biochem, Okayama, Japan.	kawanos@dbc.ous.ac.jp						Adachi N, 1997, NUCLEIC ACIDS RES, V25, P3135, DOI 10.1093/nar/25.15.3135; AUSTIN CA, 1990, FEBS LETT, V266, P115, DOI 10.1016/0014-5793(90)81520-X; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Chen SF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05406-y; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; Dickey JS, 2005, BIOCHEMISTRY-US, V44, P11546, DOI 10.1021/bi050811l; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Fortune JM, 2000, METH MOL B, V95, P275; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; JENKINS JR, 1992, NUCLEIC ACIDS RES, V20, P5587, DOI 10.1093/nar/20.21.5587; Jensen S, 1996, MOL CELL BIOL, V16, P3866; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kawano S, 2016, J BIOCHEM, V159, P363, DOI 10.1093/jb/mvv110; Koulouras G, 2018, NUCLEIC ACIDS RES, V46, pW467, DOI 10.1093/nar/gky508; Lane AB, 2013, J CELL BIOL, V203, P471, DOI 10.1083/jcb.201303045; Laponogov I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05005-x; Lee I, 2003, NUCLEIC ACIDS RES, V41, P5444; Lee S, 2012, P NATL ACAD SCI USA, V109, P2925, DOI 10.1073/pnas.1115704109; Linka RM, 2007, NUCLEIC ACIDS RES, V35, P3810, DOI 10.1093/nar/gkm102; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; Manville CM, 2015, BIOL OPEN, V4, P1436, DOI 10.1242/bio.014308; McClendon AK, 2008, BIOCHEMISTRY-US, V47, P13169, DOI 10.1021/bi800453h; Meczes EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001754; Mirski SEL, 1999, EXP CELL RES, V251, P329, DOI 10.1006/excr.1999.4587; Morotomi-Yano K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28690-6; Morris SK, 2000, J BIOL CHEM, V275, P2613, DOI 10.1074/jbc.275.4.2613; Oestergaard VH, 2004, J BIOL CHEM, V279, P28100, DOI 10.1074/jbc.M402119200; Onoda A, 2014, NUCLEIC ACIDS RES, V42, P9005, DOI 10.1093/nar/gku640; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Seol Y, 2013, J BIOL CHEM, V288, P13695, DOI 10.1074/jbc.M112.444745; SHIOZAKI K, 1992, J CELL BIOL, V119, P1023, DOI 10.1083/jcb.119.5.1023; Tiwari VK, 2012, P NATL ACAD SCI USA, V109, pE934, DOI 10.1073/pnas.1119798109; Tsutsui K, 2001, J BIOL CHEM, V276, P5769, DOI 10.1074/jbc.M008517200; TSUTSUI K, 1993, J BIOL CHEM, V268, P19076; Tsutsui K, 2001, J COMP NEUROL, V431, P228, DOI 10.1002/1096-9861(20010305)431:2<228::AID-CNE1067>3.0.CO;2-M; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Wendorff TJ, 2012, J MOL BIOL, V424, P109, DOI 10.1016/j.jmb.2012.07.014; WOESSNER RD, 1991, CELL GROWTH DIFFER, V2, P209; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239466	10.1371/journal.pone.0239466	http://dx.doi.org/10.1371/journal.pone.0239466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960919	Green Published, gold			2022-12-26	WOS:000575109500022
J	Kim, J; Kim, M; Yoon, JH				Kim, JungWan; Kim, Minyoung; Yoon, Ji Hye			The tip-of-the-tongue phenomenon in older adults with subjective memory complaints	PLOS ONE			English	Article							PEOPLES NAMES; IMPAIRMENT; DEMENTIA; YOUNG; EXPERIENCES; RETRIEVAL; SET	In older adults with subjective memory complaints (SMCs), featuring a decline in memory but not exhibiting problems during medical examinations and objective memory tests, the weak links between nodes evident in the word retrieval process can be a primary factor for predicting mild cognitive impairment and dementia. This study examined the frequency of the "Tip-of-the-Tongue" (ToT) phenomenon according to age and subjective memory complaints of older adults, and identified differences in the resolution method using sequential cues. A celebrity naming task was performed on older adults (aged 50 to 79) with SMCs (n = 30) and without SMCs (n = 30), comparing the frequency of the ToT phenomenon and in resolution methods. We found that, even if our subjects with SMCs obtained normal results in the objective neuropsychology test, they experienced a significantly higher frequency of the ToT phenomenon than those without SMCs. In addition, subjects with SMCs showed a significantly lower rate of resolution, both spontaneous and following a syllabic cue, compared to those without SMCs. SMCs can be a very early marker of degenerative diseases causing cognitive dysfunction, and thus the selection of appropriate tools for early detection of SMCs is important. The proper naming task may sensitively detect subclinical symptoms of SMCs in subjects who are not classified as patients with cognitive impairments on general neuropsychological test. In addition, this task can identify weak connections between semantic and phonological nodes due to changes in the neural region of older adults with SMCs.	[Kim, JungWan] Daegu Univ, Coll Rehabil Sci, Dept Speech & Language Pathol, Gyongsan, South Korea; [Kim, Minyoung] Lee Rehabil Clin, Div Speech Pathol, Incheon, South Korea; [Yoon, Ji Hye] Hallym Univ, Coll Nat Sci, Div Speech Pathol & Audiol, Chunchon, South Korea; [Yoon, Ji Hye] Hallym Univ, Res Inst Audiol & Speech Pathol, Chunchon, South Korea	Daegu University; Hallym University; Hallym University	Yoon, JH (corresponding author), Hallym Univ, Coll Nat Sci, Div Speech Pathol & Audiol, Chunchon, South Korea.; Yoon, JH (corresponding author), Hallym Univ, Res Inst Audiol & Speech Pathol, Chunchon, South Korea.	j.yoon@hallym.ac.kr						Abdulrab K, 2008, EUR PSYCHIAT, V23, P321, DOI 10.1016/j.eurpsy.2008.02.004; Abel S, 2005, APHASIOLOGY, V19, P831, DOI 10.1080/02687030500268902; Amer Acad Pediat, 2014, PREHOSP EMERG CARE, V18, P92, DOI 10.3109/10903127.2013.851312; Angus D, 2015, LANCET NEUROL, V14, P39, DOI 10.1016/S1474-4422(14)70262-5; Barnes LL, 2006, NEUROLOGY, V67, P1581, DOI 10.1212/01.wnl.0000242734.16663.09; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Burke D.M., 2008, HDB AGING COGNITION, V3rd ed, P373, DOI DOI 10.1016/B978-0-12-809324-5.01889-7; BURKE DM, 1991, J MEM LANG, V30, P542, DOI 10.1016/0749-596X(91)90026-G; Cho NH, 2002, REPORTS USAGE FREQUE; CRAIK FIM, 2002, SO NEUROSCI SER, P189; Dux MC, 2008, J INT NEUROPSYCH SOC, V14, P327, DOI 10.1017/S1355617708080363; Ecke P., 1998, ILHA DESTERRO COGNIT, V35, P157; Eun Lee Ko, 2011, [Korean Journal of Cognitive and Biological Psychology, 한국심리학회지: 인지 및 생물], V23, P549; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; HARRIS DM, 1995, CORTEX, V31, P575, DOI 10.1016/S0010-9452(13)80068-8; Heine MK, 1999, PSYCHOL AGING, V14, P445, DOI 10.1037/0882-7974.14.3.445; James LE, 2000, J EXP PSYCHOL LEARN, V26, P1378, DOI 10.1037//0278-7393.26.6.1378; Jessen F, 2010, ARCH GEN PSYCHIAT, V67, P414, DOI 10.1001/archgenpsychiatry.2010.30; Jonker C, 1996, J AM GERIATR SOC, V44, P44, DOI 10.1111/j.1532-5415.1996.tb05636.x; Kang Yeonwook, 2006, [Korean Journal of Psychology: General, 한국심리학회지:일반], V25, P1; Kee BS, 1996, J KOREAN NEUROPSYCHI, V35, P298; Larrabee G J, 1994, Int Psychogeriatr, V6, P95, DOI 10.1017/S1041610294001663; Lee YN, 2016, COMMUN SCI DISORD-CS, V21, P139, DOI 10.12963/csd.16294; Mitchell AJ, 2014, ACTA PSYCHIAT SCAND, V130, P439, DOI 10.1111/acps.12336; Morris JC, 2006, ALZ DIS ASSOC DIS, V20, P210, DOI 10.1097/01.wad.0000213865.09806.92; Nicholas M, 1997, NAMING NORMAL AGING, P166; 유지민, 2007, [JOURNAL OF THE KOREAN NEUROPSYCHIATRIC ASSOCIATION, 신경정신의학], V46, P560; Patterson JP., 2001, PERSPECTIVES NEUROPH, V11, P11; Robson J, 2004, APHASIOLOGY, V18, P917, DOI 10.1080/02687030444000462; Schmidtke K, 2008, AM J GERIAT PSYCHIAT, V16, P981, DOI 10.1097/JGP.0b013e318187ddf9; Treves IA, 2005, INT PSYCHOGERIATR, V17, P265, DOI 10.1017/S1041610205001596; Verstichel P, 1996, NEUROCASE, V2, P221, DOI 10.1080/13554799608402399; WARRINGTON EK, 1988, BRAIN COGNITION, V7, P184, DOI 10.1016/0278-2626(88)90029-2; Yoon JH, 2010, ALZ DIS ASSOC DIS, V24, P334, DOI 10.1097/WAD.0b013e3181eb2f53; 진주희, 2010, [Dementia and Neurocognitive Disorders, Dementia and Neurocognitive Disorders(대한치매학회지)], V9, P115	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239327	10.1371/journal.pone.0239327	http://dx.doi.org/10.1371/journal.pone.0239327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946498	gold, Green Published			2022-12-26	WOS:000573851100014
J	Nouage, L; Elanga-Ndille, E; Binyang, A; Tchouakui, M; Atsatse, T; Ndo, C; Kekeunou, S; Wondji, CS				Nouage, Lynda; Elanga-Ndille, Emmanuel; Binyang, Achille; Tchouakui, Magellan; Atsatse, Tatiane; Ndo, Cyrille; Kekeunou, Sevilor; Wondji, Charles S.			Influence of GST- and P450-based metabolic resistance to pyrethroids on blood feeding in the major African malaria vector Anopheles funestus	PLOS ONE			English	Article							HOST-SEEKING; GAMBIAE; DIPTERA; MEAL; MOSQUITOS; AEDES; CULICIDAE; EVOLUTION; STEPHENSI; SELECTION	Insecticide resistance genes are often associated with pleiotropic effects on various mosquito life-history traits. However, very little information is available on the impact of insecticide resistance on blood feeding process in mosquitoes. Here, using two recently detected DNA-based metabolic markers in the major malaria vector,An.funestus, we investigated how metabolic resistance genes could affect the blood meal intake. After allowing both the field F1 and lab F8Anopheles funestusstrains to feed on the human arm for 30 minutes, we assessed the association between key parameters of blood meal process including, probing time, feeding duration, blood feeding success, blood meal size, and markers of glutathione S-transferase (L119F-GSTe2) and cytochrome P450 (CYP6P9a_R)-mediated metabolic resistance. None of the parameters of blood meal process was associated withL119F-GSTe2genotypes. By contrast, forCYP6P9a_R, homozygous resistant mosquitoes were significantly more able to blood-feed than homozygous susceptible (OR = 3.3; CI 95%: 1.4-7.7; P = 0.01) mosquitoes. Moreover, the volume of blood meal ingested by CYP6P9a-SS mosquitoes was lower than that of CYP6P9a-RS (P<0.004) and of CYP6P9a-RR (P<0.006). This suggests thatCYP6P9agene is inked with the feeding success and blood meal size ofAn.funestus. However, no correlation was found in the expression ofCYP6P9aand that of genes encoding for salivary proteins involved in blood meal process. This study suggests that P450-based metabolic resistance may influence the blood feeding process ofAnopheles funestusmosquito and consequently its ability to transmit malaria parasites.	[Nouage, Lynda; Elanga-Ndille, Emmanuel; Binyang, Achille; Tchouakui, Magellan; Atsatse, Tatiane; Wondji, Charles S.] Ctr Res Infect Dis CRID, Dept Med Entomol, Yaounde, Cameroon; [Nouage, Lynda; Binyang, Achille; Tchouakui, Magellan; Atsatse, Tatiane; Kekeunou, Sevilor] Univ Yaounde I, Fac Sci, Dept Anim Biol & Physiol, Yaounde, Cameroon; [Ndo, Cyrille] Ctr Res Infect Dis CRID, Dept Parasitol & Microbiol, Yaounde, Cameroon; [Ndo, Cyrille] Univ Douala, Fac Med & Pharmaceut Sci, Dept Biol Sci, Douala, Cameroon; [Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England	University of Yaounde I; Liverpool School of Tropical Medicine	Nouage, L; Elanga-Ndille, E (corresponding author), Ctr Res Infect Dis CRID, Dept Med Entomol, Yaounde, Cameroon.; Nouage, L (corresponding author), Univ Yaounde I, Fac Sci, Dept Anim Biol & Physiol, Yaounde, Cameroon.	lnouage@gmail.com; emmsdille@yahoo.fr	Elanga, Emmanuel/ABC-8240-2021; KEKEUNOU, Sévilor/AAZ-7567-2021	Tchouakui, Magellan/0000-0002-1683-8057	Wellcome Trust Training fellowship [109930/Z/15/Z]	Wellcome Trust Training fellowship(Wellcome Trust)	This study was funded by a Wellcome Trust Training fellowship (109930/Z/15/Z) awarded to EEN.	[Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Berticat C, 2002, GENET RES, V79, P41, DOI 10.1017/S001667230100547X; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; BRIEGEL H, 1979, J MED ENTOMOL, V15, P235, DOI 10.1093/jmedent/15.3.235; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Diop MM, 2019, SUBLETHAL INSECTICID; EDMAN JD, 1987, INSECT SCI APPL, V8, P617, DOI 10.1017/S1742758400022694; EDMAN JD, 1975, ENTOMOL EXP APPL, V18, P492, DOI 10.1007/BF00304653; Elanga-Ndille E, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030211; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722; Islam A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39960-2; Jeanrenaud ACSN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215552; KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kumar K, 2011, ASIAN PAC J TROP MED, V4, P426, DOI 10.1016/S1995-7645(11)60119-3; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; LIVAK KJ, 1984, GENETICS, V107, P611; Lyimo IN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-425; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889; Menze BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163261; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Okoye PN, 2007, B ENTOMOL RES, V97, P599, DOI 10.1017/S0007485307005317; Owusu HF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03918-z; Ramasamy MS, 2000, J INSECT PHYSIOL, V46, P1051, DOI 10.1016/S0022-1910(99)00217-6; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ribeiro JMC, 2000, MED VET ENTOMOL, V14, P142, DOI 10.1046/j.1365-2915.2000.00227.x; Rivero A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001000; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Roitberg BD, 2005, J VECTOR ECOL, V30, P83; ROWLAND M, 1991, MED VET ENTOMOL, V5, P193, DOI 10.1111/j.1365-2915.1991.tb00542.x; Saeaue L, 2011, SE ASIAN J TROP MED, V42, P542; Saingamsook J, 2019, INSECTS, V10, DOI 10.3390/insects10090265; Samb B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1735-7; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Takken W, 2001, J INSECT PHYSIOL, V47, P303, DOI 10.1016/S0022-1910(00)00107-4; Taylor PJ, 2001, PARASITOLOGY, V122, P491, DOI 10.1017/S0031182001007776; Tchouakui M, 2020, CYTOCHROME P450 META; Tchouakui M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120645; Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001; Thievent K, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2718-x; Weedall GD, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat7386; WHO, 2019, WORLD MALARIA REPORT; Wilding CS, 2015, MOL GENET GENOMICS, V290, P201, DOI 10.1007/s00438-014-0910-9; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108	52	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0230984	10.1371/journal.pone.0230984	http://dx.doi.org/10.1371/journal.pone.0230984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946446	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000573851100083
J	Adeyemi, OA; Itanyi, IU; Ozigbu, CE; Stadnick, N; Tsuyuki, K; Olayiwola, O; Ogidi, AG; Eze, C; Aarons, GA; Onoka, CA; Ezeanolue, EE				Adeyemi, Olusegun Adewale; Itanyi, Ijeoma Uchenna; Ozigbu, Chamberline Ekene; Stadnick, Nicole; Tsuyuki, Kiyomi; Olayiwola, Olanrewaju; Ogidi, Amaka Grace; Eze, Chuka; Aarons, Gregory Alan; Onoka, Chima Ariel; Ezeanolue, Echezona Edozie			Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria	PLOS ONE			English	Article							VIRUS INFECTION; PREGNANT-WOMEN; EARLY MARRIAGE; SEROPREVALENCE; EPIDEMIOLOGY; TRENDS; STATE	Introduction Sub-Saharan Africa houses over two-thirds of the 37 million people living with human immunodeficiency virus (HIV) globally and of this, 5-20% are co-infected with Hepatitis B virus (HBV). This is double jeopardy, especially for women of reproductive age in these settings, who can transmit both viruses vertically as well as horizontally to their children. The objectives of this study were to investigate the prevalence and determinants of HBV among women of reproductive age living with HIV. Methods This was a cross-sectional study of HIV-infected women of reproductive age in Benue State, Nigeria. Participants were eligible for the study if they were HIV-infected women (ages 18-45 years) receiving care from any of the selected study sites. A global rapid hepatitis B surface antigen (HBsAg) antibody test strip was used to test for HBsAg in plasma. A pretested questionnaire was used to collect data on sociodemographic, clinical and lifestyle characteristics of participants. We estimated prevalence of HBV infection and used multivariable logistic regression to determine factors associated with the infection at a significance level of Results A total of 6577 women were screened for HBsAg. The prevalence of HBV was 10.3% (95% CI: 9.5-10.9%). Age, parity and male partner's HIV status were found to be associated with having HBV infection. Compared to women older than 40 years, the odds of HBV infection increased significantly with increasing age until age 35 years and decreased significantly with increasing parity (versus no parity). Women with HIV-infected partners and those without a partner had higher odds of HBV infection compared to women with HIV-negative partners. Conclusion HBV is hyperendemic among HIV-infected women of reproductive age in North Central Nigeria. Specific programs targeting HBV testing, vaccination and treatment of all women of reproductive age need to be developed in this resource-limited, high-need setting.	[Adeyemi, Olusegun Adewale] Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria; [Adeyemi, Olusegun Adewale] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Grad Program Life Sci, Baltimore, MD 21201 USA; [Itanyi, Ijeoma Uchenna; Ogidi, Amaka Grace; Onoka, Chima Ariel; Ezeanolue, Echezona Edozie] Univ Nigeria Nsukka, Ctr Translat & Implementat Res, Enugu, Nigeria; [Itanyi, Ijeoma Uchenna; Onoka, Chima Ariel] Univ Nigeria Nsukka, Dept Community Med, Enugu, Nigeria; [Ozigbu, Chamberline Ekene] Univ South Carolina, Dept Hlth Serv Policy & Management, Columbia, SC 29208 USA; [Stadnick, Nicole; Aarons, Gregory Alan] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Stadnick, Nicole; Aarons, Gregory Alan] UC San Diego Disseminat & Implementat Sci Ctr, San Diego, CA USA; [Tsuyuki, Kiyomi] Univ Calif San Diego, Dept Med, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA; [Olayiwola, Olanrewaju] Caritas Nigeria, Abuja, Federal Capital, Nigeria; [Eze, Chuka] Vitira Hlth, Arlington, VA USA; [Ezeanolue, Echezona Edozie] Hlth Sunrise Fdn, Las Vegas, NV USA	University System of Maryland; University of Maryland Baltimore; University of Nigeria; University of Nigeria; University of South Carolina System; University of South Carolina Columbia; University of California System; University of California San Diego; University of California System; University of California San Diego	Adeyemi, OA (corresponding author), Inst Human Virol Nigeria, Int Res Ctr Excellence, Abuja, Nigeria.; Adeyemi, OA (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Grad Program Life Sci, Baltimore, MD 21201 USA.	oadeyemi@umaryland.edu	Stadnick, Nicole Ashley/AAU-2791-2021	Stadnick, Nicole Ashley/0000-0001-6520-2920; Adeyemi, Olusegun/0000-0002-2051-002X; Itanyi, Ijeoma/0000-0002-4958-6319	Fogarty International Center of the US National Institutes of Health (NIH) [R21TW010252]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [R01HD087994, R01HD087994-S1]	Fogarty International Center of the US National Institutes of Health (NIH); Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH	EEE received funding support from Fogarty International Center of the US National Institutes of Health (NIH) (grant no. R21TW010252) and the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH (grant numbers R01HD087994 & R01HD087994-S1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adegbesan-Omilabu MA, 2015, NIGER J CLIN PRACT, V18, P819, DOI 10.4103/1119-3077.163283; Andersson MI, 2013, VACCINE, V31, P5579, DOI 10.1016/j.vaccine.2013.08.028; [Anonymous], 2009, MAGAZINE CIVIL ENG, V4, P4; [Anonymous], 2018, TOXICOL ANAL CLIN, V30, P1; [Anonymous], 2010, SISTEMNYE GIPERTENZI, V3, P5; [Anonymous], 2016, TIMBERMART S, V21, P1; [Anonymous], 2015, ISMP MSAL, V20, P1; [Anonymous], 2019, BEN STAT GOV QUICK F, P4; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Atilola G, 2018, J EPIDEMIOL GLOB HEA, V8, P115, DOI 10.2991/j.jegh.2018.09.002; Bonacini M, 2004, AIDS, V18, P2039, DOI 10.1097/00002030-200410210-00008; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; COX A, 1977, BRIT J PREV SOC MED, V31, P131; Ekpenyong M., 2016, NURS PALLIAT CARE, V1, P124, DOI [10.15761/NPC.1000130, DOI 10.15761/NPC.1000130]; Ezeanolue Echezona Edozie, 2017, JMIR Res Protoc, V6, pe100, DOI 10.2196/resprot.7743; Ezechi OC, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.197.2310; Gbadamosi SO, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.8716; Hou Jinlin, 2005, Int J Med Sci, V2, P50; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Keane E, 2016, ALIMENT PHARM THER, V44, P1005, DOI 10.1111/apt.13795; Lang KM, 2018, PREV SCI, V19, P284, DOI 10.1007/s11121-016-0644-5; Matthews PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134037; Matthews PC, 2014, J CLIN VIROL, V61, P20, DOI 10.1016/j.jcv.2014.05.018; Mbaawuaga E. M., 2008, African Journal of Biomedical Research, V11, P155; Metaferia Y, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016027; NAFDAC, 2017, NAT AG FOOD DRUG ADM; National Agency for the Control of Aids (NACA), 2019, NIG HIV AIDS IND IMP; National Population Commission (NPC), 2014, NIG ICF INT NIG DEM; Nongo B. H., 2016, Annals of Nigerian Medicine, V10, P58, DOI 10.4103/0331-3131.206213; O.F. BM Musa1 S Bussell2 MM Borodo1 AA Samaila1, 2015, PREVALENCE HEPATITIS, V18, P163, DOI [10.4103/1119-3077.151035, DOI 10.4103/1119-3077.151035]; Okeke T C, 2012, Niger J Med, V21, P57; Olokoba AB, 2011, NIGER J CLIN PRACT, V14, P10, DOI 10.4103/1119-3077.79232; Omatola CA, 2019, AFR HEALTH SCI, V19, P1938, DOI 10.4314/ahs.v19i2.17; Omatola CA, 2017, VIRAL IMMUNOL, V30, P516, DOI 10.1089/vim.2016.0163; Ophori Endurance A, 2014, Trop Med Health, V42, P67, DOI 10.2149/tmh.2013-13; Perkins NJ, 2018, AM J EPIDEMIOL, V187, P568, DOI 10.1093/aje/kwx348; Roos A, 2017, INT J CARDIOL, V232, P111, DOI 10.1016/j.ijcard.2017.01.044; Santhya KG, 2011, CURR OPIN OBSTET GYN, V23, P334, DOI 10.1097/GCO.0b013e32834a93d2; Singh KP, 2017, AIDS, V31, P2035, DOI 10.1097/QAD.0000000000001574; Tremeau-Bravard A, 2012, AFR HEALTH SCI, V12, P312, DOI 10.4314/ahs.v12i3.10; Uneke CJ, 2005, MEM I OSWALDO CRUZ, V100, P13, DOI 10.1590/S0074-02762005000100002; Walker J.A., 2012, AFR J REPROD HLTH; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; World Health Organization, 2019, ESS NUTR ACT MAINSTR, P1; World Health Organization, 2017, GLOB HEP PROGR 2017	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0236456	10.1371/journal.pone.0236456	http://dx.doi.org/10.1371/journal.pone.0236456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941424	Green Published, gold			2022-12-26	WOS:000573848800017
J	Ehrlich, LE; Gao, Z; Bischof, JC; Rabin, Y				Ehrlich, Lili E.; Gao, Zhe; Bischof, John C.; Rabin, Yoed			Thermal conductivity of cryoprotective agents loaded with nanoparticles, with application to recovery of preserved tissues and organs from cryogenic storage	PLOS ONE			English	Article							BLOOD-VESSELS; COCKTAIL DP6; PART II; CRYOPRESERVATION; ICE; VITRIFICATION; EXPANSION; CRYOMACROSCOPE; VISUALIZATION; TEMPERATURES	The objective of this study is to provide thermal conductivity data for CPA-based nanofluids for the benefit of the analyses of cryopreservation by vitrification. Thermal conductivity measurements were conducted using a hot-wire technique on an experimentation platform of the cryomacroscope, to correlate measurements with observed physical effects such as crystallization and fracturing. Tested materials in this study include the CPA cocktails M22, VS55, DP6, and DP6+sucrose. Nanofluids in this study include the above CPA cocktails as base solutions, when mixed with either iron-oxide nanoparticles (IONP) or silica-coated iron-oxide nanoparticles (sIONP). Results of this study demonstrated the addition of sIONP to any of the CPA cocktails tested did not significantly affect its thermal conductivity, its tendency to vitrify or, conversely, its tendency to form rewarming phase crystallization (RPC). Fractures were observed with cryomacroscopy at the onset of rewarming for DP6+sIONP under carefully controlled rewarming conditions without RF activation, despite the inherent opacity of the sIONP solutions. It is likely that using RF heating in order to accelerate rewarming while unifying the temperature distribution would prevent fracture and RPC. However, sIONP were not activated in this study, as the RF heating mechanism would interfere with thermal conductivity measurements. The addition of IONP to DP6 appears to hinder the tendency of the CPA to vitrify, which is a detrimental effect. But it is unlikely that uncoated nanoparticle solutions will be used in practical applications.	[Ehrlich, Lili E.; Rabin, Yoed] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA; [Gao, Zhe; Bischof, John C.] Univ Minnesota, Dept Mech Engn, 111 Church St SE, Minneapolis, MN 55455 USA; [Gao, Zhe; Bischof, John C.] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA	Carnegie Mellon University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Rabin, Y (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	rabin@cmu.edu			National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health [R01HL135046, R01HL127618]	National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health under award numbers R01HL135046 (JB and YR) and R01HL127618 (YR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armitage WJ, 2009, DEV OPHTHALMOL, V43, P63, DOI 10.1159/000223839; Baicu S, 2008, CRYOBIOLOGY, V57, P1, DOI 10.1016/j.cryobiol.2008.03.002; Baudot A, 2000, CRYOBIOLOGY, V40, P151, DOI 10.1006/cryo.2000.2234; Brockbank KGM, 2012, CELL TISSUE BANK, V13, P663, DOI 10.1007/s10561-011-9288-7; Ehrlich LE, 2017, THERMAL CONDUCTIVITY, DOI [10.1371/journal.pone.0125862, DOI 10.1371/JOURNAL.PONE.0125862]; Ehrlich LE, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4037406; Ehrlich LE, 2016, CRYOBIOLOGY, V73, P196, DOI 10.1016/j.cryobiol.2016.07.012; Ehrlich LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125862; Eisenberg DP, 2014, CRYOBIOLOGY, V68, P318, DOI 10.1016/j.cryobiol.2014.04.010; Eisenberg DP, 2012, CRYOBIOLOGY, V65, P117, DOI 10.1016/j.cryobiol.2012.04.011; Etheridge ML, 2014, TECHNOLOGY, V2, P229, DOI 10.1142/S2339547814500204; Fahy GM, 2004, CRYOBIOLOGY, V48, P157, DOI 10.1016/j.cryobiol.2004.02.002; Feig JSG, 2016, CRYOBIOLOGY, V73, P272, DOI 10.1016/j.cryobiol.2016.06.004; Feig JSG, 2014, CRYOGENICS, V62, P118, DOI 10.1016/j.cryogenics.2014.04.017; Gao Z, 2019, ADV SCI; GIWA S, 2014, CRYOBIOLOGY, V69, P523; Grosu Y, 2017, SOL ENERG MAT SOL C, V161, P170, DOI 10.1016/j.solmat.2016.12.006; HEALY JJ, 1976, PHYSICA B & C, V82, P392, DOI 10.1016/0378-4363(76)90203-5; Hey JM, 1996, CRYOBIOLOGY, V33, P205, DOI 10.1006/cryo.1996.0021; Hurley KR, 2016, MOL PHARMACEUT, V13, P2172, DOI 10.1021/acs.molpharmaceut.5b00866; Lewis JK, 2016, CRYOBIOLOGY, V72, P169, DOI 10.1016/j.cryobiol.2015.12.001; Manuchehrabadi N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4586; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; MEHL PM, 1993, CRYOBIOLOGY, V30, P509, DOI 10.1006/cryo.1993.1051; NAGASAKA Y, 1981, J PHYS E SCI INSTRUM, V14, P1435, DOI 10.1088/0022-3735/14/12/020; Pietrak K, 2015, J POWER TECHNOL, V95, P14; Plitz J., 2004, CELL PRESERV TECHNOL, V2, P215, DOI [10.1089/cpt.2004.2.215, DOI 10.1089/CPT.2004.2.215]; Rabin Yoed, 2005, Cell Preserv Technol, V3, P169, DOI 10.1089/cpt.2005.3.169; Rabin Y, 2013, CRYOBIOLOGY, V67, P264, DOI 10.1016/j.cryobiol.2013.08.005; Rios JLJ, 2006, CRYOBIOLOGY, V52, P284, DOI 10.1016/j.cryobiol.2005.12.006; Rozati H, 2017, J CLIN MED, V6, DOI 10.3390/jcm6090089; Sakazume S., 1978, B JSME, V44, P2059; Solanki PK, 2017, ASME BIOENG BIOTR C; Solanki PK, 2017, CRYOBIOLOGY, V76, P129, DOI 10.1016/j.cryobiol.2017.02.001; Steif Paul S, 2005, Cell Preserv Technol, V3, P184, DOI 10.1089/cpt.2005.3.184; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Taylor M, 2018, CRYOBIOLOGY, V80, P161; Taylor M, 2016, CRYOBIOLOGY, V73, P419, DOI [10.1016/j.cryobiol.2016.09.080, DOI 10.1016/J.CRYOBIOL.2016.09.080]; Taylor MJ, 2004, LIFE IN THE FROZEN STATE, P603, DOI 10.1201/9780203647073.ch22; Wang JF, 2006, INT J HEAT MASS TRAN, V49, P3075, DOI 10.1016/j.ijheatmasstransfer.2006.02.007; Wowk B, 2005, CRYOBIOLOGY, V51, P362; Wowk B, 2018, CRYOBIOLOGY, V82, P70, DOI 10.1016/j.cryobiol.2018.04.006; YINNON H, 1981, J NON-CRYST SOLIDS, V44, P37, DOI 10.1016/0022-3093(81)90131-9; ZELLER RC, 1971, PHYS REV B, V4, P2029, DOI 10.1103/PhysRevB.4.2029	44	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238941	10.1371/journal.pone.0238941	http://dx.doi.org/10.1371/journal.pone.0238941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941483	Green Published, gold			2022-12-26	WOS:000573848800113
J	Hale, LP				Hale, Laura P.			Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HYPER-IGM SYNDROME; COLORECTAL-CANCER; INTERLEUKIN-10-DEFICIENT MICE; COLONIC NEOPLASIA; HYPERMUTATION; HOMEOSTASIS; VARIANTS; MUTATION; AID	Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer, particularly in ulcerative colitis (UC) when the majority of colon epithelial cells may be exposed to inflammation-associated mutagenesis. In addition to mutagenesis generated by oxidative stress, inflammation can induce activation-induced cytidine deaminase (Aicda), a mutator enzyme in the APOBEC family, within colon epithelial cells. This study tested the hypothesis that deletion of theAicdagene could protect against the development of inflammation-associated colorectal cancers, using a model of UC-like colitis in "T/I" mice deficient in TNF and IL10. Results showed that T/I mice that were additionallyAicda-deficient ("TIA" mice) spontaneously developed moderate to severe UC-like colitis soon after weaning, with histologic features and colon inflammation severity scores similar those in T/I mice. Although the mean survival of TIA mice was decreased compared to T/I mice, multivariable analysis that adjusted for age when neoplasia was ascertained showed a decreased numbers of neoplastic colorectal lesions in TIA mice, with a trend toward decreased incidence of neoplasia.Aicdadeficiency increased serum IL1 alpha and slightly decreased IL12p40 and M-CSF, as compared with T/I mice, and led to undetectable levels of IgA, IgG1, IgG2a, IgG2b, and IgG3. Taken together, these studies show thatAicdadeficiency can decrease the number of neoplastic lesions but is not sufficient to prevent the risk of inflammation-associated colorectal neoplasia in the setting of severe UC-like inflammation. The TIA model may also be useful for assessing the roles of antibody class-switch recombination deficiency and somatic hypermutation on regulation of microbiota and inflammation in the small intestine and colon, as well as the pathogenesis of colitis associated with hyper-IgM syndrome in humans. Further studies will be required to determine the mechanisms that drive early mortality in TIA mice.	[Hale, Laura P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	Duke University	Hale, LP (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	laura.hale@duke.edu			United States National Institutes of Health [CA-170069]	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States National Institutes of Health (http://www.nih.gov), grant number CA-170069 to LPH. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Beaugerie L, 2015, NEW ENGL J MED, V372, P1441, DOI 10.1056/NEJMra1403718; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Chen R, 2003, AM J PATHOL, V162, P665, DOI 10.1016/S0002-9440(10)63860-6; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Chichlowski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012220; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hale LP, 2007, HELICOBACTER, V12, P598, DOI 10.1111/j.1523-5378.2007.00552.x; Hale LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041797; Hale LP, 2010, INFLAMM BOWEL DIS, V16, P2012, DOI 10.1002/ibd.21320; Hale LP, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-4; Hale LP, 2005, CLIN IMMUNOL, V116, P135, DOI 10.1016/j.clim.2005.04.011; Hussain SP, 2000, CANCER RES, V60, P3333; Imai K, 2003, J CLIN INVEST, V112, P136, DOI 10.1172/JCI200318161; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nabel CS, 2011, SCIENCE, V333, P1229, DOI 10.1126/science.1211917; Nagy E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152764; NORDENHOLTZ KE, 1995, AM J GASTROENTEROL, V90, P927; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Soderlund S, 2009, GASTROENTEROLOGY, V136, P1561, DOI 10.1053/j.gastro.2009.01.064; Sturlan S, 2001, CARCINOGENESIS, V22, P665, DOI 10.1093/carcin/22.4.665; Takai A, 2012, ONCOGENE, V31, P1733, DOI 10.1038/onc.2011.352; Upton DC, 2011, IMMUNOL RES, V49, P14, DOI 10.1007/s12026-010-8190-x; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239295	10.1371/journal.pone.0239295	http://dx.doi.org/10.1371/journal.pone.0239295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941525	gold, Green Published			2022-12-26	WOS:000573848800019
J	Khayer, N; Mirzaie, M; Marashi, SA; Jalessi, M				Khayer, Nasibeh; Mirzaie, Mehdi; Marashi, Sayed-Amir; Jalessi, Maryam			Rps27amight act as a controller of microglia activation in triggering neurodegenerative diseases	PLOS ONE			English	Article							NATURAL-KILLER-CELL; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; UBIQUITIN HOMEOSTASIS; CEREBROSPINAL-FLUID; GENE ONTOLOGY; ONCOSTATIN-M; SPINAL-CORD; EXPRESSION	Neurodegenerative diseases (NDDs) are increasing serious menaces to human health in the recent years. Despite exhibiting different clinical phenotypes and selective neuronal loss, there are certain common features in these disorders, suggesting the presence of commonly dysregulated pathways. Identifying causal genes and dysregulated pathways can be helpful in providing effective treatment in these diseases. Interestingly, in spite of the considerable researches on NDDs, to the best of our knowledge, no dysregulated genes and/or pathways were reported in common across all the major NDDs so far. In this study, for the first time, we have applied the three-way interaction model, as an approach to unravel sophisticated gene interactions, to trace switch genes and significant pathways that are involved in six major NDDs. Subsequently, a gene regulatory network was constructed to investigate the regulatory communication of statistically significant triplets. Finally, KEGG pathway enrichment analysis was applied to find possible common pathways. Because of the central role of neuroinflammation and immune system responses in both pathogenic and protective mechanisms in the NDDs, we focused on immune genes in this study. Our results suggest that "cytokine-cytokine receptor interaction" pathway is enriched in all of the studied NDDs, while "osteoclast differentiation" and "natural killer cell mediated cytotoxicity" pathways are enriched in five of the NDDs each. The results of this study indicate that three pathways that include "osteoclast differentiation", "natural killer cell mediated cytotoxicity" and "cytokine-cytokine receptor interaction" are common in five, five and six NDDs, respectively. Additionally, our analysis showed thatRps27aas a switch gene, together with the gene pair {Il-18,Cx3cl1} form a statistically significant and biologically relevant triplet in the major NDDs. More specifically, we suggested thatCx3cl1might act as a potential upstream regulator ofIl-18in microglia activation, and in turn, might be controlled withRps27ain triggering NDDs.	[Khayer, Nasibeh; Jalessi, Maryam] Iran Univ Med Sci, Skull Base Res Ctr, Five Senses Hlth Inst, Tehran, Iran; [Mirzaie, Mehdi] Tarbiat Modares Univ, Fac Math Sci, Dept Appl Math, Tehran, Iran; [Marashi, Sayed-Amir] Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran	Iran University of Medical Sciences; Tarbiat Modares University; University of Tehran	Khayer, N (corresponding author), Iran Univ Med Sci, Skull Base Res Ctr, Five Senses Hlth Inst, Tehran, Iran.; Marashi, SA (corresponding author), Univ Tehran, Coll Sci, Dept Biotechnol, Tehran, Iran.	khayer.n@iums.ac.ir; marashi@ut.ac.ir	Marashi, Sayed-Amir/A-5384-2008	Marashi, Sayed-Amir/0000-0001-9801-7449; Khayer, Nasibeh/0000-0002-3524-8589; Mirzaie, Mehdi/0000-0003-4434-5118				ABDELJABER MH, 1994, IMMUNOL INVEST, V23, P259, DOI 10.3109/08820139409066822; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Alboni S, 2013, EUR J PHARMACOL, V721, P158, DOI 10.1016/j.ejphar.2013.08.046; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Amor S, 2014, IMMUNOLOGY, V141, P287, DOI 10.1111/imm.12134; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Andersson FI, 2011, J MOL BIOL, V407, P261, DOI 10.1016/j.jmb.2010.12.029; Andrews JL, 2017, J PSYCHIATR RES, V90, P31, DOI 10.1016/j.jpsychires.2017.01.009; [Anonymous], 2006, NJI, V7, P27; [Anonymous], 2011, EC TRADE UPDATE, V8, P9, DOI DOI 10.2903/J.EFSA.2011.2017; ARAGA S, 1991, ACTA NEUROL SCAND, V84, P259, DOI 10.1111/j.1600-0404.1991.tb04948.x; Armstrong RA, 2005, NEUROPATHOLOGY, V25, P111, DOI 10.1111/j.1440-1789.2005.00605.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bian C, 2014, BRAIN BEHAV IMMUN, V37, P220, DOI 10.1016/j.bbi.2013.12.011; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Blauth K, 2015, CLIN IMMUNOL, V157, P121, DOI 10.1016/j.clim.2015.01.001; Borrego F, 2005, MOL IMMUNOL, V42, P485, DOI 10.1016/j.molimm.2004.07.031; Bossu P, 2007, J NEUROL NEUROSUR PS, V78, P807, DOI 10.1136/jnnp.2006.103242; Caiaffo V, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.231; Camous X, 2012, BIOMED RES INT, V2012, P195956; Celik SK, 2014, MOL BIOL REP, V41, P1653, DOI 10.1007/s11033-013-3013-5; Chandrasekaran S, 2016, COMPUT STRUCT BIOTEC, V14, P117, DOI 10.1016/j.csbj.2016.02.001; Chanvillard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039625; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chen PQ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8090918; Choi SW, 2012, FEBS LETT, V586, P263, DOI 10.1016/j.febslet.2011.12.033; Chu YX, 2012, NEUROSCI BULL, V28, P49, DOI 10.1007/s12264-012-1058-4; Cooper MA, 2009, EMBO REP, V10, P1103, DOI 10.1038/embor.2009.203; Cornelius C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00120; Cunha C, 2018, MOL NEUROBIOL, V55, P4207, DOI 10.1007/s12035-017-0631-2; Dantuma NP, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00070, 10.3389/fnmol.2014.00070]; Dorsey E Ray, 2013, Neurology, V80, P1989, DOI 10.1212/WNL.0b013e318293e2ce; Durrenberger PF, 2015, J NEURAL TRANSM, V122, P1055, DOI 10.1007/s00702-014-1293-0; Durrenberger PF, 2012, ACTA NEUROPATHOL, V124, P893, DOI 10.1007/s00401-012-1027-z; Elliott R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075346; Engelender S, 2008, AUTOPHAGY, V4, P372, DOI 10.4161/auto.5604; Ensoli F, 1999, J IMMUNOL, V162, P6268; Ersek Adel, 2012, Front Endocrinol (Lausanne), V3, P106, DOI 10.3389/fendo.2012.00106; Farrawell NE, 2018, J CELL SCI, V131, DOI 10.1242/jcs.209122; Gentleman R., 2015, R PACKAGE VERSION 1; Godini R, 2019, J CELL PHYSIOL, V234, P5215, DOI 10.1002/jcp.27330; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Groen EJN, 2015, TRENDS MOL MED, V21, P622, DOI 10.1016/j.molmed.2015.08.003; Gunderson T, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0371-5; Guo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100052; Han WF, 2011, MOL CELL BIOCHEM, V347, P13, DOI 10.1007/s11010-010-0607-2; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Herz J, 2010, EXP NEUROL, V225, P9, DOI 10.1016/j.expneurol.2009.11.019; Ho YY, 2011, BIOMETRICS, V67, P133, DOI 10.1111/j.1541-0420.2010.01440.x; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Jiang S, 2017, NEUROL SCI, V38, P1373, DOI 10.1007/s10072-017-2988-4; Johann S, 2015, GLIA, V63, P2260, DOI 10.1002/glia.22891; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kasama T, 2012, CLIN RHEUMATOL, V31, P853, DOI 10.1007/s10067-012-1952-1; Kaur G, 2013, BRAIN, V136, P2657, DOI 10.1093/brain/aws159; Kaur U, 2015, CURR TOP MED CHEM, V15, P446, DOI 10.2174/1568026615666150114160543; Kayano M, 2014, IEEE ACM T COMPUT BI, V11, P154, DOI 10.1109/TCBB.2013.2297921; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khayer N, 2019, EXPERT REV PROTEOMIC, V16, P161, DOI 10.1080/14789450.2019.1559734; Khayer N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184697; Kimura Y, 2010, J BIOCHEM, V147, P793, DOI 10.1093/jb/mvq044; Koopmans MM, 2014, BBA CLIN, V1, P44, DOI 10.1016/j.bbacli.2014.06.001; Kun-Rodrigues C, 2015, HUM MOL GENET, V24, P6711, DOI 10.1093/hmg/ddv376; Langou K, 2010, J NEUROCHEM, V114, P795, DOI 10.1111/j.1471-4159.2010.06806.x; Layfield R, 2008, BIOCHEM SOC T, V36, P469, DOI 10.1042/BST0360469; Li KC, 2002, P NATL ACAD SCI USA, V99, P16875, DOI 10.1073/pnas.252466999; Liu JN, 2011, DNA CELL BIOL, V30, P913, DOI 10.1089/dna.2011.1221; lusarczyk J, 2016, NEURAL PLAST, V2016, P6924505; Ma L, 2015, PSYCHIAT RES, V226, P211, DOI 10.1016/j.psychres.2015.01.001; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mechanisms Clinical Strategies., 2015, 12 INT C AD PD NIC F, V15, P1, DOI DOI 10.1520/D6415; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Mihara T, 2008, PARKINSONISM RELAT D, V14, P46, DOI 10.1016/j.parkreldis.2007.05.013; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; Morfini GA, 2009, J NEUROSCI, V29, P12776, DOI 10.1523/JNEUROSCI.3463-09.2009; Morganti JM, 2012, J NEUROSCI, V32, P14592, DOI 10.1523/JNEUROSCI.0539-12.2012; Muller C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156594; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; Park CW, 2014, BMB REP, V47, P475, DOI 10.5483/BMBRep.2014.47.9.128; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Prolo P, 2007, BIOINFORMATION, V1, P363, DOI 10.6026/97320630001363; Ragland M, 2009, AM J EPIDEMIOL, V170, P1344, DOI 10.1093/aje/kwp288; Richards CD, 2000, CYTOKINE, V12, P613, DOI 10.1006/cyto.1999.0635; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Martin E, 2015, CLIN EXP IMMUNOL, V180, P243, DOI 10.1111/cei.12580; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ryu HW, 2015, NEURAL REGEN RES, V10, P1209, DOI 10.4103/1673-5374.162693; Sato T, 2015, HELIYON, V1, DOI 10.1016/j.heliyon.2015.e00013; Sattlecker M, 2016, J ALZHEIMERS DIS, V49, P1105, DOI 10.3233/JAD-140669; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; SCHINDLER L, 1986, ACTA PSYCHIAT SCAND, V73, P651, DOI 10.1111/j.1600-0447.1986.tb02739.x; Segal BM, 2007, J NEUROIMMUNOL, V191, P2, DOI 10.1016/j.jneuroim.2007.09.006; Seksenyan A, 2010, J CELL MOL MED, V14, P2470, DOI 10.1111/j.1582-4934.2009.00863.x; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shan S, 2011, NEUROBIOL AGING, V32, P443, DOI 10.1016/j.neurobiolaging.2009.03.004; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shirts BH, 2008, AM J MED GENET B, V147B, P343, DOI 10.1002/ajmg.b.30603; Strobel S, 2015, J NEURAL TRANSM, V122, P1069, DOI 10.1007/s00702-015-1369-5; Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suguitan Jr AL, 2011, PLOS ONE, V6; Thome AD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140566; Tramutola A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2756068; UCHIDA A, 1982, IMMUNOBIOLOGY, V160, P392, DOI 10.1016/S0171-2985(82)80003-X; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Walker EC, 2010, J CLIN INVEST, V120, P582, DOI 10.1172/JCI40568; WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M; Willse JT, 2014, PACKAGE CTT; Wilshusen RA, 2014, NEUROINFLAMMATION NE, P119; WOODROOFE MN, 1995, NEUROLOGY, V45, pS6, DOI 10.1212/WNL.45.6_Suppl_6.S6; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Xu EH, 2009, J CLIN NEUROSCI, V16, P1473, DOI 10.1016/j.jocn.2009.03.027; Xu Y, 2016, J PSYCHIATR RES, V74, P10, DOI 10.1016/j.jpsychires.2015.12.013; Xuan FL, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00504; Yerbury JJ, 2016, J NEUROCHEM, V137, P489, DOI 10.1111/jnc.13575; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhao ZB, 2014, NEUROSCIENCE, V275, P232, DOI 10.1016/j.neuroscience.2014.06.013; Zhou Z, 2006, J EXP MED, V203, P1067, DOI 10.1084/jem.20051947; Zhou Zheng, 2011, Front Biosci (Schol Ed), V3, P768, DOI 10.2741/s185; Zhuang ZY, 2007, BRAIN BEHAV IMMUN, V21, P642, DOI 10.1016/j.bbi.2006.11.003	128	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239219	10.1371/journal.pone.0239219	http://dx.doi.org/10.1371/journal.pone.0239219			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941527	gold, Green Published			2022-12-26	WOS:000573848800025
J	Lee, JH; Kang, N				Lee, Joon Ho; Kang, Nyeonju			Effects of online-bandwidth visual feedback on unilateral force control capabilities	PLOS ONE			English	Article							INFORMATION GAIN; KNOWLEDGE; MOVEMENT; TIME; VARIABILITY; HANDEDNESS	Purpose The purpose of this study was to examine how different threshold ranges of online-bandwidth visual feedback influence unilateral force control capabilities in healthy young women. Methods Twenty-five right-handed young women (mean +/- standard deviation age = 23.6 +/- 1.5 years) participated in this study. Participants unilaterally executed hand-grip force control tasks with their dominant and non-dominant hands, respectively. Each participant completed four experimental blocks in a different order of block presentation for each hand condition: (a) 10% of maximum voluntary contraction (MVC) with +/- 5% bandwidth threshold range (BTR), (b) 10% of MVC with +/- 10% BTR, (c) 40% of MVC with +/- 5% BTR, and (d) 40% of MVC with +/- 10% BTR. Outcome measures on force control capabilities included: (a) force accuracy, (b) force variability, (c) force regularity, and (d) the number of times and duration out of BTR. Results The non-dominant hand showed significant improvements in force control capabilities, as indicated by higher force accuracy, less force variability, and decreased force regularity from +/- 10% BTR to +/- 5% BTR during higher targeted force level task. For both hands, the number of times and duration out of BTR increased from +/- 10% BTR to +/- 5% BTR. Conclusions The current findings suggested that the narrow threshold range of online-bandwidth visual feedback effectively revealed transient improvements in unilateral isometric force control capabilities during higher targeted force level tasks.	[Lee, Joon Ho; Kang, Nyeonju] Incheon Natl Univ, Dept Human Movement Sci, Incheon, South Korea; [Lee, Joon Ho; Kang, Nyeonju] Incheon Natl Univ, Neuromech Rehabil Res Lab, Incheon, South Korea; [Kang, Nyeonju] Incheon Natl Univ, Div Sport Sci, Incheon, South Korea; [Kang, Nyeonju] Incheon Natl Univ, Sport Sci Inst, Incheon, South Korea	Incheon National University; Incheon National University; Incheon National University; Incheon National University	Kang, N (corresponding author), Incheon Natl Univ, Dept Human Movement Sci, Incheon, South Korea.; Kang, N (corresponding author), Incheon Natl Univ, Neuromech Rehabil Res Lab, Incheon, South Korea.; Kang, N (corresponding author), Incheon Natl Univ, Div Sport Sci, Incheon, South Korea.; Kang, N (corresponding author), Incheon Natl Univ, Sport Sci Inst, Incheon, South Korea.	nyunju@inu.ac.kr	Kang, Nyeonju/AAX-1879-2021		National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF2018R1C1B5084455]	National Research Foundation of Korea (NRF) - Korea government (MSIT)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF2018R1C1B5084455) to NK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2009, STAT METHODS SOCIAL; Archer DB, 2018, NEUROIMAGE-CLIN, V17, P505, DOI 10.1016/j.nicl.2017.11.012; Bhullar A, 2015, NEUROSCI LETT, V608, P23, DOI 10.1016/j.neulet.2015.10.002; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074273; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forrest SM, 2014, MED ENG PHYS, V36, P676, DOI 10.1016/j.medengphy.2014.02.017; Fox EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055970; Ho KKL, 1997, CIRCULATION, V96, P842; Hong SL, 2008, PERCEPT PSYCHOPHYS, V70, P306, DOI 10.3758/PP.70.2.306; Hong SL, 2008, EXP BRAIN RES, V189, P61, DOI 10.1007/s00221-008-1403-z; Hong SL, 2008, CHAOS, V18, DOI 10.1063/1.2979695; Hu XG, 2011, EXP BRAIN RES, V209, P129, DOI 10.1007/s00221-010-2528-4; Hwang IS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170824; Kang N, 2018, J STROKE CEREBROVASC, V27, P3218, DOI 10.1016/j.jstrokecerebrovasdis.2018.07.019; Kang N, 2018, NEUROSCI LETT, V668, P86, DOI 10.1016/j.neulet.2018.01.019; Kang N, 2015, NEUROSCI RES, V94, P79, DOI 10.1016/j.neures.2014.12.005; Kang N, 2015, NEUROSCI LETT, V587, P41, DOI 10.1016/j.neulet.2014.12.028; Karasinski John A., 2019, Proceedings of the Human Factors and Ergonomics Society Annual Meeting, V63, P1729, DOI 10.1177/1071181319631097; Kennedy DM, 2011, EXP BRAIN RES, V213, P351, DOI 10.1007/s00221-011-2777-x; Khan MA, 2003, ACTA PSYCHOL, V113, P83, DOI 10.1016/S0001-6918(02)00156-7; Lai Q, 1999, RES Q EXERCISE SPORT, V70, P79, DOI 10.1080/02701367.1999.10607734; LEE TD, 1990, Q J EXP PSYCHOL-A, V42, P777, DOI 10.1080/14640749008401249; Leeuwen PV, 2011, EFFECTS CONCURRENT C, P482, DOI [10.17077/drivingassessment.1436, DOI 10.17077/DRIVINGASSESSMENT.1436]; Limonta E, 2015, EUR J APPL PHYSIOL, V115, P507, DOI 10.1007/s00421-014-3036-1; Moulton E, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00511; Mutha PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058582; Newell KM, 2015, CAMBRIDGE HDB APPL P, P366; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Prodoehl J, 2010, EXP BRAIN RES, V200, P67, DOI 10.1007/s00221-009-1966-3; Ramnani N, 2012, CEREBELLUM, V11, P366, DOI 10.1007/s12311-011-0272-3; Sainburg RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01092; Sarlabous L, 2010, IEEE ENG MED BIO, P5967, DOI 10.1109/IEMBS.2010.5627570; Schiffman JM, 2002, CLIN BIOMECH, V17, P486, DOI 10.1016/S0268-0033(02)00041-4; Shafer RL, 2019, BEHAV BRAIN RES, V376, DOI 10.1016/j.bbr.2019.112214; SHERWOOD DE, 1988, PERCEPT MOTOR SKILL, V66, P535, DOI 10.2466/pms.1988.66.2.535; Singh Vineeta, 2013, J Ayurveda Integr Med, V4, P77, DOI 10.4103/0975-9476.113872; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Sokolov AA, 2017, TRENDS COGN SCI, V21, P313, DOI 10.1016/j.tics.2017.02.005; Sosnoff JJ, 2006, EXP BRAIN RES, V170, P423, DOI 10.1007/s00221-005-0225-5; Sosnoff JJ, 2005, PERCEPT PSYCHOPHYS, V67, P335, DOI 10.3758/BF03206496; Tracy BL, 2007, HUM MOVEMENT SCI, V26, P796, DOI 10.1016/j.humov.2007.07.001; Tracy BL, 2007, MED SCI SPORT EXER, V39, P469, DOI 10.1249/mss.0b013e31802d3ad3; Ugrinowitsch H, 2010, PERCEPT MOTOR SKILL, V111, P643, DOI 10.2466/23.25.PMS.111.6.643-652; Vaillancourt DE, 2006, EXP BRAIN RES, V173, P742, DOI 10.1007/s00221-006-0454-2; Vaillancourt DE, 2003, J APPL PHYSIOL, V94, P903, DOI 10.1152/japplphysiol.00166.2002; Vaillancourt DE, 2002, CLIN NEUROPHYSIOL, V113, P1325, DOI 10.1016/S1388-2457(02)00167-0; Wang JS, 2007, EXP BRAIN RES, V178, P565, DOI 10.1007/s00221-007-0936-x	49	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238367	10.1371/journal.pone.0238367	http://dx.doi.org/10.1371/journal.pone.0238367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941453	gold, Green Published			2022-12-26	WOS:000573848800034
J	Chan, LM; Painter, CW; Hill, MT; Hibbitts, TJ; Leavitt, DJ; Ryberg, WA; Walkup, D; Fitzgerald, LA				Chan, Lauren M.; Painter, Charles W.; Hill, Michael T.; Hibbitts, Toby J.; Leavitt, Daniel J.; Ryberg, Wade A.; Walkup, Danielle; Fitzgerald, Lee A.			Phylogeographic structure of the dunes sagebrush lizard, an endemic habitat specialist	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; SCELOPORUS-ARENICOLUS; POPULATION DIFFERENTIATION; LANDSCAPE; SAND; GENETICS; PROGRAM; HISTORY; RANGE; FRAGMENTATION	Phylogeographic divergence and population genetic diversity within species reflect the impacts of habitat connectivity, demographics, and landscape level processes in both the recent and distant past. Characterizing patterns of differentiation across the geographic range of a species provides insight on the roles of organismal and environmental traits in evolutionary divergence and future population persistence. This is particularly true of habitat specialists where habitat availability and resource dependence may result in pronounced genetic structure as well as increased population vulnerability. We use DNA sequence data as well as microsatellite genotypes to estimate range-wide phylogeographic divergence, historical population connectivity, and historical demographics in an endemic habitat specialist, the dunes sagebrush lizard (Sceloporus arenicolus). This species is found exclusively in dune blowouts and patches of open sand within the shinnery oak-sand dune ecosystem of southeastern New Mexico and adjacent Texas. We find evidence of phylogeographic structure consistent with breaks and constrictions in suitable habitat at the range-wide scale. In addition, we find support for a dynamic and variable evolutionary history across the range ofS.arenicolus. Populations in the Monahans Sandhills have deeply divergent lineages consistent with long-term demographic stability. In contrast, populations in the Mescalero Sands are not highly differentiated, though we do find evidence of demographic expansion in some regions and relative demographic stability in others. Phylogeographic history and population genetic differentiation in this species has been shaped by the configuration of habitat patches within a geologically complex and historically dynamic landscape. Our findings identify regions as genetically distinctive conservation units as well as underscore the genetic and demographic history of different lineages ofS.arenicolus.	[Chan, Lauren M.] Pacific Univ, Dept Biol, Forest Grove, OR 97116 USA; [Painter, Charles W.] New Mexico Dept Game & Fish, Endangered Species Program, Santa Fe, NM USA; [Hibbitts, Toby J.; Fitzgerald, Lee A.] Texas A&M Univ, Dept Ecol & Conservat Biol, Biodivers Res & Teaching Collect, College Stn, TX USA; [Hibbitts, Toby J.; Ryberg, Wade A.; Walkup, Danielle] Texas A&M Univ, Nat Resources Inst, College Stn, TX USA; [Leavitt, Daniel J.] Naval Facil Engn Command South West, Nat Resources Program, San Diego, CA USA; [Fitzgerald, Lee A.] Texas A&M Univ, EEB PhD Program, College Stn, TX USA	New Mexico Department of Game and Fish; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Chan, LM (corresponding author), Pacific Univ, Dept Biol, Forest Grove, OR 97116 USA.	lchan@pacificu.edu		Chan, Lauren/0000-0001-7763-6195; Ryberg, Wade/0000-0003-2548-8113; Fitzgerald, Lee/0000-0001-5648-9480; Walkup, Danielle/0000-0001-6836-4212; Leavitt, Dan/0000-0001-9566-1730	Dunes Sagebrush Lizard/Lesser Prairie Chicken Candidate Conservation Agreement Research Funds; USA Bureau of Land Management; State Comptroller of Public Accounts through the Texas A&M University Natural Resources Institute	Dunes Sagebrush Lizard/Lesser Prairie Chicken Candidate Conservation Agreement Research Funds; USA Bureau of Land Management; State Comptroller of Public Accounts through the Texas A&M University Natural Resources Institute	Research was funded by the Dunes Sagebrush Lizard/Lesser Prairie Chicken Candidate Conservation Agreement Research Funds administered by CEHMM, Carlsbad, New Mexico (LMC, DJL, LAF, MTH), the USA Bureau of Land Management (LAF, DJL, WAR), and the State Comptroller of Public Accounts through the Texas A&M University Natural Resources Institute (LMC, LAF, TJH, DJL, WAR, DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attum O, 2006, BIOL CONSERV, V133, P52, DOI 10.1016/j.biocon.2006.05.017; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Chan LM, 2007, MOL ECOL NOTES, V7, P337, DOI 10.1111/j.1471-8286.2006.01600.x; Chan LM, 2013, ZOOTAXA, V3664, P312, DOI 10.11646/zootaxa.3664.3.2; Chan LM, 2009, MOL ECOL, V18, P3185, DOI 10.1111/j.1365-294X.2009.04273.x; Chan LM, 2009, CONSERV GENET, V10, P131, DOI 10.1007/s10592-008-9537-x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Cutter AD, 2013, MOL PHYLOGENET EVOL, V69, P1172, DOI 10.1016/j.ympev.2013.06.006; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dzialak MR, 2013, LANDSCAPE ECOL, V28, P1371, DOI 10.1007/s10980-013-9888-7; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fitzgerald L, 1997, 80516601 NEW MEX DEP; Fitzgerald L.A., 2009, LIZARDS AM SW PHOTOG, P198; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; French Consensus Conference on Acute Pancreatitis, EUR J GASTROENTER S4, V13, pS1; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hibbitts TJ, 2013, HERPETOL CONSERV BIO, V8, P104; HOLLIDAY VT, 1989, GEOL SOC AM BULL, V101, P1598, DOI 10.1130/0016-7606(1989)101&lt;1598:TBDFQA&gt;2.3.CO;2; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Joly S, 2007, SYST BIOL, V56, P857, DOI 10.1080/10635150701633153; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Laurencio LR, 2010, ATLAS DISTRIBUTION H; Leache AD, 2006, MOL PHYLOGENET EVOL, V39, P628, DOI 10.1016/j.ympev.2005.12.016; Leache AD, 2010, MOL PHYLOGENET EVOL, V54, P162, DOI 10.1016/j.ympev.2009.09.006; Leavitt Daniel J., 2014, Herpetological Review, V45, P699; Leavitt DJ, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00032.1; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Machenberg MD, 1984, GEOLOGY MONAHANS SAN, P49; MILES DB, 1994, AM ZOOL, V34, P422; MILES DB, 1994, LIZARD ECOLOGY, P207; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Muhs DR, 2017, QUATERNARY SCI REV, V171, P260, DOI 10.1016/j.quascirev.2017.07.007; MUHS DR, 1995, QUATERNARY RES, V43, P198, DOI 10.1006/qres.1995.1020; Nylander JAA., 2004, BIOINFORMATICS; Olivieri I, 2016, EVOL APPL, V9, P196, DOI 10.1111/eva.12336; Pierson JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067248; Pritchard JK, 2000, GENETICS, V155, P945; Rich J, 2011, AEOLIAN RES, V2, P221, DOI 10.1016/j.aeolia.2010.12.003; Richmond JQ, 2014, BIOL CONSERV, V172, P128, DOI 10.1016/j.biocon.2014.02.026; Richmond JQ, 2013, EVOL APPL, V6, P808, DOI 10.1111/eva.12067; Rissler LJ, 2016, P NATL ACAD SCI USA, V113, P8079, DOI 10.1073/pnas.1601073113; Roderick GK, 2012, EVOL BIOL, V39, P192, DOI 10.1007/s11692-012-9184-5; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Ryberg WA, 2015, J ZOOL, V295, P116, DOI 10.1111/jzo.12184; Ryberg WA, 2016, ECOGRAPHY, V39, P932, DOI 10.1111/ecog.01321; Ryberg WA, 2015, CONSERV BIOL, V29, P888, DOI 10.1111/cobi.12429; Ryberg WA, 2012, WEST N AM NATURALIST, V72, P582, DOI 10.3398/064.072.0413; Ryberg WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056856; Schar S, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1158; Smolensky NL, 2011, SOUTHWEST NAT, V56, P315, DOI 10.1894/F03-MLK-21.1; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D, 2002, PAUP PHYLOGENETIC AN, V2nd, DOI [10.1017/cbo9780511819049.010, DOI 10.1017/CBO9780511819049.010]; Vandergast AG, 2008, BIOL CONSERV, V141, P1648, DOI 10.1016/j.biocon.2008.04.009; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Walkup DK, 2019, LANDSCAPE ECOL, V34, P2631, DOI 10.1007/s10980-019-00909-5; Walkup DK, 2018, HERPETOL CONSERV BIO, V13, P497; Walkup DK, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1729; Wort EJG, 2019, J BIOGEOGR, V46, P369, DOI 10.1111/jbi.13502; WRIGHT S, 1946, GENETICS, V31, P39; Young ME, 2018, CAN J ZOOL, V96, P905, DOI 10.1139/cjz-2017-0048	71	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238194	10.1371/journal.pone.0238194	http://dx.doi.org/10.1371/journal.pone.0238194			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936819	Green Submitted, Green Published, gold			2022-12-26	WOS:000573658000006
J	Guo, XZ; Zhang, WP; Wang, C; Zhang, B; Li, R; Zhang, L; Zhao, K; Li, Y; Tian, LL; Li, B; Cheng, HK; Li, LX; Pei, CY; Xu, HW				Guo, Xize; Zhang, Wanping; Wang, Chun; Zhang, Bo; Li, Rui; Zhang, Lie; Zhao, Kai; Li, Yu; Tian, Linlu; Li, Bo; Cheng, Huakun; Li, Lixian; Pei, Chunying; Xu, Hongwei			IRGM promotes the PINK1-mediated mitophagy through the degradation of Mitofilin in SH-SY5Y cells	FASEB JOURNAL			English	Article						IRGM; mitochondria; mitofilin; mitophagy; PINK1	DAMAGED MITOCHONDRIA; PARKIN; MEMBRANE; AUTOPHAGY; PROTEIN; IMMUNITY; RECRUITMENT; APOPTOSIS; COMPLEX	Mitochondria is a double membrane-bound cellular organelle that generates energy to maintain the homeostasis of cells. Immunity-related GTPase M (IRGM) in human locates at the inner membrane of mitochondria and is best known for its role in regulating autophagy against intracellular pathogens. Previous studies have shown that IRGM is crucial for the normal function of mitochondria, yet, the molecular mechanisms underlying IRGM-mediated quality control of mitochondria are still not fully understood. In this study, we showed that knocking-down IRGM inhibits CCCP induced mitophagy in SH-SY5Y cells. Furthermore, we reported that IRGM decreases the stability of Mitofilin (IMMT, MIC60) in the damaged mitochondria. Knocking down Mitofilin rescues the loss of mitophagy that is observed in the IRGM KD cells, suggesting that IRGM regulates mitophagy through the inhibition of Mitofilin. These data together provide molecular insight regarding how IRGM regulates mitophagy to control the quality of mitochondria.	[Guo, Xize; Zhang, Wanping; Wang, Chun; Zhang, Lie; Tian, Linlu; Li, Bo; Pei, Chunying; Xu, Hongwei] Harbin Med Univ, Dept Immunol, Heilongjiang Prov Key Lab Infect & Immun, Harbin, Peoples R China; [Zhang, Bo] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 4, Harbin, Peoples R China; [Li, Rui] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Zhao, Kai; Li, Yu; Li, Lixian] Harbin Med Univ, Dept Neurosurg, Affiliate Hosp 1, Harbin, Peoples R China; [Cheng, Huakun] Heilongjiang Prov Hosp, Dept Neurosurg, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; University of Pennsylvania; Harbin Medical University	Pei, CY; Xu, HW (corresponding author), Harbin Med Univ, Dept Immunol, Harbin 150081, Peoples R China.	peichunying@hrbmu.edu.cn; hongwei56@hotmail.com	Li, Rui/O-7397-2016	Li, Rui/0000-0002-7210-8358; Xu, Hongwei/0000-0001-5763-3894	National Natural Science Foundation [31371080, 81401286]; Natural Science Foundation of Heilongjiang Province [H2016012]; Youth Science Foundation of Heilongjiang Province [QC2016106]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Youth Science Foundation of Heilongjiang Province	This work was supported by the National Natural Science Foundation Projects under Grant No. 31371080; the National Natural Science Foundation Projects under Grant No. 81401286; the Natural Science Foundation of Heilongjiang Province under Grant No. H2016012; the Youth Science Foundation of Heilongjiang Province under Grant No. QC2016106. We would like to thank Professor Hulun Li for project discussion and technical support.	Akabane S, 2016, MOL CELL, V62, P371, DOI 10.1016/j.molcel.2016.03.037; Bohnert M, 2012, MOL BIOL CELL, V23, P3948, DOI 10.1091/mbc.E12-04-0295; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Chauhan S, 2015, MOL CELL, V58, P507, DOI 10.1016/j.molcel.2015.03.020; Chu CT, 2010, HUM MOL GENET, V19, pR28, DOI 10.1093/hmg/ddq143; Ding CL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16064; Dong H, 2015, ONCOGENE, V34, P5363, DOI 10.1038/onc.2014.459; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Gieffers C, 1997, EXP CELL RES, V232, P395, DOI 10.1006/excr.1997.3539; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; He SY, 2012, AUTOPHAGY, V8, P1621, DOI 10.4161/auto.21561; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Itakura E, 2012, J CELL SCI, V125, P1488, DOI 10.1242/jcs.094110; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kauffman Megan E, 2016, React Oxyg Species (Apex), V2, P361, DOI 10.20455/ros.2016.865; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Oh CK, 2017, CELL REP, V21, P2171, DOI 10.1016/j.celrep.2017.10.068; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Traver MK, 2011, J BIOL CHEM, V286, P30471, DOI 10.1074/jbc.M111.251967; Van Laar VS, 2016, NEUROBIOL DIS, V91, P247, DOI 10.1016/j.nbd.2016.03.015; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang YQ, 2012, AUTOPHAGY, V8, P1462, DOI 10.4161/auto.21211; Wei X, 2015, NEUROTOXICOLOGY, V46, P19, DOI 10.1016/j.neuro.2014.11.007; Weihofen A, 2009, BIOCHEMISTRY-US, V48, P2045, DOI 10.1021/bi8019178; Xu HW, 2010, FASEB J, V24, P1583, DOI 10.1096/fj.09-137323; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zerbes RM, 2012, J MOL BIOL, V422, P183, DOI 10.1016/j.jmb.2012.05.004; Zhang XN, 2014, AUTOPHAGY, V10, P1801, DOI 10.4161/auto.32136	32	5	5	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14768	14779		10.1096/fj.202000943RR	http://dx.doi.org/10.1096/fj.202000943RR		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32939830	Bronze			2022-12-26	WOS:000572122500001
J	Park, DH; Park, S; Song, JM; Kang, M; Lee, S; Horak, M; Suh, YH				Park, Da-ha; Park, Sunha; Song, Jae-man; Kang, Minji; Lee, Sanghyeon; Horak, Martin; Suh, Young Ho			N-linked glycosylation of the mGlu7 receptor regulates the forward trafficking and transsynaptic interaction with Elfn1	FASEB JOURNAL			English	Article						degradation; extracellular domain; trafficking; transsynaptic adhesion	METABOTROPIC GLUTAMATE-RECEPTOR; PROTEIN GLYCOSYLATION; PKC PHOSPHORYLATION; SURFACE EXPRESSION; LIGAND-BINDING; PICK1; RELEASE; PHYSIOLOGY; DIVERSITY; AFFINITY	Metabotropic glutamate receptor 7 (mGlu7) regulates neurotransmitter release at the presynaptic active zone in the mammalian brain. The regulation of mGlu7 trafficking into and out of the plasma membrane by binding proteins within the C-terminal region of mGlu7 governs the bidirectional synaptic plasticity. However, the functional importance of the extracellular domain of mGlu7 has not yet been characterized. N-glycosylation is an abundant posttranslational modification that plays crucial roles in protein folding and forward trafficking, but the role of N-glycosylation in mGlu7 function remains unknown. In this study, we find that mGlu7 is N-glycosylated at four asparagine residues in heterologous cells and rat cultured neurons. We demonstrate that N-glycosylation is essential for forward transport and surface expression of mGlu7. Deglycosylated mGlu7 is retained in the ER, obstructing expression on the cell surface, and is degraded through the autophagolysosomal degradation pathway. In addition, we identify the binding domain of mGlu7 to Elfn1, a transsynaptic adhesion protein. We find that N-glycosylation of mGlu7 promotes its interaction with Elfn1, thereby enabling proper localization and stable surface expression of mGlu7 at the presynaptic active zone. These findings provide evidence that N-glycans act to modulate the surface expression, stability, and function of mGlu7.	[Park, Da-ha; Park, Sunha; Song, Jae-man; Kang, Minji; Lee, Sanghyeon; Suh, Young Ho] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Neurosci Res Inst,Transplantat Res Inst, Seoul, South Korea; [Horak, Martin] Czech Acad Sci, Inst Physiol, Inst Expt Med, Prague 4, Czech Republic	Seoul National University (SNU); Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Room 405 Convergence Res Bldg,103 Daehak Ro, Seoul 03080, South Korea.	suhyho@snu.ac.kr	Suh, Young Ho/AAJ-6405-2021; Horak, Martin/F-9819-2010	Suh, Young Ho/0000-0003-3979-1615; Horak, Martin/0000-0002-4359-051X	Korea Health Industry Development Institute (KHIDI) [HI18C0789]; National Research Foundation of Korea (NRF) [NRF-2018R1A2B6004759, NRF-2017M3C7A1029611, NRF-2020R1A5A1019023]; Czech Science Foundation [18-04329S]	Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Czech Science Foundation(Grant Agency of the Czech Republic)	Korea Health Industry Development Institute (KHIDI), Grant/Award Number: HI18C0789; National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2018R1A2B6004759, NRF-2017M3C7A1029611 and NRF-2020R1A5A1019023; Czech Science Foundation, Grant/Award Number: 18-04329S	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Andre S, 2009, BIOL CHEM, V390, P557, DOI 10.1515/BC.2009.072; Bertaso F, 2008, NAT NEUROSCI, V11, P940, DOI 10.1038/nn.2142; Bhave G, 2003, J BIOL CHEM, V278, P30294, DOI 10.1074/jbc.M303258200; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; BREWER CF, 1986, J BIOL CHEM, V261, P7306; Cai XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04844-w; Cao Y, 2015, NEURON, V87, P1248, DOI 10.1016/j.neuron.2015.09.002; Chan WY, 2001, MOL CELL NEUROSCI, V17, P577, DOI 10.1006/mcne.2001.0965; Choi JH, 2016, NEUROPHARMACOLOGY, V102, P229, DOI 10.1016/j.neuropharm.2015.11.021; Dev KK, 2001, TRENDS PHARMACOL SCI, V22, P355, DOI 10.1016/S0165-6147(00)01684-9; Dev KK, 2000, J NEUROSCI, V20, P7252; Dolan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080491; Dunn HA, 2019, MOL PSYCHIATR, V24, P1902, DOI 10.1038/s41380-019-0512-3; Dunn HA, 2018, P NATL ACAD SCI USA, V115, P5022, DOI 10.1073/pnas.1722498115; El Far O, 2000, EUR J NEUROSCI, V12, P4215, DOI 10.1046/j.1460-9568.2000.01309.x; Enz R, 2003, BIOCHEM J, V372, P183, DOI 10.1042/BJ20021750; Fregno I, 2019, CRIT REV BIOCHEM MOL, V54, P153, DOI 10.1080/10409238.2019.1610351; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Garcia-Campos A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004688; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Hanus C, 2016, ELIFE, V5, DOI 10.7554/eLife.20609; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hwang JW, 2018, TRENDS BIOCHEM SCI, V43, P593, DOI 10.1016/j.tibs.2018.06.005; Irani MA, 2017, PROTEINS, V85, P1529, DOI 10.1002/prot.25314; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Lee SM, 2019, 2019 INTERNATIONAL CONFERENCE ON PLATFORM TECHNOLOGY AND SERVICE (PLATCON), P7; Lichnerova K, 2015, J BIOL CHEM, V290, P18379, DOI 10.1074/jbc.M115.656546; Margraf-Schonfeld S, 2011, J BIOL CHEM, V286, P24142, DOI 10.1074/jbc.M111.225334; Mody N, 1999, NEUROPHARMACOLOGY, V38, P1485, DOI 10.1016/S0028-3908(99)00099-4; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nasrallah C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22729-4; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pelkey KA, 2008, J PHYSIOL-LONDON, V586, P1495, DOI 10.1113/jphysiol.2007.148635; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Robbins MJ, 1999, J NEUROCHEM, V72, P2539, DOI 10.1046/j.1471-4159.1999.0722539.x; Rondard P, 2015, CURR OPIN PHARMACOL, V20, P95, DOI 10.1016/j.coph.2014.12.001; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Selkirk JV, 2002, J NEUROCHEM, V80, P346, DOI 10.1046/j.0022-3042.2001.00704.x; Shental-Bechor D, 2009, CURR OPIN STRUC BIOL, V19, P524, DOI 10.1016/j.sbi.2009.07.002; Shimoda A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47760-x; Skrenkova K, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00188; Stachniak TJ, 2019, J NEUROSCI, V39, P4461, DOI 10.1523/JNEUROSCI.2276-18.2019; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; Suh YH, 2008, NEURON, V58, P736, DOI 10.1016/j.neuron.2008.03.028; Suh YH, 2018, MOL CELL NEUROSCI, V91, P10, DOI 10.1016/j.mcn.2018.03.014; Suh YH, 2013, J BIOL CHEM, V288, P17544, DOI 10.1074/jbc.M112.439513; Suh YH, 2010, NAT NEUROSCI, V13, P338, DOI 10.1038/nn.2488; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Tomioka NH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5501; Tucholski J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094255; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wu D, 2018, P NATL ACAD SCI USA, V115, P8763, DOI 10.1073/pnas.1807439115; Wu XD, 2018, CURR OPIN CELL BIOL, V53, P22, DOI 10.1016/j.ceb.2018.04.004; Zhang CS, 2008, J NEUROSCI, V28, P8604, DOI 10.1523/JNEUROSCI.0628-08.2008; Zhang L, 2016, MABS-AUSTIN, V8, P524, DOI 10.1080/19420862.2016.1149662	64	8	8	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14977	14996		10.1096/fj.202001544R	http://dx.doi.org/10.1096/fj.202001544R		SEP 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931036				2022-12-26	WOS:000570777800001
J	Tadesse, SE; Mekonnen, TC; Adane, M				Tadesse, Sisay Eshete; Mekonnen, Tefera Chane; Adane, Metadel			Priorities for intervention of childhood stunting in northeastern Ethiopia: A matched case-control study	PLOS ONE			English	Article							CHILDREN; UNDERNUTRITION; DETERMINANTS; PREVALENCE; COMMUNITY; GROWTH; INCOME; RISK; AGE	Background Stunting is a worldwide public health problem caused by factors that vary across regions, including in Ethiopia. Limited evidence to prevent stunting makes it difficult to design and prioritize appropriate interventions. Therefore, this study investigated the intervention priorities for the prevention of stunting among children 6-59 months old in Kemissie City Administration, northeastern Ethiopia. Methods A community-based individual matched case-control study was conducted from January to April 2017 including 107 cases and 214 controls. Controls were selected and matched with cases using the matching variable of child's age. Data were collected by open data kit (ODK) software using a structured questionnaire. Data were analyzed using STATA version 13.0 and WHO (World Health Organization) Anthro 2005. A conditional logistic regression model was used for data analysis. From multivariable conditional logistic regression analysis, determinants of stunting were identified. A statistically significant level was declared by a conditional adjusted odds ratio (cAOR) with 95% confidence interval (CI) andp-valueof less than 0.05. Main findings The wealth index 52 (48.6%) of the cases and 108 (50.5%) controls were categorized as poor. The mean height-for-age z-score (HAZ) for the cases and controls was -2.79 +/-.67 and -0.55 +/-.92, respectively. One-sixth (16.8%) of the cases and 29 (13.6%) of the controls were given prelacteal feeding. A majority 82 (86.9%) of the cases and 137 (69.1%) of the controls had undernourished mothers/care-givers. Slightly less than one-third 35 (32.7%) of cases and one-fourth 53 (24.8%) of controls were affected by repeated episodes of diarrhea. Mother's body mass index (BMI) (conditional adjusted odds ratio [cAOR]) = 2.64; 95% CI: 1.28, 5.43), giving food priority to father (cAOR = 2.42; 95% CI: 1.23, 4.75), lack of exclusive breastfeeding for at least 6 months (cAOR = 2.44; 95% CI: 1.15, 5.17), no intake of meat by child (cAOR = 2.35; 95% CI: 1.21, 4.58) and child having repeated diarrheal episodes (cAOR = 2.0: 95% CI: 1.07, 3.86) were factors associated with childhood stunting. Conclusion Maternal nutritional status, food priority, duration of exclusive breastfeeding, no intake of meat and repeated episodes of diarrhea were the main determinants of stunting among children aged 6-59 months. Therefore, intervention measures to avert childhood stunting should include strengthening action on provision of essential nutrition, providing counseling to parents on giving food priority to children, promotion of optimal duration of breastfeeding and preventing diarrheal disease among children 6-59 months old.	[Tadesse, Sisay Eshete; Mekonnen, Tefera Chane] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Nutr, Dessie, Ethiopia; [Adane, Metadel] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia	University of Gondar; University of Gondar	Adane, M (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.	metadel.adane2@gmail.com	Adane, Metadel/AFQ-9478-2022; Mekonnen, Tefera Chane/AAC-8002-2021	Adane, Metadel/0000-0002-7039-4768; 	Wollo University	Wollo University	Wollo University funded this research. The funders had no role in study design, data collection and analysis, decisions to publish, interpretation of the data and preparation of the manuscript for publication.	Adane M, 2018, J COMMUN HEALTH, V43, P400, DOI 10.1007/s10900-017-0437-1; Adane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182783; Adane M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181516; African Hunter, 2010, AFRICAN HUNTER, V13, pXI; Alemayehu M, 2015, NUTRITION, V31, P964, DOI 10.1016/j.nut.2015.01.013; Angood C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153221; [Anonymous], 2009, Rev. chil. pediatr., V80, P379; [Anonymous], 2009, HEMATOL ONCOL CLIN N, V23, pviii, DOI 10.1016/j.hoc.2008.11.006; [Anonymous], 2016, YB ILC 2, VII, P177; [Anonymous], 2014, ATMOS CHEM PHYS DISC, V14, pC9360; [Anonymous], 2011, MED SCI MONIT, V17, pCR577; [Anonymous], 2008, LANCET, V371, P1247, DOI [10.1016/S0140-6736(08)60559-0, DOI 10.1016/S0140-6736(08)60559-0]; Anteneh A, 2010, ETHIOP J HEALTH DEV, V24, P110; Asfaw M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1370-9; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Breurec S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004283; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Chirande L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0482-9; Clifton J, 2011, COUNTRY LEVEL EVALUA, V2; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; Dekker LH, 2010, FOOD NUTR BULL, V31, P242, DOI 10.1177/156482651003100207; Faldetta KF, 2012, J GLOBAL HLTH PERSPE, V1, P1; Farid-ul-Hasnain S, 2010, J PAK MED ASSOC, V60, P41; Fikadu T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-800; Garcia V, 2012, WORKING PAPER; Gomm W, 2016, JAMA NEUROL, V73, P410, DOI 10.1001/jamaneurol.2015.4791; Headey D., 2014, 70 IFPRI; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Hoppe C, 2004, AM J CLIN NUTR, V79, P494; Jennings TN, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300025; Jesmin A, 2011, J HEALTH POPUL NUTR, V29, P494; Leal VS, 2012, REV SAUDE PUBL, V46, P234, DOI 10.1590/S0034-89102012005000015; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P144; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Stephenson K, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-9; Tiwari R, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-239	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239255	10.1371/journal.pone.0239255	http://dx.doi.org/10.1371/journal.pone.0239255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970709	gold, Green Published			2022-12-26	WOS:000576265600072
J	van der Walt, M; Masuku, S; Botha, S; Nkwenika, T; Keddy, KH				van der Walt, Martie; Masuku, Sikhethiwe; Botha, Sonja; Nkwenika, Tshifhiwa; Keddy, Karen H.			Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa	PLOS ONE			English	Review							PATIENT; TB	Background Tuberculosis (TB) is amongst the top five causes of death in women of childbearing age (15-<= 44 years). Little is known about treatment of pregnant women with drug-resistant TB (DR-TB). Treatment for pregnant women remains challenging and more complex in DR-TB/HIV co-infection, where an evidence-based guide to clinical practice is limited. The study reviewed treatment and pregnancy outcomes and birth outcomes of their new-born in a cohort of pregnant women with DR-TB from three MDR-TB hospitals during 2010 and 2018. Design/Methods Data were extracted from: TB register and patient clinic notes using a standardized case record form. Information on DR-TB treatment, pregnancy and Adverse Drug Events (ADEs) of twenty-six pregnant women treated with individualized second-line TB medications were captured. The frequency of favourable and adverse outcomes regarding disease and pregnancy were evaluated. Results The mean age was 29 years (SD +/- 5.1), with the minimum and maximum age of 21 and 40 years, respectively. Eleven (42.3%) were previously treated with first-line TB drugs, 11 (42.3%) never treated before and 4 (15.4%) were previously treated for DR-TB. Of the 26 women, 15 (57.7%) had at least one ADE, but most had more than one ADE. Seventeen women were successfully treated, and 22 live births recorded. Live birth outcome was significantly associated with trimester of initiation of DR-TB treatment (p = 0.036). The proportion of live births for the pregnancy trimester when DR-TB treatment was initiated, were 60.0%, 90.9% and 100.0%, for first, second and third trimester, respectively. Conclusion DR-TB treatment should be delayed until after the first trimester. Routine pharmacovigilance surveillance integrated antenatal and delivery services with an integrated record of DR-TB treatment during pregnancy is recommended. Prospective studies using standardised case record forms for DR-TB treatment for pregnant women could provide more insight on the effect of DR-TB treatment on the birth outcome.	[van der Walt, Martie; Masuku, Sikhethiwe; Botha, Sonja; Keddy, Karen H.] South African Med Res Council, TB Platform Res Unit, Pretoria, South Africa; [Nkwenika, Tshifhiwa] South African Med Res Council, Biostat Res Unit, Pretoria, South Africa	South African Medical Research Council; South African Medical Research Council	Masuku, S (corresponding author), South African Med Res Council, TB Platform Res Unit, Pretoria, South Africa.	Sikhethiwe.Masuku@mrc.ac.za	Masuku, Sikhethiwe/GWQ-5712-2022; van der Walt, Martie/CAH-0101-2022	van der Walt, Martie/0000-0001-9987-3167	South African Medical Research Council (SAMRC)	South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by our organization, the South African Medical Research Council (SAMRC), TB Platform. The authors are employees of SAMRC therefore, received salaries, travel and accommodation during data collection. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanova Y, 2017, THORAX, V72, P850, DOI 10.1136/thoraxjnl-2016-209841; Bekker A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164249; Easterbrook PJ, 2014, AIDS, V28, pS93, DOI 10.1097/QAD.0000000000000253; Grange J, 2010, INT J GYNECOL OBSTET, V108, P181, DOI 10.1016/j.ijgo.2009.12.005; Heunis JC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3972-2; Kelly AM, 2016, INT J TUBERC LUNG D, V20, P442, DOI 10.5588/ijtld.15.0318; Khan M, 2007, INT J TUBERC LUNG D, V11, P706; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; Lange C, 2018, RESPIROLOGY, V23, P656, DOI 10.1111/resp.13304; Loveday M, 2019, EMERG INFECT DIS, V25, P609, DOI 10.3201/eid2503.181571; McKenna L, 2017, CLIN INFECT DIS, V65, P1383, DOI 10.1093/cid/cix533; National Department of Health, 2018, THE 2015 NATIONAL AN; Palacios E, 2009, CLIN INFECT DIS, V48, P1413, DOI 10.1086/598191; Raznatovska OM, 2019, ZAPOROZHYE MED J, V21, P691, DOI 10.14739/2310-1210.2019.5.179473; Schnippel K, 2016, SAMJ S AFR MED J, V106, P30, DOI [10.7196/SAMJ.2016.v106i4.10205, 10.7196/samj.2016v106i4.10205]; Statistics Canada0, 2019, MENT HLTH CAR NEEDS, P1; Sugarman J, 2014, LANCET GLOB HEALTH, V2, pE710, DOI 10.1016/S2214-109X(14)70330-4; Van der Walt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058817; Van Kampenhout E, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01724-2016; WHO, 2019, GLOB TUB REP; World Health Organization, 2020, DEF REP FRAM TUB 201	21	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239018	10.1371/journal.pone.0239018	http://dx.doi.org/10.1371/journal.pone.0239018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970722	gold, Green Published			2022-12-26	WOS:000576265600070
J	Li, JM; Ma, Y; Kong, LJ; Liu, YL				Li, Jingmiao; Ma, Yao; Kong, Lijuan; Liu, Yulin			Comprehensive profiling of phytochemical compounds, antioxidant activities, anti-HepG2 cell proliferation, and cholinesterase inhibitory potential ofElaeagnus mollisleaf extracts	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; ZANTHOXYLUM-BUNGEANUM; CHEMICAL-COMPOSITION; ASSISTED EXTRACTION; IN-VITRO; CONSTITUENTS; ALKALOIDS; INSIGHTS; LEAVES; SOLVENT	The aim of this work was to enrich the knowledge on the potential applications ofElaeagnus mollisleaf extracts. For this purpose, the bioactive compounds (phenolic, flavonoid, alkaloid, proanthocyanidin, chlorophyll and carotene content), antioxidant activity, anti-HepG2 cell proliferation, and cholinesterase inhibitory potential (AChE and BChE) ofE.mollisleaves which obtained from different habitats were quantitatively analyzed using various solvents (water, methanol, ethanol, and n-hexane). The results showed that the methanol extracts exhibited the strongest 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activity and the water extracts showed the best antioxidant activity in the 2,2'-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) free radical scavenging activity, ferric reducing antioxidant power (FRAP), and reducing power (RP) assays. Moreover, the methanol extracts showed the best inhibitory activity against cholinesterase and HepG2 cancer cells. Correlation analysis revealed that the high antioxidant and anti-HepG2 cell proliferation activities were mainly attributed to the total phenolics, flavonoids, and proanthocyanidins while AChE inhibition was attributed to the total alkaloid and carotene content. The statistical results showed that the effect of habitats was lower than that of different solvents used. Additionally, the metabolic profiles ofE.mollisleaves were evaluated using HPLC-ESI-Q TRAP-MS/MS, and a total of 1,017 chemical components were detected and classified into 23 classes. The organic acids and derivatives ranked the first, followed by flavone, amino acid and derivatives, and so on. In conclusion, the effects of different solvents were more significant than the effects of different habitats and the methanol extracts ofE.mollisleaves could be used as an effective source of functional active components, provide benefits to physical health care and be applied to the food and pharmaceutical industries.	[Li, Jingmiao; Ma, Yao; Kong, Lijuan; Liu, Yulin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Liu, YL (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	liuyulin@nwafu.edu.cn			National Natural Science Foundation of China [31600549]; Doctor Faculty Inaugurating Project of Northwest AF University [2452015296]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor Faculty Inaugurating Project of Northwest AF University	This work was supported by the National Natural Science Foundation of China (31600549) and Doctor Faculty Inaugurating Project of Northwest A&F University (2452015296).	A. AC, 2019, MOLECULES, V24, P1; Abd Hamid H, 2017, FOOD CHEM TOXICOL, V108, P451, DOI 10.1016/j.fct.2016.10.004; Ali IB, 2014, IND CROP PROD, V62, P188, DOI 10.1016/j.indcrop.2014.08.021; [Anonymous], 2019, CIRCULATION, V2019; Avello MA, 2013, REV BRAS FARMACOGN, V23, P44, DOI 10.1590/S0102-695X2012005000122; Balkan IA, 2017, IND CROP PROD, V95, P695, DOI 10.1016/j.indcrop.2016.11.038; Baloglu MC, 2019, IND CROP PROD, V134, P33, DOI 10.1016/j.indcrop.2019.03.066; Bao JZ, 2005, J AGR SCI, V26, P43; Barbouchi M, 2020, J KING SAUD UNIV SCI, V32, P302, DOI 10.1016/j.jksus.2018.05.010; Beata O, 2018, FRONT PHARM, V9, P232, DOI [10.3389/fphar.2018.00232, DOI 10.3389/FPHAR.2018.00232]; Bergantin C, 2018, MOLECULES, V23, DOI 10.3390/molecules23112791; Bhutada PR, 2016, IND CROP PROD, V82, P74, DOI 10.1016/j.indcrop.2015.12.004; Chai WM, 2018, FOOD CHEM, V260, P27, DOI 10.1016/j.foodchem.2018.04.001; Chen XQ, 2019, IND CROP PROD, V134, P225, DOI 10.1016/j.indcrop.2019.04.017; de Abreu IN, 2005, PLANT PHYSIOL BIOCH, V43, P241, DOI 10.1016/j.plaphy.2005.01.020; Dong HM, 2015, IND CROP PROD, V76, P290, DOI 10.1016/j.indcrop.2015.04.051; [冯笑笑 Feng Xiaoxiao], 2016, [食品科学, Food Science], V37, P160; Galanakis CM, 2013, INT J FOOD PROP, V16, P382, DOI 10.1080/10942912.2010.522750; Gao Xiang, 2011, Bulletin of Botanical Research, V31, P363; Ghane SG, 2018, IND CROP PROD, V125, P168, DOI 10.1016/j.indcrop.2018.08.087; Gunathilake KDPP, 2016, J FUNCT FOODS, V26, P176, DOI 10.1016/j.jff.2016.07.015; Hamidpour Rafie, 2017, J Tradit Complement Med, V7, P24, DOI 10.1016/j.jtcme.2015.09.004; Jay Mehta, 2018, ANTIOXIDANTS; Leshchyns'ka I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/6427537; LIU CY, 2019, BIOMED PHARMACOTHER, V0120, DOI DOI 10.1016/J.BI0PHA.2019.109543; Liu HanYing, 2014, Drugs and Clinic, V29, P135; Lu J, 2018, IND CROP PROD, V122, P522, DOI 10.1016/j.indcrop.2018.06.026; Ma Y, 2019, IND CROP PROD, V142, DOI 10.1016/j.indcrop.2019.111872; Majumder D, 2019, J FUNCT FOODS, V58, P266, DOI 10.1016/j.jff.2019.05.005; Mao's Chairman, 2010, DANGDAI YATAI, V4, P118; Naczk M, 2006, J PHARMACEUT BIOMED, V41, P1523, DOI 10.1016/j.jpba.2006.04.002; Nazir N, 2020, BRAZILIAN J BOT, V2020, P1; Nazir Nausheen, 2020, BMC Complement Med Ther, V20, P143, DOI 10.1186/s12906-020-02942-3; Nazir N, 2020, ENVIRON SCI POLLUT R, V27, P7639, DOI 10.1007/s11356-019-07065-y; Nazir N, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2381-8; Ozen T, 2017, COMB CHEM HIGH T SCR, V20, P559, DOI 10.2174/1386207320666170127161837; Murray AP, 2013, CURR NEUROPHARMACOL, V11, P388, DOI 10.2174/1570159X11311040004; Quan HF, 2017, NINGXIA MED J, V39, P980, DOI [10.13621/j.1001-5949.2017.11.0980, DOI 10.13621/J.1001-5949.2017.11.0980]; Rafinska K, 2019, FOOD CHEM, V289, P16, DOI 10.1016/j.foodchem.2019.03.025; Rezaie M, 2015, FOOD CHEM, V173, P577, DOI 10.1016/j.foodchem.2014.10.081; Roby MHH, 2013, IND CROP PROD, V43, P827, DOI 10.1016/j.indcrop.2012.08.029; Shao FenJuan, 2008, Acta Botanica Boreali-Occidentalia Sinica, V28, P1339; Tavsan Z, 2019, BIOMED PHARMACOTHER, V116, DOI 10.1016/j.biopha.2019.109004; Tian WY, 2018, IND CROP PROD, V125, P537, DOI 10.1016/j.indcrop.2018.09.045; Tlili N, 2010, PLANT FOOD HUM NUTR, V65, P260, DOI 10.1007/s11130-010-0180-6; Uysal S, 2018, FOOD CHEM TOXICOL, V111, P525, DOI 10.1016/j.fct.2017.11.058; V Shwetha, 2019, J Oral Biol Craniofac Res, V9, P215, DOI 10.1016/j.jobcr.2018.05.001; Vasco C, 2008, FOOD CHEM, V111, P816, DOI 10.1016/j.foodchem.2008.04.054; Wu YB, 2010, J ASIAN NAT PROD RES, V12, P278, DOI 10.1080/10286021003742665; Yang XG, 2008, J AGR FOOD CHEM, V56, P1689, DOI 10.1021/jf0728101	50	0	0	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239497	10.1371/journal.pone.0239497	http://dx.doi.org/10.1371/journal.pone.0239497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966304	Green Published, gold			2022-12-26	WOS:000575688700032
J	Diaz-Lara, A; Erickson, TM; Golino, D; Al Rwahnih, M				Diaz-Lara, Alfredo; Erickson, Teresa M.; Golino, Deborah; Al Rwahnih, Maher			Development of a universal RT-PCR assay for grapevine vitiviruses	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; RUGOSE WOOD; VIRUS-A; DEGENERATE; IDENTIFICATION; ALIGNMENT; PRIMERS; TISSUE	The genusVitivirusin the familyBetaflexiviridaeincludes eleven viruses known to infect grapevine: grapevine vitiviruses A, B, D, E, F, G, H, I, J, L and M (GVA-GVM). Three of these viruses, GVA, GVB and GVD, have been associated with the etiology of rugose wood disease in grapevine and cause agronomically significant losses. The other vitiviruses were more recently discovered and their effects on grapevine are undetermined. To certify grape material for propagation as virus tested, an updated reverse transcription PCR (RT-PCR) assay to detect all known vitiviruses is desirable. To accomplish this, multiple grapevine vitivirus sequences were aligned at the amino acid level to search for conserved motifs. Two highly conserved motifs were found at an ideal distance for RT-PCR detection in the RNA-dependent RNA polymerase region of the replicase protein. The amino acid motifs were back translated to create degenerate primers and used to successfully amplify all eleven grapevine vitiviruses. The RT-PCR primers were used to test a panel of vitivirus-infected vines for inclusivity as well as vines infected with closely related viruses in theBetaflexiviridaefamily (i.e. grapevine pinot gris virus and grapevine rupestris stem pitting-associated virus) for exclusivity. Broader use of these primers to detect vitiviruses in other plant hosts was investigated. In summary, an end-point RT-PCR assay that detects all the known grapevine vitiviruses and potentially other members of the genusVitivirushas been developed. The universal assay represents an alternative to individual assays to reduce the work associated with the diagnosis of vitiviruses, including for regulatory purposes.	[Diaz-Lara, Alfredo; Golino, Deborah; Al Rwahnih, Maher] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Erickson, Teresa M.] Univ Calif Davis, Fdn Plant Serv, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Al Rwahnih, M (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	malrwahnih@ucdavis.edu	Diaz-Lara, Alfredo/AFJ-8316-2022; Diaz-Lara, Alfredo/AAF-5150-2022	Diaz-Lara, Alfredo/0000-0002-4736-8019; Al Rwahnih, Maher/0000-0003-1589-9234	California Department of Food and Agriculture-Fruit Tree, Nut Tree and Grapevine Improvement Advisory Board	California Department of Food and Agriculture-Fruit Tree, Nut Tree and Grapevine Improvement Advisory Board	This research project was funded by the California Department of Food and Agriculture-Fruit Tree, Nut Tree and Grapevine Improvement Advisory Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabi OJ, 2019, ARCH VIROL, V164, P1739, DOI 10.1007/s00705-019-04252-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bonavia M, 1996, VITIS, V35, P53; CHEVALIER S, 1995, J PHYTOPATHOL, V143, P369, DOI 10.1111/j.1439-0434.1995.tb00277.x; Debat H, 2019, EUR J PLANT PATHOL, V155, P319, DOI 10.1007/s10658-019-01727-w; Diaz-Lara A, 2019, ARCH VIROL, V164, P2573, DOI 10.1007/s00705-019-04355-1; Digiaro M, 2007, J VIROL METHODS, V141, P34, DOI 10.1016/j.jviromet.2006.11.033; Dovas CI, 2003, J VIROL METHODS, V107, P99, DOI 10.1016/S0166-0934(02)00197-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Foissac X, 2005, PHYTOPATHOLOGY, V95, P617, DOI 10.1094/PHYTO-95-0617; Ho T, 2016, VIRUS RES, V215, P72, DOI 10.1016/j.virusres.2016.01.017; James D, 2006, CAN J PLANT PATHOL, V28, P16, DOI 10.1080/07060660609507267; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Maree HJ, 2020, ARCH VIROL, V165, P451, DOI 10.1007/s00705-019-04500-w; Martelli GP, 1997, ARCH VIROLOGY, V142; MINAFRA A, 1994, J VIROL METHODS, V47, P175, DOI 10.1016/0166-0934(94)90076-0; MINAFRA A, 1992, VITIS, V31, P221; Minafra A, 2017, GRAPEVINE VIRUSES MO, P229; Osman F, 2006, J VIROL METHODS, V133, P130, DOI 10.1016/j.jviromet.2005.11.005; Puckett J, 2018, D GRAPEVINE VIRUS CO; Rice P, 2000, EMBOSS EUROPEAN MOL; Rosa C, 2011, AM J ENOL VITICULT, V62, P207, DOI 10.5344/ajev.2011.10104; Rowhani A, 2018, EUR J PLANT PATHOL, V151, P919, DOI 10.1007/s10658-018-1426-7; Saldarelli P, 1998, EUR J PLANT PATHOL, V104, P945, DOI 10.1023/A:1008608506699; Thekke-Veetil T, 2019, ARCH VIROL, V164, P2609, DOI 10.1007/s00705-019-04344-4; Tzanetakis IE, 2007, ARCH VIROL, V152, P2027, DOI 10.1007/s00705-007-1030-1	26	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239522	10.1371/journal.pone.0239522	http://dx.doi.org/10.1371/journal.pone.0239522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960934	Green Published, gold			2022-12-26	WOS:000575109500019
J	Dougherty, RJ; Moonen, J; Yaffe, K; Sidney, S; Davatzikos, C; Habes, M; Launer, LJ				Dougherty, Ryan J.; Moonen, Justine; Yaffe, Kristine; Sidney, Stephen; Davatzikos, Christos; Habes, Mohamad; Launer, Lenore J.			Smoking mediates the relationship between SES and brain volume: The CARDIA study	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; SOCIOECONOMIC-STATUS; ALZHEIMERS-DISEASE; HEALTH BEHAVIORS; EDUCATION; POPULATION; OCCUPATION; DEMENTIA; ADULTS; DISPARITIES	Objective Investigate whether socioeconomic status (SES) was related to brain volume in aging related regions, and if so, determine whether this relationship was mediated by lifestyle factors that are known to associate with risk of dementia in a population-based sample of community dwelling middle-aged adults. Methods We studied 645 (41% black) participants (mean age 55.3 +/- 3.5) from the Coronary Artery Risk Development in Young Adults (CARDIA) study who underwent brain magnetic resonance imaging. SES was operationalized as a composite measure of annual income and years of education. Gray matter volume was estimated within the insular cortex, thalamus, cingulate, frontal, inferior parietal, and lateral temporal cortex. These regions are vulnerable to age-related atrophy captured by the Spatial Pattern of Atrophy for Recognition of Brain Aging (SPARE-BA) index. Lifestyle factors of interest included physical activity, cognitive activity (e.g. book/newspaper reading), smoking status, alcohol consumption, and diet. Multivariable linear regressions tested the association between SES and brain volume. Sobel mediation analyses determined if this association was mediated by lifestyle factors. All models were age, sex, and race adjusted. Results Higher SES was positively associated with brain volume (beta = .109 SE = .039;p< .01) and smoking status significantly mediated this relationship (z = 2.57). With respect to brain volume, smoking accounted for 27% of the variance (beta = -.179 SE = .065;p< .01) that was previously attributed to SES. Conclusion Targeting smoking cessation could be an efficacious means to reduce the health disparity of low SES on brain volume and may decrease vulnerability for dementia.	[Dougherty, Ryan J.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Dougherty, Ryan J.; Moonen, Justine; Launer, Lenore J.] NIA, Bethesda, MD 20892 USA; [Yaffe, Kristine] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yaffe, Kristine] San Francisco VA Hlth Care Syst, San Francisco, CA USA; [Sidney, Stephen] Kaiser Permanente Div Res, Oakland, CA USA; [Sidney, Stephen] Kaiser Permanente Northern Calif, Oakland, CA USA; [Davatzikos, Christos; Habes, Mohamad] Univ Penn, Philadelphia, PA 19104 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente; University of Pennsylvania	Dougherty, RJ (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.; Dougherty, RJ (corresponding author), NIA, Bethesda, MD 20892 USA.	rdoughe7@jhu.edu	s, s/HIK-1178-2022; s, s/HHD-0404-2022; Davatzikos, Christos/ABE-2057-2021; s, s/GYR-2278-2022	Dougherty, Ryan/0000-0002-8640-9549	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, HHSN268201800007I]; Intramural Research Program of the National Institute on Aging (NIA); NIA [AG0005]; NHLBI [AG0005]; National Service Research Award from the National Institute on Aging of the National Institutes of Health [F31AG062009]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Service Research Award from the National Institute on Aging of the National Institutes of Health	The Coronary Artery Risk Development in Young Adults Study (CARDIA) is supported by contracts HHSN268201800003I, HHSN268201800004I, HHSN268201800005I, HHSN268201800006I, and HHSN268201800007I from the National Heart, Lung, and Blood Institute (NHLBI). CARDIA was also partially supported by the Intramural Research Program of the National Institute on Aging (NIA) and an intra-agency agreement between NIA and NHLBI (AG0005). This manuscript has been reviewed by CARDIA for scientific content. There were no financial relationships with any organizations that might have an interest in the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kaiser Permanente provided support in the form of salary for author SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the `author contributions' section. RJD was supported by a National Service Research Award from the National Institute on Aging of the National Institutes of Health under Award Number F31AG062009.	Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Anttila T, 2002, NEUROLOGY, V59, P887, DOI 10.1212/WNL.59.6.887; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boone-Heinonen J, 2011, SOC SCI MED, V72, P641, DOI 10.1016/j.socscimed.2010.12.013; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brito NH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00276; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Cohen S, 2006, PSYCHOSOM MED, V68, P41, DOI 10.1097/01.psy.0000195967.51768.ea; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Debette S, 2011, NEUROLOGY, V77, P461, DOI 10.1212/WNL.0b013e318227b227; Doshi J, 2016, NEUROIMAGE, V127, P186, DOI 10.1016/j.neuroimage.2015.11.073; Doshi J, 2013, ACAD RADIOL, V20, P1566, DOI 10.1016/j.acra.2013.09.010; Dougherty Ryan J, 2016, Alzheimers Dement (Amst), V4, P14, DOI 10.1016/j.dadm.2016.03.005; Durazzo TC, 2017, DRUG ALCOHOL DEPEN, V177, P228, DOI 10.1016/j.drugalcdep.2017.04.012; Durazzo TC, 2015, INT J ENV RES PUB HE, V12, P8198, DOI 10.3390/ijerph120708198; Durazzo TC, 2014, ALZHEIMERS DEMENT, V10, pS122, DOI 10.1016/j.jalz.2014.04.009; Elbejjani M, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0401-1; Elbejjani M, 2017, PSYCHOSOM MED, V79, P14, DOI 10.1097/PSY.0000000000000365; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; Farah MJ, 2017, NEURON, V96, P56, DOI 10.1016/j.neuron.2017.08.034; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Fox NC, 2004, LANCET, V363, P392, DOI 10.1016/S0140-6736(04)15441-X; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Goldbourt U, 2007, J NEUROL SCI, V257, P177, DOI 10.1016/j.jns.2007.01.021; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; Habes M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.39; Habes M, 2016, BRAIN, V139, P1164, DOI 10.1093/brain/aww008; Hiscock R, 2012, ANN NY ACAD SCI, V1248, P107, DOI 10.1111/j.1749-6632.2011.06202.x; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Karp A, 2004, AM J EPIDEMIOL, V159, P175, DOI 10.1093/aje/kwh018; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Launer LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122138; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Liu YW, 2012, NEURORADIOLOGY, V54, P929, DOI 10.1007/s00234-012-1005-0; Merchant C, 1999, NEUROLOGY, V52, P1408, DOI 10.1212/WNL.52.7.1408; Munoz DG, 2000, ARCH NEUROL-CHICAGO, V57, P85, DOI 10.1001/archneur.57.1.85; Muscatell KA, 2018, ANN NY ACAD SCI, V1428, P14, DOI 10.1111/nyas.13862; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Schroeder SA, 2014, JAMA-J AM MED ASSOC, V311, P141, DOI 10.1001/jama.2013.285243; Shaked D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216338; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; SIDNEY S, 1991, AM J EPIDEMIOL, V133, P1231, DOI 10.1093/oxfordjournals.aje.a115835; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Yaffe K, 2018, JAMA INTERN MED, V178, P281, DOI 10.1001/jamainternmed.2017.7299; Zacharaki EI, 2008, LECT NOTES COMPUT SC, V5241, P620, DOI 10.1007/978-3-540-85988-8_74	54	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239548	10.1371/journal.pone.0239548	http://dx.doi.org/10.1371/journal.pone.0239548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NV8NR	32956388	gold, Green Published			2022-12-26	WOS:000574571500037
J	Gao, J; Jiang, Y; Zhang, H; Wang, FL				Gao, Jing; Jiang, Yun; Zhang, Hai; Wang, Falin			Joint disc and cup segmentation based on recurrent fully convolutional network	PLOS ONE			English	Article							DIGITAL FUNDUS IMAGES; OPTIC DISC; FEATURE-EXTRACTION; BOUNDARY	The optic disc(OD) and the optic cup(OC) segmentation is an key step in fundus medical image analysis. Previously, FCN-based methods have been proposed for medical image segmentation tasks. However, the consecutive convolution and pooling operations usually hinder dense prediction tasks which require detailed spatial information, such as image segmentation. In this paper, we propose a network called Recurrent Fully Convolution Network(RFC-Net) for automatic joint segmentation of the OD and the OC, which can captures more high-level information and subtle edge information. The RFC-Net can minimize the loss of spatial information. It is mainly composed of multi-scale input layer, recurrent fully convolutional network, multiple output layer and polar transformation. In RFC-Net, the multi-scale input layer constructs an image pyramid. We propose four recurrent units, which are respectively applied to RFC-Net. Recurrent convolution layer effectively ensures feature representation for OD and OC segmentation tasks through feature accumulation. For each multiple output image, the multiple output cross entropy loss function is applied. To better balance the cup ratio of the segmented image, the polar transformation is used to transform the fundus image from the cartesian coordinate system to the polar coordinate system. We evaluate the effectiveness and generalization of the proposed method on the DRISHTI-GS1 dataset. Compared with the original FCN method and other state-of-the-art methods, the proposed method achieves better segmentation performance.	[Gao, Jing; Jiang, Yun; Zhang, Hai; Wang, Falin] Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China	Northwest Normal University - China	Gao, J (corresponding author), Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China.	2234254566@qq.com			National Natural Science Foundation of China [61962054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant 61962054.	Al-Bander B, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10040087; Alom MdZ, 2017, INCEPTION RECURRENT; Alom MZ, 2018, ARXIV180206955, DOI [10.1117/1.JMI.6.1.014006, DOI 10.1117/1.JMI.6.1.014006]; Aquino A, 2010, IEEE T MED IMAGING, V29, P1860, DOI 10.1109/TMI.2010.2053042; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; Chakravarty A, 2019, IEEE J BIOMED HEALTH, V23, P1151, DOI 10.1109/JBHI.2018.2852635; Chakravarty A, 2017, COMPUT METH PROG BIO, V147, P51, DOI 10.1016/j.cmpb.2017.06.004; Cheng J, 2013, IEEE T MED IMAGING, V32, P1019, DOI 10.1109/TMI.2013.2247770; DAMMS T, 1993, INVEST OPHTH VIS SCI, V34, P2246; Fu HZ, 2018, IEEE T MED IMAGING, V37, P2493, DOI 10.1109/TMI.2018.2837012; Fu HZ, 2018, IEEE T MED IMAGING, V37, P1597, DOI 10.1109/TMI.2018.2791488; Gu ZW, 2019, IEEE T MED IMAGING, V38, P2281, DOI 10.1109/TMI.2019.2903562; Harizman N, 2006, ARCH OPHTHALMOL-CHIC, V124, P1579, DOI 10.1001/archopht.124.11.1579; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Jiang Y, 2019, IEEE ACCESS, V7, P64483, DOI 10.1109/ACCESS.2019.2917508; Jonas JB, 2000, INVEST OPHTH VIS SCI, V41, P1764; Joshi GD, 2012, IEEE T BIO-MED ENG, V59, P1523, DOI 10.1109/TBME.2012.2187293; Joshua AO, 2019, 2019 SOUTHERN AFRICAN UNIVERSITIES POWER ENGINEERING CONFERENCE/ROBOTICS AND MECHATRONICS/PATTERN RECOGNITION ASSOCIATION OF SOUTH AFRICA (SAUPEC/ROBMECH/PRASA), P183, DOI 10.1109/RoboMech.2019.8704727; Ketkar N., 2017, DEEP LEARNING PYTHON, V1, DOI DOI 10.1007/978-1-4842-2766-4; Li GB, 2016, IEEE T IMAGE PROCESS, V25, P5012, DOI 10.1109/TIP.2016.2602079; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Mittapalli PS, 2016, BIOMED SIGNAL PROCES, V24, P34, DOI 10.1016/j.bspc.2015.09.003; Pallawala PMDS, 2004, LECT NOTES COMPUT SC, V3022, P139; Poudel RPK, 2017, LECT NOTES COMPUT SC, V10129, P83, DOI 10.1007/978-3-319-52280-7_8; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sevastopolsky A., 2017, [Pattern Recognition and Image Analysis (Advances in Mathematical Theory and Applications), Pattern Recognition and Image Analysis. (Advances in Mathematical Theory and Applications)], V27, P618, DOI 10.1134/S1054661817030269; Sevastopolsky A, 2018, ARXIV180411294; Sivaswamy J, 2014, I S BIOMED IMAGING, P53, DOI 10.1109/ISBI.2014.6867807; Valipour S, 2017, IEEE WINT CONF APPL, P29, DOI 10.1109/WACV.2017.11; Wang L, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-019-1558-z; Wang SJ, 2019, IEEE T MED IMAGING, V38, P2485, DOI 10.1109/TMI.2019.2899910; Xu J, 2007, PATTERN RECOGN, V40, P2063, DOI 10.1016/j.patcog.2006.10.015; Zheng YJ, 2013, LECT NOTES COMPUT SC, V8150, P75, DOI 10.1007/978-3-642-40763-5_10; Zhu XL, 2008, IEEE ENG MED BIO, P3546, DOI 10.1109/IEMBS.2008.4649971; Zilly Julian G., 2015, Machine Learning in Medical Imaging. 6th International Workshop, MLMI 2015, held in conjunction with MICCAI 2015. Proceedings: LNCS 9352, P136, DOI 10.1007/978-3-319-24888-2_17	35	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238983	10.1371/journal.pone.0238983	http://dx.doi.org/10.1371/journal.pone.0238983			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956372	gold, Green Published			2022-12-26	WOS:000574571500052
J	Lin, QZ; He, T; Sun, YK; He, X; Qiu, J				Lin, Qizhao; He, Tuo; Sun, Yongke; He, Xin; Qiu, Jian			A computer-aided method for identifying the presence of softwood growth ring boundaries	PLOS ONE			English	Article							IDENTIFICATION	The objective of this study was to develop a computer-aided method to quantify the obvious degree of growth ring boundaries of softwood species, based on data analysis with some image processing technologies. For this purpose, a 5x magnified cross-section color micro-image of softwood was cropped into 20 sub-images, and then every image was binarized as a gray image according to an automatic threshold value. After that, the number of black pixels in the gray image was counted row by row and the number of black pixels was binarized to 0 or 100. Finally, a transition band from earlywood to latewood on the sub-image was identified. If everything goes as planned, the growth ring boundaries of the sub-image would be distinct. Otherwise would be indistinct or absent. If more than 50% sub-images are distinct, with the majority voting method, the growth ring boundaries of softwood would be distinct, otherwise would be indistinct or absent. The proposed method has been visualized as a growth-ring-boundary detecting system based on the .NET Framework. A sample of 100 micro-images (see S1 Fig via https://github.com/senly2019/Lin-Qizhao/) of softwood cross-sections were selected for evaluation purposes. In short, this detecting system computes the obvious degree of growth ring boundaries of softwood species by image processing involving image importing, image cropping, image reading, image grayscale, image binarization, data analysis. The results showed that the method used avoided mistakes made by the manual comparison method of identifying the presence of growth ring boundaries, and it has a high accuracy of 98%.	[Lin, Qizhao; Sun, Yongke; He, Xin; Qiu, Jian] Southwest Forestry Univ, Coll Mat Sci & Engn, Kunming, Yunnan, Peoples R China; [He, Tuo] Chinese Acad Forestry, Res Inst Wood Ind, Beijing, Peoples R China; [He, Tuo] Chinese Acad Forestry, Wood Collect WOODPEDIA, Beijing, Peoples R China	Southwest Forestry University - China; Chinese Academy of Forestry; Research Institute of Wood Industry, CAF; Chinese Academy of Forestry	Lin, QZ; Qiu, J (corresponding author), Southwest Forestry Univ, Coll Mat Sci & Engn, Kunming, Yunnan, Peoples R China.	linqizhao@swfu.edu.cn; qiujian@swfu.edu.cn		Lin, Qizhao/0000-0003-1320-6430	National Keypoint Research and Invention Program in 13th Five-Year, China [2016YFD0600702]	National Keypoint Research and Invention Program in 13th Five-Year, China	This work was supported by the National Keypoint Research and Invention Program in 13th Five-Year, China, No. 2016YFD0600702 to JQ.	[Anonymous], 2013, ROCK SOIL MECH, V34, P433; Baas P, 2004, IAWA J, V25, P1, DOI 10.1163/22941932-90000349; Boyer RS, 1991, AUTOMATED REASONING, P105, DOI DOI 10.1007/978-94-011-3488-0_5; Fahrurozi A, 2016, J PHYS CONF SER, V725, DOI 10.1088/1742-6596/725/1/012005; Fonti P, 2010, NEW PHYTOL, V185, P42, DOI 10.1111/j.1469-8137.2009.03030.x; Fuentealba C, 2005, WOOD PRODUCTS IDENTI; Gani W, 2013, QUAL RELIAB ENG INT, V29, P841, DOI 10.1002/qre.1440; He WW, 2018, CHINESE CHEM LETT, V29, P857, DOI 10.1016/j.cclet.2017.10.003; Hwang SW, 2018, J WOOD SCI, V64, P69, DOI 10.1007/s10086-017-1680-x; Jiang X., 2010, ATLAS GYMNOSPERMS WO; Kobayashi K, 2015, J WOOD SCI, V61, P630, DOI 10.1007/s10086-015-1507-6; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Peng Z, 2013, OPTIK, V124, P2833, DOI 10.1016/j.ijleo.2012.08.058; Sezgin M, 2004, J ELECTRON IMAGING, V13, P146, DOI 10.1117/1.1631315; Snel FA, 2018, WOOD SCI TECHNOL, V52, P1411, DOI 10.1007/s00226-018-1027-9; Sun Y., 2015, J COMPUT THEOR NANOS, V12, P5372, DOI [10.1166/jctn.2015.4529, DOI 10.1166/JCTN.2015.4529]; Tarelkin Y, 2016, IAWA J, V37, P275, DOI 10.1163/22941932-20160134; Vaganov EA, 2009, OECOLOGIA, V161, P729, DOI 10.1007/s00442-009-1421-y; von Arx G, 2014, DENDROCHRONOLOGIA, V32, P290, DOI 10.1016/j.dendro.2013.12.001; Wagner B, 2010, PLANT SOIL, V334, P175, DOI 10.1007/s11104-010-0370-x; Wheeler EA, 1998, IAWA J, V19, P241, DOI 10.1163/22941932-90001528; Xie YH, 2015, OPTIK, V126, P2231, DOI 10.1016/j.ijleo.2015.05.101; Yu M, 2017, PLANTA, V246, P1165, DOI 10.1007/s00425-017-2758-9; Yuce B, 2014, PROD MANUF RES, V2, P291, DOI 10.1080/21693277.2014.892442; Zhao P, 2014, OPTIK, V125, P1144, DOI 10.1016/j.ijleo.2013.07.124	25	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0235727	10.1371/journal.pone.0235727	http://dx.doi.org/10.1371/journal.pone.0235727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946443	gold, Green Submitted, Green Published			2022-12-26	WOS:000573851100010
J	Trubitsina, LI; Lisov, AV; Belova, OV; Trubitsin, IV; Demin, VV; Konstantinov, AI; Zavarzina, AG; Leontievsky, AA				Trubitsina, Liubov, I; Lisov, Alexander, V; Belova, Oxana, V; Trubitsin, Ivan, V; Demin, Vladimir V.; Konstantinov, Andrey, I; Zavarzina, Anna G.; Leontievsky, Alexey A.			Transformation of low molecular compounds and soil humic acid by two domain laccase ofStreptomyces puniceusin the presence of ferulic and caffeic acids	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR; MEDIATOR-SYSTEMS; PURIFICATION; OXIDATION; ALKALI; BIOTRANSFORMATION; POLYMERIZATION; DIMERIZATION; VERSATILE; LIGNIN	The two-domain bacterial laccases oxidize substrates at alkaline pH. The role of natural phenolic compounds in the oxidation of substrates by the enzyme is poorly understood. We have studied the role of ferulic and caffeic acids in the transformation of low molecular weight substrates and of soil humic acid (HA) by two-domain laccase ofStreptomyces puniceus(SpSL, previously undescribed). A gene encoding a two-domain laccase was cloned fromS.puniceusand over-expressed inEscherichia coli. The recombinant protein was purified by affinity chromatography to an electrophoretically homogeneous state. The enzyme showed high thermal stability, alkaline pH optimum for the oxidation of phenolic substrates and an acidic pH optimum for the oxidation of K-4[Fe(CN)(6)] (potassium ferrocyanide) and ABTS (2,2 '-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt). Phenolic compounds were oxidized with lower efficiency than K-4[Fe(CN)(6)] and ABTS. The SpSL did not oxidize 3.4-dimethoxybenzoic alcohol andp-hydroxybenzoic acid neither in the absence of phenolic acids nor in their presence. The enzyme polymerized HA-the amount of its high molecular weight fraction (>80 kDa) increased at the expense of low MW fraction (10 kDa). The addition of phenolic acids as potential mediators did not cause the destruction of HA by SpSL. In the absence of the HA, the enzyme polymerized caffeic and ferulic acids to macromolecular fractions (>80 kDa and 10-12 kDa). The interaction of SpSL with HA in the presence of phenolic acids caused an increase in the amount of HA high MW fraction and a two-fold increase in the molecular weight of its low MW fraction (from 10 to 20 kDa), suggesting a cross-coupling reaction. Infrared and solution-state(1)H-NMR spectroscopy revealed an increase in the aromaticity of HA after its interaction with phenolic acids. The results of the study expand our knowledge on the transformation of natural substrates by two-domain bacterial laccases and indicate a potentially important role of the enzyme in the formation of soil organic matter (SOM) at alkaline pH values.	[Trubitsina, Liubov, I; Lisov, Alexander, V; Belova, Oxana, V; Trubitsin, Ivan, V; Leontievsky, Alexey A.] Russian Acad Sci IBPhM RAS, GK Skryabin Inst Biochem & Physiol Microorganisms, Pushchino, Russia; [Demin, Vladimir V.; Zavarzina, Anna G.] Lomonosov Moscow State Univ, Fac Soil Sci, Moscow, Russia; [Konstantinov, Andrey, I] Lomonosov Moscow State Univ, Fac Chem, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University	Lisov, AV (corresponding author), Russian Acad Sci IBPhM RAS, GK Skryabin Inst Biochem & Physiol Microorganisms, Pushchino, Russia.	ssl208@rambler.ru	Zavarzina, Anna/ADH-3065-2022; Trubitsina, Liubov/AAE-5870-2020; Leontievsky, Alexey/AAE-7685-2022; Trubitsin, Ivan/GYV-1954-2022; Lisov, Alexander/AAO-3536-2020	Trubitsina, Liubov/0000-0002-6483-945X; Trubitsin, Ivan/0000-0002-0028-1629; Leontievsky, Alexey/0000-0002-7983-4758	Russian Science Foundation [17-14-01207]; Russian Foundation for Basic Research (RFBR) [18-34-00566]; Russian Science Foundation [20-14-18013] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The authors are grateful to the Russian Science Foundation (grant No. 17-14-01207) and Russian Foundation for Basic Research (RFBR, grant no. 18-34-00566) for financial support of this work. Experiments on gene cloning, expression and protein purification were supported by Russian Foundation for Basic Research (RFBR) (grant No. 18-34-00566). The experiments on interaction of phenolic compounds and humic acid with twodomain laccase were supported by Russian Science Foundation (grant No. 17-14-01207).	Adelakun OE, 2012, J MOL CATAL B-ENZYM, V74, P29, DOI 10.1016/j.molcatb.2011.08.010; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Ben Younes S, 2011, J MOL CATAL B-ENZYM, V73, P35, DOI 10.1016/j.molcatb.2011.07.014; BLIGNY R, 1983, BIOCHEM J, V209, P489, DOI 10.1042/bj2090489; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bunzel M., 2004, Czech Journal of Food Sciences, V22, P64; Bunzel M, 2006, J AGR FOOD CHEM, V54, P6409, DOI 10.1021/jf061196a; Call HP, 1997, J BIOTECHNOL, V53, P163, DOI 10.1016/S0168-1656(97)01683-0; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Chefetz B, 1998, APPL ENVIRON MICROB, V64, P3175; Chen XB, 1996, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MULTIMEDIA COMPUTING AND SYSTEMS, P382, DOI 10.1109/MMCS.1996.535001; Copete LS, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0192-2; Eggert C, 1996, FEBS LETT, V391, P144, DOI 10.1016/0014-5793(96)00719-3; Eggert C, 1998, APPL ENVIRON MICROB, V64, P1766; Fry Stephen C., 2004, Phytochemistry Reviews, V3, P97, DOI 10.1023/B:PHYT.0000047808.74647.43; Galletti P, 2015, ADV SYNTH CATAL, V357, P1840, DOI 10.1002/adsc.201500165; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; He Y, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10020175; Heinfling A, 1998, FEMS MICROBIOL LETT, V165, P43, DOI 10.1016/S0378-1097(98)00255-9; Hofer C, 1999, FEBS LETT, V451, P186, DOI 10.1016/S0014-5793(99)00566-9; Jaiswal N, 2015, INT J BIOL MACROMOL, V72, P326, DOI 10.1016/j.ijbiomac.2014.08.032; Janusz G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030966; Jeon JR, 2012, MICROB BIOTECHNOL, V5, P318, DOI 10.1111/j.1751-7915.2011.00273.x; Johannes C, 2000, APPL ENVIRON MICROB, V66, P524, DOI 10.1128/AEM.66.2.524-528.2000; KHANDELWAL K C, 1980, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Mikrobiologie der Landwirtschaft der Technologie und des Umweltschutzes, V135, P119; KONTCHOU CY, 1992, CAN J MICROBIOL, V38, P203, DOI 10.1139/m92-034; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kupriyanovich YN, 2007, RUSS J BIOORG CHEM+, V33, P516, DOI 10.1134/S1068162007050093; Lehmann J, 2015, NATURE, V528, P60, DOI 10.1038/nature16069; LI CY, 1970, CAN J SOIL SCI, V50, P458, DOI 10.4141/cjss70-061; Lisov AV, 2019, PROCESS BIOCHEM, V76, P128, DOI 10.1016/j.procbio.2018.11.001; Lisov A, 2012, SOIL BIOL BIOCHEM, V45, P161, DOI 10.1016/j.soilbio.2011.11.004; Machczynski MC, 2004, PROTEIN SCI, V13, P2388, DOI 10.1110/ps.04759104; Mathew S, 2006, CRIT REV MICROBIOL, V32, P115, DOI 10.1080/10408410600709628; Mattinen ML, 2008, BIORESOURCES, V3, P549; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; Morozova OV, 2007, APPL BIOCHEM MICRO+, V43, P523, DOI 10.1134/S0003683807050055; Nemadziva B, 2018, PROCESS BIOCHEM, V69, P99, DOI 10.1016/j.procbio.2018.03.009; Olofsson MA, 2014, GEODERMA, V232, P373, DOI 10.1016/j.geoderma.2014.06.005; Orlov D.S., 1990, HUMIC ACIDS SOILS GE; Park W. M., 2017, THESIS; Perminova IV, 2018, ENVIRON SCI TECHNOL, V52, P12526, DOI 10.1021/acs.est.8b01029; Senesi N, 2003, GEODERMA, V116, P325, DOI 10.1016/S0016-7061(03)00107-1; Sherif M, 2013, MICROB BIOTECHNOL, V6, P588, DOI 10.1111/1751-7915.12068; Singh R, 2017, SCI REP-UK, V7, DOI 10.1038/srep42121; Skalova T, 2009, J MOL BIOL, V385, P1165, DOI 10.1016/j.jmb.2008.11.024; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Stevenson FJ., 1994, HUMUS CHEM GENESIS C, V2, P512; Su J, 2018, CRIT REV BIOTECHNOL, V38, P294, DOI 10.1080/07388551.2017.1354353; Sun YJ, 2013, MOLECULES, V18, P561, DOI 10.3390/molecules18010561; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q; Temp U, 1999, BIOTECHNOL LETT, V21, P281, DOI 10.1023/A:1005491818192; Trubitsina LI, 2015, BIOCHIMIE, V112, P151, DOI 10.1016/j.biochi.2015.03.005; Ullrich R, 2005, APPL MICROBIOL BIOT, V67, P357, DOI 10.1007/s00253-004-1861-6; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; Yao B, 2017, SUSTAIN ENERG FUELS, V1, P1573, DOI 10.1039/c7se00209b; Zavarzina AG, 2019, EURASIAN SOIL SCI+, V52, P880, DOI 10.1134/S1064229319080167; Zavarzina AG, 2018, J GEOPHYS RES-BIOGEO, V123, P2727, DOI 10.1029/2017JG004309; Zavarzina AG, 2004, SOIL BIOL BIOCHEM, V36, P359, DOI 10.1016/j.soilbio.2003.10.010; Zhang AP, 2009, PLANTA, V229, P1099, DOI 10.1007/s00425-009-0894-6	60	8	9	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239005	10.1371/journal.pone.0239005	http://dx.doi.org/10.1371/journal.pone.0239005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946485	Green Published, gold			2022-12-26	WOS:000573851100026
J	Bandekar, G; Vestgarden, LS; Jenkins, A; Odland, A				Bandekar, Gauri; Vestgarden, Live Semb; Jenkins, Andrew; Odland, Arvid			Bioclimatic gradients and soil property trends from northernmost mainland Norway to the Svalbard archipelago. Does the arctic biome extend into mainland Norway?	PLOS ONE			English	Article							GROWING-SEASON; VEGETATION; PERMAFROST; AREA; COMMUNITIES; TEMPERATURE; ECOSYSTEMS; CLIMATE; LENGTH; NDVI	The boundary between the boreal and arctic biomes in northwest Europe has been a matter of debate for many years. Some authors consider that the boundary is marked by the northern limit of tree growth in the northernmost Norwegian mainland. In this study we have collected air and soil temperature data from 37 heath stands from northern Finnmark (71 degrees N), the northernmost part of the Norwegian mainland, through Bear Island (74 degrees N) in the Barents sea, to Adventsdalen (78)degrees N (in Spitsbergen) in Svalbard archipelago. In Finnmark, plots both south and north of the treeline were investigated. Vegetation and soil chemistry analyses were performed on the plots in Finnmark and Svalbard. Significant decreasing south-north trends in air and soil temperatures were observed from Finnmark to Spitsbergen. Soils in Finnmark were acidic and rich in organic matter, while those on Adventsdalen were basic and poor in organic matter. Vegetational analysis identified five communities: three in Finnmark and two on Adventsdalen. The communities in Finnmark had marked mutual similarities but were very different from those on Adventsdalen. No significant ecological differences between heaths south and north of the treeline in Finnmark were observed. Air and soil temperature variables in Finnmark were outside the recognized range for the arctic biome and inconsistent with the presence of permafrost both south and north of the treeline. A major difference between Finnmark and Spitsbergen was amount of soil frost and length of the growing season. Our results suggest that the boreal biome extends all the way to the north coast of mainland Norway; and previously used division of heaths in Finnmark into boreal, alpine and arctic biomes is not justified.	[Bandekar, Gauri; Vestgarden, Live Semb; Jenkins, Andrew; Odland, Arvid] Univ South Eastern Norway, Fac Technol Nat Sci & Maritime Sci, Dept Nat Sci & Environm Hlth, Bo I Telemark, Telemark, Norway; [Bandekar, Gauri] Savitribai Phule Pune Univ, Dept Environm Sci, Pune, Maharashtra, India	Savitribai Phule Pune University	Bandekar, G (corresponding author), Univ South Eastern Norway, Fac Technol Nat Sci & Maritime Sci, Dept Nat Sci & Environm Hlth, Bo I Telemark, Telemark, Norway.; Bandekar, G (corresponding author), Savitribai Phule Pune Univ, Dept Environm Sci, Pune, Maharashtra, India.	gauribandekar144@gmail.com		Jenkins, Andrew/0000-0003-2588-8483	Gunnar Knudsen og hustru Sofie fodt Cappelens familielegat funding	Gunnar Knudsen og hustru Sofie fodt Cappelens familielegat funding	Funding: Gunnar Knudsen og hustru Sofie fodt Cappelens familielegat funding provided financial support to conduct field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Akerman HJ, 2008, PERMAFROST PERIGLAC, V19, P279, DOI 10.1002/ppp.626; ALEKSANDROVA VD, 1980, ARCTIC ANTARCTIC THE; [Anonymous], 2014, R LANG ENV STAT COMP; Aune B, 1993, NATL ATLAS NORWAY MA; Bandekar G., 2017, Oecologia Montana, V26, P19; Bandekar G, 2017, PHYTOCOENOLOGIA, V47, P111, DOI 10.1127/phyto/2017/0111; BILLINGS WD, 1973, BIOSCIENCE, V23, P697, DOI 10.2307/1296827; Bliss LC, 1997, ECOSY WORLD, V3, P551; Bocher T., 1979, HOLARCTIC ECOL, V2, P218, DOI DOI 10.1111/J.1600-0587.1979.TB01292.X; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Brathen KA, 2016, FUNCT ECOL, V30, P60, DOI 10.1111/1365-2435.12458; [CAFF Conservation of Arctic Flora and Fauna (CAFF)], 1994, 1 CAFF; Chernov YI, 1997, ECOSY WORLD, V3, P361; Christiansen HH, 2010, PERMAFROST PERIGLAC, V21, P156, DOI 10.1002/ppp.687; Crawford R.M.M., 2008, ECOLOGICAL LIMITS CL; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dobinski W, 2010, POL POLAR RES, V31, P141, DOI 10.4202/ppres.2010.08; EDVARDSEN H, 1988, ARCTIC ALPINE RES, V20, P299, DOI 10.2307/1551262; EGNER HANS, 1960, KUNGL LANTBRUKSHOGSKOLANS ANN, V26, P199; ELVEBAKK A, 1985, NORD J BOT, V5, P273; ELVEBAKK A., 1999, SPECIES CONCEPT HIGH, P375; Elvebakk A., 1999, SPECIES CONCEPT HIGH, P81; Engelskjon T., 1986, POLAR RES, V5, P1; EUROLA S, 1974, AQUILO SER BOT, V13, P10; FRISVOLL AA, 1995, NINA TEMAHEFTE, V4, P1; Gisnas K, 2017, PERMAFROST PERIGLAC, V28, P359, DOI 10.1002/ppp.1922; Gj revoll O, 1956, KONG NORSKE SELSK SK, V1; Gould WA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000948; Graae BJ, 2012, OIKOS, V121, P3, DOI 10.1111/j.1600-0706.2011.19694.x; HAAPASAARI M, 1988, Acta Botanica Fennica, V135, P1; HAMET-AHTI LEENA, 1963, ANN BOT SOC ZOOL BOT FENN VANAM, V34, P1; Harper KA, 2011, CAN J FOREST RES, V41, P479, DOI 10.1139/X10-221; Harris C, 2009, EARTH-SCI REV, V92, P117, DOI 10.1016/j.earscirev.2008.12.002; Hill M.O., 2005, TWINSPAN WINDOWS VER; Holien H, 2006, NORSK LAVFLORA TAPIR; Holtmeier FK, 2003, MOUNTAIN TIMBERLINES; Hustich I., 1979, POLAR GEOGRAPHY, V3, P40; Johansen B, 2014, INT J APPL EARTH OBS, V27, P20, DOI 10.1016/j.jag.2013.07.001; Jones A., 2005, SOIL ATLAS OF EUROPE; Jones A., 2010, SOIL ATLAS NO CIRCUM, DOI [10.2788/95795, DOI 10.2788/95795]; Karlsen SR, 2005, J BIOGEOGR, V32, P1161, DOI 10.1111/j.1365-2699.2004.01199.x; Karlsen SR, 2008, INT J APPL EARTH OBS, V10, P253, DOI 10.1016/j.jag.2007.10.005; King L., 1986, Geografiska Annaler, A, V68, P131; Korner C, 2004, J BIOGEOGR, V31, P713, DOI 10.1111/j.1365-2699.2003.01043.x; Korner C, 2012, ALPINE TREELINES FUN, DOI 10.1007/978-3-0348-0396-0; Korner C, 1999, FUNCTIONAL PLANT ECO, DOI 10.1007/978-3-642-98018-3; KOROLEVA NE, 1994, J VEG SCI, V5, P803, DOI 10.2307/3236195; Lid J., 2005, NORSK FLORA; Malmstrom B., 1988, NORSK GEOGR TIDSSKR, V42, P239, DOI [10.1080/00291958808552206, DOI 10.1080/00291958808552206]; Maren Inger E., 2008, Blyttia, V66, P11; Matveyeva N, 2000, ARCTIC ENV PEOPLE PO, P233; Mazhitova GG, 2008, EURASIAN SOIL SCI+, V41, P48, DOI 10.1134/S1064229308010067; Minitab-17, 2010, MIN 17 MIN 17 STAT S; MOEN A, 1999, NATL ATLAS NORWAY; Mohr M, 2008, NEW ROUTINES GRIDDIN, V8, P1; ODLAND A, 1990, NORD J BOT, V10, P511, DOI 10.1111/j.1756-1051.1990.tb02095.x; Odland A., 2011, ALPINE ENV GEOLOGY E, P85; Oksanen J, 1997, J VEG SCI, V8, P255, DOI 10.2307/3237354; Oksanen Lauri, 1995, Acta Botanica Fennica, V153, P1; Page-Dumroese DS, 1999, SOIL SCI SOC AM J, V63, P379, DOI 10.2136/sssaj1999.03615995006300020016x; Pedlar JH, 2015, J APPL METEOROL CLIM, V54, P506, DOI 10.1175/JAMC-D-14-0045.1; Reinhardt S., 2012, Oecologia Montana, V21, P21; Robeson SM, 2002, CLIMATIC CHANGE, V52, P219, DOI 10.1023/A:1013088011223; Sjors H., 1963, N ATLANTIC BIOTA THE, P109; Skaugen TE, 2004, CLIMATE RES, V26, P221, DOI 10.3354/cr026221; Smith MW, 2002, PERMAFROST PERIGLAC, V13, P1, DOI 10.1002/ppp.410; Sollid JL, 1998, AMBIO, V27, P287; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; TUHKANEN S, 1993, NATO ADV SCI INST SE, V244, P115; TUHKANEN S, 1984, Acta Botanica Fennica, V127, P1; TUHKANEN S, 1986, NORDIA, V20, P105; Tuhkanen S., 1980, CLIMATIC PARAMETERS; Veijola P, 1998, 672 FI FINN FOR RES; VIRTANEN R, 1997, ACTA PHYTOGEOGR SUEC, V82, P1; Virtanen RJ, 1997, POLAR BIOL, V17, P95, DOI 10.1007/s003000050111; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Walker DA, 2012, ENVIRON RES LETT, V7, P1, DOI DOI 10.1088/1748-9326/7/1/015504; Walter H., 1980, VEGETATION EARTH; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Young S.B., 1971, CONTRIBUTIONS GRAY H, V201, P11; YURTSEV BA, 1994, J VEG SCI, V5, P765, DOI 10.2307/3236191	82	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239183	10.1371/journal.pone.0239183	http://dx.doi.org/10.1371/journal.pone.0239183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941518	Green Published, gold			2022-12-26	WOS:000573848800090
J	Goncalves, HVB; Canella, DS; Bandoni, DH				Barbosa Goncalves, Helida Ventura; Canella, Daniela Silva; Bandoni, Daniel Henrique			Temporal variation in food consumption of Brazilian adolescents (2009-2015)	PLOS ONE			English	Article							HEALTH-SURVEY; ENVIRONMENT; FRUIT; PENSE	Background Worldwide population has been increasingly exposed to ultra-processed foods, which are associated with obesity. Adolescence is a transition period of life and WHO recommends the surveillance of risk factors to the adolescents' health, such as diet, because experiences in this phase can result in health risks. Objective To assess the trends in food consumption of adolescents from Brazilian capitals according to sociodemographic variables, based on data from the National Survey of School Health (PeNSE). Methods Data from in 2009, 2012 and 2015 of a total of 173,310 9(th)graders enrolled in public and private schools in Brazilian capitals and in the Federal District were assessed. Food consumption was assessed from regular consumption (five or more times a week) of healthy eating markers (beans; vegetables; fruit) and unhealthy eating markers (sweets; soft drinks; fried salty snacks). For sociodemographic variables, we considered macro regions; age; race/ skin color; gender; school administrative status. We assessed these markers trends for the population and, additionally, the analyses were stratified by gender, race/ skin color, and school administrative status. Statistical significance of the temporal trends was assessed by linear regression model. Results Over six years, three types of change in Brazilian adolescents' diet were observed: decreasing regular consumption of beans, sweets and soft drinks, increasing regular consumption of vegetables, and stable consumption of fruit and fried salty snacks. Conclusion Brazilian adolescents' diet composition has changed in a short period, and therefore it is necessary to monitor it to propose actions aimed at this public.	[Barbosa Goncalves, Helida Ventura; Bandoni, Daniel Henrique] Univ Fed Sao Paulo, Inst Saude & Soc, Santos, SP, Brazil; [Canella, Daniela Silva] Univ Estado Rio de Janeiro, Inst Nutr, Rio De Janeiro, RJ, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade do Estado do Rio de Janeiro	Bandoni, DH (corresponding author), Univ Fed Sao Paulo, Inst Saude & Soc, Santos, SP, Brazil.	danielbandoni@gmail.com	Canella, Daniela/G-1553-2012	Canella, Daniela/0000-0001-9672-4983				Azeredo CM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011571; Azeredo CM, 2016, PREV MED, V88, P73, DOI 10.1016/j.ypmed.2016.03.026; Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2014, SECRETARIA DE VIGILA; Camelo LD, 2012, CAD SAUDE PUBLICA, V28, P2155, DOI 10.1590/S0102-311X2012001100015; Costa CD, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00021017, 10.1590/0102-311X00021017]; de Oliveira MM, 2017, EPIDEMIOL SERV SAUDE, V26, P605, DOI 10.5123/S1679-49742017000300017; Duran AC, 2016, PUBLIC HEALTH NUTR, V19, P1093, DOI 10.1017/S1368980015001524; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fontes AS, 2019, REV NUTR, V32, DOI 10.1590/1678-9865201932e180121; Goncalves VSS, 2019, PUBLIC HEALTH NUTR, V22, P2625, DOI 10.1017/S1368980019001010; Instituto Brasileiro de Geografia e Estatistica, 2015, PESQUISA NACIONAL PO; Instituto Brasileiro de Geografia e Estatistica, 2006, PESQ NAC AN DOM 2014; Instituto Brasileiro de Geografia e Estatistica, 2009, PESQ NAC SAUD ESC 20; Instituto Brasileiro de Geografia e Estatistica, 2013, PESQ NAC SAUD ESC 20; Instituto Brasileiro de Geografia e Estatistica, 2011, PESQ ORC FAM 2008 20; Instituto Brasileiro de Geografia e Estatistica, 2010, PESQ NAC AN DOM 2009; Instituto Brasileiro de Geografia e Estatistica, 2016, PESQ NAC SAUD ESC 20; Lago R.R., 2016, ADOLESC SAUDE, V13, P98; Locatelli NT, 2018, NUTRITION, V53, P140, DOI 10.1016/j.nut.2018.02.011; Locatelli NT, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00183615, 10.1590/0102-311X00183615]; Malta Deborah Carvalho, 2014, Rev. bras. epidemiol., V17, P77, DOI 10.1590/1809-4503201400050007; Mello MM, 2008, AM J PUBLIC HEALTH, V98, P595, DOI 10.2105/AJPH.2006.107680; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; Monteiro CA, 2018, PUBLIC HEALTH NUTR, V21, P5, DOI 10.1017/S1368980017000234; Moreno LA, 2014, ADV NUTR, V5, p615S, DOI 10.3945/an.113.005678; Noll PRES, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43611-x; Santos Jailda Silva, 2005, Rev. Nutr., V18, P623; Tavares LF, CADERNOS DE SAUDE PU; Unicef, 2011, THE STATE OF THE WOR; Wang YC, 2008, PEDIATRICS, V121, pE1604, DOI 10.1542/peds.2007-2834; World Health Organisation, 2020, DEPRESSION; World Health Organization, 2020, GLOBAL SCHOOL BASED	34	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239217	10.1371/journal.pone.0239217	http://dx.doi.org/10.1371/journal.pone.0239217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941494	gold, Green Published			2022-12-26	WOS:000573848800028
J	Saadane, A; Lessieur, EM; Du, YP; Liu, HT; Kern, TS				Saadane, Aicha; Lessieur, Emma M.; Du, Yunpeng; Liu, Haitao; Kern, Timothy S.			Successful induction of diabetes in mice demonstrates no gender difference in development of early diabetic retinopathy	PLOS ONE			English	Article							NITRIC-OXIDE; CAPILLARY DEGENERATION; PHOTORECEPTOR CELLS; OXIDATIVE STRESS; STREPTOZOTOCIN; SUPEROXIDE; MOUSE; MODEL; INFLAMMATION; GENERATION	Purpose Female mice have been found to be resistant to streptozotocin (STZ)-induced diabetes, and pre-clinical research related to diabetic complications commonly omits females. The purpose of this study was to develop a method to induce diabetes in female mice, and to determine if retinas of diabetic female mice develop molecular changes and histopathological abnormalities comparable to those which develop in male diabetic mice. Methods To induce diabetes, animals of both sexes received daily intraperitoneal (i.p.) injection of STZ for 5 consecutive days at 55 mg/kg BW (a dose that is known to induce diabetes in male mice) or for females, 75 mg/kg BW of STZ. Retinal abnormalities that have been implicated in the development of the retinopathy (superoxide generation and expression of inflammatory proteins, iNOS and ICAM-1) were evaluated at 2 months of diabetes, and retinal capillary degeneration was evaluated at 8 months of diabetes. Results Daily i.p. injection of STZ for 5 consecutive days at a concentration of 55 mg/kg BW was sufficient to induce diabetes in 100% of male mice, but only 33% of female mice. However, females did become hyperglycemic when the dose of STZ administered was increased to 75 mg/kg BW. The resulting STZ-induced hyperglycemia in female and male mice was sustained for at least 8 months. After induction of the diabetes, both sexes responded similarly with respect to the oxidative stress, expression of iNOS, and degeneration of retinal capillaries, but differed in the limited population evaluated with respect to expression of ICAM-1. Conclusions The resistance of female mice to STZ-induced diabetes can be overcome by increasing the dose of STZ used. Female mice can, and should, be included in pre-clinical studies of diabetes and its complications.	[Saadane, Aicha; Lessieur, Emma M.; Du, Yunpeng; Kern, Timothy S.] Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA; [Liu, Haitao] Univ Pittsburgh, Childrens Hosp, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15260 USA; [Kern, Timothy S.] Vet Adm Med Ctr Res Serv, Long Beach, CA USA	University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Saadane, A (corresponding author), Univ Calif Irvine, Dept Ophthalmol, Irvine, CA 92697 USA.	asaadane@uci.edu	Liu, Haitao/AAY-3944-2021	Liu, Haitao/0000-0002-3757-779X; Saadane, Aicha/0000-0001-9985-2147	NIH [EY022938, R24 EY024864]; Department of Veterans Affairs [BX003604]; Department of Veterans Affairs	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grants EY022938 and R24 EY024864, and BX003604 from the Department of Veterans Affairs. Dr. Kern is the recipient of a Research Career Scientist award from the Department of Veterans Affairs.	Aung MH, 2013, INVEST OPHTH VIS SCI, V54, P1370, DOI 10.1167/iovs.12-10927; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Bearse MA, 2006, PROG RETIN EYE RES, V25, P425, DOI 10.1016/j.preteyeres.2006.07.001; BELL RC, 1994, ENDOCRINOLOGY, V135, P2681, DOI 10.1210/en.135.6.2681; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Brucklacher RM, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-26; Chandramouli C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20703-8; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; Du YP, 2015, FASEB J, V29, P2194, DOI 10.1096/fj.14-269431; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Gurley SB, 2006, AM J PHYSIOL-RENAL, V290, pF214, DOI 10.1152/ajprenal.00204.2005; Hutchinson CV, 2014, J ENDOCRINOL, V223, pR9, DOI 10.1530/JOE-14-0349; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Kowluru RA, 2001, ACTA DIABETOL, V38, P179, DOI 10.1007/s592-001-8076-6; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Liu F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020340; Liu HT, 2019, INVEST OPHTH VIS SCI, V60, P1538, DOI 10.1167/iovs.18-26433; Liu HT, 2016, INVEST OPHTH VIS SCI, V57, P4272, DOI 10.1167/iovs.16-19415; Liu SH, 2010, ENDOCRINOLOGY, V151, P859, DOI 10.1210/en.2009-1107; Luan H, 2006, INVEST OPHTH VIS SCI, V47, P320, DOI 10.1167/iovs.05-0272; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Matsumoto T, 2008, PEPTIDES, V29, P1338, DOI 10.1016/j.peptides.2008.04.001; Moore A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-68; Nuno DW, 2010, EXP DIABETES RES, DOI 10.1155/2010/176361; Orban T, 2018, J PHARMACOL EXP THER, V364, P207, DOI 10.1124/jpet.117.245167; Ozkaya A, 2017, SAUDI J OPHTHALMOL, V31, P69, DOI 10.1016/j.sjopt.2016.12.006; PAIK SG, 1982, DIABETES, V31, P724, DOI 10.2337/diabetes.31.8.724; ROSSINI AA, 1978, ENDOCRINOLOGY, V103, P1518, DOI 10.1210/endo-103-4-1518; Saadane A, 2014, AM J PATHOL, V184, P2403, DOI 10.1016/j.ajpath.2014.05.024; Su XJ, 2003, MOL VIS, V9, P171; Talahalli R, 2013, J LEUKOCYTE BIOL, V93, P135, DOI 10.1189/jlb.0112025; Tang J, 2013, INVEST OPHTH VIS SCI, V54, P3681, DOI 10.1167/iovs.12-11018; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tian P, 2013, MOL VIS, V19, P2092; Veenstra Alexander, 2015, Curr Protoc Mouse Biol, V5, P247, DOI 10.1002/9780470942390.mo140190; Veenstra AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078405; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zheng L, 2009, FRONT BIOSCI-LANDMRK, V14, P3974, DOI [10.2735/3505, 10.2741/3505]	43	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238727	10.1371/journal.pone.0238727	http://dx.doi.org/10.1371/journal.pone.0238727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941450	gold, Green Published			2022-12-26	WOS:000573848800076
J	Sastry, KS; Ibrahim, WN; Chouchane, AI				Sastry, Konduru Seetharama; Ibrahim, Wafa Naim; Chouchane, Aouatef Ismail			Multiple signaling pathways converge on proapoptotic protein BAD to promote survival of melanocytes	FASEB JOURNAL			English	Article						AKT; apoptosis; MAPK; PKA; PKC	GREEN FLUORESCENT PROTEIN; EPIDERMAL-GROWTH-FACTOR; PROSTATE-CANCER CELLS; KINASE-C; MELANOMA-CELLS; APOPTOSIS; INACTIVATION; PHOSPHORYLATION; PROLIFERATION; EXPRESSION	Melanocyte survival is mediated by diverse signaling pathways. However, the molecular mechanisms they use and molecules that they target are incompletely understood. Here, we show that melanocyte survival is mediated by diverse, nonredundant signaling pathways, including ERK1/2, AKT, PKA, and PKC. Each of these pathways is exerting prosurvival effects by phosphorylating the BAD. While Ser112-BAD phosphorylation is regulated by pERK, pPKA and pPKC, Ser136 and Ser155 phosphorylation are exclusively controlled by pAKT and pPKA, respectively. Inhibition of these pathways individually resulted in only modest apoptosis; however, most significant apoptosis, as a result of BAD dephosphorylation, was seen when all pathways were inhibited concurrently. BAD phosphorylation was essential for survival of melanocytes as cells expressing phosphorylation-deficient BAD were not rescued by any of the identified pathway. Furthermore, melanocytes became insensitive to kinase inhibitor-induced apoptosis when BAD expression was knocked down by BAD-shRNA. Overexpression of BAD in melanocytes stimulated faster apoptosis in response to kinase inhibitors. Taken together, our results show that BAD is acting as a convergence point for diverse survival pathways in melanocytes. Understanding the molecular mechanisms of melanocyte survival provides fundamental new insights into physiological mechanisms involved in the development of various melanocyte pathologies such as melanoma and vitiligo.	[Sastry, Konduru Seetharama; Ibrahim, Wafa Naim; Chouchane, Aouatef Ismail] Sidra Med, Dermatol Res Grp, Program Immunol, Precis Med, POB 26999, Doha, Qatar	Sidra Medical & Research Center	Sastry, KS; Chouchane, AI (corresponding author), Sidra Med, Dermatol Res Grp, Program Immunol, Precis Med, POB 26999, Doha, Qatar.	skonduru@sidra.org; achouchane@sidra.org	Sastry, Konduru Seetharama/GQY-6005-2022		Sidra Medicine [001]; Qatar National Library	Sidra Medicine; Qatar National Library(Qatar National Research Fund (QNRF))	Sidra Medicine, Grant/Award Number: 001; Qatar National Library	Abdel-Malek ZA, 2011, MELANOMA DEVELOPMENT: MOLECULAR BIOLOGY, GENETICS AND CLINICAL APPLICATION, P7, DOI 10.1007/978-3-7091-0371-5_2; Chipuk Jerry Edward, 2015, Oncoscience, V2, P729; Choi HR, 2010, OXID MED CELL LONGEV, V3, P219, DOI 10.4161/oxim.3.3.8; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Denning MF, 2012, PIGM CELL MELANOMA R, V25, P466, DOI 10.1111/j.1755-148X.2012.01015.x; Diehl C, 2014, J PIGMENT DISORD, V1, P1; Eberle J, 2008, CURR GENOMICS, V9, P409, DOI 10.2174/138920208785699571; Eisenmann KM, 2003, CANCER RES, V63, P8330; Fortin M, 2005, METH MOLEC MED, V110, P121; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Jin Y, 2016, NAT GENET, V48, P1418, DOI 10.1038/ng.3680; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Kim W, 2010, J RADIAT RES, V51, P285, DOI 10.1269/jrr.09141; Laugier F, 2015, ONCOTARGET, V6, P28120, DOI 10.18632/oncotarget.4866; Lee EF, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1568-3; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Mantovani G, 2008, ONCOGENE, V27, P1834, DOI 10.1038/sj.onc.1210831; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Mosenson JA, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12208; Oka M, 2005, CANCER METAST REV, V24, P287, DOI 10.1007/s10555-005-1578-8; Oka M, 2004, J INVEST DERMATOL, V123, P930, DOI 10.1111/j.0022-202X.2004.23454.x; PLETTENBERG A, 1995, AM J PATHOL, V146, P651; Poljsak B, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/135206; Rodriguez CI, 2014, ARCH BIOCHEM BIOPHYS, V563, P22, DOI 10.1016/j.abb.2014.07.003; Sastry KSR, 2014, CELL DEATH DIFFER, V21, P1936, DOI 10.1038/cdd.2014.140; Sastry KSR, 2006, J BIOL CHEM, V281, P27367, DOI 10.1074/jbc.M511485200; Sastry KSR, 2006, J BIOL CHEM, V281, P20891, DOI 10.1074/jbc.M602928200; Sastry KS, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2841814; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sheridan C, 2008, J BIOL CHEM, V283, P22128, DOI 10.1074/jbc.M800271200; Sosman JA, 2009, CURR ONCOL REP, V11, P405, DOI 10.1007/s11912-009-0054-y; Steff AM, 2001, CYTOMETRY, V45, P237, DOI 10.1002/1097-0320(20011201)45:4<237::AID-CYTO10024>3.0.CO;2-J; SWOPE VB, 1995, EXP CELL RES, V217, P453, DOI 10.1006/excr.1995.1109	36	1	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14602	14614		10.1096/fj.202001260RR	http://dx.doi.org/10.1096/fj.202001260RR		SEP 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32941657	hybrid			2022-12-26	WOS:000572319500001
J	Cursach, J; Rita, J; Gomez-Martinez, C; Cardona, C; Cap, M; Lazaro, A				Cursach, Joana; Rita, Juan; Gomez-Martinez, Carmelo; Cardona, Carles; Cap, Miquel; Lazaro, Amparo			The role of landscape composition and heterogeneity on the taxonomical and functional diversity of Mediterranean plant communities in agricultural landscapes	PLOS ONE			English	Article							INTERMEDIATE DISTURBANCE HYPOTHESIS; TROPICAL RAIN-FORESTS; SPECIES RICHNESS; LAND-USE; BETA DIVERSITY; BIODIVERSITY; CONSERVATION; STABILITY; HABITAT; FRAGMENTATION	The expansion of agriculture is a major driver of biodiversity loss worldwide, through changes generated in the landscape. Despite this, very little is still known about the complex relationships between landscape composition and heterogeneity and plant taxonomical and functional diversity in Mediterranean ecosystems that have been extensively managed during millennia. Although according to the Intermediate Disturbance Hypothesis (IDH) plant richness might peak at intermediate disturbance levels, functional diversity might increase with landscape heterogeneity and decrease with the intensity of disturbance. Here, we evaluated the associations of landscape composition (percentage of crops) and heterogeneity (diversity of land-cover classes) with plant taxonomical diversity (richness, diversity, evenness), local contribution to beta diversity, and functional diversity (functional richness, evenness, divergence and dispersion) in 20 wildOlea europaeacommunities appearing within agricultural landscapes of Mallorca Island (Western Mediterranean Basin). In accordance with the IDH, we found that overall plant richness peaked at intermediate levels of crops in the landscape, whereas plant evenness showed the opposite pattern, because richness peak was mainly related to an increase in scarce ruderal species. Plant communities surrounded by very heterogeneous landscapes were those contributing the most to beta diversity and showing the highest functional richness and evenness, likely because diverse landscapes favour the colonization of new species and traits into the communities. In addition, landscape heterogeneity decreased functional divergence (i.e., increased trait overlap of dominant species) which may enhance community resilience against disturbances through a higher functional redundancy. However, a large extent of agriculture in the landscape might reduce such resilience, as this disturbance acted as an environmental filter that decreased functional dispersion (i.e, remaining species shared similar traits). Overall, our study highlights the importance of considering several indices of taxonomical and functional diversity to deeply understand the complex relationships between ecosystems functions and landscape context.	[Cursach, Joana; Rita, Juan; Cap, Miquel] Univ Balearic Isl, Dept Biol, Lab Bot, Res Grp Plant Biol Mediterranean Condit, Palma De Mallorca, Balearic Island, Spain; [Gomez-Martinez, Carmelo; Lazaro, Amparo] UIB CSIC, Mediterranean Inst Adv Studies, Global Change Res Grp, Esporles, Balearic Island, Spain; [Cardona, Carles] Univ Balearic Isl, Dept Biol, Lab Bot, Interdisciplinary Ecol Grp, Palma De Mallorca, Balearic Island, Spain; [Cardona, Carles] Inst Balear Nat Conselleria Medi Ambient & Terr, Ctr Forestal Illes Balears, Palma De Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Universitat de les Illes Balears	Cursach, J (corresponding author), Univ Balearic Isl, Dept Biol, Lab Bot, Res Grp Plant Biol Mediterranean Condit, Palma De Mallorca, Balearic Island, Spain.	joana.cursach@uib.es	Lázaro, Amparo/ABG-4657-2020; Cardona, Carles/AAT-3987-2021; Cursach, Joana/K-7510-2017; Rita, Juan/H-9976-2015; Gómez-Martínez, Carmelo/GXF-8764-2022; Capó, Miquel/AAS-5131-2020	Cursach, Joana/0000-0002-2382-3005; Rita, Juan/0000-0002-9372-1637; Capó, Miquel/0000-0002-4394-7080; Cardona, Carles/0000-0002-2799-4960; Gomez-Martinez, Carmelo/0000-0003-1449-0138	Spanish Ministry of Economy and Competitiveness [CGL2017-89254-R]; Feder founds; Spanish Research Agency; Spanish Ministry of Science, Innovation and Universities [RYC-2015-19034]; Spanish State Research Agency; European Social Funds (ESF invests in your future); University of the Balearic Islands; FPI predoctoral contract - Spanish Ministry of Science, Innovation and Universities [FPI PRE2018-083185]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Feder founds(European Commission); Spanish Research Agency(Spanish Government); Spanish Ministry of Science, Innovation and Universities(Spanish Government); Spanish State Research Agency(Spanish Government); European Social Funds (ESF invests in your future); University of the Balearic Islands; FPI predoctoral contract - Spanish Ministry of Science, Innovation and Universities	This study was supported by project CGL2017-89254-R financed by the Spanish Ministry of Economy and Competitiveness, Feder founds and the Spanish Research Agency (Call 2017). AL was also supported by a Ramon y Cajal contract (RYC-2015-19034) from the Spanish Ministry of Science, Innovation and Universities, the Spanish State Research Agency, European Social Funds (ESF invests in your future) and the University of the Balearic Islands. CGM was supported by an FPI predoctoral contract financed by the Spanish Ministry of Science, Innovation and Universities (FPI PRE2018-083185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, CMAJ, V189, pE1448; Baiamonte G, 2015, BIODIVERS CONSERV, V24, P3201, DOI 10.1007/s10531-015-0950-4; Balears Meteo, 2020, BAL MET XARX D EST D; Beckage B, 2000, J VEG SCI, V11, P113, DOI 10.2307/3236782; Bernhardt-Romermann M, 2011, J ECOL, V99, P777, DOI 10.1111/j.1365-2745.2011.01794.x; Biswas SR, 2010, ECOLOGY, V91, P28, DOI 10.1890/08-0887.1; Bivand R.S., 2013, APPL SPATIAL DATA AN, DOI 10.1007/978-1-4614-7618-4; Bivand RS, 2018, TEST-SPAIN, V27, P716, DOI 10.1007/s11749-018-0599-x; Bongers F, 2009, ECOL LETT, V12, P798, DOI 10.1111/j.1461-0248.2009.01329.x; Bucala A, 2015, Z GEOMORPHOL, V59, P41, DOI 10.1127/zfg_suppl/2015/S-59204; Buhk C, 2017, SCI TOTAL ENVIRON, V576, P225, DOI 10.1016/j.scitotenv.2016.10.106; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Castroviejo S., 1986, FLORA IBERICA 1 8 10; Cohn JS, 2015, FOREST ECOL MANAG, V346, P22, DOI 10.1016/j.foreco.2015.02.023; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; da Silva PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111883; de Bols O, 1996, VEGETACIO ILLES BALE; de Bols O, 2005, FLORA MANUAL DELS PA; Duflot R, 2014, ACTA OECOL, V56, P19, DOI 10.1016/j.actao.2014.01.004; Ellis EC, 2019, CURR BIOL, V29, pR831, DOI 10.1016/j.cub.2019.07.073; Environmental Systems Research Institute (ESRI), 2016, ARCGIS DESKT REL 10; ESPIGARES T, 1993, J VEG SCI, V4, P189, DOI 10.2307/3236104; Feit B, 2019, ECOL LETT, V22, P1568, DOI 10.1111/ele.13347; Fernandez-Moya J, 2011, PLANT ECOL, V212, P865, DOI 10.1007/s11258-010-9869-8; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Gallien L, 2014, METHODS ECOL EVOL, V5, P1002, DOI 10.1111/2041-210X.12257; Grime J. P., 1979, Plant strategies and vegetation processes.; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Priego-Santander AG, 2013, APPL GEOGR, V40, P171, DOI 10.1016/j.apgeog.2013.02.013; Homar V, 2010, CLIMATIC CHANGE, V98, P199, DOI 10.1007/s10584-009-9664-5; IGN (Instituto Geografico Nacional): SIOSE, 2015, SIOS MAN FOT VERS 3; Ikeda H, 2003, ECOL RES, V18, P185, DOI 10.1046/j.1440-1703.2003.00546.x; Jonason D, 2017, ECOGRAPHY, V40, P1221, DOI 10.1111/ecog.02268; Kattge J, 2020, GLOBAL CHANGE BIOL, V26, P119, DOI 10.1111/gcb.14904; Kershaw HM, 2013, CRIT REV PLANT SCI, V32, P383, DOI 10.1080/07352689.2013.791501; Kivinen S, 2006, J BIOGEOGR, V33, P862, DOI 10.1111/j.1365-2699.2006.01433.x; Kleyer M, 2008, J ECOL, V96, P1266, DOI 10.1111/j.1365-2745.2008.01430.x; Lack D, 1976, ISLAND BIOL ILLUSTRA; Laliberte E., 2014, FD MEASURING FUNCTIO, V1, P1; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; Lazaro A, 2019, AGR ECOSYST ENVIRON, V279, P149, DOI 10.1016/j.agee.2019.02.009; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Lessmeister A, 2019, APPL VEG SCI, V22, P230, DOI 10.1111/avsc.12428; Llorens L, 2017, PLANT VEG, V13, P3, DOI 10.1007/978-3-319-54867-8_1; Malavasi M, 2018, J BIOGEOGR, V45, P1367, DOI 10.1111/jbi.13215; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mayfield MM, 2006, J ECOL, V94, P522, DOI 10.1111/j.1365-2745.2006.01108.x; Medail F, 2017, REG ENVIRON CHANGE, V17, P1775, DOI 10.1007/s10113-017-1123-7; Miedema LJ, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2633; Molino JF, 2001, SCIENCE, V294, P1702, DOI 10.1126/science.1060284; NAVEH Z, 1980, VEGETATIO, V41, P171, DOI 10.1007/BF00052445; Niedrist G, 2009, PLANT ECOL, V202, P195, DOI 10.1007/s11258-008-9487-x; Peco B, 2009, J VEG SCI, V20, P8, DOI 10.1111/j.1654-1103.2009.05646.x; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Pillar VD, 2013, J VEG SCI, V24, P963, DOI 10.1111/jvs.12047; Piou C, 2008, J VEG SCI, V19, P417, DOI 10.3170/2008-8-18384; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; RAUNKIAER C., 1934; Redon M, 2014, LANDSCAPE ECOL, V29, P773, DOI 10.1007/s10980-014-0027-x; Rita J, 2006, ORSIS, V21, P41; Rocha-Santos L, 2020, J ECOL, V108, P212, DOI 10.1111/1365-2745.13232; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Santana J, 2017, J APPL ECOL, V54, P1825, DOI 10.1111/1365-2664.12898; Sasaki T, 2009, ECOL APPL, V19, P423, DOI 10.1890/08-0144.1; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Soderstrom B, 2001, BIODIVERS CONSERV, V10, P1839, DOI 10.1023/A:1013153427422; Sonnier G, 2014, LANDSCAPE ECOL, V29, P857, DOI 10.1007/s10980-014-0022-2; Tavsanoglu C, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.135; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Weithoff G, 2001, J PLANKTON RES, V23, P1147, DOI 10.1093/plankt/23.10.1147; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zuur Alain F., 2009, P1	82	6	6	18	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238222	10.1371/journal.pone.0238222	http://dx.doi.org/10.1371/journal.pone.0238222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936803	Green Published, gold			2022-12-26	WOS:000573658000037
J	Bruminhent, J; Ruangsubvilai, N; Nabhindhakara, J; Ingsathit, A; Kiertiburanakul, S				Bruminhent, Jackrapong; Ruangsubvilai, Nattanon; Nabhindhakara, Jeff; Ingsathit, Atiporn; Kiertiburanakul, Sasisopin			Clinical characteristics and risk factors for coronavirus disease 2019 (COVID-19) among patients under investigation in Thailand	PLOS ONE			English	Article								To manage coronavirus disease 2019 (COVID-19), a national health authority has implemented a case definition of patients under investigation (PUIs) to guide clinicians' diagnoses. We aimed to determine characteristics among all PUIs and those with and without COVID-19. We retrospectively reviewed clinical characteristics and risk factors for laboratory-confirmed COVID-19 cases among PUIs at a tertiary care center in Bangkok, Thailand, between March 23 and April 7, 2020. Reverse transcription-polymerase chain reaction for SARS-CoV-2 RNA was performed. There were 405 evaluable PUIs; 157 (38.8%) were men, with a mean age +/- SD of 36.2 +/- 12.6 years. The majority (68.9%) reported no comorbidities. There were 53 (13.1%) confirmed COVID-19 cases. The most common symptoms among those were cough (73.6%), fever (58.5%), sore throat (39.6%), and muscle pain (37.4%). Among these patients, diagnoses were upper respiratory tract infection (69.8%), viral syndrome (15.1%), pneumonia (11.3%), and asymptomatic infection (3.8%). Multivariate analysis identified close contact with an index case (OR, 3.49; 95%CI, 1.49-8.15; P = 0.004), visiting high-risk places (OR, 1.92; 95%CI, 1.03-3.56; P = 0.039), productive cough (OR, 2.03; 95%CI, 1.05-3.92; P = 0.034), and no medical coverage (OR, 3.91; 95%CI, 1.35-11.32; P = 0.012) as independent risk factors for COVID-19 among the PUIs. The majority had favorable outcomes, though one (1.9%) died from severe pneumonia. COVID-19 was identified in 13% of PUIs defined per a national health authority's case definition. History of contact with a COVID-19 patient, visiting a high-risk place, having no medical coverage, and productive cough may identify individuals at risk of COVID-19 in Thailand.	[Bruminhent, Jackrapong; Kiertiburanakul, Sasisopin] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Infect Dis,Dept Med, Bangkok, Thailand; [Ruangsubvilai, Nattanon; Nabhindhakara, Jeff] Mahidol Univ, Ramathibodi Hosp, Fac Med, Bangkok, Thailand; [Ingsathit, Atiporn] Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Nephrol,Dept Med, Bangkok, Thailand; [Ingsathit, Atiporn] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Clin Epidemiol & Biostat, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Kiertiburanakul, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Div Infect Dis,Dept Med, Bangkok, Thailand.	sasisopin.kie@mahidol.ac.th		Bruminhent, Jackrapong/0000-0003-0930-8936				Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Beltran-Corbellini a, 2020, EUROPEAN J NEUROLOGY, DOI [10.1111/ene.14273, DOI 10.1111/ENE.1427332320508]; Bruminhent J, 2020, J INFECT DIS ANTIMIC, V37, P39; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Department of Disease Control MoPH Thailand., 2020, GUID CLIN PRACT DIAG; Department of Disease Control MoPH Thailand, 2020, CAS DEF PAT INV PUIS; Department of Disease Control MoPH Thailand., 2020, NOV COR 2019 PNEUM S; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Filatov A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7352; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Kochi AN, 2020, J CARDIOVASC ELECTR, V31, P1003, DOI 10.1111/jce.14479; Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095; MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1036; Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272; Pongpirul WA, 2020, EMERG INFECT DIS, V26, P1580, DOI 10.3201/eid2607.200598; Pongpirul WA, 2020, NEW ENGL J MED, V382, P1067, DOI 10.1056/NEJMc2001621; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Suttha P., 2018, Journal of Infectious Diseases and Antimicrobial Agents, V35, P151; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization, UPD COVID 19 IN VITR; World Health Organization, 2020, WHO THAIL SIT REP 20; Yu P, 2020, J INFECT DIS, V221, P1757, DOI 10.1093/infdis/jiaa077; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	27	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239250	10.1371/journal.pone.0239250	http://dx.doi.org/10.1371/journal.pone.0239250			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931517	gold, Green Published			2022-12-26	WOS:000573375500017
J	Hoshikawa, S; Shimizu, K; Watahiki, A; Chiba, M; Saito, K; Wei, WY; Fukumoto, S; Inuzuka, H				Hoshikawa, Seira; Shimizu, Kouhei; Watahiki, Asami; Chiba, Mitsuki; Saito, Kan; Wei, Wenyi; Fukumoto, Satoshi; Inuzuka, Hiroyuki			Phosphorylation-dependent osterix degradation negatively regulates osteoblast differentiation	FASEB JOURNAL			English	Article						Fbw7; p38; ubiquitination	PROTEASOME INHIBITOR; BONE-FORMATION; IN-VIVO; F-BOX; MYELOMA; FBW7; BORTEZOMIB; PROTEIN; PROTEOLYSIS; ACTIVATION	Proteasome inhibitors exert an anabolic effect on bone formation with elevated levels of osteoblast markers. These findings suggest the important role of the proteasomal degradation of osteogenic regulators, while the underlying molecular mechanisms are not fully understood. Here, we report that the proteasome inhibitors bortezomib and ixazomib markedly increased protein levels of the osteoblastic key transcription factor osterix/Sp7 (Osx). Furthermore, we revealed that Osx was targeted by p38 and Fbw7 for proteasomal degradation. Mechanistically, p38-mediated Osx phosphorylation at S73/77 facilitated Fbw7 interaction to trigger subsequent Osx ubiquitination. Consistent with these findings,p38knockdown or pharmacological p38 inhibition resulted in Osx protein stabilization. Treatment with p38 inhibitors following osteogenic stimulation efficiently induced osteoblast differentiation through Osx stabilization. Conversely, pretreatment of p38 inhibitor followed by osteogenic challenge impaired osteoblastogenesis via suppressing Osx expression, suggesting that p38 exerts dual but opposite effects in the regulation of Osx level to fine-tune its activity during osteoblast differentiation. Furthermore,Fbw7-depleted human mesenchymal stem cells and primary mouse calvarial cells resulted in increased osteogenic capacity. Together, our findings unveil the molecular mechanisms underlying the Osx protein stability control and suggest that targeting the Osx degradation pathway could help enhance efficient osteogenesis and bone matrix regeneration.	[Hoshikawa, Seira; Chiba, Mitsuki; Saito, Kan; Fukumoto, Satoshi] Tohoku Univ, Div Pediat Dent, Dept Oral Hlth & Dev Sci, Grad Sch Dent, Sendai, Miyagi, Japan; [Hoshikawa, Seira; Shimizu, Kouhei; Watahiki, Asami; Chiba, Mitsuki; Fukumoto, Satoshi; Inuzuka, Hiroyuki] Tohoku Univ, Grad Sch Dent, Ctr Adv Stem Cell & Regenerat Res, Sendai, Miyagi, Japan; [Wei, Wenyi] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Fukumoto, Satoshi] Kyushu Univ, Dept Pediat Dent, Grad Sch Dent Sci, Fukuoka, Japan	Tohoku University; Tohoku University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyushu University	Fukumoto, S (corresponding author), Tohoku Univ, Dept Oral Hlth & Dev Sci, Div Pediat Dent, Grad Sch Dent,Aoba Ku, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.; Inuzuka, H (corresponding author), Tohoku Univ, Grad Sch Dent, Ctr Adv Stem Cell & Regenerat Res, Aoba Ku, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	fukumoto@dent.tohoku.ac.jp; hinuzuka@tohoku.ac.jp	Saito, Kan/AFS-5564-2022; Saito, Kan/AAG-3507-2020	Saito, Kan/0000-0002-2151-6204; Saito, Kan/0000-0002-2151-6204; Shimizu, Kouhei/0000-0001-9523-4296; Fukumoto, Satoshi/0000-0002-5046-6891	Japan Society for the Promotion of Science (JSPS) [17H01606, 19H03834, 19J11773]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 17H01606, 19H03834 and 19J11773	Aomatsu E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03652; Artigas N, 2014, J BIOL CHEM, V289, P27105, DOI 10.1074/jbc.M114.576793; Choi YH, 2015, BONE, V75, P201, DOI 10.1016/j.bone.2015.02.026; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Fukushima H, 2017, MOL CELL, V68, P645, DOI 10.1016/j.molcel.2017.10.018; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Garcia-Gomez A, 2014, CLIN CANCER RES, V20, P1542, DOI 10.1158/1078-0432.CCR-13-1657; Gasser JA, 2014, MOL CELL, V56, P595, DOI 10.1016/j.molcel.2014.09.023; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Giuliani N, 2007, BLOOD, V110, P334, DOI 10.1182/blood-2006-11-059188; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hojo H, 2016, DEV CELL, V37, P238, DOI 10.1016/j.devcel.2016.04.002; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Hurchla MA, 2013, LEUKEMIA, V27, P430, DOI 10.1038/leu.2012.183; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Ortuno MJ, 2010, J BIOL CHEM, V285, P31985, DOI 10.1074/jbc.M110.123612; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kitagawa K, 2014, MOL CELL BIOL, V34, P2732, DOI 10.1128/MCB.01549-13; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Mukherjee S, 2008, J CLIN INVEST, V118, P491, DOI [10.1172/JCI33102, 10.1172/JC133102]; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Oyajobi BO, 2007, BRIT J HAEMATOL, V139, P434, DOI 10.1111/j.1365-2141.2007.06829.x; Park JE, 2018, TRANSL RES, V198, P1, DOI 10.1016/j.trsl.2018.03.002; Peng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056451; Pennisi A, 2009, AM J HEMATOL, V84, P6, DOI 10.1002/ajh.21310; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Shimizu K, 2018, CELL SIGNAL, V46, P15, DOI 10.1016/j.cellsig.2018.02.009; Shimizu K, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4117; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Terai M, 2005, MOL BIOL CELL, V16, P1491, DOI 10.1091/mbc.e04-07-0652; Thouverey C, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.80; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Xie JM, 2015, J CELL MOL MED, V19, P1814, DOI 10.1111/jcmm.12553; Yumimoto K, 2013, J BIOL CHEM, V288, P28488, DOI 10.1074/jbc.M113.465179	45	5	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14930	14945		10.1096/fj.202001340R	http://dx.doi.org/10.1096/fj.202001340R		SEP 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931083	Bronze			2022-12-26	WOS:000570776500001
J	Wu, XF; Ruan, Y; Chen, T; Yu, ZH; Huo, D; Li, XM; Wu, FF; Jiang, X; Ren, CH				Wu, Xiaofen; Ruan, Yao; Chen, Ting; Yu, Zonghe; Huo, Da; Li, Xiaomin; Wu, Feifei; Jiang, Xiao; Ren, Chunhua			First echinoderm alpha-amylase from a tropical sea cucumber (Holothuria leucospilota): Molecular cloning, tissue distribution, cellular localization and functional production in a heterogenousE.colisystem with codon optimization	PLOS ONE			English	Article							DIGESTIVE ENZYME-ACTIVITY; MESSENGER-RNA EXPRESSION; SEABREAM SPARUS-AURATA; LARVAL DEVELOPMENT; GASTROINTESTINAL-TRACT; GENE; PURIFICATION; PANCREAS; IDENTIFICATION; ORGANIZATION	Holothuria leucospilota(Echinodermata:Holothuroidea) is a widespread tropical sea cucumber with strong value for the ecological restoration of coral reefs. Therefore, some studies regarding the artificial breeding and cultivation ofH.leucospilotahave been undertaken recently. However, the biological functions of the digestive system of this species have not been elucidated. In this study, a cDNA coding for alpha-amylase, an indicator of digestive maturity in animals, was identified fromH.leucospilotaand designatedHl-Amy. The full-length cDNA of theHl-Amygene, which is 1734 bp in length with an open reading frame (ORF) of 1578 bp, encodes a 525 amino acid (a.a.) protein with a deduced molecular weight of 59.34 kDa. According to the CaZy database annotation, Hl-Amy belongs to the class of GH-H with the official nomenclature of alpha-amylase (EC 3.2.1.1) or 4-alpha-D-glucan glucanohydrolase. The Hl-Amy protein contains a signal peptide at the N-terminal followed by a functional amylase domain, which includes the catalytic activity site. The mRNA expression ofHl-Amywas abundantly exhibited in the intestine, followed by the transverse vessel with a low level, but was hardly detected in other selected tissues. During embryonic and larval development,Hl-Amywas constitutively expressed in all stages, and the highest expression level was observed in the blastula. Byin situhybridization (ISH), positiveHl-Amysignals were observed in different parts of the three different intestinal segments (foregut, midgut and hindgut). The Hl-Amy recombinant protein was generated in anE.colisystem with codon optimization, which is necessary for Hl-Amy successfully expressed in this heterogenous system. The Hl-Amy recombinant protein was purified by immobilized metal ion affinity chromatography (IMAC), and its activity of starch hydrolysis was further detected. The optimal temperatures and pH for Hl-Amy recombinant protein were 55 degrees C and 6.0, respectively, with an activity of 62.2 U/mg. In summary, this current study has filled a knowledge gap on the biological function and expression profiles of an essential digestive enzyme in sea cucumber, which may encourage future investigation toward rationalized diets forH.leucospilotain artificial cultivation, and optimized heterogenous prokaryotic systems for producing recombinant enzymes of marine origins.	[Wu, Xiaofen; Ruan, Yao; Chen, Ting; Huo, Da; Li, Xiaomin; Wu, Feifei; Jiang, Xiao; Ren, Chunhua] Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangdong Prov Key Lab Appl Marine Biol LAMB, South China Sea Inst Oceanol, Guangzhou, Peoples R China; [Wu, Xiaofen; Ruan, Yao; Li, Xiaomin; Wu, Feifei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Ting; Jiang, Xiao; Ren, Chunhua] Southern Marine Sci & Engn Guangdong Lab Guangzho, Guangzhou, Peoples R China; [Chen, Ting; Huo, Da; Jiang, Xiao; Ren, Chunhua] Chinese Acad Sci, Inst South China Sea Ecol & Environm Engn, ISEE, CAS, Guangzhou, Peoples R China; [Yu, Zonghe] South China Agr Univ, Coll Marine Sci, Guangzhou, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hong Kong Branch of the Southern Marine Science & Engineering Guangdong Laboratory (Guangzhou); Chinese Academy of Sciences; South China Agricultural University	Ren, CH (corresponding author), Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol LMB, Guangdong Prov Key Lab Appl Marine Biol LAMB, South China Sea Inst Oceanol, Guangzhou, Peoples R China.; Ren, CH (corresponding author), Southern Marine Sci & Engn Guangdong Lab Guangzho, Guangzhou, Peoples R China.; Ren, CH (corresponding author), Chinese Acad Sci, Inst South China Sea Ecol & Environm Engn, ISEE, CAS, Guangzhou, Peoples R China.	rosemary166@sina.com		Ruan, Yao/0000-0001-5176-0729; Chen, Ting/0000-0002-5777-909X	National Key R & D Program of China [2018YFD0901605]; National Natural Science Foundation of China [41676162, 41906101]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA13020205]; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province [SDYY-2018-01]; Guangdong Province Program [2017B030314052, 2018A030313857, 2015A030310120, A2015230]; Science and Technology Service Network Initiative of Chinese Academy of Sciences [KFJ-STS-ZDTP-055]	National Key R & D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province; Guangdong Province Program; Science and Technology Service Network Initiative of Chinese Academy of Sciences	This study was supported by the National Key R & D Program of China (2018YFD0901605), the National Natural Science Foundation of China (41676162, 41906101), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA13020205), the Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province (SDYY-2018-01) and the Guangdong Province Program (2017B030314052, 2018A030313857, 2015A030310120, A2015230), and the Science and Technology Service Network Initiative of Chinese Academy of Sciences (KFJ-STS-ZDTP-055).	AZZALINA JD, 1985, COMP BIOCHEM PHYS B, V82, P679, DOI 10.1016/0305-0491(85)90507-3; Balkan B, 2007, FOOD TECHNOL BIOTECH, V45, P439; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Bonham K, 1962, U HAWAII PRESS, V2, P23; Bouayad N, 2008, J STORED PROD RES, V44, P373, DOI 10.1016/j.jspr.2008.02.012; BUONOCORE V, 1976, J BACTERIOL, V128, P515, DOI 10.1128/JB.128.2.515-521.1976; Chen T, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115030; Dzeroski S, 2003, ECOL MODEL, V170, P219, DOI 10.1016/S0304-3800(03)00229-1; ELAASSAR SA, 1992, APPL MICROBIOL BIOT, V38, P312, DOI 10.1007/BF00170078; Asencio-Alcudia GG, 2018, LAT AM J AQUAT RES, V46, P909, DOI [10.3856/vo146-issue5-fulltext-5, 10.3856/vol46-issue5-fulltext-5]; GIORGI D, 1984, EMBO J, V3, P1521, DOI 10.1002/j.1460-2075.1984.tb02005.x; Gonzalez CF, 2002, ENZYME MICROB TECH, V30, P169, DOI 10.1016/S0141-0229(01)00479-3; Gupta R, 2003, PROCESS BIOCHEM, V38, P1599, DOI 10.1016/S0032-9592(03)00053-0; HARA K, 1979, B JPN SOC SCI FISH, V45, P1005; Huang GJ, 2016, GENE, V587, P98, DOI 10.1016/j.gene.2016.04.044; Huang W, 2018, AQUACULTURE, V488, P22, DOI 10.1016/j.aquaculture.2018.01.013; Huo D, 2018, GENE, V665, P74, DOI 10.1016/j.gene.2018.04.085; Huvet A, 2015, J EXP BIOL, V218, P1740, DOI 10.1242/jeb.116699; Impson FAC, 2012, BIOLOGICAL CONTROL OF WEEDS IN AUSTRALIA, P1; Infante JLZ, 2001, COMP BIOCHEM PHYS C, V130, P477, DOI 10.1016/S1532-0456(01)00274-5; Kim KH, 2014, J COMP PHYSIOL B, V184, P221, DOI 10.1007/s00360-013-0780-1; LEVY JN, 1985, GENETICS, V110, P313; Liao Y., 1997, FAUNA SINCIA PHYLUM; Lippincott W.W, 2009, DIAGNOSTIC TESTS MAD, P29; MacTavish T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050031; Mandal N, 2019, BIOSENS BIOELECTRON, P124; Martinez I, 1999, FISH PHYSIOL BIOCHEM, V21, P317, DOI 10.1023/A:1007802708459; Martinez-Lagos R, 2014, FISH PHYSIOL BIOCHEM, V40, P773, DOI 10.1007/s10695-013-9884-5; MAUGLE PD, 1982, B JPN SOC SCI FISH, V48, P1753; MAYZAUD O, 1985, COMP BIOCHEM PHYS B, V82, P725, DOI 10.1016/0305-0491(85)90516-4; Moal J, 2000, J COMP PHYSIOL B, V170, P21, DOI 10.1007/s003600050003; Moyano FJ, 1996, FISH PHYSIOL BIOCHEM, V15, P121, DOI 10.1007/BF01875591; MunillaMoran R, 1996, COMP BIOCHEM PHYS B, V113, P827, DOI 10.1016/0305-0491(95)02101-9; MunillaMoran R, 1996, COMP BIOCHEM PHYS B, V113, P395, DOI 10.1016/0305-0491(95)02057-8; Nakayama S, 2017, CELL TISSUE RES, V370, P113, DOI 10.1007/s00441-017-2627-7; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; OOSTHUIZEN V, 1992, COMP BIOCHEM PHYS B, V101, P277, DOI 10.1016/0305-0491(92)90190-3; OSMAN AM, 1982, COMP BIOCHEM PHYS B, V73, P571, DOI 10.1016/0305-0491(82)90076-1; PALVA I, 1982, GENE, V19, P81, DOI 10.1016/0378-1119(82)90191-3; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; PODOLER H, 1971, BIOCHEM J, V121, P321, DOI 10.1042/bj1210321; Pujadas G, 2001, MOL BIOL EVOL, V18, P38, DOI 10.1093/oxfordjournals.molbev.a003718; Ren CH, 2015, FISH SHELLFISH IMMUN, V42, P41, DOI 10.1016/j.fsi.2014.10.024; Ren CH, 2014, FISH SHELLFISH IMMUN, V41, P137, DOI 10.1016/j.fsi.2014.08.030; Ren CH, 2014, FISH SHELLFISH IMMUN, V38, P265, DOI 10.1016/j.fsi.2014.03.022; ROGERS JC, 1983, J BIOL CHEM, V258, P8169; Roy I, 2004, ENZYME MICROB TECH, V34, P26, DOI 10.1016/j.enzmictec.2003.07.001; SABAPATHY U, 1992, COMP BIOCHEM PHYS B, V101, P73, DOI 10.1016/0305-0491(92)90160-S; SAITO N, 1973, ARCH BIOCHEM BIOPHYS, V155, P290, DOI 10.1016/0003-9861(73)90117-3; SCHIBLER U, 1982, J MOL BIOL, V155, P247, DOI 10.1016/0022-2836(82)90004-3; Smith EL, 1960, ARCH BIOCHEM BIOPHYS, V91, P334; Swanson KC, 2000, J NUTR, V130, P2157, DOI 10.1093/jn/130.9.2157; Swaroop VS, 2004, JAMA-J AM MED ASSOC, V291, P2865, DOI 10.1001/jama.291.23.2865; Tsao CY, 2003, J AGR FOOD CHEM, V51, P1064, DOI 10.1021/jf025837n; TSUKAGOSHI N, 1989, GENE, V84, P319, DOI 10.1016/0378-1119(89)90506-4; WARSHAW AL, 1975, NEW ENGL J MED, V292, P325, DOI 10.1056/NEJM197502132920701; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Yan AF, 2018, FISH SHELLFISH IMMUN, V72, P124, DOI 10.1016/j.fsi.2017.10.050; Yan AF, 2016, FISH SHELLFISH IMMUN, V59, P203, DOI 10.1016/j.fsi.2016.10.038	59	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239044	10.1371/journal.pone.0239044	http://dx.doi.org/10.1371/journal.pone.0239044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931501	Green Published, gold			2022-12-26	WOS:000573375500001
J	Gayatri, M; Dasvarma, GL				Gayatri, Maria; Dasvarma, Gouranga Lal			Predictors of early initiation of breastfeeding in Indonesia: A population-based cross-sectional survey	PLOS ONE			English	Article							SKIN-TO-SKIN; IMMEDIATE; CONTACT	Introduction Commencing breastfeeding within one hour of birth is defined as early initiation of breastfeeding (EIBF). Both the mother and child benefit from EIBF. This study aims to identify the predictors of EIBF among Indonesian women. Methods This paper analyses data from a weighted sample of 6,616 women collected at the Indonesia Demographic and Health Survey (IDHS) 2017.The frequency of EIBF is measured by the proportion of children born in the two years preceding the survey who received breastmilk within one hour of birth. The analysis uses bivariate and multivariate logistic regression for complex sample designs, adjusted for confounders to examine the relationship of EIBF with women's individual, household and community level characteristics. Results Overall, 57% (95% CI: 54.9%-58.2%) of the children born in the two years preceding the survey had EIBF. Statistically significant (p<0.05) predictors of EIBF are women's non-working status, second or higher order of the birth of the most recent child, average or large size of the most recent child at birth, poor status of the household and non-agricultural work of the woman's husband; while statistically highly significant (p<0.01) predictors are skin-to-skin contact with the new-born (OR: 2.62; 95% CI: 2.28-3.00), Caesarean deliveries (OR: 0.47; 95% CI: 0.40-0.56), and skilled birth attendants (OR: 1.83; 95% CI: 1.65-2.08). Caesarean deliveries reduce the likelihood of EIBF by half compared to vaginal deliveries. Women's age, education or rural-urban residence display no statistically significant relationship with EIBF. Conclusion Skin-to-skin contact, mode of delivery and type of birth attendance exert the strongest influence on EIBF in Indonesia in 2017. EIBF should be continuously promoted and supported particularly among mothers who do not have early skin-to-skin contact with their new-born, who have Caesarean deliveries and who have no skilled birth attendant.	[Gayatri, Maria] Natl Populat & Family Planning Board, Family Planning & Family Welf Res & Dev Unit, East Jakarta, Indonesia; [Dasvarma, Gouranga Lal] Flinders Univ S Australia, Coll Humanities Arts & Social Sci, Adelaide, SA, Australia	Flinders University South Australia	Gayatri, M (corresponding author), Natl Populat & Family Planning Board, Family Planning & Family Welf Res & Dev Unit, East Jakarta, Indonesia.	maria.gayatri.bkkbn@gmail.com		Gayatri, Maria/0000-0002-2792-5586; Dasvarma, Gouranga/0000-0002-1784-7967	Indonesian National Population and Family Planning Board (Family Planning and Family Welfare Research and Development Unit) [521219]; Flinders University (College of Humanities, Arts and Social Sciences) [422.30877]	Indonesian National Population and Family Planning Board (Family Planning and Family Welfare Research and Development Unit); Flinders University (College of Humanities, Arts and Social Sciences)	This study was supported by Indonesian National Population and Family Planning Board (Family Planning and Family Welfare Research and Development Unit) in the form of funds in Accredited Scientific Journal Publications to MG (Code: 521219) and Flinders University (College of Humanities, Arts and Social Sciences) in the form of funds in the Consultancy Account of GLD (Cost Centre/Project: 422.30877). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0021-6; Aghdas K, 2014, WOMEN BIRTH, V27, P37, DOI 10.1016/j.wombi.2013.09.004; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; Amin T, 2011, BREASTFEED MED, V6, P59, DOI 10.1089/bfm.2010.0018; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; [Anonymous], 2019, PROG RETIN EYE RES; [Anonymous], 2017, PLASMONICS, V12, P1; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2019, MOL MECH STUDY JIAWE, V15; Archer KJ, 2007, COMPUT STAT DATA AN, V51, P4450, DOI 10.1016/j.csda.2006.07.006; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Cox's Bazar Bangladesh, 2019, GEND PROF NO 2 ROH R, V11, P1; Croft TN, 2018, GUIDE DHS STAT; EU, 2016, FAZ, P1, DOI DOI 10.5194/ACP16-150752016; Green L, 2000, HLTH PROMOTION PLANN; Hansen K, 2016, LANCET, V387, P416, DOI 10.1016/S0140-6736(16)00012-X; Hung KJ, 2011, MCN-AM J MATERN-CHIL, V36, P318, DOI 10.1097/NMC.0b013e3182266314; IBM Knowledge Center, COMPL SAMPL LOG REGR; ICF, 2018, DEM HLTH SURV STAND; Kitano Naomi, 2016, Prev Med Rep, V3, P121, DOI 10.1016/j.pmedr.2015.12.010; Kreuter F, 2007, STATA J, V7, P1; Le Huerou-Luron I, 2010, NUTR RES REV, V23, P23, DOI 10.1017/S0954422410000065; Liben ML, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0067-8; Liu JH, 2013, CONTEMP NURSE, V45, P234, DOI 10.5172/conu.2013.45.2.234; Mithani Y, 2015, J PERINAT EDUC, V24, P249, DOI 10.1891/1058-1243.24.4.249; Moore ER, 2007, J MIDWIFERY WOM HEAL, V52, P116, DOI 10.1016/j.jmwh.2006.12.002; Nakao Y, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-1; National Population and Family Planning Board Statistics Indonesia Ministry of Health ICF, 2018, IND DEM HLTH SURV 20; NEOVITA Study Group, 2016, LANCET GLOB HEALTH, V4, pe266, DOI DOI 10.1016/S2214-109X(16)00040-1; Niela-Vilen H, 2015, MATERN CHILD NUTR, V11, P712, DOI 10.1111/mcn.12108; PerezEscamilla R, 1996, AM J PUBLIC HEALTH, V86, P832, DOI 10.2105/AJPH.86.6.832; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Smith EG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180169; Tawiah-Agyemang C, 2008, J PERINATOL, V28, pS46, DOI 10.1038/jp.2008.173; The DHS Program, PROT PRIV DHS SURV R; UNICEF, 2016, 1 HOUR LIFE; UNICEF and WHO, 2018, CAPT MOM EARL IN BRE; United Nations International Children`s Emergency Fund-UNICEF, 2019, INF YOUNG CHILD FEED; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404; WHO, 2003, INF YOUNG CHILD FEED; WHO/UNICEF, 2013, 10 STEPS SUCC BREAST; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization, 2017, PROTECTING PROMOTING; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6	46	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239446	10.1371/journal.pone.0239446	http://dx.doi.org/10.1371/journal.pone.0239446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970729	Green Published, gold			2022-12-26	WOS:000576265600008
J	Yadanar; Mya, KS; Witvorapong, N				Yadanar; Mya, Kyaw Swa; Witvorapong, Nopphol			Determinants of breastfeeding practices in Myanmar: Results from the latest nationally representative survey	PLOS ONE			English	Article							EARLY INITIATION; MOTHERS	Optimal breastfeeding practices can ensure healthy growth and development of infants, which in the long term can impact the country's economic development. Nevertheless, Myanmar has yet to achieve the WHO's target of 70% for early initiation of breastfeeding, and the country's target of 90% for exclusive breastfeeding. The purpose of this study was to assess the associations between early initiation of breastfeeding and exclusive breastfeeding and bio-demographic, socio-economic and behavioral factors in Myanmar. Using the 2015-2016 Myanmar Demographic and Health Survey, the analysis of early initiation of breastfeeding was based on a sample of 1,506 under-2 children and the analysis of exclusive breastfeeding was based on a sample of 376 children aged 0-5 months. Multiple logistic modeling, with heteroskedasticity-adjusted standard errors, was used. The prevalence rates of early initiation of breastfeeding and exclusive breastfeeding in the study were 67.9% and 52.2% respectively. Having a vaginal delivery (AOR = 2.5; 95% CI = 1.7-3.7) and having frequent (>= 4) antenatal visits (AOR = 2.4; 95% CI = 1.5-3.8) were associated with higher odds of early initiation of breastfeeding. Having a postnatal checkup (AOR = 0.5; 95% CI = 0.3-0.9) and having an infant that was perceived to be small at birth (AOR = 2.5; 95% CI = 1.1-5.7, for infants perceived to be large at birth) were significantly associated with decreased odds of exclusive breastfeeding. In order to promote optimal breastfeeding practices, this study suggested that delivery and quality of health services during pregnancy need to be strengthened in Myanmar.	[Yadanar] Univ Publ Hlth, Dept Publ Hlth Lab Sci, Yangon, Yangon Region, Myanmar; [Mya, Kyaw Swa] Univ Publ Hlth, Dept Biostat & Med Demog, Yangon, Myanmar; [Witvorapong, Nopphol] Chulalongkorn Univ, Fac Econ, Ctr Hlth Econ, Bangkok, Thailand	Chulalongkorn University	Yadanar (corresponding author), Univ Publ Hlth, Dept Publ Hlth Lab Sci, Yangon, Yangon Region, Myanmar.	dryadanar.ydn@gmail.com	Witvorapong, Nopphol/J-4360-2019	Witvorapong, Nopphol/0000-0002-7926-381X; , Kyaw Swa Mya/0000-0003-1286-1409				Adewuyi EO, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0141-x; Adhikari M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0021-6; Agho KE, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-2; Agushybana F, 2018, PAC RIM INT J NURS R, V22, P6; [Anonymous], 2015, EFSA J, V13, P81; [Anonymous], 2018, J CANC RES THER, V14, pS622; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Chandhiok N, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0059-0; Collective G.B., 2017, GLOBAL BREASTFEEDING, P7; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Department of Population Ministry of Immigration and Population, 2015, 2014 MYANM POP HOUS, V2; dewuyi E., 2016, INT J CONT PEDIAT, V3, P311, DOI [10.18203/2349-3291.ijcp20160499, DOI 10.18203/2349-3291.IJCP20160499]; Hmone MP, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0120-2; Karim F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220224; Khan J, 2015, MATERN CHILD HLTH J, V19, P468, DOI 10.1007/s10995-014-1526-8; Khanal V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-958; Lakew Y, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-015-0050-9; Lessen R, 2007, J PERINAT NEONAT NUR, V21, P256, DOI 10.1097/01.JPN.0000285817.51645.73; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Than MK, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz078; Ministry of Health and Sports DHS Program, 2017, MYANM DEM HLTH SURV; Ministry of National Planning and Economic Development Ministry of Health UNICEF, 2011, MYANM MULT IND CLUST; Ndirangu MN, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1811-4; Nilsen A, 2018, MYANMAR TAKES 1 STEP; Perez-Escamilla R, 2016, MATERN CHILD NUTR, V12, P402, DOI 10.1111/mcn.12294; Bui QTT, 2016, GLOBAL HEALTH ACTION, V9, P49, DOI 10.3402/gha.v9.29433; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Smith ER, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180722; Thet MM, 2016, APPETITE, V96, P62, DOI 10.1016/j.appet.2015.08.044; UNICEF, 2012, PROGR GUID INF YOUNG; UNICEF, 2016, 1 HOUR LIF MAK CAS I; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO UNICEF., 2012, EXT 2025 MAT INF YOU; WHO UNICEF, 2011, MULT IND CLUST SURV; World Health Organization, 1998, EV 10 STEPS SUCC BRE; World Health Organization and the United Nations Children's Fund, 2009, BAB FRIENDL HOSP IN; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6; Yilmaz E, 2017, TURK J OBSTET GYNECO, V14, P1, DOI 10.4274/tjod.90018	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239515	10.1371/journal.pone.0239515	http://dx.doi.org/10.1371/journal.pone.0239515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970726	Green Published, gold			2022-12-26	WOS:000576265600097
J	Nicolaisen, TS; Klein, AB; Dmytriyeva, O; Lund, J; Ingerslev, LR; Fritzen, AM; Carl, CS; Lundsgaard, AM; Frost, M; Ma, T; Schjerling, P; Gerhart-Hines, Z; Flamant, F; Gauthier, K; Larsen, S; Richter, EA; Kiens, B; Clemmensen, C				Nicolaisen, Trine S.; Klein, Anders B.; Dmytriyeva, Oksana; Lund, Jens; Ingerslev, Lars R.; Fritzen, Andreas M.; Carl, Christian S.; Lundsgaard, Anne-Marie; Frost, Mikkel; Ma, Tao; Schjerling, Peter; Gerhart-Hines, Zachary; Flamant, Frederic; Gauthier, Karine; Larsen, Steen; Richter, Erik A.; Kiens, Bente; Clemmensen, Christoffer			Thyroid hormone receptor alpha in skeletal muscle is essential for T3-mediated increase in energy expenditure	FASEB JOURNAL			English	Article						energy expenditure; energy metabolism; skeletal muscle; thyroid hormone	BROWN ADIPOSE-TISSUE; THERMOGENESIS; SARCOLIPIN; MICE; TRIIODOTHYRONINE; DETERMINANT; ACTIVATION; EXPRESSION; FAT	Thyroid hormones are important for homeostatic control of energy metabolism and body temperature. Although skeletal muscle is considered a key site for thyroid action, the contribution of thyroid hormone receptor signaling in muscle to whole-body energy metabolism and body temperature has not been resolved. Here, we show that T3-induced increase in energy expenditure requires thyroid hormone receptor alpha 1 (TR alpha(1)) in skeletal muscle, but that T3-mediated elevation in body temperature is achieved in the absence of muscle-TR alpha(1). In slow-twitch soleus muscle, loss-of-function of TR alpha(1)(TR alpha(HSACre)) alters the fiber-type composition toward a more oxidative phenotype. The change in fiber-type composition, however, does not influence the running capacity or motivation to run. RNA-sequencing of soleus muscle from WT mice and TR alpha(HSACre)mice revealed differentiated transcriptional regulation of genes associated with muscle thermogenesis, such as sarcolipin and UCP3, providing molecular clues pertaining to the mechanistic underpinnings of TR alpha(1)-linked control of whole-body metabolic rate. Together, this work establishes a fundamental role for skeletal muscle in T3-stimulated increase in whole-body energy expenditure.	[Nicolaisen, Trine S.; Klein, Anders B.; Dmytriyeva, Oksana; Lund, Jens; Ingerslev, Lars R.; Frost, Mikkel; Ma, Tao; Gerhart-Hines, Zachary; Clemmensen, Christoffer] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark; [Nicolaisen, Trine S.; Fritzen, Andreas M.; Carl, Christian S.; Lundsgaard, Anne-Marie; Richter, Erik A.; Kiens, Bente] Univ Copenhagen, Sect Mol Physiol, Dept Nutr Exercise & Sports, Fac Sci, Copenhagen, Denmark; [Dmytriyeva, Oksana] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Inst Sports Med Copenhagen, Dept Orthoped Surg, Bispebjerg Frederiksberg Hosp, Copenhagen, Denmark; [Schjerling, Peter] Univ Copenhagen, Ctr Hlth Aging, Fac Hlth & Med Sci, Copenhagen, Denmark; [Flamant, Frederic; Gauthier, Karine] Univ Lyon 1, Inst Genom Fonct Lyon, Univ Lyon, CNRS UMR 5242,INRA USC 1370,Ecole Normale Super L, Lyon, France; [Larsen, Steen] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Xlab,Ctr Hlth Aging, Copenhagen, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); University of Copenhagen	Clemmensen, C (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	chc@sund.ku.dk	Lund, Jens/AAA-5865-2022; Schjerling, Peter/F-6194-2011; Clemmensen, Christoffer/AAM-3347-2020; Fritzen, Andreas/D-4103-2015; Larsen, Steen/L-2069-2013; Kiens, Bente/B-1375-2015; Richter, Erik A./N-4189-2014	Schjerling, Peter/0000-0001-7138-3211; Clemmensen, Christoffer/0000-0003-2456-9667; Fritzen, Andreas/0000-0001-8793-9739; Lund, Jens/0000-0003-2338-6033; Carl, Christian Strini/0000-0002-9551-5837; Klein, Anders Bue/0000-0002-0236-3089; Ingerslev, Lars Roed/0000-0002-4164-7690; Larsen, Steen/0000-0002-5170-4337; Lundsgaard, Anne-Marie/0000-0002-5584-2366; Kiens, Bente/0000-0001-5705-5625; Nicolaisen, Trine Sand/0000-0001-5856-6443; Gerhart-Hines, Zachary/0000-0003-2981-4991; Richter, Erik A./0000-0002-6850-3056	Novo Nordisk Fonden (NNF) [NNF17SA0031406, NNF17OC0026114, NNF18CC0034900]; Alfred Benzon Foundation; Danish Council for Independent Research [7016-00389A]; Lundbeck Foundation [R2382016-2859]; University of Copenhagen; NNF Center for Basic Metabolic Research [Barres Group, SCOP Platform] Funding Source: researchfish	Novo Nordisk Fonden (NNF); Alfred Benzon Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); University of Copenhagen; NNF Center for Basic Metabolic Research(Novo Nordisk Foundation)	Novo Nordisk Fonden (NNF), Grant/Award Number: NNF17SA0031406, NNF17OC0026114 and NNF18CC0034900; Alfred Benzon Foundation; Danish Council for Independent Research, Grant/Award Number: 7016-00389A; Lundbeck Foundation, Grant/Award Number: R2382016-2859; University of Copenhagen	ARGOV Z, 1988, J CLIN INVEST, V81, P1695, DOI 10.1172/JCI113508; Bal NC, 2017, J BIOL CHEM, V292, P16616, DOI 10.1074/jbc.M117.790451; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bloise FF, 2018, J ENDOCRINOL, V236, pR57, DOI 10.1530/JOE-16-0611; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Caiozzo VJ, 2000, AM J PHYSIOL-CELL PH, V278, pC709, DOI 10.1152/ajpcell.2000.278.4.C709; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Dittner C, 2019, MOL METAB, V25, P20, DOI 10.1016/j.molmet.2019.05.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Finan B, 2016, CELL, V167, P843, DOI 10.1016/j.cell.2016.09.014; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Johann K, 2019, CELL REP, V27, P3385, DOI 10.1016/j.celrep.2019.05.054; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; Minakhina S, 2020, THYROID, V30, P1193, DOI 10.1089/thy.2019.0763; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Miyabara EH, 2005, CELL TISSUE RES, V321, P233, DOI 10.1007/s00441-005-1119-3; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Quignodon L, 2007, MOL ENDOCRINOL, V21, P2350, DOI 10.1210/me.2007-0176; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Salvatore D, 2014, NAT REV ENDOCRINOL, V10, P206, DOI 10.1038/nrendo.2013.238; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; SILVA JE, 1985, J CLIN INVEST, V76, P2296, DOI 10.1172/JCI112239; SILVA JE, 1983, NATURE, V305, P712, DOI 10.1038/305712a0; Simonides WS, 2008, THYROID, V18, P205, DOI 10.1089/thy.2007.0256; Smith WS, 2002, BIOCHEM J, V361, P277, DOI 10.1042/0264-6021:3610277; Warner A, 2013, P NATL ACAD SCI USA, V110, P16241, DOI 10.1073/pnas.1310300110; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yu FS, 2000, AM J PHYSIOL-REG I, V278, pR1545, DOI 10.1152/ajpregu.2000.278.6.R1545	34	12	12	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15480	15491		10.1096/fj.202001258RR	http://dx.doi.org/10.1096/fj.202001258RR		SEP 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32969079	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000574531200001
J	Tahseen, S; Khanzada, FM; Rizvi, AH; Qadir, M; Ghazal, A; Baloch, AQ; Mustafa, T				Tahseen, Sabira; Khanzada, Faisal Masood; Rizvi, Alamdar Hussain; Qadir, Mahmood; Ghazal, Aisha; Baloch, Aurangzaib Quadir; Mustafa, Tehmina			Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19	PLOS ONE			English	Article							DRUG-RESISTANCE; MYCOBACTERIUM-TUBERCULOSIS; FLUOROQUINOLONE; MUTATIONS; ASSAY; 1ST	Background Pakistan is among top five high burden countries for tuberculosis and drug resistant TB. Among rifampicin sensitive new pulmonary TB (PTB), prevalence of isoniazid resistance is 8.3% (95%CI: 7.0-10.7) and resistance to fluoroquinolone is higher (11 center dot 1%, 95%CI: 7 center dot 8-14 center dot 3) than isoniazid resistance. Method Five year retrospective data (2015-2019) of drug susceptibility testing (DST) forMycobacterium tuberculosisisolates, performed using recommended phenotypic (pDST) and/or genotypic (gDST) methods was analyzed stratified by rifampicin results for isoniazid resistance profiles and associated levofloxacin and pyrazinamide resistance. Findings DST data was analyzed from 11045 TB patients. Isolates were tested using pDST (87%), gDST (92%) and both methods (79.5%). For both rifampicin and isoniazid, a significant difference (P< .001) was noted between resistance detected by pDST and gDST. Among isolates, tested by both methods (8787), 49% were resistant to rifampicin and 51.7% to isoniazid with discordance in resistant results of 15.8% for each, with 13.2% (570) of rifampicin resistance reported sensitive by pDST and 14.2% (660) of isoniazid resistance missed by gDST. Estimated isoniazid resistance among rifampicin sensitive new PTB, extrapulmonary TB and previously treated PTB was 9.8% (95%CI: 8.7-11.1), 6.8% (95%CI: 5.4-8.5) and 14.6% (95%CI: 11.8-17.9) respectively. Significant differences were reported between the genotypic profile of isoniazid resistance associated with rifampicin-resistant and sensitive isolates including detectable mutations (87% vs 71.6%), frequency ofinhA (7.6% and 30.2%)and katGmutations (76.1% vs 41.2%) respectively. Among rifampicin resistant and sensitive isolates, a significantly higher level of resistance to levofloxacin and pyrazinamide was seen associated with isoniazid resistance. Conclusion There are risks and many challenges in implementing WHO recommended treatment for isoniazid resistant tuberculosis. The laboratory based surveillance can complement random surveys in country specific planning for TB diagnostics and appropriate treatment regimens.	[Tahseen, Sabira; Khanzada, Faisal Masood; Rizvi, Alamdar Hussain; Qadir, Mahmood; Ghazal, Aisha] Natl TB Reference Lab, Natl TB Control Program, Islamabad, Pakistan; [Tahseen, Sabira; Mustafa, Tehmina] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Baloch, Aurangzaib Quadir] Minist Natl Hlth Serv Regulat & Coordinat, Natl TB Control Program, Islamabad, Pakistan; [Mustafa, Tehmina] Haukeland Hosp, Dept Thorac Med, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital	Tahseen, S (corresponding author), Natl TB Reference Lab, Natl TB Control Program, Islamabad, Pakistan.; Tahseen, S (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	sabira.tahseen@gmail.com	Tahseen, Sabira/AAV-8653-2020	Tahseen, Sabira/0000-0002-6887-8149				[Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Ayaz A, 2012, INT J INFECT DIS, V16, pE303, DOI 10.1016/j.ijid.2011.12.015; Chakravorty S, 2017, J CLIN MICROBIOL, V55, P183, DOI 10.1128/JCM.01771-16; Click ES, 2020, J INFECT DIS, V221, P2072, DOI 10.1093/infdis/jiaa042; Dantes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037956; Dean AS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003008; Dooley KE, 2020, AM J RESP CRIT CARE, V201, P1416, DOI 10.1164/rccm.201910-1960OC; Fasih N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050551; Ghodousi A, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00092-19, 10.1128/aac.00092-19]; [Global Laboratory inititiative(GLI) Global Laboratory inititiative(GLI) StopTB partnership], 2014, STOPTB PARTN MYC LAB; Global Laboratory inititiative(GLI) StopTB partnership, STOPTB PARTN LIN PRO; Hofmann-Thiel S, 2017, INT J TUBERC LUNG D, V21, P721, DOI 10.5588/ijtld.17.0140; Huyen MNT, 2013, ANTIMICROB AGENTS CH, V57, P3620, DOI 10.1128/AAC.00077-13; Jabeen K, 2011, EMERG INFECT DIS, V17, P564, DOI 10.3201/eid1703.100957; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Javaid A, 2008, INT J TUBERC LUNG D, V12, P326; Javaid A, 2017, INT J TUBERC LUNG D, V21, P303, DOI 10.5588/ijtld.16.0444; Katiyar SK, 2008, INT J TUBERC LUNG D, V12, P139; Makhado NA, 2018, LANCET INFECT DIS, V18, P1350, DOI 10.1016/S1473-3099(18)30496-1; Manson AL, 2017, NAT GENET, V49, P395, DOI 10.1038/ng.3767; Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796; Nachega JB, 2020, CLIN INFECT DIS; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Siddiqui S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221485; Stagg HR, 2017, INT J TUBERC LUNG D, V21, P129, DOI 10.5588/ijtld.16.0716; Tahseen S, 2019, INT J TUBERC LUNG D, V23, P900, DOI 10.5588/ijtld.18.0531; Tahseen S, 2016, INT J TUBERC LUNG D, V20, P448, DOI 10.5588/ijtld.15.0645; Van Deun A, 2018, INT J TUBERC LUNG D, V22, P239, DOI 10.5588/ijtld.17.0660; Van Deun A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233500; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; Walsh KF, 2019, CLIN INFECT DIS, V69, P717, DOI 10.1093/cid/ciz039; Wan JCM, 2017, NAT REV CANCER, V17, P223, DOI 10.1038/nrc.2017.7; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2018, TECHN REP CRIT CONC; World Health Organization, 2017, TREATMENT TUBERCULOS; World Health Organization, 2018, END TB STRAT GLOB ST; World Health Organization, 2018, LAT TUB INF UPD CONS; Yuen CM, 2015, PEDIATRICS, V136, pE50, DOI 10.1542/peds.2015-0172; Zignol M, 2016, LANCET INFECT DIS, V16, P1185, DOI 10.1016/S1473-3099(16)30190-6	40	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239328	10.1371/journal.pone.0239328	http://dx.doi.org/10.1371/journal.pone.0239328			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966321	Green Published, gold			2022-12-26	WOS:000575688700012
J	Vendel, E; Rottschafer, V; de Lange, ECM				Vendel, Esmee; Rottschafer, Vivi; de Lange, Elizabeth C. M.			A 3D brain unit model to further improve prediction of local drug distribution within the brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TARGET RESIDENCE TIME; IN-VIVO; RECEPTOR CONCENTRATION; EXTRACELLULAR-SPACE; FLOW-VELOCITY; RAT-BRAIN; BLOOD; DIFFUSION; BARRIER	The development of drugs targeting the brain still faces a high failure rate. One of the reasons is a lack of quantitative understanding of the complex processes that govern the pharmacokinetics (PK) of a drug within the brain. While a number of models on drug distribution into and within the brain is available, none of these addresses the combination of factors that affect local drug concentrations in brain extracellular fluid (brain ECF). Here, we develop a 3D brain unit model, which builds on our previous proof-of-concept 2D brain unit model, to understand the factors that govern local unbound and bound drug PK within the brain. The 3D brain unit is a cube, in which the brain capillaries surround the brain ECF. Drug concentration-time profiles are described in both a blood-plasma-domain and a brain-ECF-domain by a set of differential equations. The model includes descriptions of blood plasma PK, transport through the blood-brain barrier (BBB), by passive transport via paracellular and transcellular routes, and by active transport, and drug binding kinetics. The impact of all these factors on ultimate local brain ECF unbound and bound drug concentrations is assessed. In this article we show that all the above mentioned factors affect brain ECF PK in an interdependent manner. This indicates that for a quantitative understanding of local drug concentrations within the brain ECF, interdependencies of all transport and binding processes should be understood. To that end, the 3D brain unit model is an excellent tool, and can be used to build a larger network of 3D brain units, in which the properties for each unit can be defined independently to reflect local differences in characteristics of the brain.	[Vendel, Esmee; Rottschafer, Vivi] Leiden Univ, Math Inst, Leiden, Netherlands; [de Lange, Elizabeth C. M.] Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Rottschafer, V (corresponding author), Leiden Univ, Math Inst, Leiden, Netherlands.; de Lange, ECM (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Leiden, Netherlands.	vivi@math.leidenuniv.nl; ecmdelange@lacdr.leidenuniv.nl		Rottschafer, Vivi/0000-0002-4150-3486				[Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Ball K, 2014, MOL PHARMACEUT, V11, P836, DOI 10.1021/mp400533q; Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; BRUNS RF, 1980, P NATL ACAD SCI-BIOL, V77, P5547, DOI 10.1073/pnas.77.9.5547; Calvetti D, 2015, J THEOR BIOL, V376, P48, DOI 10.1016/j.jtbi.2015.03.037; COLLINS JM, 1983, AM J PHYSIOL, V245, pR303, DOI 10.1152/ajpregu.1983.245.3.R303; Costes N, 2002, J CEREBR BLOOD F MET, V22, P753, DOI 10.1097/00004647-200206000-00014; CRONE C, 1963, ACTA PHYSIOL SCAND, V58, P292, DOI 10.1111/j.1748-1716.1963.tb02652.x; Dahl G, 2013, DRUG DISCOV TODAY, V18, P697, DOI 10.1016/j.drudis.2013.02.010; de Lange ECM, 2005, AAPS J, V7, pE532, DOI 10.1208/aapsj070354; de Witte WEA, 2016, TRENDS PHARMACOL SCI, V37, P831, DOI 10.1016/j.tips.2016.06.008; Ehlers W, 2015, COMPUT METHOD BIOMEC, V18, P861, DOI 10.1080/10255842.2013.853754; FARDE L, 1989, J CEREBR BLOOD F MET, V9, P696, DOI 10.1038/jcbfm.1989.98; Gaohua Lu, 2016, Drug Metab Pharmacokinet, V31, P224, DOI 10.1016/j.dmpk.2016.03.005; Gustafsson S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41828-4; Hammarlund-Udenaes M, 2008, PHARM RES-DORDR, V25, P1737, DOI 10.1007/s11095-007-9502-2; HammarlundUdenaes M, 1997, PHARMACEUT RES, V14, P128, DOI 10.1023/A:1012080106490; Hladky SB, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-26; Hoffmann J, 2009, NEURO-ONCOLOGY, V11, P158, DOI 10.1215/15228517-2008-072; Hudetz AG, 1997, MICROVASC RES, V54, P35, DOI 10.1006/mvre.1997.2023; Hutchinson EB, 2006, NEUROIMAGE, V32, P520, DOI 10.1016/j.neuroimage.2006.03.033; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; IVANOV KP, 1981, MICROVASC RES, V22, P143, DOI 10.1016/0026-2862(81)90084-4; JUCKER M, 1990, NEUROBIOL AGING, V11, P39, DOI 10.1016/0197-4580(90)90060-D; Kalvass JC, 2002, BIOPHARM DRUG DISPOS, V23, P327, DOI 10.1002/bdd.325; Karbowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026709; Lentz KA, 2000, PHARM RES-DORDR, V17, P1456, DOI 10.1023/A:1007692622216; LEVY G, 1994, CLIN PHARMACOL THER, V56, P248, DOI 10.1038/clpt.1994.134; Liu XR, 2009, DRUG METAB DISPOS, V37, P1548, DOI 10.1124/dmd.109.026674; Liu XR, 2004, DRUG METAB DISPOS, V32, P132, DOI 10.1124/dmd.32.1.132; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; McGinty S, 2016, J MATH CHEM, V54, P967, DOI 10.1007/s10910-016-0618-7; Mikitsh JL, 2014, PERSPECT MED CHEM, V6, P11, DOI 10.4137/PMC.S13384; Millet P, 2006, J NUCL MED, V47, P783; Nhan T, 2014, PHYS MED BIOL, V59, P5987, DOI 10.1088/0031-9155/59/20/5987; Nicholson C, 2000, PROG BRAIN RES, V125, P129; NICHOLSON C, 1981, J PHYSIOL-LONDON, V321, P225, DOI 10.1113/jphysiol.1981.sp013981; Nicholson C, 2001, REP PROG PHYS, V64, P815, DOI 10.1088/0034-4885/64/7/202; Nicholson C, 2011, COMPUT VIS SCI, V14, P309, DOI 10.1007/s00791-012-0185-9; Ooi QX, 2019, AAPS J, V21, DOI 10.1208/s12248-019-0366-2; Pan AC, 2013, DRUG DISCOV TODAY, V18, P667, DOI 10.1016/j.drudis.2013.02.007; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2016, EXPERT OPIN DRUG DEL, V13, P963, DOI 10.1517/17425247.2016.1171315; PERRY DC, 1980, BRAIN RES, V199, P49, DOI 10.1016/0006-8993(80)90229-2; RENKIN EM, 1959, AM J PHYSIOL, V197, P1205, DOI 10.1152/ajplegacy.1959.197.6.1205; Roanes-Lozano E, 2006, SIAM REV, V48, P133, DOI 10.1137/050634074; Rowland M, 2005, CLIN PHARMACOKINETIC; Saltzman WM, 2012, TRANSPORT PHENOMENA, P158; Schiesser WE, 2009, COMPENDIUM OF PARTIAL DIFFERENTIAL EQUATION MODELS: METHOD OF LINES ANALYSIS WITH MATLAB, P1, DOI 10.1017/CBO9780511576270; Schlageter KE, 1999, MICROVASC RES, V58, P312, DOI 10.1006/mvre.1999.2188; Seylaz J, 1999, J CEREBR BLOOD F MET, V19, P863, DOI 10.1097/00004647-199908000-00005; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Summerfield SG, 2008, XENOBIOTICA, V38, P1518, DOI 10.1080/00498250802499459; Summerfield SG, 2007, J PHARMACOL EXP THER, V322, P205, DOI 10.1124/jpet.107.121525; Summerfield SG, 2006, J PHARMACOL EXP THER, V316, P1282, DOI 10.1124/jpet.105.092916; Syvanen S, 2006, PHARM RES-DORDR, V23, P705, DOI 10.1007/s11095-006-9780-0; TAKASATO Y, 1984, AM J PHYSIOL, V247, pH484, DOI 10.1152/ajpheart.1984.247.3.H484; Tasso L, 2008, LAT AM J PHARM, V27, P270; Tata DA, 2002, J NEUROSCI METH, V113, P199, DOI 10.1016/S0165-0270(01)00494-0; Trapa PE, 2016, J PHARM SCI-US, V105, P965, DOI 10.1016/j.xphs.2015.12.005; Tsuji Akira, 2005, NeuroRx, V2, P54, DOI 10.1007/BF03206642; Tzafriri AR, 2012, J CONTROL RELEASE, V161, P918, DOI 10.1016/j.jconrel.2012.05.039; VANBREE JBMM, 1988, J PHARMACOL EXP THER, V247, P1233; Vauquelin G, 2015, EXPERT OPIN DRUG DIS, V10, P1085, DOI 10.1517/17460441.2015.1067196; Vendel E, 2019, B MATH BIOL, V81, P3477, DOI 10.1007/s11538-018-0469-4; Vendel E, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0133-x; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; Wang YF, 1996, PHARMACEUT RES, V13, P398, DOI 10.1023/A:1016092525901; Watanabe T, 2009, J PHARMACOL EXP THER, V328, P652, DOI 10.1124/jpet.108.146647; Waterhouse Rikki N, 2003, Mol Imaging Biol, V5, P376, DOI 10.1016/j.mibio.2003.09.014; Wong Andrew D, 2013, Front Neuroeng, V6, P7, DOI 10.3389/fneng.2013.00007; Yamamoto Y, 2018, EUR J PHARM SCI, V112, P168, DOI 10.1016/j.ejps.2017.11.011; Yamamoto Y, 2017, AAPS J, V19, P891, DOI 10.1208/s12248-017-0050-3; Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023; Zhan WB, 2017, PHARM RES-DORDR, V34, P860, DOI 10.1007/s11095-017-2114-6	75	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0238397	10.1371/journal.pone.0238397	http://dx.doi.org/10.1371/journal.pone.0238397			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966285	Green Published, gold, Green Submitted			2022-12-26	WOS:000575688700016
J	Esezobor, CI; Solarin, AU; Gbadegesin, R				Esezobor, Christopher, I; Solarin, Adaobi U.; Gbadegesin, Rasheed			Changing epidemiology of nephrotic syndrome in Nigerian children: A cross-sectional study	PLOS ONE			English	Article							RISK	Background Recent reports from small studies in West Africa suggest that Black children may have high rate of steroid sensitivity nephrotic syndrome (SSNS) contrary to long held knowledge. Herein, we determined the proportion of children with idiopathic nephrotic syndrome (INS) who achieved complete remission with steroid therapy and identified factors associated with complete remission. Methods We reviewed the medical records of 241 children with INS in two centres in Lagos from 2010 to 2019. We extracted demographic data, clinical features, laboratory values at the time of diagnosis, and receipt and response to steroids and other immunosuppressants. Results The median (interquartile range) age at diagnosis of INS was 5.1 (3.0-8.7) years and boys were 60.2% of the study population. Children with SSNS made up 85.9% (n = 207) of the study cohort. Among those aged 0-5 years, 92.6%were SSNS compared with 69.2% in those aged 11-17 years at the time of diagnosis. In addition, the proportion of children with SSNS increased from 73.8% between year 2010 and 2012 to 88.4% afterwards. Also, children with SSNS had lower serum creatinine (0.44 vs 0.70; p<0.001) and higher estimated glomerular filtration rate (101 vs 74.3 ml/min/1.73 m(2); p = 0.008) at the time of diagnosis than those with steroid resistant nephrotic syndrome (SRNS). Conclusion Among Black children in Lagos, the proportion with SSNS is comparable to proportions described in children of Asian and European descent. Furthermore, children with SSNS had lower serum creatinine and higher glomerular filtration rate than those with SRNS.	[Esezobor, Christopher, I] Univ Lagos, Coll Med, Fac Clin Sci, Dept Paediat, Lagos, Nigeria; [Esezobor, Christopher, I] Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Solarin, Adaobi U.] Lagos State Univ, Coll Med, Fac Clin Sci, Dept Paediat, Lagos, Nigeria; [Solarin, Adaobi U.] Lagos State Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Gbadegesin, Rasheed] Duke Univ, Med Ctr, Dept Pediat, Div Nephrol, Durham, NC 27710 USA; [Gbadegesin, Rasheed] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA; [Gbadegesin, Rasheed] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC USA	University of Lagos; Lagos State University; Lagos State University; Duke University; Duke University; Duke University	Esezobor, CI (corresponding author), Univ Lagos, Coll Med, Fac Clin Sci, Dept Paediat, Lagos, Nigeria.; Esezobor, CI (corresponding author), Lagos Univ Teaching Hosp, Dept Paediat, Lagos, Nigeria.	esezobor@gmail.com	Solarin, Adaobi/AAF-2893-2020	Solarin, Adaobi/0000-0002-2594-5815; Esezobor, Christopher/0000-0003-1736-4794	National Institutes of Health/NIDDK [5R01DK098135, 5R01DK094987]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Doris Duke Clinical Research Mentorship award	National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Doris Duke Clinical Research Mentorship award	Rasheed Gbadegesin is supported by National Institutes of Health/NIDDK grants 5R01DK098135, 5R01DK094987 and Doris Duke Charitable Foundation Clinical Scientist Development Award, and Doris Duke Clinical Research Mentorship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes MM, 2006, PEDIATR NEPHROL, V21, P1003, DOI 10.1007/s00467-006-0138-y; ADU D, 1981, Q J MED, V50, P297; Aloni MN, 2014, ACTA PAEDIATR, V103, pE365, DOI 10.1111/apa.12647; Anochie I, 2006, J NATL MED ASSOC, V98, P1977; [Anonymous], 1981, KIDNEY INT, V20, P765; [Anonymous], 1981, J PEDIATR-US, V98, P561, DOI 10.1016/s0022-3476(81)80760-3; Asinobi AO, 2019, NIGER J CLIN PRACT, V22, P790, DOI 10.4103/njcp.njcp_206_16; Bakhiet YM, 2017, AFR HEALTH SCI, V17, P1130, DOI 10.4314/ahs.v17i4.22; Banh THM, 2016, CLIN J AM SOC NEPHRO, V11, P1760, DOI 10.2215/CJN.00380116; Central Intelligence Agency (CIA), WORLD FACTB NIG; Coulibaly PNA, 2014, AFR J PAEDIAT NEPHRO, V1, P57; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gipson DS, 2006, PEDIATR NEPHROL, V21, P344, DOI 10.1007/s00467-005-2097-0; HENDRICKSE RG, 1972, LANCET, V1, P1143, DOI 10.1016/S0140-6736(72)91373-6; INGULLI E, 1991, PEDIATR NEPHROL, V5, P393, DOI 10.1007/BF01453661; Jellouli M, 2018, J PEDIATR-US, V197, P191, DOI 10.1016/j.jpeds.2018.01.008; Kim JS, 2005, KIDNEY INT, V68, P1275, DOI 10.1111/j.1523-1755.2005.00524.x; Ladapo TA, 2014, INT J NEPHROL, V2014, DOI 10.1155/2014/350640; Lombel RM, 2013, PEDIATR NEPHROL, V28, P409, DOI 10.1007/s00467-012-2304-8; McKinney PA, 2001, PEDIATR NEPHROL, V16, P1040, DOI 10.1007/s004670100021; Nandlal L, 2019, KIDNEY INT REP, V4, P522, DOI 10.1016/j.ekir.2019.01.019; National Bureau of Statistics (NBS) and United Nations Children's Fund (UNICEF), 2017, MULT INDICATORCLUSTE, P1; Okoro B A, 2000, West Afr J Med, V19, P137; Okoronkwo NC, 2014, AFR J PAEDIATR NEPHR, V1, P62; Olowu WA, 2017, PAEDIATR INT CHILD H, V37, P259, DOI 10.1080/20469047.2017.1374002; Rheault MN, 2015, CLIN J AM SOC NEPHRO, V10, P2110, DOI 10.2215/CJN.06620615; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Sharma M, 2018, CLIN KIDNEY J, V11, P655, DOI 10.1093/ckj/sfy024; Sorof JM, 1998, PEDIATR NEPHROL, V12, P764, DOI 10.1007/s004670050542; Warejko JK, 2018, CLIN J AM SOC NEPHRO, V13, P53, DOI 10.2215/CJN.04120417	30	3	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239300	10.1371/journal.pone.0239300	http://dx.doi.org/10.1371/journal.pone.0239300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956418	Green Published, gold			2022-12-26	WOS:000574571500039
J	Del Carro, KB; Leite, GR; de Oliveira, AG; dos Santos, CB; Pinto, ID; Fux, B; Falqueto, A				Del Carro, Karina Bertazo; Leite, Gustavo Rocha; de Oliveira Filho, Amandio Goncalves; dos Santos, Claudiney Biral; Pinto, Israel de Souza; Fux, Blima; Falqueto, Aloisio			Assessing geographic and climatic variables to predict the potential distribution of the visceral leishmaniasis vectorLutzomyia longipalpisin the state of Espirito Santo, Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; LUTZOMYIA-LONGIPALPIS; SPECIES DISTRIBUTIONS; DIPTERA PSYCHODIDAE; FLIES DIPTERA; VECTORS; POPULATIONS; MUNICIPALITY; CONSERVATION; COMPLEX	Visceral leishmaniasis (VL) is an infectious disease caused by the protozoaLeishmania chagasi, whose main vector in South America isLutzomyia longipalpis. The disease was diagnosed in the Brazilian state of Espirito Santo (ES) for the first time in 1968. Currently, this disease has been considered endemic in 10 municipalities. Furthermore, the presence ofL.longipalpishas been detected in eight other municipalities where the transmission has not been reported thus far. In this study, we performed species distribution modeling (SDM) to identify new and most likely receptive areas for VL transmission in ES. The sandflies were both actively and passively collected in various rural area of ES between 1986 and 2017. The collection points were georeferenced using a global positioning system device. Climatic data were retrieved from the WorldClim database, whereas geographic data were obtained from the National Institute for Space Research and the Integrated System of Geospatial Bases of the State of Espirito Santo. The maximum entropy algorithm was used through the MIAmaxent R package to train and test the distribution models forL.longipalpis. The major contributor to model generation was rocky outcrops, followed by temperature seasonality. The SDM predicted the expansion of theL.longipalpis-prone area in the Doce River Valley and limited the probability of expanding outside its watershed. Once the areas predicted suitable forL.longipalpisoccurrence are determined, we can avoid the inefficient use of public resources in conducting canine serological surveys where the vector insect does not occur.	[Del Carro, Karina Bertazo; Leite, Gustavo Rocha; dos Santos, Claudiney Biral; Pinto, Israel de Souza; Fux, Blima; Falqueto, Aloisio] Univ Fed Espirito Santo, Trop Med Unit, Vitoria, ES, Brazil; [de Oliveira Filho, Amandio Goncalves] Univ Fed Espirito Santo, Dept Civil Engn, Vitoria, ES, Brazil; [dos Santos, Claudiney Biral] Espirito Santo State Hlth Dept, Ctr Entomol & Malacol, Serra, ES, Brazil; [Falqueto, Aloisio] Univ Fed Espirito Santo, Dept Patol, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Del Carro, KB (corresponding author), Univ Fed Espirito Santo, Trop Med Unit, Vitoria, ES, Brazil.	bertazokarina@gmail.com	Rocha Leite, Gustavo/H-1292-2012	Rocha Leite, Gustavo/0000-0003-4320-3804; de Souza Pinto, Israel/0000-0001-8924-640X; Del Carro, Karina/0000-0002-9757-2595				Abrantes TR, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00021117, 10.1590/0102-311X00021117]; Aguiar, 1996, Cad Saude Publica, V12, P195; [Anonymous], 2017, J PROSTHET DENT, V11, pe1; Aparicio C, 2004, REV SAUDE PUBL, V38, P511, DOI 10.1590/S0034-89102004000400005; Araki AS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002495; Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Arrivillaga J, 2003, J MED ENTOMOL, V40, P615, DOI 10.1603/0022-2585-40.5.615; Barcellos, 1996, Cad Saude Publica, V12, P389; Bauzer LGSR, 2002, INSECT MOL BIOL, V11, P315, DOI 10.1046/j.1365-2583.2002.00340.x; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Brasil Brasil. Ministerio da Saude (MS). Secretaria de Vigilancia em Saude, 2014, MAN VIG CONTR LEISHM; Brazil RP, 2013, REV SOC BRAS MED TRO, V46, P263, DOI 10.1590/0037-8682-0101-2013; Carvalho BM, 2014, REV BRAS ENTOMOL, V58, P77, DOI 10.1590/S0085-56262014000100013; Chamaille L, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-31; Novo SPC, 2013, REV SOC BRAS MED TRO, V46, P231, DOI 10.1590/0037-8682-1190-2013; de Almeida AS, 2014, CAD SAUDE PUBLICA, V30, P1639, DOI 10.1590/0102-311X00059414; de Almeida PS, 2013, MEM I OSWALDO CRUZ, V108, P992, DOI 10.1590/0074-0276130331; de Oliveira EF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006684; Feitoza LR, 2001, NAT RES INF SYST RUR; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fischer D, 2011, PROCEDIA ENVIRON SCI, V7, P164, DOI 10.1016/j.proenv.2011.07.029; Franco AO, 2011, PARASITOLOGY, V138, P1878, DOI 10.1017/S003118201100148X; Fuzari AA, 2016, REV SOC BRAS MED TRO, V49, P616, DOI 10.1590/0037-8682-0082-2016; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Gonzalez C, 2014, ACTA TROP, V129, P83, DOI 10.1016/j.actatropica.2013.08.014; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Halvorsen R, 2015, ECOGRAPHY, V38, P172, DOI 10.1111/ecog.00565; HOSMER DW, 2000, WILEY PS TX, P1; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Mangabeira Filho O., 1969, REV BRASILEIRA MALAR, V21, P3; Margonari C, 2006, MEM I OSWALDO CRUZ, V101, P31, DOI 10.1590/S0074-02762006000100007; Martins J, 1968, HOSPITAL, V73, P69; Meneguzzi VC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164580; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; de Araujo VEM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002540; Moreira DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110929; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Nieto P, 2006, GEOSPATIAL HEALTH, V1, P115, DOI 10.4081/gh.2006.286; Pech-May A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006614; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2017, INT J PARASITOL, V47, P667, DOI 10.1016/j.ijpara.2017.04.007; Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P140; Peterson AT, 2001, CONDOR, V103, P599, DOI 10.1650/0010-5422(2001)103[0599:PSGDBO]2.0.CO;2; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pinto IdeS, 2009, ASS ENTRE VARIAVEIS; Pinto ID, 2012, J VECTOR ECOL, V37, P90, DOI 10.1111/j.1948-7134.2012.00204.x; Rezende C, 1959, J PEDIAT, V24, P323; Rodrigues de Azevedo Alfredo Carlos, 2015, EntomoBrasilis, V8, P201, DOI 10.12741/ebrasilis.v8i3.498; Saraiva L, 2011, ACTA TROP, V117, P137, DOI 10.1016/j.actatropica.2010.11.007; Sessa A, 2000, REV SOC BRAS MED S1, V33, P327; Souza NA, 2008, MEM I OSWALDO CRUZ, V103, P216, DOI 10.1590/S0074-02762008000200017; Spiegel CN, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1866-x; Tabarelli M, 2005, CONSERV BIOL, V19, P695, DOI 10.1111/j.1523-1739.2005.00694.x; Valavi R, 2019, METHODS ECOL EVOL, V10, P225, DOI 10.1111/2041-210X.13107; Vollering J, 2019, ECOL EVOL, V9, P12051, DOI 10.1002/ece3.5654; Ward R.D., 1983, Memorias do Instituto Oswaldo Cruz, V78, P269, DOI 10.1590/S0074-02761983000300005; Watts PC, 2005, AM J TROP MED HYG, V73, P734, DOI 10.4269/ajtmh.2005.73.734; World Health Organization (WHO), 2016, LEISHMANIASIS; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1; Zimmermann N. E., 2017, HABITAT SUITABILITY, DOI [10.1017/9781139028271, DOI 10.1017/9781139028271]	65	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238198	10.1371/journal.pone.0238198	http://dx.doi.org/10.1371/journal.pone.0238198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946444	gold, Green Published			2022-12-26	WOS:000573851100004
J	Chaput, G; Billings, AF; DeDiego, L; Orellana, R; Adkins, JN; Nicora, CD; Kim, YM; Chu, R; Simmons, B; DeAngelis, KM				Chaput, Gina; Billings, Andrew F.; DeDiego, Lani; Orellana, Roberto; Adkins, Joshua N.; Nicora, Carrie D.; Kim, Young-Mo; Chu, Rosalie; Simmons, Blake; DeAngelis, Kristen M.			Lignin induced iron reduction by novel sp., Tolumonas lignolytic BRL6-1	PLOS ONE			English	Article							CENTRAL CARBON METABOLISM; CORIOLUS-VERSICOLOR; DEGRADATION; BACTERIA; PROTEIN; GROWTH; BIODEGRADATION; SIDEROPHORES; MODEL; ACID	Lignin is the second most abundant carbon polymer on earth and despite having more fuel value than cellulose, it currently is considered a waste byproduct in many industrial lignocellulose applications. Valorization of lignin relies on effective and green methods of de-lignification, with a growing interest in the use of microbes. Here we investigate the physiology and molecular response of the novel facultative anaerobic bacterium,Tolumonas lignolyticaBRL6-1, to lignin under anoxic conditions. Physiological and biochemical changes were compared between cells grown anaerobically in either lignin-amended or unamended conditions. In the presence of lignin, BRL6-1 accumulates higher biomass and has a shorter lag phase compared to unamended conditions, and 14% of the proteins determined to be significantly higher in abundance by log(2)fold-change of 2 or greater were related to Fe(II) transport in late logarithmic phase. Ferrozine assays of the supernatant confirmed that Fe(III) was bound to lignin and reduced to Fe(II) only in the presence of BRL6-1, suggesting redox activity by the cells. LC-MS/MS analysis of the secretome showed an extra band at 20 kDa in lignin-amended conditions. Protein sequencing of this band identified a protein of unknown function with homology to enzymes in the radical SAM superfamily. Expression of this protein in lignin-amended conditions suggests its role in radical formation. From our findings, we suggest that BRL6-1 is using a protein in the radical SAM superfamily to interact with the Fe(III) bound to lignin and reducing it to Fe(II) for cellular use, increasing BRL6-1 yield under lignin-amended conditions. This interaction potentially generates organic free radicals and causes a radical cascade which could modify and depolymerize lignin. Further research should clarify the extent to which this mechanism is similar to previously described aerobic chelator-mediated Fenton chemistry or radical producing lignolytic enzymes, such as lignin peroxidases, but under anoxic conditions.	[Chaput, Gina; Billings, Andrew F.; DeDiego, Lani; DeAngelis, Kristen M.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Orellana, Roberto] Univ Playa Ancha, Fac Ciencias Nat & Exactas, Dept Biol, Valparaiso, Chile; [Adkins, Joshua N.; Nicora, Carrie D.; Kim, Young-Mo] Pacific Northwest Natl Lab, Biol Sci Dept, Richland, WA 99352 USA; [Chu, Rosalie] Pacific Northwest Natl Lab, Environm & Mol Sci Lab, Richland, WA 99352 USA; [Simmons, Blake] US DOE, Joint Genome Inst, Berkeley, CA USA	University of Massachusetts System; University of Massachusetts Amherst; Universidad de Playa Ancha; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Joint Genome Institute - JGI	DeAngelis, KM (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	deangelis@microbio.umass.edu	Kim, Young-Mo/AAG-2866-2019; Simmons, Blake/N-6022-2016; Kim, Young-Mo/D-3282-2009	Kim, Young-Mo/0000-0002-8972-7593; Simmons, Blake/0000-0002-1332-1810; Kim, Young-Mo/0000-0002-8972-7593; orellana, roberto/0000-0003-0633-3458; Chaput, Gina/0000-0001-5612-5687	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Office of Biological and Environmental Research [DE-AC05-76RL01830, grid.436923.9]; U.S. Environmental Protection [FP-91782301-0]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Environmental Protection	B.S.; K.M.D.; This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. K.M.D.; This research was performed using resources at the DOE Environmental Molecular Sciences Laboratory (grid.436923.9), which is an DOE Office of Science User Facilities sponsored by the Office of Biological and Environmental Research and operated under Contract No. DE-AC05-76RL01830. G.C.; This publication was also developed under Assistance Agreement No. FP-91782301-0 awarded by the U.S. Environmental Protection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed E, 2014, MICROB BIOTECHNOL, V7, P196, DOI 10.1111/1751-7915.12117; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; [Anonymous], 2001, ACTUALIDAD JURIDICA, V87, P43; [Anonymous], 2007, AGILENT TECHNOLOGIES, V1; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Antunes A, 2016, J BACTERIOL, V198, P644, DOI 10.1128/JB.00659-15; Becker J, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.02.016; Benjdia A, 2016, BIOCHEM SOC T, V44, P109, DOI 10.1042/BST20150191; Billings AF, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0100-3; Brink DP, 2019, APPL MICROBIOL BIOT, V103, P3979, DOI 10.1007/s00253-019-09692-4; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Chen XF, 2015, PROTEIN SCI, V24, P2070, DOI 10.1002/pro.2811; Chu D, 2016, SCI REP-UK, V6, DOI 10.1038/srep25191; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Clarke TE, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-27; Collyer ML, 2018, METHODS ECOL EVOL, V9, P1772, DOI 10.1111/2041-210X.13029; Cragg SM, 2015, CURR OPIN CHEM BIOL, V29, P108, DOI 10.1016/j.cbpa.2015.10.018; Cunane LM, 2000, J MOL BIOL, V295, P357, DOI 10.1006/jmbi.1999.3290; Dave B, 2000, CHEM CHARACTERIZATIO; DeAngelis KM, 2013, FRONT MICROBIOL, P4, DOI [10.3389/fmicb.2013.0000423386843, DOI 10.3389/FMICB.2013.0000423386843]; DeAngelis KM, 2013, SOIL BIOL BIOCHEM, V66, P60, DOI 10.1016/j.soilbio.2013.06.010; DeAngelis KM, 2010, ENVIRON MICROBIOL, V12, P3137, DOI 10.1111/j.1462-2920.2010.02286.x; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Durante-Rodriguez G., 2018, RSC ENERGY ENV SERIE, P333, DOI [10.1039/9781788010351-00333, DOI 10.1039/9781788010351, DOI 10.1039/9781788010351-00333]; Erde J, 2014, J PROTEOME RES, V13, P1885, DOI 10.1021/pr4010019; ERTEL JR, 1984, GEOCHIM COSMOCHIM AC, V48, P2065, DOI 10.1016/0016-7037(84)90387-9; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Fioroto AM, 2015, J AGR FOOD CHEM, V63, P6331, DOI 10.1021/acs.jafc.5b01947; Fisher AB, 2014, AIMS BIOENG, V1, P92, DOI 10.3934/bioeng.2014.2.92; Garcia CA, 2012, REV ARGENT MICROBIOL, V44, P150; Gregori J, 2013, J PROTEOMICS, V95, P55, DOI 10.1016/j.jprot.2013.05.030; Guillon E, 2001, J COLLOID INTERF SCI, V239, P39, DOI 10.1006/jcis.2001.7535; Holladay J., 2007, TOP VALUE ADDED CHEM, VII; Janssen PH, 1997, APPL ENVIRON MICROB, V63, P1382, DOI 10.1128/AEM.63.4.1382-1388.1997; Janusz G, 2017, FEMS MICROBIOL REV, V41, P941, DOI 10.1093/femsre/fux049; Jeitner TM, 2014, ANAL BIOCHEM, V454, P36, DOI 10.1016/j.ab.2014.02.026; Kahm M, 2010, J STAT SOFTW, V33, P1; Kamimura N, 2019, CURR OPIN BIOTECH, V56, P179, DOI 10.1016/j.copbio.2018.11.011; Kawai S, 1999, FEMS MICROBIOL LETT, V170, P51, DOI 10.1111/j.1574-6968.1999.tb13354.x; Kim BH, 2008, BACTERIAL PHYSIOLOGY AND METABOLISM, P1; KIRK TK, 1987, ANNU REV MICROBIOL, V41, P465, DOI 10.1146/annurev.mi.41.100187.002341; Koshkin A, 2004, ANTIMICROB AGENTS CH, V48, P2424, DOI 10.1128/AAC.48.7.2424-2430.2004; Leyn SA, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000061; Leyn SA, 2011, J BIOL CHEM, V286, P35782, DOI 10.1074/jbc.M111.267963; Ma JS, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0439-8; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; Montazeri M, 2016, ACS SUSTAIN CHEM ENG, V4, P708, DOI 10.1021/acssuschemeng.5b00550; Narna HS, 2003, GENE, V323, P125, DOI 10.1016/j.gene.2003.09.012; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Orellana R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186440; Pereira JH, 2016, J BIOL CHEM, V291, P10228, DOI 10.1074/jbc.M115.700427; Pollegioni L, 2015, FEBS J, V282, P1190, DOI 10.1111/febs.13224; Rabilloud T, 2013, PROTEOME RES 2 DIMEN; Ren TY, 2019, CHEMCATCHEM, V11, P639, DOI 10.1002/cctc.201801428; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Salvachua D, 2015, GREEN CHEM, V17, P4951, DOI [10.1039/C5GC01165E, 10.1039/c5gc01165e]; Scott GM, 2002, PROGR BIOTECHNOL, V21, P61, DOI 10.1016/S0921-0423(02)80008-9; Singh G, 2019, INT J BIOL MACROMOL, V134, P1070, DOI 10.1016/j.ijbiomac.2019.05.168; Sipe AR, 2000, APPL ENVIRON MICROB, V66, P1685, DOI 10.1128/AEM.66.4.1685-1691.2000; Solovyev V, 2013, AUTOMATIC ANNOTATION; Sudarsan S, 2014, APPL ENVIRON MICROB, V80, P5292, DOI 10.1128/AEM.01643-14; THOMPSON J, 1985, J BACTERIOL, V162, P217, DOI 10.1128/JB.162.1.217-223.1985; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460; Valcu CM, 2006, PROTEOMICS, V6, P4166, DOI 10.1002/pmic.200500660; Varman AM, 2016, PNAS; Wang L, 2008, SCI CHINA SER C, V51, P214, DOI 10.1007/s11427-008-0033-9; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3; Williams KM, 2012, INT J MOL SCI, V13, P3765, DOI 10.3390/ijms13033765; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Woo HL, 2014, STAND GENOMIC SCI, V9, DOI 10.1186/1944-3277-9-19; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zhang KJ, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1035-x	74	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0233823	10.1371/journal.pone.0233823	http://dx.doi.org/10.1371/journal.pone.0233823			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941430	Green Submitted, Green Published, gold			2022-12-26	WOS:000573848800062
J	Sampath, S; Srivastava, V				Sampath, Suchitra; Srivastava, Vipin			On stability and associative recall of memories in attractor neural networks	PLOS ONE			English	Article							FAMILIARITY DISCRIMINATION; DYNAMICS; MODELS; BRAIN; CA3	Attractor neural networks such as the Hopfield model can be used to model associative memory. An efficient associative memory should be able to store a large number of patterns which must all be stable. We study in detail the meaning and definition of stability of network states. We reexamine the meanings of retrieval, recognition and recall and assign precise mathematical meanings to each of these terms. We also examine the relation between them and how they relate to memory capacity of the network. We have shown earlier in this journal that orthogonalization scheme provides an effective way of overcoming catastrophic interference that limits the memory capacity of the Hopfield model. It is not immediately apparent whether the improvement made by orthgonalization affects the processes of retrieval, recognition and recall equally. We show that this influence occurs to different degrees and hence affects the relations between them. We then show that the conditions for pattern stability can be split into a necessary condition (recognition) and a sufficient one (recall). We interpret in cognitive terms the information being stored in the Hopfield model and also after it is orthogonalized. We also study the alterations in the network dynamics of the Hopfield network upon the introduction of orthogonalization, and their effects on the efficiency of the network as an associative memory.	[Sampath, Suchitra] Univ Hyderabad, Ctr Neural & Cognit Sci, Hyderabad, Telangana, India; [Srivastava, Vipin] Univ Hyderabad, Sch Phys, Hyderabad, Telangana, India	University of Hyderabad; University of Hyderabad	Sampath, S (corresponding author), Univ Hyderabad, Ctr Neural & Cognit Sci, Hyderabad, Telangana, India.	suchitra.s85@gmail.com						AMARI S, 1988, NEURAL NETWORKS, V1, P63, DOI 10.1016/0893-6080(88)90022-6; Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; AMIT DJ, 1985, PHYS REV A, V32, P1007, DOI 10.1103/PhysRevA.32.1007; [Anonymous], 2018, 2017 CHIN WEBS SEC S, V1, P4; Bar-yam Y., 1997, DYNAMICS COMPLEX SYS, V213; Bartlett F. C., 1995, REMEMBERING STUDY EX, V14; BEER RD, 1995, ADAPT BEHAV, V3, P469, DOI 10.1177/105971239500300405; Bogacz R, 2003, HIPPOCAMPUS, V13, P494, DOI 10.1002/hipo.10093; Bogacz R, 2001, J COMPUT NEUROSCI, V10, P5, DOI 10.1023/A:1008925909305; Brunel N., 2005, METHODS MODELS NEURO, VLXXX, P407; Donaldson W, 1996, MEM COGNITION, V24, P523, DOI 10.3758/BF03200940; Donnarumma F, 2012, CONNECT SCI, V24, P71, DOI 10.1080/09540091.2012.684670; Dunn JC, 2001, 32 EUR MATH PSYCH GR; Guzowski JF, 2004, NEURON, V44, P581, DOI 10.1016/j.neuron.2004.11.003; Hebb Donald O., 1949, ORG BEHAV; Hertz J., 1991, INTRO THEORY NEURAL, V1; Hockley WE, 1999, MEM COGNITION, V27, P657, DOI 10.3758/BF03211559; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; Kirkpatrick J., 2017, P NATL ACAD SCI USA; Lundqvist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000803; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Masse NY, 2018, ARXIV180201569; McKenzie S, 2011, NEURON, V71, P224, DOI 10.1016/j.neuron.2011.06.037; Neunuebel JP, 2014, NEURON, V81, P416, DOI 10.1016/j.neuron.2013.11.017; Pereira U, 2018, NEURON; Peretto P., 1992, INTRO MODELING NEURA, V2; Renno-Costa C, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003641; Robertson EM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004633; Rojas R., 1996, NEURAL NETWORKS SYST, DOI [10.1007/978-3-642-61068-4{\_}7, DOI 10.1007/978-3-642-61068-4]; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; Sadeh T, 2014, TRENDS COGN SCI, V18, P26, DOI 10.1016/j.tics.2013.10.008; Slorkey AJ, 1999, NEURAL NETWORKS, V12, P869, DOI 10.1016/S0893-6080(99)00038-6; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Srivastava V, 2000, PHYSICA A, V276, P352, DOI 10.1016/S0378-4371(99)00467-7; Srivastava V, 2000, J PHYS A-MATH GEN, V33, P6219, DOI 10.1088/0305-4470/33/35/310; Srivastava V, 2008, J THEOR BIOL, V253, P514, DOI 10.1016/j.jtbi.2008.03.031; Srivastava V, 2017, ADV QUANTUM CHEM, V74, P299, DOI 10.1016/bs.aiq.2016.08.001; Srivastava V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105619; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006	41	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238054	10.1371/journal.pone.0238054	http://dx.doi.org/10.1371/journal.pone.0238054			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941475	gold, Green Published			2022-12-26	WOS:000573848800038
J	Tabernero, C; Castillo-Mayen, R; Luque, B; Cuadrado, E				Tabernero, Carmen; Castillo-Mayen, Rosario; Luque, Barbara; Cuadrado, Esther			Social values, self- and collective efficacy explaining behaviours in coping with Covid-19: Self-interested consumption and physical distancing in the first 10 days of confinement in Spain	PLOS ONE			English	Article							SARS	The appearance of a new coronavirus (Covid-19) and its rapid expansion throughout the world has forced all countries to establish regulations based on social confinement. In the early days of a pandemic, the adherence to regulations is crucial to be able to block its spread. This research aims to analyse the relationship between motivational variables associated with physical distancing and self-interested consumption behaviours in the first 10 days of confinement in Spain. A total of 1,324 people participated throughout the country (mean age 28.92 years). Participants answered an online survey about socio-demographic, motivational variables, which included a) risk information seeking, b) confidence in self- and collective efficacy in coping with the pandemic, and c) the four higher-order personal values -conservation (security, conformity, and tradition), self-transcendence (universalism and benevolence), openness (self-direction actions and stimulation), and self-improvement (hedonism and power) - and the aforementioned behaviours in coping with Covid-19. Results showed a positive association between self- and collective efficacy and both coping behaviours analysed: a protective role of conservation values on normative behaviours; and a negative relationship between self-transcendence values and self-interested consumption. Additionally, risk information seeking was positively associated with the development of physical distancing behaviour.	[Tabernero, Carmen] Univ Salamanca, Inst Neurociencias Castilla & Leon INCYL, Salamanca, Spain; [Castillo-Mayen, Rosario; Luque, Barbara; Cuadrado, Esther] Univ Cordoba, Fac Educ Sci & Psychol, Cordoba, Spain	University of Salamanca; Universidad de Cordoba	Tabernero, C (corresponding author), Univ Salamanca, Inst Neurociencias Castilla & Leon INCYL, Salamanca, Spain.	carmen.tabernero@usal.es	Cuadrado, Esther/AAM-2209-2021; Castillo-Mayén, Rosario/I-6408-2018; Carmen, Tabernero/D-5173-2009	Cuadrado, Esther/0000-0002-9903-0052; Castillo-Mayén, Rosario/0000-0001-8599-2368; Carmen, Tabernero/0000-0003-4338-7367				Abroms LC, 2008, ANNU REV PUBL HEALTH, V29, P219, DOI 10.1146/annurev.publhealth.29.020907.090824; Balliet D, 2013, PSYCHOL BULL, V139, P1090, DOI 10.1037/a0030939; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bartlett MS, 1950, B J PSYCHOL-STAT SEC, V3, P77, DOI 10.1111/j.2044-8317.1950.tb00285.x; Bilancini E, 2005, ARXIV202003998; Brauer M, 2010, EUR J SOC PSYCHOL, V40, P490, DOI 10.1002/ejsp.640; Briscese G., 2020, W26916 NAT BUR EC RE; Callaghan C.W, 2015, MANAGEMENT DYNAMICS, V24, P33; Calvo RA, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1373; Caprara GV, 2017, CROSS-CULT RES, V51, P388, DOI 10.1177/1069397117712194; Chan GCT, 2006, INT MARIT HEALTH, V57, P163; Daffin Jr LW, 2012, THESIS WASHINGTON ST; Eller LS, 2018, INT J NURS KNOWL, V29, P38, DOI 10.1111/2047-3095.12143; Fong E, 2011, J COMMUN HEALTH, V36, P797, DOI 10.1007/s10900-011-9378-2; Hardin Russell, 2002, RUSSELL SAGE FDN SER; Hubner AY, 2020, RISK ANAL, V40, P1212, DOI 10.1111/risa.13456; Kahlor L, 2010, HEALTH COMMUN, V25, P345, DOI 10.1080/10410231003775172; Klassen RM, 2004, J EDUC PSYCHOL, V96, P731, DOI 10.1037/0022-0663.96.4.731; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Mak WWS, 2009, PSYCHOL HEALTH, V24, P161, DOI 10.1080/08870440701447649; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Morrison LG, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-258; Norusis M. J., 1994, SPSS 8 0 GUIDE DATA; Reeves RV., 2020, CLASS COVID LESS AFF; Roser M., 2020, OPTIMISM PESSIMISM; Rudisill C, 2013, J RISK RES, V16, P959, DOI 10.1080/13669877.2012.761271; Sagiv L, 2017, NAT HUM BEHAV, V1, P630, DOI 10.1038/s41562-017-0185-3; Sampson R.J., 2004, NEW EC, V11, P106, DOI [https://doi.org/10.1111/j.1468-0041.2004.00346.x, DOI 10.1111/J.1468-0041.2004.00346.X]; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; SCHWARTZ S.H., 2012, ONLINE READINGS PSYC, V2, DOI [10.9707/2307-0919.1116, DOI 10.9707/2307-0919.1116]; Schwartz SH, 1997, POLIT PSYCHOL, V18, P385, DOI 10.1111/0162-895X.00062; Schwartz SH, 2006, REV FR SOCIOL, V47, P929, DOI 10.3917/rfs.474.0929; Schwartz SH, 2014, POLIT BEHAV, V36, P899, DOI 10.1007/s11109-013-9255-z; Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; World Health Organization, 2020, ACC GUID COVID 19 PA; Yang JZ, 2019, RISK ANAL, V39, P1708, DOI 10.1111/risa.13282	41	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238682	10.1371/journal.pone.0238682	http://dx.doi.org/10.1371/journal.pone.0238682			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941474	gold, Green Published			2022-12-26	WOS:000573848800074
J	Sutton, J; Renshaw, SL; Butts, CT				Sutton, Jeannette; Renshaw, Scott L.; Butts, Carter T.			COVID-19: Retransmission of official communications in an emerging pandemic	PLOS ONE			English	Article							SOCIAL MEDIA; FEAR APPEALS; ENGAGEMENT; MESSAGES	As the most visible face of health expertise to the general public, health agencies have played a central role in alerting the public to the emerging COVID-19 threat, providing guidance for protective action, motivating compliance with health directives, and combating misinformation. Social media platforms such as Twitter have been a critical tool in this process, providing a communication channel that allows both rapid dissemination of messages to the public at large and individual-level engagement. Message dissemination and amplification is a necessary precursor to reaching audiences, both online and off, as well as inspiring action. Therefore, it is valuable for organizational risk communication to identify strategies and practices that may lead to increased message passing among online users. In this research, we examine message features shown in prior disasters to increase or decrease message retransmission under imminent threat conditions to develop models of official risk communicators' messages shared online from February 1, 2020-April 30, 2020. We develop a lexicon of keywords associated with risk communication about the pandemic response, then use automated coding to identify message content and message structural features. We conduct chi-square analyses and negative binomial regression modeling to identify the strategies used by official risk communicators that respectively increase and decrease message retransmission. Findings show systematic changes in message strategies over time and identify key features that affect message passing, both positively and negatively. These results have the potential to aid in message design strategies as the pandemic continues, or in similar future events.	[Sutton, Jeannette] SUNY Albany, Coll Emergency Preparedness Homeland Secur & Cybe, Albany, NY 12222 USA; [Renshaw, Scott L.; Butts, Carter T.] Univ Calif Irvine, Dept Sociol, Irvine, CA USA; [Butts, Carter T.] Univ Calif Irvine, Dept Stat, Irvine, CA USA; [Butts, Carter T.] Univ Calif Irvine, Dept Elect Engn & Comp Sci, Irvine, CA USA; [Butts, Carter T.] Univ Calif Irvine, Inst Math Behav Sci, Irvine, CA USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Sutton, J (corresponding author), SUNY Albany, Coll Emergency Preparedness Homeland Secur & Cybe, Albany, NY 12222 USA.	jsutton@albany.edu			National Science Foundation [CMMI 2027399, CMMI-2027475 CTB]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation grant number CMMI 2027399 to JS and CMMI-2027475 CTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A, 2000, CURR DIR PSYCHOL SCI, V9, P75, DOI 10.1111/1467-8721.00064; Bruns A., 2011, P 6 EUR CONS POL RES; Castillo C., 2013, P 22 INT C WORLD WID; Chiang SC, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7299-7; Dhanesh GS, 2017, PUBLIC RELAT REV, V43, P925, DOI 10.1016/j.pubrev.2017.04.001; Harris JK, 2013, AM J PUBLIC HEALTH, V103, P1700, DOI 10.2105/AJPH.2012.301166; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Lin Y-R, 2013, 7 INT AAAI C WEBL SO; Linkov F, 2010, PREHOSP DISASTER MED, V25, P482, DOI 10.1017/S1049023X00008608; McLean J, 2013, IEEE INT SYMP ELEC, P60, DOI 10.1109/ISEMC.2013.6670382; Olson MK, 2019, J CONTING CRISIS MAN, V27, P359, DOI 10.1111/1468-5973.12267; Olteanu A., 2014, P INT AAAI C WEB SOC; R CT, 2016, R LANG ENV STAT COMP; Reuter C, 2018, J CONTING CRISIS MAN, V26, P41, DOI 10.1111/1468-5973.12196; Sampson RJ, 2004, SOC PSYCHOL QUART, V67, P319, DOI 10.1177/019027250406700401; Schoch-Spana M, CLIN INFECIOUS DIS; Sutton J, 2016, EFFECTIVE COMMUNICAT, P217; Sutton J, 2014, TERSE MESSAGE AMPLIF; Sutton J, 2019, WEATHER CLIM SOC, V11, P763, DOI 10.1175/WCAS-D-19-0021.1; Sutton J, 2015, P NATL ACAD SCI USA, V112, P14793, DOI 10.1073/pnas.1508916112; Sutton J, 2014, INFORM COMMUN SOC, V17, P765, DOI 10.1080/1369118X.2013.862561; Taylor M, 2014, J PUBLIC RELAT RES, V26, P384, DOI 10.1080/1062726X.2014.956106; Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537; Venables WN., 2002, MODERN APPL STAT S 4; Vos SC, 2018, RISK ANAL, V38, P2580, DOI 10.1111/risa.13140; Vos SC, 2016, J HEALTH COMMUN, V21, P301, DOI 10.1080/10810730.2015.1064495; Vos SC, 2017, COMMUNICATING VISUAL; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276	29	13	13	8	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238491	10.1371/journal.pone.0238491	http://dx.doi.org/10.1371/journal.pone.0238491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936804	gold, Green Published			2022-12-26	WOS:000573658000007
J	Courbiere, B; Lacan, A; Grynberg, M; Grelat, A; Rio, V; Arbo, E; Solignac, C				Courbiere, Blandine; Lacan, Arnaud; Grynberg, Michael; Grelat, Anne; Rio, Virginie; Arbo, Elisangela; Solignac, Celine			Psychosocial and professional burden of Medically Assisted Reproduction (MAR): Results from a French survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; SEVERE DEPRESSIVE SYMPTOMS; INFERTILITY; WOMEN; CARE; TECHNOLOGY; COUPLES; IMPACT	Objective To evaluate the impact of infertility and Medically Assisted Reproduction (MAR) throughout all aspects of life among infertile women and men. Materials and methods An online survey included 1 045 French patients (355 men, 690 women) who were living or had lived the experience of infertility and MAR. The questionnaire included 56 questions on several domains: global feelings, treatment burden, rapport with medical staff, psychosocial impact, sexual life and professional consequences. Results Respondents had experienced an average of 3.6 (95% CI: 3.3-3.9) MAR cycles: 5% (n = 46) were pregnant, 4% (n = 47) were waiting to start MAR, 50% (n = 522) succeeded in having a live birth following MAR, 19% (n = 199) were currently undergoing ART, and 21% (n = 221) dropped out of the MAR process without a live birth. Satisfaction rates regarding the received medical care were above 80%, but 42% of patients pointed out the lack of information about non-medical support. An important impact on sexual life was reported, with 21% of patients admitted having not had intercourse for several weeks or even several months. Concerning the impact on professional life, 63% of active workers currently in an MAR program (n = 185) considered that MAR had strong repercussions on the organization of their working life with 49% of them reporting a negative impact on the quality of their work, and 46% of them reporting the necessity to lie about missing work during their treatment. Conclusion Despite a high overall level of satisfaction regarding medical care, the burden of infertility and MAR on quality of life is strong, especially on sexuality and professional organization. Clinical staff should be encouraged to develop non-medical support for all patients at any stage of infertility treatment. Enterprises should be warned about the professional impact of infertility and MAR to help their employees reconcile personal and professional life.	[Courbiere, Blandine] AP HM La Conception, Pole Femmes Parents Enfants, Ctr Clin Biol AMP, Marseille, France; [Courbiere, Blandine] Avignon Univ, Aix Marseille Univ, IMBE, CNRS,IRD, Marseille, France; [Lacan, Arnaud] EHESS, UMR 7316, CNRS, Kedge Business Sch,AMSE, Marseille, France; [Grynberg, Michael] Hop Antoine Beclere, Dept Reprod Med & Fertil Preservat, Clamart, France; [Grelat, Anne] Ctr Mistral, Clin Pasteur, Guilherand Granges, France; [Rio, Virginie] Assoc Patients AMP & Personnes Infertiles, Collectif bAMP, Quincy Sous Senart, France; [Arbo, Elisangela; Solignac, Celine] Gedeon Richter France, Med Dept, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Kedge Business School; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP	Courbiere, B (corresponding author), AP HM La Conception, Pole Femmes Parents Enfants, Ctr Clin Biol AMP, Marseille, France.; Courbiere, B (corresponding author), Avignon Univ, Aix Marseille Univ, IMBE, CNRS,IRD, Marseille, France.	blandine.courbiere@univ-amu.fr	LACAN, Arnaud/U-3431-2018	LACAN, Arnaud/0000-0001-7365-2526	IPSOS Survey; Gedeon Richter France	IPSOS Survey; Gedeon Richter France	Financial support of the IPSOS Survey and the statistical analysis was provided by Gedeon Richter France. The funder provided support in the form of salaries for C. Solignac and E. Arbo but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder also assumed all the expenses for publication's fees. The specific roles of these authors are articulated in the 'author contributions' section.	Adamson GD, 2018, FERTIL STERIL, V110, P1067, DOI 10.1016/j.fertnstert.2018.06.039; Agostini F, 2017, J ASSIST REPROD GEN, V34, P1307, DOI 10.1007/s10815-017-1000-9; [Anonymous], 2009, U BUSINESS, V12, P14; Belgherbi S, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0566-y; Boivin J, 2011, HUM REPROD, V26, P2084, DOI 10.1093/humrep/der171; Colbert CY, 2013, CLEV CLIN J MED, V80, P423, DOI 10.3949/ccjm.80a.12122; Cunningham J, 2017, JAAPA-J AM ACAD PHYS, V30, P19, DOI 10.1097/01.JAA.0000522130.01619.b7; De Geyter C, 2020, HUM REPROD OPEN, V2020, DOI 10.1093/hropen/hoz038; de Mendonca CR, 2017, EUR J OBSTET GYN R B, V215, P153, DOI 10.1016/j.ejogrb.2017.06.013; Di Paola R, 2018, ARCH GYNECOL OBSTET, V298, P1029, DOI 10.1007/s00404-018-4906-2; Duron S, 2013, HUM REPROD, V28, P2872, DOI 10.1093/humrep/det293; Facchin F, 2019, HUM REPROD, V34, P1065, DOI 10.1093/humrep/dez046; Fassino S, 2002, HUM REPROD, V17, P2986, DOI 10.1093/humrep/17.11.2986; Frederiksen Y, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006592; Galhardo A, 2011, HUM REPROD, V26, P2408, DOI 10.1093/humrep/der209; Gameiro S, 2015, HUM REPROD, V30, P2476, DOI 10.1093/humrep/dev177; Gaskins AJ, 2018, J SEX MED, V15, P519, DOI 10.1016/j.jsxm.2018.02.005; Hammerli K, 2009, HUM REPROD UPDATE, V15, P279, DOI 10.1093/humupd/dmp002; Jamil S, 2020, ANDROLOGIA, V52, DOI 10.1111/and.13460; Kitchen H, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0666-0; Koert E, 2021, HUM FERTIL, V24, P236, DOI 10.1080/14647273.2019.1648887; Lotti F, 2018, NAT REV UROL, V15, P287, DOI 10.1038/nrurol.2018.20; Lund R, 2009, HUM REPROD, V24, P2810, DOI 10.1093/humrep/dep257; Martins MV, 2016, HUM REPROD UPDATE, V22, P466, DOI 10.1093/humupd/dmw009; Massarotti C, 2019, GYNECOL ENDOCRINOL, V35, P485, DOI 10.1080/09513590.2018.1540575; MENNING BE, 1980, FERTIL STERIL, V34, P313; Milazzo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165805; Namdar A, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0712-y; Patel Ansha, 2018, J Hum Reprod Sci, V11, P180, DOI 10.4103/jhrs.JHRS_119_17; Peterson BD, 2014, HUM REPROD, V29, P76, DOI 10.1093/humrep/det412; Roustaei Z, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026336; Schmidt L, 2012, HUM REPROD UPDATE, V18, P29, DOI 10.1093/humupd/dmr040; Smith NK, 2015, J SEX MED, V12, P985, DOI 10.1111/jsm.12824; Troude P, 2016, REPROD BIOMED ONLINE, V33, P560, DOI 10.1016/j.rbmo.2016.08.010; Troude P, 2014, REPROD BIOMED ONLINE, V28, P321, DOI 10.1016/j.rbmo.2013.10.018; Verhaak CM, 2010, HUM REPROD, V25, P1234, DOI 10.1093/humrep/deq054; Zegers-Hochschild F, 2017, HUM REPROD, V32, P1786, DOI 10.1093/humrep/dex234; Zurlo MC, 2020, J CLIN PSYCHOL MED S, V27, P662, DOI 10.1007/s10880-019-09653-z	38	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238945	10.1371/journal.pone.0238945	http://dx.doi.org/10.1371/journal.pone.0238945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970695	Green Published, gold			2022-12-26	WOS:000576265600092
J	Tang, HH; Guo, YP; Zhang, ZZ; Li, ZJ; Zhang, YH; Li, YF; Kang, XT; Han, RL				Tang, Hehe; Guo, Yaping; Zhang, Zhenzhen; Li, Zhuanjian; Zhang, Yanhua; Li, Yuanfang; Kang, Xiangtao; Han, Ruili			Integrative analysis of long non-coding RNA and mRNA in broilers with valgus-varus deformity	PLOS ONE			English	Article							BONE; GROWTH; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; INHIBITION; CHICKENS; LINES; KEGG	Background Bone abnormality and leg disease in commercial broiler flocks are increasingly prominent, causing serious economic losses to the broiler breeding industry. Valgus-varus deformity (VVD) is a common deformity of the long bone in broilers that manifests as an outward or inward deviation of the tibiotarsus or tarsometatarsus. There is a paucity of studies on the molecular mechanisms of VVD. Results In this study, 6 cDNA libraries were constructed from spleen samples from VVD birds and normal birds. A total of 1951 annotated lncRNAs, 7943 novel lncRNAs and 30252 mRNAs were identified by RNA-sequencing. In addition, 420 differentially expressed (DE) mRNAs and 124 differentially expressed lncRNAs (adjusted P-value < 0.05) were obtained. A total of 16 dysregulated genes were confirmed by qPCR to be consistent with the results of the RNA-Seq. The functional lncRNA-mRNA co-expression network was constructed using differentially expressed mRNAs and target genes of the differentially expressed lncRNAs. 11 DE genes were obtained from the analysis. In order to gain insight into the interactions of genes, lncRNAs and pathways associated with VVD, we focused on the following pathways, which are involved in immunity and bone development: the Jak-stat signaling pathway, Toll-like receptor signaling pathway, Wnt-signaling pathway, mTOR signaling pathway, VEGF signaling pathway, Notch signaling pathway, TGF-beta signaling pathway and Fanconi anemia pathway. All together, 30 candidate DE genes were obtained from these pathways. We then analyzed the interaction between the DE genes and their corresponding lncRNAs. From these interaction network analyses we found that GARS, NFIC, PIK3R1, BMP6, NOTCH1, ACTB and CREBBP were the key core nodes of these networks. Conclusion This study showed that differentially expressed genes and signaling pathways were related to immunity or bone development. These results increase the understanding of the molecular mechanisms of VVD and provide some reference for the etiology and pathogenesis of VVD.	[Tang, Hehe; Guo, Yaping; Zhang, Zhenzhen; Li, Zhuanjian; Zhang, Yanhua; Li, Yuanfang; Kang, Xiangtao; Han, Ruili] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China; [Li, Zhuanjian; Kang, Xiangtao; Han, Ruili] Henan Innovat Engn Res Ctr Poultry Germplasm Reso, Zhengzhou, Peoples R China	Henan Agricultural University	Han, RL (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.; Han, RL (corresponding author), Henan Innovat Engn Res Ctr Poultry Germplasm Reso, Zhengzhou, Peoples R China.	rlhan@126.com	Li, Yuan/GXV-1310-2022		Key Scientific Research Projects of Henan Colleges and Universities [20A230006]; Program for Innovation Research Team of Ministry of Education [IRT16R23]; Scientific Studio of Zhongyuan Scholars [30601985]	Key Scientific Research Projects of Henan Colleges and Universities; Program for Innovation Research Team of Ministry of Education; Scientific Studio of Zhongyuan Scholars	This work was supported by the Key Scientific Research Projects of Henan Colleges and Universities (20A230006), the Program for Innovation Research Team of Ministry of Education (IRT16R23), and the Scientific Studio of Zhongyuan Scholars (30601985).	Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Berciano J, 2019, J PERIPHER NERV SYST, V24, P161, DOI 10.1111/jns.12300; Bihan-Duval EL, 1996, GENET SEL EVOL, V28, P181; Blanco R, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a006569; Bradshaw RH, 2002, AVIAN POULT BIOL REV, V13, P45, DOI 10.3184/147020602783698421; Bu Q, 2012, J NEUROCHEM, V123, P790, DOI 10.1111/jnc.12006; Collu GM, 2012, DEVELOPMENT, V139, P4405, DOI 10.1242/dev.081885; Corcia P, 2019, AMYOTROPH LAT SCL FR, V20, P275, DOI 10.1080/21678421.2018.1556699; CRUICKSHANK JJ, 1986, AVIAN DIS, V30, P699, DOI 10.2307/1590572; Cuvertino S, 2017, AM J HUM GENET, V101, P1021, DOI 10.1016/j.ajhg.2017.11.006; Ding YZ, 2016, GENOMICS, V107, P150, DOI 10.1016/j.ygeno.2016.01.007; Elling R, 2016, EUR J IMMUNOL, V46, P504, DOI 10.1002/eji.201444558; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Finn RD, 2008, NUCLEIC ACIDS RES, V32, P138; Frazee AC., 2014, BIORXIV; Gonzalez-Ceron F, 2015, POULTRY SCI, V94, P162, DOI 10.3382/ps/peu052; Guo YP, 2019, POULTRY SCI, V98, P4433, DOI 10.3382/ps/pez269; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Han L, 2012, INT J ONCOL, V40, P2004, DOI 10.3892/ijo.2012.1413; Hill CR, 2014, BONE, V62, P10, DOI 10.1016/j.bone.2014.01.019; JULIAN RJ, 1984, CAN VET J, V25, P254; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kapell DNRG, 2012, POULTRY SCI, V91, P3032, DOI 10.3382/ps.2012-02578; Knowles TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001545; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Konig A, 1997, LEUKEMIA, V11, P258, DOI 10.1038/sj.leu.2400556; LeBihanDuval E, 1997, J ANIM BREED GENET, V114, P239, DOI 10.1111/j.1439-0388.1997.tb00510.x; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; LETERRIER C, 1992, AVIAN PATHOL, V21, P429, DOI 10.1080/03079459208418861; Leterrier C, 1996, ARCH GEFLUGELKD, V60, P181; Li ZH, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00687; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Majidinia M, 2017, DRUG RES, V67, P13, DOI 10.1055/s-0042-115405; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McCoy MA, 1996, RES VET SCI, V60, P185, DOI 10.1016/S0034-5288(96)90017-X; Mizrahi O, 2013, GENE THER, V20, P370, DOI 10.1038/gt.2012.45; NEWBREY JW, 1988, AVIAN DIS, V32, P704, DOI 10.2307/1590988; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Perez-Casellas LA, 2009, BBA-GENE REGUL MECH, V1789, P78, DOI 10.1016/j.bbagrm.2008.08.013; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Rekaya R, 2013, POULTRY SCI, V92, P923, DOI 10.3382/ps.2012-02649; Sandestig A, 2018, MOL SYNDROMOL, V9, P259, DOI 10.1159/000492267; Shim MY, 2012, POULTRY SCI, V91, P62, DOI 10.3382/ps.2011-01599; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x; Tang ZR, 2015, J BIOMED MATER RES A, V103, P1001, DOI 10.1002/jbm.a.35242; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Xiao ZC, 2014, INT J BIOCHEM CELL B, V55, P65, DOI 10.1016/j.biocel.2014.08.009; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang YH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5333-2	53	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239450	10.1371/journal.pone.0239450	http://dx.doi.org/10.1371/journal.pone.0239450			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970714	Green Published, gold			2022-12-26	WOS:000576265600013
J	Mughal, I; Shah, Y; Tahir, S; Haider, W; Fayyaz, M; Yasmin, T; Ilyas, M; Farrakh, S				Mughal, Iram; Shah, Yusra; Tahir, Shamaila; Haider, Waseem; Fayyaz, Muhammad; Yasmin, Tayyaba; Ilyas, Maryam; Farrakh, Sumaira			Protein quantification and enzyme activity estimation of Pakistani wheat landraces	PLOS ONE			English	Article							T-CELL EPITOPES; SUPEROXIDE DISMUTASES; GENETIC DIVERSITY; OXIDATIVE STRESS; STORAGE PROTEINS; TOLERANCE; DROUGHT; QUALITY; GRAIN; IMPROVEMENT	Wheat is a major food grain in Pakistan having a prominent role in agriculture as well as the economic status of the country. In the current study, seeds of 99 wheat landraces were characterized for the quantification of seed storage proteins (Albumins, Globulin, Gliadins, and Glutenin), enzyme activities of antioxidant enzymes i.e. Ascorbate peroxidase (APX), Catalase (CAT), Superoxide dismutase (SOD), Peroxidase (POD), one hydrolytic enzyme Protease (PROT) and non-enzymatic antioxidant enzyme Ascorbic acid (AsA). The landraces were categorized into low, medium, and high based on protein concentration and enzymes activities/content. The majority of the landraces were placed in the medium category. However, for the AsA parameter majority of the landraces were placed in the low category. The highest concentration of total extracted protein (184.88 +/- 0.7 mg/g. wt.), globulins (21.35 +/- 0.43 mg/g. wt.) and glutenin (20 +/- 0.04 mg/g. wt.) as well as the high activity of SOD (303 +/- 16.80 Units/g. wt.), and Ascorbic acid (533 +/- 36.1 Units/g. wt.) was identified in the wheat landrace "11757" collected from district Panjgur (Balochistan). The wheat landrace "11760", collected from district Kech (Balochistan), contained the highest albumins concentration (65.42 +/- 0.02 mg/g. wt.) and highest activity for CAT (589.5 +/- 61.20 Units/g. wt.). The highest activity of POD (32341 +/- 91.3) and PROT was observed in seeds of the wheat landrace "11618" collected from the Gilgit Baltistan region of Pakistan. The principal component analysis showed that the great variations existed for the tested parameters among the wheat landraces. The landraces with a high concentration of seed storage proteins and antioxidant enzyme activities can be used for breeding purposes to improve the nutrimental quality of wheat cultivars.	[Mughal, Iram; Shah, Yusra; Tahir, Shamaila; Haider, Waseem; Yasmin, Tayyaba; Ilyas, Maryam; Farrakh, Sumaira] COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan; [Fayyaz, Muhammad] Natl Agr Res Ctr, Islamabad, Pakistan	COMSATS University Islamabad (CUI); National Agricultural Research Council - Pakistan	Farrakh, S (corresponding author), COMSATS Univ Islamabad, Dept Biosci, Islamabad, Pakistan.	sumaira.farrakh@comsats.edu.pk	Yasmin, Dr Tayyaba/AAF-5767-2020	Haider, Waseem/0000-0001-9200-6714				Alscher RG, 2002, J EXP BOT, V53, P1331, DOI 10.1093/jexbot/53.372.1331; Amjad Hameed, 2005, Caderno de Pesquisa Serie Biologia, V17, P51; [Anonymous], 1996, GLUTENIN P 6 INT GLU; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Bakalova S., 2004, Bulgarian Journal of Plant Physiology, V30, P64; Bano A, 2010, PAK J BOT, V42, P2579; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bhanupriya, 2014, Journal of Crop and Weed, V10, P104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; CHEN GX, 1989, PLANT CELL PHYSIOL, V30, P987; Delcour JA, 2012, ANNU REV FOOD SCI T, V3, P469, DOI 10.1146/annurev-food-022811-101303; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; Dixit V, 2001, J EXP BOT, V52, P1101, DOI 10.1093/jexbot/52.358.1101; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Drapeau G R, 1976, Methods Enzymol, V45, P469; Emanuelson J, 2003, 92 DAN I AGR SCI; Food and Agriculture Organization of United Nations, 2013, REV WHEAT SECT GRAIN; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P315, DOI 10.1104/pp.59.2.309; Gil-Humanes J, 2011, J EXP BOT, V62, P4203, DOI 10.1093/jxb/err119; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; Gupta V. K., 2006, Natural Product Radiance, V5, P326; Igrelas G, 2002, J CEREAL SCI, V36, P187, DOI 10.1006/jcrs.2002.0452; Jaradat AA, 2013, EMIR J FOOD AGR; Johansson E, 2001, CEREAL CHEM, V78, P19, DOI 10.1094/CCHEM.2001.78.1.19; Khalid A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01276; Khan Ikhtiar, 2007, Journal of Zhejiang University-Science B, V8, P555, DOI 10.1631/jzus.2007.B0555; Kruger JE, 1974, CEREAL CHEM, V51, P820; Kulp K., 1993, ADV BAKING TECHNOLOG, P152; Larre C, 2011, J PROTEOMICS, V74, P1279, DOI 10.1016/j.jprot.2011.03.014; Lobo V, 2010, Pharmacogn Rev, V4, P118, DOI 10.4103/0973-7847.70902; Ma DY, 2014, J INTEGR AGR, V13, P1258, DOI 10.1016/S2095-3119(13)60573-0; MacFarlane AJ, 2003, J BIOL CHEM, V278, P54, DOI 10.1074/jbc.M210636200; Mujeeb-Kazi A, 2013, ADV AGRON, V122, P179, DOI 10.1016/B978-0-12-417187-9.00004-8; Narwal S, 2014, J PLANT BIOCHEM BIOT, V23, P11, DOI 10.1007/s13562-012-0179-1; Noorka IR, 2013, PAK J BOT, V45, P99; Okarter N, 2010, FOOD CHEM, V119, P249, DOI 10.1016/j.foodchem.2009.06.021; Osborne T.B., 1907, PROTEINS WHEAT KERNE; Prasad TK, 1996, PLANT J, V10, P1017, DOI 10.1046/j.1365-313X.1996.10061017.x; Rasheed A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-128; Reif JC, 2005, THEOR APPL GENET, V110, P859, DOI 10.1007/s00122-004-1881-8; Revanappa SB, 2014, INT J FOOD PROP, V17, P2131, DOI 10.1080/10942912.2013.784331; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Shewry PR, 2009, J EXP BOT, V60, P1537, DOI 10.1093/jxb/erp058; Shewry PR, 2015, FOOD ENERGY SECUR, V4, P178, DOI 10.1002/fes3.64; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Shuaib M, 2010, AFR J BIOTECHNOL, V9, P243; Singh H, 2001, J CEREAL SCI, V33, P231, DOI 10.1006/jcrs.2000.0360; Sollid LM, 2012, IMMUNOGENETICS, V64, P455, DOI 10.1007/s00251-012-0599-z; Taplin CE, 2011, J PEDIATR GASTR NUTR, V52, P21, DOI 10.1097/MPG.0b013e3181f18c7b; Tatham AS, 2008, CLIN EXP ALLERGY, V38, P1712, DOI 10.1111/j.1365-2222.2008.03101.x; Tea I, 2004, CEREAL CHEM, V81, P759, DOI 10.1094/CCHEM.2004.81.6.759; Wingen LU, 2014, THEOR APPL GENET, V127, P1831, DOI 10.1007/s00122-014-2344-5; Wrigley CW, 1996, NATURE, V381, P738, DOI 10.1038/381738a0; Yu Q, 1999, PLANT SCI, V142, P1, DOI 10.1016/S0168-9452(98)00246-5; Zafar S, 2015, PAK J BOT, V47, P397	58	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239375	10.1371/journal.pone.0239375	http://dx.doi.org/10.1371/journal.pone.0239375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966325	Green Published, gold			2022-12-26	WOS:000575688700019
J	Chamseddine, S; Chmaisse, A; Akel, I; El Zein, Z; Khalil, S; Raad, SA; Khati, A; Ghandour, H; Khafaja, S; Haj, M; Abboud, M; Mahfouz, R; Araj, G; Zaraket, H; Hanna-Wakim, R; Muwakkit, S; Dbaibo, G				Chamseddine, Sarah; Chmaisse, Ahmad; Akel, Imad; Zein, Zeinab El; Khalil, Suzan; Raad, Sarah Abi; Khati, Antoine; Ghandour, Hiba; Khafaja, Sarah; Haj, Magda; Abboud, Miguel; Mahfouz, Rami; Araj, George; Zaraket, Hassan; Hanna-Wakim, Rima; Muwakkit, Samar; Dbaibo, Ghassan			Epidemiology and clinical characteristics of viral infections in hospitalized children and adolescents with cancer in Lebanon	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; RESPIRATORY SYNCYTIAL VIRUS; CELL TRANSPLANTATION; PEDIATRIC-PATIENTS; RISK-FACTORS; VARICELLA; DISEASE; NEUTROPENIA; MORBIDITY; ZOSTER	Background Viral infections in children and adolescents with malignancy are commonly encountered and have a significant impact on morbidity and mortality. Studies and epidemiological data regarding viral infections in children with cancer in developing countries are lacking. This retrospective cohort study aims to assess the burden of viral infections in children and adolescents with cancer, by assessing prevalence, risk factors, as well as morbidity and mortality of common viruses over a period of 8 years. Methods and findings Medical records of cancer patients treated at the Children Cancer Center of Lebanon were reviewed and 155 participants under the age of 21 were identified with at least one documented viral infection during the period from July 2009 to November 2017. This subset included 136 participants with active malignancy and 19 participants with a history of cancer who underwent hematopoietic stem cell transplantation [HSCT] and were in remission; the latter group was analyzed separately. Information regarding participant characteristics, hospital course, and complications were obtained. Associations between viral infections and certain factors were assessed. In the cohort, 64% were male, 81% were Lebanese. In participants with active malignancy, 90% received chemotherapy in the 6 months preceding the viral infection episode, 11% received radiotherapy. 51% of participants were neutropenic at the time of viral detection, and 77% were lymphopenic. 17% experienced a bacterial co-infection, and 3 experienced a viral co-infection. Among 162 viral infection episodes, clinically diagnosed skin infections, mainly herpes simplex virus type 1 and varicella-zoster virus, were the most common [44% of cases]. These were followed by laboratory-proven systemic herpes infections: cytomegalovirus [14%] and Epstein-Barr virus [6%]. Respiratory viruses: influenza and respiratory syncytial virus, accounted for 9% and 4%, respectively, whereas rotavirus represented 11% and BK virus represented 3% of cases. Acute lymphocytic leukemia was the most prevalent neoplasia [57%]. Fever was the most common presenting symptom [55%] and febrile neutropenia was the reason for admission in 24% of cases. The mean length of stay was significantly longer in participants with cytomegalovirus infections and significantly lower in rotavirus infection. Admission to the ICU occurred in 9%, complications in 8%, and mortality in 5%. Participants with viral infections post-HSCT were noted to have a significantly longer length of hospital stay compared to non-HSCT participants, with no other significant differences in clinical course and outcome. The study was limited by its retrospective nature and by the late introduction and underuse of multiplex PCR panels, which may have led to underdiagnosis of viral infections. Conclusions Viral infections were prevalent in our sample of cancer patients and may have contributed to morbidity and mortality. Newly available viral diagnostics are likely to vastly increase the number and scope of detectable viral infections in this population. Prospective studies using multiplex PCR technology with systematic testing of patients will be more helpful in defining the burden of viral infections. Furthermore, efforts at antimicrobial stewardship would benefit from the identification of viral causes of infection and limit the unnecessary use of antibiotics in the pediatric cancer population.	[Chamseddine, Sarah; Chmaisse, Ahmad; Akel, Imad; Zein, Zeinab El; Khalil, Suzan; Raad, Sarah Abi; Khati, Antoine; Ghandour, Hiba; Khafaja, Sarah; Haj, Magda; Mahfouz, Rami; Araj, George; Zaraket, Hassan; Hanna-Wakim, Rima; Dbaibo, Ghassan] Amer Univ Beirut, Ctr Infect Dis Res, Beirut, Lebanon; [Zein, Zeinab El; Khafaja, Sarah; Abboud, Miguel; Hanna-Wakim, Rima; Muwakkit, Samar; Dbaibo, Ghassan] Amer Univ Beirut, Med Ctr, Dept Pediat & Adolescent Med, Beirut, Lebanon; [Abboud, Miguel; Muwakkit, Samar] Amer Univ Beirut, Med Ctr, Childrens Canc Ctr Lebanon, Dept Pediat & Adolescent Med, Beirut, Lebanon; [Mahfouz, Rami; Araj, George] Amer Univ Beirut, Med Ctr, Dept Pathol & Lab Med, Beirut, Lebanon; [Zaraket, Hassan] Fac Med, Dept Expt Pathol Immunol & Microbiol, Beirut, Lebanon; [Hanna-Wakim, Rima; Dbaibo, Ghassan] Amer Univ Beirut, Med Ctr, Dept Pediat & Adolescent Med, Div Pediat Infect Dis, Beirut, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut	Dbaibo, G (corresponding author), Amer Univ Beirut, Ctr Infect Dis Res, Beirut, Lebanon.	gdbaibo@aub.edu.lb	Ghandour, Hiba/AAH-2399-2021; Dbaibo, Ghassan S./X-2978-2019	Ghandour, Hiba/0000-0002-3375-6600; Abi Raad, Sarah/0000-0003-3044-3948; Chmaisse, Ahmad/0000-0002-9523-5341				Ariza-Heredia EJ, 2014, CANCER LETT, V342, P1, DOI 10.1016/j.canlet.2013.09.004; Babady NE, 2016, J CLIN MICROBIOL, V54, P2635, DOI 10.1128/JCM.00604-16; Bailey LC, 2009, SEMIN HEMATOL, V46, P313, DOI 10.1053/j.seminhematol.2009.03.010; Basturk A, 2017, GASTROENTEROL REV, V12, P68, DOI 10.5114/pg.2016.64606; Bonomo R, 2016, ONCOLOGY CRITICAL CA; Botti C, 2018, EXP THER MED, V15, P4805, DOI 10.3892/etm.2018.6061; Brown AEC, 2016, WORLD J PEDIATR, V12, P320, DOI 10.1007/s12519-016-0025-y; Christensen MS, 2005, PEDIATR BLOOD CANCER, V45, P945, DOI 10.1002/pbc.20469; COHEN JI, 1985, MEDICINE, V64, P100, DOI 10.1097/00005792-198503000-00003; Dropulic LK, 2008, BONE MARROW TRANSPL, V41, P11, DOI 10.1038/sj.bmt.1705886; El Saleeby CM, 2008, PEDIATRICS, V121, P235, DOI 10.1542/peds.2007-1102; Fazekas T, 2012, J PEDIAT HEMATOL ONC, V34, P442, DOI 10.1097/MPH.0b013e3182580bc8; FELDMAN S, 1987, PEDIATRICS, V80, P465; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Granwehr BP, 2011, MD ANDERSON MANUAL M; Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437; Hakim H, 2016, CANCER-AM CANCER SOC, V122, P798, DOI 10.1002/cncr.29833; Hakim H, 2009, J PEDIAT HEMATOL ONC, V31, P623, DOI 10.1097/MPH.0b013e3181b1edc6; Hijano DR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03097; Hirsch HH, 2005, CLIN INFECT DIS, V41, P354, DOI 10.1086/431488; Hudson LB, 1998, OBSTET GYNECOL, V92, P642, DOI 10.1016/S0029-7844(98)00027-1; Karampatsas K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194009; Katsimpardi K, 2006, SUPPORT CARE CANCER, V14, P277, DOI 10.1007/s00520-005-0884-6; Kersun LS, 2010, PEDIATR BLOOD CANCER, V54, P79, DOI 10.1002/pbc.22228; Li X, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3195-5; Licciardello M, 2011, PEDIATRIC REP, V3, P13, DOI 10.4081/pr.2011.e5; Lighter-Fisher J, 2016, PEDIATR REV, V37, P247, DOI 10.1542/pir.2015-0059; Lindblom A, 2010, J CLIN VIROL, V47, P234, DOI 10.1016/j.jcv.2009.11.026; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; MORISON WL, 1975, BRIT J DERMATOL, V92, P625, DOI 10.1111/j.1365-2133.1975.tb03141.x; MOTTONEN M, 1995, CANCER-AM CANCER SOC, V75, P1712, DOI 10.1002/1097-0142(19950401)75:7<1712::AID-CNCR2820750724>3.0.CO;2-0; Odumade OA, 2011, CLIN MICROBIOL REV, V24, P193, DOI 10.1128/CMR.00044-10; Organization WH, 2018, HERP SIMPL VIR 2018; Torres JP, 2016, PEDIATR INFECT DIS J, V35, P949, DOI 10.1097/INF.0000000000001209; Rayani A, 2007, SCAND J GASTROENTERO, V42, P81, DOI 10.1080/00365520600842179; Rolston KVI, 2017, INFECT DIS THER, V6, P69, DOI 10.1007/s40121-017-0146-1; Schuster FR, 2005, KLIN PADIATR, V217, pS67, DOI 10.1055/s-2005-872519; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Soudani N, 2019, J MED VIROLOGY; Soudani N, 2019, J MED VIROL, V91, P1191, DOI 10.1002/jmv.25432; Tasian SK, 2008, PEDIATR BLOOD CANCER, V50, P983, DOI 10.1002/pbc.21472; Teranishi H, 2018, J PEDIAT HEMATOL ONC, V40, P605, DOI 10.1097/MPH.0000000000001300; Torres HA, 2006, CLIN LYMPHOMA MYELOM, V6, P393, DOI 10.3816/CLM.2006.n.016; Vandenbosch K, 2008, BIOL BLOOD MARROW TR, V14, P867, DOI 10.1016/j.bbmt.2008.05.006; Verdeguer A, 2011, BONE MARROW TRANSPL, V46, P119, DOI 10.1038/bmt.2010.52; Wang YC, 2011, J MICROBIOL IMMUNOL, V44, P442, DOI 10.1016/j.jmii.2011.04.004; Zaorsky NG, 2017, ANN ONCOL, V28, P400, DOI 10.1093/annonc/mdw604; Zhang HW, 2015, CLIN LAB MED, V35, P461, DOI 10.1016/j.cll.2015.02.006	48	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239258	10.1371/journal.pone.0239258	http://dx.doi.org/10.1371/journal.pone.0239258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32961548	Green Published, gold			2022-12-26	WOS:000575109500047
J	Tembo, B; Wang, ZH; Mulenga, RM; Sichilima, S; M'siska, KK; Mwale, M; Chikoti, PC; Singh, PK; He, XY; Pedley, KF; Peterson, GL; Singh, RP; Braun, HJ				Tembo, Batiseba; Wang, Zonghua; Mulenga, Rabson M.; Sichilima, Suwilanji; M'siska, Kenneth K.; Mwale, Moses; Chikoti, Patrick C.; Singh, Pawan K.; He, Xinyao; Pedley, Kerry F.; Peterson, Gary L.; Singh, Ravi P.; Braun, Hans J.			Detection and characterization of fungus (Magnaporthe oryzae pathotype Triticum) causing wheat blast disease on rain-fed grown wheat (Triticum aestivumL.) in Zambia	PLOS ONE			English	Article							PYRICULARIA-GRAMINIS-TRITICI; 1ST REPORT	Wheat blast caused byMagnaporthe oryzaepathotypeTriticum(MoT) is a threat to wheat production especially in the warmer-humid environments. In Zambia, wheat blast symptoms were observed for the first time on wheat (Triticum aestivumL.) grown in experimental plots and five farmers' fields in Mpika district of Muchinga Province during the 2017-18 rainy season. Infected plants showed the typical wheat blast symptoms with the spike becoming partially or completely bleached with the blackening of the rachis in a short span of time. Incidence of blast symptoms on nearly all wheat heads was high and ranged from 50 to 100%. Examination of diseased plant leaves showed the presence of elliptical, grayish to tan necrotic lesions with dark borders on the leaf often mixed with other foliar diseases. A study was conducted to isolate and identify the causal pathogen(s) using classical and molecular methods and determine the pathogenicity of the detected disease causal agent. Morphobiometrical determination of causal pathogen revealed conidia with characteristic pear shaped 2-septate hyaline spores associated withM.oryzaespecies. Preliminary polymerase chain reaction screening of six isolates obtained from wheat blast infected samples with diagnostic primers (MoT3F/R) was conducted at ZARI, Zambia, and subsequent analysis of two isolates with MoT3F/R and C17F/R was performed at USDA-ARS, USA. Both experiments confirmed that MoT is the causal agent of wheat blast in Zambia. Further, pathogenicity tests performed with pure culture isolates from samples WS4 and WS5 produced typical blast symptoms on all the six inoculated wheat genotypes. Results of this study indicate that MoT is causing wheat blast in rain-fed wheat grown in Zambia, thus making it the first report of MoT in Zambia and Africa. This inter-continental movement of the pathogen (disease) has serious implication for wheat production and trade that needs to be urgently addressed.	[Tembo, Batiseba; Wang, Zonghua; Mulenga, Rabson M.; Sichilima, Suwilanji; M'siska, Kenneth K.; Mwale, Moses; Chikoti, Patrick C.] Zambia Agr Res Inst, Mt Makulu Cent Res Stn, Lusaka, Zambia; [Singh, Pawan K.; He, Xinyao; Singh, Ravi P.; Braun, Hans J.] CIMMYT, Global Wheat Program, Int Maize & Wheat Improvement Ctr, El Satan, Texcoco, Mexico; [Pedley, Kerry F.; Peterson, Gary L.] ARS, Foreign Dis Weed Sci Res Unit, USDA, Ft Detrick, MD USA	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); United States Department of Agriculture (USDA)	Mulenga, RM (corresponding author), Zambia Agr Res Inst, Mt Makulu Cent Res Stn, Lusaka, Zambia.; Singh, PK (corresponding author), CIMMYT, Global Wheat Program, Int Maize & Wheat Improvement Ctr, El Satan, Texcoco, Mexico.	rabson2010@gmail.com; pk.singh@cgiar.org		Pedley, Kerry/0000-0002-6827-8231	Zambia Agriculture Research Institute; CGIAR Research Program on WHEAT; Australian Centre for International Agricultural Research, Australia [CIM/2016/219]; USDA Agricultural Research Service project [8044-22000-046-00D]	Zambia Agriculture Research Institute; CGIAR Research Program on WHEAT(CGIAR); Australian Centre for International Agricultural Research, Australia; USDA Agricultural Research Service project	Financial supports from Zambia Agriculture Research Institute, CGIAR Research Program on WHEAT, Australian Centre for International Agricultural Research (CIM/2016/219), Australia, and USDA Agricultural Research Service project 8044-22000-046-00D are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial supports from Zambia Agriculture Research Institute, CGIAR Research Program on WHEAT, Australian Centre for International Agricultural Research (CIM/2016/219), Australia, and USDA Agricultural Research Service project 8044-22000-046-00D are gratefully acknowledged.	Aghnoum R, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2436-z; Barea G, 1996, IDENTIFICACI ZONIFIC, P347; Cabrera MG, 2007, PRIMER REGISTRO PYRI; Castroagudin VL, 2016, PERSOONIA, V37, P199, DOI 10.3767/003158516X692149; Ceresini PC, 2019, MOL PLANT PATHOL, V20, P155, DOI 10.1111/mpp.12747; Ceresini PC, 2018, ANNU REV PHYTOPATHOL, V56, P427, DOI 10.1146/annurev-phyto-080417-050036; Cruz CD, 2017, TROP PLANT PATHOL, V42, P210, DOI 10.1007/s40858-017-0159-z; Duveiller E., 2016, WORLD WHEAT BOOK, V3, P1107; Igarashi S., 1986, FITOPATOL BRAS, V11, P351; Kohli MM, 2011, CZECH J GENET PLANT, V47, pS130, DOI 10.17221/3267-CJGPB; Malaker PK, 2016, PLANT DIS, V100, P2330, DOI 10.1094/PDIS-05-16-0666-PDN; Mooleki P, 1997, ZAMBIA SEED TECHNOLO, P154; Mottaleb KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197555; Mukwavi M, 1990, WHEAT NONTRADITIONAL, P34; Perello A, 2015, PLANT DIS, V99, P1177, DOI 10.1094/PDIS-11-14-1182-PDN; Pieck ML, 2017, PLANT DIS, V101, P103, DOI 10.1094/PDIS-04-16-0500-RE; Rahman MH, 2017, BARISAL U J 1, V4, P237; Tembo B, 2019, J AGR CROPS, V5, P158, DOI [10.32861/jac.59.158.161, DOI 10.32861/JAC.59.158.161]; Thierry M, 2020, PLANT DIS, V104, P60, DOI 10.1094/PDIS-04-19-0685-RE; Urashima AS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P267, DOI 10.1007/978-1-4020-9500-9_27; Valent B, 2019, MOL PLANT PATHOL, V20, P173, DOI 10.1111/mpp.12778; Viedma LQ, 2005, PHYTOPATHOLOGY, V95, pS152; Wegulo SN, 2008, EFFECT PREVIOUS CROP, P2	23	44	47	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238724	10.1371/journal.pone.0238724	http://dx.doi.org/10.1371/journal.pone.0238724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956369	Green Published, gold			2022-12-26	WOS:000574571500022
J	Camara, A; Verbrugghe, A; Cargo-Froom, C; Hogan, K; DeVries, TJ; Sanchez, A; Robinson, LE; Shoveller, AK				Camara, Alexandra; Verbrugghe, Adronie; Cargo-Froom, Cara; Hogan, Kylie; DeVries, Trevor J.; Sanchez, Andrea; Robinson, Lindsay E.; Shoveller, Anna K.			The daytime feeding frequency affects appetite-regulating hormones, amino acids, physical activity, and respiratory quotient, but not energy expenditure, in adult cats fed regimens for 21 days	PLOS ONE			English	Article							MUSCLE PROTEIN-SYNTHESIS; DIETARY WATER-CONTENT; RISK-FACTORS; SKELETAL-MUSCLE; FELINE OBESITY; BODY-WEIGHT; MEAL SIZE; INSULIN SENSITIVITY; INTERMITTENT BOLUS; ACTIVITY PATTERNS	The effects of feeding frequency on postprandial response of circulating appetite-regulating hormones, insulin, glucose and amino acids, and on physical activity, energy expenditure, and respiratory quotient were studied in healthy adult cats. Two experiments were designed as a 2 x 3 replicated incomplete Latin square design. Eight cats, with an average body weight (BW) of 4.34 kg +/- 0.04 and body condition score (BCS) of 5.4 +/- 1.4 (9 point scale), were fed isocaloric amounts of a commercial adult maintenance canned cat food either once (0800 h) or four times daily (0800 h, 1130 h, 1500 h, 1830 h). Study 1 consisted of three 21-d periods. On day 14, two fasted and 11 postprandial blood samples were collected over 24 hours to measure plasma concentrations of ghrelin, GLP-1, GIP, leptin, PYY, insulin and amino acids, and whole blood glucose. Physical activity was monitored from day 15 to 21 of each period. In Study 2 indirect calorimetry was performed on the last day of each period. Body weight was measured weekly and feed intake recorded daily in both experiments. No effect of feeding regimen on BW was detected. Cats eating four times daily had lesser plasma concentrations of GIP and GLP-1 (P<0.05) and tended to have lesser plasma PYY concentrations (P<0.1). Plasma leptin and whole blood glucose concentrations did not differ between regimens (P>0.1). Cats fed once daily had a greater postprandial plasma amino acid response, and greater plasma ghrelin and insulin concentrations (P<0.05). Physical activity was greater in cats fed four times (P<0.05), though energy expenditure was similar between treatments at fasting and in postprandial phases. Finally, cats eating one meal had a lower fasting respiratory quotient (P<0.05). Overall, these data indicate that feeding once a day may be a beneficial feeding management strategy for indoor cats to promote satiation and lean body mass.	[Camara, Alexandra; Verbrugghe, Adronie; Sanchez, Andrea] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON, Canada; [Cargo-Froom, Cara; Hogan, Kylie; DeVries, Trevor J.; Shoveller, Anna K.] Univ Guelph, Ontario Agr Coll, Ctr Nutr Modelling, Dept Anim Biosci, Guelph, ON, Canada; [Robinson, Lindsay E.] Univ Guelph, Coll Biol Sci, Dept Human Hlth & Nutr Sci, Guelph, ON, Canada	University of Guelph; University of Guelph; University of Guelph	Shoveller, AK (corresponding author), Univ Guelph, Ontario Agr Coll, Ctr Nutr Modelling, Dept Anim Biosci, Guelph, ON, Canada.	ashovell@uoguelph.ca	Sanchez, Andrea/T-5706-2019	DeVries, Trevor/0000-0001-9364-2456	WINN Feline Foundation [W18-039]	WINN Feline Foundation	AV and AKS received the grant Grant #W18-039 WINN Feline Foundation https://www.winnfelinefoundation.org/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hourani H. M., 2007, SMJ Singapore Medical Journal, V48, P906; Allan FJ, 2000, PREV VET MED, V46, P183, DOI 10.1016/S0167-5877(00)00147-1; Allirot X, 2013, PHYSIOL BEHAV, V110, P169, DOI 10.1016/j.physbeh.2013.01.009; Alsalim W, 2015, J CLIN ENDOCR METAB, V100, P561, DOI 10.1210/jc.2014-2865; American Oil Chemists' Society, 2017, OFFICIAL METHODS REC; [Anonymous], 2008, HOUSEHOLD ELECT APPL, V1, P1, DOI DOI 10.1520/E0837-08E01.practice; [Anonymous], 1981, U N MONTHLY CHRO JAN, V18, P18; Antoni R, 2017, P NUTR SOC, V76, P361, DOI 10.1017/S0029665116002986; Areta JL, 2013, J PHYSIOL-LONDON, V591, P2319, DOI 10.1113/jphysiol.2012.244897; Asaro NJ, 2018, J ANIM SCI, V96, P5052, DOI 10.1093/jas/sky365; Association of American Feed Control Officials Inc. (AAFCO), 2018, AAFCO DOG CAT FOOD F; Association of Official Analytical Chemists (AOAC International), 2016, OFFICIAL METHODS ANA, V20th; Atherton PJ, 2010, AM J CLIN NUTR, V92, P1080, DOI 10.3945/ajcn.2010.29819; Batterham RL, 2006, CELL METAB, V4, P223, DOI 10.1016/j.cmet.2006.08.001; Belinova L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174820; Bellows J, 2016, J FELINE MED SURG, V18, P551, DOI 10.1177/1098612X16649525; Boogers I, 2008, J CHROMATOGR A, V1189, P406, DOI 10.1016/j.chroma.2007.11.052; BURRIN DG, 1991, J NUTR, V121, P1099, DOI 10.1093/jn/121.7.1099; BURRIN DG, 1992, PEDIATR RES, V31, P247, DOI 10.1203/00006450-199203000-00010; Cave NJ, 2012, PREV VET MED, V107, P121, DOI 10.1016/j.prevetmed.2012.05.006; Colliard L, 2009, J FELINE MED SURG, V11, P135, DOI 10.1016/j.jfms.2008.07.002; Courcier EA, 2012, VET REC, V171, P560, DOI 10.1136/vr.100953; Courcier EA, 2010, J FELINE MED SURG, V12, P746, DOI 10.1016/j.jfms.2010.05.011; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; DAVIS TA, 1991, AM J PHYSIOL, V261, pR1373, DOI 10.1152/ajpregu.1991.261.6.R1373; DD K., 1993, AM J PHYSIOL, V265, pH586; de Godoy MRC, 2015, J ANIM SCI, V93, P2597, DOI 10.2527/jas.2014-8574; Degen L, 2005, GASTROENTEROLOGY, V129, P1430, DOI 10.1053/j.gastro.2005.09.001; Deng P, 2014, J ANIM SCI, V92, P1271, DOI 10.2527/jas.2013-7235; Deng P, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2013.32; Drazen DL, 2006, ENDOCRINOLOGY, V147, P23, DOI 10.1210/en.2005-0973; El-Kadi SW, 2018, AM J CLIN NUTR, V108, P830, DOI 10.1093/ajcn/nqy133; El-Kadi SW, 2013, PEDIATR RES, V74, P154, DOI 10.1038/pr.2013.89; El-Kadi SW, 2012, AM J PHYSIOL-ENDOC M, V302, pE674, DOI 10.1152/ajpendo.00516.2011; ELATI J, 1995, AM J CLIN NUTR, V62, P302, DOI 10.1093/ajcn/62.2.302; Farrow HA, 2013, J VET INTERN MED, V27, P1121, DOI 10.1111/jvim.12139; Freeman LM, 2012, J VET INTERN MED, V26, P3, DOI 10.1111/j.1939-1676.2011.00838.x; Gazzaneo MC, 2011, J NUTR, V141, P2152, DOI 10.3945/jn.111.147520; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; German AJ, 2010, VET J, V185, P4, DOI 10.1016/j.tvjl.2010.04.004; Gilor C, 2011, DOMEST ANIM ENDOCRIN, V40, P205, DOI 10.1016/j.domaniend.2011.01.002; Gooding MA, 2014, J ANIM PHYSIOL AN N, V98, P596, DOI 10.1111/jpn.12126; Gooding MA, 2012, J APPL ANIM WELF SCI, V15, P144, DOI 10.1080/10888705.2012.658332; Hall SL, 1998, APPL ANIM BEHAV SCI, V58, P143, DOI 10.1016/S0168-1591(97)00136-6; Harper EJ, 2001, J SMALL ANIM PRACT, V42, P433, DOI 10.1111/j.1748-5827.2001.tb02496.x; Hoenig M, 2007, AM J PHYSIOL-REG I, V292, pR227, DOI 10.1152/ajpregu.00313.2006; Hoenig M, 2010, DOMEST ANIM ENDOCRIN, V38, P95, DOI 10.1016/j.domaniend.2009.08.004; JONES PJH, 1993, AM J CLIN NUTR, V57, P868, DOI 10.1093/ajcn/57.6.868; Kang MH, 2016, VET QUART, V36, P2, DOI 10.1080/01652176.2015.1092617; Kienzle E, 2006, J NUTR, V136, p1947S, DOI 10.1093/jn/136.7.1947S; Kitamura T, 1999, J VET INTERN MED, V13, P549, DOI 10.1892/0891-6640(1999)013&lt;0549:AIRTIA&gt;2.3.CO;2; Laflamme DP, 2006, VET CLIN N AM-SMALL, V36, P1283, DOI 10.1016/j.cvsm.2006.08.005; Lascelles BDX, 2008, VET ANAESTH ANALG, V35, P173, DOI 10.1111/j.1467-2995.2007.00367.x; LEBLANC J, 1986, AM J PHYSIOL, V250, pE144, DOI 10.1152/ajpendo.1986.250.2.E144; Leidy HJ, 2011, J NUTR, V141, P154, DOI 10.3945/jn.109.114389; Leidy HJ, 2010, OBESITY, V18, P1725, DOI 10.1038/oby.2010.45; Lessan N, 2018, AM J CLIN NUTR, V107, P54, DOI 10.1093/ajcn/nqx016; Lester T, 1999, AM J PHYSIOL-REG I, V277, pR878, DOI 10.1152/ajpregu.1999.277.3.R878; Lindgren O, 2009, J CLIN ENDOCR METAB, V94, P2887, DOI 10.1210/jc.2009-0366; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; Lusk G, 1928, ELEMENTS SCI NUTR; McCool KE, 2018, DOMEST ANIM ENDOCRIN, V62, P67, DOI 10.1016/j.domaniend.2017.10.004; McGorum BC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174346; McMillan CJ, 2016, DOMEST ANIM ENDOCRIN, V54, P85, DOI 10.1016/j.domaniend.2015.10.001; McNeil J, 2014, J OBES, V2014, DOI 10.1155/2014/482547; Merkestein M, 2012, OBESITY, V20, P963, DOI 10.1038/oby.2011.389; Mitchell WK, 2015, J NUTR, V145, P207, DOI 10.3945/jn.114.199604; Moro T, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1044-0; MORRIS JG, 1979, J NUTR, V109, P724, DOI 10.1093/jn/109.4.724; National Research Council, 2006, NUTR REQ DOGS CATS; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492, DOI 10.1210/jcem-63-2-492; O'Connor PMJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE40, DOI 10.1152/ajpendo.00563.2002; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Perez-Camargo G, 2004, COMP CONT EDUC PRACT, P5; Racinais S, 2012, INT J SPORTS MED, V33, P641, DOI 10.1055/s-0032-1304645; Radziuk J, 2000, J CLIN ENDOCR METAB, V85, P4426, DOI 10.1210/jc.85.12.4426; Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057; Raynor Hollie A, 2015, Front Nutr, V2, P38, DOI 10.3389/fnut.2015.00038; Robertson ID, 1999, PREV VET MED, V40, P75, DOI 10.1016/S0167-5877(99)00024-0; ROGERS QR, 1977, ENZYME, V22, P348, DOI 10.1159/000458816; Russell K, 2000, J SMALL ANIM PRACT, V41, P12, DOI 10.1111/j.1748-5827.2000.tb03129.x; Sabatino BR, 2013, J VET INTERN MED, V27, P1049, DOI 10.1111/jvim.12165; Sadek T, 2018, J FELINE MED SURG, V20, P1049, DOI 10.1177/1098612X18791877; Sakai K, 2018, VET IMMUNOL IMMUNOP, V195, P1, DOI 10.1016/j.vetimm.2017.11.001; Scarlett JM, 1998, J AM VET MED ASSOC, V212, P1725; SCARLETT JM, 1994, INT J OBESITY, V18, pS22; Scharf MT, 2004, SEMIN LIVER DIS, V24, P335, DOI 10.1055/s-2004-860863; Shook RP, 2016, EUR J CLIN NUTR, V70, P1197, DOI 10.1038/ejcn.2015.198; SILVA SVPS, 1985, COMP BIOCHEM PHYS B, V80, P603, DOI 10.1016/0305-0491(85)90298-6; Steelman SM, 2006, J ANIM SCI, V84, P2391, DOI 10.2527/jas.2005-281; Tanaka A, 2005, VET RES COMMUN, V29, P477, DOI 10.1007/s11259-005-1868-1; Vilsboll T, 2003, J CLIN ENDOCR METAB, V88, P2706, DOI 10.1210/jc.2002-021873; Vilsboll T, 2001, DIABETES, V50, P609, DOI 10.2337/diabetes.50.3.609; Washizu T, 1999, RES VET SCI, V67, P205, DOI 10.1053/rvsc.1998.0305; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Zini E, 2009, SCHWEIZ ARCH TIERH, V151, P448, DOI 10.1024/0036-7281.151.9.448	97	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238522	10.1371/journal.pone.0238522	http://dx.doi.org/10.1371/journal.pone.0238522			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946478	Green Published, gold			2022-12-26	WOS:000573851100034
J	Feng, XY; Kebreab, E				Feng, Xiaoyu; Kebreab, Ermias			Net reductions in greenhouse gas emissions from feed additive use in California dairy cattle	PLOS ONE			English	Article							ENTERIC METHANE PRODUCTION; NITRATE; MITIGATION; DIGESTIBILITY; FERMENTATION	The livestock industry is one of the main contributors to greenhouse gas emissions and there is an increasing demand for the industry to reduce its carbon footprint. Several studies have shown that feed additives 3-nitroxypropanol and nitrate to be effective in reducing enteric methane emissions. The objective of this study was to estimate the net mitigating effect of using 3-nitroxypropanol and nitrate on total greenhouse gas emissions in California dairy industry. A life cycle assessment approach was used to conduct a cradle-to-farm gate environmental impact analysis based on dairy production system in California. Emissions associated with crop production, feed additive production, enteric methane, farm management, and manure storage were calculated and expressed as kg CO(2)equivalents (CO(2)e) per kg of energy corrected milk. The total greenhouse gas emissions from baseline, 3-nitroxypropanol and nitrate offered during lactation were 1.12, 0.993, and 1.08 kg CO(2)e/kg energy corrected milk, respectively. The average net reduction rates for 3-nitroxypropanol and nitrate were 11.7% and 3.95%, respectively. In both cases, using the feed additives on the whole herd slightly improved overall carbon footprint reduction compared to limiting its use during lactation phase. Although both 3-nitroxypropanol and nitrate had effects on decreasing the total greenhouse gas emission, the former was much more effective with no known safety issues in reducing the carbon footprint of dairy production in California.	[Feng, Xiaoyu; Kebreab, Ermias] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Kebreab, E (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	ekebreab@ucdavis.edu	; Kebreab, Ermias/E-9113-2012	Feng, Xiaoyu/0000-0003-4317-6738; Kebreab, Ermias/0000-0002-0833-1352	California Air Resources Board [17RD018]; USDA NIFA [NC2040]	California Air Resources Board; USDA NIFA(United States Department of Agriculture (USDA))	EK and XF received award from California Air Resources Board (https://ww2.arb.ca.gov/homepage) under award number 17RD018 and USDA NIFA (https://nifa.usda.gov/) under award number NC2040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu AW, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9010021; Alvarez-Hess PS, 2019, AGR SYST, V169, P14, DOI 10.1016/j.agsy.2018.11.008; [Anonymous], J ANIM SCI; [Anonymous], CURR COST RET STUD; [Anonymous], 2013 FARM RANCH IRR; Brentrup F, 2016, C PAP 10 INT C LIF C; BRUNINGFANN CS, 1993, VET HUM TOXICOL, V35, P521; California Department of Food and Agriculture, 2019, 2019 STAT AGR OV CAL; California Department of Food and Agriculture, 2014, 2014 ANN DAT CAL DAI; Chazon Esther, 2003, MEGHILLOT STUDIES DE, V1, P59; Dijkstra J, 2018, J DAIRY SCI, V101, P9041, DOI 10.3168/jds.2018-14456; Duin EC, 2016, P NATL ACAD SCI USA, V113, P6172, DOI 10.1073/pnas.1600298113; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; Gerber P, 2011, LIVEST SCI, V139, P100, DOI 10.1016/j.livsci.2011.03.012; Guyader J, 2015, J ANIM SCI, V93, P5367, DOI 10.2527/jas.2015-9367; Guyader J, 2017, AGR SYST, V152, P38, DOI 10.1016/j.agsy.2016.12.002; Haisan J, 2017, ANIM PROD SCI, V57, P282, DOI 10.1071/AN15219; Hristov AN, 2013, J ANIM SCI, V91, P5045, DOI 10.2527/jas.2013-6583; Hristov AN, 2015, P NATL ACAD SCI USA, V112, P10663, DOI 10.1073/pnas.1504124112; Huang P., 2018, FRONT MICROBIOL, V9, P1101, DOI [10.3389/fmicb.2018.01101, DOI 10.3389/FMICB.2018.01101, DOI 10.3389/FMICB.2018.01582]; IFIF FEFANA, 2015, LIFE CYCLE ASSESSMEN; Kim SH, 2019, J ANIM SCI, V97, P2687, DOI 10.1093/jas/skz140; Klop G, 2016, J DAIRY SCI, V99, P1161, DOI 10.3168/jds.2015-10214; Latham EA, 2019, SCI TOTAL ENVIRON, V671, P324, DOI 10.1016/j.scitotenv.2019.03.390; Lee C, 2017, J ANIM SCI, V95, P3700, DOI [10.2527/jas2017.1460, 10.2527/jas.2017.1460]; Lee C, 2014, CAN J ANIM SCI, V94, P557, DOI [10.4141/CJAS-2014-069, 10.4141/cjas-2014-069]; Meller RA, 2019, J DAIRY SCI, V102, P6144, DOI 10.3168/jds.2018-16008; Muhammad SO, 2015, NEPHROL DIAL TRANSPL, V30, DOI 10.1093/ndt/gfv180.43; Naranjo A, 2020, J DAIRY SCI, V103, P3760, DOI 10.3168/jds.2019-16576; National Agricultural Statistics Service, 2017, QUICK STATS; Nielsen NI, 2013, ACTA AGR SCAND A-AN, V63, P126, DOI 10.1080/09064702.2013.851275; Nkemka VN, 2019, WATER SCI TECHNOL, V80, P437, DOI 10.2166/wst.2019.302; Olijhoek DW, 2016, J DAIRY SCI, V99, P6191, DOI 10.3168/jds.2015-10691; Rebelo LR, 2019, ANIM FEED SCI TECH, V257, DOI 10.1016/j.anifeedsci.2019.114293; Thoma G, 2013, INT DAIRY J, V31, pS29, DOI 10.1016/j.idairyj.2012.09.010; USDA National Agricultural Statistics Service, 2019, CHARTS MAPS MILK PRO; USDA-Economic Research Service, 2011, DAT SETS FERT US PRI; van Gastelen S, 2019, J DAIRY SCI, V102, P6109, DOI 10.3168/jds.2018-15785; Van Wesemael D, 2019, J DAIRY SCI, V102, P1780, DOI 10.3168/jds.2018-14534; van Zijderveld SM, 2010, J DAIRY SCI, V93, P5856, DOI 10.3168/jds.2010-3281; Velazco JI, 2014, ANIM PROD SCI, V54, P1737, DOI 10.1071/AN14345; Vyas D, 2018, J ANIM SCI, V96, P2923, DOI 10.1093/jas/sky174; Zhang XM, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0312-2	43	3	4	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0234289	10.1371/journal.pone.0234289	http://dx.doi.org/10.1371/journal.pone.0234289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946456	gold, Green Submitted, Green Published			2022-12-26	WOS:000573851100044
J	Jung, M; Kim, J; Kim, K				Jung, Myeongul; Kim, Jejoong; Kim, Kwanguk			Measuring recognition of body changes over time: A human-computer interaction tool using dynamic morphing and body ownership illusion	PLOS ONE			English	Article							DISORDERED EATING BEHAVIOR; GENDER-DIFFERENCES; IMAGE FLEXIBILITY; VIRTUAL-REALITY; DISTURBANCE; CHILDREN; IMPACT	Measuring body image is crucial at both personal and social levels. Previous studies have attempted to quantitatively measure body image but methods for measuring body change recognition over time have not yet been established. The present study proposes a novel human-computer interaction technique using dynamic morphing and body ownership illusion, and we conducted a user study to investigate how body ownership illusion and gender would affect to body change recognition. The results showed that a participant's body change recognition was weak when the body ownership illusion was strong. In addition, female participants were less sensitive than male participants. With our proposed technique, we demonstrated that we were able to quantitatively measure body change recognition and our empirical data indicated that body change recognition varied depending on body ownership illusion and gender, suggesting that our methodology could not only be used in future body image studies but also in eating disorder treatments.	[Jung, Myeongul; Kim, Kwanguk] Hanyang Univ, Dept Comp Sci, Seoul, South Korea; [Kim, Jejoong] Duksung Womens Univ, Dept Psychol, Seoul, South Korea	Hanyang University; Duksung Women's University	Kim, K (corresponding author), Hanyang Univ, Dept Comp Sci, Seoul, South Korea.	kenny@hanyang.ac.kr		jung, myeongul/0000-0001-9432-103X	National Research Foundation of Korea [NRF-2017R1A2B4011151, NRF-2018R1A5A7059549]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by National Research Foundation of Korea (NRF-2017R1A2B4011151 & NRF-2018R1A5A7059549; www.nrf.re.kr).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliata D, 2004, J SOC CLIN PSYCHOL, V23, P7, DOI 10.1521/jscp.23.1.7.26988; [Anonymous], 1983, COM ENSENYAR CATALA, V2, P15; Banakou D, 2014, P NATL ACAD SCI USA, V111, P17678, DOI 10.1073/pnas.1414936111; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Blair RJR, 2001, J ABNORM CHILD PSYCH, V29, P491, DOI 10.1023/A:1012225108281; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cash TF, 1990, BODY IMAGES; Choi C, 2019, SAC '19: PROCEEDINGS OF THE 34TH ACM/SIGAPP SYMPOSIUM ON APPLIED COMPUTING, P701, DOI 10.1145/3297280.3297346; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Corno G, 2018, CYBERPSYCH BEH SOC N, V21, P679, DOI 10.1089/cyber.2018.0340; Currin L, 2005, BRIT J PSYCHIAT, V186, P132, DOI 10.1192/bjp.186.2.132; Derogatis L.R., 1992, SCL 90 R ADM SCORING, P1; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; Gorisse G, 2017, FRONT ROBOT AI, V4, DOI 10.3389/frobt.2017.00033; Grogan S., 2016, BODY IMAGE UNDERSTAN, DOI DOI 10.4324/9781315681528; Harper B, 2008, SEX ROLES, V58, P649, DOI 10.1007/s11199-007-9379-x; Hill ML, 2013, EAT BEHAV, V14, P336, DOI 10.1016/j.eatbeh.2013.06.003; Jourard S.M., 1953, J CONSULT PSYCHOL, V17, P343, DOI DOI 10.1037/H0060689; Jun J, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3174175; Keizer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163921; Kim K, 2015, J AUTISM DEV DISORD, V45, P3891, DOI 10.1007/s10803-014-2036-7; Kim SH, 2007, J HEALTH COMMUN, V12, P359, DOI 10.1080/10810730701326051; Longo MR, 2009, PERCEPTION, V38, P69, DOI 10.1068/p6045; Masuda A., 2015, Journal of Contextual Behaviour Science, V4, P12, DOI 10.1016/j.jcbs.2015.01.001; MCDONALD K, 1992, INT J EAT DISORDER, V11, P289, DOI 10.1002/1098-108X(199204)11:3&lt;289::AID-EAT2260110314&gt;3.0.CO;2-F; Molbert SC, 2018, PSYCHOL MED, V48, P642, DOI 10.1017/S0033291717002008; Normand JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016128; Piryankova IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103428; PLINER P, 1990, PERS SOC PSYCHOL B, V16, P263, DOI 10.1177/0146167290162007; Preston C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199426; Preston C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085773; Riva G, 1999, J BEHAV THER EXP PSY, V30, P221, DOI 10.1016/S0005-7916(99)00018-X; Riva G, 1997, PRESENCE-TELEOP VIRT, V6, P106, DOI 10.1162/pres.1997.6.1.106; Riva G, 2019, CYBERPSYCH BEH SOC N, V22, P82, DOI 10.1089/cyber.2017.29099.gri; Rosenthal MZ, 2011, PERSONAL DISORD, V2, P327, DOI 10.1037/a0023672; Ruffman T, 2008, NEUROSCI BIOBEHAV R, V32, P863, DOI 10.1016/j.neubiorev.2008.01.001; Sami G., 2013, NRIAG J ASTRON GEOPH, V2, P39, DOI DOI 10.1016/J.NRJAG.2013.06.007; Serino S, 2019, J CLIN PSYCHOL, V75, P313, DOI 10.1002/jclp.22724; SLADE PD, 1994, BEHAV RES THER, V32, P497, DOI 10.1016/0005-7967(94)90136-8; SLADE PD, 1988, BRIT J PSYCHIAT, V153, P20, DOI 10.1192/S0007125000298930; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; THOMPSON MA, 1995, J PERS ASSESS, V64, P258, DOI 10.1207/s15327752jpa6402_6; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Waltemate T, 2018, IEEE T VIS COMPUT GR, V24, P1643, DOI 10.1109/TVCG.2018.2794629; Zopf R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18492-7	45	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239322	10.1371/journal.pone.0239322	http://dx.doi.org/10.1371/journal.pone.0239322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946504	gold, Green Published			2022-12-26	WOS:000573851100019
J	Ma, CJ; Zhou, L; Xu, WL; Ma, SG; Wang, Y				Ma, Chenjin; Zhou, Long; Xu, Wangli; Ma, Shuangge; Wang, Yu			Associations of physical activity and screen time with suboptimal health status and sleep quality among Chinese college freshmen: A cross-sectional study	PLOS ONE			English	Article							MENTAL-HEALTH; SEDENTARY BEHAVIOR; PUBLIC-HEALTH; DEPRESSION; EXERCISE; ANXIETY; CHILDREN; SAMPLE; ADOLESCENTS; PREVALENCE	This study aimed to investigate the associations of physical activity (PA) and screen time (ST) with physiological, psychological, and social health-particularly regarding effects on sleep quality-among Chinese college freshmen. A cross-sectional survey was conducted at Renmin University of China, in Beijing. A total of 5,233 students were surveyed in September 2015. Participants completed a self-report questionnaire on their demographic characteristics, tobacco and alcohol use, PA, ST, sleep quality, and health status. Multivariate logistic regression was performed to examine the independent and interactive associations between PA and ST with sleep quality and suboptimal health status. In total, 10.43%, 13.18%, and 13.26% of the 5,233 students had physiological, psychological, and social suboptimal health status, respectively. The prevalence of poor sleep quality was 37.94%. High ST and high PA were significantly associated with physiological suboptimal health status (aOR = 1.39, 95% CI: 1.16-1.68, and aOR = 0.55, 95% CI: 0.45-0.71), psychological suboptimal health status (aOR = 1.43, 95% CI: 1.21-1.69, and aOR = 0.57, 95% CI: 0.47-0.69), social suboptimal health status (aOR = 1.27, 95% CI: 1.08-1.50, and aOR = 0.63, 95% CI: 0.52-0.77), and poor sleep quality (aOR = 1.20, 95% CI: 1.03-1.39, and aOR = 0.64, 95% CI: 0.55-0.76). Additionally, low ST and high PA were interactively negatively associated with poor sleep quality (aOR = 0.56, 95% CI: 0.45-0.70), physiological suboptimal health status (aOR = 0.49, 95% CI: 0.40-0.59), psychological suboptimal health status (aOR = 0.48, 95% CI: 0.39-0.58), and social suboptimal health status (aOR = 0.49, 95% CI: 0.40-0.59). These findings suggested there are independent and interactive associations of low ST and high PA with poor sleep quality and suboptimal health status among Chinese college freshmen.	[Ma, Chenjin; Zhou, Long; Xu, Wangli; Wang, Yu] Renmin Univ China, Ctr Appl Stat, Beijing, Peoples R China; [Ma, Chenjin; Zhou, Long; Xu, Wangli; Wang, Yu] Renmin Univ China, Sch Stat, Beijing, Peoples R China; [Ma, Chenjin; Ma, Shuangge] Yale Univ, Sch Publ Hlth, New Haven, CT USA	Renmin University of China; Renmin University of China; Yale University	Wang, Y (corresponding author), Renmin Univ China, Ctr Appl Stat, Beijing, Peoples R China.; Wang, Y (corresponding author), Renmin Univ China, Sch Stat, Beijing, Peoples R China.	abyuer@sina.com			National Natural Science Foundation of China [11971478]; MOE Project of Key Research Institute of Humanities and Social Sciences at Universities [16JJD910002]; Fund for building World-Class Universities (Disciplines) of Renmin University of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE Project of Key Research Institute of Humanities and Social Sciences at Universities; Fund for building World-Class Universities (Disciplines) of Renmin University of China	This work was supported by the National Natural Science Foundation of China (11971478), the MOE Project of Key Research Institute of Humanities and Social Sciences at Universities (16JJD910002) and Fund for building World-Class Universities (Disciplines) of Renmin University of China.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adams TB, 2007, WOMEN HEALTH, V45, P69, DOI 10.1300/J013v45n01_05; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2009, IEEE, V7, P55; Antonovsky A, 1984, BEHAV HLTH; Beiter R, 2015, J AFFECT DISORDERS, V173, P90, DOI 10.1016/j.jad.2014.10.054; Bi JL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005156; Bircher Johannes, 2005, Med Health Care Philos, V8, P335, DOI 10.1007/s11019-005-0538-y; Bloomfield SA, 2004, MED SCI SPORTS EXERC, V195, P3611; Borjesson M, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-095786; Brand S, 2010, J ADOLESCENT HEALTH, V46, P133, DOI 10.1016/j.jadohealth.2009.06.018; Breland JY, 2013, MENT HEALTH PHYS ACT, V6, P10, DOI 10.1016/j.mhpa.2012.08.002; Burr JF, 2010, PHYSICIAN SPORTSMED, V38, P72, DOI 10.3810/psm.2010.04.1764; Buysse D J, 1989, Psychiatry Res, V28, P193; Cao H, 2011, PREV MED, V53, P316, DOI 10.1016/j.ypmed.2011.09.002; Chalder M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2758; Chennaoui M, 2015, SLEEP MED REV, V20, P59, DOI 10.1016/j.smrv.2014.06.008; Chinese Social Science Net, NAT STUD PHYS HLTH R; Convertino VA, 1997, MED SCI SPORT EXER, V29, P187, DOI 10.1097/00005768-199702000-00004; Curcio G, 2013, NEUROL SCI, V34, P511, DOI 10.1007/s10072-012-1085-y; De Moor MHM, 2008, ARCH GEN PSYCHIAT, V65, P897, DOI 10.1001/archpsyc.65.8.897; Dworak M, 2008, SLEEP MED, V9, P266, DOI 10.1016/j.sleep.2007.04.017; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Feng Q, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100914, 10.1371/journal.pone.0104348]; Gauvin L, 1996, NUTR REV, V54, pS53; General Administration of Sports of China, 2015, 2014 NAT STUD PHYS H; Goldbacher EM, 2007, ANN BEHAV MED, V34, P240, DOI 10.1007/BF02874549; Gopinath B, 2011, ARTERIOSCL THROM VAS, V31, P1233, DOI 10.1161/ATVBAHA.110.219451; Hale L, 2015, SLEEP MED REV, V21, P50, DOI 10.1016/j.smrv.2014.07.007; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Hong H, 2015, MODERN PREVENTIVE ME, P38; Huang TTK, 2003, J AM COLL HEALTH, V52, P83, DOI 10.1080/07448480309595728; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Iannotti RJ, 2009, INT J PUBLIC HEALTH, V54, P191, DOI 10.1007/s00038-009-5410-z; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Kamijo K, 2009, CLIN NEUROPHYSIOL, V120, P511, DOI 10.1016/j.clinph.2008.11.022; Katzmarzyk PT, 2010, DIABETES, V59, P2717, DOI 10.2337/db10-0822; Kent RG, 2015, ANN BEHAV MED, V49, P912, DOI 10.1007/s12160-015-9711-6; Kremer P, 2014, J SCI MED SPORT, V17, P183, DOI 10.1016/j.jsams.2013.03.012; Lemma S, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-237; Lolokote S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4411-8; Ma CJ, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5002-4; Magee CA, 2014, JAMA PEDIATR, V168, P465, DOI 10.1001/jamapediatrics.2013.4183; Mahmoud Jihan Saber Raja, 2012, Issues Ment Health Nurs, V33, P149, DOI 10.3109/01612840.2011.632708; Matin N, 2017, INT HEALTH, V9, P58, DOI 10.1093/inthealth/ihw044; Melkevik O, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-46; Minges KE, 2015, HEALTH PSYCHOL, V34, P381, DOI 10.1037/hea0000172; Moghaddam JF, 2012, SLEEP BREATH, V16, P79, DOI 10.1007/s11325-010-0478-5; Moreno MA, 2011, DEPRESS ANXIETY, V28, P447, DOI 10.1002/da.20805; Nuutinen T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-684; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Rebar AL, 2015, HEALTH PSYCHOL REV, V9, P366, DOI 10.1080/17437199.2015.1022901; Salmon P, 2001, CLIN PSYCHOL REV, V21, P33, DOI 10.1016/S0272-7358(99)00032-X; Saylor Coleen, 2004, J Holist Nurs, V22, P97, DOI 10.1177/0898010104264775; Sontag-Padilla L, 2016, PSYCHIAT SERV, V67, P890, DOI 10.1176/appi.ps.201500307; Stein Cynthia, 2007, J Adolesc Health, V40, DOI 10.1016/j.jadohealth.2006.11.147; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Taras H, 2005, J SCHOOL HEALTH, V75, P248, DOI 10.1111/j.1746-1561.2005.00033.x; Tibber MS, 2013, FRONT PSYCHOL, V4, DOI [10.3389/fpsyg.2013.00088, 10.3389/fpsyt.2013.00027]; Trinh L, 2015, J CAN ACAD CHILD ADO, V24, P17; Trost SG, 2014, BRIT J SPORT MED, V48, P169, DOI 10.1136/bjsports-2013-093372; Tyson P, 2010, J MENT HEALTH, V19, P492, DOI 10.3109/09638230902968308; Velez Juan Carlos, 2013, Sleep Disord, V2013, P910104, DOI 10.1155/2013/910104; Weng CB, 2013, EUR J RADIOL, V82, P1308, DOI 10.1016/j.ejrad.2013.01.031; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; Wong ML, 2013, J PSYCHOSOM RES, V74, P271, DOI 10.1016/j.jpsychores.2012.08.014; World Medical Association, 2018, ETH PRINC MED RES IN; Xu Jun, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P33; Zhang Y, 2017, J EXP MED, V214, P2523, DOI 10.1084/jem.20161427	71	8	8	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239429	10.1371/journal.pone.0239429	http://dx.doi.org/10.1371/journal.pone.0239429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946516	Green Published, gold			2022-12-26	WOS:000573851100057
J	Usui, Y; Kurokawa, R; Maeda, E; Mori, H; Amemiya, S; Sato, J; Ino, K; Torigoe, R; Abe, O				Usui, Yukiko; Kurokawa, Ryo; Maeda, Eriko; Mori, Harushi; Amemiya, Shiori; Sato, Jiro; Ino, Kenji; Torigoe, Rumiko; Abe, Osamu			Evaluation of peripheral bronchiole visualization using model-based iterative reconstruction in quarter-detector computed tomography	PLOS ONE			English	Article							CT	This study aimed to evaluate the visualization of peripheral bronchioles in normal lungs via quarter-detector computed tomography (QDCT). Visualization of bronchioles within 10 mm from the pleura is considered a sign of bronchiectasis. However, it is not known peripheral bronchioles how close to the pleura in normal lungs can be tracked using QDCT. This study included 228 parts in 76 lungs from 38 consecutive patients who underwent QDCT. Reconstruction was performed with different thicknesses, increments, and matrix sizes: 0.5-mm thickness and increment with 512 and 1024 matrixes (Group5 and Group10, respectively) and 0.25-mm thickness and increment with 1024 matrix (Group10Thin). The distance between the most peripheral bronchiole visible and the pleura was determined in the three groups. The distance between the peripheral bronchial duct ends and the nearest pleural surface were significantly shorter in the order of Group10Thin, Group10, and Group5, and the mean distances from the pleura in Group10Thin and Group10 were shorter than 10 mm. These findings suggest the visualization of peripheral bronchioles in QDCT was better with a 1024 axial matrix than with a 512 matrix, and with a 0.25-mm slice thickness/increment than with a 0.5-mm slice thickness/increment. Our study also indicates bronchioles within 10 mm of the pleura do not necessarily indicate pathology.	[Usui, Yukiko; Kurokawa, Ryo; Maeda, Eriko; Mori, Harushi; Amemiya, Shiori; Sato, Jiro; Abe, Osamu] Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan; [Ino, Kenji] Univ Tokyo Hosp, Dept Radiat Technol, Tokyo, Japan; [Torigoe, Rumiko] Canon Med Syst Corp, Otawara, Tochigi, Japan	University of Tokyo; University of Tokyo	Kurokawa, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Radiol, Tokyo, Japan.	rkurokawa-tky@umin.ac.jp	MORI, Harushi/AAA-2669-2022; amemiya, shiori/AFI-4755-2022; Kurokawa, Ryo/ABE-9483-2021	MORI, Harushi/0000-0003-1370-5272; amemiya, shiori/0000-0002-2132-1642; Kurokawa, Ryo/0000-0002-1186-8900; Abe, Osamu/0000-0002-1180-2629; Usui, Yukiko/0000-0001-9537-1717				Hata A, 2018, ACAD RADIOL, V25, P869, DOI 10.1016/j.acra.2017.11.017; HILL AT, 2019, THORAX S1, V74, P1, DOI DOI 10.1136/THORAXJNL-2018-212463; Kakinuma R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137165; KANG EY, 1995, RADIOLOGY, V195, P649, DOI 10.1148/radiology.195.3.7753989; Motoyama S, 2018, CIRC J, V82, P1844, DOI 10.1253/circj.CJ-17-1281; Nagata H, 2019, JPN J RADIOL, V37, P283, DOI 10.1007/s11604-019-00816-4; Perera PL, 2011, EUR RESPIR MONOGR, P44, DOI 10.1183/1025448x.10003510; Tanabe N, 2019, EUR J RADIOL, V120, DOI 10.1016/j.ejrad.2019.108687; Tanabe N, 2018, RESPIR INVESTIG, V56, P489, DOI 10.1016/j.resinv.2018.07.008; Valentin J., 2007, MANAGING PATIENT DOS; Werncke T, 2017, EUR J RADIOL, V89, P191, DOI 10.1016/j.ejrad.2017.02.009; Yamashita K, 2018, EUR ARCH OTO-RHINO-L, V275, P2797, DOI 10.1007/s00405-018-5101-6; Yanagawa M, 2018, EUR RADIOL, V28, P5060, DOI 10.1007/s00330-018-5491-2	13	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239459	10.1371/journal.pone.0239459	http://dx.doi.org/10.1371/journal.pone.0239459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946530	gold, Green Published			2022-12-26	WOS:000573851100042
J	Ali, I; Amiri, S; Ullah, N; Younas, M; Rezakazemi, M				Ali, Irshad; Amiri, Saeid; Ullah, Nehar; Younas, Mohammad; Rezakazemi, Mashallah			Electrocatalytic CO(2)fixation by regenerating reduced cofactor NADH during Calvin Cycle using glassy carbon electrode	PLOS ONE			English	Article							DIRECT ELECTROCHEMICAL REGENERATION; REDUCTION; CO2; DIOXIDE; NAD(+); PHOTOSYNTHESIS; ADSORPTION; SYSTEM	In this study, an enzymatic pathway has been developed to replicate the Calvin Cycle by creating the individual steps of the carbon cycle in a bioreactor. The technology known as "artificial photosynthesis" converts CO(2)emissions into a variety of intermediates that serve as precursors to high-value products. CO2, light, water, and electricity were used as feedstock. An electrochemical reactor was also studied for the regeneration of active NADH operating at constant electrode potential. Initially, a batch electrochemical reactor containing 80 mL of 0.2 mM NAD(+)in Tris-buffer (pH 7.40) was used to evaluate the electrode material operating at normal temperature and pressure. The results showed that the cathode is highly electrocatalytically efficient and selective to regenerate 97.45 +/- 0.8% of NADH from NAD(+)at electrode potential of -2.3 Vvs. mercury standard electrode (MSE). The NADH regeneration system was then integrated with ATP regeneration system and bioreactor containing Ribulose bisphosphate carboxylase/oxygenase (RuBisCO). NADH was regenerated successfully during the process electrochemically and then was used by the enzymatic reaction to produce triose phosphate and 3-Phosphoglycerate (3GPA).	[Ali, Irshad; Ullah, Nehar; Younas, Mohammad] Univ Engn & Technol, Dept Chem Engn, Peshawar, Pakistan; [Amiri, Saeid] Sharif Univ Technol, Chem & Petr Engn Dept, Tehran, Iran; [Rezakazemi, Mashallah] Shahrood Univ Technol, Fac Chem & Mat Engn, Shahrood, Iran	University of Engineering & Technology Peshawar; Sharif University of Technology; Shahrood University of Technology	Rezakazemi, M (corresponding author), Shahrood Univ Technol, Fac Chem & Mat Engn, Shahrood, Iran.	m.younas@uetpeshawar.edu.pk	YOUNAS, Mohammad/K-9754-2018; Rezakazemi, Mashallah/H-4046-2017	YOUNAS, Mohammad/0000-0003-3234-3297; Rezakazemi, Mashallah/0000-0002-9980-6682				Ali I, 2014, J MOL CATAL A-CHEM, V387, P86, DOI 10.1016/j.molcata.2014.02.029; Ali I, 2013, INT J ELECTROCHEM SC, V8, P4283; Ali I, 2012, CHEM ENG J, V188, P173, DOI 10.1016/j.cej.2012.02.005; Ali I, 2011, ELECTROCHEM COMMUN, V13, P562, DOI 10.1016/j.elecom.2011.03.010; Atkins JdP P., 2009, ELEMENTS PHYS CHEM; Aydin R, 2002, J ELECTROANAL CHEM, V535, P107, DOI 10.1016/S0022-0728(02)01151-8; Azem A, 2004, J MOL CATAL A-CHEM, V219, P283, DOI 10.1016/j.molcata.2004.04.041; Baik SH, 1999, BIOTECHNOL TECH, V13, P1, DOI 10.1023/A:1008865212773; Bassham JA, 2003, PHOTOSYNTH RES, V76, P37; Birthday Happy, 1993, FORDHAM L REV, V61, pSI; CHENAULT HK, 1987, APPL BIOCHEM BIOTECH, V14, P147, DOI 10.1007/BF02798431; Choi HJ, 2005, NANO LETT, V5, P2538, DOI 10.1021/nl051896e; Conway K., 1997, ELECTROCHEMICAL DOUB; Damian A, 2007, CHEM BIOCHEM ENG Q, V21, P21; Damian A, 2006, J MOL CATAL A-CHEM, V253, P222, DOI 10.1016/j.molcata.2006.03.020; Delecouls-Servat K, 2004, BIOPROC BIOSYST ENG, V26, P205, DOI 10.1007/s00449-004-0356-2; DevauxBasseguy R, 1997, ENZYME MICROB TECH, V20, P248, DOI 10.1016/S0141-0229(96)00120-2; Ebenhoh O, 2018, BIOCHEM SOC T, V46, P131, DOI 10.1042/BST20170245; ELVING PJ, 1982, BIOELECTROCH BIOENER, V9, P365, DOI 10.1016/0302-4598(82)80026-3; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Filipe OMS, 2004, ELECTROANAL, V16, P994, DOI 10.1002/elan.200402911; Heldt H.W., 2011, PLANT BIOCH; Heldt H-W, 2005, 6 THE CALVIN CYCLE C; JAEGFELDT H, 1981, BIOELECTROCH BIOENER, V8, P355, DOI 10.1016/0302-4598(81)80018-9; Jiang Z, 2010, PHILOS T R SOC A, V368, P3343, DOI 10.1098/rsta.2010.0119; Karyakin AA, 2003, ELECTROCHEM COMMUN, V5, P677, DOI 10.1016/S1388-2481(03)00152-8; Kaur G, 2012, BIOCHEM ENG J, V64, P106, DOI 10.1016/j.bej.2012.03.002; Leonida MD, 2001, CURR MED CHEM, V8, P345, DOI 10.2174/0929867013373390; Liu WF, 2007, BIOTECHNOL ADV, V25, P369, DOI 10.1016/j.biotechadv.2007.03.002; MASSEY V, 1960, BIOCHEM J, V77, P341, DOI 10.1042/bj0770341; Middleton RS, 2013, APPL ENERG, V108, P66, DOI 10.1016/j.apenergy.2013.02.065; MOIROUX J, 1979, J ELECTROANAL CHEM, V102, P93, DOI 10.1016/S0022-0728(79)80033-9; Nakamura Y, 1996, BBA-GEN SUBJECTS, V1289, P221, DOI 10.1016/0304-4165(95)00143-3; Oh SJ, 2009, J MEMBRANE SCI, V345, P13, DOI 10.1016/j.memsci.2009.08.003; Olah GA, 2009, J ORG CHEM, V74, P487, DOI 10.1021/jo801260f; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Rahman G, ELECTROCHEMISTRY COM, V12, P1371; Ren X, 2017, 2017 19TH INTERNATIONAL CONFERENCE ON SOLID-STATE SENSORS, ACTUATORS AND MICROSYSTEMS (TRANSDUCERS), P1859; Sauve AA, 2008, J PHARMACOL EXP THER, V324, P883, DOI 10.1124/jpet.107.120758; SCHWARTZ M, 1993, J ELECTROCHEM SOC, V140, P614, DOI 10.1149/1.2056131; Socolow R, 2004, ENVIRONMENT, V46, P8, DOI 10.1080/00139150409605818; Solomon S, 2009, IRREVERSIBLE CLIMATE; Song CS, 2006, CATAL TODAY, V115, P2, DOI 10.1016/j.cattod.2006.02.029; Tomimatsu H, 2016, J PLANT RES, V129, P365, DOI 10.1007/s10265-016-0817-0; Tongul B, 2016, SEP PURIF TECHNOL, V163, P275, DOI 10.1016/j.seppur.2016.03.008; van der Donk WA, 2003, CURR OPIN BIOTECH, V14, P421, DOI 10.1016/S0958-1669(03)00094-6; Velez J, 2012, ELECTROCHEMICAL OXID; Vuorilehto K, 2004, BIOELECTROCHEMISTRY, V65, P1, DOI 10.1016/j.bioelechem.2004.05.006; W Wendell D, 2010, ARTIFICIAL PHOTOSYNT, P855; Wang XD, 2017, CHEM-US, V2, P621, DOI 10.1016/j.chempr.2017.04.009; Wei L, 2012, ELECTROCHEMICALLY SH; Wendell D, 2010, NANO LETT, V10, P3231, DOI 10.1021/nl100550k; Wu JJ, 2012, J ELECTROCHEM SOC, V159, pF353, DOI 10.1149/2.049207jes; Zhao X, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1644-y	54	1	1	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239340	10.1371/journal.pone.0239340	http://dx.doi.org/10.1371/journal.pone.0239340			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941542	gold, Green Published			2022-12-26	WOS:000573848800083
J	Bandaru, S; Ala, C; Ekstrand, M; Akula, MK; Pedrelli, M; Liu, X; Bergstrom, G; Haversen, L; Boren, J; Bergo, MO; Akyurek, LM				Bandaru, Sashidar; Ala, Chandu; Ekstrand, Matias; Akula, Murali K.; Pedrelli, Matteo; Liu, Xi; Bergstrom, Goran; Haversen, Liliana; Boren, Jan; Bergo, Martin O.; Akyurek, Levent M.			Lack of RAC1 in macrophages protects against atherosclerosis	PLOS ONE			English	Article							ACTIN CYTOSKELETON; FILAMIN; CELLS; MUTATIONS; RECEPTOR; GTPASE; MICE; CD36	The Rho GTPase RAC1 is an important regulator of cytoskeletal dynamics, but the role of macrophage-specific RAC1 has not been explored during atherogenesis. We analyzed RAC1 expression in human carotid atherosclerotic plaques using immunofluorescence and found higher macrophage RAC1 expression in advanced plaques compared with intermediate human atherosclerotic plaques. We then produced mice withRac1-deficient macrophages by breeding conditional floxedRac1mice (Rac1(fl/fl)) with mice expressing Cre from the macrophage-specific lysosome M promoter (LC). Atherosclerosis was studiedin vivoby infectingRac1(fl/fl)andRac1(fl/fl)/LCmice with AdPCSK9 (adenoviral vector overexpressing proprotein convertase subtilisin/kexin type 9).Rac1(fl/fl)/LC macrophages secreted lower levels of IL-6 and TNF-alpha and exhibited reduced foam cell formation and lipid uptake. The deficiency ofRac1in macrophages reduced the size of aortic atherosclerotic plaques in AdPCSK9-infectedRac1(fl/fl)/LCmice. Compare with controls, intima/media ratios, the size of necrotic cores, and numbers of CD68-positive macrophages in atherosclerotic plaques were reduced inRac1-deficient mice. Moreover, we found that RAC1 interacts with actin-binding filamin A. Macrophages expressed increased RAC1 levels in advanced human atherosclerosis. Genetic inactivation of RAC1 impaired macrophage function and reduced atherosclerosis in mice, suggesting that drugs targeting RAC1 may be useful in the treatment of atherosclerosis.	[Bandaru, Sashidar; Ala, Chandu; Liu, Xi; Akyurek, Levent M.] Univ Gothenburg, Inst Biomed, Dept Lab Med, Sahlgrenska Acad, Gothenburg, Sweden; [Ekstrand, Matias; Akula, Murali K.; Bergstrom, Goran; Haversen, Liliana; Boren, Jan] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Sahlgrenska Acad, Gothenburg, Sweden; [Akula, Murali K.; Bergo, Martin O.] Univ Gothenburg, Sahlgrenska Canc Ctr, Sahlgrenska Acad, Gothenburg, Sweden; [Pedrelli, Matteo] Karolinska Inst, Dept Lab Med, Div Clin Chem, Stockholm, Sweden; [Bergstrom, Goran] Sahlgrens Univ Hosp, Dept Clin Physiol, Vastra Gotalandregionen, Gothenburg, Sweden; [Bergo, Martin O.] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Akyurek, Levent M.] Sahlgrens Univ Hosp, Dept Clin Pathol, Vastra Gotalandregionen, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg; Karolinska Institutet; Sahlgrenska University Hospital; Karolinska Institutet; Sahlgrenska University Hospital	Akyurek, LM (corresponding author), Univ Gothenburg, Inst Biomed, Dept Lab Med, Sahlgrenska Acad, Gothenburg, Sweden.; Akyurek, LM (corresponding author), Sahlgrens Univ Hosp, Dept Clin Pathol, Vastra Gotalandregionen, Gothenburg, Sweden.	levent.akyurek@gu.se		Ekstrand, Matias/0000-0002-0403-9266	Institute of Biomedicine, University of Gothenburg; Swedish Cancer Foundation [17 0171]; ALF fund from the Sahlgrenska Academy Hospital in the Vastra Gotalandregionen [ALFGBG-495961]	Institute of Biomedicine, University of Gothenburg; Swedish Cancer Foundation; ALF fund from the Sahlgrenska Academy Hospital in the Vastra Gotalandregionen	This work was supported by the Strategic Fund from the Institute of Biomedicine, University of Gothenburg, the Swedish Cancer Foundation (Contract number 17 0171), and the ALF fund (ALFGBG-495961) from the Sahlgrenska Academy Hospital in the Vastra Gotalandregionen to LMA.	Bandaru S, 2019, CIRCULATION, V140, P67, DOI 10.1161/CIRCULATIONAHA.119.039697; Bandaru S, 2015, CARDIOVASC RES, V105, P151, DOI 10.1093/cvr/cvu226; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Bjorklund MM, 2014, CIRC RES, V114, P1684, DOI 10.1161/CIRCRESAHA.114.302937; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Castellano F, 2000, J CELL SCI, V113, P2955; Duval D, 2014, BBA-MOL CELL RES, V1843, P234, DOI 10.1016/j.bbamcr.2013.10.022; Ekstrand M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178877; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Getz GS, 2017, NAT REV CARDIOL, V14, P304, DOI 10.1038/nrcardio.2017.2; Go A, 2013, BIOMOL THER, V21, P481, DOI 10.4062/biomolther.2013.076; Goyal P, 2013, MOL HUM REPROD, V19, P528, DOI 10.1093/molehr/gat023; Haversen L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34659-2; Hsu HY, 2000, J BIOL CHEM, V275, P41035, DOI 10.1074/jbc.M003464200; Huang Z, 2011, EUR J ORAL SCI, V119, P168, DOI 10.1111/j.1600-0722.2011.00904.x; Hwaiz R, 2013, J SURG RES, V183, P798, DOI 10.1016/j.jss.2013.02.045; Jay AG, 2015, J BIOL CHEM, V290, P4590, DOI 10.1074/jbc.M114.627026; Khan OM, 2013, CIRCULATION, V127, P782, DOI 10.1161/CIRCULATIONAHA.112.000588; Marei Hadir, 2017, Small GTPases, V8, P139, DOI 10.1080/21541248.2016.1211398; Moldovan L, 1999, ANTIOXID REDOX SIGN, V1, P29, DOI 10.1089/ars.1999.1.1-29; Nallapalli RK, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-50; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Park YM, 2012, MOL BIOL CELL, V23, P3057, DOI 10.1091/mbc.E11-12-1051; Pedrelli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093552; Pourcet B, 2018, J CLIN INVEST, V128, P910, DOI 10.1172/JCI120123; Reijnders MRF, 2017, AM J HUM GENET, V101, P466, DOI 10.1016/j.ajhg.2017.08.007; Ridley AJ, 2008, J MICROSC-OXFORD, V231, P518, DOI 10.1111/j.1365-2818.2008.02064.x; Sakr SW, 2001, J BIOL CHEM, V276, P37649, DOI 10.1074/jbc.M105129200; Saric M, 2012, CURR CARDIOL REP, V14, P342, DOI 10.1007/s11886-012-0261-2; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Sayin VI, 2014, CIRC RES, V115, P781, DOI 10.1161/CIRCRESAHA.115.304992; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Tarling EJ, 2010, ARTERIOSCL THROM VAS, V30, P1174, DOI 10.1161/ATVBAHA.110.205617; Wei H, 2015, J LIPID RES, V56, P2337, DOI 10.1194/jlr.M063354; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Williams JW, 2019, IMMUNITY, V50, P941, DOI 10.1016/j.immuni.2019.03.007	38	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239284	10.1371/journal.pone.0239284	http://dx.doi.org/10.1371/journal.pone.0239284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941503	gold, Green Published			2022-12-26	WOS:000573848800001
J	Kim, YY; Yoon, JH; Um, JH; Shin, DJ; Hong, YB; Kim, JK; Kim, DH; Kim, C; Chung, CG; Lee, SB; Koh, H; Yun, J				Kim, Young Yeon; Yoon, Jeong-Hyun; Um, Jee-Hyun; Shin, Dong Jin; Hong, Young Bin; Kim, Jong Kuk; Kim, Dong Hyun; Kim, Changsoo; Chung, Chang Geon; Lee, Sung Bae; Koh, Hyongjong; Yun, Jeanho			PINK1 alleviates thermal hypersensitivity in a paclitaxel-induced Drosophila model of peripheral neuropathy	PLOS ONE			English	Article							OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; INDUCED APOPTOSIS; ALPHA-SYNUCLEIN; MITOPHAGY; NEURONS	Paclitaxel is a representative anticancer drug that induces chemotherapy-induced peripheral neuropathy (CIPN), a common side effect that limits many anticancer chemotherapies. Although PINK1, a key mediator of mitochondrial quality control, has been shown to protect neuronal cells from various toxic treatments, the role of PINK1 in CIPN has not been investigated. Here, we examined the effect of PINK1 expression on CIPN using a recently established paclitaxel-induced peripheral neuropathy model inDrosophilalarvae. We found that the class IV dendritic arborization (C4da) sensory neuron-specific expression of PINK1 significantly ameliorated the paclitaxel-induced thermal hyperalgesia phenotype. In contrast, knockdown of PINK1 resulted in an increase in thermal hypersensitivity, suggesting a critical role for PINK1 in sensory neuron-mediated thermal nociceptive sensitivity. Interestingly, analysis of the C4da neuron morphology suggests that PINK1 expression alleviates paclitaxel-induced thermal hypersensitivity by means other than preventing alterations in sensory dendrites in C4da neurons. We found that paclitaxel induces mitochondrial dysfunction in C4da neurons and that PINK1 expression suppressed the paclitaxel-induced increase in mitophagy in C4da neurons. These results suggest that PINK1 mitigates paclitaxel-induced sensory dendrite alterations and restores mitochondrial homeostasis in C4da neurons and that improvement in mitochondrial quality control could be a promising strategy for the treatment of CIPN.	[Kim, Young Yeon; Yoon, Jeong-Hyun; Um, Jee-Hyun; Shin, Dong Jin; Hong, Young Bin; Kim, Jong Kuk; Kim, Dong Hyun; Koh, Hyongjong; Yun, Jeanho] Dong A Univ, Peripheral Neuropathy Res Ctr, Busan, South Korea; [Kim, Young Yeon; Yoon, Jeong-Hyun; Um, Jee-Hyun; Shin, Dong Jin; Hong, Young Bin; Yun, Jeanho] Dong A Univ, Coll Med, Dept Biochem, Busan, South Korea; [Kim, Jong Kuk] Dong A Univ, Coll Med, Dept Neurol, Busan, South Korea; [Kim, Dong Hyun] Dong A Univ, Coll Hlth Sci, Dept Med Biotechnol, Busan, South Korea; [Kim, Changsoo] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Gwangju, South Korea; [Chung, Chang Geon] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu, South Korea; [Lee, Sung Bae; Koh, Hyongjong] Dong A Univ, Dept Pharmacol, Coll Med, Busan, South Korea	Dong A University; Dong A University; Dong A University; Dong A University; Chonnam National University; Daegu Gyeongbuk Institute of Science & Technology (DGIST); Dong A University	Yun, J (corresponding author), Dong A Univ, Peripheral Neuropathy Res Ctr, Busan, South Korea.; Yun, J (corresponding author), Dong A Univ, Coll Med, Dept Biochem, Busan, South Korea.	yunj@dau.ac.kr		Koh, Hyongjong/0000-0003-2594-4799; Chung, Chang Geon/0000-0001-8155-4926	National Research Foundation of Korea (NRF) - Korean government [2016R1A5A2007009, 2019R1A2C2003991]	National Research Foundation of Korea (NRF) - Korean government	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2016R1A5A2007009 and 2019R1A2C2003991) to JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Amadoro G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00018; Andre N, 2000, CANCER RES, V60, P5349; [Anonymous], 2015, J PEDIAT ORTHOP, V35, pe52; Bayne AN, 2019, CELL MOL LIFE SCI, V76, P4589, DOI 10.1007/s00018-019-03203-4; Brazill JM, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.032938; Burton AW, 2007, PAIN MED, V8, P189, DOI 10.1111/j.1526-4637.2006.00220.x; Cheng AW, 2010, ASN NEURO, V2, P243, DOI 10.1042/AN20100019; Cornelissen T, 2018, ELIFE, V7, DOI 10.7554/eLife.35878; Dagda RK, 2014, J NEUROCHEM, V128, P864, DOI 10.1111/jnc.12494; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Dai HM, 2015, TOXICOLOGY, V334, P72, DOI 10.1016/j.tox.2015.06.003; Du F, 2017, BRAIN, V140, P3233, DOI 10.1093/brain/awx258; Duggett NA, 2016, NEUROSCIENCE, V333, P13, DOI 10.1016/j.neuroscience.2016.06.050; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Hamoudi Zina, 2018, F1000Res, V7, P99, DOI 10.12688/f1000research.13581.2; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; Haque ME, 2012, J BIOL CHEM, V287, P23162, DOI 10.1074/jbc.M112.346437; Hernandez CJ, 2019, J MOL NEUROSCI, V69, P570, DOI 10.1007/s12031-019-01385-x; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jang W, 2015, J BIOL CHEM, V290, P2521, DOI 10.1074/jbc.M114.592758; JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552; Khalil B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.581; Kim YY, 2019, FASEB J, V33, P9742, DOI 10.1096/fj.201900073R; Koh H, 2012, MOL CELLS, V34, P7, DOI 10.1007/s10059-012-0100-8; Lee JJ, 2018, J CELL BIOL, V217, P1613, DOI 10.1083/jcb.201801044; Liang C, 2018, J ANESTH, V32, P62, DOI 10.1007/s00540-017-2431-2; Liu J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.427; Parganlija D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095288; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Park SB, 2013, CA-CANCER J CLIN, V63, P419, DOI 10.3322/caac.21204; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; POSTMA TJ, 1995, ANN ONCOL, V6, P489, DOI 10.1093/oxfordjournals.annonc.a059220; Scarffe LA, 2014, TRENDS NEUROSCI, V37, P315, DOI 10.1016/j.tins.2014.03.004; Scialo F, 2016, CELL METAB, V23, P725, DOI 10.1016/j.cmet.2016.03.009; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Steer EK, 2015, ANTIOXID REDOX SIGN, V22, P1047, DOI 10.1089/ars.2014.6206; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Todd AM, 2012, GENET MOL RES, V11, P1497, DOI 10.4238/2012.May.21.6; Todd AM, 2008, GENOME, V51, P1040, DOI 10.1139/G08-085; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Voigt A, 2016, J NEUROCHEM, V139, P232, DOI 10.1111/jnc.13655; Xiao WH, 2011, NEUROSCIENCE, V199, P461, DOI 10.1016/j.neuroscience.2011.10.010; Yang WW, 2018, ONCOTARGET, V9, P37, DOI 10.18632/oncotarget.21554; Yilmaz E, 2017, CELL CALCIUM, V62, P16, DOI 10.1016/j.ceca.2017.01.005; Yoo SM, 2018, MOL CELLS, V41, P18, DOI 10.14348/molcells.2018.2277; Zheng HE, 2011, EXP NEUROL, V232, P154, DOI 10.1016/j.expneurol.2011.08.016	48	7	7	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239126	10.1371/journal.pone.0239126	http://dx.doi.org/10.1371/journal.pone.0239126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941465	Green Published, gold			2022-12-26	WOS:000573848800070
J	Mitra, A; Roy, A; Joshi, A; Pakhare, AP				Mitra, Arun; Roy, Adrija; Joshi, Ankur; Pakhare, Abhijit P.			Impact of COVID-19 epidemic curtailment strategies in selected Indian states: An analysis by reproduction number and doubling time with incidence modelling	PLOS ONE			English	Article								The Government of India in-network with the state governments has implemented the epidemic curtailment strategies inclusive of case-isolation, quarantine and lockdown in response to ongoing novel coronavirus (COVID-19) outbreak. In this manuscript, we attempt to estimate the impact of these steps across ten selected Indian states using crowd-sourced data. The trajectory of the outbreak was parameterized by the reproduction number (R-0), doubling time, and growth rate. These parameters were estimated at two time-periods after the enforcement of the lockdown on 24(th)March 2020, i.e. 15 days into lockdown and 30 days into lockdown. The authors used a crowd sourced database which is available in the public domain. After preparing the data for analysis,R(0)was estimated using maximum likelihood (ML) method which is based on the expectation minimum algorithm where the distribution probability of secondary cases is maximized using the serial interval discretization. The doubling time and growth rate were estimated by the natural log transformation of the exponential growth equation. The overall analysis shows decreasing trends in time-varying reproduction numbers (R-(t)) and growth rate (with a few exceptions) and increasing trends in doubling time. The curtailment strategies employed by the Indian government seem to be effective in reducing the transmission parameters of the COVID-19 epidemic. The estimatedR((t))are still above the threshold of 1, and the resultant absolute case numbers show an increase with time. Future curtailment and mitigation strategies thus may take into account these findings while formulating further course of action.	[Mitra, Arun; Joshi, Ankur; Pakhare, Abhijit P.] All India Inst Med Sci, Dept Community & Family Med, Bhopal, India; [Roy, Adrija] All India Inst Med Sci, Community Med & Family Med, Bhubaneswar, India	All India Institute of Medical Sciences (AIIMS) Bhopal; All India Institute of Medical Sciences (AIIMS) Bhubaneswar	Joshi, A (corresponding author), All India Inst Med Sci, Dept Community & Family Med, Bhopal, India.	ankur.cfm@aiimsbhopal.edu.in	Roy, Adrija/GPC-6966-2022; Mitra, Arun/AHA-9307-2022; Roy, Adrija/GPX-0656-2022; Pakhare, Abhijit/K-4678-2019	Mitra, Arun/0000-0001-6742-4033; Pakhare, Abhijit/0000-0003-2897-4141; Joshi, Ankur/0000-0002-3766-376X; Roy, Adrija/0000-0002-2351-6259				Abbott S., 2020, WELLCOME OPEN RES, V5, P112, DOI [10.12688/wellcomeopenres.16006.2, DOI 10.12688/WELLCOMEOPENRES.16006.1]; Abbott S., 2020, COVID 19 NATL SUBNAT; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Banholzer N., 2020, MEDRXIV; Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Das S., 2020, ARXIV200403126; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Gostic Katelyn M, 2020, PLoS Comput Biol, V16, pe1008409, DOI [10.1101/2020.06.18.20134858, 10.1371/journal.pcbi.1008409]; Jayadev C, 2020, INDIAN J OPHTHALMOL, V68, P730, DOI 10.4103/ijo.IJO_856_20; Kamvar Zhian N, 2019, F1000Res, V8, P139, DOI 10.12688/f1000research.18002.1; Kowal P., 2012, AGING ASIA FINDINGS; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Lee VJ, 2020, J TRAVEL MED; Maier BF, 2020, ARXIV200207572; Mandal S, 2020, INDIAN J MED RES, V151, P190, DOI 10.4103/ijmr.IJMR_504_20; Mitra A, 2020, INCIDENCE MODELLING; Nikbakht R, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_888_18; Nouvellet P, 2018, EPIDEMICS-NETH, V22, P29, DOI 10.1016/j.epidem.2017.02.012; O'Driscoll M, 2020, COMP ANAL STAT METHO; Obadia T, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-147; Phua Jason, 2020, Lancet Respir Med, V8, P506, DOI 10.1016/S2213-2600(20)30161-2; Pulla P, 2020, COVID 19 INDIA IMPOS; R Core Team, 2021, R LANGUAGE ENV STAT; Resolve to Save Lives, 2020, STAYING ALERT NAV CO; Sjodin H, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.13.2000280; Thompson RN, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100356; Varghese GM, 2020, INDIAN J MED RES, V151, P401, DOI 10.4103/ijmr.IJMR_957_20; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; Zhao S, 2020, FRONT PHYS-LAUSANNE, DOI [10.1101/2020.02.21.20026559, DOI 10.3389/FPHY.2020.00347]	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0239026	10.1371/journal.pone.0239026	http://dx.doi.org/10.1371/journal.pone.0239026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936811	gold, Green Submitted, Green Published			2022-12-26	WOS:000573658000020
J	Deshpande, P; Flinkman, D; Hong, Y; Goltseva, E; Siino, V; Sun, LH; Peltonen, S; Elo, LL; Kaasinen, V; James, P; Coffey, ET				Deshpande, Prasannakumar; Flinkman, Dani; Hong, Ye; Goltseva, Elena; Siino, Valentina; Sun, Lihua; Peltonen, Sirkku; Elo, Laura L.; Kaasinen, Valtteri; James, Peter; Coffey, Eleanor T.			Protein synthesis is suppressed in sporadic and familial Parkinson's disease by LRRK2	FASEB JOURNAL			English	Article						biomarker; cellular mechanism; eEF2; LRRK2; neurodegeneration; Parkinson's disease	ELONGATION FACTOR-II; PHOSPHORYLATION SITES; DOPAMINERGIC-NEURONS; KINASE; TRANSLATION; IDENTIFICATION; MUTATIONS; REGULATOR; BRAIN; GENE	Gain of function LRRK2-G2019S is the most frequent mutation found in familial and sporadic Parkinson's disease. It is expected therefore that understanding the cellular function of LRRK2 will provide insight on the pathological mechanism not only of inherited Parkinson's, but also of sporadic Parkinson's, the more common form. Here, we show that constitutive LRRK2 activity controls nascent protein synthesis in rodent neurons. Specifically, pharmacological inhibition of LRRK2,Lrrk2knockdown orLrrk2knockout, all lead to increased translation. In the rotenone model for sporadic Parkinson's, LRRK2 activity increases, dopaminergic neuron translation decreases, and the neurites atrophy. All are prevented by LRRK2 inhibitors. Moreover, in striatum and substantia nigra of rotenone treated rats, phosphorylation changes are observed on eIF2 alpha-S52(up arrow), eIF2s2-S2(down arrow), and eEF2-T57(up arrow) in directions that signify protein synthesis arrest. Significantly, translation is reduced by 40% in fibroblasts from Parkinson's patients (G2019S and sporadic cases alike) and this is reversed upon LRRK2 inhibitor treatment. In cells from multiple system atrophy patients, translation is unchanged suggesting that repression of translation is specific to Parkinson's disease. These findings indicate that repression of translation is a proximal function of LRRK2 in Parkinson's pathology.	[Deshpande, Prasannakumar; Flinkman, Dani; Hong, Ye; Sun, Lihua; Elo, Laura L.; James, Peter; Coffey, Eleanor T.] Univ Turku, Turku Biosci, Turku, Finland; [Deshpande, Prasannakumar; Flinkman, Dani; Hong, Ye; Sun, Lihua; Elo, Laura L.; James, Peter; Coffey, Eleanor T.] Abo Akad Univ, Turku, Finland; [Flinkman, Dani; Goltseva, Elena; Siino, Valentina; James, Peter] Lund Univ, Dept Immunotechnol, Lund, Sweden; [Peltonen, Sirkku] Univ Turku, Dept Dermatol, Turku, Finland; [Peltonen, Sirkku] Turku Univ Hosp, Turku, Finland; [Kaasinen, Valtteri] Turku Univ Hosp, Div Clin Neurosci, Turku, Finland; [Kaasinen, Valtteri] Univ Turku, Turku, Finland	University of Turku; Abo Akademi University; Lund University; University of Turku; University of Turku; University of Turku; University of Turku	Coffey, ET (corresponding author), Univ Turku, Turku Biosci, Turku, Finland.; Coffey, ET (corresponding author), Abo Akad Univ, Turku, Finland.	eleanor.coffey@bioscience.fi	Peltonen, Sirkku/C-3133-2008; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Kaasinen, Valtteri/O-2086-2016	Peltonen, Sirkku/0000-0003-0990-1430; Kaasinen, Valtteri/0000-0002-3446-7093; Flinkman, Dani/0000-0002-3908-2467; Coffey, Eleanor/0000-0002-9717-5610; Deshpande, Prasannakumar/0000-0002-9965-7859; Sun, Lihua/0000-0002-9931-9497	Business Finland; Michael J. Fox Foundation for Parkinson's Research (MJFF); Abo Akademi University; Turku Graduate School of Biomedical Sciences; MATTI Graduate School; University of Lund	Business Finland; Michael J. Fox Foundation for Parkinson's Research (MJFF); Abo Akademi University; Turku Graduate School of Biomedical Sciences; MATTI Graduate School; University of Lund	Business Finland; Michael J. Fox Foundation for Parkinson's Research (MJFF); Abo Akademi University; Turku Graduate School of Biomedical Sciences; MATTI Graduate School; University of Lund	Alam M, 2004, BEHAV BRAIN RES, V153, P439, DOI 10.1016/j.bbr.2003.12.021; Albanese F, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01352; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bjorkblom B, 2005, J NEUROSCI, V25, P6350, DOI 10.1523/JNEUROSCI.1517-05.2005; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Burke RE, 2013, EXP NEUROL, V246, P72, DOI 10.1016/j.expneurol.2012.01.011; Cannon JR, 2009, NEUROBIOL DIS, V34, P279, DOI 10.1016/j.nbd.2009.01.016; Carling PJ, 2020, PROG NEUROBIOL, V187, DOI 10.1016/j.pneurobio.2020.101772; Chang D, 2017, NAT GENET, V49, P1511, DOI 10.1038/ng.3955; Collier TJ, 2011, NAT REV NEUROSCI, V12, P359, DOI 10.1038/nrn3039; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dachsel JC, 2007, PARKINSONISM RELAT D, V13, P382, DOI 10.1016/j.parkreldis.2007.01.008; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Di Maio R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar5429; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; DOMESICK VB, 1983, NEUROSCIENCE, V8, P743, DOI 10.1016/0306-4522(83)90007-6; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Fell MJ, 2015, J PHARMACOL EXP THER, V355, P397, DOI 10.1124/jpet.115.227587; Gandin V, 2014, TRANSLATION, V2, DOI 10.4161/trla.28109; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gerhard DM, 2016, DRUG DISCOV TODAY, V21, P454, DOI 10.1016/j.drudis.2016.01.016; Gilsbach BK, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00032; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; GULLEY RL, 1971, TISSUE CELL, V3, P675, DOI 10.1016/S0040-8166(71)80013-7; Haugarvoll K, 2009, PARKINSONISM RELAT D, V15, pS205, DOI 10.1016/S1353-8020(09)70815-6; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; HOEBEKE J, 1975, LIFE SCI, V17, P591, DOI 10.1016/0024-3205(75)90095-8; Hollos P, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0303-19.2019; Hongisto V, 2008, MOL CELL BIOL, V28, P1515, DOI 10.1128/MCB.02227-06; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hulihan MM, 2008, LANCET NEUROL, V7, P591, DOI 10.1016/S1474-4422(08)70116-9; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jan A, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0554-9; Jellinger KA, 2015, J NEURAL TRANSM, V122, P505, DOI 10.1007/s00702-014-1288-x; Kalia LV, 2015, JAMA NEUROL, V72, P100, DOI 10.1001/jamaneurol.2014.2704; Kearns CM, 1997, J NEUROSCI, V17, P7111; Kenmochi N, 1998, GENOME RES, V8, P509, DOI 10.1101/gr.8.5.509; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Langston RG, 2016, BIOCHEM J, V473, P221, DOI 10.1042/BJ20150985; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Llorens F, 2006, BIOCHEM J, V394, P227, DOI 10.1042/BJ20050605; Lobbestael E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33897; Manzoni C, 2017, ADV NEUROBIOL, V14, P89, DOI 10.1007/978-3-319-49969-7_5; Marin I, 2008, J MOL EVOL, V67, P41, DOI 10.1007/s00239-008-9122-4; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Mora M, 2015, EUR J HUM GENET, V23, P1116, DOI 10.1038/ejhg.2014.272; Moriya H, 2015, MOL BIOL CELL, V26, P3932, DOI 10.1091/mbc.E15-07-0512; Mutez E, 2014, NEUROBIOL DIS, V63, P165, DOI 10.1016/j.nbd.2013.11.007; Nie M, 2006, NUCLEIC ACIDS RES, V34, P5528, DOI 10.1093/nar/gkl584; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; OVCHINNIKOV LP, 1990, FEBS LETT, V275, P209, DOI 10.1016/0014-5793(90)81473-2; Padzik A, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00057; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pavitt GD, 2009, BIOCHEM SOC T, V37, P1298, DOI 10.1042/BST0371298; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Penney J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12188; Piccoli G, 2011, J NEUROSCI, V31, P2225, DOI 10.1523/JNEUROSCI.3730-10.2011; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.13, 10.1111/ene.14108]; Postuma RB, 2018, MOVEMENT DISORD, V33, P1601, DOI 10.1002/mds.27362; PRICE NT, 1991, FEBS LETT, V282, P253, DOI 10.1016/0014-5793(91)80489-P; Reith AD, 2012, BIOORG MED CHEM LETT, V22, P5625, DOI 10.1016/j.bmcl.2012.06.104; Ren Y, 2005, J BIOL CHEM, V280, P34105, DOI 10.1074/jbc.M503483200; Ressa A, 2019, J PROTEOME RES, V18, P576, DOI 10.1021/acs.jproteome.8b00576; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1989, FEBS LETT, V251, P187, DOI 10.1016/0014-5793(89)81452-8; Salvatore MF, 2012, JOVE-J VIS EXP, DOI 10.3791/4171; Sanders LH, 2013, FREE RADICAL BIO MED, V62, P111, DOI 10.1016/j.freeradbiomed.2013.01.003; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Stewart JD, 2015, BIOCHEM J, V467, P217, DOI 10.1042/BJ20141453; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Varidaki A, 2016, MOL MECH DEPRESSION; Vidyadhara DJ, 2019, J NEUROCHEM, V150, P487, DOI 10.1111/jnc.14820; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Woods YL, 2001, BIOCHEM J, V355, P609, DOI 10.1042/bj3550609; Yoshihama M, 2002, GENOME RES, V12, P379, DOI 10.1101/gr.214202; Younts TJ, 2016, NEURON, V92, P479, DOI 10.1016/j.neuron.2016.09.040; Yu LY, 2008, J NEUROSCI METH, V169, P8, DOI 10.1016/j.jneumeth.2007.11.018; Zhao Y, 2018, BRAIN, V141, P486, DOI 10.1093/brain/awx344; Zhao Y, 2012, MOL CELL NEUROSCI, V49, P300, DOI 10.1016/j.mcn.2011.12.005	88	7	7	6	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14217	14233		10.1096/fj.202001046R	http://dx.doi.org/10.1096/fj.202001046R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32926469	Green Submitted, hybrid			2022-12-26	WOS:000570669800001
J	Georgieva, JV; Goulatis, LI; Stutz, CC; Canfield, SG; Song, HW; Gastfriend, BD; Shusta, EV				Georgieva, Julia, V; Goulatis, Loukas, I; Stutz, Charles C.; Canfield, Scott G.; Song, Hannah W.; Gastfriend, Benjamin D.; Shusta, Eric, V			Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS	FASEB JOURNAL			English	Article						antibody-mediated brain drug delivery; blood-brain barrier; nicotinamide adenine dinucleotide	DRUG-DELIVERY; IN-VIVO; ENDOTHELIAL-CELLS; PHAGE; GENERATION; TRANSPORT; BINDING; PERMEABILITY; PENETRATION; MAINTENANCE	Drug delivery across the blood-brain barrier (BBB) remains a significant obstacle for the development of neurological disease therapies. The low penetration of blood-borne therapeutics into the brain can oftentimes be attributed to the restrictive nature of the brain microvascular endothelial cells (BMECs) that comprise the BBB. One strategy beginning to be successfully leveraged is the use of endogenous receptor-mediated transcytosis (RMT) systems as a means to shuttle a targeted therapeutic into the brain. Limitations of known RMT targets and their cognate targeting reagents include brain specificity, brain uptake levels, and off-target effects, driving the search for new and potentially improved brain targeting reagent-RMT pairs. To this end, we deployed human-induced pluripotent stem cell (iPSC)-derived BMEC-like cells as a model BBB substrate on which to mine for new RMT-targeting antibody pairs. A nonimmune, human single-chain variable fragment (scFv) phage display library was screened for binding, internalization, and transcytosis across iPSC-derived BMECs. Lead candidates exhibited binding and internalization into BMECs as well as binding to both human and mouse BBB in brain tissue sections. Antibodies targeted the murine BBB after intravenous administration with one particular clone, 46.1-scFv, exhibiting a 26-fold increase in brain accumulation (8.1 nM). Moreover, clone 46.1-scFv was found to associate with postvascular, parenchymal cells, indicating its successful receptor-mediated transport across the BBB. Such a new BBB targeting ligand could enhance the transport of therapeutic molecules into the brain.	[Georgieva, Julia, V; Goulatis, Loukas, I; Stutz, Charles C.; Canfield, Scott G.; Song, Hannah W.; Gastfriend, Benjamin D.; Shusta, Eric, V] Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA; [Canfield, Scott G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Terre Haute, IN USA; [Shusta, Eric, V] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Indiana University System; University of Wisconsin System; University of Wisconsin Madison	Shusta, EV (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.	eshusta@wisc.edu		Canfield, Scott/0000-0003-1328-7365	HHS \ National Institutes of Health (NIH) [NS071513]; DOD | Defense Threat Reduction Agency (DTRA) [HDTRA1-15-1-0012]	HHS \ National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD | Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: NS071513; DOD | Defense Threat Reduction Agency (DTRA), Grant/Award Number: HDTRA1-15-1-0012	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abulrob A, 2005, J NEUROCHEM, V95, P1201, DOI 10.1111/j.1471-4159.2005.03463.x; Campisi M, 2018, BIOMATERIALS, V180, P117, DOI 10.1016/j.biomaterials.2018.07.014; Couch JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005338; Delsing L, 2018, STEM CELLS, V36, P1816, DOI 10.1002/stem.2908; Faley SL, 2019, STEM CELL REP, V12, P474, DOI 10.1016/j.stemcr.2019.01.009; Farrington GK, 2014, FASEB J, V28, P4764, DOI 10.1096/fj.14-253369; Goulatis LI, 2017, CURR OPIN STRUC BIOL, V45, P109, DOI 10.1016/j.sbi.2016.12.005; Han BW, 2008, SCIENCE, V321, P1834, DOI 10.1126/science.1162484; Hanzatian DK, 2018, MABS-AUSTIN, V10, P765, DOI 10.1080/19420862.2018.1465159; Haqqani AS, 2018, J NEUROCHEM, V146, P735, DOI 10.1111/jnc.14482; Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991; Johnsen BKB, 2019, J CONTROL RELEASE, V295, P237, DOI 10.1016/j.jconrel.2019.01.005; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Jones AR, 2014, BIOTECHNOL J, V9, P664, DOI 10.1002/biot.201300550; KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2; Kurosawa T, 2018, MOL PHARMACEUT, V15, P5546, DOI 10.1021/acs.molpharmaceut.8b00697; Li JW, 2011, BIOMATERIALS, V32, P4943, DOI 10.1016/j.biomaterials.2011.03.031; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; O'Connell D, 2002, J MOL BIOL, V321, P49, DOI 10.1016/S0022-2836(02)00561-2; Pardridge WM, 2015, EXPERT OPIN DRUG DEL, V12, P207, DOI 10.1517/17425247.2014.952627; PARDRIDGE WM, 1995, PHARMACEUT RES, V12, P807, DOI 10.1023/A:1016244500596; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Park TE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10588-0; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; PODUSLO JF, 1994, P NATL ACAD SCI USA, V91, P5705, DOI 10.1073/pnas.91.12.5705; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Ribecco-Lutkiewicz M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19522-8; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Stebbins MJ, 2016, METHODS, V101, P93, DOI 10.1016/j.ymeth.2015.10.016; Stephen TL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50781-1; Stutz CC, 2018, AICHE J, V64, P4229, DOI 10.1002/aic.16360; Stutz CC, 2014, CURR PHARM DESIGN, V20, P1564, DOI 10.2174/13816128113199990459; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Umlauf BJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau4245; Urich E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14104; Vatine GD, 2017, CELL STEM CELL, V20, P831, DOI 10.1016/j.stem.2017.04.002; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; Wang XX, 2007, NAT METHODS, V4, P143, DOI 10.1038/nmeth993; Wang YI, 2017, BIOTECHNOL BIOENG, V114, P184, DOI 10.1002/bit.26045; Webster CI, 2016, FASEB J, V30, P1927, DOI 10.1096/fj.201500078; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zhou Yu, 2009, V525, P145, DOI 10.1007/978-1-59745-554-1_7; Zorniak M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16066-1; Zuchero YJY, 2016, NEURON, V89, P70, DOI 10.1016/j.neuron.2015.11.024	51	8	8	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2020	34	9					12549	12564		10.1096/fj.202000851R	http://dx.doi.org/10.1096/fj.202000851R		JUL 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	NK8TC	32960493	Green Accepted			2022-12-26	WOS:000556911000001
J	Tchesnokov, EP; Gordon, CJ; Woolner, E; Kocinkova, D; Perry, JK; Feng, JY; Porter, DP; Gotte, M				Tchesnokov, Egor P.; Gordon, Calvin J.; Woolner, Emma; Kocinkova, Dana; Perry, Jason K.; Feng, Joy Y.; Porter, Danielle P.; Gotte, Matthias			Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						COVID-19; coronavirus; CoV; SARS-CoV-2; RNA-dependent RNA polymerase; RdRp; replication; remdesivir; delayed chain termination; viral polymerase; drug development; drug resistance; RNA polymerase; RNA virus; SARS-2	REVERSE-TRANSCRIPTASE; VIRUS; EXCISION; GS-5734; EXORIBONUCLEASE; DISCOVERY; EBOLA	Remdesivir (RDV) is a direct-acting antiviral agent that is used to treat patients with severe coronavirus disease 2019 (COVID-19). RDV targets the viral RNA-dependent RNA polymerase (RdRp) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We have previously shown that incorporation of the active triphosphate form of RDV (RDV-TP) at position i causes delayed chain termination at position i + 3. Here we demonstrate that the S861G mutation in RdRp eliminates chain termination, which confirms the existence of a steric clash between Ser-861 and the incorporated RDV-TP. With WT RdRp, increasing concentrations of NTP pools cause a gradual decrease in termination and the resulting read-through increases full-length product formation. Hence, RDV residues could be embedded in copies of the first RNA strand that is later used as a template. We show that the efficiency of incorporation of the complementary UTP opposite template RDV is compromised, providing a second opportunity to inhibit replication. A structural model suggests that RDV, when serving as the template for the incoming UTP, is not properly positioned because of a significant clash with Ala-558. The adjacent Val-557 is in direct contact with the template base, and the V557L mutation is implicated in low-level resistance to RDV. We further show that the V557L mutation in RdRp lowers the nucleotide concentration required to bypass this template-dependent inhibition. The collective data provide strong evidence to show that template-dependent inhibition of SARS-CoV-2 RdRp by RDV is biologically relevant.	[Tchesnokov, Egor P.; Gordon, Calvin J.; Woolner, Emma; Kocinkova, Dana; Gotte, Matthias] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Perry, Jason K.; Feng, Joy Y.; Porter, Danielle P.] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Gotte, Matthias] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; Gilead Sciences; University of Alberta	Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Gotte, M (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.	gotte@ualberta.ca		Perry, Jason/0000-0001-5492-0652; Woolner, Emma/0000-0002-8697-7802; Tchesnokov, Egor Petrovitch/0000-0003-1698-2961; Gordon, Calvin/0000-0002-8259-6201	Canadian Institutes of Health Research (CIHR) [170343]; Gilead Sciences Grant; Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Gilead Sciences Grant(Gilead Sciences); Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium	This study was supported by Canadian Institutes of Health Research (CIHR) Grant 170343 (to M. G.); Gilead Sciences Grant (to M. G.); and Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR-One Health Consortium.	Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18; Bouvet M, 2012, P NATL ACAD SCI USA, V109, P9372, DOI 10.1073/pnas.1201130109; Brown AJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104541; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; Dulin D, 2017, CELL REP, V21, P1063, DOI 10.1016/j.celrep.2017.10.005; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056; Hillen HS, 2020, NATURE, V584, P154, DOI 10.1038/s41586-020-2368-8; Jordan PC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006889; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Lo MK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9242; Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395; Maag D, 2001, J BIOL CHEM, V276, P46094, DOI 10.1074/jbc.C100349200; Magee WC, 2008, ANTIMICROB AGENTS CH, V52, P586, DOI 10.1128/AAC.01172-07; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Peng Q, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107774; Pruijssers AJ, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107940; Seifert M., 2020, BIORXIV; Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653; Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594; Subissi L, 2014, P NATL ACAD SCI USA, V111, pE3900, DOI 10.1073/pnas.1323705111; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Tchesnokov EP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22328-3; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; U.S. FOOD & DRUG ADMIN, 2020, FDA GRANTS ACCELERAT, P2; Wang Q, 2020, CELL, V182, P417, DOI 10.1016/j.cell.2020.05.034; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839	33	67	67	5	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16156	16165		10.1074/jbc.AC120.015720	http://dx.doi.org/10.1074/jbc.AC120.015720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32967965	hybrid, Green Published			2022-12-26	WOS:000595657900028
J	Singh, AK; Nema, RK; Joshi, A; Shankar, P; Nema, S; Raghuwanshi, A; Patankar, C; Mathew, BJ; Shrivas, A; Pandey, R; Tripathi, R; Biswas, D; Singh, S				Singh, Anirudh K.; Nema, Ram Kumar; Joshi, Ankur; Shankar, Prem; Nema, Shashwati; Raghuwanshi, Arun; Patankar, Chitra; Mathew, Bijina J.; Shrivas, Arti; Pandey, Ritu; Tripathi, Ranu; Biswas, Debasis; Singh, Sarman			Evaluation of pooled sample analysis strategy in expediting case detection in areas with emerging outbreaks of COVID-19: A pilot study	PLOS ONE			English	Article							SENSITIVITY	Timely diagnosis of COVID-19 infected individuals and their prompt isolation are essential for controlling the transmission of SARS-CoV-2. Though quantitative reverse transcriptase PCR (qRT-PCR) is the method of choice for COVID-19 diagnostics, the resource-intensive and time-consuming nature of the technique impairs its wide applicability in resource-constrained settings and calls for novel strategies to meet the ever-growing demand for more testing. In this context, a pooled sample testing strategy was evaluated in the setting of emerging disease outbreak in 3 central Indian districts to assess if the cost of the test and turn-around time could be reduced without compromising its diagnostic characteristics and thus lead to early containment of the outbreak. From 545 nasopharyngeal and oropharyngeal samples received from the three emerging districts, a total of 109 pools were created with 5 consecutive samples in each pool. The diagnostic performance of qRT-PCR on pooled sample was compared with that of individual samples in a blinded manner. While pooling reduced the cost of diagnosis by 68% and the laboratory processing time by 66%, 5 of the 109 pools showed discordant results when compared with induvial samples. Four pools which tested negative contained 1 positive sample and 1 pool which was positive did not show any positive sample on deconvolution. Presence of a single infected sample with Ct value of 34 or higher, in a pool of 5, was likely to be missed in pooled sample analysis. At the reported point prevalence of 4.8% in this study, the negative predictive value of qRT-PCR on pooled samples was around 96% suggesting that the adoption of this strategy as an effective screening tool for COVID-19 needs to be carefully evaluated.	[Singh, Anirudh K.; Shankar, Prem; Nema, Shashwati; Patankar, Chitra; Mathew, Bijina J.; Shrivas, Arti; Biswas, Debasis; Singh, Sarman] All India Inst Med Sci, Dept Microbiol, Bhopal, Madhya Pradesh, India; [Nema, Ram Kumar; Raghuwanshi, Arun; Biswas, Debasis] All India Inst Med Sci, Reg Virol Lab, Bhopal, Madhya Pradesh, India; [Joshi, Ankur] All India Inst Med Sci, Dept Community & Family Med, Bhopal, Madhya Pradesh, India; [Pandey, Ritu] All India Inst Med Sci, Dept Biochem, Bhopal, Madhya Pradesh, India; [Tripathi, Ranu] All India Inst Med Sci, Dept Pediat, Bhopal, Madhya Pradesh, India	All India Institute of Medical Sciences (AIIMS) Bhopal; All India Institute of Medical Sciences (AIIMS) Bhopal; All India Institute of Medical Sciences (AIIMS) Bhopal; All India Institute of Medical Sciences (AIIMS) Bhopal; All India Institute of Medical Sciences (AIIMS) Bhopal	Biswas, D (corresponding author), All India Inst Med Sci, Dept Microbiol, Bhopal, Madhya Pradesh, India.; Biswas, D (corresponding author), All India Inst Med Sci, Reg Virol Lab, Bhopal, Madhya Pradesh, India.	debasis.microbiology@aiimsbhopal.edu.in	Singh, Sarman/AAR-8914-2020; Shankar, Dr Prem/AGR-0967-2022	Singh, Sarman/0000-0002-0749-9647; Shankar, Dr Prem/0000-0003-3087-0413; Reis, AlessanRSS/0000-0001-8486-7469				[Anonymous], 2020, JAMA; Arons MM, 2020, N ENGL J MED; Hogan C.A., 2020, JAMA; ICMR, 2020, ADV FEAS US POOL SAM; Lohse S, 2020, LANCET INFECT DIS, DOI 10.101651473-3099(20)30362-5; Munoz-Zanzi C, 2006, PREV VET MED, V74, P309, DOI 10.1016/j.prevetmed.2005.12.006; Rovira A, 2007, J VET DIAGN INVEST, V19, P502, DOI 10.1177/104063870701900507; WHO, 2020, COVID 19 STRAT UPD; Ye F, 2020, INT J INFECT DIS, V94, P133, DOI 10.1016/j.ijid.2020.03.042; Zhao S, 2020, INT J INFECT DIS, V94, P148, DOI 10.1016/j.ijid.2020.02.025	10	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239492	10.1371/journal.pone.0239492	http://dx.doi.org/10.1371/journal.pone.0239492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960929	gold, Green Published			2022-12-26	WOS:000575109500029
J	Kongsomros, S; Thanunchai, M; Manopwisedjaroen, S; Na-Ek, P; Wang, SF; Taechalertpaisarn, T; Thitithanyanont, A				Kongsomros, Supasek; Thanunchai, Maytawan; Manopwisedjaroen, Suwimon; Na-Ek, Prasit; Wang, Sheng-Fan; Taechalertpaisarn, Tana; Thitithanyanont, Arunee			Trogocytosis with monocytes associated with increased alpha 2,3 sialic acid expression on B cells during H5N1 influenza virus infection	PLOS ONE			English	Article							ANTIGEN; SUSCEPTIBILITY; MACROPHAGES; REPLICATION; LYMPHOCYTES; RESPONSES	The immunopathogenesis of H5N1 virus has been studied intensively since it caused cross-species infection and induced high mortality to human. We previously observed the interaction between monocytes and B cells, which increased the susceptibility of B cell to H5N1 virus infection after a co-culture. Levels of alpha 2,3 sialic acid (avian flu receptor) were also significantly increased on B cell surface in this co-culture model with unclear explanation. In this study, we aimed to determine the possible mechanism that responded for this increase in alpha 2,3 sialic acid on B cells. Acquisition of alpha 2,3 SA by B cells via cell contact-dependent trogocytosis was proposed. Results showed that the lack of alpha 2,3 SA was detected on B cell surface, and B cells acquired membrane-bound alpha 2,3 SA molecules from monocytes in H5N1-infected co-cultures. Occurrence of membrane exchange mainly relied on H5N1 infection and cell-cell contact as opposed to a mock infection and transwell. The increase in alpha 2,3 SA on B cell surface mediated by trogocytosis was associated with the enhanced susceptibility to H5N1 infection. These observations thus provide the evidence that H5N1 influenza virus may utilize trogocytosis to expand its cell tropism and spread to immune cells despite the lack of avian flu receptor.	[Kongsomros, Supasek; Manopwisedjaroen, Suwimon; Taechalertpaisarn, Tana; Thitithanyanont, Arunee] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Thanunchai, Maytawan] Navamindradhiraj Univ, Vajira Hosp, Fac Med, Dept Clin Pathol, Bangkok, Thailand; [Na-Ek, Prasit] Walailak Univ, Sch Med, Thasala, Nakhon Si Thamm, Thailand; [Wang, Sheng-Fan] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Sci, Kaohsiung, Taiwan	Mahidol University; Walailak University; Kaohsiung Medical University	Thitithanyanont, A (corresponding author), Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand.	arunee.thi@mahidol.ac.th	Thitithanyanont, Arunee/AAN-4383-2021; Wang, Sheng-Fan/ABA-7842-2020	Thitithanyanont, Arunee/0000-0002-9756-4763; Wang, Sheng-Fan/0000-0002-8142-4707; Wang, Sheng-Fan/0000-0002-4183-3872; Kongsomros, Supasek/0000-0001-7052-6495; Manopwisedjaroen, Suwimon/0000-0002-7571-8733; Na-Ek, Prasit/0000-0002-4976-3274	Thailand Research Fund [RSA6080088]; Ramathibodi Hospital-Faculty of Science, Mahidol University; Royal Golden Jubilee (RGJ) Ph.D. Program Scholarship from the Thailand Research Fund [PHD/0009/2558, RGJ 18];  [SC-RA2559-1]	Thailand Research Fund(Thailand Research Fund (TRF)); Ramathibodi Hospital-Faculty of Science, Mahidol University; Royal Golden Jubilee (RGJ) Ph.D. Program Scholarship from the Thailand Research Fund; 	This work was supported by The Thailand Research Fund (Grant number RSA6080088), Ramathibodi Hospital-Faculty of Science, Mahidol University joint funding; SC-RA2559-1 and The Royal Golden Jubilee (RGJ) Ph.D. Program Scholarship from the Thailand Research Fund (Grant No. PHD/0009/2558; RGJ 18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucher A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/907371; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; BONA C, 1973, IMMUNOLOGY, V24, P831; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Daubeuf S, 2010, J IMMUNOL, V184, P1897, DOI 10.4049/jimmunol.0901570; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Harvey BP, 2014, MOL IMMUNOL, V58, P56, DOI 10.1016/j.molimm.2013.10.013; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791; Kumlin U, 2008, INFLUENZA OTHER RESP, V2, P147, DOI 10.1111/j.1750-2659.2008.00051.x; Lee ACY, 2017, J GEN VIROL, V98, P922, DOI 10.1099/jgv.0.000751; Lersritwimanmaen P, 2015, BIOCHEM BIOPH RES CO, V464, P888, DOI 10.1016/j.bbrc.2015.07.061; Li YG, 2008, BIOCHEM BIOPH RES CO, V371, P484, DOI 10.1016/j.bbrc.2008.04.123; Liu Y, 2011, LABMEDICINE, V42, P310, DOI 10.1309/LMNSG3BK6GVTDAK1; Mao HW, 2017, VIROL SIN, V32, P122, DOI 10.1007/s12250-016-3918-y; Martinez-Riano A, 2018, EMBO REP, V19, DOI 10.15252/embr.201846016; Na-Ek P, 2017, BIOCHEM BIOPH RES CO, V490, P1301, DOI 10.1016/j.bbrc.2017.07.017; Organization W.H., 2018, CUMULATIVE NUMBER OF; Osborne DG, 2012, J IMMUNOL, V189, P4728, DOI 10.4049/jimmunol.1201507; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Steele S, 2016, ELIFE, V5, DOI 10.7554/eLife.10625; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Tabiasco J, 2003, J IMMUNOL, V170, P5993, DOI 10.4049/jimmunol.170.12.5993; Thitithanyanont A, 2007, J IMMUNOL, V179, P5220, DOI 10.4049/jimmunol.179.8.5220; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2010, AM J PATHOL, V176, P1614, DOI 10.2353/ajpath.2010.090949; Venkatachari NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007470; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10	32	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239488	10.1371/journal.pone.0239488	http://dx.doi.org/10.1371/journal.pone.0239488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946496	Green Published, gold			2022-12-26	WOS:000573851100024
J	Methe, BA; Hiltbrand, D; Roach, J; Xu, WW; Gordon, SG; Goodner, BW; Stapleton, AE				Methe, Barbara A.; Hiltbrand, David; Roach, Jeffrey; Xu, Wenwei; Gordon, Stuart G.; Goodner, Brad W.; Stapleton, Ann E.			Functional gene categories differentiate maize leaf drought-related microbial epiphytic communities	PLOS ONE			English	Article							PLANT; DIVERSITY; GENOME	The phyllosphere epiphytic microbiome is composed of microorganisms that colonize the external aerial portions of plants. Relationships of plant responses to specific microorganisms-both pathogenic and beneficial-have been examined, but the phyllosphere microbiome functional and metabolic profile responses are not well described. Changing crop growth conditions, such as increased drought, can have profound impacts on crop productivity. Also, epiphytic microbial communities provide a new target for crop yield optimization. We comparedZea maysleaf microbiomes collected under drought and well-watered conditions by examining functional gene annotation patterns across three physically disparate locations each with and without drought treatment, through the application of short read metagenomic sequencing. Drought samples exhibited different functional sequence compositions at each of the three field sites. Maize phyllosphere functional profiles revealed a wide variety of metabolic and regulatory processes that differed in drought and normal water conditions and provide key baseline information for future selective breeding.	[Methe, Barbara A.] J Craig Venter Inst, Med Ctr Dr, Rockville, MD USA; [Methe, Barbara A.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Hiltbrand, David; Stapleton, Ann E.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA; [Roach, Jeffrey] Univ N Carolina, Res Comp, Chapel Hill, NC 27515 USA; [Xu, Wenwei] Texas A&M AgriLife Res, Agr & Extens Ctr, Lubbock, TX USA; [Gordon, Stuart G.] Presbyterian Coll, Biol Dept, Clinton, SC USA; [Goodner, Brad W.] Hiram Coll, Hiram, OH USA	J. Craig Venter Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Wilmington; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Hiram College	Stapleton, AE (corresponding author), Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28403 USA.	stapletona@uncw.edu		Stapleton, Ann/0000-0001-7242-2673	National Science Foundation [1126938]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. 1126938 to AES and BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bringel F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00486; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Choudhary DK, 2011, BIOTECHNOL LETT, V33, P1905, DOI 10.1007/s10529-011-0662-0; Churchland C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00261; Compant S, 2019, J ADV RES, V19, P29, DOI 10.1016/j.jare.2019.03.004; Copeland JK, 2015, MOL PLANT MICROBE IN, V28, P274, DOI 10.1094/MPMI-10-14-0331-FI; Orozco-Mosqueda MD, 2018, MICROBIOL RES, V208, P25, DOI 10.1016/j.micres.2018.01.005; Doolittle WF, 2018, P NATL ACAD SCI USA, V115, P4006, DOI 10.1073/pnas.1722232115; Forneris NS, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0340-3; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; Howden AJM, 2009, MICROB BIOTECHNOL, V2, P441, DOI 10.1111/j.1751-7915.2009.00111.x; Jiao YP, 2017, NATURE, V546, P524, DOI 10.1038/nature22971; Kell DB, 1998, ANTON LEEUW INT J G, V73, P169, DOI 10.1023/A:1000664013047; Kelly LW, 2014, P NATL ACAD SCI USA, V111, P10227, DOI 10.1073/pnas.1403319111; Kerdraon L, 2019, ARXIV190302246QBIO; Knief C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00216; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Langmead B, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1290-3; Leach JE, 2017, CELL, V169, P587, DOI 10.1016/j.cell.2017.04.025; Luziatelli F, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00060; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Methe BA, 2013, CURR OPIN MICROBIOL, V16, P602, DOI 10.1016/j.mib.2013.10.002; Mine A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00423; Morella NM, 2019, SUCCESSIVE PASSAGING, DOI [10.1101/627794, DOI 10.1101/627794]; Muller C, 2005, J CHEM ECOL, V31, P2621, DOI 10.1007/s10886-005-7617-7; Parnell JJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01110; Perez-Enciso M, 2017, GENETICS, V205, P939, DOI 10.1534/genetics.116.194878; Phieler R, 2014, ADV BIOCHEM ENG BIOT, V141, P211, DOI 10.1007/10_2013_200; Pookhao N, 2015, BIOINFORMATICS, V31, P158, DOI 10.1093/bioinformatics/btu635; Rajendhran J, 2011, MICROBIOL RES, V166, P99, DOI 10.1016/j.micres.2010.02.003; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Remus-Emsermann MNP, 2018, NEW PHYTOL, V218, P1327, DOI 10.1111/nph.15054; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schlechter RO, 2019, J ADV RES, V19, P57, DOI 10.1016/j.jare.2019.03.003; Schmidhuber J, 2007, P NATL ACAD SCI USA, V104, P19703, DOI 10.1073/pnas.0701976104; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Vacher C, 2016, ANNU REV ECOL EVOL S, V47, P1, DOI 10.1146/annurev-ecolsys-121415-032238; Van P., 2009, J STAT MECH THEORY E, V2009, pP0254; Vorholt JA, 2017, CELL HOST MICROBE, V22, P142, DOI 10.1016/j.chom.2017.07.004; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Wallace J.G., 2018, BIORXIV, DOI [10.1101/268532, DOI 10.1101/268532]; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang CY, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0387-9	51	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0237493	10.1371/journal.pone.0237493	http://dx.doi.org/10.1371/journal.pone.0237493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946440	Green Submitted, Green Published, gold			2022-12-26	WOS:000573851100077
J	Pruteanu, LL; Kopanitsa, L; Modos, D; Kletnieks, E; Samarova, E; Bender, A; Gomez, LD; Bailey, DS				Pruteanu, Lavinia-Lorena; Kopanitsa, Liliya; Modos, Dezso; Kletnieks, Edgars; Samarova, Elena; Bender, Andreas; Gomez, Leonardo Dario; Bailey, David Stanley			Transcriptomics predicts compound synergy in drug and natural product treated glioblastoma cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; CENTRAL-NERVOUS-SYSTEM; DEACETYLATED PRODUCT; FUCOXANTHINOL; PATHWAY; GLIOMA; INHIBITORS; EXPRESSION; DISCOVERY; PI3K/MTOR	Pathway analysis is an informative method for comparing and contrasting drug-induced gene expression in cellular systems. Here, we define the effects of the marine natural product fucoxanthin, separately and in combination with the prototypic phosphatidylinositol 3-kinase (PI3K) inhibitor LY-294002, on gene expression in a well-established human glioblastoma cell system, U87MG. Under conditions which inhibit cell proliferation, LY-294002 and fucoxanthin modulate many pathways in common, including the retinoblastoma, DNA damage, DNA replication and cell cycle pathways. In sharp contrast, we see profound differences in the expression of genes characteristic of pathways such as apoptosis and lipid metabolism, contributing to the development of a differentiated and distinctive drug-induced gene expression signature for each compound. Furthermore, in combination, fucoxanthin synergizes with LY-294002 in inhibiting the growth of U87MG cells, suggesting complementarity in their molecular modes of action and pointing to further treatment combinations. The synergy we observe between the dietary nutraceutical fucoxanthin and the synthetic chemical LY-294002 in producing growth arrest in glioblastoma, illustrates the potential of nutri-pharmaceutical combinations in targeting this challenging disease.	[Pruteanu, Lavinia-Lorena; Kopanitsa, Liliya; Samarova, Elena; Bailey, David Stanley] IOTA Pharmaceut Ltd, St Johns Innovat Ctr, Cambridge, England; [Modos, Dezso; Kletnieks, Edgars; Bender, Andreas] Univ Cambridge, Ctr Mol Informat, Dept Chem, Cambridge, England; [Gomez, Leonardo Dario] Univ York, Ctr Novel Agr Prod, Dept Biol, York, N Yorkshire, England	St Johns Innovation Centre - UK; University of Cambridge; University of York - UK	Pruteanu, LL; Bailey, DS (corresponding author), IOTA Pharmaceut Ltd, St Johns Innovat Ctr, Cambridge, England.	lavinia.pruteanu@iotapharma.com; david.bailey@iotapharma.com	Modos, Dezso/AAM-4734-2021; Lavinia, Pruteanu/AAE-6853-2022; Módos, Dezső/H-3056-2019; Bender, Andreas/C-6942-2009	Módos, Dezső/0000-0001-9412-6867; Bender, Andreas/0000-0002-6683-7546; Pruteanu, Lavinia/0000-0001-8277-1113; Bailey, David/0000-0002-9343-3408; Kopanitsa, Liliya/0000-0002-3752-2887; Kletnieks, Edgars/0000-0002-3735-7623; Gomez, Leonardo Dario/0000-0001-6382-9447	Brain Tumour Charity (UK) as part of the WINDOW Consortium [GN-000429]; European Union Horizon 2020 Framework Programme for Research and Innovation (2014-2020), EC Grant [727892]; Solyom Laszlo Scholarship	Brain Tumour Charity (UK) as part of the WINDOW Consortium; European Union Horizon 2020 Framework Programme for Research and Innovation (2014-2020), EC Grant; Solyom Laszlo Scholarship	L.L.P, D.S.B were funded by the Brain Tumour Charity (UK) as part of the WINDOW Consortium, Grant number GN-000429, and L.K., L.D.G., D.S.B. were funded by European Union Horizon 2020 Framework Programme for Research and Innovation (2014-2020), EC Grant Agreement Number 727892. MD is funded by a Solyom Laszlo Scholarship.	Abdul KU, 2018, DRUG RESIST UPDATE, V40, P17, DOI 10.1016/j.drup.2018.10.001; Afzal S, 2019, MAR DRUGS, V17, DOI 10.3390/md17030189; Alexander-Dann B, 2018, MOL OMICS, V14, P218, DOI 10.1039/c8mo00042e; Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; Antitumor Satomi Y., 2017, ANTICANCER RES, V37, P1557, DOI [10.21873/anticanres.11484, DOI 10.21873/ANTICANRES.11484]; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Asai A, 2004, DRUG METAB DISPOS, V32, P205, DOI 10.1124/dmd.32.2.205; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartalucci N, 2013, J CELL MOL MED, V17, P1385, DOI 10.1111/jcmm.12162; Batash R, 2017, CURR MED CHEM, V24, P3002, DOI 10.2174/0929867324666170516123206; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Britt EL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219398; Buzdin A, 2018, SEMIN CANCER BIOL, V53, P110, DOI 10.1016/j.semcancer.2018.06.003; Cerrato JA, 2001, NEURO-ONCOLOGY, V3, P113, DOI 10.1093/neuonc/3.2.113; Chen LC, 2012, MOL MED REP, V5, P575, DOI 10.3892/mmr.2011.674; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dembitsky VM, 2007, PROG LIPID RES, V46, P328, DOI 10.1016/j.plipres.2007.07.001; Di Paolo C, 2018, ENVIRON SCI POLLUT R, V25, P4012, DOI 10.1007/s11356-017-8790-2; Di Veroli GY, 2016, BIOINFORMATICS, V32, P2866, DOI 10.1093/bioinformatics/btw230; Ding J, 2019, GYNECOL ONCOL, V153, P165, DOI 10.1016/j.ygyno.2019.01.010; Engstrom PG, 2012, GENOME MED, V4, DOI 10.1186/gm377; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Galasso C, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040096; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; Haage V, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0665-y; Hsu JBK, 2019, BMC MED GENOMICS, V11, DOI 10.1186/s12920-019-0479-6; Huang CT, 2019, ISCIENCE, V15, P291, DOI 10.1016/j.isci.2019.04.039; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishikawa C, 2008, INT J CANCER, V123, P2702, DOI 10.1002/ijc.23860; Jang EJ, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2164-2; Kanno H, 2013, INT J ONCOL, V42, P881, DOI 10.3892/ijo.2013.1773; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kohl M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-583; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Kulkarni S, 2018, MOL CANCER RES, V16, P103, DOI 10.1158/1541-7786.MCR-17-0146; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Lenting K, 2017, ACTA NEUROPATHOL, V133, P263, DOI 10.1007/s00401-017-1671-4; Li Y, 2018, ONCOTARGET, V9, P2158, DOI 10.18632/oncotarget.23187; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu Y, 2017, ONCOTARGET, V8, P7181, DOI 10.18632/oncotarget.12742; Liu YG, 2016, NEUROCHEM RES, V41, P2728, DOI 10.1007/s11064-016-1989-7; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Ma XF, 1997, MOL PHARMACOL, V51, P69, DOI 10.1124/mol.51.1.69; Martin LJ, 2015, MAR DRUGS, V13, P4784, DOI 10.3390/md13084784; Mbaveng AT, 2019, J ETHNOPHARMACOL, V235, P28, DOI 10.1016/j.jep.2019.01.031; Meyer CT, 2020, TRENDS PHARMACOL SCI, V41, P266, DOI 10.1016/j.tips.2020.01.011; Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111; Moffat JG, 2014, NAT REV DRUG DISCOV, V13, P588, DOI 10.1038/nrd4366; Mokhtari RB, 2017, ONCOTARGET, V8, P38022, DOI 10.18632/oncotarget.16723; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Morton SW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005261; Ostrom QT, 2017, NEURO-ONCOLOGY, V19, pV1, DOI 10.1093/neuonc/nox158; Panossian A, 2018, PHYTOMEDICINE, V50, P257, DOI 10.1016/j.phymed.2018.09.204; Pearson JRD, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.40; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pridham KJ, 2018, NEURO-ONCOLOGY, V20, P494, DOI 10.1093/neuonc/nox181; Pridham KJ, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00312; Prince LR, 2017, BLOOD, V130, P1014, DOI 10.1182/blood-2017-03-770164; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rokkaku T, 2013, INT J ONCOL, V43, P1176, DOI 10.3892/ijo.2013.2019; Sangeetha RK, 2009, MOL CELL BIOCHEM, V331, P59, DOI 10.1007/s11010-009-0145-y; Song K, 2018, AM J CANCER RES, V8, P792; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svensson F, 2018, NEURO-ONCOLOGY, V20, P1680, DOI 10.1093/neuonc/noy122; Szymanska J, 2015, ADV CLIN EXP MED, V24, P195, DOI 10.17219/acem/32934; Tasian SK, 2017, BLOOD, V129, P177, DOI 10.1182/blood-2016-05-707653; Terasaki M, 2018, ONCOL REP, V40, P414, DOI 10.3892/or.2018.6398; Terasaki M, 2017, J CLIN BIOCHEM NUTR, V61, P25, DOI 10.3164/jcbn.16-112; Tukey JW, ESTIMATORS PRINCETON; Tuncbag N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28668; Vlot AHC, 2019, DRUG DISCOV TODAY, V24, P2286, DOI 10.1016/j.drudis.2019.09.002; Yang J, 2019, MOL THER-NUCL ACIDS, V18, P1, DOI 10.1016/j.omtn.2019.08.003; Ye G., 2018, BJSTR, P9, DOI [10.26717/BJSTR.2018.09.001819, DOI 10.26717/BJSTR.2018.09.001819]; Zanders ED, 2019, DRUG DISCOV TODAY, V24, P1193, DOI 10.1016/j.drudis.2019.03.008; Zhao HF, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0670-3	81	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239551	10.1371/journal.pone.0239551	http://dx.doi.org/10.1371/journal.pone.0239551			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946518	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000573851100078
J	Zhu, H; He, CS; Zhao, HZ; Jiang, WJ; Xu, SB; Li, J; Ma, TT; Huang, C				Zhu, Hong; He, Changsheng; Zhao, Huizi; Jiang, Wenjuan; Xu, Songbing; Li, Jun; Ma, Taotao; Huang, Cheng			Sennoside A prevents liver fibrosis by binding DNMT1 and suppressing DNMT1-mediated PTEN hypermethylation in HSC activation and proliferation	FASEB JOURNAL			English	Article						DNMT1; epigenetic; hepatic stellate cell; liver fibrosis; PTEN; Sennoside A	HEPATIC STELLATE CELLS; DNA METHYLATION; RAT-LIVER; APOPTOSIS; INACTIVATION; FIBROGENESIS; PHOSPHATASE; MECHANISMS; EXPRESSION; CANCER	Hepatic stellate cell (HSC) activation is an essential event during liver fibrogenesis. Phosphatase and tension homolog deleted on chromosome 10 (PTEN) is a negative regulator of this process. DNA methyltransferase 1 (DNMT1), which catalyzes DNA methylation and subsequently leads to the transcriptional repression of PTEN, is selectively induced in myofibroblasts from diseased livers. Sennoside A (SA), a major purgative constituent of senna and the Chinese herb rhubarb, is widely used in China and other Asian countries as an irritant laxative. SA is reported to improve hepatic steatosis. However, the effect and mechanism of SA on liver fibrosis remain largely unknown. We recently identified a novel strategy for protecting liver fibrosis via epigenetic modification by targeting DNMT1. A Surface Plasmon Resonance (SPR) assay first reported that SA could directly bind DNMT1 and inhibit its activity. Administration of SA significantly prevented liver fibrosis, as evidenced by the dramatic downregulation of alpha-smooth muscle actin (alpha-SMA) and type I collagen alpha-1 (Col1 alpha 1) protein levels in a CCl4-induced mouse hepatic fibrosis model and in TGF-beta 1-activated HSC-T6 cells, in vivo and in vitro. SA decreased the expression of Cyclin D1, CDK, and C-myc, indicating that SA may inhibit the activation and proliferation of TGF-beta 1-induced HSC-T6. Moreover, SA significantly promoted the expression of PTEN and remarkably inhibited the expression of p-AKT and p-ERK in vitro. Blocking PTEN or overexpressing DNMT1 could reduce the effect of SA on liver fibrosis. These data suggest that SA directly binds and inhibits the activity and that attenuated DNMT1-mediated PTEN hypermethylation caused the loss of PTEN expression, followed by the inhibition of the AKT and ERK pathways and prevented the development of liver fibrosis. Hence, SA might be employed as a promising natural supplement for liver fibrosis drug therapy.	[Zhu, Hong; He, Changsheng; Zhao, Huizi; Jiang, Wenjuan; Xu, Songbing; Li, Jun; Ma, Taotao; Huang, Cheng] Anhui Med Univ, Anhui Prov Lab Inflammatory & Immun Dis, Anhui Inst Innovat Drugs, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China	Anhui Medical University	Ma, TT; Huang, C (corresponding author), Anhui Med Univ, Anhui Prov Lab Inflammatory & Immun Dis, Anhui Inst Innovat Drugs, Sch Pharm, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.	mataotao@ahmu.edu.cn; huangcheng@ahmu.edu.cn		Jiang, Wenjuan/0000-0002-8430-556X	National Science Foundation of China [0601011138]; Anhui Provincal Universities Natural Science Foundation [KJ2019A0233]; University Synergy Innovation Progrma of Anhui Province [GXXT-2019045]; National Science Foundation of Anhui Province [2008085MH273]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincal Universities Natural Science Foundation; University Synergy Innovation Progrma of Anhui Province; National Science Foundation of Anhui Province	The National Science Foundation of China, Grant/Award Number: 0601011138; Anhui Provincal Universities Natural Science Foundation, Grant/Award Number: KJ2019A0233; The University Synergy Innovation Progrma of Anhui Province, Grant/Award Number: GXXT-2019045; National Science Foundation of Anhui Province, Grant/Award Number: 2008085MH273	Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bian EB, 2012, TOXICOL APPL PHARM, V264, P13, DOI 10.1016/j.taap.2012.06.022; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Boyanapalli SSS, 2016, PHARMACOL RES, V114, P175, DOI 10.1016/j.phrs.2016.10.021; Butler DE, 2017, ONCOTARGET, V8, P56698, DOI 10.18632/oncotarget.18082; Cao YX, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103210; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Choi SB, 2006, LIFE SCI, V78, P934, DOI 10.1016/j.lfs.2005.05.101; Duran A, 2016, CANCER CELL, V30, P595, DOI 10.1016/j.ccell.2016.09.004; Feng J, 2009, INT REV NEUROBIOL, V89, P67, DOI 10.1016/S0074-7742(09)89004-1; Ferguson LR, 2011, CURR CANCER DRUG TAR, V11, P199; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Giannitrapani L, 2014, WORLD J GASTROENTERO, V20, P7242, DOI 10.3748/wjg.v20.i23.7242; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hong L, 2015, J CELL MOL MED, V19, P2462, DOI 10.1111/jcmm.12636; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Ismail Mona H, 2009, Saudi J Gastroenterol, V15, P72, DOI 10.4103/1319-3767.45072; Karvar S, 2020, HEPATOLOGY, V72, P1073, DOI 10.1002/hep.31078; Khomich O, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010024; Kim IH, 2012, EXP MOL MED, V44, P448, DOI 10.3858/emm.2012.44.7.051; Kisseleva T, 2013, CELL CYCLE, V12, P381, DOI 10.4161/cc.23549; Kobayashi M, 2007, BASIC CLIN PHARMACOL, V101, P121, DOI 10.1111/j.1742-7843.2007.00088.x; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Le JM, 2019, ACTA PHARM SIN B, V9, P758, DOI 10.1016/j.apsb.2019.01.014; Le JM, 2018, BIOCHEM BIOPH RES CO, V500, P484, DOI 10.1016/j.bbrc.2018.04.108; Lee JH, 2019, FORENSIC SCI INT, V303, DOI 10.1016/j.forsciint.2019.109932; LENGPESCHLOW E, 1986, J PHARM PHARMACOL, V38, P606, DOI 10.1111/j.2042-7158.1986.tb03089.x; Liu YD, 2020, J CANCER, V11, P488, DOI 10.7150/jca.31422; Massey V, 2017, SEMIN LIVER DIS, V37, P219, DOI 10.1055/s-0037-1605371; Mohammad Amro H, 2019, Oncotarget, V10, P4923, DOI 10.18632/oncotarget.27075; Movassaghi S, 2013, IRAN J BASIC MED SCI, V16, P922; Omar R, 2016, REV PHYSIOL BIOCH P, V172, P1, DOI 10.1007/112_2016_6; Pan XY, 2019, THERANOSTICS, V9, P4308, DOI 10.7150/thno.32710; Pitha-Rowe I, 2009, INVEST OPHTH VIS SCI, V50, P5339, DOI 10.1167/iovs.09-3648; Ramachandran P, 2009, ANN HEPATOL, V8, P283, DOI 10.1016/S1665-2681(19)31740-5; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Sha M, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106157; Sun X, 2013, CELL SIGNAL, V25, P1870, DOI 10.1016/j.cellsig.2013.05.013; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Wu YT, 2017, TOXICOL APPL PHARM, V315, P35, DOI 10.1016/j.taap.2016.12.002; Xiang N, 2008, CARCINOGENESIS, V29, P2175, DOI 10.1093/carcin/bgn179; Xu WT, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0795-2; Yang JA, 2015, ACTA BIOMATER, V12, P174, DOI 10.1016/j.actbio.2014.10.002; Yang JJ, 2013, CELL SIGNAL, V25, P1202, DOI 10.1016/j.cellsig.2013.01.005; Yang Z, 2015, ONCOTARGET, V6, P31916, DOI 10.18632/oncotarget.5577; Yu FJ, 2015, J CELL MOL MED, V19, P2617, DOI 10.1111/jcmm.12655; Zhang A, 2020, BIOCH BIOPHYS RES CO; Zheng JJ, 2014, FEBS J, V281, P88, DOI 10.1111/febs.12574; Zhu XB, 2019, ANN RHEUM DIS, V78, P1420, DOI 10.1136/annrheumdis-2018-214940	52	9	9	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14558	14571		10.1096/fj.202000494RR	http://dx.doi.org/10.1096/fj.202000494RR		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32946656				2022-12-26	WOS:000572281600001
J	Shiwei, N; Dritsas, S; Fernandez, JG				Shiwei, Ng; Dritsas, Stylianos; Fernandez, Javier G.			Martian biolith: A bioinspired regolith composite for closed-loop extraterrestrial manufacturing	PLOS ONE			English	Article							MARS	Given plans to revisit the lunar surface by the late 2020s and to take a crewed mission to Mars by the late 2030s, critical technologies must mature. In missions of extended duration, in situ resource utilization is necessary to both maximize scientific returns and minimize costs. While this present a significantly more complex challenge in the resource-starved environment of Mars, it is similar to the increasing need to develop resource-efficient and zero-waste ecosystems on Earth. Here, we make use of recent advances in the field of bioinspired chitinous manufacturing to develop a manufacturing technology to be used within the context of a minimal, artificial ecosystem that supports humans in a Martian environment.	[Shiwei, Ng; Fernandez, Javier G.] Singapore Univ Technol & Design, Engn Prod Dev Dept, Singapore, Singapore; [Dritsas, Stylianos] Singapore Univ Technol & Design, Architecture & Sustainable Design Dept, Singapore, Singapore	Singapore University of Technology & Design; Singapore University of Technology & Design	Fernandez, JG (corresponding author), Singapore Univ Technol & Design, Engn Prod Dev Dept, Singapore, Singapore.	javier.fernandez@sutd.edu.sg	Fernandez, Javier/ABF-1713-2020	Fernandez, Javier/0000-0003-2961-6506; , Shiwei/0000-0002-2806-5610	Singaporean Ministry of Education [MOE2018-T2-2-176]	Singaporean Ministry of Education(Ministry of Education, Singapore)	This research has been supported by the Singaporean Ministry of Education (https://www.moe.gov.sg/) through the MOE2018-T2-2-176 grant to JGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, HUMAN EXPLORATION MA; Araghi K, 2015, MARS ISRU PRODUCTION; Banks IJ, 2014, TROP MED INT HEALTH, V19, P14, DOI 10.1111/tmi.12228; Britt D, 2019, NEW SPACE, DOI DOI 10.1089/space.2019.0018; Chen T, 2018, ADV SPACE RES, V61, P830, DOI 10.1016/j.asr.2017.10.050; Chow BJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01157-w; El N, 2017, PHYS MED BIOL, V62, pR179; Fernandez JG, 2014, MACROMOL MATER ENG, V299, P932, DOI 10.1002/mame.201300426; Fikes J, 2019, SITU PRODUCTION CEME; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Jakus A, 2017, ROBUST ELASTIC LUNAR; Jakus A.E., 2017, SCI REP, V7, P1; Menezes AA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0803; Menezes AA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0715; Nangle SN, 2020, NAT BIOTECHNOL, V38, P401, DOI 10.1038/s41587-020-0485-4; Nelson M, 2010, CLOSED ECOLOGICAL SY; Norcross Jason, 2013, NASATM2013217377 CTR; Paoletti MG, 2007, ANN NUTR METAB, V51, P244, DOI 10.1159/000104144; Rivera-Rosario HT, 2017, NASATM2017219475 GLE; Rothschild LJ, 2016, BIOCHEM SOC T, V44, P1158, DOI 10.1042/BST20160067; Sanandiya ND, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61664-1; Sanandiya ND, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26985-2; Snyder JE, 2019, TRENDS BIOTECHNOL, V37, P1164, DOI 10.1016/j.tibtech.2019.05.003; Wan L, 2016, CONSTR BUILD MATER, V120, P222, DOI 10.1016/j.conbuildmat.2016.05.046; WELINDER BS, 1974, COMP BIOCHEM PHYSIOL, V47, P779, DOI 10.1016/0300-9629(74)90037-1; WHARTON DA, 1978, TISSUE CELL, V10, P427, DOI 10.1016/S0040-8166(16)30338-X; [No title captured]	27	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238606	10.1371/journal.pone.0238606	http://dx.doi.org/10.1371/journal.pone.0238606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936806	Green Published, gold			2022-12-26	WOS:000573658000031
J	Zeng, XX; Niu, YY; Qin, GC; Zhang, DK; Zhou, JY; Chen, LX				Zeng, Xiaoxu; Niu, Yingying; Qin, Guangcheng; Zhang, Dunke; Zhou, Jiying; Chen, Lixue			Deficiency in the function of inhibitory interneurons contributes to glutamate-associated central sensitization through GABABR2-SynCAM1 signaling in chronic migraine rats	FASEB JOURNAL			English	Article						c-Fos; CGRP; glutamate; PAG; PKA	GENE-RELATED PEPTIDE; MECHANICAL HYPERALGESIA; NEUROPATHIC PAIN; RECEPTOR; ACTIVATION; ANTINOCICEPTION; INVOLVEMENT; NOCICEPTION; PATHWAY; MODEL	The occurrence of pain has always been closely related to a break in the balance between excitatory and inhibitory systems, and the internal relationship between these two systems has not been studied in the pathogenesis of chronic migraine (CM). In this study, we explored how inhibitory interneurons specifically modulate the glutamate-induced hyperexcitability in the periaqueductal gray (PAG) of CM rats. The CM model was established by repeated dural infusion of inflammatory soup (IS) in rats. Then, Baclofen, a gamma-aminobutyric acid type B receptor (GABABR) agonist; CGP35348, a GABABR antagonist; H89, a protein kinase A (PKA) inhibitor; and 8-Bromo-cAMP, a PKA agonist, were applied by intraventricular injection to investigate the detailed CM mechanism. Our results showed that GABABR2 mRNA and protein levels were significantly downregulated (P < .01) in the PAG of CM rats. Similarly, gamma-aminobutyric acid (GABA) and its synthetase glutamate decarboxylase 65/67 (GAD65/67) seriously decreased (P < .01), implying a deficit in the function of inhibitory interneurons in the PAG of CM rats. Afterward, the application of Baclofen and H89 alleviated the IS-evoked hyperalgesia and extenuated vesicular glutamate transporter 2 (VGLUT2), glutamate, calcitonin gene-related peptide (CGRP), and c-Fos expression by regulating the GABABR2/PKA/SynCAM1 pathway in the PAG of CM rats, while the application of CGP35348 and 8-Bromo-cAMP exactly exerted the opposite effect. Importantly, CGP35348 induced an elevation of CGRP, and VGLUT2 expression was relieved by H89. These data suggest that the loss in the function of inhibitory interneurons contributes to glutamate-associated central sensitization through the GABABR2/PKA/SynCAM1 pathway in the PAG of CM rats.	[Zeng, Xiaoxu; Niu, Yingying; Qin, Guangcheng; Zhang, Dunke; Chen, Lixue] Chongqing Med Univ, Lab Res Ctr, Affiliated Hosp 1, 1st You Yi Rd, Chongqing 400016, Peoples R China; [Zhou, Jiying] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, LX (corresponding author), Chongqing Med Univ, Lab Res Ctr, Affiliated Hosp 1, 1st You Yi Rd, Chongqing 400016, Peoples R China.	chenlixue@hospital.cqmu.edu.cn			National Natural Science Foundation of China (NSFC) [81671093]; District Science and Technology Projects of Yuzhong Chongqing [20160107]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); District Science and Technology Projects of Yuzhong Chongqing	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671093; District Science and Technology Projects of Yuzhong Chongqing, Grant/Award Number: 20160107	Bagley EE, 2020, NEUROPHARMACOLOGY, V173, DOI 10.1016/j.neuropharm.2020.108131; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Booker SA, 2018, CELL REP, V22, P36, DOI 10.1016/j.celrep.2017.12.021; Booker SA, 2013, J NEUROSCI, V33, P7961, DOI 10.1523/JNEUROSCI.1186-12.2013; Cervo L, 1997, BRAIN RES, V775, P30, DOI 10.1016/S0006-8993(97)00866-4; Chen HS, 2008, PAIN, V135, P31, DOI 10.1016/j.pain.2007.04.040; Dodick DW, 2018, LANCET, V391, P1315, DOI 10.1016/S0140-6736(18)30478-1; Edvinsson L, 2001, CNS DRUGS, V15, P745, DOI 10.2165/00023210-200115100-00001; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; Ferrari MD, 2019, LANCET, V394, P1030, DOI 10.1016/S0140-6736(19)31946-4; Fogel AI, 2007, J NEUROSCI, V27, P12516, DOI 10.1523/JNEUROSCI.2739-07.2007; Frangaj A, 2018, NEUROPHARMACOLOGY, V136, P68, DOI 10.1016/j.neuropharm.2017.10.011; Gassmann M, 2012, NAT REV NEUROSCI, V13, P380, DOI 10.1038/nrn3249; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Gwak YS, 2006, J NEUROTRAUM, V23, P1111, DOI 10.1089/neu.2006.23.1111; Hang LH, 2013, PHARMACOL REP, V65, P710, DOI 10.1016/S1734-1140(13)71049-1; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harris JA, 1998, BRAIN RES BULL, V45, P1, DOI 10.1016/S0361-9230(97)00277-3; He W, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1459-7; Hoy JL, 2009, MOL CELL NEUROSCI, V42, P466, DOI 10.1016/j.mcn.2009.09.010; Huang ZJ, 2012, PAIN, V153, P1426, DOI 10.1016/j.pain.2012.03.025; Ibrahimi K, 2014, MATURITAS, V78, P277, DOI 10.1016/j.maturitas.2014.05.018; Ipponi A, 1999, EUR J PHARMACOL, V368, P205, DOI 10.1016/S0014-2999(99)00034-5; Iyengar S, 2017, PAIN, V158, P543, DOI 10.1097/j.pain.0000000000000831; Jia ZH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04060-6; KEHNE JH, 1987, BRAIN RES, V406, P87, DOI 10.1016/0006-8993(87)90771-2; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; Kou ZZ, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00025; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Laffray S, 2012, EMBO J, V31, P3239, DOI 10.1038/emboj.2012.161; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lazarus MS, 2015, CEREB CORTEX, V25, P1290, DOI 10.1093/cercor/bht322; Leung LS, 2005, EPILEPSIA, V46, P203, DOI 10.1111/j.0013-9580.2005.35804.x; Liu YQ, 2019, BIOCHEM BIOPH RES CO, V520, P449, DOI 10.1016/j.bbrc.2019.10.044; Long T, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1285-3; Mathew NT, 2011, HEADACHE, V51, P84, DOI 10.1111/j.1526-4610.2011.01955.x; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Melo-Carrillo A, 2013, CEPHALALGIA, V33, P1096, DOI 10.1177/0333102413486320; Miletic G, 2002, PAIN, V99, P493, DOI 10.1016/S0304-3959(02)00242-7; Mitsikostas DD, 2011, J HEADACHE PAIN, V12, P411, DOI 10.1007/s10194-011-0352-2; Oshinsky ML, 2007, HEADACHE, V47, P1026, DOI 10.1111/j.1526-4610.2007.00871.x; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Romero-Reyes M, 2013, CEPHALALGIA, V33, P566, DOI 10.1177/0333102412472557; Shafizadeh M, 1997, GEN PHARMACOL-VASC S, V28, P611, DOI 10.1016/S0306-3623(96)00241-8; Shao XM, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5320641; Silva AP, 2007, FASEB J, V21, P671, DOI 10.1096/fj.06-6163com; Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0; Tajti J, 2015, NEUROPEPTIDES, V52, P19, DOI 10.1016/j.npep.2015.03.006; Vergassola M, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00324; Wan D, 2016, EUR J PHARMACOL, V770, P92, DOI 10.1016/j.ejphar.2015.11.056; Wang J, 2020, NEUROSCIENCE, V428, P178, DOI 10.1016/j.neuroscience.2019.12.038; Wang M, 2015, NEUROSCIENCE, V298, P137, DOI 10.1016/j.neuroscience.2015.04.016; Wang XY, 2018, INT CONF SYST INFORM, P19, DOI 10.1109/ICSAI.2018.8599303; Wang ZB, 2005, PAIN, V114, P266, DOI 10.1016/j.pain.2004.12.027; Watson CJ, 2016, PAIN, V157, P2194, DOI 10.1097/j.pain.0000000000000615; Zhang JM, 2002, J NEUROPHYSIOL, V88, P1387, DOI 10.1152/jn.2002.88.3.1387; Zhou HR, 2019, NEUROSCIENCE, V398, P252, DOI 10.1016/j.neuroscience.2018.12.006; Zhou X, 2020, J NEUROCHEM, V155, P370, DOI 10.1111/jnc.14944; Zhu YS, 2019, NEUROPATHOLOGY, V39, P30, DOI 10.1111/neup.12530	61	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14780	14798		10.1096/fj.202001561R	http://dx.doi.org/10.1096/fj.202001561R		SEP 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931071				2022-12-26	WOS:000570777600001
J	Flowers, SA; Thomsson, KA; Ali, L; Huang, S; Mthembu, Y; Regmi, SC; Holgersson, J; Schmidt, TA; Rolfson, O; Bjorkman, LI; Sundqvist, M; Karlsson-Bengtsson, A; Jay, GD; Eisler, T; Krawetz, R; Karlsson, NG				Flowers, Sarah A.; Thomsson, Kristina A.; Ali, Liaqat; Huang, Shan; Mthembu, Yolanda; Regmi, Suresh C.; Holgersson, Jan; Schmidt, Tannin A.; Rolfson, Ola; Bjorkman, Lena I.; Sundqvist, Martina; Karlsson-Bengtsson, Anna; Jay, Gregory D.; Eisler, Thomas; Krawetz, Roman; Karlsson, Niclas G.			Decrease of core 2 O-glycans on synovial lubricin in osteoarthritis reduces galectin-3 mediated crosslinking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycomics; galectin; sialic acid; osteoarthritis; lubricin; biolubrication; mucin; glycobiology	HUMAN PROTEOGLYCAN 4; BOUNDARY LUBRICATION; CARTILAGE; PROTEIN; BINDING; SURFACE; CELLS; IMMUNOLOCALIZATION; GLYCOWORKBENCH; GLYCOSYLATION	The synovial fluid glycoprotein lubricin (also known as proteoglycan 4) is a mucin-type O-linked glycosylated biological lubricant implicated to be involved in osteoarthritis (OA) development. Lubricin's ability to reduce friction is related to its glycosylation consisting of sialylated and unsialylated Tn-antigens and core 1 and core 2 structures. The glycans on lubricin have also been suggested to be involved in crosslinking and stabilization of the lubricating superficial layer of cartilage by mediating interaction between lubricin and galectin-3. However, with the spectrum of glycans being found on lubricin, the glycan candidates involved in this interaction were unknown. Here, we confirm that the core 2 O-linked glycans mediate this lubricin-galectin-3 interaction, shown by surface plasmon resonance data indicating that recombinant lubricin (rhPRG4) devoid of core 2 structures did not bind to recombinant galectin-3. Conversely, transfection of Chinese hamster ovary cells with the core 2 GlcNAc transferase acting on a mucin-type O-glycoprotein displayed increased galectin-3 binding. Both the level of galectin-3 and the galectin-3 interactions with synovial lubricin were found to be decreased in late-stage OA patients, coinciding with an increase in unsialylated core 1 O-glycans (T-antigens) and Tn-antigens. These data suggest a defect in crosslinking of surface-active molecules in OA and provide novel insights into OA molecular pathology.	[Flowers, Sarah A.; Thomsson, Kristina A.; Ali, Liaqat; Huang, Shan; Karlsson, Niclas G.] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Mthembu, Yolanda; Holgersson, Jan] Univ Gothenburg, Sahlgrenska Acad, Dept Lab Med, Inst Biomed, Gothenburg, Sweden; [Regmi, Suresh C.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Schmidt, Tannin A.] Univ Connecticut, Hlth Ctr, Biomed Engn Dept, Farmington, CT USA; [Rolfson, Ola] Univ Gothenburg, Sahlgrenska Acad, Dept Orthopaed, Inst Clin Sci, Gothenburg, Sweden; [Bjorkman, Lena I.; Sundqvist, Martina; Karlsson-Bengtsson, Anna] Univ Gothenburg, Sahlgrenska Acad, Dept Rheumatol & Inflammat Res, Inst Med, Gothenburg, Sweden; [Karlsson-Bengtsson, Anna] Chalmers Univ Technol, Gothenburg, Sweden; [Jay, Gregory D.] Brown Univ, Dept Emergency Med, Warren Alpert Med Sch, Providence, RI 02912 USA; [Jay, Gregory D.] Brown Univ, Sch Engn, Div Biomed Engn, Providence, RI 02912 USA; [Eisler, Thomas] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden; [Krawetz, Roman] Univ Calgary, Cumming Sch Med, Dept Cell Biol & Anat, Calgary, AB, Canada; [Krawetz, Roman] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB, Canada	University of Gothenburg; University of Gothenburg; University of Calgary; University of Connecticut; University of Gothenburg; University of Gothenburg; Chalmers University of Technology; Brown University; Brown University; Danderyds Hospital; Karolinska Institutet; University of Calgary; University of Calgary	Karlsson, NG (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	niclas.karlsson@medkem.gu.se	Sundqvist, Martina/HCI-9371-2022; Sundqvist, Martina/AAA-8412-2019; Karlsson, Niclas/G-5235-2013	Sundqvist, Martina/0000-0002-0859-0792; Karlsson, Niclas/0000-0002-3045-2628; Flowers, Sarah/0000-0002-3513-2260; Karlsson, Anna/0000-0001-6796-1154; Schmidt, Tannin/0000-0001-7140-254X	Swedish government; county council; ALF [ALFGBG-722391, ALFGBG-726801]; Swedish Research Council [621-2013-5895, 2018-03077]; Kung Gustav V:s 80-year foundation; Petrus and Augusta Hedlund's foundation Grant [M-2016-0353]; AFA insurance research fund [150150]; National Institute of Health [R01AR067748]	Swedish government; county council; ALF; Swedish Research Council(Swedish Research CouncilEuropean Commission); Kung Gustav V:s 80-year foundation; Petrus and Augusta Hedlund's foundation Grant; AFA insurance research fund; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by grants from the Swedish state under the agreement between the Swedish government and the county council, the ALF-agreement Grants ALFGBG-722391 (to N. G. K.) and ALFGBG-726801 (J. H.), the Swedish Research Council Grants 621-2013-5895 (to N. G. K.) and 2018-03077 (A.K.), Kung Gustav V:s 80-year foundation (N. G. K.), Petrus and Augusta Hedlund's foundation Grant M-2016-0353 (to N. G. K.), AFA insurance research fund Grant dnr 150150 (to N. G. K.), and National Institute of Health R01AR067748 (to G. D. J.).	Abubacker S, 2016, ANN BIOMED ENG, V44, P1128, DOI 10.1007/s10439-015-1390-8; Ali L, 2014, MOL CELL PROTEOMICS, V13, P3396, DOI 10.1074/mcp.M114.040865; Alturfan AA, 2008, INFLAMMATION, V31, P414, DOI 10.1007/s10753-008-9093-z; Asakawa-Tanne Y, 2015, J DENT RES, V94, P337, DOI 10.1177/0022034514560588; Bumba L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020372; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cherian RM, 2015, BIOMOLECULES, V5, P1810, DOI 10.3390/biom5031810; Damerell D, 2012, BIOL CHEM, V393, P1357, DOI 10.1515/hsz-2012-0135; Estrella RP, 2010, BIOCHEM J, V429, P359, DOI 10.1042/BJ20100360; Ezzat MHM, 2011, INT J RHEUM DIS, V14, P345, DOI 10.1111/j.1756-185X.2011.01632.x; Flowers SA, 2017, OSTEOARTHR CARTILAGE, V25, P1496, DOI 10.1016/j.joca.2017.03.016; Flowers SA, 2019, ANAL CHEM, V91, P9819, DOI 10.1021/acs.analchem.9b01485; Flowers SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13558-y; Flowers SA, 2013, MOL CELL PROTEOMICS, V12, P921, DOI 10.1074/mcp.M113.028878; Greenwood-Van Meerveld B, 2018, UROLOGY, V116, DOI 10.1016/j.urology.2018.02.034; Hay SI, 2017, LANCET, V389, pE1; Hayes CA, 2012, BIOINFORMATICS, V28, P1669, DOI 10.1093/bioinformatics/bts242; Hayes CA, 2012, METHODS MOL BIOL, V842, P141, DOI 10.1007/978-1-61779-513-8_8; Hayes CA, 2011, BIOINFORMATICS, V27, P1343, DOI 10.1093/bioinformatics/btr137; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Iqbal SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep18910; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Jay GD, 2001, GLYCOCONJUGATE J, V18, P807, DOI 10.1023/A:1021159619373; Jay GD, 2014, MATRIX BIOL, V39, P17, DOI 10.1016/j.matbio.2014.08.008; Jay GD, 2010, ARTHRITIS RHEUM-US, V62, P2382, DOI 10.1002/art.27550; Jin CS, 2012, J BIOL CHEM, V287, P35922, DOI 10.1074/jbc.M112.363119; Johannes L, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208884; Kolarich D, 2013, MOL CELL PROTEOMICS, V12, P991, DOI 10.1074/mcp.O112.026492; Kuo CW, 2018, J AM SOC MASS SPECTR, V29, P1166, DOI 10.1007/s13361-018-1919-9; Lalonde ME, 2017, J BIOTECHNOL, V251, P128, DOI 10.1016/j.jbiotec.2017.04.028; Lambiase A, 2017, OCUL SURF, V15, P77, DOI 10.1016/j.jtos.2016.08.004; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lindberg L, 2013, GLYCOBIOLOGY, V23, P720, DOI 10.1093/glycob/cwt011; Liu JN, 2015, J BIOTECHNOL, V199, P77, DOI 10.1016/j.jbiotec.2015.02.017; Liu JN, 2005, GLYCOBIOLOGY, V15, P571, DOI 10.1093/glycob/cwi037; Liu JN, 1997, TRANSPLANTATION, V63, P1673, DOI 10.1097/00007890-199706150-00023; Liu YJ, 2004, BLOOD, V103, P4449, DOI 10.1182/blood-2003-06-1825; Lord MS, 2012, CONNECT TISSUE RES, V53, P132, DOI 10.3109/03008207.2011.614364; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Nielsen MI, 2018, J BIOL CHEM, V293, P20249, DOI 10.1074/jbc.RA118.004636; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Oh J, 2017, J SURG RES, V208, P20, DOI 10.1016/j.jss.2016.08.092; Ohshima S, 2003, ARTHRITIS RHEUM-US, V48, P2788, DOI 10.1002/art.11287; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rees SG, 2002, MATRIX BIOL, V21, P593, DOI 10.1016/S0945-053X(02)00056-2; Reesink HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep25463; Regmi SC, 2017, EXP EYE RES, V161, P1, DOI 10.1016/j.exer.2017.05.006; Rodriguez MC, 2015, BIOCHEMISTRY-US, V54, P4462, DOI 10.1021/acs.biochem.5b00555; Rojas-Macias MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11131-x; Rossez Y, 2011, BIOCHIMIE, V93, P593, DOI 10.1016/j.biochi.2010.12.002; Samsom M, 2018, J BIOMED MATER RES B, V106, P1329, DOI 10.1002/jbm.b.33895; Samsom ML, 2014, EXP EYE RES, V127, P14, DOI 10.1016/j.exer.2014.06.015; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; Schmidt TA, 2013, JAMA OPHTHALMOL, V131, P766, DOI 10.1001/jamaophthalmol.2013.2385; Schmidt TA, 2009, BBA-GEN SUBJECTS, V1790, P375, DOI 10.1016/j.bbagen.2009.03.016; Schumacher BL, 2005, J ORTHOP RES, V23, P562, DOI 10.1016/j.orthres.2004.11.011; Selman MHJ, 2011, ANAL CHEM, V83, P2492, DOI 10.1021/ac1027116; Struwe WB, 2016, GLYCOBIOLOGY, V26, P907, DOI 10.1093/glycob/cww082; Su JL, 2001, HYBRIDOMA, V20, P149, DOI 10.1089/027245701750293475; SWANN DA, 1985, BIOCHEM J, V225, P195, DOI 10.1042/bj2250195; Toledo AG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12672-x; Tsuboi S, 2011, EMBO J, V30, P3173, DOI 10.1038/emboj.2011.215; Waller KA, 2017, AM J SPORT MED, V45, P1512, DOI 10.1177/0363546516686965; Watkins AR, 2020, OSTEOARTHR CARTILAGE, V28, P1303, DOI 10.1016/j.joca.2020.05.009; Weinmann D, 2018, CELL MOL LIFE SCI, V75, P4187, DOI 10.1007/s00018-018-2856-2; Weinmann D, 2016, SCI REP-UK, V6, DOI 10.1038/srep39112; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200	69	0	0	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16023	16036		10.1074/jbc.RA120.012882	http://dx.doi.org/10.1074/jbc.RA120.012882			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32928962	Green Published, hybrid			2022-12-26	WOS:000595657900020
J	Miyamoto, Y; Schirripa, M; Suenaga, M; Cao, S; Zhang, W; Okazaki, S; Berger, MD; Matsusaka, S; Yang, DY; Ning, Y; Baba, H; Loupakis, F; Lonardi, S; Pietrantonio, F; Borelli, B; Cremolini, C; Yamaguchi, T; Lenz, HJ				Miyamoto, Yuji; Schirripa, Marta; Suenaga, Mitsukuni; Cao, Shu; Zhang, Wu; Okazaki, Satoshi; Berger, Martin D.; Matsusaka, Satoshi; Yang, Dongyun; Ning, Yan; Baba, Hideo; Loupakis, Fotios; Lonardi, Sara; Pietrantonio, Filippo; Borelli, Beatrice; Cremolini, Chiara; Yamaguchi, Toshiharu; Lenz, Heinz-Josef			A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer	PLOS ONE			English	Article							ACTIVIN-A; GROWTH; TRANSCRIPTION; ANGIOGENESIS; EXPRESSION; DISEASE; TAS-102; CELLS; CHEMOTHERAPY; MULTICENTER	Activin/myostatin signaling has a critical role not only in cachexia but also in tumor angiogenesis. Cachexia is a frequent complication among patients with advanced cancer and heavily pretreated patients. We aimed to evaluate the prognostic significance of cachexia-associated genetic variants in refractory metastatic colorectal cancer (mCRC) patients treated with regorafenib. Associations between twelve single nucleotide polymorphisms in 8 genes (INHBA,MSTN,ALK4,TGFBR1,ALK7,ACVR2B,SMAD2,FOXO3) and clinical outcome were evaluated in mCRC patients of three cohorts: a discovery cohort of 150 patients receiving regorafenib, a validation cohort of 80 patients receiving regorafenib and a control cohort of 128 receiving TAS-102. In the discovery cohort, patients with any G variant inFOXO3rs12212067 had a significantly lower response rate (P= 0.031) and overall survival (OS) than those with a T/T in univariate analysis (4.5 vs. 7.6 months, hazard ratio [HR] = 1.63, 95% confidence interval [CI] = 1.09-2.46,P= 0.012). Among female patients, those with any G variant inINHBArs2237432 had a significantly longer OS than those with an A/A in both univariate (7.6 vs. 4.3 months, HR = 0.57, 95%CI = 0.34-0.95,P= 0.021) and multivariable (HR = 0.53, 95%CI = 0.29-0.94, adjustedP= 0.031) analysis. This association was confirmed in female patients of the validation cohort, though without statistical significance (P= 0.059). Conversely, female patients with any G allele in the control group receiving TAS-102 did not show a longer OS. This was the first study evaluating the associations between polymorphisms in cachexia-associated genes and outcomes in refractory mCRC patients treated with regorafenib. Further studies should be conducted to confirm these associations.	[Miyamoto, Yuji; Schirripa, Marta; Suenaga, Mitsukuni; Zhang, Wu; Okazaki, Satoshi; Berger, Martin D.; Matsusaka, Satoshi; Ning, Yan; Lenz, Heinz-Josef] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Div Med Oncol, Los Angeles, CA 90007 USA; [Cao, Shu; Yang, Dongyun] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol Surg, Kumamoto, Japan; [Loupakis, Fotios; Lonardi, Sara] IRCCS, Unit Med Oncol 1, Dept Clin & Expt Oncol, Ist Oncol Veneto, Padua, Italy; [Pietrantonio, Filippo] Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy; [Borelli, Beatrice; Cremolini, Chiara] Univ Pisana, Polo Oncol, Azienda Osped, Pisa, Italy; [Yamaguchi, Toshiharu] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Tokyo, Japan	University of Southern California; University of Southern California; Kumamoto University; IRCCS Istituto Oncologico Veneto (IOV); Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Japanese Foundation for Cancer Research	Lenz, HJ (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Div Med Oncol, Los Angeles, CA 90007 USA.	lenz@usc.edu	Lonardi, Sara/F-4228-2014; Berger, Martin D./AAR-4415-2021; Berger, Martin D./AAS-1238-2021; Borelli, B/AAJ-8829-2021	Lonardi, Sara/0000-0002-7593-8138; Berger, Martin D./0000-0001-9224-7104; Yang, Dongyun/0000-0003-0736-4977; CREMOLINI, CHIARA/0000-0002-0520-4841; Miyamoto, Yuji/0000-0003-3948-5044	National Institute of Health [P30CA014089]; Gloria Borges Wunderglo Project; Dhont Family Foundation; Daniel Butler Research Fund; Call to Cure Research Fund; Japan Society for the Promotion of Science [S2606]; Takashi Tsuruo Memorial Fund; Werner and Hedy Berger-Janser Foundation for cancer research; Swiss Cancer League [BIL KLS-3334-02-2014]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gloria Borges Wunderglo Project; Dhont Family Foundation; Daniel Butler Research Fund; Call to Cure Research Fund; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takashi Tsuruo Memorial Fund; Werner and Hedy Berger-Janser Foundation for cancer research; Swiss Cancer League	This work was supported by the National Institute of Health (P30CA014089); the Gloria Borges Wunderglo Project; the Dhont Family Foundation; the Daniel Butler Research Fund; and the Call to Cure Research Fund. YM received a grant from Japan Society for the Promotion of Science (S2606). MS is the recipient of Takashi Tsuruo Memorial Fund. MDB received a grant from the Werner and Hedy Berger-Janser Foundation for cancer research and the Swiss Cancer League (BIL KLS-3334-02-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao ABK, 2018, CLIN COLORECTAL CANC, V17, P113, DOI 10.1016/j.clcc.2017.10.016; Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Bloise E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-320; Breit S, 2000, CANCER RES, V60, P4596; Burdette JE, 2007, ENDOCR-RELAT CANCER, V14, P679, DOI 10.1677/ERC-07-0054; Chen YG, 2002, EXP BIOL MED, V227, P75, DOI 10.1177/153537020222700201; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Drummond AE, 2012, MOL CELL ENDOCRINOL, V359, P85, DOI 10.1016/j.mce.2011.07.033; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gallot YS, 2014, CANCER RES, V74, P7344, DOI 10.1158/0008-5472.CAN-14-0057; Goede V, 1999, INT J CANCER, V82, P765, DOI 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F; Goto Y, 2001, CLIN CANCER RES, V7, P1952; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Han HQ, 2013, INT J BIOCHEM CELL B, V45, P2333, DOI 10.1016/j.biocel.2013.05.019; HSUEH AJW, 1989, RECENT PROG HORM RES, V45, P209; Johnston AJ, 2015, CELL, V162, P1365, DOI 10.1016/j.cell.2015.08.031; Kang JW, 2013, 2013 8TH INTERNATIONAL ICST CONFERENCE ON COMMUNICATIONS AND NETWORKING IN CHINA (CHINACOM), P534, DOI 10.1109/ChinaCom.2013.6694653; Kipp JL, 2007, ENDOCRINOLOGY, V148, P1968, DOI 10.1210/en.2006-1083; Kuningas M, 2011, AGE, V33, P615, DOI 10.1007/s11357-010-9202-4; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Li J, 2015, LANCET ONCOL, V16, P619, DOI 10.1016/S1470-2045(15)70156-7; Litvak V, 2012, NATURE, V490, P421, DOI 10.1038/nature11428; Loumaye A, 2015, J CLIN ENDOCR METAB, V100, P2030, DOI 10.1210/jc.2014-4318; Maeshima K, 2004, ENDOCRINOLOGY, V145, P3739, DOI 10.1210/en.2004-0213; Marlow G, 2015, J NUTRIGENET NUTRIGE, V8, P70, DOI 10.1159/000435783; Mayer RJ, 2015, NEW ENGL J MED, V372, P1909, DOI 10.1056/NEJMoa1414325; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Millar David S., 2010, Human Genomics, V4, P289; Miyamoto Y, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3590; Miyamoto Y, 2016, CLIN CANCER RES, V22, P3999, DOI 10.1158/1078-0432.CCR-16-0495; Miyamoto Y, 2016, EXPERT REV CLIN PHAR, V9, P355, DOI 10.1586/17512433.2016.1133285; Miyamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129742; Morishita S, 2012, SUPPORT CARE CANCER, V20, P821, DOI 10.1007/s00520-011-1156-2; Moriwaki T, 2018, ONCOLOGIST, V23, P7, DOI 10.1634/theoncologist.2017-0275; Network NCC. National Comprehensive Cancer Network (NCCN), 2016, GUID VERS 1 2016 COL; Okano M, 2013, ONCOL REP, V30, P2903, DOI 10.3892/or.2013.2761; Panopoulou E, 2005, CANCER RES, V65, P1877, DOI 10.1158/0008-5472.CAN-04-2828; Risbridger GP, 2001, ENDOCR REV, V22, P836, DOI 10.1210/er.22.6.836; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Suenaga M, 2016, ONCOTARGET, V7, P34811, DOI 10.18632/oncotarget.9187; Tabernero J, 2015, LANCET ONCOL, V16, P937, DOI 10.1016/S1470-2045(15)00138-2; Togashi Y, 2015, CANCER LETT, V356, P819, DOI 10.1016/j.canlet.2014.10.037; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Viatte S, 2016, ARTHRITIS RHEUMATOL, V68, P2629, DOI 10.1002/art.39760; Wagner K, 2004, GASTROENTEROLOGY, V126, P1828, DOI 10.1053/j.gastro.2004.03.011; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Zabaleta J, 2008, CANCER IMMUNOL IMMUN, V57, P107, DOI 10.1007/s00262-007-0358-4	49	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239439	10.1371/journal.pone.0239439	http://dx.doi.org/10.1371/journal.pone.0239439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970737	Green Published, gold			2022-12-26	WOS:000576265600034
J	Price, JT; Mabula-Bwalya, CM; Freeman, BL; Carda-Auten, J; Phiri, WM; Chibwe, K; Kantumoya, P; Vwalika, B; Stringer, JSA; Golin, CE				Price, Joan T.; Mabula-Bwalya, Chileshe M.; Freeman, Bethany L.; Carda-Auten, Jessica; Phiri, Winifreda M.; Chibwe, Kasapo; Kantumoya, Patricia; Vwalika, Bellington; Stringer, Jeffrey S. A.; Golin, Carol E.			Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ADHERENCE; DISCLOSURE; INTERVENTIONS; SEROSTATUS; IMPACT; GEL	Antenatal progesterone prevents preterm birth (PTB) in women with a short cervix or prior PTB in daily vaginal or weekly injectable formulations, respectively. Neither has been tested for the indication of maternal HIV, which is associated with an elevated risk of PTB. The Vaginal Progesterone (VP) Trial was a pilot feasibility study of VP to prevent HIV-related PTB in Lusaka, Zambia. Using mixed methods, we concurrently evaluated the acceptability of the trial and the study product among participants. Over a 1-year period, we enrolled 140 pregnant women living with HIV into a double-masked, placebo-controlled, randomized trial of daily self-administered VP or placebo. We administered an endline questionnaire to all participants and conducted in-depth interviews with 30 participants to assess barriers and facilitators to uptake and retention in the trial and to study product adherence. All interviews were audiotaped, transcribed, translated into English as needed, and independently coded by two analysts to capture emerging themes. Of 131 participants who completed the questionnaire, 128 (98%) reported that nothing was difficult when asked the hardest part about using the study product. When given a hypothetical choice between vaginal and injectable progesterone, 97 (74%) chose vaginal, 31 (24%) injectable, and 3 (2%) stated no preference. Most interviewees reported no difficulties with using the study product; others cited minor side effects and surmountable challenges. Strategies that supported adherence included setting alarms, aligning dosing with antiretrovirals, receiving encouragement from friends and family, sensing a benefit to their unborn baby, and positive feedback from study staff. Participants who reported preference of a vaginal medication over injectable described familiarity with the vaginal product, a fear of needles and resulting pain, and inconvenience of a weekly clinic visit. Those who would prefer weekly injections cited fewer doses to remember. Perceived barriers to study participation included mistrust about the motivations behind research, suspicion of Satanism, and futility or possible harm from a placebo. We report key influences on acceptability of a randomized trial of VP to prevent PTB among HIV-infected women in Zambia, which should inform methods to promote uptake, adherence, and retention in a full-scale trial.	[Price, Joan T.; Freeman, Bethany L.; Stringer, Jeffrey S. A.] Univ N Carolina, Div Global Womens Hlth, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA; [Price, Joan T.; Vwalika, Bellington] Univ Zambia, Dept Obstet & Gynaecol, Sch Med, Lusaka, Zambia; [Mabula-Bwalya, Chileshe M.; Phiri, Winifreda M.; Chibwe, Kasapo; Kantumoya, Patricia] UNC Global Projects Zambia, Lusaka, Zambia; [Carda-Auten, Jessica; Golin, Carol E.] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Zambia; University of North Carolina; University of North Carolina Chapel Hill	Price, JT (corresponding author), Univ N Carolina, Div Global Womens Hlth, Dept Obstet & Gynecol, Chapel Hill, NC 27515 USA.; Price, JT (corresponding author), Univ Zambia, Dept Obstet & Gynaecol, Sch Med, Lusaka, Zambia.	joan_price@med.unc.edu	Stringer, Jeffrey S. A./AAU-2342-2021	CHIBWE, KASAPO/0000-0002-7794-4224; Stringer, Jeffrey/0000-0002-9590-7216; Mabula-Bwalya, Chileshe/0000-0002-6329-5534; Carda-Auten, Jessica/0000-0002-2900-9194	United States National Institutes of Health [R21 HD090987]; National Institutes of Health [T32 HD075731, K01 TW010857, D43 TW010558]; University of North Carolina at Chapel Hill Center for AIDS Research [P30A150410]	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill Center for AIDS Research	The clinical trial presented in this article is funded through an award from the United States National Institutes of Health (R21 HD090987), which supports JSAS. Trainee support has been provided through the National Institutes of Health for JTP (T32 HD075731 and K01 TW010857) and for CMMB (D43 TW010558). Additional support for this work was provided by the University of North Carolina at Chapel Hill Center for AIDS Research (P30A150410). The conclusions and opinions expressed in this article are those of the authors and do not necessarily reflect those of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Baylies C, 2000, REPROD HEALTH MATTER, V8, P77, DOI 10.1016/S0968-8080(00)90008-9; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Corneli A, 2016, JAIDS-J ACQ IMM DEF, V71, P452, DOI 10.1097/QAI.0000000000000880; Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hampanda KM, 2018, AIDS BEHAV, V22, P1652, DOI 10.1007/s10461-017-1909-0; Kalichman Seth C, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P317, DOI 10.1177/1545109708328130; Luecke EH, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20875; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Mansoor LE, 2014, AIDS BEHAV, V18, P841, DOI 10.1007/s10461-014-0752-9; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Nchito M, 2004, T ROY SOC TROP MED H, V98, P218, DOI 10.1016/S0035-9203(03)00045-2; O'Reilly M, 2012, QUALITATIVE RES, DOI [10.1177/1487941111422107, DOI 10.1177/1487941111422107]; Peltzer K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-778; Price JT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0224874; Rees H, 2015, C RETR OPP INF SEATT, p26LB; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Tam M, 2015, AIDS CARE, V27, P436, DOI 10.1080/09540121.2014.997662; van der Straten A, 2014, C RETR OPP INF MARCH; van der Straten A, 2015, AIDS, V29, P2161, DOI 10.1097/QAD.0000000000000801; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; van der Straten A, 2013, SEX TRANSM DIS, V40, P950, DOI 10.1097/OLQ.0000000000000053; Wedi COO, 2016, LANCET HIV, V3, pE33, DOI 10.1016/S2352-3018(15)00207-6; Wong JMH, 2017, INT J WOMENS HEALTH, V9, DOI 10.2147/IJWH.S136191; Zulu JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108305	27	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238748	10.1371/journal.pone.0238748	http://dx.doi.org/10.1371/journal.pone.0238748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970697	gold, Green Published			2022-12-26	WOS:000576265600035
J	Kroger, H; Leopold, L				Kroeger, Hannes; Leopold, Liliya			Education differences in women's body weight trajectories: The role of motherhood	PLOS ONE			English	Article							SELF-REPORTED HEIGHT; LIFE-COURSE APPROACH; SOCIOECONOMIC-STATUS; SOCIAL-INEQUALITY; FAMILY-STRUCTURE; AIR-POLLUTION; UNITED-STATES; MASS INDEX; OBESITY; GAIN	Studies have found that education differences in women's body weight increase until middle adulthood. The explanatory mechanisms behind this increase are not well-understood. This study examined the role of education differences in theprevalence of motherhoodas a risk factor for weight gain and invulnerabilityto its effects on weight gain. We used longitudinal data from the German Socio-economic Panel Study. Our sample included 2,668 women aged between 17 and 45 and observed at least twice between 2002 and 2016 (n= 13,899 panel observations). We used OLS regression models to estimate initial education differences in body weight and fixed-effects panel regression models to estimate education differences in body-weight trajectories. Motherhood was associated with increasing body weight, and the effects of motherhood on weight gain varied by education. Motherhood partially accounted for the increase of education differences during reproductive age. Until the age of 30, differences in theprevalence of motherhoodaccounted for about 20% of the bodyweight gap between lower and higher educated women. From age 35 until 45, differentialvulnerabilityto the effects of motherhood on body weight explained about 15% of the education gap in body weight.	[Kroeger, Hannes] German Inst Econ Res DIW, German Socioecon Panel, Berlin, Germany; [Leopold, Liliya] Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands; [Leopold, Liliya] Univ Bamberg, Professorship Demog, Bamberg, Germany	DIW Berlin - Deutsches Institut fur Wirtschaftsforschung; University of Amsterdam; Otto Friedrich University Bamberg	Leopold, L (corresponding author), Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands.; Leopold, L (corresponding author), Univ Bamberg, Professorship Demog, Bamberg, Germany.	l.leopold@uva.nl	Kröger, Hannes/AAI-3799-2021	Leopold, Liliya/0000-0002-2721-8339	German Research Foundation (DFG) [EN 424/7-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG), grant nr. EN 424/7-1	Abma Joyce C, 2017, Natl Health Stat Report, P1; Ailshire JA, 2011, SOC FORCES, V90, P397, DOI 10.1093/sf/sor001; Allison PD, 2009, FIXED EFFECT REGRESS; Allmendinger J., 1989, EUROPEAN SOCIOLOGICA, V5, P231, DOI [10.1093/oxfordjournals.esr.a036524, DOI 10.1093/OXFORDJOURNALS.ESR.A036524]; Amrhein V, 2019, AM STAT, V73, P262, DOI 10.1080/00031305.2018.1543137; [Anonymous], **DATA OBJECT**; Balbo N, 2013, EUR J POPUL, V29, P1, DOI 10.1007/s10680-012-9277-y; Ball K, 2005, SOC SCI MED, V60, P1987, DOI 10.1016/j.socscimed.2004.08.056; Bastian LA, 2005, PREV MED, V40, P99, DOI 10.1016/j.ypmed.2004.05.007; Baum CL, 2009, J HEALTH ECON, V28, P635, DOI 10.1016/j.jhealeco.2009.01.004; Bell A., 2019, QUAL QUANT, V53, P1051, DOI [10.1007/s11135-018-0802-x, DOI 10.1007/S11135-018-0802-X]; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bernardi F, 2017, EUR SOCIOL REV, V33, P1, DOI 10.1093/esr/jcw047; Bernardi L, 2007, J MIX METHOD RES, V1, P23, DOI 10.1177/2345678906292238; BLOSSFELD HP, 1991, AM J SOCIOL, V97, P143, DOI 10.1086/229743; Breeze E, 2006, INT J EPIDEMIOL, V35, P169, DOI 10.1093/ije/dyi212; Brooks R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010587; Caliendo M, 2016, ECON HUM BIOL, V23, P209, DOI 10.1016/j.ehb.2016.09.004; Cavaco S, 2014, ECON HUM BIOL, V14, P62, DOI 10.1016/j.ehb.2014.04.003; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Cohen AK, 2013, OBES REV, V14, P989, DOI 10.1111/obr.12062; Cooper CE, 2009, J MARRIAGE FAM, V71, P558, DOI 10.1111/j.1741-3737.2009.00619.x; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; Della Bella S, 2015, QUAL QUANT, V49, P2577, DOI 10.1007/s11135-014-0129-1; Diderichsen F, 2019, INT J EPIDEMIOL, V48, P268, DOI 10.1093/ije/dyy167; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Drobnic S, 1999, J MARRIAGE FAM, V61, P133, DOI 10.2307/353889; Elder GH, 2003, HDB LIFE COURSE, P3, DOI DOI 10.1007/978-0-306-48247-2_1; Ferraro KF, 2016, AM SOCIOL REV, V81, P107, DOI 10.1177/0003122415619617; Ferraro KF, 2009, GERONTOLOGIST, V49, P333, DOI 10.1093/geront/gnp034; Ferraro KF, 2003, AM SOCIOL REV, V68, P707, DOI 10.2307/1519759; Forastiere F, 2007, AM J IND MED, V50, P208, DOI 10.1002/ajim.20368; Furnham A, 2002, J PSYCHOL, V136, P581, DOI 10.1080/00223980209604820; Goebel J, 2019, JAHRB NATL STAT, V239, P345, DOI 10.1515/jbnst-2018-0022; Gunderson EP, 2000, INT J OBESITY, V24, P1660, DOI 10.1038/sj.ijo.0801456; Gunderson EP, 1999, EPIDEMIOL REV, V21, P261, DOI 10.1093/oxfordjournals.epirev.a018001; Holowko N, 2014, INT J OBESITY, V38, P91, DOI 10.1038/ijo.2013.62; Holowko N, 2015, J EPIDEMIOL COMMUN H, V69, P1154, DOI 10.1136/jech-2015-205598; Huber LRB, 2007, MATERN CHILD HLTH J, V11, P137, DOI 10.1007/s10995-006-0157-0; James-Todd T, 2010, ANN EPIDEMIOL, V20, P836, DOI 10.1016/j.annepidem.2010.08.006; Khlat M, 2009, SOC SCI MED, V68, P1692, DOI 10.1016/j.socscimed.2009.02.024; Kreyenfeld M., 2004, DEMOGRAPHIC RES SPEC, V3, P275, DOI 10.4054/DemRes.2004.S3.11; Kroh M, 2012, DOCUMENTATION SAMPLE; Kroh M., 2009, SHORT DOCUMENTATION; Lappegard T, 2005, EUR J POPUL, V21, P31, DOI 10.1007/s10680-004-6756-9; Lee SK, 2005, OBES RES, V13, P1263, DOI 10.1038/oby.2005.150; Huynh M, 2014, MATERN CHILD HLTH J, V18, P138, DOI 10.1007/s10995-013-1246-5; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mills M, 2011, HUM REPROD UPDATE, V17, P848, DOI 10.1093/humupd/dmr026; Molarius A, 2000, AM J PUBLIC HEALTH, V90, P1260, DOI 10.2105/AJPH.90.8.1260; Novak M, 2006, INT J OBESITY, V30, P191, DOI 10.1038/sj.ijo.0803104; O'Brien EC, 2018, J PUBLIC HEALTH-UK, V40, P41, DOI 10.1093/pubmed/fdx038; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Ortega-Alonso A, 2009, BEHAV GENET, V39, P154, DOI 10.1007/s10519-008-9245-9; Potzsch O., 2012, STAT BUNDESAMT AUSGA, V48; Santelli JS, 2000, AM J PUBLIC HEALTH, V90, P1582, DOI 10.2105/AJPH.90.10.1582; Shavit Y., 1998, SCH WORK COMP STUDY; Shrewsbury VA, 2009, MATERN CHILD HLTH J, V13, P231, DOI 10.1007/s10995-008-0342-4; Siega-Riz AM, 2010, OBESITY, V18, P1996, DOI 10.1038/oby.2009.458; Sobotka T, 2011, COMP POPUL STUD, V36, P263, DOI 10.4232/10.CPoS-2011-11en; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; TURNER RJ, 1995, AM SOCIOL REV, V60, P104, DOI 10.2307/2096348; Umberson D, 2011, SOC SCI MED, V73, P1323, DOI 10.1016/j.socscimed.2011.08.014; Villanueva EV, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-11; Vizmanos B, 2000, EUR J CLIN NUTR, V54, P203, DOI 10.1038/sj.ejcn.1600920; Walsemann KM, 2012, ETHNIC HEALTH, V17, P337, DOI 10.1080/13557858.2011.635374; Warin M, 2008, SOCIOL HEALTH ILL, V30, P97, DOI 10.1111/j.1467-9566.2007.01029.x; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	69	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0236487	10.1371/journal.pone.0236487	http://dx.doi.org/10.1371/journal.pone.0236487			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NV8NR	32956409	Green Published, gold			2022-12-26	WOS:000574571500055
J	Jillella, DV; Janocko, NJ; Nahab, F; Benameur, K; Greene, JG; Wright, WL; Obideen, M; Rangaraju, S				Jillella, Dinesh, V; Janocko, Nicholas J.; Nahab, Fadi; Benameur, Karima; Greene, James G.; Wright, Wendy L.; Obideen, Mahmoud; Rangaraju, Srikant			Ischemic stroke in COVID-19: An urgent need for early identification and management	PLOS ONE			English	Article								Objective In the setting of the Coronavirus Disease 2019 (COVID-19) global pandemic caused by SARS-CoV-2, a potential association of this disease with stroke has been suggested. We aimed to describe the characteristics of patients who were admitted with COVID-19 and had an acute ischemic stroke (AIS). Methods This is a case series of PCR-confirmed COVID-19 patients with ischemic stroke admitted to an academic health system in metropolitan Atlanta, Georgia (USA) between March 24(th), 2020 and July 17(th), 2020. Demographic, clinical, and radiographic characteristics were described. Results Of 396 ischemic stroke patients admitted during this study period, 13 (2.5%) were also diagnosed with COVID-19. The mean age of patients was 61.6 +/- 10.8 years, 10 (76.9%) male, 8 (61.5%) were Black Americans, mean time from last normal was 4.97 +/- 5.1 days, and only one received acute reperfusion therapy. All 13 patients had at least one stroke-associated co-morbidity. The predominant pattern of ischemic stroke was embolic with 4 explained by atrial fibrillation. COVID-19 patients had a significantly higher rate of cryptogenic stroke than non-COVID-19 patients during the study period (69% vs 17%, p = 0.0001). Conclusions In our case series, ischemic stroke affected COVID-19 patients with traditional stroke risk factors at an age typically seen in non-COVID populations, and mainly affecting males and Black Americans. We observed a predominantly embolic pattern of stroke with a higher than expected rate of cryptogenic strokes, a prolonged median time to presentation and symptom recognition limiting the use of acute reperfusion treatments. These results highlight the need for increased community awareness, early identification, and management of AIS in COVID-19 patients.	[Jillella, Dinesh, V; Janocko, Nicholas J.; Nahab, Fadi; Benameur, Karima; Greene, James G.; Wright, Wendy L.; Obideen, Mahmoud; Rangaraju, Srikant] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Jillella, Dinesh, V; Janocko, Nicholas J.; Rangaraju, Srikant] Grady Mem Hosp, Atlanta, GA 30303 USA	Emory University	Jillella, DV (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.; Jillella, DV (corresponding author), Grady Mem Hosp, Atlanta, GA 30303 USA.	dineshvinayakjillella@gmail.com	Janocko, Nicholas/AFM-2650-2022; Rangaraju, S/Q-1924-2018	Janocko, Nicholas/0000-0002-6310-2616; Rangaraju, S/0000-0003-2765-1500; Jillella, Dinesh/0000-0002-5399-0170; Benameur, Karima/0000-0002-4599-5705				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Avula A, 2020, BRAIN BEHAV IMMUN, V87, P115, DOI 10.1016/j.bbi.2020.04.077; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Jillella DV, 2019, CURR OPIN INFECT DIS, V32, P285, DOI 10.1097/QCO.0000000000000547; Kansagra AP, 2020, N ENGL J MED; Kuipers S, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0688-5; Li B, 2020, CLIN RES CARDIOL, V109, P531, DOI 10.1007/s00392-020-01626-9; Mao L., 2019, JAMA NEUROL, DOI [10.1001/jamaneurol.2020.1127, DOI 10.2139/SSRN.3544840, DOI 10.1001/JAMANEUROL.2020.1127]; Oxley JMT.J., 2020, N ENGL J MED; Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850; Saver JL, 2016, NEW ENGL J MED, V374, P2065, DOI 10.1056/NEJMcp1503946; Seecheran R, 2020, J INVEST MED HIGH IM, V8, DOI 10.1177/2324709620925571; Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018; Yaghi S, 2020, STROKE, V51, P2002, DOI 10.1161/STROKEAHA.120.030335	14	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239443	10.1371/journal.pone.0239443	http://dx.doi.org/10.1371/journal.pone.0239443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946512	Green Submitted, gold, Green Published			2022-12-26	WOS:000573851100018
J	Muller, F; Canal-Bruland, R				Mueller, Florian; Canal-Bruland, Rouwen			Interindividual differences in incentive sensitivity moderate motivational effects of competition and cooperation on motor performance	PLOS ONE			English	Article							IMPLICIT POWER MOTIVATION; PICTURE STORY EXERCISE; INDIVIDUAL-DIFFERENCES; TESTOSTERONE CHANGES; ACHIEVEMENT; MOTIVES; REWARD; NEED; AFFILIATION; CONGRUENCE	Established research has documented the pervasive influence of incentives (i.e., food, sex, money) on animal and human behavior. Additionally, motivational theories postulating intra-individually stable preferences for specific types of incentives (i.e., motives) highlight that effects of a given incentive are highly dependent on the motive disposition of the individual. Indeed, also research on motor performance has documented the interactive effects of motives and motive-specific incentives on motor outcomes. However, the majority of this research has relied on correlational designs focusing on the effects of the achievement motive, with few studies addressing the role of the affiliation and power motive. In order to extend findings in this domain, we tested whether a fit between individuals' power (affiliation) motive and incentives of competition (cooperation) would improve motor performance. Following baseline measures, participants performed a dart-throwing task as part of a dyadic performance (i.e., cooperative) or a one-on-one competition scenario. In the dyadic performance scenario, a stronger affiliation motive did not translate to better performance. However, in the one-on-one competition scenario a stronger power motive was associated with better performance. Results highlight the role of the power motive in predicting motor performance, particularly in competitive situations.	[Mueller, Florian; Canal-Bruland, Rouwen] Friedrich Schiller Univ, Inst Sport Sci, Dept Psychol Human Movement & Sport, Jena, Germany	Friedrich Schiller University of Jena	Muller, F (corresponding author), Friedrich Schiller Univ, Inst Sport Sci, Dept Psychol Human Movement & Sport, Jena, Germany.	florian.mueller@uni-jena.de						Abe M, 2011, CURR BIOL, V21, P557, DOI 10.1016/j.cub.2011.02.030; ADAMS JA, 1987, PSYCHOL BULL, V101, P41, DOI 10.1037/0033-2909.101.1.41; ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; Anderson DI., 2017, MOTOR LEARNING CONTR; ANDREWS JDW, 1967, J PERS SOC PSYCHOL, V6, P163, DOI 10.1037/h0024689; [Anonymous], HAMBURGER MORGENPOST; Atkinson J. W., 1968, INTRO MOTIVATION; Baumeister RF, 2007, PERSPECT PSYCHOL SCI, V2, P396, DOI 10.1111/j.1745-6916.2007.00051.x; Beckmann J., 2008, MOTIVATION ACTION, P99, DOI [10.1017/CBO9780511499821.006, DOI 10.1017/CBO9780511499821.006]; Bos K., 1983, DIMENSIONEN SPORTMOT; Bowen HJ, 2017, COLLABRA-PSYCHOL, V3, DOI 10.1525/collabra.77; Brase GL, 2009, JUDGM DECIS MAK, V4, P419; Brase GL, 2006, Q J EXP PSYCHOL, V59, P965, DOI 10.1080/02724980543000132; Brown DMY, 2017, J SPORT EXERCISE PSY, V39, P385, DOI 10.1123/jsep.2017-0187; Brunstein JC, 1998, J PERS SOC PSYCHOL, V75, P494, DOI 10.1037/0022-3514.75.2.494; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; CATALANO JF, 1970, PSYCHON SCI, V18, P69, DOI 10.3758/BF03335700; Cesqui B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031770; Chatelain M, 2016, BIOL PSYCHOL, V117, P150, DOI 10.1016/j.biopsycho.2016.03.014; Corbett J, 2012, MED SCI SPORT EXER, V44, P509, DOI 10.1249/MSS.0b013e31823378b1; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; de l I, 2018, J CLIN GASTROENTEROL, V52, pe63; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; DECI EL, 1971, J PERS SOC PSYCHOL, V18, P105, DOI 10.1037/h0030644; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Elbe A.-M., 2003, PSYCHOL SPORT, V10, P134; Elliot AJ, 2006, MOTIV EMOTION, V30, P111, DOI 10.1007/s11031-006-9028-7; Fodor EM, 2006, J RES PERS, V40, P598, DOI 10.1016/j.jrp.2005.06.001; Fodor EM, 2012, MOTIV EMOTION, V36, P301, DOI 10.1007/s11031-011-9254-5; Fodor EM, 2009, J RES PERS, V43, P721, DOI 10.1016/j.jrp.2009.06.007; Galea JM, 2015, NAT NEUROSCI, V18, P597, DOI 10.1038/nn.3956; Gardiner CK, 2017, ANN BEHAV MED, V51, P599, DOI 10.1007/s12160-017-9882-4; Golenia L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112806; Heyns R.W., 1958, MOTIVES FANTASY ACTI, V1, P205; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hofer J, 2003, MOTIV EMOTION, V27, P251, DOI 10.1023/A:1025011815778; Hofer J, 2017, SOC PERSONAL PSYCHOL, V11, DOI 10.1111/spc3.12330; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KELLY RT, 1973, J SOC PSYCHOL, V89, P141, DOI 10.1080/00224545.1973.9922578; King AC, 2012, NEUROSCI LETT, V529, P144, DOI 10.1016/j.neulet.2012.08.014; Kordik A, 2012, J RES PERS, V46, P604, DOI 10.1016/j.jrp.2012.05.006; KUHL J, 1984, PSYCHOL RES-PSYCH FO, V46, P143, DOI 10.1007/BF00308599; Langens T., 2005, MOTIVATIONSPSYCHOLOG, P70; Lewin K., 1935, DYNAMIC THEORY PERS; McClelland D., 1975, POWER INNER EXPERIEN; MCCLELLAND DC, 1982, J APPL PSYCHOL, V67, P737, DOI 10.1037/0021-9010.67.6.737; MCCLELLAND DC, 1989, PSYCHOL REV, V96, P690, DOI 10.1037/0033-295X.96.4.690; MEHRABIAN A, 1970, EDUC PSYCHOL MEAS, V30, P417, DOI 10.1177/001316447003000226; Muller F, 2019, MOTIVATION SCI; Puca RM, 2006, J PERS, V74, P979, DOI 10.1111/j.1467-6494.2006.00400.x; Pueschel O, 2011, CLIN PSYCHOL PSYCHOT, V18, P23, DOI 10.1002/cpp.697; Rawolle M, 2016, PERS INDIV DIFFER, V89, P65, DOI 10.1016/j.paid.2015.09.030; Rosch AG, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00985; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; RYAN ED, 1965, J PERS SOC PSYCHOL, V1, P342, DOI 10.1037/h0021750; Schattke K, 2015, Z SPORTPSYCHOL, V22, P20, DOI 10.1026/1612-5010/a000134; Schiepe-Tiska A., 2014, POWER FLOW IMPACT IM; Schmalt H.-D., 2000, MULTIMOTIV GITTER AN; Schmidt RA, 2011, BEHAV EMPHASIS; Schuler J, 2013, MOTIV EMOTION, V37, P480, DOI 10.1007/s11031-012-9317-2; Schuler J, 2013, J APPL SOC PSYCHOL, V43, P687, DOI 10.1111/j.1559-1816.2013.01045.x; Schuler J, 2010, MOTIV EMOTION, V34, P2, DOI 10.1007/s11031-009-9150-4; Schuler J, 2010, J RES PERS, V44, P1, DOI 10.1016/j.jrp.2009.09.002; Schuler J, 2017, INT J SPORT PSYCHOL, V48, P133; Schultheiss O.C., 2010, IMPLICIT MOTIVES, DOI 10.1093/acprof:oso/9780195335156.001.0001; Schultheiss OC, 2005, EMOTION, V5, P41, DOI 10.1037/1528-3542.5.1.41; Schultheiss OC, 2005, J PERS SOC PSYCHOL, V88, P174, DOI 10.1037/0022-3514.88.1.174; Schultheiss OC, 2002, J PERS, V70, P553; Schultheiss OC, 2002, HORM BEHAV, V41, P195, DOI 10.1006/hbeh.2001.1745; Schultheiss OC, 1999, J PERS, V67, P1, DOI 10.1111/1467-6494.00046; Schultheiss OC, 2008, J RES PERS, V42, P1560, DOI 10.1016/j.jrp.2008.07.008; Schultheiss OC, 2009, J PERS ASSESS, V91, P72, DOI 10.1080/00223890802484456; Schultz W, 2013, CURR OPIN NEUROBIOL, V23, P229, DOI 10.1016/j.conb.2012.11.012; Sieber V, 2015, Z SPORTPSYCHOL, V22, P46, DOI 10.1026/1612-5010/a000136; SMITH M, 1982, PERCEPT MOTOR SKILL, V54, P63, DOI 10.2466/pms.1982.54.1.63; Snoddy GS, 1926, J APPL PSYCHOL, V10, P1, DOI 10.1037/h0075814; Sokolowski K, 2000, J PERS ASSESS, V74, P126, DOI 10.1207/S15327752JPA740109; SORRENTINO RM, 1978, J PERS SOC PSYCHOL, V36, P704, DOI 10.1037/0022-3514.36.7.704; SPANGLER WD, 1992, PSYCHOL BULL, V112, P140, DOI 10.1037/0033-2909.112.1.140; Stanton S. J., 2010, IMPLICIT MOTIVES; Teubel T., 2012, ANSCHLUSSMOTIV ERKLA; Thorndike E. L., 1898, Psychol Review Monograph Supplement, pUnpaginated; Thorndike E.L., 1905, ELEMENTS PSYCHOL; Wachter T, 2009, J NEUROSCI, V29, P436, DOI 10.1523/JNEUROSCI.4132-08.2009; Warden CJ, 1936, COMP PSYCHOL; Wegner M, 2014, INT J SPORT PSYCHOL, V45, P621, DOI 10.7352/IJSP.2014.45.621; Williams EL, 2015, J SCI MED SPORT, V18, P486, DOI 10.1016/j.jsams.2014.07.003; Williams SB, 1938, J EXP PSYCHOL, V23, P506, DOI 10.1037/h0053675; World Darts Federation, PLAYING TOURNM RUL	90	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0237607	10.1371/journal.pone.0237607	http://dx.doi.org/10.1371/journal.pone.0237607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7WV	32946448	Green Published, gold			2022-12-26	WOS:000573851100055
J	Ren, SB; Liu, F; Zhou, WJ; Feng, X; Siddique, CN				Ren, Shengbing; Liu, Fa; Zhou, Weijia; Feng, Xian; Siddique, Chaudry Naeem			Group-based local adaptive deep multiple kernel learning with lp norm	PLOS ONE			English	Article								The deep multiple kernel Learning (DMKL) method has attracted wide attention due to its better classification performance than shallow multiple kernel learning. However, the existing DMKL methods are hard to find suitable global model parameters to improve classification accuracy in numerous datasets and do not take into account inter-class correlation and intra-class diversity. In this paper, we present a group-based local adaptive deep multiple kernel learning (GLDMKL) method with lp norm. Our GLDMKL method can divide samples into multiple groups according to the multiple kernel k-means clustering algorithm. The learning process in each well-grouped local space is exactly adaptive deep multiple kernel learning. And our structure is adaptive, so there is no fixed number of layers. The learning model in each group is trained independently, so the number of layers of the learning model maybe different. In each local space, adapting the model by optimizing the SVM model parameter alpha and the local kernel weight beta in turn and changing the proportion of the base kernel of the combined kernel in each layer by the local kernel weight, and the local kernel weight is constrained by the lp norm to avoid the sparsity of basic kernel. The hyperparameters of the kernel are optimized by the grid search method. Experiments on UCI and Caltech 256 datasets demonstrate that the proposed method is more accurate in classification accuracy than other deep multiple kernel learning methods, especially for datasets with relatively complex data.	[Ren, Shengbing; Liu, Fa; Zhou, Weijia; Feng, Xian; Siddique, Chaudry Naeem] Cent South Univ, Sch Comp Sci & Engn, Changsha, Peoples R China	Central South University	Ren, SB (corresponding author), Cent South Univ, Sch Comp Sci & Engn, Changsha, Peoples R China.	rsb@csu.edu.cn		ren, shengbing/0000-0001-7709-4234				Abd-Elsalam RO, 2017, INT J ADV COMPUT SC, V8, P407; Afzal AL, 2021, PATTERN ANAL APPL, V24, P11, DOI 10.1007/s10044-020-00891-8; Afzal AL, 2018, EXPERT SYST APPL, V96, P149, DOI 10.1016/j.eswa.2017.11.058; Chen JX, 2018, STAT INTERFACE, V11, P401, DOI 10.4310/SII.2018.v11.n3.a1; Cigdem O, 2019, IEEE SYS MAN CYBERN, P1286, DOI 10.1109/SMC.2019.8914611; Ding SF, 2017, NEURAL COMPUT APPL, V28, P1975, DOI 10.1007/s00521-015-2170-y; Ding YJ, 2019, NEUROCOMPUTING, V325, P211, DOI 10.1016/j.neucom.2018.10.028; Dong XM, 2019, INT J WAVELETS MULTI, V17, DOI 10.1142/S0219691319500486; Fu GY, 2016, INT CONF CLOUD COMPU, P191; Georgescu MI, 2019, IEEE ACCESS, V7, P64827, DOI 10.1109/ACCESS.2019.2917266; Han YN, 2018, IEEE T NEUR NET LEAR, V29, P4997, DOI 10.1109/TNNLS.2017.2785329; Jiang YH, 2019, PROCEEDINGS OF 2019 THE 3RD INTERNATIONAL CONFERENCE ON CRYPTOGRAPHY, SECURITY AND PRIVACY (ICCSP 2019) WITH WORKSHOP 2019 THE 4TH INTERNATIONAL CONFERENCE ON MULTIMEDIA AND IMAGE PROCESSING (ICMIP 2019), P28, DOI 10.1145/3309074.3309094; Jiu MY, 2017, IEEE T IMAGE PROCESS, V26, P1820, DOI 10.1109/TIP.2017.2666038; Lauriola I, 2020, PATTERN RECOGN, V101, DOI 10.1016/j.patcog.2020.107194; Li ZB, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P2848, DOI 10.1145/3292500.3330731; Liu TZ, 2016, IEEE T GEOSCI REMOTE, V54, P7351, DOI 10.1109/TGRS.2016.2600522; Mariette J, 2018, BIOINFORMATICS, V34, P1009, DOI 10.1093/bioinformatics/btx682; Nie F., 2017, 31 AAAI C ART INT; Paquette C, 2018, ARXIV OPTIMIZATION C; Pehlevan C, 2019, INT CONF ACOUST SPEE, P7958, DOI 10.1109/ICASSP.2019.8682290; Peng JL, 2019, PATTERN RECOGN, V88, P370, DOI 10.1016/j.patcog.2018.11.027; Poria S, 2017, NEUROCOMPUTING, V261, P217, DOI 10.1016/j.neucom.2016.09.117; Rebai I, 2016, NEURAL COMPUT APPL, V27, P2305, DOI 10.1007/s00521-015-2066-x; Ren SB, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11030325; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Sheng YP, 2019, APPL INTELL, V49, P2151, DOI 10.1007/s10489-018-1380-2; Song H, 2018, IEEE T NEUR NET LEAR, V29, P5528, DOI 10.1109/TNNLS.2018.2804895; Strobl EV, 2013, 2013 12TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2013), VOL 1, P414, DOI 10.1109/ICMLA.2013.84; Sun XQ, 2018, IEEE ACCESS, V6, P20334, DOI 10.1109/ACCESS.2018.2822546; Wang QC, 2019, SOFT COMPUT, V23, P3697, DOI 10.1007/s00500-018-3025-0; Wang QW, 2016, IEEE T GEOSCI REMOTE, V54, P3912, DOI 10.1109/TGRS.2016.2530807; Wang Teng, 2020, NEUROCOMPUTING; Wang YQ, 2017, PATTERN RECOGN, V70, P104, DOI 10.1016/j.patcog.2017.05.005; Wu D, 2020, IEEE T SMART GRID, V11, P1183, DOI 10.1109/TSG.2019.2933413; Wu Y, 2016, NEUROCOMPUTING, V171, P1118, DOI 10.1016/j.neucom.2015.07.045; Ye QL, 2018, NEURAL NETWORKS, V105, P393, DOI 10.1016/j.neunet.2018.05.020; Zakrani A, 2018, 2018 IEEE 5 INT C IN, P1; Zhang TF, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11050559; Zhuang Jinfeng, 2011, J MACH LEARN RES, P909; 2019, NEW DISTRICTS, V20, P1	41	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238535	10.1371/journal.pone.0238535	http://dx.doi.org/10.1371/journal.pone.0238535			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941468	Green Published, gold			2022-12-26	WOS:000573848800096
J	Onufer, EJ; Aladegbami, B; Imai, T; Seiler, K; Bajinting, A; Courtney, C; Sutton, S; Bustos, A; Yao, JJ; Yeh, CH; Sescleifer, A; Wang, LHV; Guo, J; Warner, BW				Onufer, Emily J.; Aladegbami, Bola; Imai, Toru; Seiler, Kristen; Bajinting, Adam; Courtney, Cathleen; Sutton, Stephanie; Bustos, Aiza; Yao, Junjie; Yeh, Cheng-Hung; Sescleifer, Anne; Wang, Lihong V.; Guo, Jun; Warner, Brad W.			EGFR in enterocytes & endothelium and HIF1 alpha in enterocytes are dispensable for massive small bowel resection induced angiogenesis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HYPOXIA-INDUCIBLE FACTOR; UP-REGULATION; INTESTINAL ADAPTATION; ANGIOCRINE SIGNALS; BLOOD-FLOW; CELLS; OVEREXPRESSION; MAINTENANCE; FIBROBLASTS	Background Short bowel syndrome (SBS) results from significant loss of small intestinal length. In response to this loss, adaptation occurs, with Epidermal Growth Factor Receptor (EGFR) being a key driver. Besides enhanced enterocyte proliferation, we have revealed that adaptation is associated with angiogenesis. Further, we have found that small bowel resection (SBR) is associated with diminished oxygen delivery and elevated levels of hypoxia-inducible factor 1-alpha (HIF1 alpha). Methods We ablated EGFR in the epithelium and endothelium as well as HIF1 alpha in the epithelium, ostensibly the most hypoxic element. Using these mice, we determined the effects of these genetic manipulations on intestinal blood flow after SBR using photoacoustic microscopy (PAM), intestinal adaptation and angiogenic responses. Then, given that endothelial cells require a stromal support cell for efficient vascularization, we ablated EGFR expression in intestinal subepithelial myofibroblasts (ISEMFs) to determine its effects on angiogenesis in a microfluidic model of human small intestine. Results Despite immediate increased demand in oxygen extraction fraction measured by PAM in all mouse lines, were no differences in enterocyte and endothelial cell EGFR knockouts or enterocyte HIF1 alpha knockouts by POD3. Submucosal capillary density was also unchanged by POD7 in all mouse lines. Additionally, EGFR silencing in ISEMFs did not impact vascular network development in a microfluidic device of human small intestine. Conclusions Overall, despite the importance of EGFR in facilitating intestinal adaptation after SBR, it had no impact on angiogenesis in three cell types-enterocytes, endothelial cells, and ISEMFs. Epithelial ablation of HIF1 alpha also had no impact on angiogenesis in the setting of SBS.	[Onufer, Emily J.; Aladegbami, Bola; Seiler, Kristen; Courtney, Cathleen; Sutton, Stephanie; Bustos, Aiza; Guo, Jun; Warner, Brad W.] Washington Univ St Louis, Sch Med, St Louis Childrens Hosp, Div Pediat Surg,Dept Surg, St Louis, MO 63110 USA; [Imai, Toru; Yao, Junjie; Yeh, Cheng-Hung] Washington Univ St Louis, Dept Biomed Engn, St Louis, MO USA; [Imai, Toru; Wang, Lihong V.] CALTECH, Dept Elect Engn, Opt Imaging Lab, Andrew & Peggy Cherng Dept Med Engn, Pasadena, CA 91125 USA; [Bajinting, Adam; Sescleifer, Anne] St Louis Univ, Sch Med, St Louis, MO USA	St. Louis Children's Hospital; Washington University (WUSTL); Washington University (WUSTL); California Institute of Technology; Saint Louis University	Warner, BW (corresponding author), Washington Univ St Louis, Sch Med, St Louis Childrens Hosp, Div Pediat Surg,Dept Surg, St Louis, MO 63110 USA.	brad.warner@wustl.edu	Bajinting, Adam/AAH-7749-2021	Bajinting, Adam/0000-0001-7429-6543; Onufer, Emily/0000-0002-8802-5346	NIH [R01 DK104698, T32 DK077653]; Digestive Diseases Research Core Center of the Washington University School of Medicine (NIH) [P30DK52574]; Children's Surgical Sciences Research Institute of the St. Louis Children's Hospital Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center of the Washington University School of Medicine (NIH); Children's Surgical Sciences Research Institute of the St. Louis Children's Hospital Foundation	This work was supported by NIH R01 DK104698 (Warner), The Digestive Diseases Research Core Center of the Washington University School of Medicine (NIH #P30DK52574), the Children's Surgical Sciences Research Institute of the St. Louis Children's Hospital Foundation, and NIH T32 DK077653 (Onufer).	Alphonse RS, 2015, NAT PROTOC, V10, P1697, DOI 10.1038/nprot.2015.107; Amin DN, 2006, CANCER RES, V66, P2173, DOI 10.1158/0008-5472.CAN-05-3387; [Anonymous], 2005, AM J PHYSIOL-HEART C, V289, pH1898; Barron L, 2017, CELL MOL GASTROENTER, V3, P231, DOI 10.1016/j.jcmgh.2016.10.006; BENNETT BD, 1995, P NATL ACAD SCI USA, V92, P1866, DOI 10.1073/pnas.92.6.1866; Chen K, 2001, J BIOL CHEM, V276, P16045, DOI 10.1074/jbc.M011766200; Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]; Cole CR, 2012, J PEDIAT, V160; Diamond IR, 2007, J PEDIATR SURG, V42, P806, DOI 10.1016/j.jpedsurg.2006.12.033; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dubin A, 2008, CRIT CARE MED, V36, P535, DOI 10.1097/01.CCM.0000300083.74726.43; Erwin CR, 1999, AM J PHYSIOL-GASTR L, V277, pG533, DOI 10.1152/ajpgi.1999.277.3.G533; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Guo J, 2009, J BIOL CHEM, V284, P134, DOI 10.1074/jbc.M806133200; Helmrath MA, 1998, SURGERY, V124, P848, DOI 10.1067/msy.1998.91984; Helmrath MA, 1997, J SURG RES, V69, P76, DOI 10.1006/jsre.1997.5033; Helmrath MA, 1998, J PEDIATR SURG, V33, P229, DOI 10.1016/S0022-3468(98)90437-7; Helmrath MA, 1996, J AM COLL SURGEONS, V183, P441; Hu S, 2011, OPT LETT, V36, P1134, DOI 10.1364/OL.36.001134; Khong TL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-518; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Longshore S W, 2009, Minerva Pediatr, V61, P239; Martin CA, 2009, J PEDIATR SURG, V44, P1077, DOI 10.1016/j.jpedsurg.2009.02.036; McMellen ME, 2010, SURGERY, V148, P364, DOI 10.1016/j.surg.2010.03.020; Nguyen MP, 2013, ARCH PHARM RES, V36, P252, DOI 10.1007/s12272-013-0058-x; Modi BP, 2008, J PEDIATR SURG, V43, P20, DOI 10.1016/j.jpedsurg.2007.09.014; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; Nishi H, 2002, CANCER RES, V62, P827; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; O'Brien DP, 2002, J SURG RES, V105, P25, DOI 10.1006/jsre.2002.6440; Osei-Owusu P, 2012, J BIOL CHEM, V287, P12541, DOI 10.1074/jbc.M111.332130; Pappenheimer JR, 2003, J PHYSIOL-LONDON, V553, P561, DOI 10.1113/jphysiol.2003.043257; Parvadia JK, 2007, AM J PHYSIOL-GASTR L, V293, pG591, DOI 10.1152/ajpgi.00572.2006; Parvadia JK, 2007, AM J PHYSL GASTROINT; Pettet G, 1996, P ROY SOC B-BIOL SCI, V263, P1487, DOI 10.1098/rspb.1996.0217; POLVERINI PJ, 1995, CRIT REV ORAL BIOL M, V6, P230, DOI 10.1177/10454411950060030501; Roulis M, 2016, DIFFERENTIATION, V92, P116, DOI 10.1016/j.diff.2016.05.002; Rowland KJ, 2014, J PEDIATR SURG, V49, P976, DOI 10.1016/j.jpedsurg.2014.01.034; Rowland KJ, 2013, J PEDIATR SURG, V48, P1330, DOI 10.1016/j.jpedsurg.2013.03.031; Rowland KJ, 2012, J PEDIATR SURG, V47, P1143, DOI 10.1016/j.jpedsurg.2012.03.020; Seiler KM BA, 2020, SCI REPORTS; Seiler KM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60672-5; Squires RH, 2012, J PEDIATR-US, V161, P723, DOI 10.1016/j.jpeds.2012.03.062; Suguitan Jr AL, 2011, PLOS ONE, V6; Swinson DEB, 2006, CLIN LUNG CANCER, V7, P250, DOI 10.3816/CLC.2006.n.002; Wales PW, 2004, J PEDIATR SURG, V39, P690, DOI 10.1016/j.jpedsurg.2004.01.036; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang Y, 2012, P NATL ACAD SCI USA, V109, P4892, DOI 10.1073/pnas.1112129109; Warner BW, 2000, J AM COLL SURGEONS, V190, P725, DOI 10.1016/S1072-7515(00)00244-1; Watson CL, 2014, NAT MED, V20, P1310, DOI 10.1038/nm.3737; Wessel JJ, 2007, SEMINARS PERINATOLOG; White HA, 2017, AM J PHYSIOL-LUNG C; WILLIAMSON RCN, 1978, GASTROENTEROLOGY, V75, P249; Wouters A, 2013, CURR PHARM DESIGN, V19, P907, DOI 10.2174/138161213804547259; Yao J, 2012, PHOTONS PLUS ULTRASO; Yao JJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3339953; Yao JJ, 2010, OPT LETT, V35, P1419, DOI 10.1364/OL.35.001419; Zhang HF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435697	59	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0236964	10.1371/journal.pone.0236964	http://dx.doi.org/10.1371/journal.pone.0236964			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931498	Green Published, gold, Green Accepted			2022-12-26	WOS:000573375500019
J	Struk, T; Nair, V; Eichinger, F; Kretzler, M; Wedlich-Soldner, R; Bayraktar, S; Pavenstadt, H				Struk, Thaddaeus; Nair, Viji; Eichinger, Felix; Kretzler, Matthias; Wedlich-Soeldner, Roland; Bayraktar, Samet; Pavenstaedt, Hermann			Transcriptome analysis of primary podocytes reveals novel calcium regulated regulatory networks	FASEB JOURNAL			English	Article						CaAR; mTOR; Nephroseq; pathway analysis; RNA-sequencing	GLOMERULAR INJURY; DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; EXPRESSION; ACTIVATION; CYTOSKELETON; PROTEINURIA; PATHWAY; MTOR; ASSOCIATION	Podocytes are pivotal in establishing the selective permeability of the glomerular filtration barrier. Recently, we showed that an increase of the intracellular calcium ion concentration [Ca2+] causes a rapid and transient actin reset (CaAR) measurable through live imaging microscopy using lifeact-mCherry as an actin dye in different cell types including the podocyte. This and other studies show the critical role [Ca2+] and the actin cytoskeleton play in podocyte homeostasis. To further investigate the role of [Ca2+] and the actin cytoskeleton in podocytes, we used a double fluorescent reporter mouse model to establish a primary podocyte culture system. We treated these podocytes temporarily with a Calcium Ionophore and facultatively with Latrunculin A, an inhibitor of actin polymerization. Unbiased genome wide transcriptional analysis identified a transcriptional response in podocytes to elevated [Ca2+] levels, affecting mRNA levels of PDGF-BB, RICTOR, and MIR17HG as mediators of Ca2+-signaling. Comparison of the ex vivo transcriptional response from the primary podocyte culture with glomerular transcripts across a wide spectrum of CKD disease confirmed co-regulation of transcript sets, establishing the disease relevance of the model system. Our findings demonstrate novel [Ca2+] regulated gene networks in podocytes deepening our understanding of podocyte biology and disease.	[Struk, Thaddaeus; Bayraktar, Samet; Pavenstaedt, Hermann] Univ Munster, Dept Med, Munster, Germany; [Nair, Viji; Eichinger, Felix; Kretzler, Matthias] Univ Michigan, Michigan Kidney Translat Med Core, Ann Arbor, MI 48109 USA; [Kretzler, Matthias] Univ Michigan, Dept Nephrol, Internal Med, Ann Arbor, MI 48109 USA; [Wedlich-Soeldner, Roland] Inst Cell Dynam & Imaging, Munster, Germany	University of Munster; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Pavenstadt, H (corresponding author), Univ Munster, Div Gen Internal Med Nephrol & Rheumatol, Dept Med, Albert Schweitzer Campus 1,Gebaude A1, D-48149 Munster, Germany.	Hermann.Pavenstaedt@ukmuenster.de			NIH/NIDDK [2P30-DK-081943];  [SFB1009B10]	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); 	SFB1009B10; NIH/NIDDK, Grant/Award Number: 2P30-DK-081943; Core	Basu P, 2010, BIOMASS GASIFICATION AND PYROLYSIS: PRACTICAL DESIGN AND THEORY, P1, DOI 10.1016/B978-0-12-374988-8.00001-5; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Boehlke C, 2014, AM J KIDNEY DIS, V64, P452, DOI 10.1053/j.ajkd.2014.04.030; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Burford JL, 2014, J CLIN INVEST, V124, P2050, DOI 10.1172/JCI71702; Choi SY, 2010, ULTRASTRUCT PATHOL, V34, P195, DOI 10.3109/01913121003648402; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eid S, 2016, ANTIOXID REDOX SIGN, V25, P703, DOI 10.1089/ars.2015.6562; Fujiwara I, 2018, CURR BIOL, V28, P3183, DOI 10.1016/j.cub.2018.07.082; Garg P, 2018, AM J NEPHROL, V47, P3, DOI 10.1159/000481633; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Grahammer F, 2014, NEPHROL DIAL TRANSPL, V29, pI9, DOI 10.1093/ndt/gft491; Granado D, 2017, J AM SOC NEPHROL, V28, P3226, DOI 10.1681/ASN.2016111220; Greka A, 2012, SEMIN NEPHROL, V32, P319, DOI 10.1016/j.semnephrol.2012.06.003; Han TS, 2006, LUPUS, V15, P71, DOI 10.1191/0961203306lu2264oa; Harder JL, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122697; Henger A, 1997, KIDNEY INT, V52, P687, DOI 10.1038/ki.1997.383; Henique C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01885-7; Ilatovskaya DV, 2018, J AM SOC NEPHROL, V29, P1917, DOI 10.1681/ASN.2018030280; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jiang CS, 2019, BRIT J HAEMATOL, V185, P616, DOI 10.1111/bjh.15591; Ju WJ, 2012, TRANSL RES, V159, P290, DOI 10.1016/j.trsl.2012.01.020; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; Karaiskos N, 2018, J AM SOC NEPHROL, V29, P2060, DOI 10.1681/ASN.2018030238; Keir LS, 2015, NEPHRON, V129, P128, DOI 10.1159/000369816; Kohn S, 2002, ULTRASTRUCT PATHOL, V26, P371, DOI 10.1080/01913120290104683; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01433; Marrone AK, 2014, J AM SOC NEPHROL, V25, P1440, DOI 10.1681/ASN.2013040390; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neild GH, 2017, PEDIATR NEPHROL, V32, P243, DOI 10.1007/s00467-016-3383-8; Nozaki Y, 2012, KIDNEY INT, V82, P892, DOI 10.1038/ki.2012.226; Perez-Hernandez J, 2018, J HYPERTENS, V36, P1712, DOI 10.1097/HJH.0000000000001747; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; REED PW, 1972, J BIOL CHEM, V247, P6970; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rinschen MM, 2018, CELL REP, V23, P2495, DOI 10.1016/j.celrep.2018.04.059; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schiessl IM, 2018, J AM SOC NEPHROL, V29, P1383, DOI 10.1681/ASN.2017101069; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Smeets B, 2016, ISOLATION PRIMARY CU, P3; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Takemura T, 1996, J PATHOL, V178, P343, DOI 10.1002/(SICI)1096-9896(199603)178:3<343::AID-PATH481>3.0.CO;2-H; van Roeyen CRC, 2011, KIDNEY INT, V80, P1292, DOI 10.1038/ki.2011.278; Vassiliadis J, 2011, J AM SOC NEPHROL, V22, P1453, DOI 10.1681/ASN.2010080878; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Walentek P, 2016, ELIFE, V5, DOI 10.7554/eLife.17557; Wingett Steven W, 2018, F1000Res, V7, P1338, DOI 10.12688/f1000research.15931.2; Zhang HT, 2016, CELL PHYSIOL BIOCHEM, V40, P1079, DOI 10.1159/000453163	57	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14490	14506		10.1096/fj.201902493RR	http://dx.doi.org/10.1096/fj.201902493RR		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32931033	hybrid			2022-12-26	WOS:000570777400001
J	Zdrzalek, R; Kamoun, S; Terauchi, R; Saitoh, H; Banfield, MJ				Zdrzalek, Rafal; Kamoun, Sophien; Terauchi, Ryohei; Saitoh, Hiromasa; Banfield, Mark J.			The rice NLR pair Pikp-1/Pikp-2 initiates cell death through receptor cooperation rather than negative regulation	PLOS ONE			English	Article							PLANT IMMUNE RECEPTORS; COILED-COIL DOMAIN; NB-ARC DOMAIN; RESISTANCE PROTEIN; SELF-ASSOCIATION; STRUCTURAL BASIS; RUST RESISTANCE; REPEAT DOMAINS; TIR DOMAINS; BINDING	Plant NLR immune receptors are multidomain proteins that can function as specialized sensor/helper pairs. Paired NLR immune receptors are generally thought to function via negative regulation, where one NLR represses the activity of the second and detection of pathogen effectors relieves this repression to initiate immunity. However, whether this mechanism is common to all NLR pairs is not known. Here, we show that the rice NLR pair Pikp-1/Pikp-2, which confers resistance to strains of the blast pathogenMagnaporthe oryzae(syn.Pyricularia oryzae) expressing the AVR-PikD effector, functions via receptor cooperation, with effector-triggered activation requiring both NLRs to trigger the immune response. To investigate the mechanism of Pikp-1/Pikp-2 activation, we expressed truncated variants of these proteins, and made mutations in previously identified NLR sequence motifs. We found that any domain truncation, in either Pikp-1 or Pikp-2, prevented cell death in the presence of AVR-PikD, revealing that all domains are required for activity. Further, expression of individual Pikp-1 or Pikp-2 domains did not result in cell death. Mutations in the conserved P-loop and MHD sequence motifs in both Pikp-1 and Pikp-2 prevented cell death activation, demonstrating that these motifs are required for the function of the two partner NLRs. Finally, we showed that Pikp-1 and Pikp-2 associate to form homo- and hetero-complexes in planta in the absence of AVR-PikD; on co-expression the effector binds to Pikp-1 generating a tri-partite complex. Taken together, we provide evidence that Pikp-1 and Pikp-2 form a fine-tuned system that is activated by AVR-PikD via receptor cooperation rather than negative regulation.	[Zdrzalek, Rafal; Banfield, Mark J.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Kamoun, Sophien] Univ East Anglia, Sainsbury Lab, Norwich, Norfolk, England; [Terauchi, Ryohei] Iwate Biotechnol Res Ctr, Div Genom & Breeding, Kitakami, Iwate, Japan; [Terauchi, Ryohei] Kyoto Univ, Lab Crop Evolut, Grad Sch Agr, Kyoto, Japan; [Saitoh, Hiromasa] Tokyo Univ Agr, Lab Plant Symbiot & Parasit Microbes, Dept Mol Microbiol, Fac Life Sci, Tokyo, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; Iwate Biotechnology Research Center; Kyoto University; Tokyo University of Agriculture	Banfield, MJ (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England.; Saitoh, H (corresponding author), Tokyo Univ Agr, Lab Plant Symbiot & Parasit Microbes, Dept Mol Microbiol, Fac Life Sci, Tokyo, Japan.	hs206173@nodai.ac.jp; mark.banfield@jic.ac.uk	Terauchi, Ryohei/Y-2992-2019; Banfield, Mark/C-7453-2013; Kamoun, Sophien/B-3529-2009	Terauchi, Ryohei/0000-0002-0095-4651; Banfield, Mark/0000-0001-8921-3835; Kamoun, Sophien/0000-0002-0290-0315; Saitoh, Hiromasa/0000-0002-0124-9276; Zdrzalek, Rafal/0000-0003-3669-924X	UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK [BB/M011216/1]; UKRI BBSRC, UK [BB/P012574, BB/M02198X]; European Research Council [ERC] [743165]; John Innes Foundation; Japan Society for the Promotion of Science (JSPS KAKENHI) [18K05657, 15H05779, 20H00421]; Tokyo University of Agriculture; BBSRC [BB/M022315/1, BBS/E/J/000PR9795] Funding Source: UKRI	UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK; UKRI BBSRC, UK; European Research Council [ERC](European Research Council (ERC)); John Innes Foundation; Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokyo University of Agriculture; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the UKRI Biotechnology and Biological Sciences Research Council (BBSRC) Norwich Research Park Biosciences Doctoral Training Partnership, UK [grant BB/M011216/1 (RZ, MJB)]; the UKRI BBSRC, UK [grants BB/P012574, BB/M02198X (MJB, SK)]; the European Research Council [ERC; proposal 743165 (SK, MJB)]; the John Innes Foundation (MJB); the Japan Society for the Promotion of Science (JSPS KAKENHI; proposal 18K05657, 15H05779, and 20H00421 (RT)), and by the Strategic Research Project from Tokyo University of Agriculture (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2019, ELIFE, V8, DOI 10.7554/eLife.49956; Adachi H, 2019, CURR OPIN PLANT BIOL, V50, P121, DOI 10.1016/j.pbi.2019.04.007; Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Albrecht M, 2006, BIOCHEM BIOPH RES CO, V339, P459, DOI 10.1016/j.bbrc.2005.10.074; [Anonymous], 2017, J ONCOL PRACT, V13, pe353; [Anonymous], 2018, BNJ M; [Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Baggs E, 2017, CURR OPIN PLANT BIOL, V38, P59, DOI 10.1016/j.pbi.2017.04.012; Baudin M, 2017, PLANT PHYSIOL, V174, P2038, DOI 10.1104/pp.17.00441; Bendahmane A, 2002, PLANT J, V32, P195, DOI 10.1046/j.1365-313X.2002.01413.x; Bentham A, 2017, ANN BOT-LONDON, V119, P689, DOI 10.1093/aob/mcw171; Bernoux M, 2016, PLANT CELL, V28, P146, DOI 10.1105/tpc.15.00303; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Bonardi V, 2011, P NATL ACAD SCI USA, V108, P16463, DOI 10.1073/pnas.1113726108; Burdett H, 2019, CELL HOST MICROBE, V26, P193, DOI 10.1016/j.chom.2019.07.020; Burdett H, 2019, ARCH BIOCHEM BIOPHYS, V670, P58, DOI 10.1016/j.abb.2019.05.001; Casey LW, 2016, P NATL ACAD SCI US; Castel B, 2019, NEW PHYTOL, V222, P966, DOI 10.1111/nph.15659; Cesari S, 2017, NEW PHYTOL; Cesari S, 2016, P NATL ACAD SCI USA, V113, P10204, DOI 10.1073/pnas.1605483113; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Cesari S, 2014, EMBO J, V33, P1941, DOI 10.15252/embj.201487923; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; De la Concepcion JC, 2019, ELIFE, V8, DOI 10.7554/eLife.47713; De la Concepcion JC, 2018, NAT PLANTS, V4, P576, DOI 10.1038/s41477-018-0194-x; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P14789, DOI 10.1073/pnas.97.26.14789; Disease GBo, 2019, BMJ, V364; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; El Kasmi F, 2018, CURR OPIN PLANT BIOL, V44, P98, DOI 10.1016/j.pbi.2018.02.011; El Kasmi F, 2017, P NATL ACAD SCI USA, V114, pE7385, DOI 10.1073/pnas.1708288114; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Gao ZY, 2011, P NATL ACAD SCI USA, V108, P7619, DOI 10.1073/pnas.1104410108; Guo LW, 2018, P NATL ACAD SCI USA, V115, P11637, DOI 10.1073/pnas.1810705115; Gutierrez JR, 2010, PLANT J, V61, P507, DOI 10.1111/j.1365-313X.2009.04078.x; Hamel LP, 2016, PLANT PHYSIOL, V171, P658, DOI 10.1104/pp.16.00234; Horsefield S, 2019, SCIENCE, V365, P793, DOI 10.1126/science.aax1911; Howles P, 2005, MOL PLANT MICROBE IN, V18, P570, DOI 10.1094/MPMI-18-0570; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jubic LM, 2019, CURR OPIN PLANT BIOL, V50, P82, DOI 10.1016/j.pbi.2019.03.013; Kawano Y, 2010, CELL HOST MICROBE, V7, P362, DOI 10.1016/j.chom.2010.04.010; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; Krasileva KV, 2010, PLANT CELL, V22, P2444, DOI 10.1105/tpc.110.075358; Kroj T, 2016, NEW PHYTOL, V210, P618, DOI 10.1111/nph.13869; Lee H-Y, 2020, 878959 BIORXIV; Leibman-Markus M, 2018, PLANT CELL ENVIRON, V41, P2313, DOI 10.1111/pce.13347; Li J, 2019, MOL PLANT, V12, P248, DOI 10.1016/j.molp.2019.01.005; Ma Y, 2018, P NATL ACAD SCI USA, V115, P10218, DOI 10.1073/pnas.1811858115; Maekawa T, 2011, CELL HOST MICROBE, V9, P187, DOI 10.1016/j.chom.2011.02.008; Maqbool A, 2015, ELIFE, V4, DOI 10.7554/eLife.08709; Mestre P, 2006, PLANT CELL, V18, P491, DOI 10.1105/tpc.105.037234; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Ntoukakis V, 2014, CURR OPIN PLANT BIOL, V20, P69, DOI 10.1016/j.pbi.2014.04.002; Ortiz D, 2017, PLANT CELL, V29, P156, DOI 10.1105/tpc.16.00435; Qi D, 2012, PLANT PHYSIOL, V158, P1819, DOI 10.1104/pp.112.194035; Rairdan GJ, 2008, PLANT CELL, V20, P739, DOI 10.1105/tpc.107.056036; Rairdan GJ, 2006, PLANT CELL, V18, P2082, DOI 10.1105/tpc.106.042747; Roberts M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003465; Sarris PF, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0228-7; Saur IML, 2015, J BIOL CHEM, V290, P11258, DOI 10.1074/jbc.M114.616532; Slootweg EJ, 2013, PLANT PHYSIOL, V162, P1510, DOI 10.1104/pp.113.218842; Steele JFC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221226; Sukarta OCA, 2016, SEMIN CELL DEV BIOL, V56, P134, DOI 10.1016/j.semcdb.2016.05.012; Takken FLW, 2012, CURR OPIN PLANT BIOL, V15, P375, DOI 10.1016/j.pbi.2012.05.001; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Tameling WIL, 2006, PLANT PHYSIOL, V140, P1233, DOI 10.1104/pp.105.073510; Tenthorey JL, 2017, SCIENCE, V358, P888, DOI 10.1126/science.aao1140; Townsend PD, 2018, J BIOL CHEM, V293, P3218, DOI 10.1074/jbc.RA117.000485; van Bentem SDF, 2005, PLANT J, V43, P284, DOI 10.1111/j.1365-313X.2005.02450.x; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Veras L, 2016, ASIA PAC J CLIN ONCO, V12, pe196, DOI 10.1111/ajco.12129; Wan L, 2019, SCIENCE, V365, P799, DOI 10.1126/science.aax1771; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Williams SJ, 2014, SCIENCE, V344, P299, DOI 10.1126/science.1247357; Williams SJ, 2011, MOL PLANT MICROBE IN, V24, P897, DOI 10.1094/MPMI-03-11-0052; Win J, 2011, METHODS MOL BIOL, V712, P181, DOI 10.1007/978-1-61737-998-7_15; Wroblewski T, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005821; Wu CH, 2018, SCIENCE, V360, P1300, DOI 10.1126/science.aat2623; Wu CH, 2017, P NATL ACAD SCI USA, V114, P8113, DOI 10.1073/pnas.1702041114; Wu ZS, 2019, NEW PHYTOL, V222, P938, DOI 10.1111/nph.15665; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhang XX, 2017, ANNU REV PHYTOPATHOL, V55, P205, DOI 10.1146/annurev-phyto-080516-035250; Zhang XX, 2017, P NATL ACAD SCI USA, V114, pE2046, DOI 10.1073/pnas.1621248114; Zhang ZM, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.115; 2012, SURG OBES RELAT DIS, V8	85	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0238616	10.1371/journal.pone.0238616	http://dx.doi.org/10.1371/journal.pone.0238616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931489	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000573375500007
J	Begaj, T; Marmalidou, A; Papakostas, TD; Diaz, JD; Kim, LA; Wu, DM; Miller, JB				Begaj, Tedi; Marmalidou, Anna; Papakostas, Thanos D.; Diaz, J. Daniel; Kim, Leo A.; Wu, David M.; Miller, John B.			Outcomes of primary rhegmatogenous retinal detachment repair with extensive scleral-depressed vitreous removal and dynamic examination	PLOS ONE			English	Article							PARS-PLANA VITRECTOMY; PNEUMATIC RETINOPEXY; BUCKLE; MULTICENTER; MANAGEMENT; ILLUMINATION	There are multiple surgical approaches to the repair of rhegmatogenous retinal detachment (RRD). Here, we evaluated the outcomes of small-gauge pars plana vitrectomy (PPV), alone or in combination with scleral buckle (SB-PPV), for RRD repair using a standardized technique by 3 vitreoretinal surgeons: "extensive" removal of the vitreous with scleral depression and dynamic examination of the peripheral retina. One hundred eighty seven eyes of 180 consecutive patients treated for primary RRD by three vitreoretinal surgeons at a tertiary academic medical center from September 2015 to March 2018 were analyzed. Most RRDs occurred in males (134 [71.3%] eyes), affected the left eye (102 [54.3%]), and were phakic (119 [63.3%]). PPV alone was performed in 159 eyes (84.6%), with a combined SB-PPV used in the remaining 29 eyes (15.4%); focal endolaser was used in all (100%) cases. The single surgery anatomic success rate was 186 eyes (99.5%) at 3 months, and 187 (100%) at last follow up. Overall best-corrected visual acuity (BCVA) had significantly improved at 3 months ([Snellen 20/47] P<0.00005) and last follow up ([Snellen 20/31] P<0.00005), as compared to day of presentation ([Snellen 20/234]). Our findings suggest that "extensive" removal of the vitreous and dynamic peripheral examination with scleral depression may lead to high single surgery success in primary uncomplicated RRD repair.	[Begaj, Tedi; Marmalidou, Anna; Papakostas, Thanos D.; Diaz, J. Daniel; Kim, Leo A.; Wu, David M.; Miller, John B.] Harvard Med Sch, Massachusetts Eye & Ear, Retina Serv, Dept Ophthalmol, Boston, MA 02115 USA; [Papakostas, Thanos D.] Cornell Univ, Sch Med, Dept Ophthalmol, New York, NY 10021 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Cornell University	Miller, JB (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear, Retina Serv, Dept Ophthalmol, Boston, MA 02115 USA.	john_miller@meei.harvard.edu	Begaj, Tedi/AFQ-1992-2022; Miller, John J/GZG-5663-2022; Kim, Leo/Y-3323-2018	Begaj, Tedi/0000-0002-1880-3982; Kim, Leo/0000-0001-9106-6416				BartzSchmidt KU, 1996, BRIT J OPHTHALMOL, V80, P346, DOI 10.1136/bjo.80.4.346; Campo RV, 1999, OPHTHALMOLOGY, V106, P1811, DOI 10.1016/S0161-6420(99)90353-6; Chaturvedi V, 2014, INDIAN J OPHTHALMOL, V62, P804, DOI 10.4103/0301-4738.138621; Davis M D, 1973, Trans Am Ophthalmol Soc, V71, P343; FRIBERG TR, 1979, AM J OPHTHALMOL, V88, P943, DOI 10.1016/0002-9394(79)90579-8; GARTRY DS, 1993, BRIT J OPHTHALMOL, V77, P199, DOI 10.1136/bjo.77.4.199; Gotzaridis S, 2016, OSLI RETINA, V47, P333, DOI 10.3928/23258160-20160324-05; GREVEN CM, 1992, OPHTHALMOLOGY, V99, P257; Heimann H, 2007, OPHTHALMOLOGY, V114, P2142, DOI 10.1016/j.ophtha.2007.09.013; Hillier RJ, 2019, OPHTHALMOLOGY, V126, P531, DOI 10.1016/j.ophtha.2018.11.014; Kessner R, 2016, GRAEF ARCH CLIN EXP, V254, P2183, DOI 10.1007/s00417-016-3381-3; Kinori M, 2011, AM J OPHTHALMOL, V152, P291, DOI 10.1016/j.ajo.2011.01.049; KREIGER AE, 1993, RETINA-J RET VIT DIS, V13, P335, DOI 10.1097/00006982-199313040-00012; Lumi X, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0390-2; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; Martinez-Castillo V, 2009, ARCH OPHTHALMOL-CHIC, V127, P1297, DOI 10.1001/archophthalmol.2009.254; McLaughlin MD, 2017, OPHTHALMOLOGY, V124, P667, DOI 10.1016/j.ophtha.2017.01.001; Miller DM, 2008, RETINA-J RET VIT DIS, V28, P931, DOI 10.1097/IAE.0b013e31816b313a; Mohamed S, 2017, J OPHTHALMOL, V2017, DOI 10.1155/2017/6285869; Mulvihill A, 1996, IRISH J MED SCI, V165, P274, DOI 10.1007/BF02943089; Orlin A, 2014, RETINA-J RET VIT DIS, V34, P1069, DOI 10.1097/IAE.0000000000000050; ROSEN PH, 1989, EYE, V3, P277, DOI 10.1038/eye.1989.38; Schneider EW, 2012, RETINA-J RET VIT DIS, V32, P213, DOI 10.1097/IAE.0b013e3182278b29; Soni C, 2013, OPHTHALMOLOGY, V120, P1440, DOI 10.1016/j.ophtha.2012.12.033; Stangos AN, 2004, AM J OPHTHALMOL, V138, P952, DOI 10.1016/j.ajo.2004.06.086; Tabandeh H, 2019, BRIT J OPHTHALMOL, V103, P1765, DOI 10.1136/bjophthalmol-2018-313626; TORNAMBE PE, 1989, OPHTHALMOLOGY, V96, P772; Veckeneer M, 2009, BRIT J OPHTHALMOL, V93, P268, DOI 10.1136/bjo.2008.147306; Weichel ED, 2006, OPHTHALMOLOGY, V113, P2033, DOI 10.1016/j.ophtha.2006.05.038; Zhou CD, 2018, J INT MED RES, V46, P316, DOI 10.1177/0300060517724931	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239138	10.1371/journal.pone.0239138	http://dx.doi.org/10.1371/journal.pone.0239138			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970724	gold, Green Published			2022-12-26	WOS:000576265600068
J	Liu, QB; Fang, XM; Tokuno, SNC; Chung, U; Chen, XX; Dai, XY; Liu, XY; Xu, F; Wang, B; Peng, P				Liu, Qibin; Fang, Xuemin; Tokuno, Shinichi; Chung, Ungil; Chen, Xianxiang; Dai, Xiyong; Liu, Xiaoyu; Xu, Feng; Wang, Bing; Peng, Peng			A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity	PLOS ONE			English	Article							PERIPHERAL-BLOOD; CORONAVIRUS; INFECTION; PNEUMONIA	Wuhan, China was the epicenter of the 2019 coronavirus outbreak. As a designated hospital for COVID-19, Wuhan Pulmonary Hospital has received over 700 COVID-19 patients. With the COVID-19 becoming a pandemic all over the world, we aim to share our epidemiological and clinical findings with the global community. We studied 340 confirmed COVID-19 patients with clear clinical outcomes from Wuhan Pulmonary Hospital, including 310 discharged cases and 30 death cases. We analyzed their demographic, epidemiological, clinical and laboratory data and implemented our findings into an interactive, free access web application to evaluate COVID-19 patient's severity level. Our results show that baseline T cell subsets results differed significantly between the discharged cases and the death cases in Mann Whitney U test: Total T cells (p < 0.001), Helper T cells (p <0.001), Suppressor T cells (p <0.001), and TH/TSC (Helper/Suppressor ratio, p<0.001). Multivariate logistic regression model with death or discharge as the outcome resulted in the following significant predictors: age (OR 1.05, 95% CI, 1.00 to 1.10), underlying disease status (OR 3.42, 95% CI, 1.30 to 9.95), Helper T cells on the log scale (OR 0.22, 95% CI, 0.12 to 0.40), and TH/TSC on the log scale (OR 4.80, 95% CI, 2.12 to 11.86). The AUC for the logistic regression model is 0.90 (95% CI, 0.84 to 0.95), suggesting the model has a very good predictive power. Our findings suggest that while age and underlying diseases are known risk factors for poor prognosis, patients with a less damaged immune system at the time of hospitalization had higher chance of recovery. Close monitoring of the T cell subsets might provide valuable information of the patient's condition change during the treatment process. Our web visualization application can be used as a supplementary tool for the evaluation.	[Liu, Qibin; Chen, Xianxiang; Dai, Xiyong; Liu, Xiaoyu; Xu, Feng; Wang, Bing; Peng, Peng] Wuhan Pulm Hosp, Wuhan Inst TB Control, Wuhan, Hubei, Peoples R China; [Fang, Xuemin; Tokuno, Shinichi; Chung, Ungil] Kanagawa Univ Human Serv, Grad Sch Hlth Innovat, Kawasaki, Kanagawa, Japan		Peng, P (corresponding author), Wuhan Pulm Hosp, Wuhan Inst TB Control, Wuhan, Hubei, Peoples R China.	pengpengwg@126.com	Tokuno, Shinichi/L-1117-2019	Tokuno, Shinichi/0000-0002-2691-6979; Liu, Qibin/0000-0003-4863-4806				[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, ANESTHESIOLOGY, V133, pA12, DOI [10.1097/ALN.0000000000003457, DOI 10.1097/ALN.0000000000003457]; Aziz N, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017525; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Beely C., 2013, WEB APPL DEV R USING, V1st; Chen J, 2010, J VIROL, V84, P1289, DOI 10.1128/JVI.01281-09; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; December I, 2020, LANCET, V6736, P1; Ezenkwu Chinedu Pascal, 2015, International Journal of Advanced Research in Artificial Intelligence, V4, P40; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Garrido-Rodriguez D, 2016, IMMUNOGENETICS, V68, P703, DOI 10.1007/s00251-016-0920-3; Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Haverkos BM, 2016, CURR HEMATOL MALIG R, V11, P514, DOI 10.1007/s11899-016-0355-9; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kokuina E, 2019, MEDICC REV, V21, P16, DOI 10.37757/MR2019.V21.N2-3.5; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lever J, 2017, NAT METHODS, V14, P641, DOI 10.1038/nmeth.4346; National Health Commission of the People's Republic of China, 2020, CHIN MAN GUID COVID; R Core Team, 2021, R LANGUAGE ENV STAT; Ugarte-Gil MF, 2015, RHEUMATOLOGY, V54, P1302, DOI 10.1093/rheumatology/keu434; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang DW, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-019-02206-w; Wang YM, 2020, J INFECT DIS, V221, P1688, DOI 10.1093/infdis/jiz656; World Health Organization, 2020, MENT HLTH PSYCH CONS; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737; ZWEIG MH, 1993, CLIN CHEM, V39, P561	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239695	10.1371/journal.pone.0239695	http://dx.doi.org/10.1371/journal.pone.0239695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970753	Green Published, gold			2022-12-26	WOS:000576265600020
J	Mitroi, V; Ahi, KC; Bulot, PY; Tra, F; Deroubaix, JF; Ahoutou, MK; Quiblier, C; Kone, M; Kalpy, JC; Humbert, JF				Mitroi, Veronica; Ahi, Kouadio Chrislain; Bulot, Pierre-Yves; Tra, Fulbert; Deroubaix, Jose-Frederic; Ahoutou, Mathias Koffi; Quiblier, Catherine; Kone, Mariatou; Kalpy, Julien Coulibaly; Humbert, Jean-Francois			Can participatory approaches strengthen the monitoring of cyanobacterial blooms in developing countries? Results from a pilot study conducted in the Lagoon Aghien (Ivory Coast)	PLOS ONE			English	Article							CITIZEN SCIENCE; SHALLOW LAKE; MICROCYSTIS; DYNAMICS	Monitoring of cyanobacteria in freshwater ecosystems is a complex task, which is time consuming and expensive due to the chaotic population dynamics and highly heterogeneous distribution of cyanobacteria populations in water bodies. The financial cost constitutes a strong limitation for the implementation of long-term monitoring programs in developing countries, particularly in Africa. The work presented here was performed in the framework of an international project addressing the sustainable monitoring and management of surface water resources used for the production of drinking water in three African countries. We tested the potential of a citizen approach for monitoring cyanobacterial blooms, which are a growing threat to the drinking water supply. This pilot study was designed, implemented and evaluated in close interaction with the Pasteur Institute of the Ivory Coast and with the populations of three villages located on the shoreline of a freshwater lagoon located near Abidjan city. Based on the use of a smartphone application, the citizens of the three villages were invited to report water color changes, as these changes could reflect cyanobacteria proliferations. A two-year experimentation period has shown that it is possible to mobilize the local populations to monitor cyanobacterial blooms. The data collected by citizens were consistent with the data obtained by a classical monitoring of cyanobacteria performed over seven months, but it appeared that new approaches were needed to validate the citizen data. This participatory approach also provided great improvements to the understanding and awareness of local populations regarding water quality and cyanobacterial bloom issues. Finally, we discuss some of the difficulties and limitations of our participatory monitoring approach that should be considered by further implementations. Despite these difficulties, our work suggests that citizen monitoring is a promising approach that may complement the classical approach to sustainable monitoring of cyanobacteria in developing countries.	[Mitroi, Veronica; Bulot, Pierre-Yves; Humbert, Jean-Francois] Sorbonne Univ, iEES Paris, INRAE, Paris, France; [Ahi, Kouadio Chrislain; Tra, Fulbert; Kone, Mariatou] Univ Felix Houphouet Boigny, Inst Ethnosociol, Abidjan, Cote Ivoire; [Bulot, Pierre-Yves] INRAE LISIS, Cite Descartes, Marne La Vallee, France; [Deroubaix, Jose-Frederic] Ecole Ponts ParisTech, LEESU, Champs Sur Marne, France; [Ahoutou, Mathias Koffi; Kalpy, Julien Coulibaly] Inst Pasteur dAbidjan, Abidjan, Cote Ivoire; [Ahoutou, Mathias Koffi] Univ Jean Lorougnon Guede, Daloa, Cote Ivoire; [Quiblier, Catherine] MNHN, Mol Commun & Adaptat Microorganismes, UMR 7245, Paris, France; [Quiblier, Catherine] Univ Paris, Paris, France	INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ecole des Ponts ParisTech; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Humbert, JF (corresponding author), Sorbonne Univ, iEES Paris, INRAE, Paris, France.	jean-francois.humbert@upmc.fr		Humbert, Jean-Francois/0000-0002-1519-5651	Fonds Francais pour l'Environnement Mondial (FFEM)	Fonds Francais pour l'Environnement Mondial (FFEM)	This study was supported with funds from Fonds Francais pour l'Environnement Mondial (FFEM).	Ahn CY, 2008, HYDROBIOLOGIA, V596, P413, DOI 10.1007/s10750-007-9125-y; Bonney R, 2014, SCIENCE, V343, P1436, DOI 10.1126/science.1251554; Bos JS, 2019, LAKE RESERV MANAGE, V35, P77, DOI 10.1080/10402381.2018.1538172; Brovelli MA, 2016, ISPRS J PHOTOGRAMM, V114, P306, DOI 10.1016/j.isprsjprs.2015.04.002; Buytaert W, 2014, FRONT EARTH SC-SWITZ, V2, DOI 10.3389/feart.2014.00026; Castilla EP, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4912-9; Coccia M., 2018, J EC LIB, V5, P241; Cuypers Y, 2011, ISME J, V5, P580, DOI 10.1038/ismej.2010.154; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; Dube T, 2015, AFR J AQUAT SCI, V40, P1, DOI 10.2989/16085914.2015.1014994; Duvail S., 2017, Natures Sciences Societes, V25, P347, DOI 10.1051/nss/2018002; Garneau ME, 2013, LIMNOL OCEANOGR, V58, P1892, DOI 10.4319/lo.2013.58.5.1892; Hunter PD, 2008, LIMNOL OCEANOGR, V53, P2391, DOI 10.4319/lo.2008.53.6.2391; Koffi SE, 2019, HYDROLOG SCI J, V64, P1893, DOI 10.1080/02626667.2019.1672875; Laplace-Treyture C, 2009, PROTOCOLE STANDARDIS; Le Vu B, 2011, BIOGEOCHEMISTRY, V106, P229, DOI 10.1007/s10533-010-9446-1; Mazumdar S., 2018, CITIZEN SCI INNOVATI, P303, DOI DOI 10.14324/111.9781787352339; McGonigle AJS, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010223; Mishra DR, 2020, HARMFUL ALGAE, V96, DOI 10.1016/j.hal.2020.101828; Moore TS, 2019, REMOTE SENS ENVIRON, V225, P347, DOI 10.1016/j.rse.2019.02.025; Nare L, 2011, PHYS CHEM EARTH, V36, P1063, DOI 10.1016/j.pce.2011.08.006; Pobel D, 2011, WATER RES, V45, P1005, DOI 10.1016/j.watres.2010.10.011; Pocock MJO, 2019, J APPL ECOL, V56, P274, DOI 10.1111/1365-2664.13279; Poisson AC, 2020, FRONT ECOL ENVIRON, V18, P19, DOI 10.1002/fee.2128; Requier F, 2020, FRONT ECOL ENVIRON, V18, P101, DOI 10.1002/fee.2150; Sarnelle O, 2010, WATER RES, V44, P141, DOI 10.1016/j.watres.2009.09.014; Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017; Steffensen DA, 2008, ADV EXP MED BIOL, V619, P855, DOI 10.1007/978-0-387-75865-7_37; Sturm U, 2018, RIO, pe23394; Welker M, 2003, ARCH HYDROBIOL, V157, P227, DOI 10.1127/0003-9136/2003/0157-0227; World Bank, 2012, WAT HACK LESS LEARN	31	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238832	10.1371/journal.pone.0238832	http://dx.doi.org/10.1371/journal.pone.0238832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970701	gold, Green Published			2022-12-26	WOS:000576265600056
J	Moisan, G; Descarreaux, M; Cantin, V				Moisan, Gabriel; Descarreaux, Martin; Cantin, Vincent			The influence of footwear on walking biomechanics in individuals with chronic ankle instability	PLOS ONE			English	Article							MUSCLE-ACTIVITY; SEX-DIFFERENCES; KINEMATICS; BAREFOOT; GAIT; PRESSURE; KINETICS; SPRAIN; SHOES; YOUNG	Background/Purpose The effects of footwear on the walking kinematics, kinetics and electromyography (EMG) of individuals with chronic ankle instability (CAI) at different speeds are still unknown. The objective of this cross-sectional study was to evaluate the kinematic, kinetic and electromyography differences between shod and barefoot walking at comfortable (CW) and fast (FW) speeds in individuals with CAI. Methods Twenty-one individuals with CAI walked on a 5-meter walkway shod and barefoot at CW and FW speeds. A force plate was used to record the ground reaction forces, a 3-D motion analysis system to record the lower limb kinematics and a surface EMG system to collect the gluteus medius, vastus lateralis, gastrocnemius lateralis, gastrocnemius medialis, peroneus longus and tibialis anterior muscles activity. The dependent variables were ankle and knee angles and moments and normalized muscle activity. The shod and barefoot data during CW and FW were compared using a one-dimensional non-parametric mapping analysis. Results The main results of this study were that individuals with CAI exhibited more ankle dorsiflexion angle, knee extension and tibialis anterior muscle activation during the beginning of the stance phase during shod compared to barefoot walking. Also, the biomechanical effects of shoes are similar during walking at FW and CW. Conclusion The biomechanical deficits associated with CAI were partly attenuated during the shod compared to the barefoot condition and these effects were similar at CW and FW. These findings are compatible with the concept that locomotor interventions using suitable shoes may enhance gait abilities in individuals with CAI.	[Moisan, Gabriel] Univ Quebec Trois Rivieres, Dept Anat, Trois Rivieres, PQ, Canada; [Moisan, Gabriel; Descarreaux, Martin; Cantin, Vincent] Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ, Canada; [Moisan, Gabriel; Descarreaux, Martin; Cantin, Vincent] Univ Quebec Trois Rivieres, Grp Rech Affect Neuromusculosquelett GRAN, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Trois Rivieres	Moisan, G (corresponding author), Univ Quebec Trois Rivieres, Dept Anat, Trois Rivieres, PQ, Canada.; Moisan, G (corresponding author), Univ Quebec Trois Rivieres, Dept Human Kinet, Trois Rivieres, PQ, Canada.; Moisan, G (corresponding author), Univ Quebec Trois Rivieres, Grp Rech Affect Neuromusculosquelett GRAN, Trois Rivieres, PQ, Canada.	gabriel.moisan@uqtr.ca		Moisan, Gabriel/0000-0002-1688-4811	Canadian Institutes of Health Research (CIHR); Fonds de Recherche du Quebec-Sante (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS)	This study was funded by the Canadian Institutes of Health Research (CIHR) and the Fonds de Recherche du Quebec-Sante (FRQS) through scholarships received by the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, MED LETT DRUGS THER, V60, P1; [Anonymous], 2002, J ATHL TRAINING, V37, P364; Borloz S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-40; Boyer KA, 2017, EXP GERONTOL, V95, P63, DOI 10.1016/j.exger.2017.05.005; Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; Bruening DA, 2015, GAIT POSTURE, V41, P540, DOI 10.1016/j.gaitpost.2014.12.011; Chinn L, 2013, PHYS THER SPORT, V14, P232, DOI 10.1016/j.ptsp.2012.10.001; Criniere L, 2011, J PHYS ACT HEALTH, V8, P858, DOI 10.1123/jpah.8.6.858; Daud R, 2013, J FOOT ANKLE SURG, V52, P426, DOI 10.1053/j.jfas.2013.03.007; Dubbeldam R, 2010, CLIN BIOMECH, V25, P796, DOI 10.1016/j.clinbiomech.2010.06.007; Fong DTP, 2009, AM J SPORT MED, V37, P822, DOI 10.1177/0363546508328102; Francis CA, 2013, GAIT POSTURE, V38, P993, DOI 10.1016/j.gaitpost.2013.05.009; Franklin S, 2015, GAIT POSTURE, V42, P230, DOI 10.1016/j.gaitpost.2015.05.019; Fukano M, 2018, HUM MOVEMENT SCI, V61, P117, DOI 10.1016/j.humov.2018.06.003; Gribble PA, 2014, J ATHL TRAINING, V49, P121, DOI 10.4085/1062-6050-49.1.14; Hall JPL, 2013, SPORTS MED, V43, P1335, DOI 10.1007/s40279-013-0084-3; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Imai K, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0086-5; Jannink M, 2006, FOOT ANKLE INT, V27, P974, DOI 10.1177/107110070602701119; Keenan GS, 2011, GAIT POSTURE, V33, P350, DOI 10.1016/j.gaitpost.2010.09.019; Kristianslund E, 2011, J BIOMECH, V44, P2576, DOI 10.1016/j.jbiomech.2011.07.014; Moisan G, 2020, J ELECTROMYOGR KINES, V51, DOI 10.1016/j.jelekin.2020.102399; Moisan G, 2017, GAIT POSTURE, V52, P381, DOI 10.1016/j.gaitpost.2016.11.037; Murley GS, 2014, GAIT POSTURE, V39, P1080, DOI 10.1016/j.gaitpost.2014.01.018; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oeffinger D, 1999, GAIT POSTURE, V9, P95, DOI 10.1016/S0966-6362(99)00005-3; Otte TG, 2013, HIST J, V56, P175, DOI 10.1017/S0018246X1200057X; Pataky TC, 2015, J BIOMECH, V48, P1277, DOI 10.1016/j.jbiomech.2015.02.051; Redmond AC, 2006, CLIN BIOMECH, V21, P89, DOI 10.1016/j.clinbiomech.2005.08.002; Sacco ICN, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-24; Scott LA, 2012, J ELECTROMYOGR KINES, V22, P1010, DOI 10.1016/j.jelekin.2012.06.008; Son SJ, 2019, J ATHL TRAINING, V54, P684, DOI 10.4085/1062-6050-478-17; Trombini-Souza F, 2015, CLIN BIOMECH, V30, P1194, DOI 10.1016/j.clinbiomech.2015.08.004; Wei F, 2015, COMPUT METHOD BIOMEC, V18, P243, DOI 10.1080/10255842.2013.792809; Wirth B, 2011, FOOTWEAR SCI, V3, P159, DOI 10.1080/19424280.2011.633104; Zhang XL, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-45	36	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239621	10.1371/journal.pone.0239621	http://dx.doi.org/10.1371/journal.pone.0239621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970751	gold, Green Published			2022-12-26	WOS:000576265600085
J	Zhang, SD; Li, QY; Yin, YS; Zhang, CL				Zhang Shaodi; Li Qiuyuan; Yin Yisha; Zhang Cuilian			The effect of endometrial thickness on pregnancy outcomes of frozen-thawed embryo transfer cycles which underwent hormone replacement therapy	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; LIVE BIRTH-RATES; AFFECTS IMPLANTATION; CLINICAL PREGNANCY; NATURAL CYCLE; PATTERN; IVF	Objective To investigate the impact of endometrial thickness on the embryo transfer(ET) day on the clinical pregnancy outcomes of frozen-thawed embryo transfer cycles which have undergone hormone replacement therapy(HRT-FET). Methods A total of 10,165 HRT-FET cycles performed between January 2013 to December 2017 in the Reproductive Medicine Center of Henan Provincial People's Hospital were studied retrospectively. All patients were grouped according to their endometrial thickness on the ET day (each group having an increment of 1mm between two neighboring groups). Multivariate regression analysis, curve fitting and threshold effect analysis were performed on all data. Results After adjusting for the age, duration of infertility, body mass index(BMI), infertility type and number and type of embryos transferred, a significant correlation was observed to be between the endometrial thickness and implantation rates (aOR: 1.08; 95% CI: 1.06-1.10, p < 0.0001), clinical pregnancy rate(aOR: 1.10; 95% CI: 1.07-1.14, p < 0.0001)and live birth rate (aOR: 1.09; 95% CI: 1.06-1.12, p < 0.0001). The numerical value of the cut-off point for the endometrial thickness was 8.7 mm. When the endometrial thickness was less than 8.7 mm, with each additional 1 mm of endometrial thickness, the implantation rate increased by 32%, the clinical pregnancy rate increased by 36%, and the live birth rate increased by 45%. Conclusions In the HRT-FET cycles, the optimal live birth rate would be obtained when the endometrial thickness remains within the range of 8.7-14.5 mm. If the endometrium is too thin or too thick, the live birth rate will be reduced.	[Zhang Shaodi; Li Qiuyuan; Yin Yisha; Zhang Cuilian] Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Reprod Med Ctr,Henan Univ, Zhengzhou, Henan, Peoples R China	Henan University; Zhengzhou University	Zhang, SD (corresponding author), Zhengzhou Univ, Peoples Hosp, Henan Prov Peoples Hosp, Reprod Med Ctr,Henan Univ, Zhengzhou, Henan, Peoples R China.	zhangshd@126.com						Agha-Hosseini M, 2018, TURK J OBSTET GYNECO, V15, P12, DOI 10.4274/tjod.47855; Barker MA, 2009, J ASSIST REPROD GEN, V26, P243, DOI 10.1007/s10815-009-9312-z; Bu Z, 2015, PLOS ONE, DOI [10.1371/journal.pone.0145703, DOI 10.1371/J0URNAL.P0NE.0145703]; Bu ZQ, 2016, GYNECOL ENDOCRINOL, V32, P524, DOI 10.3109/09513590.2015.1136616; Check JH, 2004, FERTIL STERIL, V81, P1399, DOI 10.1016/j.fertnstert.2004.01.020; Delisle MF, 1998, J ULTRAS MED, V17, P481; El-Toukhy T, 2008, FERTIL STERIL, V89, P832, DOI 10.1016/j.fertnstert.2007.04.031; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Gingold JA, 2015, FERTIL STERIL, V104, P620, DOI 10.1016/j.fertnstert.2015.05.036; Groenewoud ER, 2018, ACTA OBSTET GYN SCAN, V97, P808, DOI 10.1111/aogs.13349; Groenewoud ER, 2018, FERTIL STERIL, V109, P768, DOI 10.1016/j.fertnstert.2018.02.135; Haas J, 2009, ATHEROSCLEROSIS SUPP, V10; Jimenez PT, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-35; Kasius A, 2014, HUM REPROD UPDATE, V20, P530, DOI 10.1093/humupd/dmu011; Lamanna G, 2008, FERTIL STERIL, V90, P1272, DOI 10.1016/j.fertnstert.2007.08.056; Liu KE, 2018, HUM REPROD, V33, P1883, DOI 10.1093/humrep/dey281; Momeni Mazdak, 2011, J Hum Reprod Sci, V4, P130, DOI 10.4103/0974-1208.92287; Ribeiro VC, 2018, REPROD BIOMED ONLINE, V36, P416, DOI 10.1016/j.rbmo.2017.12.016; Richter KS, 2007, FERTIL STERIL, V87, P53, DOI 10.1016/j.fertnstert.2006.05.064; Tabibzadeh S, 1998, HUM REPROD UPDATE, V4, P465, DOI 10.1093/humupd/4.5.465; Vaegter KK, 2017, FERTIL STERIL, V107, P641, DOI 10.1016/j.fertnstert.2016.12.005	21	9	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239120	10.1371/journal.pone.0239120	http://dx.doi.org/10.1371/journal.pone.0239120			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970718	Green Published, gold			2022-12-26	WOS:000576265600045
J	Zhang, Z; Guo, YS; Fu, R; Yuan, W; Wang, C				Zhang, Zhi; Guo, Yingshi; Fu, Rui; Yuan, Wei; Wang, Chang			Linking executive functions to distracted driving, does it differ between young and mature drivers?	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; COGNITIVE FUNCTION; BEHAVIOR; ATTITUDES; PERSONALITY; ADOLESCENT; IMPULSES; TIME	Distracted driving is a leading cause of traffic accidents. Certain executive functions significantly affect the willingness of distracted driving; however, little research has compared the effects of executive functions on distracted driving behaviors in different aged populations. This study explores and compares the behavioral and cognitive processes underlying distracted driving behaviors in young and mature drivers. A total of 138 participants aged 18-65 years old completed a self-report questionnaire for measuring executive function index and distracted driving behaviors. Independent sample t-tests were conducted for executive functions (motivational drive, organization, strategic planning, impulse control, and empathy) and driving variables to examine any differences between young and mature groups. Partial correlation coefficients and z-score of these comparisons were calculated to compare the differences between age groups. Furthermore, multiple hierarchical regression models were constructed to determine the relative contributions of age, gender, and executive functions on distracted driving behaviors. Results demonstrated the following: (1) Mature drivers performed better for impulse control, the executive function index as well as the measure of distracted driving behavior than young drivers; (2) the relationships between executive functions and distracted driving behaviors did not significantly differ between young and mature drivers; (3) for both young and mature drivers, motivational drive and impulse control were found to significantly improve the prediction of distracted driving behavior in regression models. The findings emphasize that similar behavioral and cognitive processes are involved in distracted driving behavior of young and mature drivers, and can promote a single strategy for driver education and accident prevention interventions for both age groups.	[Zhang, Zhi; Guo, Yingshi; Fu, Rui; Yuan, Wei; Wang, Chang] Changan Univ, Sch Automobile, Xian, Peoples R China	Chang'an University	Zhang, Z; Guo, YS (corresponding author), Changan Univ, Sch Automobile, Xian, Peoples R China.	zhangzhi@chd.edu.cn; guoys@chd.edu.cn		zhang, zhi/0000-0002-8023-2711	National Key R&D Program of China [2019YFB1600500]; National Nature Science Foundation of China [51775053]; Changjiang Scholars and Innovative Research Team in University [IRT_17R95]	National Key R&D Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work is supported by National Key R&D Program of China (2019YFB1600500), the National Nature Science Foundation of China (51775053) and the Changjiang Scholars and Innovative Research Team in University (IRT_17R95).	Aksan N, 2015, ACCIDENT ANAL PREV, V75, P236, DOI 10.1016/j.aap.2014.12.007; Albert DA, 2018, ACCIDENT ANAL PREV, V111, P125, DOI 10.1016/j.aap.2017.11.019; Atchley P, 2011, ACCIDENT ANAL PREV, V43, P134, DOI 10.1016/j.aap.2010.08.003; Beilock SL, 2005, PSYCHOL SCI, V16, P101, DOI 10.1111/j.0956-7976.2005.00789.x; Brown TG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150227; Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Friese M, 2008, BRIT J SOC PSYCHOL, V47, P397, DOI 10.1348/014466607X241540; Groeger, 2013, UNDERSTING DRIVIN; Hayashi Y, 2018, TRANSPORT RES F-TRAF, V52, P51, DOI 10.1016/j.trf.2017.11.007; Hayashi Y, 2017, ACCIDENT ANAL PREV, V102, P72, DOI 10.1016/j.aap.2017.02.016; Hofmann W, 2008, J ABNORM PSYCHOL, V117, P420, DOI 10.1037/0021-843X.117.2.420; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Ledger S, 2019, TRANSPORT RES F-TRAF, V60, P262, DOI 10.1016/j.trf.2018.10.024; Louie JF, 2019, APPL ERGON, V74, P154, DOI 10.1016/j.apergo.2018.07.004; Mantyla T, 2009, APPL NEUROPSYCHOL, V16, P11, DOI 10.1080/09084280802644086; Meyers L.S., 2016, APPL MULTIVARIATE RE, Vthird; NHTSA, 2019, DISTR DRIV FAT CRASH; Pope CN, 2017, ACCIDENT ANAL PREV, V98, P123, DOI 10.1016/j.aap.2016.09.030; Romer D, 2011, DEVELOPMENTAL SCI, V14, P1119, DOI 10.1111/j.1467-7687.2011.01061.x; Ross V, 2015, APPL NEUROPSYCH-ADUL, V22, P61, DOI 10.1080/23279095.2013.838958; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Spinella M, 2005, INT J NEUROSCI, V115, P649, DOI 10.1080/00207450590524304; Starkey NJ, 2016, TRANSPORT RES F-TRAF, V38, P127, DOI 10.1016/j.trf.2016.01.013; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tabibi Z, 2015, TRANSPORT RES F-TRAF, V34, P18, DOI 10.1016/j.trf.2015.07.015; Tekin S, 2002, J PSYCHOSOM RES, V53, P647, DOI 10.1016/S0022-3999(02)00428-2; W. H. Organization, 2018, VIOL INJ PREV WHO GL; Wang C, 2019, ACCIDENT ANAL PREV, V125, P98, DOI 10.1016/j.aap.2019.01.030; Welburn S.C., 2010, 2010 U AL BIRM EXP U; Yadav AK, 2019, TRANSPORT RES F-TRAF, V64, P227, DOI 10.1016/j.trf.2019.05.011; Zardeckaite-Matulaitiene K, 2013, TRANSP MEANS, P29; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zhang Z, 2019, IEEE ACCESS, V7, P184572, DOI 10.1109/ACCESS.2019.2960830; Zhang Z, 2020, COGN TECHNOL WORK, V22, P759, DOI 10.1007/s10111-020-00630-3; Zicat E, 2018, TRANSPORT RES F-TRAF, V55, P341, DOI 10.1016/j.trf.2018.03.013	37	5	5	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239596	10.1371/journal.pone.0239596	http://dx.doi.org/10.1371/journal.pone.0239596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NY2ZZ	32970738	gold, Green Published			2022-12-26	WOS:000576265600099
J	Kopiczko, A				Kopiczko, Anna			Determinants of bone health in adults Polish women: The influence of physical activity, nutrition, sun exposure and biological factors	PLOS ONE			English	Article							MINERAL DENSITY; VITAMIN-D; PREVENTION; MASS; OSTEOPOROSIS; CALCIUM; PREVALENCE; DIAGNOSIS; EXERCISE; FRACTURE	Purpose The aim of this study was to assess the determinants of bone health in the group of women over 40 years old. Lifestyle factors such as past and present physical activity, past and present sun exposure, current dietary intake of calcium and vitamin D, nutritional status as measured by BMI, family history of osteoporosis and current hormonal status were analysed. Methods The study involved 500 women over 40 years old. All examined women was the same ethnicity- European origin. Methods used: densitometry method (DXA), bioelectrical impedance analysis, International Physical Activity Questionnaire, nutrition questionnaire, past and present sun exposure questionnaire. Past and present physical activity, past and present sun exposure and sufficient level of calcium in the diet proved to be the most important factors determining mineralization of bone tissue of women. In order to indicate an independent association of the correct bone tissue mineralization with individual factors, multivariate analysis was used-logistic regression. Results The norm BMD in the distal part of the forearm was strongly influenced: recommended dietary calcium intake (OR = 5.95; p = 0.003), moderately (OR = 1.88; p = 0.053) and high (OR = 14.0; p<0.001) past physical activity, sufficient (OR = 4.97; p<0.001) and high (OR = 18.9; p = 0.004) level of present physical activity, sufficient past (OR = 5.15; p<0.001) and sufficient present sun exposure (OR = 10.0; p<0.001). The chance for the BMD prox norm was also increased several times: high past physical activity (OR = 68.4; p<0.0001) and sufficient past sun exposure (OR = 10.6; p<0.001), moderate past activity (OR = 4.20; p<0.001), sufficient (OR = 6.13; p<0.001) and high (OR = 10.0; p<0.001) present physical activity, sufficient present sun exposure (OR = 9.09; p<0.0001), recommended intake of calcium (OR = 9.57; p<0.001) and vitamin D (OR = 2.68; p = 0.052). Whereas e significantly lower likelihood for the BMD prox norm was found in women with the oldest hormonal status (postmenopausal period) (OR = 0.18; p<0.001), with osteoporosis in the family (OR = 0.37; p<0.001) and living in an agglomeration (OR = 0.68; p = 0.03). Conclusion Interventions to increase physical activity, especially outdoors, may help reduce risk of osteoporosis, fractures and subsequent healthcare costs.	[Kopiczko, Anna] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Biomed Sci, Warsaw, Poland	Jozef Pilsudski University Physical Education in Warsaw	Kopiczko, A (corresponding author), Jozef Pilsudski Univ Phys Educ Warsaw, Dept Biomed Sci, Warsaw, Poland.	anna.kopiczko@awf.edu.pl	KOPICZKO, ANNA/AAC-5293-2019	KOPICZKO, ANNA/0000-0002-1222-113X	Jozef Pilsudski University of Physical Education in Warsaw, Poland [DM-14, DM-62]; Ministry of Science and Higher Education at Jozef Pilsudski University of Physical Education in Warsaw "Biomedical determinants of physical fitness and sports training of the adult population [5]	Jozef Pilsudski University of Physical Education in Warsaw, Poland; Ministry of Science and Higher Education at Jozef Pilsudski University of Physical Education in Warsaw "Biomedical determinants of physical fitness and sports training of the adult population	This work was supported by the Jozef Pilsudski University of Physical Education in Warsaw, Poland under science projects DM-14 and DM-62. This work was supported by the Ministry of Science and Higher Education in the year 2020 under Research Group no 5 at Jozef Pilsudski University of Physical Education in Warsaw "Biomedical determinants of physical fitness and sports training of the adult population.	Analysis of Energy Consumption and Behavior of Television in Resident Houses in Thailand, 2010, RAK SKUNPONGB P ENG, V8, P115; Andrew T, 2005, J BONE MINER RES, V20, P67, DOI 10.1359/JBMR.041015; [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Baczyk G, 2011, ARCH MED SCI, V7, P476, DOI 10.5114/aoms.2011.23415; Benedetti MG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4840531; Berkhout J, 2016, CPT-PHARMACOMET SYST, V5, P656, DOI 10.1002/psp4.12135; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Bolton CE, 2004, AM J RESP CRIT CARE, V170, P1286, DOI 10.1164/rccm.200406-754OC; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Farrar MD, 2016, J CLIN ENDOCR METAB, V101, P3105, DOI 10.1210/jc.2016-1559; Ferrari S, 2012, OSTEOPOROSIS INT, V23, P2735, DOI 10.1007/s00198-012-2030-x; Ferrari S, 2008, BEST PRACT RES CL EN, V22, P723, DOI 10.1016/j.beem.2008.08.007; Forwood M R, 2000, Aust Fam Physician, V29, P761; Gibson R, 2005, PRINCIPLES NUTR ASSE; Hall Judith G., 2007, HDB PHYS MEASUREMENT; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Holick MF, 2008, CLIN J AM SOC NEPHRO, V3, P1548, DOI 10.2215/CJN.01350308; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollis BW, 2004, AM J CLIN NUTR, V80, p1752S, DOI 10.1093/ajcn/80.6.1752S; Ilich JZ, 2003, EUR J CLIN NUTR, V57, P554, DOI 10.1038/sj.ejcn.1601577; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kim KM, 2014, J CLIN ENDOCR METAB, V99, P2409, DOI 10.1210/jc.2014-1006; Kolarzyk E., 2017, PROBL HIG EPIDEMIOL, V98, P177; Kopiczko A, 2020, ARCH MED SCI, V16, P657, DOI 10.5114/aoms.2019.81314; Kopiczko A, 2018, HOMO, V69, P209, DOI 10.1016/j.jchb.2018.08.003; Kopiczko A, 2014, MENOPAUSE REV, V13, P79, DOI 10.5114/pm.2014.42707; Kumar A, 2010, J BONE MINER METAB, V28, P192, DOI 10.1007/s00774-009-0118-y; Lata PF, 2007, NUTR CLIN PRACT, V22, P261, DOI 10.1177/0115426507022003261; Lewiecki EM, 2016, J CLIN DENSITOM, V19, P127, DOI 10.1016/j.jocd.2016.03.003; Lombard C, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-2, 10.1186/1471-2458-9-213]; Lopuszanska-Dawid M, 2018, ANTHROPOL ANZ, V75, P175, DOI 10.1127/anthranz/2018/0814; Macdonald HM, 2004, AM J CLIN NUTR, V79, P155; O'Connor KA, 2001, AM J HUM BIOL, V13, P465, DOI 10.1002/ajhb.1078; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Potter JL, 2014, J HUM NUTR DIET, V27, P569, DOI 10.1111/jhn.12198; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; Robitaille J, 2008, AM J PREV MED, V35, P47, DOI 10.1016/j.amepre.2008.03.027; Rothman M, 2019, S AFR J CLIN NUTR, V32, P21, DOI 10.1080/16070658.2017.1415783; Saag KG, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2815; Sobas K, 2015, IRAN J PUBLIC HEALTH, V44, P939; Szklarska A, 2002, ANTHR REV, V65, P43; Wallace BA, 2000, CALCIFIED TISSUE INT, V67, P10, DOI 10.1007/s00223001089; Weaver CM, 2017, ORAL DIS, V23, P412, DOI 10.1111/odi.12515; World Health Organization, 2010, Global recommendations on physical activity for health; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; Zhao RQ, 2014, SPORTS MED, V44, P1393, DOI 10.1007/s40279-014-0220-8; Zhou ZX, 2013, CLIN INTERV AGING, V8, P1451, DOI 10.2147/CIA.S48447	48	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0238127	10.1371/journal.pone.0238127	http://dx.doi.org/10.1371/journal.pone.0238127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960898	gold, Green Published			2022-12-26	WOS:000575109500035
J	Li, F; Xu, RJ; Lin, CL; Low, BE; Cai, L; Li, S; Ji, P; Huang, LQ; Wiles, MV; Hannun, YA; Obeid, LM; Chen, Y; Mao, CG				Li, Fang; Xu, Ruijuan; Lin, Chih-Li; Low, Benjamin E.; Cai, Louise; Li, Sally; Ji, Ping; Huang, Liqun; Wiles, Michael V.; Hannun, Yusuf A.; Obeid, Lina M.; Chen, Ye; Mao, Cungui			Maternal and fetal alkaline ceramidase 2 is required for placental vascular integrity in mice	FASEB JOURNAL			English	Article						ACER2; ceramidase; placenta; sphingosine; sphingosine-1-phosphate; vasculature	PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; SPHINGOLIPID METABOLISM; CELL-PROLIFERATION; SPHINGOSINE-1-PHOSPHATE; EDG-1; ANGIOGENESIS; INVOLVEMENT; INHIBITION; EXPRESSION	Sphingolipids have been implicated in mammalian placental development and function, but their regulation in the placenta remains unclear. Herein we report that alkaline ceramidase 2 (ACER2) plays a key role in sustaining the integrity of the placental vasculature by regulating the homeostasis of sphingolipids in mice. The mouse alkaline ceramidase 2 gene (Acer2) is highly expressed in the placenta between embryonic day (E) 9.5 and E12.5.Acer2deficiency in both the mother and fetus decreases the placental levels of sphingolipids, including sphingoid bases (sphingosine and dihydrosphingosine) and sphingoid base-1-phosphates (sphingosine-1-phosphate and dihydrosphingosine-1-phosphate) and results in thein uterodeath of approximate to 50% of embryos at E12.5 whereasAcer2deficiency in either the mother or fetus has no such effects.Acer2deficiency causes hemorrhages from the maternal vasculature in the junctional and/or labyrinthine zones in E12.5 placentas. Moreover, hemorrhagic but not non-hemorrhagicAcer2-deficient placentas exhibit an expansion of parietal trophoblast giant cells with a concomitant decrease in the area of the fetal blood vessel network in the labyrinthine zone, suggesting thatAcer2deficiency results in embryonic lethality due to the atrophy of the fetal blood vessel network in the placenta. Taken together, these results suggest that ACER2 sustains the integrity of the placental vasculature by controlling the homeostasis of sphingolipids in mice.	[Li, Fang; Xu, Ruijuan; Lin, Chih-Li; Ji, Ping; Huang, Liqun; Hannun, Yusuf A.; Obeid, Lina M.; Mao, Cungui] SUNY Stony Brook, Dept Med, 9M0834,MART Bldg, Stony Brook, NY 11794 USA; [Li, Fang; Xu, Ruijuan; Lin, Chih-Li; Cai, Louise; Li, Sally; Hannun, Yusuf A.; Obeid, Lina M.; Mao, Cungui] SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA; [Li, Fang; Chen, Ye] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Dept Gastroenterol,State Key Lab Organ Failure Re, 1838 North Guangzhou Rd, Guangzhou 510515, Guangdong, Peoples R China; [Low, Benjamin E.; Wiles, Michael V.] Jackson Lab, Technol Evaluat & Dev, 600 Main St, Bar Harbor, ME 04609 USA; [Obeid, Lina M.] Ralph H Johnson Vet Adm Hosp, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Southern Medical University - China; Jackson Laboratory; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mao, CG (corresponding author), SUNY Stony Brook, Dept Med, 9M0834,MART Bldg, Stony Brook, NY 11794 USA.; Chen, Y (corresponding author), Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Dept Gastroenterol,State Key Lab Organ Failure Re, 1838 North Guangzhou Rd, Guangzhou 510515, Guangdong, Peoples R China.	yechen@smu.edu.cn; cungui.mao@stonybrook.edu	xu, rui/GRX-5734-2022	wiles, michael/0000-0002-3620-8386	National Institutes of Health [R01CA163825, P01CA097132]; National Natural Science Foundation of China [81770529]; Guangdong Gastrointestinal Disease Research Center [2017B020209003]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Gastrointestinal Disease Research Center	National Institutes of Health, Grant/Award Number: R01CA163825 and P01CA097132; National Natural Science Foundation of China, Grant/Award Number: 81770529; The Guangdong Gastrointestinal Disease Research Center, Grant/Award Number: 2017B020209003	Arroyo JA, 2008, SEMIN PERINATOL, V32, P172, DOI 10.1053/j.semperi.2008.02.006; Ben Shoham A, 2012, DEVELOPMENT, V139, P3859, DOI 10.1242/dev.078550; Blaho VA, 2014, J LIPID RES, V55, P1596, DOI 10.1194/jlr.R046300; Chauvin S, 2015, J CLIN ENDOCR METAB, V100, pE986, DOI 10.1210/jc.2015-1288; Clay H, 2016, DEV BIOL, V418, P157, DOI 10.1016/j.ydbio.2016.06.024; Coan PM, 2004, BIOL REPROD, V70, P1806, DOI 10.1095/biolreprod.103.024166; Coant Nicolas, 2017, Advances in Biological Regulation, V63, P122, DOI 10.1016/j.jbior.2016.10.002; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Del Gaudio I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031019; Del Gaudio I, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158632; Ding NZ, 2018, THERIOGENOLOGY, V106, P227, DOI 10.1016/j.theriogenology.2017.09.036; Edsall LC, 1997, J NEUROSCI, V17, P6952; Hemberger M, 2020, NAT REV GENET, V21, P27, DOI 10.1038/s41576-019-0169-4; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Johnstone ED, 2005, J LIPID RES, V46, P1833, DOI 10.1194/jlr.M500095-JLR200; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Ko P, 2016, SCI REP-UK, V6, DOI 10.1038/srep21564; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Li F, 2018, FASEB J, V32; Li F, 2018, FASEB J, V32, P3058, DOI 10.1096/fj.201700445RR; Lin CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118473; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Melland-Smith M, 2015, AUTOPHAGY, V11, P653, DOI 10.1080/15548627.2015.1034414; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Mizugishi K, 2015, J BIOL CHEM, V290, P2053, DOI 10.1074/jbc.M114.628867; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Park SW, 2010, LAB INVEST, V90, P1209, DOI 10.1038/labinvest.2010.102; Proia RL, 2015, J CLIN INVEST, V125, P1379, DOI 10.1172/JCI76369; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 1998, J CELL BIOL, V142, P229, DOI 10.1083/jcb.142.1.229; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005591; Westwood M, 2017, PLACENTA, V60, P1, DOI 10.1016/j.placenta.2017.09.009; Wiltshire R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19814; Woods L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00570; Xiang YQ, 2014, J CLIN INVEST, V124, P4823, DOI 10.1172/JCI77685; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Xu RJ, 2018, CELL DEATH DIFFER, V25, P841, DOI 10.1038/s41418-017-0018-y; Xu RJ, 2016, ONCOTARGET, V7, P18440, DOI 10.18632/oncotarget.7825; Xu RJ, 2010, FASEB J, V24, P2507, DOI 10.1096/fj.09-153635; Yang WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106725; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	51	2	2	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15252	15268		10.1096/fj.202001104R	http://dx.doi.org/10.1096/fj.202001104R		SEP 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959379	Green Accepted			2022-12-26	WOS:000573861600001
J	Chan, ST; Evans, KC; Song, TY; Selb, J; van der Kouwe, A; Rosen, BR; Zheng, YP; Ahn, AC; Kwong, KK				Chan, Suk-tak; Evans, Karleyton C.; Song, Tian-yue; Selb, Juliette; van der Kouwe, Andre; Rosen, Bruce R.; Zheng, Yong-ping; Ahn, Andrew C.; Kwong, Kenneth K.			Dynamic brain-body coupling of breath-by-breath O-2-CO(2)exchange ratio with resting state cerebral hemodynamic fluctuations	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; END-TIDAL CO2; OBSTRUCTIVE SLEEP-APNEA; PULMONARY GAS-EXCHANGE; SURFACE-BASED ANALYSIS; FALSE DISCOVERY RATE; FUNCTIONAL CONNECTIVITY; BLOOD-FLOW; GLUCOSE-METABOLISM; FREQUENCY	Background The origin of low frequency cerebral hemodynamic fluctuations (CHF) in the resting state remains unknown. Breath-by breath O-2-CO(2)exchange ratio (bER) has been reported to correlate with the cerebrovascular response to brief breath hold challenge at the frequency range of 0.008-0.03Hz in healthy adults. bER is defined as the ratio of the change in the partial pressure of oxygen (Delta PO2) to that of carbon dioxide (Delta PCO2) between end inspiration and end expiration. In this study, we aimed to investigate the contribution of respiratory gas exchange (RGE) metrics (bER, Delta PO(2)and Delta PCO2) to low frequency CHF during spontaneous breathing. Methods Twenty-two healthy adults were included. We used transcranial Doppler sonography to evaluate CHF by measuring the changes in cerebral blood flow velocity (Delta CBFv) in bilateral middle cerebral arteries. The regional CHF were mapped with blood oxygenation level dependent (Delta BOLD) signal changes using functional magnetic resonance imaging. Temporal features and frequency characteristics of RGE metrics during spontaneous breathing were examined, and the simultaneous measurements of RGE metrics and CHF (Delta CBFv and Delta BOLD) were studied for their correlation. Results We found that the time courses of Delta PO(2)and Delta PCO(2)were interdependent but not redundant. The oscillations of RGE metrics were coherent with resting state CHF at the frequency range of 0.008-0.03Hz. Both bER and Delta PO(2)were superior to Delta PCO(2)in association with CHF while CHF could correlate more strongly with bER than with Delta PO(2)in some brain regions. Brain regions with the strongest coupling between bER and Delta BOLD overlapped with many areas of default mode network including precuneus and posterior cingulate. Conclusion Although the physiological mechanisms underlying the strong correlation between bER and CHF are unclear, our findings suggest the contribution of bER to low frequency resting state CHF, providing a novel insight of brain-body interaction via CHF and oscillations of RGE metrics.	[Chan, Suk-tak; Song, Tian-yue; Selb, Juliette; van der Kouwe, Andre; Rosen, Bruce R.; Ahn, Andrew C.; Kwong, Kenneth K.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02114 USA; [Evans, Karleyton C.] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Zheng, Yong-ping] Hong Kong Polytech Univ, Dept Biomed Engn, Hong Kong, Peoples R China; [Evans, Karleyton C.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Selb, Juliette] ODS Med Inc, Montreal, PQ, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Hong Kong Polytechnic University; Biogen	Chan, ST (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Charlestown, MA 02114 USA.	phoebe@nmr.mgh.harvard.edu	; Zheng, Yong-Ping/M-1197-2015	Kwong, Kenneth K./0000-0001-5056-2173; Zheng, Yong-Ping/0000-0002-3407-9226; CHAN, SUK-TAK/0000-0001-6627-3173	National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health [P41EB015896];  [S10RR023043];  [NIH-K23MH086619]	National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); ; 	This research was carried out in whole at the Athinoula A. Martinos Center for Biomedical Imaging at the Massachusetts General Hospital, using resources provided by the Center for Functional Neuroimaging Technologies, P41EB015896 (BRR), a P41 Biotechnology Resource Grant supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health, as well as the Shared Instrumentation Grant S10RR023043 (BRR). This work was also supported, in part, by NIH-K23MH086619 (KCE). The funders had no role in study design, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; AMIS TC, 1984, RESP PHYSIOL, V56, P169, DOI 10.1016/0034-5687(84)90101-4; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Bain AR, 2012, ACTA PHYSIOL, V206, P98, DOI 10.1111/j.1748-1716.2012.02452.x; Banzett RB, 2000, J APPL PHYSIOL, V88, P1597, DOI 10.1152/jappl.2000.88.5.1597; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernjak A, 2008, MICROVASC RES, V76, P224, DOI 10.1016/j.mvr.2008.07.006; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISCOE TJ, 1970, J PHYSIOL-LONDON, V208, P121, DOI 10.1113/jphysiol.1970.sp009109; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cai BQ, 2003, NUTRITION, V19, P229, DOI 10.1016/S0899-9007(02)01064-X; Carlucci A, 2015, J CLIN SLEEP MED, V11, P981, DOI 10.5664/jcsm.5008; Cernelc M, 2002, J APPL PHYSIOL, V92, P1817, DOI 10.1152/japplphysiol.00675.2001; Chan ST, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225915; Chang C, 2013, NEUROIMAGE, V68, P93, DOI 10.1016/j.neuroimage.2012.11.038; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chaya M S, 2006, BMC Complement Altern Med, V6, P28, DOI 10.1186/1472-6882-6-28; Chen HJ, 2017, NEURORADIOLOGY, V59, P905, DOI 10.1007/s00234-017-1881-4; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cummins EP, 2020, PHYSIOL REV, V100, P463, DOI 10.1152/physrev.00003.2019; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEJOURS P, 1966, RESP PHYSIOL, V1, P265, DOI 10.1016/0034-5687(66)90046-6; Deppe M, 1997, J NEUROSCI METH, V75, P147, DOI 10.1016/S0165-0270(97)00067-8; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; FENN WO, 1946, AM J PHYSIOL, V146, P637, DOI 10.1152/ajplegacy.1946.146.5.637; Ferretti G., 2015, ENERGETICS MUSCULAR, DOI [10.1007/978-3-319-05636-4, DOI 10.1007/978-3-319-05636-4]; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Garcia MC, 2018, MENOPAUSE, V25, P992, DOI 10.1097/GME.0000000000001118; GLAISTER DH, 1967, CLIN SCI, V33, P391; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gold S, 1998, HUM BRAIN MAPP, V6, P73; Golestani AM, 2015, NEUROIMAGE, V104, P266, DOI 10.1016/j.neuroimage.2014.10.031; Gooden Brett A., 1994, Integrative Physiological and Behavioral Science, V29, P6, DOI 10.1007/BF02691277; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Guyton AC, 1966, TXB MED PHYSL, V3rd; Hill RA, 2015, NEURON, V87, P95, DOI 10.1016/j.neuron.2015.06.001; HONDA Y, 1963, J APPL PHYSIOL, V18, P1053, DOI 10.1152/jappl.1963.18.6.1053; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ishibashi K, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0433-0; Ishibashi K, 2016, HUM BRAIN MAPP, V37, P2823, DOI 10.1002/hbm.23210; Keilholz S, 2018, BRAIN CONNECTIVITY D; KESTERSON J, 1989, AM J PHYSIOL, V256, pR632, DOI 10.1152/ajpregu.1989.256.3.R632; Khamankar N, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00578; Kiviniemi V, 2016, J CEREBR BLOOD F MET, V36, P1033, DOI 10.1177/0271678X15622047; KRAUSS AN, 1975, ARCH DIS CHILD, V50, P539, DOI 10.1136/adc.50.7.539; Kumar P, 2012, COMPR PHYSIOL, V2, P141, DOI 10.1002/cphy.c100069; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; LAHIRI S, 1978, RESP PHYSIOL, V34, P359, DOI 10.1016/0034-5687(78)90134-2; LAHIRI S, 1975, RESP PHYSIOL, V24, P267, DOI 10.1016/0034-5687(75)90018-3; LENFANT C, 1967, J APPL PHYSIOL, V22, P675, DOI 10.1152/jappl.1967.22.4.675; Li L, 2017, ONCOTARGET, V8, P6283, DOI 10.18632/oncotarget.14060; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10747-7; Liu HH, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101629; Liu PY, 2017, NEUROIMAGE, V146, P320, DOI 10.1016/j.neuroimage.2016.11.054; LOCKWOOD AH, 1991, J CEREBR BLOOD F MET, V11, P331, DOI 10.1038/jcbfm.1991.66; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Markus HS, 2004, J NEUROL NEUROSUR PS, V75, P353, DOI 10.1136/jnnp.2003.025825; McKay LC, 2003, J APPL PHYSIOL, V95, P1170, DOI 10.1152/japplphysiol.00641.2002; Modell H, 2015, ADV PHYSIOL EDUC, V39, P259, DOI 10.1152/advan.00107.2015; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nishi Y, 1981, MEASUREMENT THERMAL; Petersson J, 2009, RESP PHYSIOL NEUROBI, V166, P54, DOI 10.1016/j.resp.2009.01.008; Qi RF, 2014, BRAIN RES, V1576, P73, DOI 10.1016/j.brainres.2014.05.044; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ray US, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq046; REMOLINA C, 1981, NEW ENGL J MED, V304, P523, DOI 10.1056/NEJM198102263040906; RINGELSTEIN EB, 1990, ULTRASOUND MED BIOL, V16, P745, DOI 10.1016/0301-5629(90)90039-F; Rizzo MR, 2005, J CLIN ENDOCR METAB, V90, P409, DOI 10.1210/jc.2004-0390; Rocha PL, 1998, J EXP BIOL, V201, P761; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Sood A, 2007, J CLIN SLEEP MED, V3, P575; Spiegelberg A, 2016, INTERDISCIP NEUROSUR, V6, P13, DOI 10.1016/j.inat.2016.03.004; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Talairach J., 1988, COPLANAR STEREOTAXIC; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; van den Aardweg JG, 2002, AM J RESP CRIT CARE, V165, P1041, DOI 10.1164/ajrccm.165.8.2104100; Vogt KM, 2011, MAGN RESON IMAGING, V29, P1186, DOI 10.1016/j.mri.2011.07.011; Wang ZM, 2010, AM J CLIN NUTR, V92, P1369, DOI 10.3945/ajcn.2010.29885; Ward LL, 1997, SIMULTANEOUS INFEREN; Weir EK, 2005, NEW ENGL J MED, V353, P2042, DOI 10.1056/NEJMra050002; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wells RE, 2013, NEUROSCI LETT, V556, P15, DOI 10.1016/j.neulet.2013.10.001; West JB, 1992, PULMONARY PATHOPHYSI; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Xiang Ping-chao, 2009, Zhonghua Jie He He Hu Xi Za Zhi, V32, P107; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233; Zheng GH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117360; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	96	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238946	10.1371/journal.pone.0238946	http://dx.doi.org/10.1371/journal.pone.0238946			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956397	gold, Green Published, Green Submitted			2022-12-26	WOS:000574571500047
J	Kattwinkel, M; Szocs, E; Peterson, E; Schafer, RB				Kattwinkel, Mira; Szocs, Eduard; Peterson, Erin; Schafer, Ralf B.			Preparing GIS data for analysis of stream monitoring data: The R package openSTARS	PLOS ONE			English	Article							SPATIAL STATISTICAL-MODELS; MACROINVERTEBRATES; NETWORKS	Stream monitoring data provides insights into the biological, chemical and physical status of running waters. Additionally, it can be used to identify drivers of chemical or ecological water quality, to inform related management actions, and to forecast future conditions under land use and global change scenarios. Measurements from sites along the same stream may not be statistically independent, and the R package SSN provides a way to describe spatial autocorrelation when modelling relationships between measured variables and potential drivers. However, SSN requires the user to provide the stream network and sampling locations in a certain format. Likewise, other applications require catchment delineation and intersection of different spatial data. We developed the R package openSTARS that provides the functionality to derive stream networks from a digital elevation model, delineate stream catchments and intersect them with land use or other GIS data as potential predictors. Additionally, locations for model predictions can be generated automatically along the stream network. We present an example workflow of all data preparation steps. In a case study using data from water monitoring sites in Southern Germany, the resulting stream network and derived site characteristics matched those constructed using STARS, an ArcGIS custom toolbox. An advantage of openSTARS is that it relies on free and open-source GRASS GIS and R functions, unlike the original STARS toolbox which depends on proprietary ArcGIS. openSTARS also comes without a graphical user interface, to enhance reproducibility and reusability of the workflow, thereby harmonizing and simplifying the data pre-processing prior to statistical modelling. Overall, openSTARS facilitates the use of spatial regression and other applications on stream networks and contributes to reproducible science with applications in hydrology, environmental sciences and ecology.	[Kattwinkel, Mira; Szocs, Eduard; Schafer, Ralf B.] Univ Koblenz Landau, Inst Environm Sci iES, Landau, Germany; [Peterson, Erin] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld, Australia; [Peterson, Erin] Australian Res Council Ctr Excellence Math & Stat, Brisbane, Qld, Australia; [Szocs, Eduard] BASF SE, Biostat & Data Sci, Ludwigshafen, Germany	University of Koblenz & Landau; Queensland University of Technology (QUT); BASF	Kattwinkel, M (corresponding author), Univ Koblenz Landau, Inst Environm Sci iES, Landau, Germany.	mira.kattwinkel@gmx.net	Schaefer, Ralf/E-1926-2011; Szocs, Eduard/B-6385-2015	Schaefer, Ralf/0000-0003-3510-1701; Szocs, Eduard/0000-0001-5376-1194	EUINTERREG V Upper Rhine via project 1.6 SERIOR (Security-Risk-Orientation)	EUINTERREG V Upper Rhine via project 1.6 SERIOR (Security-Risk-Orientation)	MK was partly funded by the EUINTERREG V Upper Rhine via project 1.6 SERIOR (Security-Risk-Orientation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BASF SE provided support in the form of salaries for author ES at time of preparation of the manuscript, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. All other authors received no specific funding for this work. There was no additional external funding received for this study.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2012, WORK COMM SURV AUTH; Bhowmik AK, 2015, ENVIRON MODELL SOFTW, V63, P240, DOI 10.1016/j.envsoft.2014.10.017; Cressie NAC, 1993, WILEY SERIES PROBABI, DOI [10.1002/9781119115151.ch1, DOI 10.1002/9781119115151.CH1]; Domisch S, 2019, SCI TOTAL ENVIRON, V656, P797, DOI 10.1016/j.scitotenv.2018.11.348; EEA, 2013, DIG EL MOD EUR EU DE; ESRI, 2018, ARCGIS 10 6; Filipe AF, 2017, BIOL INVASIONS, V19, P2899, DOI 10.1007/s10530-017-1492-3; Frieden JC, 2014, ENVIRON MODELL SOFTW, V60, P320, DOI 10.1016/j.envsoft.2014.06.019; GRASS Development Team, 2017, GEOGRAPHIC RESOURCES; Horizon Systems Corporation, 2007, NHDPLUSV2 DOC; Isaak DJ, 2017, WATER RESOUR RES, V53, P9181, DOI 10.1002/2017WR020969; Jasiewicz J, 2011, COMPUT GEOSCI-UK, V37, P1162, DOI 10.1016/j.cageo.2011.03.003; Mantyka-Pringle CS, 2014, J APPL ECOL, V51, P572, DOI 10.1111/1365-2664.12236; Metz M, 2011, HYDROL EARTH SYST SC, V15, P667, DOI 10.5194/hess-15-667-2011; Moschet C, 2014, ENVIRON SCI TECHNOL, V48, P5423, DOI 10.1021/es500371t; Nagel D., 2017, NATL STREAM INTERNET; Peterson E. E., 2014, J STAT SOFTW, V56, P2; Peterson EE, 2013, ECOL LETT, V16, P707, DOI 10.1111/ele.12084; Post CJ, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-6646-y; Rocchini D, 2012, TRENDS ECOL EVOL, V27, P310, DOI 10.1016/j.tree.2012.03.009; Scown MW, 2017, J AM WATER RESOUR AS, V53, P944, DOI 10.1111/1752-1688.12543; Ver Hoef J. M., 2014, J STAT SOFTW, V56, P3; Ver Hoef JM, 2010, J AM STAT ASSOC, V105, P6, DOI 10.1198/jasa.2009.ap08248	24	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239237	10.1371/journal.pone.0239237	http://dx.doi.org/10.1371/journal.pone.0239237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941523	gold, Green Published			2022-12-26	WOS:000573848800111
J	Steil, AW; Kailing, JW; Armstrong, CJ; Walgenbach, DG; Klein, JC				Steil, Alex W.; Kailing, Jacob W.; Armstrong, Cade J.; Walgenbach, Daniel G.; Klein, Jennifer C.			The calmodulin redox sensor controls myogenesis	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; SKELETAL-MUSCLE; METHIONINE OXIDATION; MYOBLAST DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; OXIDIZED CALMODULIN; IN-VITRO; EXPRESSION; ACTIVATION; PROTEINS	Muscle aging is accompanied by blunted muscle regeneration in response to injury and disuse. Oxidative stress likely underlies this diminished response, but muscle redox sensors that act in regeneration have not yet been characterized. Calmodulin contains multiple redox sensitive methionines whose oxidation alters the regulation of numerous cellular targets. We have used the CRISPR-Cas9 system to introduce a single amino acid substitution M109Q that mimics oxidation of methionine to methionine sulfoxide in one or both alleles of theCALM1gene, one of three genes encoding the muscle regulatory protein calmodulin, in C2C12 mouse myoblasts. When signaled to undergo myogenesis, mutated myoblasts failed to differentiate into myotubes. Although early myogenic regulatory factors were present, cells with theCALM1M109Q mutation in one or both alleles were unable to withdraw from the cell cycle and failed to express late myogenic factors. We have shown that a single oxidative modification to a redox-sensitive muscle regulatory protein can halt myogenesis, suggesting a molecular target for mitigating the impact of oxidative stress in age-related muscle degeneration.	[Steil, Alex W.; Kailing, Jacob W.; Armstrong, Cade J.; Walgenbach, Daniel G.; Klein, Jennifer C.] Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA	University of Wisconsin System	Klein, JC (corresponding author), Univ Wisconsin, Dept Biol, La Crosse, WI 54601 USA.	jklein@uwlax.edu		Klein, Jennifer/0000-0001-9363-865X	National Institutes for Health [R15AG048286]; University of Wisconsin La Crosse Undergraduate Research and Creativity Awards	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin La Crosse Undergraduate Research and Creativity Awards	This work was supported by the National Institutes for Health (Klein R15AG048286). AWS, DGW, and JWK were supported by University of Wisconsin La Crosse Undergraduate Research and Creativity Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; Alway SE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00246; Anderson ME, 2015, J MOL CELL CARDIOL, V89, P160, DOI 10.1016/j.yjmcc.2015.10.014; [Anonymous], 2013, WOWR, V20, P1; Ardestani G, 2019, J BIOL CHEM, V294, P11876, DOI 10.1074/jbc.RA119.009235; Ardite E, 2004, AM J PATHOL, V165, P719, DOI 10.1016/S0002-9440(10)63335-4; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Balog EM, 2006, AM J PHYSIOL-HEART C, V290, pH794, DOI 10.1152/ajpheart.00706.2005; Balog EM, 2003, J BIOL CHEM, V278, P15615, DOI 10.1074/jbc.M209180200; Balogh A, 2014, CARDIOVASC RES, V101, P108, DOI 10.1093/cvr/cvt236; Baraibar MA, 2013, BIOGERONTOLOGY, V14, P339, DOI 10.1007/s10522-013-9426-7; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Boschek CB, 2008, BIOCHEMISTRY-US, V47, P131, DOI 10.1021/bi701352w; Brioche T, 2016, CURR PHARM DESIGN, V22, P2664, DOI 10.2174/1381612822666160219120531; Canton M, 2011, J AM COLL CARDIOL, V57, P300, DOI 10.1016/j.jacc.2010.06.058; Carruthers NJ, 2008, BIOCHEMISTRY-US, V47, P3085, DOI 10.1021/bi702044x; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Cui ZJ, 2012, AMINO ACIDS, V43, P505, DOI 10.1007/s00726-011-1175-9; Drazic A, 2014, BBA-PROTEINS PROTEOM, V1844, P1367, DOI 10.1016/j.bbapap.2014.01.001; EDMONDSON DG, 1992, MOL CELL BIOL, V12, P3665, DOI 10.1128/MCB.12.9.3665; Friday BB, 2003, DIFFERENTIATION, V71, P217, DOI 10.1046/j.1432-0436.2003.710303.x; Fu X, 2013, MOL CELL BIOL, V33, P4517, DOI 10.1128/MCB.01078-13; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gao J, 1998, BIOCHEMISTRY-US, V37, P9536, DOI 10.1021/bi9803877; Gao J, 2001, BIOPHYS J, V80, P1791, DOI 10.1016/S0006-3495(01)76149-8; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; Gomes MJ, 2017, ONCOTARGET, V8, P20428, DOI 10.18632/oncotarget.14670; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Hansen JM, 2007, CELL BIOL INT, V31, P546, DOI 10.1016/j.cellbi.2006.11.027; Jacobi AM, 2017, METHODS, V121, P16, DOI 10.1016/j.ymeth.2017.03.021; Jensen HH, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00396; Kaminski J, 2012, BIOCHEM PHARMACOL, V84, P1251, DOI 10.1016/j.bcp.2012.08.023; KIESS M, 1995, ONCOGENE, V10, P159; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Le Moal E, 2017, ANTIOXID REDOX SIGN, V27, P276, DOI 10.1089/ars.2016.6782; Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8; Li JL, 2013, EXP CELL RES, V319, P447, DOI 10.1016/j.yexcr.2012.12.016; Ling F, 2014, CURR TOP DEV BIOL, V110, P189, DOI 10.1016/B978-0-12-405943-6.00005-1; Lubker C, 2015, BIOCHEM PHARMACOL, V93, P196, DOI 10.1016/j.bcp.2014.11.007; Marcelo KL, 2016, TRENDS ENDOCRIN MET, V27, P706, DOI 10.1016/j.tem.2016.06.001; MARTELLI F, 1994, ONCOGENE, V9, P3579; McCarthy MR, 2015, BIOCHEM BIOPH RES CO, V456, P567, DOI 10.1016/j.bbrc.2014.11.091; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Miura H, 2018, NAT PROTOC, V13, P195, DOI 10.1038/nprot.2017.153; Moen RJ, 2014, BIOCHEM BIOPH RES CO, V453, P345, DOI 10.1016/j.bbrc.2014.09.072; Montesano A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-310; Montgomery HJ, 2003, BIOCHEMISTRY-US, V42, P7759, DOI 10.1021/bi027097h; Myers JB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15742; Nikolaienko R, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01775; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651; Pini V, 2017, CURR STEM CELL REP, V3, P137, DOI 10.1007/s40778-017-0076-6; Prochniewicz E, 2008, BIOCHEMISTRY-US, V47, P11811, DOI 10.1021/bi801080x; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; Prochniewicz E, 2007, EXP GERONTOL, V42, P931, DOI 10.1016/j.exger.2007.06.015; Rebbeck RT, 2017, SLAS DISCOV, V22, P176, DOI 10.1177/1087057116674312; Robison AJ, 2007, BIOCHEM BIOPH RES CO, V356, P97, DOI 10.1016/j.bbrc.2007.02.087; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; SHAINBERG A, 1969, EXP CELL RES, V58, P163, DOI 10.1016/0014-4827(69)90127-X; Singh K, 2013, FEBS J, V280, P3991, DOI 10.1111/febs.12188; Smith NT, 2018, J PROTEOMICS, V177, P112, DOI 10.1016/j.jprot.2018.02.015; Snijder J, 2011, J STRUCT BIOL, V174, P187, DOI 10.1016/j.jsb.2010.12.002; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Sun HY, 1999, BIOCHEMISTRY-US, V38, P105, DOI 10.1021/bi981295k; Szentesi P, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/4617801; Toutenhoofd SL, 1998, CELL CALCIUM, V23, P323, DOI 10.1016/S0143-4160(98)90028-8; Tu MK, 2016, CELL CALCIUM, V59, P91, DOI 10.1016/j.ceca.2016.02.005; Vasilaki A, 2013, FREE RADICAL BIO MED, V65, P317, DOI 10.1016/j.freeradbiomed.2013.07.008; Vezzoli M, 2011, ANTIOXID REDOX SIGN, V15, P2161, DOI 10.1089/ars.2010.3341; Walgenbach DG, 2018, BIOCHEM BIOPH RES CO, V505, P236, DOI 10.1016/j.bbrc.2018.09.052; Williamson DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE304, DOI 10.1152/ajpendo.91007.2008; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Zammit PS, 2017, SEMIN CELL DEV BIOL, V72, P19, DOI 10.1016/j.semcdb.2017.11.011	77	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239047	10.1371/journal.pone.0239047	http://dx.doi.org/10.1371/journal.pone.0239047			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941492	gold, Green Published			2022-12-26	WOS:000573848800015
J	Zuo, WL; Rostami, MR; LeBlanc, M; Kaner, RJ; O'Beirne, SL; Mezey, JG; Leopold, PL; Quast, K; Visvanathan, S; Fine, JS; Thomas, MJ; Crystal, RG				Zuo, Wu-Lin; Rostami, Mahboubeh R.; LeBlanc, Michelle; Kaner, Robert J.; O'Beirne, Sarah L.; Mezey, Jason G.; Leopold, Philip L.; Quast, Karsten; Visvanathan, Sudha; Fine, Jay S.; Thomas, Matthew J.; Crystal, Ronald G.			Dysregulation of club cell biology in idiopathic pulmonary fibrosis	PLOS ONE			English	Article							CLARA CELLS; BRONCHOALVEOLAR LAVAGE; NEUTROPHIL RECRUITMENT; SECRETORY PROTEIN; DIFFERENTIATION; AIRWAYS; INFLAMMATION; EXPRESSION; GOBLET	Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic fibrotic lung disease with an irreversible decline of lung function. "Bronchiolization", characterized by ectopic appearance of airway epithelial cells in the alveolar regions, is one of the characteristic features in the IPF lung. Based on the knowledge that club cells are the major epithelial secretory cells in human small airways, and their major secretory product uteroglobin (SCGB1A1) is significantly increased in both serum and epithelial lining fluid of IPF lung, we hypothesize that human airway club cells contribute to the pathogenesis of IPF. By assessing the transcriptomes of the single cells from human lung of control donors and IPF patients, we identified two SCGB1A1(+)club cell subpopulations, highly expressing MUC5B, a significant genetic risk factor strongly associated with IPF, and SCGB3A2, a marker heterogeneously expressed in the club cells, respectively. Interestingly, the cellular proportion of SCGB1A1(+)MUC5B(+)club cells was significantly increased in IPF patients, and this club cell subpopulation highly expressed genes related to mucous production and immune cell chemotaxis. In contrast, though the cellular proportion did not change, the molecular phenotype of the SCGB1A1(+)SCGB3A2(high)club cell subpopulation was significantly altered in IPF lung, with increased expression of mucins, cytokine and extracellular matrix genes. The single cell transcriptomic analysis reveals the cellular and molecular heterogeneity of club cells, and provide novel insights into the biological functions of club cells in the pathogenesis of IPF.	[Zuo, Wu-Lin; Rostami, Mahboubeh R.; LeBlanc, Michelle; Kaner, Robert J.; O'Beirne, Sarah L.; Mezey, Jason G.; Leopold, Philip L.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Genet Med, New York, NY 10065 USA; [Kaner, Robert J.; O'Beirne, Sarah L.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Quast, Karsten; Thomas, Matthew J.] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany; [Visvanathan, Sudha; Fine, Jay S.] Boehringer Ingelheim Pharmaceut, Ridgefield, CT USA; [Zuo, Wu-Lin] Jackson Lab Genom Med, Farmington, CT USA	Cornell University; Cornell University; Cornell University; Boehringer Ingelheim; Boehringer Ingelheim; Jackson Laboratory	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Genet Med, New York, NY 10065 USA.; Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu	O'Beirne, Sarah/K-1214-2016	O'Beirne, Sarah/0000-0003-2876-0258; Thomas, Matthew/0000-0003-3472-3904	Boehringer Ingelheim Pharmaceuticals; Department of Genetic Medicine, Weill Cornell Medical College;  [HL107882];  [HL1189541]	Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Department of Genetic Medicine, Weill Cornell Medical College; ; 	These studies were supported, in part, HL107882, HL1189541; and Boehringer Ingelheim Pharmaceuticals; and the Department of Genetic Medicine, Weill Cornell Medical College. Boehringer Ingelheim Pharmaceuticals provided partial support in the form of salaries for authors KQ, SV, JSF and MJT, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Boers JE, 1999, AM J RESP CRIT CARE, V159, P1585, DOI 10.1164/ajrccm.159.5.9806044; Buendia-Roldan I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168552; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cai Y, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0065-4; CRYSTAL RG, 1984, NEW ENGL J MED, V310, P154, DOI 10.1056/NEJM198401193100304; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Fukumoto J, 2016, AGING-US, V8, P3091, DOI 10.18632/aging.101115; FULMER JD, 1977, J CLIN INVEST, V60, P595, DOI 10.1172/JCI108811; Gamez AS, 2015, CHEST, V147, P1467, DOI 10.1378/chest.14-1174; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Guerra S, 2016, J ALLERGY CLIN IMMUN, V138, P932, DOI 10.1016/j.jaci.2016.03.047; Guha A, 2012, P NATL ACAD SCI USA, V109, P12592, DOI 10.1073/pnas.1204710109; Habermann AC, 2019, SINGLE CELL RNA SEQU, V2019, P753806; Hancock LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07768-9; Jovic S, 2016, MUCOSAL IMMUNOL, V9, P112, DOI 10.1038/mi.2015.43; Kasper M, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20171301; KAWANAMI O, 1982, LAB INVEST, V46, P39; Knudsen L, 2017, CELL TISSUE RES, V367, P607, DOI 10.1007/s00441-016-2543-2; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Laucho-Contreras ME, 2015, EUR RESPIR J, V45, P1544, DOI 10.1183/09031936.00134214; LUMSDEN AB, 1984, THORAX, V39, P844, DOI 10.1136/thx.39.11.844; Misa K, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13383; Okamoto T, 2018, AM J PHYSIOL-LUNG C, V315, pL1, DOI 10.1152/ajplung.00395.2017; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Prasse A, 2019, AM J RESP CRIT CARE, V199, P622, DOI 10.1164/rccm.201712-2551OC; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Singh G, 1997, AM J RESP CELL MOL, V17, P141, DOI 10.1165/ajrcmb.17.2.f138; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Tokita E, 2014, EUR RESPIR J, V44, P1002, DOI 10.1183/09031936.00080913; VANVYVE T, 1995, J ALLERGY CLIN IMMUN, V95, P60, DOI 10.1016/S0091-6749(95)70153-2; Whitsett JA, 2018, ANN AM THORAC SOC, V15, pS143, DOI 10.1513/AnnalsATS.201802-128AW; Wiede A, 1999, AM J RESP CRIT CARE, V159, P1330, DOI 10.1164/ajrccm.159.4.9804149; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yokoyama T, 2017, J INFLAMM-LOND, V14, DOI 10.1186/s12950-017-0168-1; Zuo WL, 2018, AM J RESP CRIT CARE, V198, P1375, DOI 10.1164/rccm.201710-2107OC	40	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0237529	10.1371/journal.pone.0237529	http://dx.doi.org/10.1371/journal.pone.0237529			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941426	gold, Green Published			2022-12-26	WOS:000573848800040
J	Cui, LM; Orita, M; Taira, Y; Takamura, N				Cui, Limeng; Orita, Makiko; Taira, Yasuyuki; Takamura, Noboru			Radiocesium concentrations in mushrooms collected in Kawauchi Village five to eight years after the Fukushima Daiichi Nuclear Power Plant accident	PLOS ONE			English	Article							FOREST ECOSYSTEMS; CS-137; ACCUMULATION; EXPOSURE	Following the Fukushima Daiichi Nuclear Power Plant accident in March 2011, radionuclides such as iodine-131, cesium-134 and cesium-137 were released into environment. In this study, we collected wild mushrooms from the Kawauchi Village of Fukushima Prefecture, located less than 30 km southwest of the Fukushima nuclear power plant, to evaluate their radiocesium (Cs-134+Cs-137) concentrations and the risk of internal radiation exposure in local residents. 342 mushroom samples were collected from 2016 to 2019. All samples were analysed for radiocesium content by a high-purity germanium detector. Among 342 mushroom samples, 260 mushroom samples (76%) were detected the radiocesium exceeding the regulatory limit of radiocesium (100 Bq/kg for general foods in Japan). The median of committed effective dose from ingestion of wild mushrooms was in the range of 0.015-0.053 mSv in 2016, 0.0025-0.0087 mSv in 2017, 0.029-0.110 mSv in 2018 and 0.011-0.036 mSv in 2019 based on the assumption that Japanese citizens consumed wild mushrooms for 1 year. Thus, our study showed that although radiocesium is still detected in mushrooms collected in Kawauchi village even after 5 to 9 years later, the committed effective dose due to consuming mushrooms was lower than 1 mSv per year. Long-term comprehensive follow-up should monitor radiocesium concentrations in wild mushrooms to support the recovery of the community after the nuclear disaster.	[Cui, Limeng; Orita, Makiko; Taira, Yasuyuki; Takamura, Noboru] Nagasaki Univ, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki, Japan; [Cui, Limeng] Beijing Res Ctr Prevent Med, Dept Radiat Protect, Beijing Ctr Dis Prevent & Control, Beijing, Peoples R China	Nagasaki University	Orita, M (corresponding author), Nagasaki Univ, Dept Global Hlth Med & Welf, Atom Bomb Dis Inst, Grad Sch Biomed Sci, Nagasaki, Japan.	orita@nagasaki-u.ac.jp	Cui, Limeng/ABF-1692-2020	cui, limeng/0000-0003-4682-442X	Ministry of the Environment	Ministry of the Environment(Ministry of the Environment, Japan)	This study was supported by the research projects on health effects of nuclear disasters of the Ministry of the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NUCL ACIDS RES, V41, pD43; Cadova M, 2017, RADIAT ENVIRON BIOPH, V56, P167, DOI 10.1007/s00411-017-0684-7; Cocchi L, 2017, ISOT ENVIRON HEALT S, V53, P620, DOI 10.1080/10256016.2017.1337761; Consumer Affairs Agency of Japan, 2013, FOOD RAD; Falandysz J, 2016, ENVIRON SCI POLLUT R, V23, P20039, DOI 10.1007/s11356-016-7205-0; Fesenko SV, 2000, RADIAT ENVIRON BIOPH, V39, P291; Fukushima prefectural government, Q A MON RAD SUBST AG; Hashimoto S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56800-5; Hosokawa Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174549; International Atomic Energy Agency, 2002, MOD MIGR ACC RAD FOR; Kunii N, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102289; Lee SH, 2018, J ENVIRON RADIOACTIV, V184, P46, DOI 10.1016/j.jenvrad.2018.01.008; Mascanzoni D, 2009, J RADIOANAL NUCL CH, V282, P427, DOI 10.1007/s10967-009-0191-7; Ministry of Health Labour and Welfare Japan, 2016, NAT HLTH NUTR SURV J, P72; Ministry of the Environment Japan, BOOKLET PROV BAS INF; Nakashima K, 2015, PEERJ, V3, DOI 10.7717/peerj.1427; Niizato T, 2016, J ENVIRON RADIOACTIV, V161, P11, DOI 10.1016/j.jenvrad.2016.04.017; Ohnuki T, 2019, ENVIRON SCI-PROC IMP, V21, P1164, DOI [10.1039/c9em00046a, 10.1039/C9EM00046A]; Orita M, 2018, PEERJ, V6, DOI 10.7717/peerj.4222; Orita M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05963-0; Orita M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28470; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Prand-Stritzko B, 2018, ENVIRON SCI POLLUT R, V25, P2409, DOI 10.1007/s11356-017-0538-5; Siric I, 2016, ENVIRON SCI POLLUT R, V23, P18239, DOI 10.1007/s11356-016-7027-0; Skrkal J, 2013, RADIAT PROT DOSIM, V157, P579, DOI 10.1093/rpd/nct172; Strand P., 2009, Annals of the ICRP, V39, P9; Takamura N, 2016, SCIENCE, V352, P666, DOI 10.1126/science.352.6286.666-a; Travnikova IG, 2001, RADIAT PROT DOSIM, V93, P331, DOI 10.1093/oxfordjournals.rpd.a006445; Tsuchiya R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189398; Tucakovic I, 2018, J ENVIRON RADIOACTIV, V181, P147, DOI 10.1016/j.jenvrad.2017.11.004; United Nations scientific committee on the effects of atomic radiation, 2013, UNSCEAR 20202021 REP, V2; Vinichuk MM, 2003, J ENVIRON RADIOACTIV, V64, P27, DOI 10.1016/S0265-931X(02)00056-5; Zarubina N, 2016, J ENVIRON RADIOACTIV, V161, P66, DOI 10.1016/j.jenvrad.2015.11.014	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239296	10.1371/journal.pone.0239296	http://dx.doi.org/10.1371/journal.pone.0239296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931520	gold, Green Published			2022-12-26	WOS:000573375500013
J	Tempel, JLT; Atkinson, S				Larsen Tempel, Jenell T.; Atkinson, Shannon			Endocrine profiling of reproductive status and evidence of pseudopregnancy in the Pacific walrus (Odobenus rosmarus divergens)	PLOS ONE			English	Article							STEROIDOGENIC ENZYMES; CORPUS-LUTEUM; IMMUNOHISTOCHEMICAL LOCALIZATION; PROGESTERONE CONCENTRATIONS; VAGINAL CYTOLOGY; BOWHEAD WHALE; PREGNANCY; HORMONES; BLUBBER; METABOLISM	Endocrine profiling is an increasingly utilized tool for detecting pregnancies in wild populations of mammals. Given the difficulty in calculating reproductive rates of Pacific walruses (Odobenus rosmarus divergens) the use of endocrine techniques for determining pregnancy rates could be particularly useful for management of the population. The goals of this study were to 1) determine if progesterone and total estrogen concentrations in ovarian tissues of female walruses could be used to determine reproductive state and 2) determine if walruses undergo a functional postpartum estrus, as is seen in other pinnipeds. Ovaries were collected from female walruses (n= 13) hunted in subsistence hunts by Alaska Native communities. Females were categorized as postpartum, full-term pregnant, pregnant diapause or unbred. Total estrogen concentrations were greatest in unbred (n= 2) and pregnant (n= 2) females. Progesterone concentrations were also nominally larger in unbred (n= 2) than pregnant (n= 2) and postpartum (n= 9) animals. Small samples sizes precluded the use of statistical comparisons among groups. Corpora lutea tissue samples in this study did not reflect the presence of a postpartum estrus in the month of May as postpartum females yielded lower total estrogen concentrations than unbred or pregnant animals. Both unbred animals were in a state of pseudopregnancy, which has not been physiologically described for this species before. The progesterone profiles in late (59 ng/g) and early (140 ng/g) pregnancy were lower than expected and fell within the range of the postpartum females (36-210 ng/g), suggesting low production of the hormone by the corpus luteum during these phases of pregnancy. Profiling reproductive hormones in free-ranging walruses demonstrates that an endocrine approach may be a valuable tool for determining reproductive status of females, however increased sample sizes and time of year must be considered to accurately separate pregnant versus pseudopregnant individuals.	[Larsen Tempel, Jenell T.; Atkinson, Shannon] Univ Alaska Fairbanks, Dept Fisheries, Coll Fisheries & Ocean Sci, Juneau Campus, Juneau, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Tempel, JLT (corresponding author), Univ Alaska Fairbanks, Dept Fisheries, Coll Fisheries & Ocean Sci, Juneau Campus, Juneau, AK 99775 USA.	larsenjenell@gmail.com		Larsen Tempel, Jenell/0000-0002-3294-2081	North Pacific Research Board; Resilience and Adaptation Program at the University of Alaska Fairbanks; Rasmuson Fisheries Science Center at the University of Alaska Fairbanks	North Pacific Research Board; Resilience and Adaptation Program at the University of Alaska Fairbanks; Rasmuson Fisheries Science Center at the University of Alaska Fairbanks	Funding for this research was provided by the North Pacific Research Board to JLT and SA, as well as the Resilience and Adaptation Program and Rasmuson Fisheries Science Center at the University of Alaska Fairbanks to JLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral RS, 2010, AQUAT MAMM, V36, P162, DOI 10.1578/AM.36.2.2010.162; Andrade JM, 2014, ANAL CHIM ACTA, V838, P1, DOI 10.1016/j.aca.2014.04.057; [Anonymous], 2017, Future Oncol, V13, P1, DOI 10.2217/fon-2017-0071; [Anonymous], 2016, JOURNAL OF HEALTH EC, V46, P1, DOI DOI 10.1016/j.jhealeco.2016.01.004; [Anonymous], 1982, WICCAN, V74, P1; Atkinson S, 1997, Rev Reprod, V2, P175, DOI 10.1530/revreprod/2.3.175; Atkinson S, 2007, REPROD BIOL PHYLOGEN, DOI [10.1201/b11001, DOI 10.1201/B11001]; Atkinson S, 2020, MAR MAMMAL SCI, V36, P6, DOI 10.1111/mms.12616; Birukawa N, 2005, ZOOL SCI, V22, P1245, DOI 10.2108/zsj.22.1245; Born EW, 2001, J ZOOL, V255, P165, DOI 10.1017/S0952836901001236; BOYD IL, 1991, CAN J ZOOL, V69, P1135, DOI 10.1139/z91-162; Champagne CD, 2018, GEN COMP ENDOCR, V266, P178, DOI 10.1016/j.ygcen.2018.05.015; Charapata P, 2018, RAPID COMMUN MASS SP, V32, P1999, DOI 10.1002/rcm.8272; Clark CT, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow050; Concannon P. W., 2009, Animal Reproduction, V6, P172; Connor RC, 1996, BEHAVIOUR, V133, P37, DOI 10.1163/156853996X00026; Dunning KR, 2010, BIOL REPROD, V83, P909, DOI 10.1095/biolreprod.110.084145; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gales NJ, 1997, J REPROD FERTIL, V111, P159; Gardner DK, 1996, FERTIL STERIL, V65, P349, DOI 10.1016/S0015-0282(16)58097-2; Gomez-Campos E, 2011, J EXP MAR BIOL ECOL, V405, P18, DOI 10.1016/j.jembe.2011.05.013; Greig DJ, 2007, J MAMMAL, V88, P67, DOI 10.1644/06-MAMM-A-060R2.1; Hall G, 2005, J AM ACAD DERMATOL, V53, P555, DOI 10.1016/j.jaad.2004.08.039; Houston AI, 2007, BEHAV ECOL, V18, P241, DOI 10.1093/beheco/arl080; Hunt KE, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou030; Ilcol YO, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-21; Ishinazaka T, 2002, J VET MED SCI, V64, P329, DOI 10.1292/jvms.64.329; Ishinazaka T, 2001, J VET MED SCI, V63, P955, DOI 10.1292/jvms.63.955; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Kastelein RA, 2002, MAR ENVIRON RES, V53, P199, DOI 10.1016/S0141-1136(01)00123-4; Kellar Nicholas M., 2014, Bulletin Southern California Academy of Sciences, V113, P58; Kellar NM, 2013, ENDANGER SPECIES RES, V22, P61, DOI 10.3354/esr00537; Kellar NM, 2013, MAR BIOL, V160, P3113, DOI 10.1007/s00227-013-2299-0; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; Kinoshita K, 2012, THERIOGENOLOGY, V77, P933, DOI 10.1016/j.theriogenology.2011.09.024; Kjeld Matthias, 2006, Aquatic Mammals, V32, P75, DOI 10.1578/AM.32.1.2006.75; Krisher RL, 2007, ANIM REPROD SCI, V98, P72, DOI 10.1016/j.anireprosci.2006.10.006; Tempel JLT, 2020, POLAR BIOL, V43, P861, DOI 10.1007/s00300-020-02693-4; Lueders I, 2018, ANIM REPROD SCI, V197, P58, DOI 10.1016/j.anireprosci.2018.08.008; Mansour AAH, 2002, MAR MAMMAL SCI, V18, P112, DOI 10.1111/j.1748-7692.2002.tb01022.x; Mashburn KL, 2004, GEN COMP ENDOCR, V136, P371, DOI 10.1016/j.ygcen.2004.01.016; MCNEILLY AS, 1979, BRIT MED BULL, V35, P151, DOI 10.1093/oxfordjournals.bmb.a071562; Mellish JE, 2005, MAR MAMMAL SCI, V21, P162, DOI 10.1111/j.1748-7692.2005.tb01217.x; Muraco HS, 2012, J ANDROL, V33, P789, DOI 10.2164/jandrol.111.015032; Perez S, 2011, MAR BIOL, V158, P1677, DOI 10.1007/s00227-011-1676-9; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P97; PIETRASZEK J, 1994, MAR MAMMAL SCI, V10, P430, DOI 10.1111/j.1748-7692.1994.tb00499.x; R Studio Team, 2019, RSTUDIO INT DEV R; REIJNDERS PJH, 1990, J REPROD FERTIL, V90, P403; RENOUF D, 1994, J REPROD FERTIL, V101, P31; RIEGER D, 1994, J REPROD FERTIL, V100, P257; Sattler R, 2017, ZOO BIOL, V36, P323, DOI 10.1002/zoo.21381; Shero MR, 2018, GEN COMP ENDOCR, V255, P78, DOI 10.1016/j.ygcen.2017.10.007; Tarpley RJ, 2016, ANAT REC, V299, P769, DOI 10.1002/ar.23337; Tetsuka M, 2004, J REPROD DEVELOP, V50, P381, DOI 10.1262/jrd.50.381; Trego ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069709; Tsubota T, 2001, REPRODUCTION, V121, P587, DOI 10.1530/reprod/121.4.587; Valenzuela-Molina M, 2018, GEN COMP ENDOCR, V261, P127, DOI 10.1016/j.ygcen.2018.02.015; Villegas-Amtmann S, 2009, J MAMMAL, V90, P1232, DOI 10.1644/08-MAMM-A-319.1	59	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239218	10.1371/journal.pone.0239218	http://dx.doi.org/10.1371/journal.pone.0239218			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931507	Green Published, gold			2022-12-26	WOS:000573375500024
J	Liu, N; Song, M; Wang, NF; Wang, Y; Wang, RF; An, XP; Qi, JW				Liu, Na; Song, Min; Wang, Naifeng; Wang, Yuan; Wang, Ruifang; An, Xiaoping; Qi, Jingwei			The effects of solid-state fermentation on the content, composition andin vitroantioxidant activity of flavonoids from dandelion	PLOS ONE			English	Article							EXTRACT	Dandelion (Taraxacum officinale), a common plant worldwide, is used as both a medicine and food. Fermentation is a food processing technology that has many advantages, such as low energy cost, changes in product characteristics, and enhanced product quality. The purpose of this study was to investigate the effect of solid-state fermentation (SSF) on the content, composition and antioxidant activity of dandelion flavonoids. Response surface methodology was used to optimize dandelion fermentation conditions. Under optimized conditions, the maximum flavone concentration was 66.05 +/- 1.89 mg/g. The flavonoid content of the crude extract from fermented dandelion (FDF) was 183.72 +/- 2.24 mg/g. The flavonoid compounds in the crude extracts were further identified by UPLC-ESI-MS/MS. A total of 229 flavonoid compounds were identified, and 57 differential flavonoids (including 27 upregulated and 30 downregulated flavonoids) between FDF and the crude extract of unfermented dandelion (DF) were observed, of which 25 were annotated to metabolic pathways. FDF displayed superior antioxidant activity to that of DF inin vitroDPPH radical-scavenging and reducing power assays. The favorable results of our investigation could provide a new way for the exploitation and utilization of dandelion, which could be promising for its application as an antioxidant and functional food additive with flavonoids as ingredients.	[Liu, Na; Song, Min; Wang, Naifeng; Wang, Yuan; Wang, Ruifang; An, Xiaoping; Qi, Jingwei] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China; [Liu, Na; Song, Min; Wang, Naifeng; Wang, Yuan; Wang, Ruifang; An, Xiaoping; Qi, Jingwei] Inner Mongolia Herbivorous Livestock Feed Engn &, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University	An, XP; Qi, JW (corresponding author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China.; An, XP; Qi, JW (corresponding author), Inner Mongolia Herbivorous Livestock Feed Engn &, Hohhot, Inner Mongolia, Peoples R China.	xiaoping_an@163.com; qijingwei_66@126.com		Liu, Na/0000-0001-8863-9631	Technologic Innovational Specific Project of Inner Mongolia Autonomous Region [KCBJ2018009]; Science and Technology Achievement Transformation Fund of Inner Mongolia Autonomous Region [CGZH2018142]; Science and Technology Project of Inner Mongolia Autonomous Region [201802047]; Major Science and Technology Program of Inner Mongolia Autonomous Region [2020ZD0004]	Technologic Innovational Specific Project of Inner Mongolia Autonomous Region; Science and Technology Achievement Transformation Fund of Inner Mongolia Autonomous Region; Science and Technology Project of Inner Mongolia Autonomous Region; Major Science and Technology Program of Inner Mongolia Autonomous Region	This work was supported by the Technologic Innovational Specific Project of Inner Mongolia Autonomous Region (No. KCBJ2018009), the Science and Technology Achievement Transformation Fund of Inner Mongolia Autonomous Region (No. CGZH2018142) to JQ, the Science and Technology Project of Inner Mongolia Autonomous Region (No.201802047) to XA, and the Major Science and Technology Program of Inner Mongolia Autonomous Region (No. 2020ZD0004) to JQ.	Aggarwal BB, 2007, ADV EXP MED BIOL, V595, P1; AGOMELATINE (Valdoxan/ Thymanax), 2013, DRUG SAFETY UPDATE, V6, pA1; [Anonymous], 2017, CANC DISCOVERY, V7, pOF12; Ayatollahi AM, 2015, IRAN J PHARM RES, V14, P955; Ben Jeddou K, 2016, FOOD CHEM, V205, P97, DOI 10.1016/j.foodchem.2016.02.108; Cruz-Zuniga JM, 2016, FOOD CHEM, V204, P420, DOI 10.1016/j.foodchem.2016.02.130; Grauso L, 2019, PHYTOCHEM REV, V18, P1115, DOI 10.1007/s11101-019-09622-2; Guo L, 2016, FOOD BIOPROD PROCESS, V100, P303, DOI 10.1016/j.fbp.2016.08.001; Jedrejek D, 2019, FOOD CHEM TOXICOL, V126, P233, DOI 10.1016/j.fct.2019.02.017; Jedrejek D, 2017, CHEM-BIOL INTERACT, V262, P29, DOI 10.1016/j.cbi.2016.12.003; Jing L, 2019, MOLECULES, V24, DOI 10.3390/molecules24183364; Kamath P. V., 2015, Hayati Journal of Biosciences, V22, P174, DOI 10.1016/j.hjb.2015.11.001; Kim JH, 2015, FOOD SCI BIOTECHNOL, V24, P583, DOI 10.1007/s10068-015-0076-1; Lee S L, 2015, EVID-BASED COMPL ALT; Lis B, 2019, J FUNCT FOODS, V62, DOI 10.1016/j.jff.2019.103524; Lis B, 2019, J FUNCT FOODS, V59, P40, DOI 10.1016/j.jff.2019.05.012; Lis B, 2018, FOOD RES INT, V107, P605, DOI 10.1016/j.foodres.2018.03.012; Martinez M, 2015, J ETHNOPHARMACOL, V169, P244, DOI 10.1016/j.jep.2015.03.067; Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3; Sadh PK, 2018, BIORESOUR BIOPROCESS, V5, DOI 10.1186/s40643-017-0187-z; Schutz K, 2005, RAPID COMMUN MASS SP, V19, P179, DOI 10.1002/rcm.1767; Sehitoglu MH, 2014, ASIAN PAC J CANCER P, V15, P2379, DOI 10.7314/APJCP.2014.15.5.2379; Shakeri A, 2019, CURR VASC PHARMACOL, V17, P262, DOI 10.2174/1570161116666180209113014; Sharifi-Rad J, 2018, CELL MOL BIOL, V64, P57, DOI 10.14715/cmb/2018.64.8.9; Sharifi-Rad M, 2018, PHYTOTHER RES, V32; Sheng ZL, 2013, IND CROP PROD, V43, P778, DOI 10.1016/j.indcrop.2012.08.020; Song M, 2019, PLOS ONE, V14; Sun Z, 2014, J MATH BIOL, P1; Treml J, 2016, COMPR REV FOOD SCI F, V15, P720, DOI 10.1111/1541-4337.12204; Xie PJ, 2018, IND CROP PROD, V111, P238, DOI 10.1016/j.indcrop.2017.10.017; Xue YS, 2017, J FUNCT FOODS, V29, P10, DOI 10.1016/j.jff.2016.11.032; Zhang JJ, 2014, CARBOHYD POLYM, V111, P947, DOI 10.1016/j.carbpol.2014.04.074; Zhu H, 2015, ONCOTARGET, V6, P3254, DOI 10.18632/oncotarget.2410	34	16	18	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239076	10.1371/journal.pone.0239076	http://dx.doi.org/10.1371/journal.pone.0239076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931505	gold, Green Published			2022-12-26	WOS:000573375500012
J	Platsaki, S; Zhou, X; Pinan-Lucarre, B; Delauzun, V; Tu, HJ; Mansuelle, P; Fourquet, P; Bourne, Y; Bessereau, JL; Marchot, P				Platsaki, Semeli; Zhou, Xin; Pinan-Lucarre, Berangere; Delauzun, Vincent; Tu, Haijun; Mansuelle, Pascal; Fourquet, Patrick; Bourne, Yves; Bessereau, Jean-Louis; Marchot, Pascale			The Ig-like domain of Punctin/MADD-4 is the primary determinant for interaction with the ectodomain of neuroligin NLG-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS-like; GABA receptor; Punctin; MADD-4; muscle; neuroligin; neuromuscular junction; nicotinic acetylcholine receptor; postsynaptic membrane; protein-protein interaction; synapse; ADAMTS; nicotinic acetylcholine receptors (nAChR)	C. ELEGANS; PROTEOLYTIC ACTIVITIES; STRUCTURAL INSIGHTS; NEUREXIN; PROTEIN; MODULATION; SYNAPSES; REVEALS; BINDING; METALLOPROTEINASE	Punctin/MADD-4, a member of the ADAMTSL extracellular matrix protein family, was identified as an anterograde synaptic organizer in the nematode Caenorhabditis elegans. At GABAergic neuromuscular junctions, the short isoform MADD-4B binds the ectodomain of neuroligin NLG-1, itself a postsynaptic organizer of inhibitory synapses. To identify the molecular bases of their partnership, we generated recombinant forms of the two proteins and carried out a comprehensive biochemical and biophysical study of their interaction, complemented by an in vivo localization study. We show that spontaneous proteolysis of MADD-4B first generates a shorter N-MADD-4B form, which comprises four thrombospondin (TSP) domains and one Ig-like domain and binds NLG-1. A second processing event eliminates the C-terminal Ig-like domain along with the ability of N-MADD-4B to bind NLG-1. These data identify the Ig-like domain as the primary determinant for N-MADD-4B interaction with NLG-1 in vitro. We further demonstrate in vivo that this Ig-like domain is essential, albeit not sufficient per se, for efficient recruitment of GABA(A) receptors at GABAergic synapses in C. elegans. The interaction of N-MADD-4B with NLG-1 is also disrupted by heparin, used as a surrogate for the extracellular matrix component, heparan sulfate. High-affinity binding of heparin/heparan sulfate to the Ig-like domain may proceed from surface charge complementarity, as suggested by homology three-dimensional modeling. These data point to N-MADD-4B processing and cell-surface proteoglycan binding as two possible mechanisms to regulate the interaction between MADD-4B and NLG-1 at GABAergic synapses.	[Platsaki, Semeli; Delauzun, Vincent; Bourne, Yves; Marchot, Pascale] Aix Marseille Univ, Lab Architecture & Fonct Macromol Biol AFMB, CNRS, Marseille, France; [Zhou, Xin; Pinan-Lucarre, Berangere; Tu, Haijun; Bessereau, Jean-Louis] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, INSERM,Inst NeuroMyoGene INMG, Lyon, France; [Mansuelle, Pascal] Aix Marseille Univ, Inst Microbiol Mediterranee IMM, CNRS, Marseille Prote MaP, Marseille, France; [Fourquet, Patrick] Aix Marseille Univ, Inst Paoli Calmettes, Ctr Rech Cancerol Marseille CRCM, INSERM,CNRS,Marseille Prote,MaP, Marseille, France; [Tu, Haijun] Hunan Univ, Inst Neurosci, Changsha, Hunan, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Hunan University	Marchot, P (corresponding author), Aix Marseille Univ, Lab Architecture & Fonct Macromol Biol AFMB, CNRS, Marseille, France.	pascale.marchot@univ-amu.fr	Bourne, Yves/AAC-4635-2022; MARCHOT, Pascale/AAC-4752-2022; Pinan-Lucarre, Berangere/H-4542-2017; Bessereau, Jean-Louis/M-2988-2017	Bourne, Yves/0000-0003-3850-0548; MARCHOT, Pascale/0000-0003-0630-0541; mansuelle, pascal/0000-0002-4504-6809; Delauzun, Vincent/0000-0001-8466-2738; Pinan-Lucarre, Berangere/0000-0002-6866-4714; ZHOU, Xin/0000-0002-8667-0309; Bessereau, Jean-Louis/0000-0002-3088-7621	French grant [ANR-15-CE11-0016]; Campus France [PRESTIGE-2017-1-0027]; European Research Council grant ERC_Adg C. NAPSE [695295]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INBS-0005]; Marie Sklodowska-Curie Actions Seal of Excellence Award; "Fonds Europeen de Developpement Regional" (FEDER); "Infrastructures Biologie Sante et Agronomie" (IBiSA); Plateformes Technologiques Aix-Marseille; Canceropole PACA; Region Sud Provence-Alpes-Cote d'Azur; Institut Paoli-Calmettes; Centre de Recherche en Cancerologie de Marseille (CRCM); Plan Cancer	French grant; Campus France; European Research Council grant ERC_Adg C. NAPSE; French Infrastructure for Integrated Structural Biology (FRISBI); Marie Sklodowska-Curie Actions Seal of Excellence Award; "Fonds Europeen de Developpement Regional" (FEDER)(European Commission); "Infrastructures Biologie Sante et Agronomie" (IBiSA); Plateformes Technologiques Aix-Marseille; Canceropole PACA(Region Grand-Est); Region Sud Provence-Alpes-Cote d'Azur; Institut Paoli-Calmettes; Centre de Recherche en Cancerologie de Marseille (CRCM); Plan Cancer	This project was supported by the French grant ANR-15-CE11-0016 (to J.-L. B. and P. Marchot), Campus France co-financing grant PRESTIGE-2017-1-0027 (to S. P.), European Research Council grant ERC_Adg C. NAPSE 695295 (to J.-L. B.), and French Infrastructure for Integrated Structural Biology (FRISBI) grant ANR-10-INBS-0005 (to the AFMB lab). S. P. was a laureate of the Marie Sklodowska-Curie Actions Seal of Excellence Award on this project in 2017. The Marseille Proteomics (MaP) Facility is supported by "Fonds Europeen de Developpement Regional" (FEDER), "Infrastructures Biologie Sante et Agronomie" (IBiSA), "Plateformes Technologiques Aix-Marseille", "Canceropole PACA", "Region Sud Provence-Alpes-Cote d'Azur", "Institut Paoli-Calmettes", "Centre de Recherche en Cancerologie de Marseille (CRCM)", and "Plan Cancer".	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Bader HL, 2012, MATRIX BIOL, V31, P398, DOI 10.1016/j.matbio.2012.09.003; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Boulin T, 2012, NAT NEUROSCI, V15, P1374, DOI 10.1038/nn.3197; Chelini G, 2018, EUR PSYCHIAT, V50, P60, DOI 10.1016/j.eurpsy.2018.02.003; Chen F, 2011, STRUCTURE, V19, P779, DOI 10.1016/j.str.2011.03.012; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; Colige AC, 2020, METHODS MOL BIOL, V2043, P45, DOI 10.1007/978-1-4939-9698-8_4; Connor SA, 2016, NEURON, V91, P1052, DOI 10.1016/j.neuron.2016.08.016; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Dow DJ, 2011, SCHIZOPHR RES, V127, P28, DOI 10.1016/j.schres.2010.12.009; Elegheert J, 2017, NEURON, V95, P896, DOI 10.1016/j.neuron.2017.07.040; Ferrer-Ferrer M, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00040; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; FLATMARK T, 1968, J BIOL CHEM, V243, P1623; Frokjaer-Jensen C, 2014, NAT METHODS, V11, P529, DOI [10.1038/NMETH.2889, 10.1038/nmeth.2889]; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Gangwar SP, 2017, NEURON, V94, P1132, DOI 10.1016/j.neuron.2017.06.009; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; GARNAUT R, 1992, ECONOMIC REFORM AND INTERNATIONALISATION: CHINA AND THE PACIFIC REGION, P1; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hamel MG, 2008, EXP NEUROL, V210, P428, DOI 10.1016/j.expneurol.2007.11.014; Hu ZT, 2012, SCIENCE, V337, P980, DOI 10.1126/science.1224896; Hubmacher D, 2015, MATRIX BIOL, V47, P34, DOI 10.1016/j.matbio.2015.05.004; Hubmacher D, 2015, DIS MODEL MECH, V8, P487, DOI 10.1242/dmm.017046; Hunter JW, 2010, DIS MODEL MECH, V3, P366, DOI 10.1242/dmm.003442; Kahler AK, 2008, AM J MED GENET B, V147B, P1089, DOI 10.1002/ajmg.b.30726; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kim JA, 2017, NEURON, V94, P1121, DOI 10.1016/j.neuron.2017.05.034; Ko J, 2009, EMBO J, V28, P3244, DOI 10.1038/emboj.2009.249; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Kramerova IA, 2000, DEVELOPMENT, V127, P5475; Krishnaswamy VR, 2019, CELL MOL LIFE SCI, V76, P3229, DOI 10.1007/s00018-019-03182-6; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li JY, 2011, SCHIZOPHR RES, V125, P194, DOI 10.1016/j.schres.2010.11.002; Maro GS, 2015, NEURON, V86, P1420, DOI 10.1016/j.neuron.2015.05.015; MIDELFORT CF, 1972, P NATL ACAD SCI USA, V69, P1816, DOI 10.1073/pnas.69.7.1816; Miller MT, 2011, STRUCTURE, V19, P767, DOI 10.1016/j.str.2011.03.011; Pantazopoulos H, 2010, ARCH GEN PSYCHIAT, V67, P155, DOI 10.1001/archgenpsychiatry.2009.196; Pinan-Lucarre B, 2014, NATURE, V511, P466, DOI 10.1038/nature13313; Rao N, 2013, INT J CANCER, V133, P294, DOI 10.1002/ijc.28037; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Sanchez R, 1997, PROTEINS, P50; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Seetharaman A, 2011, DEV CELL, V21, P669, DOI 10.1016/j.devcel.2011.07.020; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Singh SK, 2016, CELL, V164, P183, DOI 10.1016/j.cell.2015.11.034; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Ting JT, 2012, ANNU REV NEUROSCI, V35, P49, DOI 10.1146/annurev-neuro-062111-150442; Tsutsui K, 2010, J BIOL CHEM, V285, P4870, DOI 10.1074/jbc.M109.076919; Tu HJ, 2015, NEURON, V86, P1407, DOI 10.1016/j.neuron.2015.05.013; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Whalen DM, 2013, P NATL ACAD SCI USA, V110, P16420, DOI 10.1073/pnas.1310097110; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Yuzaki M, 2018, ANNU REV PHYSIOL, V80, P243, DOI 10.1146/annurev-physiol-021317-121322; Zhang P, 2018, CELL, V174, P1450, DOI 10.1016/j.cell.2018.07.002; Zhou X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16473-5; Zhou X, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00304; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	64	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2020	295	48					16267	16279		10.1074/jbc.RA120.014591	http://dx.doi.org/10.1074/jbc.RA120.014591			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PE7CE	32928959	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000598519500008
J	Duncan, BJML; Koenders, A; Burnham, Q; Lohr, MT				Duncan, Bridget J. M. L.; Koenders, Annette; Burnham, Quinton; Lohr, Michael T.			Mus musculus populations in Western Australia lack VKORC1 mutations conferring resistance to first generation anticoagulant rodenticides: Implications for conservation and biosecurity	PLOS ONE			English	Article							RATTUS-RATTUS; HOUSE MOUSE; ADAPTIVE INTROGRESSION; GENETIC-STRUCTURE; RATS; DOMESTICUS; MICE; PHYLOGEOGRAPHY; ISLAND; POLYMORPHISM	Background Humans routinely attempt to manage pest rodent populations with anticoagulant rodenticides (ARs). We require information on resistance to ARs within rodent populations to have effective eradication programs that minimise exposure in non-target species. Mutations to the VKORC1 gene have been shown to confer resistance in rodents with high proportions of resistance in mice found in all European populations tested. We screened mutations inMus musculuswithin Western Australia, by sampling populations from the capital city (Perth) and a remote island (Browse Island). These are the first Australian mouse populations screened for resistance using this method. Additionally, the mitochondrial D-loop of house mice was sequenced to explore population genetic structure, identify the origin of Western Australian mice, and to elucidate whether resistance was linked to certain haplotypes. Results No resistance-related VKORC1 mutations were detected in either house mouse population. A genetic introgression in the intronic sequence of the VKORC1 gene of Browse Island house mouse was detected which is thought to have originated through hybridisation with the Algerian mouse (Mus spretus). Analysis of the mitochondrial D-loop reported two haplotypes in the house mouse population of Perth, and two haplotypes in the population of Browse Island. Conclusions Both house mouse populations exhibited no genetic resistance to ARs, in spite of free use of ARs in Western Australia. Therefore weaker anticoagulant rodenticides can be employed in pest control and eradication attempts, which will result in reduced negative impacts on non-target species. Biosecurity measures must be in place to avoid introduction of resistant house mice, and new house mouse subspecies to Western Australia.	[Duncan, Bridget J. M. L.; Koenders, Annette; Burnham, Quinton; Lohr, Michael T.] Edith Cowan Univ, Ctr Ecosyst Management, Sch Sci, Joondalup, WA, Australia	Edith Cowan University	Duncan, BJML (corresponding author), Edith Cowan Univ, Ctr Ecosyst Management, Sch Sci, Joondalup, WA, Australia.	duncanbridget95@gmail.com		Duncan, Bridget Judith Maria Lucrezia/0000-0001-8203-4295; Burnham, Quinton/0000-0001-5765-7415; Lohr, Michael/0000-0001-5219-2962	Edith Cowan University; Centre for Ecosystem Management	Edith Cowan University; Centre for Ecosystem Management	This work was funded by Edith Cowan University and the Centre for Ecosystem Management. https://www.ecu.edu.au/https://www.ecu.edu.au/schools/science/research-activity/centre-for-ecosystem-management/overview The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2019, DIABETES CARE, V42, pS90, DOI 10.2337/dc19-S009; [Anonymous], 2012, ACTA CRYSTALLOGR C, V68, pe3, DOI 10.1107/S0108270111047019; Baldwin RA, 2016, J PEST SCI, V89, P129, DOI 10.1007/s10340-015-0653-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Billing J, 2000, WILDLIFE RES, V27, P659, DOI 10.1071/WR99013; Bozikova E, 2005, BIOL J LINN SOC, V84, P363, DOI 10.1111/j.1095-8312.2005.00440.x; BRADFIELD AAG, 1984, J HYG-CAMBRIDGE, V93, P389, DOI 10.1017/S0022172400064950; Brouat C, 2014, MOL ECOL, V23, P4153, DOI 10.1111/mec.12848; Bundesarztekammer Medizinische Indikationsstellung und Okonomisierung, 2015, DTSCH ARZTEBL, V112; Capizzi D, 2014, MAMMAL REV, V44, P148, DOI 10.1111/mam.12019; Cory Frances, 2011, Ecological Management & Restoration, V12, P102, DOI 10.1111/j.1442-8903.2011.00583.x; Cowan PE, 2017, PEST MANAG SCI, V73, P262, DOI 10.1002/ps.4304; Cucchi T., 2012, EVOLUTION HOUSE MOUS, P65, DOI DOI 10.1017/CBO9781139044547.005; Cuthbert RJ, 2011, WILDLIFE RES, V38, P196, DOI 10.1071/WR11016; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Department of Primary Industries and Regional Development, 2017, QUAR WA BORD CHECKP; Department of Primary Industries and Regional Development, BIOS QUAR; Department of Primary Industries and Regional Development, 2015, WA STAT BARR AN INSP; Department of Treasury and Finance, 2004, EC HIST W AUSTR COL; Fisher P., 2005, DOC SCI INTERNAL SER, V198, P1; Gabriel SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028622; Goulois J, 2017, ECOL EVOL, V7, P2767, DOI 10.1002/ece3.2829; Goulois J, 2017, PEST MANAG SCI, V73, P325, DOI 10.1002/ps.4319; Grandemange A, 2010, PEST MANAG SCI, V66, P270, DOI 10.1002/ps.1869; Gryseels S, 2015, J HERED, V106, P637, DOI 10.1093/jhered/esv054; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Heiberg AC, 2006, PEST MANAG SCI, V62, P862, DOI 10.1002/ps.1249; Horak K.E., 2018, ANTICOAGULANT RODENT, P87, DOI DOI 10.1007/978-3-319-64377-9_4; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; Ishizuka M T. T, 2008, J TOXICOL SCI, V33; Ishizuka M, 2007, DRUG METAB DISPOS, V35, P62, DOI 10.1124/dmd.106.011775; Iwagami M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-184; Jing MD, 2014, MOL ECOL, V23, P4387, DOI 10.1111/mec.12873; Jones EP, 2011, J ZOOL, V283, P257, DOI 10.1111/j.1469-7998.2010.00767.x; Kotthoff M, 2019, ENVIRON SCI POLLUT R, V26, P7315, DOI 10.1007/s11356-018-1385-8; Limdi NA, 2008, PHARMACOTHERAPY, V28, P1084, DOI 10.1592/phco.28.9.1084; Lippens C, 2017, HEREDITY, V119, P64, DOI 10.1038/hdy.2017.18; Lohr MT, 2018, SCI TOTAL ENVIRON, V634, P1372, DOI 10.1016/j.scitotenv.2018.04.069; Lopez-Perea JJ, 2019, ENVIRON POLLUT, V244, P801, DOI 10.1016/j.envpol.2018.10.101; MAHMOUD W, 1981, J HYG-CAMBRIDGE, V86, P329, DOI 10.1017/S0022172400069072; Markussen MDK, 2003, PEST MANAG SCI, V59, P913, DOI 10.1002/ps.703; Masuda BM, 2015, ECOTOX ENVIRON SAFE, V113, P1, DOI 10.1016/j.ecoenv.2014.11.013; Mooney J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22815-7; Mora MS, 2013, J MAMMAL, V94, P459, DOI 10.1644/11-MAMM-A-242.1; Moro D, 2018, LANDSCOPE, P22; Pelz HJ, 2012, PEST MANAG SCI, V68, P254, DOI 10.1002/ps.2254; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Pocock MJO, 2005, BIOL J LINN SOC, V84, P565, DOI 10.1111/j.1095-8312.2005.00455.x; Prescott C, 2018, ANTICOAGULANT RESIST; Rajabi-Maham H, 2012, BIOL J LINN SOC, V107, P295, DOI 10.1111/j.1095-8312.2012.01957.x; Rattner BA, 2014, ENVIRON SCI TECHNOL, V48, P8433, DOI 10.1021/es501740n; Ruiz-Suarez N, 2014, SCI TOTAL ENVIRON, V485, P371, DOI 10.1016/j.scitotenv.2014.03.094; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P201, DOI 10.1098/rspb.2008.0958; Singleton GR, 2003, RATS MICE PEOPLE ROD; SMITH M., 2003, ACIAR MONOGRAPH, V96, p[238, 69]; Song Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088425; Song Y, 2011, CURR BIOL, V21, P1296, DOI 10.1016/j.cub.2011.06.043; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stacey N, 2007, ASIA-PAC ENV MONOGR, V2, P1; Staubach F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002891; Tang Q, 2018, EVOL APPL, V11, P1598, DOI 10.1111/eva.12650; Tasmania Parks and Wildlife Service, 2009, MACQ ISL ER PLAN; The Lancet Planetary Health, 2017, LANCET PLANET HLTH, V1, pe209; Vergeest JSM, 2011, WSCG 2011: COMMUNICATION PAPERS PROCEEDINGS, P67; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	67	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0236234	10.1371/journal.pone.0236234	http://dx.doi.org/10.1371/journal.pone.0236234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970676	gold, Green Submitted, Green Published			2022-12-26	WOS:000576265600086
J	Jiang, XW; Bai, JJ				Jiang, Xiaowei; Bai, Jianjun			Quantifying the impacts of drought and ecological restoration on net primary production changes in the Chinese Loess Plateau	PLOS ONE			English	Article							LAND-USE; NPP; PROGRAM; MODELS	Net primary production (NPP) can regulate global climate change and carbon balance. Although scholars have qualitatively studied the influencing factors of NPP, few have quantified the contribution of different degrees of drought aggravation or mitigation and major land-use changes to NPP changes. Based on the temporal and spatial characteristics of NPP for 2000-2015 in the Chinese Loess Plateau, we quantified the contribution of drought, land use and land cover change (LUCC), and hydrothermal conditions to changes in NPP. Particularly, we analyzed the contribution of major land-use change and different drought levels to NPP. Our results showed that the 15-years average NPP was approximately 227 gC/m(2)and decreased from southeast to northwest. Overall, NPP showed a linear increasing trend over the 15-years period. The results suggested that changes in hydrothermal conditions had the strongest impact on NPP (similar to 61%), followed by drought (similar to 33%), and land use and land cover change had the weakest impact (similar to 1.4%). In particular, similar to 13% of the NPP decreases was affected by light drought aggravation, similar to 10% of the NPP decreases was affected by moderate drought aggravation, and similar to 0.3% was affected by the conversion of cropland to grassland or non-NPP main production land. Moreover, similar to 12.7% of the NPP increase was affected by light drought alleviation, similar to 9.4% was affected by moderate drought alleviation, and similar to 1.1% was affected by the conversion of grassland to cropland or forestland. The mechanisms underlying the effect of drought and land-use change on NPP were clarified and provide an important reference value for future research on the carbon cycle and regional ecological environmental restoration.	[Jiang, Xiaowei; Bai, Jianjun] Shaanxi Normal Univ, Sch Geog & Tourism, Xian, Peoples R China	Shaanxi Normal University	Bai, JJ (corresponding author), Shaanxi Normal Univ, Sch Geog & Tourism, Xian, Peoples R China.	bjj@snnu.edu.cn						[Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2015, PULSE INT, V16, P1; [Anonymous], 2012, HOMOFOBE PROGLASITE, V6, P4; Cai SS, 2014, REMOTE SENS ENVIRON, V147, P243, DOI 10.1016/j.rse.2014.03.012; Cao MK, 2004, ECOSYSTEMS, V7, P233, DOI 10.1007/s10021-003-0189-x; Cheng J, 2011, PLANT SOIL ENVIRON, V57, P40, DOI 10.17221/153/2010-PSE; [池源 Chi Yuan], 2018, [生态学报, Acta Ecologica Sinica], V38, P2683; Cleveland CC, 2011, ECOL LETT, V14, P1313, DOI 10.1111/j.1461-0248.2011.01711.x; Fang JY., 2000, CHIN J PLANT ECOL, V24, P513; Gang CC, 2018, SCI TOTAL ENVIRON, V645, P827, DOI 10.1016/j.scitotenv.2018.07.161; Guo Q, 2012, GLOBAL CHANGE BIOL, V18, P3624, DOI 10.1111/gcb.12010; Haberl H, 2001, GLOBAL BIOGEOCHEM CY, V15, P929, DOI 10.1029/2000GB001280; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; [江笑薇 Jiang Xiaowei], 2019, [地球科学进展, Advance in Earth Sciences], V34, P275; Liang L, 2010, 2010 18 INT C GEOINF, DOI [10.1109/GEOINFORMATICS.2010.5567991, DOI 10.1109/GEOINFORMATICS.2010.5567991]; [刘刚 Liu Gang], 2017, [生态学报, Acta Ecologica Sinica], V37, P4936; [刘雪佳 Liu Xuejia], 2018, [水土保持通报, Bulletin of Soil and Water Conservation], V38, P299; Liu Yang-yang, 2019, Yingyong Shengtai Xuebao, V30, P2309, DOI 10.13287/j.1001-9332.201907.002; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Pederson GT, 2006, EARTH INTERACT, V10; Piao SL, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003339; Potter C, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034024; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; [史晓亮 Shi Xiaoliang], 2016, [中国农业气象, Chinese Journal of Agrometeorology], V37, P445; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Su CH, 2013, GLOBAL PLANET CHANGE, V101, P119, DOI 10.1016/j.gloplacha.2012.12.014; Vicente-Serrano S, 2006, WATER RESOUR MANAG, V20, P37, DOI 10.1007/s11269-006-2974-8; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; [王娟 Wang Juan], 2017, [水土保持通报, Bulletin of Soil and Water Conservation], V37, P264; Wang XM, 2010, J ARID ENVIRON, V74, P13, DOI 10.1016/j.jaridenv.2009.08.001; Xiao XM, 2005, REMOTE SENS ENVIRON, V94, P105, DOI 10.1016/j.rse.2004.08.015; [徐玉霞 Xu Yuxia], 2017, [水土保持通报, Bulletin of Soil and Water Conservation], V37, P248; Zhang L, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045706; Zhang LX, 2015, ECOL MODEL, V300, P30, DOI 10.1016/j.ecolmodel.2015.01.001; Zhao AZ, 2017, ECOL ENG, V104, P13, DOI 10.1016/j.ecoleng.2017.03.013; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhu Ying-ying, 2019, Shengtaixue Zazhi, V38, P1861, DOI 10.13292/j.1000-4890.201906.012	39	4	4	19	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0238997	10.1371/journal.pone.0238997	http://dx.doi.org/10.1371/journal.pone.0238997			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970703	gold, Green Published			2022-12-26	WOS:000576265600010
J	Li, J; Wu, T; Fan, TX; He, Y; Meng, LS; Han, ZY				Li, Jing; Wu, Tong; Fan, Tianxin; He, Yan; Meng, Lingshuai; Han, Zuoyue			Clamping force control of electro-mechanical brakes based on driver intentions	PLOS ONE			English	Article							WHEEL	Electro-mechanical brakes (EMBs) are the future of braking systems, particularly in commercial vehicles. Therefore, it is important to design a simple EMB scheme and establish its clamping force control strategy to satisfy the demands of commercial vehicle braking systems. This study proposes a pneumatic disc-brake-based EMB for an electric bus. Its working principle was established, and the system model was analyzed. Subsequently, the hidden Markov models (HMMs) of driver decelerate and brake intentions were built and recognized based on the analytic hierarchy process (AHP). Given the time-consuming behavior of the proposed EMB to eliminate brake clearance due to the leverage effect of the arm and motor performance limitation, a clamping force control strategy factoring in the driver intentions was developed to improve the response performance without changing the structure or size of the EMB. Furthermore, simulation analyses were performed using MATLAB/Simulink. The results confirmed that under the action of a step and 5 Hz triangular sawtooth signals, the clamping force output from the EMB corresponds well with the target signal. The clamping force gradually increases when approaching the target without overshoot and jitter during the process. The overall clamping force response time is decreased by approximately 0.25 s under the driver emergency brake than the conventional control method. Hence, the response performance of the EMB is improved.	[Li, Jing; Wu, Tong; Fan, Tianxin; He, Yan; Meng, Lingshuai] Jilin Univ, Coll Automot Engn, Changchun, Jilin, Peoples R China; [Han, Zuoyue] UISEE Shanghai Automot Technol Ltd, Shanghai, Peoples R China	Jilin University	Wu, T (corresponding author), Jilin Univ, Coll Automot Engn, Changchun, Jilin, Peoples R China.	wut18@mails.jlu.edu.cn		Wu, Tong/0000-0003-4007-8796	National Key R&D Program of China [2018YFB0105900]	National Key R&D Program of China	JL received support from the National Key R&D Program of China (2018YFB0105900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The UISEE (Shanghai) Automotive Technologies Ltd provided support in the form of salaries for author ZH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ahmad F, 2017, STROJ VESTN-J MECH E, V63, P181, DOI 10.5545/sv-jme.2016.3508; Anders L, 2010, European patent, Patent No. [EP1939484B1, 1939484]; Atia MRA, 2016, J DYN SYST-T ASME, V138, DOI 10.1115/1.4032484; Eum S, 2017, ENERGIES, V10, DOI 10.3390/en10020220; Hoseinnezhad R, 2008, IEEE T VEH TECHNOL, V57, P770, DOI 10.1109/TVT.2007.906374; Hu XS, 2020, PROG ENERG COMBUST, V77, DOI 10.1016/j.pecs.2019.100806; Hu XS, 2019, IEEE T TRANSP ELECTR, V5, P1237, DOI 10.1109/TTE.2019.2953606; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Jeon K, 2012, INT J AUTO TECH-KOR, V13, P1067, DOI 10.1007/s12239-012-0109-1; Jo C, 2010, IEEE T VEH TECHNOL, V59, P3205, DOI 10.1109/TVT.2010.2043696; Keller F., 2003, U.S. Patent, Patent No. [US006536561B1, 006536561, 6536561]; Ki YH, 2013, INT J AUTO TECH-KOR, V14, P739, DOI 10.1007/s12239-013-0081-4; Kim C, 2018, ADV MECH ENG, V10, DOI 10.1177/1687814018755215; Kim JG, 2009, SAE TECHNICAL PAPERS; Kim J, 2014, SAE INT J PASSEN CAR, V7, P1369, DOI 10.4271/2014-01-2538; Kim S, 2016, INT J AUTO TECH-KOR, V17, P923, DOI 10.1007/s12239-016-0090-1; Krishnamurthy P, 2009, IEEE T CONTR SYST T, V17, P1306, DOI 10.1109/TCST.2008.2006908; Lee YO, 2013, IEEE T VEH TECHNOL, V62, P2937, DOI 10.1109/TVT.2013.2251029; Line C, 2008, IEEE T CONTR SYST T, V16, P446, DOI 10.1109/TCST.2007.908200; Long B, 2014, ENERGIES, V7, P99, DOI 10.3390/en7010099; Olsson H, 1998, EUR J CONTROL, V4, P176, DOI 10.1016/S0947-3580(98)70113-X; Ono E, 2006, VEHICLE SYST DYN, V44, P139, DOI 10.1080/00423110500385790; Park G, 2017, INT J AUTO TECH-KOR, V18, P883, DOI 10.1007/s12239-017-0086-5; Park H, 2013, IEEE T CONTR SYST T, V21, P1328, DOI 10.1109/TCST.2012.2204750; Qiao G, 2017, SAE INT J VEH DYN ST, V1, P471, DOI 10.4271/2017-01-1902; Semsey A, 2006, SAE TECHNICAL PAPERS; Todeschini F, 2014, EUR J CONTROL, V20, P79, DOI 10.1016/j.ejcon.2013.12.003; Vaiciulyte J, 2020, J STAT COMPUT SIM, V90, P306, DOI 10.1080/00949655.2019.1679144; Yu LY, 2016, IEEE-ASME T MECH, V21, P2568, DOI 10.1109/TMECH.2015.2512579; Yu Z.S., 2009, AUTOMOBILE THEORY, V5th ed.	30	3	3	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239608	10.1371/journal.pone.0239608	http://dx.doi.org/10.1371/journal.pone.0239608			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970768	Green Published, gold			2022-12-26	WOS:000576265600004
J	Mui, ML; Famula, TR; Henthorn, PS; Hess, RS				Mui, Mei Lun; Famula, Thomas R.; Henthorn, Paula S.; Hess, Rebecka S.			Heritability and complex segregation analysis of naturally-occurring diabetes in Australian Terrier Dogs	PLOS ONE			English	Article							MELLITUS; MODEL; HUMANS	The Australian Terrier breed is the breed at highest risk for naturally-occurring diabetes mellitus in the United States, where it is 32 times more likely to develop diabetes compared to mixed breed dogs. However, the heritability and mode of inheritance of spontaneous diabetes in Australian Terriers has not been reported. The aim of this study was therefore to investigate the heritability and mode of inheritance of diabetes in Australian Terriers. A cohort of related Australian Terriers including 383 Australian Terriers without diabetes, 86 Australian Terriers with spontaneous diabetes, and 14 Australian Terriers with an unknown phenotype, was analyzed. A logistic regression model including the effects of sex was formulated to evaluate the heritability of diabetes. The inheritance pattern of spontaneous diabetes in Australian Terriers was investigated by use of complex segregation analysis. Six possible inheritance models were studied, and the Akaike Information Criterion was used to determine the best model for diabetes inheritance in Australian Terriers, among the models deemed biologically feasible. Heritability of diabetes in Australian Terriers was estimated at 0.18 (95% confidence interval 0.0-0.67). There was no significant difference in the effect of males and females on disease outcome. Complex segregation analysis suggested that the mode of diabetes inheritance in Australian Terriers is polygenic, with no evidence for a large effect single gene influencing diabetes. It is concluded that in the population of Australian Terriers bred in the United States, a relatively small degree of genetic variation contributes to spontaneous diabetes. A genetic uniformity for diabetes-susceptible genes within the population of Australian Terriers bred in the Unites States could increase the risk of diabetes in this cohort. These findings hold promise for future genetic studies of canine diabetes focused on this particular breed.	[Mui, Mei Lun; Henthorn, Paula S.; Hess, Rebecka S.] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Famula, Thomas R.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	University of Pennsylvania; University of California System; University of California Davis	Hess, RS (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA.	rhess@vet.upenn.edu			American Kennel Club Canine Health Foundation [610]	American Kennel Club Canine Health Foundation	Both awards were received by RSH. This work was supported by the American Kennel Club Canine Health Foundation (http://www.akcchf.org, Grant #610); and by a gift from Ms. Catherine Adler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TEXTS STAT SCI SERIE; Axenovich TI, 2008, HUM HERED, V65, P57, DOI 10.1159/000108937; Cai SV, 2019, J VET INTERN MED, V33, P1926, DOI 10.1111/jvim.15570; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Catchpole B, 2013, VET J, V195, P139, DOI 10.1016/j.tvjl.2012.11.013; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Fall T, 2007, J VET INTERN MED, V21, P1209, DOI 10.1892/07-021.1; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; GIANOLA D, 1983, GENET SEL EVOL, V15, P201, DOI 10.1186/1297-9686-15-2-201; Guptill L, 2003, VET J, V165, P240, DOI 10.1016/S1090-0233(02)00242-3; Hess R, 2019, J HERED, V110, P793, DOI 10.1093/jhered/esz059; Hess RS, 2013, JAVMA-J AM VET MED A, V243, P1154, DOI 10.2460/javma.243.8.1154; Hess RS, 2000, J AM VET MED ASSOC, V216, P1414, DOI 10.2460/javma.2000.216.1414; Hume DZ, 2006, J VET INTERN MED, V20, P547, DOI 10.1892/0891-6640(2006)20[547:OODWDK]2.0.CO;2; Karunaratne PM, 1998, AM J MED GENET, V76, P428, DOI 10.1002/(SICI)1096-8628(19980413)76:5<428::AID-AJMG12>3.0.CO;2-O; Kuo CF, 2018, CLIN EPIDEMIOL, V10, P1447, DOI 10.2147/CLEP.S172207; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Morran MP, 2015, MOL ASPECTS MED, V42, P42, DOI 10.1016/j.mam.2014.12.004; O'Kell AL, 2017, DIABETES, V66, P1443, DOI 10.2337/db16-1551; Parker HG, 2017, CELL REP, V19, P697, DOI 10.1016/j.celrep.2017.03.079; R Core Team, 2018, R LANG ENV STAT COMP; Shields EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129809; Walsh B., 1998, GENETICS ANAL QUANTI; Yoon S, 2020, VET REC, V187, DOI [10.1136/vetrec-2019-105467, 10.1136/vr.105467]	26	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239542	10.1371/journal.pone.0239542	http://dx.doi.org/10.1371/journal.pone.0239542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970763	gold, Green Published			2022-12-26	WOS:000576265600028
J	Toncheva, D; Serbezov, D; Karachanak-Yankova, S; Nesheva, D				Toncheva, Draga; Serbezov, Dimitar; Karachanak-Yankova, Sena; Nesheva, Desislava			Ancient mitochondrial DNA pathogenic variants putatively associated with mitochondrial disease	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; RESPIRATORY-CHAIN DEFICIENCY; POINT MUTATION; MYOCLONIC EPILEPSY; SEQUENCE VARIATION; DIABETES-MELLITUS; TRNA(ASN) GENE; TRNA(LYS); MYOPATHY; PREVALENCE	Mitochondrial DNA variants associated with diseases are widely studied in contemporary populations, but their prevalence has not yet been investigated in ancient populations. The publicly available AmtDB database contains 1443 ancient mtDNA Eurasian genomes from different periods. The objective of this study was to use this data to establish the presence of pathogenic mtDNA variants putatively associated with mitochondrial diseases in ancient populations. The clinical significance, pathogenicity prediction and contemporary frequency of mtDNA variants were determined using online platforms. The analyzed ancient mtDNAs contain six variants designated as being "confirmed pathogenic" in modern patients. The oldest of these, m.7510T>C in theMT-TS1gene, was found in a sample from the Neolithic period, dated 5800-5400 BCE. All six have well established clinical association, and their pathogenic effect is corroborated by very low population frequencies in contemporary populations. Analysis of the geographic location of the ancient samples, contemporary epidemiological trends and probable haplogroup association indicate diverse spatiotemporal dynamics of these variants. The dynamics in the prevalence and distribution is conceivably result ofde novomutations or human migrations and subsequent evolutionary processes. In addition, ten variants designated as possibly or likely pathogenic were found, but the clinical effect of these is not yet well established and further research is warranted. All detected mutations putatively associated with mitochondrial disease in ancient mtDNA samples are in tRNA coding genes. Most of these mutations are in a mt-tRNA type (Model 2) that is characterized by loss of D-loop/T-loop interaction. Exposing pathogenic variants in ancient human populations expands our understanding of their origin and prevalence dynamics.	[Toncheva, Draga; Serbezov, Dimitar; Karachanak-Yankova, Sena; Nesheva, Desislava] Med Univ Sofia, Bulgarian Acad Sci, Dept Med Genet, Sofia, Bulgaria; [Toncheva, Draga] Bulgarian Acad Sci BAS, Sofia, Bulgaria; [Karachanak-Yankova, Sena] Sofia Univ St Kliment Ohridski, Dept Genet, Fac Biol, Sofia, Bulgaria	Bulgarian Academy of Sciences; Medical University Sofia; University of Sofia	Toncheva, D (corresponding author), Med Univ Sofia, Bulgarian Acad Sci, Dept Med Genet, Sofia, Bulgaria.; Toncheva, D (corresponding author), Bulgarian Acad Sci BAS, Sofia, Bulgaria.	dragatoncheva@gmail.com	Karachanak-Yankova, Sena/AAL-2721-2021	Karachanak-Yankova, Sena/0000-0001-6441-629X; Nesheva, Desislava/0000-0002-8574-8477				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 2013, J SOC PHILOS, V44, P1; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Berens AJ, 2017, HUM BIOL, V89, P7, DOI 10.13110/humanbiology.89.1.01; Binder M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090924; Blakely EL, 2007, J NEUROL, V254, P1283, DOI 10.1007/s00415-006-0490-7; Blakely EL, 2013, HUM MUTAT, V34, P1260, DOI 10.1002/humu.22358; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943; Caporali L, 2017, MITOCHONDRION, V36, P130, DOI 10.1016/j.mito.2017.07.004; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Damgaard PD, 2018, NATURE, V557, P369, DOI 10.1038/s41586-018-0094-2; de Laat P, 2016, BBA CLIN, V6, P19, DOI 10.1016/j.bbacli.2016.04.007; del Castillo F J, 2002, J Med Genet, V39, pe82, DOI 10.1136/jmg.39.12.e82; Derenko M, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0217-9; Diroma MA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1193-4; Edward JO, 2016, S AFRICAN J SCI, V112; Entezami P, 2011, HAND CLIN, V27, P1, DOI 10.1016/j.hcl.2010.09.006; Finnila S, 2001, J MOL MED, V79, P641, DOI 10.1007/s001090100268; Finsterer J, 2019, CHINESE MED J-PEKING, V132, P1752, DOI 10.1097/CM9.0000000000000337; Fu J, 2019, CHINESE MED J-PEKING, V132, P865, DOI 10.1097/CM9.0000000000000151; Gamba J, 2012, J NEUROL SCI, V320, P131, DOI 10.1016/j.jns.2012.05.037; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; Gilbert MTP, 2006, NUCL ACID M, V18, P91; Gill JS, 2017, BRIT J OPHTHALMOL, V101, P1298, DOI 10.1136/bjophthalmol-2017-310370; Gonzalez-Vioque E, 2014, MOL GENET GENOM MED, V2, P107, DOI 10.1002/mgg3.47; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Horvath R, 2003, J MED GENET, V40, P752, DOI 10.1136/jmg.40.10.752; Horvath R, 2010, NEUROMUSCULAR DISORD, V20, pS25, DOI 10.1016/S0960-8966(10)70090-0; Horvath R, 2009, BRAIN, V132, P3165, DOI 10.1093/brain/awp221; Hutchin TP, 2000, J MED GENET, V37, P692, DOI 10.1136/jmg.37.9.692; Jeppesen TD, 2003, ANN NEUROL, V54, P86, DOI 10.1002/ana.10594; Jeppesen TD, 2014, NEUROMUSCULAR DISORD, V24, P162, DOI 10.1016/j.nmd.2013.08.004; Juras A, 2017, SCI REP-UK, V7, DOI 10.1038/srep43950; Kameoka K, 1998, BIOCHEM BIOPH RES CO, V245, P523, DOI 10.1006/bbrc.1998.8437; Kaufmann P, 2011, NEUROLOGY, V77, P1965, DOI 10.1212/WNL.0b013e31823a0c7f; Knipper C, 2017, P NATL ACAD SCI USA; Komlosi K, 2012, JIMD REPORTS CASE RE, P105; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kytovuori L, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.859; Labay V, 2008, CLIN GENET, V73, P50, DOI 10.1111/j.1399-0004.2007.00925.x; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Langdahl JH, 2018, CLIN GENET, V93, P925, DOI 10.1111/cge.13201; Lehmann D, 2015, EUR J HUM GENET, V23, P1735, DOI 10.1038/ejhg.2015.73; Lehmann D, 2015, NEUROMUSCULAR DISORD, V25, P81, DOI 10.1016/j.nmd.2014.09.008; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Mancuso M, 2014, J NEUROL, V261, P504, DOI 10.1007/s00415-013-7225-3; MANOUVRIER S, 1995, J MED GENET, V32, P654, DOI 10.1136/jmg.32.8.654; Manwaring N, 2007, MITOCHONDRION, V7, P230, DOI 10.1016/j.mito.2006.12.004; Martin-Jimenez R, 2012, MITOCHONDRION, V12, P288, DOI 10.1016/j.mito.2011.10.004; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; McDonald J., 1993, GENEREVIEWS R; McFarland R, 2008, NEUROMUSCULAR DISORD, V18, P63, DOI 10.1016/j.nmd.2007.07.007; Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111; Mitchell AL, 2006, J MED GENET, V43, P175, DOI 10.1136/jmg.2005.032474; Modi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41945-0; Monge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064539; MONTAGNA P, 1988, HEADACHE, V28, P477, DOI 10.1111/j.1526-4610.1988.hed2807477.x; MORAES CT, 1993, J CLIN INVEST, V92, P2906, DOI 10.1172/JCI116913; MORAES CT, 1993, NEUROMUSCULAR DISORD, V3, P43, DOI 10.1016/0960-8966(93)90040-Q; Murphy WA, 2003, RADIOLOGY, V226, P614, DOI 10.1148/radiol.2263020338; Niedermayr K, 2018, CONGENIT HEART DIS, V13, P671, DOI 10.1111/chd.12634; Nishino I, 1996, BIOCHEM BIOPH RES CO, V225, P180, DOI 10.1006/bbrc.1996.1150; Odes EJ, 2016, S AFR J SCI, V112, P100, DOI 10.17159/sajs.2016/20150471; Olivieri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070492; Pala M, 2012, AM J HUM GENET, V90, P915, DOI 10.1016/j.ajhg.2012.04.003; Phelan J., 2007, ORAL SURG ORAL MED O, V103, P20, DOI DOI 10.1016/J.TRIPPLE0.2006.12.041; Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532; Sacconi S, 2008, HUM MOL GENET, V17, P1814, DOI 10.1093/hmg/ddn073; Sangatsuda Y, 2012, MITOCHONDRION, V12, P617, DOI 10.1016/j.mito.2012.10.002; Scarpelli M, 2018, NEUROMUSCULAR DISORD, V28, P137, DOI 10.1016/j.nmd.2017.10.006; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Schroeder H, 2019, P NATL ACAD SCI USA, V116, P10705, DOI 10.1073/pnas.1820210116; Shtilbans A, 1999, J CHILD NEUROL, V14, P610, DOI 10.1177/088307389901400910; Sonney S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005867; Souilem S, 2011, J NEUROL SCI, V300, P187, DOI 10.1016/j.jns.2010.08.065; Spagnolo M, 2001, NEUROMUSCULAR DISORD, V11, P481, DOI 10.1016/S0960-8966(01)00195-X; Stolarek I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20705-6; Suzuki S, 1998, DIABETOLOGIA, V41, P584, DOI 10.1007/s001250050950; Tarnopolsky MA, 2019, MITOCHONDRION, V46, P69, DOI 10.1016/j.mito.2018.02.008; The UniProt C, 2018, NUCLEIC ACIDS RES, V47, pD506; The UniProt C, 2018, NUCLEIC ACIDS RES, V47, pD506; Tiranti V, 1999, NEUROMUSCULAR DISORD, V9, P66, DOI 10.1016/S0960-8966(98)00103-5; Tranah GJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30255-6; Uusimaa J, 2011, J MED GENET, V48, P660, DOI 10.1136/jmg.2011.089995; VANDENOUWELAND JMW, 1994, DIABETES, V43, P746, DOI 10.2337/diabetes.43.6.746; Vives-Bauza C, 2003, J INHERIT METAB DIS, V26, P507, DOI 10.1023/A:1025133629685; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Wei W, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007126; Wibrand F, 2010, MUSCLE NERVE, V41, P607, DOI 10.1002/mus.21541; Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807; Yarham JW, 2011, HUM MUTAT, V32, P1319, DOI 10.1002/humu.21575	94	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0233666	10.1371/journal.pone.0233666	http://dx.doi.org/10.1371/journal.pone.0233666			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970680	Green Submitted, gold, Green Published			2022-12-26	WOS:000576265600050
J	Arantes, I; Ribeiro-Alves, M; de Azevedo, SSD; Delatorre, E; Bello, G				Arantes, Ighor; Ribeiro-Alves, Marcelo; S. D. de Azevedo, Suwellen; Delatorre, Edson; Bello, Gonzalo			Few amino acid signatures distinguish HIV-1 subtype B pandemic and non-pandemic strains	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; ANTI-APOBEC3G ACTIVITY; DISEASE PROGRESSION; HOMOSEXUAL-MEN; WEB SERVER; VIRAL LOAD; NEF GENE; TYPE-1; PHENOTYPE; INFECTION	The Human Immunodeficiency Virus Type I (HIV-1) subtype B comprises approximately 10% of all HIV infections in the world. The HIV-1 subtype B epidemic comprehends a pandemic variant (named B-PANDEMIC) disseminated worldwide and non-pandemic variants (named B-CAR) that are mostly restricted to the Caribbean. The goal of this work was the identification of amino acid signatures (AAs) characteristic to the B(CAR)and B(PANDEMIC)variants. To this end, we analyzed HIV-1 subtype B full-length (n = 486) and partial (n = 814) genomic sequences from the Americas classified within the B(CAR)and B(PANDEMIC)clades and reconstructed the sequences of their most recent common ancestors (MRCA). Analysis of contemporary HIV-1 sequences revealed 13 AAs between B(CAR)and B(PANDEMIC)variants (four on Gag, three on Pol, three on Rev, and one in Vif, Vpu, and Tat) of which only two (one on Gag and one on Pol) were traced to the MRCA. All AAs correspond to polymorphic sites located outside essential functional proteins domains, except the AAs in Tat. The absence of stringent AAs inherited from their ancestors between modern B(CAR)and B(PANDEMIC)variants support that ecological factors, rather than viral determinants, were the main driving force behind the successful spread of the B(PANDEMIC)strain.	[Arantes, Ighor; S. D. de Azevedo, Suwellen; Bello, Gonzalo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil; [Ribeiro-Alves, Marcelo] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin DST AIDS, Rio De Janeiro, Brazil; [Delatorre, Edson] Univ Fed Espirito Santo, Ctr Ciencias Exatas Nat & Saude, Dept Biol, Alegre, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Espirito Santo	Bello, G (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil.	gbello@ioc.fiocruz.br	Delatorre, Edson/J-8330-2015	Delatorre, Edson/0000-0002-5746-0820; Ribeiro-Alves, Marcelo/0000-0002-8663-3364	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [302317/2017-1]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ [E-26/202.896/2018]; Coordination for the Improvement of Higher Education Personnel (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	I.A. is funded by a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). G.B. is funded by fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (Grant number 302317/2017-1) and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ (Grant number E-26/202.896/2018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dra Ana Carolina Paulo Vicente for logistic support. We are grateful for support from the Coordination for the Improvement of Higher Education Personnel (CAPES).	A R. FigTree, 2009, FIGTREE V1 4 TREE FI; Alizon S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001123; Andrew A, 2010, MOL ASPECTS MED, V31, P407, DOI 10.1016/j.mam.2010.08.002; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2014, TRACER V1 6; Bello G, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01340; Bello G, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01738; Bertels F, 2018, MOL BIOL EVOL, V35, P27, DOI 10.1093/molbev/msx246; Blanquart F, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001855; Cabello M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33971; Cabello M, 2015, AIDS, V29, P483, DOI 10.1097/QAD.0000000000000552; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Caly L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-67; Churchill MJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-43; Cleghorn FR, 2000, P NATL ACAD SCI USA, V97, P10532, DOI 10.1073/pnas.97.19.10532; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Corro G, 2012, AIDS RES HUM RETROV, V28, P1617, DOI [10.1089/aid.2012.0020, 10.1089/AID.2012.0020]; Cruz NVG, 2013, J MED VIROL, V85, P563, DOI 10.1002/jmv.23512; Das K, 2013, CURR OPIN VIROL, V3, P119, DOI 10.1016/j.coviro.2013.03.014; Das K, 2013, CURR OPIN VIROL, V3, P111, DOI 10.1016/j.coviro.2013.03.012; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Divino F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162112; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gaschen B, 2001, BIOINFORMATICS, V17, P415, DOI 10.1093/bioinformatics/17.5.415; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hassaine G, 2000, VIROLOGY, V276, P169, DOI 10.1006/viro.2000.0543; Hemelaar J, 2019, LANCET INFECT DIS, V19, P143, DOI 10.1016/S1473-3099(18)30647-9; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; IVERSEN AKN, 1995, J VIROL, V69, P5743, DOI 10.1128/JVI.69.9.5743-5753.1995; JAFFE HW, 1985, ANN INTERN MED, V103, P210, DOI 10.7326/0003-4819-103-2-210; Jin SW, 2019, CELL REP, V29, P1449, DOI 10.1016/j.celrep.2019.10.007; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; Kikuchi T, 2015, J VIROL, V89, P4992, DOI 10.1128/JVI.03464-14; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Le Noury DA, 2015, CELL IMMUNOL, V298, P25, DOI 10.1016/j.cellimm.2015.08.005; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Li YC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025286, 10.1371/journal.pone.0018954]; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Mitov V, 2018, MOL BIOL EVOL; Mologni D, 2006, AIDS, V20, P567, DOI 10.1097/01.aids.0000210611.60459.0e; Peng JY, 2013, J MOL BIOL, V425, P2840, DOI 10.1016/j.jmb.2013.05.015; Premkumar DRD, 1996, AIDS RES HUM RETROV, V12, P337, DOI 10.1089/aid.1996.12.337; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Regoes RR, 2005, TRENDS MICROBIOL, V13, P269, DOI 10.1016/j.tim.2005.04.005; Reza SM, 2003, J VIROL, V77, P8602, DOI 10.1128/JVI.77.15.8602-8606.2003; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Somasundaran M, 2002, P NATL ACAD SCI USA, V99, P9503, DOI 10.1073/pnas.142313699; STEVENS CE, 1986, JAMA-J AM MED ASSOC, V255, P2167, DOI 10.1001/jama.255.16.2167; Su CTT, 2019, MOLECULES, V24, DOI 10.3390/molecules24183243; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Suguitan Jr AL, 2011, PLOS ONE, V6; Team,R.C, 2018, R LANG ENV STAT COMP; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Vercruysse T, 2013, CURR HIV RES, V11, P623, DOI 10.2174/1570162X12666140307094603; Voshavar C, 2019, CURR TOP MED CHEM, V19, P1571, DOI 10.2174/1568026619666190619115243; Yoon CH, 2015, J VIROL, V89, P4262, DOI 10.1128/JVI.03087-14; Zhao YQ, 2002, VIRUS RES, V89, P103, DOI 10.1016/S0168-1702(02)00127-2	70	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0238995	10.1371/journal.pone.0238995	http://dx.doi.org/10.1371/journal.pone.0238995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960906	Green Published, gold			2022-12-26	WOS:000575109500010
J	Narayanan, RP; Nordlund, J; Pace, RK; Ratnadiwakara, D				Narayanan, Rajesh P.; Nordlund, James; Pace, R. Kelley; Ratnadiwakara, Dimuthu			Demographic, jurisdictional, and spatial effects on social distancing in the United States during the COVID-19 pandemic	PLOS ONE			English	Article							ECONOMETRICS; MODELS	Social distancing, a non-pharmaceutical tactic aimed at reducing the spread of COVID-19, can arise because individuals voluntarily distance from others to avoid contracting the disease. Alternatively, it can arise because of jurisdictional restrictions imposed by local authorities. We run reduced form models of social distancing as a function of county-level exogenous demographic variables and jurisdictional fixed effects for 49 states to assess the relative contributions of demographic and jurisdictional effects in explaining social distancing behavior. To allow for possible spatial aspects of a contagious disease, we also model the spillovers associated with demographic variables in surrounding counties as well as allow for disturbances that depend upon those in surrounding counties. We run our models weekly and examine the evolution of the estimated coefficients over time since the onset of the COVID-19 pandemic in the United States. These estimated coefficients express the revealed preferences of individuals who were able to and chose to stay at home to avoid the disease. Stay-at-home behavior measured using cell phone tracking data exhibits considerable cross-sectional variation, increasing over nine-fold from the end of January 2020 to the end of March 2020, and then decreasing by about 50% through mid-June 2020. Our estimation results show that demographic exogenous variables explain substantially more of this variation than predictions from jurisdictional fixed effects. Moreover, the explanations from demographic exogenous variables and jurisdictional fixed effects show an evolving correlation over the sample period, initially partially offsetting, and eventually reinforcing each other. Furthermore, the predicted social distance from demographic exogenous variables shows substantial spatial autoregressive dependence, indicating clustering in social distancing behavior. The increased variance of stay-at-home behavior coupled with the high level of spatial dependence can result in relatively intense hotspots and coldspots of social distance, which has implications for disease spread and mitigation.	[Narayanan, Rajesh P.; Nordlund, James; Pace, R. Kelley; Ratnadiwakara, Dimuthu] Louisiana State Univ, EJ Ourso Coll Business Adm, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Nordlund, J (corresponding author), Louisiana State Univ, EJ Ourso Coll Business Adm, Baton Rouge, LA 70803 USA.	nordlund@lsu.edu		Nordlund, James/0000-0003-1308-5667; Reis, AlessanRSS/0000-0001-8486-7469				Acemoglu D., 2020, NBER WORKING PAPERS; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allcot H, 2020, 3570274 SSRN; Anderson M., 2020, 27138 NBER; [Anonymous], 2012, REGEN MED S3, V7, pS14; Aum S, 2020, INEQUALITY FEAR SELF; Avery C., 2020, 27007 NBER; Baker MG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232452; Barrios John M, 2020, 27008 NBER; Bavaud F, 1998, GEOGR ANAL, V30, P153; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brzezinski A, 2020, 3587990 SSRN; Carroll RJ, 2006, MEASUREMENT ERROR NO; Chae Y.K., 2009, PLOS ONE, V4, pe6523; Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301; Chiou L., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); CHRIST CF, 1994, J ECON LIT, V32, P30; Davidson R, 1993, ESTIMATION INFERENCE; Elhorst JP, 2010, SPAT ECON ANAL, V5, P9, DOI 10.1080/17421770903541772; Guliyev H, 2020, SPAT STAT-NETH, V38, DOI 10.1016/j.spasta.2020.100443; Jones CI., 2020, ESTIMATING SIMULATIN; Kennedy P, 1982, GUIDE ECONOMETRICS, VThird; Krisztin T, 2020, WORKING PAPER; LeSage J, 2009, STAT TEXTB MONOGR, P1; LeSage JP, 2014, ECONOMETRICS, V2, P217, DOI 10.3390/econometrics2040217; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Mongey S., 2020, 27085 NBER; ORD K, 1975, J AM STAT ASSOC, V70, P120, DOI 10.2307/2285387; Pace RK, 2008, ECON LETT, V101, P282, DOI 10.1016/j.econlet.2008.09.003; Painter M., 2020, POLITICAL BELIEFS AF; Raifman J., 2021, COVID 19 US STATE PO, DOI DOI 10.3886/E119446V143; Rampini A. A, 2020, NBER WORKING PAPER N, DOI [10.3386/w27063, DOI 10.3386/W27063]; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sharfstein JM, 2020, JAMA-J AM MED ASSOC, V323, P1437, DOI 10.1001/jama.2020.3864; Stock J.H, 2020, 26902 NBER; Vega SH, 2015, J REGIONAL SCI, V55, P339, DOI 10.1111/jors.12188	36	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239572	10.1371/journal.pone.0239572	http://dx.doi.org/10.1371/journal.pone.0239572			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NW6FH	32960932	Green Published, gold			2022-12-26	WOS:000575109500027
J	Pecoraro, F; Clemente, F; Luzi, D				Pecoraro, Fabrizio; Clemente, Fabrizio; Luzi, Daniela			The efficiency in the ordinary hospital bed management in Italy: An in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak	PLOS ONE			English	Article							ALLOCATION; INDEX; COSTS	Since the end of February 2020 a severe diffusion of COVID-19 has affected Italy and in particular its northern regions, resulting in a high demand of hospitalizations in particular in the intensive care units (ICUs). Hospitals are suffering the high degree of patients to be treated for respiratory diseases and the majority of the health structures, especially in the north of Italy, are or are at risk of saturation. Therefore, the question whether and to what extent the reduction of hospital beds occurred in the past years has biased the management of the emergency has come to the front in the public debate. In our opinion, to start a robust analysis it is necessary to consider the Italian health system capacity prior to the emergency. Therefore, the aim of this study is to analyse the availability of hospital beds across the country as well as to determine their management in terms of complexity and performance of cases treated at regional level. The results of this study underlines that, despite the reduction of beds for the majority of the hospital wards, ICUs availabilities did not change between 2010 and 2017. Moreover, this study confirms that the majority of the Italian regions have a routinely efficient management of their facilities allowing hospitals to treat patients without the risk of having an overabundance of patients and a scarcity of beds. In fact, this analysis shows that, in normal situations, the management of hospital and ICU beds has no critical levels.	[Pecoraro, Fabrizio; Luzi, Daniela] CNR, Inst Res Populat & Social Policies, Rome, Italy; [Clemente, Fabrizio] CNR, Inst Crystallog, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Pecoraro, F (corresponding author), CNR, Inst Res Populat & Social Policies, Rome, Italy.	f.pecoraro@irpps.cnr.it	; clemente, fabrizio/A-9738-2010	Reis, AlessanRSS/0000-0001-8486-7469; clemente, fabrizio/0000-0002-6536-7300				[Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2016, CURR BIOL CB, V26, pR1258; [Anonymous], BED OCC EM AC MED CA; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2020, BMC PEDIATR, V20, P1, DOI DOI 10.1016/J.CLAE.2020.04.011; Armocida B, 2020, LANCET PUBLIC HEALTH, V5, pE253, DOI 10.1016/S2468-2667(20)30074-8; Balia Silvia, 2014, Dev Health Econ Public Policy, V12, P133; Bellavia M, 2012, IRAN J PUBLIC HEALTH, V41, P1; Davis DP, 2005, PREHOSPITAL DISASTER, V20, P169, DOI 10.1017/S1049023X00002405; De Belvis AG, 2020, HLTH POLICY, V106, P10; De Rosa S, 2020, EUR HEART J, V41, P2083, DOI 10.1093/eurheartj/ehaa409; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Giancotti M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174533; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Griffin KM, 2020, AM J RESP CRITICAL C; Han BR, 2018, J NURS MANAGE, V26, P647, DOI 10.1111/jonm.12593; Keegan AD, 2010, MED J AUSTRALIA, V193, P291, DOI 10.5694/j.1326-5377.2010.tb03910.x; Kok L, 2015, EUR J HEALTH ECON, V16, P119, DOI 10.1007/s10198-013-0557-1; Lapolla P, 2021, INFECT CONT HOSP EP, V42, P364, DOI 10.1017/ice.2020.241; Liotta G, 2016, ANN IG MED PREV COMU, V28, P319, DOI 10.7416/ai.2016.2112; Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344; Marino D, 2019, EUR RES MANAG BUS EC, V25, P23, DOI 10.1016/j.iedeen.2018.10.001; Ministry of Health, PER B COVID 19; Ministry of Health, COVID 19 CASES ITALY; Ministry of Health, 2019, NAT HEALTHC SERV DAT; Nacoti M., 2020, NEW ENGL J MED, DOI 10.1056/CAT.20.0080; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pecoraro F, 2015, J PHYS CONF SER, V588, DOI 10.1088/1742-6596/588/1/012027; Pecoraro F, 2015, E-HEALTH BIOENG CONF; Perera VAP, 2019, J HEALTHC QUAL RES, V34, P124, DOI 10.1016/j.jhqr.2019.02.001; Rhodes A, 2012, INTENS CARE MED, V38, P1647, DOI 10.1007/s00134-012-2627-8; Scalzo A. L., 2009, Health Systems in Transition (European Observatory on Health Systems and Policies), V11; Tortorella F, 2013, J NURS ADMIN, V43, P37, DOI 10.1097/NNA.0b013e3182785fe7; Wu Z, 2020, JAMA-J AM MED ASSOC, P25, DOI [10.1001/jama.2020.9540, DOI 10.1001/JAMA.2020.9540]	34	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0239249	10.1371/journal.pone.0239249	http://dx.doi.org/10.1371/journal.pone.0239249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960908	Green Published, Green Submitted, gold			2022-12-26	WOS:000575109500013
J	Junger, C; Reimann, M; Krabbe, L; Gaede, KI; Lange, C; Herzmann, C; Ruller, S				Juenger, Christoph; Reimann, Maja; Krabbe, Lenka; Gaede, Karoline, I; Lange, Christoph; Herzmann, Christian; Rueller, Stephan			Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MECHANICAL VENTILATION; MULTICENTER	Purpose Long-term non-invasive ventilation (NIV) is recommended for patients with stable chronic obstructive lung disease (COPD) and chronic hypercapnia. High inspiratory pressure NIV (hiNIV) and a significant reduction of arterial pCO(2)have been shown to prolong survival. Often, patients on hiNIV describe severe respiratory distress, known as "deventilation syndrome", after removal of the NIV mask in the morning. Mechanical pursed lips breathing ventilation (PLBV) is a new non-invasive ventilation mode that mimics the pressure-curve of pursed lips breathing during expiration. The clinical impact of switching patients from standard NIV to PLBV has not been studied so far. Patients and methods In this hypothesis generating study, we retrospectively analysed the effects of switching COPD patients (stage GOLD III-IV) from conventional NIV to PLBV. Medical records of all patients who had an established NIV and were switched to PLBV between March 2016 and October 2017 were screened. Patients were included if they complained of shortness of breath on mask removal, used their conventional NIV regularly, and had a documented complete diagnostic workup including lung function testing, blood gas analysis and 6-minute walk test (6MWT) before and after 3-7 days of PLBV. Results Six male and 10 female patients (median age 65.4 years; IQR 64.0-71.3) with a previous NIV treatment duration of 38 months (median; IQR 20-42) were analysed. After PLVB initiation, the median inspiratory ventilation pressure needed to maintain the capillary pre-switch pCO(2)level was reduced from 19.5 mbar (IQR 16.0-26.0) to 13.8 mbar (IQR 12.5-14.9; p<0.001). The median 6MWT distance increased from 200m (IQR 153.8-266.3) to 270m (IQR 211.3-323.8; p<0.001). Median forced vital capacity (FVC) increased from 49.5% to 53.0% of the predicted value (p = 0.04), while changes in FEV(1)and residual volume (RV) were non-significant. Conclusion Based on this small retrospective analysis, we hypothesise that switching patients with COPD GOLD III-IV and chronic hypercapnia from conventional NIV to PLBV may increase exercise tolerance and FVC in the short term.	[Juenger, Christoph; Krabbe, Lenka; Gaede, Karoline, I; Lange, Christoph; Herzmann, Christian; Rueller, Stephan] Leibniz Lung Ctr, Res Ctr Borstel, Med Clin, Borstel, Germany; [Reimann, Maja; Lange, Christoph; Herzmann, Christian] German Ctr Infect Res DZIF, Lubeck, Riems, Germany; [Reimann, Maja; Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Reimann, Maja; Lange, Christoph] Univ Lubeck, Resp Med & Int Hlth, Lubeck, Germany; [Gaede, Karoline, I; Herzmann, Christian] German Ctr Lung Res DZL, Airway Res Ctr North ARCN, Giessen, Germany; [Gaede, Karoline, I] Leibniz Lung Ctr, Res Ctr Borstel, BioMaterialBank Nord, Borstel, Germany; [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden	Forschungszentrum Borstel; German Center for Infection Research; Forschungszentrum Borstel; University of Lubeck; Forschungszentrum Borstel; Karolinska Institutet	Herzmann, C (corresponding author), Leibniz Lung Ctr, Res Ctr Borstel, Med Clin, Borstel, Germany.; Herzmann, C (corresponding author), German Ctr Infect Res DZIF, Lubeck, Riems, Germany.; Herzmann, C (corresponding author), German Ctr Lung Res DZL, Airway Res Ctr North ARCN, Giessen, Germany.	cherzmann@fz-borstel.de			German Leibniz-Gemeinschaft; German Center for Lung Research	German Leibniz-Gemeinschaft; German Center for Lung Research	Fees for open access publishing were covered by a grant of the German Leibniz-Gemeinschaft, Open Access Publikation Fonds to Dr Christian Herzmann. The BioMaterialBank Nord is supported by the German Center for Lung Research. The BioMaterialBank Nord is a member of popgen 2.0 network (P2N). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	[Anonymous], 2019, EVALUATION NONINVASI; [Anonymous], 2019, AM J KIDNEY DIS, V73, pS1; Blanch Lluis, 2005, Respir Care, V50, P110; Budweiser S, 2006, RESP CARE, V51, P126; Clini E, 2002, EUR RESPIR J, V20, P529, DOI 10.1183/09031936.02.02162001; Dreher M, 2010, THORAX, V65, P303, DOI 10.1136/thx.2009.124263; Duiverman ML, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-112; Ergan B, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.01003-2019; Esquinas AM, 2014, SLEEP BREATH, V18, P225, DOI 10.1007/s11325-013-0931-3; JONES DJM, 1995, AM J RESP CRIT CARE, V152, P538; Kohnlein T, 2014, LANCET RESP MED, V2, P698, DOI 10.1016/S2213-2600(14)70153-5; Raveling T, 2018, INT J CHRONIC OBSTR, V13, P3625, DOI 10.2147/COPD.S169951; Singh D, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00164-2019; Storre JH, 2008, EUR RESPIR MONOGR, P319; Team RC, 2014, LANG ENV STAT COMP; Zikyri A, 2018, INT J CHRONIC OBSTR, V13, P2191, DOI 10.2147/COPD.S152574	16	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238619	10.1371/journal.pone.0238619	http://dx.doi.org/10.1371/journal.pone.0238619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956395	gold, Green Published			2022-12-26	WOS:000574571500031
J	Wertli, MM; Schlapbach, JM; Haynes, AG; Scheuter, C; Jegerlehner, SN; Panczak, R; Chiolero, A; Rodondi, N; Aujesky, D				Wertli, Maria M.; Schlapbach, Judith M.; Haynes, Alan G.; Scheuter, Claudia; Jegerlehner, Sabrina N.; Panczak, Radoslaw; Chiolero, Arnaud; Rodondi, Nicolas; Aujesky, Drahomir			Regional variation in hip and knee arthroplasty rates in Switzerland: A population-based small area analysis	PLOS ONE			English	Article							DECISION-MAKING; HEALTH LITERACY; OSTEOARTHRITIS; REPLACEMENT; CARE; LIFE; APPROPRIATENESS; ASSOCIATION; PREFERENCES; PREVALENCE	Background Compared to other OECD countries, Switzerland has the highest rates of hip (HA) and knee arthroplasty (KA). Objective We assessed the regional variation in HA/KA rates and potential determinants of variation in Switzerland. Methods We conducted a population-based analysis using discharge data from all Swiss hospitals during 2013-2016. We derived hospital service areas (HSAs) by analyzing patient flows. We calculated age-/sex-standardized procedure rates and measures of variation (the extremal quotient [EQ, highest divided by lowest rate] and the systemic component of variation [SCV]). We estimated the reduction in variance of HA/KA rates across HSAs in multilevel regression models, with incremental adjustment for procedure year, age, sex, language, urbanization, socioeconomic factors, burden of disease, and the number of orthopedic surgeons. Results Overall, 69,578 HA and 69,899 KA from 55 HSAs were analyzed. The mean age-/sex-standardized HA rate was 265 (range 179-342) and KA rate was 256 (range 186-378) per 100,000 persons and increased over time. The EQ was 1.9 for HA and 2.5 for KA. The SCV was 2.0 for HA and 2.2 for KA, indicating a low variation across HSAs. When adjusted for procedure year and demographic, cultural, and sociodemographic factors, the models explained 75% of the variance in HA and 63% in KA across Swiss HSAs. Conclusion Switzerland has high HA/KA rates with a modest regional variation, suggesting that the threshold to perform HA/KA may be uniformly low across regions. One third of the variation remained unexplained and may, at least in part, represent differing physician beliefs and attitudes towards joint arthroplasty.	[Wertli, Maria M.; Schlapbach, Judith M.; Scheuter, Claudia; Jegerlehner, Sabrina N.; Rodondi, Nicolas; Aujesky, Drahomir] Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Inselspital, Bern, Switzerland; [Haynes, Alan G.; Panczak, Radoslaw] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Haynes, Alan G.] Univ Bern, CTU Bern, Bern, Switzerland; [Panczak, Radoslaw] Univ Queensland, Queensland Ctr Populat Res, Sch Earth & Environm Sci, Brisbane, Qld, Australia; [Chiolero, Arnaud; Rodondi, Nicolas] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Chiolero, Arnaud] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Chiolero, Arnaud] Univ Fribourg, Populat Hlth Lab PopHealthLab, Fribourg, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Queensland; University of Bern; McGill University; University of Fribourg	Wertli, MM (corresponding author), Univ Bern, Bern Univ Hosp, Dept Gen Internal Med, Inselspital, Bern, Switzerland.	Maria.Wertli@insel.ch	Panczak, Radoslaw/E-7384-2018; Wertli, Maria/Q-3349-2017	Panczak, Radoslaw/0000-0001-5141-683X; Wertli, Maria/0000-0001-6347-0198; Rodondi, Nicolas/0000-0001-9083-6896	National Research Program 74 of the Swiss National Science Foundation (SNSF) [SNSF 407440_167339]; Health Services Research funding program of the Gottfried and Julia Bangerter-Rhyner-Stiftung; Swiss Society of General Internal Medicine Foundation	National Research Program 74 of the Swiss National Science Foundation (SNSF); Health Services Research funding program of the Gottfried and Julia Bangerter-Rhyner-Stiftung; Swiss Society of General Internal Medicine Foundation	DA, MMW, AC, RP, CS, and NR were awarded a grant by the National Research Program 74 of the Swiss National Science Foundation (SNSF), Grant number SNSF 407440_167339, the Health Services Research funding program of the Gottfried and Julia Bangerter-Rhyner-Stiftung and the Swiss Society of General Internal Medicine Foundation. The sponsors did not have influence on the study design, the collection, analysis and interpretation of the data, the writing of the report, and in the decision to submit the manuscript for publication.	American Academy of Orthopaedic Surgeons (AAOS), MAN OST HIP EV BAS C; American Joint Replacement Registry, 2018, ANN REP HIP KNEE ART; [Anonymous], 2018, NUNCIUS, V33, P25; Anthony DL, 2009, HEALTH AFFAIR, V28, P864, DOI 10.1377/hlthaff.28.3.864; Appleby J, 2017, VARIATIONS HEALTHCAR; Bayliss LE, 2017, LANCET, V389, P1424, DOI 10.1016/S0140-6736(17)30059-4; Bederman SS, 2011, SPINE, V36, P481, DOI 10.1097/BRS.0b013e3181d25e6f; Belmont PJ, 2014, J BONE JOINT SURG AM, V96A, P20, DOI 10.2106/JBJS.M.00018; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Biller-Andorno N, 2015, NEW ENGL J MED, V373, P2193, DOI 10.1056/NEJMp1508256; Birkmeyer JD, 2013, LANCET, V382, P1121, DOI 10.1016/S0140-6736(13)61215-5; Bozic KJ, 2013, J BONE JOINT SURG AM, V95A, P1633, DOI 10.2106/JBJS.M.00004; BRESLOW NE, 1975, J CHRON DIS, V28, P289, DOI 10.1016/0021-9681(75)90010-7; Busato A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-8; Camerini AL, 2016, PATIENT EDUC COUNS, V99, P462, DOI 10.1016/j.pec.2015.10.018; Carlson VR, 2018, J AM ACAD ORTHOP SUR, V26, P103, DOI 10.5435/JAAOS-D-17-00164; Connor M, 2013, PATIENT EDUC COUNS, V90, P12, DOI 10.1016/j.pec.2012.08.018; Crivelli L, 2006, HEALTH ECON, V15, P535, DOI 10.1002/hec.1072; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Culliford DJ, 2012, OSTEOARTHR CARTILAGE, V20, P519, DOI 10.1016/j.joca.2012.02.636; Daigle ME, 2012, BEST PRACT RES CL RH, V26, P649, DOI 10.1016/j.berh.2012.07.013; Egger M, 2014, SWISS NATL COHORT; Eurostat Labour Market Working Group, 2011, DEGR URB DEGURBA LOC; Fischer S, 2006, SWISS MED WKLY, V136, P370; Fisher ES, 2010, DARTMOUTH ALTAS SUGE; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; Goebel V, 2014, RAUM STADTISCHEM CHA, P1; Grosso MJ, 2019, J ARTHROPLASTY, V34, P422, DOI 10.1016/j.arth.2018.11.005; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Hasler S., 2016, PLAUSIBILISIERUNGSKO; Hawker GA, 2000, NEW ENGL J MED, V342, P1016, DOI 10.1056/NEJM200004063421405; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; Hawker GA, 2006, ARTHRITIS RHEUM, V54, P3212, DOI 10.1002/art.22146; Haynes AG, 2020, HEALTH SERV RES, V55, P469, DOI 10.1111/1475-6773.13275; Hofstede SN, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009117; Ibanez B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-60; Klauss G, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-33; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mantwill S, 2017, PATIENT EDUC COUNS, V100, P2020, DOI 10.1016/j.pec.2017.05.023; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; McPherson K, 1996, SYSTEMATIC VARIATION; Mihailovic N, 2016, HEALTH SERV RES MANA, V3, DOI 10.1177/2333392816647892; Moser A, 2014, J EPIDEMIOL COMMUN H, V68, P1125, DOI 10.1136/jech-2014-204352; Mota REM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-225; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; OECD, 2015, HLTH GLANC 2015 OECD, DOI [10.1787/health_glance-2015-34-en, DOI 10.1787/HEALTH_GLANCE-2015-EN, 10.1787/health_glance-2015-en]; OECD, 2017, HIP KNEE REPL, DOI 10.1787/health_glance-2017-65-en; OECD, 2014, GEOGRAPHIC VARIATION, DOI [DOI 10.23062/2010.11.6, 10.1787/9789264216594-en]; Panczak R, 2017, MED CARE, V55, P155, DOI 10.1097/MLR.0000000000000634; Panczak R, 2012, J EPIDEMIOL COMMUN H, V66, P1129, DOI 10.1136/jech-2011-200699; Parker K., 2015, MOVEMENT ADVANCEMENT; Quinn RH, 2018, J AM ACAD ORTHOP SUR, V26, pE191, DOI 10.5435/JAAOS-D-17-00424; Quintana JM, 2000, RHEUMATOLOGY, V39, P1234, DOI 10.1093/rheumatology/39.11.1234; Quintana JM, 2008, ARCH INTERN MED, V168, P1576, DOI 10.1001/archinte.168.14.1576; R Development Core Team, 2017, R LANG ENV STAT COMP; Riddle DL, 2014, ARTHRITIS RHEUMATOL, V66, P2134, DOI 10.1002/art.38685; Rillo O, 2016, JCR-J CLIN RHEUMATOL, V22, P345, DOI 10.1097/RHU.0000000000000449; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Scheuter C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208578; Sepucha K, 2017, J BONE JOINT SURG AM, V99, P1253, DOI 10.2106/JBJS.16.01045; (SFSO) SFSO, 2014, RAUMGL SCHWEIZ; Skou ST, 2016, NEW ENGL J MED, V374, P692, DOI 10.1056/NEJMc1514794; Stacey D, 2016, OSTEOARTHR CARTILAGE, V24, P99, DOI 10.1016/j.joca.2015.07.024; Suarez-Almazor ME, 2005, ARCH INTERN MED, V165, P1117, DOI 10.1001/archinte.165.10.1117; Swiss Federal Statistical Office (SFSO), 2008, SCHWEIZ OP CHOP ICD; Swiss Federal Statistical Office (SFSO), 2013, MEDST REG SCHWEIZ WO; Vina ER, 2018, CURR OPIN RHEUMATOL, V30, P160, DOI 10.1097/BOR.0000000000000479; WENNBERG JE, 1987, LANCET, V1, P1185, DOI 10.1016/s0140-6736(87)92152-0; Wennberg JE, 2010, TRACKING MED RES QUE, V1; Wennberg JE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1513; Widmer M, 2009, HEALTH PLACE, V15, P791, DOI 10.1016/j.healthplace.2008.12.009; Wright JG, 2011, J ARTHROPLASTY, V26, P569, DOI 10.1016/j.arth.2010.04.028; Wright JG, 1999, MED CARE, V37, P946, DOI 10.1097/00005650-199909000-00010	75	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238287	10.1371/journal.pone.0238287	http://dx.doi.org/10.1371/journal.pone.0238287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NV8NR	32956363	gold, Green Published, Green Submitted			2022-12-26	WOS:000574571500025
J	Gumul, D; Korus, J; Surma, M; Ziobro, R				Gumul, Dorota; Korus, Jaroslaw; Surma, Magdalena; Ziobro, Rafal			Pulp obtained after isolation of starch from red and purple potatoes (Solanum tuberosum L.) as an innovative ingredient in the production of gluten-free bread	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; DIETARY FIBER; DRIED RED; ACRYLAMIDE; ANTHOCYANIN; PHENOLICS; CEREALS; QUALITY; ACIDS	Starch based gluten-free bread (formulations containing mixture of corn and potato starch with hydrocolloids) are deficient in nutrients and do not contain health promoting compounds. Therefore they could be supplemented with raw materials rich in such components, especially antioxidants. Among them pseudo-cereals, seeds, fruits and vegetables are often applied to this purpose. Potato pulp produced by processing red fleshed (Magenta Love) and purple fleshed (Violetta) varieties could become a new innovative substrate for gluten-free bread enrichment, because of high levels of endogenous polyphenols, namely flavonoids, flavonols, phenolic acids and especially anthocyanins with high antioxidant potential, as well as dietary fiber. Study material consisted of gluten-free bread enriched in the pulp. Dietary fiber, acrylamide content and antioxidant and antiradical potential of the bread were determined. Sensory evaluation included crumb elasticity, porosity and other characteristics, taste and smell. Among all analyzed gluten-free breads, the sample containing 7.5% share of freeze-dried red potato pulp Magenta Love was characterized by high content of phenolic compounds and dietary fiber, pronounced antioxidant activity, low levels of potentially dangerous acrylamide and good physical and sensory characteristics. Therefore such an addition (7.5% Magenta Love) could be recommended for industrial production of gluten-free bread.	[Gumul, Dorota; Korus, Jaroslaw; Ziobro, Rafal] Agr Univ Krakow, Fac Food Technol, Dept Carbohydrate Technol, Krakow, Poland; [Surma, Magdalena] Agr Univ Krakow, Fac Food Technol, Dept Plant Prod Technol & Nutr Hyg, Krakow, Poland	Agricultural University Krakow; Agricultural University Krakow	Gumul, D (corresponding author), Agr Univ Krakow, Fac Food Technol, Dept Carbohydrate Technol, Krakow, Poland.	rrgumul@cyf-kr.edu.pl		Gumul, Dorota/0000-0002-8217-5992	Ministry of Science and Higher Education of the Republic of Poland	Ministry of Science and Higher Education of the Republic of Poland(Ministry of Science and Higher Education, Poland)	The research was financed by the Ministry of Science and Higher Education of the Republic of Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AACC (American Association of Cereal Chemists), 2000, APPR METH AACC; AKK-Karup, 2009, KAR KART POT STARCH; Alvarez-Jubete L, 2010, TRENDS FOOD SCI TECH, V21, P106, DOI 10.1016/j.tifs.2009.10.014; [Anonymous], 1999, FREE RADICAL BIO MED, V26, P1231; [Anonymous], 1996, PNA741081996; Antuszewicz A., 2006, THESIS AGR U WARSAW, P115; AOAC, 2006, AOAC OFF METH AN; Brathen E, 2005, FOOD CHEM, V92, P693, DOI 10.1016/j.foodchem.2004.08.030; Brown CR, 2005, J AM SOC HORTIC SCI, V130, P174, DOI 10.21273/JASHS.130.2.174; Burgos G, 2013, J FOOD COMPOS ANAL, V30, P6, DOI 10.1016/j.jfca.2012.12.001; Cheng L, 2019, INT J BIOL MACROMOL, V131, P564, DOI 10.1016/j.ijbiomac.2019.02.164; Crawford LM, 2019, J FOOD SCI, V84, P659, DOI 10.1111/1750-3841.14456; Desborough SL, 1985, POTATO PHYSL; EPPENDORFER WH, 1994, PLANT FOOD HUM NUTR, V45, P299, DOI 10.1007/BF01088079; Ezekiel R, 2013, FOOD RES INT, DOI [10.1016/j.foodres.2013.08.024, DOI 10.1016/J.FOODRES.2013.08.024]; Fang C, 2011, BIORESOURCE TECHNOL, V102, P5734, DOI 10.1016/j.biortech.2011.03.013; Gomez-Mascaraque LG, 2017, J FUNCT FOODS, V37, P283, DOI 10.1016/j.jff.2017.07.062; Gumul D, 2018, QUAL ASSUR SAF CROP, V10, P51, DOI 10.3920/QAS2016.1055; Gumul D, 2017, CYTA-J FOOD, V15, P629, DOI 10.1080/19476337.2017.1331265; HARIRI EB, 1991, PROTOPLASMA, V162, P20; Hopper AD, 2007, BRIT MED J, V335, P558, DOI 10.1136/bmj.39316.442338.AD; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jakob S, 1999, BIOL PANCREAS GROWIN, V361-370, P20; Keramat J, 2011, FOOD BIOPROCESS TECH, V4, P530, DOI 10.1007/s11947-010-0495-1; Lachman J, 2009, FOOD CHEM, V114, P836, DOI 10.1016/j.foodchem.2008.10.029; MAILLARD MN, 1995, J AGR FOOD CHEM, V43, P1789, DOI 10.1021/jf00055a008; Marconi O, 2010, ANAL METHODS-UK, V2, P1686, DOI 10.1039/c0ay00191k; Mazza G, 1999, J AGR FOOD CHEM, V47, P4009, DOI 10.1021/jf990449f; Oomah BD, 2005, J SCI FOOD AGR, V85, P935, DOI 10.1002/jsfa.2019; Pastuszewska Barbara, 2009, Polish Journal of Food and Nutrition Sciences, V59, P205; Peksa A, 2013, FOOD CHEM, V141, P2960, DOI 10.1016/j.foodchem.2013.05.125; Ragaee S, 2006, FOOD CHEM, V98, P32, DOI 10.1016/j.foodchem.2005.04.039; RedCorn R, 2018, ENGINEERING-PRC, V4, P371, DOI 10.1016/j.eng.2018.05.010; Robin F, 2012, TRENDS FOOD SCI TECH, V28, P23, DOI 10.1016/j.tifs.2012.06.008; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sivam AS, 2010, J FOOD SCI, V75, pR163, DOI 10.1111/j.1750-3841.2010.01815.x; Surdyk N, 2004, J AGR FOOD CHEM, V52, P2047, DOI 10.1021/jf034999w; Surma M, 2017, MICROCHEM J, V131, P98, DOI 10.1016/j.microc.2016.11.021; Svensson K, 2003, FOOD CHEM TOXICOL, V41, P1581, DOI 10.1016/S0278-6915(03)00188-1; Teow CC, 2007, FOOD CHEM, V103, P829, DOI 10.1016/j.foodchem.2006.09.033; Thomassen LV, 2011, APPL MICROBIOL BIOT, V90, P873, DOI 10.1007/s00253-011-3092-y; Tornqvist M, 2005, ADV EXP MED BIOL, V561, P1; Wischmann B, 2007, J FOOD ENG, V79, P970, DOI 10.1016/j.jfoodeng.2006.01.090; Yang JS, 2018, FOOD CHEM, V244, P197, DOI 10.1016/j.foodchem.2017.10.059; Zielinski H, 2009, J AGR FOOD CHEM, V57, P4771, DOI 10.1021/jf900313e	45	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0229841	10.1371/journal.pone.0229841	http://dx.doi.org/10.1371/journal.pone.0229841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946470	gold, Green Published			2022-12-26	WOS:000573851100082
J	Pereyra, MM; Diaz, MA; Meinhardt, F; Dib, JR				Maria Pereyra, Martina; Andrea Diaz, Mariana; Meinhardt, Friedhelm; Rafael Dib, Julian			Effect of stress factors associated with postharvest citrus conditions on the viability and biocontrol activity ofClavispora lusitaniaestrain 146	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; CANDIDA-OLEOPHILA; ANTAGONISTIC YEASTS; OXIDATIVE STRESS; PICHIA-ANOMALA; HYPOCHLORITE; DISEASES; TOLERANCE; EFFICACY; SACCHAROMYCES	Only quite recently, we have shown that yeast strainsClavispora lusitaniae146 andPichia fermentans27 can act as efficient biocontrol agents for combating postharvest fungal diseases in lemons. During postharvest and storage conditions, microorganisms are subject to different stress factors that could affect both their survival and their protective capacity. Understanding the tolerance of yeasts to environmental stress factors could support the future development and commercial application of biological control formulations based on such organisms. Thus, the impact of different stressors on the viability and protection efficiency ofC.lusitaniaestrain 146 andP.fermentansstrain 27 was evaluated, and the yeasts were subjected to oxidative stress, thermal treatments, exposure to NaOCl, osmotic stress, and ultraviolet irradiation.Candida oleophilastrain O served as the reference control.C.lusitaniae146 was more resistant to H(2)O(2)in plate assays; however, in liquid media there was no significant difference to the other strains. Strain 146 was less affected by NaOCl, being able to survive with 300 ppm.P.fermentans27 was the strain most heavily affected by osmotic pressure, while strains 146 and strain O showed a similar adaptation. UV-B irradiation severely affectedC.oleophilaandP.fermentans, whileC.lusitaniaewas the most resistant. Strains 146 and 27 were similarly tolerant to thermal shocks, compared to the reference strain, which was less viable. Inin vivotests, exposure to 10 mM H2O2, 45 degrees C or 200 ppm NaOCl prior to fruit inoculation, reduced the antagonistic activity against the pathogenPenicillium digitatum. However, in no case was the biocontrol efficiency reduced to less than 50%. AsC.lusitaniae146 demonstrated a great potential to combatP.digitatumunder a wide range of conditions, the organism is a promising candidate as an effective and valuable alternative to toxic fungicides.	[Maria Pereyra, Martina; Andrea Diaz, Mariana; Rafael Dib, Julian] Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc Ind Microbiol PROIMI, San Miguel De Tucuman, Argentina; [Meinhardt, Friedhelm] Westfalische Wilhelms Univ Munster, Inst Mol Mikrobiol & Biotechnol IMMB, Munster, Germany; [Rafael Dib, Julian] Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Microbiol, San Miguel De Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Munster; Universidad Nacional de Tucuman	Dib, JR (corresponding author), Consejo Nacl Invest Cient & Tecn, Planta Piloto Proc Ind Microbiol PROIMI, San Miguel De Tucuman, Argentina.; Meinhardt, F (corresponding author), Westfalische Wilhelms Univ Munster, Inst Mol Mikrobiol & Biotechnol IMMB, Munster, Germany.; Dib, JR (corresponding author), Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Microbiol, San Miguel De Tucuman, Argentina.	meinhar@uni-muenster.de; jdib@conicet.gov.ar			CONICET;  [PIUNT A618/2]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); 	This work was partially funded by "Proyecto PIUNT A618/2". Martina Mari ' a Pereyra and Mariana Andrea Diaz received a PhD fellowship from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Hernando A, 2010, INT J FOOD MICROBIOL, V137, P130, DOI 10.1016/j.ijfoodmicro.2009.11.022; An B, 2012, CURR MICROBIOL, V65, P122, DOI 10.1007/s00284-012-0133-4; [Anonymous], 2016, GRUPO INFOSTAT FCA; [Anonymous], 2014, JURIST STUDIES CHURC, V74, P59; Buschini A, 2004, MUTAGENESIS, V19, P157, DOI 10.1093/mutage/geh012; Castoria R, 2003, PHYTOPATHOLOGY, V93, P564, DOI 10.1094/PHYTO.2003.93.5.564; COTTER JL, 1985, ANTIMICROB AGENTS CH, V28, P118, DOI 10.1128/AAC.28.1.118; Droby S, 1998, BIOL CONTROL, V12, P97, DOI 10.1006/bcon.1998.0615; Droby S, 2009, POSTHARVEST BIOL TEC, V52, P137, DOI 10.1016/j.postharvbio.2008.11.009; Estrela Carlos, 2003, Braz. Dent. J., V14, P58, DOI 10.1590/S0103-64402003000100011; Perez MF, 2019, POSTHARVEST BIOL TEC, V155, P57, DOI 10.1016/j.postharvbio.2019.05.012; Perez MF, 2017, BIOL CONTROL, V115, P135, DOI 10.1016/j.biocontrol.2017.10.006; Perez MF, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0146588, 10.1371/journal.pone.0165590]; Fredlund E, 2002, FEMS YEAST RES, V2, P395, DOI 10.1111/j.1567-1364.2002.tb00109.x; Ingram PR, 2004, FREE RADICAL RES, V38, P739, DOI 10.1080/10715760410001712773; Ingram PR, 2003, ARCH BIOCHEM BIOPHYS, V410, P121, DOI 10.1016/S0003-9861(02)00659-8; Ippolito A, 2000, CROP PROT, V19, P715, DOI 10.1016/S0261-2194(00)00095-8; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Jijakli M, 1993, POSTHARVEST APPLES 2, V58; Kwolek-Mirek M, 2011, YEAST, V28, P595, DOI 10.1002/yea.1889; Lahlali R., 2004, Communications in Agricultural and Applied Biological Sciences, V69, P601; Lahlali R, 2011, PLANT PATHOL, V60, P288, DOI 10.1111/j.1365-3059.2010.02368.x; Lahlali R, 2011, PLANT DIS, V95, P311, DOI 10.1094/PDIS-04-10-0265; Lahlali R, 2009, BIOL CONTROL, V51, P403, DOI 10.1016/j.biocontrol.2009.07.014; Lewinska A, 2004, FREE RADICAL RES, V38, P1159, DOI 10.1080/10715760400009860; Liu J, 2013, INT J FOOD MICROBIOL, V167, P153, DOI 10.1016/j.ijfoodmicro.2013.09.004; Liu J, 2012, FEMS MICROBIOL ECOL, V80, P578, DOI 10.1111/j.1574-6941.2012.01324.x; Liu J, 2011, FEMS MICROBIOL ECOL, V76, P145, DOI 10.1111/j.1574-6941.2010.01037.x; Liu J, 2011, INT J FOOD MICROBIOL, V146, P76, DOI 10.1016/j.ijfoodmicro.2011.02.007; Macarisin D, 2010, POSTHARVEST BIOL TEC, V58, P194, DOI 10.1016/j.postharvbio.2010.07.008; Magan N., 2001, Fungi as biocontrol agents: progress, problems and potential, P239, DOI 10.1079/9780851993560.0239; Morales H, 2010, FOOD CONTROL, V21, P953, DOI 10.1016/j.foodcont.2009.12.016; Nally MC, 2013, POSTHARVEST BIOL TEC, V86, P456, DOI 10.1016/j.postharvbio.2013.07.022; Petersson S, 1999, POSTHARVEST BIOL TEC, V15, P175, DOI 10.1016/S0925-5214(98)00081-7; Portero LR, 2019, PHOTOCHEM PHOTOBIOL, V95, P315, DOI 10.1111/php.13061; Rees MD, 2005, BIOCHEM J, V391, P125, DOI 10.1042/BJ20050630; Spencer Jennifer, 2014, BMC Res Notes, V7, P151, DOI 10.1186/1756-0500-7-151; Sui Y, 2015, APPL ENVIRON MICROB, V81, P2968, DOI 10.1128/AEM.04203-14; Teixido N, 1999, INT J FOOD MICROBIOL, V50, P203, DOI 10.1016/S0168-1605(99)00105-1; Teixido N, 1998, J APPL MICROBIOL, V84, P192; VINAS I, 1993, MYCOPATHOLOGIA, V123, P27, DOI 10.1007/BF01103485; Wang YF, 2010, INT J FOOD MICROBIOL, V143, P103, DOI 10.1016/j.ijfoodmicro.2010.07.035; Wang YH, 2018, BIOL CONTROL, V127, P109, DOI 10.1016/j.biocontrol.2018.09.002; WILSON CL, 1989, ANNU REV PHYTOPATHOL, V27, P425, DOI 10.1146/annurev.py.27.090189.002233; Wisniewski M, 2007, BIOLOGICAL CONTROL: A GLOBAL PERSPECTIVE, P262, DOI 10.1079/9781845932657.0262	45	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239432	10.1371/journal.pone.0239432	http://dx.doi.org/10.1371/journal.pone.0239432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946508	Green Published, gold			2022-12-26	WOS:000573851100093
J	Shin, J; Kang, MS; Park, K; Lee, JS				Shin, Jonghoon; Kang, Min Seung; Park, Keunheung; Lee, Jong Soo			Association between metabolic risk factors and optic disc cupping identified by deep learning method	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; TYPE-2 DIABETES-MELLITUS; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; INTRAOCULAR-PRESSURE; PERFUSION-PRESSURE; POPULATION; PREVALENCE; HYPERTENSION; OBESITY	Purpose This study aims to investigate correlation between metabolic risk factors and optic disc cupping and the development of glaucoma. Methods This study is a retrospective, cross-sectional study with over 20-year-old patients that underwent health screening examinations. Intraocular pressure (IOP), fundus photographs, Body Mass Index (BMI), waist circumference (WC), serum triglycerides, serum HDL cholesterol (HDL-C), serum LDL cholesterol (LDL-C), systolic blood pressure (BP), diastolic BP, and serum HbA1c were obtained to analyse correlation between metabolic risk factors and glaucoma. Eye with glaucomatous optic neuropathy(GON) was defined as having an optic disc with either vertical cup-to-disc ratio(VCDR) >= 0.7 or a VCDR difference >= 0.2 between the right and left eyes by measuring VCDR with deep learning approach. Results The study comprised 15,585 subjects and 877 subjects were diagnosed as GON. In univariate analyses, age, BMI, systolic BP, diastolic BP, WC, triglyceride, LDL-C, HbA1c, and IOP were significantly and positively correlated with VCDR in the optic nerve head. In linear regression analysis as independent variables, stepwise multiple regression analyses revealed that age, BMI, systolic BP, HbA1c, and IOP showed positive correlation with VCDR. In multivariate logistic analyses of risk factors and GON, higher age (odds ratio [OR], 1.054; 95% confidence interval [CI], 1.046-1.063), male gender (OR, 0.730; 95% CI, 0.609-0.876), more obese (OR, 1.267; 95% CI, 1.065-1.507), and diabetes (OR, 1.575; 95% CI, 1.214-2.043) remained statistically significant correlation with GON. Conclusions Among the metabolic risk factors, obesity and diabetes as well as older age and male gender are risk factors of developing GON. The glaucoma screening examinations should be considered in the populations with these indicated risk factors.	[Shin, Jonghoon; Kang, Min Seung] Pusan Natl Univ, Dept Ophthalmol, Sch Med, Yangsan, South Korea; [Shin, Jonghoon; Kang, Min Seung] Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Yangsan Hosp, Yangsan, South Korea; [Park, Keunheung; Lee, Jong Soo] Pusan Natl Univ, Dept Ophthalmol, Coll Med, Busan, South Korea; [Park, Keunheung; Lee, Jong Soo] Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Pusan National University Hospital	Lee, JS (corresponding author), Pusan Natl Univ, Dept Ophthalmol, Coll Med, Busan, South Korea.; Lee, JS (corresponding author), Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea.	jongsool@pusan.ac.kr		lee, Jong soo/0000-0002-1052-2924; Shin, Jonghoon/0000-0003-1721-1253				[Anonymous], 2017, LANCET HIV, V2017, pPE475; Baskaran M, 2015, JAMA OPHTHALMOL, V133, P874, DOI 10.1001/jamaophthalmol.2015.1110; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Chopra V, 2008, OPHTHALMOLOGY, V115, P227, DOI 10.1016/j.ophtha.2007.04.049; Costa VP, 2009, BRIT J OPHTHALMOL, V93, P1276, DOI 10.1136/bjo.2008.149047; Doshi V, 2008, OPHTHALMOLOGY, V115, P639, DOI 10.1016/j.ophtha.2007.05.032; Imai K, 2010, INT J OBESITY, V34, P1209, DOI 10.1038/ijo.2010.32; Iwashima Y, 2010, AM J HYPERTENS, V23, P290, DOI 10.1038/ajh.2009.253; Jonas JB, 2013, J GLAUCOMA, V22, P13; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Leegaard A, 2011, DIABETES CARE, V34, P2530, DOI 10.2337/dc11-0902; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Lin SC, 2018, J GLAUCOMA, V27, P239, DOI 10.1097/IJG.0000000000000867; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Pasquale LR, 2013, MOL VIS, V19, P1471; Pasquale LR, 2010, OPHTHALMOLOGY, V117, P1521, DOI 10.1016/j.ophtha.2009.12.017; Piltz-Seymour IR, 2001, AM J OPHTHALMOL, V132, P63, DOI 10.1016/S0002-9394(01)00871-6; Poh S, 2016, DIABETES RES CLIN PR, V113, P86, DOI 10.1016/j.diabres.2016.01.016; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Rahman MM, 2004, BRIT J OPHTHALMOL, V88, P1493, DOI 10.1136/bjo.2004.043612; Redmon J, 2018, ARXIV; Redmon JSDRGAF, 2016, YOLO YOU ONLY LOOK O; Sekeroglu MA, 2011, ACTA OPHTHALMOL, V89, P429, DOI 10.1111/j.1755-3768.2009.01713.x; Sommer A, 1996, ARCH OPHTHALMOL-CHIC, V114, P235, DOI 10.1001/archopht.1996.01100130229029; Tham YC, 2017, CLIN EXP OPHTHALMOL, V45, P24, DOI 10.1111/ceo.12763; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216, DOI 10.1001/archopht.1995.01100020100038; Topouzis F, 2006, AM J OPHTHALMOL, V142, P60, DOI 10.1016/j.ajo.2006.02.055; VARMA R, 1989, ARCH OPHTHALMOL-CHIC, V107, P526, DOI 10.1001/archopht.1989.01070010540027; Yamamoto S, 2014, OPHTHALMOLOGY, V121, P1558, DOI 10.1016/j.ophtha.2014.03.003; Zhao D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112460; Zhao D, 2014, AM J OPHTHALMOL, V158, P615, DOI 10.1016/j.ajo.2014.05.029; 2014, REG ANESTH PAIN MED, V9; 2014, REG ANESTH PAIN MED, V9	38	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239071	10.1371/journal.pone.0239071	http://dx.doi.org/10.1371/journal.pone.0239071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941514	Green Published, gold			2022-12-26	WOS:000573848800105
J	Montagnani, V; Maresca, L; Apollo, A; Pepe, S; Carr, RM; Fernandez-Zapico, ME; Stecca, B				Montagnani, Valentina; Maresca, Luisa; Apollo, Alessandro; Pepe, Sara; Carr, Ryan M.; Fernandez-Zapico, Martin E.; Stecca, Barbara			E3 ubiquitin ligase PARK2, an inhibitor of melanoma cell growth, is repressed by the oncogenic ERK1/2-ELK1 transcriptional axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						melanoma; mitogen-activated protein kinase; MAPK; gene regulation; chromatin immunoprecipitation; ChIP; parkin; extracellular signal-regulated kinase; ERK; transcription factor; tumor suppressor gene	CANCER; ACTIVATION; MUTATIONS; PROLIFERATION; DEFICIENCY; EXPRESSION; BRAF	Malignant melanoma, the most aggressive form of skin cancer, is characterized by high prevalence of BRAF/NRAS mutations and hyperactivation of extracellular signal-regulated kinase 1 and 2 (ERK1/2), mitogen-activated protein kinases (MAPK), leading to uncontrolled melanoma growth. Efficacy of current targeted therapies against mutant BRAF or MEK1/2 have been hindered by existence of innate or development of acquired resistance. Therefore, a better understanding of the mechanisms controlled by MAPK pathway driving melanogenesis will help develop new treatment approaches targeting this oncogenic cascade. Here, we identify E3 ubiquitin ligase PARK2 as a direct target of ELK1, a known transcriptional effector of MAPK signaling in melanoma cells. We show that pharmacological inhibition of BRAF-V600E or ERK1/2 in melanoma cells increases PARK2 expression. PARK2 overexpression reduces melanoma cell growth in vitro and in vivo and induces apoptosis. Conversely, its genetic silencing increases melanoma cell proliferation and reduces cell death. Further, we demonstrate that ELK1 is required by the BRAF-ERK1/2 pathway to repress PARK2 expression and promoter activity in melanoma cells. Clinically, PARK2 is highly expressed in WT BRAF and NRAS melanomas, but it is expressed at low levels in melanomas carrying BRAF/NRAS mutations. Overall, our data provide new insights into the tumor suppressive role of PARK2 in malignant melanoma and uncover a novel mechanism for the negative regulation of PARK2 via the ERK1/2-ELK1 axis. These findings suggest that reactivation of PARK2 may be a promising therapeutic approach to counteract melanoma growth.	[Montagnani, Valentina; Maresca, Luisa; Apollo, Alessandro; Pepe, Sara; Stecca, Barbara] Inst Canc Res Prevent & Clin Network ISPRO, Core Res Lab, Florence, Italy; [Pepe, Sara] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Carr, Ryan M.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Dept Oncol, Schulze Ctr Novel Therapeut, Rochester, MN USA; [Apollo, Alessandro] Humanitas Clin & Res Ctr, Milan, Italy	University of Siena; Mayo Clinic	Stecca, B (corresponding author), Inst Canc Res Prevent & Clin Network ISPRO, Core Res Lab, Florence, Italy.	b.stecca@ispro.toscana.it		Stecca, Barbara/0000-0003-1197-1622; Carr, Ryan/0000-0001-5762-367X	Institute for Cancer Research, Prevention and Clinical Network (ISPRO); Italian Association for Cancer Research (AIRC) [19580, 22644]	Institute for Cancer Research, Prevention and Clinical Network (ISPRO); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Institute for Cancer Research, Prevention and Clinical Network (ISPRO) funding and by postdoctoral fellowships from Italian Association for Cancer Research (AIRC) Projects 19580 (to V. M.) and 22644 (to L. M.).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Carroll RG, 2014, CELL REP, V9, P1538, DOI 10.1016/j.celrep.2014.10.046; Caulfield TR, 2015, BIOCHEM SOC T, V43, P269, DOI 10.1042/BST20140321; Caulfield TR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003935; Duan HJ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00790; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gong YX, 2017, NEOPLASIA, V19, P75, DOI 10.1016/j.neo.2016.12.006; Gong YX, 2014, NAT GENET, V46, P588, DOI 10.1038/ng.2981; Gupta A, 2017, MOL CELL, V65, P999, DOI 10.1016/j.molcel.2017.02.019; Hu HH, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv340; Inzelberg R, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000070; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lee YS, 2018, CANCER LETT, V433, P156, DOI 10.1016/j.canlet.2018.07.007; Lei Z, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0401-8; Levin L, 2016, J GENET GENOMICS, V43, P369, DOI 10.1016/j.jgg.2016.05.005; Li CF, 2018, DEV CELL, V46, P441, DOI 10.1016/j.devcel.2018.07.012; Lin DC, 2015, CANCER RES, V75, P1815, DOI 10.1158/0008-5472.CAN-14-1433; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Liu J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01947-w; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Luo XJ, 2015, ONCOTARGET, V6, P42704, DOI 10.18632/oncotarget.5678; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Mary Goldman B. C., 2019, BIORXIV, DOI [DOI 10.1101/326470, 10.1101/326470]; Montagnani V, 2016, ONCOTARGET, V7, P30365, DOI 10.18632/oncotarget.8758; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Mylona A, 2016, SCIENCE, V354, P233, DOI 10.1126/science.aad1872; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pandolfi S, 2015, CELL DEATH DIFFER, V22, P2006, DOI 10.1038/cdd.2015.56; Periquet M, 2003, BRAIN, V126, P1271, DOI 10.1093/brain/awg136; Picchio MC, 2004, CLIN CANCER RES, V10, P2720, DOI 10.1158/1078-0432.CCR-03-0086; Pietrobono S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0142-0; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Riverso M, 2017, ONCOGENE, V36, P3322, DOI 10.1038/onc.2016.481; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Santini R, 2012, STEM CELLS, V30, P1808, DOI 10.1002/stem.1160; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Sun XD, 2013, CELL CYCLE, V12, P1133, DOI 10.4161/cc.24215; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Tay SP, 2010, J BIOL CHEM, V285, P29231, DOI 10.1074/jbc.M110.108241; Veeriah S, 2010, NAT GENET, V42, P77, DOI 10.1038/ng.491; Xu L, 2014, J MOL MED, V92, P31, DOI 10.1007/s00109-013-1107-0; Yeo CWS, 2012, CANCER RES, V72, P2543, DOI 10.1158/0008-5472.CAN-11-3060	51	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 20	2020	295	47					16058	16071		10.1074/jbc.RA120.014615	http://dx.doi.org/10.1074/jbc.RA120.014615			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	PA5ED	32938713	Green Published, hybrid			2022-12-26	WOS:000595657900022
J	Zhuang, H; Cui, JC; Liu, TR; Wang, H				Zhuang, Hui; Cui, Jiancong; Liu, Taoran; Wang, Hong			A physical model inspired density peak clustering	PLOS ONE			English	Article							FAST SEARCH; COMMUNITY DETECTION; FIND; ALGORITHM	Clustering is an important technology of data mining, which plays a vital role in bioscience, social network and network analysis. As a clustering algorithm based on density and distance, density peak clustering is extensively used to solve practical problems. The algorithm assumes that the clustering center has a larger local density and is farther away from the higher density points. However, the density peak clustering algorithm is highly sensitive to density and distance and cannot accurately identify clusters in a dataset having significant differences in cluster structure. In addition, the density peak clustering algorithm's allocation strategy can easily cause attached allocation errors in data point allocation. To solve these problems, this study proposes a potential-field-diffusion-based density peak clustering. As compared to existing clustering algorithms, the advantages of the potential-field-diffusion-based density peak clustering algorithm is three-fold: 1) The potential field concept is introduced in the proposed algorithm, and a density measure based on the potential field's diffusion is proposed. The cluster center can be accurately selected using this measure. 2) The potential-field-diffusion-based density peak clustering algorithm defines the judgment conditions of similar points and adopts different allocation strategies for dissimilar points to avoid attached errors in data point allocation. 3) This study conducted many experiments on synthetic and real-world datasets. Results demonstrate that the proposed potential-field-diffusion-based density peak clustering algorithm achieves excellent clustering effect and is suitable for complex datasets of different sizes, dimensions, and shapes. Besides, the proposed potential-field-diffusion-based density peak clustering algorithm shows particularly excellent performance on variable density and nonconvex datasets.	[Zhuang, Hui; Cui, Jiancong; Liu, Taoran; Wang, Hong] Shandong Normal Univ, Sch Informat Sci & Engn, Jinan, Peoples R China; [Wang, Hong] Shandong Normal Univ, Shandong Prov Key Lab Distributed Comp Software N, Jinan, Peoples R China	Shandong Normal University; Shandong Normal University	Wang, H (corresponding author), Shandong Normal Univ, Sch Informat Sci & Engn, Jinan, Peoples R China.; Wang, H (corresponding author), Shandong Normal Univ, Shandong Prov Key Lab Distributed Comp Software N, Jinan, Peoples R China.	wanghong106@163.com			National Nature Science Foundation of China [61672329, 61472233, 61572300, 81273704]; Shandong Provincial Project of Graduate Education Quality Improvement [SDYY18058]; Taishan Scholar Program of Shandong Province [TSHW201502038, 20110819]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Project of Graduate Education Quality Improvement; Taishan Scholar Program of Shandong Province	This work is supported by National Nature Science Foundation of China (No. 61672329, No. 61472233, No. 61572300, No. 81273704), Shandong Provincial Project of Graduate Education Quality Improvement (No. SDYY18058), Taishan Scholar Program of Shandong Province (No. TSHW201502038, No.20110819).	Aggarwal CC, 2001, LECTURE NOTES IN COM; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Bai XY, 2017, NEUROCOMPUTING, V226, P7, DOI 10.1016/j.neucom.2016.11.019; Bie RF, 2016, PERS UBIQUIT COMPUT, V20, P785, DOI 10.1007/s00779-016-0954-4; Chang H, 2008, PATTERN RECOGN, V41, P191, DOI 10.1016/j.patcog.2007.04.010; Chen YW, 2016, MULTIMED TOOLS APPL, V75, P2877, DOI 10.1007/s11042-015-2485-9; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Du MJ, 2016, KNOWL-BASED SYST, V99, P135, DOI 10.1016/j.knosys.2016.02.001; Du T, 2015, INF FUSION, DOI [10.1016/j.inffus.2015.08.005, DOI 10.1016/J.INFFUS.2015.08.005]; Dua D., 2017, MACHINE LEARNING REP; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; Franti P, 2006, IEEE T PATTERN ANAL, V28, P1875, DOI 10.1109/TPAMI.2006.227; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Guha S, 2001, INFORM SYST, V26, P35, DOI 10.1016/S0306-4379(01)00008-4; Han YD, 2020, IEEE T CYBERNETICS, V50, P1697, DOI 10.1109/TCYB.2018.2881539; Hu BF, 2019, J AMB INTEL HUM COMP, V10, P175, DOI 10.1007/s12652-017-0630-1; Jain AK, 2005, LECT NOTES COMPUT SC, V3540, P1; Jose-Garcia A, 2016, APPL SOFT COMPUT, V41, P192, DOI 10.1016/j.asoc.2015.12.001; Kaufman L., 1987, Statistical Data Analysis Based on the L1-Norm and Related Methods. First International Conference, P405; Kempe D, 2003, P 9 ACM SIGKDD INT C, V2003, P137, DOI DOI 10.1145/956750.956769; [李涛 Li Tao], 2016, [计算机科学与探索, Journal of Frontiers of Computer Science & Technology], V10, P1614; [李昕 Li Xin], 2019, [信号处理, Journal of Signal Processing], V35, P1919; Liang Z, 2016, PATTERN RECOGN LETT, V73, P52, DOI 10.1016/j.patrec.2016.01.009; Little MA, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-23; Liu R, 2018, INFORM SCIENCES, V450, P200, DOI 10.1016/j.ins.2018.03.031; Liu YH, 2017, KNOWL-BASED SYST, V133, P208, DOI 10.1016/j.knosys.2017.07.010; Lotfi A, 2016, 2016 6TH INTERNATIONAL CONFERENCE ON COMPUTER AND KNOWLEDGE ENGINEERING (ICCKE), P263, DOI 10.1109/ICCKE.2016.7802150; Lu YG, 2012, PATTERN RECOGN, V45, P3512, DOI 10.1016/j.patcog.2012.02.035; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mehmood R, 2018, PERS UBIQUIT COMPUT, V22, P615, DOI 10.1007/s00779-018-1112-y; Mehmood R, 2016, NEUROCOMPUTING, V208, P210, DOI 10.1016/j.neucom.2016.01.102; Pikoula M, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0805-0; Prabhakar S, 1998, PROC INT CONF DATA, P94, DOI 10.1109/ICDE.1998.655763; Qaddoura R, 2019, INT J MACH LEARN CYB, P1; Qiu T, 2018, INT C PATT RECOG, P1414, DOI 10.1109/ICPR.2018.8545142; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Seyedi SA, 2019, EXPERT SYST APPL, V115, P314, DOI 10.1016/j.eswa.2018.07.075; Sheikholeslami G, 2000, VLDB J, V8, P289, DOI 10.1007/s007780050009; [时小虎 Shi Xiaohu], 2017, [吉林大学学报. 工学版, Journal of Jilin University. Engineering and Technology Edition], V47, P242; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tan PN., 2016, INTRO DATA MINING; Tsaparas, 2007, ACM T KNOWL DISCOV D, V1, P4, DOI [10.1145/1217299.1217303, DOI 10.1145/1217299.1217303]; Veenman CJ, 2002, IEEE T PATTERN ANAL, V24, P1273, DOI 10.1109/TPAMI.2002.1033218; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang SL, 2016, CHINESE J ELECTRON, V25, P397, DOI 10.1049/cje.2016.05.001; Wang W, 1997, PROCEEDINGS OF THE TWENTY-THIRD INTERNATIONAL CONFERENCE ON VERY LARGE DATABASES, P186; Wu BC, 2021, J DERMATOL TREAT, V32, P595, DOI 10.1080/09546634.2019.1687828; XIE J, 2016, CHINESE SCI INF SCI, V280; Xie JY, 2016, INFORM SCIENCES, V354, P19, DOI 10.1016/j.ins.2016.03.011; Yongsheng J, 2016, RES MANIFOLD BASED D; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]; Zhang YQ, 2015, EUR J ORG CHEM, V2015, P2030, DOI 10.1002/ejoc.201403673	56	0	0	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0239406	10.1371/journal.pone.0239406	http://dx.doi.org/10.1371/journal.pone.0239406			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970727	gold, Green Published			2022-12-26	WOS:000576265600052
J	Chang, RX; Li, YM; Chen, Q; Gong, XY; Qi, ZC				Chang, Ruixue; Li, Yanming; Chen, Qing; Gong, Xiaoyan; Qi, Zicheng			Effects of carbon-based additives and ventilation rate on nitrogen loss and microbial community during chicken manure composting	PLOS ONE			English	Article							BIOCHAR AMENDMENT; ORGANIC WASTES; NH3 EMISSIONS; DAIRY MANURE; AERATION; HUMIFICATION; DEGRADATION; RESIDUES; MATURITY; IMPROVE	Aerobic composting is a sustainable method for chicken manure recycling, while its unsuitable porosity and carbon to nitrogen ratio (C/N) may result in high nitrogen loss and incomplete composting. With the aim to investigate the effects of carbon-based additives and two ventilation rates on chicken manure composting and microbial community, two series of treatments were set up for chicken manure composting, in order to investigate their effects on the biodegradation process, ammonia (NH3) emission, nitrogen loss, physiochemical properties and microbial community. The results showed that additives and ventilation rates set in the current study influenced the carbon dioxide (CO2) production from the 2(nd)week and also the physiochemical parameters during the entire process, while no inhibitory effect on the maturity were observed. With woody peat as additive, the NH(3)emission amount and nitrogen loss rate were shown as 15.86 mg and 4.02%, less than those in other treatments, 31.08-80.13 mg and 24.26-34.24%, respectively. The high aeration rate increased the NH(3)emission and nitrogen loss, which were varied when the additives were different. The terminal restriction fragment length polymorphism (T-RFLP) results showed that the additives and the ventilation rates changed the microbial community, while the prominent microbial clones belonged to the class ofBacilliandClostridia(in the phylum ofFirmicutes), andAlphaproteobacteria,DeltaproteobacteriaandGammaproteobacteria(in the phylum ofProteobacteria).Bacillus spp. was observed to be the most dominant bacteria in all the composting stages and treatments. It was concluded that woody peat could improve chicken manure composting more than other additives, especially on reducing nitrogen loss, meanwhile 0.18 Lx2027;min(-1)x2027;kg(-1)DM was suitable for various additives. Therefore, suitable additive and aeration rate could be used in practical application, which could significantly reduce nitrogen loss without influence on the compos maturity process.	[Chang, Ruixue; Li, Yanming; Chen, Qing; Gong, Xiaoyan] China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China; [Qi, Zicheng] Shandong Acad Agr Machinery Sci, Jinan, Shandong, Peoples R China	China Agricultural University	Li, YM (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China.	liym@cau.edu.cn	li, yan/GTI-4638-2022	Chen, Qing/0000-0002-4589-0161	National Key R&D Program of China [2018YFC1901000]; China Agriculture Research System [CAR-23-B16]; Shandong Academy of Agricultural Sciences "Science and Technology Innovation Project" [CXGC2018D06]	National Key R&D Program of China; China Agriculture Research System; Shandong Academy of Agricultural Sciences "Science and Technology Innovation Project"	Financial supported was provided by National Key R&D Program of China (2018YFC1901000), China Agriculture Research System (CAR-23-B16) and Shandong Academy of Agricultural Sciences "Science and Technology Innovation Project" (CXGC2018D06).	Alegbeleye OO, 2018, FOOD MICROBIOL, V73, P177, DOI 10.1016/j.fm.2018.01.003; Alkoaik FN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220343; Aulinas-Maso M, 2008, BIORESOURCE TECHNOL, V99, P5120, DOI 10.1016/j.biortech.2007.09.083; Awasthi MK, 2017, BIORESOURCE TECHNOL, V224, P428, DOI 10.1016/j.biortech.2016.11.014; Awasthi MK, 2016, BIORESOURCE TECHNOL, V219, P270, DOI 10.1016/j.biortech.2016.07.128; Brito LM, 2015, ENVIRON TECHNOL, V36, P1632, DOI 10.1080/09593330.2014.1002863; Chan MT, 2016, BIORESOURCE TECHNOL, V200, P838, DOI 10.1016/j.biortech.2015.10.093; Chang RX, 2019, J ENVIRON SCI, V80, P306, DOI 10.1016/j.jes.2017.10.004; Chang RX, 2019, J ENVIRON MANAGE, V230, P119, DOI 10.1016/j.jenvman.2018.09.076; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Eklind Y, 2000, BIORESOURCE TECHNOL, V74, P125, DOI 10.1016/S0960-8524(00)00005-5; Erickson MC, 2010, BIORESOURCE TECHNOL, V101, P1014, DOI 10.1016/j.biortech.2009.08.105; Feng YZ, 2012, SOIL BIOL BIOCHEM, V46, P80, DOI 10.1016/j.soilbio.2011.11.016; Gao MC, 2010, BIORESOURCE TECHNOL, V101, P1899, DOI 10.1016/j.biortech.2009.10.027; Ge MS, 2020, BIORESOURCE TECHNOL, V304, DOI 10.1016/j.biortech.2020.122928; Guo R, 2012, BIORESOURCE TECHNOL, V112, P171, DOI 10.1016/j.biortech.2012.02.099; Hagemann N, 2018, SCI TOTAL ENVIRON, V613, P20, DOI 10.1016/j.scitotenv.2017.08.161; Jia W, 2018, J CLEAN PROD, V188, P954, DOI 10.1016/j.jclepro.2018.03.300; Jiang Tao, 2015, Journal of Ecology and Rural Environment, V31, P124, DOI 10.3772/j.issn.1673-4831.2015.01.019; Koyama M, 2018, BIORESOURCE TECHNOL, V265, P207, DOI 10.1016/j.biortech.2018.05.109; Li XJ, 2008, BIORESOURCE TECHNOL, V99, P359, DOI 10.1016/j.biortech.2006.12.009; Liu DY, 2011, BIORESOURCE TECHNOL, V102, P9040, DOI 10.1016/j.biortech.2011.07.052; Lu SG, 2001, ENVIRON TECHNOL, V22, P1177, DOI 10.1080/09593332208618200; Mao H, 2018, BIORESOURCE TECHNOL, V258, P195, DOI 10.1016/j.biortech.2018.02.082; Michel FC, 1998, COMPOST SCI UTIL, V6, P6; Nigussie A, 2017, CHEMOSPHERE, V166, P352, DOI 10.1016/j.chemosphere.2016.09.123; Pagans E, 2006, CHEMOSPHERE, V62, P1534, DOI 10.1016/j.chemosphere.2005.06.044; Qasim W, 2019, J AIR WASTE MANAGE, V69, P633, DOI 10.1080/10962247.2019.1569570; Qiu XW, 2019, BIORESOURCE TECHNOL, V273, P666, DOI 10.1016/j.biortech.2018.12.001; Sharma D, 2018, BIORESOURCE TECHNOL, V264, P285, DOI 10.1016/j.biortech.2018.05.091; Shen YJ, 2011, WASTE MANAGE, V31, P33, DOI 10.1016/j.wasman.2010.08.019; Shi MZ, 2018, BIORESOURCE TECHNOL, V258, P390, DOI 10.1016/j.biortech.2018.03.056; Wang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep14932; Wang Q, 2017, BIORESOURCE TECHNOL, V243, P771, DOI 10.1016/j.biortech.2017.07.021; Wang Q, 2016, BIORESOURCE TECHNOL, V220, P297, DOI 10.1016/j.biortech.2016.08.081; Wong JWC, 2001, BIORESOURCE TECHNOL, V76, P99, DOI 10.1016/S0960-8524(00)00103-6; Wu D, 2020, BIORESOURCE TECHNOL, V303, DOI 10.1016/j.biortech.2020.122849; Wu JQ, 2020, BIORESOURCE TECHNOL, V303, DOI 10.1016/j.biortech.2020.122927; Xu Z, 2012, J RESIDUALS SCI TECH, V9, P107; Zhang HY, 2016, WASTE MANAGE, V58, P369, DOI 10.1016/j.wasman.2016.08.022; Zhang JN, 2014, BIORESOURCE TECHNOL, V168, P252, DOI 10.1016/j.biortech.2014.02.080	41	2	4	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0229880	10.1371/journal.pone.0229880	http://dx.doi.org/10.1371/journal.pone.0229880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966333	Green Published, gold, Green Submitted			2022-12-26	WOS:000575688700053
J	Nyborg, C; Melau, J; Bonnevie-Svendsen, M; Mathiasen, M; Melsom, HS; Storsve, AB; Hisdal, J				Nyborg, Christoffer; Melau, Jorgen; Bonnevie-Svendsen, Martin; Mathiasen, Maria; Melsom, Helene Stole; Storsve, Andreas B.; Hisdal, Jonny			Biochemical markers after the Norseman Extreme Triathlon	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BRAIN NATRIURETIC PEPTIDE; BLOOD-CELL COUNT; NT-PROBNP; HEART-FAILURE; ASPARTATE-AMINOTRANSFERASE; EXERCISE; BNP; LEUKOCYTOSIS; OBESITY	Prolonged exercise is known to cause changes in common biomarkers. Occasionally, competition athletes need medical assistance and hospitalisation during prolonged exercise events. To aid clinicians treating patients and medical teams in such events we have studied common biomarkers after at The Norseman Xtreme Triathlon (Norseman), an Ironman distance triathlon with an accumulated climb of 5200 m, and an Olympic triathlon for comparison. Blood samples were collected before, immediately after, and the day following the Norseman Xtreme Triatlon (n = 98) and Oslo Olympic Triathlon (n = 15). Increased levels of clinical significance were seen at the finish line of the Norseman in white blood cells count (WBC) (14.2 [13.5-14.9] 109/L, p < 0.001), creatinine kinase (CK) (2450 [1620-3950] U/L, p < 0.001) and NT-proBNP (576 [331-856] ng/L, p < 0.001). The following day there were clinically significant changes in CRP (39 [27-56] mg/L, p < 0.001) and Aspartate Aminotransferase (AST) (142 [99-191] U/L, p < 0.001). In comparison, after the Olympic triathlon distance, there were statistically significant, but less clinically important, changes in WBC (7.8 [6.7-9.6] 109/L, p < 0.001), CK (303 [182-393] U/L, p < 0.001) and NT-proBNP (77 [49-88] ng/L, p < 0.01) immediately after the race, and in CRP (2 [1-3] mg/L, p < 0.001) and AST (31 [26-41] U/L, p < 0.01) the following day. Subclinical changes were also observed in Hemoglobin, Thrombocytes, K+, Ca2+, Mg2+, Creatinine, Alanine Aminotransferase and Thyroxine after the Norseman. In conclusion, there were significant changes in biomarkers used in a clinical setting after the Norseman. Of largest clinical importance were clinically significant increased WBC, CRP, AST, CK and NT-proBNP after the Norseman. This is important to be aware of when athletes engaging in prolonged exercise events receive medical assistance or are hospitalised.	[Nyborg, Christoffer; Melau, Jorgen; Melsom, Helene Stole; Hisdal, Jonny] Univ Oslo, Fac Med, Dept Clin Med, Oslo, Norway; [Nyborg, Christoffer; Melau, Jorgen; Bonnevie-Svendsen, Martin; Melsom, Helene Stole; Hisdal, Jonny] Oslo Univ Hosp, Sect Vasc Invest, Aker, Norway; [Melau, Jorgen] Vestfold Hosp Trust, Prehosp Div, Tonsberg, Norway; [Mathiasen, Maria] Telemark Hosp Trust, Dept Cardiol, Notodden, Norway; [Storsve, Andreas B.] Aker BioMarine Antarctic AS, Lysaker, Norway	University of Oslo; University of Oslo; Telemark Hospital Trust	Nyborg, C (corresponding author), Univ Oslo, Fac Med, Dept Clin Med, Oslo, Norway.; Nyborg, C (corresponding author), Oslo Univ Hosp, Sect Vasc Invest, Aker, Norway.	nyborgchristoffer@gmail.com	Melau, Jørgen/G-9021-2016	Melau, Jørgen/0000-0002-3860-3988; Storsve, Andreas B/0000-0001-6807-8638; Nyborg, Christoffer/0000-0002-6777-0670	Aker BioMarine Antarctic AS	Aker BioMarine Antarctic AS	This study was founded through a grant form Aker BioMarine Antarctic AS (http://www.akerbiomarine.com/).The funder provided support in the form of salaries for author ABS and research materials but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the `author contributions' section."; This study was conducted by the Norseman Research team. The Norseman Research team consists of scientists from serval institutions furthering the knowledge of extreme endurance exercise in cooperation with the Norseman Xtreme Triathlon and volunteering participants.	AHLBORG B, 1970, ACTA MED SCAND, V187, P241; APPLE FS, 1988, J APPL PHYSIOL, V65, P2598, DOI 10.1152/jappl.1988.65.6.2598; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; Bhavsar P, 2013, INDIAN J SURG, V75, P17, DOI 10.1007/s12262-012-0451-6; Bizheh N, 2011, IRAN J BASIC MED SCI, V14, P568; Cerqueira E, 2020, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01550; Cipryan L, 2015, J SPORT MED PHYS FIT, V55, P813; Dallam GM, 2005, SPORTS MED, V35, P143, DOI 10.2165/00007256-200535020-00004; Daniels LB, 2006, AM HEART J, V151, P999, DOI 10.1016/j.ahj.2005.10.011; Danielsson T, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000486; Danielsson T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179324; Degerstrom J, 2006, MED SCI SPORT EXER, V38, P1297, DOI 10.1249/01.mss.0000227315.93351.8d; Due-Andersen R, 2008, J APPL PHYSIOL, V104, P1080, DOI 10.1152/japplphysiol.01082.2007; Ferdinal Frans, 2009, Acta Med Indones, V41, P136; FOSTER NK, 1986, J APPL PHYSIOL, V61, P2218; GALUN E, 1987, INT J SPORTS MED, V8, P253, DOI 10.1055/s-2008-1025664; Gupta R, 2002, Indian J Med Sci, V56, P501; Hall C, 2005, J CARD FAIL, V11, pS81, DOI 10.1016/j.cardfail.2005.04.019; Hansen SI, 2020, CLIN CHEM LAB MED, V58, P69, DOI 10.1515/cclm-2019-0334; Harada M, 1998, J CARDIOVASC PHARM, V31, pS357, DOI 10.1097/00005344-199800001-00100; Harris HW, 1999, J TRAUMA, V46, P656, DOI 10.1097/00005373-199904000-00016; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hill SA, 2014, HEART FAIL REV, V19, P421, DOI 10.1007/s10741-014-9447-6; HOFFMANGOETZ L, 1994, IMMUNOL TODAY, V15, P382, DOI 10.1016/0167-5699(94)90177-5; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; Jastrzebski Z, 2016, INT J OCCUP MED ENV, V29, P801, DOI 10.13075/ijomeh.1896.00610; Keyzer JM, 2014, CLIN CHEM LAB MED, V52, P1341, DOI 10.1515/cclm-2013-0791; Knechtle B, 2011, SCAND J MED SCI SPOR, V21, pE82, DOI 10.1111/j.1600-0838.2010.01160.x; Knechtle B, 2016, CHINESE J PHYSIOL, V59, P276, DOI 10.4077/CJP.2016.BAE420; Koizumi M, 2012, HEART VESSELS, V27, P287, DOI 10.1007/s00380-011-0143-3; KUSHNER I, 1978, J EXP MED, V148, P466, DOI 10.1084/jem.148.2.466; Laird RH, 2012, SPORTS MED ARTHROSC, V20, P239, DOI 10.1097/JSA.0b013e3182736e8e; MacIntyre DL, 1996, J APPL PHYSIOL, V80, P1006, DOI 10.1152/jappl.1996.80.3.1006; MAGGA J, 1994, ENDOCRINOLOGY, V134, P2505, DOI 10.1210/en.134.6.2505; Martin HE, 1932, J PHYSIOL-LONDON, V75, P113, DOI 10.1113/jphysiol.1932.sp002879; Martinez V, 2019, EUR J APPL PHYSIOL, V119, P961, DOI 10.1007/s00421-019-04085-x; Mayers LB, 2000, PHYSICIAN SPORTSMED, V28, P35, DOI 10.3810/psm.2000.08.1157; Melau J, 2019, SPORTS, V7, DOI 10.3390/sports7060130; Mera JR, 2008, DIGEST DIS SCI, V53, P799, DOI 10.1007/s10620-007-9924-z; Neubauer O, 2008, EUR J APPL PHYSIOL, V104, P417, DOI 10.1007/s00421-008-0787-6; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Oremus M, 2014, HEART FAIL REV, V19, P413, DOI 10.1007/s10741-014-9440-0; Park CH, 2014, KOREAN J PHYSIOL PHA, V18, P419, DOI 10.4196/kjpp.2014.18.5.419; Pemberton CJ, 2000, HYPERTENSION, V36, P355, DOI 10.1161/01.HYP.36.3.355; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Pettersson J, 2008, BRIT J CLIN PHARMACO, V65, P253, DOI 10.1111/j.1365-2125.2007.03001.x; R Core Team, 2018, R LANG ENV STAT COMP; Risoy Bjorn Audun, 2003, BMC Physiol, V3, P14, DOI 10.1186/1472-6793-3-14; Rostomily KA, 2020, DIVING HYPERB MED, V50, P24, DOI 10.28920/dhm50.1.24-27; Rust CA, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1255-5; Rust CA, 2012, CHINESE J PHYSIOL, V55, P147, DOI 10.4077/CJP.2012.BAA010; Sand Kristin L, 2013, World J Exp Med, V3, P11, DOI 10.5493/wjem.v3.i1.11; SAWHNEY R C, 1984, Indian Journal of Physiology and Pharmacology, V28, P153; Saycell J, 2019, BRIT J SPORT MED, V53, P1078, DOI 10.1136/bjsports-2018-099978; Schulz G, 1893, EXPT UNTERSUCHUNGEN; Stassen NA, 2002, SURGERY, V132, P642, DOI 10.1067/msy.2002.127556; Vilela EM, 2015, ACTA CARDIOL, V70, P501, DOI [10.1080/AC.70.5.3110509, 10.2143/AC.70.5.3110509]; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wigernaes I, 2001, EUR J APPL PHYSIOL, V84, P358, DOI 10.1007/s004210000365; Zebrowska A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010057	61	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239158	10.1371/journal.pone.0239158	http://dx.doi.org/10.1371/journal.pone.0239158			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966338	gold, Green Published			2022-12-26	WOS:000575688700065
J	Imam, YZ; Kamran, S; Saqqur, M; Ibrahim, F; Chandra, P; Perkins, JD; Malik, RA; Akhtar, N; Al-Jerdi, S; Deleu, D; Elalamy, O; Osman, Y; Malikyan, G; Elkhider, H; Elmakki, S; ElSheikh, L; Mhjob, N; Abdelmoneim, MS; Alkhawad, N; Own, A; Shuaib, A				Imam, Yahia Z.; Kamran, Saadat; Saqqur, Maher; Ibrahim, Faisal; Chandra, Prem; Perkins, Jon D.; Malik, Rayaz A.; Akhtar, Naveed; Al-Jerdi, Salman; Deleu, Dirk; Elalamy, Osama; Osman, Yasir; Malikyan, Gayane; Elkhider, Hisham; Elmakki, Suha; ElSheikh, Lubna; Mhjob, Noha; Abdelmoneim, Mohamed S.; Alkhawad, Nima; Own, Ahmed; Shuaib, Ashfaq			Stroke in the adult Qatari population (Q-stroke) a hospital-based retrospective cohort study	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; RISK-FACTORS; GENDER-DIFFERENCES; SUBTYPES; EPIDEMIOLOGY; GUIDELINES; MANAGEMENT; SCALE; COMMUNITY; SURVIVAL	Background Studies assessing the burden of stroke in Qataris are limited. We aim to study stroke in the Qatari population. Methods A retrospective review was undertaken of all Qatari adults presenting with stroke to Hamad Medical Corporation over a 5-year period. Descriptive statistics were used to summarize demographic and all other clinical characteristics of the patients. The primary outcome was the incidence of stroke in the Qatari patients. Comparison was made between the sexes. Results 862 patients were included, with 58.9% being male. The average incidence of stroke over the 5-year period was 92.04 per 100,000 adult Qatari population. The mean age of the cohort was 64.3 +/- 14.4 years, (range 19-105 years). The mean age of first ever cerebrovascular event was 63.2 +/- 14.5 years. The diagnosis was ischemic stroke in (73.7%), transient ischemic attack in (13.8%), intracerebral hemorrhage (ICH) in (11.6%), subarachnoid hemorrhage in (0.7%) and (0.2%) cerebral venous sinus thrombosis. Small vessel disease was the most common cause of ischemic stroke accounting for (46.5%), followed by large artery atherosclerosis (24.5%). Hypertension (82.7%) and diabetes (71.6%) were particularly prevalent in this cohort. Females were older (65.8 +/- 14.1 vs 63.4 +/- 14.5 years), had more hypertension and diabetes and more disability or death at 90 days (p<0.05) compared to Qatari males. Conclusion Stroke occurs at a significantly lower age in Qataris compared to the western population. This study has uncovered sex differences that need to be studied further.	[Imam, Yahia Z.; Kamran, Saadat; Saqqur, Maher; Ibrahim, Faisal; Perkins, Jon D.; Akhtar, Naveed; Deleu, Dirk; Elalamy, Osama; Osman, Yasir; Malikyan, Gayane; Elkhider, Hisham; Elmakki, Suha; ElSheikh, Lubna; Mhjob, Noha; Abdelmoneim, Mohamed S.; Alkhawad, Nima; Own, Ahmed] Hamad Med Corp, Neurosci Inst, Doha, Qatar; [Chandra, Prem] Hamad Med Corp, Med Res Ctr, Doha, Qatar; [Malik, Rayaz A.; Al-Jerdi, Salman] Weill Cornell Med Qatar, Doha, Qatar; [Shuaib, Ashfaq] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB, Canada	Hamad Medical Corporation; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Alberta	Imam, YZ (corresponding author), Hamad Med Corp, Neurosci Inst, Doha, Qatar.	yimam@hamad.qa	Abdelmoneim, Mohamed Sayed/ABD-6695-2020; Imam, Yahia/GYU-0939-2022; Imam, Yahia/AAA-1602-2022; Malik, Rayaz/H-9231-2019	Abdelmoneim, Mohamed Sayed/0000-0001-5073-6532; Imam, Yahia/0000-0003-4623-733X; Malik, Rayaz/0000-0002-7188-8903; Elkhider, Hisham/0000-0003-3266-6483; Ibrahim, Faisal/0000-0001-6424-8994				Abdul-Ghaffar NU, STROKE KUWAIT 3 YEAR; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ahangar AA, 2001, EPIDEMIOLOGICAL EVAL; Akhtar N, 2009, EUR J NEUROL, V16, P1004, DOI 10.1111/j.1468-1331.2009.02709.x; Akhtar N, 2020, EUROPEAN NEUROLOGY; Al Banna M, STROKE BAHRAIN RISIN; Al Banna M, 2015, INT J STROKE, V10, P615, DOI 10.1111/ijs.12513; Al-Jishi AA, PROFILE STROKE BAHRA; al-Rajeh S, STROKE REGISTER EXPE; Al-Shammri S, 2003, MED PRIN PRACT, V12, P218, DOI 10.1159/000072287; Al-Shenqiti AM, INCIDENCE 1 TIME STR; Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; Alhyas Layla, 2011, JRSM Short Rep, V2, P55, DOI 10.1258/shorts.2011.011019; ALRAJEH S, 1993, STROKE, V24, P1635, DOI 10.1161/01.STR.24.11.1635; Althoff T, 2017, NATURE, V547, P336, DOI 10.1038/nature23018; [Anonymous], 1983, Br Med J (Clin Res Ed), V287, P713; [Anonymous], 2012, AHRAM; [Anonymous], 2012, HPC HOUSEHOLD PERSON, V1, P35; Authority QPaS, 2015, QATAR 2015 MIN CENS; Azarpazhooh MR, EXCESSIVE INCIDENCE; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Butler J, 2015, INT DIABETES NURS, V12, P63; Caso V, 2010, WOMENS HEALTH, V6, P51, DOI [10.2217/whe.09.82, 10.2217/WHE.09.82]; Catapano AL, 2016, EUR HEART J, V37, P2999, DOI 10.1093/eurheartj/ehw272; Christos PJ, 2013, J LOC GLOB HLTH PERS, DOI [10.5339/jlghp.2013.4, DOI 10.5339/JLGHP.2013.4]; Daneshfard B, 2015, IRAN J NEUROL, V14, P158; de Castilla Nuria Martinez, 2017, J QURANIC STUDIES, V19, P3; El-Hajj M, 2016, EUR STROKE J, V1, P180, DOI 10.1177/2396987316654338; Freedman SP, 2013, EVID BASED CHILD HLT, P8; Gibson CL, 2013, J CEREBR BLOOD F MET, V33, P1355, DOI 10.1038/jcbfm.2013.102; Gulli G, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0618-2; Hamad A, 2001, J Stroke Cerebrovasc Dis, V10, P236, DOI 10.1053/jscd.2001.30382; Ibrahim F, 2015, J STROKE CEREBROVASC, V24, P2875, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.024; Imam YZ, 2020, INT J STROKE, V15, P85, DOI 10.1177/1747493019830577; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Khan Fahmi Yousef, 2008, J Stroke Cerebrovasc Dis, V17, P69, DOI 10.1016/j.jstrokecerebrovasdis.2007.11.004; Khatri S, 2017, DOHA NEWS; Kolominsky-Rabas PL, 1998, STROKE, V29, P2501, DOI 10.1161/01.STR.29.12.2501; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Krisberg K, 2016, THE NATIONS HLTH, V46, pE2; Kwah LK, 2014, J PHYSIOTHER, V60, P61, DOI 10.1016/j.jphys.2013.12.012; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Petrea RE, 2009, STROKE, V40, P1032, DOI 10.1161/STROKEAHA.108.542894; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Qatar Population, 2018, WORLD; Robert AA, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.14.3015; Ryan R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007768.pub3; Santalucia P, 2013, EUR J INTERN MED, V24, P167, DOI 10.1016/j.ejim.2012.10.004; Shehab A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175405; Wagstaff AJ, 2014, QJM-INT J MED, V107, P955, DOI 10.1093/qjmed/hcu054; Williams G R, 2001, BMC Neurol, V1, P2, DOI 10.1186/1471-2377-1-2; Zafar A, 2016, NEUROSCIENCES, V21, P246, DOI 10.17712/nsj.2016.3.20150731	55	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238865	10.1371/journal.pone.0238865	http://dx.doi.org/10.1371/journal.pone.0238865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956364	gold, Green Published			2022-12-26	WOS:000574571500048
J	Chuang, CJ; Hsu, CW; Lu, MC; Koo, M				Chuang, Chi-Jou; Hsu, Chia-Wen; Lu, Ming-Chi; Koo, Malcolm			Increased risk of developing dental diseases in patients with primary Sjogren's syndrome-A secondary cohort analysis of population-based claims data	PLOS ONE			English	Article							CARIES; CLASSIFICATION; MANIFESTATIONS; PERIODONTITIS; CRITERIA	Background Although it is known that patients with primary Sjogren's syndrome (pSS) have impaired dental conditions, incidence rates and incidence rate ratios of various dental diseases in these patients are not clear. The aim of this study was to investigate the frequency and prevalence of dental diseases in patients with pSS, and to evaluate the risk of common dental diseases in these patients. Methods A population-based retrospective cohort study was conducted using the data from the Taiwan's National Health Insurance Research Database. A total of 709 patients with newly diagnosed pSS between 2000 and 2012 were identified to form the pSS cohort. A comparison cohort of patients without pSS was assembled based on frequency matching for sex, 5-year age interval, and index year at a ratio of 10:1. All participants were followed until the end of the follow-up period or when the outcome of interest occurred. The incidence of dental caries, pulpitis, gingivitis, periodontitis, oral ulceration, and stomatitis were calculated using multiple Poisson regression models. Results A significantly higher prevalence (74.6% vs. 63.0%,P= 0.001) and frequency (median 5.37 vs. 1.45 per year,P< 0.001) dental visits were observed in patients with pSS compared with patients in the comparison cohort. The risk of dental caries (adjusted incidence rate ratio [aIRR] 1.64,P< 0.001), pulpitis (aIRR 1.42,P <0.001), gingivitis (aIRR 1.43,P< 0.001), periodontitis (aIRR 1.44,P< 0.001), oral ulceration (aIRR 1.98,P <0.001), and stomatitis (aIRR 2.06,P< 0.001) were significantly higher in patients with pSS. Conclusions In this nationwide, population-based cohort study, a higher prevalence and frequency of dental visits were found in patients with pSS. Patients with PSS had increased risk of six most common dental disorders, including dental caries, pulpitis, gingivitis, periodontitis, oral ulceration, and stomatitis. Rheumatologists should remain vigilant for the dental health of patients with pSS.	[Chuang, Chi-Jou] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Obstet & Gynecol, Chiayi, Taiwan; [Chuang, Chi-Jou; Lu, Ming-Chi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hsu, Chia-Wen] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Lu, Ming-Chi] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Koo, Malcolm] Tzu Chi Univ Sci & Technol, Dept Nursing, Hualien, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University of Science & Technology; University of Toronto	Lu, MC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Lu, MC (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan.; Koo, M (corresponding author), Tzu Chi Univ Sci & Technol, Dept Nursing, Hualien, Taiwan.; Koo, M (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	e360187@yahoo.com.tw; m.koo@utoronto.ca						Antoniazzi RP, 2009, J PERIODONTOL, V80, P429, DOI [10.1902/jop.2009.080350, 10.1902/jop.2009.080350 ]; Bolstad Anne Isine, 2016, Curr Oral Health Rep, V3, P328; Bui FQ, 2019, BIOMED J, V42, P27, DOI 10.1016/j.bj.2018.12.001; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Christensen LB, 2001, ACTA ODONTOL SCAND, V59, P116; Fox PC, 2008, J AM DENT ASSOC, V139, P1592, DOI 10.14219/jada.archive.2008.0101; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; HSU CY, 2019, ARTHRITIS RES THER, V21, DOI DOI 10.1186/S13075-019-2031-731775834; Le Gall M, 2016, JOINT BONE SPINE, V83, P235, DOI 10.1016/j.jbspin.2015.02.015; Lugonja B, 2016, J CLIN PERIODONTOL, V43, P26, DOI 10.1111/jcpe.12485; Mariette X, 2018, NEW ENGL J MED, V378, P931, DOI 10.1056/NEJMcp1702514; Mathews SA, 2008, J DENT RES, V87, P308, DOI 10.1177/154405910808700411; National Health Insurance Administration, NAT HLHT INS TAIW 20; Olate S, 2014, INT J CLIN EXP MED, V7, P1140; Pedersen AML, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-4; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Shikama Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040836; Turner M, 2008, J AM DENT ASSOC, V139, P146, DOI 10.14219/jada.archive.2008.0129; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vivino FB, 2019, CLIN IMMUNOL, V203, P81, DOI 10.1016/j.clim.2019.04.009; Xin WN, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0296-7; Zero DT, 2016, J AM DENT ASSOC, V147, P295, DOI 10.1016/j.adaj.2015.11.008; Zhou ZF, 2018, PEERJ, V6, DOI 10.7717/peerj.5649	24	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239442	10.1371/journal.pone.0239442	http://dx.doi.org/10.1371/journal.pone.0239442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946501	Green Published, gold			2022-12-26	WOS:000573851100020
J	Wu, CM; Chen, L				Wu, Chunming; Chen, Long			Infrared and visible image fusion method of dual NSCT and PCNN	PLOS ONE			English	Article							ALGORITHM; LIGHT	To solve the problem that the details of fusion images are not retained well and the information of feature targets is incomplete, we proposed a new fusion method of infrared (IR) and visible (VI) image-IR and VI image fusion method of dual non-subsampled contourlet transform (NSCT) and pulse-coupled neural network (PCNN). The method makes full use of the flexible multi-resolution and multi-directional of NSCT, and the global coupling and pulse synchronization excitation characteristics of PCNN, effectively combining the features of IR image with the texture details of VI image. Experimental results show that the algorithm can combine IR and VI image features well. At the same time, the obtained fusion image can better display the texture information of image. The fusion performance in contrast, detail information and other aspects is better than the classical fusion algorithm, which has better visual effect and evaluation index.	[Wu, Chunming] Northeast Elect Power Univ, Minist Educ, Key Lab Modern Power Syst Simulat & Control & Ren, Jilin, Jilin, Peoples R China; [Wu, Chunming; Chen, Long] Northeast Elect Power Univ, Dept Elect Engn, Jilin, Jilin, Peoples R China	Northeast Electric Power University; Northeast Electric Power University	Chen, L (corresponding author), Northeast Elect Power Univ, Dept Elect Engn, Jilin, Jilin, Peoples R China.	157241969@qq.com						Akhloufi MA, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/450101; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; Bhatnagar G, 2013, IEEE T MULTIMEDIA, V15, P1014, DOI 10.1109/TMM.2013.2244870; Cheng BY, 2018, INFRARED PHYS TECHN, V91, P153, DOI 10.1016/j.infrared.2018.04.004; Dai JD, 2018, CONDITION MONITORING, P23, DOI [10.1109/CMD.2018.8535827, DOI 10.1109/CMD.2018.8535827]; Ding SF, 2018, IET COMPUT VIS, V12, P377, DOI 10.1049/iet-cvi.2017.0285; Fu ZZ, 2016, INFRARED PHYS TECHN, V77, P114, DOI 10.1016/j.infrared.2016.05.012; Goh CM, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SIGNAL AND IMAGE PROCESSING APPLICATIONS (ICSIPA), P383, DOI 10.1109/ICSIPA.2015.7412221; Huang Y, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041169; Jin X, 2018, SIGNAL PROCESS, V153, P379, DOI 10.1016/j.sigpro.2018.08.002; Jin X, 2017, INFRARED PHYS TECHN, V85, P478, DOI 10.1016/j.infrared.2017.07.010; Kaur M, 2020, CLUSTER COMPUT, V23, P1439, DOI 10.1007/s10586-019-02999-x; Kong WW, 2018, ELECTRON LETT, V54, P1282, DOI 10.1049/el.2018.5415; Kong WW, 2016, NEUROCOMPUTING, V212, P12, DOI 10.1016/j.neucom.2016.01.120; Kong WW, 2014, INFRARED PHYS TECHN, V65, P103, DOI 10.1016/j.infrared.2014.04.003; Li F, 2019, PERS UBIQUIT COMPUT, V23, P487, DOI 10.1007/s00779-019-01225-0; Li M, 2018, J PHYS CONF SER, V1069, DOI 10.1088/1742-6596/1069/1/012151; Liu X, 2016, IEEE GEOSCI REMOTE S, V13, P2039, DOI 10.1109/LGRS.2016.2622726; Liu ZW, 2017, OPT LASER ENG, V97, P71, DOI 10.1016/j.optlaseng.2017.05.007; Ma JY, 2016, INFORM FUSION, V31, P100, DOI 10.1016/j.inffus.2016.02.001; Pannu HS, 2018, CLEAN-SOIL AIR WATER, V46, DOI 10.1002/clen.201700162; Pannu HS, 2019, NEURAL COMPUT APPL, V31, P2195, DOI 10.1007/s00521-017-3181-7; Pathak Y, 2022, IRBM, V43, P87, DOI 10.1016/j.irbm.2020.05.003; Polinati Srinivasu, 2019, 2019 International Conference on Communication and Signal Processing (ICCSP), P0554, DOI 10.1109/ICCSP.2019.8697906; Shukla PK, 2020, IET SYST BIOL, V14, P211, DOI 10.1049/iet-syb.2019.0116; Singh D, 2020, EUR J CLIN MICROBIOL, V39, P1379, DOI 10.1007/s10096-020-03901-z; Wang JJ, 2015, OPTIK, V126, P2508, DOI 10.1016/j.ijleo.2015.06.019; [王烈 Wang Lie], 2018, [计算机工程与应用, Computer Engineering and Application], V54, P192; [徐心怡 Xu Xinyi], 2016, [电网技术, Power System Technology], V40, P781; [岳静静 Yue Jingjing], 2017, [红外技术, Infrared Technology], V39, P798; Zhao CH, 2015, INFRARED PHYS TECHN, V72, P266, DOI 10.1016/j.infrared.2015.07.026; 2013, AM EC REV PAPERS P, V11, P11	32	6	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0239535	10.1371/journal.pone.0239535	http://dx.doi.org/10.1371/journal.pone.0239535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946533	gold, Green Published			2022-12-26	WOS:000573851100035
J	Groarke, A; Curtis, R; Skelton, J; Groarke, JM				Groarke, AnnMarie; Curtis, Ruth; Skelton, Jean; Groarke, Jenny M.			Quality of life and adjustment in men with prostate cancer: Interplay of stress, threat and resilience	PLOS ONE			English	Article							META-SYNTHESIS; DEPRESSION; OUTCOMES; DISTRESS; SURVIVORS; ASSOCIATION; VALIDATION; PREDICTORS; CARCINOMA; SYMPTOMS	Purpose Diagnosis and treatment of prostate cancer can generate many challenges which impact on adjustment, so understanding the psychosocial factors which contribute to individual vulnerability to poor adaptation warrants further investigation. This study investigates stress and masculine identity threat as predictors of quality of life and emotional adjustment in men with localized prostate cancer and the role of resilience as a potential protective psychological factor. Methods Participants were invited to complete a survey study via online prostate cancer forums. Participants were 204 men ranging in age from 44-88 years (M = 65.24 +/- 7.51) and who were diagnosed with early localized prostate cancer within the previous five years. Measures used included the Perceived Stress Scale, Cancer-Related Masculine Threat Scale and the Conor-Davidson Resilience Scale. Using a cross-sectional online survey design, the extent to which perceived stress, masculine threat and psychological resilience are associated with quality of life, positive and negative affect and distress was assessed. Results Hierarchical regression analysis demonstrated that perceived stress accounted for 26%-44% of variance on quality of life and adjustment indices, with high stress associated with low mood and poor quality of life. Low masculine threat and high resilience predicted better quality of life and emotional adjustment accounting for between 1-7% of the variance. Resilience moderated the relationship between stress and distress and mediated the association between masculine threat and distress and negative affect. Conclusion Perceived stress was the most powerful predictor in the model and findings suggest it contributes significantly to functional and affective status in survivors of prostate cancer. Psychological resilience is a protective factor which buffers the negative effect of stress and masculine identity threat on emotional adjustment. Findings indicate that men should be screened as part of the diagnostic and treatment process for high perceived stress and low resilience to identify those at risk for poor adjustment during survivorship.	[Groarke, AnnMarie; Curtis, Ruth; Skelton, Jean] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland; [Groarke, Jenny M.] Queens Univ Belfast, Ctr Improving Hlth Related Qual Life, Sch Psychol, Belfast, Antrim, North Ireland	Ollscoil na Gaillimhe-University of Galway; Queens University Belfast	Groarke, JM (corresponding author), Queens Univ Belfast, Ctr Improving Hlth Related Qual Life, Sch Psychol, Belfast, Antrim, North Ireland.	j.groarke@qub.ac.uk		Groarke, Jenny/0000-0001-6370-7116; Skelton, Jean/0000-0003-1728-5885	Cancer Care West, Ireland a registered charity [CHY 11260]	Cancer Care West, Ireland a registered charity	The study was funded by Cancer Care West, Ireland a registered charity (CHY 11260) dedicated to supporting those whose lives have been affected by a cancer diagnosis to AMG and RC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.cancercarewest.ie/.	Alexis O, 2018, CANCER NURS, V41, P298, DOI 10.1097/NCC.0000000000000509; [Anonymous], 1994, FORUM, V10, pS6; Appleton L, 2015, EUR J CANCER CARE, V24, P71, DOI 10.1111/ecc.12233; Arrington M. I., 2008, INT J MENS HLTH, V7, P299, DOI [DOI 10.3149/JMH.0703.299, 10.3149/jmh.0703.299]; Baker H, 2016, ONCOL NURS FORUM, V43, P199, DOI 10.1188/16.ONF.199-218; Bennett G, 2005, ONCOL NURS FORUM, V32, P545, DOI 10.1188/05.ONF.545-556; Bisson JI, 2002, BJU INT, V90, P56, DOI 10.1046/j.1464-410X.2002.02806.x; Bloch S, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-2; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Chambers SK, 2014, PSYCHO-ONCOLOGY, V23, P195, DOI 10.1002/pon.3391; Chen RC, 2017, JAMA-J AM MED ASSOC, V317, P1141, DOI 10.1001/jama.2017.1652; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Drummond FJ, 2015, J CANCER SURVIV, V9, P361, DOI 10.1007/s11764-014-0419-6; Dubey C, 2015, EUR J ONCOL NURS, V19, P582, DOI 10.1016/j.ejon.2015.03.004; Esser P, 2020, PSYCHO-ONCOLOGY, V13, P1; Eton DT, 2002, PSYCHO-ONCOL, V11, P307, DOI 10.1002/pon.572; Eton DT, 2001, CANCER, V92, P1451, DOI 10.1002/1097-0142(20010915)92:6<1451::AID-CNCR1469>3.0.CO;2-R; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Folkman S., 1984, STRESS APPRAISAL COP; Gavin AT, 2015, BJU INT, V116, P397, DOI 10.1111/bju.13036; Gibbons A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2964-z; Golden-Kreutz DM, 2004, PSYCHO-ONCOLOGY, V13, P211, DOI 10.1002/pon.736; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Groarke A, 2018, BMC UROL, V18, DOI 10.1186/s12894-018-0340-9; Groarke A, 2013, PSYCHO-ONCOLOGY, V22, P177, DOI 10.1002/pon.2071; Hayes AF, 2017, GUILFORD PUBLICATION; Hoyt MA, 2013, HEALTH PSYCHOL, V32, P66, DOI 10.1037/a0030020; Hoyt MA, 2009, PSYCHOL HEALTH, V24, P981, DOI 10.1080/08870440802311330; Hsiao CP, 2011, CANCER NURS, V34, P470, DOI 10.1097/NCC.0b013e31820a5943; Jackson T, 2010, PATIENT EDUC COUNS, V79, P239, DOI 10.1016/j.pec.2009.08.004; Jan M, 2016, SCAND J UROL, V50, P47, DOI 10.3109/21681805.2015.1079796; Katz A, 2007, CANCER NURS, V30, P302, DOI 10.1097/01.NCC.0000281726.87490.f2; Korfage IJ, 2006, SOC SCI MED, V63, P911, DOI 10.1016/j.socscimed.2006.01.027; Krahn M, 2000, J CLIN EPIDEMIOL, V53, P920, DOI 10.1016/S0895-4356(00)00211-0; Kreitler S, 2007, PSYCHO-ONCOLOGY, V16, P329, DOI 10.1002/pon.1063; Lardas M, 2017, EUR UROL, V72, P869, DOI 10.1016/j.eururo.2017.06.035; Lev EL, 2009, SUPPORT CARE CANCER, V17, P509, DOI 10.1007/s00520-008-0493-2; Loprinzi CE, 2011, CLIN BREAST CANCER, V11, P364, DOI 10.1016/j.clbc.2011.06.008; Mancini AD, 2009, J PERS, V77, P1805, DOI 10.1111/j.1467-6494.2009.00601.x; Namiki S, 2010, INT J UROL, V17, P125, DOI 10.1111/j.1442-2042.2009.02437.x; Orom H, 2015, PSYCHO-ONCOLOGY, V24, P1416, DOI 10.1002/pon.3751; Ralph N, 2020, PSYCHO-ONCOLOGY, V29, P444, DOI 10.1002/pon.5255; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Roesch SC, 2005, J BEHAV MED, V28, P281, DOI 10.1007/s10865-005-4664-z; Roth AJ, 1998, CANCER, V82, P1904, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X; Schwartz CE, 2000, ADAPTATION CHANGING; Seiler A, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00208; Sharpley CF, 2014, EUR J CANCER CARE, V23, P545, DOI 10.1111/ecc.12170; Sharpley CF, 2013, EUR J CANCER CARE, V22, P815, DOI 10.1111/ecc.12090; Sharpley CF, 2018, PSYCHO-ONCOLOGY, V27, P223, DOI 10.1002/pon.4496; Sharpley CF, 2017, PSYCHO-ONCOLOGY, V26, P1400, DOI 10.1002/pon.4327; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Spendelow JS, 2018, J CANCER SURVIV, V12, P155, DOI 10.1007/s11764-017-0654-8; Tsang VWL, 2019, PSYCHOL MEN MASCULIN, V20, P214, DOI 10.1037/men0000184; Tsikriktsis N, 2005, J OPER MANAG, V24, P53, DOI 10.1016/j.jom.2005.03.001; Tucker SR, 2016, SOC SCI MED, V163, P80, DOI 10.1016/j.socscimed.2016.07.001; Wall David, 2005, Nurs Inq, V12, P87, DOI 10.1111/j.1440-1800.2005.00258.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Watson M, 2012, STRESS HEALTH, V28, P353, DOI 10.1002/smi.2473; Watts S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003901; Whiting PF, 2016, BJU INT, V118, P193, DOI 10.1111/bju.13499; Wootten AC, 2007, PSYCHO-ONCOL, V16, P994, DOI 10.1002/pon.1159	63	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239469	10.1371/journal.pone.0239469	http://dx.doi.org/10.1371/journal.pone.0239469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU7VY	32941547	Green Published, gold			2022-12-26	WOS:000573848800094
J	Jauneau, A; Cerutti, A; Auriac, MC; Noel, LD				Jauneau, Alain; Cerutti, Aude; Auriac, Marie-Christine; Noel, Laurent D.			Anatomy of leaf apical hydathodes in four monocotyledon plants of economic and academic relevance	PLOS ONE			English	Article							XANTHOMONAS-ORYZAE; GUTTATION FLUID; LEAVES; WATER; RICE; EVOLUTION; DIVERSITY; STOMATA; BARLEY; UNIQUE	Hydathode is a plant organ responsible for guttation in vascular plants, i.e. the release of droplets at leaf margin or surface. Because this organ connects the plant vasculature to the external environment, it is also a known entry site for several vascular pathogens. In this study, we present a detailed microscopic examination of leaf apical hydathodes in monocots for three crops (maize, rice and sugarcane) and the model plantBrachypodium distachyon. Our study highlights both similarities and specificities of those epithemal hydathodes. These observations will serve as a foundation for future studies on the physiology and the immunity of hydathodes in monocots.	[Jauneau, Alain; Auriac, Marie-Christine] Univ Toulouse, Univ Paul Sabatier, CNRS, Federat Rech 3450, Castanet Tolosan, France; [Cerutti, Aude; Auriac, Marie-Christine; Noel, Laurent D.] Univ Toulouse, Univ Paul Sabatier, CNRS, INRAE,LIPM, Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Jauneau, A (corresponding author), Univ Toulouse, Univ Paul Sabatier, CNRS, Federat Rech 3450, Castanet Tolosan, France.; Noel, LD (corresponding author), Univ Toulouse, Univ Paul Sabatier, CNRS, INRAE,LIPM, Castanet Tolosan, France.	jauneau@lrsv.ups-tlse.fr; laurent.moel@inrae.fr	NOEL, Laurent/A-4885-2009	NOEL, Laurent/0000-0002-0110-1423; Auriac, Marie-Christine/0000-0002-1202-032X; Cerutti, Aude/0000-0003-2838-5021	NEPHRON project [ANR-18-CE20-0020-01]; French Ministry of National Education and Research; TULIP LabEx [ANR-10-LABX-41, ANR-11-IDEX-0002-02]	NEPHRON project; French Ministry of National Education and Research; TULIP LabEx	AJ and LDN are supported by the NEPHRON project (ANR-18-CE20-0020-01). This work was supported by a PhD grant from the French Ministry of National Education and Research to AC. LIPM is part of the TULIP LabEx (ANR-10-LABX-41; ANR-11-IDEX-0002-02).	[Anonymous], 2017, CANCER DISCOV, V7, pOF12; Bailey KJ, 2016, J EXP BOT, V67, P2901, DOI 10.1093/jxb/erw132; Balcerowicz M, 2014, TRENDS PLANT SCI, V19, P747, DOI 10.1016/j.tplants.2014.10.006; Beattie GA, 2002, PHYTOPATHOLOGY, V92, P1015, DOI 10.1094/PHYTO.2002.92.9.1015; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Bragard C, 1997, PHYTOPATHOLOGY, V87, P1111, DOI 10.1094/PHYTO.1997.87.11.1111; Carlton WM, 1998, PHYTOPATHOLOGY, V88, P525, DOI 10.1094/PHYTO.1998.88.6.525; Cerutti A, 2019, ANNU REV PHYTOPATHOL, V57, P91, DOI 10.1146/annurev-phyto-082718-100228; Cerutti A, 2017, PLANT PHYSIOL, V174, P700, DOI 10.1104/pp.16.01852; Chater CCC, 2017, PLANT PHYSIOL, V174, P624, DOI 10.1104/pp.17.00183; Chen CC, 2019, TAIWANIA, V64, P149, DOI 10.6165/tai.2019.64.149; Chen YC, 2014, PHOTOSYNTHETICA, V52, P371, DOI 10.1007/s11099-014-0040-y; DIEFFENBACH H, 1980, ANN BOT-LONDON, V45, P397, DOI 10.1093/oxfordjournals.aob.a085837; Duveiller E., 1997, BACTERIAL DIS WHEAT; FENG TY, 1975, BOT BULL ACAD SINICA, V16, P126; Haberlandt G., 1914, PHYSL PLANT ANATOMY; Hossain MB, 2016, PLANT PROD SCI, V19, P528, DOI 10.1080/1343943X.2016.1210990; Kawata S-i, 1963, JAPANESE J CROP SCI, V31, P332, DOI [10.1626/jcs.31.332, DOI 10.1626/JCS.31.332]; MAEDA E, 1988, JPN J CROP SCI, V57, P733, DOI 10.1626/jcs.57.733; Mechaber WL, 1996, P NATL ACAD SCI USA, V93, P4600, DOI 10.1073/pnas.93.10.4600; Muller-Moule P, 2016, PEERJ, V4, DOI 10.7717/peerj.2574; Nagai M, 2013, PLANT CELL ENVIRON, V36, P1826, DOI 10.1111/pce.12090; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; PEDERSEN O, 1993, PLANT PHYSIOL, V103, P1369, DOI 10.1104/pp.103.4.1369; Pedersen O, 1997, PLANTA, V202, P43, DOI 10.1007/s004250050101; Perrin A, 1972, CONTRIBUTION ETUDE O; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; Pieretti I, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00289; Pieretti I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-658; Robene-Soustrade I, 2006, APPL ENVIRON MICROB, V72, P1072, DOI 10.1128/AEM.72.2.1072-1078.2006; Shapira O, 2013, PLANT CELL ENVIRON, V36, P275, DOI 10.1111/j.1365-3040.2012.02572.x; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; The guideline revising committee of Japanese Society of Gout and Nucleic Acid Metabolism, 2010, GOUT NUCL ACID METAB, V34, P107; Toves PJ, 2008, ENHANCEMENT BIOL CON; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vauterin L, 2000, PHYTOPATHOLOGY, V90, P677, DOI 10.1094/PHYTO.2000.90.7.677; Yamamoto Y, 2007, PLANT PHYSIOL, V143, P1362, DOI 10.1104/pp.106.091561; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008	39	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0232566	10.1371/journal.pone.0232566	http://dx.doi.org/10.1371/journal.pone.0232566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941421	Green Published, Green Submitted, gold			2022-12-26	WOS:000573848800108
J	So, KA; Yang, EJ; Kim, NR; Hong, SR; Lee, JH; Hwang, CS; Shim, SH; Lee, SJ; Kim, TJ				So, Kyeong A.; Yang, Eun Jung; Kim, Nae Ry; Hong, Sung Ran; Lee, Jae-Ho; Hwang, Chang-Sun; Shim, Seung-Hyuk; Lee, Sun Joo; Kim, Tae Jin			Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection	PLOS ONE			English	Article							GARDNERELLA-VAGINALIS; ASSOCIATION; PREVOTELLA; RISK	Objective To evaluate the changes of vaginal microbiota during cervical carcinogenesis in women with high-risk human papillomavirus infection. Materials and methods Vaginal microbiota was analyzed using next-generation sequencing in women with normal, cervical intraepithelial neoplasia (CIN), or cervical cancer. Results A marked decrease ofLactobacillus crispatuswas found in the CIN/cancer groups compared with that in the normal group. The diversity of microorganisms increased in patients with CIN or cervical cancer with HPV infection.Atopobium vaginae(OR 4.33, 95% CI 1.15-16.32),Dialister invisus(OR 4.89, 95% CI 1.20-19.94),Finegoldia magna(OR 6.00, 95% CI 1.08-33.27),Gardnerella vaginalis(OR 7.43, 95% CI 1.78-31.04),Prevotella buccalis(OR 11.00, 95% CI 2.00-60.57), andPrevotella timonensis(OR 6.00, 95% CI 1.46-24.69) were significantly associated with the risk of CIN 2/3 or cervical cancer. Conclusion Women with the CIN and cervical cancer showed a high diversity in vaginal microbiota. Depletion ofLactobacillus crispatusand increased abundance of anaerobic bacteria were detected in women with cervical disease.	[So, Kyeong A.; Yang, Eun Jung; Kim, Nae Ry; Shim, Seung-Hyuk; Lee, Sun Joo; Kim, Tae Jin] Konkuk Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea; [Hong, Sung Ran] CHA Univ, CHA Ilsan Med Ctr, Dept Pathol, Gyeonggi Do, South Korea; [Lee, Jae-Ho] Cheil Gen Hosp & Womens Healthcare Ctr, Lab Mol Oncol, Seoul, South Korea; [Hwang, Chang-Sun] Cheil Gen Hosp & Womens Healthcare Ctr, Human Resource Biobank, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Pochon Cha University	Kim, TJ (corresponding author), Konkuk Univ, Dept Obstet & Gynecol, Sch Med, Seoul, South Korea.	kimonc111@naver.com						Amorim AT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2835-5; [Anonymous], 2007, HUMAN PAPILLOMAVIRUS; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Brusselaers N, 2019, AM J OBSTET GYNECOL, V221, P9, DOI 10.1016/j.ajog.2018.12.011; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Clarke MA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-33; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Giampaoli S, 2017, J FORENSIC SCI, V62, P192, DOI 10.1111/1556-4029.13222; Glazunova OO, 2007, INT J SYST EVOL MICR, V57, P883, DOI 10.1099/ijs.0.64609-0; Hilbert DW, 2017, EUR J CLIN MICROBIOL, V36, P1269, DOI 10.1007/s10096-017-2933-8; Ilhan ZE, 2019, EBIOMEDICINE, V44, P675, DOI 10.1016/j.ebiom.2019.04.028; Korshunov VM, 1994, ZH MIKROBIOL EPIDEMI, V5, P13; Kroon SJ, 2018, FERTIL STERIL, V110, P327, DOI 10.1016/j.fertnstert.2018.06.036; Kwasniewski W, 2018, ONCOL LETT, V16, P7035, DOI 10.3892/ol.2018.9509; Linhares IM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.07.010; Mitra A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16865; Murphy EC, 2013, FEMS MICROBIOL REV, V37, P520, DOI 10.1111/1574-6976.12005; NG J, 1994, J CLIN MICROBIOL, V32, P1302, DOI 10.1128/JCM.32.5.1302-1307.1994; Norenhag J, 2020, BJOG-INT J OBSTET GY, V127, P171, DOI 10.1111/1471-0528.15854; Olsen I, 1999, PERIODONTOL 2000, V20, P14, DOI 10.1111/j.1600-0757.1999.tb00156.x; Park CH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48925-4; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Seo SS, 2016, CLIN NUTR, V35, P1434, DOI 10.1016/j.clnu.2016.03.019; Si J, 2017, CELL HOST MICROBE, V21, P97, DOI 10.1016/j.chom.2016.11.010; Tamarelle J, 2019, CLIN MICROBIOL INFEC, V25, P35, DOI 10.1016/j.cmi.2018.04.019; Wang HY, 2019, J INFECT DIS, V220, P1243, DOI 10.1093/infdis/jiz325; Wheeler CM, 2013, OBSTET GYN CLIN N AM, V40, P165, DOI 10.1016/j.ogc.2013.02.004; Wu RT, 2019, CANCER PREV RES, V12, P43, DOI 10.1158/1940-6207.CAPR-18-0233; Zhou X, 2010, FEMS IMMUNOL MED MIC, V58, P169, DOI 10.1111/j.1574-695X.2009.00618.x; 2014, REG ANESTH PAIN MED, V9	31	18	21	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0238705	10.1371/journal.pone.0238705	http://dx.doi.org/10.1371/journal.pone.0238705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941440	gold, Green Published			2022-12-26	WOS:000573848800110
J	De Niz, M; Kehrer, J; Brancucci, NMB; Moalli, F; Reynaud, EG; Stein, JV; Frischknecht, F				De Niz, Mariana; Kehrer, Jessica; Brancucci, Nicolas M. B.; Moalli, Federica; Reynaud, Emmanuel G.; Stein, Jens, V; Frischknecht, Friedrich			3D imaging of undissected optically cleared Anopheles stephensi mosquitoes and midguts infected with Plasmodium parasites	PLOS ONE			English	Article							LIGHT-SHEET MICROSCOPY; PROJECTION TOMOGRAPHY; MALARIA PARASITE; SALIVA; AGENT	Malaria is a life-threatening disease, caused by Apicomplexan parasites of thePlasmodiumgenus. TheAnophelesmosquito is necessary for the sexual replication of these parasites and for their transmission to vertebrate hosts, including humans. Imaging of the parasite within the insect vector has been attempted using multiple microscopy methods, most of which are hampered by the presence of the light scattering opaque cuticle of the mosquito. So far, most imaging of thePlasmodiummosquito stages depended on either sectioning or surgical dissection of important anatomical sites, such as the midgut and the salivary glands. Optical projection tomography (OPT) and light sheet fluorescence microscopy (LSFM) enable imaging fields of view in the centimeter scale whilst providing micrometer resolution. In this paper, we compare different optical clearing protocols and present reconstructions of the whole body ofPlasmodium-infected, optically clearedAnopheles stephensimosquitoes and their midguts. The 3D-reconstructions from OPT imaging show detailed features of the mosquito anatomy and enable overall localization of parasites in midguts. Additionally, LSFM imaging of mosquito midguts shows detailed distribution of oocysts in extracted midguts. This work was submitted as a pre-print tobioRxiv, available at https://www.biorxiv.org/content/10.1101/682054v2..	[De Niz, Mariana] Univ Bern, Inst Cell Biol, Heussler Res Grp, Bern, Switzerland; [Kehrer, Jessica; Frischknecht, Friedrich] Heidelberg Univ, Ctr Infect Dis Integrat Parasitol, Med Sch, Heidelberg, Germany; [Brancucci, Nicolas M. B.] Univ Glasgow, Wellcome Ctr Integrat Parasitol, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Moalli, Federica] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Reynaud, Emmanuel G.] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin, Ireland; [Stein, Jens, V] Univ Fribourg, Dept Oncol Microbiol & Immunol, Fribourg, Switzerland; [De Niz, Mariana] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal; [Brancucci, Nicolas M. B.] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Moalli, Federica] Ist Sci San Raffaele, Milan, Italy	University of Bern; Ruprecht Karls University Heidelberg; University of Glasgow; University of Bern; University College Dublin; University of Fribourg; Universidade de Lisboa; University of Basel; Swiss Tropical & Public Health Institute; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Niz, M (corresponding author), Univ Bern, Inst Cell Biol, Heussler Res Grp, Bern, Switzerland.; De Niz, M (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal.	mariana.deniz@medicina.ulisboa.pt		Reynaud, Emmanuel/0000-0003-1502-661X; De Niz, Mariana/0000-0001-6987-6789; Frischknecht, Friedrich/0000-0002-8332-6668; Brancucci, Nicolas/0000-0003-0655-3266; Kehrer, Jessica/0000-0001-5084-3485	European Union's Seventh Framework Programme (FP7/2007-2013) [242095]; Swiss National Foundation [310030_159519]; ERC Starting Grant [StG 281719]; Chica and Heinz Schaller Foundation; IZB, University of Bern; Microscopy Imaging Center, University of Bern, Switzerland	European Union's Seventh Framework Programme (FP7/2007-2013); Swiss National Foundation(Swiss National Science Foundation (SNSF)); ERC Starting Grant(European Research Council (ERC)); Chica and Heinz Schaller Foundation; IZB, University of Bern; Microscopy Imaging Center, University of Bern, Switzerland	This work was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement 242095: EVIMalar (to VH and MDN; ec.europa.eu/growth/sectors/space/research/fp7_en), by a Swiss National Foundation Grant (310030_159519 to VH; http://www.snf.ch/en/funding/Pages/default.aspx), by an ERC Starting Grant (StG 281719 to FF; www.erc.europa.eu/funding/starting-grants); and by the Chica and Heinz Schaller Foundation (to FF; www.chs-stiftung.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Volker Heussler (IZB, University of Bern) for his intellectual input and funding of this project. We thank Uros. Krz.ic for acquisition and processing of Movie 2 included in this manuscript. We thank Renzo Danuser (Theodor Kocher Institute, University of Bern) for important input for the OPT technique, and Leandro Lemgruber (Wellcome Trust Centre for Molecular Parasitology) for his input on image processing. OPT and confocal microscopy was performed on equipment supported by the Microscopy Imaging Center, University of Bern, Switzerland. We thank Ernst Stelzer and Pavel Tomancak for motivation to use SPIM.	Abe J, 2016, J IMMUNOL METHODS, V431, P1, DOI 10.1016/j.jim.2016.01.015; Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; [Anonymous], 1991, BIOL BLOOD SUCKING I; Beaty B.J., 1996, BIOL DIS VECTORS; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Burda PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004760; CDC, 2014, CDC DIV VECT BORN DI; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; De Niz M, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13201; De Niz M, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13117; De Niz M, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13023; De Niz M, 2019, TRENDS PARASITOL, V35, P193, DOI 10.1016/j.pt.2019.01.002; DENT JA, 1989, DEVELOPMENT, V105, P61; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Eldridge B.F., 2000, MED ENTOMOLOGY; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Fang L., 2019, DEEP LEARNING BASED, DOI [10.1101/740548, DOI 10.1101/740548]; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Frischknecht F, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-23; Genina EA, 2010, EXPERT REV MED DEVIC, V7, P825, DOI 10.1586/ERD.10.50; Gerger A, 2005, J INVEST DERMATOL, V124, P493, DOI 10.1111/j.0022-202X.2004.23569.x; Gualda EJ, 2013, NAT METHODS, V10, P599, DOI 10.1038/nmeth.2508; Haase R, 2020, NAT METHODS, V17, P5, DOI 10.1038/s41592-019-0650-1; Hama H, 2015, NAT NEUROSCI, V18, P1518, DOI 10.1038/nn.4107; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Jahrling N, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.001.2010; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kettle DS, 1995, MED VET ENTOMOL, P248; Lefevre T, 2007, PROTEOMICS, V7, P1908, DOI 10.1002/pmic.200601021; Liu A, 2019, J MICROSC-OXFORD, V275, P3, DOI 10.1111/jmi.12796; Mayer J, 2014, OPT LETT, V39, P1053, DOI 10.1364/OL.39.001053; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; Mori T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38529-3; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pitrone PG, 2013, NAT METHODS, V10, P598, DOI 10.1038/nmeth.2507; Poguzhelskaya E, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-19; Prado M, 2015, AUTOPHAGY, V11, P1561, DOI 10.1080/15548627.2015.1067361; Ramirez PPV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52065-0; Reynaud EG, 2015, NAT METHODS, V12, P30, DOI 10.1038/nmeth.3222; RIBEIRO JMC, 1984, J EXP BIOL, V108, P1; ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Silvie O, 2008, CURR OPIN MICROBIOL, V11, P352, DOI 10.1016/j.mib.2008.06.005; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Von Chamier L., 2020, ZEROCOSTDL4MIC OPEN, DOI [10.1101/2020.03.20.000133, DOI 10.1101/2020.03.20.000133]; World Health Organization, 2015, WORLD MAL REP 2015	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2020	15	9							e0238134	10.1371/journal.pone.0238134	http://dx.doi.org/10.1371/journal.pone.0238134			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU5BZ	32936796	Green Published, gold, Green Submitted			2022-12-26	WOS:000573658000018
J	Gebreweld, A; Fiseha, T; Girma, N; Haileslasie, H; Gebretsadik, D				Gebreweld, Angesom; Fiseha, Temesgen; Girma, Nibret; Haileslasie, Haftay; Gebretsadik, Daniel			Prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEMATOLOGICAL ABNORMALITIES; ANEMIA; THROMBOCYTOPENIA; NEUTROPENIA; DISEASE; CARE	Background Cytopenias affect the outcomes of highly active anti-retroviral therapy that results in higher morbidity, mortality, and impaired quality of life. The purpose of this study was to assess the prevalence of cytopenia and its associated factors among HIV infected adults on highly active antiretroviral therapy at Mehal Meda Hospital, North Shewa Zone, Ethiopia. Method A cross-sectional health facility based study was conducted among 499 consecutively selected adult HIV infected patients taking HAART for at least six months from January to April 2018. The study participant's socio-demographic and clinical information was collected using a pre-tested questionnaire and reviewing of medical records by trained clinical nurses. Complete blood count and CD4 T cell count were determined by Sysmex KX-21 N and BD FACS count respectively. Bivariate and multivariate analysis was performed to identify the independently associated factors of cytopenia and prevalence ratios and their 95% confidence intervals were estimated using Poisson regression model with robust error variance to quantify the strength of statistical association. In all cases, a P value less than 0.05 was considered statistically significant. Result Out of the total study participants, 39.9% had at least one form of cytopenia, 23.2% had anemia, 13.8% had leukopenia, 12.4% had thrombocytopenia, 11.62% had bi-cytopenias, and only 1% had pancytopenia. In multivariate analysis, cytopenia was independently associated with older age groups, male gender, ZDV based regimen, and CD4 count less than 200 cells/mm(3). Conclusions In this study, the magnitude of any cytopenia was 40% among adult HIV infected patients taking highly active antiretroviral therapy and the prevalence increased as the CD4 count decreases. Therefore, these warrant the need for monitoring hematological parameters of HIV infected patients on HAART to reduce morbidity and mortality.	[Gebreweld, Angesom; Haileslasie, Haftay] Mekelle Univ, Coll Hlth Sci, Dept Med Lab Sci, Mekelle, Ethiopia; [Fiseha, Temesgen; Gebretsadik, Daniel] Wollo Univ, Coll Med & Hlth Sci, Dept Med Lab Sci, Dessie, Ethiopia; [Girma, Nibret] Mehal Meda Hosp, Dept Lab, Mehal Meda, Ethiopia	Mekelle University	Gebreweld, A (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Med Lab Sci, Mekelle, Ethiopia.	afsaha@gmail.com	Weldehanna, Daniel/ABA-8617-2020	Weldehanna, Daniel/0000-0001-5032-5143				Afari S, 2018, INT J VIROL AIDS, V5, P39, DOI DOI 10.23937/2469-567X/151003920; Ageru TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221853; AGOMELATINE (Valdoxan/ Thymanax), 2013, DRUG SAFETY UPDATE, V6, pA1; [Anonymous], 2018, STANOWISKO POLSKIEGO, V4, P5; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2019, CIRCULATION, V2019; [Anonymous], 2017, J DEMOCRACY, V28, P63; [Anonymous], 2016, BIOL BLOOD MARROW TR, V22, pS1; Assefa Muluken, 2015, BMC Hematol, V15, P6, DOI 10.1186/s12878-015-0024-6; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; CALENDA V, 1992, EUR J HAEMATOL, V48, P181; De Santis GC, 2011, INT J INFECT DIS, V15, pE808, DOI 10.1016/j.ijid.2011.08.001; Deressa Tekalign, 2018, EJIFCC, V29, P36; Durandt C, 2019, SAMJ S AFR MED J, V109, pS41, DOI 10.7196/SAMJ.2019.v109i8b.13829; Enawgaw Bamlaku, 2014, BMC Hematol, V14, P8, DOI 10.1186/2052-1839-14-8; Evans RH, 2000, BEST PRACT RES CL HA, V13, P215, DOI 10.1053/beha.1999.0069; Federal HIV/AIDS Prevention and Control Office (FHAPCO), 2018, HIV PREV ETH NAT ROA; Fekene Tamirat Edie, 2018, BMC Hematol, V18, P8, DOI 10.1186/s12878-018-0102-7; Firnhaber C, 2010, INT J INFECT DIS, V14, pE1088, DOI 10.1016/j.ijid.2010.08.002; Gunda DW, 2017, MALAWI MED J, V29, P43, DOI 10.4314/mmj.v29i1.9; Harris RJ, 2008, ANTIVIR THER, V13, P959; Herbst CL, 2018, J Cancer Policy, V15, P18, DOI 10.1016/j.jcpo.2017.11.005; Kathuria S., 2016, J CONT MED RES, V3, P3495, DOI DOI 10.18203/2349-3933.IJAM2019147626; Koka PS, 2004, CURR HIV RES, V2, P275, DOI 10.2174/1570162043351282; Kumar MB, 2016, INT J SCI STUDY, V3, P1, DOI 10.17354/ijss/2016/46; Kyeyune R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-496; Melese H, 2017, HIV AIDS-RES PALLIAT, V9, P25, DOI 10.2147/HIV.S121021; Mitra JK, 2015, INT J HLTH SCI RES, V5, P18; Nassiri R, 2006, J AM OSTEOPATH ASSOC, V106, P111; Nka AD, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4664-7; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Omoregie R, 2009, NIGERIA TANZAN J HLT, V11, P1, DOI DOI 10.4314/THRB.V11I1.43242; Opie J, 2012, SAMJ S AFR MED J, V102, P465, DOI 10.7196/SAMJ.5595; Ordre des Ingenieurs du Quebec, 2004, PLAN, V3, P1; Petraro P, 2016, AM J TROP MED HYG, V94, P384, DOI 10.4269/ajtmh.15-0587; Prazeres F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111097; Shi X, 2014, INT REV IMMUNOL, V33, P511, DOI 10.3109/08830185.2014.893301; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Tamir Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211708; Taremwa IM, 2015, J BLOOD MED, V6, P109, DOI 10.2147/JBM.S80857; Torre D, 2008, CURR HIV RES, V6, P411, DOI 10.2174/157016208785861140; UNAIDS, GLOB HIV AIDS STAT 2; Vishnu P, 2015, BRIT J HAEMATOL, V171, P695, DOI 10.1111/bjh.13783; Volberding Paul A, 2004, Clin Infect Dis, V38, P1454, DOI 10.1086/383031; WHO, 2011, WHO TECH REP SER, V959, P1; Woldeamanuel Gashaw Garedew, 2018, BMC Hematol, V18, P9, DOI 10.1186/s12878-018-0103-6; Woldeamanuel Gashaw Garedew, 2018, BMC Hematol, V18, P7, DOI 10.1186/s12878-018-0099-y; Zerihun KW, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4214-3	48	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239215	10.1371/journal.pone.0239215	http://dx.doi.org/10.1371/journal.pone.0239215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931523	gold, Green Published			2022-12-26	WOS:000573375500022
J	Gulati, S; Singh, R; Prakash, R; Sangwan, S				Gulati, Susheel; Singh, Rajvir; Prakash, Ram; Sangwan, Suman			One-pot three component synthesis of substituted dihydropyrimidinones using fruit juices as biocatalyst and their biological studies	PLOS ONE			English	Article							BIGINELLI; BLOCKERS; CATALYST; PROTOCOL	New and facile one-pot three component approach for the synthesis of substituted dihydropyrimidinones derivatives (4a-4h) from reaction of equimolar substituted aldehydes (1a-1h), methyl acetoacetate (2a) and urea (3a) in presence of nature derived catalystviz.Cocos nuciferaL. juice,Solanum lycopersicumL. juice andCitrus limettajuice, commonly known as coconut juice, tomato juice and musambi juice respectively, at room temperature has been carried out. All synthesized compounds were evaluated forin vitroherbicidal activity againstRaphanus sativusL. (Radish seeds). The compounds (4a-4h) were also screened for their antifungal activity againstRhizoctonia solaniandColletotrichum gloeosporioidesby poisoned food techniques method. Antibacterial activity was also studied againstErwinia cartovoraandXanthomonas citriby inhibition zone method. From activity data, it was found that compounds 4g and 4d were most active againstRaphanus sativusL. (root) andRaphanus sativusL. (shoot) respectively. Compounds 4f and 4c was found most active againstRhizoctonia solaniandColletotrichum gloeosporioidesfungus respectively at highest concentration. Compound 4g has shown maximum inhibition zone i.e. 1.00-5.50 mm againstErwinia cartovoraat 2000 mu g/mL concentration. MaximumXanthomonas citriigrowth was inhibited by compounds 4f showing inhibition zone 4.00-12.00 mm at highest concentration. Short reaction time, high yields, mild reaction condition and simple work-up are some merits of present methodology.	[Gulati, Susheel; Singh, Rajvir; Sangwan, Suman] Chaudhary Charan Singh Haryana Agr Univ, Dept Chem, Hisar, Haryana, India; [Prakash, Ram] Chaudhary Charan Singh Haryana Agr Univ, Dept Soil Sci, Hisar, Haryana, India	CCS Haryana Agricultural University; CCS Haryana Agricultural University	Gulati, S (corresponding author), Chaudhary Charan Singh Haryana Agr Univ, Dept Chem, Hisar, Haryana, India.	sgbhuna108@gmail.com	GULATI, Dr SUSHEEL/ABG-4043-2020; Prakash, Ram/ABG-4191-2020	GULATI, Dr SUSHEEL/0000-0002-2989-6758; 				[Anonymous], 2013, EMERGEN MED, V1, P47; Aridoss G, 2010, B KOREAN CHEM SOC, V31, P863, DOI 10.5012/bkcs.2010.31.04.863; ATWAL KS, 1990, J MED CHEM, V33, P2629, DOI 10.1021/jm00171a044; Burton J. D., 1997, HERBICIDE ACTIVITY T; CHO H, 1989, J MED CHEM, V32, P2399, DOI 10.1021/jm00130a029; Deshmukh MB, EFFICIENT SIMPLE ONE; Fonseca AM, 2009, J MOL CATAL B-ENZYM, V57, P78, DOI 10.1016/j.molcatb.2008.06.022; Fu NY, 2002, CHINESE CHEM LETT, V13, P921; Gangadasu B, CALCIUM CHLORIDE CAT; GROVER RK, 1962, PHYTOPATHOLOGY, V52, P876; Jamil NE, 2015, INT J BASIC APPL SCI, V15, P157301; Jin TS, 2002, SYNTHETIC COMMUN, V32, P1847, DOI 10.1081/SCC-120004068; Kundu SK, ENV BENIGN AQUEOUS Z; Ma JJ, ONE POT SYNTHESIS 3; Paraskar AS, 2003, TETRAHEDRON LETT, V44, P3305, DOI 10.1016/S0040-4039(03)00619-1; Participants in the 2006 Georgetown University Workshop on the Ancillary-Care Obligations of Medical Researchers Working in Developing Countries, 2008, PLOS MED, V5, pe90; Pasha MA, 2005, INDIAN J CHEM B, V44, P823; Pramanik T, 2013, RES J PHARM BIO CHEM, V5, P444; Ramu E., 2008, RASAYAN J CHEM, V1, P188; ROVNYAK GC, 1995, J MED CHEM, V38, P119, DOI 10.1021/jm00001a017; Shaikh, 2014, PHARM SIN, V5, P64; Suresh Patil, 2011, Archives of Applied Science Research, V3, P203; Tamuli KJ, 2017, CHEMISTRYSELECT, V2, P7787, DOI 10.1002/slct.201701487; The clinical guideline for medical treatment of acute stage Kawasaki disease from the scientific committee, 2012, PEDIAT CARDIOLOGY S3, V28, P1; THORNBERRY HH, 1950, PHYTOPATHOLOGY, V40, P29; Wolverton B., 2008, CHRON HIGHER EDUC, V55, pA1; Xue S, 2002, CHINESE J CHEM, V20, P385; Zia M, 2017, IET NANOBIOTECHNOL, V11, P193, DOI 10.1049/iet-nbt.2015.0099	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0238092	10.1371/journal.pone.0238092	http://dx.doi.org/10.1371/journal.pone.0238092			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931491	gold, Green Published			2022-12-26	WOS:000573375500004
J	Sunthankar, KI; Griffith, KN; Talutis, SD; Rosen, AK; McAneny, DB; Kulke, MH; Tseng, JF; Sachs, TE				Sunthankar, Kathryn I.; Griffith, Kevin N.; Talutis, Stephanie D.; Rosen, Amy K.; McAneny, David B.; Kulke, Matthew H.; Tseng, Jennifer F.; Sachs, Teviah E.			Cancer stage at presentation for incarcerated patients at a single urban tertiary care center	PLOS ONE			English	Article							LUNG-CANCER; MORTALITY; PRISON; BLACK; RISK; MEN	Patients who are incarcerated are a vulnerable patient population and may suffer from less access to routine cancer screenings compared to their non-incarcerated counterparts. Therefore, a thorough evaluation of potential differences in cancer diagnosis staging is needed. We sought to examine whether there are differences in cancer stage at initial diagnosis between non-incarcerated and incarcerated patients by pursuing a retrospective chart review from 2010-2017 for all patients who were newly diagnosed with cancer at an urban safety net hospital. Incarceration status was determined by insurance status. Our primary outcome was incarceration status at time of initial cancer diagnosis. Overall, patients who were incarcerated presented at a later cancer stage for all cancer types compared to the non-incarcerated (+.14 T stage, p = .033; +.23 N stage, p < .001). Incarcerated patients were diagnosed at later stages for colorectal (+0.93 T stage, p < .001; +.48 N stage, p < .001), oropharyngeal (+0.37 N stage, p = .003), lung (+0.60 N stage, p = .018), skin (+0.59 N stage, p = 0.014), and screenable cancers (colorectal, prostate, lung) as a whole (+0.23 T stage, p = 0.002; +0.17 N stage, p = 0.008). Incarcerated patients may benefit from more structured screening protocols in order to improve the stage at presentation for certain malignancies.	[Sunthankar, Kathryn I.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Griffith, Kevin N.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Talutis, Stephanie D.; McAneny, David B.; Kulke, Matthew H.; Tseng, Jennifer F.; Sachs, Teviah E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Rosen, Amy K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA USA	Vanderbilt University; Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Sachs, TE (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.	teviah.sachs@bmc.org			AHRQ HHS [R36 HS027306] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Aisyah DN, 2018, J VIRAL HEPATITIS, V25, P1260, DOI 10.1111/jvh.12936; [Anonymous], 2000, J Am Geriatr Soc, V48, P333; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Baillargen J, 2009, PUBLIC HEALTH REP, V124, P120, DOI 10.1177/003335490912400115; Binswanger IA, 2005, AM J PUBLIC HEALTH, V95, P1781, DOI 10.2105/AJPH.2004.052498; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Carbonnaux M, 2013, ONCOLOGY-BASEL, V85, P370, DOI 10.1159/000356877; Cortes A, 2018, J CANCER EDUC, V33, P686, DOI 10.1007/s13187-016-1141-z; Edge SB, 2010, AJCC CANC STAGING MA; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2019, J Hepatol, V70, P817, DOI 10.1016/j.jhep.2019.01.020; Harzke Amy J, 2011, J Correct Health Care, V17, P241, DOI 10.1177/1078345811401362; Hurst A, 2019, ANN INTERN MED, V170, P563, DOI 10.7326/M17-3154; Khan MR, 2019, AIDS CARE, V31, P349, DOI 10.1080/09540121.2018.1499861; Kouyoumdjian FG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175837; Kouyoumdjian FG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171131; Lafferty L, 2018, J VIRAL HEPATITIS, V25, P1526, DOI 10.1111/jvh.12987; Massoglia M, 2015, ANNU REV SOCIOL, V41, P291, DOI 10.1146/annurev-soc-073014-112326; McConnon A, 2019, AM J PREV MED; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; O'Gorman CM, 2012, CAN J PUBLIC HEALTH, V103, pE379, DOI 10.1007/BF03404446; Quinn C, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0708-7; Renault L, 2018, LUNG, V196, P115, DOI 10.1007/s00408-017-0066-6; Rosen DL, 2011, ANN EPIDEMIOL, V21, P719, DOI 10.1016/j.annepidem.2011.04.007; Spaulding AC, 2011, AM J PUBLIC HEALTH, V101, pS347, DOI 10.2105/AJPH.2010.300004; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Yao XXI, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw323	26	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0237439	10.1371/journal.pone.0237439	http://dx.doi.org/10.1371/journal.pone.0237439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NU1BO	32931490	gold, Green Published			2022-12-26	WOS:000573375500021
J	Reiss, RA; Lowe, TC; Sena, JA; Makhnin, O; Connick, MC; Illescas, PE; Davis, CF				Reiss, Rebecca A.; Lowe, Terry C.; Sena, Johnny A.; Makhnin, Oleg; Connick, Melanie C.; Illescas, Patrick E.; Davis, Casey F.			Bio-activating ultrafine grain titanium: RNA sequencing reveals enhanced mechano-activation of osteoconduction on nanostructured substrates	PLOS ONE			English	Article							CIRCADIAN CLOCK; CELL-ADHESION; CIRCULAR RNAS; OSTEOGENESIS; INTEGRATION; PROTEINS; GENOMICS; GADD45	Titanium is essentially absent from biological systems yet reliably integrates into bone. To achieve osseointegration, titanium must activate biological processes without entering cells, defining it as a bio-activating material. Nanostructuring bulk titanium reduces grain size, increases strength, and improves other quantifiable physical properties, including cytocompatibility. The biological processes activated by increasing grain boundary availability were detected with total RNA-sequencing in mouse pre-osteoblasts grown for 72 hours on nanometrically smooth substrates of either coarse grain or nanostructured ultrafine grain titanium. The average grain boundary length under cells on the conventional coarse grain substrates is 273.0 mu m, compared to 70,881.5 mu m for cells adhered to the nanostructured ultrafine grain substrates; a 260-fold difference. Cells on both substrates exhibit similar expression profiles for genes whose products are critical for mechanosensation and transduction of cues that trigger osteoconduction. Biological process Gene Ontology term enrichment analysis of differentially expressed genes reveals that cell cycle, chromatin modification, telomere maintenance, and RNA metabolism processes are upregulated on ultrafine grain titanium. Processes related to immune response, including apoptosis, are downregulated. Tumor-suppressor genes are upregulated while tumor-promoting genes are downregulated. Upregulation of genes involved in chromatin remodeling and downregulation of genes under the control of the peripheral circadian clock implicate both processes in the transduction of mechanosensory information. Non-coding RNAs may also play a role in the response. Merging transcriptomics with well-established mechanobiology principles generates a unified model to explain the bio-activating properties of titanium. The modulation of processes is accomplished through chromatin remodeling in which the nucleus responds like a rheostat to grain boundary concentration. This convergence of biological and materials science reveals a pathway toward understanding the biotic-abiotic interface and will inform the development of effective bio-activating and bio-inactivating materials.	[Reiss, Rebecca A.; Connick, Melanie C.; Illescas, Patrick E.] New Mexico Inst Min & Technol, Biol Dept, Socorro, NM 87801 USA; [Lowe, Terry C.; Davis, Casey F.] Colorado Sch Mines, George S Ansell Dept Met & Mat Engn, Golden, CO 80401 USA; [Sena, Johnny A.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Makhnin, Oleg] New Mexico Inst Min & Technol, Math Dept, Socorro, NM 87801 USA	New Mexico Institute of Mining Technology; Colorado School of Mines; National Center for Genome Resources (NCGR); New Mexico Institute of Mining Technology	Reiss, RA (corresponding author), New Mexico Inst Min & Technol, Biol Dept, Socorro, NM 87801 USA.	rebecca.reiss@nmt.edu		Illescas, Patrick/0000-0003-3111-4302; Lowe, Terry/0000-0001-9288-1076; Reiss, Rebecca/0000-0002-9884-0440	National Center for Research Resources from the National Institutes of Health [5P20RR016480-12]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103451-12]; New Mexico Tech President's Fund; Colorado School of Mines Metallurgical and Materials Engineering Department Program Development Fund	National Center for Research Resources from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); New Mexico Tech President's Fund; Colorado School of Mines Metallurgical and Materials Engineering Department Program Development Fund	This project was partially supported by grants from the National Center for Research Resources (5P20RR016480-12) and the National Institute of General Medical Sciences (8 P20 GM103451-12) from the National Institutes of Health. The New Mexico Tech President's Fund also provided financial support. Support was also provided through the Colorado School of Mines Metallurgical and Materials Engineering Department Program Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Carpenter Technology Corporation donated commercial purity titanium for this pilot project in the form of a gift to T. Lowe. Carpenter did not provide financial support and did not have any role in the study design, data collection, analysis, manuscript preparation or decision to publish.	Adamic L, 2011, NATURE, V474, P164, DOI 10.1038/474164a; Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2020, AM J PHYSL CELL PHYS, V318, pC137; Aureille J, 2017, CURR OPIN CELL BIOL, V44, P59, DOI 10.1016/j.ceb.2016.10.003; Bagherifard S, 2014, ACS APPL MATER INTER, V6, P7963, DOI 10.1021/am501119k; Berendsen AD, 2015, J INTERN MED, V277, P674, DOI 10.1111/joim.12364; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blake JA, 2014, NUCLEIC ACIDS RES, V42, pD810, DOI 10.1093/nar/gkt1225; Chen JC, 2016, FASEB J, V30, P1504, DOI 10.1096/fj.15-276402; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Dicarlo M, 2015, CELLS TISSUES ORGANS, V201, P333, DOI 10.1159/000445346; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Feillet C, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur2015.00096, 10.3389/fneur.2015.00096]; Ferretti C, 2014, TISSUE ENG PT A, V20, P2473, DOI [10.1089/ten.tea.2013.0453, 10.1089/ten.TEA.2013.0453]; Ghasemi M, 2014, CURR BIOINFORM, V9, P426, DOI 10.2174/15748936113086660013; Groen N, 2016, ACTA BIOMATER, V34, P133, DOI 10.1016/j.actbio.2016.02.015; Gruner H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38907; Gu JG, 2008, CELL ADHES MIGR, V2, P243, DOI 10.4161/cam.2.4.6748; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Hirai T, 2017, J ORAL BIOSCI, V59, P179, DOI 10.1016/j.job.2017.06.001; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang SH, 2020, CANCER BIOL THER, V21, P379, DOI 10.1080/15384047.2019.1702405; Irianto J, 2016, CELL, V165, P1820, DOI 10.1016/j.cell.2016.06.002; Izawa Ichiro, 2015, Cilia, V4, P12, DOI 10.1186/s13630-015-0021-1; Kirby TJ, 2018, NAT CELL BIOL, V20, P373, DOI 10.1038/s41556-018-0038-y; Liu HH, 2017, BIOINFORMATICS, V33, P1431, DOI 10.1093/bioinformatics/btw818; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe TC, 2019, TOTAL RNA SEQUENCING; Lowe TC, 2020, MATER RES LETT, V8, P239, DOI 10.1080/21663831.2020.1744758; Lowe TC, 2014, IOP CONF SER-MAT SCI, V63, DOI 10.1088/1757-899X/63/1/012172; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Marullo F, 2016, NUCLEUS-PHILA, V7, P103, DOI 10.1080/19491034.2016.1157675; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Niehrs C, 2012, TRENDS CELL BIOL, V22, P220, DOI 10.1016/j.tcb.2012.01.002; Ozata DM, 2019, NAT REV GENET, V20, P89, DOI 10.1038/s41576-018-0073-3; Parton RG, 2018, ANNU REV CELL DEV BI, V34, P111, DOI 10.1146/annurev-cellbio-100617-062737; Peng SP, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/8273648; Petridou NI, 2017, NAT CELL BIOL, V19, P581, DOI 10.1038/ncb3524; Reiss RA, 2019, EMTAB7528 EMBLEBI; Reiss RA, 2018, TOTAL RNA SEQUENCING; Reiss RA, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0209-z; Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Shostak A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040873; Shur I, 2006, J CELL PHYSIOL, V207, P374, DOI 10.1002/jcp.20586; Sorushanova A, 2019, ADV MATER, V31, DOI 10.1002/adma.201801651; St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007; Subramaniam M, 2010, BIOFACTORS, V36, P8, DOI 10.1002/biof.67; Suh JH, 2008, BIOCHEM BIOPH RES CO, V367, P97, DOI 10.1016/j.bbrc.2007.12.100; Sun SF, 2019, P NATL ACAD SCI USA, V116, P9370, DOI 10.1073/pnas.1821064116; Tashima T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0038-2; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Valiev RZ, 2016, JOM-US, V68, P1216, DOI 10.1007/s11837-016-1820-6; Vromman M, 2021, BRIEF BIOINFORM, V22, P288, DOI 10.1093/bib/bbz175; Wang B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230594; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wen J, 2020, INT J BIOCHEM CELL B, V122, DOI 10.1016/j.biocel.2020.105719; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wu TD, 2016, METHODS MOL BIOL, V1418, P283, DOI 10.1007/978-1-4939-3578-9_15; Xiao MS, 2020, TRENDS CELL BIOL, V30, P226, DOI 10.1016/j.tcb.2019.12.004; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang LM, 2019, THERANOSTICS, V9, P196, DOI 10.7150/thno.27550; Zhu Y, 2017, BIOMATERIALS, V147, P133, DOI 10.1016/j.biomaterials.2017.09.018	69	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2020	15	9							e0237463	10.1371/journal.pone.0237463	http://dx.doi.org/10.1371/journal.pone.0237463			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NY2ZZ	32970688	Green Published, gold			2022-12-26	WOS:000576265600063
J	Yu, YB; Yang, WJ; Bilotta, AJ; Yu, Y; Zhao, XJ; Zhou, Z; Yao, SX; Xu, JM; Zhou, J; Dann, SM; Li, YQ; Cong, YZ				Yu, Yanbo; Yang, Wenjing; Bilotta, Anthony J.; Yu, Yu; Zhao, Xiaojing; Zhou, Zheng; Yao, Suxia; Xu, Jimin; Zhou, Jia; Dann, Sara M.; Li, Yanqing; Cong, Yingzi			STING controls intestinal homeostasis through promoting antimicrobial peptide expression in epithelial cells	FASEB JOURNAL			English	Article						IEC; intestinal homeostasis; REG3 gamma; STING	EMERGING ROLES; HOST-DEFENSE; MICROBIOTA; RECOGNITION; CANCER; ESTABLISHMENT; GLYCOLYSIS; METABOLISM; INHIBITOR; IMMUNITY	Stimulator of interferon genes (STING) has been shown to play a critical role in orchestrating immune responses to various pathogens through sensing cyclic dinucleotides. However, how STING regulates intestinal homeostasis is still not completely understood. In this study, we found that STING(-/-)mice were more susceptible to enteric infection withCitrobacter rodentiumcompared to wild-type (WT) mice evidenced by more severe intestinal inflammation and impaired bacterial clearance. STING(-/-)mice demonstrated lower expression of REG3 gamma but not beta-defensins and Cramp in IECs. Consistently, STING(-/-)IECs showed reduced capacity to inhibit bacterial growth. STING agonists, both 10-carboxymethyl-9-acridanone (CMA) and 5,6-dimethylxanthenone-4-acetic acid (DMXAA), promoted REG3 gamma expression IECs. Furthermore, STING agonists promoted WT but not REG3 gamma-deficient IEC bacterial killing. Mechanistically, STING agonists activated STAT3 and promoted glycolysis in IECs. Inhibition of STAT3 pathway and glycolysis suppressed STING-induced REG3 gamma production in IECs, and abrogated STING-mediated IEC killing ofC. rodentium. Additionally, treatment with the STING ligand, 2,3-cGAMP, inhibitedC. rodentium-induced colitis in vivo. Overall, STING promotes IEC REG3 gamma expression to inhibit enteric infection and intestinal inflammation, thus, maintaining the intestinal homeostasis.u	[Yu, Yanbo; Yang, Wenjing; Bilotta, Anthony J.; Yu, Yu; Zhao, Xiaojing; Zhou, Zheng; Yao, Suxia; Cong, Yingzi] Univ Texas Med Branch, Dept Microbiol & Immunol, 4-142C Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA; [Yu, Yanbo; Yu, Yu; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Peoples R China; [Xu, Jimin; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Chem Biol Program, Galveston, TX 77555 USA; [Dann, Sara M.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Cong, Yingzi] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Shandong University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Cong, YZ (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 4-142C Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	yicong@utmb.edu	Xu, Jimin/AAA-7584-2021; yu, yanbo/GZM-8474-2022; Yang, Wenjing/AAE-5924-2021	Yang, Wenjing/0000-0003-1541-1892; xu, jimin/0000-0001-8245-7263	Foundation for the National Institutes of Health (FNIH) [DK105585, DK112436, DK125011, AI150210]; University of Texas system STARs award; McLaughlin postdoctoral Fellowship, UTMB	Foundation for the National Institutes of Health (FNIH); University of Texas system STARs award; McLaughlin postdoctoral Fellowship, UTMB	Foundation for the National Institutes of Health (FNIH), Grant/Award Number: DK105585, DK112436, DK125011 and AI150210; University of Texas system STARs award; McLaughlin postdoctoral Fellowship, UTMB	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Ahn J, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0333-0; Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Canesso MCC, 2018, MUCOSAL IMMUNOL, V11, P820, DOI 10.1038/mi.2017.88; Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082; Ching CB, 2018, KIDNEY INT, V93, P1320, DOI 10.1016/j.kint.2017.12.006; Choi SM, 2013, J EXP MED, V210, P551, DOI 10.1084/jem.20120260; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Douros JD, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00465; Duffy MM, 1998, DIS COLON RECTUM, V41, P1399, DOI 10.1007/BF02237056; El Aidy S, 2012, MUCOSAL IMMUNOL, V5, P567, DOI 10.1038/mi.2012.32; Fukata M, 2013, MUCOSAL IMMUNOL, V6, P451, DOI 10.1038/mi.2013.13; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Goto Y, 2013, IMMUNOL CELL BIOL, V91, P204, DOI 10.1038/icb.2012.80; Hu QY, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13194; Huang CC, 2015, DIS MODEL MECH, V8, P1247, DOI 10.1242/dmm.021667; Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Li M, 2017, ONCOTARGET, V8, P24777, DOI 10.18632/oncotarget.15801; Li ZQ, 2019, AM J CANCER RES, V9, P699; Liu S, 2015, INFLAMM BOWEL DIS, V21, P901, DOI 10.1097/MIB.0000000000000299; Liu X, 2016, IMMUNOLOGY, V147, P285, DOI 10.1111/imm.12561; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marinho FV, 2017, TRENDS MICROBIOL, V25, P906, DOI 10.1016/j.tim.2017.05.008; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Rambold AS, 2018, TRENDS IMMUNOL, V39, P6, DOI 10.1016/j.it.2017.08.006; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Shin JH, 2019, ENDOCRINOLOGY, V160, P1506, DOI 10.1210/en.2019-00073; Sola-Penna M, 2020, BRIT J CANCER, V122, P194, DOI 10.1038/s41416-019-0640-1; Sun M, 2015, MUCOSAL IMMUNOL, V8, P969, DOI 10.1038/mi.2015.49; Taboada B, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq254; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Xiao Y, 2019, CELL MOL GASTROENTER, V8, P21, DOI 10.1016/j.jcmgh.2019.02.006; Zasloff M, 2019, ADV EXP MED BIOL, V1117, P3, DOI 10.1007/978-981-13-3588-4_1; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022; Zhao Y, 2018, MUCOSAL IMMUNOL, V11, P752, DOI 10.1038/mi.2017.118	49	6	6	3	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					15417	15430		10.1096/fj.202001524R	http://dx.doi.org/10.1096/fj.202001524R		SEP 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32969062	Green Accepted			2022-12-26	WOS:000574532600001
J	Vazquez-Marrufo, M; Caballero-Diaz, R; Martin-Clemente, R; Galvao-Carmona, A; Gonzalez-Rosa, JJ				Vazquez-Marrufo, Manuel; Caballero-Diaz, Rocio; Martin-Clemente, Ruben; Galvao-Carmona, Alejandro; Gonzalez-Rosa, Javier J.			Individual test-retest reliability of evoked and induced alpha activity in human EEG data	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; OSCILLATIONS; BAND; SYNCHRONIZATION; VARIABILITY; CONSISTENCY; POTENTIALS; MODULATION; COMPONENTS; STABILITY	Diverse psychological mechanisms have been associated with modulations of different EEG frequencies. To the extent of our knowledge, there are few studies of the test-retest reliability of these modulations in the human brain. To assess evoked and induced alpha reliabilities related to cognitive processing, EEG data from twenty subjects were recorded in 58 derivations in two different sessions separated by 49.5 +/- 48.9 (mean +/- standard deviation) days. A visual oddball was selected as the cognitive task, and three main parameters were analyzed for evoked and induced alpha modulations (latency, amplitude and topography). Latency and amplitude for evoked and induced modulations showed stable behavior between the two sessions. The correlation between sessions for alpha evoked and induced topographies in the grand average (group level) was r = 0.923, p<0.001; r = 0.962, p<0.001, respectively. The within-subject correlation values for evoked modulation ranged from 0.472 to 0.974 (mean: 0.766), whereas induced activity showed a different range, 0.193 to 0.892 (mean: 0.655). Individual analysis of the test-retest reliability showed a higher heterogeneity in the induced modulation, probably due to the heterogeneous phases found in the second case. However, despite this heterogeneity in phase values for induced activity relative to the onset of the stimuli, an excellent correlation score was obtained for group topography, with values that were better than those of the grand average evoked topography. As a main conclusion, induced alpha activity can be observed as a stable and reproducible response in the cognitive processing of the human brain.	[Vazquez-Marrufo, Manuel; Caballero-Diaz, Rocio] Univ Seville, Fac Psychol, Expt Psychol Dept, Seville, Spain; [Martin-Clemente, Ruben] Univ Seville, Higher Tech Sch Engn, Signal Proc & Commun Dept, Seville, Spain; [Galvao-Carmona, Alejandro] Univ Loyola Andalucia, Dept Psychol, Seville, Spain; [Gonzalez-Rosa, Javier J.] Univ Cadiz, Dept Psychol, Cadiz, Spain; [Gonzalez-Rosa, Javier J.] Inst Biomed Res & Innovat Cadiz INiBICA, Cadiz, Spain	University of Sevilla; University of Sevilla; Universidad Loyola Andalucia; Universidad de Cadiz	Vazquez-Marrufo, M (corresponding author), Univ Seville, Fac Psychol, Expt Psychol Dept, Seville, Spain.	marrufo@us.es	Marrufo, Manuel Vazquez/Y-8460-2019; Gonzalez-Rosa, Javier J./K-1291-2014; Galvao-Carmona, Alejandro/A-1725-2015; Gonzalez-Rosa, Javier J./AAK-6791-2021; Martin-Clemente, Ruben/E-8977-2012; FCADIZ, INIBICA/AFS-0591-2022	Marrufo, Manuel Vazquez/0000-0002-0456-7165; Gonzalez-Rosa, Javier J./0000-0002-5609-1103; Galvao-Carmona, Alejandro/0000-0002-5126-1273; Gonzalez-Rosa, Javier J./0000-0002-5609-1103; Martin-Clemente, Ruben/0000-0002-5905-7189; 	Plan Nacional de Excelencia (Ministerio de Economia y Competitividad, Government of Spain) [PSI201678133-P]; Ramon y Cajal research fellowship - Spanish Ministry of Economy and Competitiveness [RYC-2015-18467]	Plan Nacional de Excelencia (Ministerio de Economia y Competitividad, Government of Spain); Ramon y Cajal research fellowship - Spanish Ministry of Economy and Competitiveness	This study was supported by Plan Nacional de Excelencia (Ministerio de Economia y Competitividad, Government of Spain, PSI201678133-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JJGR was funded through a Ramon y Cajal research fellowship (RYC-2015-18467) awarded by the Spanish Ministry of Economy and Competitiveness.	American EEG, 1994, J CLIN NEUROPHYSIOL, V11, P1, DOI DOI 10.1097/00004691-199401000-00014; Andino SLG, 2005, HUM BRAIN MAPP, V24, P50, DOI 10.1002/hbm.20056; [Anonymous], 1997, JAMAICA J, V26, P51; Arakaki X, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208517; Babiloni C, 2004, BEHAV BRAIN RES, V153, P261, DOI 10.1016/j.bbr.2003.12.012; Burgess AP, 1996, INT J PSYCHOPHYSIOL, V23, P163, DOI 10.1016/S0167-8760(96)00046-3; Capilla A, 2014, CEREB CORTEX, V24, P550, DOI 10.1093/cercor/bhs343; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Cohen MX, 2014, ISS CLIN COGN NEUROP, P1; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Ellmore TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186072; Enatsu R, 2014, J NEUROL SCI, V337, P201, DOI 10.1016/j.jns.2013.12.011; Flevaris AV, 2013, J VISION, V13, DOI 10.1167/13.13.17; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P61, DOI 10.1016/j.clinph.2012.05.020; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hidalgo-Munoz AR, 2014, MED BIOL ENG COMPUT, V52, P149, DOI 10.1007/s11517-013-1126-6; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Kline P., 2000, HDB PSYCHOL TESTING; Kompatsiari K, 2016, NEUROSCI LETT, V617, P166, DOI 10.1016/j.neulet.2016.02.012; Krause CM, 2001, CLIN NEUROPHYSIOL, V112, P750, DOI 10.1016/S1388-2457(01)00501-6; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; McKewen M, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13533; Munneke GJ, 2015, BRAIN RES, V1618, P222, DOI 10.1016/j.brainres.2015.05.030; Nelli S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02176-x; Neuper C, 2005, CLIN NEUROPHYSIOL, V116, P1681, DOI 10.1016/j.clinph.2005.03.013; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V43, P757, DOI 10.1016/0013-4694(77)90092-X; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P1, DOI 10.1016/S0167-8760(00)00126-4; Riecansky I, 2010, NEUROSCI LETT, V482, P133, DOI 10.1016/j.neulet.2010.07.017; Sabate M, 2011, NEUROSCIENCE, V189, P236, DOI 10.1016/j.neuroscience.2011.05.011; Truccolo WA, 2002, CLIN NEUROPHYSIOL, V113, P206, DOI 10.1016/S1388-2457(01)00739-8; Vazquez-Marrufo M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223055; Vazquez-Marrufo M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187244; Vazquez-Marrufo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062523; Worden MS, 2000, J NEUROSCI, V20	36	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2020	15	9							e0239612	10.1371/journal.pone.0239612	http://dx.doi.org/10.1371/journal.pone.0239612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NX4NF	32966341	Green Published, gold			2022-12-26	WOS:000575688700026
J	Lopez, DM; Kahlau, L; Jungnickel, KEJ; Low, C; Damme, M				Lopez, David Massa; Kaehlau, Lea; Jungnickel, Katharina Esther Julia; Loew, Christian; Damme, Markus			Characterization of the complex of the lysosomal membrane transporter MFSD1 and its accessory subunit GLMP	FASEB JOURNAL			English	Article						accessory subunit; GLMP; lysosomal; MFSD1; transporter	REQUIRES OSTM1; PROTEINS; LAMP-1; TRAFFICKING; REVEALS; NCU-G1; ATPASE	The two lysosomal integral membrane proteins MFSD1 and GLMP form a tight complex that confers protection of both interaction partners against lysosomal proteolysis. We here refined the molecular interaction of the two proteins and found that the luminal domain of GLMP alone, but not its transmembrane domain or its short cytosolic tail, conveys protection and mediates the interaction with MFSD1. Our data support the finding that the interaction is essential for the stabilization of the complex. These results are complemented by the observation that N-glycosylation of GLMP in general, but not the type of N-glycans (high-mannose-type or complex-type) or individual N-glycan chains, are essential for protection. We observed that the interaction of both proteins already starts in the endoplasmic reticulum, and quantitatively depends on each other. Both proteins can affect vice versa their intracellular trafficking to lysosomes in addition to the protection from proteolysis. Finally, we provide evidence that MFSD1 can form homodimers both in vitro and in vivo. Our data refine the complex interplay between an intimate couple of a lysosomal transporter and its accessory subunit.	[Lopez, David Massa; Kaehlau, Lea; Damme, Markus] Christian Albrechts Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany; [Jungnickel, Katharina Esther Julia; Loew, Christian] DESY, Ctr Struct Syst Biol CSSB, Hamburg, Germany; [Jungnickel, Katharina Esther Julia; Loew, Christian] European Mol Biol Lab Hamburg, Hamburg, Germany	University of Kiel; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); European Molecular Biology Laboratory (EMBL)	Damme, M (corresponding author), Christian Albrechts Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany.	mdamme@biochem.uni-kiel.de		Jungnickel, Katharina E. J./0000-0002-2850-5911; Loew, Christian/0000-0003-0764-7483	Deutsche Forschungsgemeinschaft (DFG) [DA 1785-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was in part supported by the Deutsche Forschungsgemeinschaft (DFG) to MD (DA 1785-1).	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Adams JN, 2019, ELIFE, V8, DOI 10.7554/eLife.49132; Alguel Y, 2016, BIOCHEM SOC T, V44, P1737, DOI 10.1042/BST20160217; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; CARLSSON SR, 1989, J BIOL CHEM, V264, P20526; CARLSSON Sr, 1990, J BIOL CHEM, V265, P20488; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Demirel O, 2012, J CELL SCI, V125, P4230, DOI 10.1242/jcs.087346; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Fettelschoss V, 2017, J BIOL CHEM, V292, P11980, DOI 10.1074/jbc.M117.784819; Fontenot EB, 2015, PLANT CELL ENVIRON, V38, P2012, DOI 10.1111/pce.12522; Gonzalez AC, 2018, CELL REP, V22, P1040, DOI 10.1016/j.celrep.2017.12.100; Kong XY, 2014, DIS MODEL MECH, V7, P351, DOI 10.1242/dmm.014050; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schieweck O, 2009, BIOCHEM J, V422, P83, DOI 10.1042/BJ20090567; Schwappach B, 2000, NEURON, V26, P155, DOI 10.1016/S0896-6273(00)81146-0; Visser WE, 2009, ENDOCRINOLOGY, V150, P5163, DOI 10.1210/en.2009-0699; Weinert S, 2014, EMBO REP, V15, P784, DOI 10.15252/embr.201438553; Winchester B, 2005, GLYCOBIOLOGY, V15, p1R, DOI 10.1093/glycob/cwi041; Yu Z, 2018, ELIFE, V7, DOI 10.7554/eLife.36620	26	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2020	34	11					14695	14709		10.1096/fj.202000912RR	http://dx.doi.org/10.1096/fj.202000912RR		SEP 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	OP5RX	32959924	hybrid, Green Published			2022-12-26	WOS:000573860500001
J	McDiarmid, TA; Au, VC; Moerman, DG; Rankin, CH				McDiarmid, Troy A.; Au, Vinci; Moerman, Donald G.; Rankin, Catharine H.			Peel-1 negative selection promotes screening-free CRISPR-Cas9 genome editing in Caenorhabditis elegans	PLOS ONE			English	Article							C. ELEGANS; CRISPR/CAS9; CONVERSION; MUTATION; RNAI	Improved genome engineering methods that enable automation of large and precise edits are essential for systematic investigations of genome function. We adaptedpeel-1negative selection to an optimized Dual-Marker Selection (DMS) cassette protocol for CRISPR-Cas9 genome engineering inCaenorhabditis elegansand observed robust increases in multiple measures of efficiency that were consistent across injectors and four genomic loci. The use of Peel-1-DMS selection killed animals harboring transgenes as extrachromosomal arrays and spared genome-edited integrants, often circumventing the need for visual screening to identify genome-edited animals. To demonstrate the applicability of the approach, we created deletion alleles in the putative proteasomal subunitpbs-1and the uncharacterized geneK04F10.3and used machine vision to automatically characterize their phenotypic profiles, revealing homozygous essential and heterozygous behavioral phenotypes. These results provide a robust and scalable approach to rapidly generate and phenotype genome-edited animals without the need for screening or scoring by eye.	[McDiarmid, Troy A.; Rankin, Catharine H.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Au, Vinci; Moerman, Donald G.] Univ British Columbia, Life Sci Ctr, Dept Zool, Vancouver, BC, Canada; [Rankin, Catharine H.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Rankin, CH (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.; Rankin, CH (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	crankin@psych.ubc.ca			Canadian Institutes of Health Research (CIHR); CIHR [PJT-148549, PJT-165947]; NIH [5R240D023041]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Canadian Institutes of Health Research (CIHR) (https://cihrirsc.gc.ca/e/193.html) Doctoral Award to TAM, a CIHR grant to DGM (PJT-148549), a NIH grant 5R240D023041 to DGM, and a CIHR project grant (PJT-165947) to CHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Associated Press, 2016, HOUSTON CHRONIC 0930, V115, pA7; Au V, 2019, G3-GENES GENOM GENET, V9, P135, DOI 10.1534/g3.118.200778; BRENNER S, 1974, GENETICS, V77, P71; Calarco JA, 2015, METHODS MOL BIOL, V1327, P59, DOI 10.1007/978-1-4939-2842-2_6; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Chen XY, 2015, GENETICS, V201, P1295, DOI 10.1534/genetics.115.181883; Chiu H, 2013, GENETICS, V195, P1167, DOI 10.1534/genetics.113.155879; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dejima K, 2018, CELL REP, V22, P232, DOI 10.1016/j.celrep.2017.12.024; Dickinson DJ, 2016, GENETICS, V202, P885, DOI 10.1534/genetics.115.182162; Dickinson DJ, 2015, GENETICS, V200, P1035, DOI 10.1534/genetics.115.178335; Dickinson DJ, 2013, NAT METHODS, V10, P1028, DOI 10.1038/NMETH.2641; Dokshin GA, 2018, GENETICS, V210, P781, DOI 10.1534/genetics.118.301532; Farboud B, 2019, GENETICS, V211, P431, DOI 10.1534/genetics.118.301775; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katic I, 2013, GENETICS, V195, P1173, DOI 10.1534/genetics.113.155754; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Lo TW, 2013, GENETICS, V195, P331, DOI 10.1534/genetics.113.155382; McDiarmid TA, 2020, P NATL ACAD SCI USA, V117, P656, DOI 10.1073/pnas.1912049116; McDiarmid TA, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036517; Mello C, 1995, METHOD CELL BIOL, V48, P451; Monitoring vosstanovitel'nyh praktik, 2012, VESTNIK VOSSTANOVITE, V9, P117; Monsalve GC, 2019, GENETICS, V211, P419, DOI 10.1534/genetics.118.301705; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Nance J, 2019, GENETICS, V212, P959, DOI 10.1534/genetics.119.301506; Norris AD, 2015, GENETICS, P201, DOI [10.1534/genetics.115.178699, DOI 10.1534/GENETICS.115.178699]; Paix A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw502; Paix A, 2015, GENETICS, V201, P47, DOI 10.1534/genetics.115.179382; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Seidel HS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001115; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Swierczek NA, 2011, NAT METHODS, V8, P592, DOI [10.1038/NMETH.1625, 10.1038/nmeth.1625]; Takahashi M, 2002, BIOL CHEM, V383, P1263, DOI 10.1515/BC.2002.140; Tzur YB, 2013, GENETICS, V195, P1181, DOI 10.1534/genetics.113.156075; Vicencio J, 2019, GENETICS, V211, P1143, DOI 10.1534/genetics.119.301965; Waaijers S, 2013, GENETICS, V195, P1187, DOI 10.1534/genetics.113.156299; Wei X, 2012, NAT METHODS, V9, P391, DOI [10.1038/NMETH.1929, 10.1038/nmeth.1929]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood AJ, 2011, SCIENCE, V333, P307, DOI 10.1126/science.1207773; Yoshimura J, 2019, GENOME RES, V29, P1009, DOI 10.1101/gr.244830.118; 2014, NATURE METHODS, V11, P529	49	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2020	15	9							e0238950	10.1371/journal.pone.0238950	http://dx.doi.org/10.1371/journal.pone.0238950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NW6FH	32960926	Green Published, gold, Green Submitted			2022-12-26	WOS:000575109500021
J	Porsani, MYH; de Oliveira, VV; de Oliveira, AG; Teixeira, FA; Pedrinelli, V; Martins, CM; German, AJ; Brunetto, MA				Hayasaki Porsani, Mariana Yukari; de Oliveira, Vinicius Vasques; de Oliveira, Ariane Galdino; Teixeira, Fabio Alves; Pedrinelli, Vivian; Martins, Camila Marinelli; German, Alexander James; Brunetto, Marcio Antonio			What do Brazilian owners know about canine obesity and what risks does this knowledge generate?	PLOS ONE			English	Article							WEIGHT-LOSS; BODY CONDITION; DOG; PROGRAM	Canine obesity is associated with genetic, environmental, and behavioural factors, with the latter including both the behaviour of the dog and the owner. Knowledge about owner perception of canine obesity and its treatment can inform the development of new strategies to help prevent and manage this disease. Therefore, the aim of this study was to evaluate the opinions of dog owners regarding canine obesity and weight management. Dog owners residing in the city of Sao Paulo (Brazil) completed a questionnaire, either at home or in the waiting rooms of 3 veterinary hospitals. Owners determined their dog's body condition score (BCS), and this was compared with BCS determined by a veterinarian. Questionnaire findings from dogs that were in overweight (BCS 6-7/9) or obese (BCS (8-9/9) condition were compared with those in ideal weight (4-5/9) using chi-square tests and odds ratios. A total of 926 dogs were included, of which 480 (52%), 317 (34%) and 129 (14%) were in ideal, overweight and obese condition, respectively. Many owners under-estimated their dog's weight status, with the proportion increasing as the dog's weight status increased (ideal 60/480, 13%; overweight 174/317, 55%; obese 88/129, 68%;P<0.001). Although most owners (890/926, 96%) believed that canine obesity could pose health risks, the proportion that disagreed increased as weight status increased (ideal 12/480, 2%; overweight 14/317, 4%; 10/129, 8%;P= 0.006). Finally, although most owners (880/926, 95%) stated that they would let their dog undergo weight management, only a minority (182/926; 20%) believed that a trained professional was needed, and they had various misperceptions including potential cost and what the strategies that would be effective. Based on the findings of this study, it would be advisable for veterinarians to spend time addressing these misperceptions, in the hope of both improving awareness of obesity and the outcomes of weight management.	[Hayasaki Porsani, Mariana Yukari; de Oliveira, Vinicius Vasques; de Oliveira, Ariane Galdino; Teixeira, Fabio Alves; Pedrinelli, Vivian; Brunetto, Marcio Antonio] Univ Sao Paulo, Teaching Vet Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, Brazil; [Teixeira, Fabio Alves] ANCLIVEPAs Vet Coll, Sao Paulo, SP, Brazil; [Martins, Camila Marinelli] Univ Estadual Ponta Grossa, Publ Hlth Dept, Ponta Grossa, Parana, Brazil; [German, Alexander James] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool, Merseyside, England; [Brunetto, Marcio Antonio] Univ Sao Paulo, Pet Nutrol Res Ctr, Sch Vet Med & Anim Sci, Nutr & Prod Dept, Pirassununga, Brazil	Universidade de Sao Paulo; Universidade Estadual de Ponta Grossa; University of Liverpool; Universidade de Sao Paulo	Brunetto, MA (corresponding author), Univ Sao Paulo, Teaching Vet Hosp, Sch Vet Med & Anim Sci, Vet Nutrol Serv, Sao Paulo, Brazil.; Brunetto, MA (corresponding author), Univ Sao Paulo, Pet Nutrol Res Ctr, Sch Vet Med & Anim Sci, Nutr & Prod Dept, Pirassununga, Brazil.	mabrunetto@usp.br	Pedrinelli, Vivian/AAH-4103-2019; Brunetto, Marcio/AAQ-9767-2021; Pedrinelli, Vivian/AFG-3190-2022; Pedrinelli, Vivian/AAF-1350-2022	Pedrinelli, Vivian/0000-0001-5954-4086; Pedrinelli, Vivian/0000-0001-5954-4086; Brunetto, Marcio/0000-0003-3240-0343				ABINPET. AssociacAo Brasileira da Industria de Produtos para Animais de Companhia, 2018, POP PETS CRESC 5 AN, P1; Aptekmann KP, 2014, CIENC RURAL, V44, P2039, DOI 10.1590/0103-8478cr20130524; Bland IM, 2010, PREV VET MED, V94, P310, DOI 10.1016/j.prevetmed.2010.01.013; Bland IM, 2009, PREV VET MED, V92, P333, DOI 10.1016/j.prevetmed.2009.08.016; Cairns-haylor T, 2017, VET REC; Cairns-Haylor T, 2017, VET REC, V180, P149, DOI [10.1136/vr.103808, 10.1136/vr.103878]; Canatto BD, 2012, ARQ BRAS MED VET ZOO, V64, P1515, DOI 10.1590/S0102-09352012000600017; Carciofi Aulus Cavalieri, 2005, Cienc. Rural, V35, P1331, DOI 10.1590/S0103-84782005000600016; Chapman M, 2019, VET J, V243, P65, DOI 10.1016/j.tvjl.2018.11.013; Courcier EA, 2010, J SMALL ANIM PRACT, V51, P362, DOI 10.1111/j.1748-5827.2010.00933.x; Dominguez-Munoz JE, 2018, GASTROENTEROL CLIN N, V47, P95, DOI 10.1016/j.gtc.2017.09.004; Eastland-Jones RC, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.25; Flanagan J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184199; Fruh SM, 2017, J AM ASSOC NURSE PRA, V29, pS3, DOI 10.1002/2327-6924.12510; German AJ, 2015, J SMALL ANIM PRACT, V56, P366, DOI 10.1111/jsap.12338; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; German AJ, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0570-y; Ramirez MTG, 2014, J VET BEHAV, V9, P311, DOI 10.1016/j.jveb.2014.08.002; Kienzle E, 1998, J NUTR, V128, p2609S, DOI [10.1093/jn/128.12.2609S, 10.1093/jn/128.12.2598S, 10.1093/jn/128.12.2680S]; Laflamme D, 1997, CANINE PRACT, V22, P10; Lundahl A, 2014, PEDIATRICS, V133, pE689, DOI 10.1542/peds.2013-2690; Mubanga M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16118-6; Munoz-Prieto A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31532-0; Roudebush P, 2008, JAVMA-J AM VET MED A, V232, P1646, DOI 10.2460/javma.232.11.1646; Saker KE, 2005, VET THER, V6, P291; Singh R, 2002, J VET INTERN MED, P362; Soder J, 2019, ACTA VET SCAND, V61, DOI 10.1186/s13028-019-0446-4; Storengen LM, 2014, APPL ANIM BEHAV SCI, V159, P82, DOI 10.1016/j.applanim.2014.07.006; Suarez L, 2012, J ANIM PHYSIOL AN N, V96, P663, DOI 10.1111/j.1439-0396.2011.01193.x; Teixeira FA, 2015, J ANIM PHYSIOL AN N, V99, P99; Vitger AD, 2016, JAVMA-J AM VET MED A, V248, P174, DOI 10.2460/javma.248.2.174; White GA, 2011, J SMALL ANIM PRACT, V52, P622, DOI 10.1111/j.1748-5827.2011.01138.x	32	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0238771	10.1371/journal.pone.0238771	http://dx.doi.org/10.1371/journal.pone.0238771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956414	Green Published, gold			2022-12-26	WOS:000574571500040
J	Pastel, S; Chen, CH; Petri, K; Witte, K				Pastel, Stefan; Chen, Chien-Hsi; Petri, Katharina; Witte, Kerstin			Effects of body visualization on performance in head-mounted display virtual reality	PLOS ONE			English	Article							OWNERSHIP; BALANCE	Although there are many virtual reality (VR) applications in sports, only a handful of studies visualized the whole body. There is still a lack of understanding, how much of the own body must be visualized in the head-mounted display (HMD) based VR, to ensure fidelity and similar performance outcome as in the real-world. In the current study, 20 young and healthy participants completed three tasks in a real and virtual environment: balance task, grasping task, and throwing task with a ball. The aim was to find out the meaning of the visualization of different body parts for the quality of movement execution and to derive future guidelines for virtual body presentation. In addition, a comparison of human performance between reality and VR, with whole-body visualization was made. Focusing on the main goal of the current study, there were differences within the measured parameters due to the visualization of different body parts. In the balance task, the differences within the VR body visualization consisted mainly through no-body visualization (NB) compared to the other visualization types defined as whole-body (WB), WB except feet (NF), as well as WB except feet and legs (NLF). In the grasping task, the different body visualization seemed to have no impact on the participants' performances. In the throwing task, the whole-body visualization led to higher accuracy compared to the other visualization types. Regarding the comparison between the conditions, we found significant differences between reality and VR, which had a large effect on the parameters time for completion in the balance and grasping task, the number of foot strikes on the beam in the balance task, as well as the subjective estimation of the difficulty for all tasks. However, the number of errors and the quality of the performances did not differ significantly. The current study was the first study comparing sports-related tasks in VR and reality with further manipulations (occlusions of body parts) of the virtual body. For studies analyzing perception and sports performance or for VR sports interventions, we recommend the visualization of the whole body in real-time.	[Pastel, Stefan; Chen, Chien-Hsi; Petri, Katharina; Witte, Kerstin] Otto Guericke Univ Magdeburg, Inst Sports Sci 3, Dept Sports Engn & Movement Sci, Magdeburg, Germany	Otto von Guericke University	Pastel, S (corresponding author), Otto Guericke Univ Magdeburg, Inst Sports Sci 3, Dept Sports Engn & Movement Sci, Magdeburg, Germany.	stefan.pastel@ovgu.de		Witte, Kerstin/0000-0001-8711-9335; Pastel, Stefan/0000-0002-3662-2683; Chen, Chien-Hsi/0000-0002-5631-2025	German Research Foundation (DFG) [WI 1456/22-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was financed by the German Research Foundation (DFG) under grant WI 1456/22-1.	[Anonymous], 2011, BONE MINER RES, V4, P2, DOI DOI 10.3969/j.issn.1674-2591.2011.01.002; Bailenson JN, 2003, PERS SOC PSYCHOL B, V29, P819, DOI 10.1177/0146167203029007002; Bandow N., 2018, INT J COMPUTER SCI S, V17, P1, DOI [10.2478/ijcss-2018-0001, DOI 10.2478/IJCSS-2018-0001]; Bideau B, 2004, NEUROSCI LETT, V372, P119, DOI 10.1016/j.neulet.2004.09.023; Biocca F, 1997, SECOND INTERNATIONAL CONFERENCE ON COGNITIVE TECHNOLOGY, PROCEEDINGS, P12, DOI 10.1109/CT.1997.617676; Bisson E, 2007, CYBERPSYCHOL BEHAV, V10, P16, DOI 10.1089/cpb.2006.9997; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Camporesi C, 2016, IEEE T VIS COMPUT GR, V22, P1592, DOI 10.1109/TVCG.2015.2440231; Canal-Bruland R, 2010, HUM MOVEMENT SCI, V29, P94, DOI 10.1016/j.humov.2009.10.001; Carruth D.W., 2017, ICETA 2017 15 IEEE I, DOI [10.1109/ICETA.2017.8102472, DOI 10.1109/ICETA.2017.8102472]; Caserman P, 2020, IEEE T VIS COMPUT GR, V26, P3089, DOI 10.1109/TVCG.2019.2912607; Covaci A, 2015, IEEE COMPUT GRAPH, V35, P55, DOI 10.1109/MCG.2015.95; Debarba HG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190109; Donath L, 2016, SPORTS MED, V46, P143, DOI 10.1007/s40279-015-0389-5; dos Santos LF, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0289-4; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Faure C, 2020, J SPORT SCI, V38, P192, DOI 10.1080/02640414.2019.1689807; Filippetti ML, 2017, COGNITION, V159, P1, DOI 10.1016/j.cognition.2016.11.002; Gonzalez-Franco M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01125; Guterstam A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09831; Harris DJ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00605; Harris DJ, 2019, EXP BRAIN RES, V237, P2761, DOI 10.1007/s00221-019-05642-8; Hulsmann F, 2019, FRONT ROBOT AI, V6, DOI 10.3389/frobt.2019.00043; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kilteni K, 2012, PRESENCE-TELEOP VIRT, V21, P373, DOI 10.1162/PRES_a_00124; Kim A, 2018, J NEUROPHYSIOL, V120, P839, DOI 10.1152/jn.00931.2017; Lin CJ, 2015, J SOC INF DISPLAY, V23, P319, DOI 10.1002/jsid.378; Mestre D R, 2018, ELECT IMAGING ENG RE, DOI [10.2352/ISSN.2470-1173.2018.03.ERVR-433, DOI 10.2352/ISSN.2470-1173.2018.03.ERVR-433]; Michalski SC, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02159; Molbert SC, 2018, PSYCHOL MED, V48, P642, DOI 10.1017/S0033291717002008; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Petri K, 2019, J SPORT AREA, V4, P211, DOI [10.25299/sportarea.2019.vol4(1).2195, DOI 10.25299/SPORTAREA.2019.VOL4(1).2195]; Petri K, 2019, SPORTS ENG, V22, DOI 10.1007/s12283-019-0299-0; Pioneer Network, 2011, TOOLS CHANGE, V1, P1; Renner RS, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2543581.2543590; Ries B, 2008, P 2008 ACM S VIRT RE, P167; Robert MT, 2016, GAIT POSTURE, V48, P261, DOI 10.1016/j.gaitpost.2016.06.010; Roth D., 2017, VRST 17 P 23 ACM S V, P1, DOI [10.1145/3139131.3139156, DOI 10.1145/3139131.3139156]; Saldana SJ, 2017, CLIN INTERV AGING, V12, DOI 10.2147/CIA.S141251; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Slater M, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778829; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Steptoe W, 2013, IEEE T VIS COMPUT GR, V19, P583, DOI 10.1109/TVCG.2013.32; Vignais N, 2009, J SPORT SCI MED, V8, P501; Witmer BG, 2005, PRESENCE-TELEOP VIRT, V14, P298, DOI 10.1162/105474605323384654; 2019, PROCESS BIOCH, V8, P55	49	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239226	10.1371/journal.pone.0239226	http://dx.doi.org/10.1371/journal.pone.0239226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NV8NR	32956420	gold, Green Published			2022-12-26	WOS:000574571500035
J	Tadesse, AW; Alagaw, A; Kassa, M; Bekele, M				Tadesse, Addisu Walelign; Alagaw, Amisalu; Kassa, Mekidim; Bekele, Muluken			Tuberculosis infection control practices and associated factors among healthcare workers in hospitals of Gamo Gofa Zone, Southern Ethiopia, institution-based cross-sectional study	PLOS ONE			English	Article							PREVENTION	Background Tuberculosis infection control is a combination of measures designed to minimize the risk of tuberculosis transmission within populations. Healthcare workers are not sufficiently protected from tuberculosis infection in healthcare facilities where infection control protocols are not followed completely. Studies conducted in Ethiopia about tuberculosis infection control practices were self-report. Objective To assess tuberculosis infection control practices and associated factors among health care workers in hospitals of Gamo Gofa Zone, Southern Ethiopia. Method A facility-based cross-sectional study was conducted from March 6 to April 2, 2019. The sample size was 422. The sample was proportionally allocated to each hospital and the respective discipline. Simple random sampling was used to select participants from each discipline. Data were entered into EpiData version 4.4.2.1 and analyzed using SPSS Version 21 software. Multicollinearity and Model goodness-of-fit was checked. A multivariate logistic regression model at 95% CI was used to identify the predictors. Result The response rate was 97.4%. The proportion of good tuberculosis infection control practice was 39.9% [95% CI (35.5, 44.9)]. Knowledge on tuberculosis infection control measures [AOR = 3.65, 95% CI (2.07, 6.43)], educational level of degree and above [AOR = 2.78, 95% CI (1.7, 4.53)] and ever having tuberculosis-related training [AOR = 2.02, 95% CI (1.24, 3.31)] were significantly associated with good tuberculosis infection control practice. Conclusion and recommendation The proportion of good tuberculosis infection control practice among healthcare workers in hospitals of the Gamo Gofa Zone was 39.9%. The good practice of tuberculosis infection control was determined by educational level, working department, knowledge on tuberculosis infection control measures, and having tuberculosis-related training. Hence, training of healthcare workers, targeting diploma-holders in upgrading educational level programs, developing knowledge on tuberculosis infection control measures, and qualitative research to explore reasons for not practicing infection control measures is recommended.	[Tadesse, Addisu Walelign] Selale Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Fiche, Ethiopia; [Alagaw, Amisalu; Kassa, Mekidim; Bekele, Muluken] Arba Minch Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Arba Minch, Ethiopia	Arba Minch University	Tadesse, AW (corresponding author), Selale Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Fiche, Ethiopia.	addisuwalelign21@gmail.com		Waleligne, Addisu/0000-0002-6762-2627; Bekele, Muluken/0000-0002-3464-2584				Agaya J, 2015, TROP MED INT HEALTH, V20, P1797, DOI 10.1111/tmi.12601; Alele FO, 2019, ARCH ENVIRON OCCUP H, V74, P95, DOI 10.1080/19338244.2018.1461600; Alene KA Adane A, 2019, BMJ OPEN; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Brouwer M, 2015, INT J TUBERC LUNG D, V19, P44, DOI 10.5588/ijtld.14.0337; Engelbrecht M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1984-2; Gizaw GD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0062-3; He GX, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-313; Kanjee Z, 2011, J HOSP INFECT, V79, P333, DOI 10.1016/j.jhin.2011.06.017; Kuyinu YA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1453-y; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Rutanga C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124485; Tamir K, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1608-y; Temesgen C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0593-2; Tudor C, 2013, Int J Tuberc Lung Dis, V17, P22, DOI 10.5588/ijtld.13.0109; Uden L, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx137; Verkuijl S, 2016, CLIN INFECT DIS, V62, pS231, DOI 10.1093/cid/civ1184; World Health Organization, 2009, WHO POL TB INF CONTR	19	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2020	15	9							e0239159	10.1371/journal.pone.0239159	http://dx.doi.org/10.1371/journal.pone.0239159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NV8NR	32956378	Green Published, gold			2022-12-26	WOS:000574571500054
J	Croft, S; Franzetti, B; Gill, R; Massei, G				Croft, Simon; Franzetti, Barbara; Gill, Robin; Massei, Giovanna			Too many wild boar? Modelling fertility control and culling to reduce wild boar numbers in isolated populations	PLOS ONE			English	Article							SUS-SCROFA; LITTER SIZE; FERAL SWINE; DYNAMICS; SURVIVAL; IMPACT; AREAS; DEER; REPRODUCTION; MANAGEMENT	Wild boar and feral swine number and range are increasing worldwide in parallel with their impact on biodiversity and human activities. The ecological and economic impact of this species include spread of diseases, vehicle collisions, damage to crops, amenities and infrastructures and reduction in plant and animal abundance and richness. As traditional methods such as culling have not contained the growth and spread of wild boar and feral pigs, alternative methods such as fertility control are now advocated. We used empirical data on two isolated wild boar populations to model and compare the effects of different regimes of culling and fertility control on population trends. We built a Bayesian population model and applied it to explore the implications for population control of various management options combining culling and/or contraception. The results showed that, whilst fertility control on its own was not sufficient to achieve the target reduction in wild boar number, adding fertility control to culling was more effective than culling alone. In particular, using contraceptives on 40% of the population to complement the culling of 60% of the animals, halved the time to achieve our target reduction compared with culling only. We conclude that, assuming the effort of adding fertility control to culling was found to be cost-effective in terms of population reduction, these two methods should be used simultaneously if a rapid decrease in wild boar number is required for a closed population.	[Croft, Simon; Massei, Giovanna] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England; [Franzetti, Barbara] Inst Environm Protect & Res ISPRA, Rome, Italy; [Gill, Robin] Ctr Ecosyst Soc & Biosecur Forest Res, Farnham, Surrey, England	Animal & Plant Health Agency UK; Italian Institute for Environmental Protection & Research (ISPRA)	Croft, S (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England.	simon.croft@apha.gov.uk			Segretariato Generale della Presidenza della Repubblica	Segretariato Generale della Presidenza della Repubblica	The original data collection used to underpin this work was funded by the Segretariato Generale della Presidenza della Repubblica.	Acevedo P, 2020, EFSA SUPP PUBL, V17, P28; AHMAD E, 1995, ACTA THERIOL, V40, P163, DOI 10.4098/AT.arch.95-17; Anderson A, 2016, CROP PROT, V89, P89, DOI 10.1016/j.cropro.2016.06.023; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2013, TEXTS STAT SCI SERIE; [Anonymous], 2004, FILARIA J S1, V2, pS2; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Ballari SA, 2015, BIOL INVASIONS, V17, P1595, DOI 10.1007/s10530-014-0818-7; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Bengsen AJ, 2016, ECOLOGY EVOLUTION MA; Bengsen AJ, 2016, MAMMAL REV, V46, P297, DOI 10.1111/mam.12070; Bengsen AJ, 2014, MAMMAL REV, V44, P135, DOI 10.1111/mam.12011; Bevins SN, 2014, BIOSCIENCE, V64, P291, DOI 10.1093/biosci/biu015; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Boitani L, 1995, IBEX J MT ECOL, V3, P197; Briedermann L., 1990, SCHWARZWILD, V2nd ed.; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cahill S, 2012, ANIM BIODIV CONSERV, V35, P221; Campbell TA, 2011, PREV VET MED, V98, P243, DOI 10.1016/j.prevetmed.2010.11.018; Centner TJ, 2015, AMBIO, V44, P121, DOI 10.1007/s13280-014-0532-9; Conejero C, 2019, MAMM BIOL, V96, P68, DOI 10.1016/j.mambio.2019.04.002; Cremasco P, 2016, 5 QUEENSL PEST AN S, P103; Fernandez-Llario P, 1999, ANIM BEHAV, V58, P1079, DOI 10.1006/anbe.1999.1234; Focardi S, 1996, FOREST ECOL MANAG, V88, P7, DOI 10.1016/S0378-1127(96)03804-2; Focardi S, 2008, J MAMMAL, V89, P1113, DOI 10.1644/07-MAMM-A-164.1; Franzetti B, 2012, EUR J WILDLIFE RES, V58, P385, DOI 10.1007/s10344-011-0587-x; Frauendorf M, 2016, SCI TOTAL ENVIRON, V541, P877, DOI 10.1016/j.scitotenv.2015.09.128; Fruzinski B, 2002, Z JAGDWISS, V48, P201, DOI 10.1007/BF02192409; Gamelon M, 2017, OECOLOGIA, V183, P1065, DOI 10.1007/s00442-017-3821-8; Gamelon M, 2014, EVOLUTION, V68, P3636, DOI 10.1111/evo.12519; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Giacomelli S, 2018, ECOL SOC, V23, DOI 10.5751/ES-10353-230412; Gill R., 2015, FERAL WILD BOAR DEER; Gill RMA, 1997, J APPL ECOL, V34, P1273, DOI 10.2307/2405237; Gill RMA, 2018, FERAL WILD BOAR DEER; Gonzalez-Crespo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202289; Graitson E, 2019, ANIM CONSERV, V22, P165, DOI 10.1111/acv.12447; Guberti V, 2018, HDB AFRICAN SWINE FE; Bueno CG, 2010, EUR J WILDLIFE RES, V56, P765, DOI 10.1007/s10344-010-0372-2; Guo X, 2016, TRANSBOUND EMERG DIS, V63, P296, DOI 10.1111/tbed.12274; Halasa T, 2016, VET MICROBIOL, V193, P7, DOI 10.1016/j.vetmic.2016.08.004; Holland EP, 2009, ECOL MODEL, V220, P1203, DOI 10.1016/j.ecolmodel.2009.02.013; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; Hone J., 2012, APPL POPULATION COMM; Imperio S, 2012, OIKOS, V121, P1613, DOI 10.1111/j.1600-0706.2011.20085.x; JEZIERSKI W, 1977, ACTA THERIOL, V22, P337, DOI 10.4098/AT.arch.77-31; Keuling O, 2016, SCI TOTAL ENVIRON, V554, P311, DOI 10.1016/j.scitotenv.2016.02.159; Keuling O, 2013, EUR J WILDLIFE RES, V59, P805, DOI 10.1007/s10344-013-0733-8; Lange M, 2015, ALTERNATIVE CONTROL, V12, p843E; LANGE M, 2018, EFSA SUPPORT PUBL, V15, P1521, DOI DOI 10.2903/sp.efsa.2018.EN-1521; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; MARTYS M, 1982, Z SAUGETIERKD, V47, P100; Massei G, 1996, ACTA THERIOL, V41, P307, DOI 10.4098/AT.arch.96-29; Massei Giovanna, 2004, Galemys, V16, P135; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Massei G, 2014, WILDLIFE RES, V41, P1, DOI 10.1071/WR13141; Massei G, 2012, WILDLIFE RES, V39, P378, DOI 10.1071/WR11196; Massei Giovanna, 2011, Human-Wildlife Interactions, V5, P79; Massei G, 2010, J WILDLIFE MANAGE, V74, P333, DOI 10.2193/2008-489; Mauget R., 1984, S INT SANGL C, P15; Moore N, 2004, ECOLOGY MANAGEMENT W; Moretti M, 1995, IBEX J MOUNT ECOL, V3, P192; Nahlik A, 2003, WILDLIFE BIOL, V9, P37, DOI 10.2981/wlb.2003.062; Neet C.R., 1995, IBEX J M E, V3, P188; Oliviero C, 2019, J ANIM SCI, V97, P2283, DOI 10.1093/jas/skz066; Oloff HB, 1951, BIOL OKOLOGIE SCHWAR; Parkes JP, 2010, BIOL CONSERV, V143, P634, DOI 10.1016/j.biocon.2009.11.028; Pepin KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183441; Plummer M., 2016, RJAGS BAYESIAN GRAPH; Plummer M., 2003, P 3 INT WORKSH DISTR, V10; Raiho AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143122; Servanty S, 2007, BEHAV ECOL, V18, P427, DOI 10.1093/beheco/arl099; Servanty S, 2011, J APPL ECOL, V48, P835, DOI 10.1111/j.1365-2664.2011.02017.x; Shapiro L, 2016, J PEST SCI, V89, P489, DOI 10.1007/s10340-015-0706-7; SHARP T, 2004, MODEL CODE PRACTICE; SJARMIDI A, 1988, MONIT ZOOL ITAL, V22, P415; Smart JCR, 2004, MAMMAL REV, V34, P99, DOI 10.1046/j.0305-1838.2003.00026.x; Snow NP, 2017, J APPL ECOL, V54, P2022, DOI 10.1111/1365-2664.12866; Stillfried M, 2017, J APPL ECOL, V54, P272, DOI 10.1111/1365-2664.12756; Toigo C, 2008, J WILDLIFE MANAGE, V72, P1532, DOI 10.2193/2007-378; Twigg LE, 2006, WILDLIFE RES, V33, P417, DOI 10.1071/WR05098; Venables WN., 2002, MODERN APPL STAT S 4; Welander J, 2000, J ZOOL, V252, P263, DOI 10.1111/j.1469-7998.2000.tb00621.x; Wilson C.J., 2014, Wildlife Biology in Practice, V10, P1	84	11	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238429	10.1371/journal.pone.0238429	http://dx.doi.org/10.1371/journal.pone.0238429			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946480	Green Published, gold			2022-12-26	WOS:000573851100084
J	Rinamalo, M; Pezzoli, L; Kama, M; Rafai, E; Kubuabola, I; Salusalu, M; Kim, SH				Rinamalo, Milika; Pezzoli, Lorenzo; Kama, Mike; Rafai, Eric; Kubuabola, Ilisapeci; Salusalu, Mosese; Kim, Sung Hye			Lot quality assurance sampling to assess coverage and compliance following mass drug administration to eliminate lymphatic filariasis in Fiji: A methodological approach	PLOS ONE			English	Article							PROGRAM; LQAS; TOOL	Background Assessing the quality of mass drug administration (MDA) rounds is a key component of lymphatic filariasis (LF) elimination programs. Routine collection of administrative coverage is unreliable, especially when pockets with low program coverage exist. To address this gap, we used lot quality assurance sampling (LQAS) following the 10th annual LF-MDA round in Fiji to explore whether there was any area in which target coverage was not reached. We also assessed the level of drug compliance and satisfaction with the LF-MDA implementation strategy. Methodology/principal findings We conducted a cross-sectional household survey in 3 divisions of Fiji. For LQAS, we defined 19 lots in 7 medical areas of the Suva sub-division and another 12 sub-divisions in the Central, Northern, and Eastern Divisions. A sample of 16 randomly selected household members was taken un each lot. We defined our decision rule as follows: if more than 1 person in a given lot did not swallow the medication, coverage was considered inadequate, i.e. less than 80%. Of the 7 lots in Suva sub-division and 12 lots in the 3 divisions, five and two lots, respectively, were identified as having inadequate coverage. The overall program coverage estimated from 304 samples was 92%, which was higher than the reported administrative coverage of 82%. About 98% of interviewees were offered the medication and 96% swallowed it. Non-participation arose from insufficient information on how to obtain the drugs. At least 92% were satisfied with the LF-MDA implementation strategy. Conclusions Areas of low program coverage with results discordant with the reported administrative coverage existed in both urban and rural settings. Drug compliance and satisfaction were high, even after repeated rounds. We recommend increasing efforts to deliver the service in those areas with inadequate program coverage, as well as conducting timely coverage assessment through LQAS for corrective action.	[Rinamalo, Milika; Kama, Mike; Rafai, Eric] Minist Hlth & Med Serv, Dinem House, Suva, Fiji; [Kubuabola, Ilisapeci; Salusalu, Mosese] Fiji Natl Univ, Coll Med Nursing & Hlth Sci, Suva, Fiji; [Kim, Sung Hye] Univ Liverpool Liverpool Sch Trop Med, Dept Trop Dis Biol, Liverpool, Merseyside, England; [Kim, Sung Hye] Hanyang Univ, Dept Environm Biol & Med Parasitol, Coll Med, Seoul, South Korea	Fiji National University (FNU); Liverpool School of Tropical Medicine; Hanyang University	Kim, SH (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Trop Dis Biol, Liverpool, Merseyside, England.; Kim, SH (corresponding author), Hanyang Univ, Dept Environm Biol & Med Parasitol, Coll Med, Seoul, South Korea.	sunghye.kim@post.harvard.edu						Adams AM, 2018, TROP MED INFECT DIS, V3, DOI 10.3390/tropicalmed3040122; Anoke SC, 2015, TROP MED INT HEALTH, V20, P1756, DOI 10.1111/tmi.12605; [Anonymous], 1996, MON IMM SERV US LOT; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2017, J PROSTHET DENT, V11, pe1; [Anonymous], 2018, CONSIDERATIONS COUNT; Astale T, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006270; Biritwum NK, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005619; Bosch-Capblanch X, 2009, TROP MED INT HEALTH, V14, P2, DOI 10.1111/j.1365-3156.2008.02181.x; Brixtonhealth, SAMPLELQ V1 10; Brown AE, 2014, J INFECT DIS, V210, pS333, DOI 10.1093/infdis/jit816; Burkot T, 2002, TRENDS PARASITOL, V18, P109, DOI 10.1016/S1471-4922(01)02221-8; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; Caini S, 2013, VACCINE, V31, P1597, DOI 10.1016/j.vaccine.2013.01.015; Capurro D, 2014, J MED INTERNET RES, V16, P213, DOI 10.2196/jmir.2679; Danovaro-Holliday MC, 2018, VACCINE, V36, P5150, DOI 10.1016/j.vaccine.2018.07.019; Fiji Bureau of Statistics, 2009, 2007 CENS POP; Fiji Bureau of Statistics, 2018, FIJ GOV ONL PORT FIJ; Kimura E, 1996, PARASITOL TODAY, V12, P240, DOI 10.1016/0169-4758(96)10014-4; Kimura Eisaku, 2011, Trop Med Health, V39, P17, DOI 10.2149/tmh.39-1-suppl_2-57; Krentel A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005027; LANATA CF, 1988, LANCET, V1, P122; LEMESHOW S, 1991, World Health Statistics Quarterly, V44, P115; Maroto-Camino C, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007337; Ministry of Health and Medical Services, 2016, FIJ ANN REP 2015; Mwanza M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2229-9; Njomo DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083413; Oladele EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044319; Ottesen EA, 2000, TROP MED INT HEALTH, V5, P591, DOI 10.1046/j.1365-3156.2000.00620.x; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Rhoda DA, 2010, INT J EPIDEMIOL, V39, P60, DOI 10.1093/ije/dyn366; SANDIFORD P, 1993, HEALTH POLICY PLANN, V8, P217, DOI 10.1093/heapol/8.3.217; Singh J, 1996, B WORLD HEALTH ORGAN, V74, P269; Swaminathan S, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-2; Titaley CR, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2881-x; Vanamail P, 2006, TROP MED INT HEALTH, V11, P1256, DOI 10.1111/j.1365-3156.2006.01670.x; WHO, 2017, WHO GLOB PROGR EL; WHO, 2005, WHO WHO VACC COV CLU; WHO, 2018, SUP COV TOOL NEGL TR; WHO, 2016, WHO 9 M STRAT TECHN; WHO, 2017, WHO PCT DAT; WHO, 2016, COV EV SURV PREV CHE; WHO, 2019, WHO PREV CHEM TOOLS; WHO WPRO, 2006, PAC WAY EL LYMPH FIL; WHO WPRO, 2011, FIJI ISLANDS HLTH SY; Zuber PLF, 2003, J INFECT DIS, V187, pS86, DOI 10.1086/368052	47	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2020	15	9							e0238622	10.1371/journal.pone.0238622	http://dx.doi.org/10.1371/journal.pone.0238622			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7WV	32946536	Green Accepted, Green Published, gold			2022-12-26	WOS:000573851100089
J	Wu, CC; Wei, FJ; Chiou, WY; Tsai, YC; Wu, HP; Gotarkar, D; Wei, ZH; Lai, MH; Hsing, YIC				Wu, Cheng-Chieh; Wei, Fu-Jin; Chiou, Wan-Yi; Tsai, Yuan-Ching; Wu, Hshin-Ping; Gotarkar, Dhananjay; Wei, Zhi-Han; Lai, Ming-Hsin; Hsing, Yue-Ie Caroline			Studies of rice Hd1 haplotypes worldwide reveal adaptation of flowering time to different environments	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; CONTROLLING HEADING DATE; CRITICAL DAY LENGTH; WEEDY RICE; ARTIFICIAL SELECTION; GENE-EXPRESSION; ORIGIN; HD3A; IDENTIFICATION; ARABIDOPSIS	Rice domestication/adaptation is a good model for studies of the development and spread of this important crop. Mutations that caused morphological and physiological change, followed by human selection/expansion, finally led to the improvement of phenotypes suitable for different kinds of environments. We used the sequence information forHeading date 1(Hd1) gene to reveal the association between sequence changes and flowering phenotypes of rice in different regions. Seven loss-of-functionhd1haplotypes had been reported. By data-mining the genome sequencing information in the public domain, we discovered 3 other types. These loss-of-function allele haplotypes are present in subtropical and tropical regions, which indicates human selection. Some of these haplotypes are present locally. However, types 7 and 13 are present in more than one-third of the world's rice accessions, including landraces and modern varieties. In the present study, phylogenetic, allele network and selection pressure analyses revealed that these two haplotypes might have occurred early in Southeastern Asia and then were introgressed in many local landraces in nearby regions. We also demonstrate that these haplotypes are present in weedy rice populations, which again indicates that these alleles were present in rice cultivation for long time. In comparing the wild rice sequence information, these loss-of-function haplotypes occurredin agrobut were not from wild rice.	[Wu, Cheng-Chieh; Wei, Fu-Jin; Chiou, Wan-Yi; Wu, Hshin-Ping; Gotarkar, Dhananjay; Hsing, Yue-Ie Caroline] Acad Sinica, Inst Plant & Microbial Biol, Taipei, Taiwan; [Wu, Cheng-Chieh] Natl Taiwan Univ, Inst Plant Sci, Taipei, Taiwan; [Tsai, Yuan-Ching; Wei, Zhi-Han] Natl Chia Yi Univ, Dept Agron, Chiayi, Taiwan; [Lai, Ming-Hsin] Agr Res Inst Taiwan, Crop Sci Div, Taichung, Taiwan; [Hsing, Yue-Ie Caroline] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Wei, Fu-Jin] FourOneFour Studio, Taoyuan, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Chiayi University; Agricultural Research Institute of Taiwan; National Taiwan University	Hsing, YIC (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei, Taiwan.; Hsing, YIC (corresponding author), Natl Taiwan Univ, Dept Agron, Taipei, Taiwan.	bohsing@gate.sinica.edu.tw		WU, Cheng-chieh/0000-0002-5495-9095; Wei, Fu-Jin/0000-0001-8337-2835; Chiou, Wan-Yi/0000-0003-3346-5851	Ministry of Science and Technology [MOST 107-2313-B-001-007-MY2]; Academia Sinica Investigator Award	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica Investigator Award(Academia Sinica - Taiwan)	This project was supported by funding from Ministry of Science and Technology Grant MOST 107-2313-B-001-007-MY2 to YICH, and Academia Sinica Investigator Award. URL of MoST: https://www.most.gov.tw/?l=en URL of Academia Sinica: https://www.sinica.edu.tw/en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2005, PHYLIP PHYLOGENY INF; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Chae Y.K., 2009, PLOS ONE, V4, pe6523; CHANDRARATNA M. F., 1955, JOUR GENETICS, V53, P215, DOI 10.1007/BF02993976; Cho LH, 2017, PLANT J, V90, P708, DOI 10.1111/tpj.13461; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Endo-Higashi N, 2011, PLANT CELL PHYSIOL, V52, P1083, DOI 10.1093/pcp/pcr059; Fujino K, 2010, MOL GENET GENOMICS, V284, P137, DOI 10.1007/s00438-010-0555-2; FUKE YUTAKA, 1955, BULL NATL INST AGRIC SCI [JAPAN] SER D PLANT PHYSIOL, V5, P72; Genetical Kudo M., 1968, B NATL I AGR SCI D, V19, P1; He Q, 2017, PLANT BIOTECHNOL J, V15, P357, DOI 10.1111/pbi.12630; Hori K, 2016, THEOR APPL GENET, V129, P2241, DOI 10.1007/s00122-016-2773-4; Huang CL, 2012, PLANT J, V70, P769, DOI 10.1111/j.1365-313X.2012.04915.x; Inheritance Jodon N., 1940, AGRON J, V32, P342; Ishikawa R, 2005, GENET RESOUR CROP EV, V52, P395, DOI 10.1007/s10722-005-2257-x; Itoh H, 2018, PLANT J, V94, P895, DOI 10.1111/tpj.13906; Itoh H, 2013, MOL PLANT, V6, P635, DOI 10.1093/mp/sst022; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kim SR, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01827; Kinoshita T., 1998, RICE GENET NEWSL, V15, P13; Knowles A, 2015, PHILOSOPHIA-J CONT F, V5, P1; Komiya R, 2008, DEVELOPMENT, V135, P767, DOI 10.1242/dev.008631; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LF, 2017, NAT GENET, V49, P811, DOI 10.1038/ng.3825; Lin HX, 2002, BREEDING SCI, V52, P35, DOI 10.1270/jsbbs.52.35; Lin SY, 1998, THEOR APPL GENET, V96, P997, DOI 10.1007/s001220050831; Mansueto L, 2017, NUCLEIC ACIDS RES, V45, pD1075, DOI 10.1093/nar/gkw1135; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ortiz E.M., 2019, VCF2PHYLIP V2 0 CONV; Qiu J, 2014, PLANTA, V240, P1353, DOI 10.1007/s00425-014-2159-2; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Shrestha R, 2014, ANN BOT-LONDON, V114, P1445, DOI 10.1093/aob/mcu032; Song BK, 2014, MOL ECOL, V23, P5003, DOI 10.1111/mec.12922; Stein JC, 2018, NAT GENET, V50, P285, DOI 10.1038/s41588-018-0040-0; Sun J, 2019, MOL PLANT, V12, P632, DOI 10.1016/j.molp.2019.01.019; Sun J, 2013, NEW PHYTOL, V197, P290, DOI 10.1111/nph.12012; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Takahashi Y, 2011, GENES GENET SYST, V86, P175, DOI 10.1266/ggs.86.175; Takahashi Y, 2009, P NATL ACAD SCI USA, V106, P4555, DOI 10.1073/pnas.0812092106; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsuji H, 2013, CURR OPIN PLANT BIOL, V16, P228, DOI 10.1016/j.pbi.2013.01.005; Vergara BS, 1985, INT RICE RES I; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei FJ, 2016, PLANT SCI, V242, P187, DOI 10.1016/j.plantsci.2015.09.005; Wei XJ, 2010, PLANT PHYSIOL, V153, P1747, DOI 10.1104/pp.110.156943; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamamoto T, 2000, GENETICS, V154, P885; Yano M, 1997, THEOR APPL GENET, V95, P1025, DOI 10.1007/s001220050658; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; YOKOO M, 1978, Japanese Journal of Breeding, V28, P49; Zhang JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep10591; Zhao Q, 2018, NAT GENET, V50, P279, DOI 10.1038/s41588-018-0041-z	69	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2020	15	9							e0239028	10.1371/journal.pone.0239028	http://dx.doi.org/10.1371/journal.pone.0239028			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU7VY	32941524	Green Published, Green Submitted, gold			2022-12-26	WOS:000573848800044
J	Hibstie, YT; Kibret, GD; Talie, A; Temesgen, B; Melkamu, MW; Alebel, A				Hibstie, Yitbarek Tenaw; Kibret, Getiye Dejenu; Talie, Asmare; Temesgen, Belisty; Melkamu, Mamaru Wubale; Alebel, Animut			Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos Referral Hospital, Northwest Ethiopia: A 14-year retrospective follow-up study	PLOS ONE			English	Article							PEDIATRIC ANTIRETROVIRAL THERAPY; OUTCOMES; ADHERENCE; PROGRAMS; CARE	Background Although antiretroviral therapy (ART) significantly improves the survival status and quality of life among human immunodeficiency virus (HIV)-infected children, loss to follow-up (LTFU) from HIV-care profoundly affecting the treatment outcomes of this vulnerable population. For better interventions, up-to-date information concerning LTFU among HIV-infected children on ART is vital. However, only a few studies have been conducted in Ethiopia to address this concern. Thus, this study aims to identify the predictors of LTFU among HIV-infected children receiving ART at Debre Markos Referral Hospital. Methods An institution-based retrospective follow-up study was done among 408 HIV-infected children receiving ART at Debre Markos Referral Hospital between 2005 and March 15, 2019. Data were abstracted from the medical records of HIV-infected children using a standardized data abstracted checklist. We used Epi-Data Version 3.1 for data entry and Stata Version 14 for statistical analysis. The Kaplan-Meier survival curve was used to estimate the survival time. A generalized log-rank test was used to compare the survival curves of different categorical variables. Finally, both bi-variable and multivariable Cox proportional hazard regression models were used to identify the predictors of LTFU. Results Of 408 HIV-infected children included in the final analysis, 70 (17.1%) children were LTFU at the end of the study. The overall incidence rate of LTFU among HIV-infected children was found to be 4.5 (95%CI: 3.5-5.7) per 100-child years of observation. HIV-infected children living in rural areas (AHR: 3.2, 95%CI: 2.0-5.3), having fair or poor ART drug adherence (AHR: 2.3, 95%CI: 1.4-3.7), children started ART through test and treat approach (AHR: 2.7, 95%CI: 1.4-5.5), and children started protease inhibiter (PI)-based ART regimens (AHR: 2.2, 95%CI: 1.1-4.4) were at higher risk of LTFU. Conclusion This study found that one in every six HIV-infected children lost form ART follow-up. HIV-infected children living in rural areas, having fair or poor ART drug adherence, started ART based on test and treat approach, and taking PI-based ART regimens were at higher risk of LTFU.	[Hibstie, Yitbarek Tenaw; Temesgen, Belisty; Melkamu, Mamaru Wubale] Debre Markos Referral Hosp, Debre Markos, Ethiopia; [Kibret, Getiye Dejenu; Talie, Asmare; Alebel, Animut] Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia; [Kibret, Getiye Dejenu; Alebel, Animut] Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Ultimo, NSW, Australia	University of Technology Sydney	Alebel, A (corresponding author), Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia.; Alebel, A (corresponding author), Univ Technol Sydney, Fac Hlth, Sch Publ Hlth, Ultimo, NSW, Australia.	animut.a23@gmail.com	Alebel, Animut/L-4278-2019; Kibret, Getiye Dejenu/ACX-4494-2022	Alebel, Animut/0000-0003-2822-2062; Kibret, Getiye Dejenu/0000-0002-1374-5744				[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2016, EV CHILD END AIDS 7; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Ardura-Garcia C, 2015, JAIDS-J ACQ IMM DEF, V70, pE160, DOI 10.1097/QAI.0000000000000772; Balde A, 2019, HIV MED, V20, P47, DOI 10.1111/hiv.12668; Braitstein P, 2011, JAIDS-J ACQ IMM DEF, V57, pE40, DOI 10.1097/QAI.0b013e3182167f0d; EMOH, 2017, NAT GUID COMPR HIV P; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365, DOI DOI 10.1016/J.JACR.2018.09.023; Federal HIV/AIDS Prevention and Control Office Federal Ministry of Health, 2007, GUID PAED HIV AIDS C; Fetzer BC, 2011, AIDS PATIENT CARE ST, V25, P611, DOI 10.1089/apc.2011.0083; Ford N, 2018, AIDS, V32, P17, DOI [10.1097/QAD.0000000000001671, 10.1097/qad.0000000000001671]; Hosmer DW, 2013, APPL LOGISTIC REGRES, V398; Leroy V, 2013, JAIDS-J ACQ IMM DEF, V62, P208, DOI 10.1097/QAI.0b013e31827b70bf; MCCORMICK, 2016, J ACQUIRED IMMUNE DE; McNairy ML, 2013, JAIDS-J ACQ IMM DEF, V62, pE70, DOI 10.1097/QAI.0b013e318278bcb0; Melaku Z, 2017, TROP MED INT HEALTH, V22, P474, DOI 10.1111/tmi.12834; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Mukherjee JS, 2016, CURR HIV-AIDS REP, V13, P359, DOI 10.1007/s11904-016-0335-7; Pandhi Deepika, 2014, Indian J Sex Transm Dis AIDS, V35, P1, DOI 10.4103/0253-7184.132399; President's Emergency Plan for AIDS Relief (PEPFAR), 2018, ETH COUNTR OP PLAN C; Sengayi M, 2013, GLOBAL HEALTH ACTION, V6, P169, DOI 10.3402/gha.v6i0.19248; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Susuman AS, 2017, J ASIAN AFR STUD, V52, P302, DOI 10.1177/0021909615570957; The Ethiopian Federal Ministry of Health, 2017, NAT COMPR HIV PREV C; The Ethiopian Public Health Institute, HIV RELATED ESTIMATE; Trabanco Jorge Alves, 2014, IOSR JORNAL ENG IOSR, V4, P9; Turck D, 2013, J PEDIATR GASTR NUTR, V57, P258, DOI 10.1097/MPG.0b013e318298003f; UNAIDS, GLOB HIV AIDS STAT 2; WHO, 2010, HIV PROGR; World Health Organization, 2017, END HIV AIDS 2030 FR; Zhao Y, 2013, CLIN INFECT DIS, V56, P735, DOI 10.1093/cid/cis941	34	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2020	15	9							e0239013	10.1371/journal.pone.0239013	http://dx.doi.org/10.1371/journal.pone.0239013			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NU1BO	32931502	Green Published, gold			2022-12-26	WOS:000573375500025
